pmid,year,mesh,meshTreeNumber
20045663,2010-01-04T00:00:00,Bayes Theorem,E05.318.740.600.200
20045663,2010-01-04T00:00:00,Bayes Theorem,N05.715.360.750.625.150
20045663,2010-01-04T00:00:00,Bayes Theorem,N06.850.520.830.600.200
20045663,2010-01-04T00:00:00,Case-Control Studies,E05.318.760.500.500
20045663,2010-01-04T00:00:00,Case-Control Studies,N05.715.360.775.175.200
20045663,2010-01-04T00:00:00,Case-Control Studies,N06.850.520.450.500.500
20045663,2010-01-04T00:00:00,Child,M01.060.406
20045663,2010-01-04T00:00:00,Developmental Disabilities,F03.550.362
20045663,2010-01-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20045663,2010-01-04T00:00:00,Mercury,D01.268.556.504
20045663,2010-01-04T00:00:00,Mercury,D01.268.956.437
20045663,2010-01-04T00:00:00,Mercury,D01.552.544.504
20045663,2010-01-04T00:00:00,Metals,D01.552
20045663,2010-01-04T00:00:00,Pregnancy,G08.686.785.760.769
20045663,2010-01-04T00:00:00,Prenatal Exposure Delayed Effects,C13.703.824.500
20059572,2010-01-04T00:00:00,AIDS-Related Opportunistic Infections,C01.539.597.050
20059572,2010-01-04T00:00:00,AIDS-Related Opportunistic Infections,C02.597.050
20059572,2010-01-04T00:00:00,AIDS-Related Opportunistic Infections,C02.782.815.616.400.100
20059572,2010-01-04T00:00:00,AIDS-Related Opportunistic Infections,C03.684.050
20059572,2010-01-04T00:00:00,AIDS-Related Opportunistic Infections,C20.673.480.100
20059572,2010-01-04T00:00:00,Adult,M01.060.116
20059572,2010-01-04T00:00:00,Aged,M01.060.116.100
20059572,2010-01-04T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
20059572,2010-01-04T00:00:00,Anti-Retroviral Agents,D27.505.954.122.388.077
20059572,2010-01-04T00:00:00,CD4 Lymphocyte Count,E01.450.375.107.595.500.150
20059572,2010-01-04T00:00:00,CD4 Lymphocyte Count,E05.200.500.195.107.595.500.150
20059572,2010-01-04T00:00:00,CD4 Lymphocyte Count,G04.170.107.595.500.150
20059572,2010-01-04T00:00:00,CD4 Lymphocyte Count,G09.188.105.595.500.150
20059572,2010-01-04T00:00:00,Carrier State,N06.850.160
20059572,2010-01-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20059572,2010-01-04T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.300.390.400.800.750.100.500
20059572,2010-01-04T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.510.100.750.750.100.500
20059572,2010-01-04T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.510.400.790.750.100.500
20059572,2010-01-04T00:00:00,Microbial Sensitivity Tests,E05.200.875.595
20059572,2010-01-04T00:00:00,Microbial Sensitivity Tests,E05.337.550.400
20059572,2010-01-04T00:00:00,Middle Aged,M01.060.116.630
20059572,2010-01-04T00:00:00,Outpatients,M01.643.630
20059572,2010-01-04T00:00:00,Young Adult,M01.060.116.815
21122784,2010-01-04T00:00:00,Child,M01.060.406
21122784,2010-01-04T00:00:00,"Child Development Disorders, Pervasive",F03.550.325
21122784,2010-01-04T00:00:00,Cognition,F02.463.188
21122784,2010-01-04T00:00:00,Developmental Disabilities,F03.550.362
21122784,2010-01-04T00:00:00,Hispanic Americans,M01.686.754.441
21122784,2010-01-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21122784,2010-01-04T00:00:00,Intelligence Tests,F04.711.141.493
21122784,2010-01-04T00:00:00,Mass Screening,E01.370.500
21122784,2010-01-04T00:00:00,Mass Screening,E05.318.308.250.580
21122784,2010-01-04T00:00:00,Mass Screening,N02.421.143.827.233.443
21122784,2010-01-04T00:00:00,Mass Screening,N02.421.726.233.443
21122784,2010-01-04T00:00:00,Mass Screening,N05.715.360.300.375.500
21122784,2010-01-04T00:00:00,Mass Screening,N06.850.520.308.250.580
21122784,2010-01-04T00:00:00,Mass Screening,N06.850.780.500
21122784,2010-01-04T00:00:00,Population Surveillance,E05.318.308.250.700
21122784,2010-01-04T00:00:00,Population Surveillance,N05.715.360.300.375.625
21122784,2010-01-04T00:00:00,Population Surveillance,N06.850.520.308.250.700
21122784,2010-01-04T00:00:00,Population Surveillance,N06.850.780.675
21122784,2010-01-04T00:00:00,Psychometrics,F04.711.780
21122784,2010-01-04T00:00:00,United States,Z01.107.567.875
20052414,2010-01-05T00:00:00,Exosomes,A11.284.430.214.190.875.190.880.495
20052414,2010-01-05T00:00:00,Gene Expression Profiling,E05.393.332
20052414,2010-01-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20052414,2010-01-05T00:00:00,Nanostructures,J01.637.512
20052414,2010-01-05T00:00:00,Saliva,A12.200.666
20052466,2010-01-06T00:00:00,CD4-Positive T-Lymphocytes,A11.118.637.555.567.569.200
20052466,2010-01-06T00:00:00,CD4-Positive T-Lymphocytes,A15.145.229.637.555.567.569.200
20052466,2010-01-06T00:00:00,CD4-Positive T-Lymphocytes,A15.382.490.555.567.569.200
20052466,2010-01-06T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
20052466,2010-01-06T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
20052466,2010-01-06T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
20052466,2010-01-06T00:00:00,Cancer Vaccines,D20.215.894.200
20052466,2010-01-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20052466,2010-01-06T00:00:00,"Immunotherapy, Adoptive",E02.095.465.425.400.330.050.400
20052466,2010-01-06T00:00:00,"Immunotherapy, Adoptive",E05.478.550.520.050.400
20052466,2010-01-06T00:00:00,Melanoma,C04.557.465.625.650.510
20052466,2010-01-06T00:00:00,Melanoma,C04.557.580.625.650.510
20052466,2010-01-06T00:00:00,Melanoma,C04.557.665.510
20052466,2010-01-06T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
20052466,2010-01-06T00:00:00,"Transduction, Genetic",E05.393.350.800
20052466,2010-01-06T00:00:00,"Transduction, Genetic",G05.355.760.850
20053788,2010-01-06T00:00:00,Adult,M01.060.116
20053788,2010-01-06T00:00:00,"Behavior, Addictive",F01.145.527.100.120
20053788,2010-01-06T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
20053788,2010-01-06T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
20053788,2010-01-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20053788,2010-01-06T00:00:00,Middle Aged,M01.060.116.630
20053788,2010-01-06T00:00:00,Nicotine,D03.132.760.570
20053788,2010-01-06T00:00:00,Nicotine,D03.383.725.518
20053788,2010-01-06T00:00:00,Pilot Projects,E05.318.760.750
20053788,2010-01-06T00:00:00,Pilot Projects,E05.337.737
20053788,2010-01-06T00:00:00,Pilot Projects,N05.715.360.775.625
20053788,2010-01-06T00:00:00,Pilot Projects,N06.850.520.450.720
20053788,2010-01-06T00:00:00,Self Efficacy,F01.752.747.792.700
20053788,2010-01-06T00:00:00,Smoking,F01.145.466.753
20053788,2010-01-06T00:00:00,Smoking Cessation,F01.145.940.700
20053788,2010-01-06T00:00:00,Substance Withdrawal Syndrome,C21.739.835
20053788,2010-01-06T00:00:00,Substance Withdrawal Syndrome,F03.900.825
20053788,2010-01-06T00:00:00,Tobacco Use Disorder,C21.739.912
20053788,2010-01-06T00:00:00,Tobacco Use Disorder,F03.900.912
20053811,2010-01-06T00:00:00,Adult,M01.060.116
20053811,2010-01-06T00:00:00,Aged,M01.060.116.100
20053811,2010-01-06T00:00:00,Contrast Media,D27.720.259
20053811,2010-01-06T00:00:00,Gadolinium DTPA,D01.632.400
20053811,2010-01-06T00:00:00,Gadolinium DTPA,D02.092.782.590.401
20053811,2010-01-06T00:00:00,Gadolinium DTPA,D02.241.081.038.694.400
20053811,2010-01-06T00:00:00,Gadolinium DTPA,D02.691.400
20053811,2010-01-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20053811,2010-01-06T00:00:00,Magnetic Resonance Angiography,E01.370.350.500.500
20053811,2010-01-06T00:00:00,Magnetic Resonance Angiography,E01.370.350.825.500.500
20053811,2010-01-06T00:00:00,Magnetic Resonance Angiography,E01.370.370.050.500
20053811,2010-01-06T00:00:00,Middle Aged,M01.060.116.630
20053811,2010-01-06T00:00:00,Organometallic Compounds,D01.632
20053811,2010-01-06T00:00:00,Organometallic Compounds,D02.691
20053811,2010-01-06T00:00:00,Spinal Cord,A08.186.854
20053811,2010-01-06T00:00:00,Young Adult,M01.060.116.815
20059662,2010-01-06T00:00:00,Adult,M01.060.116
20059662,2010-01-06T00:00:00,Aged,M01.060.116.100
20059662,2010-01-06T00:00:00,Combined Modality Therapy,E02.186
20059662,2010-01-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20059662,2010-01-06T00:00:00,Middle Aged,M01.060.116.630
20059662,2010-01-06T00:00:00,Postoperative Complications,C23.550.767
20059662,2010-01-06T00:00:00,Prostatectomy,E04.950.774.860.625
20059662,2010-01-06T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
20059662,2010-01-06T00:00:00,Prostatic Neoplasms,C12.294.260.750
20059662,2010-01-06T00:00:00,Prostatic Neoplasms,C12.294.565.625
20059662,2010-01-06T00:00:00,Prostatic Neoplasms,C12.758.409.750
20206891,2010-01-06T00:00:00,Adolescent,M01.060.057
20206891,2010-01-06T00:00:00,Adult,M01.060.116
20206891,2010-01-06T00:00:00,Aged,M01.060.116.100
20206891,2010-01-06T00:00:00,Heart Failure,C14.280.434
20206891,2010-01-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20206891,2010-01-06T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
20206891,2010-01-06T00:00:00,Middle Aged,M01.060.116.630
20206891,2010-01-06T00:00:00,Probability,E05.318.740.600
20206891,2010-01-06T00:00:00,Probability,G17.680
20206891,2010-01-06T00:00:00,Probability,N05.715.360.750.625
20206891,2010-01-06T00:00:00,Probability,N06.850.520.830.600
20206891,2010-01-06T00:00:00,Risk Assessment,E05.318.740.600.800.715
20206891,2010-01-06T00:00:00,Risk Assessment,N04.452.871.715
20206891,2010-01-06T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20206891,2010-01-06T00:00:00,Risk Assessment,N06.850.505.715
20206891,2010-01-06T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20206891,2010-01-06T00:00:00,Treatment Outcome,E01.789.800
20206891,2010-01-06T00:00:00,Treatment Outcome,N04.761.559.590.800
20206891,2010-01-06T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20206891,2010-01-06T00:00:00,Young Adult,M01.060.116.815
20054577,2010-01-07T00:00:00,Animals,B01.050
20054577,2010-01-07T00:00:00,"Disease Models, Animal",C22.232
20054577,2010-01-07T00:00:00,"Disease Models, Animal",E05.598.500
20054577,2010-01-07T00:00:00,"Disease Models, Animal",E05.599.395.080
20054577,2010-01-07T00:00:00,Stomach Neoplasms,C04.588.274.476.767
20054577,2010-01-07T00:00:00,Stomach Neoplasms,C06.301.371.767
20054577,2010-01-07T00:00:00,Stomach Neoplasms,C06.405.249.767
20054577,2010-01-07T00:00:00,Stomach Neoplasms,C06.405.748.789
20054577,2010-01-07T00:00:00,Suture Techniques,E04.901
20054577,2010-01-07T00:00:00,Swine,B01.050.150.900.649.077.880
20056928,2010-01-07T00:00:00,Caregivers,M01.085
20056928,2010-01-07T00:00:00,Caregivers,M01.526.485.200
20056928,2010-01-07T00:00:00,Caregivers,N02.360.200
20056928,2010-01-07T00:00:00,Computer Graphics,L01.224.108
20056928,2010-01-07T00:00:00,Computer Graphics,L01.296.110
20056928,2010-01-07T00:00:00,"Data Interpretation, Statistical",E05.245.380
20056928,2010-01-07T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
20056928,2010-01-07T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
20056928,2010-01-07T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
20056928,2010-01-07T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
20056928,2010-01-07T00:00:00,Decision Support Techniques,E05.245
20056928,2010-01-07T00:00:00,Decision Support Techniques,L01.700.508.190
20056928,2010-01-07T00:00:00,"Education, Medical, Continuing",I02.358.212.350
20056928,2010-01-07T00:00:00,"Education, Medical, Continuing",I02.358.399.250
20056928,2010-01-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20056928,2010-01-07T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
20056928,2010-01-07T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
20056928,2010-01-07T00:00:00,Patient Education as Topic,I02.233.332.500
20056928,2010-01-07T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
20056928,2010-01-07T00:00:00,Patient Education as Topic,N02.421.726.407.680
20056928,2010-01-07T00:00:00,Risk Assessment,E05.318.740.600.800.715
20056928,2010-01-07T00:00:00,Risk Assessment,N04.452.871.715
20056928,2010-01-07T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20056928,2010-01-07T00:00:00,Risk Assessment,N06.850.505.715
20056928,2010-01-07T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20056928,2010-01-07T00:00:00,Stroke,C10.228.140.300.775
20056928,2010-01-07T00:00:00,Stroke,C14.907.253.855
20056928,2010-01-07T00:00:00,Thrombolytic Therapy,E02.319.913
20056957,2010-01-07T00:00:00,Adult,M01.060.116
20056957,2010-01-07T00:00:00,Combined Modality Therapy,E02.186
20056957,2010-01-07T00:00:00,Directive Counseling,F02.784.176.279
20056957,2010-01-07T00:00:00,Directive Counseling,F04.408.413.349
20056957,2010-01-07T00:00:00,Directive Counseling,N02.421.461.363.349
20056957,2010-01-07T00:00:00,Health Education,I02.233.332
20056957,2010-01-07T00:00:00,Health Education,N02.421.143.827.407
20056957,2010-01-07T00:00:00,Health Education,N02.421.726.407
20056957,2010-01-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20056957,2010-01-07T00:00:00,Medication Adherence,F01.145.488.500.500
20056957,2010-01-07T00:00:00,Medication Adherence,N05.300.150.600.600.500
20056957,2010-01-07T00:00:00,Middle Aged,M01.060.116.630
20056957,2010-01-07T00:00:00,Patient Education as Topic,I02.233.332.500
20056957,2010-01-07T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
20056957,2010-01-07T00:00:00,Patient Education as Topic,N02.421.726.407.680
20056957,2010-01-07T00:00:00,Program Evaluation,E05.337.820
20056957,2010-01-07T00:00:00,Program Evaluation,N04.761.685
20056957,2010-01-07T00:00:00,Program Evaluation,N05.715.360.650
20056957,2010-01-07T00:00:00,Smoking,F01.145.466.753
20056957,2010-01-07T00:00:00,Smoking Cessation,F01.145.940.700
20056957,2010-01-07T00:00:00,Treatment Outcome,E01.789.800
20056957,2010-01-07T00:00:00,Treatment Outcome,N04.761.559.590.800
20056957,2010-01-07T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20056957,2010-01-07T00:00:00,United States,Z01.107.567.875
20056958,2010-01-07T00:00:00,Aged,M01.060.116.100
20056958,2010-01-07T00:00:00,Aortic Diseases,C14.907.109
20056958,2010-01-07T00:00:00,Aortic Valve Stenosis,C14.280.484.150
20056958,2010-01-07T00:00:00,Aortic Valve Stenosis,C14.280.955.249
20056958,2010-01-07T00:00:00,Bioprosthesis,E07.695.100
20056958,2010-01-07T00:00:00,Blood Vessel Prosthesis,E07.695.110
20056958,2010-01-07T00:00:00,Blood Vessel Prosthesis Implantation,E04.100.814.200
20056958,2010-01-07T00:00:00,Blood Vessel Prosthesis Implantation,E04.650.200
20056958,2010-01-07T00:00:00,Calcinosis,C18.452.174.130
20056958,2010-01-07T00:00:00,"Echocardiography, Transesophageal",E01.370.350.850.220.235
20056958,2010-01-07T00:00:00,"Echocardiography, Transesophageal",E01.370.370.380.220.235
20056958,2010-01-07T00:00:00,Heart Valve Prosthesis,E07.695.310
20056958,2010-01-07T00:00:00,Heart Valve Prosthesis Implantation,E04.100.376.485
20056958,2010-01-07T00:00:00,Heart Valve Prosthesis Implantation,E04.650.410
20056958,2010-01-07T00:00:00,Heart Valve Prosthesis Implantation,E04.928.220.410
20056958,2010-01-07T00:00:00,Heart Ventricles,A07.541.560
20056958,2010-01-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20056958,2010-01-07T00:00:00,Prosthesis Design,E05.320.550
20056958,2010-01-07T00:00:00,Prosthesis Design,E07.695.680
20056958,2010-01-07T00:00:00,Treatment Outcome,E01.789.800
20056958,2010-01-07T00:00:00,Treatment Outcome,N04.761.559.590.800
20056958,2010-01-07T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20056958,2010-01-07T00:00:00,"Ultrasonography, Interventional",E01.370.350.850.855
20139699,2010-01-07T00:00:00,"Adaptor Proteins, Signal Transducing",D12.644.360.024
20139699,2010-01-07T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.157.057
20139699,2010-01-07T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.476.024
20139699,2010-01-07T00:00:00,Animals,B01.050
20139699,2010-01-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20139699,2010-01-07T00:00:00,Lung,A04.411
20139699,2010-01-07T00:00:00,Lung Neoplasms,C04.588.894.797.520
20139699,2010-01-07T00:00:00,Lung Neoplasms,C08.381.540
20139699,2010-01-07T00:00:00,Lung Neoplasms,C08.785.520
20139699,2010-01-07T00:00:00,Signal Transduction,G02.111.087.800
20139699,2010-01-07T00:00:00,Signal Transduction,G02.149.115.800
20139699,2010-01-07T00:00:00,Signal Transduction,G04.299.880
20061412,2010-01-08T00:00:00,Aged,M01.060.116.100
20061412,2010-01-08T00:00:00,Bone Resorption,C05.116.264
20061412,2010-01-08T00:00:00,Bone Resorption,G11.427.590.195.150
20061412,2010-01-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20061412,2010-01-08T00:00:00,Hypercalcemia,C18.452.174.451
20061412,2010-01-08T00:00:00,Hypercalcemia,C18.452.950.340
20061412,2010-01-08T00:00:00,Middle Aged,M01.060.116.630
20061412,2010-01-08T00:00:00,Osteogenesis,G07.700.320.500.325.377.625.100.729
20061412,2010-01-08T00:00:00,Osteogenesis,G11.427.590.560.100.729
20062810,2010-01-08T00:00:00,Action Potentials,G04.580.100
20062810,2010-01-08T00:00:00,Action Potentials,G07.265.750.100
20062810,2010-01-08T00:00:00,Action Potentials,G11.561.570.100
20062810,2010-01-08T00:00:00,Animals,B01.050
20062810,2010-01-08T00:00:00,Hippocampus,A08.186.211.464.405
20062810,2010-01-08T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
20062810,2010-01-08T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20062810,2010-01-08T00:00:00,Synapses,A08.850
20062810,2010-01-08T00:00:00,Synapses,A11.284.149.165.420.780
20005327,2010-01-11T00:00:00,Avidin,D12.776.034.614.300
20005327,2010-01-11T00:00:00,Avidin,D12.776.256.317.663.300
20005327,2010-01-11T00:00:00,Avidin,D12.776.290.663.100
20005327,2010-01-11T00:00:00,Avidin,D12.776.395.175
20005327,2010-01-11T00:00:00,Biosensing Techniques,E05.601.123
20005327,2010-01-11T00:00:00,Carbon,D01.268.150
20005327,2010-01-11T00:00:00,Electrodes,E07.305.250
20064838,2010-01-11T00:00:00,Health Education,I02.233.332
20064838,2010-01-11T00:00:00,Health Education,N02.421.143.827.407
20064838,2010-01-11T00:00:00,Health Education,N02.421.726.407
20064838,2010-01-11T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
20064838,2010-01-11T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
20064838,2010-01-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20064838,2010-01-11T00:00:00,Nicotine,D03.132.760.570
20064838,2010-01-11T00:00:00,Nicotine,D03.383.725.518
20064838,2010-01-11T00:00:00,Smoking,F01.145.466.753
20064838,2010-01-11T00:00:00,Smoking Cessation,F01.145.940.700
20064953,2010-01-11T00:00:00,Adult,M01.060.116
20064953,2010-01-11T00:00:00,Aged,M01.060.116.100
20064953,2010-01-11T00:00:00,Benzazepines,D03.438.079
20064953,2010-01-11T00:00:00,Blood Urea Nitrogen,E01.370.390.400.100
20064953,2010-01-11T00:00:00,Blood Urea Nitrogen,E01.450.150.100.115
20064953,2010-01-11T00:00:00,Hospitalization,E02.760.400
20064953,2010-01-11T00:00:00,Hospitalization,N02.421.585.400
20064953,2010-01-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20064953,2010-01-11T00:00:00,Hyponatremia,C18.452.950.620
20064953,2010-01-11T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
20064953,2010-01-11T00:00:00,Middle Aged,M01.060.116.630
20064953,2010-01-11T00:00:00,"Receptors, Vasopressin",D12.776.543.750.100.910
20064953,2010-01-11T00:00:00,"Receptors, Vasopressin",D12.776.543.750.720.600.925
20064953,2010-01-11T00:00:00,"Receptors, Vasopressin",D12.776.543.750.750.555.925
20064953,2010-01-11T00:00:00,"Receptors, Vasopressin",D12.776.543.750.750.660.900
20064953,2010-01-11T00:00:00,Sodium,D01.268.549.750
20064953,2010-01-11T00:00:00,Sodium,D01.552.528.850
20065032,2010-01-11T00:00:00,"Adaptor Proteins, Signal Transducing",D12.644.360.024
20065032,2010-01-11T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.157.057
20065032,2010-01-11T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.476.024
20065032,2010-01-11T00:00:00,Amino Acids,D12.125
20065032,2010-01-11T00:00:00,Animals,B01.050
20065032,2010-01-11T00:00:00,Carrier Proteins,D12.776.157
20065032,2010-01-11T00:00:00,Cell Line,A11.251.210
20065032,2010-01-11T00:00:00,Cytoplasmic Structures,A11.284.430.214.190
20065032,2010-01-11T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D08.811.277.040.330.300.200.100.200
20065032,2010-01-11T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.644.360.375.100.200
20065032,2010-01-11T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.157.325.332.100.200
20065032,2010-01-11T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.476.375.100.200
20065032,2010-01-11T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.543.325.100.200
20065032,2010-01-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20065032,2010-01-11T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
20065032,2010-01-11T00:00:00,Protein Transport,G03.495.166.700
20065032,2010-01-11T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20065203,2010-01-11T00:00:00,Decision Making,F02.463.785.373
20065203,2010-01-11T00:00:00,Dementia,C10.228.140.380
20065203,2010-01-11T00:00:00,Dementia,F03.087.400
20065203,2010-01-11T00:00:00,Enteral Nutrition,E02.421.360
20065203,2010-01-11T00:00:00,Enteral Nutrition,E02.642.500.360
20065203,2010-01-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20065203,2010-01-11T00:00:00,Interviews as Topic,E05.318.308.420
20065203,2010-01-11T00:00:00,Interviews as Topic,L01.280.520
20065203,2010-01-11T00:00:00,Interviews as Topic,N05.715.360.300.400
20065203,2010-01-11T00:00:00,Interviews as Topic,N06.850.520.308.420
20065203,2010-01-11T00:00:00,Nursing Homes,N02.278.825.610
20065203,2010-01-11T00:00:00,Observation,E05.581.249
20065203,2010-01-11T00:00:00,South Carolina,Z01.107.567.875.075.662
20065203,2010-01-11T00:00:00,South Carolina,Z01.107.567.875.750.700
20047247,2010-01-12T00:00:00,Aged,M01.060.116.100
20047247,2010-01-12T00:00:00,Drug Interactions,G07.690.812.240
20047247,2010-01-12T00:00:00,Drug Interactions,G07.700.680.240
20047247,2010-01-12T00:00:00,Drug Monitoring,E01.370.520.200
20047247,2010-01-12T00:00:00,Geriatric Assessment,E05.318.308.225
20047247,2010-01-12T00:00:00,Geriatric Assessment,I01.240.425.350
20047247,2010-01-12T00:00:00,Geriatric Assessment,L01.280.360
20047247,2010-01-12T00:00:00,Geriatric Assessment,N01.224.425.350
20047247,2010-01-12T00:00:00,Geriatric Assessment,N05.715.360.300.360
20047247,2010-01-12T00:00:00,Geriatric Assessment,N06.850.505.400.425.350
20047247,2010-01-12T00:00:00,Geriatric Assessment,N06.850.520.308.225
20047247,2010-01-12T00:00:00,Geriatric Nursing,H02.478.676.236
20047247,2010-01-12T00:00:00,Geriatric Nursing,N02.421.533.245
20047247,2010-01-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20047247,2010-01-12T00:00:00,Nursing Assessment,N04.590.233.508.480
20047247,2010-01-12T00:00:00,Patient Selection,E05.581.500.653
20047247,2010-01-12T00:00:00,Patient Selection,N04.590.731
20047247,2010-01-12T00:00:00,Polypharmacy,E02.319.698
20047247,2010-01-12T00:00:00,Risk Assessment,E05.318.740.600.800.715
20047247,2010-01-12T00:00:00,Risk Assessment,N04.452.871.715
20047247,2010-01-12T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20047247,2010-01-12T00:00:00,Risk Assessment,N06.850.505.715
20047247,2010-01-12T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20066500,2010-01-12T00:00:00,Deglutition,G10.261.326.215
20066500,2010-01-12T00:00:00,Esophagus,A03.556.875.500
20066500,2010-01-12T00:00:00,Gastroplasty,E02.065.062.750
20066500,2010-01-12T00:00:00,Gastroplasty,E04.062.750
20066500,2010-01-12T00:00:00,Gastroplasty,E04.210.485
20066500,2010-01-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20066500,2010-01-12T00:00:00,Laparoscopy,E01.370.388.250.520
20066500,2010-01-12T00:00:00,Laparoscopy,E04.800.250.520
20066500,2010-01-12T00:00:00,Manometry,E05.559
20066500,2010-01-12T00:00:00,Middle Aged,M01.060.116.630
20066500,2010-01-12T00:00:00,Muscle Contraction,G11.427.590.540
20066500,2010-01-12T00:00:00,"Obesity, Morbid",C18.654.726.500.700
20066500,2010-01-12T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
20066500,2010-01-12T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
20066500,2010-01-12T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
20068046,2010-01-12T00:00:00,Alkaline Ceramidase,D08.811.277.087.250.300
20068046,2010-01-12T00:00:00,Apoptosis,G04.299.139.160
20068046,2010-01-12T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
20068046,2010-01-12T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
20068046,2010-01-12T00:00:00,Cell Division,G04.299.134.220
20068046,2010-01-12T00:00:00,Cell Division,G04.299.233.750.500
20068046,2010-01-12T00:00:00,Cell Division,G05.355.105
20068046,2010-01-12T00:00:00,Cell Division,G07.700.320.249.410.750.500
20068046,2010-01-12T00:00:00,Ceramides,D02.065.313
20068046,2010-01-12T00:00:00,Ceramides,D09.400.410.420.525.200
20068046,2010-01-12T00:00:00,Ceramides,D10.390.470.675.200
20068046,2010-01-12T00:00:00,Ceramides,D10.570.877.360.612.200
20068046,2010-01-12T00:00:00,Cyclin-Dependent Kinase Inhibitor p21,D12.644.360.225.500
20068046,2010-01-12T00:00:00,Cyclin-Dependent Kinase Inhibitor p21,D12.776.167.187.500
20068046,2010-01-12T00:00:00,Cyclin-Dependent Kinase Inhibitor p21,D12.776.476.225.500
20068046,2010-01-12T00:00:00,Cyclin-Dependent Kinase Inhibitor p21,D12.776.624.776.355.500
20068046,2010-01-12T00:00:00,Down-Regulation,G02.111.087.225
20068046,2010-01-12T00:00:00,Down-Regulation,G02.149.115.225
20068046,2010-01-12T00:00:00,Down-Regulation,G05.355.315.200
20068046,2010-01-12T00:00:00,Down-Regulation,G07.690.812.230
20068046,2010-01-12T00:00:00,Down-Regulation,G07.700.680.230
20068046,2010-01-12T00:00:00,Endothelial Cells,A11.436.275
20068046,2010-01-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20068046,2010-01-12T00:00:00,Keratinocytes,A11.436.397
20068046,2010-01-12T00:00:00,"Muscle, Smooth, Vascular",A02.633.570.491
20068046,2010-01-12T00:00:00,"Muscle, Smooth, Vascular",A07.231.491
20068046,2010-01-12T00:00:00,"Muscle, Smooth, Vascular",A10.690.467.491
20068046,2010-01-12T00:00:00,"RNA, Messenger",D13.444.735.544
20068046,2010-01-12T00:00:00,Skin Neoplasms,C04.588.805
20068046,2010-01-12T00:00:00,Skin Neoplasms,C17.800.882
20068046,2010-01-12T00:00:00,Umbilical Veins,A07.231.908.670.874
20068046,2010-01-12T00:00:00,Umbilical Veins,A16.378.693.807
20068067,2010-01-12T00:00:00,Animals,B01.050
20068067,2010-01-12T00:00:00,CHO Cells,A11.251.210.200
20068067,2010-01-12T00:00:00,CHO Cells,A11.436.155
20068067,2010-01-12T00:00:00,Cricetinae,B01.050.150.900.649.865.635.150
20068067,2010-01-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20068067,2010-01-12T00:00:00,Lipid Metabolism,G03.495.520
20068067,2010-01-12T00:00:00,Protein Biosynthesis,G02.111.087.675.871
20068067,2010-01-12T00:00:00,Protein Biosynthesis,G02.149.115.675.871
20068067,2010-01-12T00:00:00,Protein Biosynthesis,G03.495.770.871
20068067,2010-01-12T00:00:00,Protein Biosynthesis,G05.355.310.670
20068067,2010-01-12T00:00:00,Protein Stability,G02.111.700
20068067,2010-01-12T00:00:00,Ubiquitin-Protein Ligases,D08.811.464.938.750
20068115,2010-01-12T00:00:00,Adult,M01.060.116
20068115,2010-01-12T00:00:00,Alcoholic Intoxication,C21.739.100.175
20068115,2010-01-12T00:00:00,Alcoholic Intoxication,F03.900.100.300
20068115,2010-01-12T00:00:00,Crime Victims,M01.135
20068115,2010-01-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20068115,2010-01-12T00:00:00,Interpersonal Relations,F01.829.401
20068115,2010-01-12T00:00:00,Questionnaires,E05.318.308.750
20068115,2010-01-12T00:00:00,Questionnaires,L01.280.800
20068115,2010-01-12T00:00:00,Questionnaires,N05.715.360.300.695
20068115,2010-01-12T00:00:00,Questionnaires,N06.850.520.308.750
20068115,2010-01-12T00:00:00,Rape,I01.198.240.748.640
20068115,2010-01-12T00:00:00,Risk Factors,E05.318.740.600.800.725
20068115,2010-01-12T00:00:00,Risk Factors,N05.715.350.200.700
20068115,2010-01-12T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20068115,2010-01-12T00:00:00,Risk Factors,N06.850.490.625.750
20068115,2010-01-12T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20068115,2010-01-12T00:00:00,Risk-Taking,F01.145.722
20068115,2010-01-12T00:00:00,Students,I02.233.748
20068115,2010-01-12T00:00:00,Students,I02.851
20068115,2010-01-12T00:00:00,Students,M01.848
20068115,2010-01-12T00:00:00,United States,Z01.107.567.875
20068115,2010-01-12T00:00:00,Young Adult,M01.060.116.815
20069625,2010-01-12T00:00:00,Biostatistics,E05.318.740.237
20069625,2010-01-12T00:00:00,Case-Control Studies,E05.318.760.500.500
20069625,2010-01-12T00:00:00,Case-Control Studies,N05.715.360.775.175.200
20069625,2010-01-12T00:00:00,Case-Control Studies,N06.850.520.450.500.500
20069625,2010-01-12T00:00:00,Computer Simulation,L01.224.160
20069625,2010-01-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20069625,2010-01-12T00:00:00,Interleukin-6,D12.644.276.374.465.506
20069625,2010-01-12T00:00:00,Interleukin-6,D12.776.467.374.465.506
20069625,2010-01-12T00:00:00,Interleukin-6,D23.529.374.465.506
20069625,2010-01-12T00:00:00,Multiple Myeloma,C04.557.595.500
20069625,2010-01-12T00:00:00,Multiple Myeloma,C14.907.454.460
20069625,2010-01-12T00:00:00,Multiple Myeloma,C15.378.147.780.650
20069625,2010-01-12T00:00:00,Multiple Myeloma,C15.378.463.835.460
20069625,2010-01-12T00:00:00,Multiple Myeloma,C20.683.515.845
20069625,2010-01-12T00:00:00,Multiple Myeloma,C20.683.780.650
20069625,2010-01-12T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
20070976,2010-01-12T00:00:00,Adolescent,M01.060.057
20070976,2010-01-12T00:00:00,African Americans,M01.686.508.100.100
20070976,2010-01-12T00:00:00,African Americans,M01.686.754.100
20070976,2010-01-12T00:00:00,Body Weight,C23.888.144
20070976,2010-01-12T00:00:00,Body Weight,E01.370.600.115.100.160.120
20070976,2010-01-12T00:00:00,Body Weight,E05.041.124.160.750
20070976,2010-01-12T00:00:00,Body Weight,G07.100.100.160.120
20070976,2010-01-12T00:00:00,Body Weight,G07.700.320.249.314.120
20070976,2010-01-12T00:00:00,DNA,D13.444.308
20070976,2010-01-12T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
20070976,2010-01-12T00:00:00,Genetic Predisposition to Disease,G05.380.355
20070976,2010-01-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20070976,2010-01-12T00:00:00,Incidence,E05.318.308.985.525.375
20070976,2010-01-12T00:00:00,Incidence,L01.280.975.525.375
20070976,2010-01-12T00:00:00,Incidence,N01.224.935.597.500
20070976,2010-01-12T00:00:00,Incidence,N06.850.505.400.975.525.375
20070976,2010-01-12T00:00:00,Incidence,N06.850.520.308.985.525.375
20070976,2010-01-12T00:00:00,Obesity,C18.654.726.500
20070976,2010-01-12T00:00:00,Obesity,C23.888.144.699.500
20070976,2010-01-12T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
20070976,2010-01-12T00:00:00,Obesity,G07.100.100.160.120.699.500
20070976,2010-01-12T00:00:00,Polymerase Chain Reaction,E05.393.620.500
20070976,2010-01-12T00:00:00,"Polymorphism, Genetic",G05.365.795
20070976,2010-01-12T00:00:00,Sex Factors,N05.715.350.675
20070976,2010-01-12T00:00:00,Sex Factors,N06.850.490.875
20070976,2010-01-12T00:00:00,United States,Z01.107.567.875
20074790,2010-01-12T00:00:00,"Antiretroviral Therapy, Highly Active",E02.319.310.075
20074790,2010-01-12T00:00:00,HIV Infections,C02.782.815.616.400
20074790,2010-01-12T00:00:00,HIV Infections,C02.800.801.400
20074790,2010-01-12T00:00:00,HIV Infections,C20.673.480
20074790,2010-01-12T00:00:00,HIV Protease Inhibitors,D27.505.519.389.745.420
20074790,2010-01-12T00:00:00,HIV Protease Inhibitors,D27.505.954.122.388.077.088.420
20074790,2010-01-12T00:00:00,HIV-1,B04.820.650.589.650.350.400
20074790,2010-01-12T00:00:00,HIV-1,B04.909.777.731.589.650.350.400
20074790,2010-01-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20074790,2010-01-12T00:00:00,Treatment Outcome,E01.789.800
20074790,2010-01-12T00:00:00,Treatment Outcome,N04.761.559.590.800
20074790,2010-01-12T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20056238,2010-01-13T00:00:00,"Child, Preschool",M01.060.406.448
20056238,2010-01-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20056238,2010-01-13T00:00:00,Immunization,E02.095.465.425.400
20056238,2010-01-13T00:00:00,Immunization,E05.478.550
20056238,2010-01-13T00:00:00,Immunization,N02.421.726.758.310
20056238,2010-01-13T00:00:00,Immunization,N06.850.780.200.425
20056238,2010-01-13T00:00:00,Immunization,N06.850.780.680.310
20056238,2010-01-13T00:00:00,Immunization Programs,N02.421.143.827.608
20056238,2010-01-13T00:00:00,Immunization Programs,N02.421.726.608
20056238,2010-01-13T00:00:00,Infant,M01.060.703
20056238,2010-01-13T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
20056238,2010-01-13T00:00:00,Practice Guidelines as Topic,N05.700.350.650
20056238,2010-01-13T00:00:00,United States,Z01.107.567.875
20069435,2010-01-13T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
20069435,2010-01-13T00:00:00,Bacteremia,C01.252.100
20069435,2010-01-13T00:00:00,Bacteremia,C01.539.757.100
20069435,2010-01-13T00:00:00,Bacteremia,C23.550.470.790.500.100
20069435,2010-01-13T00:00:00,Case-Control Studies,E05.318.760.500.500
20069435,2010-01-13T00:00:00,Case-Control Studies,N05.715.360.775.175.200
20069435,2010-01-13T00:00:00,Case-Control Studies,N06.850.520.450.500.500
20069435,2010-01-13T00:00:00,Fever,C23.888.119.344
20069435,2010-01-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20069435,2010-01-13T00:00:00,Incidence,E05.318.308.985.525.375
20069435,2010-01-13T00:00:00,Incidence,L01.280.975.525.375
20069435,2010-01-13T00:00:00,Incidence,N01.224.935.597.500
20069435,2010-01-13T00:00:00,Incidence,N06.850.505.400.975.525.375
20069435,2010-01-13T00:00:00,Incidence,N06.850.520.308.985.525.375
20069435,2010-01-13T00:00:00,Middle Aged,M01.060.116.630
20069435,2010-01-13T00:00:00,Vancomycin,D09.400.420.925
20069435,2010-01-13T00:00:00,Vancomycin,D12.644.233.925
20071122,2010-01-13T00:00:00,Algorithms,G17.035
20071122,2010-01-13T00:00:00,Algorithms,L01.224.050
20071122,2010-01-13T00:00:00,"Carcinoma, Hepatocellular",C04.557.470.200.025.255
20071122,2010-01-13T00:00:00,"Carcinoma, Hepatocellular",C04.588.274.623.160
20071122,2010-01-13T00:00:00,"Carcinoma, Hepatocellular",C06.301.623.160
20071122,2010-01-13T00:00:00,"Carcinoma, Hepatocellular",C06.552.697.160
20071122,2010-01-13T00:00:00,Contrast Media,D27.720.259
20071122,2010-01-13T00:00:00,Gadolinium DTPA,D01.632.400
20071122,2010-01-13T00:00:00,Gadolinium DTPA,D02.092.782.590.401
20071122,2010-01-13T00:00:00,Gadolinium DTPA,D02.241.081.038.694.400
20071122,2010-01-13T00:00:00,Gadolinium DTPA,D02.691.400
20071122,2010-01-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20071122,2010-01-13T00:00:00,Image Enhancement,E01.370.350.600.350
20071122,2010-01-13T00:00:00,Image Enhancement,L01.224.308.380
20071122,2010-01-13T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
20071122,2010-01-13T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
20071122,2010-01-13T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
20071122,2010-01-13T00:00:00,Liver Neoplasms,C04.588.274.623
20071122,2010-01-13T00:00:00,Liver Neoplasms,C06.301.623
20071122,2010-01-13T00:00:00,Liver Neoplasms,C06.552.697
20071122,2010-01-13T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20071122,2010-01-13T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20071122,2010-01-13T00:00:00,Middle Aged,M01.060.116.630
20072130,2010-01-13T00:00:00,Animals,B01.050
20072130,2010-01-13T00:00:00,Antineoplastic Agents,D27.505.954.248
20072130,2010-01-13T00:00:00,Drug Delivery Systems,E02.319.300
20072130,2010-01-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20072130,2010-01-13T00:00:00,Leukemia,C04.557.337
20072130,2010-01-13T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
20072130,2010-01-13T00:00:00,Transcription Factors,D12.776.930
20074751,2010-01-13T00:00:00,Aged,M01.060.116.100
20074751,2010-01-13T00:00:00,Cardiopulmonary Bypass,E04.292.413
20074751,2010-01-13T00:00:00,Hemodynamics,G09.330.190.400
20074751,2010-01-13T00:00:00,Hemodynamics,G09.330.380
20074751,2010-01-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20074751,2010-01-13T00:00:00,Isoxazoles,D03.383.129.385
20074751,2010-01-13T00:00:00,Middle Aged,M01.060.116.630
20074751,2010-01-13T00:00:00,Postoperative Complications,C23.550.767
20074751,2010-01-13T00:00:00,"Receptor, Endothelin A",D12.776.543.750.100.220.100
20074751,2010-01-13T00:00:00,"Receptor, Endothelin A",D12.776.543.750.750.320.100
20074751,2010-01-13T00:00:00,Risk Factors,E05.318.740.600.800.725
20074751,2010-01-13T00:00:00,Risk Factors,N05.715.350.200.700
20074751,2010-01-13T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20074751,2010-01-13T00:00:00,Risk Factors,N06.850.490.625.750
20074751,2010-01-13T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20074751,2010-01-13T00:00:00,Thiophenes,D02.886.778
20074751,2010-01-13T00:00:00,Thiophenes,D03.383.903
20074751,2010-01-13T00:00:00,Time Factors,G01.910.857
20074751,2010-01-13T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
20031449,2010-01-14T00:00:00,Aged,M01.060.116.100
20031449,2010-01-14T00:00:00,"Anastomosis, Surgical",E04.035
20031449,2010-01-14T00:00:00,Catheter Ablation,E01.370.370.380.410.200
20031449,2010-01-14T00:00:00,Catheter Ablation,E02.148.110
20031449,2010-01-14T00:00:00,Catheter Ablation,E02.148.442.110
20031449,2010-01-14T00:00:00,Catheter Ablation,E02.154.402.110
20031449,2010-01-14T00:00:00,Catheter Ablation,E04.014.170.402.110
20031449,2010-01-14T00:00:00,Catheterization,E02.148
20031449,2010-01-14T00:00:00,Catheterization,E05.157
20031449,2010-01-14T00:00:00,Drainage,E02.309
20031449,2010-01-14T00:00:00,Drainage,E04.237
20031449,2010-01-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20031449,2010-01-14T00:00:00,Middle Aged,M01.060.116.630
20031449,2010-01-14T00:00:00,Time Factors,G01.910.857
20031449,2010-01-14T00:00:00,Treatment Outcome,E01.789.800
20031449,2010-01-14T00:00:00,Treatment Outcome,N04.761.559.590.800
20031449,2010-01-14T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20071765,2010-01-14T00:00:00,Algorithms,G17.035
20071765,2010-01-14T00:00:00,Algorithms,L01.224.050
20071765,2010-01-14T00:00:00,Computer Simulation,L01.224.160
20071765,2010-01-14T00:00:00,Eye,A01.456.505.420
20071765,2010-01-14T00:00:00,Eye,A09.371
20071765,2010-01-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20071765,2010-01-14T00:00:00,"Models, Biological",E05.599.395
20071765,2010-01-14T00:00:00,Monte Carlo Method,E05.318.740.525
20071765,2010-01-14T00:00:00,Monte Carlo Method,L01.906.575.422
20071765,2010-01-14T00:00:00,Monte Carlo Method,N05.715.360.750.540
20071765,2010-01-14T00:00:00,Monte Carlo Method,N06.850.520.830.525
20071765,2010-01-14T00:00:00,"Phantoms, Imaging",E07.671
20071765,2010-01-14T00:00:00,Protons,D01.248.497.300.459.700
20071765,2010-01-14T00:00:00,Protons,D01.435.550
20071765,2010-01-14T00:00:00,Protons,G01.249.765
20071765,2010-01-14T00:00:00,Radiotherapy Dosage,E02.815.639
20071765,2010-01-14T00:00:00,"Radiotherapy Planning, Computer-Assisted",E02.950.825
20071765,2010-01-14T00:00:00,"Radiotherapy Planning, Computer-Assisted",L01.700.508.100.710.600.608
20071765,2010-01-14T00:00:00,Water,D01.455.900
20071765,2010-01-14T00:00:00,Water,D01.650.550.925
20075064,2010-01-14T00:00:00,Animals,B01.050
20075064,2010-01-14T00:00:00,Apoptosis,G04.299.139.160
20075064,2010-01-14T00:00:00,"Disease Models, Animal",C22.232
20075064,2010-01-14T00:00:00,"Disease Models, Animal",E05.598.500
20075064,2010-01-14T00:00:00,"Disease Models, Animal",E05.599.395.080
20075064,2010-01-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20075064,2010-01-14T00:00:00,Kidney,A05.810.453
20075064,2010-01-14T00:00:00,RNA,D13.444.735
20075064,2010-01-14T00:00:00,Regeneration,G16.100.856
20075064,2010-01-14T00:00:00,Reperfusion Injury,C14.907.725
20075064,2010-01-14T00:00:00,Reperfusion Injury,C23.550.767.877
20075064,2010-01-14T00:00:00,Telomerase,D08.811.913.696.445.308.300.750.750
20075064,2010-01-14T00:00:00,Telomerase,D12.776.157.725.500.921
20075064,2010-01-14T00:00:00,Telomerase,D12.776.664.962.500.921
20075347,2010-01-14T00:00:00,Adolescent,M01.060.057
20075347,2010-01-14T00:00:00,Adult,M01.060.116
20075347,2010-01-14T00:00:00,Aged,M01.060.116.100
20075347,2010-01-14T00:00:00,Brain,A08.186.211
20075347,2010-01-14T00:00:00,Cause of Death,E05.318.308.985.550.250
20075347,2010-01-14T00:00:00,Cause of Death,L01.280.975.550.250
20075347,2010-01-14T00:00:00,Cause of Death,N01.224.935.698.100
20075347,2010-01-14T00:00:00,Cause of Death,N06.850.505.400.975.550.250
20075347,2010-01-14T00:00:00,Cause of Death,N06.850.520.308.985.550.250
20075347,2010-01-14T00:00:00,Child,M01.060.406
20075347,2010-01-14T00:00:00,"Child, Preschool",M01.060.406.448
20075347,2010-01-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20075347,2010-01-14T00:00:00,Infant,M01.060.703
20075347,2010-01-14T00:00:00,Lung Neoplasms,C04.588.894.797.520
20075347,2010-01-14T00:00:00,Lung Neoplasms,C08.381.540
20075347,2010-01-14T00:00:00,Lung Neoplasms,C08.785.520
20075347,2010-01-14T00:00:00,Middle Aged,M01.060.116.630
20075347,2010-01-14T00:00:00,Myocardial Ischemia,C14.280.647
20075347,2010-01-14T00:00:00,Myocardial Ischemia,C14.907.585
20075347,2010-01-14T00:00:00,Stroke,C10.228.140.300.775
20075347,2010-01-14T00:00:00,Stroke,C14.907.253.855
20075347,2010-01-14T00:00:00,Treatment Outcome,E01.789.800
20075347,2010-01-14T00:00:00,Treatment Outcome,N04.761.559.590.800
20075347,2010-01-14T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20075347,2010-01-14T00:00:00,United States,Z01.107.567.875
20075347,2010-01-14T00:00:00,Young Adult,M01.060.116.815
20075362,2010-01-14T00:00:00,Aged,M01.060.116.100
20075362,2010-01-14T00:00:00,Cerebral Hemorrhage,C10.228.140.300.535.200
20075362,2010-01-14T00:00:00,Cerebral Hemorrhage,C14.907.253.573.200
20075362,2010-01-14T00:00:00,Cerebral Hemorrhage,C23.550.414.913.100
20075362,2010-01-14T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
20075362,2010-01-14T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
20075362,2010-01-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20075362,2010-01-14T00:00:00,Image Enhancement,E01.370.350.600.350
20075362,2010-01-14T00:00:00,Image Enhancement,L01.224.308.380
20075362,2010-01-14T00:00:00,Middle Aged,M01.060.116.630
20075362,2010-01-14T00:00:00,Perfusion Imaging,E01.370.350.710.600
20075362,2010-01-14T00:00:00,Perfusion Imaging,E01.370.384.730.354
19819427,2010-01-15T00:00:00,Adult,M01.060.116
19819427,2010-01-15T00:00:00,Brain Mapping,E01.370.350.086
19819427,2010-01-15T00:00:00,Brain Mapping,E01.370.376.149
19819427,2010-01-15T00:00:00,Brain Mapping,E05.132
19819427,2010-01-15T00:00:00,Deep Brain Stimulation,E02.342.250
19819427,2010-01-15T00:00:00,Deep Brain Stimulation,E04.190
19819427,2010-01-15T00:00:00,"Depressive Disorder, Major",F03.600.300.375
19819427,2010-01-15T00:00:00,Functional Laterality,F02.830.297.425
19819427,2010-01-15T00:00:00,Functional Laterality,G11.561.225.425
19819427,2010-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19819427,2010-01-15T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
19819427,2010-01-15T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
19819427,2010-01-15T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19819427,2010-01-15T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19819427,2010-01-15T00:00:00,Middle Aged,M01.060.116.630
19819427,2010-01-15T00:00:00,Neuropsychological Tests,F04.711.513
19819427,2010-01-15T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
19819427,2010-01-15T00:00:00,Psychiatric Status Rating Scales,F04.586
19819427,2010-01-15T00:00:00,Treatment Outcome,E01.789.800
19819427,2010-01-15T00:00:00,Treatment Outcome,N04.761.559.590.800
19819427,2010-01-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19904772,2010-01-15T00:00:00,Bayes Theorem,E05.318.740.600.200
19904772,2010-01-15T00:00:00,Bayes Theorem,N05.715.360.750.625.150
19904772,2010-01-15T00:00:00,Bayes Theorem,N06.850.520.830.600.200
19904772,2010-01-15T00:00:00,Computer Simulation,L01.224.160
19904772,2010-01-15T00:00:00,Developmental Disabilities,F03.550.362
19904772,2010-01-15T00:00:00,Environmental Exposure,N06.850.460.350
19904772,2010-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19904772,2010-01-15T00:00:00,Infant,M01.060.703
19904772,2010-01-15T00:00:00,"Models, Statistical",E05.318.740.500
19904772,2010-01-15T00:00:00,"Models, Statistical",E05.599.835
19904772,2010-01-15T00:00:00,"Models, Statistical",N05.715.360.750.530
19904772,2010-01-15T00:00:00,"Models, Statistical",N06.850.520.830.500
19904772,2010-01-15T00:00:00,Pregnancy,G08.686.785.760.769
19904772,2010-01-15T00:00:00,South Carolina,Z01.107.567.875.075.662
19904772,2010-01-15T00:00:00,South Carolina,Z01.107.567.875.750.700
19904772,2010-01-15T00:00:00,United States,Z01.107.567.875
19914602,2010-01-15T00:00:00,"Depressive Disorder, Major",F03.600.300.375
19914602,2010-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19914602,2010-01-15T00:00:00,Multicenter Studies as Topic,E05.318.760.535.500
19914602,2010-01-15T00:00:00,Multicenter Studies as Topic,E05.337.250.500
19914602,2010-01-15T00:00:00,Multicenter Studies as Topic,N05.715.360.775.235.545
19914602,2010-01-15T00:00:00,Multicenter Studies as Topic,N06.850.520.450.535.500
19914602,2010-01-15T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
19914602,2010-01-15T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
19914602,2010-01-15T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
19914602,2010-01-15T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
19914602,2010-01-15T00:00:00,Time Factors,G01.910.857
19914602,2010-01-15T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
19914602,2010-01-15T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
20000680,2010-01-15T00:00:00,Disinfectants,D27.505.954.122.425
20000680,2010-01-15T00:00:00,Disinfectants,D27.720.274
20000680,2010-01-15T00:00:00,Environmental Monitoring,N06.850.460.350.080
20000680,2010-01-15T00:00:00,Environmental Monitoring,N06.850.780.375
20000680,2010-01-15T00:00:00,Methane,D02.455.326.146.571
20000680,2010-01-15T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
20000680,2010-01-15T00:00:00,Water Supply,N06.850.860.510.915
20034345,2010-01-15T00:00:00,Adult,M01.060.116
20034345,2010-01-15T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
20034345,2010-01-15T00:00:00,Bacterial Infections,C01.252
20034345,2010-01-15T00:00:00,Child,M01.060.406
20034345,2010-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20061921,2010-01-15T00:00:00,Adult,M01.060.116
20061921,2010-01-15T00:00:00,Central Nervous System Diseases,C10.228
20061921,2010-01-15T00:00:00,Cryptococcosis,C01.703.248
20061921,2010-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20061921,2010-01-15T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
20061921,2010-01-15T00:00:00,Middle Aged,M01.060.116.630
20061921,2010-01-15T00:00:00,Organ Transplantation,E04.936.450
20061921,2010-01-15T00:00:00,Postoperative Complications,C23.550.767
20061921,2010-01-15T00:00:00,Regression Analysis,E05.318.740.750
20061921,2010-01-15T00:00:00,Regression Analysis,N05.715.360.750.695
20061921,2010-01-15T00:00:00,Regression Analysis,N06.850.520.830.750
20079551,2010-01-15T00:00:00,Data Collection,E05.318.308
20079551,2010-01-15T00:00:00,Data Collection,L01.280
20079551,2010-01-15T00:00:00,Data Collection,N05.715.360.300
20079551,2010-01-15T00:00:00,Data Collection,N06.850.520.308
20079551,2010-01-15T00:00:00,Diabetes Mellitus,C18.452.394.750
20079551,2010-01-15T00:00:00,Diabetes Mellitus,C19.246
20079551,2010-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20079551,2010-01-15T00:00:00,Oral Health,N01.400.535
20079551,2010-01-15T00:00:00,Patient Education as Topic,I02.233.332.500
20079551,2010-01-15T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
20079551,2010-01-15T00:00:00,Patient Education as Topic,N02.421.726.407.680
20079551,2010-01-15T00:00:00,Questionnaires,E05.318.308.750
20079551,2010-01-15T00:00:00,Questionnaires,L01.280.800
20079551,2010-01-15T00:00:00,Questionnaires,N05.715.360.300.695
20079551,2010-01-15T00:00:00,Questionnaires,N06.850.520.308.750
20079551,2010-01-15T00:00:00,Self Care,E02.900
20079551,2010-01-15T00:00:00,Self Care,N02.421.784.680
20079551,2010-01-15T00:00:00,Teaching,I02.903
20079997,2010-01-15T00:00:00,Curriculum,I02.158
20079997,2010-01-15T00:00:00,"Education, Medical, Undergraduate",I02.358.399.450
20079997,2010-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20079997,2010-01-15T00:00:00,Manikins,J01.897.280.500.545.129.400
20079997,2010-01-15T00:00:00,Manikins,L01.178.820.090.545.129.400
20079997,2010-01-15T00:00:00,Mass Casualty Incidents,I01.198.240.856.800.537
20079997,2010-01-15T00:00:00,Mass Casualty Incidents,I01.880.735.900.800.575
20079997,2010-01-15T00:00:00,Mass Casualty Incidents,N06.230.100.160
20080037,2010-01-15T00:00:00,Bipolar Disorder,F03.600.150.150
20080037,2010-01-15T00:00:00,"Brain Diseases, Metabolic",C10.228.140.163
20080037,2010-01-15T00:00:00,"Brain Diseases, Metabolic",C18.452.132
20080037,2010-01-15T00:00:00,Brain Mapping,E01.370.350.086
20080037,2010-01-15T00:00:00,Brain Mapping,E01.370.376.149
20080037,2010-01-15T00:00:00,Brain Mapping,E05.132
20080037,2010-01-15T00:00:00,Case-Control Studies,E05.318.760.500.500
20080037,2010-01-15T00:00:00,Case-Control Studies,N05.715.360.775.175.200
20080037,2010-01-15T00:00:00,Case-Control Studies,N06.850.520.450.500.500
20080037,2010-01-15T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
20080037,2010-01-15T00:00:00,Fluorodeoxyglucose F18,D09.254.229.500
20080037,2010-01-15T00:00:00,Functional Laterality,F02.830.297.425
20080037,2010-01-15T00:00:00,Functional Laterality,G11.561.225.425
20080037,2010-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20080037,2010-01-15T00:00:00,Limbic System,A08.186.211.464
20080037,2010-01-15T00:00:00,Middle Aged,M01.060.116.630
20080037,2010-01-15T00:00:00,Neural Pathways,A08.612
20080037,2010-01-15T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
20080037,2010-01-15T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
20080037,2010-01-15T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
20080037,2010-01-15T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
20080037,2010-01-15T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
20081040,2010-01-15T00:00:00,Biological Markers,D23.101
20081040,2010-01-15T00:00:00,Data Collection,E05.318.308
20081040,2010-01-15T00:00:00,Data Collection,L01.280
20081040,2010-01-15T00:00:00,Data Collection,N05.715.360.300
20081040,2010-01-15T00:00:00,Data Collection,N06.850.520.308
20081040,2010-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20081040,2010-01-15T00:00:00,Pilot Projects,E05.318.760.750
20081040,2010-01-15T00:00:00,Pilot Projects,E05.337.737
20081040,2010-01-15T00:00:00,Pilot Projects,N05.715.360.775.625
20081040,2010-01-15T00:00:00,Pilot Projects,N06.850.520.450.720
20081040,2010-01-15T00:00:00,Saliva,A12.200.666
20081040,2010-01-15T00:00:00,Smoking,F01.145.466.753
20081040,2010-01-15T00:00:00,Tobacco,B01.650.388.100.905.900
20081097,2010-01-15T00:00:00,Adolescent,M01.060.057
20081097,2010-01-15T00:00:00,Adult,M01.060.116
20081097,2010-01-15T00:00:00,Aged,M01.060.116.100
20081097,2010-01-15T00:00:00,Attitude to Health,F01.100.150
20081097,2010-01-15T00:00:00,Attitude to Health,N05.300.150
20081097,2010-01-15T00:00:00,Critical Illness,C23.550.291.625
20081097,2010-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20081097,2010-01-15T00:00:00,Intensive Care Units,N02.278.388.493
20081097,2010-01-15T00:00:00,Middle Aged,M01.060.116.630
20081097,2010-01-15T00:00:00,Risk Factors,E05.318.740.600.800.725
20081097,2010-01-15T00:00:00,Risk Factors,N05.715.350.200.700
20081097,2010-01-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20081097,2010-01-15T00:00:00,Risk Factors,N06.850.490.625.750
20081097,2010-01-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20081097,2010-01-15T00:00:00,Young Adult,M01.060.116.815
20081110,2010-01-15T00:00:00,Animals,B01.050
20081110,2010-01-15T00:00:00,Down-Regulation,G02.111.087.225
20081110,2010-01-15T00:00:00,Down-Regulation,G02.149.115.225
20081110,2010-01-15T00:00:00,Down-Regulation,G05.355.315.200
20081110,2010-01-15T00:00:00,Down-Regulation,G07.690.812.230
20081110,2010-01-15T00:00:00,Down-Regulation,G07.700.680.230
20081110,2010-01-15T00:00:00,"Endothelium, Vascular",A07.231.330
20081110,2010-01-15T00:00:00,"Endothelium, Vascular",A10.272.491.355
20081110,2010-01-15T00:00:00,Hydrogen Peroxide,D01.248.497.158.685.750.424
20081110,2010-01-15T00:00:00,Hydrogen Peroxide,D01.339.431.374.424
20081110,2010-01-15T00:00:00,Hydrogen Peroxide,D01.650.550.750.400
20081110,2010-01-15T00:00:00,"Models, Animal",E05.598
20081110,2010-01-15T00:00:00,Nerve Tissue Proteins,D12.776.641
20081110,2010-01-15T00:00:00,Oxidative Stress,G03.495.710
20081110,2010-01-15T00:00:00,Oxidative Stress,G07.700.830.750
20081110,2010-01-15T00:00:00,Phosphorylation,G02.111.087.677
20081110,2010-01-15T00:00:00,Phosphorylation,G02.149.115.677
20081110,2010-01-15T00:00:00,Phosphorylation,G02.149.465.700
20081110,2010-01-15T00:00:00,Phosphorylation,G02.607.750.700
20081110,2010-01-15T00:00:00,Phosphorylation,G03.495.790
20081110,2010-01-15T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20081110,2010-01-15T00:00:00,Serpins,D12.644.822.750
20081110,2010-01-15T00:00:00,Serpins,D12.644.861
20081110,2010-01-15T00:00:00,Serpins,D12.776.645.750
20081110,2010-01-15T00:00:00,Serpins,D12.776.872
20081110,2010-01-15T00:00:00,Signal Transduction,G02.111.087.800
20081110,2010-01-15T00:00:00,Signal Transduction,G02.149.115.800
20081110,2010-01-15T00:00:00,Signal Transduction,G04.299.880
20116722,2010-01-15T00:00:00,Adult,M01.060.116
20116722,2010-01-15T00:00:00,"Diagnosis, Differential",E01.171
20116722,2010-01-15T00:00:00,Hair Follicle,A10.272.497.500
20116722,2010-01-15T00:00:00,Hair Follicle,A17.360.710
20116722,2010-01-15T00:00:00,Hair Follicle,A17.815.250.500
20116722,2010-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20116722,2010-01-15T00:00:00,Middle Aged,M01.060.116.630
20116722,2010-01-15T00:00:00,Mouth Mucosa,A10.615.550.599
20116722,2010-01-15T00:00:00,Mouth Mucosa,A14.549.512
20116722,2010-01-15T00:00:00,Skin Diseases,C17.800
20129809,2010-01-15T00:00:00,Adolescent,M01.060.057
20129809,2010-01-15T00:00:00,Bayes Theorem,E05.318.740.600.200
20129809,2010-01-15T00:00:00,Bayes Theorem,N05.715.360.750.625.150
20129809,2010-01-15T00:00:00,Bayes Theorem,N06.850.520.830.600.200
20129809,2010-01-15T00:00:00,Child,M01.060.406
20129809,2010-01-15T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
20129809,2010-01-15T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
20129809,2010-01-15T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
20129809,2010-01-15T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
20129809,2010-01-15T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
20129809,2010-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20129809,2010-01-15T00:00:00,Incidence,E05.318.308.985.525.375
20129809,2010-01-15T00:00:00,Incidence,L01.280.975.525.375
20129809,2010-01-15T00:00:00,Incidence,N01.224.935.597.500
20129809,2010-01-15T00:00:00,Incidence,N06.850.505.400.975.525.375
20129809,2010-01-15T00:00:00,Incidence,N06.850.520.308.985.525.375
20129809,2010-01-15T00:00:00,United States,Z01.107.567.875
20129809,2010-01-15T00:00:00,Young Adult,M01.060.116.815
20488271,2010-01-15T00:00:00,Adult,M01.060.116
20488271,2010-01-15T00:00:00,Aged,M01.060.116.100
20488271,2010-01-15T00:00:00,Cause of Death,E05.318.308.985.550.250
20488271,2010-01-15T00:00:00,Cause of Death,L01.280.975.550.250
20488271,2010-01-15T00:00:00,Cause of Death,N01.224.935.698.100
20488271,2010-01-15T00:00:00,Cause of Death,N06.850.505.400.975.550.250
20488271,2010-01-15T00:00:00,Cause of Death,N06.850.520.308.985.550.250
20488271,2010-01-15T00:00:00,Depressive Disorder,F03.600.300
20488271,2010-01-15T00:00:00,Health Surveys,E05.318.308.250
20488271,2010-01-15T00:00:00,Health Surveys,N05.715.360.300.375
20488271,2010-01-15T00:00:00,Health Surveys,N06.850.520.308.250
20488271,2010-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20488271,2010-01-15T00:00:00,Middle Aged,M01.060.116.630
20488271,2010-01-15T00:00:00,Stroke,C10.228.140.300.775
20488271,2010-01-15T00:00:00,Stroke,C14.907.253.855
20082663,2010-01-17T00:00:00,Animals,B01.050
20082663,2010-01-17T00:00:00,Apoptosis,G04.299.139.160
20082663,2010-01-17T00:00:00,Calcium,D01.268.552.100
20082663,2010-01-17T00:00:00,Calcium,D01.552.539.288
20082663,2010-01-17T00:00:00,Calcium,D23.119.100
20082663,2010-01-17T00:00:00,Glutamic Acid,D12.125.067.750
20082663,2010-01-17T00:00:00,Glutamic Acid,D12.125.119.450
20082663,2010-01-17T00:00:00,Glutamic Acid,D12.125.427.300
20082663,2010-01-17T00:00:00,Hydrogen Peroxide,D01.248.497.158.685.750.424
20082663,2010-01-17T00:00:00,Hydrogen Peroxide,D01.339.431.374.424
20082663,2010-01-17T00:00:00,Hydrogen Peroxide,D01.650.550.750.400
20082663,2010-01-17T00:00:00,Motor Neurons,A08.663.655.500
20082663,2010-01-17T00:00:00,Motor Neurons,A11.671.655.500
20082663,2010-01-17T00:00:00,Oxidative Stress,G03.495.710
20082663,2010-01-17T00:00:00,Oxidative Stress,G07.700.830.750
20082663,2010-01-17T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
20082663,2010-01-17T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
20082663,2010-01-17T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
20082663,2010-01-17T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
20082663,2010-01-17T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
20082663,2010-01-17T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
20082663,2010-01-17T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
20082663,2010-01-17T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
20082663,2010-01-17T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
20082663,2010-01-17T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
20082663,2010-01-17T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
20083296,2010-01-17T00:00:00,Animals,B01.050
20083296,2010-01-17T00:00:00,Liver,A03.620
20083296,2010-01-17T00:00:00,Reproduction,G08.686.785.760
20083262,2010-01-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20083262,2010-01-18T00:00:00,Patient Selection,E05.581.500.653
20083262,2010-01-18T00:00:00,Patient Selection,N04.590.731
20083262,2010-01-18T00:00:00,Prostatectomy,E04.950.774.860.625
20083262,2010-01-18T00:00:00,Urinary Incontinence,C12.777.934.852
20083262,2010-01-18T00:00:00,Urinary Incontinence,C13.351.968.934.814
20083262,2010-01-18T00:00:00,Urinary Incontinence,C23.888.942.800
20083496,2010-01-18T00:00:00,"Depressive Disorder, Major",F03.600.300.375
20083496,2010-01-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20083496,2010-01-18T00:00:00,Information Management,L01.399
20083496,2010-01-18T00:00:00,Internet,L01.224.230.110.500
20083496,2010-01-18T00:00:00,Multicenter Studies as Topic,E05.318.760.535.500
20083496,2010-01-18T00:00:00,Multicenter Studies as Topic,E05.337.250.500
20083496,2010-01-18T00:00:00,Multicenter Studies as Topic,N05.715.360.775.235.545
20083496,2010-01-18T00:00:00,Multicenter Studies as Topic,N06.850.520.450.535.500
20083496,2010-01-18T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
20083496,2010-01-18T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
20083496,2010-01-18T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
20083496,2010-01-18T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
20083496,2010-01-18T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
20083496,2010-01-18T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
20083664,2010-01-18T00:00:00,Animals,B01.050
20083664,2010-01-18T00:00:00,Cell Proliferation,G04.299.233.750
20083664,2010-01-18T00:00:00,Cell Proliferation,G07.700.320.249.410.750
20083664,2010-01-18T00:00:00,Cyclophosphamide,D02.455.526.728.650.730.243
20083664,2010-01-18T00:00:00,Cyclophosphamide,D02.705.670.243
20083664,2010-01-18T00:00:00,Dendritic Cells,A11.066.270
20083664,2010-01-18T00:00:00,Dendritic Cells,A11.436.270
20083664,2010-01-18T00:00:00,Dendritic Cells,A15.382.066.270
20083664,2010-01-18T00:00:00,Dendritic Cells,A15.382.812.260
20083664,2010-01-18T00:00:00,Membrane Proteins,D12.776.543
20139695,2010-01-18T00:00:00,Clinical Trials as Topic,E05.318.760.535
20139695,2010-01-18T00:00:00,Clinical Trials as Topic,E05.337.250
20139695,2010-01-18T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
20139695,2010-01-18T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
20139695,2010-01-18T00:00:00,Early Detection of Cancer,E01.390.500
20139695,2010-01-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20139695,2010-01-18T00:00:00,Lung Neoplasms,C04.588.894.797.520
20139695,2010-01-18T00:00:00,Lung Neoplasms,C08.381.540
20139695,2010-01-18T00:00:00,Lung Neoplasms,C08.785.520
20139695,2010-01-18T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
20139695,2010-01-18T00:00:00,Practice Guidelines as Topic,N05.700.350.650
20034680,2010-01-19T00:00:00,Animals,B01.050
20034680,2010-01-19T00:00:00,B-Lymphocytes,A11.063.438
20034680,2010-01-19T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
20034680,2010-01-19T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
20034680,2010-01-19T00:00:00,B-Lymphocytes,A15.382.032.438
20034680,2010-01-19T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
20034680,2010-01-19T00:00:00,Brain,A08.186.211
20034680,2010-01-19T00:00:00,Cytokines,D12.644.276.374
20034680,2010-01-19T00:00:00,Cytokines,D12.776.467.374
20034680,2010-01-19T00:00:00,Cytokines,D23.529.374
20034680,2010-01-19T00:00:00,"Disease Models, Animal",C22.232
20034680,2010-01-19T00:00:00,"Disease Models, Animal",E05.598.500
20034680,2010-01-19T00:00:00,"Disease Models, Animal",E05.599.395.080
20034680,2010-01-19T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.114.703.300
20034680,2010-01-19T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.314.350.250
20034680,2010-01-19T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C20.111.258.625.300
20034680,2010-01-19T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",E05.598.500.500.500
20034680,2010-01-19T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
20034680,2010-01-19T00:00:00,Flow Cytometry,E05.200.500.386.350
20034680,2010-01-19T00:00:00,Gene Expression Regulation,G05.355.315
20034680,2010-01-19T00:00:00,Glycoproteins,D09.400.430
20034680,2010-01-19T00:00:00,Glycoproteins,D12.776.395
20034680,2010-01-19T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
20034680,2010-01-19T00:00:00,Lymph Nodes,A10.549.400
20034680,2010-01-19T00:00:00,Lymph Nodes,A15.382.520.604.412
20034680,2010-01-19T00:00:00,Peptide Fragments,D12.644.541
20034680,2010-01-19T00:00:00,Peptides,D12.644
20034680,2010-01-19T00:00:00,"RNA, Messenger",D13.444.735.544
20034680,2010-01-19T00:00:00,Spleen,A10.549.700
20034680,2010-01-19T00:00:00,Spleen,A15.382.520.604.700
20086111,2010-01-19T00:00:00,Adult,M01.060.116
20086111,2010-01-19T00:00:00,African Americans,M01.686.508.100.100
20086111,2010-01-19T00:00:00,African Americans,M01.686.754.100
20086111,2010-01-19T00:00:00,Breast Neoplasms,C04.588.180
20086111,2010-01-19T00:00:00,Breast Neoplasms,C17.800.090.500
20086111,2010-01-19T00:00:00,European Continental Ancestry Group,M01.686.508.400
20086111,2010-01-19T00:00:00,Hispanic Americans,M01.686.754.441
20086111,2010-01-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20086111,2010-01-19T00:00:00,Mammography,E01.370.350.700.500
20086111,2010-01-19T00:00:00,Middle Aged,M01.060.116.630
20086111,2010-01-19T00:00:00,Neoplasm Staging,E01.370.550
20086111,2010-01-19T00:00:00,Survivors,M01.643.836
20086111,2010-01-19T00:00:00,Survivors,M01.860
20086111,2010-01-19T00:00:00,Vitamin D,D04.808.812.768
20089516,2010-01-19T00:00:00,Aged,M01.060.116.100
20089516,2010-01-19T00:00:00,Angina Pectoris,C14.280.647.187
20089516,2010-01-19T00:00:00,Angina Pectoris,C14.907.585.187
20089516,2010-01-19T00:00:00,Angina Pectoris,C23.888.646.215.500
20089516,2010-01-19T00:00:00,Hemorrhage,C23.550.414
20089516,2010-01-19T00:00:00,Hospitalization,E02.760.400
20089516,2010-01-19T00:00:00,Hospitalization,N02.421.585.400
20089516,2010-01-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20089516,2010-01-19T00:00:00,Middle Aged,M01.060.116.630
20089516,2010-01-19T00:00:00,Myocardial Infarction,C14.280.647.500
20089516,2010-01-19T00:00:00,Myocardial Infarction,C14.907.585.500
20089516,2010-01-19T00:00:00,Thrombocytopenia,C15.378.140.855
20633425,2010-01-19T00:00:00,Brain,A08.186.211
20633425,2010-01-19T00:00:00,Deep Brain Stimulation,E02.342.250
20633425,2010-01-19T00:00:00,Deep Brain Stimulation,E04.190
20633425,2010-01-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20633425,2010-01-19T00:00:00,Periodicals as Topic,L01.178.682.829.678
20633425,2010-01-19T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
20633425,2010-01-19T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
20089675,2010-01-20T00:00:00,Angiotensin II,D06.472.699.094.078
20089675,2010-01-20T00:00:00,Angiotensin II,D12.644.400.070.078
20089675,2010-01-20T00:00:00,Angiotensin II,D12.644.456.073.041
20089675,2010-01-20T00:00:00,Angiotensin II,D12.644.548.058.078
20089675,2010-01-20T00:00:00,Angiotensin II,D12.776.641.650.070.078
20089675,2010-01-20T00:00:00,Angiotensin II,D23.469.050.050.050
20089675,2010-01-20T00:00:00,Animals,B01.050
20089675,2010-01-20T00:00:00,Antibodies,D12.776.124.486.485.114
20089675,2010-01-20T00:00:00,Antibodies,D12.776.124.790.651.114
20089675,2010-01-20T00:00:00,Antibodies,D12.776.377.715.548.114
20089675,2010-01-20T00:00:00,Cell Line,A11.251.210
20089675,2010-01-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20089675,2010-01-20T00:00:00,Kidney Diseases,C12.777.419
20089675,2010-01-20T00:00:00,Kidney Diseases,C13.351.968.419
20089675,2010-01-20T00:00:00,"Kidney Tubules, Proximal",A05.810.453.736.560.570
20089675,2010-01-20T00:00:00,Oxidative Stress,G03.495.710
20089675,2010-01-20T00:00:00,Oxidative Stress,G07.700.830.750
20089675,2010-01-20T00:00:00,Plasminogen Activator Inhibitor 1,D12.644.822.750.695.500
20089675,2010-01-20T00:00:00,Plasminogen Activator Inhibitor 1,D12.644.861.695.500
20089675,2010-01-20T00:00:00,Plasminogen Activator Inhibitor 1,D12.776.124.125.640
20089675,2010-01-20T00:00:00,Plasminogen Activator Inhibitor 1,D12.776.645.750.695.500
20089675,2010-01-20T00:00:00,Plasminogen Activator Inhibitor 1,D12.776.872.695.500
20089675,2010-01-20T00:00:00,Plasminogen Activator Inhibitor 1,D23.119.832.500
20089675,2010-01-20T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20089675,2010-01-20T00:00:00,Reactive Oxygen Species,D01.339.431
20089675,2010-01-20T00:00:00,Reactive Oxygen Species,D01.650.775
20089675,2010-01-20T00:00:00,Tissue Kallikreins,D08.811.277.656.300.760.442.875
20089675,2010-01-20T00:00:00,Tissue Kallikreins,D08.811.277.656.959.350.442.875
20089675,2010-01-20T00:00:00,Tissue Kallikreins,D23.101.840.870
20089675,2010-01-20T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
20089675,2010-01-20T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
20089675,2010-01-20T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
20089675,2010-01-20T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
20089675,2010-01-20T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
20089675,2010-01-20T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
20089675,2010-01-20T00:00:00,Transforming Growth Factor beta,D23.529.374.687
20089675,2010-01-20T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
20089675,2010-01-20T00:00:00,Transforming Growth Factor beta,D23.529.960.720
20089856,2010-01-20T00:00:00,Alkaline Ceramidase,D08.811.277.087.250.300
20089856,2010-01-20T00:00:00,"Antigens, CD29",D12.776.543.750.705.408.200.500
20089856,2010-01-20T00:00:00,"Antigens, CD29",D23.050.301.264.035.129
20089856,2010-01-20T00:00:00,"Antigens, CD29",D23.050.301.264.129
20089856,2010-01-20T00:00:00,"Antigens, CD29",D23.101.100.110.129
20089856,2010-01-20T00:00:00,"Antigens, CD29",D23.101.100.129
20089856,2010-01-20T00:00:00,Calcium,D01.268.552.100
20089856,2010-01-20T00:00:00,Calcium,D01.552.539.288
20089856,2010-01-20T00:00:00,Calcium,D23.119.100
20089856,2010-01-20T00:00:00,Cell Membrane,A11.284.149
20089856,2010-01-20T00:00:00,Endoplasmic Reticulum,A11.284.430.214.190.875.248
20089856,2010-01-20T00:00:00,Golgi Apparatus,A11.284.430.214.190.875.336
20089856,2010-01-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20089856,2010-01-20T00:00:00,Lipids,D10
20089856,2010-01-20T00:00:00,Mutation,G05.365.590
20089856,2010-01-20T00:00:00,Sphingolipids,D10.570.877
20089856,2010-01-20T00:00:00,Sphingolipids,D10.808
20099381,2010-01-20T00:00:00,Carcinogens,D27.888.569.100
20099381,2010-01-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20099381,2010-01-20T00:00:00,Risk Assessment,E05.318.740.600.800.715
20099381,2010-01-20T00:00:00,Risk Assessment,N04.452.871.715
20099381,2010-01-20T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20099381,2010-01-20T00:00:00,Risk Assessment,N06.850.505.715
20099381,2010-01-20T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20099381,2010-01-20T00:00:00,Smoking,F01.145.466.753
20099381,2010-01-20T00:00:00,United States,Z01.107.567.875
20099381,2010-01-20T00:00:00,Urinary Bladder Neoplasms,C04.588.945.947.960
20099381,2010-01-20T00:00:00,Urinary Bladder Neoplasms,C12.758.820.968
20099381,2010-01-20T00:00:00,Urinary Bladder Neoplasms,C12.777.829.813
20099381,2010-01-20T00:00:00,Urinary Bladder Neoplasms,C13.351.937.820.945
20099381,2010-01-20T00:00:00,Urinary Bladder Neoplasms,C13.351.968.829.707
20091246,2010-01-21T00:00:00,Animals,B01.050
20091246,2010-01-21T00:00:00,CD4-Positive T-Lymphocytes,A11.118.637.555.567.569.200
20091246,2010-01-21T00:00:00,CD4-Positive T-Lymphocytes,A15.145.229.637.555.567.569.200
20091246,2010-01-21T00:00:00,CD4-Positive T-Lymphocytes,A15.382.490.555.567.569.200
20091246,2010-01-21T00:00:00,Cell Differentiation,G04.299.151
20091246,2010-01-21T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.114.703.300
20091246,2010-01-21T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.314.350.250
20091246,2010-01-21T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C20.111.258.625.300
20091246,2010-01-21T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",E05.598.500.500.500
20091246,2010-01-21T00:00:00,Glycoproteins,D09.400.430
20091246,2010-01-21T00:00:00,Glycoproteins,D12.776.395
20091246,2010-01-21T00:00:00,Peptide Fragments,D12.644.541
20091246,2010-01-21T00:00:00,Phosphorylation,G02.111.087.677
20091246,2010-01-21T00:00:00,Phosphorylation,G02.149.115.677
20091246,2010-01-21T00:00:00,Phosphorylation,G02.149.465.700
20091246,2010-01-21T00:00:00,Phosphorylation,G02.607.750.700
20091246,2010-01-21T00:00:00,Phosphorylation,G03.495.790
20091246,2010-01-21T00:00:00,S-Nitrosoglutathione,D02.654.846.500.249
20091246,2010-01-21T00:00:00,S-Nitrosoglutathione,D02.886.489.650.750
20091246,2010-01-21T00:00:00,S-Nitrosoglutathione,D12.644.456.448.750
20091246,2010-01-21T00:00:00,Spinal Cord,A08.186.854
20098685,2010-01-21T00:00:00,Animals,B01.050
20098685,2010-01-21T00:00:00,"Disease Models, Animal",C22.232
20098685,2010-01-21T00:00:00,"Disease Models, Animal",E05.598.500
20098685,2010-01-21T00:00:00,"Disease Models, Animal",E05.599.395.080
20098685,2010-01-21T00:00:00,Histone Deacetylase Inhibitors,D27.505.519.389.360
20098685,2010-01-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20098685,2010-01-21T00:00:00,"Models, Animal",E05.598
20098685,2010-01-21T00:00:00,Polymerase Chain Reaction,E05.393.620.500
20094081,2010-01-22T00:00:00,Biosensing Techniques,E05.601.123
20094081,2010-01-22T00:00:00,Drug Carriers,D26.255.260
20094081,2010-01-22T00:00:00,Drug Carriers,D27.720.280.260
20094081,2010-01-22T00:00:00,Drug Carriers,E02.319.300.380
20094081,2010-01-22T00:00:00,"Models, Molecular",E05.599.595
20094081,2010-01-22T00:00:00,Nanoparticles,J01.637.512.600
20094081,2010-01-22T00:00:00,Polymers,D05.750
20094081,2010-01-22T00:00:00,Polymers,D25.720
20094081,2010-01-22T00:00:00,Polymers,J01.637.051.720
20094081,2010-01-22T00:00:00,Surface Properties,G02.842.850
20096780,2010-01-22T00:00:00,ADAM Proteins,D08.811.277.656.675.374.102
20096780,2010-01-22T00:00:00,ADAM Proteins,D09.400.430.500
20096780,2010-01-22T00:00:00,ADAM Proteins,D12.776.395.033
20096780,2010-01-22T00:00:00,Animals,B01.050
20096780,2010-01-22T00:00:00,Blood Vessels,A07.231
20096780,2010-01-22T00:00:00,Cardiovascular System,A07
20096780,2010-01-22T00:00:00,Embryonic Development,G07.700.320.500.325.180
20096780,2010-01-22T00:00:00,Embryonic Development,G08.686.785.760.170.104
20096780,2010-01-22T00:00:00,Extracellular Matrix,A11.284.295.310
20096780,2010-01-22T00:00:00,Heart,A07.541
20096780,2010-01-22T00:00:00,"Heart Defects, Congenital",C14.240.400
20096780,2010-01-22T00:00:00,"Heart Defects, Congenital",C14.280.400
20096780,2010-01-22T00:00:00,"Heart Defects, Congenital",C16.131.240.400
20096780,2010-01-22T00:00:00,Heart Ventricles,A07.541.560
20096780,2010-01-22T00:00:00,Myocardium,A02.633.580
20096780,2010-01-22T00:00:00,Myocardium,A07.541.704
20096780,2010-01-22T00:00:00,Myocardium,A10.690.552.750
20096780,2010-01-22T00:00:00,"Myocytes, Cardiac",A07.541.704.570
20096780,2010-01-22T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
20096780,2010-01-22T00:00:00,"Myocytes, Cardiac",A11.620.500
20096780,2010-01-22T00:00:00,Versicans,D09.698.735.830.750
20096780,2010-01-22T00:00:00,Versicans,D12.776.395.650.750.750
20096780,2010-01-22T00:00:00,Versicans,D12.776.503.280.625
20097785,2010-01-22T00:00:00,African Americans,M01.686.508.100.100
20097785,2010-01-22T00:00:00,African Americans,M01.686.754.100
20097785,2010-01-22T00:00:00,Aged,M01.060.116.100
20097785,2010-01-22T00:00:00,Blood Pressure,E01.370.600.875.249
20097785,2010-01-22T00:00:00,Blood Pressure,G09.330.380.076
20097785,2010-01-22T00:00:00,Diabetes Mellitus,C18.452.394.750
20097785,2010-01-22T00:00:00,Diabetes Mellitus,C19.246
20097785,2010-01-22T00:00:00,European Continental Ancestry Group,M01.686.508.400
20097785,2010-01-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20097785,2010-01-22T00:00:00,Hypertension,C14.907.489
20097785,2010-01-22T00:00:00,Middle Aged,M01.060.116.630
20097785,2010-01-22T00:00:00,United States,Z01.107.567.875
20110644,2010-01-22T00:00:00,Alligators and Crocodiles,B01.050.150.900.833.100
20110644,2010-01-22T00:00:00,Animals,B01.050
20110644,2010-01-22T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
20110644,2010-01-22T00:00:00,Ovary,A05.360.319.114.630
20110644,2010-01-22T00:00:00,Ovary,A05.360.576.497
20110644,2010-01-22T00:00:00,Ovary,A06.407.312.497
20110644,2010-01-22T00:00:00,"RNA, Messenger",D13.444.735.544
20110644,2010-01-22T00:00:00,Signal Transduction,G02.111.087.800
20110644,2010-01-22T00:00:00,Signal Transduction,G02.149.115.800
20110644,2010-01-22T00:00:00,Signal Transduction,G04.299.880
20110644,2010-01-22T00:00:00,Testis,A05.360.444.849
20110644,2010-01-22T00:00:00,Testis,A05.360.576.782
20110644,2010-01-22T00:00:00,Testis,A06.407.312.782
20110644,2010-01-22T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
20110644,2010-01-22T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
20110644,2010-01-22T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
20110644,2010-01-22T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
20110644,2010-01-22T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
20110644,2010-01-22T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
20110644,2010-01-22T00:00:00,Transforming Growth Factor beta,D23.529.374.687
20110644,2010-01-22T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
20110644,2010-01-22T00:00:00,Transforming Growth Factor beta,D23.529.960.720
20093099,2010-01-25T00:00:00,Adolescent,M01.060.057
20093099,2010-01-25T00:00:00,Child,M01.060.406
20093099,2010-01-25T00:00:00,"Child, Preschool",M01.060.406.448
20093099,2010-01-25T00:00:00,Electroencephalography,E01.370.376.300
20093099,2010-01-25T00:00:00,Electroencephalography,E01.370.405.245
20093099,2010-01-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20093099,2010-01-25T00:00:00,Infant,M01.060.703
20093099,2010-01-25T00:00:00,Seizures,C10.228.140.490.631
20093099,2010-01-25T00:00:00,Seizures,C10.597.742
20093099,2010-01-25T00:00:00,Seizures,C23.888.592.742
20097153,2010-01-25T00:00:00,Animals,B01.050
20097153,2010-01-25T00:00:00,Antioxidants,D27.505.519.217
20097153,2010-01-25T00:00:00,Antioxidants,D27.505.696.706.125
20097153,2010-01-25T00:00:00,Antioxidants,D27.720.799.047
20097153,2010-01-25T00:00:00,Calcium,D01.268.552.100
20097153,2010-01-25T00:00:00,Calcium,D01.552.539.288
20097153,2010-01-25T00:00:00,Calcium,D23.119.100
20097153,2010-01-25T00:00:00,Calcium Channels,D12.776.157.530.400.150
20097153,2010-01-25T00:00:00,Calcium Channels,D12.776.543.550.425.150
20097153,2010-01-25T00:00:00,Calcium Channels,D12.776.543.585.400.150
20097153,2010-01-25T00:00:00,Computer Simulation,L01.224.160
20097153,2010-01-25T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
20097153,2010-01-25T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
20097153,2010-01-25T00:00:00,"Models, Biological",E05.599.395
20097153,2010-01-25T00:00:00,Oxidative Stress,G03.495.710
20097153,2010-01-25T00:00:00,Oxidative Stress,G07.700.830.750
20097153,2010-01-25T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20097153,2010-01-25T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
20097153,2010-01-25T00:00:00,Superoxides,D01.248.497.158.685.750.850
20097153,2010-01-25T00:00:00,Superoxides,D01.339.431.374.850
20097153,2010-01-25T00:00:00,Superoxides,D01.339.431.750
20097153,2010-01-25T00:00:00,Superoxides,D01.650.550.750.800
20097153,2010-01-25T00:00:00,Voltage-Dependent Anion Channels,D12.776.157.530.400.500.520
20097153,2010-01-25T00:00:00,Voltage-Dependent Anion Channels,D12.776.543.550.425.730.520
20097153,2010-01-25T00:00:00,Voltage-Dependent Anion Channels,D12.776.543.585.400.730.520
20100677,2010-01-25T00:00:00,Adolescent,M01.060.057
20100677,2010-01-25T00:00:00,Chernobyl Nuclear Accident,K01.400.504.968.150
20100677,2010-01-25T00:00:00,Chernobyl Nuclear Accident,N06.850.135.848.500
20100677,2010-01-25T00:00:00,Child,M01.060.406
20100677,2010-01-25T00:00:00,"Child, Preschool",M01.060.406.448
20100677,2010-01-25T00:00:00,Environmental Exposure,N06.850.460.350
20100677,2010-01-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20100677,2010-01-25T00:00:00,Lung Injury,C08.381.520
20100677,2010-01-25T00:00:00,Lung Injury,C21.866.891.554
20100677,2010-01-25T00:00:00,Radiation Injuries,C21.866.733
20100677,2010-01-25T00:00:00,Radiation Injuries,N06.850.810.300.360
20100754,2010-01-25T00:00:00,Algorithms,G17.035
20100754,2010-01-25T00:00:00,Algorithms,L01.224.050
20100754,2010-01-25T00:00:00,Child Development,F01.525.200
20100754,2010-01-25T00:00:00,Child Development,G07.700.320.374.750
20100754,2010-01-25T00:00:00,"Child, Preschool",M01.060.406.448
20100754,2010-01-25T00:00:00,Developmental Disabilities,F03.550.362
20100754,2010-01-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20100754,2010-01-25T00:00:00,Infant,M01.060.703
20100754,2010-01-25T00:00:00,"Infant, Newborn",M01.060.703.520
20100754,2010-01-25T00:00:00,Mass Screening,E01.370.500
20100754,2010-01-25T00:00:00,Mass Screening,E05.318.308.250.580
20100754,2010-01-25T00:00:00,Mass Screening,N02.421.143.827.233.443
20100754,2010-01-25T00:00:00,Mass Screening,N02.421.726.233.443
20100754,2010-01-25T00:00:00,Mass Screening,N05.715.360.300.375.500
20100754,2010-01-25T00:00:00,Mass Screening,N06.850.520.308.250.580
20100754,2010-01-25T00:00:00,Mass Screening,N06.850.780.500
20100754,2010-01-25T00:00:00,Pediatrics,H02.403.670
20100754,2010-01-25T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
20100754,2010-01-25T00:00:00,Practice Guidelines as Topic,N05.700.350.650
20100754,2010-01-25T00:00:00,Primary Health Care,N04.590.233.727
20100754,2010-01-25T00:00:00,Referral and Consultation,N04.452.758.849
20100754,2010-01-25T00:00:00,United States,Z01.107.567.875
20100896,2010-01-25T00:00:00,Adolescent,M01.060.057
20100896,2010-01-25T00:00:00,Adult,M01.060.116
20100896,2010-01-25T00:00:00,Aged,M01.060.116.100
20100896,2010-01-25T00:00:00,Alcohol Drinking,F01.145.317.269
20100896,2010-01-25T00:00:00,Alcoholic Intoxication,C21.739.100.175
20100896,2010-01-25T00:00:00,Alcoholic Intoxication,F03.900.100.300
20100896,2010-01-25T00:00:00,Data Collection,E05.318.308
20100896,2010-01-25T00:00:00,Data Collection,L01.280
20100896,2010-01-25T00:00:00,Data Collection,N05.715.360.300
20100896,2010-01-25T00:00:00,Data Collection,N06.850.520.308
20100896,2010-01-25T00:00:00,Depression,F01.145.126.350
20100896,2010-01-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20100896,2010-01-25T00:00:00,Middle Aged,M01.060.116.630
20100896,2010-01-25T00:00:00,Rape,I01.198.240.748.640
20100896,2010-01-25T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
20100896,2010-01-25T00:00:00,United States,Z01.107.567.875
20100896,2010-01-25T00:00:00,Young Adult,M01.060.116.815
20103585,2010-01-26T00:00:00,Adenosine Triphosphate,D03.438.759.646.138.236
20103585,2010-01-26T00:00:00,Adenosine Triphosphate,D13.695.667.138.236
20103585,2010-01-26T00:00:00,Adenosine Triphosphate,D13.695.827.068.236
20103585,2010-01-26T00:00:00,Animals,B01.050
20103585,2010-01-26T00:00:00,"DNA, Mitochondrial",D13.444.308.283.225
20103585,2010-01-26T00:00:00,"Kidney Tubules, Proximal",A05.810.453.736.560.570
20103585,2010-01-26T00:00:00,Mitochondria,A11.284.430.214.190.875.564
20103585,2010-01-26T00:00:00,Mitochondria,A11.284.835.626
20103585,2010-01-26T00:00:00,Oxidative Stress,G03.495.710
20103585,2010-01-26T00:00:00,Oxidative Stress,G07.700.830.750
20103585,2010-01-26T00:00:00,Oxygen Consumption,G03.730
20103585,2010-01-26T00:00:00,Polymerase Chain Reaction,E05.393.620.500
20103585,2010-01-26T00:00:00,Rabbits,B01.050.150.900.649.521.700
20103619,2010-01-26T00:00:00,Animals,B01.050
20103619,2010-01-26T00:00:00,Calcium,D01.268.552.100
20103619,2010-01-26T00:00:00,Calcium,D01.552.539.288
20103619,2010-01-26T00:00:00,Calcium,D23.119.100
20103619,2010-01-26T00:00:00,Cell Line,A11.251.210
20103619,2010-01-26T00:00:00,Cell Survival,G04.299.316
20103619,2010-01-26T00:00:00,Ceramides,D02.065.313
20103619,2010-01-26T00:00:00,Ceramides,D09.400.410.420.525.200
20103619,2010-01-26T00:00:00,Ceramides,D10.390.470.675.200
20103619,2010-01-26T00:00:00,Ceramides,D10.570.877.360.612.200
20103619,2010-01-26T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
20103619,2010-01-26T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
20103619,2010-01-26T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
20103619,2010-01-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20103619,2010-01-26T00:00:00,Mass Spectrometry,E05.196.566
20103619,2010-01-26T00:00:00,Mutation,G05.365.590
20103619,2010-01-26T00:00:00,Oxidoreductases,D08.811.682
20103619,2010-01-26T00:00:00,RNA Interference,G05.355.315.203.374.790
20103619,2010-01-26T00:00:00,Reactive Oxygen Species,D01.339.431
20103619,2010-01-26T00:00:00,Reactive Oxygen Species,D01.650.775
20103619,2010-01-26T00:00:00,Superoxide Dismutase,D08.811.682.881
20103619,2010-01-26T00:00:00,Thioredoxins,D12.776.915
20162228,2010-01-26T00:00:00,Biosensing Techniques,E05.601.123
20162228,2010-01-26T00:00:00,Cell Survival,G04.299.316
20162228,2010-01-26T00:00:00,Equipment Failure Analysis,E05.325.192
20162228,2010-01-26T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
20162228,2010-01-26T00:00:00,Flow Cytometry,E05.200.500.386.350
20162228,2010-01-26T00:00:00,Microfluidic Analytical Techniques,E05.196.630.465
20162228,2010-01-26T00:00:00,Microfluidic Analytical Techniques,E05.588.465
20162228,2010-01-26T00:00:00,Saccharomyces cerevisiae,B01.300.107.795.785.800
20162228,2010-01-26T00:00:00,Saccharomyces cerevisiae,B01.300.930.705.655
20118074,2010-01-28T00:00:00,Adolescent,M01.060.057
20118074,2010-01-28T00:00:00,Carbamates,D02.241.081.251
20118074,2010-01-28T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
20118074,2010-01-28T00:00:00,"Emergency Service, Hospital",N02.421.297.195
20118074,2010-01-28T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
20118074,2010-01-28T00:00:00,Hand,A01.378.800.667
20118074,2010-01-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20118074,2010-01-28T00:00:00,Risk Assessment,E05.318.740.600.800.715
20118074,2010-01-28T00:00:00,Risk Assessment,N04.452.871.715
20118074,2010-01-28T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20118074,2010-01-28T00:00:00,Risk Assessment,N06.850.505.715
20118074,2010-01-28T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20118074,2010-01-28T00:00:00,Vision Disorders,C10.597.751.941
20118074,2010-01-28T00:00:00,Vision Disorders,C11.966
20118074,2010-01-28T00:00:00,Vision Disorders,C23.888.592.763.941
20430344,2010-01-28T00:00:00,Adenosine,D03.438.759.590.138
20430344,2010-01-28T00:00:00,Adenosine,D13.570.583.138
20430344,2010-01-28T00:00:00,Adenosine,D13.570.800.096
20430344,2010-01-28T00:00:00,Aged,M01.060.116.100
20430344,2010-01-28T00:00:00,Algorithms,G17.035
20430344,2010-01-28T00:00:00,Algorithms,L01.224.050
20430344,2010-01-28T00:00:00,Cardiac Volume,G09.330.380.249
20430344,2010-01-28T00:00:00,Coronary Aneurysm,C14.280.647.250.250
20430344,2010-01-28T00:00:00,Coronary Aneurysm,C14.907.055.395
20430344,2010-01-28T00:00:00,Coronary Aneurysm,C14.907.585.250.250
20430344,2010-01-28T00:00:00,Coronary Angiography,E01.370.350.700.060.200
20430344,2010-01-28T00:00:00,Coronary Angiography,E01.370.370.050.200
20430344,2010-01-28T00:00:00,Coronary Angiography,E01.370.370.380.200
20430344,2010-01-28T00:00:00,Coronary Vessels,A07.231.114.269
20430344,2010-01-28T00:00:00,Coronary Vessels,A07.231.908.194
20430344,2010-01-28T00:00:00,Heart Diseases,C14.280
20430344,2010-01-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20430344,2010-01-28T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20430344,2010-01-28T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20430344,2010-01-28T00:00:00,Middle Aged,M01.060.116.630
20430344,2010-01-28T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.350.800.800
20430344,2010-01-28T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.600.350.800.800
20430344,2010-01-28T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.710.800.800
20430344,2010-01-28T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.825.800.800
20430344,2010-01-28T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.384.730.800.800
20430344,2010-01-28T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20430344,2010-01-28T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20430344,2010-01-28T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20430344,2010-01-28T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20430344,2010-01-28T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20569777,2010-01-28T00:00:00,Anxiety,F01.470.132
20569777,2010-01-28T00:00:00,Cognition,F02.463.188
20569777,2010-01-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20569777,2010-01-28T00:00:00,Psychiatric Status Rating Scales,F04.586
20569777,2010-01-28T00:00:00,Psychometrics,F04.711.780
20569777,2010-01-28T00:00:00,Questionnaires,E05.318.308.750
20569777,2010-01-28T00:00:00,Questionnaires,L01.280.800
20569777,2010-01-28T00:00:00,Questionnaires,N05.715.360.300.695
20569777,2010-01-28T00:00:00,Questionnaires,N06.850.520.308.750
20569777,2010-01-28T00:00:00,Young Adult,M01.060.116.815
20118113,2010-01-29T00:00:00,"Arrhythmias, Cardiac",C14.280.067
20118113,2010-01-29T00:00:00,"Arrhythmias, Cardiac",C23.550.073
20118113,2010-01-29T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
20118113,2010-01-29T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
20118113,2010-01-29T00:00:00,"Defibrillators, Implantable",E07.695.175
20118113,2010-01-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20126446,2010-01-29T00:00:00,Animals,B01.050
20126446,2010-01-29T00:00:00,Cell Line,A11.251.210
20126446,2010-01-29T00:00:00,Endothelial Cells,A11.436.275
20126446,2010-01-29T00:00:00,Gene Expression Regulation,G05.355.315
20126446,2010-01-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20126446,2010-01-29T00:00:00,Macrophages,A11.329.372
20126446,2010-01-29T00:00:00,Macrophages,A11.627.482
20126446,2010-01-29T00:00:00,Macrophages,A11.733.397
20126446,2010-01-29T00:00:00,Macrophages,A15.382.680.397
20126446,2010-01-29T00:00:00,Macrophages,A15.382.812.522
20126446,2010-01-29T00:00:00,MicroRNAs,D13.150.650.319
20126446,2010-01-29T00:00:00,MicroRNAs,D13.444.735.150.319
20126446,2010-01-29T00:00:00,MicroRNAs,D13.444.735.790.099
20126446,2010-01-29T00:00:00,Neoplasm Staging,E01.370.550
20126446,2010-01-29T00:00:00,Oxidative Stress,G03.495.710
20126446,2010-01-29T00:00:00,Oxidative Stress,G07.700.830.750
20126446,2010-01-29T00:00:00,Polymerase Chain Reaction,E05.393.620.500
20126446,2010-01-29T00:00:00,Reactive Nitrogen Species,D01.625.700
20126446,2010-01-29T00:00:00,Reactive Nitrogen Species,D02.654.846
19959345,2010-01-30T00:00:00,Adult,M01.060.116
19959345,2010-01-30T00:00:00,Brain,A08.186.211
19959345,2010-01-30T00:00:00,Brain Mapping,E01.370.350.086
19959345,2010-01-30T00:00:00,Brain Mapping,E01.370.376.149
19959345,2010-01-30T00:00:00,Brain Mapping,E05.132
19959345,2010-01-30T00:00:00,Chronic Disease,C23.550.291.500
19959345,2010-01-30T00:00:00,Cocaine-Related Disorders,C21.739.300
19959345,2010-01-30T00:00:00,Cocaine-Related Disorders,F03.900.300
19959345,2010-01-30T00:00:00,Functional Laterality,F02.830.297.425
19959345,2010-01-30T00:00:00,Functional Laterality,G11.561.225.425
19959345,2010-01-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19959345,2010-01-30T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19959345,2010-01-30T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19959345,2010-01-30T00:00:00,Motor Activity,F01.145.632
19959345,2010-01-30T00:00:00,Motor Activity,G11.427.590.530.698
19959345,2010-01-30T00:00:00,Neuropsychological Tests,F04.711.513
19959345,2010-01-30T00:00:00,Oxygen,D01.268.185.550
19959345,2010-01-30T00:00:00,Oxygen,D01.362.670
19959345,2010-01-30T00:00:00,Psychomotor Performance,F02.808
19959345,2010-01-30T00:00:00,Psychomotor Performance,G11.427.700
19959345,2010-01-30T00:00:00,Psychomotor Performance,G11.561.623
19959345,2010-01-30T00:00:00,Reaction Time,F02.830.650
19959345,2010-01-30T00:00:00,Reaction Time,F04.669.817
19959345,2010-01-30T00:00:00,Reaction Time,G11.561.677
19959345,2010-01-30T00:00:00,Touch Perception,F02.463.593.894
19400684,2010-02-01T00:00:00,Acoustic Stimulation,E02.037
19400684,2010-02-01T00:00:00,Acoustic Stimulation,E02.190.888.030
19400684,2010-02-01T00:00:00,Acoustic Stimulation,E05.723.136
19400684,2010-02-01T00:00:00,Adult,M01.060.116
19400684,2010-02-01T00:00:00,Attention,F02.830.104.214
19400684,2010-02-01T00:00:00,Auditory Perception,F02.463.593.071
19400684,2010-02-01T00:00:00,Brain,A08.186.211
19400684,2010-02-01T00:00:00,Brain Mapping,E01.370.350.086
19400684,2010-02-01T00:00:00,Brain Mapping,E01.370.376.149
19400684,2010-02-01T00:00:00,Brain Mapping,E05.132
19400684,2010-02-01T00:00:00,Cues,F02.463.425.234
19400684,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19400684,2010-02-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
19400684,2010-02-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
19400684,2010-02-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
19400684,2010-02-01T00:00:00,Neuropsychological Tests,F04.711.513
19400684,2010-02-01T00:00:00,Oxygen,D01.268.185.550
19400684,2010-02-01T00:00:00,Oxygen,D01.362.670
19400684,2010-02-01T00:00:00,"Pattern Recognition, Visual",F02.463.593.524.500
19400684,2010-02-01T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.622
19400684,2010-02-01T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.869.435.673
19400684,2010-02-01T00:00:00,Photic Stimulation,E05.723.729
19400684,2010-02-01T00:00:00,Space Perception,F02.463.593.778
19400684,2010-02-01T00:00:00,Space Perception,F02.463.593.932.869
19400684,2010-02-01T00:00:00,Young Adult,M01.060.116.815
19586367,2010-02-01T00:00:00,Animals,B01.050
19586367,2010-02-01T00:00:00,Biocompatible Materials,D25.130
19586367,2010-02-01T00:00:00,Biocompatible Materials,D27.720.102.130
19586367,2010-02-01T00:00:00,Biocompatible Materials,J01.637.051.130
19586367,2010-02-01T00:00:00,Cell Survival,G04.299.316
19586367,2010-02-01T00:00:00,Hydrogel,D02.033.455.250.700.485
19586367,2010-02-01T00:00:00,Hydrogel,D05.750.741.485
19586367,2010-02-01T00:00:00,Hydrogel,D25.720.741.485
19586367,2010-02-01T00:00:00,Hydrogel,D26.255.165.320.375.375
19586367,2010-02-01T00:00:00,Hydrogel,J01.637.051.720.741.485
19586367,2010-02-01T00:00:00,Microcirculation,G09.330.190.163.645
19586367,2010-02-01T00:00:00,"Myocytes, Smooth Muscle",A11.620.520
19586367,2010-02-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19586367,2010-02-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
19586367,2010-02-01T00:00:00,Regeneration,G16.100.856
19586367,2010-02-01T00:00:00,"Stress, Mechanical",G01.374.676.830
19586367,2010-02-01T00:00:00,"Stress, Mechanical",G01.595.540.830
19586367,2010-02-01T00:00:00,Tissue Engineering,E05.200.249.750
19586367,2010-02-01T00:00:00,Tissue Scaffolds,E07.206.627
19586367,2010-02-01T00:00:00,Tissue Scaffolds,E07.695.825
19669642,2010-02-01T00:00:00,Animals,B01.050
19669642,2010-02-01T00:00:00,"Carcinoma, Lewis Lung",C04.557.470.200.280
19669642,2010-02-01T00:00:00,"Carcinoma, Lewis Lung",C04.619.230
19669642,2010-02-01T00:00:00,Endothelial Cells,A11.436.275
19669642,2010-02-01T00:00:00,Immune Tolerance,G12.425.746.425
19669642,2010-02-01T00:00:00,Interferon-gamma,D12.644.276.374.440.893
19669642,2010-02-01T00:00:00,Interferon-gamma,D12.644.276.374.480.350
19669642,2010-02-01T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
19669642,2010-02-01T00:00:00,Interferon-gamma,D12.644.276.718.550
19669642,2010-02-01T00:00:00,Interferon-gamma,D12.776.467.374.440.893
19669642,2010-02-01T00:00:00,Interferon-gamma,D12.776.467.374.480.350
19669642,2010-02-01T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
19669642,2010-02-01T00:00:00,Interferon-gamma,D12.776.467.718.550
19669642,2010-02-01T00:00:00,Interferon-gamma,D23.529.374.440.893
19669642,2010-02-01T00:00:00,Interferon-gamma,D23.529.374.480.350
19669642,2010-02-01T00:00:00,Interferon-gamma,D23.529.374.480.615.350
19669642,2010-02-01T00:00:00,Interferon-gamma,D23.529.718.550
19669642,2010-02-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
19669642,2010-02-01T00:00:00,Lung Neoplasms,C08.381.540
19669642,2010-02-01T00:00:00,Lung Neoplasms,C08.785.520
19669642,2010-02-01T00:00:00,Macrophages,A11.329.372
19669642,2010-02-01T00:00:00,Macrophages,A11.627.482
19669642,2010-02-01T00:00:00,Macrophages,A11.733.397
19669642,2010-02-01T00:00:00,Macrophages,A15.382.680.397
19669642,2010-02-01T00:00:00,Macrophages,A15.382.812.522
19669642,2010-02-01T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
19669642,2010-02-01T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
19669642,2010-02-01T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
19697249,2010-02-01T00:00:00,"Adaptation, Psychological",F01.058
19697249,2010-02-01T00:00:00,Bereavement,F01.470.142
19697249,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19697249,2010-02-01T00:00:00,Interpersonal Relations,F01.829.401
19697249,2010-02-01T00:00:00,Mental Recall,F02.463.425.540.641
19813252,2010-02-01T00:00:00,Age Factors,N05.715.350.075
19813252,2010-02-01T00:00:00,Age Factors,N06.850.490.250
19813252,2010-02-01T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
19813252,2010-02-01T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
19813252,2010-02-01T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
19813252,2010-02-01T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
19813252,2010-02-01T00:00:00,"Clinical Trials, Phase III as Topic",E05.318.760.535.220
19813252,2010-02-01T00:00:00,"Clinical Trials, Phase III as Topic",E05.337.250.220
19813252,2010-02-01T00:00:00,"Clinical Trials, Phase III as Topic",N05.715.360.775.235.220
19813252,2010-02-01T00:00:00,"Clinical Trials, Phase III as Topic",N06.850.520.450.535.220
19813252,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19813252,2010-02-01T00:00:00,Infant,M01.060.703
19813252,2010-02-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
19813252,2010-02-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
19813252,2010-02-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
19813252,2010-02-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
19813252,2010-02-01T00:00:00,Stroke,C10.228.140.300.775
19813252,2010-02-01T00:00:00,Stroke,C14.907.253.855
19813252,2010-02-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.700.560.260.850
19813252,2010-02-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.260.850
19813252,2010-02-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.850.870
19813252,2010-02-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.376.560.260.850
19901829,2010-02-01T00:00:00,"Anesthesia, Intravenous",E03.155.308
19901829,2010-02-01T00:00:00,Bronchoscopy,E01.370.386.105
19901829,2010-02-01T00:00:00,Bronchoscopy,E01.370.388.250.100
19901829,2010-02-01T00:00:00,Bronchoscopy,E04.800.250.100
19901829,2010-02-01T00:00:00,Bronchoscopy,E04.928.600.080
19901829,2010-02-01T00:00:00,Dexmedetomidine,D03.383.129.308.245
19901829,2010-02-01T00:00:00,Fiber Optic Technology,H01.671.617.249
19901829,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19901829,2010-02-01T00:00:00,"Intubation, Intratracheal",E05.497.578
19901829,2010-02-01T00:00:00,Ketamine,D02.455.426.392.368.367.652
19901829,2010-02-01T00:00:00,Trachea,A04.889
19901829,2010-02-01T00:00:00,"Wounds, Nonpenetrating",C21.866.974
19901829,2010-02-01T00:00:00,"Wounds, Penetrating",C21.866.986
19918756,2010-02-01T00:00:00,Animals,B01.050
19918756,2010-02-01T00:00:00,Blood Vessels,A07.231
19918756,2010-02-01T00:00:00,Collagen,D05.750.078.280
19918756,2010-02-01T00:00:00,Collagen,D12.776.860.300.250
19918756,2010-02-01T00:00:00,Hydrogels,D20.280.320.375
19918756,2010-02-01T00:00:00,Hydrogels,D26.255.165.320.375
19918756,2010-02-01T00:00:00,"Models, Cardiovascular",E05.599.395.161
19918756,2010-02-01T00:00:00,Pregnancy,G08.686.785.760.769
19918756,2010-02-01T00:00:00,Rabbits,B01.050.150.900.649.521.700
19918756,2010-02-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19918756,2010-02-01T00:00:00,"Spheroids, Cellular",A11.251.800
19918756,2010-02-01T00:00:00,Tissue Engineering,E05.200.249.750
19926627,2010-02-01T00:00:00,Adolescent,M01.060.057
19926627,2010-02-01T00:00:00,"Child Abuse, Sexual",I01.198.240.748.300
19926627,2010-02-01T00:00:00,"Child Abuse, Sexual",I01.198.240.856.350.250.255
19926627,2010-02-01T00:00:00,"Child Abuse, Sexual",I01.880.735.900.350.250.255
19926627,2010-02-01T00:00:00,"Child Abuse, Sexual",I01.880.787.293.292.325
19926627,2010-02-01T00:00:00,Depression,F01.145.126.350
19926627,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19926627,2010-02-01T00:00:00,Juvenile Delinquency,I01.880.735.479
19926627,2010-02-01T00:00:00,Risk-Taking,F01.145.722
19926627,2010-02-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
19926627,2010-02-01T00:00:00,Substance-Related Disorders,C21.739
19926627,2010-02-01T00:00:00,Substance-Related Disorders,F03.900
19926627,2010-02-01T00:00:00,Violence,I01.198.240.856
19926627,2010-02-01T00:00:00,Violence,I01.880.735.900
19935109,2010-02-01T00:00:00,Adolescent,M01.060.057
19935109,2010-02-01T00:00:00,Adult,M01.060.116
19935109,2010-02-01T00:00:00,Aged,M01.060.116.100
19935109,2010-02-01T00:00:00,Cost of Illness,I01.137
19935109,2010-02-01T00:00:00,Cost of Illness,N03.219.151.165
19935109,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19935109,2010-02-01T00:00:00,Intensive Care Units,N02.278.388.493
19935109,2010-02-01T00:00:00,Length of Stay,E02.760.400.480
19935109,2010-02-01T00:00:00,Length of Stay,N02.421.585.400.480
19935109,2010-02-01T00:00:00,Middle Aged,M01.060.116.630
19935109,2010-02-01T00:00:00,"Pneumonia, Ventilator-Associated",C01.539.248.500
19935109,2010-02-01T00:00:00,"Pneumonia, Ventilator-Associated",C08.381.520.750.750
19935109,2010-02-01T00:00:00,"Pneumonia, Ventilator-Associated",C08.381.677.800
19935109,2010-02-01T00:00:00,"Pneumonia, Ventilator-Associated",C08.730.610.750
19935109,2010-02-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
19935109,2010-02-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
19935109,2010-02-01T00:00:00,Regression Analysis,E05.318.740.750
19935109,2010-02-01T00:00:00,Regression Analysis,N05.715.360.750.695
19935109,2010-02-01T00:00:00,Regression Analysis,N06.850.520.830.750
19935109,2010-02-01T00:00:00,Treatment Outcome,E01.789.800
19935109,2010-02-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19935109,2010-02-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19935109,2010-02-01T00:00:00,Wounds and Injuries,C21.866
19935109,2010-02-01T00:00:00,Young Adult,M01.060.116.815
19950378,2010-02-01T00:00:00,Adult,M01.060.116
19950378,2010-02-01T00:00:00,Aged,M01.060.116.100
19950378,2010-02-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
19950378,2010-02-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
19950378,2010-02-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
19950378,2010-02-01T00:00:00,Cisplatin,D01.210.375
19950378,2010-02-01T00:00:00,Cisplatin,D01.625.125
19950378,2010-02-01T00:00:00,Cisplatin,D01.710.100
19950378,2010-02-01T00:00:00,Combined Modality Therapy,E02.186
19950378,2010-02-01T00:00:00,Head and Neck Neoplasms,C04.588.443
19950378,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19950378,2010-02-01T00:00:00,Middle Aged,M01.060.116.630
19950378,2010-02-01T00:00:00,Radiation Injuries,C21.866.733
19950378,2010-02-01T00:00:00,Radiation Injuries,N06.850.810.300.360
19998405,2010-02-01T00:00:00,Enzyme Inhibitors,D27.505.519.389
19998405,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19998405,2010-02-01T00:00:00,"Models, Molecular",E05.599.595
19998405,2010-02-01T00:00:00,Molecular Structure,G02.111.570
19998405,2010-02-01T00:00:00,Molecular Structure,G02.575
19998405,2010-02-01T00:00:00,Molecular Structure,G02.842.575
19998405,2010-02-01T00:00:00,Transglutaminases,D08.811.913.050.200.800
20001422,2010-02-01T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
20001422,2010-02-01T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
20001422,2010-02-01T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
20001422,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20001422,2010-02-01T00:00:00,"Immunity, Innate",G12.450.575
20001422,2010-02-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
20001422,2010-02-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
20001422,2010-02-01T00:00:00,Reactive Nitrogen Species,D01.625.700
20001422,2010-02-01T00:00:00,Reactive Nitrogen Species,D02.654.846
20001422,2010-02-01T00:00:00,Reactive Oxygen Species,D01.339.431
20001422,2010-02-01T00:00:00,Reactive Oxygen Species,D01.650.775
20018355,2010-02-01T00:00:00,Adult,M01.060.116
20018355,2010-02-01T00:00:00,Aged,M01.060.116.100
20018355,2010-02-01T00:00:00,Cryosurgery,E04.014.180
20018355,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20018355,2010-02-01T00:00:00,Kidney Neoplasms,C04.588.945.947.535
20018355,2010-02-01T00:00:00,Kidney Neoplasms,C12.758.820.750
20018355,2010-02-01T00:00:00,Kidney Neoplasms,C12.777.419.473
20018355,2010-02-01T00:00:00,Kidney Neoplasms,C13.351.937.820.535
20018355,2010-02-01T00:00:00,Kidney Neoplasms,C13.351.968.419.473
20018355,2010-02-01T00:00:00,Laparoscopy,E01.370.388.250.520
20018355,2010-02-01T00:00:00,Laparoscopy,E04.800.250.520
20018355,2010-02-01T00:00:00,Middle Aged,M01.060.116.630
20030593,2010-02-01T00:00:00,Animals,B01.050
20030593,2010-02-01T00:00:00,Apoptosis,G04.299.139.160
20030593,2010-02-01T00:00:00,Gene Expression Regulation,G05.355.315
20030593,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20030593,2010-02-01T00:00:00,Methylmercury Compounds,D01.632.750.100.738
20030593,2010-02-01T00:00:00,Methylmercury Compounds,D02.691.750.100.738
20030593,2010-02-01T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
20030593,2010-02-01T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
20030593,2010-02-01T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
20030593,2010-02-01T00:00:00,Skin,A17.815
20030593,2010-02-01T00:00:00,"Transcription, Genetic",G02.111.087.847
20030593,2010-02-01T00:00:00,"Transcription, Genetic",G02.149.115.847
20030593,2010-02-01T00:00:00,"Transcription, Genetic",G05.355.310.700
20040828,2010-02-01T00:00:00,Adult,M01.060.116
20040828,2010-02-01T00:00:00,Aged,M01.060.116.100
20040828,2010-02-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
20040828,2010-02-01T00:00:00,Delivery of Health Care,N04.590.374
20040828,2010-02-01T00:00:00,Delivery of Health Care,N05.300
20040828,2010-02-01T00:00:00,Health Promotion,N02.370
20040828,2010-02-01T00:00:00,Health Promotion,N02.421.726.507
20040828,2010-02-01T00:00:00,Health Services Accessibility,N04.590.374.350
20040828,2010-02-01T00:00:00,Health Services Accessibility,N05.300.430
20040828,2010-02-01T00:00:00,Healthcare Disparities,N04.590.374.380
20040828,2010-02-01T00:00:00,Healthcare Disparities,N05.300.493
20040828,2010-02-01T00:00:00,Hearing Aids,E07.814.458
20040828,2010-02-01T00:00:00,Hearing Loss,C09.218.458.341
20040828,2010-02-01T00:00:00,Hearing Loss,C10.597.751.418.341
20040828,2010-02-01T00:00:00,Hearing Loss,C23.888.592.763.393.341
20040828,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20040828,2010-02-01T00:00:00,Mass Screening,E01.370.500
20040828,2010-02-01T00:00:00,Mass Screening,E05.318.308.250.580
20040828,2010-02-01T00:00:00,Mass Screening,N02.421.143.827.233.443
20040828,2010-02-01T00:00:00,Mass Screening,N02.421.726.233.443
20040828,2010-02-01T00:00:00,Mass Screening,N05.715.360.300.375.500
20040828,2010-02-01T00:00:00,Mass Screening,N06.850.520.308.250.580
20040828,2010-02-01T00:00:00,Mass Screening,N06.850.780.500
20040828,2010-02-01T00:00:00,Middle Aged,M01.060.116.630
20040828,2010-02-01T00:00:00,Research,H01.770.644
20040828,2010-02-01T00:00:00,United States,Z01.107.567.875
20065683,2010-02-01T00:00:00,Animals,B01.050
20065683,2010-02-01T00:00:00,Biological Markers,D23.101
20065683,2010-02-01T00:00:00,Blood Proteins,D12.776.124
20065683,2010-02-01T00:00:00,Brain,A08.186.211
20065683,2010-02-01T00:00:00,Radiation Dosage,E05.799.513
20065683,2010-02-01T00:00:00,Radiation Dosage,G01.201.875.740
20065683,2010-02-01T00:00:00,Radiation Dosage,N06.850.810.250
20065683,2010-02-01T00:00:00,Radiation Injuries,C21.866.733
20065683,2010-02-01T00:00:00,Radiation Injuries,N06.850.810.300.360
20065683,2010-02-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20075276,2010-02-01T00:00:00,Animals,B01.050
20075276,2010-02-01T00:00:00,Chickens,B01.050.150.900.248.350.150
20075276,2010-02-01T00:00:00,Chickens,B01.050.150.900.248.617.192
20075276,2010-02-01T00:00:00,Dietary Fats,D10.212.302
20075276,2010-02-01T00:00:00,Dietary Fats,J02.500.375
20075276,2010-02-01T00:00:00,Mycoplasma Infections,C01.252.400.610.610
20075276,2010-02-01T00:00:00,Mycoplasma gallisepticum,B03.440.560.580.553.553.345
20075276,2010-02-01T00:00:00,Poultry Diseases,C22.131.728
20087081,2010-02-01T00:00:00,Aged,M01.060.116.100
20087081,2010-02-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
20087081,2010-02-01T00:00:00,Alzheimer Disease,C10.574.945.249
20087081,2010-02-01T00:00:00,Alzheimer Disease,F03.087.400.100
20087081,2010-02-01T00:00:00,Depression,F01.145.126.350
20087081,2010-02-01T00:00:00,Double-Blind Method,E05.318.780.300
20087081,2010-02-01T00:00:00,Double-Blind Method,E05.581.500.300
20087081,2010-02-01T00:00:00,Double-Blind Method,N05.715.360.780.320
20087081,2010-02-01T00:00:00,Double-Blind Method,N06.850.520.445.300
20087081,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20087081,2010-02-01T00:00:00,Medication Adherence,F01.145.488.500.500
20087081,2010-02-01T00:00:00,Medication Adherence,N05.300.150.600.600.500
20087081,2010-02-01T00:00:00,Patient Dropouts,M01.643.673
20087081,2010-02-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.600.850
20087081,2010-02-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.850.900
20087081,2010-02-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.600.850
20087081,2010-02-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.850.900
20087081,2010-02-01T00:00:00,Sertraline,D02.092.705.800
20087081,2010-02-01T00:00:00,Sertraline,D02.455.426.559.847.638.845.800
20087081,2010-02-01T00:00:00,Sertraline,D04.615.638.845.800
20087081,2010-02-01T00:00:00,Treatment Outcome,E01.789.800
20087081,2010-02-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20087081,2010-02-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20093597,2010-02-01T00:00:00,Adult,M01.060.116
20093597,2010-02-01T00:00:00,Breast Neoplasms,C04.588.180
20093597,2010-02-01T00:00:00,Breast Neoplasms,C17.800.090.500
20093597,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20093597,2010-02-01T00:00:00,Mammography,E01.370.350.700.500
20093597,2010-02-01T00:00:00,Middle Aged,M01.060.116.630
20093597,2010-02-01T00:00:00,Radiation Dosage,E05.799.513
20093597,2010-02-01T00:00:00,Radiation Dosage,G01.201.875.740
20093597,2010-02-01T00:00:00,Radiation Dosage,N06.850.810.250
20093597,2010-02-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
20093597,2010-02-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
20093597,2010-02-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
20093597,2010-02-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
20093597,2010-02-01T00:00:00,United States,Z01.107.567.875
20094000,2010-02-01T00:00:00,Adolescent,M01.060.057
20094000,2010-02-01T00:00:00,Albuterol,D02.033.100.291.057
20094000,2010-02-01T00:00:00,Albuterol,D02.092.063.291.057
20094000,2010-02-01T00:00:00,Albuterol,D02.092.471.683.061
20094000,2010-02-01T00:00:00,Anaphylaxis,C20.543.480.099
20094000,2010-02-01T00:00:00,Child,M01.060.406
20094000,2010-02-01T00:00:00,"Child, Preschool",M01.060.406.448
20094000,2010-02-01T00:00:00,Emergencies,C23.550.291.781
20094000,2010-02-01T00:00:00,Emergencies,N06.230.100.083
20094000,2010-02-01T00:00:00,Emergencies,N06.850.376
20094000,2010-02-01T00:00:00,Emergency Medical Services,N02.421.297
20094000,2010-02-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
20094000,2010-02-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
20094000,2010-02-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
20094000,2010-02-01T00:00:00,Hospitalization,E02.760.400
20094000,2010-02-01T00:00:00,Hospitalization,N02.421.585.400
20094000,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20094000,2010-02-01T00:00:00,Infant,M01.060.703
20094000,2010-02-01T00:00:00,"Infant, Newborn",M01.060.703.520
20100020,2010-02-01T00:00:00,Adolescent,M01.060.057
20100020,2010-02-01T00:00:00,Adult,M01.060.116
20100020,2010-02-01T00:00:00,Asthma,C08.127.108
20100020,2010-02-01T00:00:00,Asthma,C08.381.495.108
20100020,2010-02-01T00:00:00,Asthma,C08.674.095
20100020,2010-02-01T00:00:00,Asthma,C20.543.480.680.095
20100020,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20100020,2010-02-01T00:00:00,"Infant, Low Birth Weight",M01.060.703.520.460
20100020,2010-02-01T00:00:00,"Infant, Newborn",M01.060.703.520
20100020,2010-02-01T00:00:00,Pre-Eclampsia,C13.703.395.249
20100020,2010-02-01T00:00:00,Pregnancy,G08.686.785.760.769
20100020,2010-02-01T00:00:00,Pregnancy Complications,C13.703
20100020,2010-02-01T00:00:00,Pregnancy Outcome,E01.789.700
20100020,2010-02-01T00:00:00,Pregnancy Outcome,G08.686.785.760.769.530
20100020,2010-02-01T00:00:00,Premature Birth,C13.703.420.491.500
20100020,2010-02-01T00:00:00,Quality of Life,I01.800
20100020,2010-02-01T00:00:00,Quality of Life,K01.752.400.750
20100020,2010-02-01T00:00:00,Questionnaires,E05.318.308.750
20100020,2010-02-01T00:00:00,Questionnaires,L01.280.800
20100020,2010-02-01T00:00:00,Questionnaires,N05.715.360.300.695
20100020,2010-02-01T00:00:00,Questionnaires,N06.850.520.308.750
20100020,2010-02-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
20100020,2010-02-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
20100020,2010-02-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
20100020,2010-02-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
20100020,2010-02-01T00:00:00,Young Adult,M01.060.116.815
20103337,2010-02-01T00:00:00,Age Factors,N05.715.350.075
20103337,2010-02-01T00:00:00,Age Factors,N06.850.490.250
20103337,2010-02-01T00:00:00,Body Weight,C23.888.144
20103337,2010-02-01T00:00:00,Body Weight,E01.370.600.115.100.160.120
20103337,2010-02-01T00:00:00,Body Weight,E05.041.124.160.750
20103337,2010-02-01T00:00:00,Body Weight,G07.100.100.160.120
20103337,2010-02-01T00:00:00,Body Weight,G07.700.320.249.314.120
20103337,2010-02-01T00:00:00,Child,M01.060.406
20103337,2010-02-01T00:00:00,"Child, Preschool",M01.060.406.448
20103337,2010-02-01T00:00:00,Echocardiography,E01.370.350.850.220
20103337,2010-02-01T00:00:00,Echocardiography,E01.370.370.380.220
20103337,2010-02-01T00:00:00,"Heart Defects, Congenital",C14.240.400
20103337,2010-02-01T00:00:00,"Heart Defects, Congenital",C14.280.400
20103337,2010-02-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
20103337,2010-02-01T00:00:00,Hemodynamics,G09.330.190.400
20103337,2010-02-01T00:00:00,Hemodynamics,G09.330.380
20103337,2010-02-01T00:00:00,Hospital Mortality,E05.318.308.985.550.400
20103337,2010-02-01T00:00:00,Hospital Mortality,L01.280.975.550.400
20103337,2010-02-01T00:00:00,Hospital Mortality,N01.224.935.698.400
20103337,2010-02-01T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
20103337,2010-02-01T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
20103337,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20103337,2010-02-01T00:00:00,Infant,M01.060.703
20103337,2010-02-01T00:00:00,"Infant, Newborn",M01.060.703.520
20103337,2010-02-01T00:00:00,Length of Stay,E02.760.400.480
20103337,2010-02-01T00:00:00,Length of Stay,N02.421.585.400.480
20103337,2010-02-01T00:00:00,Postoperative Complications,C23.550.767
20103337,2010-02-01T00:00:00,Reoperation,E04.690
20103337,2010-02-01T00:00:00,Treatment Outcome,E01.789.800
20103337,2010-02-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20103337,2010-02-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20104486,2010-02-01T00:00:00,Adenoviridae,B04.280.030
20104486,2010-02-01T00:00:00,Adenoviridae,B04.909.204.097
20104486,2010-02-01T00:00:00,Animals,B01.050
20104486,2010-02-01T00:00:00,Cyclin-Dependent Kinase Inhibitor p21,D12.644.360.225.500
20104486,2010-02-01T00:00:00,Cyclin-Dependent Kinase Inhibitor p21,D12.776.167.187.500
20104486,2010-02-01T00:00:00,Cyclin-Dependent Kinase Inhibitor p21,D12.776.476.225.500
20104486,2010-02-01T00:00:00,Cyclin-Dependent Kinase Inhibitor p21,D12.776.624.776.355.500
20104486,2010-02-01T00:00:00,Gene Transfer Techniques,E05.393.350
20104486,2010-02-01T00:00:00,Liver Regeneration,G10.261.326.520
20104486,2010-02-01T00:00:00,Liver Regeneration,G16.100.856.468
20104486,2010-02-01T00:00:00,Liver Transplantation,E04.210.650
20104486,2010-02-01T00:00:00,Liver Transplantation,E04.936.450.490
20104486,2010-02-01T00:00:00,Liver Transplantation,E04.936.580.490
20104486,2010-02-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20104486,2010-02-01T00:00:00,Signal Transduction,G02.111.087.800
20104486,2010-02-01T00:00:00,Signal Transduction,G02.149.115.800
20104486,2010-02-01T00:00:00,Signal Transduction,G04.299.880
20104486,2010-02-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.374.687.100
20104486,2010-02-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.954.800.720.100
20104486,2010-02-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.963.720.100
20104486,2010-02-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.374.687.100
20104486,2010-02-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.942.800.720.100
20104486,2010-02-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.960.720.100
20104486,2010-02-01T00:00:00,Transforming Growth Factor beta1,D23.529.374.687.100
20104486,2010-02-01T00:00:00,Transforming Growth Factor beta1,D23.529.942.800.720.100
20104486,2010-02-01T00:00:00,Transforming Growth Factor beta1,D23.529.960.720.100
20104486,2010-02-01T00:00:00,beta-Galactosidase,D08.811.277.450.410.100
20119827,2010-02-01T00:00:00,Animals,B01.050
20119827,2010-02-01T00:00:00,Autoimmune Diseases,C20.111
20119827,2010-02-01T00:00:00,Autoimmunity,G12.450.192
20119827,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20119827,2010-02-01T00:00:00,"Immunity, Innate",G12.450.575
20119827,2010-02-01T00:00:00,Vitamin D,D04.808.812.768
20122344,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20122344,2010-02-01T00:00:00,Middle Aged,M01.060.116.630
20122344,2010-02-01T00:00:00,Nasal Polyps,C08.460.572
20122344,2010-02-01T00:00:00,Nasal Polyps,C09.603.557
20122344,2010-02-01T00:00:00,Nasal Polyps,C23.300.825.557
20122344,2010-02-01T00:00:00,Turbinates,A02.835.232.781.324.948
20122344,2010-02-01T00:00:00,Turbinates,A04.531.898
20122954,2010-02-01T00:00:00,Alcohol Drinking,F01.145.317.269
20122954,2010-02-01T00:00:00,Animals,B01.050
20122954,2010-02-01T00:00:00,Drug Interactions,G07.690.812.240
20122954,2010-02-01T00:00:00,Drug Interactions,G07.700.680.240
20122954,2010-02-01T00:00:00,Ethanol,D02.033.375
20122954,2010-02-01T00:00:00,Methylphenidate,D02.241.223.601.600
20122954,2010-02-01T00:00:00,Methylphenidate,D03.383.621.460
20122954,2010-02-01T00:00:00,Motor Activity,F01.145.632
20122954,2010-02-01T00:00:00,Motor Activity,G11.427.590.530.698
20123692,2010-02-01T00:00:00,Disability Evaluation,E01.370.400
20123692,2010-02-01T00:00:00,Gait,E01.370.600.250
20123692,2010-02-01T00:00:00,Gait,G11.427.590.530.389
20123692,2010-02-01T00:00:00,"Gait Disorders, Neurologic",C10.597.404
20123692,2010-02-01T00:00:00,"Gait Disorders, Neurologic",C23.888.592.413
20123692,2010-02-01T00:00:00,Hip Joint,A02.835.583.411
20123692,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20123692,2010-02-01T00:00:00,Lower Extremity,A01.378.610
20123692,2010-02-01T00:00:00,Postural Balance,G11.427.690
20123692,2010-02-01T00:00:00,Postural Balance,G11.561.600.810.541.595
20123692,2010-02-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
20123692,2010-02-01T00:00:00,Spinal Cord Injuries,C10.900.850
20123692,2010-02-01T00:00:00,Spinal Cord Injuries,C21.866.819
20123692,2010-02-01T00:00:00,Walking,G11.427.590.530.568.900
20123692,2010-02-01T00:00:00,Walking,G11.427.590.530.698.940
20123692,2010-02-01T00:00:00,Walking,I03.450.642.845.940
20124191,2010-02-01T00:00:00,Carbohydrates,D09
20124191,2010-02-01T00:00:00,"History, 20th Century",K01.400.504.968
20124191,2010-02-01T00:00:00,United States,Z01.107.567.875
20130160,2010-02-01T00:00:00,Home Care Services,N02.421.143.524
20130160,2010-02-01T00:00:00,Home Care Services,N02.421.539.089
20130160,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20130160,2010-02-01T00:00:00,Patient Care Team,N04.590.715
20135555,2010-02-01T00:00:00,Family Practice,H02.403.280
20135555,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20135555,2010-02-01T00:00:00,Internet,L01.224.230.110.500
20135555,2010-02-01T00:00:00,United States,Z01.107.567.875
20135560,2010-02-01T00:00:00,Chronic Disease,C23.550.291.500
20135560,2010-02-01T00:00:00,"Education, Medical, Graduate",I02.358.337.350
20135560,2010-02-01T00:00:00,"Education, Medical, Graduate",I02.358.399.350
20135560,2010-02-01T00:00:00,Family Practice,H02.403.280
20135560,2010-02-01T00:00:00,Health Services Accessibility,N04.590.374.350
20135560,2010-02-01T00:00:00,Health Services Accessibility,N05.300.430
20135560,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20135560,2010-02-01T00:00:00,Internship and Residency,I02.358.399.644
20135560,2010-02-01T00:00:00,Patient-Centered Care,N04.590.233.675
20135560,2010-02-01T00:00:00,Patient-Centered Care,N04.590.233.727.407
20135560,2010-02-01T00:00:00,Patient-Centered Care,N04.590.720
20135560,2010-02-01T00:00:00,United States,Z01.107.567.875
20135565,2010-02-01T00:00:00,Attitude to Health,F01.100.150
20135565,2010-02-01T00:00:00,Attitude to Health,N05.300.150
20135565,2010-02-01T00:00:00,"Education, Medical",I02.358.399
20135565,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20135565,2010-02-01T00:00:00,Medicine in Literature,K01.517.584
20135565,2010-02-01T00:00:00,Narration,E05.318.308.502
20135565,2010-02-01T00:00:00,Narration,F01.145.209.459
20135565,2010-02-01T00:00:00,Narration,L01.280.660
20135565,2010-02-01T00:00:00,Narration,N05.715.360.300.480
20135565,2010-02-01T00:00:00,Narration,N06.850.520.308.502
20135565,2010-02-01T00:00:00,Teaching,I02.903
20135675,2010-02-01T00:00:00,Adult,M01.060.116
20135675,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20135675,2010-02-01T00:00:00,Occupational Exposure,N06.850.460.350.600
20135675,2010-02-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
20135675,2010-02-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
20135675,2010-02-01T00:00:00,Pilot Projects,E05.318.760.750
20135675,2010-02-01T00:00:00,Pilot Projects,E05.337.737
20135675,2010-02-01T00:00:00,Pilot Projects,N05.715.360.775.625
20135675,2010-02-01T00:00:00,Pilot Projects,N06.850.520.450.720
20135675,2010-02-01T00:00:00,Psychotherapy,F04.754
20135675,2010-02-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
20135675,2010-02-01T00:00:00,Telemedicine,H02.403.840
20135675,2010-02-01T00:00:00,Telemedicine,L01.178.847.652
20135675,2010-02-01T00:00:00,Telemedicine,N04.590.374.800
20135675,2010-02-01T00:00:00,Veterans,M01.930
20135675,2010-02-01T00:00:00,Young Adult,M01.060.116.815
20135676,2010-02-01T00:00:00,Adolescent,M01.060.057
20135676,2010-02-01T00:00:00,Adult,M01.060.116
20135676,2010-02-01T00:00:00,Data Collection,E05.318.308
20135676,2010-02-01T00:00:00,Data Collection,L01.280
20135676,2010-02-01T00:00:00,Data Collection,N05.715.360.300
20135676,2010-02-01T00:00:00,Data Collection,N06.850.520.308
20135676,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20135676,2010-02-01T00:00:00,Interviews as Topic,E05.318.308.420
20135676,2010-02-01T00:00:00,Interviews as Topic,L01.280.520
20135676,2010-02-01T00:00:00,Interviews as Topic,N05.715.360.300.400
20135676,2010-02-01T00:00:00,Interviews as Topic,N06.850.520.308.420
20135676,2010-02-01T00:00:00,Rape,I01.198.240.748.640
20135676,2010-02-01T00:00:00,Substance-Related Disorders,C21.739
20135676,2010-02-01T00:00:00,Substance-Related Disorders,F03.900
20135676,2010-02-01T00:00:00,United States,Z01.107.567.875
20135676,2010-02-01T00:00:00,Young Adult,M01.060.116.815
20136228,2010-02-01T00:00:00,Acoustic Stimulation,E02.037
20136228,2010-02-01T00:00:00,Acoustic Stimulation,E02.190.888.030
20136228,2010-02-01T00:00:00,Acoustic Stimulation,E05.723.136
20136228,2010-02-01T00:00:00,Adult,M01.060.116
20136228,2010-02-01T00:00:00,Aged,M01.060.116.100
20136228,2010-02-01T00:00:00,Algorithms,G17.035
20136228,2010-02-01T00:00:00,Algorithms,L01.224.050
20136228,2010-02-01T00:00:00,Computer Simulation,L01.224.160
20136228,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20136228,2010-02-01T00:00:00,Middle Aged,M01.060.116.630
20136228,2010-02-01T00:00:00,"Models, Neurological",E05.599.395.642
20136228,2010-02-01T00:00:00,Speech Perception,F02.463.593.071.875
20136228,2010-02-01T00:00:00,Young Adult,M01.060.116.815
20141289,2010-02-01T00:00:00,Animals,B01.050
20141289,2010-02-01T00:00:00,Cocaine,D02.145.074.722.388
20141289,2010-02-01T00:00:00,Cocaine,D03.132.889.354
20141289,2010-02-01T00:00:00,Cocaine,D03.605.869.388
20141289,2010-02-01T00:00:00,Cocaine,D04.075.080.875.099.722.388
20141289,2010-02-01T00:00:00,"Conditioning, Operant",F02.463.425.179.509
20141289,2010-02-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
20141289,2010-02-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
20141289,2010-02-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
20141289,2010-02-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
20141289,2010-02-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20141289,2010-02-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
20141289,2010-02-01T00:00:00,Retention (Psychology),F02.463.425.540.772
20141289,2010-02-01T00:00:00,Time Factors,G01.910.857
20141721,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20141721,2010-02-01T00:00:00,Mass Screening,E01.370.500
20141721,2010-02-01T00:00:00,Mass Screening,E05.318.308.250.580
20141721,2010-02-01T00:00:00,Mass Screening,N02.421.143.827.233.443
20141721,2010-02-01T00:00:00,Mass Screening,N02.421.726.233.443
20141721,2010-02-01T00:00:00,Mass Screening,N05.715.360.300.375.500
20141721,2010-02-01T00:00:00,Mass Screening,N06.850.520.308.250.580
20141721,2010-02-01T00:00:00,Mass Screening,N06.850.780.500
20141721,2010-02-01T00:00:00,Primary Health Care,N04.590.233.727
20141721,2010-02-01T00:00:00,Psychotherapy,F04.754
20141721,2010-02-01T00:00:00,Questionnaires,E05.318.308.750
20141721,2010-02-01T00:00:00,Questionnaires,L01.280.800
20141721,2010-02-01T00:00:00,Questionnaires,N05.715.360.300.695
20141721,2010-02-01T00:00:00,Questionnaires,N06.850.520.308.750
20141721,2010-02-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20141721,2010-02-01T00:00:00,Risk Factors,N05.715.350.200.700
20141721,2010-02-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20141721,2010-02-01T00:00:00,Risk Factors,N06.850.490.625.750
20141721,2010-02-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20141721,2010-02-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.600.850
20141721,2010-02-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.850.900
20141721,2010-02-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.600.850
20141721,2010-02-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.850.900
20141721,2010-02-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
20141721,2010-02-01T00:00:00,Time Factors,G01.910.857
20141818,2010-02-01T00:00:00,Composite Resins,D05.750.716.822.308
20141818,2010-02-01T00:00:00,Composite Resins,D25.339.816.500
20141818,2010-02-01T00:00:00,Composite Resins,D25.720.716.822.308
20141818,2010-02-01T00:00:00,Composite Resins,J01.637.051.339.816.500
20141818,2010-02-01T00:00:00,Composite Resins,J01.637.051.720.716.822.308
20141818,2010-02-01T00:00:00,Dental Materials,D25.339
20141818,2010-02-01T00:00:00,Dental Materials,D27.720.102.339
20141818,2010-02-01T00:00:00,Dental Materials,J01.637.051.339
20141818,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20141818,2010-02-01T00:00:00,Polymethyl Methacrylate,D02.241.081.069.800.550.500
20141818,2010-02-01T00:00:00,Polymethyl Methacrylate,D05.750.716.822.111.650.605.500
20141818,2010-02-01T00:00:00,Polymethyl Methacrylate,D25.720.716.822.111.650.605.500
20141818,2010-02-01T00:00:00,Polymethyl Methacrylate,J01.637.051.720.716.822.111.650.605.500
20141818,2010-02-01T00:00:00,Surface Properties,G02.842.850
20145507,2010-02-01T00:00:00,Adolescent,M01.060.057
20145507,2010-02-01T00:00:00,Bradycardia,C14.280.067.319
20145507,2010-02-01T00:00:00,Bradycardia,C23.550.073.300
20145507,2010-02-01T00:00:00,Emergencies,C23.550.291.781
20145507,2010-02-01T00:00:00,Emergencies,N06.230.100.083
20145507,2010-02-01T00:00:00,Emergencies,N06.850.376
20145507,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20145507,2010-02-01T00:00:00,Nerve Compression Syndromes,C10.668.829.550
20145507,2010-02-01T00:00:00,Oculomotor Muscles,A02.633.567.700
20145507,2010-02-01T00:00:00,Oculomotor Muscles,A09.371.613
20145507,2010-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20145507,2010-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20145507,2010-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20145507,2010-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20145507,2010-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20145507,2010-02-01T00:00:00,Vomiting,C23.888.821.937
20145550,2010-02-01T00:00:00,Animals,B01.050
20145550,2010-02-01T00:00:00,"Antigens, CD",D23.050.301.264.035
20145550,2010-02-01T00:00:00,"Antigens, CD",D23.101.100.110
20145550,2010-02-01T00:00:00,"Carcinoma, Lewis Lung",C04.557.470.200.280
20145550,2010-02-01T00:00:00,"Carcinoma, Lewis Lung",C04.619.230
20145550,2010-02-01T00:00:00,Dinoprostone,D10.251.355.255.100.637.250.200
20145550,2010-02-01T00:00:00,Dinoprostone,D10.251.355.255.550.250.200
20145550,2010-02-01T00:00:00,Dinoprostone,D23.469.050.175.725.780.200
20145550,2010-02-01T00:00:00,Endothelial Cells,A11.436.275
20145550,2010-02-01T00:00:00,Indomethacin,D03.438.473.420
20145550,2010-02-01T00:00:00,Interferon-gamma,D12.644.276.374.440.893
20145550,2010-02-01T00:00:00,Interferon-gamma,D12.644.276.374.480.350
20145550,2010-02-01T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
20145550,2010-02-01T00:00:00,Interferon-gamma,D12.644.276.718.550
20145550,2010-02-01T00:00:00,Interferon-gamma,D12.776.467.374.440.893
20145550,2010-02-01T00:00:00,Interferon-gamma,D12.776.467.374.480.350
20145550,2010-02-01T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
20145550,2010-02-01T00:00:00,Interferon-gamma,D12.776.467.718.550
20145550,2010-02-01T00:00:00,Interferon-gamma,D23.529.374.440.893
20145550,2010-02-01T00:00:00,Interferon-gamma,D23.529.374.480.350
20145550,2010-02-01T00:00:00,Interferon-gamma,D23.529.374.480.615.350
20145550,2010-02-01T00:00:00,Interferon-gamma,D23.529.718.550
20145550,2010-02-01T00:00:00,Interleukin-2,D12.644.276.374.465.502
20145550,2010-02-01T00:00:00,Interleukin-2,D12.644.276.374.480.372
20145550,2010-02-01T00:00:00,Interleukin-2,D12.776.467.374.465.502
20145550,2010-02-01T00:00:00,Interleukin-2,D12.776.467.374.480.372
20145550,2010-02-01T00:00:00,Interleukin-2,D23.529.374.465.502
20145550,2010-02-01T00:00:00,Interleukin-2,D23.529.374.480.372
20145550,2010-02-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
20145550,2010-02-01T00:00:00,Lung Neoplasms,C08.381.540
20145550,2010-02-01T00:00:00,Lung Neoplasms,C08.785.520
20145550,2010-02-01T00:00:00,Lymphocyte Activation,E01.450.495.482
20145550,2010-02-01T00:00:00,Lymphocyte Activation,E05.478.594.530
20145550,2010-02-01T00:00:00,Lymphocyte Activation,G12.425.747
20145550,2010-02-01T00:00:00,Lymphocyte Activation,G12.450.050.400.545
20145550,2010-02-01T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
20145550,2010-02-01T00:00:00,Pyrroles,D03.383.129.578
20145550,2010-02-01T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
20145550,2010-02-01T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
20145550,2010-02-01T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
20145550,2010-02-01T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
20145550,2010-02-01T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
20145550,2010-02-01T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
20146648,2010-02-01T00:00:00,Brain,A08.186.211
20146648,2010-02-01T00:00:00,Cognition Disorders,F03.087.250
20146648,2010-02-01T00:00:00,Electroconvulsive Therapy,F04.570.200.583
20146648,2010-02-01T00:00:00,Electroconvulsive Therapy,F04.669.224.300
20146648,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20146648,2010-02-01T00:00:00,Mental Disorders,F03
20146648,2010-02-01T00:00:00,Suicide,F01.145.126.980.875
20146648,2010-02-01T00:00:00,Suicide,I01.880.735.856
20146648,2010-02-01T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
20146648,2010-02-01T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
20154532,2010-02-01T00:00:00,"Accidents, Traffic",N06.850.135.392
20154532,2010-02-01T00:00:00,Adolescent,M01.060.057
20154532,2010-02-01T00:00:00,Debridement,E04.176
20154532,2010-02-01T00:00:00,Digestive System Surgical Procedures,E04.210
20154532,2010-02-01T00:00:00,"Fractures, Bone",C21.866.404
20154532,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20154532,2010-02-01T00:00:00,Multiple Trauma,C21.866.640
20154532,2010-02-01T00:00:00,Reoperation,E04.690
20154532,2010-02-01T00:00:00,Surgical Wound Infection,C01.539.947.692
20154532,2010-02-01T00:00:00,Surgical Wound Infection,C23.550.767.925
20154532,2010-02-01T00:00:00,Wound Healing,G16.100.856.891
20163262,2010-02-01T00:00:00,Adult,M01.060.116
20163262,2010-02-01T00:00:00,Case Management,N04.590.233.624.250
20163262,2010-02-01T00:00:00,Child,M01.060.406
20163262,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20163262,2010-02-01T00:00:00,Peritonitis,C06.844.640
20186985,2010-02-01T00:00:00,Adult,M01.060.116
20186985,2010-02-01T00:00:00,Aged,M01.060.116.100
20186985,2010-02-01T00:00:00,Attention,F02.830.104.214
20186985,2010-02-01T00:00:00,Cardiac Output,E01.370.370.380.150
20186985,2010-02-01T00:00:00,Cardiac Output,G09.330.380.124
20186985,2010-02-01T00:00:00,"Cardiac Pacing, Artificial",E02.145
20186985,2010-02-01T00:00:00,Cognition,F02.463.188
20186985,2010-02-01T00:00:00,Cognition Disorders,F03.087.250
20186985,2010-02-01T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
20186985,2010-02-01T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
20186985,2010-02-01T00:00:00,"Defibrillators, Implantable",E07.695.175
20186985,2010-02-01T00:00:00,Electric Countershock,E02.342.287
20186985,2010-02-01T00:00:00,Executive Function,F02.463.217
20186985,2010-02-01T00:00:00,Heart Failure,C14.280.434
20186985,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20186985,2010-02-01T00:00:00,Middle Aged,M01.060.116.630
20186985,2010-02-01T00:00:00,Neuropsychological Tests,F04.711.513
20186985,2010-02-01T00:00:00,Pilot Projects,E05.318.760.750
20186985,2010-02-01T00:00:00,Pilot Projects,E05.337.737
20186985,2010-02-01T00:00:00,Pilot Projects,N05.715.360.775.625
20186985,2010-02-01T00:00:00,Pilot Projects,N06.850.520.450.720
20186985,2010-02-01T00:00:00,Quality of Life,I01.800
20186985,2010-02-01T00:00:00,Quality of Life,K01.752.400.750
20186985,2010-02-01T00:00:00,Questionnaires,E05.318.308.750
20186985,2010-02-01T00:00:00,Questionnaires,L01.280.800
20186985,2010-02-01T00:00:00,Questionnaires,N05.715.360.300.695
20186985,2010-02-01T00:00:00,Questionnaires,N06.850.520.308.750
20186985,2010-02-01T00:00:00,Time Factors,G01.910.857
20186985,2010-02-01T00:00:00,Treatment Outcome,E01.789.800
20186985,2010-02-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20186985,2010-02-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20186985,2010-02-01T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
20193646,2010-02-01T00:00:00,Adolescent,M01.060.057
20193646,2010-02-01T00:00:00,Adult,M01.060.116
20193646,2010-02-01T00:00:00,Aged,M01.060.116.100
20193646,2010-02-01T00:00:00,Combined Modality Therapy,E02.186
20193646,2010-02-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
20193646,2010-02-01T00:00:00,Electroconvulsive Therapy,F04.570.200.583
20193646,2010-02-01T00:00:00,Electroconvulsive Therapy,F04.669.224.300
20193646,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20193646,2010-02-01T00:00:00,Middle Aged,M01.060.116.630
20193646,2010-02-01T00:00:00,Neuropsychological Tests,F04.711.513
20193646,2010-02-01T00:00:00,Nortriptyline,D02.455.426.559.847.181.384.535
20193646,2010-02-01T00:00:00,Nortriptyline,D04.615.181.384.535
20193646,2010-02-01T00:00:00,Psychiatric Status Rating Scales,F04.586
20193646,2010-02-01T00:00:00,Treatment Outcome,E01.789.800
20193646,2010-02-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20193646,2010-02-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20201897,2010-02-01T00:00:00,Animals,B01.050
20201897,2010-02-01T00:00:00,Extracellular Matrix,A11.284.295.310
20201897,2010-02-01T00:00:00,Extracellular Space,A10.082.500
20201897,2010-02-01T00:00:00,Extracellular Space,A11.284.295
20201897,2010-02-01T00:00:00,Fibroblasts,A11.329.228
20201897,2010-02-01T00:00:00,Fibroblasts,A11.872.228
20201897,2010-02-01T00:00:00,Interleukin-6,D12.644.276.374.465.506
20201897,2010-02-01T00:00:00,Interleukin-6,D12.776.467.374.465.506
20201897,2010-02-01T00:00:00,Interleukin-6,D23.529.374.465.506
20201897,2010-02-01T00:00:00,"Microscopy, Electron, Transmission",E01.370.350.515.402.580
20201897,2010-02-01T00:00:00,"Microscopy, Electron, Transmission",E05.595.402.580
20201897,2010-02-01T00:00:00,Myocardium,A02.633.580
20201897,2010-02-01T00:00:00,Myocardium,A07.541.704
20201897,2010-02-01T00:00:00,Myocardium,A10.690.552.750
20201897,2010-02-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20201897,2010-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
20201897,2010-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
20201897,2010-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
20201897,2010-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
20201897,2010-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
20201897,2010-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
20201897,2010-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
20201897,2010-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
20201897,2010-02-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
20201897,2010-02-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
20201897,2010-02-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
20201898,2010-02-01T00:00:00,Amino Acid Sequence,G02.111.570.060
20201898,2010-02-01T00:00:00,Amino Acid Sequence,L01.453.245.667.060
20201898,2010-02-01T00:00:00,Binding Sites,G02.111.570.120
20201898,2010-02-01T00:00:00,"Calcium Channels, L-Type",D12.776.157.530.400.150.400
20201898,2010-02-01T00:00:00,"Calcium Channels, L-Type",D12.776.543.550.425.150.400
20201898,2010-02-01T00:00:00,"Calcium Channels, L-Type",D12.776.543.585.400.150.400
20201898,2010-02-01T00:00:00,Calcium Signaling,G02.111.087.800.800.100
20201898,2010-02-01T00:00:00,Calcium Signaling,G02.149.115.800.800.100
20201898,2010-02-01T00:00:00,Calcium Signaling,G03.495.166.500.100
20201898,2010-02-01T00:00:00,Calcium Signaling,G04.299.880.800.100
20201898,2010-02-01T00:00:00,Calmodulin,D12.644.360.381.249
20201898,2010-02-01T00:00:00,Calmodulin,D12.776.157.125.412.249
20201898,2010-02-01T00:00:00,Calmodulin,D12.776.476.387.249
20201898,2010-02-01T00:00:00,Cell Line,A11.251.210
20201898,2010-02-01T00:00:00,Cyclic AMP-Dependent Protein Kinases,D08.811.913.696.620.682.700.150.125
20201898,2010-02-01T00:00:00,Cyclic AMP-Dependent Protein Kinases,D12.644.360.200.125
20201898,2010-02-01T00:00:00,Cyclic AMP-Dependent Protein Kinases,D12.776.476.200.125
20201898,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20201898,2010-02-01T00:00:00,Molecular Sequence Data,L01.453.245.667
20201898,2010-02-01T00:00:00,Myocardium,A02.633.580
20201898,2010-02-01T00:00:00,Myocardium,A07.541.704
20201898,2010-02-01T00:00:00,Myocardium,A10.690.552.750
20201898,2010-02-01T00:00:00,Oxygen,D01.268.185.550
20201898,2010-02-01T00:00:00,Oxygen,D01.362.670
20201898,2010-02-01T00:00:00,Phosphorylation,G02.111.087.677
20201898,2010-02-01T00:00:00,Phosphorylation,G02.149.115.677
20201898,2010-02-01T00:00:00,Phosphorylation,G02.149.465.700
20201898,2010-02-01T00:00:00,Phosphorylation,G02.607.750.700
20201898,2010-02-01T00:00:00,Phosphorylation,G03.495.790
20201901,2010-02-01T00:00:00,Aging,G07.700.320.124
20201901,2010-02-01T00:00:00,Animals,B01.050
20201901,2010-02-01T00:00:00,"Cardiomyopathy, Hypertrophic",C14.280.238.100
20201901,2010-02-01T00:00:00,"Cardiomyopathy, Hypertrophic",C14.280.484.150.070.160
20201901,2010-02-01T00:00:00,Cell Differentiation,G04.299.151
20201901,2010-02-01T00:00:00,Heart Valve Diseases,C14.280.484
20201901,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20201901,2010-02-01T00:00:00,"Models, Cardiovascular",E05.599.395.161
20201901,2010-02-01T00:00:00,Mutation,G05.365.590
20227617,2010-02-01T00:00:00,Adolescent,M01.060.057
20227617,2010-02-01T00:00:00,Cataract Extraction,E04.540.825.249
20227617,2010-02-01T00:00:00,Child,M01.060.406
20227617,2010-02-01T00:00:00,"Child, Preschool",M01.060.406.448
20227617,2010-02-01T00:00:00,Eye,A01.456.505.420
20227617,2010-02-01T00:00:00,Eye,A09.371
20227617,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20227617,2010-02-01T00:00:00,Infant,M01.060.703
20227617,2010-02-01T00:00:00,"Infant, Newborn",M01.060.703.520
20227617,2010-02-01T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
20227617,2010-02-01T00:00:00,Postoperative Complications,C23.550.767
20227617,2010-02-01T00:00:00,Visual Acuity,E01.370.380.850.950
20227617,2010-02-01T00:00:00,Visual Acuity,F02.463.593.932.901
20227617,2010-02-01T00:00:00,Visual Acuity,G14.940
20227629,2010-02-01T00:00:00,Cataract Extraction,E04.540.825.249
20227629,2010-02-01T00:00:00,Disease Progression,C23.550.291.656
20227629,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20227629,2010-02-01T00:00:00,Infant,M01.060.703
20227629,2010-02-01T00:00:00,"Lens Capsule, Crystalline",A09.371.060.500.155
20227629,2010-02-01T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
20227629,2010-02-01T00:00:00,"Lens, Crystalline",A09.371.060.500
20229893,2010-02-01T00:00:00,Adult,M01.060.116
20229893,2010-02-01T00:00:00,Body Burden,E05.799.638.231
20229893,2010-02-01T00:00:00,Body Burden,N06.850.460.200
20229893,2010-02-01T00:00:00,Body Weight,C23.888.144
20229893,2010-02-01T00:00:00,Body Weight,E01.370.600.115.100.160.120
20229893,2010-02-01T00:00:00,Body Weight,E05.041.124.160.750
20229893,2010-02-01T00:00:00,Body Weight,G07.100.100.160.120
20229893,2010-02-01T00:00:00,Body Weight,G07.700.320.249.314.120
20229893,2010-02-01T00:00:00,Computer Simulation,L01.224.160
20229893,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20229893,2010-02-01T00:00:00,"Models, Biological",E05.599.395
20229893,2010-02-01T00:00:00,"Radiography, Thoracic",E01.370.350.700.730
20229893,2010-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20229893,2010-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20229893,2010-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20229893,2010-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20229893,2010-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20229893,2010-02-01T00:00:00,Whole-Body Counting,E05.799.950
20336907,2010-02-01T00:00:00,Abdominal Pain,C23.888.646.100
20336907,2010-02-01T00:00:00,Abdominal Pain,C23.888.821.030
20336907,2010-02-01T00:00:00,Adult,M01.060.116
20336907,2010-02-01T00:00:00,Angiography,E01.370.350.700.060
20336907,2010-02-01T00:00:00,Angiography,E01.370.370.050
20336907,2010-02-01T00:00:00,"Diagnosis, Differential",E01.171
20336907,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20336907,2010-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20336907,2010-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20336907,2010-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20336907,2010-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20336907,2010-02-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20370244,2010-02-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
20370244,2010-02-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
20370244,2010-02-01T00:00:00,Gait,E01.370.600.250
20370244,2010-02-01T00:00:00,Gait,G11.427.590.530.389
20370244,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20370244,2010-02-01T00:00:00,Knee Joint,A02.835.583.475
20469621,2010-02-01T00:00:00,Adult,M01.060.116
20469621,2010-02-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
20469621,2010-02-01T00:00:00,Cause of Death,E05.318.308.985.550.250
20469621,2010-02-01T00:00:00,Cause of Death,L01.280.975.550.250
20469621,2010-02-01T00:00:00,Cause of Death,N01.224.935.698.100
20469621,2010-02-01T00:00:00,Cause of Death,N06.850.505.400.975.550.250
20469621,2010-02-01T00:00:00,Cause of Death,N06.850.520.308.985.550.250
20469621,2010-02-01T00:00:00,Cystic Fibrosis,C06.689.202
20469621,2010-02-01T00:00:00,Cystic Fibrosis,C08.381.187
20469621,2010-02-01T00:00:00,Cystic Fibrosis,C16.320.190
20469621,2010-02-01T00:00:00,Cystic Fibrosis,C16.614.213
20469621,2010-02-01T00:00:00,Hemoptysis,C08.381.348
20469621,2010-02-01T00:00:00,Hemoptysis,C23.550.414.896
20469621,2010-02-01T00:00:00,Hemoptysis,C23.888.852.430
20469621,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20469621,2010-02-01T00:00:00,Patient Care Team,N04.590.715
20469621,2010-02-01T00:00:00,Pneumothorax,C08.528.778
20469621,2010-02-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
20469621,2010-02-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
20469621,2010-02-01T00:00:00,Respiratory Insufficiency,C08.618.846
20469632,2010-02-01T00:00:00,Aged,M01.060.116.100
20469632,2010-02-01T00:00:00,Anticoagulants,D27.505.954.502.119
20469632,2010-02-01T00:00:00,Double-Blind Method,E05.318.780.300
20469632,2010-02-01T00:00:00,Double-Blind Method,E05.581.500.300
20469632,2010-02-01T00:00:00,Double-Blind Method,N05.715.360.780.320
20469632,2010-02-01T00:00:00,Double-Blind Method,N06.850.520.445.300
20469632,2010-02-01T00:00:00,Enoxaparin,D09.698.373.400.300.200
20469632,2010-02-01T00:00:00,Hospitalization,E02.760.400
20469632,2010-02-01T00:00:00,Hospitalization,N02.421.585.400
20469632,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20469632,2010-02-01T00:00:00,Incidence,E05.318.308.985.525.375
20469632,2010-02-01T00:00:00,Incidence,L01.280.975.525.375
20469632,2010-02-01T00:00:00,Incidence,N01.224.935.597.500
20469632,2010-02-01T00:00:00,Incidence,N06.850.505.400.975.525.375
20469632,2010-02-01T00:00:00,Incidence,N06.850.520.308.985.525.375
20469632,2010-02-01T00:00:00,Pulmonary Embolism,C08.381.746
20469632,2010-02-01T00:00:00,Pulmonary Embolism,C14.907.355.350.700
20469632,2010-02-01T00:00:00,Venous Thrombosis,C14.907.355.830.925
23272376,2010-02-01T00:00:00,Automobile Driving,I03.125
23272376,2010-02-01T00:00:00,Epilepsy,C10.228.140.490
23272376,2010-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23272376,2010-02-01T00:00:00,Mandatory Reporting,F01.145.209.259.300
23272376,2010-02-01T00:00:00,Mandatory Reporting,I01.880.604.583.527
23272376,2010-02-01T00:00:00,Mandatory Reporting,I01.880.604.622.249
23272376,2010-02-01T00:00:00,Mandatory Reporting,N03.706.535.615
23272376,2010-02-01T00:00:00,Mandatory Reporting,N03.706.657.249
23272376,2010-02-01T00:00:00,Risk-Taking,F01.145.722
23272376,2010-02-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23272376,2010-02-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23272377,2010-02-01T00:00:00,Animals,B01.050
23272377,2010-02-01T00:00:00,Estrogens,D27.505.696.399.472.277
23272377,2010-02-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23272377,2010-02-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
23272377,2010-02-01T00:00:00,Spinal Cord Injuries,C10.900.850
23272377,2010-02-01T00:00:00,Spinal Cord Injuries,C21.866.819
20124494,2010-02-02T00:00:00,Animals,B01.050
20124494,2010-02-02T00:00:00,Cyclophosphamide,D02.455.526.728.650.730.243
20124494,2010-02-02T00:00:00,Cyclophosphamide,D02.705.670.243
20124494,2010-02-02T00:00:00,DNA,D13.444.308
20124494,2010-02-02T00:00:00,DNA Damage,C21.111
20124494,2010-02-02T00:00:00,DNA Damage,G05.355.180
20124494,2010-02-02T00:00:00,DNA Repair,G02.111.087.219
20124494,2010-02-02T00:00:00,DNA Repair,G02.149.115.219
20124494,2010-02-02T00:00:00,DNA Repair,G05.355.195
20124494,2010-02-02T00:00:00,Ethylnitrosourea,D02.654.692.300
20124494,2010-02-02T00:00:00,Ethylnitrosourea,D02.948.594.310
20124494,2010-02-02T00:00:00,"Models, Animal",E05.598
20124494,2010-02-02T00:00:00,Spermatozoa,A05.360.490.890
20124494,2010-02-02T00:00:00,Spermatozoa,A11.497.760
20124494,2010-02-02T00:00:00,Testis,A05.360.444.849
20124494,2010-02-02T00:00:00,Testis,A05.360.576.782
20124494,2010-02-02T00:00:00,Testis,A06.407.312.782
20124494,2010-02-02T00:00:00,Tumor Suppressor Protein p53,D12.776.260.820
20124494,2010-02-02T00:00:00,Tumor Suppressor Protein p53,D12.776.624.776.775
20124494,2010-02-02T00:00:00,Tumor Suppressor Protein p53,D12.776.660.825
20124494,2010-02-02T00:00:00,Tumor Suppressor Protein p53,D12.776.744.845
20129663,2010-02-02T00:00:00,Animals,B01.050
20129663,2010-02-02T00:00:00,Cell Differentiation,G04.299.151
20129663,2010-02-02T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
20129663,2010-02-02T00:00:00,Flow Cytometry,E05.200.500.386.350
20129663,2010-02-02T00:00:00,Heart,A07.541
20129663,2010-02-02T00:00:00,Hematopoietic Stem Cells,A11.148.378
20129663,2010-02-02T00:00:00,Hematopoietic Stem Cells,A11.872.378
20129663,2010-02-02T00:00:00,Hematopoietic Stem Cells,A15.378.316.378
20129663,2010-02-02T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
20129663,2010-02-02T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
20129663,2010-02-02T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
20129663,2010-02-02T00:00:00,"Microscopy, Confocal",E05.595.395
20129663,2010-02-02T00:00:00,"Microscopy, Electron, Transmission",E01.370.350.515.402.580
20129663,2010-02-02T00:00:00,"Microscopy, Electron, Transmission",E05.595.402.580
20129663,2010-02-02T00:00:00,"RNA, Messenger",D13.444.735.544
20129663,2010-02-02T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20129663,2010-02-02T00:00:00,Regeneration,G16.100.856
20133512,2010-02-04T00:00:00,Atrial Fibrillation,C14.280.067.198
20133512,2010-02-04T00:00:00,Atrial Fibrillation,C23.550.073.198
20133512,2010-02-04T00:00:00,Contrast Media,D27.720.259
20133512,2010-02-04T00:00:00,Fibrosis,C23.550.355
20133512,2010-02-04T00:00:00,Heart Atria,A07.541.358
20133512,2010-02-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20133512,2010-02-04T00:00:00,Image Enhancement,E01.370.350.600.350
20133512,2010-02-04T00:00:00,Image Enhancement,L01.224.308.380
20133512,2010-02-04T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
20133512,2010-02-04T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
20133512,2010-02-04T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20133512,2010-02-04T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20133512,2010-02-04T00:00:00,Middle Aged,M01.060.116.630
20133512,2010-02-04T00:00:00,Organometallic Compounds,D01.632
20133512,2010-02-04T00:00:00,Organometallic Compounds,D02.691
20140035,2010-02-04T00:00:00,Colonoscopy,E01.370.372.250.250.200
20140035,2010-02-04T00:00:00,Colonoscopy,E01.370.388.250.250.250.160
20140035,2010-02-04T00:00:00,Colonoscopy,E04.210.240.250.160
20140035,2010-02-04T00:00:00,Colonoscopy,E04.800.250.250.250.160
20140035,2010-02-04T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
20140035,2010-02-04T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
20140035,2010-02-04T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
20140035,2010-02-04T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
20140035,2010-02-04T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
20140035,2010-02-04T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
20140035,2010-02-04T00:00:00,Early Detection of Cancer,E01.390.500
20140035,2010-02-04T00:00:00,Evidence-Based Medicine,H02.249.750
20140035,2010-02-04T00:00:00,Evidence-Based Medicine,H02.403.200.400
20140035,2010-02-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20140035,2010-02-04T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
20140035,2010-02-04T00:00:00,Practice Guidelines as Topic,N05.700.350.650
20140035,2010-02-04T00:00:00,Risk Assessment,E05.318.740.600.800.715
20140035,2010-02-04T00:00:00,Risk Assessment,N04.452.871.715
20140035,2010-02-04T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20140035,2010-02-04T00:00:00,Risk Assessment,N06.850.505.715
20140035,2010-02-04T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20140035,2010-02-04T00:00:00,Risk Factors,E05.318.740.600.800.725
20140035,2010-02-04T00:00:00,Risk Factors,N05.715.350.200.700
20140035,2010-02-04T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20140035,2010-02-04T00:00:00,Risk Factors,N06.850.490.625.750
20140035,2010-02-04T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20140035,2010-02-04T00:00:00,United States,Z01.107.567.875
20139077,2010-02-05T00:00:00,Animals,B01.050
20139077,2010-02-05T00:00:00,Apoptosis,G04.299.139.160
20139077,2010-02-05T00:00:00,Cell Cycle,G04.299.134
20139077,2010-02-05T00:00:00,Cell Proliferation,G04.299.233.750
20139077,2010-02-05T00:00:00,Cell Proliferation,G07.700.320.249.410.750
20139077,2010-02-05T00:00:00,Cyclin-Dependent Kinase Inhibitor p21,D12.644.360.225.500
20139077,2010-02-05T00:00:00,Cyclin-Dependent Kinase Inhibitor p21,D12.776.167.187.500
20139077,2010-02-05T00:00:00,Cyclin-Dependent Kinase Inhibitor p21,D12.776.476.225.500
20139077,2010-02-05T00:00:00,Cyclin-Dependent Kinase Inhibitor p21,D12.776.624.776.355.500
20139077,2010-02-05T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
20139077,2010-02-05T00:00:00,Gene Silencing,G05.355.315.203.374
20139077,2010-02-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20139077,2010-02-05T00:00:00,"Mammary Neoplasms, Animal",C04.588.531
20139077,2010-02-05T00:00:00,"Mammary Neoplasms, Animal",C22.520
20139077,2010-02-05T00:00:00,Proto-Oncogene Proteins c-ets,D12.776.260.665
20139077,2010-02-05T00:00:00,Proto-Oncogene Proteins c-ets,D12.776.624.664.700.175
20139077,2010-02-05T00:00:00,Proto-Oncogene Proteins c-ets,D12.776.930.635
20123656,2010-02-07T00:00:00,"Air Pollution, Indoor",N06.850.460.100.080
20123656,2010-02-07T00:00:00,Environmental Exposure,N06.850.460.350
20123656,2010-02-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20123656,2010-02-07T00:00:00,Occupational Exposure,N06.850.460.350.600
20123656,2010-02-07T00:00:00,Smoking,F01.145.466.753
20123656,2010-02-07T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
20123656,2010-02-07T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
20116787,2010-02-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20116787,2010-02-08T00:00:00,Middle Aged,M01.060.116.630
20116787,2010-02-08T00:00:00,Ovarian Neoplasms,C04.588.322.455
20116787,2010-02-08T00:00:00,Ovarian Neoplasms,C13.351.500.056.630.705
20116787,2010-02-08T00:00:00,Ovarian Neoplasms,C13.351.937.418.685
20116787,2010-02-08T00:00:00,Ovarian Neoplasms,C19.344.410
20116787,2010-02-08T00:00:00,Ovarian Neoplasms,C19.391.630.705
20116787,2010-02-08T00:00:00,Syndrome,C23.550.288.500
20116787,2010-02-08T00:00:00,Vascular Malformations,C14.240.850
20116787,2010-02-08T00:00:00,Vascular Malformations,C16.131.240.850
20116928,2010-02-08T00:00:00,Adult,M01.060.116
20116928,2010-02-08T00:00:00,Combat Disorders,F03.080.931.249
20116928,2010-02-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20116928,2010-02-08T00:00:00,Hydroxyindoleacetic Acid,D03.066.288.478
20116928,2010-02-08T00:00:00,Hydroxyindoleacetic Acid,D03.438.473.404.478
20116928,2010-02-08T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
20116928,2010-02-08T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
20116928,2010-02-08T00:00:00,Middle Aged,M01.060.116.630
20116928,2010-02-08T00:00:00,Neuropeptides,D12.644.400
20116928,2010-02-08T00:00:00,Neuropeptides,D12.776.641.650
20116928,2010-02-08T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
20116928,2010-02-08T00:00:00,Veterans,M01.930
20116928,2010-02-08T00:00:00,Young Adult,M01.060.116.815
20142602,2010-02-08T00:00:00,Adult,M01.060.116
20142602,2010-02-08T00:00:00,Aged,M01.060.116.100
20142602,2010-02-08T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
20142602,2010-02-08T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
20142602,2010-02-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20142602,2010-02-08T00:00:00,Middle Aged,M01.060.116.630
20142602,2010-02-08T00:00:00,Mouth Neoplasms,C04.588.443.591
20142602,2010-02-08T00:00:00,Mouth Neoplasms,C07.465.565
20142602,2010-02-08T00:00:00,Neoplasm Staging,E01.370.550
20143180,2010-02-09T00:00:00,Adult,M01.060.116
20143180,2010-02-09T00:00:00,Deglutition Disorders,C06.405.117.119
20143180,2010-02-09T00:00:00,Deglutition Disorders,C09.775.174
20143180,2010-02-09T00:00:00,Gastroplasty,E02.065.062.750
20143180,2010-02-09T00:00:00,Gastroplasty,E04.062.750
20143180,2010-02-09T00:00:00,Gastroplasty,E04.210.485
20143180,2010-02-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20143180,2010-02-09T00:00:00,Middle Aged,M01.060.116.630
20143180,2010-02-09T00:00:00,Postoperative Complications,C23.550.767
20143180,2010-02-09T00:00:00,Quality of Life,I01.800
20143180,2010-02-09T00:00:00,Quality of Life,K01.752.400.750
20143180,2010-02-09T00:00:00,Satiety Response,F02.830.749.658
20143180,2010-02-09T00:00:00,Treatment Outcome,E01.789.800
20143180,2010-02-09T00:00:00,Treatment Outcome,N04.761.559.590.800
20143180,2010-02-09T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20143180,2010-02-09T00:00:00,Weight Loss,C23.888.144.243.963
20143180,2010-02-09T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
20144216,2010-02-09T00:00:00,Animals,B01.050
20144216,2010-02-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20144216,2010-02-09T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
20144216,2010-02-09T00:00:00,"Influenza, Human",C02.782.620.365
20144216,2010-02-09T00:00:00,"Influenza, Human",C08.730.310
20144216,2010-02-09T00:00:00,Lung,A04.411
20144216,2010-02-09T00:00:00,Orthomyxoviridae Infections,C02.782.620
20144216,2010-02-09T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
20145228,2010-02-10T00:00:00,Adolescent,M01.060.057
20145228,2010-02-10T00:00:00,Gastroplasty,E02.065.062.750
20145228,2010-02-10T00:00:00,Gastroplasty,E04.062.750
20145228,2010-02-10T00:00:00,Gastroplasty,E04.210.485
20145228,2010-02-10T00:00:00,Health Status,I01.240.425
20145228,2010-02-10T00:00:00,Health Status,N01.224.425
20145228,2010-02-10T00:00:00,Health Status,N06.850.505.400.425
20145228,2010-02-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20145228,2010-02-10T00:00:00,Laparoscopy,E01.370.388.250.520
20145228,2010-02-10T00:00:00,Laparoscopy,E04.800.250.520
20145228,2010-02-10T00:00:00,Life Style,F01.829.458
20145228,2010-02-10T00:00:00,Obesity,C18.654.726.500
20145228,2010-02-10T00:00:00,Obesity,C23.888.144.699.500
20145228,2010-02-10T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
20145228,2010-02-10T00:00:00,Obesity,G07.100.100.160.120.699.500
20145228,2010-02-10T00:00:00,Quality of Life,I01.800
20145228,2010-02-10T00:00:00,Quality of Life,K01.752.400.750
20145228,2010-02-10T00:00:00,Reoperation,E04.690
20145228,2010-02-10T00:00:00,Treatment Outcome,E01.789.800
20145228,2010-02-10T00:00:00,Treatment Outcome,N04.761.559.590.800
20145228,2010-02-10T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20145228,2010-02-10T00:00:00,Weight Loss,C23.888.144.243.963
20145228,2010-02-10T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
20147890,2010-02-10T00:00:00,Adolescent,M01.060.057
20147890,2010-02-10T00:00:00,Adult,M01.060.116
20147890,2010-02-10T00:00:00,African Americans,M01.686.508.100.100
20147890,2010-02-10T00:00:00,African Americans,M01.686.754.100
20147890,2010-02-10T00:00:00,Aged,M01.060.116.100
20147890,2010-02-10T00:00:00,"Alcohol-Induced Disorders, Nervous System",C10.720.112
20147890,2010-02-10T00:00:00,"Alcohol-Induced Disorders, Nervous System",C21.613.705.150
20147890,2010-02-10T00:00:00,"Alcohol-Induced Disorders, Nervous System",C21.739.100.087.193
20147890,2010-02-10T00:00:00,Alcoholism,C21.739.100.250
20147890,2010-02-10T00:00:00,Alcoholism,F03.900.100.350
20147890,2010-02-10T00:00:00,European Continental Ancestry Group,M01.686.508.400
20147890,2010-02-10T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
20147890,2010-02-10T00:00:00,Genetic Predisposition to Disease,G05.380.355
20147890,2010-02-10T00:00:00,Genome-Wide Association Study,E05.318.416.249
20147890,2010-02-10T00:00:00,Genome-Wide Association Study,E05.318.780.392
20147890,2010-02-10T00:00:00,Genome-Wide Association Study,E05.393.385.500
20147890,2010-02-10T00:00:00,Genome-Wide Association Study,E05.393.522.500
20147890,2010-02-10T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
20147890,2010-02-10T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
20147890,2010-02-10T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
20147890,2010-02-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20147890,2010-02-10T00:00:00,Middle Aged,M01.060.116.630
20147890,2010-02-10T00:00:00,Young Adult,M01.060.116.815
20148025,2010-02-11T00:00:00,Animals,B01.050
20148025,2010-02-11T00:00:00,"Behavior, Addictive",F01.145.527.100.120
20148025,2010-02-11T00:00:00,Dopamine,D02.092.211.215.311.342
20148025,2010-02-11T00:00:00,Dopamine,D02.092.311.342
20148025,2010-02-11T00:00:00,Glutamic Acid,D12.125.067.750
20148025,2010-02-11T00:00:00,Glutamic Acid,D12.125.119.450
20148025,2010-02-11T00:00:00,Glutamic Acid,D12.125.427.300
20148025,2010-02-11T00:00:00,"Models, Biological",E05.599.395
20148025,2010-02-11T00:00:00,Morphine,D03.132.577.249.547
20148025,2010-02-11T00:00:00,Morphine,D03.549.686.575
20148025,2010-02-11T00:00:00,Morphine,D03.605.497.575
20148025,2010-02-11T00:00:00,Morphine,D04.615.723.795.547
20148025,2010-02-11T00:00:00,"Receptors, AMPA",D12.776.543.750.720.200.450.200
20148025,2010-02-11T00:00:00,Ventral Tegmental Area,A08.186.211.132.659.822.820
20148025,2010-02-11T00:00:00,Ventral Tegmental Area,A08.186.211.653.822.820
20148251,2010-02-11T00:00:00,Adult,M01.060.116
20148251,2010-02-11T00:00:00,Aged,M01.060.116.100
20148251,2010-02-11T00:00:00,Carcinoma,C04.557.470.200
20148251,2010-02-11T00:00:00,Contrast Media,D27.720.259
20148251,2010-02-11T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
20148251,2010-02-11T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
20148251,2010-02-11T00:00:00,Gadolinium DTPA,D01.632.400
20148251,2010-02-11T00:00:00,Gadolinium DTPA,D02.092.782.590.401
20148251,2010-02-11T00:00:00,Gadolinium DTPA,D02.241.081.038.694.400
20148251,2010-02-11T00:00:00,Gadolinium DTPA,D02.691.400
20148251,2010-02-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20148251,2010-02-11T00:00:00,Image Enhancement,E01.370.350.600.350
20148251,2010-02-11T00:00:00,Image Enhancement,L01.224.308.380
20148251,2010-02-11T00:00:00,Liver Neoplasms,C04.588.274.623
20148251,2010-02-11T00:00:00,Liver Neoplasms,C06.301.623
20148251,2010-02-11T00:00:00,Liver Neoplasms,C06.552.697
20148251,2010-02-11T00:00:00,Middle Aged,M01.060.116.630
20150580,2010-02-11T00:00:00,Adult,M01.060.116
20150580,2010-02-11T00:00:00,Biological Markers,D23.101
20150580,2010-02-11T00:00:00,Bone Resorption,C05.116.264
20150580,2010-02-11T00:00:00,Bone Resorption,G11.427.590.195.150
20150580,2010-02-11T00:00:00,Bone and Bones,A02.835.232
20150580,2010-02-11T00:00:00,Bone and Bones,A10.165.265
20150580,2010-02-11T00:00:00,Calcium,D01.268.552.100
20150580,2010-02-11T00:00:00,Calcium,D01.552.539.288
20150580,2010-02-11T00:00:00,Calcium,D23.119.100
20150580,2010-02-11T00:00:00,Estradiol,D04.808.365.415.248
20150580,2010-02-11T00:00:00,Estradiol,D06.472.334.851.437.500
20150580,2010-02-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20150580,2010-02-11T00:00:00,Lactation,G08.686.702.500
20150580,2010-02-11T00:00:00,Lactation,G08.686.785.420
20150580,2010-02-11T00:00:00,Parathyroid Hormone,D06.472.699.590
20150580,2010-02-11T00:00:00,Parathyroid Hormone,D12.644.548.587
20150580,2010-02-11T00:00:00,Procollagen,D12.776.811.690
20150580,2010-02-11T00:00:00,Procollagen,D12.776.860.300.250.600
20150580,2010-02-11T00:00:00,Vitamin D,D04.808.812.768
20150580,2010-02-11T00:00:00,Young Adult,M01.060.116.815
20153370,2010-02-11T00:00:00,Action Potentials,G04.580.100
20153370,2010-02-11T00:00:00,Action Potentials,G07.265.750.100
20153370,2010-02-11T00:00:00,Action Potentials,G11.561.570.100
20153370,2010-02-11T00:00:00,Animals,B01.050
20153370,2010-02-11T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
20153370,2010-02-11T00:00:00,"Coated Materials, Biocompatible",D25.130.420
20153370,2010-02-11T00:00:00,"Coated Materials, Biocompatible",J01.637.051.130.420
20153370,2010-02-11T00:00:00,"Models, Animal",E05.598
20153370,2010-02-11T00:00:00,Neurons,A08.663
20153370,2010-02-11T00:00:00,Neurons,A11.671
20153370,2010-02-11T00:00:00,Neurophysiology,H01.158.610.268
20153370,2010-02-11T00:00:00,Neurophysiology,H01.158.782.562
20153370,2010-02-11T00:00:00,Neurosurgical Procedures,E04.525
20153370,2010-02-11T00:00:00,Prosthesis Implantation,E04.650
20153370,2010-02-11T00:00:00,Titanium,D01.268.557.800
20153370,2010-02-11T00:00:00,Titanium,D01.268.956.878
20153370,2010-02-11T00:00:00,Titanium,D01.552.547.800
20215790,2010-02-11T00:00:00,Adolescent,M01.060.057
20215790,2010-02-11T00:00:00,Adult,M01.060.116
20215790,2010-02-11T00:00:00,Age Factors,N05.715.350.075
20215790,2010-02-11T00:00:00,Age Factors,N06.850.490.250
20215790,2010-02-11T00:00:00,Aged,M01.060.116.100
20215790,2010-02-11T00:00:00,Bariatric Surgery,E02.065.062
20215790,2010-02-11T00:00:00,Bariatric Surgery,E04.062
20215790,2010-02-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20215790,2010-02-11T00:00:00,Middle Aged,M01.060.116.630
20215790,2010-02-11T00:00:00,"Obesity, Morbid",C18.654.726.500.700
20215790,2010-02-11T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
20215790,2010-02-11T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
20215790,2010-02-11T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
20215790,2010-02-11T00:00:00,Perception,F02.463.593
20215790,2010-02-11T00:00:00,Self Concept,F01.752.747.792
20215790,2010-02-11T00:00:00,Weight Loss,C23.888.144.243.963
20215790,2010-02-11T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
20215790,2010-02-11T00:00:00,Young Adult,M01.060.116.815
20153501,2010-02-12T00:00:00,Disinfectants,D27.505.954.122.425
20153501,2010-02-12T00:00:00,Disinfectants,D27.720.274
20153501,2010-02-12T00:00:00,Environmental Monitoring,N06.850.460.350.080
20153501,2010-02-12T00:00:00,Environmental Monitoring,N06.850.780.375
20153501,2010-02-12T00:00:00,"Hydrocarbons, Chlorinated",D02.455.526.439
20153501,2010-02-12T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
20163442,2010-02-12T00:00:00,Adult,M01.060.116
20163442,2010-02-12T00:00:00,Amygdala,A08.186.211.464.090
20163442,2010-02-12T00:00:00,Amygdala,A08.186.211.730.885.287.249.152
20163442,2010-02-12T00:00:00,Brain Mapping,E01.370.350.086
20163442,2010-02-12T00:00:00,Brain Mapping,E01.370.376.149
20163442,2010-02-12T00:00:00,Brain Mapping,E05.132
20163442,2010-02-12T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
20163442,2010-02-12T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
20163442,2010-02-12T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
20163442,2010-02-12T00:00:00,Diffusion Tensor Imaging,E01.370.350.500.150.500
20163442,2010-02-12T00:00:00,Diffusion Tensor Imaging,E01.370.376.224
20163442,2010-02-12T00:00:00,Diffusion Tensor Imaging,E05.278
20163442,2010-02-12T00:00:00,"Epilepsy, Temporal Lobe",C10.228.140.490.360.290
20163442,2010-02-12T00:00:00,Hippocampus,A08.186.211.464.405
20163442,2010-02-12T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
20163442,2010-02-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20163442,2010-02-12T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
20163442,2010-02-12T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
20163442,2010-02-12T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
20163442,2010-02-12T00:00:00,Limbic System,A08.186.211.464
20163442,2010-02-12T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20163442,2010-02-12T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20163442,2010-02-12T00:00:00,Middle Aged,M01.060.116.630
20163442,2010-02-12T00:00:00,Temporal Lobe,A08.186.211.730.885.287.500.863
20198231,2010-02-12T00:00:00,"Crystallography, X-Ray",E05.196.309.742.225
20198231,2010-02-12T00:00:00,Halogens,D01.268.380
20198231,2010-02-12T00:00:00,Hydrogen Bonding,G02.149.767.620
20198231,2010-02-12T00:00:00,Hydrogen Bonding,G02.842.750.620
20198231,2010-02-12T00:00:00,Iodine,D01.268.380.400
20198231,2010-02-12T00:00:00,Sulfur,D01.268.185.900
20198231,2010-02-12T00:00:00,Thioamides,D02.065.900
20198231,2010-02-12T00:00:00,Thioamides,D02.886.685
20004661,2010-02-13T00:00:00,Adult,M01.060.116
20004661,2010-02-13T00:00:00,Aged,M01.060.116.100
20004661,2010-02-13T00:00:00,Double-Blind Method,E05.318.780.300
20004661,2010-02-13T00:00:00,Double-Blind Method,E05.581.500.300
20004661,2010-02-13T00:00:00,Double-Blind Method,N05.715.360.780.320
20004661,2010-02-13T00:00:00,Double-Blind Method,N06.850.520.445.300
20004661,2010-02-13T00:00:00,"Hepatitis C, Chronic",C02.440.440.120
20004661,2010-02-13T00:00:00,"Hepatitis C, Chronic",C02.782.350.350.120
20004661,2010-02-13T00:00:00,"Hepatitis C, Chronic",C06.552.380.350.120
20004661,2010-02-13T00:00:00,"Hepatitis C, Chronic",C06.552.380.705.440.120
20004661,2010-02-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20004661,2010-02-13T00:00:00,Liver,A03.620
20004661,2010-02-13T00:00:00,Liver Cirrhosis,C06.552.630
20004661,2010-02-13T00:00:00,Middle Aged,M01.060.116.630
20004661,2010-02-13T00:00:00,Tyrosine,D12.125.072.050.875
20154680,2010-02-14T00:00:00,3' Untranslated Regions,D13.444.735.544.875.880
20154680,2010-02-14T00:00:00,3' Untranslated Regions,D13.444.735.790.878.880
20154680,2010-02-14T00:00:00,3' Untranslated Regions,G05.360.340.024.220.880.880
20154680,2010-02-14T00:00:00,3' Untranslated Regions,G05.360.340.024.340.137.910.880
20154680,2010-02-14T00:00:00,"Adaptor Proteins, Vesicular Transport",D12.776.543.990.150
20154680,2010-02-14T00:00:00,Animals,B01.050
20154680,2010-02-14T00:00:00,Carrier Proteins,D12.776.157
20154680,2010-02-14T00:00:00,Cytokines,D12.644.276.374
20154680,2010-02-14T00:00:00,Cytokines,D12.776.467.374
20154680,2010-02-14T00:00:00,Cytokines,D23.529.374
20154680,2010-02-14T00:00:00,Epithelial Cells,A11.436
20154680,2010-02-14T00:00:00,Gene Expression,G05.355.310
20154680,2010-02-14T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
20154680,2010-02-14T00:00:00,Insulin,D06.472.699.587.740.625
20154680,2010-02-14T00:00:00,Insulin,D12.644.548.586.740.625
20154680,2010-02-14T00:00:00,Mesoderm,A16.504.660
20154680,2010-02-14T00:00:00,Neoplasm Proteins,D12.776.624
20154680,2010-02-14T00:00:00,Phosphorylation,G02.111.087.677
20154680,2010-02-14T00:00:00,Phosphorylation,G02.149.115.677
20154680,2010-02-14T00:00:00,Phosphorylation,G02.149.465.700
20154680,2010-02-14T00:00:00,Phosphorylation,G02.607.750.700
20154680,2010-02-14T00:00:00,Phosphorylation,G03.495.790
20154680,2010-02-14T00:00:00,Protein Biosynthesis,G02.111.087.675.871
20154680,2010-02-14T00:00:00,Protein Biosynthesis,G02.149.115.675.871
20154680,2010-02-14T00:00:00,Protein Biosynthesis,G03.495.770.871
20154680,2010-02-14T00:00:00,Protein Biosynthesis,G05.355.310.670
20154680,2010-02-14T00:00:00,Protein Isoforms,D12.776.800
20154680,2010-02-14T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
20154680,2010-02-14T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
20154680,2010-02-14T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
20154680,2010-02-14T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
20154680,2010-02-14T00:00:00,"RNA, Messenger",D13.444.735.544
20154680,2010-02-14T00:00:00,Signal Transduction,G02.111.087.800
20154680,2010-02-14T00:00:00,Signal Transduction,G02.149.115.800
20154680,2010-02-14T00:00:00,Signal Transduction,G04.299.880
20154680,2010-02-14T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
20154680,2010-02-14T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
20154680,2010-02-14T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
20154680,2010-02-14T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
20154680,2010-02-14T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
20154680,2010-02-14T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
20154680,2010-02-14T00:00:00,Transforming Growth Factor beta,D23.529.374.687
20154680,2010-02-14T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
20154680,2010-02-14T00:00:00,Transforming Growth Factor beta,D23.529.960.720
20145519,2010-02-15T00:00:00,Animals,B01.050
20145519,2010-02-15T00:00:00,Enzyme Inhibitors,D27.505.519.389
20145519,2010-02-15T00:00:00,Fatty Liver,C06.552.241
20145519,2010-02-15T00:00:00,Graft Survival,G12.425.901.545.340
20145519,2010-02-15T00:00:00,Liver,A03.620
20145519,2010-02-15T00:00:00,Liver Transplantation,E04.210.650
20145519,2010-02-15T00:00:00,Liver Transplantation,E04.936.450.490
20145519,2010-02-15T00:00:00,Liver Transplantation,E04.936.580.490
20145519,2010-02-15T00:00:00,Mitochondria,A11.284.430.214.190.875.564
20145519,2010-02-15T00:00:00,Mitochondria,A11.284.835.626
20145519,2010-02-15T00:00:00,Nitric Oxide Synthase Type II,D08.811.682.664.500.772.500
20145519,2010-02-15T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20145519,2010-02-15T00:00:00,Tyrosine,D12.125.072.050.875
20156897,2010-02-15T00:00:00,"Child, Preschool",M01.060.406.448
20156897,2010-02-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20156897,2010-02-15T00:00:00,Infant,M01.060.703
20156897,2010-02-15T00:00:00,Vaccination,E02.095.465.425.400.530.890
20156897,2010-02-15T00:00:00,Vaccination,E05.478.550.600.890
20156897,2010-02-15T00:00:00,Vaccination,N02.421.726.758.310.890
20156897,2010-02-15T00:00:00,Vaccination,N06.850.780.200.425.900
20156897,2010-02-15T00:00:00,Vaccination,N06.850.780.680.310.890
19817406,2010-02-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19817406,2010-02-16T00:00:00,Protein Folding,G01.154.100.640
19817406,2010-02-16T00:00:00,Protein Folding,G01.595.100.640
19817406,2010-02-16T00:00:00,Protein Folding,G02.111.087.690
19817406,2010-02-16T00:00:00,Protein Folding,G02.149.115.690
19817406,2010-02-16T00:00:00,Tumor Suppressor Protein p53,D12.776.260.820
19817406,2010-02-16T00:00:00,Tumor Suppressor Protein p53,D12.776.624.776.775
19817406,2010-02-16T00:00:00,Tumor Suppressor Protein p53,D12.776.660.825
19817406,2010-02-16T00:00:00,Tumor Suppressor Protein p53,D12.776.744.845
19817406,2010-02-16T00:00:00,Water,D01.455.900
19817406,2010-02-16T00:00:00,Water,D01.650.550.925
19852473,2010-02-16T00:00:00,Electromagnetic Fields,G01.201.260
19852473,2010-02-16T00:00:00,Electromagnetic Fields,G01.201.875.240
19852473,2010-02-16T00:00:00,Surface Properties,G02.842.850
20157161,2010-02-16T00:00:00,Adolescent,M01.060.057
20157161,2010-02-16T00:00:00,Adult,M01.060.116
20157161,2010-02-16T00:00:00,African Americans,M01.686.508.100.100
20157161,2010-02-16T00:00:00,African Americans,M01.686.754.100
20157161,2010-02-16T00:00:00,Aged,M01.060.116.100
20157161,2010-02-16T00:00:00,Child,M01.060.406
20157161,2010-02-16T00:00:00,"Child, Preschool",M01.060.406.448
20157161,2010-02-16T00:00:00,European Continental Ancestry Group,M01.686.508.400
20157161,2010-02-16T00:00:00,Hospitalization,E02.760.400
20157161,2010-02-16T00:00:00,Hospitalization,N02.421.585.400
20157161,2010-02-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20157161,2010-02-16T00:00:00,Infant,M01.060.703
20157161,2010-02-16T00:00:00,Middle Aged,M01.060.116.630
20157161,2010-02-16T00:00:00,Myocardial Infarction,C14.280.647.500
20157161,2010-02-16T00:00:00,Myocardial Infarction,C14.907.585.500
20157161,2010-02-16T00:00:00,South Carolina,Z01.107.567.875.075.662
20157161,2010-02-16T00:00:00,South Carolina,Z01.107.567.875.750.700
20157161,2010-02-16T00:00:00,Stroke,C10.228.140.300.775
20157161,2010-02-16T00:00:00,Stroke,C14.907.253.855
20157161,2010-02-16T00:00:00,Time Factors,G01.910.857
20157161,2010-02-16T00:00:00,Young Adult,M01.060.116.815
20159837,2010-02-16T00:00:00,Adult,M01.060.116
20159837,2010-02-16T00:00:00,"Echocardiography, Three-Dimensional",E01.370.350.400.200
20159837,2010-02-16T00:00:00,"Echocardiography, Three-Dimensional",E01.370.350.850.220.230
20159837,2010-02-16T00:00:00,"Echocardiography, Three-Dimensional",E01.370.370.380.220.230
20159837,2010-02-16T00:00:00,Electrodes,E07.305.250
20159837,2010-02-16T00:00:00,Heart Ventricles,A07.541.560
20159837,2010-02-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20159837,2010-02-16T00:00:00,"Pacemaker, Artificial",E07.858.082.748
20159837,2010-02-16T00:00:00,Risk Factors,E05.318.740.600.800.725
20159837,2010-02-16T00:00:00,Risk Factors,N05.715.350.200.700
20159837,2010-02-16T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20159837,2010-02-16T00:00:00,Risk Factors,N06.850.490.625.750
20159837,2010-02-16T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20159837,2010-02-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20159837,2010-02-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20159837,2010-02-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20159837,2010-02-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20159837,2010-02-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20160710,2010-02-16T00:00:00,Bayes Theorem,E05.318.740.600.200
20160710,2010-02-16T00:00:00,Bayes Theorem,N05.715.360.750.625.150
20160710,2010-02-16T00:00:00,Bayes Theorem,N06.850.520.830.600.200
20160710,2010-02-16T00:00:00,Lipid Metabolism,G03.495.520
20160710,2010-02-16T00:00:00,Mutation,G05.365.590
20160710,2010-02-16T00:00:00,Saccharomyces cerevisiae,B01.300.107.795.785.800
20160710,2010-02-16T00:00:00,Saccharomyces cerevisiae,B01.300.930.705.655
20160710,2010-02-16T00:00:00,Saccharomyces cerevisiae Proteins,D12.776.354.750
20160710,2010-02-16T00:00:00,Signal Transduction,G02.111.087.800
20160710,2010-02-16T00:00:00,Signal Transduction,G02.149.115.800
20160710,2010-02-16T00:00:00,Signal Transduction,G04.299.880
20160710,2010-02-16T00:00:00,Sphingolipids,D10.570.877
20160710,2010-02-16T00:00:00,Sphingolipids,D10.808
20160710,2010-02-16T00:00:00,Sphingosine,D02.033.100.700
20160710,2010-02-16T00:00:00,Sphingosine,D02.033.455.843
20160710,2010-02-16T00:00:00,Sphingosine,D02.092.063.700
20160710,2010-02-16T00:00:00,Transcription Factors,D12.776.930
20163400,2010-02-16T00:00:00,Animals,B01.050
20163400,2010-02-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20163400,2010-02-16T00:00:00,Inflammation,C23.550.470
20163400,2010-02-16T00:00:00,Interleukin-10,D12.644.276.374.465.510
20163400,2010-02-16T00:00:00,Interleukin-10,D12.776.467.374.465.510
20163400,2010-02-16T00:00:00,Interleukin-10,D23.529.374.465.510
20163400,2010-02-16T00:00:00,"Mice, Inbred CBA",B01.050.050.157.520.440
20163400,2010-02-16T00:00:00,"Mice, Inbred CBA",B01.050.050.199.520.520.440
20163400,2010-02-16T00:00:00,"Mice, Inbred CBA",B01.050.150.900.649.865.635.505.500.400.440
20163400,2010-02-16T00:00:00,"Mice, Inbred DBA",B01.050.050.157.520.460
20163400,2010-02-16T00:00:00,"Mice, Inbred DBA",B01.050.050.199.520.520.460
20163400,2010-02-16T00:00:00,"Mice, Inbred DBA",B01.050.150.900.649.865.635.505.500.400.460
20163400,2010-02-16T00:00:00,Pregnancy,G08.686.785.760.769
20163400,2010-02-16T00:00:00,Pregnancy Outcome,E01.789.700
20163400,2010-02-16T00:00:00,Pregnancy Outcome,G08.686.785.760.769.530
20169063,2010-02-16T00:00:00,Adolescent,M01.060.057
20169063,2010-02-16T00:00:00,Adult,M01.060.116
20169063,2010-02-16T00:00:00,African Americans,M01.686.508.100.100
20169063,2010-02-16T00:00:00,African Americans,M01.686.754.100
20169063,2010-02-16T00:00:00,Aged,M01.060.116.100
20169063,2010-02-16T00:00:00,Carrier Proteins,D12.776.157
20169063,2010-02-16T00:00:00,Child,M01.060.406
20169063,2010-02-16T00:00:00,Cytoskeletal Proteins,D12.776.220
20169063,2010-02-16T00:00:00,Dendritic Cells,A11.066.270
20169063,2010-02-16T00:00:00,Dendritic Cells,A11.436.270
20169063,2010-02-16T00:00:00,Dendritic Cells,A15.382.066.270
20169063,2010-02-16T00:00:00,Dendritic Cells,A15.382.812.260
20169063,2010-02-16T00:00:00,European Continental Ancestry Group,M01.686.508.400
20169063,2010-02-16T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
20169063,2010-02-16T00:00:00,Flow Cytometry,E05.200.500.386.350
20169063,2010-02-16T00:00:00,GTP-Binding Proteins,D08.811.277.040.330.300
20169063,2010-02-16T00:00:00,GTP-Binding Proteins,D12.776.157.325
20169063,2010-02-16T00:00:00,Gene Expression,G05.355.310
20169063,2010-02-16T00:00:00,Hispanic Americans,M01.686.754.441
20169063,2010-02-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20169063,2010-02-16T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
20169063,2010-02-16T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
20169063,2010-02-16T00:00:00,Middle Aged,M01.060.116.630
20169063,2010-02-16T00:00:00,Vitamin D,D04.808.812.768
20169063,2010-02-16T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
20169063,2010-02-16T00:00:00,Young Adult,M01.060.116.815
20164334,2010-02-17T00:00:00,Animals,B01.050
20164334,2010-02-17T00:00:00,Carrier Proteins,D12.776.157
20164334,2010-02-17T00:00:00,Eye Proteins,D12.776.306
20164334,2010-02-17T00:00:00,Phosphorylation,G02.111.087.677
20164334,2010-02-17T00:00:00,Phosphorylation,G02.149.115.677
20164334,2010-02-17T00:00:00,Phosphorylation,G02.149.465.700
20164334,2010-02-17T00:00:00,Phosphorylation,G02.607.750.700
20164334,2010-02-17T00:00:00,Phosphorylation,G03.495.790
20164334,2010-02-17T00:00:00,Photic Stimulation,E05.723.729
20164334,2010-02-17T00:00:00,Retinal Degeneration,C11.768.585
20164334,2010-02-17T00:00:00,Retinal Rod Photoreceptor Cells,A08.663.650.850.625.670.650
20164334,2010-02-17T00:00:00,Retinal Rod Photoreceptor Cells,A08.663.650.915.937.670.650
20164334,2010-02-17T00:00:00,Retinal Rod Photoreceptor Cells,A08.800.950.937.670.650
20164334,2010-02-17T00:00:00,Retinal Rod Photoreceptor Cells,A09.371.729.831.625.670.650
20164334,2010-02-17T00:00:00,Retinal Rod Photoreceptor Cells,A11.671.650.850.625.670.650
20164334,2010-02-17T00:00:00,Retinal Rod Photoreceptor Cells,A11.671.650.915.937.670.650
20164334,2010-02-17T00:00:00,Transducin,D08.811.277.040.330.300.200.800
20164334,2010-02-17T00:00:00,Transducin,D12.644.360.375.940
20164334,2010-02-17T00:00:00,Transducin,D12.776.157.325.332.940
20164334,2010-02-17T00:00:00,Transducin,D12.776.476.375.940
20164334,2010-02-17T00:00:00,Transducin,D12.776.543.325.800
20164334,2010-02-17T00:00:00,"Vision, Ocular",F02.830.816.964
20164334,2010-02-17T00:00:00,"Vision, Ocular",G02.111.087.800.480.900
20164334,2010-02-17T00:00:00,"Vision, Ocular",G02.149.115.800.480.900
20164334,2010-02-17T00:00:00,"Vision, Ocular",G04.299.880.480.900
20164334,2010-02-17T00:00:00,"Vision, Ocular",G11.561.600.810.964
20164334,2010-02-17T00:00:00,"Vision, Ocular",G14.640.816
20164449,2010-02-17T00:00:00,Animals,B01.050
20164449,2010-02-17T00:00:00,Histone Deacetylase Inhibitors,D27.505.519.389.360
20164449,2010-02-17T00:00:00,Histones,D12.776.660.470
20164449,2010-02-17T00:00:00,Histones,D12.776.664.469
20164449,2010-02-17T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.205.351
20164449,2010-02-17T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.525.700.100
20164449,2010-02-17T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.205.351
20164449,2010-02-17T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.525.700.100
20164449,2010-02-17T00:00:00,Matrix Metalloproteinase 3,D08.811.277.656.300.480.525.700.200
20164449,2010-02-17T00:00:00,Matrix Metalloproteinase 3,D08.811.277.656.675.374.525.700.200
20164449,2010-02-17T00:00:00,Neuroprotective Agents,D27.505.696.706.548
20164449,2010-02-17T00:00:00,Neuroprotective Agents,D27.505.954.427.575
20164449,2010-02-17T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20164449,2010-02-17T00:00:00,Reperfusion Injury,C14.907.725
20164449,2010-02-17T00:00:00,Reperfusion Injury,C23.550.767.877
20164449,2010-02-17T00:00:00,Retina,A09.371.729
20164449,2010-02-17T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
20164449,2010-02-17T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
20164449,2010-02-17T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
20164449,2010-02-17T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
20164449,2010-02-17T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
20164449,2010-02-17T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
20164449,2010-02-17T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
20164449,2010-02-17T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
20164449,2010-02-17T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
20164449,2010-02-17T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
20164449,2010-02-17T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
20180839,2010-02-17T00:00:00,Animals,B01.050
20180839,2010-02-17T00:00:00,"Behavior, Addictive",F01.145.527.100.120
20180839,2010-02-17T00:00:00,Central Nervous System Stimulants,D27.505.696.282
20180839,2010-02-17T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
20180839,2010-02-17T00:00:00,Cocaine,D02.145.074.722.388
20180839,2010-02-17T00:00:00,Cocaine,D03.132.889.354
20180839,2010-02-17T00:00:00,Cocaine,D03.605.869.388
20180839,2010-02-17T00:00:00,Cocaine,D04.075.080.875.099.722.388
20180839,2010-02-17T00:00:00,Cues,F02.463.425.234
20180839,2010-02-17T00:00:00,Methamphetamine,D02.092.471.683.152.619
20180839,2010-02-17T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
20180839,2010-02-17T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
20180839,2010-02-17T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20180839,2010-02-17T00:00:00,Self Administration,E02.319.890
20180839,2010-02-17T00:00:00,Self Administration,E02.900.890
20180839,2010-02-17T00:00:00,Substance-Related Disorders,C21.739
20180839,2010-02-17T00:00:00,Substance-Related Disorders,F03.900
20206451,2010-02-17T00:00:00,Adolescent,M01.060.057
20206451,2010-02-17T00:00:00,Adult,M01.060.116
20206451,2010-02-17T00:00:00,"Behavior, Addictive",F01.145.527.100.120
20206451,2010-02-17T00:00:00,Cues,F02.463.425.234
20206451,2010-02-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20206451,2010-02-17T00:00:00,Questionnaires,E05.318.308.750
20206451,2010-02-17T00:00:00,Questionnaires,L01.280.800
20206451,2010-02-17T00:00:00,Questionnaires,N05.715.360.300.695
20206451,2010-02-17T00:00:00,Questionnaires,N06.850.520.308.750
20206451,2010-02-17T00:00:00,Smoking,F01.145.466.753
20206451,2010-02-17T00:00:00,Smoking Cessation,F01.145.940.700
20206451,2010-02-17T00:00:00,Tobacco Use Disorder,C21.739.912
20206451,2010-02-17T00:00:00,Tobacco Use Disorder,F03.900.912
20206451,2010-02-17T00:00:00,Young Adult,M01.060.116.815
20167904,2010-02-18T00:00:00,Aged,M01.060.116.100
20167904,2010-02-18T00:00:00,Caregivers,M01.085
20167904,2010-02-18T00:00:00,Caregivers,M01.526.485.200
20167904,2010-02-18T00:00:00,Caregivers,N02.360.200
20167904,2010-02-18T00:00:00,Hispanic Americans,M01.686.754.441
20167904,2010-02-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20167904,2010-02-18T00:00:00,Interviews as Topic,E05.318.308.420
20167904,2010-02-18T00:00:00,Interviews as Topic,L01.280.520
20167904,2010-02-18T00:00:00,Interviews as Topic,N05.715.360.300.400
20167904,2010-02-18T00:00:00,Interviews as Topic,N06.850.520.308.420
20167904,2010-02-18T00:00:00,Language,F01.145.209.399
20167904,2010-02-18T00:00:00,Language,L01.143.506
20167904,2010-02-18T00:00:00,Middle Aged,M01.060.116.630
20167904,2010-02-18T00:00:00,Patient Compliance,F01.145.488.500
20167904,2010-02-18T00:00:00,Patient Compliance,N05.300.150.600.600
20167904,2010-02-18T00:00:00,Patient Education as Topic,I02.233.332.500
20167904,2010-02-18T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
20167904,2010-02-18T00:00:00,Patient Education as Topic,N02.421.726.407.680
20167904,2010-02-18T00:00:00,Questionnaires,E05.318.308.750
20167904,2010-02-18T00:00:00,Questionnaires,L01.280.800
20167904,2010-02-18T00:00:00,Questionnaires,N05.715.360.300.695
20167904,2010-02-18T00:00:00,Questionnaires,N06.850.520.308.750
20167904,2010-02-18T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
20167904,2010-02-18T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
20167904,2010-02-18T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
20167904,2010-02-18T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
20167904,2010-02-18T00:00:00,Risk Reduction Behavior,F01.145.699
20167904,2010-02-18T00:00:00,Secondary Prevention,N02.421.726.825
20167904,2010-02-18T00:00:00,Secondary Prevention,N06.850.780.750
20167904,2010-02-18T00:00:00,Self Care,E02.900
20167904,2010-02-18T00:00:00,Self Care,N02.421.784.680
20167904,2010-02-18T00:00:00,Stroke,C10.228.140.300.775
20167904,2010-02-18T00:00:00,Stroke,C14.907.253.855
20170909,2010-02-18T00:00:00,Animals,B01.050
20170909,2010-02-18T00:00:00,Bacterial Infections,C01.252
20170909,2010-02-18T00:00:00,Colon,A03.556.124.526.356
20170909,2010-02-18T00:00:00,Colon,A03.556.249.249.356
20170909,2010-02-18T00:00:00,Laparoscopy,E01.370.388.250.520
20170909,2010-02-18T00:00:00,Laparoscopy,E04.800.250.520
20170909,2010-02-18T00:00:00,Peritonitis,C06.844.640
20170909,2010-02-18T00:00:00,Risk Factors,E05.318.740.600.800.725
20170909,2010-02-18T00:00:00,Risk Factors,N05.715.350.200.700
20170909,2010-02-18T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20170909,2010-02-18T00:00:00,Risk Factors,N06.850.490.625.750
20170909,2010-02-18T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20170909,2010-02-18T00:00:00,Streptococcal Infections,C01.252.410.890
20170909,2010-02-18T00:00:00,Surgical Wound Infection,C01.539.947.692
20170909,2010-02-18T00:00:00,Surgical Wound Infection,C23.550.767.925
20170909,2010-02-18T00:00:00,Suture Techniques,E04.901
20170909,2010-02-18T00:00:00,Swine,B01.050.150.900.649.077.880
20170909,2010-02-18T00:00:00,Wound Healing,G16.100.856.891
20173212,2010-02-20T00:00:00,ATP-Binding Cassette Transporters,D12.776.157.530.100
20173212,2010-02-20T00:00:00,ATP-Binding Cassette Transporters,D12.776.395.550.020
20173212,2010-02-20T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.550.192
20173212,2010-02-20T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.585.100
20173212,2010-02-20T00:00:00,Adrenoleukodystrophy,C10.228.140.163.100.680.100
20173212,2010-02-20T00:00:00,Adrenoleukodystrophy,C10.314.400.250
20173212,2010-02-20T00:00:00,Adrenoleukodystrophy,C10.597.606.643.455.124
20173212,2010-02-20T00:00:00,Adrenoleukodystrophy,C16.320.322.500.124
20173212,2010-02-20T00:00:00,Adrenoleukodystrophy,C16.320.400.525.124
20173212,2010-02-20T00:00:00,Adrenoleukodystrophy,C16.320.565.189.680.100
20173212,2010-02-20T00:00:00,Adrenoleukodystrophy,C16.320.565.663.112
20173212,2010-02-20T00:00:00,Adrenoleukodystrophy,C18.452.132.100.680.100
20173212,2010-02-20T00:00:00,Adrenoleukodystrophy,C18.452.648.189.680.100
20173212,2010-02-20T00:00:00,Adrenoleukodystrophy,C18.452.648.663.112
20173212,2010-02-20T00:00:00,Adrenoleukodystrophy,C19.053.500.270
20173212,2010-02-20T00:00:00,Animals,B01.050
20173212,2010-02-20T00:00:00,Arachidonate 5-Lipoxygenase,D08.811.682.690.416.444.050.055
20173212,2010-02-20T00:00:00,Arachidonate 5-Lipoxygenase,D12.776.556.579.374.450.025.020
20173212,2010-02-20T00:00:00,Astrocytes,A08.637.200
20173212,2010-02-20T00:00:00,Astrocytes,A11.650.200
20173212,2010-02-20T00:00:00,Brain,A08.186.211
20173212,2010-02-20T00:00:00,Child,M01.060.406
20173212,2010-02-20T00:00:00,Cyclooxygenase 2,D08.811.600.720.750
20173212,2010-02-20T00:00:00,Fatty Acids,D10.251
20173212,2010-02-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20173212,2010-02-20T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
22749467,2010-02-20T00:00:00,Bayes Theorem,E05.318.740.600.200
22749467,2010-02-20T00:00:00,Bayes Theorem,N05.715.360.750.625.150
22749467,2010-02-20T00:00:00,Bayes Theorem,N06.850.520.830.600.200
22749467,2010-02-20T00:00:00,Communicable Diseases,C01.539.221
22749467,2010-02-20T00:00:00,Disease Outbreaks,N06.850.290
22749467,2010-02-20T00:00:00,Health Surveys,E05.318.308.250
22749467,2010-02-20T00:00:00,Health Surveys,N05.715.360.300.375
22749467,2010-02-20T00:00:00,Health Surveys,N06.850.520.308.250
22749467,2010-02-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22749467,2010-02-20T00:00:00,Incidence,E05.318.308.985.525.375
22749467,2010-02-20T00:00:00,Incidence,L01.280.975.525.375
22749467,2010-02-20T00:00:00,Incidence,N01.224.935.597.500
22749467,2010-02-20T00:00:00,Incidence,N06.850.505.400.975.525.375
22749467,2010-02-20T00:00:00,Incidence,N06.850.520.308.985.525.375
22749467,2010-02-20T00:00:00,Population Surveillance,E05.318.308.250.700
22749467,2010-02-20T00:00:00,Population Surveillance,N05.715.360.300.375.625
22749467,2010-02-20T00:00:00,Population Surveillance,N06.850.520.308.250.700
22749467,2010-02-20T00:00:00,Population Surveillance,N06.850.780.675
20172568,2010-02-21T00:00:00,Adolescent,M01.060.057
20172568,2010-02-21T00:00:00,Cadaver,C23.550.260.224
20172568,2010-02-21T00:00:00,Child,M01.060.406
20172568,2010-02-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20172568,2010-02-21T00:00:00,Rectus Abdominis,A02.633.567.050.800
20172568,2010-02-21T00:00:00,Surgical Flaps,A10.850.710
20172568,2010-02-21T00:00:00,Surgical Flaps,E07.862.710
20172568,2010-02-21T00:00:00,Urinary Bladder Fistula,C12.706.881.312
20172568,2010-02-21T00:00:00,Urinary Bladder Fistula,C12.777.829.733
20172568,2010-02-21T00:00:00,Urinary Bladder Fistula,C13.351.875.881.312
20172568,2010-02-21T00:00:00,Urinary Bladder Fistula,C13.351.968.829.548
20172568,2010-02-21T00:00:00,Urinary Bladder Fistula,C23.300.575.825.250
20172568,2010-02-21T00:00:00,"Urinary Bladder, Neurogenic",C10.597.900
20172568,2010-02-21T00:00:00,"Urinary Bladder, Neurogenic",C12.777.829.839
20172568,2010-02-21T00:00:00,"Urinary Bladder, Neurogenic",C13.351.968.829.760
20172568,2010-02-21T00:00:00,"Urinary Bladder, Neurogenic",C23.888.592.900
20172568,2010-02-21T00:00:00,Urinary Incontinence,C12.777.934.852
20172568,2010-02-21T00:00:00,Urinary Incontinence,C13.351.968.934.814
20172568,2010-02-21T00:00:00,Urinary Incontinence,C23.888.942.800
20172568,2010-02-21T00:00:00,Urologic Surgical Procedures,E04.950.774
20176676,2010-02-22T00:00:00,Adult,M01.060.116
20176676,2010-02-22T00:00:00,Ethnic Groups,M01.686.754
20176676,2010-02-22T00:00:00,Ethnic Groups,N01.224.317
20176676,2010-02-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20176676,2010-02-22T00:00:00,Middle Aged,M01.060.116.630
20176676,2010-02-22T00:00:00,Minority Groups,I01.880.371
20176676,2010-02-22T00:00:00,Pediatrics,H02.403.670
20176676,2010-02-22T00:00:00,Physician's Practice Patterns,N04.590.748
20176676,2010-02-22T00:00:00,Physician's Practice Patterns,N05.300.625
20176676,2010-02-22T00:00:00,United States,Z01.107.567.875
20088597,2010-02-23T00:00:00,Animals,B01.050
20088597,2010-02-23T00:00:00,Cattle,B01.050.150.900.649.077.380.271
20088597,2010-02-23T00:00:00,Water,D01.455.900
20088597,2010-02-23T00:00:00,Water,D01.650.550.925
20177011,2010-02-23T00:00:00,Heart Diseases,C14.280
20177011,2010-02-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20177011,2010-02-23T00:00:00,Risk Factors,E05.318.740.600.800.725
20177011,2010-02-23T00:00:00,Risk Factors,N05.715.350.200.700
20177011,2010-02-23T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20177011,2010-02-23T00:00:00,Risk Factors,N06.850.490.625.750
20177011,2010-02-23T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20177011,2010-02-23T00:00:00,Stroke,C10.228.140.300.775
20177011,2010-02-23T00:00:00,Stroke,C14.907.253.855
20177011,2010-02-23T00:00:00,United States,Z01.107.567.875
20179250,2010-02-23T00:00:00,African Continental Ancestry Group,M01.686.508.100
20179250,2010-02-23T00:00:00,Aged,M01.060.116.100
20179250,2010-02-23T00:00:00,Behavior,F01.145
20179250,2010-02-23T00:00:00,Behavior Therapy,F04.754.137
20179250,2010-02-23T00:00:00,Blood Glucose,D09.546.359.448.500
20179250,2010-02-23T00:00:00,Depression,F01.145.126.350
20179250,2010-02-23T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
20179250,2010-02-23T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
20179250,2010-02-23T00:00:00,European Continental Ancestry Group,M01.686.508.400
20179250,2010-02-23T00:00:00,Health Status,I01.240.425
20179250,2010-02-23T00:00:00,Health Status,N01.224.425
20179250,2010-02-23T00:00:00,Health Status,N06.850.505.400.425
20179250,2010-02-23T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
20179250,2010-02-23T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
20179250,2010-02-23T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
20179250,2010-02-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20179250,2010-02-23T00:00:00,Income,N01.824.417
20179250,2010-02-23T00:00:00,Middle Aged,M01.060.116.630
20179250,2010-02-23T00:00:00,Motivation,F01.658
20179250,2010-02-23T00:00:00,Motivation,F01.752.543.500.750
20179250,2010-02-23T00:00:00,Self Care,E02.900
20179250,2010-02-23T00:00:00,Self Care,N02.421.784.680
20179294,2010-02-23T00:00:00,Animals,B01.050
20179294,2010-02-23T00:00:00,Apoptosis,G04.299.139.160
20179294,2010-02-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20179294,2010-02-23T00:00:00,Inflammation,C23.550.470
20179294,2010-02-23T00:00:00,Lymphocytes,A11.118.637.555.567
20179294,2010-02-23T00:00:00,Lymphocytes,A15.145.229.637.555.567
20179294,2010-02-23T00:00:00,Lymphocytes,A15.382.490.555.567
20179294,2010-02-23T00:00:00,Tumor Suppressor Protein p53,D12.776.260.820
20179294,2010-02-23T00:00:00,Tumor Suppressor Protein p53,D12.776.624.776.775
20179294,2010-02-23T00:00:00,Tumor Suppressor Protein p53,D12.776.660.825
20179294,2010-02-23T00:00:00,Tumor Suppressor Protein p53,D12.776.744.845
20179323,2010-02-23T00:00:00,Cell Cycle Proteins,D12.776.167
20179323,2010-02-23T00:00:00,DNA Replication,G02.111.087.222
20179323,2010-02-23T00:00:00,DNA Replication,G02.149.115.222
20179323,2010-02-23T00:00:00,DNA Replication,G05.355.200
20179323,2010-02-23T00:00:00,"DNA, Fungal",D13.444.308.300
20179323,2010-02-23T00:00:00,DNA-Binding Proteins,D12.776.260
20179323,2010-02-23T00:00:00,Gene Silencing,G05.355.315.203.374
20179323,2010-02-23T00:00:00,Multiprotein Complexes,D05.500
20179323,2010-02-23T00:00:00,RNA Polymerase II,D08.811.913.696.445.735.270.762
20179323,2010-02-23T00:00:00,Saccharomyces cerevisiae,B01.300.107.795.785.800
20179323,2010-02-23T00:00:00,Saccharomyces cerevisiae,B01.300.930.705.655
20179323,2010-02-23T00:00:00,Saccharomyces cerevisiae Proteins,D12.776.354.750
20179323,2010-02-23T00:00:00,"Transcription, Genetic",G02.111.087.847
20179323,2010-02-23T00:00:00,"Transcription, Genetic",G02.149.115.847
20179323,2010-02-23T00:00:00,"Transcription, Genetic",G05.355.310.700
20181405,2010-02-23T00:00:00,Depressive Disorder,F03.600.300
20181405,2010-02-23T00:00:00,Diabetes Mellitus,C18.452.394.750
20181405,2010-02-23T00:00:00,Diabetes Mellitus,C19.246
20181405,2010-02-23T00:00:00,Health Care Costs,N03.219.151.400
20181405,2010-02-23T00:00:00,Health Care Costs,N05.300.375
20181405,2010-02-23T00:00:00,Health Services,N02.421
20181405,2010-02-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20181405,2010-02-23T00:00:00,Life Style,F01.829.458
20181405,2010-02-23T00:00:00,Quality of Health Care,N04.761
20181405,2010-02-23T00:00:00,Quality of Health Care,N05.715
20181405,2010-02-23T00:00:00,Quality of Life,I01.800
20181405,2010-02-23T00:00:00,Quality of Life,K01.752.400.750
20181405,2010-02-23T00:00:00,Self Care,E02.900
20181405,2010-02-23T00:00:00,Self Care,N02.421.784.680
20181679,2010-02-24T00:00:00,Aged,M01.060.116.100
20181679,2010-02-24T00:00:00,Brain Ischemia,C10.228.140.300.150
20181679,2010-02-24T00:00:00,Brain Ischemia,C14.907.253.092
20181679,2010-02-24T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
20181679,2010-02-24T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
20181679,2010-02-24T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
20181679,2010-02-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20181679,2010-02-24T00:00:00,Middle Aged,M01.060.116.630
20181679,2010-02-24T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
20181679,2010-02-24T00:00:00,Recovery of Function,G16.757
20181679,2010-02-24T00:00:00,Stroke,C10.228.140.300.775
20181679,2010-02-24T00:00:00,Stroke,C14.907.253.855
20181679,2010-02-24T00:00:00,Ticlopidine,D02.886.778.834
20181679,2010-02-24T00:00:00,Ticlopidine,D03.383.903.834
20181679,2010-02-24T00:00:00,Treatment Outcome,E01.789.800
20181679,2010-02-24T00:00:00,Treatment Outcome,N04.761.559.590.800
20181679,2010-02-24T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20359856,2010-02-24T00:00:00,Animals,B01.050
20359856,2010-02-24T00:00:00,Cisplatin,D01.210.375
20359856,2010-02-24T00:00:00,Cisplatin,D01.625.125
20359856,2010-02-24T00:00:00,Cisplatin,D01.710.100
20359856,2010-02-24T00:00:00,Glutathione,D12.644.456.448
20359856,2010-02-24T00:00:00,Glutathione Disulfide,D12.644.456.448.500
20359856,2010-02-24T00:00:00,Nonlinear Dynamics,E05.599.850
20359856,2010-02-24T00:00:00,Nonlinear Dynamics,H01.548.675
20359856,2010-02-24T00:00:00,Oxidative Stress,G03.495.710
20359856,2010-02-24T00:00:00,Oxidative Stress,G07.700.830.750
20188594,2010-02-25T00:00:00,Adult,M01.060.116
20188594,2010-02-25T00:00:00,Antibodies,D12.776.124.486.485.114
20188594,2010-02-25T00:00:00,Antibodies,D12.776.124.790.651.114
20188594,2010-02-25T00:00:00,Antibodies,D12.776.377.715.548.114
20188594,2010-02-25T00:00:00,"Antigens, CD",D23.050.301.264.035
20188594,2010-02-25T00:00:00,"Antigens, CD",D23.101.100.110
20188594,2010-02-25T00:00:00,Coronary Artery Disease,C14.280.647.250.260
20188594,2010-02-25T00:00:00,Coronary Artery Disease,C14.907.137.126.339
20188594,2010-02-25T00:00:00,Coronary Artery Disease,C14.907.585.250.260
20188594,2010-02-25T00:00:00,Graft Rejection,G12.425.901.545.328
20188594,2010-02-25T00:00:00,Heart Transplantation,E04.100.376.475
20188594,2010-02-25T00:00:00,Heart Transplantation,E04.928.220.390
20188594,2010-02-25T00:00:00,Heart Transplantation,E04.936.450.475
20188594,2010-02-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20188594,2010-02-25T00:00:00,Matched-Pair Analysis,E05.318.740.475
20188594,2010-02-25T00:00:00,Matched-Pair Analysis,E05.318.780.485
20188594,2010-02-25T00:00:00,Matched-Pair Analysis,N05.715.360.750.500
20188594,2010-02-25T00:00:00,Matched-Pair Analysis,N05.715.360.780.500
20188594,2010-02-25T00:00:00,Matched-Pair Analysis,N06.850.520.445.485
20188594,2010-02-25T00:00:00,Matched-Pair Analysis,N06.850.520.830.475
20188594,2010-02-25T00:00:00,Middle Aged,M01.060.116.630
20188594,2010-02-25T00:00:00,Myocardium,A02.633.580
20188594,2010-02-25T00:00:00,Myocardium,A07.541.704
20188594,2010-02-25T00:00:00,Myocardium,A10.690.552.750
20188594,2010-02-25T00:00:00,Peptide Fragments,D12.644.541
20188594,2010-02-25T00:00:00,Risk Factors,E05.318.740.600.800.725
20188594,2010-02-25T00:00:00,Risk Factors,N05.715.350.200.700
20188594,2010-02-25T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20188594,2010-02-25T00:00:00,Risk Factors,N06.850.490.625.750
20188594,2010-02-25T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20201953,2010-02-25T00:00:00,Collagen Type I,D05.750.078.280.300.100
20201953,2010-02-25T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
20201953,2010-02-25T00:00:00,Connective Tissue Growth Factor,D12.644.276.200.100
20201953,2010-02-25T00:00:00,Connective Tissue Growth Factor,D12.776.467.200.100
20201953,2010-02-25T00:00:00,Connective Tissue Growth Factor,D12.776.860.300.200.100
20201953,2010-02-25T00:00:00,Connective Tissue Growth Factor,D23.529.237.100
20201953,2010-02-25T00:00:00,Fibroblasts,A11.329.228
20201953,2010-02-25T00:00:00,Fibroblasts,A11.872.228
20201953,2010-02-25T00:00:00,Gene Expression,G05.355.310
20201953,2010-02-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20201953,2010-02-25T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.205.351
20201953,2010-02-25T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.525.700.100
20201953,2010-02-25T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.205.351
20201953,2010-02-25T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.525.700.100
20201953,2010-02-25T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.567.342.750
20201953,2010-02-25T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.646.750.249.750
20201953,2010-02-25T00:00:00,Mitogen-Activated Protein Kinase 3,D12.644.360.450.169.750
20201953,2010-02-25T00:00:00,Mitogen-Activated Protein Kinase 3,D12.776.476.450.169.750
20201953,2010-02-25T00:00:00,Phosphorylation,G02.111.087.677
20201953,2010-02-25T00:00:00,Phosphorylation,G02.149.115.677
20201953,2010-02-25T00:00:00,Phosphorylation,G02.149.465.700
20201953,2010-02-25T00:00:00,Phosphorylation,G02.607.750.700
20201953,2010-02-25T00:00:00,Phosphorylation,G03.495.790
20201953,2010-02-25T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
20201953,2010-02-25T00:00:00,Proto-Oncogene Protein c-ets-1,D12.776.260.665.100
20201953,2010-02-25T00:00:00,Proto-Oncogene Protein c-ets-1,D12.776.624.664.700.175.100
20201953,2010-02-25T00:00:00,Proto-Oncogene Protein c-ets-1,D12.776.930.635.100
20201953,2010-02-25T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
20201953,2010-02-25T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
20201953,2010-02-25T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
20201953,2010-02-25T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.260.108.820
20201953,2010-02-25T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.624.664.700.182
20201953,2010-02-25T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.660.763
20201953,2010-02-25T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.930.127.820
20201953,2010-02-25T00:00:00,Signal Transduction,G02.111.087.800
20201953,2010-02-25T00:00:00,Signal Transduction,G02.149.115.800
20201953,2010-02-25T00:00:00,Signal Transduction,G04.299.880
20201953,2010-02-25T00:00:00,Skin,A17.815
20201953,2010-02-25T00:00:00,"Transduction, Genetic",E05.393.350.800
20201953,2010-02-25T00:00:00,"Transduction, Genetic",G05.355.760.850
20201953,2010-02-25T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
20201953,2010-02-25T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
20201953,2010-02-25T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
20201953,2010-02-25T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
20201953,2010-02-25T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
20201953,2010-02-25T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
20201953,2010-02-25T00:00:00,Transforming Growth Factor beta,D23.529.374.687
20201953,2010-02-25T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
20201953,2010-02-25T00:00:00,Transforming Growth Factor beta,D23.529.960.720
20199602,2010-02-28T00:00:00,Bacterial Adhesion,G06.099.112.100
20199602,2010-02-28T00:00:00,Bacterial Adhesion,G06.590.110.100
20199602,2010-02-28T00:00:00,Bacterial Proteins,D12.776.097
20199602,2010-02-28T00:00:00,Host-Pathogen Interactions,G06.590.470
20199602,2010-02-28T00:00:00,Host-Pathogen Interactions,G16.100.380
20199602,2010-02-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20199602,2010-02-28T00:00:00,Membrane Proteins,D12.776.543
20199602,2010-02-28T00:00:00,Meningococcal Infections,C01.252.400.625.549
20199602,2010-02-28T00:00:00,Neisseria meningitidis,B03.440.400.425.550.550.641
20199602,2010-02-28T00:00:00,Neisseria meningitidis,B03.660.075.525.520.500
20199602,2010-02-28T00:00:00,Protein Transport,G03.495.166.700
19813266,2010-03-01T00:00:00,Anticarcinogenic Agents,D27.505.696.706.018
19813266,2010-03-01T00:00:00,Anticarcinogenic Agents,D27.505.954.248.125
19813266,2010-03-01T00:00:00,Anticarcinogenic Agents,D27.720.799.018
19813266,2010-03-01T00:00:00,Apoptosis,G04.299.139.160
19813266,2010-03-01T00:00:00,Fas Ligand Protein,D12.644.276.374.750.249
19813266,2010-03-01T00:00:00,Fas Ligand Protein,D12.644.276.972.249
19813266,2010-03-01T00:00:00,Fas Ligand Protein,D12.776.395.550.312
19813266,2010-03-01T00:00:00,Fas Ligand Protein,D12.776.467.374.750.249
19813266,2010-03-01T00:00:00,Fas Ligand Protein,D12.776.467.972.249
19813266,2010-03-01T00:00:00,Fas Ligand Protein,D12.776.543.550.312
19813266,2010-03-01T00:00:00,Fas Ligand Protein,D23.050.301.264.035.283
19813266,2010-03-01T00:00:00,Fas Ligand Protein,D23.101.100.110.282
19813266,2010-03-01T00:00:00,Fas Ligand Protein,D23.529.374.750.249
19813266,2010-03-01T00:00:00,Fas Ligand Protein,D23.529.972.249
19813266,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19813266,2010-03-01T00:00:00,Mitochondria,A11.284.430.214.190.875.564
19813266,2010-03-01T00:00:00,Mitochondria,A11.284.835.626
19813266,2010-03-01T00:00:00,Neuroblastoma,C04.557.465.625.600.590.650.550
19813266,2010-03-01T00:00:00,Neuroblastoma,C04.557.470.670.590.650.550
19813266,2010-03-01T00:00:00,Neuroblastoma,C04.557.580.625.600.590.650.550
19813266,2010-03-01T00:00:00,Signal Transduction,G02.111.087.800
19813266,2010-03-01T00:00:00,Signal Transduction,G02.149.115.800
19813266,2010-03-01T00:00:00,Signal Transduction,G04.299.880
19813266,2010-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
19813266,2010-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
19813266,2010-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
19813266,2010-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
19813266,2010-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
19813266,2010-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
19813266,2010-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
19813266,2010-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
19813266,2010-03-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
19813266,2010-03-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
19813266,2010-03-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
19827138,2010-03-01T00:00:00,Adolescent,M01.060.057
19827138,2010-03-01T00:00:00,Adult,M01.060.116
19827138,2010-03-01T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
19827138,2010-03-01T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
19827138,2010-03-01T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
19827138,2010-03-01T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
19827138,2010-03-01T00:00:00,Child,M01.060.406
19827138,2010-03-01T00:00:00,"Child, Preschool",M01.060.406.448
19827138,2010-03-01T00:00:00,Echocardiography,E01.370.350.850.220
19827138,2010-03-01T00:00:00,Echocardiography,E01.370.370.380.220
19827138,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19827138,2010-03-01T00:00:00,"Hypertension, Pulmonary",C08.381.423
19827138,2010-03-01T00:00:00,Young Adult,M01.060.116.815
19882516,2010-03-01T00:00:00,Adult,M01.060.116
19882516,2010-03-01T00:00:00,Aged,M01.060.116.100
19882516,2010-03-01T00:00:00,"Decompression, Surgical",E04.188
19882516,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19882516,2010-03-01T00:00:00,Middle Aged,M01.060.116.630
19882516,2010-03-01T00:00:00,Oculomotor Muscles,A02.633.567.700
19882516,2010-03-01T00:00:00,Oculomotor Muscles,A09.371.613
19882516,2010-03-01T00:00:00,Ophthalmologic Surgical Procedures,E04.540
19882516,2010-03-01T00:00:00,Postoperative Complications,C23.550.767
19882516,2010-03-01T00:00:00,Strabismus,C10.292.562.887
19882516,2010-03-01T00:00:00,Strabismus,C11.590.810
19907322,2010-03-01T00:00:00,Age Factors,N05.715.350.075
19907322,2010-03-01T00:00:00,Age Factors,N06.850.490.250
19907322,2010-03-01T00:00:00,Aged,M01.060.116.100
19907322,2010-03-01T00:00:00,Deglutition Disorders,C06.405.117.119
19907322,2010-03-01T00:00:00,Deglutition Disorders,C09.775.174
19907322,2010-03-01T00:00:00,Dementia,C10.228.140.380
19907322,2010-03-01T00:00:00,Dementia,F03.087.400
19907322,2010-03-01T00:00:00,Enteral Nutrition,E02.421.360
19907322,2010-03-01T00:00:00,Enteral Nutrition,E02.642.500.360
19907322,2010-03-01T00:00:00,Gastrostomy,E04.210.496
19907322,2010-03-01T00:00:00,Gastrostomy,E04.579.408
19907322,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19907322,2010-03-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
19907322,2010-03-01T00:00:00,Risk Assessment,N04.452.871.715
19907322,2010-03-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
19907322,2010-03-01T00:00:00,Risk Assessment,N06.850.505.715
19907322,2010-03-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
19907322,2010-03-01T00:00:00,Stroke,C10.228.140.300.775
19907322,2010-03-01T00:00:00,Stroke,C14.907.253.855
19907322,2010-03-01T00:00:00,Treatment Outcome,E01.789.800
19907322,2010-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19907322,2010-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19916748,2010-03-01T00:00:00,Adolescent,M01.060.057
19916748,2010-03-01T00:00:00,Child,M01.060.406
19916748,2010-03-01T00:00:00,"Child, Preschool",M01.060.406.448
19916748,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19916748,2010-03-01T00:00:00,Infant,M01.060.703
19916748,2010-03-01T00:00:00,Laparoscopy,E01.370.388.250.520
19916748,2010-03-01T00:00:00,Laparoscopy,E04.800.250.520
19916748,2010-03-01T00:00:00,Testis,A05.360.444.849
19916748,2010-03-01T00:00:00,Testis,A05.360.576.782
19916748,2010-03-01T00:00:00,Testis,A06.407.312.782
19916748,2010-03-01T00:00:00,Treatment Outcome,E01.789.800
19916748,2010-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19916748,2010-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19937735,2010-03-01T00:00:00,Apoptosis,G04.299.139.160
19937735,2010-03-01T00:00:00,Carcinoma,C04.557.470.200
19937735,2010-03-01T00:00:00,Cell Survival,G04.299.316
19937735,2010-03-01T00:00:00,Ceramides,D02.065.313
19937735,2010-03-01T00:00:00,Ceramides,D09.400.410.420.525.200
19937735,2010-03-01T00:00:00,Ceramides,D10.390.470.675.200
19937735,2010-03-01T00:00:00,Ceramides,D10.570.877.360.612.200
19937735,2010-03-01T00:00:00,Endoplasmic Reticulum,A11.284.430.214.190.875.248
19937735,2010-03-01T00:00:00,Enzyme Inhibitors,D27.505.519.389
19937735,2010-03-01T00:00:00,"Fatty Acids, Monounsaturated",D10.251.355.325
19937735,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19937735,2010-03-01T00:00:00,Phosphorylation,G02.111.087.677
19937735,2010-03-01T00:00:00,Phosphorylation,G02.149.115.677
19937735,2010-03-01T00:00:00,Phosphorylation,G02.149.465.700
19937735,2010-03-01T00:00:00,Phosphorylation,G02.607.750.700
19937735,2010-03-01T00:00:00,Phosphorylation,G03.495.790
19937735,2010-03-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
19937735,2010-03-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
19937735,2010-03-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
19937735,2010-03-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
19937735,2010-03-01T00:00:00,Protein Phosphatase 2,D08.811.277.352.650.625.706
19937735,2010-03-01T00:00:00,Protein Phosphatase 2,D12.644.360.583
19937735,2010-03-01T00:00:00,Protein Phosphatase 2,D12.776.476.561
19937735,2010-03-01T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.644.360.075.718
19937735,2010-03-01T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.476.075.718
19937735,2010-03-01T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.624.664.700.169
19937735,2010-03-01T00:00:00,RNA Interference,G05.355.315.203.374.790
19937735,2010-03-01T00:00:00,Recombinant Proteins,D12.776.828
19937735,2010-03-01T00:00:00,Signal Transduction,G02.111.087.800
19937735,2010-03-01T00:00:00,Signal Transduction,G02.149.115.800
19937735,2010-03-01T00:00:00,Signal Transduction,G04.299.880
19937735,2010-03-01T00:00:00,Sphingomyelin Phosphodiesterase,D08.811.277.352.640.750
19937735,2010-03-01T00:00:00,"Stress, Physiological",G07.700.830
19937735,2010-03-01T00:00:00,Time Factors,G01.910.857
19937735,2010-03-01T00:00:00,"Transduction, Genetic",E05.393.350.800
19937735,2010-03-01T00:00:00,"Transduction, Genetic",G05.355.760.850
20009261,2010-03-01T00:00:00,Helicobacter Infections,C01.252.400.466
20009261,2010-03-01T00:00:00,Helicobacter pylori,B03.440.500.550
20009261,2010-03-01T00:00:00,Helicobacter pylori,B03.660.150.280.550
20009261,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20009261,2010-03-01T00:00:00,Incidence,E05.318.308.985.525.375
20009261,2010-03-01T00:00:00,Incidence,L01.280.975.525.375
20009261,2010-03-01T00:00:00,Incidence,N01.224.935.597.500
20009261,2010-03-01T00:00:00,Incidence,N06.850.505.400.975.525.375
20009261,2010-03-01T00:00:00,Incidence,N06.850.520.308.985.525.375
20009261,2010-03-01T00:00:00,Infant,M01.060.703
20009261,2010-03-01T00:00:00,United States,Z01.107.567.875
20009261,2010-03-01T00:00:00,Water Supply,N06.850.860.510.915
20037921,2010-03-01T00:00:00,Adult,M01.060.116
20037921,2010-03-01T00:00:00,Aged,M01.060.116.100
20037921,2010-03-01T00:00:00,Anxiety Disorders,F03.080
20037921,2010-03-01T00:00:00,Cyclonic Storms,G16.500.240.135.500
20037921,2010-03-01T00:00:00,Environmental Exposure,N06.850.460.350
20037921,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20037921,2010-03-01T00:00:00,Middle Aged,M01.060.116.630
20037921,2010-03-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
20052530,2010-03-01T00:00:00,Adolescent,M01.060.057
20052530,2010-03-01T00:00:00,Adolescent Health Services,N02.421.044
20052530,2010-03-01T00:00:00,Child,M01.060.406
20052530,2010-03-01T00:00:00,Child Health Services,N02.421.143.130
20052530,2010-03-01T00:00:00,Child Welfare,I01.880.787.293
20052530,2010-03-01T00:00:00,Community Mental Health Services,F04.408.307
20052530,2010-03-01T00:00:00,Community Mental Health Services,N02.421.143.183
20052530,2010-03-01T00:00:00,Community Mental Health Services,N02.421.461.232
20052530,2010-03-01T00:00:00,Cooperative Behavior,F01.145.813.115
20052530,2010-03-01T00:00:00,Feedback,L01.143.283.425
20052530,2010-03-01T00:00:00,Forecasting,I01.320
20052530,2010-03-01T00:00:00,Health Services Research,N03.349.380
20052530,2010-03-01T00:00:00,Health Services Research,N05.425
20052530,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20052530,2010-03-01T00:00:00,Interdisciplinary Communication,F01.145.209.381
20052530,2010-03-01T00:00:00,Interdisciplinary Communication,F01.829.401.205.249
20052530,2010-03-01T00:00:00,Interdisciplinary Communication,L01.143.474
20052530,2010-03-01T00:00:00,Outcome and Process Assessment (Health Care),N04.761.559
20052530,2010-03-01T00:00:00,Outcome and Process Assessment (Health Care),N05.715.360.575
20052530,2010-03-01T00:00:00,United States,Z01.107.567.875
20065871,2010-03-01T00:00:00,Aged,M01.060.116.100
20065871,2010-03-01T00:00:00,Anticoagulants,D27.505.954.502.119
20065871,2010-03-01T00:00:00,Brain Injuries,C10.228.140.199
20065871,2010-03-01T00:00:00,Brain Injuries,C10.900.300.087
20065871,2010-03-01T00:00:00,Brain Injuries,C21.866.260.118
20065871,2010-03-01T00:00:00,Brain Injuries,C21.866.915.300.200
20065871,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20065871,2010-03-01T00:00:00,Intensive Care,E02.760.190.400
20065871,2010-03-01T00:00:00,Intensive Care,N02.421.585.190.400
20065871,2010-03-01T00:00:00,Length of Stay,E02.760.400.480
20065871,2010-03-01T00:00:00,Length of Stay,N02.421.585.400.480
20065871,2010-03-01T00:00:00,Middle Aged,M01.060.116.630
20065871,2010-03-01T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
20065871,2010-03-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20065871,2010-03-01T00:00:00,Risk Factors,N05.715.350.200.700
20065871,2010-03-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20065871,2010-03-01T00:00:00,Risk Factors,N06.850.490.625.750
20065871,2010-03-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20065871,2010-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20065871,2010-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20065871,2010-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20065871,2010-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20065871,2010-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20065871,2010-03-01T00:00:00,"Wounds, Nonpenetrating",C21.866.974
20082451,2010-03-01T00:00:00,Adolescent,M01.060.057
20082451,2010-03-01T00:00:00,Adult,M01.060.116
20082451,2010-03-01T00:00:00,Aged,M01.060.116.100
20082451,2010-03-01T00:00:00,Antineoplastic Agents,D27.505.954.248
20082451,2010-03-01T00:00:00,"Carcinoma, Renal Cell",C04.557.470.200.025.390
20082451,2010-03-01T00:00:00,"Carcinoma, Renal Cell",C04.588.945.947.535.160
20082451,2010-03-01T00:00:00,"Carcinoma, Renal Cell",C12.758.820.750.160
20082451,2010-03-01T00:00:00,"Carcinoma, Renal Cell",C12.777.419.473.160
20082451,2010-03-01T00:00:00,"Carcinoma, Renal Cell",C13.351.937.820.535.160
20082451,2010-03-01T00:00:00,"Carcinoma, Renal Cell",C13.351.968.419.473.160
20082451,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20082451,2010-03-01T00:00:00,Kidney Neoplasms,C04.588.945.947.535
20082451,2010-03-01T00:00:00,Kidney Neoplasms,C12.758.820.750
20082451,2010-03-01T00:00:00,Kidney Neoplasms,C12.777.419.473
20082451,2010-03-01T00:00:00,Kidney Neoplasms,C13.351.937.820.535
20082451,2010-03-01T00:00:00,Kidney Neoplasms,C13.351.968.419.473
20082451,2010-03-01T00:00:00,Middle Aged,M01.060.116.630
20082451,2010-03-01T00:00:00,North America,Z01.107.567
20082451,2010-03-01T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
20082451,2010-03-01T00:00:00,Pyridines,D03.383.725
20091886,2010-03-01T00:00:00,Animals,B01.050
20091886,2010-03-01T00:00:00,"Embryo, Nonmammalian",A13.350
20091886,2010-03-01T00:00:00,"Embryo, Nonmammalian",A16.331
20091886,2010-03-01T00:00:00,"RNA, Messenger",D13.444.735.544
20091886,2010-03-01T00:00:00,Retinal Cone Photoreceptor Cells,A08.663.650.850.625.670.100
20091886,2010-03-01T00:00:00,Retinal Cone Photoreceptor Cells,A08.663.650.915.937.670.100
20091886,2010-03-01T00:00:00,Retinal Cone Photoreceptor Cells,A08.800.950.937.670.100
20091886,2010-03-01T00:00:00,Retinal Cone Photoreceptor Cells,A09.371.729.831.625.670.100
20091886,2010-03-01T00:00:00,Retinal Cone Photoreceptor Cells,A11.671.650.850.625.670.100
20091886,2010-03-01T00:00:00,Retinal Cone Photoreceptor Cells,A11.671.650.915.937.670.100
20091886,2010-03-01T00:00:00,Retinal Rod Photoreceptor Cells,A08.663.650.850.625.670.650
20091886,2010-03-01T00:00:00,Retinal Rod Photoreceptor Cells,A08.663.650.915.937.670.650
20091886,2010-03-01T00:00:00,Retinal Rod Photoreceptor Cells,A08.800.950.937.670.650
20091886,2010-03-01T00:00:00,Retinal Rod Photoreceptor Cells,A09.371.729.831.625.670.650
20091886,2010-03-01T00:00:00,Retinal Rod Photoreceptor Cells,A11.671.650.850.625.670.650
20091886,2010-03-01T00:00:00,Retinal Rod Photoreceptor Cells,A11.671.650.915.937.670.650
20091886,2010-03-01T00:00:00,Xenopus laevis,B01.050.150.900.090.180.610.500.562
20131302,2010-03-01T00:00:00,Adolescent,M01.060.057
20131302,2010-03-01T00:00:00,Adult,M01.060.116
20131302,2010-03-01T00:00:00,Aged,M01.060.116.100
20131302,2010-03-01T00:00:00,Antineoplastic Agents,D27.505.954.248
20131302,2010-03-01T00:00:00,Disease Progression,C23.550.291.656
20131302,2010-03-01T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
20131302,2010-03-01T00:00:00,"Fusion Proteins, bcr-abl",D08.811.913.696.620.682.725.500.500
20131302,2010-03-01T00:00:00,"Fusion Proteins, bcr-abl",D12.776.602.500.500.100
20131302,2010-03-01T00:00:00,"Fusion Proteins, bcr-abl",D12.776.624.100
20131302,2010-03-01T00:00:00,"Fusion Proteins, bcr-abl",D12.776.624.664.500.100
20131302,2010-03-01T00:00:00,Gastrointestinal Hemorrhage,C06.405.227
20131302,2010-03-01T00:00:00,Gastrointestinal Hemorrhage,C23.550.414.788
20131302,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20131302,2010-03-01T00:00:00,Middle Aged,M01.060.116.630
20131302,2010-03-01T00:00:00,Neoplasm Proteins,D12.776.624
20131302,2010-03-01T00:00:00,Piperazines,D03.383.606
20131302,2010-03-01T00:00:00,Pleural Effusion,C08.528.652
20131302,2010-03-01T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
20131302,2010-03-01T00:00:00,Pyrimidines,D03.383.742
20131302,2010-03-01T00:00:00,"RNA, Messenger",D13.444.735.544
20131302,2010-03-01T00:00:00,Salvage Therapy,E02.186.800
20131302,2010-03-01T00:00:00,Salvage Therapy,E02.895
20131302,2010-03-01T00:00:00,Thiazoles,D02.886.675
20131302,2010-03-01T00:00:00,Thiazoles,D03.383.129.708
20131302,2010-03-01T00:00:00,Young Adult,M01.060.116.815
20131302,2010-03-01T00:00:00,src-Family Kinases,D08.811.913.696.620.682.725.800
20132061,2010-03-01T00:00:00,Animals,B01.050
20132061,2010-03-01T00:00:00,Blood Vessels,A07.231
20132061,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20132061,2010-03-01T00:00:00,Robotics,H01.671.293.643
20132061,2010-03-01T00:00:00,Robotics,J01.897.104.834
20132061,2010-03-01T00:00:00,Robotics,L01.224.065.630
20132061,2010-03-01T00:00:00,Tissue Engineering,E05.200.249.750
20141349,2010-03-01T00:00:00,Animals,B01.050
20141349,2010-03-01T00:00:00,Antineoplastic Agents,D27.505.954.248
20141349,2010-03-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
20141349,2010-03-01T00:00:00,Clinical Trials as Topic,E05.337.250
20141349,2010-03-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
20141349,2010-03-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
20141349,2010-03-01T00:00:00,Drug Delivery Systems,E02.319.300
20141349,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20141349,2010-03-01T00:00:00,"Leukemia, Myeloid, Acute",C04.557.337.539.550
20141349,2010-03-01T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
20145990,2010-03-01T00:00:00,Adolescent,M01.060.057
20145990,2010-03-01T00:00:00,Child,M01.060.406
20145990,2010-03-01T00:00:00,Clinical Competence,I02.399.630.210
20145990,2010-03-01T00:00:00,Clinical Competence,N04.761.210
20145990,2010-03-01T00:00:00,Community Mental Health Services,F04.408.307
20145990,2010-03-01T00:00:00,Community Mental Health Services,N02.421.143.183
20145990,2010-03-01T00:00:00,Community Mental Health Services,N02.421.461.232
20145990,2010-03-01T00:00:00,Delivery of Health Care,N04.590.374
20145990,2010-03-01T00:00:00,Delivery of Health Care,N05.300
20145990,2010-03-01T00:00:00,Health Services Research,N03.349.380
20145990,2010-03-01T00:00:00,Health Services Research,N05.425
20145990,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20145990,2010-03-01T00:00:00,Mental Disorders,F03
20145990,2010-03-01T00:00:00,Outcome and Process Assessment (Health Care),N04.761.559
20145990,2010-03-01T00:00:00,Outcome and Process Assessment (Health Care),N05.715.360.575
20145990,2010-03-01T00:00:00,Patient Care Team,N04.590.715
20145990,2010-03-01T00:00:00,Staff Development,I02.574.700
20145990,2010-03-01T00:00:00,Staff Development,N04.452.677.822
20145990,2010-03-01T00:00:00,Substance-Related Disorders,C21.739
20145990,2010-03-01T00:00:00,Substance-Related Disorders,F03.900
20145990,2010-03-01T00:00:00,United States,Z01.107.567.875
20148622,2010-03-01T00:00:00,"Education, Medical",I02.358.399
20148622,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20148622,2010-03-01T00:00:00,Interprofessional Relations,F01.829.401.205
20148622,2010-03-01T00:00:00,"Schools, Medical",I02.783.660.552
20148622,2010-03-01T00:00:00,"Schools, Medical",N02.278.020.578
20148622,2010-03-01T00:00:00,United States,Z01.107.567.875
20156083,2010-03-01T00:00:00,Adolescent,M01.060.057
20156083,2010-03-01T00:00:00,Adult,M01.060.116
20156083,2010-03-01T00:00:00,Diet,E05.272
20156083,2010-03-01T00:00:00,Diet,G07.610.240
20156083,2010-03-01T00:00:00,Exercise,G11.427.590.237
20156083,2010-03-01T00:00:00,Exercise,I03.350
20156083,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20156083,2010-03-01T00:00:00,Middle Aged,M01.060.116.630
20156083,2010-03-01T00:00:00,Patient Education as Topic,I02.233.332.500
20156083,2010-03-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
20156083,2010-03-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
20156083,2010-03-01T00:00:00,Postpartum Period,G08.686.702
20156083,2010-03-01T00:00:00,Weight Loss,C23.888.144.243.963
20156083,2010-03-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
20159435,2010-03-01T00:00:00,Brain,A08.186.211
20159435,2010-03-01T00:00:00,Child,M01.060.406
20159435,2010-03-01T00:00:00,"Child, Preschool",M01.060.406.448
20159435,2010-03-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
20159435,2010-03-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
20159435,2010-03-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
20159435,2010-03-01T00:00:00,Genetic Testing,E01.370.427
20159435,2010-03-01T00:00:00,Genetic Testing,E05.393.435
20159435,2010-03-01T00:00:00,Genetic Testing,N02.421.143.827.233.221
20159435,2010-03-01T00:00:00,Genetic Testing,N02.421.308.430
20159435,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20159435,2010-03-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20159435,2010-03-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20159435,2010-03-01T00:00:00,Membrane Proteins,D12.776.543
20159435,2010-03-01T00:00:00,"Mutation, Missense",G05.365.590.650
20159435,2010-03-01T00:00:00,Neurodegenerative Diseases,C10.574
20159435,2010-03-01T00:00:00,Polymerase Chain Reaction,E05.393.620.500
20159435,2010-03-01T00:00:00,TRPM Cation Channels,D12.776.157.530.400.901.555
20159435,2010-03-01T00:00:00,TRPM Cation Channels,D12.776.543.585.400.901.555
20163382,2010-03-01T00:00:00,Adolescent,M01.060.057
20163382,2010-03-01T00:00:00,Adult,M01.060.116
20163382,2010-03-01T00:00:00,"Behavior, Addictive",F01.145.527.100.120
20163382,2010-03-01T00:00:00,Cognitive Therapy,F04.754.137.428
20163382,2010-03-01T00:00:00,Combined Modality Therapy,E02.186
20163382,2010-03-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
20163382,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20163382,2010-03-01T00:00:00,Nicotine,D03.132.760.570
20163382,2010-03-01T00:00:00,Nicotine,D03.383.725.518
20163382,2010-03-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
20163382,2010-03-01T00:00:00,Smoking Cessation,F01.145.940.700
20163382,2010-03-01T00:00:00,Substance-Related Disorders,C21.739
20163382,2010-03-01T00:00:00,Substance-Related Disorders,F03.900
20163382,2010-03-01T00:00:00,Treatment Outcome,E01.789.800
20163382,2010-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20163382,2010-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20163391,2010-03-01T00:00:00,Acetylcysteine,D02.886.030.230.259
20163391,2010-03-01T00:00:00,Acetylcysteine,D12.125.166.230.259
20163391,2010-03-01T00:00:00,Adolescent,M01.060.057
20163391,2010-03-01T00:00:00,"Behavior, Addictive",F01.145.527.100.120
20163391,2010-03-01T00:00:00,Cannabinoids,D02.455.849.090
20163391,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20163391,2010-03-01T00:00:00,Marijuana Abuse,C21.739.635
20163391,2010-03-01T00:00:00,Marijuana Abuse,F03.900.635
20163391,2010-03-01T00:00:00,Pilot Projects,E05.318.760.750
20163391,2010-03-01T00:00:00,Pilot Projects,E05.337.737
20163391,2010-03-01T00:00:00,Pilot Projects,N05.715.360.775.625
20163391,2010-03-01T00:00:00,Pilot Projects,N06.850.520.450.720
20163391,2010-03-01T00:00:00,Young Adult,M01.060.116.815
20170320,2010-03-01T00:00:00,Adolescent,M01.060.057
20170320,2010-03-01T00:00:00,Adult,M01.060.116
20170320,2010-03-01T00:00:00,Asthma,C08.127.108
20170320,2010-03-01T00:00:00,Asthma,C08.381.495.108
20170320,2010-03-01T00:00:00,Asthma,C08.674.095
20170320,2010-03-01T00:00:00,Asthma,C20.543.480.680.095
20170320,2010-03-01T00:00:00,Birth Weight,C23.888.144.186
20170320,2010-03-01T00:00:00,Birth Weight,E01.370.600.115.100.160.120.186
20170320,2010-03-01T00:00:00,Birth Weight,E05.041.124.160.750.149
20170320,2010-03-01T00:00:00,Birth Weight,G07.100.100.160.120.186
20170320,2010-03-01T00:00:00,Birth Weight,G07.700.320.249.314.120.186
20170320,2010-03-01T00:00:00,Body Weight,C23.888.144
20170320,2010-03-01T00:00:00,Body Weight,E01.370.600.115.100.160.120
20170320,2010-03-01T00:00:00,Body Weight,E05.041.124.160.750
20170320,2010-03-01T00:00:00,Body Weight,G07.100.100.160.120
20170320,2010-03-01T00:00:00,Body Weight,G07.700.320.249.314.120
20170320,2010-03-01T00:00:00,Head,A01.456
20170320,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20170320,2010-03-01T00:00:00,"Infant, Newborn",M01.060.703.520
20170320,2010-03-01T00:00:00,Pregnancy,G08.686.785.760.769
20170320,2010-03-01T00:00:00,Pregnancy Complications,C13.703
20170320,2010-03-01T00:00:00,Smoking,F01.145.466.753
20170320,2010-03-01T00:00:00,United States,Z01.107.567.875
20170320,2010-03-01T00:00:00,Young Adult,M01.060.116.815
20173124,2010-03-01T00:00:00,Coronary Stenosis,C14.280.647.250.285
20173124,2010-03-01T00:00:00,Coronary Stenosis,C14.907.585.250.285
20173124,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20173124,2010-03-01T00:00:00,Metals,D01.552
20173124,2010-03-01T00:00:00,"Models, Cardiovascular",E05.599.395.161
20173124,2010-03-01T00:00:00,"Phantoms, Imaging",E07.671
20173124,2010-03-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
20173124,2010-03-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
20173124,2010-03-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
20173124,2010-03-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
20173124,2010-03-01T00:00:00,Stents,E07.695.750
20173124,2010-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20173124,2010-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20173124,2010-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20173124,2010-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20173124,2010-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20176307,2010-03-01T00:00:00,Consumer Satisfaction,N04.452.822.360
20176307,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20176307,2010-03-01T00:00:00,Smoking Cessation,F01.145.940.700
20176307,2010-03-01T00:00:00,Tobacco Industry,J01.576.919
20185649,2010-03-01T00:00:00,Animals,B01.050
20185649,2010-03-01T00:00:00,Fibrin Fibrinogen Degradation Products,D12.776.124.270.300
20185649,2010-03-01T00:00:00,Fibrin Fibrinogen Degradation Products,D12.776.811.300.290
20185649,2010-03-01T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
20185649,2010-03-01T00:00:00,Kidney,A05.810.453
20185649,2010-03-01T00:00:00,Liver,A03.620
20185649,2010-03-01T00:00:00,"Models, Animal",E05.598
20185649,2010-03-01T00:00:00,Myocardium,A02.633.580
20185649,2010-03-01T00:00:00,Myocardium,A07.541.704
20185649,2010-03-01T00:00:00,Myocardium,A10.690.552.750
20185649,2010-03-01T00:00:00,Quadriceps Muscle,A02.633.567.850
20185649,2010-03-01T00:00:00,"Spectrometry, Fluorescence",E05.196.712.516.600.676
20185649,2010-03-01T00:00:00,"Spectrometry, Fluorescence",E05.196.867.726
20185649,2010-03-01T00:00:00,Swine,B01.050.150.900.649.077.880
20185649,2010-03-01T00:00:00,Time Factors,G01.910.857
20186028,2010-03-01T00:00:00,Adult,M01.060.116
20186028,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20186028,2010-03-01T00:00:00,Neoplasm Staging,E01.370.550
20186028,2010-03-01T00:00:00,Protein-Tyrosine Kinases,D08.811.913.696.620.682.725
20186028,2010-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20186028,2010-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20186028,2010-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20186028,2010-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20186028,2010-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20186028,2010-03-01T00:00:00,Treatment Outcome,E01.789.800
20186028,2010-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20186028,2010-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20189092,2010-03-01T00:00:00,Carotid Stenosis,C10.228.140.300.200.360
20189092,2010-03-01T00:00:00,Carotid Stenosis,C14.907.137.230
20189092,2010-03-01T00:00:00,Carotid Stenosis,C14.907.253.123.360
20189092,2010-03-01T00:00:00,Education,I02
20189092,2010-03-01T00:00:00,"Endarterectomy, Carotid",E04.100.814.456.250
20189092,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20189092,2010-03-01T00:00:00,Iatrogenic Disease,C23.550.291.875
20189092,2010-03-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
20189092,2010-03-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
20189092,2010-03-01T00:00:00,Postoperative Complications,C23.550.767
20189092,2010-03-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
20189092,2010-03-01T00:00:00,"Quality Assurance, Health Care",N05.700
20189092,2010-03-01T00:00:00,Stents,E07.695.750
20189092,2010-03-01T00:00:00,Treatment Outcome,E01.789.800
20189092,2010-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20189092,2010-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20189092,2010-03-01T00:00:00,Vascular Surgical Procedures,E04.100.814
20189503,2010-03-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
20189503,2010-03-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
20189503,2010-03-01T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
20189503,2010-03-01T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
20189503,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20189503,2010-03-01T00:00:00,Postoperative Complications,C23.550.767
20189503,2010-03-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20189503,2010-03-01T00:00:00,Risk Factors,N05.715.350.200.700
20189503,2010-03-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20189503,2010-03-01T00:00:00,Risk Factors,N06.850.490.625.750
20189503,2010-03-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20189503,2010-03-01T00:00:00,Terminology as Topic,L01.143.506.598.400
20193836,2010-03-01T00:00:00,Cognition,F02.463.188
20193836,2010-03-01T00:00:00,Cognition Disorders,F03.087.250
20193836,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20193836,2010-03-01T00:00:00,Incidence,E05.318.308.985.525.375
20193836,2010-03-01T00:00:00,Incidence,L01.280.975.525.375
20193836,2010-03-01T00:00:00,Incidence,N01.224.935.597.500
20193836,2010-03-01T00:00:00,Incidence,N06.850.505.400.975.525.375
20193836,2010-03-01T00:00:00,Incidence,N06.850.520.308.985.525.375
20193836,2010-03-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20193836,2010-03-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20193836,2010-03-01T00:00:00,Middle Aged,M01.060.116.630
20193836,2010-03-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20193836,2010-03-01T00:00:00,Risk Factors,N05.715.350.200.700
20193836,2010-03-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20193836,2010-03-01T00:00:00,Risk Factors,N06.850.490.625.750
20193836,2010-03-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20194337,2010-03-01T00:00:00,Conflict of Interest,K01.316.130
20194337,2010-03-01T00:00:00,Conflict of Interest,N05.350.225
20194337,2010-03-01T00:00:00,Decision Making,F02.463.785.373
20194337,2010-03-01T00:00:00,Diffusion of Innovation,L01.143.320
20194337,2010-03-01T00:00:00,Government Regulation,I01.880.604.394
20194337,2010-03-01T00:00:00,Government Regulation,N03.706.358
20194337,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20194337,2010-03-01T00:00:00,Licensure,N03.706.110.510
20194337,2010-03-01T00:00:00,Licensure,N05.700.200.450
20194337,2010-03-01T00:00:00,Orthopedics,H02.403.810.494
20194337,2010-03-01T00:00:00,United States,Z01.107.567.875
20194546,2010-03-01T00:00:00,Adult,M01.060.116
20194546,2010-03-01T00:00:00,Aged,M01.060.116.100
20194546,2010-03-01T00:00:00,Cognition,F02.463.188
20194546,2010-03-01T00:00:00,Cognition Disorders,F03.087.250
20194546,2010-03-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
20194546,2010-03-01T00:00:00,Double-Blind Method,E05.318.780.300
20194546,2010-03-01T00:00:00,Double-Blind Method,E05.581.500.300
20194546,2010-03-01T00:00:00,Double-Blind Method,N05.715.360.780.320
20194546,2010-03-01T00:00:00,Double-Blind Method,N06.850.520.445.300
20194546,2010-03-01T00:00:00,Electroconvulsive Therapy,F04.570.200.583
20194546,2010-03-01T00:00:00,Electroconvulsive Therapy,F04.669.224.300
20194546,2010-03-01T00:00:00,Electrodes,E07.305.250
20194546,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20194546,2010-03-01T00:00:00,Middle Aged,M01.060.116.630
20194546,2010-03-01T00:00:00,Neuropsychological Tests,F04.711.513
20194546,2010-03-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
20194546,2010-03-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
20194546,2010-03-01T00:00:00,Psychiatric Status Rating Scales,F04.586
20194546,2010-03-01T00:00:00,Remission Induction,E02.860
20194546,2010-03-01T00:00:00,Seizures,C10.228.140.490.631
20194546,2010-03-01T00:00:00,Seizures,C10.597.742
20194546,2010-03-01T00:00:00,Seizures,C23.888.592.742
20194546,2010-03-01T00:00:00,Young Adult,M01.060.116.815
20195242,2010-03-01T00:00:00,Alternative Splicing,G02.111.087.750.700.100
20195242,2010-03-01T00:00:00,Alternative Splicing,G02.149.115.750.700.100
20195242,2010-03-01T00:00:00,Alternative Splicing,G03.495.839.700.100
20195242,2010-03-01T00:00:00,Alternative Splicing,G05.355.315.700.700.100
20195242,2010-03-01T00:00:00,Amino Acid Sequence,G02.111.570.060
20195242,2010-03-01T00:00:00,Amino Acid Sequence,L01.453.245.667.060
20195242,2010-03-01T00:00:00,Animals,B01.050
20195242,2010-03-01T00:00:00,Cell Proliferation,G04.299.233.750
20195242,2010-03-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
20195242,2010-03-01T00:00:00,"Fatty Acids, Monounsaturated",D10.251.355.325
20195242,2010-03-01T00:00:00,Gene Expression Profiling,E05.393.332
20195242,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20195242,2010-03-01T00:00:00,Liver,A03.620
20195242,2010-03-01T00:00:00,Molecular Sequence Data,L01.453.245.667
20195242,2010-03-01T00:00:00,Oxidoreductases,D08.811.682
20195242,2010-03-01T00:00:00,"Sequence Homology, Amino Acid",G02.111.810.200
20195242,2010-03-01T00:00:00,"Sequence Homology, Amino Acid",G05.810.200
20201810,2010-03-01T00:00:00,Alcohol Deterrents,D27.505.954.427.020
20201810,2010-03-01T00:00:00,"Alcohol-Induced Disorders, Nervous System",C10.720.112
20201810,2010-03-01T00:00:00,"Alcohol-Induced Disorders, Nervous System",C21.613.705.150
20201810,2010-03-01T00:00:00,"Alcohol-Induced Disorders, Nervous System",C21.739.100.087.193
20201810,2010-03-01T00:00:00,Alcoholism,C21.739.100.250
20201810,2010-03-01T00:00:00,Alcoholism,F03.900.100.350
20201810,2010-03-01T00:00:00,Brain Chemistry,G02.111.100
20201810,2010-03-01T00:00:00,Brain Chemistry,G03.200
20201810,2010-03-01T00:00:00,Cocaine-Related Disorders,C21.739.300
20201810,2010-03-01T00:00:00,Cocaine-Related Disorders,F03.900.300
20201810,2010-03-01T00:00:00,Disulfiram,D02.241.081.251.869.220.250
20201810,2010-03-01T00:00:00,Disulfiram,D02.886.520.150.175
20201810,2010-03-01T00:00:00,Disulfiram,D02.886.706.200.200
20201810,2010-03-01T00:00:00,Enzyme Inhibitors,D27.505.519.389
20201810,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20201810,2010-03-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
20201815,2010-03-01T00:00:00,"Alcohol-Induced Disorders, Nervous System",C10.720.112
20201815,2010-03-01T00:00:00,"Alcohol-Induced Disorders, Nervous System",C21.613.705.150
20201815,2010-03-01T00:00:00,"Alcohol-Induced Disorders, Nervous System",C21.739.100.087.193
20201815,2010-03-01T00:00:00,Alcoholism,C21.739.100.250
20201815,2010-03-01T00:00:00,Alcoholism,F03.900.100.350
20201815,2010-03-01T00:00:00,Animals,B01.050
20201815,2010-03-01T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
20201815,2010-03-01T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
20201815,2010-03-01T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
20201815,2010-03-01T00:00:00,Brain Chemistry,G02.111.100
20201815,2010-03-01T00:00:00,Brain Chemistry,G03.200
20201815,2010-03-01T00:00:00,Frontal Lobe,A08.186.211.730.885.287.500.270
20201815,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20201815,2010-03-01T00:00:00,Piperazines,D03.383.606
20201815,2010-03-01T00:00:00,Quinolones,D03.438.810.835
20201815,2010-03-01T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.070.300.400.500
20201815,2010-03-01T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.100.150.400.500
20201815,2010-03-01T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.720.300.300.400.500
20201815,2010-03-01T00:00:00,"Receptors, Serotonin",D12.776.543.750.070.800
20201815,2010-03-01T00:00:00,"Receptors, Serotonin",D12.776.543.750.100.800
20201815,2010-03-01T00:00:00,"Receptors, Serotonin",D12.776.543.750.720.300.800
20202950,2010-03-01T00:00:00,Health Policy,I01.880.604.825.608.400
20202950,2010-03-01T00:00:00,Health Policy,N03.706.825.608.428
20202950,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20202950,2010-03-01T00:00:00,"Liability, Legal",I01.880.604.583.490
20202950,2010-03-01T00:00:00,"Liability, Legal",N03.706.535.547
20202950,2010-03-01T00:00:00,Smoking,F01.145.466.753
20202950,2010-03-01T00:00:00,State Government,I01.409.775
20202950,2010-03-01T00:00:00,State Government,N03.540.348.875
20202950,2010-03-01T00:00:00,Tobacco Industry,J01.576.919
20202950,2010-03-01T00:00:00,United States,Z01.107.567.875
20203454,2010-03-01T00:00:00,Aged,M01.060.116.100
20203454,2010-03-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
20203454,2010-03-01T00:00:00,Blood Pressure,E01.370.600.875.249
20203454,2010-03-01T00:00:00,Blood Pressure,G09.330.380.076
20203454,2010-03-01T00:00:00,Cardiovascular Diseases,C14
20203454,2010-03-01T00:00:00,Diet,E05.272
20203454,2010-03-01T00:00:00,Diet,G07.610.240
20203454,2010-03-01T00:00:00,Drug Interactions,G07.690.812.240
20203454,2010-03-01T00:00:00,Drug Interactions,G07.700.680.240
20203454,2010-03-01T00:00:00,Drug Resistance,G07.690.320
20203454,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20203454,2010-03-01T00:00:00,Hypertension,C14.907.489
20203454,2010-03-01T00:00:00,Life Style,F01.829.458
20203454,2010-03-01T00:00:00,Pain,C10.597.617
20203454,2010-03-01T00:00:00,Pain,C23.888.592.612
20203454,2010-03-01T00:00:00,Pain,C23.888.646
20203454,2010-03-01T00:00:00,Pain,F02.830.816.444
20203454,2010-03-01T00:00:00,Pain,G11.561.600.810.444
20203454,2010-03-01T00:00:00,Patient Compliance,F01.145.488.500
20203454,2010-03-01T00:00:00,Patient Compliance,N05.300.150.600.600
20203454,2010-03-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20203454,2010-03-01T00:00:00,Risk Factors,N05.715.350.200.700
20203454,2010-03-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20203454,2010-03-01T00:00:00,Risk Factors,N06.850.490.625.750
20203454,2010-03-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20204887,2010-03-01T00:00:00,Family Practice,H02.403.280
20204887,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20204887,2010-03-01T00:00:00,Leadership,F01.752.609
20204887,2010-03-01T00:00:00,United States,Z01.107.567.875
20204894,2010-03-01T00:00:00,"Adaptation, Psychological",F01.058
20204894,2010-03-01T00:00:00,Adolescent,M01.060.057
20204894,2010-03-01T00:00:00,Adult,M01.060.116
20204894,2010-03-01T00:00:00,Aged,M01.060.116.100
20204894,2010-03-01T00:00:00,Data Collection,E05.318.308
20204894,2010-03-01T00:00:00,Data Collection,L01.280
20204894,2010-03-01T00:00:00,Data Collection,N05.715.360.300
20204894,2010-03-01T00:00:00,Data Collection,N06.850.520.308
20204894,2010-03-01T00:00:00,Depression,F01.145.126.350
20204894,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20204894,2010-03-01T00:00:00,Middle Aged,M01.060.116.630
20204894,2010-03-01T00:00:00,Primary Health Care,N04.590.233.727
20204894,2010-03-01T00:00:00,Psychometrics,F04.711.780
20204894,2010-03-01T00:00:00,Questionnaires,E05.318.308.750
20204894,2010-03-01T00:00:00,Questionnaires,L01.280.800
20204894,2010-03-01T00:00:00,Questionnaires,N05.715.360.300.695
20204894,2010-03-01T00:00:00,Questionnaires,N06.850.520.308.750
20204894,2010-03-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20204894,2010-03-01T00:00:00,Risk Factors,N05.715.350.200.700
20204894,2010-03-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20204894,2010-03-01T00:00:00,Risk Factors,N06.850.490.625.750
20204894,2010-03-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20204894,2010-03-01T00:00:00,Sex Factors,N05.715.350.675
20204894,2010-03-01T00:00:00,Sex Factors,N06.850.490.875
20204894,2010-03-01T00:00:00,South Carolina,Z01.107.567.875.075.662
20204894,2010-03-01T00:00:00,South Carolina,Z01.107.567.875.750.700
20204894,2010-03-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
20204894,2010-03-01T00:00:00,"Stress, Psychological",F01.145.126.990
20204894,2010-03-01T00:00:00,"Stress, Psychological",F02.830.900
20204894,2010-03-01T00:00:00,United States,Z01.107.567.875
20204894,2010-03-01T00:00:00,Wounds and Injuries,C21.866
20204894,2010-03-01T00:00:00,Young Adult,M01.060.116.815
20207676,2010-03-01T00:00:00,Adolescent,M01.060.057
20207676,2010-03-01T00:00:00,Adult,M01.060.116
20207676,2010-03-01T00:00:00,Age Factors,N05.715.350.075
20207676,2010-03-01T00:00:00,Age Factors,N06.850.490.250
20207676,2010-03-01T00:00:00,Aged,M01.060.116.100
20207676,2010-03-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
20207676,2010-03-01T00:00:00,Employment,N01.824.245
20207676,2010-03-01T00:00:00,Health Status,I01.240.425
20207676,2010-03-01T00:00:00,Health Status,N01.224.425
20207676,2010-03-01T00:00:00,Health Status,N06.850.505.400.425
20207676,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20207676,2010-03-01T00:00:00,Mental Disorders,F03
20207676,2010-03-01T00:00:00,Middle Aged,M01.060.116.630
20207676,2010-03-01T00:00:00,Psychiatric Status Rating Scales,F04.586
20207676,2010-03-01T00:00:00,Sex Factors,N05.715.350.675
20207676,2010-03-01T00:00:00,Sex Factors,N06.850.490.875
20207676,2010-03-01T00:00:00,Young Adult,M01.060.116.815
20211299,2010-03-01T00:00:00,African Americans,M01.686.508.100.100
20211299,2010-03-01T00:00:00,African Americans,M01.686.754.100
20211299,2010-03-01T00:00:00,Aged,M01.060.116.100
20211299,2010-03-01T00:00:00,Cardiovascular Diseases,C14
20211299,2010-03-01T00:00:00,Coronary Disease,C14.280.647.250
20211299,2010-03-01T00:00:00,Coronary Disease,C14.907.585.250
20211299,2010-03-01T00:00:00,Demography,I01.240
20211299,2010-03-01T00:00:00,Demography,N01.224
20211299,2010-03-01T00:00:00,Demography,N06.850.505.400
20211299,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20211299,2010-03-01T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
20211299,2010-03-01T00:00:00,Metabolic Syndrome X,C18.452.625
20211299,2010-03-01T00:00:00,Middle Aged,M01.060.116.630
20211299,2010-03-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
20211299,2010-03-01T00:00:00,Risk Assessment,N04.452.871.715
20211299,2010-03-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20211299,2010-03-01T00:00:00,Risk Assessment,N06.850.505.715
20211299,2010-03-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20211299,2010-03-01T00:00:00,Stroke,C10.228.140.300.775
20211299,2010-03-01T00:00:00,Stroke,C14.907.253.855
20211299,2010-03-01T00:00:00,United States,Z01.107.567.875
20215904,2010-03-01T00:00:00,Algorithms,G17.035
20215904,2010-03-01T00:00:00,Algorithms,L01.224.050
20215904,2010-03-01T00:00:00,Cerebral Hemorrhage,C10.228.140.300.535.200
20215904,2010-03-01T00:00:00,Cerebral Hemorrhage,C14.907.253.573.200
20215904,2010-03-01T00:00:00,Cerebral Hemorrhage,C23.550.414.913.100
20215904,2010-03-01T00:00:00,Coronary Disease,C14.280.647.250
20215904,2010-03-01T00:00:00,Coronary Disease,C14.907.585.250
20215904,2010-03-01T00:00:00,Critical Pathways,N04.590.233.624.625
20215904,2010-03-01T00:00:00,Critical Pathways,N04.590.275
20215904,2010-03-01T00:00:00,Hospitalization,E02.760.400
20215904,2010-03-01T00:00:00,Hospitalization,N02.421.585.400
20215904,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20215904,2010-03-01T00:00:00,Influenza Vaccines,D20.215.894.899.302
20215904,2010-03-01T00:00:00,"Influenza, Human",C02.782.620.365
20215904,2010-03-01T00:00:00,"Influenza, Human",C08.730.310
20215904,2010-03-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
20215904,2010-03-01T00:00:00,"Quality Assurance, Health Care",N05.700
20215904,2010-03-01T00:00:00,Stroke,C10.228.140.300.775
20215904,2010-03-01T00:00:00,Stroke,C14.907.253.855
20215904,2010-03-01T00:00:00,Treatment Outcome,E01.789.800
20215904,2010-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20215904,2010-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20216180,2010-03-01T00:00:00,Cardiopulmonary Bypass,E04.292.413
20216180,2010-03-01T00:00:00,"Heart Defects, Congenital",C14.240.400
20216180,2010-03-01T00:00:00,"Heart Defects, Congenital",C14.280.400
20216180,2010-03-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
20216180,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20216180,2010-03-01T00:00:00,Infant,M01.060.703
20216180,2010-03-01T00:00:00,"Infant, Newborn",M01.060.703.520
20216180,2010-03-01T00:00:00,"Intensive Care Units, Pediatric",N02.278.388.493.390
20216180,2010-03-01T00:00:00,Myocardial Contraction,G09.330.190.541
20216180,2010-03-01T00:00:00,Myocardial Contraction,G11.427.590.540.570
20216180,2010-03-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
20216180,2010-03-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
20216180,2010-03-01T00:00:00,Vasodilator Agents,D27.505.954.411.918
20223424,2010-03-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
20223424,2010-03-01T00:00:00,Body Mass Index,E05.041.124.125
20223424,2010-03-01T00:00:00,Body Mass Index,G07.100.100.125
20223424,2010-03-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
20223424,2010-03-01T00:00:00,Heart Diseases,C14.280
20223424,2010-03-01T00:00:00,Heart Ventricles,A07.541.560
20223424,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20223424,2010-03-01T00:00:00,Obesity,C18.654.726.500
20223424,2010-03-01T00:00:00,Obesity,C23.888.144.699.500
20223424,2010-03-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
20223424,2010-03-01T00:00:00,Obesity,G07.100.100.160.120.699.500
20223424,2010-03-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
20223424,2010-03-01T00:00:00,Risk Assessment,N04.452.871.715
20223424,2010-03-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20223424,2010-03-01T00:00:00,Risk Assessment,N06.850.505.715
20223424,2010-03-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20223424,2010-03-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20223424,2010-03-01T00:00:00,Risk Factors,N05.715.350.200.700
20223424,2010-03-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20223424,2010-03-01T00:00:00,Risk Factors,N06.850.490.625.750
20223424,2010-03-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20223424,2010-03-01T00:00:00,Stroke Volume,E01.370.370.380.150.700
20223424,2010-03-01T00:00:00,Stroke Volume,G09.330.380.124.882
20223424,2010-03-01T00:00:00,Ventricular Remodeling,C23.300.985
20223424,2010-03-01T00:00:00,Ventricular Remodeling,G09.330.190.962.975
20226960,2010-03-01T00:00:00,Anticoagulants,D27.505.954.502.119
20226960,2010-03-01T00:00:00,Catheterization,E02.148
20226960,2010-03-01T00:00:00,Catheterization,E05.157
20226960,2010-03-01T00:00:00,Combined Modality Therapy,E02.186
20226960,2010-03-01T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
20226960,2010-03-01T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
20226960,2010-03-01T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
20226960,2010-03-01T00:00:00,Hemodynamics,G09.330.190.400
20226960,2010-03-01T00:00:00,Hemodynamics,G09.330.380
20226960,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20226960,2010-03-01T00:00:00,Pulmonary Embolism,C08.381.746
20226960,2010-03-01T00:00:00,Pulmonary Embolism,C14.907.355.350.700
20226960,2010-03-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
20226960,2010-03-01T00:00:00,Risk Assessment,N04.452.871.715
20226960,2010-03-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20226960,2010-03-01T00:00:00,Risk Assessment,N06.850.505.715
20226960,2010-03-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20226960,2010-03-01T00:00:00,Thrombectomy,E04.100.814.842
20226960,2010-03-01T00:00:00,Thrombolytic Therapy,E02.319.913
20226960,2010-03-01T00:00:00,Treatment Outcome,E01.789.800
20226960,2010-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20226960,2010-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20228652,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20228652,2010-03-01T00:00:00,Urinary Incontinence,C12.777.934.852
20228652,2010-03-01T00:00:00,Urinary Incontinence,C13.351.968.934.814
20228652,2010-03-01T00:00:00,Urinary Incontinence,C23.888.942.800
20228652,2010-03-01T00:00:00,Wounds and Injuries,C21.866
20232723,2010-03-01T00:00:00,Adult,M01.060.116
20232723,2010-03-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
20232723,2010-03-01T00:00:00,Appendicitis,C06.405.205.099
20232723,2010-03-01T00:00:00,Appendicitis,C06.405.469.110.207
20232723,2010-03-01T00:00:00,Combined Modality Therapy,E02.186
20232723,2010-03-01T00:00:00,Drainage,E02.309
20232723,2010-03-01T00:00:00,Drainage,E04.237
20232723,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20232723,2010-03-01T00:00:00,Pregnancy,G08.686.785.760.769
20232723,2010-03-01T00:00:00,"Pregnancy Complications, Infectious",C01.539.674
20232723,2010-03-01T00:00:00,"Pregnancy Complications, Infectious",C13.703.700
20232723,2010-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20232723,2010-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20232723,2010-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20232723,2010-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20232723,2010-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20233861,2010-03-01T00:00:00,Animals,B01.050
20233861,2010-03-01T00:00:00,"Disease Models, Animal",C22.232
20233861,2010-03-01T00:00:00,"Disease Models, Animal",E05.598.500
20233861,2010-03-01T00:00:00,"Disease Models, Animal",E05.599.395.080
20233861,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20233861,2010-03-01T00:00:00,"Hypertension, Pulmonary",C08.381.423
20233861,2010-03-01T00:00:00,Pulmonary Artery,A07.231.114.715
20234226,2010-03-01T00:00:00,Brain Injuries,C10.228.140.199
20234226,2010-03-01T00:00:00,Brain Injuries,C10.900.300.087
20234226,2010-03-01T00:00:00,Brain Injuries,C21.866.260.118
20234226,2010-03-01T00:00:00,Brain Injuries,C21.866.915.300.200
20234226,2010-03-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
20234226,2010-03-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
20234226,2010-03-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
20234226,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20234226,2010-03-01T00:00:00,Incidence,E05.318.308.985.525.375
20234226,2010-03-01T00:00:00,Incidence,L01.280.975.525.375
20234226,2010-03-01T00:00:00,Incidence,N01.224.935.597.500
20234226,2010-03-01T00:00:00,Incidence,N06.850.505.400.975.525.375
20234226,2010-03-01T00:00:00,Incidence,N06.850.520.308.985.525.375
20234226,2010-03-01T00:00:00,Population Surveillance,E05.318.308.250.700
20234226,2010-03-01T00:00:00,Population Surveillance,N05.715.360.300.375.625
20234226,2010-03-01T00:00:00,Population Surveillance,N06.850.520.308.250.700
20234226,2010-03-01T00:00:00,Population Surveillance,N06.850.780.675
20234226,2010-03-01T00:00:00,United States,Z01.107.567.875
20304757,2010-03-01T00:00:00,Alcohol Drinking,F01.145.317.269
20304757,2010-03-01T00:00:00,Crime Victims,M01.135
20304757,2010-03-01T00:00:00,Health Surveys,E05.318.308.250
20304757,2010-03-01T00:00:00,Health Surveys,N05.715.360.300.375
20304757,2010-03-01T00:00:00,Health Surveys,N06.850.520.308.250
20304757,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20304757,2010-03-01T00:00:00,Questionnaires,E05.318.308.750
20304757,2010-03-01T00:00:00,Questionnaires,L01.280.800
20304757,2010-03-01T00:00:00,Questionnaires,N05.715.360.300.695
20304757,2010-03-01T00:00:00,Questionnaires,N06.850.520.308.750
20304757,2010-03-01T00:00:00,Rape,I01.198.240.748.640
20304757,2010-03-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20304757,2010-03-01T00:00:00,Risk Factors,N05.715.350.200.700
20304757,2010-03-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20304757,2010-03-01T00:00:00,Risk Factors,N06.850.490.625.750
20304757,2010-03-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20304757,2010-03-01T00:00:00,South Carolina,Z01.107.567.875.075.662
20304757,2010-03-01T00:00:00,South Carolina,Z01.107.567.875.750.700
20304757,2010-03-01T00:00:00,Students,I02.233.748
20304757,2010-03-01T00:00:00,Students,I02.851
20304757,2010-03-01T00:00:00,Students,M01.848
20304757,2010-03-01T00:00:00,Substance-Related Disorders,C21.739
20304757,2010-03-01T00:00:00,Substance-Related Disorders,F03.900
20304757,2010-03-01T00:00:00,Young Adult,M01.060.116.815
20306612,2010-03-01T00:00:00,Adult,M01.060.116
20306612,2010-03-01T00:00:00,Community-Based Participatory Research,N05.425.104
20306612,2010-03-01T00:00:00,Environment Design,I01.283
20306612,2010-03-01T00:00:00,Environment Design,I01.880.709.359
20306612,2010-03-01T00:00:00,Environment Design,N06.230.200
20306612,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20306612,2010-03-01T00:00:00,Middle Aged,M01.060.116.630
20306612,2010-03-01T00:00:00,Needs Assessment,I02.594
20306612,2010-03-01T00:00:00,Needs Assessment,N03.349.380.565
20306612,2010-03-01T00:00:00,Needs Assessment,N05.300.537
20306612,2010-03-01T00:00:00,Photography,E01.370.350.600
20306612,2010-03-01T00:00:00,Photography,E05.712
20306612,2010-03-01T00:00:00,South Carolina,Z01.107.567.875.075.662
20306612,2010-03-01T00:00:00,South Carolina,Z01.107.567.875.750.700
20306612,2010-03-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
20306612,2010-03-01T00:00:00,Spinal Cord Injuries,C10.900.850
20306612,2010-03-01T00:00:00,Spinal Cord Injuries,C21.866.819
20337507,2010-03-01T00:00:00,Adolescent,M01.060.057
20337507,2010-03-01T00:00:00,Adult,M01.060.116
20337507,2010-03-01T00:00:00,Amphetamine-Related Disorders,C21.739.225
20337507,2010-03-01T00:00:00,Amphetamine-Related Disorders,F03.900.225
20337507,2010-03-01T00:00:00,"Behavior, Addictive",F01.145.527.100.120
20337507,2010-03-01T00:00:00,Conditioning (Psychology),F02.463.425.179
20337507,2010-03-01T00:00:00,Cues,F02.463.425.234
20337507,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20337507,2010-03-01T00:00:00,Methamphetamine,D02.092.471.683.152.619
20337507,2010-03-01T00:00:00,Middle Aged,M01.060.116.630
20337507,2010-03-01T00:00:00,Patient Selection,E05.581.500.653
20337507,2010-03-01T00:00:00,Patient Selection,N04.590.731
20337507,2010-03-01T00:00:00,Photic Stimulation,E05.723.729
20337507,2010-03-01T00:00:00,Psychiatric Status Rating Scales,F04.586
20347644,2010-03-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
20347644,2010-03-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
20347644,2010-03-01T00:00:00,Genome-Wide Association Study,E05.318.416.249
20347644,2010-03-01T00:00:00,Genome-Wide Association Study,E05.318.780.392
20347644,2010-03-01T00:00:00,Genome-Wide Association Study,E05.393.385.500
20347644,2010-03-01T00:00:00,Genome-Wide Association Study,E05.393.522.500
20347644,2010-03-01T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
20347644,2010-03-01T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
20347644,2010-03-01T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
20347644,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20347644,2010-03-01T00:00:00,Hypertension,C14.907.489
20347644,2010-03-01T00:00:00,Kidney Diseases,C12.777.419
20347644,2010-03-01T00:00:00,Kidney Diseases,C13.351.968.419
20377108,2010-03-01T00:00:00,Androgens,D27.505.696.399.472.161
20377108,2010-03-01T00:00:00,"Angioedemas, Hereditary",C14.907.079.500
20377108,2010-03-01T00:00:00,"Angioedemas, Hereditary",C16.320.078
20377108,2010-03-01T00:00:00,"Angioedemas, Hereditary",C17.800.862.945.066.500
20377108,2010-03-01T00:00:00,"Angioedemas, Hereditary",C20.543.480.904.066.500
20377108,2010-03-01T00:00:00,Bradykinin,D12.644.276.812.169
20377108,2010-03-01T00:00:00,Bradykinin,D12.644.400.090
20377108,2010-03-01T00:00:00,Bradykinin,D12.644.456.193
20377108,2010-03-01T00:00:00,Bradykinin,D12.776.467.812.169
20377108,2010-03-01T00:00:00,Bradykinin,D12.776.641.650.090
20377108,2010-03-01T00:00:00,Bradykinin,D23.469.050.375.110
20377108,2010-03-01T00:00:00,Bradykinin,D23.529.812.169
20377108,2010-03-01T00:00:00,Endothelial Cells,A11.436.275
20377108,2010-03-01T00:00:00,Factor XII,D12.776.124.125.450
20377108,2010-03-01T00:00:00,Factor XII,D23.119.450
20377108,2010-03-01T00:00:00,HSP90 Heat-Shock Proteins,D12.776.580.216.380
20377108,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20377108,2010-03-01T00:00:00,Kallikreins,D08.811.277.656.300.760.442
20377108,2010-03-01T00:00:00,Kallikreins,D08.811.277.656.959.350.442
20377108,2010-03-01T00:00:00,Kallikreins,D12.776.124.125.597
20377108,2010-03-01T00:00:00,Kallikreins,D23.119.597
20377108,2010-03-01T00:00:00,"Kininogen, High-Molecular-Weight",D12.644.276.812.654.350
20377108,2010-03-01T00:00:00,"Kininogen, High-Molecular-Weight",D12.776.124.125.635.480
20377108,2010-03-01T00:00:00,"Kininogen, High-Molecular-Weight",D12.776.467.812.654.350
20377108,2010-03-01T00:00:00,"Kininogen, High-Molecular-Weight",D12.776.811.420.350
20377108,2010-03-01T00:00:00,"Kininogen, High-Molecular-Weight",D23.119.630.480
20377108,2010-03-01T00:00:00,"Kininogen, High-Molecular-Weight",D23.469.050.375.425.350
20377108,2010-03-01T00:00:00,"Kininogen, High-Molecular-Weight",D23.529.812.654.350
20377108,2010-03-01T00:00:00,Prekallikrein,D08.811.277.656.300.760.442.725
20377108,2010-03-01T00:00:00,Prekallikrein,D08.811.277.656.959.350.442.725
20377108,2010-03-01T00:00:00,Prekallikrein,D12.776.124.125.597.712
20377108,2010-03-01T00:00:00,Prekallikrein,D23.119.597.712
20377108,2010-03-01T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.100.080.500
20377108,2010-03-01T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.720.600.220.500
20377108,2010-03-01T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.750.555.220.500
20389193,2010-03-01T00:00:00,Community Health Services,N02.421.143
20389193,2010-03-01T00:00:00,Disasters,N06.230.100
20389193,2010-03-01T00:00:00,Health Services Accessibility,N04.590.374.350
20389193,2010-03-01T00:00:00,Health Services Accessibility,N05.300.430
20389193,2010-03-01T00:00:00,Healthcare Disparities,N04.590.374.380
20389193,2010-03-01T00:00:00,Healthcare Disparities,N05.300.493
20389193,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20389193,2010-03-01T00:00:00,Quality of Life,I01.800
20389193,2010-03-01T00:00:00,Quality of Life,K01.752.400.750
20389193,2010-03-01T00:00:00,Rural Health Services,N02.421.816
20389193,2010-03-01T00:00:00,Rural Population,N01.600.725
20389193,2010-03-01T00:00:00,United States,Z01.107.567.875
20389227,2010-03-01T00:00:00,Attitude of Health Personnel,F01.100.050
20389227,2010-03-01T00:00:00,Attitude of Health Personnel,N05.300.100
20389227,2010-03-01T00:00:00,Communication,F01.145.209
20389227,2010-03-01T00:00:00,Communication,L01.143
20389227,2010-03-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
20389227,2010-03-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
20389227,2010-03-01T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
20389227,2010-03-01T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
20389227,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20389227,2010-03-01T00:00:00,Interprofessional Relations,F01.829.401.205
20389227,2010-03-01T00:00:00,Leadership,F01.752.609
20389227,2010-03-01T00:00:00,Nurse Administrators,M01.526.070.670
20389227,2010-03-01T00:00:00,Nurse Administrators,M01.526.485.650.580
20389227,2010-03-01T00:00:00,Nurse Administrators,N02.360.650.580
20389227,2010-03-01T00:00:00,"Nursing Staff, Hospital",M01.526.485.680.490
20389227,2010-03-01T00:00:00,"Nursing Staff, Hospital",M01.526.485.740.523
20389227,2010-03-01T00:00:00,"Nursing Staff, Hospital",N02.360.680.490
20389227,2010-03-01T00:00:00,"Nursing Staff, Hospital",N02.360.740.523
20391819,2010-03-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
20391819,2010-03-01T00:00:00,Gentamicins,D09.408.051.374
20391819,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20391819,2010-03-01T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.300.390.400.800.750.100.500
20391819,2010-03-01T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.510.100.750.750.100.500
20391819,2010-03-01T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.510.400.790.750.100.500
20391819,2010-03-01T00:00:00,Middle Aged,M01.060.116.630
20391819,2010-03-01T00:00:00,"Nephritis, Interstitial",C12.777.419.570.643
20391819,2010-03-01T00:00:00,"Nephritis, Interstitial",C13.351.968.419.570.643
20391819,2010-03-01T00:00:00,Osteomyelitis,C01.539.160.495
20391819,2010-03-01T00:00:00,Osteomyelitis,C05.116.165.495
20391819,2010-03-01T00:00:00,Prednisone,D04.808.745.432.719.702
20391819,2010-03-01T00:00:00,Staphylococcal Infections,C01.252.410.868
20391819,2010-03-01T00:00:00,Vancomycin,D09.400.420.925
20391819,2010-03-01T00:00:00,Vancomycin,D12.644.233.925
20412481,2010-03-01T00:00:00,Birth Weight,C23.888.144.186
20412481,2010-03-01T00:00:00,Birth Weight,E01.370.600.115.100.160.120.186
20412481,2010-03-01T00:00:00,Birth Weight,E05.041.124.160.750.149
20412481,2010-03-01T00:00:00,Birth Weight,G07.100.100.160.120.186
20412481,2010-03-01T00:00:00,Birth Weight,G07.700.320.249.314.120.186
20412481,2010-03-01T00:00:00,"Heart Defects, Congenital",C14.240.400
20412481,2010-03-01T00:00:00,"Heart Defects, Congenital",C14.280.400
20412481,2010-03-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
20412481,2010-03-01T00:00:00,Heart Ventricles,A07.541.560
20412481,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20412481,2010-03-01T00:00:00,"Infant, Low Birth Weight",M01.060.703.520.460
20412481,2010-03-01T00:00:00,"Infant, Newborn",M01.060.703.520
20412481,2010-03-01T00:00:00,"Infant, Premature",M01.060.703.520.520
20412481,2010-03-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
20412481,2010-03-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
20412481,2010-03-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
20412481,2010-03-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
20425163,2010-03-01T00:00:00,"Aneurysm, Dissecting",C14.907.055.050
20425163,2010-03-01T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.055.239.125
20425163,2010-03-01T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.109.139.125
20425163,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20425163,2010-03-01T00:00:00,Mutation,G05.365.590
20425163,2010-03-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20425163,2010-03-01T00:00:00,Risk Factors,N05.715.350.200.700
20425163,2010-03-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20425163,2010-03-01T00:00:00,Risk Factors,N06.850.490.625.750
20425163,2010-03-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20425163,2010-03-01T00:00:00,Signal Transduction,G02.111.087.800
20425163,2010-03-01T00:00:00,Signal Transduction,G02.149.115.800
20425163,2010-03-01T00:00:00,Signal Transduction,G04.299.880
20425163,2010-03-01T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
20425163,2010-03-01T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
20425163,2010-03-01T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
20425163,2010-03-01T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
20425163,2010-03-01T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
20425163,2010-03-01T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
20425163,2010-03-01T00:00:00,Transforming Growth Factor beta,D23.529.374.687
20425163,2010-03-01T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
20425163,2010-03-01T00:00:00,Transforming Growth Factor beta,D23.529.960.720
20437917,2010-03-01T00:00:00,Automobile Driving,I03.125
20437917,2010-03-01T00:00:00,Community-Based Participatory Research,N05.425.104
20437917,2010-03-01T00:00:00,Health Promotion,N02.370
20437917,2010-03-01T00:00:00,Health Promotion,N02.421.726.507
20437917,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20437917,2010-03-01T00:00:00,"Models, Theoretical",E05.599
20437917,2010-03-01T00:00:00,Psychometrics,F04.711.780
20487188,2010-03-01T00:00:00,Delphi Technique,L01.280.800.310
20487188,2010-03-01T00:00:00,Disaster Planning,N06.230.100.035
20487188,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20487188,2010-03-01T00:00:00,Mass Casualty Incidents,I01.198.240.856.800.537
20487188,2010-03-01T00:00:00,Mass Casualty Incidents,I01.880.735.900.800.575
20487188,2010-03-01T00:00:00,Mass Casualty Incidents,N06.230.100.160
20487188,2010-03-01T00:00:00,"Models, Theoretical",E05.599
20487188,2010-03-01T00:00:00,Triage,N02.421.297.900
20487188,2010-03-01T00:00:00,United States,Z01.107.567.875
20500304,2010-03-01T00:00:00,Adult,M01.060.116
20500304,2010-03-01T00:00:00,Decision Making,F02.463.785.373
20500304,2010-03-01T00:00:00,Dementia,C10.228.140.380
20500304,2010-03-01T00:00:00,Dementia,F03.087.400
20500304,2010-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20500304,2010-03-01T00:00:00,Middle Aged,M01.060.116.630
20500304,2010-03-01T00:00:00,Nursing Homes,N02.278.825.610
19891457,2010-03-02T00:00:00,Adsorption,G02.149.047
19891457,2010-03-02T00:00:00,Adsorption,G02.149.767.029
19891457,2010-03-02T00:00:00,Adsorption,G02.842.750.029
19891457,2010-03-02T00:00:00,Amino Acid Sequence,G02.111.570.060
19891457,2010-03-02T00:00:00,Amino Acid Sequence,L01.453.245.667.060
19891457,2010-03-02T00:00:00,Mass Spectrometry,E05.196.566
19891457,2010-03-02T00:00:00,"Models, Molecular",E05.599.595
19891457,2010-03-02T00:00:00,Molecular Sequence Data,L01.453.245.667
19891457,2010-03-02T00:00:00,Peptides,D12.644
19891457,2010-03-02T00:00:00,"Protein Structure, Secondary",G02.111.570.790.709.600
19891457,2010-03-02T00:00:00,Surface Properties,G02.842.850
20193972,2010-03-02T00:00:00,Case-Control Studies,E05.318.760.500.500
20193972,2010-03-02T00:00:00,Case-Control Studies,N05.715.360.775.175.200
20193972,2010-03-02T00:00:00,Case-Control Studies,N06.850.520.450.500.500
20193972,2010-03-02T00:00:00,Chronic Disease,C23.550.291.500
20193972,2010-03-02T00:00:00,"Gait Disorders, Neurologic",C10.597.404
20193972,2010-03-02T00:00:00,"Gait Disorders, Neurologic",C23.888.592.413
20193972,2010-03-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20193972,2010-03-02T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
20193972,2010-03-02T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
20193972,2010-03-02T00:00:00,Middle Aged,M01.060.116.630
20193972,2010-03-02T00:00:00,Paresis,C10.597.636
20193972,2010-03-02T00:00:00,Paresis,C23.888.592.643
20193972,2010-03-02T00:00:00,Posture,G11.427.695
20193972,2010-03-02T00:00:00,Weight-Bearing,G01.374.676.965
20193972,2010-03-02T00:00:00,Weight-Bearing,G01.595.540.965
20195575,2010-03-02T00:00:00,Adolescent,M01.060.057
20195575,2010-03-02T00:00:00,Adult,M01.060.116
20195575,2010-03-02T00:00:00,Anticonvulsants,D27.505.954.427.080
20195575,2010-03-02T00:00:00,Brain Mapping,E01.370.350.086
20195575,2010-03-02T00:00:00,Brain Mapping,E01.370.376.149
20195575,2010-03-02T00:00:00,Brain Mapping,E05.132
20195575,2010-03-02T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
20195575,2010-03-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20195575,2010-03-02T00:00:00,Limbic System,A08.186.211.464
20195575,2010-03-02T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20195575,2010-03-02T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20195575,2010-03-02T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
20195575,2010-03-02T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
20195575,2010-03-02T00:00:00,Triazines,D03.383.931
20195575,2010-03-02T00:00:00,Valproic Acid,D02.241.081.944.509.900
20195575,2010-03-02T00:00:00,Valproic Acid,D10.251.400.895.593.900
20200161,2010-03-03T00:00:00,"Antigens, CD44",D12.776.395.550.200.625.144
20200161,2010-03-03T00:00:00,"Antigens, CD44",D12.776.543.550.200.625.144
20200161,2010-03-03T00:00:00,"Antigens, CD44",D12.776.543.750.705.877.144
20200161,2010-03-03T00:00:00,"Antigens, CD44",D23.050.301.264.035.850.144
20200161,2010-03-03T00:00:00,"Antigens, CD44",D23.050.301.350.625.144
20200161,2010-03-03T00:00:00,"Antigens, CD44",D23.101.100.110.850.144
20200161,2010-03-03T00:00:00,Cell Line,A11.251.210
20200161,2010-03-03T00:00:00,Cell Movement,G04.299.283
20200161,2010-03-03T00:00:00,Cell Movement,G07.700.560.500.180
20200161,2010-03-03T00:00:00,Cell Proliferation,G04.299.233.750
20200161,2010-03-03T00:00:00,Cell Proliferation,G07.700.320.249.410.750
20200161,2010-03-03T00:00:00,Cell Survival,G04.299.316
20200161,2010-03-03T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
20200161,2010-03-03T00:00:00,Hepatocyte Growth Factor,D12.644.276.374.420
20200161,2010-03-03T00:00:00,Hepatocyte Growth Factor,D12.776.467.374.420
20200161,2010-03-03T00:00:00,Hepatocyte Growth Factor,D23.529.374.420
20200161,2010-03-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20200161,2010-03-03T00:00:00,Hyaluronic Acid,D09.698.373.475
20200161,2010-03-03T00:00:00,"Models, Biological",E05.599.395
20200161,2010-03-03T00:00:00,Neoplasm Invasiveness,C04.697.645
20200161,2010-03-03T00:00:00,Neoplasm Invasiveness,C23.550.727.645
20200161,2010-03-03T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
20200161,2010-03-03T00:00:00,Prostatic Neoplasms,C12.294.260.750
20200161,2010-03-03T00:00:00,Prostatic Neoplasms,C12.294.565.625
20200161,2010-03-03T00:00:00,Prostatic Neoplasms,C12.758.409.750
20200161,2010-03-03T00:00:00,RNA Interference,G05.355.315.203.374.790
20200161,2010-03-03T00:00:00,"Receptors, Androgen",D12.776.260.698.750.150
20200161,2010-03-03T00:00:00,"Receptors, Androgen",D12.776.826.750.150
20200161,2010-03-03T00:00:00,"Receptors, Androgen",D12.776.930.669.750.150
20200423,2010-03-03T00:00:00,"Genes, BRCA1",G05.360.340.024.340.375.249.100
20200423,2010-03-03T00:00:00,"Genes, BRCA1",G05.360.340.024.340.415.400.100
20200423,2010-03-03T00:00:00,"Genes, BRCA2",G05.360.340.024.340.375.249.105
20200423,2010-03-03T00:00:00,"Genes, BRCA2",G05.360.340.024.340.415.400.105
20200423,2010-03-03T00:00:00,Genetic Counseling,H01.158.273.343.315.384
20200423,2010-03-03T00:00:00,Genetic Counseling,N02.421.308.400
20200423,2010-03-03T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
20200423,2010-03-03T00:00:00,Genetic Predisposition to Disease,G05.380.355
20200423,2010-03-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20200423,2010-03-03T00:00:00,Mutation,G05.365.590
20206184,2010-03-03T00:00:00,Amino Acid Sequence,G02.111.570.060
20206184,2010-03-03T00:00:00,Amino Acid Sequence,L01.453.245.667.060
20206184,2010-03-03T00:00:00,Bacterial Proteins,D12.776.097
20206184,2010-03-03T00:00:00,Binding Sites,G02.111.570.120
20206184,2010-03-03T00:00:00,"Crystallography, X-Ray",E05.196.309.742.225
20206184,2010-03-03T00:00:00,Molecular Sequence Data,L01.453.245.667
20206184,2010-03-03T00:00:00,Molecular Weight,G02.842.580
20206184,2010-03-03T00:00:00,Mycobacterium tuberculosis,B03.510.024.049.525.500.702
20206184,2010-03-03T00:00:00,Mycobacterium tuberculosis,B03.510.460.400.410.552.552.702
20206184,2010-03-03T00:00:00,Penicillin-Binding Proteins,D08.811.710
20206184,2010-03-03T00:00:00,Penicillin-Binding Proteins,D12.776.097.545
20206184,2010-03-03T00:00:00,Penicillins,D02.065.589.099.750
20206184,2010-03-03T00:00:00,Penicillins,D02.886.108.750
20206184,2010-03-03T00:00:00,Penicillins,D03.438.260.825
20206184,2010-03-03T00:00:00,Penicillins,D03.605.084.737
20206184,2010-03-03T00:00:00,Penicillins,D04.075.080.875.099.221.750
20206184,2010-03-03T00:00:00,Phosphorylation,G02.111.087.677
20206184,2010-03-03T00:00:00,Phosphorylation,G02.149.115.677
20206184,2010-03-03T00:00:00,Phosphorylation,G02.149.465.700
20206184,2010-03-03T00:00:00,Phosphorylation,G02.607.750.700
20206184,2010-03-03T00:00:00,Phosphorylation,G03.495.790
20206184,2010-03-03T00:00:00,Protein Conformation,G02.111.570.790.709
20206184,2010-03-03T00:00:00,"Protein Structure, Secondary",G02.111.570.790.709.600
20206184,2010-03-03T00:00:00,X-Ray Diffraction,E05.196.309.742
20206184,2010-03-03T00:00:00,X-Ray Diffraction,E05.196.822.950
20206184,2010-03-03T00:00:00,X-Ray Diffraction,G01.595.861.950
20206184,2010-03-03T00:00:00,X-Ray Diffraction,G02.149.767.915
20206184,2010-03-03T00:00:00,X-Ray Diffraction,G02.842.750.915
20203485,2010-03-04T00:00:00,Aged,M01.060.116.100
20203485,2010-03-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20203485,2010-03-04T00:00:00,Middle Aged,M01.060.116.630
20203485,2010-03-04T00:00:00,Oxidative Stress,G03.495.710
20203485,2010-03-04T00:00:00,Oxidative Stress,G07.700.830.750
20203485,2010-03-04T00:00:00,Stroke,C10.228.140.300.775
20203485,2010-03-04T00:00:00,Stroke,C14.907.253.855
20203485,2010-03-04T00:00:00,Time Factors,G01.910.857
20203485,2010-03-04T00:00:00,Vascular Patency,G09.330.920
20209104,2010-03-04T00:00:00,Amino Acid Sequence,G02.111.570.060
20209104,2010-03-04T00:00:00,Amino Acid Sequence,L01.453.245.667.060
20209104,2010-03-04T00:00:00,Animals,B01.050
20209104,2010-03-04T00:00:00,"Evolution, Molecular",G05.355.265.250
20209104,2010-03-04T00:00:00,"Evolution, Molecular",G16.100.275.250
20209104,2010-03-04T00:00:00,Genomics,H01.158.273.180.350
20209104,2010-03-04T00:00:00,Genomics,H01.158.273.343.350
20209104,2010-03-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20209104,2010-03-04T00:00:00,"Models, Biological",E05.599.395
20209104,2010-03-04T00:00:00,Molecular Sequence Data,L01.453.245.667
20209104,2010-03-04T00:00:00,Phylogeny,G05.697
20209104,2010-03-04T00:00:00,Phylogeny,G16.100.275.605
20209104,2010-03-04T00:00:00,Phylogeny,L01.100.697
20209104,2010-03-04T00:00:00,"Sequence Homology, Amino Acid",G02.111.810.200
20209104,2010-03-04T00:00:00,"Sequence Homology, Amino Acid",G05.810.200
20209104,2010-03-04T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
20209104,2010-03-04T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
20209104,2010-03-04T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
20209104,2010-03-04T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
20209104,2010-03-04T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
20209104,2010-03-04T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
20209104,2010-03-04T00:00:00,Transforming Growth Factor beta,D23.529.374.687
20209104,2010-03-04T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
20209104,2010-03-04T00:00:00,Transforming Growth Factor beta,D23.529.960.720
20207939,2010-03-05T00:00:00,Alkaline Ceramidase,D08.811.277.087.250.300
20207939,2010-03-05T00:00:00,Animals,B01.050
20207939,2010-03-05T00:00:00,Cell Differentiation,G04.299.151
20207939,2010-03-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20207939,2010-03-05T00:00:00,Lysophospholipids,D10.570.755.375.760.550
20207939,2010-03-05T00:00:00,Sphingosine,D02.033.100.700
20207939,2010-03-05T00:00:00,Sphingosine,D02.033.455.843
20207939,2010-03-05T00:00:00,Sphingosine,D02.092.063.700
20211135,2010-03-05T00:00:00,Animals,B01.050
20211135,2010-03-05T00:00:00,Heterogeneous-Nuclear Ribonucleoproteins,D12.776.157.725.500.500
20211135,2010-03-05T00:00:00,Heterogeneous-Nuclear Ribonucleoproteins,D12.776.664.962.500.500
20211135,2010-03-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20211135,2010-03-05T00:00:00,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",C04.557.337.539.250
20211135,2010-03-05T00:00:00,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",C15.378.190.636.370
20211135,2010-03-05T00:00:00,MicroRNAs,D13.150.650.319
20211135,2010-03-05T00:00:00,MicroRNAs,D13.444.735.150.319
20211135,2010-03-05T00:00:00,MicroRNAs,D13.444.735.790.099
20211135,2010-03-05T00:00:00,Proto-Oncogene Proteins c-pim-1,D08.811.913.696.620.682.700.776
20211135,2010-03-05T00:00:00,Proto-Oncogene Proteins c-pim-1,D12.776.624.664.700.191
20207396,2010-03-07T00:00:00,African Americans,M01.686.508.100.100
20207396,2010-03-07T00:00:00,African Americans,M01.686.754.100
20207396,2010-03-07T00:00:00,European Continental Ancestry Group,M01.686.508.400
20207396,2010-03-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20207396,2010-03-07T00:00:00,Middle Aged,M01.060.116.630
20207396,2010-03-07T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
20207396,2010-03-07T00:00:00,Prostatic Neoplasms,C12.294.260.750
20207396,2010-03-07T00:00:00,Prostatic Neoplasms,C12.294.565.625
20207396,2010-03-07T00:00:00,Prostatic Neoplasms,C12.758.409.750
20207396,2010-03-07T00:00:00,Quality of Life,I01.800
20207396,2010-03-07T00:00:00,Quality of Life,K01.752.400.750
20211941,2010-03-08T00:00:00,Animals,B01.050
20211941,2010-03-08T00:00:00,Astrocytes,A08.637.200
20211941,2010-03-08T00:00:00,Astrocytes,A11.650.200
20211941,2010-03-08T00:00:00,Cell Differentiation,G04.299.151
20211941,2010-03-08T00:00:00,Corpus Striatum,A08.186.211.730.885.287.249.487
20211941,2010-03-08T00:00:00,Enzyme Inhibitors,D27.505.519.389
20211941,2010-03-08T00:00:00,Gene Expression,G05.355.310
20211941,2010-03-08T00:00:00,Glutathione,D12.644.456.448
20211941,2010-03-08T00:00:00,Mitochondria,A11.284.430.214.190.875.564
20211941,2010-03-08T00:00:00,Mitochondria,A11.284.835.626
20211941,2010-03-08T00:00:00,NF-E2-Related Factor 2,D12.776.260.108.737
20211941,2010-03-08T00:00:00,NF-E2-Related Factor 2,D12.776.930.127.737
20211941,2010-03-08T00:00:00,Neurons,A08.663
20211941,2010-03-08T00:00:00,Neurons,A11.671
20211941,2010-03-08T00:00:00,"RNA, Messenger",D13.444.735.544
20211941,2010-03-08T00:00:00,Stem Cells,A11.872
20212040,2010-03-08T00:00:00,Cell Line,A11.251.210
20212040,2010-03-08T00:00:00,Green Fluorescent Proteins,D12.776.532.265
20212040,2010-03-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20212040,2010-03-08T00:00:00,"Mutagenesis, Site-Directed",E05.393.420.601.575
20212040,2010-03-08T00:00:00,Polymerase Chain Reaction,E05.393.620.500
20212092,2010-03-08T00:00:00,Animals,B01.050
20212092,2010-03-08T00:00:00,Antigen Presentation,G12.425.107
20212092,2010-03-08T00:00:00,Antigen Presentation,G12.450.050.400.070
20212092,2010-03-08T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
20212092,2010-03-08T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
20212092,2010-03-08T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
20212092,2010-03-08T00:00:00,Endothelial Cells,A11.436.275
20212092,2010-03-08T00:00:00,Immune Tolerance,G12.425.746.425
20212092,2010-03-08T00:00:00,Liver,A03.620
20212092,2010-03-08T00:00:00,Lymphocyte Activation,E01.450.495.482
20212092,2010-03-08T00:00:00,Lymphocyte Activation,E05.478.594.530
20212092,2010-03-08T00:00:00,Lymphocyte Activation,G12.425.747
20212092,2010-03-08T00:00:00,Lymphocyte Activation,G12.450.050.400.545
20215494,2010-03-09T00:00:00,Adolescent,M01.060.057
20215494,2010-03-09T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
20215494,2010-03-09T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
20215494,2010-03-09T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
20215494,2010-03-09T00:00:00,Bipolar Disorder,F03.600.150.150
20215494,2010-03-09T00:00:00,Bradycardia,C14.280.067.319
20215494,2010-03-09T00:00:00,Bradycardia,C23.550.073.300
20215494,2010-03-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20215494,2010-03-09T00:00:00,Piperazines,D03.383.606
20215494,2010-03-09T00:00:00,Psychotic Disorders,F03.700.675
20215494,2010-03-09T00:00:00,Quinolones,D03.438.810.835
20215494,2010-03-09T00:00:00,Thiazoles,D02.886.675
20215494,2010-03-09T00:00:00,Thiazoles,D03.383.129.708
20215542,2010-03-09T00:00:00,"Clinical Trials, Phase I as Topic",E05.318.760.535.200
20215542,2010-03-09T00:00:00,"Clinical Trials, Phase I as Topic",E05.337.250.200
20215542,2010-03-09T00:00:00,"Clinical Trials, Phase I as Topic",N05.715.360.775.235.200
20215542,2010-03-09T00:00:00,"Clinical Trials, Phase I as Topic",N06.850.520.450.535.200
20215542,2010-03-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20215542,2010-03-09T00:00:00,Neoplasms,C04
20215542,2010-03-09T00:00:00,Patient Selection,E05.581.500.653
20215542,2010-03-09T00:00:00,Patient Selection,N04.590.731
20215542,2010-03-09T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
20215542,2010-03-09T00:00:00,Practice Guidelines as Topic,N05.700.350.650
20215542,2010-03-09T00:00:00,Research Design,E05.581.500
20215542,2010-03-09T00:00:00,Research Design,H01.770.644.728
20215542,2010-03-09T00:00:00,United States,Z01.107.567.875
20219212,2010-03-09T00:00:00,Angiotensin II,D06.472.699.094.078
20219212,2010-03-09T00:00:00,Angiotensin II,D12.644.400.070.078
20219212,2010-03-09T00:00:00,Angiotensin II,D12.644.456.073.041
20219212,2010-03-09T00:00:00,Angiotensin II,D12.644.548.058.078
20219212,2010-03-09T00:00:00,Angiotensin II,D12.776.641.650.070.078
20219212,2010-03-09T00:00:00,Angiotensin II,D23.469.050.050.050
20219212,2010-03-09T00:00:00,Animals,B01.050
20219212,2010-03-09T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
20219212,2010-03-09T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.055.239.125
20219212,2010-03-09T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.109.139.125
20219212,2010-03-09T00:00:00,"Disease Models, Animal",C22.232
20219212,2010-03-09T00:00:00,"Disease Models, Animal",E05.598.500
20219212,2010-03-09T00:00:00,"Disease Models, Animal",E05.599.395.080
20219212,2010-03-09T00:00:00,Disease Progression,C23.550.291.656
20219212,2010-03-09T00:00:00,Endothelin-1,D12.644.276.400.225
20219212,2010-03-09T00:00:00,Endothelin-1,D12.776.467.400.225
20219212,2010-03-09T00:00:00,Endothelin-1,D23.529.400.225
20219212,2010-03-09T00:00:00,Extracellular Matrix Proteins,D12.776.860.300
20219212,2010-03-09T00:00:00,Fibroblasts,A11.329.228
20219212,2010-03-09T00:00:00,Fibroblasts,A11.872.228
20219212,2010-03-09T00:00:00,Gene Expression Profiling,E05.393.332
20219212,2010-03-09T00:00:00,Gene Expression Regulation,G05.355.315
20219212,2010-03-09T00:00:00,Phenotype,G05.695
20221584,2010-03-11T00:00:00,Animals,B01.050
20221584,2010-03-11T00:00:00,Blood Glucose,D09.546.359.448.500
20221584,2010-03-11T00:00:00,Body Weight,C23.888.144
20221584,2010-03-11T00:00:00,Body Weight,E01.370.600.115.100.160.120
20221584,2010-03-11T00:00:00,Body Weight,E05.041.124.160.750
20221584,2010-03-11T00:00:00,Body Weight,G07.100.100.160.120
20221584,2010-03-11T00:00:00,Body Weight,G07.700.320.249.314.120
20221584,2010-03-11T00:00:00,Dietary Fats,D10.212.302
20221584,2010-03-11T00:00:00,Dietary Fats,J02.500.375
20221584,2010-03-11T00:00:00,Eating,G07.610.593.260
20221584,2010-03-11T00:00:00,Eating,G07.700.620.260
20221584,2010-03-11T00:00:00,Eating,G10.261.326.240
20221584,2010-03-11T00:00:00,Hyperglycemia,C18.452.394.952
20221584,2010-03-11T00:00:00,Hypothalamus,A08.186.211.464.482
20221584,2010-03-11T00:00:00,Hypothalamus,A08.186.211.730.317.357
20221584,2010-03-11T00:00:00,Insulin,D06.472.699.587.740.625
20221584,2010-03-11T00:00:00,Insulin,D12.644.548.586.740.625
20221584,2010-03-11T00:00:00,Neurons,A08.663
20221584,2010-03-11T00:00:00,Neurons,A11.671
20221584,2010-03-11T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
20221584,2010-03-11T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
20221584,2010-03-11T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
20221584,2010-03-11T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20224981,2010-03-12T00:00:00,Adult,M01.060.116
20224981,2010-03-12T00:00:00,Aged,M01.060.116.100
20224981,2010-03-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20224981,2010-03-12T00:00:00,Intraoperative Complications,C23.550.505
20224981,2010-03-12T00:00:00,Length of Stay,E02.760.400.480
20224981,2010-03-12T00:00:00,Length of Stay,N02.421.585.400.480
20224981,2010-03-12T00:00:00,Middle Aged,M01.060.116.630
20224981,2010-03-12T00:00:00,Pancreatectomy,E04.210.752
20224981,2010-03-12T00:00:00,Pancreatic Neoplasms,C04.588.274.761
20224981,2010-03-12T00:00:00,Pancreatic Neoplasms,C04.588.322.421
20224981,2010-03-12T00:00:00,Pancreatic Neoplasms,C06.301.761
20224981,2010-03-12T00:00:00,Pancreatic Neoplasms,C06.689.667
20224981,2010-03-12T00:00:00,Pancreatic Neoplasms,C19.344.421
20224981,2010-03-12T00:00:00,Pancreaticoduodenectomy,E04.210.760
20224981,2010-03-12T00:00:00,"Pancreatitis, Chronic",C06.689.750.830
20224981,2010-03-12T00:00:00,Postoperative Complications,C23.550.767
20224981,2010-03-12T00:00:00,Reoperation,E04.690
20224981,2010-03-12T00:00:00,Risk Assessment,E05.318.740.600.800.715
20224981,2010-03-12T00:00:00,Risk Assessment,N04.452.871.715
20224981,2010-03-12T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20224981,2010-03-12T00:00:00,Risk Assessment,N06.850.505.715
20224981,2010-03-12T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20224981,2010-03-12T00:00:00,Treatment Outcome,E01.789.800
20224981,2010-03-12T00:00:00,Treatment Outcome,N04.761.559.590.800
20224981,2010-03-12T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20224981,2010-03-12T00:00:00,Wounds and Injuries,C21.866
20228226,2010-03-12T00:00:00,Actins,D05.750.078.730.250
20228226,2010-03-12T00:00:00,Actins,D12.776.210.500.100
20228226,2010-03-12T00:00:00,Actins,D12.776.220.525.255
20228226,2010-03-12T00:00:00,Alleles,G05.360.340.024.340.030
20228226,2010-03-12T00:00:00,Animals,B01.050
20228226,2010-03-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20228226,2010-03-12T00:00:00,Microcirculation,G09.330.190.163.645
20228226,2010-03-12T00:00:00,Phenotype,G05.695
20228226,2010-03-12T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.260.665.400
20228226,2010-03-12T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.624.664.700.175.400
20228226,2010-03-12T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.930.635.400
20228226,2010-03-12T00:00:00,"Scleroderma, Systemic",C17.300.799
20228226,2010-03-12T00:00:00,"Scleroderma, Systemic",C17.800.784
20228226,2010-03-12T00:00:00,Skin,A17.815
20228401,2010-03-14T00:00:00,Aged,M01.060.116.100
20228401,2010-03-14T00:00:00,Antihypertensive Agents,D27.505.954.411.162
20228401,2010-03-14T00:00:00,Blood Pressure,E01.370.600.875.249
20228401,2010-03-14T00:00:00,Blood Pressure,G09.330.380.076
20228401,2010-03-14T00:00:00,Cardiovascular Diseases,C14
20228401,2010-03-14T00:00:00,Creatinine,D03.383.129.308.207
20228401,2010-03-14T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
20228401,2010-03-14T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
20228401,2010-03-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20228401,2010-03-14T00:00:00,Hypertension,C14.907.489
20228401,2010-03-14T00:00:00,Middle Aged,M01.060.116.630
20228401,2010-03-14T00:00:00,Myocardial Infarction,C14.280.647.500
20228401,2010-03-14T00:00:00,Myocardial Infarction,C14.907.585.500
20228401,2010-03-14T00:00:00,Stroke,C10.228.140.300.775
20228401,2010-03-14T00:00:00,Stroke,C14.907.253.855
19739116,2010-03-15T00:00:00,"Antimetabolites, Antineoplastic",D27.505.519.186.144
19739116,2010-03-15T00:00:00,"Antimetabolites, Antineoplastic",D27.505.954.248.144
19739116,2010-03-15T00:00:00,"Antimetabolites, Antineoplastic",D27.888.569.042.030
19739116,2010-03-15T00:00:00,Apoptosis,G04.299.139.160
19739116,2010-03-15T00:00:00,Cell Line,A11.251.210
19739116,2010-03-15T00:00:00,Cell Proliferation,G04.299.233.750
19739116,2010-03-15T00:00:00,Cell Proliferation,G07.700.320.249.410.750
19739116,2010-03-15T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
19739116,2010-03-15T00:00:00,Gene Expression Profiling,E05.393.332
19739116,2010-03-15T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
19739116,2010-03-15T00:00:00,Green Fluorescent Proteins,D12.776.532.265
19739116,2010-03-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19739116,2010-03-15T00:00:00,Membrane Proteins,D12.776.543
19739116,2010-03-15T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
19739116,2010-03-15T00:00:00,"Microscopy, Confocal",E05.595.395
19739116,2010-03-15T00:00:00,NF-kappa B,D12.776.260.600
19739116,2010-03-15T00:00:00,NF-kappa B,D12.776.660.600
19739116,2010-03-15T00:00:00,NF-kappa B,D12.776.930.600
19739116,2010-03-15T00:00:00,Nasopharyngeal Neoplasms,C04.588.443.665.710.650
19739116,2010-03-15T00:00:00,Nasopharyngeal Neoplasms,C07.550.350.650
19739116,2010-03-15T00:00:00,Nasopharyngeal Neoplasms,C07.550.745.650
19739116,2010-03-15T00:00:00,Nasopharyngeal Neoplasms,C09.647.710.650
19739116,2010-03-15T00:00:00,Nasopharyngeal Neoplasms,C09.775.350.650
19739116,2010-03-15T00:00:00,Nasopharyngeal Neoplasms,C09.775.549.650
19739116,2010-03-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
19739116,2010-03-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
19739116,2010-03-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
19739116,2010-03-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
19739116,2010-03-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
19739116,2010-03-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
19739116,2010-03-15T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
19739116,2010-03-15T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
19739116,2010-03-15T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
19739116,2010-03-15T00:00:00,Signal Transduction,G02.111.087.800
19739116,2010-03-15T00:00:00,Signal Transduction,G02.149.115.800
19739116,2010-03-15T00:00:00,Signal Transduction,G04.299.880
20208039,2010-03-15T00:00:00,Adult,M01.060.116
20208039,2010-03-15T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
20208039,2010-03-15T00:00:00,Child,M01.060.406
20208039,2010-03-15T00:00:00,"Child, Preschool",M01.060.406.448
20208039,2010-03-15T00:00:00,Cystic Fibrosis,C06.689.202
20208039,2010-03-15T00:00:00,Cystic Fibrosis,C08.381.187
20208039,2010-03-15T00:00:00,Cystic Fibrosis,C16.320.190
20208039,2010-03-15T00:00:00,Cystic Fibrosis,C16.614.213
20208039,2010-03-15T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
20208039,2010-03-15T00:00:00,Genetic Predisposition to Disease,G05.380.355
20208039,2010-03-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20208039,2010-03-15T00:00:00,Infant,M01.060.703
20208039,2010-03-15T00:00:00,"Infant, Newborn",M01.060.703.520
20208039,2010-03-15T00:00:00,Lung Transplantation,E04.928.600.495
20208039,2010-03-15T00:00:00,Lung Transplantation,E04.936.450.495
20208039,2010-03-15T00:00:00,Mass Screening,E01.370.500
20208039,2010-03-15T00:00:00,Mass Screening,E05.318.308.250.580
20208039,2010-03-15T00:00:00,Mass Screening,N02.421.143.827.233.443
20208039,2010-03-15T00:00:00,Mass Screening,N02.421.726.233.443
20208039,2010-03-15T00:00:00,Mass Screening,N05.715.360.300.375.500
20208039,2010-03-15T00:00:00,Mass Screening,N06.850.520.308.250.580
20208039,2010-03-15T00:00:00,Mass Screening,N06.850.780.500
20208039,2010-03-15T00:00:00,"Polymorphism, Genetic",G05.365.795
20208039,2010-03-15T00:00:00,Pseudomonas Infections,C01.252.400.739
20208039,2010-03-15T00:00:00,Pseudomonas aeruginosa,B03.440.400.425.625.625.100
20208039,2010-03-15T00:00:00,Pseudomonas aeruginosa,B03.660.250.580.590.050
20227840,2010-03-15T00:00:00,Adult,M01.060.116
20227840,2010-03-15T00:00:00,Aged,M01.060.116.100
20227840,2010-03-15T00:00:00,Alcohol Drinking,F01.145.317.269
20227840,2010-03-15T00:00:00,Alcoholism,C21.739.100.250
20227840,2010-03-15T00:00:00,Alcoholism,F03.900.100.350
20227840,2010-03-15T00:00:00,Health Surveys,E05.318.308.250
20227840,2010-03-15T00:00:00,Health Surveys,N05.715.360.300.375
20227840,2010-03-15T00:00:00,Health Surveys,N06.850.520.308.250
20227840,2010-03-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20227840,2010-03-15T00:00:00,Middle Aged,M01.060.116.630
20227840,2010-03-15T00:00:00,Sex Factors,N05.715.350.675
20227840,2010-03-15T00:00:00,Sex Factors,N06.850.490.875
20227840,2010-03-15T00:00:00,Smoking Cessation,F01.145.940.700
20227840,2010-03-15T00:00:00,Treatment Outcome,E01.789.800
20227840,2010-03-15T00:00:00,Treatment Outcome,N04.761.559.590.800
20227840,2010-03-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20227840,2010-03-15T00:00:00,United States,Z01.107.567.875
20227840,2010-03-15T00:00:00,Young Adult,M01.060.116.815
20231531,2010-03-15T00:00:00,Aged,M01.060.116.100
20231531,2010-03-15T00:00:00,Antihypertensive Agents,D27.505.954.411.162
20231531,2010-03-15T00:00:00,Biphenyl Compounds,D02.455.426.559.389.185
20231531,2010-03-15T00:00:00,Cause of Death,E05.318.308.985.550.250
20231531,2010-03-15T00:00:00,Cause of Death,L01.280.975.550.250
20231531,2010-03-15T00:00:00,Cause of Death,N01.224.935.698.100
20231531,2010-03-15T00:00:00,Cause of Death,N06.850.505.400.975.550.250
20231531,2010-03-15T00:00:00,Cause of Death,N06.850.520.308.985.550.250
20231531,2010-03-15T00:00:00,Heart Failure,C14.280.434
20231531,2010-03-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20231531,2010-03-15T00:00:00,Middle Aged,M01.060.116.630
20231531,2010-03-15T00:00:00,Stroke Volume,E01.370.370.380.150.700
20231531,2010-03-15T00:00:00,Stroke Volume,G09.330.380.124.882
20298760,2010-03-15T00:00:00,Amphetamine,D02.092.471.683.152.110
20298760,2010-03-15T00:00:00,Animals,B01.050
20298760,2010-03-15T00:00:00,"Behavior, Animal",F01.145.113
20298760,2010-03-15T00:00:00,Central Nervous System Stimulants,D27.505.696.282
20298760,2010-03-15T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
20298760,2010-03-15T00:00:00,Frontal Lobe,A08.186.211.730.885.287.500.270
20298760,2010-03-15T00:00:00,"RNA, Messenger",D13.444.735.544
20298760,2010-03-15T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20298760,2010-03-15T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
20298760,2010-03-15T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.070.300.400.500
20298760,2010-03-15T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.100.150.400.500
20298760,2010-03-15T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.720.300.300.400.500
20232108,2010-03-16T00:00:00,Azo Compounds,D02.172
20232108,2010-03-16T00:00:00,Cell Death,G04.299.139
20232108,2010-03-16T00:00:00,Cell Differentiation,G04.299.151
20232108,2010-03-16T00:00:00,Cell Proliferation,G04.299.233.750
20232108,2010-03-16T00:00:00,Cell Proliferation,G07.700.320.249.410.750
20232108,2010-03-16T00:00:00,Cell Survival,G04.299.316
20232108,2010-03-16T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
20232108,2010-03-16T00:00:00,Glutathione,D12.644.456.448
20232108,2010-03-16T00:00:00,Glutathione Transferase,D08.811.913.225.500
20232108,2010-03-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20232108,2010-03-16T00:00:00,Nitric Oxide,D01.339.387
20232108,2010-03-16T00:00:00,Nitric Oxide,D01.625.550.500
20232108,2010-03-16T00:00:00,Nitric Oxide,D01.625.700.500
20232108,2010-03-16T00:00:00,Nitric Oxide,D01.650.550.587.600
20233880,2010-03-16T00:00:00,Animals,B01.050
20233880,2010-03-16T00:00:00,Immune Tolerance,G12.425.746.425
20233880,2010-03-16T00:00:00,Interferon Type I,D12.644.276.374.440.890
20233880,2010-03-16T00:00:00,Interferon Type I,D12.644.276.718.500
20233880,2010-03-16T00:00:00,Interferon Type I,D12.776.467.374.440.890
20233880,2010-03-16T00:00:00,Interferon Type I,D12.776.467.718.500
20233880,2010-03-16T00:00:00,Interferon Type I,D23.529.374.440.890
20233880,2010-03-16T00:00:00,Interferon Type I,D23.529.718.500
20233880,2010-03-16T00:00:00,Poly I-C,D13.695.578.550.560.600
20233880,2010-03-16T00:00:00,Poly I-C,D13.695.578.550.650.600
20233880,2010-03-16T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
20233880,2010-03-16T00:00:00,Prostatic Neoplasms,C12.294.260.750
20233880,2010-03-16T00:00:00,Prostatic Neoplasms,C12.294.565.625
20233880,2010-03-16T00:00:00,Prostatic Neoplasms,C12.758.409.750
20233880,2010-03-16T00:00:00,"T-Lymphocytes, Regulatory",A11.118.637.555.567.569.200.700
20233880,2010-03-16T00:00:00,"T-Lymphocytes, Regulatory",A15.145.229.637.555.567.569.200.700
20233880,2010-03-16T00:00:00,"T-Lymphocytes, Regulatory",A15.382.490.555.567.569.200.700
20233912,2010-03-16T00:00:00,Aged,M01.060.116.100
20233912,2010-03-16T00:00:00,Anticonvulsants,D27.505.954.427.080
20233912,2010-03-16T00:00:00,"Chemistry, Pharmaceutical",H01.158.703.007
20233912,2010-03-16T00:00:00,"Chemistry, Pharmaceutical",H01.181.466
20233912,2010-03-16T00:00:00,Child,M01.060.406
20233912,2010-03-16T00:00:00,"Clinical Trials, Phase III as Topic",E05.318.760.535.220
20233912,2010-03-16T00:00:00,"Clinical Trials, Phase III as Topic",E05.337.250.220
20233912,2010-03-16T00:00:00,"Clinical Trials, Phase III as Topic",N05.715.360.775.235.220
20233912,2010-03-16T00:00:00,"Clinical Trials, Phase III as Topic",N06.850.520.450.535.220
20233912,2010-03-16T00:00:00,Counseling,F02.784.176
20233912,2010-03-16T00:00:00,Counseling,F04.408.413
20233912,2010-03-16T00:00:00,Counseling,N02.421.143.303
20233912,2010-03-16T00:00:00,Counseling,N02.421.461.363
20233912,2010-03-16T00:00:00,Drug Resistance,G07.690.320
20233912,2010-03-16T00:00:00,Epilepsy,C10.228.140.490
20233912,2010-03-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20233912,2010-03-16T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
20233912,2010-03-16T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
20233912,2010-03-16T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
20233912,2010-03-16T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
20233912,2010-03-16T00:00:00,Seizures,C10.228.140.490.631
20233912,2010-03-16T00:00:00,Seizures,C10.597.742
20233912,2010-03-16T00:00:00,Seizures,C23.888.592.742
20233912,2010-03-16T00:00:00,Syndrome,C23.550.288.500
20233912,2010-03-16T00:00:00,Triazoles,D03.383.129.799
20233917,2010-03-16T00:00:00,"Antimetabolites, Antineoplastic",D27.505.519.186.144
20233917,2010-03-16T00:00:00,"Antimetabolites, Antineoplastic",D27.505.954.248.144
20233917,2010-03-16T00:00:00,"Antimetabolites, Antineoplastic",D27.888.569.042.030
20233917,2010-03-16T00:00:00,Breast Neoplasms,C04.588.180
20233917,2010-03-16T00:00:00,Breast Neoplasms,C17.800.090.500
20233917,2010-03-16T00:00:00,Deoxycytidine,D03.383.742.680.245.500
20233917,2010-03-16T00:00:00,Deoxycytidine,D13.570.230.329
20233917,2010-03-16T00:00:00,Deoxycytidine,D13.570.685.245.500
20233917,2010-03-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20233917,2010-03-16T00:00:00,Liver Diseases,C06.552
20233917,2010-03-16T00:00:00,Neoplasms,C04
20233917,2010-03-16T00:00:00,Pancreatic Neoplasms,C04.588.274.761
20233917,2010-03-16T00:00:00,Pancreatic Neoplasms,C04.588.322.421
20233917,2010-03-16T00:00:00,Pancreatic Neoplasms,C06.301.761
20233917,2010-03-16T00:00:00,Pancreatic Neoplasms,C06.689.667
20233917,2010-03-16T00:00:00,Pancreatic Neoplasms,C19.344.421
20234119,2010-03-17T00:00:00,African Americans,M01.686.508.100.100
20234119,2010-03-17T00:00:00,African Americans,M01.686.754.100
20234119,2010-03-17T00:00:00,Breast Neoplasms,C04.588.180
20234119,2010-03-17T00:00:00,Breast Neoplasms,C17.800.090.500
20234119,2010-03-17T00:00:00,Genetic Counseling,H01.158.273.343.315.384
20234119,2010-03-17T00:00:00,Genetic Counseling,N02.421.308.400
20234119,2010-03-17T00:00:00,Genetic Testing,E01.370.427
20234119,2010-03-17T00:00:00,Genetic Testing,E05.393.435
20234119,2010-03-17T00:00:00,Genetic Testing,N02.421.143.827.233.221
20234119,2010-03-17T00:00:00,Genetic Testing,N02.421.308.430
20234119,2010-03-17T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
20234119,2010-03-17T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
20234119,2010-03-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20234119,2010-03-17T00:00:00,Middle Aged,M01.060.116.630
20234119,2010-03-17T00:00:00,Mutation,G05.365.590
20234119,2010-03-17T00:00:00,Risk Factors,E05.318.740.600.800.725
20234119,2010-03-17T00:00:00,Risk Factors,N05.715.350.200.700
20234119,2010-03-17T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20234119,2010-03-17T00:00:00,Risk Factors,N06.850.490.625.750
20234119,2010-03-17T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20234127,2010-03-17T00:00:00,Alligators and Crocodiles,B01.050.150.900.833.100
20234127,2010-03-17T00:00:00,Amino Acid Sequence,G02.111.570.060
20234127,2010-03-17T00:00:00,Amino Acid Sequence,L01.453.245.667.060
20234127,2010-03-17T00:00:00,Animals,B01.050
20234127,2010-03-17T00:00:00,Genomics,H01.158.273.180.350
20234127,2010-03-17T00:00:00,Genomics,H01.158.273.343.350
20234127,2010-03-17T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
20234127,2010-03-17T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
20234127,2010-03-17T00:00:00,Molecular Sequence Data,L01.453.245.667
20234127,2010-03-17T00:00:00,Phylogeny,G05.697
20234127,2010-03-17T00:00:00,Phylogeny,G16.100.275.605
20234127,2010-03-17T00:00:00,Phylogeny,L01.100.697
20234127,2010-03-17T00:00:00,"RNA, Messenger",D13.444.735.544
20234127,2010-03-17T00:00:00,Signal Transduction,G02.111.087.800
20234127,2010-03-17T00:00:00,Signal Transduction,G02.149.115.800
20234127,2010-03-17T00:00:00,Signal Transduction,G04.299.880
20234127,2010-03-17T00:00:00,Turtles,B01.050.150.900.833.848
20299099,2010-03-17T00:00:00,Biological Markers,D23.101
20299099,2010-03-17T00:00:00,Diabetes Mellitus,C18.452.394.750
20299099,2010-03-17T00:00:00,Diabetes Mellitus,C19.246
20299099,2010-03-17T00:00:00,Environmental Exposure,N06.850.460.350
20299099,2010-03-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20299099,2010-03-17T00:00:00,Nutrition Surveys,E05.318.308.250.600
20299099,2010-03-17T00:00:00,Nutrition Surveys,E05.318.308.585.550
20299099,2010-03-17T00:00:00,Nutrition Surveys,N05.715.360.300.375.560
20299099,2010-03-17T00:00:00,Nutrition Surveys,N05.715.360.300.560.565
20299099,2010-03-17T00:00:00,Nutrition Surveys,N06.850.520.308.250.600
20299099,2010-03-17T00:00:00,Nutrition Surveys,N06.850.520.308.585.550
20299099,2010-03-17T00:00:00,Pesticides,D27.720.031.700
20299099,2010-03-17T00:00:00,Pesticides,D27.720.723
20299099,2010-03-17T00:00:00,Pesticides,D27.888.723
20299099,2010-03-17T00:00:00,United States,Z01.107.567.875
20302882,2010-03-17T00:00:00,Animals,B01.050
20302882,2010-03-17T00:00:00,Benzazepines,D03.438.079
20302882,2010-03-17T00:00:00,Discrimination (Psychology),F02.463.593.257
20302882,2010-03-17T00:00:00,Isoxazoles,D03.383.129.385
20302882,2010-03-17T00:00:00,Nicotine,D03.132.760.570
20302882,2010-03-17T00:00:00,Nicotine,D03.383.725.518
20302882,2010-03-17T00:00:00,Nicotinic Agonists,D27.505.519.625.120.140.700
20302882,2010-03-17T00:00:00,Nicotinic Agonists,D27.505.696.577.120.140.700
20302882,2010-03-17T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20302882,2010-03-17T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
20303353,2010-03-18T00:00:00,ADAM Proteins,D08.811.277.656.675.374.102
20303353,2010-03-18T00:00:00,ADAM Proteins,D09.400.430.500
20303353,2010-03-18T00:00:00,ADAM Proteins,D12.776.395.033
20303353,2010-03-18T00:00:00,"Antigens, CD29",D12.776.543.750.705.408.200.500
20303353,2010-03-18T00:00:00,"Antigens, CD29",D23.050.301.264.035.129
20303353,2010-03-18T00:00:00,"Antigens, CD29",D23.050.301.264.129
20303353,2010-03-18T00:00:00,"Antigens, CD29",D23.101.100.110.129
20303353,2010-03-18T00:00:00,"Antigens, CD29",D23.101.100.129
20303353,2010-03-18T00:00:00,Helicobacter pylori,B03.440.500.550
20303353,2010-03-18T00:00:00,Helicobacter pylori,B03.660.150.280.550
20303353,2010-03-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20303353,2010-03-18T00:00:00,Intercellular Signaling Peptides and Proteins,D12.644.276
20303353,2010-03-18T00:00:00,Intercellular Signaling Peptides and Proteins,D12.776.467
20303353,2010-03-18T00:00:00,Intercellular Signaling Peptides and Proteins,D23.529
20303353,2010-03-18T00:00:00,Oligopeptides,D12.644.456
20303353,2010-03-18T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
20303353,2010-03-18T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
20303353,2010-03-18T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
20303353,2010-03-18T00:00:00,Sodium-Potassium-Exchanging ATPase,D08.811.277.040.025.810
20303353,2010-03-18T00:00:00,Sodium-Potassium-Exchanging ATPase,D12.776.157.530.450.162.780
20303353,2010-03-18T00:00:00,Sodium-Potassium-Exchanging ATPase,D12.776.157.530.450.250.880
20303353,2010-03-18T00:00:00,Sodium-Potassium-Exchanging ATPase,D12.776.543.585.450.162.800
20303353,2010-03-18T00:00:00,Sodium-Potassium-Exchanging ATPase,D12.776.543.585.450.250.890
20304819,2010-03-19T00:00:00,Adenosine Triphosphate,D03.438.759.646.138.236
20304819,2010-03-19T00:00:00,Adenosine Triphosphate,D13.695.667.138.236
20304819,2010-03-19T00:00:00,Adenosine Triphosphate,D13.695.827.068.236
20304819,2010-03-19T00:00:00,Aging,G07.700.320.124
20304819,2010-03-19T00:00:00,Animals,B01.050
20304819,2010-03-19T00:00:00,Calcium,D01.268.552.100
20304819,2010-03-19T00:00:00,Calcium,D01.552.539.288
20304819,2010-03-19T00:00:00,Calcium,D23.119.100
20304819,2010-03-19T00:00:00,Calcium Signaling,G02.111.087.800.800.100
20304819,2010-03-19T00:00:00,Calcium Signaling,G02.149.115.800.800.100
20304819,2010-03-19T00:00:00,Calcium Signaling,G03.495.166.500.100
20304819,2010-03-19T00:00:00,Calcium Signaling,G04.299.880.800.100
20304819,2010-03-19T00:00:00,"Myocytes, Cardiac",A07.541.704.570
20304819,2010-03-19T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
20304819,2010-03-19T00:00:00,"Myocytes, Cardiac",A11.620.500
20304819,2010-03-19T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20304819,2010-03-19T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.157.530.400.150.800
20304819,2010-03-19T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.210.500.800
20304819,2010-03-19T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.543.550.425.150.800
20304819,2010-03-19T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.543.585.400.150.800
20304425,2010-03-20T00:00:00,Adolescent,M01.060.057
20304425,2010-03-20T00:00:00,Child,M01.060.406
20304425,2010-03-20T00:00:00,"Child, Preschool",M01.060.406.448
20304425,2010-03-20T00:00:00,Head,A01.456
20304425,2010-03-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20304425,2010-03-20T00:00:00,Infant,M01.060.703
20304425,2010-03-20T00:00:00,"Infant, Newborn",M01.060.703.520
20304425,2010-03-20T00:00:00,United States,Z01.107.567.875
20304425,2010-03-20T00:00:00,Young Adult,M01.060.116.815
22749473,2010-03-20T00:00:00,Bayes Theorem,E05.318.740.600.200
22749473,2010-03-20T00:00:00,Bayes Theorem,N05.715.360.750.625.150
22749473,2010-03-20T00:00:00,Bayes Theorem,N06.850.520.830.600.200
22749473,2010-03-20T00:00:00,Disease Outbreaks,N06.850.290
22749473,2010-03-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22749473,2010-03-20T00:00:00,Incidence,E05.318.308.985.525.375
22749473,2010-03-20T00:00:00,Incidence,L01.280.975.525.375
22749473,2010-03-20T00:00:00,Incidence,N01.224.935.597.500
22749473,2010-03-20T00:00:00,Incidence,N06.850.505.400.975.525.375
22749473,2010-03-20T00:00:00,Incidence,N06.850.520.308.985.525.375
22749473,2010-03-20T00:00:00,"Influenza, Human",C02.782.620.365
22749473,2010-03-20T00:00:00,"Influenza, Human",C08.730.310
22749473,2010-03-20T00:00:00,"Models, Statistical",E05.318.740.500
22749473,2010-03-20T00:00:00,"Models, Statistical",E05.599.835
22749473,2010-03-20T00:00:00,"Models, Statistical",N05.715.360.750.530
22749473,2010-03-20T00:00:00,"Models, Statistical",N06.850.520.830.500
22749473,2010-03-20T00:00:00,South Carolina,Z01.107.567.875.075.662
22749473,2010-03-20T00:00:00,South Carolina,Z01.107.567.875.750.700
20309565,2010-03-23T00:00:00,Acute Chest Syndrome,C08.381.074
20309565,2010-03-23T00:00:00,Acute Chest Syndrome,C08.618.009
20309565,2010-03-23T00:00:00,Acute Chest Syndrome,C15.378.071.141.150.150.219
20309565,2010-03-23T00:00:00,Acute Chest Syndrome,C15.378.420.155.219
20309565,2010-03-23T00:00:00,Acute Chest Syndrome,C16.320.070.150.219
20309565,2010-03-23T00:00:00,Acute Chest Syndrome,C16.320.365.155.219
20309565,2010-03-23T00:00:00,Adolescent,M01.060.057
20309565,2010-03-23T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
20309565,2010-03-23T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
20309565,2010-03-23T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
20309565,2010-03-23T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
20309565,2010-03-23T00:00:00,Child,M01.060.406
20309565,2010-03-23T00:00:00,"Child, Preschool",M01.060.406.448
20309565,2010-03-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20309565,2010-03-23T00:00:00,Incidence,E05.318.308.985.525.375
20309565,2010-03-23T00:00:00,Incidence,L01.280.975.525.375
20309565,2010-03-23T00:00:00,Incidence,N01.224.935.597.500
20309565,2010-03-23T00:00:00,Incidence,N06.850.505.400.975.525.375
20309565,2010-03-23T00:00:00,Incidence,N06.850.520.308.985.525.375
20309565,2010-03-23T00:00:00,Infant,M01.060.703
20309565,2010-03-23T00:00:00,Laparoscopy,E01.370.388.250.520
20309565,2010-03-23T00:00:00,Laparoscopy,E04.800.250.520
20309565,2010-03-23T00:00:00,"Pain, Postoperative",C23.550.767.700
20309565,2010-03-23T00:00:00,"Pain, Postoperative",C23.888.646.530
20309565,2010-03-23T00:00:00,Postoperative Complications,C23.550.767
20309565,2010-03-23T00:00:00,Risk Factors,E05.318.740.600.800.725
20309565,2010-03-23T00:00:00,Risk Factors,N05.715.350.200.700
20309565,2010-03-23T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20309565,2010-03-23T00:00:00,Risk Factors,N06.850.490.625.750
20309565,2010-03-23T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20309565,2010-03-23T00:00:00,Sepsis,C01.539.757
20309565,2010-03-23T00:00:00,Sepsis,C23.550.470.790.500
20309565,2010-03-23T00:00:00,Splenectomy,E04.726
20309565,2010-03-23T00:00:00,Stroke,C10.228.140.300.775
20309565,2010-03-23T00:00:00,Stroke,C14.907.253.855
20332188,2010-03-23T00:00:00,Animals,B01.050
20332188,2010-03-23T00:00:00,"Behavior, Animal",F01.145.113
20332188,2010-03-23T00:00:00,Cocaine,D02.145.074.722.388
20332188,2010-03-23T00:00:00,Cocaine,D03.132.889.354
20332188,2010-03-23T00:00:00,Cocaine,D03.605.869.388
20332188,2010-03-23T00:00:00,Cocaine,D04.075.080.875.099.722.388
20332188,2010-03-23T00:00:00,"Conditioning, Operant",F02.463.425.179.509
20332188,2010-03-23T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
20332188,2010-03-23T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
20332188,2010-03-23T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
20332188,2010-03-23T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
20332188,2010-03-23T00:00:00,Frontal Lobe,A08.186.211.730.885.287.500.270
20332188,2010-03-23T00:00:00,Propanolamines,D02.033.100.624
20332188,2010-03-23T00:00:00,Propanolamines,D02.033.755.624
20332188,2010-03-23T00:00:00,Propanolamines,D02.092.063.624
20332188,2010-03-23T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20332188,2010-03-23T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
20332188,2010-03-23T00:00:00,Self Administration,E02.319.890
20332188,2010-03-23T00:00:00,Self Administration,E02.900.890
20332188,2010-03-23T00:00:00,Time Factors,G01.910.857
20334951,2010-03-23T00:00:00,Academic Medical Centers,N02.278.020
20334951,2010-03-23T00:00:00,Adult,M01.060.116
20334951,2010-03-23T00:00:00,Aged,M01.060.116.100
20334951,2010-03-23T00:00:00,Case-Control Studies,E05.318.760.500.500
20334951,2010-03-23T00:00:00,Case-Control Studies,N05.715.360.775.175.200
20334951,2010-03-23T00:00:00,Case-Control Studies,N06.850.520.450.500.500
20334951,2010-03-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20334951,2010-03-23T00:00:00,Incidence,E05.318.308.985.525.375
20334951,2010-03-23T00:00:00,Incidence,L01.280.975.525.375
20334951,2010-03-23T00:00:00,Incidence,N01.224.935.597.500
20334951,2010-03-23T00:00:00,Incidence,N06.850.505.400.975.525.375
20334951,2010-03-23T00:00:00,Incidence,N06.850.520.308.985.525.375
20334951,2010-03-23T00:00:00,Melanoma,C04.557.465.625.650.510
20334951,2010-03-23T00:00:00,Melanoma,C04.557.580.625.650.510
20334951,2010-03-23T00:00:00,Melanoma,C04.557.665.510
20334951,2010-03-23T00:00:00,Middle Aged,M01.060.116.630
20334951,2010-03-23T00:00:00,Neoplasm Staging,E01.370.550
20334951,2010-03-23T00:00:00,Skin Neoplasms,C04.588.805
20334951,2010-03-23T00:00:00,Skin Neoplasms,C17.800.882
20334951,2010-03-23T00:00:00,Smoking,F01.145.466.753
20338186,2010-03-23T00:00:00,Animals,B01.050
20338186,2010-03-23T00:00:00,"Behavior, Addictive",F01.145.527.100.120
20338186,2010-03-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20338186,2010-03-23T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
20338186,2010-03-23T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
20338186,2010-03-23T00:00:00,Neuropeptides,D12.644.400
20338186,2010-03-23T00:00:00,Neuropeptides,D12.776.641.650
20338186,2010-03-23T00:00:00,Obesity,C18.654.726.500
20338186,2010-03-23T00:00:00,Obesity,C23.888.144.699.500
20338186,2010-03-23T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
20338186,2010-03-23T00:00:00,Obesity,G07.100.100.160.120.699.500
20338186,2010-03-23T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
20338186,2010-03-23T00:00:00,"Receptors, Neuropeptide",D12.776.543.750.720.600
20338186,2010-03-23T00:00:00,"Receptors, Neuropeptide",D12.776.543.750.750.555
20352118,2010-03-23T00:00:00,Animals,B01.050
20352118,2010-03-23T00:00:00,Apoptosis,G04.299.139.160
20352118,2010-03-23T00:00:00,Cell Proliferation,G04.299.233.750
20352118,2010-03-23T00:00:00,Cell Proliferation,G07.700.320.249.410.750
20352118,2010-03-23T00:00:00,Fibroblasts,A11.329.228
20352118,2010-03-23T00:00:00,Fibroblasts,A11.872.228
20352118,2010-03-23T00:00:00,Genetic Vectors,G05.360.337
20352118,2010-03-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20352118,2010-03-23T00:00:00,"Lipoproteins, LDL",D10.532.515
20352118,2010-03-23T00:00:00,"Lipoproteins, LDL",D12.776.521.550
20352118,2010-03-23T00:00:00,Liver,A03.620
20352118,2010-03-23T00:00:00,Sphingolipids,D10.570.877
20352118,2010-03-23T00:00:00,Sphingolipids,D10.808
20352118,2010-03-23T00:00:00,Sphingomyelin Phosphodiesterase,D08.811.277.352.640.750
20352118,2010-03-23T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
20352118,2010-03-23T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
20352118,2010-03-23T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
20352118,2010-03-23T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
20352118,2010-03-23T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
20352118,2010-03-23T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
20352118,2010-03-23T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
20352118,2010-03-23T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
20352118,2010-03-23T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
20352118,2010-03-23T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
20352118,2010-03-23T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
20335527,2010-03-24T00:00:00,Cell Line,A11.251.210
20335527,2010-03-24T00:00:00,Down-Regulation,G02.111.087.225
20335527,2010-03-24T00:00:00,Down-Regulation,G02.149.115.225
20335527,2010-03-24T00:00:00,Down-Regulation,G05.355.315.200
20335527,2010-03-24T00:00:00,Down-Regulation,G07.690.812.230
20335527,2010-03-24T00:00:00,Down-Regulation,G07.700.680.230
20335527,2010-03-24T00:00:00,Endoplasmic Reticulum,A11.284.430.214.190.875.248
20335527,2010-03-24T00:00:00,Endothelin-1,D12.644.276.400.225
20335527,2010-03-24T00:00:00,Endothelin-1,D12.776.467.400.225
20335527,2010-03-24T00:00:00,Endothelin-1,D23.529.400.225
20335527,2010-03-24T00:00:00,"Endothelium, Vascular",A07.231.330
20335527,2010-03-24T00:00:00,"Endothelium, Vascular",A10.272.491.355
20335527,2010-03-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20335527,2010-03-24T00:00:00,"Hypertension, Pulmonary",C08.381.423
20335527,2010-03-24T00:00:00,Nitric Oxide Synthase Type III,D08.811.682.664.500.772.750
20335527,2010-03-24T00:00:00,"Stress, Physiological",G07.700.830
20338901,2010-03-25T00:00:00,Health Behavior,F01.145.488
20338901,2010-03-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20338901,2010-03-25T00:00:00,Nicotine,D03.132.760.570
20338901,2010-03-25T00:00:00,Nicotine,D03.383.725.518
20338901,2010-03-25T00:00:00,Nicotinic Agonists,D27.505.519.625.120.140.700
20338901,2010-03-25T00:00:00,Nicotinic Agonists,D27.505.696.577.120.140.700
20338901,2010-03-25T00:00:00,Research Design,E05.581.500
20338901,2010-03-25T00:00:00,Research Design,H01.770.644.728
20338901,2010-03-25T00:00:00,Smoking Cessation,F01.145.940.700
20345772,2010-03-25T00:00:00,Adult,M01.060.116
20345772,2010-03-25T00:00:00,Biological Markers,D23.101
20345772,2010-03-25T00:00:00,Case-Control Studies,E05.318.760.500.500
20345772,2010-03-25T00:00:00,Case-Control Studies,N05.715.360.775.175.200
20345772,2010-03-25T00:00:00,Case-Control Studies,N06.850.520.450.500.500
20345772,2010-03-25T00:00:00,"Creatine Kinase, MB Form",D08.811.913.696.640.150.625
20345772,2010-03-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20345772,2010-03-25T00:00:00,Middle Aged,M01.060.116.630
20345772,2010-03-25T00:00:00,Myocardial Infarction,C14.280.647.500
20345772,2010-03-25T00:00:00,Myocardial Infarction,C14.907.585.500
20336396,2010-03-26T00:00:00,Animals,B01.050
20336396,2010-03-26T00:00:00,Cell Lineage,G04.172
20336396,2010-03-26T00:00:00,Cell Lineage,G07.700.320.500.325.180.500
20336396,2010-03-26T00:00:00,Cell Lineage,G08.686.155
20336396,2010-03-26T00:00:00,Cell Lineage,G08.686.785.760.170.104.249
20336396,2010-03-26T00:00:00,Hematologic Diseases,C15.378
20336396,2010-03-26T00:00:00,Hematopoietic Stem Cell Transplantation,E04.936.225.687.500
20336396,2010-03-26T00:00:00,Hematopoietic Stem Cells,A11.148.378
20336396,2010-03-26T00:00:00,Hematopoietic Stem Cells,A11.872.378
20336396,2010-03-26T00:00:00,Hematopoietic Stem Cells,A15.378.316.378
20336396,2010-03-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20336396,2010-03-26T00:00:00,Mesenchymal Stem Cell Transplantation,E04.936.225.687.625
20348092,2010-03-26T00:00:00,Animals,B01.050
20348092,2010-03-26T00:00:00,Antibodies,D12.776.124.486.485.114
20348092,2010-03-26T00:00:00,Antibodies,D12.776.124.790.651.114
20348092,2010-03-26T00:00:00,Antibodies,D12.776.377.715.548.114
20348092,2010-03-26T00:00:00,Antigen-Antibody Complex,D12.776.124.486.485.114.257
20348092,2010-03-26T00:00:00,Antigen-Antibody Complex,D12.776.124.790.651.114.257
20348092,2010-03-26T00:00:00,Antigen-Antibody Complex,D12.776.377.715.548.114.257
20348092,2010-03-26T00:00:00,Antigen-Antibody Complex,D23.050.101
20348092,2010-03-26T00:00:00,Cell Survival,G04.299.316
20348092,2010-03-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20348092,2010-03-26T00:00:00,Interleukin-10,D12.644.276.374.465.510
20348092,2010-03-26T00:00:00,Interleukin-10,D12.776.467.374.465.510
20348092,2010-03-26T00:00:00,Interleukin-10,D23.529.374.465.510
20348092,2010-03-26T00:00:00,"Lipoproteins, LDL",D10.532.515
20348092,2010-03-26T00:00:00,"Lipoproteins, LDL",D12.776.521.550
20348092,2010-03-26T00:00:00,Macrophages,A11.329.372
20348092,2010-03-26T00:00:00,Macrophages,A11.627.482
20348092,2010-03-26T00:00:00,Macrophages,A11.733.397
20348092,2010-03-26T00:00:00,Macrophages,A15.382.680.397
20348092,2010-03-26T00:00:00,Macrophages,A15.382.812.522
20348092,2010-03-26T00:00:00,Phosphotransferases (Alcohol Group Acceptor),D08.811.913.696.620
20348092,2010-03-26T00:00:00,Protein Transport,G03.495.166.700
20348092,2010-03-26T00:00:00,"RNA, Messenger",D13.444.735.544
20350346,2010-03-26T00:00:00,Animals,B01.050
20350346,2010-03-26T00:00:00,Carrier Proteins,D12.776.157
20350346,2010-03-26T00:00:00,Cell Differentiation,G04.299.151
20350346,2010-03-26T00:00:00,Cell Movement,G04.299.283
20350346,2010-03-26T00:00:00,Cell Movement,G07.700.560.500.180
20350346,2010-03-26T00:00:00,Cell Survival,G04.299.316
20350346,2010-03-26T00:00:00,"Disease Models, Animal",C22.232
20350346,2010-03-26T00:00:00,"Disease Models, Animal",E05.598.500
20350346,2010-03-26T00:00:00,"Disease Models, Animal",E05.599.395.080
20350346,2010-03-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20350346,2010-03-26T00:00:00,Huntington Disease,C10.228.140.079.545
20350346,2010-03-26T00:00:00,Huntington Disease,C10.228.140.380.278
20350346,2010-03-26T00:00:00,Huntington Disease,C10.228.662.262.249.750
20350346,2010-03-26T00:00:00,Huntington Disease,C10.574.500.497
20350346,2010-03-26T00:00:00,Huntington Disease,C16.320.400.430
20350346,2010-03-26T00:00:00,Huntington Disease,F03.087.250.400
20350346,2010-03-26T00:00:00,Huntington Disease,F03.087.400.390
20350346,2010-03-26T00:00:00,Neurons,A08.663
20350346,2010-03-26T00:00:00,Neurons,A11.671
20350346,2010-03-26T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20105137,2010-03-29T00:00:00,Cell Line,A11.251.210
20105137,2010-03-29T00:00:00,Ceramides,D02.065.313
20105137,2010-03-29T00:00:00,Ceramides,D09.400.410.420.525.200
20105137,2010-03-29T00:00:00,Ceramides,D10.390.470.675.200
20105137,2010-03-29T00:00:00,Ceramides,D10.570.877.360.612.200
20105137,2010-03-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20105137,2010-03-29T00:00:00,Oxidative Stress,G03.495.710
20105137,2010-03-29T00:00:00,Oxidative Stress,G07.700.830.750
20105137,2010-03-29T00:00:00,Oxidoreductases,D08.811.682
20105137,2010-03-29T00:00:00,Protein Stability,G02.111.700
20303102,2010-03-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20303102,2010-03-29T00:00:00,Postoperative Complications,C23.550.767
20303102,2010-03-29T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
20303102,2010-03-29T00:00:00,Practice Guidelines as Topic,N05.700.350.650
20303102,2010-03-29T00:00:00,United States,Z01.107.567.875
20303102,2010-03-29T00:00:00,"Urinary Incontinence, Stress",C12.777.934.852.249
20303102,2010-03-29T00:00:00,"Urinary Incontinence, Stress",C13.351.968.934.814.500
20303102,2010-03-29T00:00:00,"Urinary Incontinence, Stress",C23.888.942.800.500
20346198,2010-03-29T00:00:00,Adolescent,M01.060.057
20346198,2010-03-29T00:00:00,Angiography,E01.370.350.700.060
20346198,2010-03-29T00:00:00,Angiography,E01.370.370.050
20346198,2010-03-29T00:00:00,Cardiac Surgical Procedures,E04.100.376
20346198,2010-03-29T00:00:00,Cardiac Surgical Procedures,E04.928.220
20346198,2010-03-29T00:00:00,Child,M01.060.406
20346198,2010-03-29T00:00:00,"Child, Preschool",M01.060.406.448
20346198,2010-03-29T00:00:00,"Heart Defects, Congenital",C14.240.400
20346198,2010-03-29T00:00:00,"Heart Defects, Congenital",C14.280.400
20346198,2010-03-29T00:00:00,"Heart Defects, Congenital",C16.131.240.400
20346198,2010-03-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20346198,2010-03-29T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
20346198,2010-03-29T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
20346198,2010-03-29T00:00:00,Infant,M01.060.703
20346198,2010-03-29T00:00:00,"Infant, Newborn",M01.060.703.520
20346198,2010-03-29T00:00:00,Preoperative Care,E02.760.795
20346198,2010-03-29T00:00:00,Preoperative Care,E04.641
20346198,2010-03-29T00:00:00,Preoperative Care,N02.421.585.795
20346198,2010-03-29T00:00:00,Reoperation,E04.690
20346198,2010-03-29T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20346198,2010-03-29T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20346198,2010-03-29T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20346198,2010-03-29T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20346198,2010-03-29T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20346198,2010-03-29T00:00:00,Young Adult,M01.060.116.815
20349350,2010-03-29T00:00:00,Mass Spectrometry,E05.196.566
20349350,2010-03-29T00:00:00,Plant Extracts,D20.215.784.500
20349350,2010-03-29T00:00:00,Plant Extracts,D26.667
20350322,2010-03-29T00:00:00,Adult,M01.060.116
20350322,2010-03-29T00:00:00,African Americans,M01.686.508.100.100
20350322,2010-03-29T00:00:00,African Americans,M01.686.754.100
20350322,2010-03-29T00:00:00,Biological Markers,D23.101
20350322,2010-03-29T00:00:00,Counseling,F02.784.176
20350322,2010-03-29T00:00:00,Counseling,F04.408.413
20350322,2010-03-29T00:00:00,Counseling,N02.421.143.303
20350322,2010-03-29T00:00:00,Counseling,N02.421.461.363
20350322,2010-03-29T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
20350322,2010-03-29T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
20350322,2010-03-29T00:00:00,Health Behavior,F01.145.488
20350322,2010-03-29T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
20350322,2010-03-29T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
20350322,2010-03-29T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
20350322,2010-03-29T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
20350322,2010-03-29T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
20350322,2010-03-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20350322,2010-03-29T00:00:00,Hypoglycemic Agents,D27.505.696.422
20350322,2010-03-29T00:00:00,Motivation,F01.658
20350322,2010-03-29T00:00:00,Motivation,F01.752.543.500.750
20350322,2010-03-29T00:00:00,Patient Education as Topic,I02.233.332.500
20350322,2010-03-29T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
20350322,2010-03-29T00:00:00,Patient Education as Topic,N02.421.726.407.680
20350322,2010-03-29T00:00:00,Research Design,E05.581.500
20350322,2010-03-29T00:00:00,Research Design,H01.770.644.728
20350322,2010-03-29T00:00:00,Time Factors,G01.910.857
20350322,2010-03-29T00:00:00,Treatment Outcome,E01.789.800
20350322,2010-03-29T00:00:00,Treatment Outcome,N04.761.559.590.800
20350322,2010-03-29T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20350981,2010-03-30T00:00:00,Animals,B01.050
20350981,2010-03-30T00:00:00,Brain Ischemia,C10.228.140.300.150
20350981,2010-03-30T00:00:00,Brain Ischemia,C14.907.253.092
20350981,2010-03-30T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
20350981,2010-03-30T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
20350981,2010-03-30T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
20350981,2010-03-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20350981,2010-03-30T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
20350981,2010-03-30T00:00:00,Recombinant Proteins,D12.776.828
20350981,2010-03-30T00:00:00,Stroke,C10.228.140.300.775
20350981,2010-03-30T00:00:00,Stroke,C14.907.253.855
20350981,2010-03-30T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
20350981,2010-03-30T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
20350981,2010-03-30T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
20350981,2010-03-30T00:00:00,Tissue Plasminogen Activator,D23.119.970
20351759,2010-03-30T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
20351759,2010-03-30T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
20351759,2010-03-30T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
20351759,2010-03-30T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
20351759,2010-03-30T00:00:00,Gastrointestinal Hemorrhage,C06.405.227
20351759,2010-03-30T00:00:00,Gastrointestinal Hemorrhage,C23.550.414.788
20351759,2010-03-30T00:00:00,Hemostatic Techniques,E02.520
20351759,2010-03-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20352413,2010-03-30T00:00:00,Amphetamine-Related Disorders,C21.739.225
20352413,2010-03-30T00:00:00,Amphetamine-Related Disorders,F03.900.225
20352413,2010-03-30T00:00:00,Animals,B01.050
20352413,2010-03-30T00:00:00,"Behavior, Addictive",F01.145.527.100.120
20352413,2010-03-30T00:00:00,"Disease Models, Animal",C22.232
20352413,2010-03-30T00:00:00,"Disease Models, Animal",E05.598.500
20352413,2010-03-30T00:00:00,"Disease Models, Animal",E05.599.395.080
20352413,2010-03-30T00:00:00,Methamphetamine,D02.092.471.683.152.619
20352413,2010-03-30T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20352413,2010-03-30T00:00:00,Self Administration,E02.319.890
20352413,2010-03-30T00:00:00,Self Administration,E02.900.890
20357437,2010-03-30T00:00:00,Age Factors,N05.715.350.075
20357437,2010-03-30T00:00:00,Age Factors,N06.850.490.250
20357437,2010-03-30T00:00:00,Aged,M01.060.116.100
20357437,2010-03-30T00:00:00,Aging,G07.700.320.124
20357437,2010-03-30T00:00:00,Atrial Fibrillation,C14.280.067.198
20357437,2010-03-30T00:00:00,Atrial Fibrillation,C23.550.073.198
20357437,2010-03-30T00:00:00,Clinical Trials as Topic,E05.318.760.535
20357437,2010-03-30T00:00:00,Clinical Trials as Topic,E05.337.250
20357437,2010-03-30T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
20357437,2010-03-30T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
20357437,2010-03-30T00:00:00,Guidelines as Topic,N04.761.700.350
20357437,2010-03-30T00:00:00,Guidelines as Topic,N05.700.350
20357437,2010-03-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20357437,2010-03-30T00:00:00,Hypertension,C14.907.489
20357437,2010-03-30T00:00:00,Population Dynamics,I01.240.600
20357437,2010-03-30T00:00:00,Population Dynamics,N01.224.625
20357437,2010-03-30T00:00:00,Population Dynamics,N06.850.505.400.700
20357437,2010-03-30T00:00:00,Stroke,C10.228.140.300.775
20357437,2010-03-30T00:00:00,Stroke,C14.907.253.855
20357437,2010-03-30T00:00:00,Thrombolytic Therapy,E02.319.913
20359549,2010-03-30T00:00:00,African Americans,M01.686.508.100.100
20359549,2010-03-30T00:00:00,African Americans,M01.686.754.100
20359549,2010-03-30T00:00:00,Community-Based Participatory Research,N05.425.104
20359549,2010-03-30T00:00:00,Exercise,G11.427.590.237
20359549,2010-03-30T00:00:00,Exercise,I03.350
20359549,2010-03-30T00:00:00,Health Education,I02.233.332
20359549,2010-03-30T00:00:00,Health Education,N02.421.143.827.407
20359549,2010-03-30T00:00:00,Health Education,N02.421.726.407
20359549,2010-03-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20359549,2010-03-30T00:00:00,Life Style,F01.829.458
20359549,2010-03-30T00:00:00,Research Design,E05.581.500
20359549,2010-03-30T00:00:00,Research Design,H01.770.644.728
20357360,2010-03-31T00:00:00,Adipocytes,A11.329.114
20357360,2010-03-31T00:00:00,Body Mass Index,E01.370.600.115.100.125
20357360,2010-03-31T00:00:00,Body Mass Index,E05.041.124.125
20357360,2010-03-31T00:00:00,Body Mass Index,G07.100.100.125
20357360,2010-03-31T00:00:00,Body Mass Index,N06.850.505.200.100.175
20357360,2010-03-31T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
20357360,2010-03-31T00:00:00,Flow Cytometry,E05.200.500.386.350
20357360,2010-03-31T00:00:00,Glucose,D09.546.359.448
20357360,2010-03-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20357360,2010-03-31T00:00:00,Inflammation,C23.550.470
20357360,2010-03-31T00:00:00,Insulin,D06.472.699.587.740.625
20357360,2010-03-31T00:00:00,Insulin,D12.644.548.586.740.625
20357360,2010-03-31T00:00:00,Insulin Resistance,C18.452.394.968.500
20357360,2010-03-31T00:00:00,Insulin Resistance,G07.690.320.617
20357360,2010-03-31T00:00:00,Macrophages,A11.329.372
20357360,2010-03-31T00:00:00,Macrophages,A11.627.482
20357360,2010-03-31T00:00:00,Macrophages,A11.733.397
20357360,2010-03-31T00:00:00,Macrophages,A15.382.680.397
20357360,2010-03-31T00:00:00,Macrophages,A15.382.812.522
20357360,2010-03-31T00:00:00,Obesity,C18.654.726.500
20357360,2010-03-31T00:00:00,Obesity,C23.888.144.699.500
20357360,2010-03-31T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
20357360,2010-03-31T00:00:00,Obesity,G07.100.100.160.120.699.500
20357360,2010-03-31T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
20357360,2010-03-31T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
20357360,2010-03-31T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
20357360,2010-03-31T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
20357360,2010-03-31T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
20357360,2010-03-31T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
19754349,2010-04-01T00:00:00,Anemia,C15.378.071
19754349,2010-04-01T00:00:00,Animals,B01.050
19754349,2010-04-01T00:00:00,Brain Ischemia,C10.228.140.300.150
19754349,2010-04-01T00:00:00,Brain Ischemia,C14.907.253.092
19754349,2010-04-01T00:00:00,Enzyme Inhibitors,D27.505.519.389
19754349,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19754349,2010-04-01T00:00:00,"Hypertension, Pulmonary",C08.381.423
19754349,2010-04-01T00:00:00,Hypoxia-Inducible Factor 1,D12.776.260.103.625
19754349,2010-04-01T00:00:00,Hypoxia-Inducible Factor 1,D12.776.930.125.625
19754349,2010-04-01T00:00:00,Iron,D01.268.556.412
19754349,2010-04-01T00:00:00,Iron,D01.268.956.287
19754349,2010-04-01T00:00:00,Iron,D01.552.544.412
19754349,2010-04-01T00:00:00,Kidney Diseases,C12.777.419
19754349,2010-04-01T00:00:00,Kidney Diseases,C13.351.968.419
19754349,2010-04-01T00:00:00,Myocardial Ischemia,C14.280.647
19754349,2010-04-01T00:00:00,Myocardial Ischemia,C14.907.585
19754349,2010-04-01T00:00:00,Neoplasms,C04
19754349,2010-04-01T00:00:00,Oxygen,D01.268.185.550
19754349,2010-04-01T00:00:00,Oxygen,D01.362.670
19754349,2010-04-01T00:00:00,Procollagen-Proline Dioxygenase,D08.811.682.690.708.673
19754349,2010-04-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
19761407,2010-04-01T00:00:00,Anemia,C15.378.071
19761407,2010-04-01T00:00:00,Drug Discovery,E05.295
19761407,2010-04-01T00:00:00,Drug Discovery,H01.158.703.007.675
19761407,2010-04-01T00:00:00,Drug Discovery,H01.181.466.675
19761407,2010-04-01T00:00:00,Enzyme Inhibitors,D27.505.519.389
19761407,2010-04-01T00:00:00,Homeostasis,G07.700.360
19761407,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19761407,2010-04-01T00:00:00,"Hypertension, Pulmonary",C08.381.423
19761407,2010-04-01T00:00:00,Iron,D01.268.556.412
19761407,2010-04-01T00:00:00,Iron,D01.268.956.287
19761407,2010-04-01T00:00:00,Iron,D01.552.544.412
19761407,2010-04-01T00:00:00,Myocardial Ischemia,C14.280.647
19761407,2010-04-01T00:00:00,Myocardial Ischemia,C14.907.585
19761407,2010-04-01T00:00:00,Neoplasms,C04
19761407,2010-04-01T00:00:00,Neuroprotective Agents,D27.505.696.706.548
19761407,2010-04-01T00:00:00,Neuroprotective Agents,D27.505.954.427.575
19761407,2010-04-01T00:00:00,Oxygen,D01.268.185.550
19761407,2010-04-01T00:00:00,Oxygen,D01.362.670
19761407,2010-04-01T00:00:00,Procollagen-Proline Dioxygenase,D08.811.682.690.708.673
19761407,2010-04-01T00:00:00,Stroke,C10.228.140.300.775
19761407,2010-04-01T00:00:00,Stroke,C14.907.253.855
20009768,2010-04-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
20009768,2010-04-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
20009768,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20009768,2010-04-01T00:00:00,Hypertension,C14.907.489
20009768,2010-04-01T00:00:00,Obesity,C18.654.726.500
20009768,2010-04-01T00:00:00,Obesity,C23.888.144.699.500
20009768,2010-04-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
20009768,2010-04-01T00:00:00,Obesity,G07.100.100.160.120.699.500
20009768,2010-04-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
20009768,2010-04-01T00:00:00,Sex,G08.686.810
20009768,2010-04-01T00:00:00,Sodium-Potassium-Exchanging ATPase,D08.811.277.040.025.810
20009768,2010-04-01T00:00:00,Sodium-Potassium-Exchanging ATPase,D12.776.157.530.450.162.780
20009768,2010-04-01T00:00:00,Sodium-Potassium-Exchanging ATPase,D12.776.157.530.450.250.880
20009768,2010-04-01T00:00:00,Sodium-Potassium-Exchanging ATPase,D12.776.543.585.450.162.800
20009768,2010-04-01T00:00:00,Sodium-Potassium-Exchanging ATPase,D12.776.543.585.450.250.890
20075746,2010-04-01T00:00:00,Adolescent,M01.060.057
20075746,2010-04-01T00:00:00,African Americans,M01.686.508.100.100
20075746,2010-04-01T00:00:00,African Americans,M01.686.754.100
20075746,2010-04-01T00:00:00,Age Factors,N05.715.350.075
20075746,2010-04-01T00:00:00,Age Factors,N06.850.490.250
20075746,2010-04-01T00:00:00,Blood Pressure,E01.370.600.875.249
20075746,2010-04-01T00:00:00,Blood Pressure,G09.330.380.076
20075746,2010-04-01T00:00:00,"Blood Pressure Monitoring, Ambulatory",E01.370.370.140.100
20075746,2010-04-01T00:00:00,"Blood Pressure Monitoring, Ambulatory",E01.370.520.500.100
20075746,2010-04-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
20075746,2010-04-01T00:00:00,Body Mass Index,E05.041.124.125
20075746,2010-04-01T00:00:00,Body Mass Index,G07.100.100.125
20075746,2010-04-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
20075746,2010-04-01T00:00:00,Diastole,G09.330.190.541.295
20075746,2010-04-01T00:00:00,Diastole,G11.427.590.540.554.250
20075746,2010-04-01T00:00:00,Diastole,G11.427.590.540.570.295
20075746,2010-04-01T00:00:00,Ethnic Groups,M01.686.754
20075746,2010-04-01T00:00:00,Ethnic Groups,N01.224.317
20075746,2010-04-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
20075746,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20075746,2010-04-01T00:00:00,Hypertension,C14.907.489
20075746,2010-04-01T00:00:00,Obesity,C18.654.726.500
20075746,2010-04-01T00:00:00,Obesity,C23.888.144.699.500
20075746,2010-04-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
20075746,2010-04-01T00:00:00,Obesity,G07.100.100.160.120.699.500
20075746,2010-04-01T00:00:00,Sex Factors,N05.715.350.675
20075746,2010-04-01T00:00:00,Sex Factors,N06.850.490.875
20082561,2010-04-01T00:00:00,Animals,B01.050
20082561,2010-04-01T00:00:00,Bradykinin,D12.644.276.812.169
20082561,2010-04-01T00:00:00,Bradykinin,D12.644.400.090
20082561,2010-04-01T00:00:00,Bradykinin,D12.644.456.193
20082561,2010-04-01T00:00:00,Bradykinin,D12.776.467.812.169
20082561,2010-04-01T00:00:00,Bradykinin,D12.776.641.650.090
20082561,2010-04-01T00:00:00,Bradykinin,D23.469.050.375.110
20082561,2010-04-01T00:00:00,Bradykinin,D23.529.812.169
20082561,2010-04-01T00:00:00,Cyclic AMP,D03.438.759.646.138.395
20082561,2010-04-01T00:00:00,Cyclic AMP,D13.695.462.200
20082561,2010-04-01T00:00:00,Cyclic AMP,D13.695.667.138.395
20082561,2010-04-01T00:00:00,Cyclic AMP,D13.695.827.068.395
20082561,2010-04-01T00:00:00,Insulin-Like Growth Factor I,D12.644.276.937.400
20082561,2010-04-01T00:00:00,Insulin-Like Growth Factor I,D12.776.124.862.400
20082561,2010-04-01T00:00:00,Insulin-Like Growth Factor I,D12.776.467.937.400
20082561,2010-04-01T00:00:00,Insulin-Like Growth Factor I,D23.529.937.400
20082561,2010-04-01T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.567.342.500
20082561,2010-04-01T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.646.750.249.500
20082561,2010-04-01T00:00:00,Mitogen-Activated Protein Kinase 1,D12.644.360.450.169.500
20082561,2010-04-01T00:00:00,Mitogen-Activated Protein Kinase 1,D12.776.476.450.169.500
20082561,2010-04-01T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.567.342.750
20082561,2010-04-01T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.646.750.249.750
20082561,2010-04-01T00:00:00,Mitogen-Activated Protein Kinase 3,D12.644.360.450.169.750
20082561,2010-04-01T00:00:00,Mitogen-Activated Protein Kinase 3,D12.776.476.450.169.750
20082561,2010-04-01T00:00:00,"Muscle, Smooth, Vascular",A02.633.570.491
20082561,2010-04-01T00:00:00,"Muscle, Smooth, Vascular",A07.231.491
20082561,2010-04-01T00:00:00,"Muscle, Smooth, Vascular",A10.690.467.491
20082561,2010-04-01T00:00:00,Proto-Oncogene Proteins c-fos,D12.776.260.108.765
20082561,2010-04-01T00:00:00,Proto-Oncogene Proteins c-fos,D12.776.624.664.700.179
20082561,2010-04-01T00:00:00,Proto-Oncogene Proteins c-fos,D12.776.660.760
20082561,2010-04-01T00:00:00,Proto-Oncogene Proteins c-fos,D12.776.930.127.765
20082561,2010-04-01T00:00:00,"RNA, Messenger",D13.444.735.544
20082561,2010-04-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20082561,2010-04-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
20082561,2010-04-01T00:00:00,"Receptor, IGF Type 1",D08.811.913.696.620.682.725.400.185
20082561,2010-04-01T00:00:00,"Receptor, IGF Type 1",D12.776.543.750.060.468
20082561,2010-04-01T00:00:00,"Receptor, IGF Type 1",D12.776.543.750.750.400.780.400
20082561,2010-04-01T00:00:00,Signal Transduction,G02.111.087.800
20082561,2010-04-01T00:00:00,Signal Transduction,G02.149.115.800
20082561,2010-04-01T00:00:00,Signal Transduction,G04.299.880
20082561,2010-04-01T00:00:00,Vasodilator Agents,D27.505.954.411.918
20084041,2010-04-01T00:00:00,Adolescent,M01.060.057
20084041,2010-04-01T00:00:00,Adult,M01.060.116
20084041,2010-04-01T00:00:00,Aged,M01.060.116.100
20084041,2010-04-01T00:00:00,Cerebrospinal Fluid Otorrhea,C10.597.230
20084041,2010-04-01T00:00:00,Cerebrospinal Fluid Otorrhea,C10.900.300.131
20084041,2010-04-01T00:00:00,Cerebrospinal Fluid Otorrhea,C21.866.260.177
20084041,2010-04-01T00:00:00,Cerebrospinal Fluid Otorrhea,C21.866.915.300.250
20084041,2010-04-01T00:00:00,Cerebrospinal Fluid Otorrhea,C23.888.592.230
20084041,2010-04-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C10.597.267
20084041,2010-04-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C10.900.300.153
20084041,2010-04-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C21.866.260.207
20084041,2010-04-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C21.866.915.300.300
20084041,2010-04-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C23.888.592.264
20084041,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20084041,2010-04-01T00:00:00,Middle Aged,M01.060.116.630
20084041,2010-04-01T00:00:00,Otologic Surgical Procedures,E04.580.450
20084041,2010-04-01T00:00:00,Suture Techniques,E04.901
20087214,2010-04-01T00:00:00,Adult,M01.060.116
20087214,2010-04-01T00:00:00,Aging,G07.700.320.124
20087214,2010-04-01T00:00:00,Cardiovascular Diseases,C14
20087214,2010-04-01T00:00:00,Coronary Disease,C14.280.647.250
20087214,2010-04-01T00:00:00,Coronary Disease,C14.907.585.250
20087214,2010-04-01T00:00:00,Diabetes Mellitus,C18.452.394.750
20087214,2010-04-01T00:00:00,Diabetes Mellitus,C19.246
20087214,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20087214,2010-04-01T00:00:00,Pregnancy,G08.686.785.760.769
20087214,2010-04-01T00:00:00,Stroke,C10.228.140.300.775
20087214,2010-04-01T00:00:00,Stroke,C14.907.253.855
20112407,2010-04-01T00:00:00,"Affective Disorders, Psychotic",F03.600.150
20112407,2010-04-01T00:00:00,Attitude of Health Personnel,F01.100.050
20112407,2010-04-01T00:00:00,Attitude of Health Personnel,N05.300.100
20112407,2010-04-01T00:00:00,Clinical Competence,I02.399.630.210
20112407,2010-04-01T00:00:00,Clinical Competence,N04.761.210
20112407,2010-04-01T00:00:00,Cognitive Therapy,F04.754.137.428
20112407,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20112407,2010-04-01T00:00:00,Schizophrenia,F03.700.750
20112407,2010-04-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
20147844,2010-04-01T00:00:00,Actins,D05.750.078.730.250
20147844,2010-04-01T00:00:00,Actins,D12.776.210.500.100
20147844,2010-04-01T00:00:00,Actins,D12.776.220.525.255
20147844,2010-04-01T00:00:00,Animals,B01.050
20147844,2010-04-01T00:00:00,Blood Pressure,E01.370.600.875.249
20147844,2010-04-01T00:00:00,Blood Pressure,G09.330.380.076
20147844,2010-04-01T00:00:00,Caspases,D08.811.277.656.262.500.126
20147844,2010-04-01T00:00:00,Caspases,D08.811.277.656.300.200.126
20147844,2010-04-01T00:00:00,Caspases,D12.644.360.075.405
20147844,2010-04-01T00:00:00,Caspases,D12.776.476.075.405
20147844,2010-04-01T00:00:00,Collagen,D05.750.078.280
20147844,2010-04-01T00:00:00,Collagen,D12.776.860.300.250
20147844,2010-04-01T00:00:00,Heart,A07.541
20147844,2010-04-01T00:00:00,Heart Ventricles,A07.541.560
20147844,2010-04-01T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
20147844,2010-04-01T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
20147844,2010-04-01T00:00:00,Myocardial Infarction,C14.280.647.500
20147844,2010-04-01T00:00:00,Myocardial Infarction,C14.907.585.500
20147844,2010-04-01T00:00:00,Myocardium,A02.633.580
20147844,2010-04-01T00:00:00,Myocardium,A07.541.704
20147844,2010-04-01T00:00:00,Myocardium,A10.690.552.750
20147844,2010-04-01T00:00:00,"Myocytes, Cardiac",A07.541.704.570
20147844,2010-04-01T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
20147844,2010-04-01T00:00:00,"Myocytes, Cardiac",A11.620.500
20147844,2010-04-01T00:00:00,Oligopeptides,D12.644.456
20147844,2010-04-01T00:00:00,Recombinant Proteins,D12.776.828
20147844,2010-04-01T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
20147844,2010-04-01T00:00:00,Ventricular Remodeling,C23.300.985
20147844,2010-04-01T00:00:00,Ventricular Remodeling,G09.330.190.962.975
20148778,2010-04-01T00:00:00,"Adaptation, Physiological",G07.700.062
20148778,2010-04-01T00:00:00,"Adaptation, Physiological",G16.100.057.500
20148778,2010-04-01T00:00:00,Alcoholism,C21.739.100.250
20148778,2010-04-01T00:00:00,Alcoholism,F03.900.100.350
20148778,2010-04-01T00:00:00,Animals,B01.050
20148778,2010-04-01T00:00:00,Brain,A08.186.211
20148778,2010-04-01T00:00:00,Ethanol,D02.033.375
20148778,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20148778,2010-04-01T00:00:00,Phenotype,G05.695
20148778,2010-04-01T00:00:00,"Stress, Psychological",F01.145.126.990
20148778,2010-04-01T00:00:00,"Stress, Psychological",F02.830.900
20148778,2010-04-01T00:00:00,Substance Withdrawal Syndrome,C21.739.835
20148778,2010-04-01T00:00:00,Substance Withdrawal Syndrome,F03.900.825
20166196,2010-04-01T00:00:00,Alligators and Crocodiles,B01.050.150.900.833.100
20166196,2010-04-01T00:00:00,Animals,B01.050
20166196,2010-04-01T00:00:00,"Animals, Newborn",B01.050.050.282
20166196,2010-04-01T00:00:00,Estradiol,D04.808.365.415.248
20166196,2010-04-01T00:00:00,Estradiol,D06.472.334.851.437.500
20166196,2010-04-01T00:00:00,Ovary,A05.360.319.114.630
20166196,2010-04-01T00:00:00,Ovary,A05.360.576.497
20166196,2010-04-01T00:00:00,Ovary,A06.407.312.497
20166196,2010-04-01T00:00:00,Pesticides,D27.720.031.700
20166196,2010-04-01T00:00:00,Pesticides,D27.720.723
20166196,2010-04-01T00:00:00,Pesticides,D27.888.723
20166196,2010-04-01T00:00:00,"RNA, Messenger",D13.444.735.544
20166196,2010-04-01T00:00:00,Signal Transduction,G02.111.087.800
20166196,2010-04-01T00:00:00,Signal Transduction,G02.149.115.800
20166196,2010-04-01T00:00:00,Signal Transduction,G04.299.880
20166196,2010-04-01T00:00:00,Testosterone,D04.808.054.079.429.824
20166196,2010-04-01T00:00:00,Testosterone,D06.472.334.851.968.984
20180642,2010-04-01T00:00:00,"Carcinoma, Renal Cell",C04.557.470.200.025.390
20180642,2010-04-01T00:00:00,"Carcinoma, Renal Cell",C04.588.945.947.535.160
20180642,2010-04-01T00:00:00,"Carcinoma, Renal Cell",C12.758.820.750.160
20180642,2010-04-01T00:00:00,"Carcinoma, Renal Cell",C12.777.419.473.160
20180642,2010-04-01T00:00:00,"Carcinoma, Renal Cell",C13.351.937.820.535.160
20180642,2010-04-01T00:00:00,"Carcinoma, Renal Cell",C13.351.968.419.473.160
20180642,2010-04-01T00:00:00,Chromosome Aberrations,C23.550.210
20180642,2010-04-01T00:00:00,Chromosome Aberrations,G05.365.590.175
20180642,2010-04-01T00:00:00,Computational Biology,H01.158.273.180
20180642,2010-04-01T00:00:00,"Evolution, Molecular",G05.355.265.250
20180642,2010-04-01T00:00:00,"Evolution, Molecular",G16.100.275.250
20180642,2010-04-01T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
20180642,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20180642,2010-04-01T00:00:00,Kallikreins,D08.811.277.656.300.760.442
20180642,2010-04-01T00:00:00,Kallikreins,D08.811.277.656.959.350.442
20180642,2010-04-01T00:00:00,Kallikreins,D12.776.124.125.597
20180642,2010-04-01T00:00:00,Kallikreins,D23.119.597
20180642,2010-04-01T00:00:00,Kidney Neoplasms,C04.588.945.947.535
20180642,2010-04-01T00:00:00,Kidney Neoplasms,C12.758.820.750
20180642,2010-04-01T00:00:00,Kidney Neoplasms,C12.777.419.473
20180642,2010-04-01T00:00:00,Kidney Neoplasms,C13.351.937.820.535
20180642,2010-04-01T00:00:00,Kidney Neoplasms,C13.351.968.419.473
20180642,2010-04-01T00:00:00,MicroRNAs,D13.150.650.319
20180642,2010-04-01T00:00:00,MicroRNAs,D13.444.735.150.319
20180642,2010-04-01T00:00:00,MicroRNAs,D13.444.735.790.099
20180642,2010-04-01T00:00:00,Phylogeny,G05.697
20180642,2010-04-01T00:00:00,Phylogeny,G16.100.275.605
20180642,2010-04-01T00:00:00,Phylogeny,L01.100.697
20180642,2010-04-01T00:00:00,"Tumor Markers, Biological",D23.101.840
20180644,2010-04-01T00:00:00,Animals,B01.050
20180644,2010-04-01T00:00:00,Cardiovascular Diseases,C14
20180644,2010-04-01T00:00:00,Cerebrovascular Disorders,C10.228.140.300
20180644,2010-04-01T00:00:00,Cerebrovascular Disorders,C14.907.253
20180644,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20180644,2010-04-01T00:00:00,Kidney Diseases,C12.777.419
20180644,2010-04-01T00:00:00,Kidney Diseases,C13.351.968.419
20180644,2010-04-01T00:00:00,Skin,A17.815
20180644,2010-04-01T00:00:00,Tissue Kallikreins,D08.811.277.656.300.760.442.875
20180644,2010-04-01T00:00:00,Tissue Kallikreins,D08.811.277.656.959.350.442.875
20180644,2010-04-01T00:00:00,Tissue Kallikreins,D23.101.840.870
20180644,2010-04-01T00:00:00,Wound Healing,G16.100.856.891
20184396,2010-04-01T00:00:00,ADAM Proteins,D08.811.277.656.675.374.102
20184396,2010-04-01T00:00:00,ADAM Proteins,D09.400.430.500
20184396,2010-04-01T00:00:00,ADAM Proteins,D12.776.395.033
20184396,2010-04-01T00:00:00,Animals,B01.050
20184396,2010-04-01T00:00:00,Enzyme Inhibitors,D27.505.519.389
20184396,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20184396,2010-04-01T00:00:00,Inflammation,C23.550.470
20184396,2010-04-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
20184396,2010-04-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
20184396,2010-04-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
20184396,2010-04-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
20184396,2010-04-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
20184396,2010-04-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
20184396,2010-04-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
20184396,2010-04-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
20184396,2010-04-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
20184396,2010-04-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
20184396,2010-04-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
20210563,2010-04-01T00:00:00,Adult,M01.060.116
20210563,2010-04-01T00:00:00,Aged,M01.060.116.100
20210563,2010-04-01T00:00:00,Depression,F01.145.126.350
20210563,2010-04-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
20210563,2010-04-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
20210563,2010-04-01T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
20210563,2010-04-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
20210563,2010-04-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
20210563,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20210563,2010-04-01T00:00:00,Middle Aged,M01.060.116.630
20210563,2010-04-01T00:00:00,Quality of Life,I01.800
20210563,2010-04-01T00:00:00,Quality of Life,K01.752.400.750
20220589,2010-04-01T00:00:00,Activities of Daily Living,E02.831.067
20220589,2010-04-01T00:00:00,Activities of Daily Living,I03.050
20220589,2010-04-01T00:00:00,Activities of Daily Living,N02.421.784.110
20220589,2010-04-01T00:00:00,Aged,M01.060.116.100
20220589,2010-04-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
20220589,2010-04-01T00:00:00,Alzheimer Disease,C10.574.945.249
20220589,2010-04-01T00:00:00,Alzheimer Disease,F03.087.400.100
20220589,2010-04-01T00:00:00,Antidepressive Agents,D27.505.954.427.700.122
20220589,2010-04-01T00:00:00,Cognition Disorders,F03.087.250
20220589,2010-04-01T00:00:00,Depression,F01.145.126.350
20220589,2010-04-01T00:00:00,Geriatric Assessment,E05.318.308.225
20220589,2010-04-01T00:00:00,Geriatric Assessment,I01.240.425.350
20220589,2010-04-01T00:00:00,Geriatric Assessment,L01.280.360
20220589,2010-04-01T00:00:00,Geriatric Assessment,N01.224.425.350
20220589,2010-04-01T00:00:00,Geriatric Assessment,N05.715.360.300.360
20220589,2010-04-01T00:00:00,Geriatric Assessment,N06.850.505.400.425.350
20220589,2010-04-01T00:00:00,Geriatric Assessment,N06.850.520.308.225
20220589,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20220589,2010-04-01T00:00:00,Mental Disorders,F03
20220589,2010-04-01T00:00:00,Patient Compliance,F01.145.488.500
20220589,2010-04-01T00:00:00,Patient Compliance,N05.300.150.600.600
20220589,2010-04-01T00:00:00,Quality of Life,I01.800
20220589,2010-04-01T00:00:00,Quality of Life,K01.752.400.750
20220589,2010-04-01T00:00:00,Sertraline,D02.092.705.800
20220589,2010-04-01T00:00:00,Sertraline,D02.455.426.559.847.638.845.800
20220589,2010-04-01T00:00:00,Sertraline,D04.615.638.845.800
20224435,2010-04-01T00:00:00,Algorithms,G17.035
20224435,2010-04-01T00:00:00,Algorithms,L01.224.050
20224435,2010-04-01T00:00:00,Biological Markers,D23.101
20224435,2010-04-01T00:00:00,"Diagnosis, Differential",E01.171
20224435,2010-04-01T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.196.401.250
20224435,2010-04-01T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.196.401.402.250
20224435,2010-04-01T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.301.300.230
20224435,2010-04-01T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.301.300.319.450
20224435,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20224435,2010-04-01T00:00:00,Middle Aged,M01.060.116.630
20224435,2010-04-01T00:00:00,Neural Networks (Computer),G17.485
20224435,2010-04-01T00:00:00,Neural Networks (Computer),L01.224.065.605
20224435,2010-04-01T00:00:00,Neural Networks (Computer),L01.725.500
20224435,2010-04-01T00:00:00,Proteomics,H01.158.201.843
20224435,2010-04-01T00:00:00,Proteomics,H01.158.273.180.350.700
20224435,2010-04-01T00:00:00,Proteomics,H01.158.273.343.350.700
20224435,2010-04-01T00:00:00,Proteomics,H01.181.122.738
20224435,2010-04-01T00:00:00,Serum Albumin,D12.776.034.841
20224435,2010-04-01T00:00:00,Serum Albumin,D12.776.124.050.700
20224435,2010-04-01T00:00:00,Serum Albumin,D12.776.124.727
20224504,2010-04-01T00:00:00,Academic Medical Centers,N02.278.020
20224504,2010-04-01T00:00:00,Adolescent,M01.060.057
20224504,2010-04-01T00:00:00,Adolescent Health Services,N02.421.044
20224504,2010-04-01T00:00:00,Chronic Disease,C23.550.291.500
20224504,2010-04-01T00:00:00,Continuity of Patient Care,N04.590.233.727.210
20224504,2010-04-01T00:00:00,Health Services Accessibility,N04.590.374.350
20224504,2010-04-01T00:00:00,Health Services Accessibility,N05.300.430
20224504,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20224504,2010-04-01T00:00:00,South Carolina,Z01.107.567.875.075.662
20224504,2010-04-01T00:00:00,South Carolina,Z01.107.567.875.750.700
20224504,2010-04-01T00:00:00,Young Adult,M01.060.116.815
20228715,2010-04-01T00:00:00,Adolescent,M01.060.057
20228715,2010-04-01T00:00:00,Adult,M01.060.116
20228715,2010-04-01T00:00:00,Age Factors,N05.715.350.075
20228715,2010-04-01T00:00:00,Age Factors,N06.850.490.250
20228715,2010-04-01T00:00:00,Aged,M01.060.116.100
20228715,2010-04-01T00:00:00,Brain Injuries,C10.228.140.199
20228715,2010-04-01T00:00:00,Brain Injuries,C10.900.300.087
20228715,2010-04-01T00:00:00,Brain Injuries,C21.866.260.118
20228715,2010-04-01T00:00:00,Brain Injuries,C21.866.915.300.200
20228715,2010-04-01T00:00:00,Child,M01.060.406
20228715,2010-04-01T00:00:00,"Child, Preschool",M01.060.406.448
20228715,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20228715,2010-04-01T00:00:00,Infant,M01.060.703
20228715,2010-04-01T00:00:00,Middle Aged,M01.060.116.630
20228715,2010-04-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
20228715,2010-04-01T00:00:00,Risk Assessment,N04.452.871.715
20228715,2010-04-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20228715,2010-04-01T00:00:00,Risk Assessment,N06.850.505.715
20228715,2010-04-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20228715,2010-04-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20228715,2010-04-01T00:00:00,Risk Factors,N05.715.350.200.700
20228715,2010-04-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20228715,2010-04-01T00:00:00,Risk Factors,N06.850.490.625.750
20228715,2010-04-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20228715,2010-04-01T00:00:00,Sex Factors,N05.715.350.675
20228715,2010-04-01T00:00:00,Sex Factors,N06.850.490.875
20228715,2010-04-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
20228715,2010-04-01T00:00:00,Spinal Cord Injuries,C10.900.850
20228715,2010-04-01T00:00:00,Spinal Cord Injuries,C21.866.819
20228715,2010-04-01T00:00:00,Trauma Centers,N02.278.354.422.336.500
20228715,2010-04-01T00:00:00,Trauma Centers,N02.421.297.195.480
20228715,2010-04-01T00:00:00,Trauma Centers,N04.452.442.422.336.400
20232413,2010-04-01T00:00:00,Chronic Disease,C23.550.291.500
20232413,2010-04-01T00:00:00,Endoscopy,E01.370.388.250
20232413,2010-04-01T00:00:00,Endoscopy,E04.800.250
20232413,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20232413,2010-04-01T00:00:00,Middle Aged,M01.060.116.630
20232413,2010-04-01T00:00:00,Otorhinolaryngologic Surgical Procedures,E04.580
20232413,2010-04-01T00:00:00,Rhinitis,C08.460.799
20232413,2010-04-01T00:00:00,Rhinitis,C08.730.674
20232413,2010-04-01T00:00:00,Rhinitis,C09.603.799
20232413,2010-04-01T00:00:00,Sinusitis,C08.460.692.752
20232413,2010-04-01T00:00:00,Sinusitis,C08.730.749
20232413,2010-04-01T00:00:00,Sinusitis,C09.603.692.752
20232413,2010-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20232413,2010-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20232413,2010-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20232413,2010-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20232413,2010-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20232413,2010-04-01T00:00:00,Treatment Outcome,E01.789.800
20232413,2010-04-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20232413,2010-04-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20232413,2010-04-01T00:00:00,Turbinates,A02.835.232.781.324.948
20232413,2010-04-01T00:00:00,Turbinates,A04.531.898
20237121,2010-04-01T00:00:00,African Americans,M01.686.508.100.100
20237121,2010-04-01T00:00:00,African Americans,M01.686.754.100
20237121,2010-04-01T00:00:00,"Arthritis, Rheumatoid",C05.550.114.154
20237121,2010-04-01T00:00:00,"Arthritis, Rheumatoid",C05.799.114
20237121,2010-04-01T00:00:00,"Arthritis, Rheumatoid",C17.300.775.099
20237121,2010-04-01T00:00:00,"Arthritis, Rheumatoid",C20.111.199
20237121,2010-04-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
20237121,2010-04-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
20237121,2010-04-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
20237121,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20237121,2010-04-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
20301126,2010-04-01T00:00:00,Electromagnetic Fields,G01.201.260
20301126,2010-04-01T00:00:00,Electromagnetic Fields,G01.201.875.240
20301126,2010-04-01T00:00:00,Electrophoresis,E05.196.401
20301126,2010-04-01T00:00:00,Electrophoresis,E05.301.300
20301126,2010-04-01T00:00:00,Electrophoresis,G02.149.767.570
20301126,2010-04-01T00:00:00,Electrophoresis,G02.842.750.570
20301126,2010-04-01T00:00:00,"Models, Theoretical",E05.599
20301126,2010-04-01T00:00:00,Physicochemical Phenomena,G02.842
20304142,2010-04-01T00:00:00,Adenocarcinoma,C04.557.470.200.025
20304142,2010-04-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
20304142,2010-04-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
20304142,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20304142,2010-04-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
20304142,2010-04-01T00:00:00,Lung Neoplasms,C08.381.540
20304142,2010-04-01T00:00:00,Lung Neoplasms,C08.785.520
20304142,2010-04-01T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
20304142,2010-04-01T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
20304282,2010-04-01T00:00:00,Adenoidectomy,E04.580.068
20304282,2010-04-01T00:00:00,Child,M01.060.406
20304282,2010-04-01T00:00:00,Cleft Palate,C05.500.460.185
20304282,2010-04-01T00:00:00,Cleft Palate,C05.660.207.540.460.185
20304282,2010-04-01T00:00:00,Cleft Palate,C07.320.440.185
20304282,2010-04-01T00:00:00,Cleft Palate,C07.465.525.185
20304282,2010-04-01T00:00:00,Cleft Palate,C07.650.500.460.185
20304282,2010-04-01T00:00:00,Cleft Palate,C07.650.525.185
20304282,2010-04-01T00:00:00,Cleft Palate,C16.131.621.207.540.460.185
20304282,2010-04-01T00:00:00,Cleft Palate,C16.131.850.500.460.185
20304282,2010-04-01T00:00:00,Cleft Palate,C16.131.850.525.185
20304282,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20304282,2010-04-01T00:00:00,Length of Stay,E02.760.400.480
20304282,2010-04-01T00:00:00,Length of Stay,N02.421.585.400.480
20304282,2010-04-01T00:00:00,Postoperative Care,E02.760.722.700
20304282,2010-04-01T00:00:00,Postoperative Care,E04.624
20304282,2010-04-01T00:00:00,Postoperative Care,N02.421.585.722.700
20304282,2010-04-01T00:00:00,Postoperative Complications,C23.550.767
20304282,2010-04-01T00:00:00,Reconstructive Surgical Procedures,E04.680
20308485,2010-04-01T00:00:00,Fetus,A16.378
20308485,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20308485,2010-04-01T00:00:00,Monte Carlo Method,E05.318.740.525
20308485,2010-04-01T00:00:00,Monte Carlo Method,L01.906.575.422
20308485,2010-04-01T00:00:00,Monte Carlo Method,N05.715.360.750.540
20308485,2010-04-01T00:00:00,Monte Carlo Method,N06.850.520.830.525
20308485,2010-04-01T00:00:00,"Phantoms, Imaging",E07.671
20308485,2010-04-01T00:00:00,Pregnancy,G08.686.785.760.769
20308485,2010-04-01T00:00:00,Radiation Dosage,E05.799.513
20308485,2010-04-01T00:00:00,Radiation Dosage,G01.201.875.740
20308485,2010-04-01T00:00:00,Radiation Dosage,N06.850.810.250
20308485,2010-04-01T00:00:00,Radiometry,E05.799
20308485,2010-04-01T00:00:00,"Tomography Scanners, X-Ray Computed",E07.913
20308485,2010-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20308485,2010-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20308485,2010-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20308485,2010-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20308485,2010-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20308485,2010-04-01T00:00:00,Uterus,A05.360.319.679
20308485,2010-04-01T00:00:00,Whole Body Imaging,E01.370.350.925
20308485,2010-04-01T00:00:00,Whole Body Imaging,E05.979
20336674,2010-04-01T00:00:00,Adult,M01.060.116
20336674,2010-04-01T00:00:00,Crime Victims,M01.135
20336674,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20336674,2010-04-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
20336674,2010-04-01T00:00:00,Social Support,I01.880.656.600
20336674,2010-04-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
20336674,2010-04-01T00:00:00,United States,Z01.107.567.875
20336706,2010-04-01T00:00:00,Adult,M01.060.116
20336706,2010-04-01T00:00:00,Crime Victims,M01.135
20336706,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20336706,2010-04-01T00:00:00,"Interview, Psychological",F04.669.599
20336706,2010-04-01T00:00:00,Mass Screening,E01.370.500
20336706,2010-04-01T00:00:00,Mass Screening,E05.318.308.250.580
20336706,2010-04-01T00:00:00,Mass Screening,N02.421.143.827.233.443
20336706,2010-04-01T00:00:00,Mass Screening,N02.421.726.233.443
20336706,2010-04-01T00:00:00,Mass Screening,N05.715.360.300.375.500
20336706,2010-04-01T00:00:00,Mass Screening,N06.850.520.308.250.580
20336706,2010-04-01T00:00:00,Mass Screening,N06.850.780.500
20336706,2010-04-01T00:00:00,Mental Disorders,F03
20336706,2010-04-01T00:00:00,Questionnaires,E05.318.308.750
20336706,2010-04-01T00:00:00,Questionnaires,L01.280.800
20336706,2010-04-01T00:00:00,Questionnaires,N05.715.360.300.695
20336706,2010-04-01T00:00:00,Questionnaires,N06.850.520.308.750
20336706,2010-04-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
20336706,2010-04-01T00:00:00,Violence,I01.198.240.856
20336706,2010-04-01T00:00:00,Violence,I01.880.735.900
20338291,2010-04-01T00:00:00,Adult,M01.060.116
20338291,2010-04-01T00:00:00,Chronic Disease,C23.550.291.500
20338291,2010-04-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
20338291,2010-04-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
20338291,2010-04-01T00:00:00,Health Behavior,F01.145.488
20338291,2010-04-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
20338291,2010-04-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
20338291,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20338291,2010-04-01T00:00:00,Hypertension,C14.907.489
20338291,2010-04-01T00:00:00,Middle Aged,M01.060.116.630
20338291,2010-04-01T00:00:00,Nutrition Surveys,E05.318.308.250.600
20338291,2010-04-01T00:00:00,Nutrition Surveys,E05.318.308.585.550
20338291,2010-04-01T00:00:00,Nutrition Surveys,N05.715.360.300.375.560
20338291,2010-04-01T00:00:00,Nutrition Surveys,N05.715.360.300.560.565
20338291,2010-04-01T00:00:00,Nutrition Surveys,N06.850.520.308.250.600
20338291,2010-04-01T00:00:00,Nutrition Surveys,N06.850.520.308.585.550
20338291,2010-04-01T00:00:00,Patient Education as Topic,I02.233.332.500
20338291,2010-04-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
20338291,2010-04-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
20338291,2010-04-01T00:00:00,United States,Z01.107.567.875
20338291,2010-04-01T00:00:00,Young Adult,M01.060.116.815
20347749,2010-04-01T00:00:00,Hospitals,N02.278.421
20347749,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20347749,2010-04-01T00:00:00,"Models, Theoretical",E05.599
20347749,2010-04-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
20347749,2010-04-01T00:00:00,"Quality Assurance, Health Care",N05.700
20347749,2010-04-01T00:00:00,Reoperation,E04.690
20347749,2010-04-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
20347749,2010-04-01T00:00:00,Risk Assessment,N04.452.871.715
20347749,2010-04-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20347749,2010-04-01T00:00:00,Risk Assessment,N06.850.505.715
20347749,2010-04-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20347749,2010-04-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20347749,2010-04-01T00:00:00,Risk Factors,N05.715.350.200.700
20347749,2010-04-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20347749,2010-04-01T00:00:00,Risk Factors,N06.850.490.625.750
20347749,2010-04-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20347749,2010-04-01T00:00:00,United States,Z01.107.567.875
20347749,2010-04-01T00:00:00,Wounds and Injuries,C21.866
20348931,2010-04-01T00:00:00,Adult,M01.060.116
20348931,2010-04-01T00:00:00,Anti-Infective Agents,D27.505.954.122
20348931,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20350644,2010-04-01T00:00:00,Adult,M01.060.116
20350644,2010-04-01T00:00:00,Case-Control Studies,E05.318.760.500.500
20350644,2010-04-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
20350644,2010-04-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
20350644,2010-04-01T00:00:00,Fever,C23.888.119.344
20350644,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20350644,2010-04-01T00:00:00,"Infant, Newborn",M01.060.703.520
20350644,2010-04-01T00:00:00,Oxidative Stress,G03.495.710
20350644,2010-04-01T00:00:00,Oxidative Stress,G07.700.830.750
20350644,2010-04-01T00:00:00,Pregnancy,G08.686.785.760.769
20350644,2010-04-01T00:00:00,Pregnancy Complications,C13.703
20350644,2010-04-01T00:00:00,Sepsis,C01.539.757
20350644,2010-04-01T00:00:00,Sepsis,C23.550.470.790.500
20350644,2010-04-01T00:00:00,Young Adult,M01.060.116.815
20350970,2010-04-01T00:00:00,Animals,B01.050
20350970,2010-04-01T00:00:00,Carrier Proteins,D12.776.157
20350970,2010-04-01T00:00:00,Genetic Vectors,G05.360.337
20350970,2010-04-01T00:00:00,Glucose,D09.546.359.448
20350970,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20350970,2010-04-01T00:00:00,Inflammation,C23.550.470
20350970,2010-04-01T00:00:00,Insulin,D06.472.699.587.740.625
20350970,2010-04-01T00:00:00,Insulin,D12.644.548.586.740.625
20350970,2010-04-01T00:00:00,"Muscle, Skeletal",A02.633.567
20350970,2010-04-01T00:00:00,"Muscle, Skeletal",A10.690.552.500
20350970,2010-04-01T00:00:00,Plasmids,G05.360.600
20350970,2010-04-01T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
20350970,2010-04-01T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
20350970,2010-04-01T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
20353340,2010-04-01T00:00:00,Animals,B01.050
20353340,2010-04-01T00:00:00,Carcinoma,C04.557.470.200
20353340,2010-04-01T00:00:00,Liver Neoplasms,C04.588.274.623
20353340,2010-04-01T00:00:00,Liver Neoplasms,C06.301.623
20353340,2010-04-01T00:00:00,Liver Neoplasms,C06.552.697
20353340,2010-04-01T00:00:00,"Mammary Neoplasms, Animal",C04.588.531
20353340,2010-04-01T00:00:00,"Mammary Neoplasms, Animal",C22.520
20353340,2010-04-01T00:00:00,"Mice, Inbred CBA",B01.050.050.157.520.440
20353340,2010-04-01T00:00:00,"Mice, Inbred CBA",B01.050.050.199.520.520.440
20353340,2010-04-01T00:00:00,"Mice, Inbred CBA",B01.050.150.900.649.865.635.505.500.400.440
20353340,2010-04-01T00:00:00,"Neoplasms, Radiation-Induced",C04.682
20353340,2010-04-01T00:00:00,"Neoplasms, Radiation-Induced",C21.866.733.476
20353340,2010-04-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
20353340,2010-04-01T00:00:00,Risk Assessment,N04.452.871.715
20353340,2010-04-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20353340,2010-04-01T00:00:00,Risk Assessment,N06.850.505.715
20353340,2010-04-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20353340,2010-04-01T00:00:00,Sarcoma,C04.557.450.795
20353340,2010-04-01T00:00:00,Uterine Neoplasms,C04.588.945.418.948
20353340,2010-04-01T00:00:00,Uterine Neoplasms,C13.351.500.852.762
20353340,2010-04-01T00:00:00,Uterine Neoplasms,C13.351.937.418.875
20354396,2010-04-01T00:00:00,Academic Medical Centers,N02.278.020
20354396,2010-04-01T00:00:00,"Education, Medical",I02.358.399
20354396,2010-04-01T00:00:00,Health Surveys,E05.318.308.250
20354396,2010-04-01T00:00:00,Health Surveys,N05.715.360.300.375
20354396,2010-04-01T00:00:00,Health Surveys,N06.850.520.308.250
20354396,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20354396,2010-04-01T00:00:00,Incidence,E05.318.308.985.525.375
20354396,2010-04-01T00:00:00,Incidence,L01.280.975.525.375
20354396,2010-04-01T00:00:00,Incidence,N01.224.935.597.500
20354396,2010-04-01T00:00:00,Incidence,N06.850.505.400.975.525.375
20354396,2010-04-01T00:00:00,Incidence,N06.850.520.308.985.525.375
20354396,2010-04-01T00:00:00,"Models, Educational",E05.599.545
20354396,2010-04-01T00:00:00,"Models, Educational",I02.903.302
20354396,2010-04-01T00:00:00,Program Evaluation,E05.337.820
20354396,2010-04-01T00:00:00,Program Evaluation,N04.761.685
20354396,2010-04-01T00:00:00,Program Evaluation,N05.715.360.650
20354396,2010-04-01T00:00:00,South Carolina,Z01.107.567.875.075.662
20354396,2010-04-01T00:00:00,South Carolina,Z01.107.567.875.750.700
20355261,2010-04-01T00:00:00,Alcohol Deterrents,D27.505.954.427.020
20355261,2010-04-01T00:00:00,Alcoholism,C21.739.100.250
20355261,2010-04-01T00:00:00,Alcoholism,F03.900.100.350
20355261,2010-04-01T00:00:00,Behavior Therapy,F04.754.137
20355261,2010-04-01T00:00:00,Combined Modality Therapy,E02.186
20355261,2010-04-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
20355261,2010-04-01T00:00:00,Health Expenditures,N03.219.151.450
20355261,2010-04-01T00:00:00,Health Expenditures,N05.300.385
20355261,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20355261,2010-04-01T00:00:00,Naltrexone,D03.132.577.249.706.550
20355261,2010-04-01T00:00:00,Naltrexone,D03.549.686.750.550
20355261,2010-04-01T00:00:00,Naltrexone,D03.605.497.750.550
20355261,2010-04-01T00:00:00,Naltrexone,D04.615.723.795.706.550
20355261,2010-04-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
20355261,2010-04-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
20355261,2010-04-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
20355261,2010-04-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
20355261,2010-04-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
20355261,2010-04-01T00:00:00,Taurine,D02.455.326.146.100.850
20355261,2010-04-01T00:00:00,Taurine,D02.886.645.600.055.850
20355261,2010-04-01T00:00:00,United States,Z01.107.567.875
20357828,2010-04-01T00:00:00,Animals,B01.050
20357828,2010-04-01T00:00:00,Cystic Fibrosis,C06.689.202
20357828,2010-04-01T00:00:00,Cystic Fibrosis,C08.381.187
20357828,2010-04-01T00:00:00,Cystic Fibrosis,C16.320.190
20357828,2010-04-01T00:00:00,Cystic Fibrosis,C16.614.213
20357828,2010-04-01T00:00:00,Genetic Vectors,G05.360.337
20357828,2010-04-01T00:00:00,Interleukin-10,D12.644.276.374.465.510
20357828,2010-04-01T00:00:00,Interleukin-10,D12.776.467.374.465.510
20357828,2010-04-01T00:00:00,Interleukin-10,D23.529.374.465.510
20357828,2010-04-01T00:00:00,"Intubation, Intratracheal",E05.497.578
20357828,2010-04-01T00:00:00,Neutrophils,A11.118.637.415.583
20357828,2010-04-01T00:00:00,Neutrophils,A11.627.340.583
20357828,2010-04-01T00:00:00,Neutrophils,A11.733.689
20357828,2010-04-01T00:00:00,Neutrophils,A15.145.229.637.415.583
20357828,2010-04-01T00:00:00,Neutrophils,A15.382.490.315.583
20357828,2010-04-01T00:00:00,Neutrophils,A15.382.680.689
20357828,2010-04-01T00:00:00,Pseudomonas Infections,C01.252.400.739
20357828,2010-04-01T00:00:00,Pseudomonas aeruginosa,B03.440.400.425.625.625.100
20357828,2010-04-01T00:00:00,Pseudomonas aeruginosa,B03.660.250.580.590.050
20357976,2010-04-01T00:00:00,Animals,B01.050
20357976,2010-04-01T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.196.401.250
20357976,2010-04-01T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.196.401.402.250
20357976,2010-04-01T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.301.300.230
20357976,2010-04-01T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.301.300.319.450
20357976,2010-04-01T00:00:00,Heart Ventricles,A07.541.560
20357976,2010-04-01T00:00:00,Proteins,D12.776
20357976,2010-04-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20359363,2010-04-01T00:00:00,"Databases, Genetic",L01.470.750.750.325
20359363,2010-04-01T00:00:00,"Databases, Genetic",L01.700.508.300.188.400.325
20359363,2010-04-01T00:00:00,Gene Expression Profiling,E05.393.332
20359363,2010-04-01T00:00:00,Internet,L01.224.230.110.500
20359363,2010-04-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
20359363,2010-04-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
20359363,2010-04-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
20359363,2010-04-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
20359363,2010-04-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
20359363,2010-04-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
20359363,2010-04-01T00:00:00,Software,L01.224.900
20359363,2010-04-01T00:00:00,User-Computer Interface,L01.224.900.910
20360017,2010-04-01T00:00:00,Adolescent,M01.060.057
20360017,2010-04-01T00:00:00,Child,M01.060.406
20360017,2010-04-01T00:00:00,Depression,F01.145.126.350
20360017,2010-04-01T00:00:00,Fibromyalgia,C05.651.324
20360017,2010-04-01T00:00:00,Fibromyalgia,C05.799.321
20360017,2010-04-01T00:00:00,Fibromyalgia,C10.668.491.425
20360017,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20360017,2010-04-01T00:00:00,Pain,C10.597.617
20360017,2010-04-01T00:00:00,Pain,C23.888.592.612
20360017,2010-04-01T00:00:00,Pain,C23.888.646
20360017,2010-04-01T00:00:00,Pain,F02.830.816.444
20360017,2010-04-01T00:00:00,Pain,G11.561.600.810.444
20360017,2010-04-01T00:00:00,Pain Measurement,E01.370.376.550.600
20360017,2010-04-01T00:00:00,Schools,I02.233.659
20360017,2010-04-01T00:00:00,Schools,I02.783
20360446,2010-04-01T00:00:00,Critical Illness,C23.550.291.625
20360446,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20360446,2010-04-01T00:00:00,"Pneumonia, Ventilator-Associated",C01.539.248.500
20360446,2010-04-01T00:00:00,"Pneumonia, Ventilator-Associated",C08.381.520.750.750
20360446,2010-04-01T00:00:00,"Pneumonia, Ventilator-Associated",C08.381.677.800
20360446,2010-04-01T00:00:00,"Pneumonia, Ventilator-Associated",C08.730.610.750
20360446,2010-04-01T00:00:00,Posture,G11.427.695
20360446,2010-04-01T00:00:00,Treatment Outcome,E01.789.800
20360446,2010-04-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20360446,2010-04-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20362373,2010-04-01T00:00:00,Ankle Joint,A02.835.583.378.062
20362373,2010-04-01T00:00:00,"Decision Support Systems, Clinical",L01.700.508.300.190
20362373,2010-04-01T00:00:00,Gait,E01.370.600.250
20362373,2010-04-01T00:00:00,Gait,G11.427.590.530.389
20362373,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20362373,2010-04-01T00:00:00,Orthotic Devices,E07.858.442.743
20362373,2010-04-01T00:00:00,Software,L01.224.900
20362373,2010-04-01T00:00:00,"Stress, Mechanical",G01.374.676.830
20362373,2010-04-01T00:00:00,"Stress, Mechanical",G01.595.540.830
20362373,2010-04-01T00:00:00,Walking,G11.427.590.530.568.900
20362373,2010-04-01T00:00:00,Walking,G11.427.590.530.698.940
20362373,2010-04-01T00:00:00,Walking,I03.450.642.845.940
20362787,2010-04-01T00:00:00,Adenocarcinoma,C04.557.470.200.025
20362787,2010-04-01T00:00:00,Autoimmune Diseases,C20.111
20362787,2010-04-01T00:00:00,Endosonography,E01.370.350.850.280
20362787,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20362787,2010-04-01T00:00:00,Laparoscopy,E01.370.388.250.520
20362787,2010-04-01T00:00:00,Laparoscopy,E04.800.250.520
20362787,2010-04-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20362787,2010-04-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20362787,2010-04-01T00:00:00,Pancreatectomy,E04.210.752
20362787,2010-04-01T00:00:00,Pancreatic Neoplasms,C04.588.274.761
20362787,2010-04-01T00:00:00,Pancreatic Neoplasms,C04.588.322.421
20362787,2010-04-01T00:00:00,Pancreatic Neoplasms,C06.301.761
20362787,2010-04-01T00:00:00,Pancreatic Neoplasms,C06.689.667
20362787,2010-04-01T00:00:00,Pancreatic Neoplasms,C19.344.421
20362787,2010-04-01T00:00:00,Pancreatitis,C06.689.750
20362787,2010-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20362787,2010-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20362787,2010-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20362787,2010-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20362787,2010-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20362939,2010-04-01T00:00:00,"Education, Medical, Continuing",I02.358.212.350
20362939,2010-04-01T00:00:00,"Education, Medical, Continuing",I02.358.399.250
20362939,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20362939,2010-04-01T00:00:00,Prostatic Diseases,C12.294.565
20362939,2010-04-01T00:00:00,Radiology,H02.403.740
20362939,2010-04-01T00:00:00,United States,Z01.107.567.875
20363415,2010-04-01T00:00:00,Adult,M01.060.116
20363415,2010-04-01T00:00:00,Catheterization,E02.148
20363415,2010-04-01T00:00:00,Catheterization,E05.157
20363415,2010-04-01T00:00:00,Gastric Outlet Obstruction,C06.405.748.340
20363415,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20363415,2010-04-01T00:00:00,Treatment Outcome,E01.789.800
20363415,2010-04-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20363415,2010-04-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20363415,2010-04-01T00:00:00,Young Adult,M01.060.116.815
20367104,2010-04-01T00:00:00,Adult,M01.060.116
20367104,2010-04-01T00:00:00,Collagen,D05.750.078.280
20367104,2010-04-01T00:00:00,Collagen,D12.776.860.300.250
20367104,2010-04-01T00:00:00,Double-Blind Method,E05.318.780.300
20367104,2010-04-01T00:00:00,Double-Blind Method,E05.581.500.300
20367104,2010-04-01T00:00:00,Double-Blind Method,N05.715.360.780.320
20367104,2010-04-01T00:00:00,Double-Blind Method,N06.850.520.445.300
20367104,2010-04-01T00:00:00,Fibroblasts,A11.329.228
20367104,2010-04-01T00:00:00,Fibroblasts,A11.872.228
20367104,2010-04-01T00:00:00,Gingival Recession,C07.465.714.258.447
20367104,2010-04-01T00:00:00,Gingival Recession,C07.465.714.354.625
20367104,2010-04-01T00:00:00,Gingivoplasty,E04.545.355
20367104,2010-04-01T00:00:00,Gingivoplasty,E06.645.355
20367104,2010-04-01T00:00:00,Gingivoplasty,E06.721.384
20367104,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20367104,2010-04-01T00:00:00,Middle Aged,M01.060.116.630
20367104,2010-04-01T00:00:00,"Skin, Artificial",E07.858.082.800
20367104,2010-04-01T00:00:00,Surgical Flaps,A10.850.710
20367104,2010-04-01T00:00:00,Surgical Flaps,E07.862.710
20367104,2010-04-01T00:00:00,Tissue Engineering,E05.200.249.750
20367104,2010-04-01T00:00:00,Tissue Scaffolds,E07.206.627
20367104,2010-04-01T00:00:00,Tissue Scaffolds,E07.695.825
20367104,2010-04-01T00:00:00,Young Adult,M01.060.116.815
20368370,2010-04-01T00:00:00,Drug-Induced Liver Injury,C06.552.195
20368370,2010-04-01T00:00:00,Drug-Induced Liver Injury,C21.613.260
20368370,2010-04-01T00:00:00,Hepatocytes,A11.436.348
20368370,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20368370,2010-04-01T00:00:00,Liver,A03.620
20368370,2010-04-01T00:00:00,Mitochondria,A11.284.430.214.190.875.564
20368370,2010-04-01T00:00:00,Mitochondria,A11.284.835.626
20368370,2010-04-01T00:00:00,"Models, Biological",E05.599.395
20372128,2010-04-01T00:00:00,Adult,M01.060.116
20372128,2010-04-01T00:00:00,Algorithms,G17.035
20372128,2010-04-01T00:00:00,Algorithms,L01.224.050
20372128,2010-04-01T00:00:00,"Diagnosis, Differential",E01.171
20372128,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20372128,2010-04-01T00:00:00,Middle Aged,M01.060.116.630
20372128,2010-04-01T00:00:00,Pain,C10.597.617
20372128,2010-04-01T00:00:00,Pain,C23.888.592.612
20372128,2010-04-01T00:00:00,Pain,C23.888.646
20372128,2010-04-01T00:00:00,Pain,F02.830.816.444
20372128,2010-04-01T00:00:00,Pain,G11.561.600.810.444
20373164,2010-04-01T00:00:00,"Education, Medical",I02.358.399
20373164,2010-04-01T00:00:00,Family Practice,H02.403.280
20373164,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20373164,2010-04-01T00:00:00,"Students, Medical",I02.851.686.602
20373164,2010-04-01T00:00:00,"Students, Medical",M01.848.769.602
20373164,2010-04-01T00:00:00,Terminology as Topic,L01.143.506.598.400
20375384,2010-04-01T00:00:00,"Biopsy, Needle",E01.370.388.100.100
20375384,2010-04-01T00:00:00,"Biopsy, Needle",E01.450.230.100.100
20375384,2010-04-01T00:00:00,"Biopsy, Needle",E01.450.865.100.100
20375384,2010-04-01T00:00:00,"Biopsy, Needle",E01.450.865.632.100
20375384,2010-04-01T00:00:00,"Biopsy, Needle",E04.074.119
20375384,2010-04-01T00:00:00,"Breast Neoplasms, Male",C04.588.180.260
20375384,2010-04-01T00:00:00,"Breast Neoplasms, Male",C17.800.090.500.260
20375384,2010-04-01T00:00:00,"Diagnosis, Differential",E01.171
20375384,2010-04-01T00:00:00,"Hemangioma, Cavernous",C04.557.645.375.385
20375384,2010-04-01T00:00:00,"Hemangioma, Cavernous",C14.907.454.385
20375384,2010-04-01T00:00:00,"Hemangioma, Cavernous",C15.378.463.835.385
20375384,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20375384,2010-04-01T00:00:00,Mammography,E01.370.350.700.500
20375384,2010-04-01T00:00:00,Middle Aged,M01.060.116.630
20375384,2010-04-01T00:00:00,"Ultrasonography, Mammary",E01.370.350.850.860
20375384,2010-04-01T00:00:00,"Ultrasonography, Mammary",E01.370.378.850
20377310,2010-04-01T00:00:00,Animals,B01.050
20377310,2010-04-01T00:00:00,Environmental Exposure,N06.850.460.350
20377310,2010-04-01T00:00:00,Environmental Pollutants,D27.888.284
20377310,2010-04-01T00:00:00,Fishes,B01.050.150.900.493
20377310,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20377310,2010-04-01T00:00:00,"Hydrocarbons, Chlorinated",D02.455.526.439
20377310,2010-04-01T00:00:00,Pesticides,D27.720.031.700
20377310,2010-04-01T00:00:00,Pesticides,D27.720.723
20377310,2010-04-01T00:00:00,Pesticides,D27.888.723
20377310,2010-04-01T00:00:00,Reproduction,G08.686.785.760
20377310,2010-04-01T00:00:00,Reptiles,B01.050.150.900.833
20381781,2010-04-01T00:00:00,Adolescent,M01.060.057
20381781,2010-04-01T00:00:00,Anti-Anxiety Agents,D27.505.696.277.950.015
20381781,2010-04-01T00:00:00,Anti-Anxiety Agents,D27.505.954.427.210.950.015
20381781,2010-04-01T00:00:00,Anti-Anxiety Agents,D27.505.954.427.700.872.015
20381781,2010-04-01T00:00:00,Anxiety Disorders,F03.080
20381781,2010-04-01T00:00:00,Child,M01.060.406
20381781,2010-04-01T00:00:00,Child Development,F01.525.200
20381781,2010-04-01T00:00:00,Child Development,G07.700.320.374.750
20381781,2010-04-01T00:00:00,"Child, Preschool",M01.060.406.448
20381781,2010-04-01T00:00:00,Cognitive Therapy,F04.754.137.428
20381781,2010-04-01T00:00:00,"Diagnosis, Differential",E01.171
20381781,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20381781,2010-04-01T00:00:00,Mass Screening,E01.370.500
20381781,2010-04-01T00:00:00,Mass Screening,E05.318.308.250.580
20381781,2010-04-01T00:00:00,Mass Screening,N02.421.143.827.233.443
20381781,2010-04-01T00:00:00,Mass Screening,N02.421.726.233.443
20381781,2010-04-01T00:00:00,Mass Screening,N05.715.360.300.375.500
20381781,2010-04-01T00:00:00,Mass Screening,N06.850.520.308.250.580
20381781,2010-04-01T00:00:00,Mass Screening,N06.850.780.500
20381781,2010-04-01T00:00:00,"Models, Psychological",E05.599.695
20381781,2010-04-01T00:00:00,Pediatrics,H02.403.670
20381781,2010-04-01T00:00:00,Primary Health Care,N04.590.233.727
20381781,2010-04-01T00:00:00,Referral and Consultation,N04.452.758.849
20381781,2010-04-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20381781,2010-04-01T00:00:00,Risk Factors,N05.715.350.200.700
20381781,2010-04-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20381781,2010-04-01T00:00:00,Risk Factors,N06.850.490.625.750
20381781,2010-04-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20381781,2010-04-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.600.850
20381781,2010-04-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.850.900
20381781,2010-04-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.600.850
20381781,2010-04-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.850.900
20384738,2010-04-01T00:00:00,Aged,M01.060.116.100
20384738,2010-04-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
20384738,2010-04-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
20384738,2010-04-01T00:00:00,Cicatrix,A10.165.450.300
20384738,2010-04-01T00:00:00,Cicatrix,C23.550.355.274
20384738,2010-04-01T00:00:00,Cicatrix,G16.100.856.891.249
20384738,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20384738,2010-04-01T00:00:00,Lip,A01.456.505.631.515
20384738,2010-04-01T00:00:00,Lip,A14.549.336
20384738,2010-04-01T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
20384738,2010-04-01T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
20384738,2010-04-01T00:00:00,Reconstructive Surgical Procedures,E04.680
20384738,2010-04-01T00:00:00,Reoperation,E04.690
20384738,2010-04-01T00:00:00,Surgical Flaps,A10.850.710
20384738,2010-04-01T00:00:00,Surgical Flaps,E07.862.710
20394033,2010-04-01T00:00:00,Adult,M01.060.116
20394033,2010-04-01T00:00:00,"Diagnosis, Differential",E01.171
20394033,2010-04-01T00:00:00,Gastroenteritis,C06.405.205
20394033,2010-04-01T00:00:00,Gastroenterology,H02.403.429.405
20394033,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20394033,2010-04-01T00:00:00,Periodicity,G01.910.645
20394033,2010-04-01T00:00:00,Periodicity,G07.180.562
20394033,2010-04-01T00:00:00,Syndrome,C23.550.288.500
20394033,2010-04-01T00:00:00,Vomiting,C23.888.821.937
20397832,2010-04-01T00:00:00,Animals,B01.050
20397832,2010-04-01T00:00:00,Brain Ischemia,C10.228.140.300.150
20397832,2010-04-01T00:00:00,Brain Ischemia,C14.907.253.092
20397832,2010-04-01T00:00:00,Cell Death,G04.299.139
20397832,2010-04-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
20397832,2010-04-01T00:00:00,Clinical Trials as Topic,E05.337.250
20397832,2010-04-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
20397832,2010-04-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
20397832,2010-04-01T00:00:00,"Disease Models, Animal",C22.232
20397832,2010-04-01T00:00:00,"Disease Models, Animal",E05.598.500
20397832,2010-04-01T00:00:00,"Disease Models, Animal",E05.599.395.080
20397832,2010-04-01T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
20397832,2010-04-01T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
20397832,2010-04-01T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
20397832,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20397832,2010-04-01T00:00:00,"Hypothermia, Induced",E02.258.750
20397832,2010-04-01T00:00:00,Stroke,C10.228.140.300.775
20397832,2010-04-01T00:00:00,Stroke,C14.907.253.855
20397832,2010-04-01T00:00:00,Time Factors,G01.910.857
20397832,2010-04-01T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
20397832,2010-04-01T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
20397832,2010-04-01T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
20397832,2010-04-01T00:00:00,Tissue Plasminogen Activator,D23.119.970
20404245,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20409077,2010-04-01T00:00:00,Animals,B01.050
20409077,2010-04-01T00:00:00,Apoptosis,G04.299.139.160
20409077,2010-04-01T00:00:00,Neurodegenerative Diseases,C10.574
20409077,2010-04-01T00:00:00,Peptide Fragments,D12.644.541
20409077,2010-04-01T00:00:00,Signal Transduction,G02.111.087.800
20409077,2010-04-01T00:00:00,Signal Transduction,G02.149.115.800
20409077,2010-04-01T00:00:00,Signal Transduction,G04.299.880
20409077,2010-04-01T00:00:00,Tumor Suppressor Protein p53,D12.776.260.820
20409077,2010-04-01T00:00:00,Tumor Suppressor Protein p53,D12.776.624.776.775
20409077,2010-04-01T00:00:00,Tumor Suppressor Protein p53,D12.776.660.825
20409077,2010-04-01T00:00:00,Tumor Suppressor Protein p53,D12.776.744.845
20409077,2010-04-01T00:00:00,tau Proteins,D12.776.220.600.450.510
20409077,2010-04-01T00:00:00,tau Proteins,D12.776.641.560.510
20411905,2010-04-01T00:00:00,Aged,M01.060.116.100
20411905,2010-04-01T00:00:00,Depression,F01.145.126.350
20411905,2010-04-01T00:00:00,Drug Monitoring,E01.370.520.200
20411905,2010-04-01T00:00:00,Drug Therapy,E02.319
20411905,2010-04-01T00:00:00,Geriatric Nursing,H02.478.676.236
20411905,2010-04-01T00:00:00,Geriatric Nursing,N02.421.533.245
20411905,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20411905,2010-04-01T00:00:00,Nurse's Role,F01.829.316.616.625.450
20411905,2010-04-01T00:00:00,Nurse's Role,N05.300.100.337
20411905,2010-04-01T00:00:00,Pain,C10.597.617
20411905,2010-04-01T00:00:00,Pain,C23.888.592.612
20411905,2010-04-01T00:00:00,Pain,C23.888.646
20411905,2010-04-01T00:00:00,Pain,F02.830.816.444
20411905,2010-04-01T00:00:00,Pain,G11.561.600.810.444
20411905,2010-04-01T00:00:00,Polypharmacy,E02.319.698
20419728,2010-04-01T00:00:00,"Adaptation, Psychological",F01.058
20419728,2010-04-01T00:00:00,Crime Victims,M01.135
20419728,2010-04-01T00:00:00,Employment,N01.824.245
20419728,2010-04-01T00:00:00,Health Status,I01.240.425
20419728,2010-04-01T00:00:00,Health Status,N01.224.425
20419728,2010-04-01T00:00:00,Health Status,N06.850.505.400.425
20419728,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20419728,2010-04-01T00:00:00,Interpersonal Relations,F01.829.401
20419728,2010-04-01T00:00:00,Parenting,F01.829.263.370.310
20419728,2010-04-01T00:00:00,Quality of Life,I01.800
20419728,2010-04-01T00:00:00,Quality of Life,K01.752.400.750
20419728,2010-04-01T00:00:00,Social Adjustment,F01.145.813.621
20419728,2010-04-01T00:00:00,United States,Z01.107.567.875
20420267,2010-04-01T00:00:00,Aged,M01.060.116.100
20420267,2010-04-01T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
20420267,2010-04-01T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
20420267,2010-04-01T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
20420267,2010-04-01T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
20420267,2010-04-01T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
20420267,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20420267,2010-04-01T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
20420267,2010-04-01T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
20420267,2010-04-01T00:00:00,Palliative Care,E02.760.666
20420267,2010-04-01T00:00:00,Palliative Care,N02.421.585.666
20420267,2010-04-01T00:00:00,Stents,E07.695.750
20420647,2010-04-01T00:00:00,African Americans,M01.686.508.100.100
20420647,2010-04-01T00:00:00,African Americans,M01.686.754.100
20420647,2010-04-01T00:00:00,Hispanic Americans,M01.686.754.441
20420647,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20420647,2010-04-01T00:00:00,Kidney,A05.810.453
20420647,2010-04-01T00:00:00,Liver,A03.620
20420647,2010-04-01T00:00:00,Living Donors,M01.898.656
20420647,2010-04-01T00:00:00,Lung,A04.411
20420647,2010-04-01T00:00:00,Minority Groups,I01.880.371
20420647,2010-04-01T00:00:00,Tissue Donors,M01.898
20420647,2010-04-01T00:00:00,Tissue and Organ Procurement,N02.421.911
20420647,2010-04-01T00:00:00,United States,Z01.107.567.875
20433545,2010-04-01T00:00:00,Adult,M01.060.116
20433545,2010-04-01T00:00:00,Aged,M01.060.116.100
20433545,2010-04-01T00:00:00,Angiotensin-Converting Enzyme Inhibitors,D27.505.519.389.745.085
20433545,2010-04-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
20433545,2010-04-01T00:00:00,Blood Pressure,E01.370.600.875.249
20433545,2010-04-01T00:00:00,Blood Pressure,G09.330.380.076
20433545,2010-04-01T00:00:00,Drug Prescriptions,E02.319.307
20433545,2010-04-01T00:00:00,Drug Prescriptions,N02.421.668.778.500
20433545,2010-04-01T00:00:00,"Hospitals, Teaching",N02.278.020.300
20433545,2010-04-01T00:00:00,"Hospitals, Teaching",N02.278.421.639
20433545,2010-04-01T00:00:00,"Hospitals, University",N02.278.020.300.310
20433545,2010-04-01T00:00:00,"Hospitals, University",N02.278.421.639.725
20433545,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20433545,2010-04-01T00:00:00,Hypertension,C14.907.489
20433545,2010-04-01T00:00:00,Inpatients,M01.643.470
20433545,2010-04-01T00:00:00,Length of Stay,E02.760.400.480
20433545,2010-04-01T00:00:00,Length of Stay,N02.421.585.400.480
20433545,2010-04-01T00:00:00,Middle Aged,M01.060.116.630
20433545,2010-04-01T00:00:00,Physician's Practice Patterns,N04.590.748
20433545,2010-04-01T00:00:00,Physician's Practice Patterns,N05.300.625
20433545,2010-04-01T00:00:00,Treatment Outcome,E01.789.800
20433545,2010-04-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20433545,2010-04-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20433545,2010-04-01T00:00:00,United States,Z01.107.567.875
20436227,2010-04-01T00:00:00,Aging,G07.700.320.124
20436227,2010-04-01T00:00:00,Animals,B01.050
20436227,2010-04-01T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
20436227,2010-04-01T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
20436227,2010-04-01T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
20436227,2010-04-01T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
20436227,2010-04-01T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
20436227,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20436227,2010-04-01T00:00:00,NF-kappa B,D12.776.260.600
20436227,2010-04-01T00:00:00,NF-kappa B,D12.776.660.600
20436227,2010-04-01T00:00:00,NF-kappa B,D12.776.930.600
20436227,2010-04-01T00:00:00,Stilbenes,D02.455.426.559.389.150.700
20439226,2010-04-01T00:00:00,Chlorine,D01.268.380.150
20439226,2010-04-01T00:00:00,Chlorine,D01.362.225
20439226,2010-04-01T00:00:00,Demography,I01.240
20439226,2010-04-01T00:00:00,Demography,N01.224
20439226,2010-04-01T00:00:00,Demography,N06.850.505.400
20439226,2010-04-01T00:00:00,Disaster Planning,N06.230.100.035
20439226,2010-04-01T00:00:00,Disasters,N06.230.100
20439226,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20439226,2010-04-01T00:00:00,Relief Work,I01.880.787.839
20439226,2010-04-01T00:00:00,Relief Work,N06.230.100.300
20439226,2010-04-01T00:00:00,South Carolina,Z01.107.567.875.075.662
20439226,2010-04-01T00:00:00,South Carolina,Z01.107.567.875.750.700
20510710,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20510710,2010-04-01T00:00:00,Parathyroid Glands,A06.407.560
20510710,2010-04-01T00:00:00,Pregnancy,G08.686.785.760.769
20510710,2010-04-01T00:00:00,Recurrent Laryngeal Nerve,A08.800.050.050.925.450.700
20510710,2010-04-01T00:00:00,Recurrent Laryngeal Nerve,A08.800.050.600.825.450.700
20510710,2010-04-01T00:00:00,Recurrent Laryngeal Nerve,A08.800.800.060.920.450.700
20510710,2010-04-01T00:00:00,Recurrent Laryngeal Nerve,A08.800.800.120.900.450.700
20574947,2010-04-01T00:00:00,Aged,M01.060.116.100
20574947,2010-04-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.555.110.110.110
20574947,2010-04-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.650.110.110
20574947,2010-04-01T00:00:00,Hip Prosthesis,E07.695.400.400
20574947,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20574947,2010-04-01T00:00:00,Polyethylene,D02.455.326.271.665.550.500
20574947,2010-04-01T00:00:00,Polyethylene,D05.750.716.507.500
20574947,2010-04-01T00:00:00,Polyethylene,D25.720.716.507.500
20574947,2010-04-01T00:00:00,Polyethylene,J01.637.051.720.716.507.500
20574947,2010-04-01T00:00:00,Recovery of Function,G16.757
20574947,2010-04-01T00:00:00,Reoperation,E04.690
20590889,2010-04-01T00:00:00,Adolescent,M01.060.057
20590889,2010-04-01T00:00:00,Adult,M01.060.116
20590889,2010-04-01T00:00:00,Aged,M01.060.116.100
20590889,2010-04-01T00:00:00,"Anastomosis, Surgical",E04.035
20590889,2010-04-01T00:00:00,"Constriction, Pathologic",C23.300.287
20590889,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20590889,2010-04-01T00:00:00,Length of Stay,E02.760.400.480
20590889,2010-04-01T00:00:00,Length of Stay,N02.421.585.400.480
20590889,2010-04-01T00:00:00,Middle Aged,M01.060.116.630
20590889,2010-04-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
20590889,2010-04-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
20590889,2010-04-01T00:00:00,"Pancreatitis, Chronic",C06.689.750.830
20590889,2010-04-01T00:00:00,Postoperative Complications,C23.550.767
20590889,2010-04-01T00:00:00,Reoperation,E04.690
20590889,2010-04-01T00:00:00,Young Adult,M01.060.116.815
20633435,2010-04-01T00:00:00,Brain,A08.186.211
20633435,2010-04-01T00:00:00,Deep Brain Stimulation,E02.342.250
20633435,2010-04-01T00:00:00,Deep Brain Stimulation,E04.190
20633435,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20633435,2010-04-01T00:00:00,Periodicals as Topic,L01.178.682.829.678
20633435,2010-04-01T00:00:00,Pregnancy,G08.686.785.760.769
20633435,2010-04-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
20633435,2010-04-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
20633435,2010-04-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
20633435,2010-04-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
20633435,2010-04-01T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
20633435,2010-04-01T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
20730038,2010-04-01T00:00:00,Adult,M01.060.116
20730038,2010-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20730038,2010-04-01T00:00:00,"Models, Psychological",E05.599.695
20730038,2010-04-01T00:00:00,Personality,F01.752
20730038,2010-04-01T00:00:00,Personality Inventory,F04.711.647.513
20730038,2010-04-01T00:00:00,Regression Analysis,E05.318.740.750
20730038,2010-04-01T00:00:00,Regression Analysis,N05.715.360.750.695
20730038,2010-04-01T00:00:00,Regression Analysis,N06.850.520.830.750
20363261,2010-04-02T00:00:00,Animals,B01.050
20363261,2010-04-02T00:00:00,Brain,A08.186.211
20363261,2010-04-02T00:00:00,"Disease Models, Animal",C22.232
20363261,2010-04-02T00:00:00,"Disease Models, Animal",E05.598.500
20363261,2010-04-02T00:00:00,"Disease Models, Animal",E05.599.395.080
20363261,2010-04-02T00:00:00,Down Syndrome,C10.597.606.643.220
20363261,2010-04-02T00:00:00,Down Syndrome,C16.131.077.327
20363261,2010-04-02T00:00:00,Down Syndrome,C16.131.260.260
20363261,2010-04-02T00:00:00,Down Syndrome,C16.320.180.260
20363261,2010-04-02T00:00:00,Excitatory Amino Acid Antagonists,D27.505.519.625.190.300
20363261,2010-04-02T00:00:00,Excitatory Amino Acid Antagonists,D27.505.696.577.190.300
20363261,2010-04-02T00:00:00,Maze Learning,F02.463.425.507
20363261,2010-04-02T00:00:00,Motor Activity,F01.145.632
20363261,2010-04-02T00:00:00,Motor Activity,G11.427.590.530.698
20363261,2010-04-02T00:00:00,Trisomy,C23.550.210.050.750
20363261,2010-04-02T00:00:00,Trisomy,G05.365.590.175.050.750
20363261,2010-04-02T00:00:00,Trisomy,G05.700.131.750
20371233,2010-04-02T00:00:00,Animals,B01.050
20371233,2010-04-02T00:00:00,Brain,A08.186.211
20371233,2010-04-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20371233,2010-04-02T00:00:00,Neurons,A08.663
20371233,2010-04-02T00:00:00,Neurons,A11.671
20371233,2010-04-02T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.100.450
20371233,2010-04-02T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.720.200.450.500
20371233,2010-04-02T00:00:00,Substance-Related Disorders,C21.739
20371233,2010-04-02T00:00:00,Substance-Related Disorders,F03.900
20363161,2010-04-03T00:00:00,Adult,M01.060.116
20363161,2010-04-03T00:00:00,Aged,M01.060.116.100
20363161,2010-04-03T00:00:00,Algorithms,G17.035
20363161,2010-04-03T00:00:00,Algorithms,L01.224.050
20363161,2010-04-03T00:00:00,Coronary Angiography,E01.370.350.700.060.200
20363161,2010-04-03T00:00:00,Coronary Angiography,E01.370.370.050.200
20363161,2010-04-03T00:00:00,Coronary Angiography,E01.370.370.380.200
20363161,2010-04-03T00:00:00,Coronary Artery Disease,C14.280.647.250.260
20363161,2010-04-03T00:00:00,Coronary Artery Disease,C14.907.137.126.339
20363161,2010-04-03T00:00:00,Coronary Artery Disease,C14.907.585.250.260
20363161,2010-04-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20363161,2010-04-03T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
20363161,2010-04-03T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
20363161,2010-04-03T00:00:00,Middle Aged,M01.060.116.630
20363161,2010-04-03T00:00:00,"Pattern Recognition, Automated",L01.725
20363161,2010-04-03T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
20363161,2010-04-03T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
20363161,2010-04-03T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
20363161,2010-04-03T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
20363161,2010-04-03T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
20363161,2010-04-03T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
20363161,2010-04-03T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
20363161,2010-04-03T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20363161,2010-04-03T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20363161,2010-04-03T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20363161,2010-04-03T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20363161,2010-04-03T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20374210,2010-04-05T00:00:00,Alcohol Drinking,F01.145.317.269
20374210,2010-04-05T00:00:00,Alcohol-Related Disorders,C21.739.100
20374210,2010-04-05T00:00:00,Alcohol-Related Disorders,F03.900.100
20374210,2010-04-05T00:00:00,Biological Markers,D23.101
20374210,2010-04-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20374210,2010-04-05T00:00:00,Transferrin,D12.776.124.050.800
20374210,2010-04-05T00:00:00,Transferrin,D12.776.124.790.223.839
20374210,2010-04-05T00:00:00,Transferrin,D12.776.157.427.500
20374210,2010-04-05T00:00:00,Transferrin,D12.776.377.715.182.839
20374210,2010-04-05T00:00:00,Transferrin,D12.776.556.579.500
20374210,2010-04-05T00:00:00,United States,Z01.107.567.875
20372958,2010-04-06T00:00:00,Action Potentials,G04.580.100
20372958,2010-04-06T00:00:00,Action Potentials,G07.265.750.100
20372958,2010-04-06T00:00:00,Action Potentials,G11.561.570.100
20372958,2010-04-06T00:00:00,"Adaptation, Physiological",G07.700.062
20372958,2010-04-06T00:00:00,"Adaptation, Physiological",G16.100.057.500
20372958,2010-04-06T00:00:00,Aging,G07.700.320.124
20372958,2010-04-06T00:00:00,Animals,B01.050
20372958,2010-04-06T00:00:00,Cochlear Nerve,A08.800.800.120.910.120
20372958,2010-04-06T00:00:00,"Disease Models, Animal",C22.232
20372958,2010-04-06T00:00:00,"Disease Models, Animal",E05.598.500
20372958,2010-04-06T00:00:00,"Disease Models, Animal",E05.599.395.080
20372958,2010-04-06T00:00:00,Gerbillinae,B01.050.150.900.649.865.635.300
20372958,2010-04-06T00:00:00,"Hair Cells, Auditory",A08.663.650.250
20372958,2010-04-06T00:00:00,"Hair Cells, Auditory",A08.663.650.915.750.600.350
20372958,2010-04-06T00:00:00,"Hair Cells, Auditory",A08.800.950.750.600.350
20372958,2010-04-06T00:00:00,"Hair Cells, Auditory",A09.246.631.246.577.325
20372958,2010-04-06T00:00:00,"Hair Cells, Auditory",A11.671.650.250
20372958,2010-04-06T00:00:00,"Hair Cells, Auditory",A11.671.650.915.750.600.350
20372958,2010-04-06T00:00:00,Presbycusis,C09.218.458.341.887.772
20372958,2010-04-06T00:00:00,Presbycusis,C10.597.751.418.341.887.772
20372958,2010-04-06T00:00:00,Presbycusis,C23.888.592.763.393.341.887.772
20374628,2010-04-07T00:00:00,Adult,M01.060.116
20374628,2010-04-07T00:00:00,African Continental Ancestry Group,M01.686.508.100
20374628,2010-04-07T00:00:00,European Continental Ancestry Group,M01.686.508.400
20374628,2010-04-07T00:00:00,Hispanic Americans,M01.686.754.441
20374628,2010-04-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20374628,2010-04-07T00:00:00,Middle Aged,M01.060.116.630
20374628,2010-04-07T00:00:00,New York,Z01.107.567.875.075.437
20374628,2010-04-07T00:00:00,New York,Z01.107.567.875.350.530
20374628,2010-04-07T00:00:00,New York,Z01.107.567.875.500.530
20374628,2010-04-07T00:00:00,Nicotine,D03.132.760.570
20374628,2010-04-07T00:00:00,Nicotine,D03.383.725.518
20374628,2010-04-07T00:00:00,Program Evaluation,E05.337.820
20374628,2010-04-07T00:00:00,Program Evaluation,N04.761.685
20374628,2010-04-07T00:00:00,Program Evaluation,N05.715.360.650
20374628,2010-04-07T00:00:00,Questionnaires,E05.318.308.750
20374628,2010-04-07T00:00:00,Questionnaires,L01.280.800
20374628,2010-04-07T00:00:00,Questionnaires,N05.715.360.300.695
20374628,2010-04-07T00:00:00,Questionnaires,N06.850.520.308.750
20374628,2010-04-07T00:00:00,Smoking,F01.145.466.753
20374628,2010-04-07T00:00:00,Smoking Cessation,F01.145.940.700
20377842,2010-04-07T00:00:00,Animals,B01.050
20377842,2010-04-07T00:00:00,Contrast Media,D27.720.259
20377842,2010-04-07T00:00:00,"Diagnosis, Differential",E01.171
20377842,2010-04-07T00:00:00,"Disease Models, Animal",C22.232
20377842,2010-04-07T00:00:00,"Disease Models, Animal",E05.598.500
20377842,2010-04-07T00:00:00,"Disease Models, Animal",E05.599.395.080
20377842,2010-04-07T00:00:00,Dogs,B01.050.150.900.649.147.153.200
20377842,2010-04-07T00:00:00,Gadolinium DTPA,D01.632.400
20377842,2010-04-07T00:00:00,Gadolinium DTPA,D02.092.782.590.401
20377842,2010-04-07T00:00:00,Gadolinium DTPA,D02.241.081.038.694.400
20377842,2010-04-07T00:00:00,Gadolinium DTPA,D02.691.400
20377842,2010-04-07T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20377842,2010-04-07T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20377842,2010-04-07T00:00:00,Myocardial Infarction,C14.280.647.500
20377842,2010-04-07T00:00:00,Myocardial Infarction,C14.907.585.500
20377842,2010-04-07T00:00:00,Myocardium,A02.633.580
20377842,2010-04-07T00:00:00,Myocardium,A07.541.704
20377842,2010-04-07T00:00:00,Myocardium,A10.690.552.750
20377842,2010-04-07T00:00:00,Organometallic Compounds,D01.632
20377842,2010-04-07T00:00:00,Organometallic Compounds,D02.691
20377842,2010-04-07T00:00:00,Time Factors,G01.910.857
20378127,2010-04-07T00:00:00,Adult,M01.060.116
20378127,2010-04-07T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
20378127,2010-04-07T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
20378127,2010-04-07T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
20378127,2010-04-07T00:00:00,Bipolar Disorder,F03.600.150.150
20378127,2010-04-07T00:00:00,Depression,F01.145.126.350
20378127,2010-04-07T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
20378127,2010-04-07T00:00:00,Dibenzothiazepines,D02.886.680.702.500
20378127,2010-04-07T00:00:00,Dibenzothiazepines,D03.494.276
20378127,2010-04-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20378127,2010-04-07T00:00:00,Middle Aged,M01.060.116.630
20378127,2010-04-07T00:00:00,Outpatients,M01.643.630
20378127,2010-04-07T00:00:00,Psychiatric Status Rating Scales,F04.586
20378127,2010-04-07T00:00:00,Time Factors,G01.910.857
20378127,2010-04-07T00:00:00,Treatment Outcome,E01.789.800
20378127,2010-04-07T00:00:00,Treatment Outcome,N04.761.559.590.800
20378127,2010-04-07T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20377784,2010-04-08T00:00:00,Deglutition,G10.261.326.215
20377784,2010-04-08T00:00:00,Esophagus,A03.556.875.500
20377784,2010-04-08T00:00:00,"History, 20th Century",K01.400.504.968
20377784,2010-04-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20377784,2010-04-08T00:00:00,Manometry,E05.559
20377784,2010-04-08T00:00:00,Pressure,G01.374.715
20378483,2010-04-08T00:00:00,Algorithms,G17.035
20378483,2010-04-08T00:00:00,Algorithms,L01.224.050
20378483,2010-04-08T00:00:00,"Data Interpretation, Statistical",E05.245.380
20378483,2010-04-08T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
20378483,2010-04-08T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
20378483,2010-04-08T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
20378483,2010-04-08T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
20378483,2010-04-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20378483,2010-04-08T00:00:00,Robotics,H01.671.293.643
20378483,2010-04-08T00:00:00,Robotics,J01.897.104.834
20378483,2010-04-08T00:00:00,Robotics,L01.224.065.630
20378483,2010-04-08T00:00:00,Software,L01.224.900
20378483,2010-04-08T00:00:00,User-Computer Interface,L01.224.900.910
20377915,2010-04-09T00:00:00,African Americans,M01.686.508.100.100
20377915,2010-04-09T00:00:00,African Americans,M01.686.754.100
20377915,2010-04-09T00:00:00,Body Mass Index,E01.370.600.115.100.125
20377915,2010-04-09T00:00:00,Body Mass Index,E05.041.124.125
20377915,2010-04-09T00:00:00,Body Mass Index,G07.100.100.125
20377915,2010-04-09T00:00:00,Body Mass Index,N06.850.505.200.100.175
20377915,2010-04-09T00:00:00,Child,M01.060.406
20377915,2010-04-09T00:00:00,Energy Intake,G07.610.240.340
20377915,2010-04-09T00:00:00,European Continental Ancestry Group,M01.686.508.400
20377915,2010-04-09T00:00:00,Genome-Wide Association Study,E05.318.416.249
20377915,2010-04-09T00:00:00,Genome-Wide Association Study,E05.318.780.392
20377915,2010-04-09T00:00:00,Genome-Wide Association Study,E05.393.385.500
20377915,2010-04-09T00:00:00,Genome-Wide Association Study,E05.393.522.500
20377915,2010-04-09T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
20377915,2010-04-09T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
20377915,2010-04-09T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
20377915,2010-04-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20377915,2010-04-09T00:00:00,Motor Activity,F01.145.632
20377915,2010-04-09T00:00:00,Motor Activity,G11.427.590.530.698
20377915,2010-04-09T00:00:00,"Polymorphism, Genetic",G05.365.795
20377915,2010-04-09T00:00:00,Proteins,D12.776
20381848,2010-04-09T00:00:00,"Angioedemas, Hereditary",C14.907.079.500
20381848,2010-04-09T00:00:00,"Angioedemas, Hereditary",C16.320.078
20381848,2010-04-09T00:00:00,"Angioedemas, Hereditary",C17.800.862.945.066.500
20381848,2010-04-09T00:00:00,"Angioedemas, Hereditary",C20.543.480.904.066.500
20381848,2010-04-09T00:00:00,Animals,B01.050
20381848,2010-04-09T00:00:00,Bradykinin,D12.644.276.812.169
20381848,2010-04-09T00:00:00,Bradykinin,D12.644.400.090
20381848,2010-04-09T00:00:00,Bradykinin,D12.644.456.193
20381848,2010-04-09T00:00:00,Bradykinin,D12.776.467.812.169
20381848,2010-04-09T00:00:00,Bradykinin,D12.776.641.650.090
20381848,2010-04-09T00:00:00,Bradykinin,D23.469.050.375.110
20381848,2010-04-09T00:00:00,Bradykinin,D23.529.812.169
20381848,2010-04-09T00:00:00,Epithelial Cells,A11.436
20381848,2010-04-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20381848,2010-04-09T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20381848,2010-04-09T00:00:00,Vasodilator Agents,D27.505.954.411.918
20382699,2010-04-09T00:00:00,Animals,B01.050
20382699,2010-04-09T00:00:00,Frontal Lobe,A08.186.211.730.885.287.500.270
20382699,2010-04-09T00:00:00,HIV,B04.820.650.589.650.350
20382699,2010-04-09T00:00:00,HIV,B04.909.777.731.589.650.350
20382699,2010-04-09T00:00:00,HIV Infections,C02.782.815.616.400
20382699,2010-04-09T00:00:00,HIV Infections,C02.800.801.400
20382699,2010-04-09T00:00:00,HIV Infections,C20.673.480
20382699,2010-04-09T00:00:00,Hippocampus,A08.186.211.464.405
20382699,2010-04-09T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
20382699,2010-04-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20382699,2010-04-09T00:00:00,Macaca mulatta,B01.050.150.900.649.801.400.112.199.120.510.550
20382699,2010-04-09T00:00:00,Neurons,A08.663
20382699,2010-04-09T00:00:00,Neurons,A11.671
20382699,2010-04-09T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20382699,2010-04-09T00:00:00,Simian Acquired Immunodeficiency Syndrome,C02.782.815.616.850
20382699,2010-04-09T00:00:00,Simian Acquired Immunodeficiency Syndrome,C02.839.850
20382699,2010-04-09T00:00:00,Simian Acquired Immunodeficiency Syndrome,C22.735.500.850
20382699,2010-04-09T00:00:00,Synapses,A08.850
20382699,2010-04-09T00:00:00,Synapses,A11.284.149.165.420.780
20383210,2010-04-12T00:00:00,Algorithms,G17.035
20383210,2010-04-12T00:00:00,Algorithms,L01.224.050
20383210,2010-04-12T00:00:00,Cost Savings,N03.219.151.160.200
20383210,2010-04-12T00:00:00,Decision Support Techniques,E05.245
20383210,2010-04-12T00:00:00,Decision Support Techniques,L01.700.508.190
20383210,2010-04-12T00:00:00,Graft Survival,G12.425.901.545.340
20383210,2010-04-12T00:00:00,Granulocyte Colony-Stimulating Factor,D12.644.276.374.410.240.350
20383210,2010-04-12T00:00:00,Granulocyte Colony-Stimulating Factor,D12.776.395.240.200
20383210,2010-04-12T00:00:00,Granulocyte Colony-Stimulating Factor,D12.776.467.374.410.240.350
20383210,2010-04-12T00:00:00,Granulocyte Colony-Stimulating Factor,D23.529.374.410.240.350
20383210,2010-04-12T00:00:00,Hematopoietic Stem Cell Mobilization,E02.095.410
20383210,2010-04-12T00:00:00,Heterocyclic Compounds,D03
20383210,2010-04-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20383210,2010-04-12T00:00:00,Middle Aged,M01.060.116.630
20383210,2010-04-12T00:00:00,Multiple Myeloma,C04.557.595.500
20383210,2010-04-12T00:00:00,Multiple Myeloma,C14.907.454.460
20383210,2010-04-12T00:00:00,Multiple Myeloma,C15.378.147.780.650
20383210,2010-04-12T00:00:00,Multiple Myeloma,C15.378.463.835.460
20383210,2010-04-12T00:00:00,Multiple Myeloma,C20.683.515.845
20383210,2010-04-12T00:00:00,Multiple Myeloma,C20.683.780.650
20385709,2010-04-12T00:00:00,Animals,B01.050
20385709,2010-04-12T00:00:00,Cell Line,A11.251.210
20385709,2010-04-12T00:00:00,Integrin alpha5beta1,D12.776.395.550.625.379
20385709,2010-04-12T00:00:00,Integrin alpha5beta1,D12.776.543.550.625.379
20385709,2010-04-12T00:00:00,Integrin alpha5beta1,D12.776.543.750.705.408.530.750
20385709,2010-04-12T00:00:00,Integrin alpha5beta1,D12.776.543.750.705.408.850.349
20385709,2010-04-12T00:00:00,Integrin alpha5beta1,D12.776.543.750.705.675.460
20385709,2010-04-12T00:00:00,Integrin alpha5beta1,D12.776.543.750.705.876.374
20385709,2010-04-12T00:00:00,Kidney,A05.810.453
20385709,2010-04-12T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
20385709,2010-04-12T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
20385709,2010-04-12T00:00:00,Phosphorylation,G02.111.087.677
20385709,2010-04-12T00:00:00,Phosphorylation,G02.149.115.677
20385709,2010-04-12T00:00:00,Phosphorylation,G02.149.465.700
20385709,2010-04-12T00:00:00,Phosphorylation,G02.607.750.700
20385709,2010-04-12T00:00:00,Phosphorylation,G03.495.790
20385709,2010-04-12T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.100.080.500
20385709,2010-04-12T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.720.600.220.500
20385709,2010-04-12T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.750.555.220.500
20385709,2010-04-12T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
20385709,2010-04-12T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
20385709,2010-04-12T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
20385709,2010-04-12T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
20498736,2010-04-12T00:00:00,Curriculum,I02.158
20498736,2010-04-12T00:00:00,Data Collection,E05.318.308
20498736,2010-04-12T00:00:00,Data Collection,L01.280
20498736,2010-04-12T00:00:00,Data Collection,N05.715.360.300
20498736,2010-04-12T00:00:00,Data Collection,N06.850.520.308
20498736,2010-04-12T00:00:00,"Education, Pharmacy",I02.358.525
20498736,2010-04-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20498736,2010-04-12T00:00:00,"Internship, Nonmedical",I02.358.750
20498736,2010-04-12T00:00:00,"Schools, Pharmacy",I02.783.660.694
20498736,2010-04-12T00:00:00,"Students, Pharmacy",I02.851.686.768
20498736,2010-04-12T00:00:00,"Students, Pharmacy",M01.848.769.768
20498736,2010-04-12T00:00:00,United States,Z01.107.567.875
20180499,2010-04-13T00:00:00,Aged,M01.060.116.100
20180499,2010-04-13T00:00:00,Chronic Disease,C23.550.291.500
20180499,2010-04-13T00:00:00,Drug Interactions,G07.690.812.240
20180499,2010-04-13T00:00:00,Drug Interactions,G07.700.680.240
20180499,2010-04-13T00:00:00,Drug Monitoring,E01.370.520.200
20180499,2010-04-13T00:00:00,Geriatric Nursing,H02.478.676.236
20180499,2010-04-13T00:00:00,Geriatric Nursing,N02.421.533.245
20180499,2010-04-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20180499,2010-04-13T00:00:00,Nursing Assessment,N04.590.233.508.480
20180499,2010-04-13T00:00:00,Nursing Homes,N02.278.825.610
20180499,2010-04-13T00:00:00,Pain,C10.597.617
20180499,2010-04-13T00:00:00,Pain,C23.888.592.612
20180499,2010-04-13T00:00:00,Pain,C23.888.646
20180499,2010-04-13T00:00:00,Pain,F02.830.816.444
20180499,2010-04-13T00:00:00,Pain,G11.561.600.810.444
20180499,2010-04-13T00:00:00,Pain Measurement,E01.370.376.550.600
20180499,2010-04-13T00:00:00,Patient Care Team,N04.590.715
20180499,2010-04-13T00:00:00,Patient Selection,E05.581.500.653
20180499,2010-04-13T00:00:00,Patient Selection,N04.590.731
20180499,2010-04-13T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
20180499,2010-04-13T00:00:00,Practice Guidelines as Topic,N05.700.350.650
20180499,2010-04-13T00:00:00,United States,Z01.107.567.875
20349853,2010-04-13T00:00:00,Aged,M01.060.116.100
20349853,2010-04-13T00:00:00,Geriatric Assessment,E05.318.308.225
20349853,2010-04-13T00:00:00,Geriatric Assessment,I01.240.425.350
20349853,2010-04-13T00:00:00,Geriatric Assessment,L01.280.360
20349853,2010-04-13T00:00:00,Geriatric Assessment,N01.224.425.350
20349853,2010-04-13T00:00:00,Geriatric Assessment,N05.715.360.300.360
20349853,2010-04-13T00:00:00,Geriatric Assessment,N06.850.505.400.425.350
20349853,2010-04-13T00:00:00,Geriatric Assessment,N06.850.520.308.225
20349853,2010-04-13T00:00:00,Geriatric Nursing,H02.478.676.236
20349853,2010-04-13T00:00:00,Geriatric Nursing,N02.421.533.245
20349853,2010-04-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20349853,2010-04-13T00:00:00,Immunization,E02.095.465.425.400
20349853,2010-04-13T00:00:00,Immunization,E05.478.550
20349853,2010-04-13T00:00:00,Immunization,N02.421.726.758.310
20349853,2010-04-13T00:00:00,Immunization,N06.850.780.200.425
20349853,2010-04-13T00:00:00,Immunization,N06.850.780.680.310
20349853,2010-04-13T00:00:00,Immunization Schedule,E02.095.465.425.400.470
20349853,2010-04-13T00:00:00,Immunization Schedule,E05.478.550.545
20349853,2010-04-13T00:00:00,Nursing Assessment,N04.590.233.508.480
20349853,2010-04-13T00:00:00,Patient Education as Topic,I02.233.332.500
20349853,2010-04-13T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
20349853,2010-04-13T00:00:00,Patient Education as Topic,N02.421.726.407.680
20349853,2010-04-13T00:00:00,Referral and Consultation,N04.452.758.849
20349853,2010-04-13T00:00:00,Risk Assessment,E05.318.740.600.800.715
20349853,2010-04-13T00:00:00,Risk Assessment,N04.452.871.715
20349853,2010-04-13T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20349853,2010-04-13T00:00:00,Risk Assessment,N06.850.505.715
20349853,2010-04-13T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20349853,2010-04-13T00:00:00,Travel,I03.883
20388702,2010-04-13T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
20388702,2010-04-13T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
20388702,2010-04-13T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
20388702,2010-04-13T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
20388702,2010-04-13T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
20388702,2010-04-13T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
20388702,2010-04-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20388702,2010-04-13T00:00:00,Mass Screening,E01.370.500
20388702,2010-04-13T00:00:00,Mass Screening,E05.318.308.250.580
20388702,2010-04-13T00:00:00,Mass Screening,N02.421.143.827.233.443
20388702,2010-04-13T00:00:00,Mass Screening,N02.421.726.233.443
20388702,2010-04-13T00:00:00,Mass Screening,N05.715.360.300.375.500
20388702,2010-04-13T00:00:00,Mass Screening,N06.850.520.308.250.580
20388702,2010-04-13T00:00:00,Mass Screening,N06.850.780.500
20388702,2010-04-13T00:00:00,National Institutes of Health (U.S.),I01.409.137.500.600.480
20388702,2010-04-13T00:00:00,National Institutes of Health (U.S.),N03.540.348.500.500.600.480
20388702,2010-04-13T00:00:00,Population Surveillance,E05.318.308.250.700
20388702,2010-04-13T00:00:00,Population Surveillance,N05.715.360.300.375.625
20388702,2010-04-13T00:00:00,Population Surveillance,N06.850.520.308.250.700
20388702,2010-04-13T00:00:00,Population Surveillance,N06.850.780.675
20388702,2010-04-13T00:00:00,United States,Z01.107.567.875
20394835,2010-04-13T00:00:00,Cell Cycle,G04.299.134
20394835,2010-04-13T00:00:00,Cell Movement,G04.299.283
20394835,2010-04-13T00:00:00,Cell Movement,G07.700.560.500.180
20394835,2010-04-13T00:00:00,Cell Proliferation,G04.299.233.750
20394835,2010-04-13T00:00:00,Cell Proliferation,G07.700.320.249.410.750
20394835,2010-04-13T00:00:00,Cell Survival,G04.299.316
20394835,2010-04-13T00:00:00,Down-Regulation,G02.111.087.225
20394835,2010-04-13T00:00:00,Down-Regulation,G02.149.115.225
20394835,2010-04-13T00:00:00,Down-Regulation,G05.355.315.200
20394835,2010-04-13T00:00:00,Down-Regulation,G07.690.812.230
20394835,2010-04-13T00:00:00,Down-Regulation,G07.700.680.230
20394835,2010-04-13T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
20394835,2010-04-13T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
20394835,2010-04-13T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
20394835,2010-04-13T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
20394835,2010-04-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20394835,2010-04-13T00:00:00,Interferon-gamma,D12.644.276.374.440.893
20394835,2010-04-13T00:00:00,Interferon-gamma,D12.644.276.374.480.350
20394835,2010-04-13T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
20394835,2010-04-13T00:00:00,Interferon-gamma,D12.644.276.718.550
20394835,2010-04-13T00:00:00,Interferon-gamma,D12.776.467.374.440.893
20394835,2010-04-13T00:00:00,Interferon-gamma,D12.776.467.374.480.350
20394835,2010-04-13T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
20394835,2010-04-13T00:00:00,Interferon-gamma,D12.776.467.718.550
20394835,2010-04-13T00:00:00,Interferon-gamma,D23.529.374.440.893
20394835,2010-04-13T00:00:00,Interferon-gamma,D23.529.374.480.350
20394835,2010-04-13T00:00:00,Interferon-gamma,D23.529.374.480.615.350
20394835,2010-04-13T00:00:00,Interferon-gamma,D23.529.718.550
20394835,2010-04-13T00:00:00,Neoplasm Invasiveness,C04.697.645
20394835,2010-04-13T00:00:00,Neoplasm Invasiveness,C23.550.727.645
20394835,2010-04-13T00:00:00,"RNA, Messenger",D13.444.735.544
20394835,2010-04-13T00:00:00,Telomerase,D08.811.913.696.445.308.300.750.750
20394835,2010-04-13T00:00:00,Telomerase,D12.776.157.725.500.921
20394835,2010-04-13T00:00:00,Telomerase,D12.776.664.962.500.921
20394835,2010-04-13T00:00:00,"Transcription, Genetic",G02.111.087.847
20394835,2010-04-13T00:00:00,"Transcription, Genetic",G02.149.115.847
20394835,2010-04-13T00:00:00,"Transcription, Genetic",G05.355.310.700
20395062,2010-04-13T00:00:00,Aged,M01.060.116.100
20395062,2010-04-13T00:00:00,Breast Neoplasms,C04.588.180
20395062,2010-04-13T00:00:00,Breast Neoplasms,C17.800.090.500
20395062,2010-04-13T00:00:00,"Carcinoma, Ductal, Breast",C04.557.470.200.025.232.500
20395062,2010-04-13T00:00:00,"Carcinoma, Ductal, Breast",C04.557.470.615.132.500
20395062,2010-04-13T00:00:00,"Carcinoma, Ductal, Breast",C04.588.180.390
20395062,2010-04-13T00:00:00,"Carcinoma, Ductal, Breast",C17.800.090.500.390
20395062,2010-04-13T00:00:00,Combined Modality Therapy,E02.186
20395062,2010-04-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20395062,2010-04-13T00:00:00,Middle Aged,M01.060.116.630
20395062,2010-04-13T00:00:00,Patient Satisfaction,N04.452.822.360.600
20395062,2010-04-13T00:00:00,Patient Satisfaction,N05.300.150.600.630
20395062,2010-04-13T00:00:00,Patient Satisfaction,N05.715.360.600
20395062,2010-04-13T00:00:00,Radiotherapy Dosage,E02.815.639
20395062,2010-04-13T00:00:00,Treatment Outcome,E01.789.800
20395062,2010-04-13T00:00:00,Treatment Outcome,N04.761.559.590.800
20395062,2010-04-13T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20196539,2010-04-14T00:00:00,Magnetics,H01.671.493
20196539,2010-04-14T00:00:00,Nanostructures,J01.637.512
20196539,2010-04-14T00:00:00,Nanotechnology,H01.603
20196539,2010-04-14T00:00:00,Nanotechnology,J01.897.520.600
20196539,2010-04-14T00:00:00,Oxygen,D01.268.185.550
20196539,2010-04-14T00:00:00,Oxygen,D01.362.670
20196539,2010-04-14T00:00:00,Surface Properties,G02.842.850
20196539,2010-04-14T00:00:00,Temperature,G01.906.595
20196539,2010-04-14T00:00:00,Temperature,G16.500.275.063.725.710
20196539,2010-04-14T00:00:00,Temperature,G16.500.750.775.710
20196539,2010-04-14T00:00:00,Temperature,N06.230.150.450
20196539,2010-04-14T00:00:00,Temperature,N06.230.300.100.725.710
20196539,2010-04-14T00:00:00,Zinc Oxide,D01.650.550.975
20196539,2010-04-14T00:00:00,Zinc Oxide,D01.975.975
20393453,2010-04-14T00:00:00,Adult,M01.060.116
20393453,2010-04-14T00:00:00,African Americans,M01.686.508.100.100
20393453,2010-04-14T00:00:00,African Americans,M01.686.754.100
20393453,2010-04-14T00:00:00,Alcoholism,C21.739.100.250
20393453,2010-04-14T00:00:00,Alcoholism,F03.900.100.350
20393453,2010-04-14T00:00:00,European Continental Ancestry Group,M01.686.508.400
20393453,2010-04-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20393453,2010-04-14T00:00:00,Linkage Disequilibrium,G05.540.500
20393453,2010-04-14T00:00:00,Middle Aged,M01.060.116.630
20393453,2010-04-14T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
20393453,2010-04-14T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
20058914,2010-04-15T00:00:00,Animals,B01.050
20058914,2010-04-15T00:00:00,Polychlorinated Biphenyls,D02.455.426.559.389.185.698
20058914,2010-04-15T00:00:00,Polychlorinated Biphenyls,D02.455.526.439.773
20384371,2010-04-15T00:00:00,Animals,B01.050
20384371,2010-04-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20384371,2010-04-15T00:00:00,Polychlorinated Biphenyls,D02.455.426.559.389.185.698
20384371,2010-04-15T00:00:00,Polychlorinated Biphenyls,D02.455.526.439.773
20395340,2010-04-15T00:00:00,Animals,B01.050
20395340,2010-04-15T00:00:00,Apoptosis,G04.299.139.160
20395340,2010-04-15T00:00:00,Cardiology,H02.403.429.163
20395340,2010-04-15T00:00:00,Diagnostic Imaging,E01.370.350
20395340,2010-04-15T00:00:00,Heart,A07.541
20395340,2010-04-15T00:00:00,Heart Ventricles,A07.541.560
20395340,2010-04-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20395340,2010-04-15T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20395340,2010-04-15T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20395340,2010-04-15T00:00:00,Myocardium,A02.633.580
20395340,2010-04-15T00:00:00,Myocardium,A07.541.704
20395340,2010-04-15T00:00:00,Myocardium,A10.690.552.750
20395340,2010-04-15T00:00:00,Stem Cells,A11.872
20395340,2010-04-15T00:00:00,Ventricular Remodeling,C23.300.985
20395340,2010-04-15T00:00:00,Ventricular Remodeling,G09.330.190.962.975
20395360,2010-04-15T00:00:00,Adolescent,M01.060.057
20395360,2010-04-15T00:00:00,Adult,M01.060.116
20395360,2010-04-15T00:00:00,Aged,M01.060.116.100
20395360,2010-04-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20395360,2010-04-15T00:00:00,Middle Aged,M01.060.116.630
20395360,2010-04-15T00:00:00,New York,Z01.107.567.875.075.437
20395360,2010-04-15T00:00:00,New York,Z01.107.567.875.350.530
20395360,2010-04-15T00:00:00,New York,Z01.107.567.875.500.530
20395360,2010-04-15T00:00:00,Smoking,F01.145.466.753
20395360,2010-04-15T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
20395360,2010-04-15T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
20395360,2010-04-15T00:00:00,Young Adult,M01.060.116.815
20395418,2010-04-15T00:00:00,Animals,B01.050
20395418,2010-04-15T00:00:00,Cell Proliferation,G04.299.233.750
20395418,2010-04-15T00:00:00,Cell Proliferation,G07.700.320.249.410.750
20395418,2010-04-15T00:00:00,Cytokines,D12.644.276.374
20395418,2010-04-15T00:00:00,Cytokines,D12.776.467.374
20395418,2010-04-15T00:00:00,Cytokines,D23.529.374
20395418,2010-04-15T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
20395418,2010-04-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20395418,2010-04-15T00:00:00,"Leukocytes, Mononuclear",A11.118.637.555
20395418,2010-04-15T00:00:00,"Leukocytes, Mononuclear",A15.145.229.637.555
20395418,2010-04-15T00:00:00,"Leukocytes, Mononuclear",A15.382.490.555
20395418,2010-04-15T00:00:00,Multiple Myeloma,C04.557.595.500
20395418,2010-04-15T00:00:00,Multiple Myeloma,C14.907.454.460
20395418,2010-04-15T00:00:00,Multiple Myeloma,C15.378.147.780.650
20395418,2010-04-15T00:00:00,Multiple Myeloma,C15.378.463.835.460
20395418,2010-04-15T00:00:00,Multiple Myeloma,C20.683.515.845
20395418,2010-04-15T00:00:00,Multiple Myeloma,C20.683.780.650
20395418,2010-04-15T00:00:00,"T-Lymphocytes, Helper-Inducer",A11.118.637.555.567.569.200.400
20395418,2010-04-15T00:00:00,"T-Lymphocytes, Helper-Inducer",A15.145.229.637.555.567.569.200.400
20395418,2010-04-15T00:00:00,"T-Lymphocytes, Helper-Inducer",A15.382.490.555.567.569.200.400
20411690,2010-04-15T00:00:00,Continuous Positive Airway Pressure,E02.880.820.790.259
20411690,2010-04-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20411690,2010-04-15T00:00:00,Middle Aged,M01.060.116.630
20411690,2010-04-15T00:00:00,Patient Satisfaction,N04.452.822.360.600
20411690,2010-04-15T00:00:00,Patient Satisfaction,N05.300.150.600.630
20411690,2010-04-15T00:00:00,Patient Satisfaction,N05.715.360.600
20411690,2010-04-15T00:00:00,Pilot Projects,E05.318.760.750
20411690,2010-04-15T00:00:00,Pilot Projects,E05.337.737
20411690,2010-04-15T00:00:00,Pilot Projects,N05.715.360.775.625
20411690,2010-04-15T00:00:00,Pilot Projects,N06.850.520.450.720
20411690,2010-04-15T00:00:00,Polysomnography,E01.370.520.625
20411690,2010-04-15T00:00:00,Quality of Life,I01.800
20411690,2010-04-15T00:00:00,Quality of Life,K01.752.400.750
20411690,2010-04-15T00:00:00,Questionnaires,E05.318.308.750
20411690,2010-04-15T00:00:00,Questionnaires,L01.280.800
20411690,2010-04-15T00:00:00,Questionnaires,N05.715.360.300.695
20411690,2010-04-15T00:00:00,Questionnaires,N06.850.520.308.750
20411690,2010-04-15T00:00:00,"Sleep Apnea, Obstructive",C08.618.085.852.850
20411690,2010-04-15T00:00:00,"Sleep Apnea, Obstructive",C10.886.425.800.750.850
20411690,2010-04-15T00:00:00,South Carolina,Z01.107.567.875.075.662
20411690,2010-04-15T00:00:00,South Carolina,Z01.107.567.875.750.700
20411690,2010-04-15T00:00:00,Treatment Outcome,E01.789.800
20411690,2010-04-15T00:00:00,Treatment Outcome,N04.761.559.590.800
20411690,2010-04-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20411690,2010-04-15T00:00:00,Wakefulness,F02.830.104.821
20411690,2010-04-15T00:00:00,Wakefulness,G11.561.600.042.738
20965449,2010-04-15T00:00:00,Adult,M01.060.116
20965449,2010-04-15T00:00:00,Animals,B01.050
20965449,2010-04-15T00:00:00,Cognitive Therapy,F04.754.137.428
20965449,2010-04-15T00:00:00,"Depressive Disorder, Major",F03.600.300.375
20965449,2010-04-15T00:00:00,"Disease Models, Animal",C22.232
20965449,2010-04-15T00:00:00,"Disease Models, Animal",E05.598.500
20965449,2010-04-15T00:00:00,"Disease Models, Animal",E05.599.395.080
20965449,2010-04-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20965449,2010-04-15T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
20965449,2010-04-15T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
20965449,2010-04-15T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
20965449,2010-04-15T00:00:00,Treatment Outcome,E01.789.800
20965449,2010-04-15T00:00:00,Treatment Outcome,N04.761.559.590.800
20965449,2010-04-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20400698,2010-04-16T00:00:00,Animals,B01.050
20400698,2010-04-16T00:00:00,Biological Transport,G03.495.166
20400698,2010-04-16T00:00:00,Cell Death,G04.299.139
20400698,2010-04-16T00:00:00,"Disease Models, Animal",C22.232
20400698,2010-04-16T00:00:00,"Disease Models, Animal",E05.598.500
20400698,2010-04-16T00:00:00,"Disease Models, Animal",E05.599.395.080
20400698,2010-04-16T00:00:00,"Endothelium, Vascular",A07.231.330
20400698,2010-04-16T00:00:00,"Endothelium, Vascular",A10.272.491.355
20400698,2010-04-16T00:00:00,Interleukin-10,D12.644.276.374.465.510
20400698,2010-04-16T00:00:00,Interleukin-10,D12.776.467.374.465.510
20400698,2010-04-16T00:00:00,Interleukin-10,D23.529.374.465.510
20400698,2010-04-16T00:00:00,Ischemia,C23.550.513
20400698,2010-04-16T00:00:00,Lipopolysaccharides,D09.400.500
20400698,2010-04-16T00:00:00,Lipopolysaccharides,D09.698.718.450
20400698,2010-04-16T00:00:00,Lipopolysaccharides,D10.494
20400698,2010-04-16T00:00:00,Lipopolysaccharides,D23.050.161.616.525
20400698,2010-04-16T00:00:00,Lipopolysaccharides,D23.946.123.329.500
20400698,2010-04-16T00:00:00,Liposomes,D25.479.517
20400698,2010-04-16T00:00:00,Liposomes,D26.255.260.517
20400698,2010-04-16T00:00:00,Liposomes,D27.720.280.260.517
20400698,2010-04-16T00:00:00,Liposomes,J01.637.051.479.517
20400698,2010-04-16T00:00:00,Liposomes,J01.637.087.500.517
20400698,2010-04-16T00:00:00,Liver Transplantation,E04.210.650
20400698,2010-04-16T00:00:00,Liver Transplantation,E04.936.450.490
20400698,2010-04-16T00:00:00,Liver Transplantation,E04.936.580.490
20400698,2010-04-16T00:00:00,Reperfusion Injury,C14.907.725
20400698,2010-04-16T00:00:00,Reperfusion Injury,C23.550.767.877
20401643,2010-04-17T00:00:00,Actins,D05.750.078.730.250
20401643,2010-04-17T00:00:00,Actins,D12.776.210.500.100
20401643,2010-04-17T00:00:00,Actins,D12.776.220.525.255
20401643,2010-04-17T00:00:00,Animals,B01.050
20401643,2010-04-17T00:00:00,Cocaine,D02.145.074.722.388
20401643,2010-04-17T00:00:00,Cocaine,D03.132.889.354
20401643,2010-04-17T00:00:00,Cocaine,D03.605.869.388
20401643,2010-04-17T00:00:00,Cocaine,D04.075.080.875.099.722.388
20401643,2010-04-17T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
20401643,2010-04-17T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20401643,2010-04-17T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
20401643,2010-04-17T00:00:00,Substance Withdrawal Syndrome,C21.739.835
20401643,2010-04-17T00:00:00,Substance Withdrawal Syndrome,F03.900.825
20400121,2010-04-18T00:00:00,Adult,M01.060.116
20400121,2010-04-18T00:00:00,Aged,M01.060.116.100
20400121,2010-04-18T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
20400121,2010-04-18T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
20400121,2010-04-18T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
20400121,2010-04-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20400121,2010-04-18T00:00:00,Lung Neoplasms,C04.588.894.797.520
20400121,2010-04-18T00:00:00,Lung Neoplasms,C08.381.540
20400121,2010-04-18T00:00:00,Lung Neoplasms,C08.785.520
20400121,2010-04-18T00:00:00,Middle Aged,M01.060.116.630
20400121,2010-04-18T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
20400121,2010-04-18T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
20400121,2010-04-18T00:00:00,Neoplasm Staging,E01.370.550
20400121,2010-04-18T00:00:00,Pneumonectomy,E04.928.600.600
20400121,2010-04-18T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
20400121,2010-04-18T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
20400121,2010-04-18T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
20400121,2010-04-18T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
20400121,2010-04-18T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
20400121,2010-04-18T00:00:00,Radiosurgery,E02.815.530
20400121,2010-04-18T00:00:00,Radiosurgery,E04.525.800.650
20400121,2010-04-18T00:00:00,Radiosurgery,E05.873.500
20400121,2010-04-18T00:00:00,Risk Assessment,E05.318.740.600.800.715
20400121,2010-04-18T00:00:00,Risk Assessment,N04.452.871.715
20400121,2010-04-18T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20400121,2010-04-18T00:00:00,Risk Assessment,N06.850.505.715
20400121,2010-04-18T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20400121,2010-04-18T00:00:00,Risk Factors,E05.318.740.600.800.725
20400121,2010-04-18T00:00:00,Risk Factors,N05.715.350.200.700
20400121,2010-04-18T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20400121,2010-04-18T00:00:00,Risk Factors,N06.850.490.625.750
20400121,2010-04-18T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20400121,2010-04-18T00:00:00,Time Factors,G01.910.857
20400121,2010-04-18T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20400121,2010-04-18T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20400121,2010-04-18T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20400121,2010-04-18T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20400121,2010-04-18T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20400121,2010-04-18T00:00:00,Treatment Outcome,E01.789.800
20400121,2010-04-18T00:00:00,Treatment Outcome,N04.761.559.590.800
20400121,2010-04-18T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20400244,2010-04-18T00:00:00,Double-Blind Method,E05.318.780.300
20400244,2010-04-18T00:00:00,Double-Blind Method,E05.581.500.300
20400244,2010-04-18T00:00:00,Double-Blind Method,N05.715.360.780.320
20400244,2010-04-18T00:00:00,Double-Blind Method,N06.850.520.445.300
20400244,2010-04-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20400244,2010-04-18T00:00:00,Pilot Projects,E05.318.760.750
20400244,2010-04-18T00:00:00,Pilot Projects,E05.337.737
20400244,2010-04-18T00:00:00,Pilot Projects,N05.715.360.775.625
20400244,2010-04-18T00:00:00,Pilot Projects,N06.850.520.450.720
20400244,2010-04-18T00:00:00,"Radiotherapy, Conformal",E02.815.635.700
20400244,2010-04-18T00:00:00,"Radiotherapy, Conformal",L01.700.508.100.710.600.550
22749466,2010-04-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22749466,2010-04-18T00:00:00,Periodicals as Topic,L01.178.682.829.678
22749466,2010-04-18T00:00:00,South Carolina,Z01.107.567.875.075.662
22749466,2010-04-18T00:00:00,South Carolina,Z01.107.567.875.750.700
20404157,2010-04-19T00:00:00,Animals,B01.050
20404157,2010-04-19T00:00:00,Macrophages,A11.329.372
20404157,2010-04-19T00:00:00,Macrophages,A11.627.482
20404157,2010-04-19T00:00:00,Macrophages,A11.733.397
20404157,2010-04-19T00:00:00,Macrophages,A15.382.680.397
20404157,2010-04-19T00:00:00,Macrophages,A15.382.812.522
20404157,2010-04-19T00:00:00,Membrane Proteins,D12.776.543
20404157,2010-04-19T00:00:00,Mutation,G05.365.590
20404157,2010-04-19T00:00:00,Phosphoproteins,D12.776.744
20404157,2010-04-19T00:00:00,Retina,A09.371.729
20404213,2010-04-19T00:00:00,Cardiovascular Diseases,C14
20404213,2010-04-19T00:00:00,Evidence-Based Medicine,H02.249.750
20404213,2010-04-19T00:00:00,Evidence-Based Medicine,H02.403.200.400
20404213,2010-04-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20404213,2010-04-19T00:00:00,Hypertension,C14.907.489
20404213,2010-04-19T00:00:00,Incidence,E05.318.308.985.525.375
20404213,2010-04-19T00:00:00,Incidence,L01.280.975.525.375
20404213,2010-04-19T00:00:00,Incidence,N01.224.935.597.500
20404213,2010-04-19T00:00:00,Incidence,N06.850.505.400.975.525.375
20404213,2010-04-19T00:00:00,Incidence,N06.850.520.308.985.525.375
20404213,2010-04-19T00:00:00,Life Style,F01.829.458
20404213,2010-04-19T00:00:00,Primary Prevention,N02.421.726.758
20404213,2010-04-19T00:00:00,Primary Prevention,N06.850.780.680
20404213,2010-04-19T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
20404213,2010-04-19T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
20404213,2010-04-19T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
20404213,2010-04-19T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
20404213,2010-04-19T00:00:00,Treatment Outcome,E01.789.800
20404213,2010-04-19T00:00:00,Treatment Outcome,N04.761.559.590.800
20404213,2010-04-19T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20404253,2010-04-19T00:00:00,Animals,B01.050
20404253,2010-04-19T00:00:00,Apoptosis,G04.299.139.160
20404253,2010-04-19T00:00:00,Carbon Monoxide,D01.200.250
20404253,2010-04-19T00:00:00,Carbon Monoxide,D01.362.200
20404253,2010-04-19T00:00:00,Carbon Monoxide,D01.650.550.250
20404253,2010-04-19T00:00:00,Cardiotonic Agents,D27.505.954.411.222
20404253,2010-04-19T00:00:00,Cardiotonic Agents,D27.720.799.080
20404253,2010-04-19T00:00:00,Chronic Disease,C23.550.291.500
20404253,2010-04-19T00:00:00,Fibrosis,C23.550.355
20404253,2010-04-19T00:00:00,Gene Expression,G05.355.310
20404253,2010-04-19T00:00:00,Heart Failure,C14.280.434
20404253,2010-04-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20404253,2010-04-19T00:00:00,Mitochondria,A11.284.430.214.190.875.564
20404253,2010-04-19T00:00:00,Mitochondria,A11.284.835.626
20404253,2010-04-19T00:00:00,Myocardial Infarction,C14.280.647.500
20404253,2010-04-19T00:00:00,Myocardial Infarction,C14.907.585.500
20404253,2010-04-19T00:00:00,Myocardium,A02.633.580
20404253,2010-04-19T00:00:00,Myocardium,A07.541.704
20404253,2010-04-19T00:00:00,Myocardium,A10.690.552.750
20404253,2010-04-19T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
20404253,2010-04-19T00:00:00,Organometallic Compounds,D01.632
20404253,2010-04-19T00:00:00,Organometallic Compounds,D02.691
20404253,2010-04-19T00:00:00,Oxidative Stress,G03.495.710
20404253,2010-04-19T00:00:00,Oxidative Stress,G07.700.830.750
20404253,2010-04-19T00:00:00,Stroke Volume,E01.370.370.380.150.700
20404253,2010-04-19T00:00:00,Stroke Volume,G09.330.380.124.882
20404253,2010-04-19T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
20404253,2010-04-19T00:00:00,Ventricular Remodeling,C23.300.985
20404253,2010-04-19T00:00:00,Ventricular Remodeling,G09.330.190.962.975
20406742,2010-04-20T00:00:00,Cone-Beam Computed Tomography,E01.370.350.700.810.810.490
20406742,2010-04-20T00:00:00,Cone-Beam Computed Tomography,E01.370.350.825.810.810.399
20406742,2010-04-20T00:00:00,Head,A01.456
20406742,2010-04-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20406742,2010-04-20T00:00:00,"Models, Biological",E05.599.395
20406742,2010-04-20T00:00:00,"Phantoms, Imaging",E07.671
20406742,2010-04-20T00:00:00,Radiometry,E05.799
20406742,2010-04-20T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20406742,2010-04-20T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20406742,2010-04-20T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20406742,2010-04-20T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20406742,2010-04-20T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20406882,2010-04-20T00:00:00,Adult,M01.060.116
20406882,2010-04-20T00:00:00,Aged,M01.060.116.100
20406882,2010-04-20T00:00:00,Case-Control Studies,E05.318.760.500.500
20406882,2010-04-20T00:00:00,Case-Control Studies,N05.715.360.775.175.200
20406882,2010-04-20T00:00:00,Case-Control Studies,N06.850.520.450.500.500
20406882,2010-04-20T00:00:00,Contrast Media,D27.720.259
20406882,2010-04-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20406882,2010-04-20T00:00:00,Incidence,E05.318.308.985.525.375
20406882,2010-04-20T00:00:00,Incidence,L01.280.975.525.375
20406882,2010-04-20T00:00:00,Incidence,N01.224.935.597.500
20406882,2010-04-20T00:00:00,Incidence,N06.850.505.400.975.525.375
20406882,2010-04-20T00:00:00,Incidence,N06.850.520.308.985.525.375
20406882,2010-04-20T00:00:00,Middle Aged,M01.060.116.630
20406882,2010-04-20T00:00:00,Questionnaires,E05.318.308.750
20406882,2010-04-20T00:00:00,Questionnaires,L01.280.800
20406882,2010-04-20T00:00:00,Questionnaires,N05.715.360.300.695
20406882,2010-04-20T00:00:00,Questionnaires,N06.850.520.308.750
20406882,2010-04-20T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20406882,2010-04-20T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20406882,2010-04-20T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20406882,2010-04-20T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20406882,2010-04-20T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20406987,2010-04-20T00:00:00,"Antigens, CD147",D12.776.395.550.045
20406987,2010-04-20T00:00:00,"Antigens, CD147",D12.776.543.550.188
20406987,2010-04-20T00:00:00,"Antigens, CD147",D23.050.285.040
20406987,2010-04-20T00:00:00,"Antigens, CD147",D23.050.301.264.035.247
20406987,2010-04-20T00:00:00,"Antigens, CD147",D23.101.100.110.247
20406987,2010-04-20T00:00:00,"Antigens, Viral",D23.050.327
20406987,2010-04-20T00:00:00,Cell Adhesion,G04.299.117
20406987,2010-04-20T00:00:00,Cell Movement,G04.299.283
20406987,2010-04-20T00:00:00,Cell Movement,G07.700.560.500.180
20406987,2010-04-20T00:00:00,Cell Proliferation,G04.299.233.750
20406987,2010-04-20T00:00:00,Cell Proliferation,G07.700.320.249.410.750
20406987,2010-04-20T00:00:00,"Endothelium, Vascular",A07.231.330
20406987,2010-04-20T00:00:00,"Endothelium, Vascular",A10.272.491.355
20406987,2010-04-20T00:00:00,Fibroblasts,A11.329.228
20406987,2010-04-20T00:00:00,Fibroblasts,A11.872.228
20406987,2010-04-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20406987,2010-04-20T00:00:00,Neoplasm Invasiveness,C04.697.645
20406987,2010-04-20T00:00:00,Neoplasm Invasiveness,C23.550.727.645
20406987,2010-04-20T00:00:00,Nuclear Proteins,D12.776.660
20406987,2010-04-20T00:00:00,"RNA, Messenger",D13.444.735.544
20412832,2010-04-20T00:00:00,Animals,B01.050
20412832,2010-04-20T00:00:00,Hematopoietic Stem Cell Transplantation,E04.936.225.687.500
20412832,2010-04-20T00:00:00,Hematopoietic Stem Cells,A11.148.378
20412832,2010-04-20T00:00:00,Hematopoietic Stem Cells,A11.872.378
20412832,2010-04-20T00:00:00,Hematopoietic Stem Cells,A15.378.316.378
20412832,2010-04-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20410070,2010-04-21T00:00:00,Adult,M01.060.116
20410070,2010-04-21T00:00:00,Aged,M01.060.116.100
20410070,2010-04-21T00:00:00,Animals,B01.050
20410070,2010-04-21T00:00:00,Caveolin 1,D12.644.360.024.264
20410070,2010-04-21T00:00:00,Caveolin 1,D12.776.157.057.010
20410070,2010-04-21T00:00:00,Caveolin 1,D12.776.476.024.280
20410070,2010-04-21T00:00:00,Caveolin 1,D12.776.543.990.100.500
20410070,2010-04-21T00:00:00,Caveolin 1,D12.776.744.287
20410070,2010-04-21T00:00:00,"Disease Models, Animal",C22.232
20410070,2010-04-21T00:00:00,"Disease Models, Animal",E05.598.500
20410070,2010-04-21T00:00:00,"Disease Models, Animal",E05.599.395.080
20410070,2010-04-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20410070,2010-04-21T00:00:00,Middle Aged,M01.060.116.630
20410070,2010-04-21T00:00:00,Monocytes,A11.118.637.555.652
20410070,2010-04-21T00:00:00,Monocytes,A11.148.580
20410070,2010-04-21T00:00:00,Monocytes,A11.627.624
20410070,2010-04-21T00:00:00,Monocytes,A11.733.547
20410070,2010-04-21T00:00:00,Monocytes,A15.145.229.637.555.652
20410070,2010-04-21T00:00:00,Monocytes,A15.378.316.580
20410070,2010-04-21T00:00:00,Monocytes,A15.382.490.555.652
20410070,2010-04-21T00:00:00,Monocytes,A15.382.680.547
20410070,2010-04-21T00:00:00,Monocytes,A15.382.812.547
20410070,2010-04-21T00:00:00,Peptide Fragments,D12.644.541
20410070,2010-04-21T00:00:00,Pulmonary Fibrosis,C08.381.765
20410070,2010-04-21T00:00:00,"Scleroderma, Systemic",C17.300.799
20410070,2010-04-21T00:00:00,"Scleroderma, Systemic",C17.800.784
20410070,2010-04-21T00:00:00,Signal Transduction,G02.111.087.800
20410070,2010-04-21T00:00:00,Signal Transduction,G02.149.115.800
20410070,2010-04-21T00:00:00,Signal Transduction,G04.299.880
20410070,2010-04-21T00:00:00,Young Adult,M01.060.116.815
20421998,2010-04-21T00:00:00,Aging,G07.700.320.124
20421998,2010-04-21T00:00:00,Animals,B01.050
20421998,2010-04-21T00:00:00,Energy Metabolism,G03.495.335
20421998,2010-04-21T00:00:00,Mitochondria,A11.284.430.214.190.875.564
20421998,2010-04-21T00:00:00,Mitochondria,A11.284.835.626
20421998,2010-04-21T00:00:00,Reactive Oxygen Species,D01.339.431
20421998,2010-04-21T00:00:00,Reactive Oxygen Species,D01.650.775
20413418,2010-04-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20413418,2010-04-22T00:00:00,Neoplasms,C04
20413418,2010-04-22T00:00:00,Occupational Exposure,N06.850.460.350.600
20413418,2010-04-22T00:00:00,Radiation Dosage,E05.799.513
20413418,2010-04-22T00:00:00,Radiation Dosage,G01.201.875.740
20413418,2010-04-22T00:00:00,Radiation Dosage,N06.850.810.250
20413418,2010-04-22T00:00:00,Radiation Injuries,C21.866.733
20413418,2010-04-22T00:00:00,Radiation Injuries,N06.850.810.300.360
20413615,2010-04-22T00:00:00,Drug Prescriptions,E02.319.307
20413615,2010-04-22T00:00:00,Drug Prescriptions,N02.421.668.778.500
20413615,2010-04-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20413615,2010-04-22T00:00:00,Medication Errors,E02.319.529
20413615,2010-04-22T00:00:00,Medication Errors,N02.421.450.500
20413615,2010-04-22T00:00:00,Primary Health Care,N04.590.233.727
20413615,2010-04-22T00:00:00,"Quality Indicators, Health Care",N04.761.789
20413615,2010-04-22T00:00:00,United States,Z01.107.567.875
20418476,2010-04-23T00:00:00,Animals,B01.050
20418476,2010-04-23T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
20418476,2010-04-23T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.055.239.125
20418476,2010-04-23T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.109.139.125
20418476,2010-04-23T00:00:00,Contrast Media,D27.720.259
20418476,2010-04-23T00:00:00,"Disease Models, Animal",C22.232
20418476,2010-04-23T00:00:00,"Disease Models, Animal",E05.598.500
20418476,2010-04-23T00:00:00,"Disease Models, Animal",E05.599.395.080
20418476,2010-04-23T00:00:00,Fibroblasts,A11.329.228
20418476,2010-04-23T00:00:00,Fibroblasts,A11.872.228
20418476,2010-04-23T00:00:00,Matrix Metalloproteinase 14,D08.811.277.656.300.480.525.300.500
20418476,2010-04-23T00:00:00,Matrix Metalloproteinase 14,D08.811.277.656.675.374.525.300.500
20418476,2010-04-23T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.205.352
20418476,2010-04-23T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.252.420
20418476,2010-04-23T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.525.700.150
20418476,2010-04-23T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.205.352
20418476,2010-04-23T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.252.420
20418476,2010-04-23T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.525.700.150
20418476,2010-04-23T00:00:00,"RNA, Messenger",D13.444.735.544
20418476,2010-04-23T00:00:00,Time Factors,G01.910.857
20418183,2010-04-24T00:00:00,Adolescent,M01.060.057
20418183,2010-04-24T00:00:00,Aging,G07.700.320.124
20418183,2010-04-24T00:00:00,Child,M01.060.406
20418183,2010-04-24T00:00:00,Chronic Disease,C23.550.291.500
20418183,2010-04-24T00:00:00,Depressive Disorder,F03.600.300
20418183,2010-04-24T00:00:00,Disability Evaluation,E01.370.400
20418183,2010-04-24T00:00:00,Fibromyalgia,C05.651.324
20418183,2010-04-24T00:00:00,Fibromyalgia,C05.799.321
20418183,2010-04-24T00:00:00,Fibromyalgia,C10.668.491.425
20418183,2010-04-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20418183,2010-04-24T00:00:00,"Monitoring, Physiologic",E01.370.520
20418183,2010-04-24T00:00:00,Mood Disorders,F03.600
20418183,2010-04-24T00:00:00,Motor Activity,F01.145.632
20418183,2010-04-24T00:00:00,Motor Activity,G11.427.590.530.698
20418183,2010-04-24T00:00:00,Pain,C10.597.617
20418183,2010-04-24T00:00:00,Pain,C23.888.592.612
20418183,2010-04-24T00:00:00,Pain,C23.888.646
20418183,2010-04-24T00:00:00,Pain,F02.830.816.444
20418183,2010-04-24T00:00:00,Pain,G11.561.600.810.444
20418183,2010-04-24T00:00:00,Psychiatric Status Rating Scales,F04.586
20423716,2010-04-25T00:00:00,"Analgesics, Non-Narcotic",D27.505.696.663.850.014.040
20423716,2010-04-25T00:00:00,"Analgesics, Non-Narcotic",D27.505.954.427.040.100
20423716,2010-04-25T00:00:00,Animals,B01.050
20423716,2010-04-25T00:00:00,Apoptosis,G04.299.139.160
20423716,2010-04-25T00:00:00,Liver,A03.620
20423716,2010-04-25T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
20423716,2010-04-25T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
20423716,2010-04-25T00:00:00,Nitric Oxide Synthase,D08.811.682.664.500.772
20423716,2010-04-25T00:00:00,Oxidative Stress,G03.495.710
20423716,2010-04-25T00:00:00,Oxidative Stress,G07.700.830.750
20423716,2010-04-25T00:00:00,Peroxynitrous Acid,D01.625.600.800
20423716,2010-04-25T00:00:00,Peroxynitrous Acid,D01.625.700.750
20423716,2010-04-25T00:00:00,Phosphorylation,G02.111.087.677
20423716,2010-04-25T00:00:00,Phosphorylation,G02.149.115.677
20423716,2010-04-25T00:00:00,Phosphorylation,G02.149.465.700
20423716,2010-04-25T00:00:00,Phosphorylation,G02.607.750.700
20423716,2010-04-25T00:00:00,Phosphorylation,G03.495.790
20423716,2010-04-25T00:00:00,"Translocation, Genetic",C23.550.210.870
20423716,2010-04-25T00:00:00,"Translocation, Genetic",G05.355.600.860
20423716,2010-04-25T00:00:00,"Translocation, Genetic",G05.365.590.175.870
20423716,2010-04-25T00:00:00,bcl-2-Associated X Protein,D12.644.360.075.718.400
20423716,2010-04-25T00:00:00,bcl-2-Associated X Protein,D12.776.476.075.718.400
20340115,2010-04-26T00:00:00,Gold,D01.268.556.322
20340115,2010-04-26T00:00:00,Gold,D01.268.956.186
20340115,2010-04-26T00:00:00,Gold,D01.552.544.322
20340115,2010-04-26T00:00:00,Nanostructures,J01.637.512
20340115,2010-04-26T00:00:00,Nanotechnology,H01.603
20340115,2010-04-26T00:00:00,Nanotechnology,J01.897.520.600
20340115,2010-04-26T00:00:00,"Nanotubes, Carbon",D01.268.150.250.500
20340115,2010-04-26T00:00:00,"Nanotubes, Carbon",J01.637.512.850.500
20340115,2010-04-26T00:00:00,"Nuclear Magnetic Resonance, Biomolecular",E05.196.867.519.550
20340115,2010-04-26T00:00:00,Solubility,G02.842.800
20340115,2010-04-26T00:00:00,"Spectroscopy, Fourier Transform Infrared",E05.196.712.726.676.700
20340115,2010-04-26T00:00:00,"Spectroscopy, Fourier Transform Infrared",E05.196.867.826.676.700
20340115,2010-04-26T00:00:00,Surface Plasmon Resonance,E05.196.890
20340115,2010-04-26T00:00:00,Surface Plasmon Resonance,E05.601.123.700
20340115,2010-04-26T00:00:00,Surface Properties,G02.842.850
20421499,2010-04-26T00:00:00,Genome-Wide Association Study,E05.318.416.249
20421499,2010-04-26T00:00:00,Genome-Wide Association Study,E05.318.780.392
20421499,2010-04-26T00:00:00,Genome-Wide Association Study,E05.393.385.500
20421499,2010-04-26T00:00:00,Genome-Wide Association Study,E05.393.522.500
20421499,2010-04-26T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
20421499,2010-04-26T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
20421499,2010-04-26T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
20421499,2010-04-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20421499,2010-04-26T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
20218655,2010-04-27T00:00:00,Adult,M01.060.116
20218655,2010-04-27T00:00:00,"Antigens, CD",D23.050.301.264.035
20218655,2010-04-27T00:00:00,"Antigens, CD",D23.101.100.110
20218655,2010-04-27T00:00:00,Biological Markers,D23.101
20218655,2010-04-27T00:00:00,Exosomes,A11.284.430.214.190.875.190.880.495
20218655,2010-04-27T00:00:00,Gold,D01.268.556.322
20218655,2010-04-27T00:00:00,Gold,D01.268.956.186
20218655,2010-04-27T00:00:00,Gold,D01.552.544.322
20218655,2010-04-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20218655,2010-04-27T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
20218655,2010-04-27T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
20218655,2010-04-27T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
20218655,2010-04-27T00:00:00,Nanoparticles,J01.637.512.600
20218655,2010-04-27T00:00:00,Platelet Membrane Glycoproteins,D12.776.395.550.625
20218655,2010-04-27T00:00:00,Platelet Membrane Glycoproteins,D12.776.543.550.625
20218655,2010-04-27T00:00:00,Platelet Membrane Glycoproteins,D12.776.543.750.705.675
20218655,2010-04-27T00:00:00,Saliva,A12.200.666
20424113,2010-04-27T00:00:00,Animals,B01.050
20424113,2010-04-27T00:00:00,Breast Neoplasms,C04.588.180
20424113,2010-04-27T00:00:00,Breast Neoplasms,C17.800.090.500
20424113,2010-04-27T00:00:00,Copper,D01.268.556.195
20424113,2010-04-27T00:00:00,Copper,D01.268.956.170
20424113,2010-04-27T00:00:00,Copper,D01.552.544.195
20424113,2010-04-27T00:00:00,Disulfiram,D02.241.081.251.869.220.250
20424113,2010-04-27T00:00:00,Disulfiram,D02.886.520.150.175
20424113,2010-04-27T00:00:00,Disulfiram,D02.886.706.200.200
20424113,2010-04-27T00:00:00,Enzyme Inhibitors,D27.505.519.389
20424113,2010-04-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20424113,2010-04-27T00:00:00,Mutation,G05.365.590
20424113,2010-04-27T00:00:00,PTEN Phosphohydrolase,D08.811.277.352.650.850
20424113,2010-04-27T00:00:00,PTEN Phosphohydrolase,D12.776.476.590
20424113,2010-04-27T00:00:00,PTEN Phosphohydrolase,D12.776.624.776.695
20424167,2010-04-27T00:00:00,Amino Acid Sequence,G02.111.570.060
20424167,2010-04-27T00:00:00,Amino Acid Sequence,L01.453.245.667.060
20424167,2010-04-27T00:00:00,Animals,B01.050
20424167,2010-04-27T00:00:00,"Animals, Newborn",B01.050.050.282
20424167,2010-04-27T00:00:00,Calcium,D01.268.552.100
20424167,2010-04-27T00:00:00,Calcium,D01.552.539.288
20424167,2010-04-27T00:00:00,Calcium,D23.119.100
20424167,2010-04-27T00:00:00,Calmodulin,D12.644.360.381.249
20424167,2010-04-27T00:00:00,Calmodulin,D12.776.157.125.412.249
20424167,2010-04-27T00:00:00,Calmodulin,D12.776.476.387.249
20424167,2010-04-27T00:00:00,Cell Death,G04.299.139
20424167,2010-04-27T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
20424167,2010-04-27T00:00:00,Hippocampus,A08.186.211.464.405
20424167,2010-04-27T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
20424167,2010-04-27T00:00:00,Molecular Sequence Data,L01.453.245.667
20424167,2010-04-27T00:00:00,Neurons,A08.663
20424167,2010-04-27T00:00:00,Neurons,A11.671
20424167,2010-04-27T00:00:00,Neuroprotective Agents,D27.505.696.706.548
20424167,2010-04-27T00:00:00,Neuroprotective Agents,D27.505.954.427.575
20424167,2010-04-27T00:00:00,Peptide Fragments,D12.644.541
20424167,2010-04-27T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
20424167,2010-04-27T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20424167,2010-04-27T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
20424167,2010-04-27T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
20424167,2010-04-27T00:00:00,Stroke,C10.228.140.300.775
20424167,2010-04-27T00:00:00,Stroke,C14.907.253.855
20427326,2010-04-27T00:00:00,Aged,M01.060.116.100
20427326,2010-04-27T00:00:00,Algorithms,G17.035
20427326,2010-04-27T00:00:00,Algorithms,L01.224.050
20427326,2010-04-27T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
20427326,2010-04-27T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
20427326,2010-04-27T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
20427326,2010-04-27T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
20427326,2010-04-27T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
20427326,2010-04-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20427326,2010-04-27T00:00:00,Middle Aged,M01.060.116.630
20427326,2010-04-27T00:00:00,"Models, Statistical",E05.318.740.500
20427326,2010-04-27T00:00:00,"Models, Statistical",E05.599.835
20427326,2010-04-27T00:00:00,"Models, Statistical",N05.715.360.750.530
20427326,2010-04-27T00:00:00,"Models, Statistical",N06.850.520.830.500
20427326,2010-04-27T00:00:00,Regression Analysis,E05.318.740.750
20427326,2010-04-27T00:00:00,Regression Analysis,N05.715.360.750.695
20427326,2010-04-27T00:00:00,Regression Analysis,N06.850.520.830.750
20427326,2010-04-27T00:00:00,Risk Factors,E05.318.740.600.800.725
20427326,2010-04-27T00:00:00,Risk Factors,N05.715.350.200.700
20427326,2010-04-27T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20427326,2010-04-27T00:00:00,Risk Factors,N06.850.490.625.750
20427326,2010-04-27T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20427326,2010-04-27T00:00:00,South Carolina,Z01.107.567.875.075.662
20427326,2010-04-27T00:00:00,South Carolina,Z01.107.567.875.750.700
20427326,2010-04-27T00:00:00,Time Factors,G01.910.857
20427326,2010-04-27T00:00:00,Veterans,M01.930
20427692,2010-04-28T00:00:00,Endocytosis,G04.299.482
20427692,2010-04-28T00:00:00,GTP-Binding Protein Regulators,D12.644.360.325
20427692,2010-04-28T00:00:00,GTP-Binding Protein Regulators,D12.776.402
20427692,2010-04-28T00:00:00,GTP-Binding Protein Regulators,D12.776.476.325
20427692,2010-04-28T00:00:00,Heterotrimeric GTP-Binding Proteins,D08.811.277.040.330.300.200
20427692,2010-04-28T00:00:00,Heterotrimeric GTP-Binding Proteins,D12.644.360.375
20427692,2010-04-28T00:00:00,Heterotrimeric GTP-Binding Proteins,D12.776.157.325.332
20427692,2010-04-28T00:00:00,Heterotrimeric GTP-Binding Proteins,D12.776.476.375
20427692,2010-04-28T00:00:00,Heterotrimeric GTP-Binding Proteins,D12.776.543.325
20427692,2010-04-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20427692,2010-04-28T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
20427692,2010-04-28T00:00:00,Signal Transduction,G02.111.087.800
20427692,2010-04-28T00:00:00,Signal Transduction,G02.149.115.800
20427692,2010-04-28T00:00:00,Signal Transduction,G04.299.880
20436252,2010-04-30T00:00:00,Genome-Wide Association Study,E05.318.416.249
20436252,2010-04-30T00:00:00,Genome-Wide Association Study,E05.318.780.392
20436252,2010-04-30T00:00:00,Genome-Wide Association Study,E05.393.385.500
20436252,2010-04-30T00:00:00,Genome-Wide Association Study,E05.393.522.500
20436252,2010-04-30T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
20436252,2010-04-30T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
20436252,2010-04-30T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
20436252,2010-04-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20436252,2010-04-30T00:00:00,Hypertension,C14.907.489
20436252,2010-04-30T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
19408346,2010-05-01T00:00:00,African Americans,M01.686.508.100.100
19408346,2010-05-01T00:00:00,African Americans,M01.686.754.100
19408346,2010-05-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
19408346,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19408346,2010-05-01T00:00:00,Middle Aged,M01.060.116.630
19408346,2010-05-01T00:00:00,Neoplasm Staging,E01.370.550
19408346,2010-05-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
19408346,2010-05-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
19408346,2010-05-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
19408346,2010-05-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
19408346,2010-05-01T00:00:00,Psychology,F04.096.628
19408346,2010-05-01T00:00:00,Questionnaires,E05.318.308.750
19408346,2010-05-01T00:00:00,Questionnaires,L01.280.800
19408346,2010-05-01T00:00:00,Questionnaires,N05.715.360.300.695
19408346,2010-05-01T00:00:00,Questionnaires,N06.850.520.308.750
20013789,2010-05-01T00:00:00,Alligators and Crocodiles,B01.050.150.900.833.100
20013789,2010-05-01T00:00:00,Animals,B01.050
20013789,2010-05-01T00:00:00,"Environment, Controlled",N06.230.150
20013789,2010-05-01T00:00:00,Oogenesis,G04.299.151.650.249
20013789,2010-05-01T00:00:00,Oogenesis,G08.686.785.760.310.500
20013789,2010-05-01T00:00:00,Ovary,A05.360.319.114.630
20013789,2010-05-01T00:00:00,Ovary,A05.360.576.497
20013789,2010-05-01T00:00:00,Ovary,A06.407.312.497
20013789,2010-05-01T00:00:00,Reproduction,G08.686.785.760
20013789,2010-05-01T00:00:00,Temperature,G01.906.595
20013789,2010-05-01T00:00:00,Temperature,G16.500.275.063.725.710
20013789,2010-05-01T00:00:00,Temperature,G16.500.750.775.710
20013789,2010-05-01T00:00:00,Temperature,N06.230.150.450
20013789,2010-05-01T00:00:00,Temperature,N06.230.300.100.725.710
20013789,2010-05-01T00:00:00,Testis,A05.360.444.849
20013789,2010-05-01T00:00:00,Testis,A05.360.576.782
20013789,2010-05-01T00:00:00,Testis,A06.407.312.782
20186963,2010-05-01T00:00:00,Animals,B01.050
20186963,2010-05-01T00:00:00,Biological Markers,D23.101
20186963,2010-05-01T00:00:00,Chickens,B01.050.150.900.248.350.150
20186963,2010-05-01T00:00:00,Chickens,B01.050.150.900.248.617.192
20186963,2010-05-01T00:00:00,Coronary Vessels,A07.231.114.269
20186963,2010-05-01T00:00:00,Coronary Vessels,A07.231.908.194
20186963,2010-05-01T00:00:00,Endocardium,A07.541.207
20186963,2010-05-01T00:00:00,Heart,A07.541
20186963,2010-05-01T00:00:00,Heart Septum,A07.541.459
20186963,2010-05-01T00:00:00,Heart Valves,A07.541.510
20186963,2010-05-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
20186963,2010-05-01T00:00:00,Myocardium,A02.633.580
20186963,2010-05-01T00:00:00,Myocardium,A07.541.704
20186963,2010-05-01T00:00:00,Myocardium,A10.690.552.750
20186963,2010-05-01T00:00:00,Proteins,D12.776
20186963,2010-05-01T00:00:00,Proteomics,H01.158.201.843
20186963,2010-05-01T00:00:00,Proteomics,H01.158.273.180.350.700
20186963,2010-05-01T00:00:00,Proteomics,H01.158.273.343.350.700
20186963,2010-05-01T00:00:00,Proteomics,H01.181.122.738
20186963,2010-05-01T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
20191602,2010-05-01T00:00:00,Amyotrophic Lateral Sclerosis,C10.228.854.139
20191602,2010-05-01T00:00:00,Amyotrophic Lateral Sclerosis,C10.574.562.250
20191602,2010-05-01T00:00:00,Amyotrophic Lateral Sclerosis,C10.574.950.050
20191602,2010-05-01T00:00:00,Amyotrophic Lateral Sclerosis,C10.668.460.250
20191602,2010-05-01T00:00:00,Amyotrophic Lateral Sclerosis,C18.452.845.800.050
20191602,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20191602,2010-05-01T00:00:00,United States,Z01.107.567.875
20191602,2010-05-01T00:00:00,Veterans,M01.930
20224387,2010-05-01T00:00:00,"Arrhythmias, Cardiac",C14.280.067
20224387,2010-05-01T00:00:00,"Arrhythmias, Cardiac",C23.550.073
20224387,2010-05-01T00:00:00,"Death, Sudden, Cardiac",C14.280.383.220
20224387,2010-05-01T00:00:00,"Death, Sudden, Cardiac",C23.550.260.322.250
20224387,2010-05-01T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
20224387,2010-05-01T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
20224387,2010-05-01T00:00:00,"Defibrillators, Implantable",E07.695.175
20224387,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20224387,2010-05-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
20224387,2010-05-01T00:00:00,Risk Assessment,N04.452.871.715
20224387,2010-05-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20224387,2010-05-01T00:00:00,Risk Assessment,N06.850.505.715
20224387,2010-05-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20224387,2010-05-01T00:00:00,Stroke Volume,E01.370.370.380.150.700
20224387,2010-05-01T00:00:00,Stroke Volume,G09.330.380.124.882
20225236,2010-05-01T00:00:00,Cell Line,A11.251.210
20225236,2010-05-01T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.567.342
20225236,2010-05-01T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.646.750.249
20225236,2010-05-01T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.644.360.450.169
20225236,2010-05-01T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.776.476.450.169
20225236,2010-05-01T00:00:00,Glucose,D09.546.359.448
20225236,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20225236,2010-05-01T00:00:00,Interleukin-6,D12.644.276.374.465.506
20225236,2010-05-01T00:00:00,Interleukin-6,D12.776.467.374.465.506
20225236,2010-05-01T00:00:00,Interleukin-6,D23.529.374.465.506
20225236,2010-05-01T00:00:00,Lipopolysaccharides,D09.400.500
20225236,2010-05-01T00:00:00,Lipopolysaccharides,D09.698.718.450
20225236,2010-05-01T00:00:00,Lipopolysaccharides,D10.494
20225236,2010-05-01T00:00:00,Lipopolysaccharides,D23.050.161.616.525
20225236,2010-05-01T00:00:00,Lipopolysaccharides,D23.946.123.329.500
20225236,2010-05-01T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
20225236,2010-05-01T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
20225236,2010-05-01T00:00:00,MAP Kinase Signaling System,G03.495.553.560
20225236,2010-05-01T00:00:00,MAP Kinase Signaling System,G04.299.880.560
20225236,2010-05-01T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.205.351
20225236,2010-05-01T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.525.700.100
20225236,2010-05-01T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.205.351
20225236,2010-05-01T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.525.700.100
20225236,2010-05-01T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.567.342.500
20225236,2010-05-01T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.646.750.249.500
20225236,2010-05-01T00:00:00,Mitogen-Activated Protein Kinase 1,D12.644.360.450.169.500
20225236,2010-05-01T00:00:00,Mitogen-Activated Protein Kinase 1,D12.776.476.450.169.500
20225236,2010-05-01T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.567.342.750
20225236,2010-05-01T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.646.750.249.750
20225236,2010-05-01T00:00:00,Mitogen-Activated Protein Kinase 3,D12.644.360.450.169.750
20225236,2010-05-01T00:00:00,Mitogen-Activated Protein Kinase 3,D12.776.476.450.169.750
20225236,2010-05-01T00:00:00,Monocytes,A11.118.637.555.652
20225236,2010-05-01T00:00:00,Monocytes,A11.148.580
20225236,2010-05-01T00:00:00,Monocytes,A11.627.624
20225236,2010-05-01T00:00:00,Monocytes,A11.733.547
20225236,2010-05-01T00:00:00,Monocytes,A15.145.229.637.555.652
20225236,2010-05-01T00:00:00,Monocytes,A15.378.316.580
20225236,2010-05-01T00:00:00,Monocytes,A15.382.490.555.652
20225236,2010-05-01T00:00:00,Monocytes,A15.382.680.547
20225236,2010-05-01T00:00:00,Monocytes,A15.382.812.547
20225236,2010-05-01T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.260.108.820
20225236,2010-05-01T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.624.664.700.182
20225236,2010-05-01T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.660.763
20225236,2010-05-01T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.930.127.820
20225236,2010-05-01T00:00:00,Simvastatin,D02.455.426.559.847.638.400.900
20225236,2010-05-01T00:00:00,Simvastatin,D04.615.638.400.900
20225236,2010-05-01T00:00:00,Tissue Inhibitor of Metalloproteinases,D12.776.926
20225966,2010-05-01T00:00:00,Carrier State,N06.850.160
20225966,2010-05-01T00:00:00,"Hospitals, University",N02.278.020.300.310
20225966,2010-05-01T00:00:00,"Hospitals, University",N02.278.421.639.725
20225966,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20225966,2010-05-01T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.300.390.400.800.750.100.500
20225966,2010-05-01T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.510.100.750.750.100.500
20225966,2010-05-01T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.510.400.790.750.100.500
20225966,2010-05-01T00:00:00,Middle Aged,M01.060.116.630
20225966,2010-05-01T00:00:00,Nasal Cavity,A04.531.449
20225966,2010-05-01T00:00:00,Population Surveillance,E05.318.308.250.700
20225966,2010-05-01T00:00:00,Population Surveillance,N05.715.360.300.375.625
20225966,2010-05-01T00:00:00,Population Surveillance,N06.850.520.308.250.700
20225966,2010-05-01T00:00:00,Population Surveillance,N06.850.780.675
20225966,2010-05-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20225966,2010-05-01T00:00:00,Risk Factors,N05.715.350.200.700
20225966,2010-05-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20225966,2010-05-01T00:00:00,Risk Factors,N06.850.490.625.750
20225966,2010-05-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20225966,2010-05-01T00:00:00,South Carolina,Z01.107.567.875.075.662
20225966,2010-05-01T00:00:00,South Carolina,Z01.107.567.875.750.700
20225966,2010-05-01T00:00:00,Staphylococcal Infections,C01.252.410.868
20228671,2010-05-01T00:00:00,Evidence-Based Medicine,H02.249.750
20228671,2010-05-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
20228671,2010-05-01T00:00:00,Heart Diseases,C14.280
20228671,2010-05-01T00:00:00,"History, 20th Century",K01.400.504.968
20228671,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20228671,2010-05-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
20228671,2010-05-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
20334489,2010-05-01T00:00:00,Head and Neck Neoplasms,C04.588.443
20334489,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20334489,2010-05-01T00:00:00,Sphingolipids,D10.570.877
20334489,2010-05-01T00:00:00,Sphingolipids,D10.808
20371835,2010-05-01T00:00:00,Animals,B01.050
20371835,2010-05-01T00:00:00,Body Weight,C23.888.144
20371835,2010-05-01T00:00:00,Body Weight,E01.370.600.115.100.160.120
20371835,2010-05-01T00:00:00,Body Weight,E05.041.124.160.750
20371835,2010-05-01T00:00:00,Body Weight,G07.100.100.160.120
20371835,2010-05-01T00:00:00,Body Weight,G07.700.320.249.314.120
20371835,2010-05-01T00:00:00,Chick Embryo,A13.350.150
20371835,2010-05-01T00:00:00,Chick Embryo,A16.331.200
20371835,2010-05-01T00:00:00,Chickens,B01.050.150.900.248.350.150
20371835,2010-05-01T00:00:00,Chickens,B01.050.150.900.248.617.192
20371835,2010-05-01T00:00:00,Glucose,D09.546.359.448
20371835,2010-05-01T00:00:00,Liver,A03.620
20371835,2010-05-01T00:00:00,"Muscle, Skeletal",A02.633.567
20371835,2010-05-01T00:00:00,"Muscle, Skeletal",A10.690.552.500
20371835,2010-05-01T00:00:00,Proteins,D12.776
20371842,2010-05-01T00:00:00,Animals,B01.050
20371842,2010-05-01T00:00:00,Chickens,B01.050.150.900.248.350.150
20371842,2010-05-01T00:00:00,Chickens,B01.050.150.900.248.617.192
20371842,2010-05-01T00:00:00,Dietary Supplements,J02.500.456
20371842,2010-05-01T00:00:00,Mycoplasma Infections,C01.252.400.610.610
20371842,2010-05-01T00:00:00,Mycoplasma gallisepticum,B03.440.560.580.553.553.345
20380904,2010-05-01T00:00:00,Adolescent,M01.060.057
20380904,2010-05-01T00:00:00,Adult,M01.060.116
20380904,2010-05-01T00:00:00,Aged,M01.060.116.100
20380904,2010-05-01T00:00:00,Automobile Driving,I03.125
20380904,2010-05-01T00:00:00,Automobiles,J01.937.500.100
20380904,2010-05-01T00:00:00,Computer Simulation,L01.224.160
20380904,2010-05-01T00:00:00,Eye Movements,G11.427.590.530.140
20380904,2010-05-01T00:00:00,Eye Movements,G14.640.260
20380904,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20380904,2010-05-01T00:00:00,Middle Aged,M01.060.116.630
20380904,2010-05-01T00:00:00,Motion Sickness,C21.335
20380904,2010-05-01T00:00:00,Posture,G11.427.695
20380904,2010-05-01T00:00:00,Questionnaires,E05.318.308.750
20380904,2010-05-01T00:00:00,Questionnaires,L01.280.800
20380904,2010-05-01T00:00:00,Questionnaires,N05.715.360.300.695
20380904,2010-05-01T00:00:00,Questionnaires,N06.850.520.308.750
20380904,2010-05-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20380904,2010-05-01T00:00:00,Risk Factors,N05.715.350.200.700
20380904,2010-05-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20380904,2010-05-01T00:00:00,Risk Factors,N06.850.490.625.750
20380904,2010-05-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20380904,2010-05-01T00:00:00,Young Adult,M01.060.116.815
20381783,2010-05-01T00:00:00,Asthma,C08.127.108
20381783,2010-05-01T00:00:00,Asthma,C08.381.495.108
20381783,2010-05-01T00:00:00,Asthma,C08.674.095
20381783,2010-05-01T00:00:00,Asthma,C20.543.480.680.095
20381783,2010-05-01T00:00:00,Cardiovascular Diseases,C14
20381783,2010-05-01T00:00:00,Child,M01.060.406
20381783,2010-05-01T00:00:00,Child Welfare,I01.880.787.293
20381783,2010-05-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
20381783,2010-05-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
20381783,2010-05-01T00:00:00,Fatty Liver,C06.552.241
20381783,2010-05-01T00:00:00,Health Promotion,N02.370
20381783,2010-05-01T00:00:00,Health Promotion,N02.421.726.507
20381783,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20381783,2010-05-01T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
20381783,2010-05-01T00:00:00,Metabolic Syndrome X,C18.452.625
20381783,2010-05-01T00:00:00,Obesity,C18.654.726.500
20381783,2010-05-01T00:00:00,Obesity,C23.888.144.699.500
20381783,2010-05-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
20381783,2010-05-01T00:00:00,Obesity,G07.100.100.160.120.699.500
20381783,2010-05-01T00:00:00,Pediatrics,H02.403.670
20381783,2010-05-01T00:00:00,Sedentary Lifestyle,F01.829.458.705
20381783,2010-05-01T00:00:00,"Sleep Apnea, Obstructive",C08.618.085.852.850
20381783,2010-05-01T00:00:00,"Sleep Apnea, Obstructive",C10.886.425.800.750.850
20381783,2010-05-01T00:00:00,United States,Z01.107.567.875
20381783,2010-05-01T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
20399394,2010-05-01T00:00:00,Adolescent,M01.060.057
20399394,2010-05-01T00:00:00,Carbamazepine,D03.494.240.127
20399394,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20399394,2010-05-01T00:00:00,Mutation,G05.365.590
20417752,2010-05-01T00:00:00,Adolescent,M01.060.057
20417752,2010-05-01T00:00:00,Adult,M01.060.116
20417752,2010-05-01T00:00:00,Aged,M01.060.116.100
20417752,2010-05-01T00:00:00,Aortic Valve,A07.541.510.110
20417752,2010-05-01T00:00:00,Bioprosthesis,E07.695.100
20417752,2010-05-01T00:00:00,Heart Valve Diseases,C14.280.484
20417752,2010-05-01T00:00:00,Heart Valve Prosthesis,E07.695.310
20417752,2010-05-01T00:00:00,Heart Valve Prosthesis Implantation,E04.100.376.485
20417752,2010-05-01T00:00:00,Heart Valve Prosthesis Implantation,E04.650.410
20417752,2010-05-01T00:00:00,Heart Valve Prosthesis Implantation,E04.928.220.410
20417752,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20417752,2010-05-01T00:00:00,Middle Aged,M01.060.116.630
20417752,2010-05-01T00:00:00,Mitral Valve,A07.541.510.507
20417752,2010-05-01T00:00:00,Postoperative Complications,C23.550.767
20417752,2010-05-01T00:00:00,Probability,E05.318.740.600
20417752,2010-05-01T00:00:00,Probability,G17.680
20417752,2010-05-01T00:00:00,Probability,N05.715.360.750.625
20417752,2010-05-01T00:00:00,Probability,N06.850.520.830.600
20417752,2010-05-01T00:00:00,Prosthesis Design,E05.320.550
20417752,2010-05-01T00:00:00,Prosthesis Design,E07.695.680
20417752,2010-05-01T00:00:00,Prosthesis Failure,C23.550.767.865
20417752,2010-05-01T00:00:00,Prosthesis Failure,E05.325.771
20417752,2010-05-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
20417752,2010-05-01T00:00:00,Risk Assessment,N04.452.871.715
20417752,2010-05-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20417752,2010-05-01T00:00:00,Risk Assessment,N06.850.505.715
20417752,2010-05-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20417752,2010-05-01T00:00:00,Time Factors,G01.910.857
20417752,2010-05-01T00:00:00,Treatment Outcome,E01.789.800
20417752,2010-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20417752,2010-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20417752,2010-05-01T00:00:00,Young Adult,M01.060.116.815
20417774,2010-05-01T00:00:00,Animals,B01.050
20417774,2010-05-01T00:00:00,"Disease Models, Animal",C22.232
20417774,2010-05-01T00:00:00,"Disease Models, Animal",E05.598.500
20417774,2010-05-01T00:00:00,"Disease Models, Animal",E05.599.395.080
20417774,2010-05-01T00:00:00,Heart,A07.541
20417774,2010-05-01T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
20417774,2010-05-01T00:00:00,Kidney,A05.810.453
20417774,2010-05-01T00:00:00,Liver,A03.620
20417774,2010-05-01T00:00:00,Probability,E05.318.740.600
20417774,2010-05-01T00:00:00,Probability,G17.680
20417774,2010-05-01T00:00:00,Probability,N05.715.360.750.625
20417774,2010-05-01T00:00:00,Probability,N06.850.520.830.600
20417774,2010-05-01T00:00:00,Quadriceps Muscle,A02.633.567.850
20417774,2010-05-01T00:00:00,"Spectrometry, Fluorescence",E05.196.712.516.600.676
20417774,2010-05-01T00:00:00,"Spectrometry, Fluorescence",E05.196.867.726
20417774,2010-05-01T00:00:00,Swine,B01.050.150.900.649.077.880
20421057,2010-05-01T00:00:00,Adult,M01.060.116
20421057,2010-05-01T00:00:00,"Financial Management, Hospital",N02.278.354.180
20421057,2010-05-01T00:00:00,"Financial Management, Hospital",N03.219.463.280
20421057,2010-05-01T00:00:00,"Financial Management, Hospital",N04.452.442.180
20421057,2010-05-01T00:00:00,Health Care Costs,N03.219.151.400
20421057,2010-05-01T00:00:00,Health Care Costs,N05.300.375
20421057,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20421057,2010-05-01T00:00:00,Length of Stay,E02.760.400.480
20421057,2010-05-01T00:00:00,Length of Stay,N02.421.585.400.480
20421057,2010-05-01T00:00:00,Trauma Centers,N02.278.354.422.336.500
20421057,2010-05-01T00:00:00,Trauma Centers,N02.421.297.195.480
20421057,2010-05-01T00:00:00,Trauma Centers,N04.452.442.422.336.400
20421057,2010-05-01T00:00:00,United States,Z01.107.567.875
20421057,2010-05-01T00:00:00,Wounds and Injuries,C21.866
20424206,2010-05-01T00:00:00,Adult,M01.060.116
20424206,2010-05-01T00:00:00,Bacteremia,C01.252.100
20424206,2010-05-01T00:00:00,Bacteremia,C01.539.757.100
20424206,2010-05-01T00:00:00,Bacteremia,C23.550.470.790.500.100
20424206,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20424206,2010-05-01T00:00:00,Peritonitis,C06.844.640
20424206,2010-05-01T00:00:00,Sepsis,C01.539.757
20424206,2010-05-01T00:00:00,Sepsis,C23.550.470.790.500
20425806,2010-05-01T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
20425806,2010-05-01T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
20425806,2010-05-01T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
20425806,2010-05-01T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
20425806,2010-05-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
20425806,2010-05-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
20425806,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20425806,2010-05-01T00:00:00,Mutation,G05.365.590
20432291,2010-05-01T00:00:00,Adolescent,M01.060.057
20432291,2010-05-01T00:00:00,Adult,M01.060.116
20432291,2010-05-01T00:00:00,Biological Markers,D23.101
20432291,2010-05-01T00:00:00,Ferritins,D12.776.157.427.249
20432291,2010-05-01T00:00:00,Ferritins,D12.776.556.579.249
20432291,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20432291,2010-05-01T00:00:00,Image Enhancement,E01.370.350.600.350
20432291,2010-05-01T00:00:00,Image Enhancement,L01.224.308.380
20432291,2010-05-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
20432291,2010-05-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
20432291,2010-05-01T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
20432291,2010-05-01T00:00:00,Liver,A03.620
20432291,2010-05-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20432291,2010-05-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20432291,2010-05-01T00:00:00,Young Adult,M01.060.116.815
20435284,2010-05-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
20435284,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20435284,2010-05-01T00:00:00,"Intensive Care, Neonatal",E02.760.190.400.405
20435284,2010-05-01T00:00:00,"Intensive Care, Neonatal",N02.421.088.120.120
20435284,2010-05-01T00:00:00,"Intensive Care, Neonatal",N02.421.585.190.400.405
20435284,2010-05-01T00:00:00,Length of Stay,E02.760.400.480
20435284,2010-05-01T00:00:00,Length of Stay,N02.421.585.400.480
20435284,2010-05-01T00:00:00,Pregnancy,G08.686.785.760.769
20435284,2010-05-01T00:00:00,Pregnancy Outcome,E01.789.700
20435284,2010-05-01T00:00:00,Pregnancy Outcome,G08.686.785.760.769.530
20435284,2010-05-01T00:00:00,Time Factors,G01.910.857
20436166,2010-05-01T00:00:00,Animals,B01.050
20436166,2010-05-01T00:00:00,Cardiomegaly,C14.280.195
20436166,2010-05-01T00:00:00,Cardiomegaly,C23.300.775.250
20436166,2010-05-01T00:00:00,Mass Spectrometry,E05.196.566
20436166,2010-05-01T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
20436166,2010-05-01T00:00:00,"Microscopy, Confocal",E05.595.395
20436166,2010-05-01T00:00:00,Mutation,G05.365.590
20436166,2010-05-01T00:00:00,Myocardium,A02.633.580
20436166,2010-05-01T00:00:00,Myocardium,A07.541.704
20436166,2010-05-01T00:00:00,Myocardium,A10.690.552.750
20436166,2010-05-01T00:00:00,"Myocytes, Cardiac",A07.541.704.570
20436166,2010-05-01T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
20436166,2010-05-01T00:00:00,"Myocytes, Cardiac",A11.620.500
20436166,2010-05-01T00:00:00,Phosphorylation,G02.111.087.677
20436166,2010-05-01T00:00:00,Phosphorylation,G02.149.115.677
20436166,2010-05-01T00:00:00,Phosphorylation,G02.149.465.700
20436166,2010-05-01T00:00:00,Phosphorylation,G02.607.750.700
20436166,2010-05-01T00:00:00,Phosphorylation,G03.495.790
20436166,2010-05-01T00:00:00,Pressure,G01.374.715
20436166,2010-05-01T00:00:00,Serine,D12.125.154.800
20436166,2010-05-01T00:00:00,Serine,D12.125.837
20436201,2010-05-01T00:00:00,Attention,F02.830.104.214
20436201,2010-05-01T00:00:00,Field Dependence-Independence,F02.463.593.343
20436201,2010-05-01T00:00:00,Field Dependence-Independence,F02.463.593.932.345
20436201,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20436201,2010-05-01T00:00:00,Infant,M01.060.703
20436201,2010-05-01T00:00:00,Infant Behavior,F01.145.179.500
20436201,2010-05-01T00:00:00,"Pattern Recognition, Visual",F02.463.593.524.500
20436201,2010-05-01T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.622
20436201,2010-05-01T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.869.435.673
20436201,2010-05-01T00:00:00,Photic Stimulation,E05.723.729
20438889,2010-05-01T00:00:00,Academic Medical Centers,N02.278.020
20438889,2010-05-01T00:00:00,Aged,M01.060.116.100
20438889,2010-05-01T00:00:00,Clinical Competence,I02.399.630.210
20438889,2010-05-01T00:00:00,Clinical Competence,N04.761.210
20438889,2010-05-01T00:00:00,Educational Measurement,I02.399
20438889,2010-05-01T00:00:00,Endoscopy,E01.370.388.250
20438889,2010-05-01T00:00:00,Endoscopy,E04.800.250
20438889,2010-05-01T00:00:00,Forecasting,I01.320
20438889,2010-05-01T00:00:00,Gastroenterology,H02.403.429.405
20438889,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20438889,2010-05-01T00:00:00,Medicare,N03.219.521.346.506.564.663
20438889,2010-05-01T00:00:00,Medicare,N03.219.521.576.343.840
20438889,2010-05-01T00:00:00,Medicare,N03.706.615.696
20438889,2010-05-01T00:00:00,United States,Z01.107.567.875
20438953,2010-05-01T00:00:00,Adolescent,M01.060.057
20438953,2010-05-01T00:00:00,Chronic Disease,C23.550.291.500
20438953,2010-05-01T00:00:00,Constipation,C23.888.821.150
20438953,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20438953,2010-05-01T00:00:00,Video Recording,L01.240.960
20439832,2010-05-01T00:00:00,Adult,M01.060.116
20439832,2010-05-01T00:00:00,Aged,M01.060.116.100
20439832,2010-05-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
20439832,2010-05-01T00:00:00,Double-Blind Method,E05.318.780.300
20439832,2010-05-01T00:00:00,Double-Blind Method,E05.581.500.300
20439832,2010-05-01T00:00:00,Double-Blind Method,N05.715.360.780.320
20439832,2010-05-01T00:00:00,Double-Blind Method,N06.850.520.445.300
20439832,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20439832,2010-05-01T00:00:00,Middle Aged,M01.060.116.630
20439832,2010-05-01T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
20439832,2010-05-01T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
20439832,2010-05-01T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
20439832,2010-05-01T00:00:00,Treatment Outcome,E01.789.800
20439832,2010-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20439832,2010-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20439832,2010-05-01T00:00:00,Young Adult,M01.060.116.815
20446843,2010-05-01T00:00:00,Adult,M01.060.116
20446843,2010-05-01T00:00:00,Athletic Injuries,C21.866.115
20446843,2010-05-01T00:00:00,Continuity of Patient Care,N04.590.233.727.210
20446843,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20446843,2010-05-01T00:00:00,Middle Aged,M01.060.116.630
20446843,2010-05-01T00:00:00,Qualitative Research,H01.770.644.241.850
20446843,2010-05-01T00:00:00,Social Support,I01.880.656.600
20446843,2010-05-01T00:00:00,"Stress, Psychological",F01.145.126.990
20446843,2010-05-01T00:00:00,"Stress, Psychological",F02.830.900
20446843,2010-05-01T00:00:00,United States,Z01.107.567.875
20448521,2010-05-01T00:00:00,Adult,M01.060.116
20448521,2010-05-01T00:00:00,Aged,M01.060.116.100
20448521,2010-05-01T00:00:00,Cognition Disorders,F03.087.250
20448521,2010-05-01T00:00:00,Depression,F01.145.126.350
20448521,2010-05-01T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
20448521,2010-05-01T00:00:00,Electroconvulsive Therapy,F04.570.200.583
20448521,2010-05-01T00:00:00,Electroconvulsive Therapy,F04.669.224.300
20448521,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20448521,2010-05-01T00:00:00,Middle Aged,M01.060.116.630
20448521,2010-05-01T00:00:00,Neuropsychological Tests,F04.711.513
20448521,2010-05-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
20448521,2010-05-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
20448521,2010-05-01T00:00:00,Regression Analysis,E05.318.740.750
20448521,2010-05-01T00:00:00,Regression Analysis,N05.715.360.750.695
20448521,2010-05-01T00:00:00,Regression Analysis,N06.850.520.830.750
20453366,2010-05-01T00:00:00,Adult,M01.060.116
20453366,2010-05-01T00:00:00,Aged,M01.060.116.100
20453366,2010-05-01T00:00:00,Delivery of Health Care,N04.590.374
20453366,2010-05-01T00:00:00,Delivery of Health Care,N05.300
20453366,2010-05-01T00:00:00,Health Expenditures,N03.219.151.450
20453366,2010-05-01T00:00:00,Health Expenditures,N05.300.385
20453366,2010-05-01T00:00:00,Health Status,I01.240.425
20453366,2010-05-01T00:00:00,Health Status,N01.224.425
20453366,2010-05-01T00:00:00,Health Status,N06.850.505.400.425
20453366,2010-05-01T00:00:00,Health Surveys,E05.318.308.250
20453366,2010-05-01T00:00:00,Health Surveys,N05.715.360.300.375
20453366,2010-05-01T00:00:00,Health Surveys,N06.850.520.308.250
20453366,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20453366,2010-05-01T00:00:00,Income,N01.824.417
20453366,2010-05-01T00:00:00,Middle Aged,M01.060.116.630
20453366,2010-05-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
20453366,2010-05-01T00:00:00,Risk Assessment,N04.452.871.715
20453366,2010-05-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20453366,2010-05-01T00:00:00,Risk Assessment,N06.850.505.715
20453366,2010-05-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20453366,2010-05-01T00:00:00,Rural Population,N01.600.725
20455638,2010-05-01T00:00:00,Aged,M01.060.116.100
20455638,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20455638,2010-05-01T00:00:00,Middle Aged,M01.060.116.630
20455638,2010-05-01T00:00:00,Neoplasm Staging,E01.370.550
20455638,2010-05-01T00:00:00,Patient Preference,N04.452.822.360.600.500
20455638,2010-05-01T00:00:00,Patient Preference,N05.300.150.600.630.500
20455638,2010-05-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
20455638,2010-05-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
20455638,2010-05-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
20455638,2010-05-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
20455638,2010-05-01T00:00:00,United States,Z01.107.567.875
20457955,2010-05-01T00:00:00,Aged,M01.060.116.100
20457955,2010-05-01T00:00:00,Blood Pressure,E01.370.600.875.249
20457955,2010-05-01T00:00:00,Blood Pressure,G09.330.380.076
20457955,2010-05-01T00:00:00,Brain,A08.186.211
20457955,2010-05-01T00:00:00,Brain Ischemia,C10.228.140.300.150
20457955,2010-05-01T00:00:00,Brain Ischemia,C14.907.253.092
20457955,2010-05-01T00:00:00,Cerebrovascular Disorders,C10.228.140.300
20457955,2010-05-01T00:00:00,Cerebrovascular Disorders,C14.907.253
20457955,2010-05-01T00:00:00,Disability Evaluation,E01.370.400
20457955,2010-05-01T00:00:00,Homeostasis,G07.700.360
20457955,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20457955,2010-05-01T00:00:00,Hypertension,C14.907.489
20457955,2010-05-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20457955,2010-05-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20457955,2010-05-01T00:00:00,"Nerve Fibers, Myelinated",A08.663.542.512
20457955,2010-05-01T00:00:00,"Nerve Fibers, Myelinated",A11.671.514
20457955,2010-05-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20457955,2010-05-01T00:00:00,Risk Factors,N05.715.350.200.700
20457955,2010-05-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20457955,2010-05-01T00:00:00,Risk Factors,N06.850.490.625.750
20457955,2010-05-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20457956,2010-05-01T00:00:00,Adult,M01.060.116
20457956,2010-05-01T00:00:00,Aged,M01.060.116.100
20457956,2010-05-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
20457956,2010-05-01T00:00:00,Blood Pressure,E01.370.600.875.249
20457956,2010-05-01T00:00:00,Blood Pressure,G09.330.380.076
20457956,2010-05-01T00:00:00,Brain,A08.186.211
20457956,2010-05-01T00:00:00,Emergency Medical Services,N02.421.297
20457956,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20457956,2010-05-01T00:00:00,Hypertension,C14.907.489
20457956,2010-05-01T00:00:00,"Intracranial Hemorrhage, Hypertensive",C10.228.140.300.535.325
20457956,2010-05-01T00:00:00,"Intracranial Hemorrhage, Hypertensive",C14.907.253.573.350
20457956,2010-05-01T00:00:00,Middle Aged,M01.060.116.630
20457956,2010-05-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
20457956,2010-05-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
20457956,2010-05-01T00:00:00,Time Factors,G01.910.857
20457956,2010-05-01T00:00:00,Treatment Outcome,E01.789.800
20457956,2010-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20457956,2010-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20461565,2010-05-01T00:00:00,Family Practice,H02.403.280
20461565,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20461565,2010-05-01T00:00:00,"Medical Records Systems, Computerized",E05.318.308.940.968.625
20461565,2010-05-01T00:00:00,"Medical Records Systems, Computerized",L01.280.900.968.775
20461565,2010-05-01T00:00:00,"Medical Records Systems, Computerized",L01.700.508.300.695
20461565,2010-05-01T00:00:00,"Medical Records Systems, Computerized",N04.452.859.564.650
20461565,2010-05-01T00:00:00,"Medical Records Systems, Computerized",N05.715.360.300.715.500.530
20461565,2010-05-01T00:00:00,"Medical Records Systems, Computerized",N06.850.520.308.940.968.625
20461565,2010-05-01T00:00:00,Quality of Health Care,N04.761
20461565,2010-05-01T00:00:00,Quality of Health Care,N05.715
20461565,2010-05-01T00:00:00,South Carolina,Z01.107.567.875.075.662
20461565,2010-05-01T00:00:00,South Carolina,Z01.107.567.875.750.700
20461784,2010-05-01T00:00:00,Adult,M01.060.116
20461784,2010-05-01T00:00:00,African Americans,M01.686.508.100.100
20461784,2010-05-01T00:00:00,African Americans,M01.686.754.100
20461784,2010-05-01T00:00:00,Aged,M01.060.116.100
20461784,2010-05-01T00:00:00,"Arthritis, Rheumatoid",C05.550.114.154
20461784,2010-05-01T00:00:00,"Arthritis, Rheumatoid",C05.799.114
20461784,2010-05-01T00:00:00,"Arthritis, Rheumatoid",C17.300.775.099
20461784,2010-05-01T00:00:00,"Arthritis, Rheumatoid",C20.111.199
20461784,2010-05-01T00:00:00,Disease Progression,C23.550.291.656
20461784,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20461784,2010-05-01T00:00:00,Middle Aged,M01.060.116.630
20461784,2010-05-01T00:00:00,United States,Z01.107.567.875
20479344,2010-05-01T00:00:00,Adult,M01.060.116
20479344,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20479344,2010-05-01T00:00:00,Middle Aged,M01.060.116.630
20479344,2010-05-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20479344,2010-05-01T00:00:00,Risk Factors,N05.715.350.200.700
20479344,2010-05-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20479344,2010-05-01T00:00:00,Risk Factors,N06.850.490.625.750
20479344,2010-05-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20479344,2010-05-01T00:00:00,Spleen,A10.549.700
20479344,2010-05-01T00:00:00,Spleen,A15.382.520.604.700
20479344,2010-05-01T00:00:00,Splenectomy,E04.726
20479344,2010-05-01T00:00:00,Trauma Centers,N02.278.354.422.336.500
20479344,2010-05-01T00:00:00,Trauma Centers,N02.421.297.195.480
20479344,2010-05-01T00:00:00,Trauma Centers,N04.452.442.422.336.400
20479344,2010-05-01T00:00:00,"Wounds, Nonpenetrating",C21.866.974
20479344,2010-05-01T00:00:00,Young Adult,M01.060.116.815
20488404,2010-05-01T00:00:00,Aged,M01.060.116.100
20488404,2010-05-01T00:00:00,Cardiovascular Agents,D27.505.954.411
20488404,2010-05-01T00:00:00,Cardiovascular Diseases,C14
20488404,2010-05-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
20488404,2010-05-01T00:00:00,Coronary Angiography,E01.370.370.050.200
20488404,2010-05-01T00:00:00,Coronary Angiography,E01.370.370.380.200
20488404,2010-05-01T00:00:00,Coronary Restenosis,C14.280.647.250.285.200
20488404,2010-05-01T00:00:00,Coronary Restenosis,C14.907.585.250.285.200
20488404,2010-05-01T00:00:00,Double-Blind Method,E05.318.780.300
20488404,2010-05-01T00:00:00,Double-Blind Method,E05.581.500.300
20488404,2010-05-01T00:00:00,Double-Blind Method,N05.715.360.780.320
20488404,2010-05-01T00:00:00,Double-Blind Method,N06.850.520.445.300
20488404,2010-05-01T00:00:00,Drug-Eluting Stents,E07.695.750.500
20488404,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20488404,2010-05-01T00:00:00,Metals,D01.552
20488404,2010-05-01T00:00:00,Middle Aged,M01.060.116.630
20488404,2010-05-01T00:00:00,Prosthesis Design,E05.320.550
20488404,2010-05-01T00:00:00,Prosthesis Design,E07.695.680
20488404,2010-05-01T00:00:00,Stents,E07.695.750
20488404,2010-05-01T00:00:00,Thrombosis,C14.907.355.830
20488404,2010-05-01T00:00:00,Time Factors,G01.910.857
20488404,2010-05-01T00:00:00,Treatment Outcome,E01.789.800
20488404,2010-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20488404,2010-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20488404,2010-05-01T00:00:00,"Ultrasonography, Interventional",E01.370.350.850.855
20498547,2010-05-01T00:00:00,Angiography,E01.370.350.700.060
20498547,2010-05-01T00:00:00,Angiography,E01.370.370.050
20498547,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20498547,2010-05-01T00:00:00,Pulmonary Artery,A07.231.114.715
20498547,2010-05-01T00:00:00,Young Adult,M01.060.116.815
20506878,2010-05-01T00:00:00,Adolescent,M01.060.057
20506878,2010-05-01T00:00:00,Adult,M01.060.116
20506878,2010-05-01T00:00:00,Alcoholism,C21.739.100.250
20506878,2010-05-01T00:00:00,Alcoholism,F03.900.100.350
20506878,2010-05-01T00:00:00,Biological Markers,D23.101
20506878,2010-05-01T00:00:00,Child,M01.060.406
20506878,2010-05-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
20506878,2010-05-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
20506878,2010-05-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
20506878,2010-05-01T00:00:00,Hospitalization,E02.760.400
20506878,2010-05-01T00:00:00,Hospitalization,N02.421.585.400
20506878,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20506878,2010-05-01T00:00:00,Intensive Care,E02.760.190.400
20506878,2010-05-01T00:00:00,Intensive Care,N02.421.585.190.400
20506878,2010-05-01T00:00:00,Middle Aged,M01.060.116.630
20506878,2010-05-01T00:00:00,Pilot Projects,E05.318.760.750
20506878,2010-05-01T00:00:00,Pilot Projects,E05.337.737
20506878,2010-05-01T00:00:00,Pilot Projects,N05.715.360.775.625
20506878,2010-05-01T00:00:00,Pilot Projects,N06.850.520.450.720
20506878,2010-05-01T00:00:00,Transferrin,D12.776.124.050.800
20506878,2010-05-01T00:00:00,Transferrin,D12.776.124.790.223.839
20506878,2010-05-01T00:00:00,Transferrin,D12.776.157.427.500
20506878,2010-05-01T00:00:00,Transferrin,D12.776.377.715.182.839
20506878,2010-05-01T00:00:00,Transferrin,D12.776.556.579.500
20506878,2010-05-01T00:00:00,Treatment Outcome,E01.789.800
20506878,2010-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20506878,2010-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20506878,2010-05-01T00:00:00,Wounds and Injuries,C21.866
20506878,2010-05-01T00:00:00,Young Adult,M01.060.116.815
20519787,2010-05-01T00:00:00,Adolescent,M01.060.057
20519787,2010-05-01T00:00:00,Child,M01.060.406
20519787,2010-05-01T00:00:00,"Child, Preschool",M01.060.406.448
20519787,2010-05-01T00:00:00,Developmental Disabilities,F03.550.362
20519787,2010-05-01T00:00:00,Fragile X Syndrome,C10.597.606.643.455.500
20519787,2010-05-01T00:00:00,Fragile X Syndrome,C16.131.260.800.300
20519787,2010-05-01T00:00:00,Fragile X Syndrome,C16.320.180.800.300
20519787,2010-05-01T00:00:00,Fragile X Syndrome,C16.320.322.500.500
20519787,2010-05-01T00:00:00,Fragile X Syndrome,C16.320.400.525.500
20519787,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20519787,2010-05-01T00:00:00,Infant,M01.060.703
20519787,2010-05-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20519787,2010-05-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20519787,2010-05-01T00:00:00,Mass Screening,E01.370.500
20519787,2010-05-01T00:00:00,Mass Screening,E05.318.308.250.580
20519787,2010-05-01T00:00:00,Mass Screening,N02.421.143.827.233.443
20519787,2010-05-01T00:00:00,Mass Screening,N02.421.726.233.443
20519787,2010-05-01T00:00:00,Mass Screening,N05.715.360.300.375.500
20519787,2010-05-01T00:00:00,Mass Screening,N06.850.520.308.250.580
20519787,2010-05-01T00:00:00,Mass Screening,N06.850.780.500
20519787,2010-05-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
20519787,2010-05-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
20519787,2010-05-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
20519787,2010-05-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
20519787,2010-05-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
20519787,2010-05-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
20525031,2010-05-01T00:00:00,Adult,M01.060.116
20525031,2010-05-01T00:00:00,Behavior Therapy,F04.754.137
20525031,2010-05-01T00:00:00,Bulimia,C23.888.821.645.500
20525031,2010-05-01T00:00:00,Depression,F01.145.126.350
20525031,2010-05-01T00:00:00,Eating Disorders,F03.375
20525031,2010-05-01T00:00:00,Health Surveys,E05.318.308.250
20525031,2010-05-01T00:00:00,Health Surveys,N05.715.360.300.375
20525031,2010-05-01T00:00:00,Health Surveys,N06.850.520.308.250
20525031,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20525031,2010-05-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
20525031,2010-05-01T00:00:00,Substance Abuse Treatment Centers,N02.278.035.128.800
20525031,2010-05-01T00:00:00,Substance Abuse Treatment Centers,N02.278.808.930
20525031,2010-05-01T00:00:00,Substance-Related Disorders,C21.739
20525031,2010-05-01T00:00:00,Substance-Related Disorders,F03.900
20533774,2010-05-01T00:00:00,Adult,M01.060.116
20533774,2010-05-01T00:00:00,African Americans,M01.686.508.100.100
20533774,2010-05-01T00:00:00,African Americans,M01.686.754.100
20533774,2010-05-01T00:00:00,Aged,M01.060.116.100
20533774,2010-05-01T00:00:00,Cardiovascular Diseases,C14
20533774,2010-05-01T00:00:00,Counseling,F02.784.176
20533774,2010-05-01T00:00:00,Counseling,F04.408.413
20533774,2010-05-01T00:00:00,Counseling,N02.421.143.303
20533774,2010-05-01T00:00:00,Counseling,N02.421.461.363
20533774,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20533774,2010-05-01T00:00:00,Middle Aged,M01.060.116.630
20533774,2010-05-01T00:00:00,Neoplasms,C04
20533774,2010-05-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
20533774,2010-05-01T00:00:00,Risk Assessment,N04.452.871.715
20533774,2010-05-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20533774,2010-05-01T00:00:00,Risk Assessment,N06.850.505.715
20533774,2010-05-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20533774,2010-05-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20533774,2010-05-01T00:00:00,Risk Factors,N05.715.350.200.700
20533774,2010-05-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20533774,2010-05-01T00:00:00,Risk Factors,N06.850.490.625.750
20533774,2010-05-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20533774,2010-05-01T00:00:00,Risk-Taking,F01.145.722
20533774,2010-05-01T00:00:00,Urban Population,N01.600.900
20533774,2010-05-01T00:00:00,Young Adult,M01.060.116.815
20539081,2010-05-01T00:00:00,Anti-HIV Agents,D27.505.954.122.388.077.088
20539081,2010-05-01T00:00:00,HIV Infections,C02.782.815.616.400
20539081,2010-05-01T00:00:00,HIV Infections,C02.800.801.400
20539081,2010-05-01T00:00:00,HIV Infections,C20.673.480
20539081,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20539081,2010-05-01T00:00:00,Mass Screening,E01.370.500
20539081,2010-05-01T00:00:00,Mass Screening,E05.318.308.250.580
20539081,2010-05-01T00:00:00,Mass Screening,N02.421.143.827.233.443
20539081,2010-05-01T00:00:00,Mass Screening,N02.421.726.233.443
20539081,2010-05-01T00:00:00,Mass Screening,N05.715.360.300.375.500
20539081,2010-05-01T00:00:00,Mass Screening,N06.850.520.308.250.580
20539081,2010-05-01T00:00:00,Mass Screening,N06.850.780.500
20539081,2010-05-01T00:00:00,Microbial Sensitivity Tests,E05.200.875.595
20539081,2010-05-01T00:00:00,Microbial Sensitivity Tests,E05.337.550.400
20819403,2010-05-01T00:00:00,Adolescent,M01.060.057
20819403,2010-05-01T00:00:00,Attention Deficit Disorder with Hyperactivity,F03.550.150.150
20819403,2010-05-01T00:00:00,Autistic Disorder,F03.550.325.125
20819403,2010-05-01T00:00:00,Child,M01.060.406
20819403,2010-05-01T00:00:00,"Child, Preschool",M01.060.406.448
20819403,2010-05-01T00:00:00,Dental Care for Children,E06.170.152
20819403,2010-05-01T00:00:00,Dental Care for Children,N02.421.240.190.215
20819403,2010-05-01T00:00:00,Health Services Accessibility,N04.590.374.350
20819403,2010-05-01T00:00:00,Health Services Accessibility,N05.300.430
20819403,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20819403,2010-05-01T00:00:00,Infant,M01.060.703
20819403,2010-05-01T00:00:00,United States,Z01.107.567.875
21457638,2010-05-01T00:00:00,Hepatectomy,E04.210.556
21457638,2010-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21457638,2010-05-01T00:00:00,Liver Neoplasms,C04.588.274.623
21457638,2010-05-01T00:00:00,Liver Neoplasms,C06.301.623
21457638,2010-05-01T00:00:00,Liver Neoplasms,C06.552.697
21457638,2010-05-01T00:00:00,Middle Aged,M01.060.116.630
20441793,2010-05-02T00:00:00,Animals,B01.050
20441793,2010-05-02T00:00:00,"Animals, Newborn",B01.050.050.282
20441793,2010-05-02T00:00:00,Bone Development,G07.700.320.500.325.377.625.100
20441793,2010-05-02T00:00:00,Bone Development,G11.427.590.560.100
20441793,2010-05-02T00:00:00,Cytokines,D12.644.276.374
20441793,2010-05-02T00:00:00,Cytokines,D12.776.467.374
20441793,2010-05-02T00:00:00,Cytokines,D23.529.374
20441793,2010-05-02T00:00:00,"Disease Models, Animal",C22.232
20441793,2010-05-02T00:00:00,"Disease Models, Animal",E05.598.500
20441793,2010-05-02T00:00:00,"Disease Models, Animal",E05.599.395.080
20441793,2010-05-02T00:00:00,Insulin-Like Growth Factor I,D12.644.276.937.400
20441793,2010-05-02T00:00:00,Insulin-Like Growth Factor I,D12.776.124.862.400
20441793,2010-05-02T00:00:00,Insulin-Like Growth Factor I,D12.776.467.937.400
20441793,2010-05-02T00:00:00,Insulin-Like Growth Factor I,D23.529.937.400
20441793,2010-05-02T00:00:00,"Leukodystrophy, Globoid Cell",C10.228.140.163.100.435.825.590
20441793,2010-05-02T00:00:00,"Leukodystrophy, Globoid Cell",C10.314.400.500
20441793,2010-05-02T00:00:00,"Leukodystrophy, Globoid Cell",C16.320.565.189.435.825.590
20441793,2010-05-02T00:00:00,"Leukodystrophy, Globoid Cell",C16.320.565.398.641.803.585
20441793,2010-05-02T00:00:00,"Leukodystrophy, Globoid Cell",C16.320.565.595.554.825.590
20441793,2010-05-02T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.132.100.435.825.590
20441793,2010-05-02T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.584.687.803.585
20441793,2010-05-02T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.648.189.435.825.590
20441793,2010-05-02T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.648.398.641.803.585
20441793,2010-05-02T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.648.595.554.825.590
20441793,2010-05-02T00:00:00,Liver,A03.620
20441793,2010-05-02T00:00:00,Psychosine,D02.033.100.700.700
20441793,2010-05-02T00:00:00,Psychosine,D02.092.063.700.700
20441793,2010-05-02T00:00:00,Psychosine,D09.400.410.420.806
20441793,2010-05-02T00:00:00,Psychosine,D10.390.470.806
20441793,2010-05-02T00:00:00,Psychosine,D10.570.877.360.806
20441793,2010-05-02T00:00:00,Risk Factors,E05.318.740.600.800.725
20441793,2010-05-02T00:00:00,Risk Factors,N05.715.350.200.700
20441793,2010-05-02T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20441793,2010-05-02T00:00:00,Risk Factors,N06.850.490.625.750
20441793,2010-05-02T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20439819,2010-05-03T00:00:00,Age Factors,N05.715.350.075
20439819,2010-05-03T00:00:00,Age Factors,N06.850.490.250
20439819,2010-05-03T00:00:00,Aged,M01.060.116.100
20439819,2010-05-03T00:00:00,Antihypertensive Agents,D27.505.954.411.162
20439819,2010-05-03T00:00:00,Cardiovascular Diseases,C14
20439819,2010-05-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20439819,2010-05-03T00:00:00,Hypertension,C14.907.489
20439819,2010-05-03T00:00:00,Middle Aged,M01.060.116.630
20439819,2010-05-03T00:00:00,Patient Compliance,F01.145.488.500
20439819,2010-05-03T00:00:00,Patient Compliance,N05.300.150.600.600
20439819,2010-05-03T00:00:00,Primary Prevention,N02.421.726.758
20439819,2010-05-03T00:00:00,Primary Prevention,N06.850.780.680
20439819,2010-05-03T00:00:00,Risk Assessment,E05.318.740.600.800.715
20439819,2010-05-03T00:00:00,Risk Assessment,N04.452.871.715
20439819,2010-05-03T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20439819,2010-05-03T00:00:00,Risk Assessment,N06.850.505.715
20439819,2010-05-03T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20439819,2010-05-03T00:00:00,Sex Factors,N05.715.350.675
20439819,2010-05-03T00:00:00,Sex Factors,N06.850.490.875
20441591,2010-05-04T00:00:00,Adult,M01.060.116
20441591,2010-05-04T00:00:00,Communication,F01.145.209
20441591,2010-05-04T00:00:00,Communication,L01.143
20441591,2010-05-04T00:00:00,Environmental Exposure,N06.850.460.350
20441591,2010-05-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20441591,2010-05-04T00:00:00,Polychlorinated Biphenyls,D02.455.426.559.389.185.698
20441591,2010-05-04T00:00:00,Polychlorinated Biphenyls,D02.455.526.439.773
20441591,2010-05-04T00:00:00,Pregnancy,G08.686.785.760.769
20442308,2010-05-04T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
20442308,2010-05-04T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
20442308,2010-05-04T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
20442308,2010-05-04T00:00:00,Apoptosis,G04.299.139.160
20442308,2010-05-04T00:00:00,Calcium,D01.268.552.100
20442308,2010-05-04T00:00:00,Calcium,D01.552.539.288
20442308,2010-05-04T00:00:00,Calcium,D23.119.100
20442308,2010-05-04T00:00:00,Carcinoma,C04.557.470.200
20442308,2010-05-04T00:00:00,Ceramides,D02.065.313
20442308,2010-05-04T00:00:00,Ceramides,D09.400.410.420.525.200
20442308,2010-05-04T00:00:00,Ceramides,D10.390.470.675.200
20442308,2010-05-04T00:00:00,Ceramides,D10.570.877.360.612.200
20442308,2010-05-04T00:00:00,Down-Regulation,G02.111.087.225
20442308,2010-05-04T00:00:00,Down-Regulation,G02.149.115.225
20442308,2010-05-04T00:00:00,Down-Regulation,G05.355.315.200
20442308,2010-05-04T00:00:00,Down-Regulation,G07.690.812.230
20442308,2010-05-04T00:00:00,Down-Regulation,G07.700.680.230
20442308,2010-05-04T00:00:00,Drug Interactions,G07.690.812.240
20442308,2010-05-04T00:00:00,Drug Interactions,G07.700.680.240
20442308,2010-05-04T00:00:00,Heat-Shock Proteins,D12.776.580.216
20442308,2010-05-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20442308,2010-05-04T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
20442308,2010-05-04T00:00:00,Reactive Oxygen Species,D01.339.431
20442308,2010-05-04T00:00:00,Reactive Oxygen Species,D01.650.775
20442308,2010-05-04T00:00:00,Signal Transduction,G02.111.087.800
20442308,2010-05-04T00:00:00,Signal Transduction,G02.149.115.800
20442308,2010-05-04T00:00:00,Signal Transduction,G04.299.880
20442339,2010-05-04T00:00:00,Adolescent,M01.060.057
20442339,2010-05-04T00:00:00,Algorithms,G17.035
20442339,2010-05-04T00:00:00,Algorithms,L01.224.050
20442339,2010-05-04T00:00:00,Asthma,C08.127.108
20442339,2010-05-04T00:00:00,Asthma,C08.381.495.108
20442339,2010-05-04T00:00:00,Asthma,C08.674.095
20442339,2010-05-04T00:00:00,Asthma,C20.543.480.680.095
20442339,2010-05-04T00:00:00,Child,M01.060.406
20442339,2010-05-04T00:00:00,"Child, Preschool",M01.060.406.448
20442339,2010-05-04T00:00:00,Delivery of Health Care,N04.590.374
20442339,2010-05-04T00:00:00,Delivery of Health Care,N05.300
20442339,2010-05-04T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
20442339,2010-05-04T00:00:00,"Emergency Service, Hospital",N02.421.297.195
20442339,2010-05-04T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
20442339,2010-05-04T00:00:00,Health Services Accessibility,N04.590.374.350
20442339,2010-05-04T00:00:00,Health Services Accessibility,N05.300.430
20442339,2010-05-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20442339,2010-05-04T00:00:00,Infant,M01.060.703
20442339,2010-05-04T00:00:00,"Infant, Newborn",M01.060.703.520
20442339,2010-05-04T00:00:00,Patient Care Team,N04.590.715
20442339,2010-05-04T00:00:00,Patient-Centered Care,N04.590.233.675
20442339,2010-05-04T00:00:00,Patient-Centered Care,N04.590.233.727.407
20442339,2010-05-04T00:00:00,Patient-Centered Care,N04.590.720
20442339,2010-05-04T00:00:00,Physician-Patient Relations,F01.829.401.650.675
20442339,2010-05-04T00:00:00,Physician-Patient Relations,N05.300.660.625
20442339,2010-05-04T00:00:00,Poisson Distribution,E05.318.740.994.750
20442339,2010-05-04T00:00:00,Poisson Distribution,G17.820.750
20442339,2010-05-04T00:00:00,Poisson Distribution,N05.715.360.750.750.620
20442339,2010-05-04T00:00:00,Poisson Distribution,N06.850.520.830.994.750
20442339,2010-05-04T00:00:00,Primary Health Care,N04.590.233.727
20442339,2010-05-04T00:00:00,Quality of Health Care,N04.761
20442339,2010-05-04T00:00:00,Quality of Health Care,N05.715
20465566,2010-05-04T00:00:00,Animals,B01.050
20465566,2010-05-04T00:00:00,Arrestins,D12.776.306.090
20465566,2010-05-04T00:00:00,Arrestins,D12.776.543.090
20465566,2010-05-04T00:00:00,Inflammation,C23.550.470
20465566,2010-05-04T00:00:00,Interleukin-10,D12.644.276.374.465.510
20465566,2010-05-04T00:00:00,Interleukin-10,D12.776.467.374.465.510
20465566,2010-05-04T00:00:00,Interleukin-10,D23.529.374.465.510
20465566,2010-05-04T00:00:00,Interleukin-6,D12.644.276.374.465.506
20465566,2010-05-04T00:00:00,Interleukin-6,D12.776.467.374.465.506
20465566,2010-05-04T00:00:00,Interleukin-6,D23.529.374.465.506
20465566,2010-05-04T00:00:00,Liver,A03.620
20465566,2010-05-04T00:00:00,Lung,A04.411
20465566,2010-05-04T00:00:00,Macrophages,A11.329.372
20465566,2010-05-04T00:00:00,Macrophages,A11.627.482
20465566,2010-05-04T00:00:00,Macrophages,A11.733.397
20465566,2010-05-04T00:00:00,Macrophages,A15.382.680.397
20465566,2010-05-04T00:00:00,Macrophages,A15.382.812.522
20465566,2010-05-04T00:00:00,Sepsis,C01.539.757
20465566,2010-05-04T00:00:00,Sepsis,C23.550.470.790.500
20465566,2010-05-04T00:00:00,Spleen,A10.549.700
20465566,2010-05-04T00:00:00,Spleen,A15.382.520.604.700
20465566,2010-05-04T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
20465566,2010-05-04T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
20465566,2010-05-04T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
20465566,2010-05-04T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
20465566,2010-05-04T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
20465566,2010-05-04T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
20465566,2010-05-04T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
20465566,2010-05-04T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
20465566,2010-05-04T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
20465566,2010-05-04T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
20465566,2010-05-04T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
20465566,2010-05-04T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
20465566,2010-05-04T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
20465566,2010-05-04T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
20444266,2010-05-05T00:00:00,Adult,M01.060.116
20444266,2010-05-05T00:00:00,African Americans,M01.686.508.100.100
20444266,2010-05-05T00:00:00,African Americans,M01.686.754.100
20444266,2010-05-05T00:00:00,Alleles,G05.360.340.024.340.030
20444266,2010-05-05T00:00:00,Antibodies,D12.776.124.486.485.114
20444266,2010-05-05T00:00:00,Antibodies,D12.776.124.790.651.114
20444266,2010-05-05T00:00:00,Antibodies,D12.776.377.715.548.114
20444266,2010-05-05T00:00:00,"Arthritis, Rheumatoid",C05.550.114.154
20444266,2010-05-05T00:00:00,"Arthritis, Rheumatoid",C05.799.114
20444266,2010-05-05T00:00:00,"Arthritis, Rheumatoid",C17.300.775.099
20444266,2010-05-05T00:00:00,"Arthritis, Rheumatoid",C20.111.199
20444266,2010-05-05T00:00:00,Hand,A01.378.800.667
20444266,2010-05-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20444266,2010-05-05T00:00:00,Middle Aged,M01.060.116.630
20444266,2010-05-05T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
20445170,2010-05-05T00:00:00,Animals,B01.050
20445170,2010-05-05T00:00:00,Cell Line,A11.251.210
20445170,2010-05-05T00:00:00,Kidney Glomerulus,A05.810.453.324.359
20445170,2010-05-05T00:00:00,Kidney Glomerulus,A05.810.453.736.520
20445170,2010-05-05T00:00:00,"Mice, Inbred Strains",B01.050.050.157.520
20445170,2010-05-05T00:00:00,"Mice, Inbred Strains",B01.050.050.199.520.520
20445170,2010-05-05T00:00:00,"Mice, Inbred Strains",B01.050.150.900.649.865.635.505.500.400
20445170,2010-05-05T00:00:00,Mitochondria,A11.284.430.214.190.875.564
20445170,2010-05-05T00:00:00,Mitochondria,A11.284.835.626
20445170,2010-05-05T00:00:00,Oxygen Consumption,G03.730
20445170,2010-05-05T00:00:00,Podocytes,A05.810.453.324.359.720
20445170,2010-05-05T00:00:00,Podocytes,A05.810.453.736.520.720
20445170,2010-05-05T00:00:00,Podocytes,A11.436.720
20445170,2010-05-05T00:00:00,Signal Transduction,G02.111.087.800
20445170,2010-05-05T00:00:00,Signal Transduction,G02.149.115.800
20445170,2010-05-05T00:00:00,Signal Transduction,G04.299.880
20447825,2010-05-05T00:00:00,Adult,M01.060.116
20447825,2010-05-05T00:00:00,Aged,M01.060.116.100
20447825,2010-05-05T00:00:00,Breast Neoplasms,C04.588.180
20447825,2010-05-05T00:00:00,Breast Neoplasms,C17.800.090.500
20447825,2010-05-05T00:00:00,Clinical Trials as Topic,E05.318.760.535
20447825,2010-05-05T00:00:00,Clinical Trials as Topic,E05.337.250
20447825,2010-05-05T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
20447825,2010-05-05T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
20447825,2010-05-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20447825,2010-05-05T00:00:00,Middle Aged,M01.060.116.630
20447825,2010-05-05T00:00:00,Patient Selection,E05.581.500.653
20447825,2010-05-05T00:00:00,Patient Selection,N04.590.731
20447825,2010-05-05T00:00:00,Schizophrenia,F03.700.750
20447825,2010-05-05T00:00:00,Treatment Outcome,E01.789.800
20447825,2010-05-05T00:00:00,Treatment Outcome,N04.761.559.590.800
20447825,2010-05-05T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20453546,2010-05-05T00:00:00,Adult,M01.060.116
20453546,2010-05-05T00:00:00,Aged,M01.060.116.100
20453546,2010-05-05T00:00:00,Bandages,E07.101
20453546,2010-05-05T00:00:00,Cellulase,D08.811.277.450.420.200.200
20453546,2010-05-05T00:00:00,Chronic Disease,C23.550.291.500
20453546,2010-05-05T00:00:00,Debridement,E04.176
20453546,2010-05-05T00:00:00,Endoscopy,E01.370.388.250
20453546,2010-05-05T00:00:00,Endoscopy,E04.800.250
20453546,2010-05-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20453546,2010-05-05T00:00:00,Hyaluronic Acid,D09.698.373.475
20453546,2010-05-05T00:00:00,Middle Aged,M01.060.116.630
20453546,2010-05-05T00:00:00,Nasal Cavity,A04.531.449
20453546,2010-05-05T00:00:00,Postoperative Complications,C23.550.767
20453546,2010-05-05T00:00:00,Sinusitis,C08.460.692.752
20453546,2010-05-05T00:00:00,Sinusitis,C08.730.749
20453546,2010-05-05T00:00:00,Sinusitis,C09.603.692.752
20453546,2010-05-05T00:00:00,Treatment Outcome,E01.789.800
20453546,2010-05-05T00:00:00,Treatment Outcome,N04.761.559.590.800
20453546,2010-05-05T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20453546,2010-05-05T00:00:00,Young Adult,M01.060.116.815
20451233,2010-05-06T00:00:00,HSP90 Heat-Shock Proteins,D12.776.580.216.380
20451233,2010-05-06T00:00:00,Host-Pathogen Interactions,G06.590.470
20451233,2010-05-06T00:00:00,Host-Pathogen Interactions,G16.100.380
20451233,2010-05-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20451233,2010-05-06T00:00:00,Lymphocytes,A11.118.637.555.567
20451233,2010-05-06T00:00:00,Lymphocytes,A15.145.229.637.555.567
20451233,2010-05-06T00:00:00,Lymphocytes,A15.382.490.555.567
20451233,2010-05-06T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567
20451233,2010-05-06T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750
20451233,2010-05-06T00:00:00,Mitogen-Activated Protein Kinases,D12.644.360.450
20451233,2010-05-06T00:00:00,Mitogen-Activated Protein Kinases,D12.776.476.450
20334419,2010-05-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20334419,2010-05-07T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
20334419,2010-05-07T00:00:00,Prostatic Neoplasms,C12.294.260.750
20334419,2010-05-07T00:00:00,Prostatic Neoplasms,C12.294.565.625
20334419,2010-05-07T00:00:00,Prostatic Neoplasms,C12.758.409.750
20334419,2010-05-07T00:00:00,Proteomics,H01.158.201.843
20334419,2010-05-07T00:00:00,Proteomics,H01.158.273.180.350.700
20334419,2010-05-07T00:00:00,Proteomics,H01.158.273.343.350.700
20334419,2010-05-07T00:00:00,Proteomics,H01.181.122.738
20334419,2010-05-07T00:00:00,"Tumor Markers, Biological",D23.101.840
20452976,2010-05-07T00:00:00,Animals,B01.050
20452976,2010-05-07T00:00:00,Cell Line,A11.251.210
20452976,2010-05-07T00:00:00,GTP-Binding Protein Regulators,D12.644.360.325
20452976,2010-05-07T00:00:00,GTP-Binding Protein Regulators,D12.776.402
20452976,2010-05-07T00:00:00,GTP-Binding Protein Regulators,D12.776.476.325
20452976,2010-05-07T00:00:00,Homeostasis,G07.700.360
20452976,2010-05-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20452976,2010-05-07T00:00:00,Kidney,A05.810.453
20452976,2010-05-07T00:00:00,"Mutagenesis, Site-Directed",E05.393.420.601.575
20452976,2010-05-07T00:00:00,RGS Proteins,D12.644.360.325.150.750
20452976,2010-05-07T00:00:00,RGS Proteins,D12.776.402.150.750
20452976,2010-05-07T00:00:00,RGS Proteins,D12.776.476.325.150.750
20452976,2010-05-07T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
20453056,2010-05-07T00:00:00,Aged,M01.060.116.100
20453056,2010-05-07T00:00:00,Blood Glucose,D09.546.359.448.500
20453056,2010-05-07T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
20453056,2010-05-07T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
20453056,2010-05-07T00:00:00,Exercise Therapy,E02.779.483
20453056,2010-05-07T00:00:00,Exercise Therapy,E02.831.387
20453056,2010-05-07T00:00:00,Hispanic Americans,M01.686.754.441
20453056,2010-05-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20453056,2010-05-07T00:00:00,Information Dissemination,F01.145.209.364
20453056,2010-05-07T00:00:00,Information Dissemination,L01.143.443
20453056,2010-05-07T00:00:00,Middle Aged,M01.060.116.630
20453056,2010-05-07T00:00:00,Motivation,F01.658
20453056,2010-05-07T00:00:00,Motivation,F01.752.543.500.750
20453056,2010-05-07T00:00:00,Risk Reduction Behavior,F01.145.699
20453056,2010-05-07T00:00:00,Self Care,E02.900
20453056,2010-05-07T00:00:00,Self Care,N02.421.784.680
20453056,2010-05-07T00:00:00,United States,Z01.107.567.875
20457480,2010-05-08T00:00:00,Aged,M01.060.116.100
20457480,2010-05-08T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
20457480,2010-05-08T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
20457480,2010-05-08T00:00:00,Body Mass Index,E01.370.600.115.100.125
20457480,2010-05-08T00:00:00,Body Mass Index,E05.041.124.125
20457480,2010-05-08T00:00:00,Body Mass Index,G07.100.100.125
20457480,2010-05-08T00:00:00,Body Mass Index,N06.850.505.200.100.175
20457480,2010-05-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20457480,2010-05-08T00:00:00,Knee Joint,A02.835.583.475
20457480,2010-05-08T00:00:00,Knee Prosthesis,E07.695.400.410
20457480,2010-05-08T00:00:00,Middle Aged,M01.060.116.630
20457480,2010-05-08T00:00:00,"Models, Theoretical",E05.599
20457480,2010-05-08T00:00:00,Polyethylene,D02.455.326.271.665.550.500
20457480,2010-05-08T00:00:00,Polyethylene,D05.750.716.507.500
20457480,2010-05-08T00:00:00,Polyethylene,D25.720.716.507.500
20457480,2010-05-08T00:00:00,Polyethylene,J01.637.051.720.716.507.500
20457480,2010-05-08T00:00:00,Prosthesis Design,E05.320.550
20457480,2010-05-08T00:00:00,Prosthesis Design,E07.695.680
20438736,2010-05-11T00:00:00,Adenylate Cyclase Toxin,D08.811.520.650.200.040
20438736,2010-05-11T00:00:00,Adenylate Cyclase Toxin,D23.946.123.946.040
20438736,2010-05-11T00:00:00,Adenylate Cyclase Toxin,D23.946.896.980.040
20438736,2010-05-11T00:00:00,Calcium,D01.268.552.100
20438736,2010-05-11T00:00:00,Calcium,D01.552.539.288
20438736,2010-05-11T00:00:00,Calcium,D23.119.100
20438736,2010-05-11T00:00:00,Molecular Sequence Data,L01.453.245.667
20438736,2010-05-11T00:00:00,Polyethylene Glycols,D02.033.455.250.700
20438736,2010-05-11T00:00:00,Polyethylene Glycols,D05.750.741
20438736,2010-05-11T00:00:00,Polyethylene Glycols,D25.720.741
20438736,2010-05-11T00:00:00,Polyethylene Glycols,J01.637.051.720.741
20438736,2010-05-11T00:00:00,Protein Folding,G01.154.100.640
20438736,2010-05-11T00:00:00,Protein Folding,G01.595.100.640
20438736,2010-05-11T00:00:00,Protein Folding,G02.111.087.690
20438736,2010-05-11T00:00:00,Protein Folding,G02.149.115.690
20438736,2010-05-11T00:00:00,"Protein Structure, Secondary",G02.111.570.790.709.600
20438736,2010-05-11T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
20438736,2010-05-11T00:00:00,"Sequence Homology, Amino Acid",G02.111.810.200
20438736,2010-05-11T00:00:00,"Sequence Homology, Amino Acid",G05.810.200
20460606,2010-05-11T00:00:00,Adolescent,M01.060.057
20460606,2010-05-11T00:00:00,Conflict of Interest,K01.316.130
20460606,2010-05-11T00:00:00,Conflict of Interest,N05.350.225
20460606,2010-05-11T00:00:00,Gastroplasty,E02.065.062.750
20460606,2010-05-11T00:00:00,Gastroplasty,E04.062.750
20460606,2010-05-11T00:00:00,Gastroplasty,E04.210.485
20460606,2010-05-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20460606,2010-05-11T00:00:00,Obesity,C18.654.726.500
20460606,2010-05-11T00:00:00,Obesity,C23.888.144.699.500
20460606,2010-05-11T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
20460606,2010-05-11T00:00:00,Obesity,G07.100.100.160.120.699.500
20465991,2010-05-11T00:00:00,Animals,B01.050
20465991,2010-05-11T00:00:00,Anti-Infective Agents,D27.505.954.122
20465991,2010-05-11T00:00:00,Antineoplastic Agents,D27.505.954.248
20465991,2010-05-11T00:00:00,Apoptosis,G04.299.139.160
20465991,2010-05-11T00:00:00,Cisplatin,D01.210.375
20465991,2010-05-11T00:00:00,Cisplatin,D01.625.125
20465991,2010-05-11T00:00:00,Cisplatin,D01.710.100
20465991,2010-05-11T00:00:00,Gentamicins,D09.408.051.374
20465991,2010-05-11T00:00:00,"Kidney Tubules, Proximal",A05.810.453.736.560.570
20465991,2010-05-11T00:00:00,Mitochondria,A11.284.430.214.190.875.564
20465991,2010-05-11T00:00:00,Mitochondria,A11.284.835.626
20465991,2010-05-11T00:00:00,Oxygen Consumption,G03.730
20465991,2010-05-11T00:00:00,Smegmamorpha,B01.050.150.900.493.850
20466059,2010-05-11T00:00:00,Cardiovascular Diseases,C14
20466059,2010-05-11T00:00:00,Central Nervous System Diseases,C10.228
20466059,2010-05-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20466059,2010-05-11T00:00:00,Kidney Diseases,C12.777.419
20466059,2010-05-11T00:00:00,Kidney Diseases,C13.351.968.419
20466059,2010-05-11T00:00:00,Lung Diseases,C08.381
20466059,2010-05-11T00:00:00,Signal Transduction,G02.111.087.800
20466059,2010-05-11T00:00:00,Signal Transduction,G02.149.115.800
20466059,2010-05-11T00:00:00,Signal Transduction,G04.299.880
20705153,2010-05-11T00:00:00,Adult,M01.060.116
20705153,2010-05-11T00:00:00,Contraception,E02.875.194
20705153,2010-05-11T00:00:00,"Contraceptive Agents, Female",D27.505.696.875.360.276
20705153,2010-05-11T00:00:00,"Contraceptive Agents, Female",D27.505.954.705.360.276
20705153,2010-05-11T00:00:00,Estrogens,D27.505.696.399.472.277
20705153,2010-05-11T00:00:00,Hemorrhage,C23.550.414
20705153,2010-05-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20705153,2010-05-11T00:00:00,Patient Satisfaction,N04.452.822.360.600
20705153,2010-05-11T00:00:00,Patient Satisfaction,N05.300.150.600.630
20705153,2010-05-11T00:00:00,Patient Satisfaction,N05.715.360.600
20585424,2010-05-12T00:00:00,Attitude of Health Personnel,F01.100.050
20585424,2010-05-12T00:00:00,Attitude of Health Personnel,N05.300.100
20585424,2010-05-12T00:00:00,"Education, Pharmacy",I02.358.525
20585424,2010-05-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20585424,2010-05-12T00:00:00,Learning,F02.463.425
20585424,2010-05-12T00:00:00,Learning,F02.784.629.529
20585424,2010-05-12T00:00:00,"Schools, Pharmacy",I02.783.660.694
20585424,2010-05-12T00:00:00,"Students, Pharmacy",I02.851.686.768
20585424,2010-05-12T00:00:00,"Students, Pharmacy",M01.848.769.768
20585424,2010-05-12T00:00:00,Teaching,I02.903
20466377,2010-05-13T00:00:00,Case-Control Studies,E05.318.760.500.500
20466377,2010-05-13T00:00:00,Case-Control Studies,N05.715.360.775.175.200
20466377,2010-05-13T00:00:00,Case-Control Studies,N06.850.520.450.500.500
20466377,2010-05-13T00:00:00,Gait,E01.370.600.250
20466377,2010-05-13T00:00:00,Gait,G11.427.590.530.389
20466377,2010-05-13T00:00:00,"Gait Disorders, Neurologic",C10.597.404
20466377,2010-05-13T00:00:00,"Gait Disorders, Neurologic",C23.888.592.413
20466377,2010-05-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20466377,2010-05-13T00:00:00,Leg,A01.378.610.500
20466377,2010-05-13T00:00:00,Middle Aged,M01.060.116.630
20466377,2010-05-13T00:00:00,"Models, Biological",E05.599.395
20466377,2010-05-13T00:00:00,"Muscle, Skeletal",A02.633.567
20466377,2010-05-13T00:00:00,"Muscle, Skeletal",A10.690.552.500
20466377,2010-05-13T00:00:00,Paresis,C10.597.636
20466377,2010-05-13T00:00:00,Paresis,C23.888.592.643
20466377,2010-05-13T00:00:00,Walking,G11.427.590.530.568.900
20466377,2010-05-13T00:00:00,Walking,G11.427.590.530.698.940
20466377,2010-05-13T00:00:00,Walking,I03.450.642.845.940
20471861,2010-05-14T00:00:00,Adolescent,M01.060.057
20471861,2010-05-14T00:00:00,Child,M01.060.406
20471861,2010-05-14T00:00:00,"Child, Preschool",M01.060.406.448
20471861,2010-05-14T00:00:00,Graft Rejection,G12.425.901.545.328
20471861,2010-05-14T00:00:00,Heart,A07.541
20471861,2010-05-14T00:00:00,Heart Transplantation,E04.100.376.475
20471861,2010-05-14T00:00:00,Heart Transplantation,E04.928.220.390
20471861,2010-05-14T00:00:00,Heart Transplantation,E04.936.450.475
20471861,2010-05-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20471861,2010-05-14T00:00:00,Infant,M01.060.703
20471861,2010-05-14T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
20471861,2010-05-14T00:00:00,Young Adult,M01.060.116.815
20472724,2010-05-14T00:00:00,Animals,B01.050
20472724,2010-05-14T00:00:00,Gastrointestinal Tract,A03.556
20472759,2010-05-14T00:00:00,Animals,B01.050
20472759,2010-05-14T00:00:00,"Arrhythmias, Cardiac",C14.280.067
20472759,2010-05-14T00:00:00,"Arrhythmias, Cardiac",C23.550.073
20472759,2010-05-14T00:00:00,Blood Pressure,E01.370.600.875.249
20472759,2010-05-14T00:00:00,Blood Pressure,G09.330.380.076
20472759,2010-05-14T00:00:00,"Cardiac Pacing, Artificial",E02.145
20472759,2010-05-14T00:00:00,"Disease Models, Animal",C22.232
20472759,2010-05-14T00:00:00,"Disease Models, Animal",E05.598.500
20472759,2010-05-14T00:00:00,"Disease Models, Animal",E05.599.395.080
20472759,2010-05-14T00:00:00,Heart Conduction System,A07.541.409
20472759,2010-05-14T00:00:00,Heart Ventricles,A07.541.560
20472759,2010-05-14T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
20472759,2010-05-14T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
20472759,2010-05-14T00:00:00,Recovery of Function,G16.757
20472759,2010-05-14T00:00:00,Swine,B01.050.150.900.649.077.880
20472759,2010-05-14T00:00:00,Time Factors,G01.910.857
20472759,2010-05-14T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
20472759,2010-05-14T00:00:00,Ventricular Pressure,G09.330.190.962.950
20472759,2010-05-14T00:00:00,Ventricular Pressure,G09.330.380.937
20472759,2010-05-14T00:00:00,Ventricular Remodeling,C23.300.985
20472759,2010-05-14T00:00:00,Ventricular Remodeling,G09.330.190.962.975
20483724,2010-05-14T00:00:00,Animals,B01.050
20483724,2010-05-14T00:00:00,Antigen Presentation,G12.425.107
20483724,2010-05-14T00:00:00,Antigen Presentation,G12.450.050.400.070
20483724,2010-05-14T00:00:00,"Antigens, CD",D23.050.301.264.035
20483724,2010-05-14T00:00:00,"Antigens, CD",D23.101.100.110
20483724,2010-05-14T00:00:00,CD4-Positive T-Lymphocytes,A11.118.637.555.567.569.200
20483724,2010-05-14T00:00:00,CD4-Positive T-Lymphocytes,A15.145.229.637.555.567.569.200
20483724,2010-05-14T00:00:00,CD4-Positive T-Lymphocytes,A15.382.490.555.567.569.200
20483724,2010-05-14T00:00:00,Cell Separation,E05.200.500.363
20483724,2010-05-14T00:00:00,Cytokines,D12.644.276.374
20483724,2010-05-14T00:00:00,Cytokines,D12.776.467.374
20483724,2010-05-14T00:00:00,Cytokines,D23.529.374
20483724,2010-05-14T00:00:00,Dendritic Cells,A11.066.270
20483724,2010-05-14T00:00:00,Dendritic Cells,A11.436.270
20483724,2010-05-14T00:00:00,Dendritic Cells,A15.382.066.270
20483724,2010-05-14T00:00:00,Dendritic Cells,A15.382.812.260
20483724,2010-05-14T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
20483724,2010-05-14T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
20483724,2010-05-14T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
20483724,2010-05-14T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
20483724,2010-05-14T00:00:00,Flow Cytometry,E05.200.500.386.350
20483724,2010-05-14T00:00:00,Lymphocyte Activation,E01.450.495.482
20483724,2010-05-14T00:00:00,Lymphocyte Activation,E05.478.594.530
20483724,2010-05-14T00:00:00,Lymphocyte Activation,G12.425.747
20483724,2010-05-14T00:00:00,Lymphocyte Activation,G12.450.050.400.545
19816883,2010-05-15T00:00:00,Animals,B01.050
19816883,2010-05-15T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
19816883,2010-05-15T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
19816883,2010-05-15T00:00:00,Cell Differentiation,G04.299.151
19816883,2010-05-15T00:00:00,Chemokine CXCL13,D12.644.276.374.200.120.650
19816883,2010-05-15T00:00:00,Chemokine CXCL13,D12.776.467.374.200.120.650
19816883,2010-05-15T00:00:00,Chemokine CXCL13,D23.125.300.120.650
19816883,2010-05-15T00:00:00,Chemokine CXCL13,D23.469.200.120.650
19816883,2010-05-15T00:00:00,Chemokine CXCL13,D23.529.374.200.120.650
19816883,2010-05-15T00:00:00,"Disease Models, Animal",C22.232
19816883,2010-05-15T00:00:00,"Disease Models, Animal",E05.598.500
19816883,2010-05-15T00:00:00,"Disease Models, Animal",E05.599.395.080
19816883,2010-05-15T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
19816883,2010-05-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19816883,2010-05-15T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.205.360
19816883,2010-05-15T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.252.445
19816883,2010-05-15T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.525.700.350
19816883,2010-05-15T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.205.360
19816883,2010-05-15T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.252.445
19816883,2010-05-15T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.525.700.350
19816883,2010-05-15T00:00:00,Mouth Neoplasms,C04.588.443.591
19816883,2010-05-15T00:00:00,Mouth Neoplasms,C07.465.565
19816883,2010-05-15T00:00:00,RANK Ligand,D12.644.276.374.750.562
19816883,2010-05-15T00:00:00,RANK Ligand,D12.644.276.972.562
19816883,2010-05-15T00:00:00,RANK Ligand,D12.776.467.374.750.562
19816883,2010-05-15T00:00:00,RANK Ligand,D12.776.467.972.562
19816883,2010-05-15T00:00:00,RANK Ligand,D23.529.374.750.562
19816883,2010-05-15T00:00:00,RANK Ligand,D23.529.972.562
20201067,2010-05-15T00:00:00,"Crystallography, X-Ray",E05.196.309.742.225
20201067,2010-05-15T00:00:00,"Models, Chemical",E05.599.495
20201067,2010-05-15T00:00:00,Molecular Dynamics Simulation,E05.599.595.500
20201067,2010-05-15T00:00:00,Molecular Dynamics Simulation,G02.575.750
20201067,2010-05-15T00:00:00,Molecular Dynamics Simulation,L01.224.160.500
20201067,2010-05-15T00:00:00,Protein Conformation,G02.111.570.790.709
20201067,2010-05-15T00:00:00,Proteins,D12.776
20472461,2010-05-15T00:00:00,Adult,M01.060.116
20472461,2010-05-15T00:00:00,Aged,M01.060.116.100
20472461,2010-05-15T00:00:00,Cerebral Hemorrhage,C10.228.140.300.535.200
20472461,2010-05-15T00:00:00,Cerebral Hemorrhage,C14.907.253.573.200
20472461,2010-05-15T00:00:00,Cerebral Hemorrhage,C23.550.414.913.100
20472461,2010-05-15T00:00:00,"Hospitals, University",N02.278.020.300.310
20472461,2010-05-15T00:00:00,"Hospitals, University",N02.278.421.639.725
20472461,2010-05-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20472461,2010-05-15T00:00:00,Kidney,A05.810.453
20472461,2010-05-15T00:00:00,Middle Aged,M01.060.116.630
20472461,2010-05-15T00:00:00,Nursing Homes,N02.278.825.610
20472461,2010-05-15T00:00:00,Patient Discharge,E02.760.400.610
20472461,2010-05-15T00:00:00,Patient Discharge,N02.421.585.400.610
20472461,2010-05-15T00:00:00,Proteinuria,C12.777.934.734
20472461,2010-05-15T00:00:00,Proteinuria,C13.351.968.934.734
20472461,2010-05-15T00:00:00,Proteinuria,C23.888.942.750
20472461,2010-05-15T00:00:00,Renal Insufficiency,C12.777.419.780
20472461,2010-05-15T00:00:00,Renal Insufficiency,C13.351.968.419.780
20472461,2010-05-15T00:00:00,Risk Assessment,E05.318.740.600.800.715
20472461,2010-05-15T00:00:00,Risk Assessment,N04.452.871.715
20472461,2010-05-15T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20472461,2010-05-15T00:00:00,Risk Assessment,N06.850.505.715
20472461,2010-05-15T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20472461,2010-05-15T00:00:00,Risk Factors,E05.318.740.600.800.725
20472461,2010-05-15T00:00:00,Risk Factors,N05.715.350.200.700
20472461,2010-05-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20472461,2010-05-15T00:00:00,Risk Factors,N06.850.490.625.750
20472461,2010-05-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20472493,2010-05-15T00:00:00,Centers for Disease Control and Prevention (U.S.),I01.409.137.500.600.650.225
20472493,2010-05-15T00:00:00,Centers for Disease Control and Prevention (U.S.),N03.540.348.500.500.600.650.225
20472493,2010-05-15T00:00:00,Information Dissemination,F01.145.209.364
20472493,2010-05-15T00:00:00,Information Dissemination,L01.143.443
20472493,2010-05-15T00:00:00,Internet,L01.224.230.110.500
20472493,2010-05-15T00:00:00,Organizational Objectives,N04.452.615
20472493,2010-05-15T00:00:00,United States,Z01.107.567.875
20473513,2010-05-15T00:00:00,Child,M01.060.406
20473513,2010-05-15T00:00:00,Electroencephalography,E01.370.376.300
20473513,2010-05-15T00:00:00,Electroencephalography,E01.370.405.245
20473513,2010-05-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20473513,2010-05-15T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20473513,2010-05-15T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20222735,2010-05-18T00:00:00,Adsorption,G02.149.047
20222735,2010-05-18T00:00:00,Adsorption,G02.149.767.029
20222735,2010-05-18T00:00:00,Adsorption,G02.842.750.029
20222735,2010-05-18T00:00:00,"Models, Chemical",E05.599.495
20222735,2010-05-18T00:00:00,"Models, Molecular",E05.599.595
20222735,2010-05-18T00:00:00,Molecular Dynamics Simulation,E05.599.595.500
20222735,2010-05-18T00:00:00,Molecular Dynamics Simulation,G02.575.750
20222735,2010-05-18T00:00:00,Molecular Dynamics Simulation,L01.224.160.500
20222735,2010-05-18T00:00:00,Oligopeptides,D12.644.456
20222735,2010-05-18T00:00:00,Proteins,D12.776
20222735,2010-05-18T00:00:00,Surface Properties,G02.842.850
20484042,2010-05-18T00:00:00,Animals,B01.050
20484042,2010-05-18T00:00:00,Cell Adhesion,G04.299.117
20484042,2010-05-18T00:00:00,Endothelial Cells,A11.436.275
20484042,2010-05-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20484042,2010-05-18T00:00:00,Lung Neoplasms,C04.588.894.797.520
20484042,2010-05-18T00:00:00,Lung Neoplasms,C08.381.540
20484042,2010-05-18T00:00:00,Lung Neoplasms,C08.785.520
20485328,2010-05-19T00:00:00,Adult,M01.060.116
20485328,2010-05-19T00:00:00,African Americans,M01.686.508.100.100
20485328,2010-05-19T00:00:00,African Americans,M01.686.754.100
20485328,2010-05-19T00:00:00,European Continental Ancestry Group,M01.686.508.400
20485328,2010-05-19T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
20485328,2010-05-19T00:00:00,Genetic Predisposition to Disease,G05.380.355
20485328,2010-05-19T00:00:00,Genome-Wide Association Study,E05.318.416.249
20485328,2010-05-19T00:00:00,Genome-Wide Association Study,E05.318.780.392
20485328,2010-05-19T00:00:00,Genome-Wide Association Study,E05.393.385.500
20485328,2010-05-19T00:00:00,Genome-Wide Association Study,E05.393.522.500
20485328,2010-05-19T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
20485328,2010-05-19T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
20485328,2010-05-19T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
20485328,2010-05-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20485328,2010-05-19T00:00:00,Linkage Disequilibrium,G05.540.500
20485328,2010-05-19T00:00:00,Middle Aged,M01.060.116.630
20485328,2010-05-19T00:00:00,Phenotype,G05.695
20485328,2010-05-19T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
20485328,2010-05-19T00:00:00,"Receptors, Nicotinic",D12.776.543.750.720.360.550
20485328,2010-05-19T00:00:00,Substance-Related Disorders,C21.739
20485328,2010-05-19T00:00:00,Substance-Related Disorders,F03.900
20485332,2010-05-19T00:00:00,Adolescent,M01.060.057
20485332,2010-05-19T00:00:00,Adult,M01.060.116
20485332,2010-05-19T00:00:00,Biological Markers,D23.101
20485332,2010-05-19T00:00:00,Child,M01.060.406
20485332,2010-05-19T00:00:00,"Child, Preschool",M01.060.406.448
20485332,2010-05-19T00:00:00,Creatinine,D03.383.129.308.207
20485332,2010-05-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20485332,2010-05-19T00:00:00,Kidney Glomerulus,A05.810.453.324.359
20485332,2010-05-19T00:00:00,Kidney Glomerulus,A05.810.453.736.520
20485332,2010-05-19T00:00:00,Middle Aged,M01.060.116.630
20485332,2010-05-19T00:00:00,Remission Induction,E02.860
20485332,2010-05-19T00:00:00,Young Adult,M01.060.116.815
20490536,2010-05-19T00:00:00,Colloids,D20.280
20490536,2010-05-19T00:00:00,Colloids,D26.255.165
20490536,2010-05-19T00:00:00,Colloids,D27.720.280.165
20490536,2010-05-19T00:00:00,"Glycosylation End Products, Advanced",D02.415
20490536,2010-05-19T00:00:00,Gold,D01.268.556.322
20490536,2010-05-19T00:00:00,Gold,D01.268.956.186
20490536,2010-05-19T00:00:00,Gold,D01.552.544.322
20490536,2010-05-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20490536,2010-05-19T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
20490536,2010-05-19T00:00:00,Lysine,D12.125.068.555
20490536,2010-05-19T00:00:00,Lysine,D12.125.095.647
20490536,2010-05-19T00:00:00,Lysine,D12.125.142.497
20490536,2010-05-19T00:00:00,Middle Aged,M01.060.116.630
20490536,2010-05-19T00:00:00,Myocardium,A02.633.580
20490536,2010-05-19T00:00:00,Myocardium,A07.541.704
20490536,2010-05-19T00:00:00,Myocardium,A10.690.552.750
20490536,2010-05-19T00:00:00,Surface Properties,G02.842.850
20538262,2010-05-19T00:00:00,Adolescent,M01.060.057
20538262,2010-05-19T00:00:00,Adult,M01.060.116
20538262,2010-05-19T00:00:00,Amphetamine-Related Disorders,C21.739.225
20538262,2010-05-19T00:00:00,Amphetamine-Related Disorders,F03.900.225
20538262,2010-05-19T00:00:00,Association Learning,F02.463.425.069.296
20538262,2010-05-19T00:00:00,Behavior Therapy,F04.754.137
20538262,2010-05-19T00:00:00,Central Nervous System Stimulants,D27.505.696.282
20538262,2010-05-19T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
20538262,2010-05-19T00:00:00,Cues,F02.463.425.234
20538262,2010-05-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20538262,2010-05-19T00:00:00,Methamphetamine,D02.092.471.683.152.619
20538262,2010-05-19T00:00:00,Middle Aged,M01.060.116.630
20538262,2010-05-19T00:00:00,Treatment Outcome,E01.789.800
20538262,2010-05-19T00:00:00,Treatment Outcome,N04.761.559.590.800
20538262,2010-05-19T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20538262,2010-05-19T00:00:00,Young Adult,M01.060.116.815
20488757,2010-05-20T00:00:00,"Adaptation, Psychological",F01.058
20488757,2010-05-20T00:00:00,Adolescent,M01.060.057
20488757,2010-05-20T00:00:00,Caregivers,M01.085
20488757,2010-05-20T00:00:00,Caregivers,M01.526.485.200
20488757,2010-05-20T00:00:00,Caregivers,N02.360.200
20488757,2010-05-20T00:00:00,Child,M01.060.406
20488757,2010-05-20T00:00:00,Cognitive Therapy,F04.754.137.428
20488757,2010-05-20T00:00:00,Epilepsy,C10.228.140.490
20488757,2010-05-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20488757,2010-05-20T00:00:00,Personality,F01.752
20488757,2010-05-20T00:00:00,Personality Inventory,F04.711.647.513
20488757,2010-05-20T00:00:00,Pilot Projects,E05.318.760.750
20488757,2010-05-20T00:00:00,Pilot Projects,E05.337.737
20488757,2010-05-20T00:00:00,Pilot Projects,N05.715.360.775.625
20488757,2010-05-20T00:00:00,Pilot Projects,N06.850.520.450.720
20488757,2010-05-20T00:00:00,Self Efficacy,F01.752.747.792.700
20488757,2010-05-20T00:00:00,Treatment Outcome,E01.789.800
20488757,2010-05-20T00:00:00,Treatment Outcome,N04.761.559.590.800
20488757,2010-05-20T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20488951,2010-05-20T00:00:00,Animals,B01.050
20488951,2010-05-20T00:00:00,Carrier Proteins,D12.776.157
20488951,2010-05-20T00:00:00,Cell Proliferation,G04.299.233.750
20488951,2010-05-20T00:00:00,Cell Proliferation,G07.700.320.249.410.750
20488951,2010-05-20T00:00:00,Epithelial Cells,A11.436
20488951,2010-05-20T00:00:00,Gene Expression,G05.355.310
20488951,2010-05-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20488951,2010-05-20T00:00:00,Polycystic Kidney Diseases,C12.777.419.403.875
20488951,2010-05-20T00:00:00,Polycystic Kidney Diseases,C13.351.968.419.403.875
20489145,2010-05-20T00:00:00,Animals,B01.050
20489145,2010-05-20T00:00:00,Cesarean Section,E04.520.252.500
20489145,2010-05-20T00:00:00,Cicatrix,A10.165.450.300
20489145,2010-05-20T00:00:00,Cicatrix,C23.550.355.274
20489145,2010-05-20T00:00:00,Cicatrix,G16.100.856.891.249
20489145,2010-05-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20489145,2010-05-20T00:00:00,"Mice, Inbred Strains",B01.050.050.157.520
20489145,2010-05-20T00:00:00,"Mice, Inbred Strains",B01.050.050.199.520.520
20489145,2010-05-20T00:00:00,"Mice, Inbred Strains",B01.050.150.900.649.865.635.505.500.400
20489145,2010-05-20T00:00:00,Pregnancy,G08.686.785.760.769
20489145,2010-05-20T00:00:00,Regeneration,G16.100.856
20489145,2010-05-20T00:00:00,Uterus,A05.360.319.679
20489145,2010-05-20T00:00:00,Wound Healing,G16.100.856.891
20599084,2010-05-20T00:00:00,"Decompression, Surgical",E04.188
20599084,2010-05-20T00:00:00,Endoscopy,E01.370.388.250
20599084,2010-05-20T00:00:00,Endoscopy,E04.800.250
20599084,2010-05-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20599084,2010-05-20T00:00:00,Intraoperative Complications,C23.550.505
20599084,2010-05-20T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20599084,2010-05-20T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20599084,2010-05-20T00:00:00,Oculomotor Muscles,A02.633.567.700
20599084,2010-05-20T00:00:00,Oculomotor Muscles,A09.371.613
20599084,2010-05-20T00:00:00,Otorhinolaryngologic Surgical Procedures,E04.580
20599084,2010-05-20T00:00:00,Paranasal Sinuses,A04.531.621
20599084,2010-05-20T00:00:00,Postoperative Care,E02.760.722.700
20599084,2010-05-20T00:00:00,Postoperative Care,E04.624
20599084,2010-05-20T00:00:00,Postoperative Care,N02.421.585.722.700
20599084,2010-05-20T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20599084,2010-05-20T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20599084,2010-05-20T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20599084,2010-05-20T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20599084,2010-05-20T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20494406,2010-05-21T00:00:00,Esophagus,A03.556.875.500
20494406,2010-05-21T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
20494406,2010-05-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20494406,2010-05-21T00:00:00,Lung,A04.411
20494406,2010-05-21T00:00:00,"Lung Diseases, Interstitial",C08.381.483
20494406,2010-05-21T00:00:00,Manometry,E05.559
20494406,2010-05-21T00:00:00,"Scleroderma, Systemic",C17.300.799
20494406,2010-05-21T00:00:00,"Scleroderma, Systemic",C17.800.784
20620635,2010-05-21T00:00:00,Animals,B01.050
20620635,2010-05-21T00:00:00,Complement Activation,G12.425.255
20620635,2010-05-21T00:00:00,Complement C3,D12.776.124.050.140
20620635,2010-05-21T00:00:00,Complement C3,D12.776.124.486.274.250
20620635,2010-05-21T00:00:00,Epithelial Cells,A11.436
20620635,2010-05-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20620635,2010-05-21T00:00:00,Rhinitis,C08.460.799
20620635,2010-05-21T00:00:00,Rhinitis,C08.730.674
20620635,2010-05-21T00:00:00,Rhinitis,C09.603.799
20620635,2010-05-21T00:00:00,Sinusitis,C08.460.692.752
20620635,2010-05-21T00:00:00,Sinusitis,C08.730.749
20620635,2010-05-21T00:00:00,Sinusitis,C09.603.692.752
20620635,2010-05-21T00:00:00,Smoking,F01.145.466.753
20620635,2010-05-21T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
20620635,2010-05-21T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
20638690,2010-05-22T00:00:00,Adult,M01.060.116
20638690,2010-05-22T00:00:00,Aged,M01.060.116.100
20638690,2010-05-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20638690,2010-05-22T00:00:00,Middle Aged,M01.060.116.630
20638690,2010-05-22T00:00:00,Needs Assessment,I02.594
20638690,2010-05-22T00:00:00,Needs Assessment,N03.349.380.565
20638690,2010-05-22T00:00:00,Needs Assessment,N05.300.537
20638690,2010-05-22T00:00:00,Quality of Life,I01.800
20638690,2010-05-22T00:00:00,Quality of Life,K01.752.400.750
20638690,2010-05-22T00:00:00,Survivors,M01.643.836
20638690,2010-05-22T00:00:00,Survivors,M01.860
20638690,2010-05-22T00:00:00,Young Adult,M01.060.116.815
20498129,2010-05-24T00:00:00,Adolescent,M01.060.057
20498129,2010-05-24T00:00:00,African Americans,M01.686.508.100.100
20498129,2010-05-24T00:00:00,African Americans,M01.686.754.100
20498129,2010-05-24T00:00:00,Child Abuse,I01.198.240.856.350.250
20498129,2010-05-24T00:00:00,Child Abuse,I01.880.735.900.350.250
20498129,2010-05-24T00:00:00,Child Abuse,I01.880.787.293.292
20498129,2010-05-24T00:00:00,Ethnic Groups,M01.686.754
20498129,2010-05-24T00:00:00,Ethnic Groups,N01.224.317
20498129,2010-05-24T00:00:00,European Continental Ancestry Group,M01.686.508.400
20498129,2010-05-24T00:00:00,Health Surveys,E05.318.308.250
20498129,2010-05-24T00:00:00,Health Surveys,N05.715.360.300.375
20498129,2010-05-24T00:00:00,Health Surveys,N06.850.520.308.250
20498129,2010-05-24T00:00:00,Hispanic Americans,M01.686.754.441
20498129,2010-05-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20498129,2010-05-24T00:00:00,United States,Z01.107.567.875
20498374,2010-05-24T00:00:00,Aldehyde Dehydrogenase,D08.811.682.657.163.249
20498374,2010-05-24T00:00:00,Amino Acid Sequence,G02.111.570.060
20498374,2010-05-24T00:00:00,Amino Acid Sequence,L01.453.245.667.060
20498374,2010-05-24T00:00:00,Animals,B01.050
20498374,2010-05-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20498374,2010-05-24T00:00:00,Mitochondria,A11.284.430.214.190.875.564
20498374,2010-05-24T00:00:00,Mitochondria,A11.284.835.626
20498374,2010-05-24T00:00:00,Molecular Sequence Data,L01.453.245.667
20498374,2010-05-24T00:00:00,Oxidoreductases Acting on CH-NH Group Donors,D08.811.682.662
20498374,2010-05-24T00:00:00,Protein Transport,G03.495.166.700
20498374,2010-05-24T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20498374,2010-05-24T00:00:00,"Sequence Homology, Amino Acid",G02.111.810.200
20498374,2010-05-24T00:00:00,"Sequence Homology, Amino Acid",G05.810.200
20498374,2010-05-24T00:00:00,Swine,B01.050.150.900.649.077.880
20498643,2010-05-24T00:00:00,"Adaptor Proteins, Signal Transducing",D12.644.360.024
20498643,2010-05-24T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.157.057
20498643,2010-05-24T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.476.024
20498643,2010-05-24T00:00:00,Amino Acid Sequence,G02.111.570.060
20498643,2010-05-24T00:00:00,Amino Acid Sequence,L01.453.245.667.060
20498643,2010-05-24T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
20498643,2010-05-24T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
20498643,2010-05-24T00:00:00,Case-Control Studies,E05.318.760.500.500
20498643,2010-05-24T00:00:00,Case-Control Studies,N05.715.360.775.175.200
20498643,2010-05-24T00:00:00,Case-Control Studies,N06.850.520.450.500.500
20498643,2010-05-24T00:00:00,Cell Movement,G04.299.283
20498643,2010-05-24T00:00:00,Cell Movement,G07.700.560.500.180
20498643,2010-05-24T00:00:00,Head and Neck Neoplasms,C04.588.443
20498643,2010-05-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20498643,2010-05-24T00:00:00,Molecular Sequence Data,L01.453.245.667
20498643,2010-05-24T00:00:00,Neoplasm Invasiveness,C04.697.645
20498643,2010-05-24T00:00:00,Neoplasm Invasiveness,C23.550.727.645
20498643,2010-05-24T00:00:00,Phosphoproteins,D12.776.744
20498643,2010-05-24T00:00:00,Proteomics,H01.158.201.843
20498643,2010-05-24T00:00:00,Proteomics,H01.158.273.180.350.700
20498643,2010-05-24T00:00:00,Proteomics,H01.158.273.343.350.700
20498643,2010-05-24T00:00:00,Proteomics,H01.181.122.738
20498643,2010-05-24T00:00:00,Tandem Mass Spectrometry,E05.196.566.880
20498643,2010-05-24T00:00:00,Tissue Array Analysis,E05.196.630.570.850
20498643,2010-05-24T00:00:00,Tissue Array Analysis,E05.588.570.850
20498643,2010-05-24T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
20498643,2010-05-24T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
20498643,2010-05-24T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
20499107,2010-05-25T00:00:00,"Adaptation, Psychological",F01.058
20499107,2010-05-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20499107,2010-05-25T00:00:00,Middle Aged,M01.060.116.630
20499107,2010-05-25T00:00:00,Prostatectomy,E04.950.774.860.625
20499107,2010-05-25T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
20499107,2010-05-25T00:00:00,Prostatic Neoplasms,C12.294.260.750
20499107,2010-05-25T00:00:00,Prostatic Neoplasms,C12.294.565.625
20499107,2010-05-25T00:00:00,Prostatic Neoplasms,C12.758.409.750
20499107,2010-05-25T00:00:00,Psychometrics,F04.711.780
20499107,2010-05-25T00:00:00,Quality of Life,I01.800
20499107,2010-05-25T00:00:00,Quality of Life,K01.752.400.750
20499107,2010-05-25T00:00:00,Sexuality,F01.145.802.975
20499107,2010-05-25T00:00:00,Sexuality,G08.686.867
20499107,2010-05-25T00:00:00,Spouses,F01.829.263.500.660
20499107,2010-05-25T00:00:00,Spouses,I01.880.225.500.670
20499107,2010-05-25T00:00:00,Spouses,M01.816
20499107,2010-05-25T00:00:00,"Stress, Psychological",F01.145.126.990
20499107,2010-05-25T00:00:00,"Stress, Psychological",F02.830.900
20499107,2010-05-25T00:00:00,Time Factors,G01.910.857
20501666,2010-05-25T00:00:00,Animals,B01.050
20501666,2010-05-25T00:00:00,Bradykinin,D12.644.276.812.169
20501666,2010-05-25T00:00:00,Bradykinin,D12.644.400.090
20501666,2010-05-25T00:00:00,Bradykinin,D12.644.456.193
20501666,2010-05-25T00:00:00,Bradykinin,D12.776.467.812.169
20501666,2010-05-25T00:00:00,Bradykinin,D12.776.641.650.090
20501666,2010-05-25T00:00:00,Bradykinin,D23.469.050.375.110
20501666,2010-05-25T00:00:00,Bradykinin,D23.529.812.169
20501666,2010-05-25T00:00:00,"Diabetes Mellitus, Experimental",C18.452.394.750.074
20501666,2010-05-25T00:00:00,"Diabetes Mellitus, Experimental",C19.246.240
20501666,2010-05-25T00:00:00,"Diabetes Mellitus, Experimental",E05.598.500.374
20501666,2010-05-25T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
20501666,2010-05-25T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
20501666,2010-05-25T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
20501666,2010-05-25T00:00:00,Heart,A07.541
20501666,2010-05-25T00:00:00,Heart Diseases,C14.280
20501666,2010-05-25T00:00:00,"Mitochondria, Heart",A11.284.430.214.190.875.564.627.603
20501666,2010-05-25T00:00:00,"Mitochondria, Heart",A11.284.835.626.627.603
20501666,2010-05-25T00:00:00,Myocardium,A02.633.580
20501666,2010-05-25T00:00:00,Myocardium,A07.541.704
20501666,2010-05-25T00:00:00,Myocardium,A10.690.552.750
20501666,2010-05-25T00:00:00,Oxidative Stress,G03.495.710
20501666,2010-05-25T00:00:00,Oxidative Stress,G07.700.830.750
20501666,2010-05-25T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.100.080.500
20501666,2010-05-25T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.720.600.220.500
20501666,2010-05-25T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.750.555.220.500
20501666,2010-05-25T00:00:00,Signal Transduction,G02.111.087.800
20501666,2010-05-25T00:00:00,Signal Transduction,G02.149.115.800
20501666,2010-05-25T00:00:00,Signal Transduction,G04.299.880
20501666,2010-05-25T00:00:00,Time Factors,G01.910.857
20501750,2010-05-25T00:00:00,Adolescent,M01.060.057
20501750,2010-05-25T00:00:00,Adult,M01.060.116
20501750,2010-05-25T00:00:00,Biological Markers,D23.101
20501750,2010-05-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20501750,2010-05-25T00:00:00,Middle Aged,M01.060.116.630
20501750,2010-05-25T00:00:00,Nicotine,D03.132.760.570
20501750,2010-05-25T00:00:00,Nicotine,D03.383.725.518
20501750,2010-05-25T00:00:00,Pyridines,D03.383.725
20501750,2010-05-25T00:00:00,Saliva,A12.200.666
20501750,2010-05-25T00:00:00,Smoking,F01.145.466.753
20501750,2010-05-25T00:00:00,Tobacco,B01.650.388.100.905.900
20501750,2010-05-25T00:00:00,Young Adult,M01.060.116.815
20501926,2010-05-26T00:00:00,Adult,M01.060.116
20501926,2010-05-26T00:00:00,Antihypertensive Agents,D27.505.954.411.162
20501926,2010-05-26T00:00:00,Blood Pressure,E01.370.600.875.249
20501926,2010-05-26T00:00:00,Blood Pressure,G09.330.380.076
20501926,2010-05-26T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
20501926,2010-05-26T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
20501926,2010-05-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20501926,2010-05-26T00:00:00,Hypertension,C14.907.489
20501926,2010-05-26T00:00:00,Middle Aged,M01.060.116.630
20501926,2010-05-26T00:00:00,Nutrition Surveys,E05.318.308.250.600
20501926,2010-05-26T00:00:00,Nutrition Surveys,E05.318.308.585.550
20501926,2010-05-26T00:00:00,Nutrition Surveys,N05.715.360.300.375.560
20501926,2010-05-26T00:00:00,Nutrition Surveys,N05.715.360.300.560.565
20501926,2010-05-26T00:00:00,Nutrition Surveys,N06.850.520.308.250.600
20501926,2010-05-26T00:00:00,Nutrition Surveys,N06.850.520.308.585.550
20501926,2010-05-26T00:00:00,United States,Z01.107.567.875
20504946,2010-05-26T00:00:00,Clinical Trials as Topic,E05.318.760.535
20504946,2010-05-26T00:00:00,Clinical Trials as Topic,E05.337.250
20504946,2010-05-26T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
20504946,2010-05-26T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
20504946,2010-05-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20504946,2010-05-26T00:00:00,Nicotine,D03.132.760.570
20504946,2010-05-26T00:00:00,Nicotine,D03.383.725.518
20504946,2010-05-26T00:00:00,Nicotinic Agonists,D27.505.519.625.120.140.700
20504946,2010-05-26T00:00:00,Nicotinic Agonists,D27.505.696.577.120.140.700
20504946,2010-05-26T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
20504946,2010-05-26T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
20504946,2010-05-26T00:00:00,Smoking,F01.145.466.753
20504946,2010-05-26T00:00:00,Smoking Cessation,F01.145.940.700
20504946,2010-05-26T00:00:00,Substance Withdrawal Syndrome,C21.739.835
20504946,2010-05-26T00:00:00,Substance Withdrawal Syndrome,F03.900.825
20504946,2010-05-26T00:00:00,Tobacco Use Disorder,C21.739.912
20504946,2010-05-26T00:00:00,Tobacco Use Disorder,F03.900.912
20505173,2010-05-26T00:00:00,Adult,M01.060.116
20505173,2010-05-26T00:00:00,Aged,M01.060.116.100
20505173,2010-05-26T00:00:00,Carotid Stenosis,C10.228.140.300.200.360
20505173,2010-05-26T00:00:00,Carotid Stenosis,C14.907.137.230
20505173,2010-05-26T00:00:00,Carotid Stenosis,C14.907.253.123.360
20505173,2010-05-26T00:00:00,"Endarterectomy, Carotid",E04.100.814.456.250
20505173,2010-05-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20505173,2010-05-26T00:00:00,Middle Aged,M01.060.116.630
20505173,2010-05-26T00:00:00,Myocardial Infarction,C14.280.647.500
20505173,2010-05-26T00:00:00,Myocardial Infarction,C14.907.585.500
20505173,2010-05-26T00:00:00,Quality of Life,I01.800
20505173,2010-05-26T00:00:00,Quality of Life,K01.752.400.750
20505173,2010-05-26T00:00:00,Stents,E07.695.750
20505173,2010-05-26T00:00:00,Stroke,C10.228.140.300.775
20505173,2010-05-26T00:00:00,Stroke,C14.907.253.855
20516710,2010-05-26T00:00:00,Creatinine,D03.383.129.308.207
20516710,2010-05-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20516710,2010-05-26T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
20516710,2010-05-26T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
20516710,2010-05-26T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
20516710,2010-05-26T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
20516710,2010-05-26T00:00:00,Middle Aged,M01.060.116.630
20516710,2010-05-26T00:00:00,Nutrition Surveys,E05.318.308.250.600
20516710,2010-05-26T00:00:00,Nutrition Surveys,E05.318.308.585.550
20516710,2010-05-26T00:00:00,Nutrition Surveys,N05.715.360.300.375.560
20516710,2010-05-26T00:00:00,Nutrition Surveys,N05.715.360.300.560.565
20516710,2010-05-26T00:00:00,Nutrition Surveys,N06.850.520.308.250.600
20516710,2010-05-26T00:00:00,Nutrition Surveys,N06.850.520.308.585.550
20516710,2010-05-26T00:00:00,Risk Factors,E05.318.740.600.800.725
20516710,2010-05-26T00:00:00,Risk Factors,N05.715.350.200.700
20516710,2010-05-26T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20516710,2010-05-26T00:00:00,Risk Factors,N06.850.490.625.750
20516710,2010-05-26T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20516710,2010-05-26T00:00:00,Stroke,C10.228.140.300.775
20516710,2010-05-26T00:00:00,Stroke,C14.907.253.855
20516710,2010-05-26T00:00:00,Survivors,M01.643.836
20516710,2010-05-26T00:00:00,Survivors,M01.860
20516710,2010-05-26T00:00:00,United States,Z01.107.567.875
20537811,2010-05-26T00:00:00,Alcoholism,C21.739.100.250
20537811,2010-05-26T00:00:00,Alcoholism,F03.900.100.350
20537811,2010-05-26T00:00:00,Cognitive Therapy,F04.754.137.428
20537811,2010-05-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20537811,2010-05-26T00:00:00,Patient Education as Topic,I02.233.332.500
20537811,2010-05-26T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
20537811,2010-05-26T00:00:00,Patient Education as Topic,N02.421.726.407.680
20537811,2010-05-26T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
20537811,2010-05-26T00:00:00,Treatment Outcome,E01.789.800
20537811,2010-05-26T00:00:00,Treatment Outcome,N04.761.559.590.800
20537811,2010-05-26T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20537811,2010-05-26T00:00:00,United States,Z01.107.567.875
20410854,2010-05-27T00:00:00,Acyclovir,D03.438.759.758.399.454.250
20410854,2010-05-27T00:00:00,Adult,M01.060.116
20410854,2010-05-27T00:00:00,Aged,M01.060.116.100
20410854,2010-05-27T00:00:00,Antiviral Agents,D27.505.954.122.388
20410854,2010-05-27T00:00:00,Cytomegalovirus,B04.280.382.150.150
20410854,2010-05-27T00:00:00,Cytomegalovirus,B04.909.204.382.150.150
20410854,2010-05-27T00:00:00,Ganciclovir,D03.438.759.758.399.454.250.300
20410854,2010-05-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20410854,2010-05-27T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
20410854,2010-05-27T00:00:00,Middle Aged,M01.060.116.630
20410854,2010-05-27T00:00:00,Organ Transplantation,E04.936.450
20410854,2010-05-27T00:00:00,Patient Selection,E05.581.500.653
20410854,2010-05-27T00:00:00,Patient Selection,N04.590.731
20410854,2010-05-27T00:00:00,Risk Assessment,E05.318.740.600.800.715
20410854,2010-05-27T00:00:00,Risk Assessment,N04.452.871.715
20410854,2010-05-27T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20410854,2010-05-27T00:00:00,Risk Assessment,N06.850.505.715
20410854,2010-05-27T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20410854,2010-05-27T00:00:00,Risk Factors,E05.318.740.600.800.725
20410854,2010-05-27T00:00:00,Risk Factors,N05.715.350.200.700
20410854,2010-05-27T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20410854,2010-05-27T00:00:00,Risk Factors,N06.850.490.625.750
20410854,2010-05-27T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20438064,2010-05-27T00:00:00,Animals,B01.050
20438064,2010-05-27T00:00:00,Antimalarials,D27.505.954.122.250.100.085
20438064,2010-05-27T00:00:00,Aspartic Acid Endopeptidases,D08.811.277.656.074.500
20438064,2010-05-27T00:00:00,Aspartic Acid Endopeptidases,D08.811.277.656.300.048
20438064,2010-05-27T00:00:00,CHO Cells,A11.251.210.200
20438064,2010-05-27T00:00:00,CHO Cells,A11.436.155
20438064,2010-05-27T00:00:00,Cricetinae,B01.050.150.900.649.865.635.150
20438064,2010-05-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20438064,2010-05-27T00:00:00,"Models, Molecular",E05.599.595
20438064,2010-05-27T00:00:00,Protozoan Proteins,D12.776.820
20438064,2010-05-27T00:00:00,Pyridines,D03.383.725
20505177,2010-05-27T00:00:00,Cardiac Surgical Procedures,E04.100.376
20505177,2010-05-27T00:00:00,Cardiac Surgical Procedures,E04.928.220
20505177,2010-05-27T00:00:00,Heart Transplantation,E04.100.376.475
20505177,2010-05-27T00:00:00,Heart Transplantation,E04.928.220.390
20505177,2010-05-27T00:00:00,Heart Transplantation,E04.936.450.475
20505177,2010-05-27T00:00:00,Heart Ventricles,A07.541.560
20505177,2010-05-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20505177,2010-05-27T00:00:00,Hypoplastic Left Heart Syndrome,C14.240.400.625
20505177,2010-05-27T00:00:00,Hypoplastic Left Heart Syndrome,C14.280.400.625
20505177,2010-05-27T00:00:00,Hypoplastic Left Heart Syndrome,C16.131.240.400.625
20505177,2010-05-27T00:00:00,"Infant, Newborn",M01.060.703.520
20505177,2010-05-27T00:00:00,Postoperative Complications,C23.550.767
20505177,2010-05-27T00:00:00,Pulmonary Artery,A07.231.114.715
20505954,2010-05-27T00:00:00,Albuminuria,C12.777.934.734.269
20505954,2010-05-27T00:00:00,Albuminuria,C13.351.968.934.734.269
20505954,2010-05-27T00:00:00,Albuminuria,C23.888.942.750.269
20505954,2010-05-27T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
20505954,2010-05-27T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
20505954,2010-05-27T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
20505954,2010-05-27T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
20505954,2010-05-27T00:00:00,Blood Pressure,E01.370.600.875.249
20505954,2010-05-27T00:00:00,Blood Pressure,G09.330.380.076
20505954,2010-05-27T00:00:00,Blood Transfusion,E02.095.135
20505954,2010-05-27T00:00:00,Child,M01.060.406
20505954,2010-05-27T00:00:00,Creatinine,D03.383.129.308.207
20505954,2010-05-27T00:00:00,Hemoglobins,D12.776.124.400
20505954,2010-05-27T00:00:00,Hemoglobins,D12.776.422.316.762
20505954,2010-05-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20505954,2010-05-27T00:00:00,Hypertension,C14.907.489
20505954,2010-05-27T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
20505954,2010-05-27T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
20505954,2010-05-27T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
20505954,2010-05-27T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
20505954,2010-05-27T00:00:00,Proteinuria,C12.777.934.734
20505954,2010-05-27T00:00:00,Proteinuria,C13.351.968.934.734
20505954,2010-05-27T00:00:00,Proteinuria,C23.888.942.750
20507990,2010-05-27T00:00:00,Amino Acid Sequence,G02.111.570.060
20507990,2010-05-27T00:00:00,Amino Acid Sequence,L01.453.245.667.060
20507990,2010-05-27T00:00:00,Animals,B01.050
20507990,2010-05-27T00:00:00,Bacterial Proteins,D12.776.097
20507990,2010-05-27T00:00:00,Cell Adhesion,G04.299.117
20507990,2010-05-27T00:00:00,Fibroblasts,A11.329.228
20507990,2010-05-27T00:00:00,Fibroblasts,A11.872.228
20507990,2010-05-27T00:00:00,Fibronectins,D12.776.377.715.390
20507990,2010-05-27T00:00:00,Fibronectins,D12.776.395.550.350
20507990,2010-05-27T00:00:00,Fibronectins,D12.776.543.550.350
20507990,2010-05-27T00:00:00,Fibronectins,D12.776.860.300.450
20507990,2010-05-27T00:00:00,Helicobacter pylori,B03.440.500.550
20507990,2010-05-27T00:00:00,Helicobacter pylori,B03.660.150.280.550
20507990,2010-05-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20507990,2010-05-27T00:00:00,Integrins,D12.776.543.750.705.408
20507990,2010-05-27T00:00:00,Oligopeptides,D12.644.456
20507990,2010-05-27T00:00:00,Phosphotyrosine,D12.125.072.050.875.750
20507990,2010-05-27T00:00:00,Phosphotyrosine,D12.125.740.740
20507990,2010-05-27T00:00:00,Protein-Tyrosine Kinases,D08.811.913.696.620.682.725
20507990,2010-05-27T00:00:00,Signal Transduction,G02.111.087.800
20507990,2010-05-27T00:00:00,Signal Transduction,G02.149.115.800
20507990,2010-05-27T00:00:00,Signal Transduction,G04.299.880
20508070,2010-05-27T00:00:00,Animals,B01.050
20508070,2010-05-27T00:00:00,Anoxia,C23.888.852.079
20508070,2010-05-27T00:00:00,Cell Line,A11.251.210
20508070,2010-05-27T00:00:00,Enzyme Inhibitors,D27.505.519.389
20508070,2010-05-27T00:00:00,Heme,D03.383.129.578.840.500.640.587
20508070,2010-05-27T00:00:00,Heme,D03.549.909.500.640.587
20508070,2010-05-27T00:00:00,Heme,D04.345.783.500.640.587
20508070,2010-05-27T00:00:00,Heme,D23.767.727.640.587
20508070,2010-05-27T00:00:00,Hemoglobins,D12.776.124.400
20508070,2010-05-27T00:00:00,Hemoglobins,D12.776.422.316.762
20508070,2010-05-27T00:00:00,Procollagen-Proline Dioxygenase,D08.811.682.690.708.673
20508182,2010-05-27T00:00:00,Aged,M01.060.116.100
20508182,2010-05-27T00:00:00,Hospitalization,E02.760.400
20508182,2010-05-27T00:00:00,Hospitalization,N02.421.585.400
20508182,2010-05-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20508182,2010-05-27T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
20508182,2010-05-27T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
20508182,2010-05-27T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
20508182,2010-05-27T00:00:00,Middle Aged,M01.060.116.630
20508182,2010-05-27T00:00:00,Patient Discharge,E02.760.400.610
20508182,2010-05-27T00:00:00,Patient Discharge,N02.421.585.400.610
20508182,2010-05-27T00:00:00,Stroke,C10.228.140.300.775
20508182,2010-05-27T00:00:00,Stroke,C14.907.253.855
20508182,2010-05-27T00:00:00,Time Factors,G01.910.857
20508182,2010-05-27T00:00:00,Treatment Outcome,E01.789.800
20508182,2010-05-27T00:00:00,Treatment Outcome,N04.761.559.590.800
20508182,2010-05-27T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20508182,2010-05-27T00:00:00,United States,Z01.107.567.875
20508193,2010-05-27T00:00:00,Adult,M01.060.116
20508193,2010-05-27T00:00:00,Body Weight,C23.888.144
20508193,2010-05-27T00:00:00,Body Weight,E01.370.600.115.100.160.120
20508193,2010-05-27T00:00:00,Body Weight,E05.041.124.160.750
20508193,2010-05-27T00:00:00,Body Weight,G07.100.100.160.120
20508193,2010-05-27T00:00:00,Body Weight,G07.700.320.249.314.120
20508193,2010-05-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20508193,2010-05-27T00:00:00,Middle Aged,M01.060.116.630
20508193,2010-05-27T00:00:00,Nutrition Surveys,E05.318.308.250.600
20508193,2010-05-27T00:00:00,Nutrition Surveys,E05.318.308.585.550
20508193,2010-05-27T00:00:00,Nutrition Surveys,N05.715.360.300.375.560
20508193,2010-05-27T00:00:00,Nutrition Surveys,N05.715.360.300.560.565
20508193,2010-05-27T00:00:00,Nutrition Surveys,N06.850.520.308.250.600
20508193,2010-05-27T00:00:00,Nutrition Surveys,N06.850.520.308.585.550
20508193,2010-05-27T00:00:00,Obesity,C18.654.726.500
20508193,2010-05-27T00:00:00,Obesity,C23.888.144.699.500
20508193,2010-05-27T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
20508193,2010-05-27T00:00:00,Obesity,G07.100.100.160.120.699.500
20508193,2010-05-27T00:00:00,Risk Factors,E05.318.740.600.800.725
20508193,2010-05-27T00:00:00,Risk Factors,N05.715.350.200.700
20508193,2010-05-27T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20508193,2010-05-27T00:00:00,Risk Factors,N06.850.490.625.750
20508193,2010-05-27T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20508193,2010-05-27T00:00:00,Sex Characteristics,G08.686.815
20508193,2010-05-27T00:00:00,Stroke,C10.228.140.300.775
20508193,2010-05-27T00:00:00,Stroke,C14.907.253.855
20508193,2010-05-27T00:00:00,United States,Z01.107.567.875
20541179,2010-05-27T00:00:00,Aged,M01.060.116.100
20541179,2010-05-27T00:00:00,Anxiety Disorders,F03.080
20541179,2010-05-27T00:00:00,"Diagnosis, Differential",E01.171
20541179,2010-05-27T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
20541179,2010-05-27T00:00:00,Disability Evaluation,E01.370.400
20541179,2010-05-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20541179,2010-05-27T00:00:00,Middle Aged,M01.060.116.630
20541179,2010-05-27T00:00:00,"Models, Psychological",E05.599.695
20541179,2010-05-27T00:00:00,Mood Disorders,F03.600
20541179,2010-05-27T00:00:00,Psychiatric Status Rating Scales,F04.586
20541179,2010-05-27T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
20541179,2010-05-27T00:00:00,Veterans,M01.930
20509975,2010-05-31T00:00:00,Animals,B01.050
20509975,2010-05-31T00:00:00,"Carcinoma, Lewis Lung",C04.557.470.200.280
20509975,2010-05-31T00:00:00,"Carcinoma, Lewis Lung",C04.619.230
20509975,2010-05-31T00:00:00,Cell Movement,G04.299.283
20509975,2010-05-31T00:00:00,Cell Movement,G07.700.560.500.180
20509975,2010-05-31T00:00:00,Cell Proliferation,G04.299.233.750
20509975,2010-05-31T00:00:00,Cell Proliferation,G07.700.320.249.410.750
20509975,2010-05-31T00:00:00,Genetic Vectors,G05.360.337
20509975,2010-05-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20509975,2010-05-31T00:00:00,Lentivirus,B04.820.650.589
20509975,2010-05-31T00:00:00,Lentivirus,B04.909.777.731.589
20509975,2010-05-31T00:00:00,Lung Neoplasms,C04.588.894.797.520
20509975,2010-05-31T00:00:00,Lung Neoplasms,C08.381.540
20509975,2010-05-31T00:00:00,Lung Neoplasms,C08.785.520
20509975,2010-05-31T00:00:00,NF-kappa B,D12.776.260.600
20509975,2010-05-31T00:00:00,NF-kappa B,D12.776.660.600
20509975,2010-05-31T00:00:00,NF-kappa B,D12.776.930.600
20509975,2010-05-31T00:00:00,Neoplasm Invasiveness,C04.697.645
20509975,2010-05-31T00:00:00,Neoplasm Invasiveness,C23.550.727.645
20509975,2010-05-31T00:00:00,"Neovascularization, Pathologic",C23.550.589.500
20509975,2010-05-31T00:00:00,Serpins,D12.644.822.750
20509975,2010-05-31T00:00:00,Serpins,D12.644.861
20509975,2010-05-31T00:00:00,Serpins,D12.776.645.750
20509975,2010-05-31T00:00:00,Serpins,D12.776.872
20509975,2010-05-31T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
20509975,2010-05-31T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
20509975,2010-05-31T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
20509975,2010-05-31T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
20509975,2010-05-31T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
20509975,2010-05-31T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
20509975,2010-05-31T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
20509975,2010-05-31T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
20509975,2010-05-31T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
20509975,2010-05-31T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
20509975,2010-05-31T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
20509975,2010-05-31T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
20509975,2010-05-31T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
20509975,2010-05-31T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
20570051,2010-05-31T00:00:00,Adult,M01.060.116
20570051,2010-05-31T00:00:00,Child,M01.060.406
20570051,2010-05-31T00:00:00,Child Abuse,I01.198.240.856.350.250
20570051,2010-05-31T00:00:00,Child Abuse,I01.880.735.900.350.250
20570051,2010-05-31T00:00:00,Child Abuse,I01.880.787.293.292
20570051,2010-05-31T00:00:00,Cocaine-Related Disorders,C21.739.300
20570051,2010-05-31T00:00:00,Cocaine-Related Disorders,F03.900.300
20570051,2010-05-31T00:00:00,Corticotropin-Releasing Hormone,D06.472.699.327.740.140
20570051,2010-05-31T00:00:00,Corticotropin-Releasing Hormone,D12.644.400.400.740.140
20570051,2010-05-31T00:00:00,Corticotropin-Releasing Hormone,D12.644.548.365.740.140
20570051,2010-05-31T00:00:00,Corticotropin-Releasing Hormone,D12.776.641.650.405.740.140
20570051,2010-05-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20570051,2010-05-31T00:00:00,Hydrocortisone,D04.808.745.745.654.600
20570051,2010-05-31T00:00:00,Hydrocortisone,D06.472.040.585.353.476
20570051,2010-05-31T00:00:00,Hydrocortisone,D06.472.040.585.478.392
20570051,2010-05-31T00:00:00,Pituitary-Adrenal System,A06.407.691
20570051,2010-05-31T00:00:00,Psychological Tests,F04.711
20570051,2010-05-31T00:00:00,Sex Characteristics,G08.686.815
20570051,2010-05-31T00:00:00,Social Environment,I01.880.656
20570051,2010-05-31T00:00:00,"Stress, Psychological",F01.145.126.990
20570051,2010-05-31T00:00:00,"Stress, Psychological",F02.830.900
20082174,2010-06-01T00:00:00,Adult,M01.060.116
20082174,2010-06-01T00:00:00,Clinical Competence,I02.399.630.210
20082174,2010-06-01T00:00:00,Clinical Competence,N04.761.210
20082174,2010-06-01T00:00:00,Dentists,M01.526.485.330
20082174,2010-06-01T00:00:00,Dentists,N02.360.330
20082174,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20082174,2010-06-01T00:00:00,Middle Aged,M01.060.116.630
20082174,2010-06-01T00:00:00,Mouth Neoplasms,C04.588.443.591
20082174,2010-06-01T00:00:00,Mouth Neoplasms,C07.465.565
20082174,2010-06-01T00:00:00,Patient Education as Topic,I02.233.332.500
20082174,2010-06-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
20082174,2010-06-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
20082174,2010-06-01T00:00:00,Physicians,M01.526.485.810
20082174,2010-06-01T00:00:00,Physicians,N02.360.810
20082174,2010-06-01T00:00:00,Smoking Cessation,F01.145.940.700
20082174,2010-06-01T00:00:00,South Carolina,Z01.107.567.875.075.662
20082174,2010-06-01T00:00:00,South Carolina,Z01.107.567.875.750.700
20091771,2010-06-01T00:00:00,Animals,B01.050
20091771,2010-06-01T00:00:00,Astrocytes,A08.637.200
20091771,2010-06-01T00:00:00,Astrocytes,A11.650.200
20091771,2010-06-01T00:00:00,Calpain,D08.811.277.656.262.500.120
20091771,2010-06-01T00:00:00,Calpain,D08.811.277.656.300.200.120
20091771,2010-06-01T00:00:00,Chronic Disease,C23.550.291.500
20091771,2010-06-01T00:00:00,Cyclooxygenase 2,D08.811.600.720.750
20091771,2010-06-01T00:00:00,"Disease Models, Animal",C22.232
20091771,2010-06-01T00:00:00,"Disease Models, Animal",E05.598.500
20091771,2010-06-01T00:00:00,"Disease Models, Animal",E05.599.395.080
20091771,2010-06-01T00:00:00,Estrogens,D27.505.696.399.472.277
20091771,2010-06-01T00:00:00,Macrophages,A11.329.372
20091771,2010-06-01T00:00:00,Macrophages,A11.627.482
20091771,2010-06-01T00:00:00,Macrophages,A11.733.397
20091771,2010-06-01T00:00:00,Macrophages,A15.382.680.397
20091771,2010-06-01T00:00:00,Macrophages,A15.382.812.522
20091771,2010-06-01T00:00:00,Motor Activity,F01.145.632
20091771,2010-06-01T00:00:00,Motor Activity,G11.427.590.530.698
20091771,2010-06-01T00:00:00,NF-kappa B,D12.776.260.600
20091771,2010-06-01T00:00:00,NF-kappa B,D12.776.660.600
20091771,2010-06-01T00:00:00,NF-kappa B,D12.776.930.600
20091771,2010-06-01T00:00:00,"Nerve Fibers, Myelinated",A08.663.542.512
20091771,2010-06-01T00:00:00,"Nerve Fibers, Myelinated",A11.671.514
20091771,2010-06-01T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.644.360.075.718
20091771,2010-06-01T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.476.075.718
20091771,2010-06-01T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.624.664.700.169
20091771,2010-06-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20091771,2010-06-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
20091771,2010-06-01T00:00:00,Spinal Cord,A08.186.854
20091771,2010-06-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
20091771,2010-06-01T00:00:00,Spinal Cord Injuries,C10.900.850
20091771,2010-06-01T00:00:00,Spinal Cord Injuries,C21.866.819
20091771,2010-06-01T00:00:00,bcl-2-Associated X Protein,D12.644.360.075.718.400
20091771,2010-06-01T00:00:00,bcl-2-Associated X Protein,D12.776.476.075.718.400
20224428,2010-06-01T00:00:00,Animals,B01.050
20224428,2010-06-01T00:00:00,Apoptosis,G04.299.139.160
20224428,2010-06-01T00:00:00,Calpain,D08.811.277.656.262.500.120
20224428,2010-06-01T00:00:00,Calpain,D08.811.277.656.300.200.120
20224428,2010-06-01T00:00:00,Cardiomegaly,C14.280.195
20224428,2010-06-01T00:00:00,Cardiomegaly,C23.300.775.250
20224428,2010-06-01T00:00:00,Heart Failure,C14.280.434
20224428,2010-06-01T00:00:00,Integrin beta3,D12.776.543.750.705.408.200.750
20224428,2010-06-01T00:00:00,Integrin beta3,D23.050.301.264.035.302
20224428,2010-06-01T00:00:00,Integrin beta3,D23.101.100.110.299
20224428,2010-06-01T00:00:00,Integrins,D12.776.543.750.705.408
20224428,2010-06-01T00:00:00,Myocardium,A02.633.580
20224428,2010-06-01T00:00:00,Myocardium,A07.541.704
20224428,2010-06-01T00:00:00,Myocardium,A10.690.552.750
20224428,2010-06-01T00:00:00,"Myocytes, Cardiac",A07.541.704.570
20224428,2010-06-01T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
20224428,2010-06-01T00:00:00,"Myocytes, Cardiac",A11.620.500
20224428,2010-06-01T00:00:00,Pressure,G01.374.715
20224428,2010-06-01T00:00:00,Signal Transduction,G02.111.087.800
20224428,2010-06-01T00:00:00,Signal Transduction,G02.149.115.800
20224428,2010-06-01T00:00:00,Signal Transduction,G04.299.880
20310056,2010-06-01T00:00:00,African Americans,M01.686.508.100.100
20310056,2010-06-01T00:00:00,African Americans,M01.686.754.100
20310056,2010-06-01T00:00:00,Early Detection of Cancer,E01.390.500
20310056,2010-06-01T00:00:00,Healthcare Disparities,N04.590.374.380
20310056,2010-06-01T00:00:00,Healthcare Disparities,N05.300.493
20310056,2010-06-01T00:00:00,Hispanic Americans,M01.686.754.441
20310056,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20310056,2010-06-01T00:00:00,Papillomavirus Vaccines,D20.215.894.899.498
20310056,2010-06-01T00:00:00,United States,Z01.107.567.875
20310056,2010-06-01T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
20310056,2010-06-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
20310056,2010-06-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
20310056,2010-06-01T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
20385341,2010-06-01T00:00:00,Adult,M01.060.116
20385341,2010-06-01T00:00:00,Anxiety,F01.470.132
20385341,2010-06-01T00:00:00,Eating Disorders,F03.375
20385341,2010-06-01T00:00:00,Gonadal Steroid Hormones,D06.472.334.851
20385341,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20385341,2010-06-01T00:00:00,Mood Disorders,F03.600
20385341,2010-06-01T00:00:00,Psychotherapy,F04.754
20385341,2010-06-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20385341,2010-06-01T00:00:00,Risk Factors,N05.715.350.200.700
20385341,2010-06-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20385341,2010-06-01T00:00:00,Risk Factors,N06.850.490.625.750
20385341,2010-06-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20385341,2010-06-01T00:00:00,Sex Factors,N05.715.350.675
20385341,2010-06-01T00:00:00,Sex Factors,N06.850.490.875
20385341,2010-06-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
20385341,2010-06-01T00:00:00,"Stress, Psychological",F01.145.126.990
20385341,2010-06-01T00:00:00,"Stress, Psychological",F02.830.900
20385341,2010-06-01T00:00:00,Substance-Related Disorders,C21.739
20385341,2010-06-01T00:00:00,Substance-Related Disorders,F03.900
20385341,2010-06-01T00:00:00,Treatment Outcome,E01.789.800
20385341,2010-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20385341,2010-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20390243,2010-06-01T00:00:00,Aged,M01.060.116.100
20390243,2010-06-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
20390243,2010-06-01T00:00:00,Coronary Angiography,E01.370.370.050.200
20390243,2010-06-01T00:00:00,Coronary Angiography,E01.370.370.380.200
20390243,2010-06-01T00:00:00,Coronary Stenosis,C14.280.647.250.285
20390243,2010-06-01T00:00:00,Coronary Stenosis,C14.907.585.250.285
20390243,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20390243,2010-06-01T00:00:00,Middle Aged,M01.060.116.630
20390243,2010-06-01T00:00:00,Radiation Dosage,E05.799.513
20390243,2010-06-01T00:00:00,Radiation Dosage,G01.201.875.740
20390243,2010-06-01T00:00:00,Radiation Dosage,N06.850.810.250
20390243,2010-06-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
20390243,2010-06-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
20390243,2010-06-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
20390243,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20390243,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20390243,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20390243,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20390243,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20406164,2010-06-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
20406164,2010-06-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
20406164,2010-06-01T00:00:00,Glucose,D09.546.359.448
20406164,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20406164,2010-06-01T00:00:00,Hyperglycemia,C18.452.394.952
20406164,2010-06-01T00:00:00,Hypertension,C14.907.489
20406164,2010-06-01T00:00:00,Insulin Resistance,C18.452.394.968.500
20406164,2010-06-01T00:00:00,Insulin Resistance,G07.690.320.617
20406164,2010-06-01T00:00:00,Lipids,D10
20406164,2010-06-01T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
20406164,2010-06-01T00:00:00,Metabolic Syndrome X,C18.452.625
20406164,2010-06-01T00:00:00,Obesity,C18.654.726.500
20406164,2010-06-01T00:00:00,Obesity,C23.888.144.699.500
20406164,2010-06-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
20406164,2010-06-01T00:00:00,Obesity,G07.100.100.160.120.699.500
20407365,2010-06-01T00:00:00,Adult,M01.060.116
20407365,2010-06-01T00:00:00,Aged,M01.060.116.100
20407365,2010-06-01T00:00:00,Animals,B01.050
20407365,2010-06-01T00:00:00,Cell Differentiation,G04.299.151
20407365,2010-06-01T00:00:00,Cell Movement,G04.299.283
20407365,2010-06-01T00:00:00,Cell Movement,G07.700.560.500.180
20407365,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20407365,2010-06-01T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
20407365,2010-06-01T00:00:00,"Microscopy, Confocal",E05.595.395
20407365,2010-06-01T00:00:00,Middle Aged,M01.060.116.630
20407365,2010-06-01T00:00:00,"Muscle, Skeletal",A02.633.567
20407365,2010-06-01T00:00:00,"Muscle, Skeletal",A10.690.552.500
20407365,2010-06-01T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
20407365,2010-06-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20407365,2010-06-01T00:00:00,Reconstructive Surgical Procedures,E04.680
20407365,2010-06-01T00:00:00,Regeneration,G16.100.856
20407365,2010-06-01T00:00:00,"Satellite Cells, Skeletal Muscle",A11.635.500.700
20407365,2010-06-01T00:00:00,"Satellite Cells, Skeletal Muscle",A11.872.645.500.700
20407365,2010-06-01T00:00:00,Stem Cells,A11.872
20407365,2010-06-01T00:00:00,Tissue Engineering,E05.200.249.750
20407365,2010-06-01T00:00:00,Tissue and Organ Harvesting,E01.450.865.820
20407365,2010-06-01T00:00:00,Tissue and Organ Harvesting,E04.932
20407365,2010-06-01T00:00:00,Young Adult,M01.060.116.815
20425588,2010-06-01T00:00:00,Blood Glucose,D09.546.359.448.500
20425588,2010-06-01T00:00:00,"Diabetes, Gestational",C13.703.170
20425588,2010-06-01T00:00:00,"Diabetes, Gestational",C18.452.394.750.448
20425588,2010-06-01T00:00:00,"Diabetes, Gestational",C19.246.200
20425588,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20425588,2010-06-01T00:00:00,Mass Screening,E01.370.500
20425588,2010-06-01T00:00:00,Mass Screening,E05.318.308.250.580
20425588,2010-06-01T00:00:00,Mass Screening,N02.421.143.827.233.443
20425588,2010-06-01T00:00:00,Mass Screening,N02.421.726.233.443
20425588,2010-06-01T00:00:00,Mass Screening,N05.715.360.300.375.500
20425588,2010-06-01T00:00:00,Mass Screening,N06.850.520.308.250.580
20425588,2010-06-01T00:00:00,Mass Screening,N06.850.780.500
20425588,2010-06-01T00:00:00,Postpartum Period,G08.686.702
20425588,2010-06-01T00:00:00,Pregnancy,G08.686.785.760.769
20446739,2010-06-01T00:00:00,Adsorption,G02.149.047
20446739,2010-06-01T00:00:00,Adsorption,G02.149.767.029
20446739,2010-06-01T00:00:00,Adsorption,G02.842.750.029
20446739,2010-06-01T00:00:00,Amines,D02.092
20446739,2010-06-01T00:00:00,Carbon,D01.268.150
20446739,2010-06-01T00:00:00,Water Supply,N06.850.860.510.915
20457417,2010-06-01T00:00:00,Algorithms,G17.035
20457417,2010-06-01T00:00:00,Algorithms,L01.224.050
20457417,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20457417,2010-06-01T00:00:00,Mammography,E01.370.350.700.500
20457417,2010-06-01T00:00:00,"Phantoms, Imaging",E07.671
20457417,2010-06-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
20457417,2010-06-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
20457417,2010-06-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
20457417,2010-06-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
20457417,2010-06-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
20457417,2010-06-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
20457417,2010-06-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
20457417,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20457417,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20457417,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20457417,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20457417,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20470227,2010-06-01T00:00:00,Adolescent,M01.060.057
20470227,2010-06-01T00:00:00,Adult,M01.060.116
20470227,2010-06-01T00:00:00,Aged,M01.060.116.100
20470227,2010-06-01T00:00:00,Diabetes Mellitus,C18.452.394.750
20470227,2010-06-01T00:00:00,Diabetes Mellitus,C19.246
20470227,2010-06-01T00:00:00,Health Services Accessibility,N04.590.374.350
20470227,2010-06-01T00:00:00,Health Services Accessibility,N05.300.430
20470227,2010-06-01T00:00:00,Health Status,I01.240.425
20470227,2010-06-01T00:00:00,Health Status,N01.224.425
20470227,2010-06-01T00:00:00,Health Status,N06.850.505.400.425
20470227,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20470227,2010-06-01T00:00:00,Middle Aged,M01.060.116.630
20470227,2010-06-01T00:00:00,Quality of Health Care,N04.761
20470227,2010-06-01T00:00:00,Quality of Health Care,N05.715
20470227,2010-06-01T00:00:00,Regression Analysis,E05.318.740.750
20470227,2010-06-01T00:00:00,Regression Analysis,N05.715.360.750.695
20470227,2010-06-01T00:00:00,Regression Analysis,N06.850.520.830.750
20470227,2010-06-01T00:00:00,Self Care,E02.900
20470227,2010-06-01T00:00:00,Self Care,N02.421.784.680
20470227,2010-06-01T00:00:00,United States,Z01.107.567.875
20470227,2010-06-01T00:00:00,United States Department of Veterans Affairs,I01.409.137.500.700
20470227,2010-06-01T00:00:00,United States Department of Veterans Affairs,N03.540.348.500.500.700
20470227,2010-06-01T00:00:00,Veterans,M01.930
20470665,2010-06-01T00:00:00,Anti-Infective Agents,D27.505.954.122
20470665,2010-06-01T00:00:00,Chronic Disease,C23.550.291.500
20470665,2010-06-01T00:00:00,Combined Modality Therapy,E02.186
20470665,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20470665,2010-06-01T00:00:00,Nebulizers and Vaporizers,E07.605
20470665,2010-06-01T00:00:00,Nebulizers and Vaporizers,E07.858.400
20470665,2010-06-01T00:00:00,Otorhinolaryngologic Surgical Procedures,E04.580
20470665,2010-06-01T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
20470665,2010-06-01T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
20470665,2010-06-01T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
20473215,2010-06-01T00:00:00,African Americans,M01.686.508.100.100
20473215,2010-06-01T00:00:00,African Americans,M01.686.754.100
20473215,2010-06-01T00:00:00,Aged,M01.060.116.100
20473215,2010-06-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
20473215,2010-06-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
20473215,2010-06-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
20473215,2010-06-01T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
20473215,2010-06-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
20473215,2010-06-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
20473215,2010-06-01T00:00:00,Hispanic Americans,M01.686.754.441
20473215,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20473215,2010-06-01T00:00:00,Hypoglycemic Agents,D27.505.696.422
20473215,2010-06-01T00:00:00,Insulin,D06.472.699.587.740.625
20473215,2010-06-01T00:00:00,Insulin,D12.644.548.586.740.625
20473215,2010-06-01T00:00:00,Middle Aged,M01.060.116.630
20473215,2010-06-01T00:00:00,United States,Z01.107.567.875
20473215,2010-06-01T00:00:00,United States Department of Veterans Affairs,I01.409.137.500.700
20473215,2010-06-01T00:00:00,United States Department of Veterans Affairs,N03.540.348.500.500.700
20473215,2010-06-01T00:00:00,Veterans,M01.930
20489089,2010-06-01T00:00:00,Aged,M01.060.116.100
20489089,2010-06-01T00:00:00,Contrast Media,D27.720.259
20489089,2010-06-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
20489089,2010-06-01T00:00:00,Coronary Angiography,E01.370.370.050.200
20489089,2010-06-01T00:00:00,Coronary Angiography,E01.370.370.380.200
20489089,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20489089,2010-06-01T00:00:00,Pulmonary Embolism,C08.381.746
20489089,2010-06-01T00:00:00,Pulmonary Embolism,C14.907.355.350.700
20489089,2010-06-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
20489089,2010-06-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
20489089,2010-06-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
20489089,2010-06-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
20489089,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20489089,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20489089,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20489089,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20489089,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20489089,2010-06-01T00:00:00,"Ventricular Dysfunction, Right",C14.280.945.910
20494016,2010-06-01T00:00:00,"Ethics, Medical",K01.316.333.132.750
20494016,2010-06-01T00:00:00,"Ethics, Medical",N05.350.340.162.500
20494016,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20494016,2010-06-01T00:00:00,Thoracic Surgical Procedures,E04.928
20494016,2010-06-01T00:00:00,Time Factors,G01.910.857
20494019,2010-06-01T00:00:00,Aged,M01.060.116.100
20494019,2010-06-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
20494019,2010-06-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
20494019,2010-06-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
20494019,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20494019,2010-06-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
20494019,2010-06-01T00:00:00,Lung Neoplasms,C08.381.540
20494019,2010-06-01T00:00:00,Lung Neoplasms,C08.785.520
20494019,2010-06-01T00:00:00,Lymph Node Excision,E04.446
20494019,2010-06-01T00:00:00,Pneumonectomy,E04.928.600.600
20494019,2010-06-01T00:00:00,"Thoracic Surgery, Video-Assisted",E01.370.388.250.840.830
20494019,2010-06-01T00:00:00,"Thoracic Surgery, Video-Assisted",E01.370.388.250.950.830
20494019,2010-06-01T00:00:00,"Thoracic Surgery, Video-Assisted",E04.800.250.840.830
20494019,2010-06-01T00:00:00,"Thoracic Surgery, Video-Assisted",E04.800.250.950.830
20494019,2010-06-01T00:00:00,"Thoracic Surgery, Video-Assisted",E04.928.752.830
20494037,2010-06-01T00:00:00,Aprotinin,D12.776.083
20494037,2010-06-01T00:00:00,Cardiopulmonary Bypass,E04.292.413
20494037,2010-06-01T00:00:00,Cytokines,D12.644.276.374
20494037,2010-06-01T00:00:00,Cytokines,D12.776.467.374
20494037,2010-06-01T00:00:00,Cytokines,D23.529.374
20494037,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20494037,2010-06-01T00:00:00,Infant,M01.060.703
20494037,2010-06-01T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
20494037,2010-06-01T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
20494037,2010-06-01T00:00:00,Serine Proteinase Inhibitors,D27.505.519.389.745.800
20494062,2010-06-01T00:00:00,Cardiac Surgical Procedures,E04.100.376
20494062,2010-06-01T00:00:00,Cardiac Surgical Procedures,E04.928.220
20494062,2010-06-01T00:00:00,"Echocardiography, Transesophageal",E01.370.350.850.220.235
20494062,2010-06-01T00:00:00,"Echocardiography, Transesophageal",E01.370.370.380.220.235
20494062,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20494062,2010-06-01T00:00:00,Infant,M01.060.703
20494062,2010-06-01T00:00:00,"Infant, Low Birth Weight",M01.060.703.520.460
20494062,2010-06-01T00:00:00,"Infant, Newborn",M01.060.703.520
20494062,2010-06-01T00:00:00,Miniaturization,J01.897.520
20494095,2010-06-01T00:00:00,"History, 20th Century",K01.400.504.968
20494095,2010-06-01T00:00:00,Thoracic Surgery,H02.403.810.803
20494095,2010-06-01T00:00:00,Virginia,Z01.107.567.875.075.837
20494095,2010-06-01T00:00:00,Virginia,Z01.107.567.875.750.870
20502767,2010-06-01T00:00:00,Adult,M01.060.116
20502767,2010-06-01T00:00:00,Case-Control Studies,E05.318.760.500.500
20502767,2010-06-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
20502767,2010-06-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
20502767,2010-06-01T00:00:00,Cystic Fibrosis,C06.689.202
20502767,2010-06-01T00:00:00,Cystic Fibrosis,C08.381.187
20502767,2010-06-01T00:00:00,Cystic Fibrosis,C16.320.190
20502767,2010-06-01T00:00:00,Cystic Fibrosis,C16.614.213
20502767,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20502767,2010-06-01T00:00:00,Paranasal Sinuses,A04.531.621
20502767,2010-06-01T00:00:00,Rhinitis,C08.460.799
20502767,2010-06-01T00:00:00,Rhinitis,C08.730.674
20502767,2010-06-01T00:00:00,Rhinitis,C09.603.799
20502767,2010-06-01T00:00:00,Sinusitis,C08.460.692.752
20502767,2010-06-01T00:00:00,Sinusitis,C08.730.749
20502767,2010-06-01T00:00:00,Sinusitis,C09.603.692.752
20502767,2010-06-01T00:00:00,Temporal Bone,A02.835.232.781.885
20502767,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20502767,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20502767,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20502767,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20502767,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20502995,2010-06-01T00:00:00,Acoustic Stimulation,E02.037
20502995,2010-06-01T00:00:00,Acoustic Stimulation,E02.190.888.030
20502995,2010-06-01T00:00:00,Acoustic Stimulation,E05.723.136
20502995,2010-06-01T00:00:00,Adult,M01.060.116
20502995,2010-06-01T00:00:00,Auditory Perception,F02.463.593.071
20502995,2010-06-01T00:00:00,Brain,A08.186.211
20502995,2010-06-01T00:00:00,Brain Mapping,E01.370.350.086
20502995,2010-06-01T00:00:00,Brain Mapping,E01.370.376.149
20502995,2010-06-01T00:00:00,Brain Mapping,E05.132
20502995,2010-06-01T00:00:00,Cues,F02.463.425.234
20502995,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20502995,2010-06-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20502995,2010-06-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20502995,2010-06-01T00:00:00,Middle Aged,M01.060.116.630
20502995,2010-06-01T00:00:00,Movement,G07.700.560
20502995,2010-06-01T00:00:00,Movement,G11.427.590.530
20502995,2010-06-01T00:00:00,Neural Pathways,A08.612
20502995,2010-06-01T00:00:00,"Signal Processing, Computer-Assisted",L01.224.800
20504785,2010-06-01T00:00:00,Animals,B01.050
20504785,2010-06-01T00:00:00,Endosonography,E01.370.350.850.280
20504785,2010-06-01T00:00:00,Laparoscopy,E01.370.388.250.520
20504785,2010-06-01T00:00:00,Laparoscopy,E04.800.250.520
20504785,2010-06-01T00:00:00,"Models, Animal",E05.598
20504785,2010-06-01T00:00:00,"Surgical Procedures, Minimally Invasive",E04.800
20504785,2010-06-01T00:00:00,Swine,B01.050.150.900.649.077.880
20504785,2010-06-01T00:00:00,Water,D01.455.900
20504785,2010-06-01T00:00:00,Water,D01.650.550.925
20507373,2010-06-01T00:00:00,Adult,M01.060.116
20507373,2010-06-01T00:00:00,African Americans,M01.686.508.100.100
20507373,2010-06-01T00:00:00,African Americans,M01.686.754.100
20507373,2010-06-01T00:00:00,Aged,M01.060.116.100
20507373,2010-06-01T00:00:00,Blood Glucose,D09.546.359.448.500
20507373,2010-06-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
20507373,2010-06-01T00:00:00,Body Mass Index,E05.041.124.125
20507373,2010-06-01T00:00:00,Body Mass Index,G07.100.100.125
20507373,2010-06-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
20507373,2010-06-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
20507373,2010-06-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
20507373,2010-06-01T00:00:00,Disease Progression,C23.550.291.656
20507373,2010-06-01T00:00:00,Ethnic Groups,M01.686.754
20507373,2010-06-01T00:00:00,Ethnic Groups,N01.224.317
20507373,2010-06-01T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
20507373,2010-06-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
20507373,2010-06-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
20507373,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20507373,2010-06-01T00:00:00,Hypoglycemic Agents,D27.505.696.422
20507373,2010-06-01T00:00:00,Middle Aged,M01.060.116.630
20507373,2010-06-01T00:00:00,Periodontal Pocket,C07.465.714.533.750
20507373,2010-06-01T00:00:00,Periodontitis,C07.465.714.533
20507373,2010-06-01T00:00:00,Smoking,F01.145.466.753
20507373,2010-06-01T00:00:00,South Carolina,Z01.107.567.875.075.662
20507373,2010-06-01T00:00:00,South Carolina,Z01.107.567.875.750.700
20511051,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20511051,2010-06-01T00:00:00,Vitamin D,D04.808.812.768
20512999,2010-06-01T00:00:00,Adult,M01.060.116
20512999,2010-06-01T00:00:00,Aged,M01.060.116.100
20512999,2010-06-01T00:00:00,Drug-Induced Liver Injury,C06.552.195
20512999,2010-06-01T00:00:00,Drug-Induced Liver Injury,C21.613.260
20512999,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20512999,2010-06-01T00:00:00,Middle Aged,M01.060.116.630
20515838,2010-06-01T00:00:00,Animals,B01.050
20515838,2010-06-01T00:00:00,Crohn Disease,C06.405.205.731.500
20515838,2010-06-01T00:00:00,Crohn Disease,C06.405.469.432.500
20515838,2010-06-01T00:00:00,"Disease Models, Animal",C22.232
20515838,2010-06-01T00:00:00,"Disease Models, Animal",E05.598.500
20515838,2010-06-01T00:00:00,"Disease Models, Animal",E05.599.395.080
20515838,2010-06-01T00:00:00,Hematopoietic Stem Cell Transplantation,E04.936.225.687.500
20515838,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20515838,2010-06-01T00:00:00,Mesenchymal Stem Cell Transplantation,E04.936.225.687.625
20515838,2010-06-01T00:00:00,"Models, Biological",E05.599.395
20515838,2010-06-01T00:00:00,Signal Transduction,G02.111.087.800
20515838,2010-06-01T00:00:00,Signal Transduction,G02.149.115.800
20515838,2010-06-01T00:00:00,Signal Transduction,G04.299.880
20515838,2010-06-01T00:00:00,"T-Lymphocytes, Helper-Inducer",A11.118.637.555.567.569.200.400
20515838,2010-06-01T00:00:00,"T-Lymphocytes, Helper-Inducer",A15.145.229.637.555.567.569.200.400
20515838,2010-06-01T00:00:00,"T-Lymphocytes, Helper-Inducer",A15.382.490.555.567.569.200.400
20520216,2010-06-01T00:00:00,Aged,M01.060.116.100
20520216,2010-06-01T00:00:00,Caregivers,M01.085
20520216,2010-06-01T00:00:00,Caregivers,M01.526.485.200
20520216,2010-06-01T00:00:00,Caregivers,N02.360.200
20520216,2010-06-01T00:00:00,Health Behavior,F01.145.488
20520216,2010-06-01T00:00:00,Health Services Accessibility,N04.590.374.350
20520216,2010-06-01T00:00:00,Health Services Accessibility,N05.300.430
20520216,2010-06-01T00:00:00,Health Services Research,N03.349.380
20520216,2010-06-01T00:00:00,Health Services Research,N05.425
20520216,2010-06-01T00:00:00,Hispanic Americans,M01.686.754.441
20520216,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20520216,2010-06-01T00:00:00,Middle Aged,M01.060.116.630
20520216,2010-06-01T00:00:00,Nurse's Role,F01.829.316.616.625.450
20520216,2010-06-01T00:00:00,Nurse's Role,N05.300.100.337
20520216,2010-06-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
20520216,2010-06-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
20520216,2010-06-01T00:00:00,Patient Compliance,F01.145.488.500
20520216,2010-06-01T00:00:00,Patient Compliance,N05.300.150.600.600
20520216,2010-06-01T00:00:00,Patient Education as Topic,I02.233.332.500
20520216,2010-06-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
20520216,2010-06-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
20520216,2010-06-01T00:00:00,Qualitative Research,H01.770.644.241.850
20520216,2010-06-01T00:00:00,Risk Reduction Behavior,F01.145.699
20520216,2010-06-01T00:00:00,Stroke,C10.228.140.300.775
20520216,2010-06-01T00:00:00,Stroke,C14.907.253.855
20522428,2010-06-01T00:00:00,Adolescent,M01.060.057
20522428,2010-06-01T00:00:00,Adult,M01.060.116
20522428,2010-06-01T00:00:00,Connective Tissue Growth Factor,D12.644.276.200.100
20522428,2010-06-01T00:00:00,Connective Tissue Growth Factor,D12.776.467.200.100
20522428,2010-06-01T00:00:00,Connective Tissue Growth Factor,D12.776.860.300.200.100
20522428,2010-06-01T00:00:00,Connective Tissue Growth Factor,D23.529.237.100
20522428,2010-06-01T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
20522428,2010-06-01T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
20522428,2010-06-01T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
20522428,2010-06-01T00:00:00,Diabetic Nephropathies,C12.777.419.192
20522428,2010-06-01T00:00:00,Diabetic Nephropathies,C13.351.968.419.192
20522428,2010-06-01T00:00:00,Diabetic Nephropathies,C19.246.099.875
20522428,2010-06-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
20522428,2010-06-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
20522428,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20522428,2010-06-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
20522428,2010-06-01T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
20522428,2010-06-01T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
20522428,2010-06-01T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
20522428,2010-06-01T00:00:00,RNA Interference,G05.355.315.203.374.790
20522428,2010-06-01T00:00:00,Young Adult,M01.060.116.815
20525502,2010-06-01T00:00:00,Endoscopy,E01.370.388.250
20525502,2010-06-01T00:00:00,Endoscopy,E04.800.250
20525502,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20525502,2010-06-01T00:00:00,Interdisciplinary Communication,F01.145.209.381
20525502,2010-06-01T00:00:00,Interdisciplinary Communication,F01.829.401.205.249
20525502,2010-06-01T00:00:00,Interdisciplinary Communication,L01.143.474
20525502,2010-06-01T00:00:00,Otorhinolaryngologic Surgical Procedures,E04.580
20525502,2010-06-01T00:00:00,Rhinitis,C08.460.799
20525502,2010-06-01T00:00:00,Rhinitis,C08.730.674
20525502,2010-06-01T00:00:00,Rhinitis,C09.603.799
20525502,2010-06-01T00:00:00,Sinusitis,C08.460.692.752
20525502,2010-06-01T00:00:00,Sinusitis,C08.730.749
20525502,2010-06-01T00:00:00,Sinusitis,C09.603.692.752
20525513,2010-06-01T00:00:00,Endoscopy,E01.370.388.250
20525513,2010-06-01T00:00:00,Endoscopy,E04.800.250
20525513,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20525513,2010-06-01T00:00:00,Mucocele,C04.182.511
20525513,2010-06-01T00:00:00,Salvage Therapy,E02.186.800
20525513,2010-06-01T00:00:00,Salvage Therapy,E02.895
20525513,2010-06-01T00:00:00,Surgical Flaps,A10.850.710
20525513,2010-06-01T00:00:00,Surgical Flaps,E07.862.710
20525513,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20525513,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20525513,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20525513,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20525513,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20525513,2010-06-01T00:00:00,Turbinates,A02.835.232.781.324.948
20525513,2010-06-01T00:00:00,Turbinates,A04.531.898
20525514,2010-06-01T00:00:00,Endoscopy,E01.370.388.250
20525514,2010-06-01T00:00:00,Endoscopy,E04.800.250
20525514,2010-06-01T00:00:00,Health Status,I01.240.425
20525514,2010-06-01T00:00:00,Health Status,N01.224.425
20525514,2010-06-01T00:00:00,Health Status,N06.850.505.400.425
20525514,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20525514,2010-06-01T00:00:00,Quality of Life,I01.800
20525514,2010-06-01T00:00:00,Quality of Life,K01.752.400.750
20525514,2010-06-01T00:00:00,Questionnaires,E05.318.308.750
20525514,2010-06-01T00:00:00,Questionnaires,L01.280.800
20525514,2010-06-01T00:00:00,Questionnaires,N05.715.360.300.695
20525514,2010-06-01T00:00:00,Questionnaires,N06.850.520.308.750
20525514,2010-06-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20525514,2010-06-01T00:00:00,Risk Factors,N05.715.350.200.700
20525514,2010-06-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20525514,2010-06-01T00:00:00,Risk Factors,N06.850.490.625.750
20525514,2010-06-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20525514,2010-06-01T00:00:00,Sinusitis,C08.460.692.752
20525514,2010-06-01T00:00:00,Sinusitis,C08.730.749
20525514,2010-06-01T00:00:00,Sinusitis,C09.603.692.752
20538181,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20538181,2010-06-01T00:00:00,Physicians,M01.526.485.810
20538181,2010-06-01T00:00:00,Physicians,N02.360.810
20538181,2010-06-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
20538181,2010-06-01T00:00:00,"Quality Assurance, Health Care",N05.700
20538181,2010-06-01T00:00:00,Questionnaires,E05.318.308.750
20538181,2010-06-01T00:00:00,Questionnaires,L01.280.800
20538181,2010-06-01T00:00:00,Questionnaires,N05.715.360.300.695
20538181,2010-06-01T00:00:00,Questionnaires,N06.850.520.308.750
20538181,2010-06-01T00:00:00,Terminal Care,E02.760.905
20538181,2010-06-01T00:00:00,Terminal Care,N02.421.585.905
20538181,2010-06-01T00:00:00,Treatment Outcome,E01.789.800
20538181,2010-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20538181,2010-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20538181,2010-06-01T00:00:00,United States,Z01.107.567.875
20545390,2010-06-01T00:00:00,Animals,B01.050
20545390,2010-06-01T00:00:00,"Behavior, Animal",F01.145.113
20545390,2010-06-01T00:00:00,Central Nervous System Stimulants,D27.505.696.282
20545390,2010-06-01T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
20545390,2010-06-01T00:00:00,"Conditioning, Operant",F02.463.425.179.509
20545390,2010-06-01T00:00:00,Feeding Behavior,F01.145.113.547
20545390,2010-06-01T00:00:00,Feeding Behavior,F01.145.407
20545390,2010-06-01T00:00:00,Methylphenidate,D02.241.223.601.600
20545390,2010-06-01T00:00:00,Methylphenidate,D03.383.621.460
20545390,2010-06-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20545390,2010-06-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
20545390,2010-06-01T00:00:00,Self Administration,E02.319.890
20545390,2010-06-01T00:00:00,Self Administration,E02.900.890
20545390,2010-06-01T00:00:00,Time Factors,G01.910.857
20557814,2010-06-01T00:00:00,Adult,M01.060.116
20557814,2010-06-01T00:00:00,Aged,M01.060.116.100
20557814,2010-06-01T00:00:00,Ankle Joint,A02.835.583.378.062
20557814,2010-06-01T00:00:00,Arthritis,C05.550.114
20557814,2010-06-01T00:00:00,Bone Plates,E07.695.125
20557814,2010-06-01T00:00:00,Bone Plates,E07.858.442.660.110
20557814,2010-06-01T00:00:00,Bone Plates,E07.858.690.650.110
20557814,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20557814,2010-06-01T00:00:00,Middle Aged,M01.060.116.630
20557814,2010-06-01T00:00:00,Pain Measurement,E01.370.376.550.600
20557814,2010-06-01T00:00:00,Reoperation,E04.690
20583929,2010-06-01T00:00:00,Algorithms,G17.035
20583929,2010-06-01T00:00:00,Algorithms,L01.224.050
20583929,2010-06-01T00:00:00,Bayes Theorem,E05.318.740.600.200
20583929,2010-06-01T00:00:00,Bayes Theorem,N05.715.360.750.625.150
20583929,2010-06-01T00:00:00,Bayes Theorem,N06.850.520.830.600.200
20583929,2010-06-01T00:00:00,Computational Biology,H01.158.273.180
20583929,2010-06-01T00:00:00,Gene Regulatory Networks,G05.360.080.689.360
20583929,2010-06-01T00:00:00,Time Factors,G01.910.857
20590534,2010-06-01T00:00:00,Animals,B01.050
20590534,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20590534,2010-06-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20590534,2010-06-01T00:00:00,Recovery of Function,G16.757
20590534,2010-06-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
20590534,2010-06-01T00:00:00,Spinal Cord Injuries,C10.900.850
20590534,2010-06-01T00:00:00,Spinal Cord Injuries,C21.866.819
20597709,2010-06-01T00:00:00,Adult,M01.060.116
20597709,2010-06-01T00:00:00,Clinical Competence,I02.399.630.210
20597709,2010-06-01T00:00:00,Clinical Competence,N04.761.210
20597709,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20597709,2010-06-01T00:00:00,Middle Aged,M01.060.116.630
20597709,2010-06-01T00:00:00,Terminal Care,E02.760.905
20597709,2010-06-01T00:00:00,Terminal Care,N02.421.585.905
20597709,2010-06-01T00:00:00,United States,Z01.107.567.875
20598257,2010-06-01T00:00:00,Adenocarcinoma,C04.557.470.200.025
20598257,2010-06-01T00:00:00,Aged,M01.060.116.100
20598257,2010-06-01T00:00:00,"Carcinoma, Pancreatic Ductal",C04.557.470.200.025.232.750
20598257,2010-06-01T00:00:00,"Carcinoma, Pancreatic Ductal",C04.557.470.615.132.750
20598257,2010-06-01T00:00:00,"Carcinoma, Pancreatic Ductal",C04.588.274.761.750
20598257,2010-06-01T00:00:00,"Carcinoma, Pancreatic Ductal",C04.588.322.421.750
20598257,2010-06-01T00:00:00,"Carcinoma, Pancreatic Ductal",C06.301.761.750
20598257,2010-06-01T00:00:00,"Carcinoma, Pancreatic Ductal",C06.689.667.625
20598257,2010-06-01T00:00:00,"Carcinoma, Pancreatic Ductal",C19.344.421.750
20598257,2010-06-01T00:00:00,"Diagnosis, Differential",E01.171
20598257,2010-06-01T00:00:00,Endosonography,E01.370.350.850.280
20598257,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20598257,2010-06-01T00:00:00,Pancreatectomy,E04.210.752
20598257,2010-06-01T00:00:00,Pancreatic Neoplasms,C04.588.274.761
20598257,2010-06-01T00:00:00,Pancreatic Neoplasms,C04.588.322.421
20598257,2010-06-01T00:00:00,Pancreatic Neoplasms,C06.301.761
20598257,2010-06-01T00:00:00,Pancreatic Neoplasms,C06.689.667
20598257,2010-06-01T00:00:00,Pancreatic Neoplasms,C19.344.421
20598257,2010-06-01T00:00:00,Stomach Neoplasms,C04.588.274.476.767
20598257,2010-06-01T00:00:00,Stomach Neoplasms,C06.301.371.767
20598257,2010-06-01T00:00:00,Stomach Neoplasms,C06.405.249.767
20598257,2010-06-01T00:00:00,Stomach Neoplasms,C06.405.748.789
20624149,2010-06-01T00:00:00,Emergency Medicine,H02.403.250
20624149,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20624149,2010-06-01T00:00:00,Multicenter Studies as Topic,E05.318.760.535.500
20624149,2010-06-01T00:00:00,Multicenter Studies as Topic,E05.337.250.500
20624149,2010-06-01T00:00:00,Multicenter Studies as Topic,N05.715.360.775.235.545
20624149,2010-06-01T00:00:00,Multicenter Studies as Topic,N06.850.520.450.535.500
20624149,2010-06-01T00:00:00,Patient Selection,E05.581.500.653
20624149,2010-06-01T00:00:00,Patient Selection,N04.590.731
20624149,2010-06-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
20624149,2010-06-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
20624149,2010-06-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
20624149,2010-06-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
20633112,2010-06-01T00:00:00,Animals,B01.050
20633112,2010-06-01T00:00:00,Estrogens,D27.505.696.399.472.277
20633112,2010-06-01T00:00:00,Neuroprotective Agents,D27.505.696.706.548
20633112,2010-06-01T00:00:00,Neuroprotective Agents,D27.505.954.427.575
20633112,2010-06-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20633112,2010-06-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
20633112,2010-06-01T00:00:00,Spinal Cord Injuries,C10.900.850
20633112,2010-06-01T00:00:00,Spinal Cord Injuries,C21.866.819
20633113,2010-06-01T00:00:00,Animals,B01.050
20633113,2010-06-01T00:00:00,Estrogens,D27.505.696.399.472.277
20633113,2010-06-01T00:00:00,Neuroprotective Agents,D27.505.696.706.548
20633113,2010-06-01T00:00:00,Neuroprotective Agents,D27.505.954.427.575
20633113,2010-06-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20633113,2010-06-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
20633113,2010-06-01T00:00:00,Spinal Cord Injuries,C10.900.850
20633113,2010-06-01T00:00:00,Spinal Cord Injuries,C21.866.819
20710131,2010-06-01T00:00:00,Adult,M01.060.116
20710131,2010-06-01T00:00:00,Aged,M01.060.116.100
20710131,2010-06-01T00:00:00,"Analgesics, Opioid",D27.505.696.663.850.014.520
20710131,2010-06-01T00:00:00,"Analgesics, Opioid",D27.505.954.427.040.325
20710131,2010-06-01T00:00:00,"Analgesics, Opioid",D27.505.954.427.210.049
20710131,2010-06-01T00:00:00,Calcinosis,C18.452.174.130
20710131,2010-06-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
20710131,2010-06-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
20710131,2010-06-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
20710131,2010-06-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
20710131,2010-06-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
20710131,2010-06-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
20710131,2010-06-01T00:00:00,Combined Modality Therapy,E02.186
20710131,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20710131,2010-06-01T00:00:00,Middle Aged,M01.060.116.630
20710131,2010-06-01T00:00:00,Pain,C10.597.617
20710131,2010-06-01T00:00:00,Pain,C23.888.592.612
20710131,2010-06-01T00:00:00,Pain,C23.888.646
20710131,2010-06-01T00:00:00,Pain,F02.830.816.444
20710131,2010-06-01T00:00:00,Pain,G11.561.600.810.444
20710131,2010-06-01T00:00:00,"Pancreatitis, Chronic",C06.689.750.830
20710131,2010-06-01T00:00:00,Patient Care Team,N04.590.715
20710131,2010-06-01T00:00:00,Treatment Outcome,E01.789.800
20710131,2010-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20710131,2010-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20858615,2010-06-01T00:00:00,Angioplasty,E02.148.050
20858615,2010-06-01T00:00:00,Angioplasty,E04.100.814.050
20858615,2010-06-01T00:00:00,Carotid Stenosis,C10.228.140.300.200.360
20858615,2010-06-01T00:00:00,Carotid Stenosis,C14.907.137.230
20858615,2010-06-01T00:00:00,Carotid Stenosis,C14.907.253.123.360
20858615,2010-06-01T00:00:00,Clinical Competence,I02.399.630.210
20858615,2010-06-01T00:00:00,Clinical Competence,N04.761.210
20858615,2010-06-01T00:00:00,Coronary Artery Disease,C14.280.647.250.260
20858615,2010-06-01T00:00:00,Coronary Artery Disease,C14.907.137.126.339
20858615,2010-06-01T00:00:00,Coronary Artery Disease,C14.907.585.250.260
20858615,2010-06-01T00:00:00,Diagnostic Imaging,E01.370.350
20858615,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20858615,2010-06-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
20858615,2010-06-01T00:00:00,Risk Assessment,N04.452.871.715
20858615,2010-06-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20858615,2010-06-01T00:00:00,Risk Assessment,N06.850.505.715
20858615,2010-06-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20858615,2010-06-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20858615,2010-06-01T00:00:00,Risk Factors,N05.715.350.200.700
20858615,2010-06-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20858615,2010-06-01T00:00:00,Risk Factors,N06.850.490.625.750
20858615,2010-06-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20858615,2010-06-01T00:00:00,Stents,E07.695.750
20858615,2010-06-01T00:00:00,Stroke,C10.228.140.300.775
20858615,2010-06-01T00:00:00,Stroke,C14.907.253.855
20858615,2010-06-01T00:00:00,Treatment Outcome,E01.789.800
20858615,2010-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20858615,2010-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21418768,2010-06-01T00:00:00,Abdominal Pain,C23.888.646.100
21418768,2010-06-01T00:00:00,Abdominal Pain,C23.888.821.030
21418768,2010-06-01T00:00:00,Adolescent,M01.060.057
21418768,2010-06-01T00:00:00,"Biopsy, Needle",E01.370.388.100.100
21418768,2010-06-01T00:00:00,"Biopsy, Needle",E01.450.230.100.100
21418768,2010-06-01T00:00:00,"Biopsy, Needle",E01.450.865.100.100
21418768,2010-06-01T00:00:00,"Biopsy, Needle",E01.450.865.632.100
21418768,2010-06-01T00:00:00,"Biopsy, Needle",E04.074.119
21418768,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21418768,2010-06-01T00:00:00,Laparoscopy,E01.370.388.250.520
21418768,2010-06-01T00:00:00,Laparoscopy,E04.800.250.520
21418768,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
21418768,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
21418768,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
21418768,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
21418768,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
21418768,2010-06-01T00:00:00,Treatment Outcome,E01.789.800
21418768,2010-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
21418768,2010-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21418772,2010-06-01T00:00:00,Cough,C08.618.248
21418772,2010-06-01T00:00:00,Cough,C23.888.852.293
21418772,2010-06-01T00:00:00,Disease Progression,C23.550.291.656
21418772,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21418772,2010-06-01T00:00:00,Infant,M01.060.703
21418772,2010-06-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
21418772,2010-06-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
21418772,2010-06-01T00:00:00,Neoplasm Staging,E01.370.550
21418772,2010-06-01T00:00:00,"Radiography, Thoracic",E01.370.350.700.730
21418772,2010-06-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
21418772,2010-06-01T00:00:00,Risk Assessment,N04.452.871.715
21418772,2010-06-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
21418772,2010-06-01T00:00:00,Risk Assessment,N06.850.505.715
21418772,2010-06-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
21418772,2010-06-01T00:00:00,Teratoma,C04.557.465.910
21418772,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
21418772,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
21418772,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
21418772,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
21418772,2010-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
21418772,2010-06-01T00:00:00,Treatment Outcome,E01.789.800
21418772,2010-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
21418772,2010-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21418773,2010-06-01T00:00:00,Adult,M01.060.116
21418773,2010-06-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
21418773,2010-06-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
21418773,2010-06-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
21418773,2010-06-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
21418773,2010-06-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
21418773,2010-06-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
21418773,2010-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21418773,2010-06-01T00:00:00,Multiple Trauma,C21.866.640
21418773,2010-06-01T00:00:00,Pancreaticoduodenectomy,E04.210.760
21418773,2010-06-01T00:00:00,"Pancreatitis, Chronic",C06.689.750.830
21418773,2010-06-01T00:00:00,Postoperative Complications,C23.550.767
21418773,2010-06-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
21418773,2010-06-01T00:00:00,Risk Assessment,N04.452.871.715
21418773,2010-06-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
21418773,2010-06-01T00:00:00,Risk Assessment,N06.850.505.715
21418773,2010-06-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
21418773,2010-06-01T00:00:00,Treatment Outcome,E01.789.800
21418773,2010-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
21418773,2010-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21418773,2010-06-01T00:00:00,War,I01.880.735.944
21418773,2010-06-01T00:00:00,"Wounds, Penetrating",C21.866.986
20554285,2010-06-02T00:00:00,Adsorption,G02.149.047
20554285,2010-06-02T00:00:00,Adsorption,G02.149.767.029
20554285,2010-06-02T00:00:00,Adsorption,G02.842.750.029
20554285,2010-06-02T00:00:00,Anion Exchange Resins,D27.720.470.420.050
20554285,2010-06-02T00:00:00,Escherichia coli,B03.440.450.425.325.300
20554285,2010-06-02T00:00:00,Escherichia coli,B03.660.250.150.180.100
20554285,2010-06-02T00:00:00,"Membranes, Artificial",D25.479
20554285,2010-06-02T00:00:00,"Membranes, Artificial",J01.637.051.479
20554285,2010-06-02T00:00:00,"Membranes, Artificial",J01.637.087.500
20522601,2010-06-03T00:00:00,Adipocytes,A11.329.114
20522601,2010-06-03T00:00:00,Animals,B01.050
20522601,2010-06-03T00:00:00,Ceramides,D02.065.313
20522601,2010-06-03T00:00:00,Ceramides,D09.400.410.420.525.200
20522601,2010-06-03T00:00:00,Ceramides,D10.390.470.675.200
20522601,2010-06-03T00:00:00,Ceramides,D10.570.877.360.612.200
20522601,2010-06-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20522601,2010-06-03T00:00:00,Lysophospholipids,D10.570.755.375.760.550
20522601,2010-06-03T00:00:00,Plasminogen Activator Inhibitor 1,D12.644.822.750.695.500
20522601,2010-06-03T00:00:00,Plasminogen Activator Inhibitor 1,D12.644.861.695.500
20522601,2010-06-03T00:00:00,Plasminogen Activator Inhibitor 1,D12.776.124.125.640
20522601,2010-06-03T00:00:00,Plasminogen Activator Inhibitor 1,D12.776.645.750.695.500
20522601,2010-06-03T00:00:00,Plasminogen Activator Inhibitor 1,D12.776.872.695.500
20522601,2010-06-03T00:00:00,Plasminogen Activator Inhibitor 1,D23.119.832.500
20522601,2010-06-03T00:00:00,"Receptors, Lysosphingolipid",D12.776.543.750.100.420.500
20522601,2010-06-03T00:00:00,Signal Transduction,G02.111.087.800
20522601,2010-06-03T00:00:00,Signal Transduction,G02.149.115.800
20522601,2010-06-03T00:00:00,Signal Transduction,G04.299.880
20522601,2010-06-03T00:00:00,Sphingolipids,D10.570.877
20522601,2010-06-03T00:00:00,Sphingolipids,D10.808
20522601,2010-06-03T00:00:00,Sphingosine,D02.033.100.700
20522601,2010-06-03T00:00:00,Sphingosine,D02.033.455.843
20522601,2010-06-03T00:00:00,Sphingosine,D02.092.063.700
20522886,2010-06-03T00:00:00,Adult,M01.060.116
20522886,2010-06-03T00:00:00,Battered Women,M01.975.155
20522886,2010-06-03T00:00:00,Crime Victims,M01.135
20522886,2010-06-03T00:00:00,Health Status,I01.240.425
20522886,2010-06-03T00:00:00,Health Status,N01.224.425
20522886,2010-06-03T00:00:00,Health Status,N06.850.505.400.425
20522886,2010-06-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20522886,2010-06-03T00:00:00,Middle Aged,M01.060.116.630
20522886,2010-06-03T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
20522886,2010-06-03T00:00:00,Rape,I01.198.240.748.640
20522886,2010-06-03T00:00:00,United States,Z01.107.567.875
20522886,2010-06-03T00:00:00,Violence,I01.198.240.856
20522886,2010-06-03T00:00:00,Violence,I01.880.735.900
20522886,2010-06-03T00:00:00,Young Adult,M01.060.116.815
20605479,2010-06-03T00:00:00,Adult,M01.060.116
20605479,2010-06-03T00:00:00,Antigen-Antibody Complex,D12.776.124.486.485.114.257
20605479,2010-06-03T00:00:00,Antigen-Antibody Complex,D12.776.124.790.651.114.257
20605479,2010-06-03T00:00:00,Antigen-Antibody Complex,D12.776.377.715.548.114.257
20605479,2010-06-03T00:00:00,Antigen-Antibody Complex,D23.050.101
20605479,2010-06-03T00:00:00,Blood Chemical Analysis,E01.450.150.100
20605479,2010-06-03T00:00:00,Clinical Trials as Topic,E05.318.760.535
20605479,2010-06-03T00:00:00,Clinical Trials as Topic,E05.337.250
20605479,2010-06-03T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
20605479,2010-06-03T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
20605479,2010-06-03T00:00:00,Diabetes Complications,C19.246.099
20605479,2010-06-03T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
20605479,2010-06-03T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
20605479,2010-06-03T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
20605479,2010-06-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20605479,2010-06-03T00:00:00,"Lipoproteins, LDL",D10.532.515
20605479,2010-06-03T00:00:00,"Lipoproteins, LDL",D12.776.521.550
20605479,2010-06-03T00:00:00,Middle Aged,M01.060.116.630
20605479,2010-06-03T00:00:00,"Nuclear Magnetic Resonance, Biomolecular",E05.196.867.519.550
20605479,2010-06-03T00:00:00,Sex Characteristics,G08.686.815
20627452,2010-06-03T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
20627452,2010-06-03T00:00:00,Antibiotic Prophylaxis,E02.319.162.150
20627452,2010-06-03T00:00:00,Antibiotic Prophylaxis,E02.319.703.150
20627452,2010-06-03T00:00:00,Cephalosporins,D02.065.589.099.249
20627452,2010-06-03T00:00:00,Cephalosporins,D02.886.665.074
20627452,2010-06-03T00:00:00,Cephalosporins,D04.075.080.875.099.221.249
20627452,2010-06-03T00:00:00,Cesarean Section,E04.520.252.500
20627452,2010-06-03T00:00:00,Cross Infection,C01.539.248
20627452,2010-06-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20627452,2010-06-03T00:00:00,Incidence,E05.318.308.985.525.375
20627452,2010-06-03T00:00:00,Incidence,L01.280.975.525.375
20627452,2010-06-03T00:00:00,Incidence,N01.224.935.597.500
20627452,2010-06-03T00:00:00,Incidence,N06.850.505.400.975.525.375
20627452,2010-06-03T00:00:00,Incidence,N06.850.520.308.985.525.375
20627452,2010-06-03T00:00:00,Infection Control,N06.850.780.200.450
20627452,2010-06-03T00:00:00,Methicillin Resistance,G06.099.225.500.600.525
20627452,2010-06-03T00:00:00,Methicillin Resistance,G06.225.347.500.600.525
20627452,2010-06-03T00:00:00,Methicillin Resistance,G07.690.320.269.347.500.600.525
20627452,2010-06-03T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.300.390.400.800.750.100.500
20627452,2010-06-03T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.510.100.750.750.100.500
20627452,2010-06-03T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.510.400.790.750.100.500
20627452,2010-06-03T00:00:00,Postoperative Complications,C23.550.767
20627452,2010-06-03T00:00:00,Pregnancy,G08.686.785.760.769
20627452,2010-06-03T00:00:00,Preoperative Care,E02.760.795
20627452,2010-06-03T00:00:00,Preoperative Care,E04.641
20627452,2010-06-03T00:00:00,Preoperative Care,N02.421.585.795
20627452,2010-06-03T00:00:00,Staphylococcal Infections,C01.252.410.868
20627452,2010-06-03T00:00:00,Surgical Wound Infection,C01.539.947.692
20627452,2010-06-03T00:00:00,Surgical Wound Infection,C23.550.767.925
20627452,2010-06-03T00:00:00,Treatment Outcome,E01.789.800
20627452,2010-06-03T00:00:00,Treatment Outcome,N04.761.559.590.800
20627452,2010-06-03T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20627682,2010-06-04T00:00:00,Cell Death,G04.299.139
20627682,2010-06-04T00:00:00,Cell Proliferation,G04.299.233.750
20627682,2010-06-04T00:00:00,Cell Proliferation,G07.700.320.249.410.750
20627682,2010-06-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20627682,2010-06-04T00:00:00,Neoplasms,C04
20627682,2010-06-04T00:00:00,Oxidative Stress,G03.495.710
20627682,2010-06-04T00:00:00,Oxidative Stress,G07.700.830.750
20627682,2010-06-04T00:00:00,Reactive Nitrogen Species,D01.625.700
20627682,2010-06-04T00:00:00,Reactive Nitrogen Species,D02.654.846
20627682,2010-06-04T00:00:00,Reactive Oxygen Species,D01.339.431
20627682,2010-06-04T00:00:00,Reactive Oxygen Species,D01.650.775
20627682,2010-06-04T00:00:00,Signal Transduction,G02.111.087.800
20627682,2010-06-04T00:00:00,Signal Transduction,G02.149.115.800
20627682,2010-06-04T00:00:00,Signal Transduction,G04.299.880
21990620,2010-06-04T00:00:00,Aged,M01.060.116.100
21990620,2010-06-04T00:00:00,Angioplasty,E02.148.050
21990620,2010-06-04T00:00:00,Angioplasty,E04.100.814.050
21990620,2010-06-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21990620,2010-06-04T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
21990620,2010-06-04T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
21990620,2010-06-04T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
21990620,2010-06-04T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
21990620,2010-06-04T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
21990620,2010-06-04T00:00:00,Stents,E07.695.750
21990620,2010-06-04T00:00:00,Stroke,C10.228.140.300.775
21990620,2010-06-04T00:00:00,Stroke,C14.907.253.855
20530003,2010-06-07T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
20530003,2010-06-07T00:00:00,Aortic Diseases,C14.907.109
20530003,2010-06-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20530003,2010-06-07T00:00:00,Stents,E07.695.750
20530003,2010-06-07T00:00:00,United States,Z01.107.567.875
20530003,2010-06-07T00:00:00,Vascular Surgical Procedures,E04.100.814
20530752,2010-06-08T00:00:00,Animals,B01.050
20530752,2010-06-08T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.205.360
20530752,2010-06-08T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.252.445
20530752,2010-06-08T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.525.700.350
20530752,2010-06-08T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.205.360
20530752,2010-06-08T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.252.445
20530752,2010-06-08T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.525.700.350
20530752,2010-06-08T00:00:00,Myocardial Infarction,C14.280.647.500
20530752,2010-06-08T00:00:00,Myocardial Infarction,C14.907.585.500
20530752,2010-06-08T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
20530752,2010-06-08T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
20530752,2010-06-08T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
20530752,2010-06-08T00:00:00,"Transcription, Genetic",G02.111.087.847
20530752,2010-06-08T00:00:00,"Transcription, Genetic",G02.149.115.847
20530752,2010-06-08T00:00:00,"Transcription, Genetic",G05.355.310.700
20532659,2010-06-08T00:00:00,African Continental Ancestry Group,M01.686.508.100
20532659,2010-06-08T00:00:00,Aged,M01.060.116.100
20532659,2010-06-08T00:00:00,"Databases, Factual",L01.470.750.750
20532659,2010-06-08T00:00:00,"Databases, Factual",L01.700.508.300.188.400
20532659,2010-06-08T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
20532659,2010-06-08T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
20532659,2010-06-08T00:00:00,European Continental Ancestry Group,M01.686.508.400
20532659,2010-06-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20532659,2010-06-08T00:00:00,Middle Aged,M01.060.116.630
20532659,2010-06-08T00:00:00,Veterans,M01.930
20534594,2010-06-08T00:00:00,Adolescent,M01.060.057
20534594,2010-06-08T00:00:00,"Child Abuse, Sexual",I01.198.240.748.300
20534594,2010-06-08T00:00:00,"Child Abuse, Sexual",I01.198.240.856.350.250.255
20534594,2010-06-08T00:00:00,"Child Abuse, Sexual",I01.880.735.900.350.250.255
20534594,2010-06-08T00:00:00,"Child Abuse, Sexual",I01.880.787.293.292.325
20534594,2010-06-08T00:00:00,Depressive Disorder,F03.600.300
20534594,2010-06-08T00:00:00,Family Therapy,F04.754.864.581.273
20534594,2010-06-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20534594,2010-06-08T00:00:00,Pilot Projects,E05.318.760.750
20534594,2010-06-08T00:00:00,Pilot Projects,E05.337.737
20534594,2010-06-08T00:00:00,Pilot Projects,N05.715.360.775.625
20534594,2010-06-08T00:00:00,Pilot Projects,N06.850.520.450.720
20534594,2010-06-08T00:00:00,Psychiatric Status Rating Scales,F04.586
20534594,2010-06-08T00:00:00,Risk Factors,E05.318.740.600.800.725
20534594,2010-06-08T00:00:00,Risk Factors,N05.715.350.200.700
20534594,2010-06-08T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20534594,2010-06-08T00:00:00,Risk Factors,N06.850.490.625.750
20534594,2010-06-08T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20534594,2010-06-08T00:00:00,Risk Reduction Behavior,F01.145.699
20534594,2010-06-08T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
20534594,2010-06-08T00:00:00,Substance-Related Disorders,C21.739
20534594,2010-06-08T00:00:00,Substance-Related Disorders,F03.900
20534594,2010-06-08T00:00:00,Time Factors,G01.910.857
20534594,2010-06-08T00:00:00,Treatment Outcome,E01.789.800
20534594,2010-06-08T00:00:00,Treatment Outcome,N04.761.559.590.800
20534594,2010-06-08T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20536720,2010-06-08T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
20536720,2010-06-08T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
20536720,2010-06-08T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
20536720,2010-06-08T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
20536720,2010-06-08T00:00:00,Gastric Mucosa,A03.556.875.875.440
20536720,2010-06-08T00:00:00,Gastric Mucosa,A10.615.550.291
20536720,2010-06-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20536720,2010-06-08T00:00:00,"Hypertension, Portal",C06.552.494
20536720,2010-06-08T00:00:00,Incidence,E05.318.308.985.525.375
20536720,2010-06-08T00:00:00,Incidence,L01.280.975.525.375
20536720,2010-06-08T00:00:00,Incidence,N01.224.935.597.500
20536720,2010-06-08T00:00:00,Incidence,N06.850.505.400.975.525.375
20536720,2010-06-08T00:00:00,Incidence,N06.850.520.308.985.525.375
20580230,2010-06-08T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.567.342
20580230,2010-06-08T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.646.750.249
20580230,2010-06-08T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.644.360.450.169
20580230,2010-06-08T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.776.476.450.169
20580230,2010-06-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20580230,2010-06-08T00:00:00,Mitogen-Activated Protein Kinase Kinases,D08.811.913.696.620.682.700.565
20580230,2010-06-08T00:00:00,Mitogen-Activated Protein Kinase Kinases,D08.811.913.696.620.682.725.200
20580230,2010-06-08T00:00:00,Mitogen-Activated Protein Kinase Kinases,D12.644.360.440
20580230,2010-06-08T00:00:00,Mitogen-Activated Protein Kinase Kinases,D12.776.476.440
20580230,2010-06-08T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
20580230,2010-06-08T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
20580230,2010-06-08T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
20580230,2010-06-08T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
20580230,2010-06-08T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
20580230,2010-06-08T00:00:00,Signal Transduction,G02.111.087.800
20580230,2010-06-08T00:00:00,Signal Transduction,G02.149.115.800
20580230,2010-06-08T00:00:00,Signal Transduction,G04.299.880
20627380,2010-06-08T00:00:00,Environmental Monitoring,N06.850.460.350.080
20627380,2010-06-08T00:00:00,Environmental Monitoring,N06.850.780.375
20627380,2010-06-08T00:00:00,Geologic Sediments,G01.311.500
20627380,2010-06-08T00:00:00,Geologic Sediments,G16.500.320
20627380,2010-06-08T00:00:00,"Models, Theoretical",E05.599
20627380,2010-06-08T00:00:00,Radioisotopes,D01.496.749
20530853,2010-06-09T00:00:00,Adult,M01.060.116
20530853,2010-06-09T00:00:00,Body Weight,C23.888.144
20530853,2010-06-09T00:00:00,Body Weight,E01.370.600.115.100.160.120
20530853,2010-06-09T00:00:00,Body Weight,E05.041.124.160.750
20530853,2010-06-09T00:00:00,Body Weight,G07.100.100.160.120
20530853,2010-06-09T00:00:00,Body Weight,G07.700.320.249.314.120
20530853,2010-06-09T00:00:00,Heart,A07.541
20530853,2010-06-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20530853,2010-06-09T00:00:00,"Models, Biological",E05.599.395
20530853,2010-06-09T00:00:00,"Phantoms, Imaging",E07.671
20530853,2010-06-09T00:00:00,Radiation Dosage,E05.799.513
20530853,2010-06-09T00:00:00,Radiation Dosage,G01.201.875.740
20530853,2010-06-09T00:00:00,Radiation Dosage,N06.850.810.250
20530853,2010-06-09T00:00:00,"Radiography, Thoracic",E01.370.350.700.730
20530853,2010-06-09T00:00:00,Radiometry,E05.799
20530853,2010-06-09T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20530853,2010-06-09T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20530853,2010-06-09T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20530853,2010-06-09T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20530853,2010-06-09T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20530853,2010-06-09T00:00:00,Water,D01.455.900
20530853,2010-06-09T00:00:00,Water,D01.650.550.925
20534846,2010-06-09T00:00:00,Animals,B01.050
20534846,2010-06-09T00:00:00,"Behavior, Addictive",F01.145.527.100.120
20534846,2010-06-09T00:00:00,C-Reactive Protein,D12.776.034.145
20534846,2010-06-09T00:00:00,C-Reactive Protein,D12.776.124.050.120
20534846,2010-06-09T00:00:00,C-Reactive Protein,D12.776.124.486.157
20534846,2010-06-09T00:00:00,Carrier Proteins,D12.776.157
20534846,2010-06-09T00:00:00,Cocaine,D02.145.074.722.388
20534846,2010-06-09T00:00:00,Cocaine,D03.132.889.354
20534846,2010-06-09T00:00:00,Cocaine,D03.605.869.388
20534846,2010-06-09T00:00:00,Cocaine,D04.075.080.875.099.722.388
20534846,2010-06-09T00:00:00,Cocaine-Related Disorders,C21.739.300
20534846,2010-06-09T00:00:00,Cocaine-Related Disorders,F03.900.300
20534846,2010-06-09T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
20534846,2010-06-09T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
20534846,2010-06-09T00:00:00,Long-Term Synaptic Depression,G11.561.600.635.355
20534846,2010-06-09T00:00:00,Membrane Proteins,D12.776.543
20534846,2010-06-09T00:00:00,Nerve Tissue Proteins,D12.776.641
20534846,2010-06-09T00:00:00,Neuronal Plasticity,G11.561.600.635
20534846,2010-06-09T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
20534846,2010-06-09T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
20534846,2010-06-09T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20534846,2010-06-09T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
20534846,2010-06-09T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.100.450
20534846,2010-06-09T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.720.200.450.500
20534846,2010-06-09T00:00:00,Self Administration,E02.319.890
20534846,2010-06-09T00:00:00,Self Administration,E02.900.890
20534846,2010-06-09T00:00:00,Synaptic Transmission,G02.111.087.800.850
20534846,2010-06-09T00:00:00,Synaptic Transmission,G02.149.115.800.850
20534846,2010-06-09T00:00:00,Synaptic Transmission,G04.299.880.850
20534846,2010-06-09T00:00:00,Synaptic Transmission,G07.265.337.900
20534846,2010-06-09T00:00:00,Synaptic Transmission,G07.700.240.900
20534846,2010-06-09T00:00:00,Synaptic Transmission,G11.561.600.835
20538327,2010-06-09T00:00:00,Adrenal Cortex Hormones,D06.472.040
20538327,2010-06-09T00:00:00,Asthma,C08.127.108
20538327,2010-06-09T00:00:00,Asthma,C08.381.495.108
20538327,2010-06-09T00:00:00,Asthma,C08.674.095
20538327,2010-06-09T00:00:00,Asthma,C20.543.480.680.095
20538327,2010-06-09T00:00:00,Child,M01.060.406
20538327,2010-06-09T00:00:00,Double-Blind Method,E05.318.780.300
20538327,2010-06-09T00:00:00,Double-Blind Method,E05.581.500.300
20538327,2010-06-09T00:00:00,Double-Blind Method,N05.715.360.780.320
20538327,2010-06-09T00:00:00,Double-Blind Method,N06.850.520.445.300
20538327,2010-06-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20538327,2010-06-09T00:00:00,Vitamin D,D04.808.812.768
20544558,2010-06-09T00:00:00,Aged,M01.060.116.100
20544558,2010-06-09T00:00:00,Cognition Disorders,F03.087.250
20544558,2010-06-09T00:00:00,Geriatric Assessment,E05.318.308.225
20544558,2010-06-09T00:00:00,Geriatric Assessment,I01.240.425.350
20544558,2010-06-09T00:00:00,Geriatric Assessment,L01.280.360
20544558,2010-06-09T00:00:00,Geriatric Assessment,N01.224.425.350
20544558,2010-06-09T00:00:00,Geriatric Assessment,N05.715.360.300.360
20544558,2010-06-09T00:00:00,Geriatric Assessment,N06.850.505.400.425.350
20544558,2010-06-09T00:00:00,Geriatric Assessment,N06.850.520.308.225
20544558,2010-06-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20544558,2010-06-09T00:00:00,Middle Aged,M01.060.116.630
20544558,2010-06-09T00:00:00,"Models, Psychological",E05.599.695
20544558,2010-06-09T00:00:00,Neuropsychological Tests,F04.711.513
20804953,2010-06-09T00:00:00,Adolescent,M01.060.057
20804953,2010-06-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20804953,2010-06-09T00:00:00,Otitis Media,C09.218.705.663
20804953,2010-06-09T00:00:00,Thrombosis,C14.907.355.830
20534889,2010-06-10T00:00:00,Animals,B01.050
20534889,2010-06-10T00:00:00,Antibodies,D12.776.124.486.485.114
20534889,2010-06-10T00:00:00,Antibodies,D12.776.124.790.651.114
20534889,2010-06-10T00:00:00,Antibodies,D12.776.377.715.548.114
20534889,2010-06-10T00:00:00,Cell Death,G04.299.139
20534889,2010-06-10T00:00:00,Cell Survival,G04.299.316
20534889,2010-06-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20534889,2010-06-10T00:00:00,Light,G01.201.875.770.578
20534889,2010-06-10T00:00:00,Light,G01.590.540
20534889,2010-06-10T00:00:00,"Lipoproteins, LDL",D10.532.515
20534889,2010-06-10T00:00:00,"Lipoproteins, LDL",D12.776.521.550
20534889,2010-06-10T00:00:00,Macrophages,A11.329.372
20534889,2010-06-10T00:00:00,Macrophages,A11.627.482
20534889,2010-06-10T00:00:00,Macrophages,A11.733.397
20534889,2010-06-10T00:00:00,Macrophages,A15.382.680.397
20534889,2010-06-10T00:00:00,Macrophages,A15.382.812.522
20534889,2010-06-10T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
20534889,2010-06-10T00:00:00,"Microscopy, Confocal",E05.595.395
20534889,2010-06-10T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
20534889,2010-06-10T00:00:00,"Microscopy, Fluorescence",E05.595.458
20534889,2010-06-10T00:00:00,Nanoparticles,J01.637.512.600
20534889,2010-06-10T00:00:00,Polyesters,D05.750.728
20534889,2010-06-10T00:00:00,Polyesters,D25.720.728
20534889,2010-06-10T00:00:00,Polyesters,J01.637.051.720.728
20534889,2010-06-10T00:00:00,"Scattering, Radiation",E05.196.822
20534889,2010-06-10T00:00:00,"Scattering, Radiation",G01.595.861
20534889,2010-06-10T00:00:00,Time Factors,G01.910.857
20535624,2010-06-10T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
20535624,2010-06-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20535624,2010-06-10T00:00:00,Pseudomonas Infections,C01.252.400.739
20535624,2010-06-10T00:00:00,Pseudomonas aeruginosa,B03.440.400.425.625.625.100
20535624,2010-06-10T00:00:00,Pseudomonas aeruginosa,B03.660.250.580.590.050
20538968,2010-06-10T00:00:00,Adolescent,M01.060.057
20538968,2010-06-10T00:00:00,Adult,M01.060.116
20538968,2010-06-10T00:00:00,Aged,M01.060.116.100
20538968,2010-06-10T00:00:00,Amphetamine-Related Disorders,C21.739.225
20538968,2010-06-10T00:00:00,Amphetamine-Related Disorders,F03.900.225
20538968,2010-06-10T00:00:00,Attention Deficit Disorder with Hyperactivity,F03.550.150.150
20538968,2010-06-10T00:00:00,Central Nervous System Stimulants,D27.505.696.282
20538968,2010-06-10T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
20538968,2010-06-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20538968,2010-06-10T00:00:00,Methylphenidate,D02.241.223.601.600
20538968,2010-06-10T00:00:00,Methylphenidate,D03.383.621.460
20538968,2010-06-10T00:00:00,Middle Aged,M01.060.116.630
20538968,2010-06-10T00:00:00,Treatment Outcome,E01.789.800
20538968,2010-06-10T00:00:00,Treatment Outcome,N04.761.559.590.800
20538968,2010-06-10T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20541521,2010-06-10T00:00:00,Cell Line,A11.251.210
20541521,2010-06-10T00:00:00,Escherichia coli,B03.440.450.425.325.300
20541521,2010-06-10T00:00:00,Escherichia coli,B03.660.250.150.180.100
20541521,2010-06-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20541521,2010-06-10T00:00:00,Insulin-Like Growth Factor Binding Protein 2,D12.776.157.420.260
20541521,2010-06-10T00:00:00,Insulin-Like Growth Factor I,D12.644.276.937.400
20541521,2010-06-10T00:00:00,Insulin-Like Growth Factor I,D12.776.124.862.400
20541521,2010-06-10T00:00:00,Insulin-Like Growth Factor I,D12.776.467.937.400
20541521,2010-06-10T00:00:00,Insulin-Like Growth Factor I,D23.529.937.400
20541521,2010-06-10T00:00:00,"Nuclear Magnetic Resonance, Biomolecular",E05.196.867.519.550
20541521,2010-06-10T00:00:00,Protein Conformation,G02.111.570.790.709
20541521,2010-06-10T00:00:00,Recombinant Proteins,D12.776.828
20576213,2010-06-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20576213,2010-06-10T00:00:00,Interprofessional Relations,F01.829.401.205
20576213,2010-06-10T00:00:00,Malnutrition,C18.654.521
20576213,2010-06-10T00:00:00,Mass Screening,E01.370.500
20576213,2010-06-10T00:00:00,Mass Screening,E05.318.308.250.580
20576213,2010-06-10T00:00:00,Mass Screening,N02.421.143.827.233.443
20576213,2010-06-10T00:00:00,Mass Screening,N02.421.726.233.443
20576213,2010-06-10T00:00:00,Mass Screening,N05.715.360.300.375.500
20576213,2010-06-10T00:00:00,Mass Screening,N06.850.520.308.250.580
20576213,2010-06-10T00:00:00,Mass Screening,N06.850.780.500
20576213,2010-06-10T00:00:00,North America,Z01.107.567
20576213,2010-06-10T00:00:00,Questionnaires,E05.318.308.750
20576213,2010-06-10T00:00:00,Questionnaires,L01.280.800
20576213,2010-06-10T00:00:00,Questionnaires,N05.715.360.300.695
20576213,2010-06-10T00:00:00,Questionnaires,N06.850.520.308.750
20576213,2010-06-10T00:00:00,"Scleroderma, Systemic",C17.300.799
20576213,2010-06-10T00:00:00,"Scleroderma, Systemic",C17.800.784
21558266,2010-06-10T00:00:00,Animals,B01.050
21558266,2010-06-10T00:00:00,Rivers,G01.311.750
21558266,2010-06-10T00:00:00,Rivers,G16.500.275.280.500
21558266,2010-06-10T00:00:00,Rivers,N06.230.232.500
21558266,2010-06-10T00:00:00,Water Movements,G16.500.240.960
21558266,2010-06-10T00:00:00,Water Movements,N06.230.850
20541192,2010-06-11T00:00:00,"Biopsy, Fine-Needle",E01.370.388.100.100.500
20541192,2010-06-11T00:00:00,"Biopsy, Fine-Needle",E01.450.230.100.100.500
20541192,2010-06-11T00:00:00,"Biopsy, Fine-Needle",E01.450.865.100.100.500
20541192,2010-06-11T00:00:00,"Biopsy, Fine-Needle",E04.074.119.500
20541192,2010-06-11T00:00:00,Endosonography,E01.370.350.850.280
20541192,2010-06-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20541192,2010-06-11T00:00:00,Lung Neoplasms,C04.588.894.797.520
20541192,2010-06-11T00:00:00,Lung Neoplasms,C08.381.540
20541192,2010-06-11T00:00:00,Lung Neoplasms,C08.785.520
20541192,2010-06-11T00:00:00,Lymph Nodes,A10.549.400
20541192,2010-06-11T00:00:00,Lymph Nodes,A15.382.520.604.412
20541192,2010-06-11T00:00:00,Neoplasm Staging,E01.370.550
20541485,2010-06-11T00:00:00,Child,M01.060.406
20541485,2010-06-11T00:00:00,Drug Prescriptions,E02.319.307
20541485,2010-06-11T00:00:00,Drug Prescriptions,N02.421.668.778.500
20541485,2010-06-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20541485,2010-06-11T00:00:00,Medication Errors,E02.319.529
20541485,2010-06-11T00:00:00,Medication Errors,N02.421.450.500
20541485,2010-06-11T00:00:00,Pediatrics,H02.403.670
20541733,2010-06-11T00:00:00,Adult,M01.060.116
20541733,2010-06-11T00:00:00,Case-Control Studies,E05.318.760.500.500
20541733,2010-06-11T00:00:00,Case-Control Studies,N05.715.360.775.175.200
20541733,2010-06-11T00:00:00,Case-Control Studies,N06.850.520.450.500.500
20541733,2010-06-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20541733,2010-06-11T00:00:00,Lipids,D10
20541733,2010-06-11T00:00:00,Pregnancy,G08.686.785.760.769
20541733,2010-06-11T00:00:00,Premature Birth,C13.703.420.491.500
20541805,2010-06-12T00:00:00,Adult,M01.060.116
20541805,2010-06-12T00:00:00,"Chromosomes, Human, Pair 3",A11.284.187.520.300.235.250
20541805,2010-06-12T00:00:00,"Chromosomes, Human, Pair 3",G05.360.162.520.300.235.250
20541805,2010-06-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20541805,2010-06-12T00:00:00,"Translocation, Genetic",C23.550.210.870
20541805,2010-06-12T00:00:00,"Translocation, Genetic",G05.355.600.860
20541805,2010-06-12T00:00:00,"Translocation, Genetic",G05.365.590.175.870
20547163,2010-06-12T00:00:00,Adolescent,M01.060.057
20547163,2010-06-12T00:00:00,Adult,M01.060.116
20547163,2010-06-12T00:00:00,Child,M01.060.406
20547163,2010-06-12T00:00:00,"Child, Preschool",M01.060.406.448
20547163,2010-06-12T00:00:00,Gastrointestinal Hemorrhage,C06.405.227
20547163,2010-06-12T00:00:00,Gastrointestinal Hemorrhage,C23.550.414.788
20547163,2010-06-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20547163,2010-06-12T00:00:00,"Hypertension, Portal",C06.552.494
20550962,2010-06-13T00:00:00,Animals,B01.050
20550962,2010-06-13T00:00:00,DNA Damage,C21.111
20550962,2010-06-13T00:00:00,DNA Damage,G05.355.180
20550962,2010-06-13T00:00:00,Drug Resistance,G07.690.320
20550962,2010-06-13T00:00:00,Escherichia coli,B03.440.450.425.325.300
20550962,2010-06-13T00:00:00,Escherichia coli,B03.660.250.150.180.100
20550962,2010-06-13T00:00:00,Lung,A04.411
20550962,2010-06-13T00:00:00,Microbial Sensitivity Tests,E05.200.875.595
20550962,2010-06-13T00:00:00,Microbial Sensitivity Tests,E05.337.550.400
20550962,2010-06-13T00:00:00,Oxidative Stress,G03.495.710
20550962,2010-06-13T00:00:00,Oxidative Stress,G07.700.830.750
20550962,2010-06-13T00:00:00,Reactive Nitrogen Species,D01.625.700
20550962,2010-06-13T00:00:00,Reactive Nitrogen Species,D02.654.846
20550962,2010-06-13T00:00:00,Thioredoxins,D12.776.915
20550962,2010-06-13T00:00:00,"Transformation, Genetic",G05.355.760.865
19938943,2010-06-15T00:00:00,Aging,G07.700.320.124
19938943,2010-06-15T00:00:00,Animals,B01.050
19938943,2010-06-15T00:00:00,Apoptosis,G04.299.139.160
19938943,2010-06-15T00:00:00,Gene Expression Regulation,G05.355.315
19938943,2010-06-15T00:00:00,Hydrogen Peroxide,D01.248.497.158.685.750.424
19938943,2010-06-15T00:00:00,Hydrogen Peroxide,D01.339.431.374.424
19938943,2010-06-15T00:00:00,Hydrogen Peroxide,D01.650.550.750.400
19938943,2010-06-15T00:00:00,Myocardium,A02.633.580
19938943,2010-06-15T00:00:00,Myocardium,A07.541.704
19938943,2010-06-15T00:00:00,Myocardium,A10.690.552.750
19938943,2010-06-15T00:00:00,"Myocytes, Cardiac",A07.541.704.570
19938943,2010-06-15T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
19938943,2010-06-15T00:00:00,"Myocytes, Cardiac",A11.620.500
19938943,2010-06-15T00:00:00,NF-kappa B,D12.776.260.600
19938943,2010-06-15T00:00:00,NF-kappa B,D12.776.660.600
19938943,2010-06-15T00:00:00,NF-kappa B,D12.776.930.600
19938943,2010-06-15T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.644.360.075.718
19938943,2010-06-15T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.476.075.718
19938943,2010-06-15T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.624.664.700.169
19938943,2010-06-15T00:00:00,"RNA, Messenger",D13.444.735.544
19938943,2010-06-15T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20529941,2010-06-15T00:00:00,Animals,B01.050
20529941,2010-06-15T00:00:00,Computational Biology,H01.158.273.180
20529941,2010-06-15T00:00:00,"Databases, Genetic",L01.470.750.750.325
20529941,2010-06-15T00:00:00,"Databases, Genetic",L01.700.508.300.188.400.325
20529941,2010-06-15T00:00:00,Gene Expression Profiling,E05.393.332
20529941,2010-06-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20529941,2010-06-15T00:00:00,Software,L01.224.900
20551097,2010-06-15T00:00:00,Adult,M01.060.116
20551097,2010-06-15T00:00:00,Aged,M01.060.116.100
20551097,2010-06-15T00:00:00,Clinical Trials as Topic,E05.318.760.535
20551097,2010-06-15T00:00:00,Clinical Trials as Topic,E05.337.250
20551097,2010-06-15T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
20551097,2010-06-15T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
20551097,2010-06-15T00:00:00,"Databases, Factual",L01.470.750.750
20551097,2010-06-15T00:00:00,"Databases, Factual",L01.700.508.300.188.400
20551097,2010-06-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20551097,2010-06-15T00:00:00,Inflammation,C23.550.470
20551097,2010-06-15T00:00:00,Joint Diseases,C05.550
20551097,2010-06-15T00:00:00,Joints,A02.835.583
20551097,2010-06-15T00:00:00,Middle Aged,M01.060.116.630
20551097,2010-06-15T00:00:00,"Scleroderma, Systemic",C17.300.799
20551097,2010-06-15T00:00:00,"Scleroderma, Systemic",C17.800.784
20554456,2010-06-15T00:00:00,Adolescent,M01.060.057
20554456,2010-06-15T00:00:00,Adult,M01.060.116
20554456,2010-06-15T00:00:00,Age Factors,N05.715.350.075
20554456,2010-06-15T00:00:00,Age Factors,N06.850.490.250
20554456,2010-06-15T00:00:00,Age of Onset,N05.715.350.075.100
20554456,2010-06-15T00:00:00,Age of Onset,N06.850.490.250.100
20554456,2010-06-15T00:00:00,Aged,M01.060.116.100
20554456,2010-06-15T00:00:00,Anticonvulsants,D27.505.954.427.080
20554456,2010-06-15T00:00:00,Developing Countries,I01.615.500.300
20554456,2010-06-15T00:00:00,Emergency Medical Services,N02.421.297
20554456,2010-06-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20554456,2010-06-15T00:00:00,Inpatients,M01.643.470
20554456,2010-06-15T00:00:00,Middle Aged,M01.060.116.630
20554456,2010-06-15T00:00:00,Patient Compliance,F01.145.488.500
20554456,2010-06-15T00:00:00,Patient Compliance,N05.300.150.600.600
20554456,2010-06-15T00:00:00,Seizures,C10.228.140.490.631
20554456,2010-06-15T00:00:00,Seizures,C10.597.742
20554456,2010-06-15T00:00:00,Seizures,C23.888.592.742
20554456,2010-06-15T00:00:00,Status Epilepticus,C10.228.140.490.690
20554456,2010-06-15T00:00:00,Treatment Outcome,E01.789.800
20554456,2010-06-15T00:00:00,Treatment Outcome,N04.761.559.590.800
20554456,2010-06-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20554456,2010-06-15T00:00:00,Young Adult,M01.060.116.815
20558324,2010-06-15T00:00:00,Aged,M01.060.116.100
20558324,2010-06-15T00:00:00,"Cardiac Pacing, Artificial",E02.145
20558324,2010-06-15T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
20558324,2010-06-15T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
20558324,2010-06-15T00:00:00,"Defibrillators, Implantable",E07.695.175
20558324,2010-06-15T00:00:00,Heart Ventricles,A07.541.560
20558324,2010-06-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20558324,2010-06-15T00:00:00,Middle Aged,M01.060.116.630
20558829,2010-06-17T00:00:00,Adult,M01.060.116
20558829,2010-06-17T00:00:00,Age Factors,N05.715.350.075
20558829,2010-06-17T00:00:00,Age Factors,N06.850.490.250
20558829,2010-06-17T00:00:00,Aged,M01.060.116.100
20558829,2010-06-17T00:00:00,Hospital Mortality,E05.318.308.985.550.400
20558829,2010-06-17T00:00:00,Hospital Mortality,L01.280.975.550.400
20558829,2010-06-17T00:00:00,Hospital Mortality,N01.224.935.698.400
20558829,2010-06-17T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
20558829,2010-06-17T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
20558829,2010-06-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20558829,2010-06-17T00:00:00,Middle Aged,M01.060.116.630
20558829,2010-06-17T00:00:00,Sex Factors,N05.715.350.675
20558829,2010-06-17T00:00:00,Sex Factors,N06.850.490.875
20558829,2010-06-17T00:00:00,Stroke,C10.228.140.300.775
20558829,2010-06-17T00:00:00,Stroke,C14.907.253.855
20558829,2010-06-17T00:00:00,United States,Z01.107.567.875
20559296,2010-06-17T00:00:00,Adult,M01.060.116
20559296,2010-06-17T00:00:00,Antidepressive Agents,D27.505.954.427.700.122
20559296,2010-06-17T00:00:00,Behavior Therapy,F04.754.137
20559296,2010-06-17T00:00:00,"Chemotherapy, Adjuvant",E02.186.170
20559296,2010-06-17T00:00:00,"Chemotherapy, Adjuvant",E02.319.170
20559296,2010-06-17T00:00:00,Combined Modality Therapy,E02.186
20559296,2010-06-17T00:00:00,Double-Blind Method,E05.318.780.300
20559296,2010-06-17T00:00:00,Double-Blind Method,E05.581.500.300
20559296,2010-06-17T00:00:00,Double-Blind Method,N05.715.360.780.320
20559296,2010-06-17T00:00:00,Double-Blind Method,N06.850.520.445.300
20559296,2010-06-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20559296,2010-06-17T00:00:00,Middle Aged,M01.060.116.630
20559296,2010-06-17T00:00:00,Naltrexone,D03.132.577.249.706.550
20559296,2010-06-17T00:00:00,Naltrexone,D03.549.686.750.550
20559296,2010-06-17T00:00:00,Naltrexone,D03.605.497.750.550
20559296,2010-06-17T00:00:00,Naltrexone,D04.615.723.795.706.550
20559296,2010-06-17T00:00:00,Narcotic Antagonists,D27.505.696.543
20559296,2010-06-17T00:00:00,Narcotic Antagonists,D27.505.696.663.850.512
20559296,2010-06-17T00:00:00,Narcotic Antagonists,D27.505.954.427.550
20559296,2010-06-17T00:00:00,Obesity,C18.654.726.500
20559296,2010-06-17T00:00:00,Obesity,C23.888.144.699.500
20559296,2010-06-17T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
20559296,2010-06-17T00:00:00,Obesity,G07.100.100.160.120.699.500
20559296,2010-06-17T00:00:00,Treatment Outcome,E01.789.800
20559296,2010-06-17T00:00:00,Treatment Outcome,N04.761.559.590.800
20559296,2010-06-17T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20559296,2010-06-17T00:00:00,Weight Loss,C23.888.144.243.963
20559296,2010-06-17T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
20576579,2010-06-17T00:00:00,Adult,M01.060.116
20576579,2010-06-17T00:00:00,Aged,M01.060.116.100
20576579,2010-06-17T00:00:00,Brachytherapy,E02.815.150
20576579,2010-06-17T00:00:00,Diagnostic Imaging,E01.370.350
20576579,2010-06-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20576579,2010-06-17T00:00:00,Middle Aged,M01.060.116.630
20576579,2010-06-17T00:00:00,Neoplasm Staging,E01.370.550
20576579,2010-06-17T00:00:00,Radiotherapy Dosage,E02.815.639
20576579,2010-06-17T00:00:00,"Radiotherapy, Adjuvant",E02.186.775
20576579,2010-06-17T00:00:00,"Radiotherapy, Adjuvant",E02.815.600
20576579,2010-06-17T00:00:00,Sarcoma,C04.557.450.795
21255753,2010-06-17T00:00:00,Adult,M01.060.116
21255753,2010-06-17T00:00:00,Electric Stimulation Therapy,E02.342
21255753,2010-06-17T00:00:00,Electric Stimulation Therapy,E02.779.468
21255753,2010-06-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21255753,2010-06-17T00:00:00,Middle Aged,M01.060.116.630
21255753,2010-06-17T00:00:00,Pain,C10.597.617
21255753,2010-06-17T00:00:00,Pain,C23.888.592.612
21255753,2010-06-17T00:00:00,Pain,C23.888.646
21255753,2010-06-17T00:00:00,Pain,F02.830.816.444
21255753,2010-06-17T00:00:00,Pain,G11.561.600.810.444
20561637,2010-06-18T00:00:00,Biological Markers,D23.101
20561637,2010-06-18T00:00:00,Cytokines,D12.644.276.374
20561637,2010-06-18T00:00:00,Cytokines,D12.776.467.374
20561637,2010-06-18T00:00:00,Cytokines,D23.529.374
20561637,2010-06-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20561637,2010-06-18T00:00:00,Infant,M01.060.703
20561637,2010-06-18T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
20561637,2010-06-18T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
20561642,2010-06-18T00:00:00,Heart Ventricles,A07.541.560
20561642,2010-06-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20561642,2010-06-18T00:00:00,Hypoplastic Left Heart Syndrome,C14.240.400.625
20561642,2010-06-18T00:00:00,Hypoplastic Left Heart Syndrome,C14.280.400.625
20561642,2010-06-18T00:00:00,Hypoplastic Left Heart Syndrome,C16.131.240.400.625
20561642,2010-06-18T00:00:00,"Infant, Newborn",M01.060.703.520
20561642,2010-06-18T00:00:00,Multicenter Studies as Topic,E05.318.760.535.500
20561642,2010-06-18T00:00:00,Multicenter Studies as Topic,E05.337.250.500
20561642,2010-06-18T00:00:00,Multicenter Studies as Topic,N05.715.360.775.235.545
20561642,2010-06-18T00:00:00,Multicenter Studies as Topic,N06.850.520.450.535.500
20561642,2010-06-18T00:00:00,Pregnancy,G08.686.785.760.769
20561642,2010-06-18T00:00:00,Prenatal Diagnosis,E01.370.378.630
20561642,2010-06-18T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
20561642,2010-06-18T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
20561642,2010-06-18T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
20561642,2010-06-18T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
20561642,2010-06-18T00:00:00,Risk Factors,E05.318.740.600.800.725
20561642,2010-06-18T00:00:00,Risk Factors,N05.715.350.200.700
20561642,2010-06-18T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20561642,2010-06-18T00:00:00,Risk Factors,N06.850.490.625.750
20561642,2010-06-18T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20561642,2010-06-18T00:00:00,Treatment Outcome,E01.789.800
20561642,2010-06-18T00:00:00,Treatment Outcome,N04.761.559.590.800
20561642,2010-06-18T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20562255,2010-06-18T00:00:00,"Blood Pressure Monitoring, Ambulatory",E01.370.370.140.100
20562255,2010-06-18T00:00:00,"Blood Pressure Monitoring, Ambulatory",E01.370.520.500.100
20562255,2010-06-18T00:00:00,Diastole,G09.330.190.541.295
20562255,2010-06-18T00:00:00,Diastole,G11.427.590.540.554.250
20562255,2010-06-18T00:00:00,Diastole,G11.427.590.540.570.295
20562255,2010-06-18T00:00:00,Heart Failure,C14.280.434
20562255,2010-06-18T00:00:00,Hemodynamics,G09.330.190.400
20562255,2010-06-18T00:00:00,Hemodynamics,G09.330.380
20562255,2010-06-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20562255,2010-06-18T00:00:00,Middle Aged,M01.060.116.630
20562255,2010-06-18T00:00:00,Posture,G11.427.695
20562255,2010-06-18T00:00:00,Pulmonary Artery,A07.231.114.715
20562255,2010-06-18T00:00:00,Ventricular Pressure,G09.330.190.962.950
20562255,2010-06-18T00:00:00,Ventricular Pressure,G09.330.380.937
20601154,2010-06-18T00:00:00,Alcohol Drinking,F01.145.317.269
20601154,2010-06-18T00:00:00,"Death, Sudden, Cardiac",C14.280.383.220
20601154,2010-06-18T00:00:00,"Death, Sudden, Cardiac",C23.550.260.322.250
20601154,2010-06-18T00:00:00,Ethanol,D02.033.375
20601154,2010-06-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20601154,2010-06-18T00:00:00,Questionnaires,E05.318.308.750
20601154,2010-06-18T00:00:00,Questionnaires,L01.280.800
20601154,2010-06-18T00:00:00,Questionnaires,N05.715.360.300.695
20601154,2010-06-18T00:00:00,Questionnaires,N06.850.520.308.750
20646859,2010-06-18T00:00:00,Cone-Beam Computed Tomography,E01.370.350.700.810.810.490
20646859,2010-06-18T00:00:00,Cone-Beam Computed Tomography,E01.370.350.825.810.810.399
20646859,2010-06-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20646859,2010-06-18T00:00:00,Movement,G07.700.560
20646859,2010-06-18T00:00:00,Movement,G11.427.590.530
20646859,2010-06-18T00:00:00,Patient Positioning,E02.760.670
20646859,2010-06-18T00:00:00,Patient Positioning,N02.421.585.700
20646859,2010-06-18T00:00:00,"Phantoms, Imaging",E07.671
20646859,2010-06-18T00:00:00,Radiosurgery,E02.815.530
20646859,2010-06-18T00:00:00,Radiosurgery,E04.525.800.650
20646859,2010-06-18T00:00:00,Radiosurgery,E05.873.500
20646711,2010-06-19T00:00:00,Ankle Joint,A02.835.583.378.062
20646711,2010-06-19T00:00:00,Computer Simulation,L01.224.160
20646711,2010-06-19T00:00:00,Gait,E01.370.600.250
20646711,2010-06-19T00:00:00,Gait,G11.427.590.530.389
20646711,2010-06-19T00:00:00,Hip Joint,A02.835.583.411
20646711,2010-06-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20646711,2010-06-19T00:00:00,Joints,A02.835.583
20646711,2010-06-19T00:00:00,Knee Joint,A02.835.583.475
20646711,2010-06-19T00:00:00,Leg,A01.378.610.500
20646711,2010-06-19T00:00:00,Postural Balance,G11.427.690
20646711,2010-06-19T00:00:00,Postural Balance,G11.561.600.810.541.595
20646940,2010-06-19T00:00:00,Mammography,E01.370.350.700.500
20646940,2010-06-19T00:00:00,Professional Competence,I02.399.630
20646940,2010-06-19T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
20646940,2010-06-19T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
20646940,2010-06-19T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
20646940,2010-06-19T00:00:00,Radiology,H02.403.740
20646940,2010-06-19T00:00:00,Task Performance and Analysis,F02.784.412.846
20646940,2010-06-19T00:00:00,Task Performance and Analysis,F02.784.692.746
20646940,2010-06-19T00:00:00,Task Performance and Analysis,F02.808.600
20646940,2010-06-19T00:00:00,Workflow,L01.906.893
20566668,2010-06-21T00:00:00,ADAM Proteins,D08.811.277.656.675.374.102
20566668,2010-06-21T00:00:00,ADAM Proteins,D09.400.430.500
20566668,2010-06-21T00:00:00,ADAM Proteins,D12.776.395.033
20566668,2010-06-21T00:00:00,Animals,B01.050
20566668,2010-06-21T00:00:00,Bradykinin,D12.644.276.812.169
20566668,2010-06-21T00:00:00,Bradykinin,D12.644.400.090
20566668,2010-06-21T00:00:00,Bradykinin,D12.644.456.193
20566668,2010-06-21T00:00:00,Bradykinin,D12.776.467.812.169
20566668,2010-06-21T00:00:00,Bradykinin,D12.776.641.650.090
20566668,2010-06-21T00:00:00,Bradykinin,D23.469.050.375.110
20566668,2010-06-21T00:00:00,Bradykinin,D23.529.812.169
20566668,2010-06-21T00:00:00,Kidney Glomerulus,A05.810.453.324.359
20566668,2010-06-21T00:00:00,Kidney Glomerulus,A05.810.453.736.520
20566668,2010-06-21T00:00:00,Membrane Proteins,D12.776.543
20566668,2010-06-21T00:00:00,Phosphoproteins,D12.776.744
20566668,2010-06-21T00:00:00,Podocytes,A05.810.453.324.359.720
20566668,2010-06-21T00:00:00,Podocytes,A05.810.453.736.520.720
20566668,2010-06-21T00:00:00,Podocytes,A11.436.720
20566668,2010-06-21T00:00:00,RNA Interference,G05.355.315.203.374.790
20566668,2010-06-21T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.100.080.500
20566668,2010-06-21T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.720.600.220.500
20566668,2010-06-21T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.750.555.220.500
20566668,2010-06-21T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
20566668,2010-06-21T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
20566668,2010-06-21T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
20566668,2010-06-21T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
20566668,2010-06-21T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
20566668,2010-06-21T00:00:00,Signal Transduction,G02.111.087.800
20566668,2010-06-21T00:00:00,Signal Transduction,G02.149.115.800
20566668,2010-06-21T00:00:00,Signal Transduction,G04.299.880
20566756,2010-06-21T00:00:00,Age Factors,N05.715.350.075
20566756,2010-06-21T00:00:00,Age Factors,N06.850.490.250
20566756,2010-06-21T00:00:00,Animals,B01.050
20566756,2010-06-21T00:00:00,Extracellular Matrix,A11.284.295.310
20566756,2010-06-21T00:00:00,Fibrillar Collagens,D05.750.078.280.300
20566756,2010-06-21T00:00:00,Fibrillar Collagens,D12.776.860.300.250.300
20566756,2010-06-21T00:00:00,Fibroblasts,A11.329.228
20566756,2010-06-21T00:00:00,Fibroblasts,A11.872.228
20566756,2010-06-21T00:00:00,Homeostasis,G07.700.360
20566756,2010-06-21T00:00:00,Osteonectin,D12.776.157.125.715
20566756,2010-06-21T00:00:00,Osteonectin,D12.776.395.600
20566951,2010-06-21T00:00:00,Animals,B01.050
20566951,2010-06-21T00:00:00,Diastole,G09.330.190.541.295
20566951,2010-06-21T00:00:00,Diastole,G11.427.590.540.554.250
20566951,2010-06-21T00:00:00,Diastole,G11.427.590.540.570.295
20566951,2010-06-21T00:00:00,Echocardiography,E01.370.350.850.220
20566951,2010-06-21T00:00:00,Echocardiography,E01.370.370.380.220
20566951,2010-06-21T00:00:00,Electric Stimulation Therapy,E02.342
20566951,2010-06-21T00:00:00,Electric Stimulation Therapy,E02.779.468
20566951,2010-06-21T00:00:00,Fibroblasts,A11.329.228
20566951,2010-06-21T00:00:00,Fibroblasts,A11.872.228
20566951,2010-06-21T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.205.352
20566951,2010-06-21T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.252.420
20566951,2010-06-21T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.525.700.150
20566951,2010-06-21T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.205.352
20566951,2010-06-21T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.252.420
20566951,2010-06-21T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.525.700.150
20566951,2010-06-21T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.205.360
20566951,2010-06-21T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.252.445
20566951,2010-06-21T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.525.700.350
20566951,2010-06-21T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.205.360
20566951,2010-06-21T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.252.445
20566951,2010-06-21T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.525.700.350
20566951,2010-06-21T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
20566951,2010-06-21T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
20566951,2010-06-21T00:00:00,Myocardial Infarction,C14.280.647.500
20566951,2010-06-21T00:00:00,Myocardial Infarction,C14.907.585.500
20566951,2010-06-21T00:00:00,"Pacemaker, Artificial",E07.858.082.748
20566951,2010-06-21T00:00:00,Stroke Volume,E01.370.370.380.150.700
20566951,2010-06-21T00:00:00,Stroke Volume,G09.330.380.124.882
20566951,2010-06-21T00:00:00,Swine,B01.050.150.900.649.077.880
20566951,2010-06-21T00:00:00,"Tachycardia, Ventricular",C14.280.067.845.940
20566951,2010-06-21T00:00:00,"Tachycardia, Ventricular",C23.550.073.845.940
20566951,2010-06-21T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
20566951,2010-06-21T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
20566951,2010-06-21T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
20566951,2010-06-21T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
20566951,2010-06-21T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
20566951,2010-06-21T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
20566951,2010-06-21T00:00:00,Transforming Growth Factor beta,D23.529.374.687
20566951,2010-06-21T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
20566951,2010-06-21T00:00:00,Transforming Growth Factor beta,D23.529.960.720
20566951,2010-06-21T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
20566951,2010-06-21T00:00:00,Ventricular Remodeling,C23.300.985
20566951,2010-06-21T00:00:00,Ventricular Remodeling,G09.330.190.962.975
20566960,2010-06-21T00:00:00,Animals,B01.050
20566960,2010-06-21T00:00:00,Arthritis,C05.550.114
20566960,2010-06-21T00:00:00,"Disease Models, Animal",C22.232
20566960,2010-06-21T00:00:00,"Disease Models, Animal",E05.598.500
20566960,2010-06-21T00:00:00,"Disease Models, Animal",E05.599.395.080
20566960,2010-06-21T00:00:00,"Endothelium, Vascular",A07.231.330
20566960,2010-06-21T00:00:00,"Endothelium, Vascular",A10.272.491.355
20566960,2010-06-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20566960,2010-06-21T00:00:00,Inflammation,C23.550.470
20566960,2010-06-21T00:00:00,Kallikreins,D08.811.277.656.300.760.442
20566960,2010-06-21T00:00:00,Kallikreins,D08.811.277.656.959.350.442
20566960,2010-06-21T00:00:00,Kallikreins,D12.776.124.125.597
20566960,2010-06-21T00:00:00,Kallikreins,D23.119.597
20566960,2010-06-21T00:00:00,NF-kappa B,D12.776.260.600
20566960,2010-06-21T00:00:00,NF-kappa B,D12.776.660.600
20566960,2010-06-21T00:00:00,NF-kappa B,D12.776.930.600
20566960,2010-06-21T00:00:00,Plasmids,G05.360.600
20566960,2010-06-21T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20566960,2010-06-21T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
20566960,2010-06-21T00:00:00,Serpins,D12.644.822.750
20566960,2010-06-21T00:00:00,Serpins,D12.644.861
20566960,2010-06-21T00:00:00,Serpins,D12.776.645.750
20566960,2010-06-21T00:00:00,Serpins,D12.776.872
20566960,2010-06-21T00:00:00,Signal Transduction,G02.111.087.800
20566960,2010-06-21T00:00:00,Signal Transduction,G02.149.115.800
20566960,2010-06-21T00:00:00,Signal Transduction,G04.299.880
20566960,2010-06-21T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
20566960,2010-06-21T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
20566960,2010-06-21T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
20566960,2010-06-21T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
20566960,2010-06-21T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
20566960,2010-06-21T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
20566960,2010-06-21T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
20566960,2010-06-21T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
20566960,2010-06-21T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
20566960,2010-06-21T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
20566960,2010-06-21T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
20566960,2010-06-21T00:00:00,Umbilical Veins,A07.231.908.670.874
20566960,2010-06-21T00:00:00,Umbilical Veins,A16.378.693.807
20573061,2010-06-21T00:00:00,Adult,M01.060.116
20573061,2010-06-21T00:00:00,Bronchoscopy,E01.370.386.105
20573061,2010-06-21T00:00:00,Bronchoscopy,E01.370.388.250.100
20573061,2010-06-21T00:00:00,Bronchoscopy,E04.800.250.100
20573061,2010-06-21T00:00:00,Bronchoscopy,E04.928.600.080
20573061,2010-06-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20573061,2010-06-21T00:00:00,"Tuberculosis, Lymph Node",C01.252.410.040.552.846.719
20573061,2010-06-21T00:00:00,"Tuberculosis, Lymph Node",C15.604.315.809
20573061,2010-06-21T00:00:00,"Tuberculosis, Lymph Node",C15.604.921
20570907,2010-06-22T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
20570907,2010-06-22T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
20570907,2010-06-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20570907,2010-06-22T00:00:00,Risk Factors,E05.318.740.600.800.725
20570907,2010-06-22T00:00:00,Risk Factors,N05.715.350.200.700
20570907,2010-06-22T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20570907,2010-06-22T00:00:00,Risk Factors,N06.850.490.625.750
20570907,2010-06-22T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20570907,2010-06-22T00:00:00,Skin Neoplasms,C04.588.805
20570907,2010-06-22T00:00:00,Skin Neoplasms,C17.800.882
20571027,2010-06-22T00:00:00,3' Untranslated Regions,D13.444.735.544.875.880
20571027,2010-06-22T00:00:00,3' Untranslated Regions,D13.444.735.790.878.880
20571027,2010-06-22T00:00:00,3' Untranslated Regions,G05.360.340.024.220.880.880
20571027,2010-06-22T00:00:00,3' Untranslated Regions,G05.360.340.024.340.137.910.880
20571027,2010-06-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20571027,2010-06-22T00:00:00,Leukemia,C04.557.337
20571027,2010-06-22T00:00:00,"Models, Biological",E05.599.395
20571027,2010-06-22T00:00:00,Phosphoproteins,D12.776.744
20571027,2010-06-22T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.644.360.075.718
20571027,2010-06-22T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.476.075.718
20571027,2010-06-22T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.624.664.700.169
20571027,2010-06-22T00:00:00,RNA Stability,G02.111.780
20571027,2010-06-22T00:00:00,RNA-Binding Proteins,D12.776.157.725
20571027,2010-06-22T00:00:00,RNA-Binding Proteins,D12.776.664.962
20598809,2010-06-22T00:00:00,Adolescent,M01.060.057
20598809,2010-06-22T00:00:00,Adult,M01.060.116
20598809,2010-06-22T00:00:00,"Analgesics, Opioid",D27.505.696.663.850.014.520
20598809,2010-06-22T00:00:00,"Analgesics, Opioid",D27.505.954.427.040.325
20598809,2010-06-22T00:00:00,"Analgesics, Opioid",D27.505.954.427.210.049
20598809,2010-06-22T00:00:00,Child,M01.060.406
20598809,2010-06-22T00:00:00,Drug Prescriptions,E02.319.307
20598809,2010-06-22T00:00:00,Drug Prescriptions,N02.421.668.778.500
20598809,2010-06-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20598809,2010-06-22T00:00:00,Opioid-Related Disorders,C21.739.675
20598809,2010-06-22T00:00:00,Opioid-Related Disorders,F03.900.675
20598809,2010-06-22T00:00:00,Risk Factors,E05.318.740.600.800.725
20598809,2010-06-22T00:00:00,Risk Factors,N05.715.350.200.700
20598809,2010-06-22T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20598809,2010-06-22T00:00:00,Risk Factors,N06.850.490.625.750
20598809,2010-06-22T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20598809,2010-06-22T00:00:00,Sex Factors,N05.715.350.675
20598809,2010-06-22T00:00:00,Sex Factors,N06.850.490.875
20598809,2010-06-22T00:00:00,Substance-Related Disorders,C21.739
20598809,2010-06-22T00:00:00,Substance-Related Disorders,F03.900
20598809,2010-06-22T00:00:00,United States,Z01.107.567.875
20598809,2010-06-22T00:00:00,Young Adult,M01.060.116.815
20620018,2010-06-22T00:00:00,Adolescent,M01.060.057
20620018,2010-06-22T00:00:00,Crime Victims,M01.135
20620018,2010-06-22T00:00:00,Data Collection,E05.318.308
20620018,2010-06-22T00:00:00,Data Collection,L01.280
20620018,2010-06-22T00:00:00,Data Collection,N05.715.360.300
20620018,2010-06-22T00:00:00,Data Collection,N06.850.520.308
20620018,2010-06-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20620018,2010-06-22T00:00:00,Mental Health Services,F04.408
20620018,2010-06-22T00:00:00,Mental Health Services,N02.421.461
20620018,2010-06-22T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
20620018,2010-06-22T00:00:00,Rape,I01.198.240.748.640
20620018,2010-06-22T00:00:00,United States,Z01.107.567.875
20620018,2010-06-22T00:00:00,Young Adult,M01.060.116.815
20624670,2010-06-22T00:00:00,Adolescent,M01.060.057
20624670,2010-06-22T00:00:00,Child,M01.060.406
20624670,2010-06-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20624670,2010-06-22T00:00:00,Questionnaires,E05.318.308.750
20624670,2010-06-22T00:00:00,Questionnaires,L01.280.800
20624670,2010-06-22T00:00:00,Questionnaires,N05.715.360.300.695
20624670,2010-06-22T00:00:00,Questionnaires,N06.850.520.308.750
20624670,2010-06-22T00:00:00,Self Disclosure,F01.752.747.792.662
20624670,2010-06-22T00:00:00,Tobacco Use Disorder,C21.739.912
20624670,2010-06-22T00:00:00,Tobacco Use Disorder,F03.900.912
20624670,2010-06-22T00:00:00,Young Adult,M01.060.116.815
20574023,2010-06-23T00:00:00,Animals,B01.050
20574023,2010-06-23T00:00:00,Carrier Proteins,D12.776.157
20574023,2010-06-23T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
20574023,2010-06-23T00:00:00,Collagen,D05.750.078.280
20574023,2010-06-23T00:00:00,Collagen,D12.776.860.300.250
20574023,2010-06-23T00:00:00,Drug Delivery Systems,E02.319.300
20574023,2010-06-23T00:00:00,Eye Proteins,D12.776.306
20574023,2010-06-23T00:00:00,Retinal Cone Photoreceptor Cells,A08.663.650.850.625.670.100
20574023,2010-06-23T00:00:00,Retinal Cone Photoreceptor Cells,A08.663.650.915.937.670.100
20574023,2010-06-23T00:00:00,Retinal Cone Photoreceptor Cells,A08.800.950.937.670.100
20574023,2010-06-23T00:00:00,Retinal Cone Photoreceptor Cells,A09.371.729.831.625.670.100
20574023,2010-06-23T00:00:00,Retinal Cone Photoreceptor Cells,A11.671.650.850.625.670.100
20574023,2010-06-23T00:00:00,Retinal Cone Photoreceptor Cells,A11.671.650.915.937.670.100
20574023,2010-06-23T00:00:00,Retinal Rod Photoreceptor Cells,A08.663.650.850.625.670.650
20574023,2010-06-23T00:00:00,Retinal Rod Photoreceptor Cells,A08.663.650.915.937.670.650
20574023,2010-06-23T00:00:00,Retinal Rod Photoreceptor Cells,A08.800.950.937.670.650
20574023,2010-06-23T00:00:00,Retinal Rod Photoreceptor Cells,A09.371.729.831.625.670.650
20574023,2010-06-23T00:00:00,Retinal Rod Photoreceptor Cells,A11.671.650.850.625.670.650
20574023,2010-06-23T00:00:00,Retinal Rod Photoreceptor Cells,A11.671.650.915.937.670.650
20574023,2010-06-23T00:00:00,Retinaldehyde,D02.047.850
20574023,2010-06-23T00:00:00,Retinaldehyde,D02.455.326.271.665.202.495.690
20574023,2010-06-23T00:00:00,Retinaldehyde,D02.455.426.392.368.367.379.249.700.690
20574023,2010-06-23T00:00:00,Retinaldehyde,D02.455.849.131.495.690
20574023,2010-06-23T00:00:00,Retinaldehyde,D23.767.261.700.690
20574023,2010-06-23T00:00:00,Rhodopsin,D12.776.543.750.100.955
20574023,2010-06-23T00:00:00,Rhodopsin,D23.767.930.750.500.500
20599789,2010-06-23T00:00:00,Antineoplastic Agents,D27.505.954.248
20599789,2010-06-23T00:00:00,Drug Delivery Systems,E02.319.300
20599789,2010-06-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20599789,2010-06-23T00:00:00,Neoplasms,C04
20599789,2010-06-23T00:00:00,"Receptor, IGF Type 1",D08.811.913.696.620.682.725.400.185
20599789,2010-06-23T00:00:00,"Receptor, IGF Type 1",D12.776.543.750.060.468
20599789,2010-06-23T00:00:00,"Receptor, IGF Type 1",D12.776.543.750.750.400.780.400
20481538,2010-06-24T00:00:00,Analgesics,D27.505.696.663.850.014
20481538,2010-06-24T00:00:00,Analgesics,D27.505.954.427.040
20481538,2010-06-24T00:00:00,Animals,B01.050
20481538,2010-06-24T00:00:00,Calcium,D01.268.552.100
20481538,2010-06-24T00:00:00,Calcium,D01.552.539.288
20481538,2010-06-24T00:00:00,Calcium,D23.119.100
20481538,2010-06-24T00:00:00,Cell Line,A11.251.210
20481538,2010-06-24T00:00:00,Drug Tolerance,G07.690.812.260
20481538,2010-06-24T00:00:00,Drug Tolerance,G07.700.680.260
20481538,2010-06-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20481538,2010-06-24T00:00:00,Neurotensin,D12.644.400.550
20481538,2010-06-24T00:00:00,Neurotensin,D12.776.641.650.550
20481538,2010-06-24T00:00:00,Oligopeptides,D12.644.456
20481538,2010-06-24T00:00:00,Pain Measurement,E01.370.376.550.600
20481538,2010-06-24T00:00:00,Peptide Fragments,D12.644.541
20481538,2010-06-24T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20481538,2010-06-24T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
20481538,2010-06-24T00:00:00,"Receptors, Neurotensin",D12.776.543.750.100.550
20481538,2010-06-24T00:00:00,"Receptors, Neurotensin",D12.776.543.750.720.600.560
20481538,2010-06-24T00:00:00,"Receptors, Neurotensin",D12.776.543.750.750.555.560
20574437,2010-06-24T00:00:00,Animals,B01.050
20574437,2010-06-24T00:00:00,Hair,A17.360
20576216,2010-06-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20576216,2010-06-24T00:00:00,"Lung Diseases, Interstitial",C08.381.483
20576216,2010-06-24T00:00:00,Multicenter Studies as Topic,E05.318.760.535.500
20576216,2010-06-24T00:00:00,Multicenter Studies as Topic,E05.337.250.500
20576216,2010-06-24T00:00:00,Multicenter Studies as Topic,N05.715.360.775.235.545
20576216,2010-06-24T00:00:00,Multicenter Studies as Topic,N06.850.520.450.535.500
20576216,2010-06-24T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
20576216,2010-06-24T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
20576216,2010-06-24T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
20576216,2010-06-24T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
20576216,2010-06-24T00:00:00,Research Design,E05.581.500
20576216,2010-06-24T00:00:00,Research Design,H01.770.644.728
20576216,2010-06-24T00:00:00,"Scleroderma, Systemic",C17.300.799
20576216,2010-06-24T00:00:00,"Scleroderma, Systemic",C17.800.784
20576216,2010-06-24T00:00:00,Treatment Outcome,E01.789.800
20576216,2010-06-24T00:00:00,Treatment Outcome,N04.761.559.590.800
20576216,2010-06-24T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20544707,2010-06-25T00:00:00,Adult,M01.060.116
20544707,2010-06-25T00:00:00,Aged,M01.060.116.100
20544707,2010-06-25T00:00:00,"Biopsy, Fine-Needle",E01.370.388.100.100.500
20544707,2010-06-25T00:00:00,"Biopsy, Fine-Needle",E01.450.230.100.100.500
20544707,2010-06-25T00:00:00,"Biopsy, Fine-Needle",E01.450.865.100.100.500
20544707,2010-06-25T00:00:00,"Biopsy, Fine-Needle",E04.074.119.500
20544707,2010-06-25T00:00:00,"Diagnosis, Differential",E01.171
20544707,2010-06-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20544707,2010-06-25T00:00:00,Middle Aged,M01.060.116.630
20544707,2010-06-25T00:00:00,Neoplasms,C04
20544707,2010-06-25T00:00:00,Telepathology,H02.403.650.600
20544707,2010-06-25T00:00:00,Telepathology,H02.403.840.600
20544707,2010-06-25T00:00:00,Telepathology,L01.178.847.652.600
20544707,2010-06-25T00:00:00,Telepathology,N04.590.374.800.600
20584761,2010-06-27T00:00:00,Animals,B01.050
20584761,2010-06-27T00:00:00,Hepatocytes,A11.436.348
20584761,2010-06-27T00:00:00,Iron,D01.268.556.412
20584761,2010-06-27T00:00:00,Iron,D01.268.956.287
20584761,2010-06-27T00:00:00,Iron,D01.552.544.412
20584761,2010-06-27T00:00:00,Lysosomes,A11.284.430.214.190.875.190.550
20584761,2010-06-27T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
20584761,2010-06-27T00:00:00,"Microscopy, Confocal",E05.595.395
20584761,2010-06-27T00:00:00,Reactive Oxygen Species,D01.339.431
20584761,2010-06-27T00:00:00,Reactive Oxygen Species,D01.650.775
20584894,2010-06-28T00:00:00,Heterogeneous-Nuclear Ribonucleoproteins,D12.776.157.725.500.500
20584894,2010-06-28T00:00:00,Heterogeneous-Nuclear Ribonucleoproteins,D12.776.664.962.500.500
20584894,2010-06-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20584894,2010-06-28T00:00:00,"RNA, Messenger",D13.444.735.544
20584894,2010-06-28T00:00:00,RNA-Binding Proteins,D12.776.157.725
20584894,2010-06-28T00:00:00,RNA-Binding Proteins,D12.776.664.962
20591510,2010-06-28T00:00:00,Animals,B01.050
20591510,2010-06-28T00:00:00,Blood-Brain Barrier,A07.035
20591510,2010-06-28T00:00:00,Blood-Brain Barrier,A08.186.211.035
20591510,2010-06-28T00:00:00,Cannabinoids,D02.455.849.090
20591510,2010-06-28T00:00:00,Graft Rejection,G12.425.901.545.328
20591510,2010-06-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20591510,2010-06-28T00:00:00,Organ Transplantation,E04.936.450
20591510,2010-06-28T00:00:00,"Receptor, Cannabinoid, CB1",D12.776.543.750.100.125.100
20591510,2010-06-28T00:00:00,"Receptor, Cannabinoid, CB2",D12.776.543.750.100.125.200
20616028,2010-06-28T00:00:00,Adult,M01.060.116
20616028,2010-06-28T00:00:00,Anoxia,C23.888.852.079
20616028,2010-06-28T00:00:00,Exercise,G11.427.590.237
20616028,2010-06-28T00:00:00,Exercise,I03.350
20616028,2010-06-28T00:00:00,Gene Expression Regulation,G05.355.315
20616028,2010-06-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20616028,2010-06-28T00:00:00,Lactic Acid,D02.241.511.459.450
20616028,2010-06-28T00:00:00,"Muscle, Skeletal",A02.633.567
20616028,2010-06-28T00:00:00,"Muscle, Skeletal",A10.690.552.500
20616028,2010-06-28T00:00:00,Muscles,A02.633
20616028,2010-06-28T00:00:00,Muscles,A10.690
20616028,2010-06-28T00:00:00,Oxygen,D01.268.185.550
20616028,2010-06-28T00:00:00,Oxygen,D01.362.670
20616028,2010-06-28T00:00:00,Transcription Factors,D12.776.930
20584336,2010-06-29T00:00:00,Antibodies,D12.776.124.486.485.114
20584336,2010-06-29T00:00:00,Antibodies,D12.776.124.790.651.114
20584336,2010-06-29T00:00:00,Antibodies,D12.776.377.715.548.114
20584336,2010-06-29T00:00:00,Cell Line,A11.251.210
20584336,2010-06-29T00:00:00,Complement Activation,G12.425.255
20584336,2010-06-29T00:00:00,Complement C3,D12.776.124.050.140
20584336,2010-06-29T00:00:00,Complement C3,D12.776.124.486.274.250
20584336,2010-06-29T00:00:00,Down-Regulation,G02.111.087.225
20584336,2010-06-29T00:00:00,Down-Regulation,G02.149.115.225
20584336,2010-06-29T00:00:00,Down-Regulation,G05.355.315.200
20584336,2010-06-29T00:00:00,Down-Regulation,G07.690.812.230
20584336,2010-06-29T00:00:00,Down-Regulation,G07.700.680.230
20584336,2010-06-29T00:00:00,HIV Infections,C02.782.815.616.400
20584336,2010-06-29T00:00:00,HIV Infections,C02.800.801.400
20584336,2010-06-29T00:00:00,HIV Infections,C20.673.480
20584336,2010-06-29T00:00:00,HIV-1,B04.820.650.589.650.350.400
20584336,2010-06-29T00:00:00,HIV-1,B04.909.777.731.589.650.350.400
20584336,2010-06-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20584336,2010-06-29T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
20584336,2010-06-29T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
20584336,2010-06-29T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
20585829,2010-06-29T00:00:00,Actins,D05.750.078.730.250
20585829,2010-06-29T00:00:00,Actins,D12.776.210.500.100
20585829,2010-06-29T00:00:00,Actins,D12.776.220.525.255
20585829,2010-06-29T00:00:00,Animals,B01.050
20585829,2010-06-29T00:00:00,Collagen Type I,D05.750.078.280.300.100
20585829,2010-06-29T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
20585829,2010-06-29T00:00:00,Inflammation,C23.550.470
20585829,2010-06-29T00:00:00,Liver,A03.620
20585829,2010-06-29T00:00:00,Liver Cirrhosis,C06.552.630
20585829,2010-06-29T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20585829,2010-06-29T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
20587745,2010-06-29T00:00:00,Adult,M01.060.116
20587745,2010-06-29T00:00:00,Antihypertensive Agents,D27.505.954.411.162
20587745,2010-06-29T00:00:00,Blood Pressure,E01.370.600.875.249
20587745,2010-06-29T00:00:00,Blood Pressure,G09.330.380.076
20587745,2010-06-29T00:00:00,Graft Rejection,G12.425.901.545.328
20587745,2010-06-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20587745,2010-06-29T00:00:00,Hypertension,C14.907.489
20587745,2010-06-29T00:00:00,Kidney Transplantation,E02.870.500
20587745,2010-06-29T00:00:00,Kidney Transplantation,E04.936.450.485
20587745,2010-06-29T00:00:00,Kidney Transplantation,E04.950.774.400
20587745,2010-06-29T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
20587745,2010-06-29T00:00:00,Practice Guidelines as Topic,N05.700.350.650
20585921,2010-06-30T00:00:00,Aged,M01.060.116.100
20585921,2010-06-30T00:00:00,Combined Modality Therapy,E02.186
20585921,2010-06-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20585921,2010-06-30T00:00:00,Lung Neoplasms,C04.588.894.797.520
20585921,2010-06-30T00:00:00,Lung Neoplasms,C08.381.540
20585921,2010-06-30T00:00:00,Lung Neoplasms,C08.785.520
20585921,2010-06-30T00:00:00,Middle Aged,M01.060.116.630
20585921,2010-06-30T00:00:00,Radiotherapy Dosage,E02.815.639
20585921,2010-06-30T00:00:00,Treatment Outcome,E01.789.800
20585921,2010-06-30T00:00:00,Treatment Outcome,N04.761.559.590.800
20585921,2010-06-30T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20585929,2010-06-30T00:00:00,B-Lymphocytes,A11.063.438
20585929,2010-06-30T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
20585929,2010-06-30T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
20585929,2010-06-30T00:00:00,B-Lymphocytes,A15.382.032.438
20585929,2010-06-30T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
20585929,2010-06-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20585929,2010-06-30T00:00:00,Middle Aged,M01.060.116.630
20585929,2010-06-30T00:00:00,Skin Diseases,C17.800
20591971,2010-06-30T00:00:00,African Continental Ancestry Group,M01.686.508.100
20591971,2010-06-30T00:00:00,Body Mass Index,E01.370.600.115.100.125
20591971,2010-06-30T00:00:00,Body Mass Index,E05.041.124.125
20591971,2010-06-30T00:00:00,Body Mass Index,G07.100.100.125
20591971,2010-06-30T00:00:00,Body Mass Index,N06.850.505.200.100.175
20591971,2010-06-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20591971,2010-06-30T00:00:00,Hypertension,C14.907.489
20591971,2010-06-30T00:00:00,Phenotype,G05.695
20591971,2010-06-30T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
20135703,2010-07-01T00:00:00,Adolescent,M01.060.057
20135703,2010-07-01T00:00:00,Child,M01.060.406
20135703,2010-07-01T00:00:00,"Child, Preschool",M01.060.406.448
20135703,2010-07-01T00:00:00,Data Collection,E05.318.308
20135703,2010-07-01T00:00:00,Data Collection,L01.280
20135703,2010-07-01T00:00:00,Data Collection,N05.715.360.300
20135703,2010-07-01T00:00:00,Data Collection,N06.850.520.308
20135703,2010-07-01T00:00:00,Hematopoietic Stem Cell Transplantation,E04.936.225.687.500
20135703,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20135703,2010-07-01T00:00:00,Infant,M01.060.703
20135703,2010-07-01T00:00:00,Physician's Practice Patterns,N04.590.748
20135703,2010-07-01T00:00:00,Physician's Practice Patterns,N05.300.625
20135703,2010-07-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
20135703,2010-07-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
20135703,2010-07-01T00:00:00,Vaccination,E02.095.465.425.400.530.890
20135703,2010-07-01T00:00:00,Vaccination,E05.478.550.600.890
20135703,2010-07-01T00:00:00,Vaccination,N02.421.726.758.310.890
20135703,2010-07-01T00:00:00,Vaccination,N06.850.780.200.425.900
20135703,2010-07-01T00:00:00,Vaccination,N06.850.780.680.310.890
20210515,2010-07-01T00:00:00,Adolescent,M01.060.057
20210515,2010-07-01T00:00:00,Adult,M01.060.116
20210515,2010-07-01T00:00:00,Aged,M01.060.116.100
20210515,2010-07-01T00:00:00,Carrier State,N06.850.160
20210515,2010-07-01T00:00:00,Child,M01.060.406
20210515,2010-07-01T00:00:00,"Child, Preschool",M01.060.406.448
20210515,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20210515,2010-07-01T00:00:00,Infant,M01.060.703
20210515,2010-07-01T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.300.390.400.800.750.100.500
20210515,2010-07-01T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.510.100.750.750.100.500
20210515,2010-07-01T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.510.400.790.750.100.500
20210515,2010-07-01T00:00:00,Middle Aged,M01.060.116.630
20210515,2010-07-01T00:00:00,Nasal Cavity,A04.531.449
20210515,2010-07-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20210515,2010-07-01T00:00:00,Risk Factors,N05.715.350.200.700
20210515,2010-07-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20210515,2010-07-01T00:00:00,Risk Factors,N06.850.490.625.750
20210515,2010-07-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20210515,2010-07-01T00:00:00,Staphylococcal Infections,C01.252.410.868
20210515,2010-07-01T00:00:00,Vitamin D,D04.808.812.768
20210515,2010-07-01T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
20220579,2010-07-01T00:00:00,Aged,M01.060.116.100
20220579,2010-07-01T00:00:00,Elder Abuse,I01.198.240.856.350.390
20220579,2010-07-01T00:00:00,Elder Abuse,I01.880.735.900.350.390
20220579,2010-07-01T00:00:00,Geriatric Assessment,E05.318.308.225
20220579,2010-07-01T00:00:00,Geriatric Assessment,I01.240.425.350
20220579,2010-07-01T00:00:00,Geriatric Assessment,L01.280.360
20220579,2010-07-01T00:00:00,Geriatric Assessment,N01.224.425.350
20220579,2010-07-01T00:00:00,Geriatric Assessment,N05.715.360.300.360
20220579,2010-07-01T00:00:00,Geriatric Assessment,N06.850.505.400.425.350
20220579,2010-07-01T00:00:00,Geriatric Assessment,N06.850.520.308.225
20220579,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20220579,2010-07-01T00:00:00,Middle Aged,M01.060.116.630
20220579,2010-07-01T00:00:00,Questionnaires,E05.318.308.750
20220579,2010-07-01T00:00:00,Questionnaires,L01.280.800
20220579,2010-07-01T00:00:00,Questionnaires,N05.715.360.300.695
20220579,2010-07-01T00:00:00,Questionnaires,N06.850.520.308.750
20220579,2010-07-01T00:00:00,United States,Z01.107.567.875
20309867,2010-07-01T00:00:00,Fibroblasts,A11.329.228
20309867,2010-07-01T00:00:00,Fibroblasts,A11.872.228
20309867,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20309867,2010-07-01T00:00:00,PTEN Phosphohydrolase,D08.811.277.352.650.850
20309867,2010-07-01T00:00:00,PTEN Phosphohydrolase,D12.776.476.590
20309867,2010-07-01T00:00:00,PTEN Phosphohydrolase,D12.776.624.776.695
20309867,2010-07-01T00:00:00,"Scleroderma, Systemic",C17.300.799
20309867,2010-07-01T00:00:00,"Scleroderma, Systemic",C17.800.784
20309867,2010-07-01T00:00:00,Signal Transduction,G02.111.087.800
20309867,2010-07-01T00:00:00,Signal Transduction,G02.149.115.800
20309867,2010-07-01T00:00:00,Signal Transduction,G04.299.880
20309867,2010-07-01T00:00:00,Sphingosine,D02.033.100.700
20309867,2010-07-01T00:00:00,Sphingosine,D02.033.455.843
20309867,2010-07-01T00:00:00,Sphingosine,D02.092.063.700
20373856,2010-07-01T00:00:00,Adult,M01.060.116
20373856,2010-07-01T00:00:00,Brain Injuries,C10.228.140.199
20373856,2010-07-01T00:00:00,Brain Injuries,C10.900.300.087
20373856,2010-07-01T00:00:00,Brain Injuries,C21.866.260.118
20373856,2010-07-01T00:00:00,Brain Injuries,C21.866.915.300.200
20373856,2010-07-01T00:00:00,Brain Ischemia,C10.228.140.300.150
20373856,2010-07-01T00:00:00,Brain Ischemia,C14.907.253.092
20373856,2010-07-01T00:00:00,Carbon Dioxide,D01.200.200
20373856,2010-07-01T00:00:00,Carbon Dioxide,D01.362.150
20373856,2010-07-01T00:00:00,Carbon Dioxide,D01.650.550.200
20373856,2010-07-01T00:00:00,Emergency Medical Services,N02.421.297
20373856,2010-07-01T00:00:00,Hospitalization,E02.760.400
20373856,2010-07-01T00:00:00,Hospitalization,N02.421.585.400
20373856,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20373856,2010-07-01T00:00:00,Middle Aged,M01.060.116.630
20373856,2010-07-01T00:00:00,Oxygen,D01.268.185.550
20373856,2010-07-01T00:00:00,Oxygen,D01.362.670
20373856,2010-07-01T00:00:00,"Respiration, Artificial",E02.365.647.729
20373856,2010-07-01T00:00:00,"Respiration, Artificial",E02.880.820
20438391,2010-07-01T00:00:00,Adult,M01.060.116
20438391,2010-07-01T00:00:00,Birth Weight,C23.888.144.186
20438391,2010-07-01T00:00:00,Birth Weight,E01.370.600.115.100.160.120.186
20438391,2010-07-01T00:00:00,Birth Weight,E05.041.124.160.750.149
20438391,2010-07-01T00:00:00,Birth Weight,G07.100.100.160.120.186
20438391,2010-07-01T00:00:00,Birth Weight,G07.700.320.249.314.120.186
20438391,2010-07-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
20438391,2010-07-01T00:00:00,Body Mass Index,E05.041.124.125
20438391,2010-07-01T00:00:00,Body Mass Index,G07.100.100.125
20438391,2010-07-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
20438391,2010-07-01T00:00:00,Cesarean Section,E04.520.252.500
20438391,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20438391,2010-07-01T00:00:00,Incidence,E05.318.308.985.525.375
20438391,2010-07-01T00:00:00,Incidence,L01.280.975.525.375
20438391,2010-07-01T00:00:00,Incidence,N01.224.935.597.500
20438391,2010-07-01T00:00:00,Incidence,N06.850.505.400.975.525.375
20438391,2010-07-01T00:00:00,Incidence,N06.850.520.308.985.525.375
20438391,2010-07-01T00:00:00,"Infant, Newborn",M01.060.703.520
20438391,2010-07-01T00:00:00,"Obesity, Morbid",C18.654.726.500.700
20438391,2010-07-01T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
20438391,2010-07-01T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
20438391,2010-07-01T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
20438391,2010-07-01T00:00:00,Pre-Eclampsia,C13.703.395.249
20438391,2010-07-01T00:00:00,Pregnancy,G08.686.785.760.769
20438391,2010-07-01T00:00:00,Pregnancy Complications,C13.703
20438391,2010-07-01T00:00:00,Pregnancy Outcome,E01.789.700
20438391,2010-07-01T00:00:00,Pregnancy Outcome,G08.686.785.760.769.530
20438391,2010-07-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20438391,2010-07-01T00:00:00,Risk Factors,N05.715.350.200.700
20438391,2010-07-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20438391,2010-07-01T00:00:00,Risk Factors,N06.850.490.625.750
20438391,2010-07-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20438391,2010-07-01T00:00:00,United States,Z01.107.567.875
20467065,2010-07-01T00:00:00,Cognition,F02.463.188
20467065,2010-07-01T00:00:00,Computer Graphics,L01.224.108
20467065,2010-07-01T00:00:00,Computer Graphics,L01.296.110
20467065,2010-07-01T00:00:00,Computer Simulation,L01.224.160
20467065,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20467065,2010-07-01T00:00:00,"Models, Theoretical",E05.599
20467065,2010-07-01T00:00:00,Movement,G07.700.560
20467065,2010-07-01T00:00:00,Movement,G11.427.590.530
20467065,2010-07-01T00:00:00,Task Performance and Analysis,F02.784.412.846
20467065,2010-07-01T00:00:00,Task Performance and Analysis,F02.784.692.746
20467065,2010-07-01T00:00:00,Task Performance and Analysis,F02.808.600
20467065,2010-07-01T00:00:00,User-Computer Interface,L01.224.900.910
20482314,2010-07-01T00:00:00,Aprotinin,D12.776.083
20482314,2010-07-01T00:00:00,Bradykinin,D12.644.276.812.169
20482314,2010-07-01T00:00:00,Bradykinin,D12.644.400.090
20482314,2010-07-01T00:00:00,Bradykinin,D12.644.456.193
20482314,2010-07-01T00:00:00,Bradykinin,D12.776.467.812.169
20482314,2010-07-01T00:00:00,Bradykinin,D12.776.641.650.090
20482314,2010-07-01T00:00:00,Bradykinin,D23.469.050.375.110
20482314,2010-07-01T00:00:00,Bradykinin,D23.529.812.169
20482314,2010-07-01T00:00:00,Cell Movement,G04.299.283
20482314,2010-07-01T00:00:00,Cell Movement,G07.700.560.500.180
20482314,2010-07-01T00:00:00,Cell Proliferation,G04.299.233.750
20482314,2010-07-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
20482314,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20482314,2010-07-01T00:00:00,Kinins,D12.644.276.812
20482314,2010-07-01T00:00:00,Kinins,D12.776.467.812
20482314,2010-07-01T00:00:00,Kinins,D23.469.050.375
20482314,2010-07-01T00:00:00,Kinins,D23.529.812
20482314,2010-07-01T00:00:00,Neoplasm Invasiveness,C04.697.645
20482314,2010-07-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
20482314,2010-07-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
20482314,2010-07-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
20482314,2010-07-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
20482314,2010-07-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
20482314,2010-07-01T00:00:00,Signal Transduction,G02.111.087.800
20482314,2010-07-01T00:00:00,Signal Transduction,G02.149.115.800
20482314,2010-07-01T00:00:00,Signal Transduction,G04.299.880
20482314,2010-07-01T00:00:00,Tissue Kallikreins,D08.811.277.656.300.760.442.875
20482314,2010-07-01T00:00:00,Tissue Kallikreins,D08.811.277.656.959.350.442.875
20482314,2010-07-01T00:00:00,Tissue Kallikreins,D23.101.840.870
20494802,2010-07-01T00:00:00,Communication,F01.145.209
20494802,2010-07-01T00:00:00,Communication,L01.143
20494802,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20494802,2010-07-01T00:00:00,United States,Z01.107.567.875
20494802,2010-07-01T00:00:00,United States Department of Veterans Affairs,I01.409.137.500.700
20494802,2010-07-01T00:00:00,United States Department of Veterans Affairs,N03.540.348.500.500.700
20495461,2010-07-01T00:00:00,Animals,B01.050
20495461,2010-07-01T00:00:00,Biocompatible Materials,D25.130
20495461,2010-07-01T00:00:00,Biocompatible Materials,D27.720.102.130
20495461,2010-07-01T00:00:00,Biocompatible Materials,J01.637.051.130
20495461,2010-07-01T00:00:00,Cattle,B01.050.150.900.649.077.380.271
20495461,2010-07-01T00:00:00,Collagen,D05.750.078.280
20495461,2010-07-01T00:00:00,Collagen,D12.776.860.300.250
20495461,2010-07-01T00:00:00,Durapatite,D01.146.360.050.300.200
20495461,2010-07-01T00:00:00,Durapatite,D01.578.122.477.300
20495461,2010-07-01T00:00:00,Durapatite,D01.695.625.675.650.075.025.300.150
20495461,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20495461,2010-07-01T00:00:00,Tissue Engineering,E05.200.249.750
20495461,2010-07-01T00:00:00,"Urinary Incontinence, Stress",C12.777.934.852.249
20495461,2010-07-01T00:00:00,"Urinary Incontinence, Stress",C13.351.968.934.814.500
20495461,2010-07-01T00:00:00,"Urinary Incontinence, Stress",C23.888.942.800.500
20505511,2010-07-01T00:00:00,Animals,B01.050
20505511,2010-07-01T00:00:00,Cocaine,D02.145.074.722.388
20505511,2010-07-01T00:00:00,Cocaine,D03.132.889.354
20505511,2010-07-01T00:00:00,Cocaine,D03.605.869.388
20505511,2010-07-01T00:00:00,Cocaine,D04.075.080.875.099.722.388
20505511,2010-07-01T00:00:00,"Conditioning, Operant",F02.463.425.179.509
20505511,2010-07-01T00:00:00,Motivation,F01.658
20505511,2010-07-01T00:00:00,Motivation,F01.752.543.500.750
20505511,2010-07-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20505511,2010-07-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
20520365,2010-07-01T00:00:00,Adolescent,M01.060.057
20520365,2010-07-01T00:00:00,Adult,M01.060.116
20520365,2010-07-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
20520365,2010-07-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
20520365,2010-07-01T00:00:00,Health Surveys,E05.318.308.250
20520365,2010-07-01T00:00:00,Health Surveys,N05.715.360.300.375
20520365,2010-07-01T00:00:00,Health Surveys,N06.850.520.308.250
20520365,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20520365,2010-07-01T00:00:00,Middle Aged,M01.060.116.630
20520365,2010-07-01T00:00:00,New York,Z01.107.567.875.075.437
20520365,2010-07-01T00:00:00,New York,Z01.107.567.875.350.530
20520365,2010-07-01T00:00:00,New York,Z01.107.567.875.500.530
20520365,2010-07-01T00:00:00,Smoking,F01.145.466.753
20520365,2010-07-01T00:00:00,Smoking Cessation,F01.145.940.700
20520365,2010-07-01T00:00:00,Tobacco Industry,J01.576.919
20520365,2010-07-01T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
20520365,2010-07-01T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
20520365,2010-07-01T00:00:00,Young Adult,M01.060.116.815
20540637,2010-07-01T00:00:00,Blood Urea Nitrogen,E01.370.390.400.100
20540637,2010-07-01T00:00:00,Blood Urea Nitrogen,E01.450.150.100.115
20540637,2010-07-01T00:00:00,Demography,I01.240
20540637,2010-07-01T00:00:00,Demography,N01.224
20540637,2010-07-01T00:00:00,Demography,N06.850.505.400
20540637,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20540637,2010-07-01T00:00:00,Kidney Transplantation,E02.870.500
20540637,2010-07-01T00:00:00,Kidney Transplantation,E04.936.450.485
20540637,2010-07-01T00:00:00,Kidney Transplantation,E04.950.774.400
20540637,2010-07-01T00:00:00,Middle Aged,M01.060.116.630
20540637,2010-07-01T00:00:00,Tissue Donors,M01.898
20540637,2010-07-01T00:00:00,Treatment Outcome,E01.789.800
20540637,2010-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20540637,2010-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20549724,2010-07-01T00:00:00,Animals,B01.050
20549724,2010-07-01T00:00:00,Binding Sites,G02.111.570.120
20549724,2010-07-01T00:00:00,Heart,A07.541
20549724,2010-07-01T00:00:00,Heart Ventricles,A07.541.560
20549724,2010-07-01T00:00:00,Homeodomain Proteins,D12.776.260.400
20549724,2010-07-01T00:00:00,Mesoderm,A16.504.660
20549724,2010-07-01T00:00:00,Nerve Tissue Proteins,D12.776.641
20549724,2010-07-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
20549724,2010-07-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
20549724,2010-07-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
20549724,2010-07-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
20549724,2010-07-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
20549724,2010-07-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
20549724,2010-07-01T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
20549724,2010-07-01T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
20549724,2010-07-01T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
20549724,2010-07-01T00:00:00,Transcription Factors,D12.776.930
20549728,2010-07-01T00:00:00,Animals,B01.050
20549728,2010-07-01T00:00:00,Contractile Proteins,D12.776.210
20549728,2010-07-01T00:00:00,Endocardium,A07.541.207
20549728,2010-07-01T00:00:00,Heart,A07.541
20549728,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20549728,2010-07-01T00:00:00,Mesoderm,A16.504.660
20551899,2010-07-01T00:00:00,Aging,G07.700.320.124
20551899,2010-07-01T00:00:00,Animals,B01.050
20551899,2010-07-01T00:00:00,Cognition,F02.463.188
20551899,2010-07-01T00:00:00,Cognition Disorders,F03.087.250
20551899,2010-07-01T00:00:00,"Disease Models, Animal",C22.232
20551899,2010-07-01T00:00:00,"Disease Models, Animal",E05.598.500
20551899,2010-07-01T00:00:00,"Disease Models, Animal",E05.599.395.080
20563237,2010-07-01T00:00:00,African Continental Ancestry Group,M01.686.508.100
20563237,2010-07-01T00:00:00,Bayes Theorem,E05.318.740.600.200
20563237,2010-07-01T00:00:00,Bayes Theorem,N05.715.360.750.625.150
20563237,2010-07-01T00:00:00,Bayes Theorem,N06.850.520.830.600.200
20563237,2010-07-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
20563237,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20563237,2010-07-01T00:00:00,Incidence,E05.318.308.985.525.375
20563237,2010-07-01T00:00:00,Incidence,L01.280.975.525.375
20563237,2010-07-01T00:00:00,Incidence,N01.224.935.597.500
20563237,2010-07-01T00:00:00,Incidence,N06.850.505.400.975.525.375
20563237,2010-07-01T00:00:00,Incidence,N06.850.520.308.985.525.375
20563237,2010-07-01T00:00:00,Joint Diseases,C05.550
20563237,2010-07-01T00:00:00,Oropharyngeal Neoplasms,C04.588.443.665.710.684
20563237,2010-07-01T00:00:00,Oropharyngeal Neoplasms,C07.550.745.671
20563237,2010-07-01T00:00:00,Oropharyngeal Neoplasms,C09.647.710.685
20563237,2010-07-01T00:00:00,Oropharyngeal Neoplasms,C09.775.549.685
20563237,2010-07-01T00:00:00,Papillomavirus Infections,C02.256.650
20563237,2010-07-01T00:00:00,Papillomavirus Infections,C02.928.725
20563237,2010-07-01T00:00:00,Poisson Distribution,E05.318.740.994.750
20563237,2010-07-01T00:00:00,Poisson Distribution,G17.820.750
20563237,2010-07-01T00:00:00,Poisson Distribution,N05.715.360.750.750.620
20563237,2010-07-01T00:00:00,Poisson Distribution,N06.850.520.830.994.750
20563237,2010-07-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
20563237,2010-07-01T00:00:00,Risk Assessment,N04.452.871.715
20563237,2010-07-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20563237,2010-07-01T00:00:00,Risk Assessment,N06.850.505.715
20563237,2010-07-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20563237,2010-07-01T00:00:00,South Carolina,Z01.107.567.875.075.662
20563237,2010-07-01T00:00:00,South Carolina,Z01.107.567.875.750.700
20563237,2010-07-01T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
20563237,2010-07-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
20563237,2010-07-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
20563237,2010-07-01T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
20563944,2010-07-01T00:00:00,Community Health Services,N02.421.143
20563944,2010-07-01T00:00:00,Cooperative Behavior,F01.145.813.115
20563944,2010-07-01T00:00:00,"Education, Medical",I02.358.399
20563944,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20563944,2010-07-01T00:00:00,Interprofessional Relations,F01.829.401.205
20563944,2010-07-01T00:00:00,Motivation,F01.658
20563944,2010-07-01T00:00:00,Motivation,F01.752.543.500.750
20563944,2010-07-01T00:00:00,Program Evaluation,E05.337.820
20563944,2010-07-01T00:00:00,Program Evaluation,N04.761.685
20563944,2010-07-01T00:00:00,Program Evaluation,N05.715.360.650
20563944,2010-07-01T00:00:00,"Schools, Medical",I02.783.660.552
20563944,2010-07-01T00:00:00,"Schools, Medical",N02.278.020.578
20563944,2010-07-01T00:00:00,"Students, Medical",I02.851.686.602
20563944,2010-07-01T00:00:00,"Students, Medical",M01.848.769.602
20571371,2010-07-01T00:00:00,Academic Medical Centers,N02.278.020
20571371,2010-07-01T00:00:00,Bias (Epidemiology),N05.715.350.150
20571371,2010-07-01T00:00:00,Bias (Epidemiology),N06.850.490.500
20571371,2010-07-01T00:00:00,"Computers, Handheld",L01.224.230.260.550.500
20571371,2010-07-01T00:00:00,Documentation,L01.453.245
20571371,2010-07-01T00:00:00,"Education, Nursing, Continuing",I02.358.212.450
20571371,2010-07-01T00:00:00,"Education, Nursing, Continuing",I02.358.462.399
20571371,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20571371,2010-07-01T00:00:00,"Medical Records Systems, Computerized",E05.318.308.940.968.625
20571371,2010-07-01T00:00:00,"Medical Records Systems, Computerized",L01.280.900.968.775
20571371,2010-07-01T00:00:00,"Medical Records Systems, Computerized",L01.700.508.300.695
20571371,2010-07-01T00:00:00,"Medical Records Systems, Computerized",N04.452.859.564.650
20571371,2010-07-01T00:00:00,"Medical Records Systems, Computerized",N05.715.360.300.715.500.530
20571371,2010-07-01T00:00:00,"Medical Records Systems, Computerized",N06.850.520.308.940.968.625
20571371,2010-07-01T00:00:00,Nursing Assessment,N04.590.233.508.480
20571371,2010-07-01T00:00:00,"Nursing Staff, Hospital",M01.526.485.680.490
20571371,2010-07-01T00:00:00,"Nursing Staff, Hospital",M01.526.485.740.523
20571371,2010-07-01T00:00:00,"Nursing Staff, Hospital",N02.360.680.490
20571371,2010-07-01T00:00:00,"Nursing Staff, Hospital",N02.360.740.523
20571371,2010-07-01T00:00:00,South Carolina,Z01.107.567.875.075.662
20571371,2010-07-01T00:00:00,South Carolina,Z01.107.567.875.750.700
20574082,2010-07-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
20574082,2010-07-01T00:00:00,Clinical Trials as Topic,E05.337.250
20574082,2010-07-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
20574082,2010-07-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
20574082,2010-07-01T00:00:00,Contrast Media,D27.720.259
20574082,2010-07-01T00:00:00,Creatinine,D03.383.129.308.207
20574082,2010-07-01T00:00:00,Diagnostic Imaging,E01.370.350
20574082,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20574082,2010-07-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20574082,2010-07-01T00:00:00,Risk Factors,N05.715.350.200.700
20574082,2010-07-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20574082,2010-07-01T00:00:00,Risk Factors,N06.850.490.625.750
20574082,2010-07-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20574082,2010-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20574082,2010-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20574082,2010-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20574082,2010-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20574082,2010-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20581234,2010-07-01T00:00:00,Adult,M01.060.116
20581234,2010-07-01T00:00:00,"Antigens, Bacterial",D23.050.161
20581234,2010-07-01T00:00:00,Bacterial Proteins,D12.776.097
20581234,2010-07-01T00:00:00,Gastric Acid,A12.200.307.603
20581234,2010-07-01T00:00:00,Gastric Mucosa,A03.556.875.875.440
20581234,2010-07-01T00:00:00,Gastric Mucosa,A10.615.550.291
20581234,2010-07-01T00:00:00,H(+)-K(+)-Exchanging ATPase,D08.811.277.040.025.325.625
20581234,2010-07-01T00:00:00,H(+)-K(+)-Exchanging ATPase,D12.776.157.530.450.250.875.500.625
20581234,2010-07-01T00:00:00,H(+)-K(+)-Exchanging ATPase,D12.776.543.585.450.250.875.500.625
20581234,2010-07-01T00:00:00,Helicobacter Infections,C01.252.400.466
20581234,2010-07-01T00:00:00,Helicobacter pylori,B03.440.500.550
20581234,2010-07-01T00:00:00,Helicobacter pylori,B03.660.150.280.550
20581234,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20581234,2010-07-01T00:00:00,Middle Aged,M01.060.116.630
20581234,2010-07-01T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
20581234,2010-07-01T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
20581234,2010-07-01T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
20581234,2010-07-01T00:00:00,"RNA, Messenger",D13.444.735.544
20581234,2010-07-01T00:00:00,Young Adult,M01.060.116.815
20585269,2010-07-01T00:00:00,Adolescent,M01.060.057
20585269,2010-07-01T00:00:00,African Americans,M01.686.508.100.100
20585269,2010-07-01T00:00:00,African Americans,M01.686.754.100
20585269,2010-07-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
20585269,2010-07-01T00:00:00,Body Mass Index,E05.041.124.125
20585269,2010-07-01T00:00:00,Body Mass Index,G07.100.100.125
20585269,2010-07-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
20585269,2010-07-01T00:00:00,Child,M01.060.406
20585269,2010-07-01T00:00:00,"Diet, Reducing",E02.642.249.285
20585269,2010-07-01T00:00:00,"Diet, Reducing",G07.610.240.285
20585269,2010-07-01T00:00:00,Exercise,G11.427.590.237
20585269,2010-07-01T00:00:00,Exercise,I03.350
20585269,2010-07-01T00:00:00,Family Therapy,F04.754.864.581.273
20585269,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20585269,2010-07-01T00:00:00,"Obesity, Morbid",C18.654.726.500.700
20585269,2010-07-01T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
20585269,2010-07-01T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
20585269,2010-07-01T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
20585269,2010-07-01T00:00:00,Social Support,I01.880.656.600
20585269,2010-07-01T00:00:00,Weight Loss,C23.888.144.243.963
20585269,2010-07-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
20595656,2010-07-01T00:00:00,Hospitals,N02.278.421
20595656,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20595656,2010-07-01T00:00:00,Incidence,E05.318.308.985.525.375
20595656,2010-07-01T00:00:00,Incidence,L01.280.975.525.375
20595656,2010-07-01T00:00:00,Incidence,N01.224.935.597.500
20595656,2010-07-01T00:00:00,Incidence,N06.850.505.400.975.525.375
20595656,2010-07-01T00:00:00,Incidence,N06.850.520.308.985.525.375
20595656,2010-07-01T00:00:00,Inpatients,M01.643.470
20595656,2010-07-01T00:00:00,International Classification of Diseases,L01.453.245.945.400
20595656,2010-07-01T00:00:00,Population Surveillance,E05.318.308.250.700
20595656,2010-07-01T00:00:00,Population Surveillance,N05.715.360.300.375.625
20595656,2010-07-01T00:00:00,Population Surveillance,N06.850.520.308.250.700
20595656,2010-07-01T00:00:00,Population Surveillance,N06.850.780.675
20595656,2010-07-01T00:00:00,Sex Factors,N05.715.350.675
20595656,2010-07-01T00:00:00,Sex Factors,N06.850.490.875
20595656,2010-07-01T00:00:00,Stroke,C10.228.140.300.775
20595656,2010-07-01T00:00:00,Stroke,C14.907.253.855
20595656,2010-07-01T00:00:00,United States,Z01.107.567.875
20600039,2010-07-01T00:00:00,Amino Acid Sequence,G02.111.570.060
20600039,2010-07-01T00:00:00,Amino Acid Sequence,L01.453.245.667.060
20600039,2010-07-01T00:00:00,Animals,B01.050
20600039,2010-07-01T00:00:00,Molecular Sequence Data,L01.453.245.667
20600039,2010-07-01T00:00:00,Phylogeny,G05.697
20600039,2010-07-01T00:00:00,Phylogeny,G16.100.275.605
20600039,2010-07-01T00:00:00,Phylogeny,L01.100.697
20600039,2010-07-01T00:00:00,"Receptors, Estrogen",D12.776.260.698.750.350
20600039,2010-07-01T00:00:00,"Receptors, Estrogen",D12.776.826.750.350
20600039,2010-07-01T00:00:00,"Receptors, Estrogen",D12.776.930.669.750.350
20600039,2010-07-01T00:00:00,"Sequence Homology, Amino Acid",G02.111.810.200
20600039,2010-07-01T00:00:00,"Sequence Homology, Amino Acid",G05.810.200
20601202,2010-07-01T00:00:00,Adult,M01.060.116
20601202,2010-07-01T00:00:00,Aged,M01.060.116.100
20601202,2010-07-01T00:00:00,Autoimmunity,G12.450.192
20601202,2010-07-01T00:00:00,Bone and Bones,A02.835.232
20601202,2010-07-01T00:00:00,Bone and Bones,A10.165.265
20601202,2010-07-01T00:00:00,Calcium,D01.268.552.100
20601202,2010-07-01T00:00:00,Calcium,D01.552.539.288
20601202,2010-07-01T00:00:00,Calcium,D23.119.100
20601202,2010-07-01T00:00:00,Cardiovascular Diseases,C14
20601202,2010-07-01T00:00:00,"Fractures, Bone",C21.866.404
20601202,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20601202,2010-07-01T00:00:00,Immune System,A15.382
20601202,2010-07-01T00:00:00,Middle Aged,M01.060.116.630
20601202,2010-07-01T00:00:00,Musculoskeletal Diseases,C05
20601202,2010-07-01T00:00:00,Neoplasms,C04
20601202,2010-07-01T00:00:00,Vitamin D,D04.808.812.768
20601202,2010-07-01T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
20601202,2010-07-01T00:00:00,Young Adult,M01.060.116.815
20609695,2010-07-01T00:00:00,"Endothelium, Vascular",A07.231.330
20609695,2010-07-01T00:00:00,"Endothelium, Vascular",A10.272.491.355
20609695,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20609695,2010-07-01T00:00:00,Hypertension,C14.907.489
20609695,2010-07-01T00:00:00,Nitric Oxide,D01.339.387
20609695,2010-07-01T00:00:00,Nitric Oxide,D01.625.550.500
20609695,2010-07-01T00:00:00,Nitric Oxide,D01.625.700.500
20609695,2010-07-01T00:00:00,Nitric Oxide,D01.650.550.587.600
20609695,2010-07-01T00:00:00,Vasodilator Agents,D27.505.954.411.918
20609697,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20609697,2010-07-01T00:00:00,Hypertension,C14.907.489
20609697,2010-07-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
20609697,2010-07-01T00:00:00,Risk Assessment,N04.452.871.715
20609697,2010-07-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20609697,2010-07-01T00:00:00,Risk Assessment,N06.850.505.715
20609697,2010-07-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20609697,2010-07-01T00:00:00,Stroke,C10.228.140.300.775
20609697,2010-07-01T00:00:00,Stroke,C14.907.253.855
20609697,2010-07-01T00:00:00,Vasodilator Agents,D27.505.954.411.918
20609739,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20609739,2010-07-01T00:00:00,Thoracic Surgery,H02.403.810.803
20609743,2010-07-01T00:00:00,"Anastomosis, Surgical",E04.035
20609743,2010-07-01T00:00:00,Cardiac Surgical Procedures,E04.100.376
20609743,2010-07-01T00:00:00,Cardiac Surgical Procedures,E04.928.220
20609743,2010-07-01T00:00:00,Child,M01.060.406
20609743,2010-07-01T00:00:00,"Child, Preschool",M01.060.406.448
20609743,2010-07-01T00:00:00,Fontan Procedure,E04.035.410.295
20609743,2010-07-01T00:00:00,Fontan Procedure,E04.100.376.410.295
20609743,2010-07-01T00:00:00,Fontan Procedure,E04.928.220.370.295
20609743,2010-07-01T00:00:00,"Heart Defects, Congenital",C14.240.400
20609743,2010-07-01T00:00:00,"Heart Defects, Congenital",C14.280.400
20609743,2010-07-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
20609743,2010-07-01T00:00:00,Heart Ventricles,A07.541.560
20609743,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20609743,2010-07-01T00:00:00,Hypoplastic Left Heart Syndrome,C14.240.400.625
20609743,2010-07-01T00:00:00,Hypoplastic Left Heart Syndrome,C14.280.400.625
20609743,2010-07-01T00:00:00,Hypoplastic Left Heart Syndrome,C16.131.240.400.625
20609743,2010-07-01T00:00:00,Pulmonary Artery,A07.231.114.715
20609811,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20609811,2010-07-01T00:00:00,Middle Aged,M01.060.116.630
20609811,2010-07-01T00:00:00,Streptococcal Infections,C01.252.410.890
20610972,2010-07-01T00:00:00,Heart Failure,C14.280.434
20610972,2010-07-01T00:00:00,Homeostasis,G07.700.360
20610972,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20610972,2010-07-01T00:00:00,Hyponatremia,C18.452.950.620
20610972,2010-07-01T00:00:00,Sodium,D01.268.549.750
20610972,2010-07-01T00:00:00,Sodium,D01.552.528.850
20618781,2010-07-01T00:00:00,Adult,M01.060.116
20618781,2010-07-01T00:00:00,Attitude to Health,F01.100.150
20618781,2010-07-01T00:00:00,Attitude to Health,N05.300.150
20618781,2010-07-01T00:00:00,Employment,N01.824.245
20618781,2010-07-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
20618781,2010-07-01T00:00:00,Health Care Costs,N03.219.151.400
20618781,2010-07-01T00:00:00,Health Care Costs,N05.300.375
20618781,2010-07-01T00:00:00,Health Services Accessibility,N04.590.374.350
20618781,2010-07-01T00:00:00,Health Services Accessibility,N05.300.430
20618781,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20618781,2010-07-01T00:00:00,Income,N01.824.417
20618781,2010-07-01T00:00:00,Middle Aged,M01.060.116.630
20618781,2010-07-01T00:00:00,Needs Assessment,I02.594
20618781,2010-07-01T00:00:00,Needs Assessment,N03.349.380.565
20618781,2010-07-01T00:00:00,Needs Assessment,N05.300.537
20618781,2010-07-01T00:00:00,Quadriplegia,C10.597.622.760
20618781,2010-07-01T00:00:00,Quadriplegia,C23.888.592.636.786
20618781,2010-07-01T00:00:00,Self Concept,F01.752.747.792
20618781,2010-07-01T00:00:00,Sex Factors,N05.715.350.675
20618781,2010-07-01T00:00:00,Sex Factors,N06.850.490.875
20618781,2010-07-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
20618781,2010-07-01T00:00:00,Spinal Cord Injuries,C10.900.850
20618781,2010-07-01T00:00:00,Spinal Cord Injuries,C21.866.819
20618781,2010-07-01T00:00:00,United States,Z01.107.567.875
20626745,2010-07-01T00:00:00,ATP-Binding Cassette Transporters,D12.776.157.530.100
20626745,2010-07-01T00:00:00,ATP-Binding Cassette Transporters,D12.776.395.550.020
20626745,2010-07-01T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.550.192
20626745,2010-07-01T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.585.100
20626745,2010-07-01T00:00:00,Adrenoleukodystrophy,C10.228.140.163.100.680.100
20626745,2010-07-01T00:00:00,Adrenoleukodystrophy,C10.314.400.250
20626745,2010-07-01T00:00:00,Adrenoleukodystrophy,C10.597.606.643.455.124
20626745,2010-07-01T00:00:00,Adrenoleukodystrophy,C16.320.322.500.124
20626745,2010-07-01T00:00:00,Adrenoleukodystrophy,C16.320.400.525.124
20626745,2010-07-01T00:00:00,Adrenoleukodystrophy,C16.320.565.189.680.100
20626745,2010-07-01T00:00:00,Adrenoleukodystrophy,C16.320.565.663.112
20626745,2010-07-01T00:00:00,Adrenoleukodystrophy,C18.452.132.100.680.100
20626745,2010-07-01T00:00:00,Adrenoleukodystrophy,C18.452.648.189.680.100
20626745,2010-07-01T00:00:00,Adrenoleukodystrophy,C18.452.648.663.112
20626745,2010-07-01T00:00:00,Adrenoleukodystrophy,C19.053.500.270
20626745,2010-07-01T00:00:00,Brain,A08.186.211
20626745,2010-07-01T00:00:00,Fatty Acids,D10.251
20626745,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20626745,2010-07-01T00:00:00,Oxidative Stress,G03.495.710
20626745,2010-07-01T00:00:00,Oxidative Stress,G07.700.830.750
20629807,2010-07-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
20629807,2010-07-01T00:00:00,Blood Pressure,E01.370.600.875.249
20629807,2010-07-01T00:00:00,Blood Pressure,G09.330.380.076
20629807,2010-07-01T00:00:00,Cardiovascular Diseases,C14
20629807,2010-07-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
20629807,2010-07-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
20629807,2010-07-01T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
20629807,2010-07-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
20629807,2010-07-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
20629807,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20629807,2010-07-01T00:00:00,Hypertension,C14.907.489
20629807,2010-07-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
20629807,2010-07-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
20629807,2010-07-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20629807,2010-07-01T00:00:00,Risk Factors,N05.715.350.200.700
20629807,2010-07-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20629807,2010-07-01T00:00:00,Risk Factors,N06.850.490.625.750
20629807,2010-07-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20629807,2010-07-01T00:00:00,Stroke,C10.228.140.300.775
20629807,2010-07-01T00:00:00,Stroke,C14.907.253.855
20637933,2010-07-01T00:00:00,Clinical Competence,I02.399.630.210
20637933,2010-07-01T00:00:00,Clinical Competence,N04.761.210
20637933,2010-07-01T00:00:00,Cooperative Behavior,F01.145.813.115
20637933,2010-07-01T00:00:00,Curriculum,I02.158
20637933,2010-07-01T00:00:00,"Data Interpretation, Statistical",E05.245.380
20637933,2010-07-01T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
20637933,2010-07-01T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
20637933,2010-07-01T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
20637933,2010-07-01T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
20637933,2010-07-01T00:00:00,"Education, Nursing, Graduate",I02.358.337.450
20637933,2010-07-01T00:00:00,"Education, Nursing, Graduate",I02.358.462.565
20637933,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20637933,2010-07-01T00:00:00,Income,N01.824.417
20637933,2010-07-01T00:00:00,Interprofessional Relations,F01.829.401.205
20637933,2010-07-01T00:00:00,Program Development,N04.452.760
20637933,2010-07-01T00:00:00,Resource Allocation,I01.261.750
20637933,2010-07-01T00:00:00,Salaries and Fringe Benefits,N01.824.417.700
20637933,2010-07-01T00:00:00,Salaries and Fringe Benefits,N04.452.677.800
20637933,2010-07-01T00:00:00,"Schools, Nursing",I02.783.660.623
20637933,2010-07-01T00:00:00,South Carolina,Z01.107.567.875.075.662
20637933,2010-07-01T00:00:00,South Carolina,Z01.107.567.875.750.700
20637933,2010-07-01T00:00:00,"Students, Nursing",I02.851.686.685
20637933,2010-07-01T00:00:00,"Students, Nursing",M01.848.769.685
20637933,2010-07-01T00:00:00,Workload,N04.452.677.950
20638543,2010-07-01T00:00:00,Adolescent,M01.060.057
20638543,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20638543,2010-07-01T00:00:00,Ovarian Neoplasms,C04.588.322.455
20638543,2010-07-01T00:00:00,Ovarian Neoplasms,C13.351.500.056.630.705
20638543,2010-07-01T00:00:00,Ovarian Neoplasms,C13.351.937.418.685
20638543,2010-07-01T00:00:00,Ovarian Neoplasms,C19.344.410
20638543,2010-07-01T00:00:00,Ovarian Neoplasms,C19.391.630.705
20638543,2010-07-01T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
20638543,2010-07-01T00:00:00,Teratoma,C04.557.465.910
20647492,2010-07-01T00:00:00,"Cardiac Pacing, Artificial",E02.145
20647492,2010-07-01T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
20647492,2010-07-01T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
20647492,2010-07-01T00:00:00,"Defibrillators, Implantable",E07.695.175
20647492,2010-07-01T00:00:00,Evidence-Based Medicine,H02.249.750
20647492,2010-07-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
20647492,2010-07-01T00:00:00,Forecasting,I01.320
20647492,2010-07-01T00:00:00,Heart Failure,C14.280.434
20647492,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20647492,2010-07-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
20647492,2010-07-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
20647492,2010-07-01T00:00:00,United States,Z01.107.567.875
20653639,2010-07-01T00:00:00,Adolescent,M01.060.057
20653639,2010-07-01T00:00:00,Adolescent Behavior,F01.145.022
20653639,2010-07-01T00:00:00,Attention Deficit Disorder with Hyperactivity,F03.550.150.150
20653639,2010-07-01T00:00:00,Child,M01.060.406
20653639,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20653639,2010-07-01T00:00:00,Substance Withdrawal Syndrome,C21.739.835
20653639,2010-07-01T00:00:00,Substance Withdrawal Syndrome,F03.900.825
20653639,2010-07-01T00:00:00,Tobacco Use Disorder,C21.739.912
20653639,2010-07-01T00:00:00,Tobacco Use Disorder,F03.900.912
20653639,2010-07-01T00:00:00,Young Adult,M01.060.116.815
20658648,2010-07-01T00:00:00,Animals,B01.050
20658648,2010-07-01T00:00:00,DNA Repair,G02.111.087.219
20658648,2010-07-01T00:00:00,DNA Repair,G02.149.115.219
20658648,2010-07-01T00:00:00,DNA Repair,G05.355.195
20658648,2010-07-01T00:00:00,DNA-Binding Proteins,D12.776.260
20658648,2010-07-01T00:00:00,Endonucleases,D08.811.277.352.355
20658648,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20658648,2010-07-01T00:00:00,"Models, Biological",E05.599.395
20660931,2010-07-01T00:00:00,"Diagnosis, Differential",E01.171
20660931,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20660931,2010-07-01T00:00:00,"Lymphoma, Large B-Cell, Diffuse",C04.557.386.480.150.585
20660931,2010-07-01T00:00:00,"Lymphoma, Large B-Cell, Diffuse",C15.604.515.569.480.150.585
20660931,2010-07-01T00:00:00,"Lymphoma, Large B-Cell, Diffuse",C20.683.515.761.480.150.585
20660931,2010-07-01T00:00:00,"Tumor Markers, Biological",D23.101.840
20683094,2010-07-01T00:00:00,Adolescent,M01.060.057
20683094,2010-07-01T00:00:00,Adult,M01.060.116
20683094,2010-07-01T00:00:00,Exercise,G11.427.590.237
20683094,2010-07-01T00:00:00,Exercise,I03.350
20683094,2010-07-01T00:00:00,Goals,F01.658.500
20683094,2010-07-01T00:00:00,Health Behavior,F01.145.488
20683094,2010-07-01T00:00:00,Health Promotion,N02.370
20683094,2010-07-01T00:00:00,Health Promotion,N02.421.726.507
20683094,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20683094,2010-07-01T00:00:00,Self Efficacy,F01.752.747.792.700
20683094,2010-07-01T00:00:00,Students,I02.233.748
20683094,2010-07-01T00:00:00,Students,I02.851
20683094,2010-07-01T00:00:00,Students,M01.848
20683094,2010-07-01T00:00:00,Young Adult,M01.060.116.815
20698379,2010-07-01T00:00:00,Adult,M01.060.116
20698379,2010-07-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
20698379,2010-07-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
20698379,2010-07-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
20698379,2010-07-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
20698379,2010-07-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
20698379,2010-07-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
20698379,2010-07-01T00:00:00,"Diagnosis, Differential",E01.171
20698379,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20698379,2010-07-01T00:00:00,Pancreatectomy,E04.210.752
20698379,2010-07-01T00:00:00,Pancreatic Neoplasms,C04.588.274.761
20698379,2010-07-01T00:00:00,Pancreatic Neoplasms,C04.588.322.421
20698379,2010-07-01T00:00:00,Pancreatic Neoplasms,C06.301.761
20698379,2010-07-01T00:00:00,Pancreatic Neoplasms,C06.689.667
20698379,2010-07-01T00:00:00,Pancreatic Neoplasms,C19.344.421
20698379,2010-07-01T00:00:00,Splenectomy,E04.726
20698382,2010-07-01T00:00:00,Biomedical Research,H01.770.644.145
20698382,2010-07-01T00:00:00,General Surgery,H02.403.810.300
20698382,2010-07-01T00:00:00,"Hospitals, University",N02.278.020.300.310
20698382,2010-07-01T00:00:00,"Hospitals, University",N02.278.421.639.725
20698382,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20698382,2010-07-01T00:00:00,Internship and Residency,I02.358.399.644
20698382,2010-07-01T00:00:00,South Carolina,Z01.107.567.875.075.662
20698382,2010-07-01T00:00:00,South Carolina,Z01.107.567.875.750.700
20698384,2010-07-01T00:00:00,Aged,M01.060.116.100
20698384,2010-07-01T00:00:00,"Anastomosis, Surgical",E04.035
20698384,2010-07-01T00:00:00,Combined Modality Therapy,E02.186
20698384,2010-07-01T00:00:00,Drainage,E02.309
20698384,2010-07-01T00:00:00,Drainage,E04.237
20698384,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20698384,2010-07-01T00:00:00,Middle Aged,M01.060.116.630
20698384,2010-07-01T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
20698384,2010-07-01T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
20698384,2010-07-01T00:00:00,Neoplasm Staging,E01.370.550
20698384,2010-07-01T00:00:00,Postoperative Complications,C23.550.767
20698384,2010-07-01T00:00:00,Reoperation,E04.690
20698384,2010-07-01T00:00:00,Treatment Outcome,E01.789.800
20698384,2010-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20698384,2010-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20819467,2010-07-01T00:00:00,Biological Markers,D23.101
20819467,2010-07-01T00:00:00,Chronic Disease,C23.550.291.500
20819467,2010-07-01T00:00:00,Endoscopy,E01.370.388.250
20819467,2010-07-01T00:00:00,Endoscopy,E04.800.250
20819467,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20819467,2010-07-01T00:00:00,Inflammation,C23.550.470
20819467,2010-07-01T00:00:00,Nasal Polyps,C08.460.572
20819467,2010-07-01T00:00:00,Nasal Polyps,C09.603.557
20819467,2010-07-01T00:00:00,Nasal Polyps,C23.300.825.557
20819467,2010-07-01T00:00:00,Recovery of Function,G16.757
20819467,2010-07-01T00:00:00,Rhinitis,C08.460.799
20819467,2010-07-01T00:00:00,Rhinitis,C08.730.674
20819467,2010-07-01T00:00:00,Rhinitis,C09.603.799
20819467,2010-07-01T00:00:00,Sinusitis,C08.460.692.752
20819467,2010-07-01T00:00:00,Sinusitis,C08.730.749
20819467,2010-07-01T00:00:00,Sinusitis,C09.603.692.752
20819467,2010-07-01T00:00:00,Treatment Outcome,E01.789.800
20819467,2010-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20819467,2010-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20819470,2010-07-01T00:00:00,Endoscopy,E01.370.388.250
20819470,2010-07-01T00:00:00,Endoscopy,E04.800.250
20819470,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20819470,2010-07-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
20819470,2010-07-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
20819470,2010-07-01T00:00:00,Quality of Health Care,N04.761
20819470,2010-07-01T00:00:00,Quality of Health Care,N05.715
20819470,2010-07-01T00:00:00,Skull Base,A01.456.830
20819470,2010-07-01T00:00:00,Skull Base,A02.835.232.781.750
20819470,2010-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20819470,2010-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20819470,2010-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20819470,2010-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20819470,2010-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
21279162,2010-07-01T00:00:00,Animals,B01.050
21279162,2010-07-01T00:00:00,Columbidae,B01.050.150.900.248.165.150
21279162,2010-07-01T00:00:00,"Conditioning, Operant",F02.463.425.179.509
21279162,2010-07-01T00:00:00,Cues,F02.463.425.234
21279162,2010-07-01T00:00:00,Discrimination Learning,F02.463.425.280
21279162,2010-07-01T00:00:00,Photic Stimulation,E05.723.729
21279162,2010-07-01T00:00:00,Time Factors,G01.910.857
21299986,2010-07-01T00:00:00,Academic Medical Centers,N02.278.020
21299986,2010-07-01T00:00:00,"History, 20th Century",K01.400.504.968
21299986,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21299986,2010-07-01T00:00:00,Neurosurgery,H02.403.810.425
21683001,2010-07-01T00:00:00,Autoimmune Diseases,C20.111
21683001,2010-07-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
21683001,2010-07-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
21683001,2010-07-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
21683001,2010-07-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
21683001,2010-07-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
21683001,2010-07-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
21683001,2010-07-01T00:00:00,"Diagnosis, Differential",E01.171
21683001,2010-07-01T00:00:00,Endosonography,E01.370.350.850.280
21683001,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21683001,2010-07-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
21683001,2010-07-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
21683001,2010-07-01T00:00:00,Middle Aged,M01.060.116.630
21683001,2010-07-01T00:00:00,Pancreatectomy,E04.210.752
21683001,2010-07-01T00:00:00,Pancreatitis,C06.689.750
21683001,2010-07-01T00:00:00,Splenectomy,E04.726
21683001,2010-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
21683001,2010-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
21683001,2010-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
21683001,2010-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
21683001,2010-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
21683007,2010-07-01T00:00:00,Aged,M01.060.116.100
21683007,2010-07-01T00:00:00,"Carcinoma, Renal Cell",C04.557.470.200.025.390
21683007,2010-07-01T00:00:00,"Carcinoma, Renal Cell",C04.588.945.947.535.160
21683007,2010-07-01T00:00:00,"Carcinoma, Renal Cell",C12.758.820.750.160
21683007,2010-07-01T00:00:00,"Carcinoma, Renal Cell",C12.777.419.473.160
21683007,2010-07-01T00:00:00,"Carcinoma, Renal Cell",C13.351.937.820.535.160
21683007,2010-07-01T00:00:00,"Carcinoma, Renal Cell",C13.351.968.419.473.160
21683007,2010-07-01T00:00:00,Drainage,E02.309
21683007,2010-07-01T00:00:00,Drainage,E04.237
21683007,2010-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21683007,2010-07-01T00:00:00,Kidney Neoplasms,C04.588.945.947.535
21683007,2010-07-01T00:00:00,Kidney Neoplasms,C12.758.820.750
21683007,2010-07-01T00:00:00,Kidney Neoplasms,C12.777.419.473
21683007,2010-07-01T00:00:00,Kidney Neoplasms,C13.351.937.820.535
21683007,2010-07-01T00:00:00,Kidney Neoplasms,C13.351.968.419.473
21683007,2010-07-01T00:00:00,Laparoscopy,E01.370.388.250.520
21683007,2010-07-01T00:00:00,Laparoscopy,E04.800.250.520
21683007,2010-07-01T00:00:00,Pancreatectomy,E04.210.752
21683007,2010-07-01T00:00:00,Pancreatic Neoplasms,C04.588.274.761
21683007,2010-07-01T00:00:00,Pancreatic Neoplasms,C04.588.322.421
21683007,2010-07-01T00:00:00,Pancreatic Neoplasms,C06.301.761
21683007,2010-07-01T00:00:00,Pancreatic Neoplasms,C06.689.667
21683007,2010-07-01T00:00:00,Pancreatic Neoplasms,C19.344.421
21683007,2010-07-01T00:00:00,Splenectomy,E04.726
21683007,2010-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
21683007,2010-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
21683007,2010-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
21683007,2010-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
21683007,2010-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20584535,2010-07-02T00:00:00,Adolescent,M01.060.057
20584535,2010-07-02T00:00:00,Adult,M01.060.116
20584535,2010-07-02T00:00:00,Aged,M01.060.116.100
20584535,2010-07-02T00:00:00,Combined Modality Therapy,E02.186
20584535,2010-07-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20584535,2010-07-02T00:00:00,"Immunotherapy, Adoptive",E02.095.465.425.400.330.050.400
20584535,2010-07-02T00:00:00,"Immunotherapy, Adoptive",E05.478.550.520.050.400
20584535,2010-07-02T00:00:00,Melanoma,C04.557.465.625.650.510
20584535,2010-07-02T00:00:00,Melanoma,C04.557.580.625.650.510
20584535,2010-07-02T00:00:00,Melanoma,C04.557.665.510
20584535,2010-07-02T00:00:00,Middle Aged,M01.060.116.630
20584535,2010-07-02T00:00:00,Palliative Care,E02.760.666
20584535,2010-07-02T00:00:00,Palliative Care,N02.421.585.666
20584535,2010-07-02T00:00:00,Postoperative Complications,C23.550.767
20584535,2010-07-02T00:00:00,Risk Factors,E05.318.740.600.800.725
20584535,2010-07-02T00:00:00,Risk Factors,N05.715.350.200.700
20584535,2010-07-02T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20584535,2010-07-02T00:00:00,Risk Factors,N06.850.490.625.750
20584535,2010-07-02T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20584535,2010-07-02T00:00:00,"Thoracic Surgery, Video-Assisted",E01.370.388.250.840.830
20584535,2010-07-02T00:00:00,"Thoracic Surgery, Video-Assisted",E01.370.388.250.950.830
20584535,2010-07-02T00:00:00,"Thoracic Surgery, Video-Assisted",E04.800.250.840.830
20584535,2010-07-02T00:00:00,"Thoracic Surgery, Video-Assisted",E04.800.250.950.830
20584535,2010-07-02T00:00:00,"Thoracic Surgery, Video-Assisted",E04.928.752.830
20584535,2010-07-02T00:00:00,Treatment Outcome,E01.789.800
20584535,2010-07-02T00:00:00,Treatment Outcome,N04.761.559.590.800
20584535,2010-07-02T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20598395,2010-07-02T00:00:00,Hamartoma,C04.445
20598395,2010-07-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20598395,2010-07-02T00:00:00,"Infant, Newborn",M01.060.703.520
20598621,2010-07-02T00:00:00,Antiparkinson Agents,D27.505.954.427.090.050
20598621,2010-07-02T00:00:00,Cognition,F02.463.188
20598621,2010-07-02T00:00:00,Cognition Disorders,F03.087.250
20598621,2010-07-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20598621,2010-07-02T00:00:00,Middle Aged,M01.060.116.630
20598621,2010-07-02T00:00:00,Multicenter Studies as Topic,E05.318.760.535.500
20598621,2010-07-02T00:00:00,Multicenter Studies as Topic,E05.337.250.500
20598621,2010-07-02T00:00:00,Multicenter Studies as Topic,N05.715.360.775.235.545
20598621,2010-07-02T00:00:00,Multicenter Studies as Topic,N06.850.520.450.535.500
20598621,2010-07-02T00:00:00,National Institutes of Health (U.S.),I01.409.137.500.600.480
20598621,2010-07-02T00:00:00,National Institutes of Health (U.S.),N03.540.348.500.500.600.480
20598621,2010-07-02T00:00:00,Neuropsychological Tests,F04.711.513
20598621,2010-07-02T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
20598621,2010-07-02T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
20598621,2010-07-02T00:00:00,Parkinson Disease,C10.228.140.079.862.500
20598621,2010-07-02T00:00:00,Parkinson Disease,C10.228.662.600.400
20598621,2010-07-02T00:00:00,Parkinson Disease,C10.574.812
20598621,2010-07-02T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
20598621,2010-07-02T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
20598621,2010-07-02T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
20598621,2010-07-02T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
20598621,2010-07-02T00:00:00,Research Design,E05.581.500
20598621,2010-07-02T00:00:00,Research Design,H01.770.644.728
20598621,2010-07-02T00:00:00,United States,Z01.107.567.875
20633441,2010-07-02T00:00:00,Brain,A08.186.211
20633441,2010-07-02T00:00:00,Electric Stimulation,E05.723.402
20633441,2010-07-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20633441,2010-07-02T00:00:00,Magnetics,H01.671.493
20633441,2010-07-02T00:00:00,Periodicals as Topic,L01.178.682.829.678
20633441,2010-07-02T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
20633441,2010-07-02T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
20863528,2010-07-02T00:00:00,Animals,B01.050
20863528,2010-07-02T00:00:00,Coronary Vessels,A07.231.114.269
20863528,2010-07-02T00:00:00,Coronary Vessels,A07.231.908.194
20863528,2010-07-02T00:00:00,"Disease Models, Animal",C22.232
20863528,2010-07-02T00:00:00,"Disease Models, Animal",E05.598.500
20863528,2010-07-02T00:00:00,"Disease Models, Animal",E05.599.395.080
20863528,2010-07-02T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.205.352
20863528,2010-07-02T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.252.420
20863528,2010-07-02T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.525.700.150
20863528,2010-07-02T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.205.352
20863528,2010-07-02T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.252.420
20863528,2010-07-02T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.525.700.150
20863528,2010-07-02T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.205.360
20863528,2010-07-02T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.252.445
20863528,2010-07-02T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.525.700.350
20863528,2010-07-02T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.205.360
20863528,2010-07-02T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.252.445
20863528,2010-07-02T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.525.700.350
20863528,2010-07-02T00:00:00,Myocardial Infarction,C14.280.647.500
20863528,2010-07-02T00:00:00,Myocardial Infarction,C14.907.585.500
20863528,2010-07-02T00:00:00,Myocardium,A02.633.580
20863528,2010-07-02T00:00:00,Myocardium,A07.541.704
20863528,2010-07-02T00:00:00,Myocardium,A10.690.552.750
20863528,2010-07-02T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
20863528,2010-07-02T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
20863528,2010-07-02T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
20863528,2010-07-02T00:00:00,Tissue Inhibitor of Metalloproteinase-1,D12.776.926.450
20863528,2010-07-02T00:00:00,Ventricular Remodeling,C23.300.985
20863528,2010-07-02T00:00:00,Ventricular Remodeling,G09.330.190.962.975
20863528,2010-07-02T00:00:00,beta-Galactosidase,D08.811.277.450.410.100
20598928,2010-07-03T00:00:00,"Abnormalities, Multiple",C16.131.077
20598928,2010-07-03T00:00:00,Cataract,C11.510.245
20598928,2010-07-03T00:00:00,Cataract Extraction,E04.540.825.249
20598928,2010-07-03T00:00:00,"Child, Preschool",M01.060.406.448
20598928,2010-07-03T00:00:00,Cornea,A09.371.060.217
20598928,2010-07-03T00:00:00,"Diagnosis, Differential",E01.171
20598928,2010-07-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20598928,2010-07-03T00:00:00,"Lenses, Intraocular",E07.632.500.460
20598928,2010-07-03T00:00:00,"Lenses, Intraocular",E07.695.460
20598928,2010-07-03T00:00:00,Video Recording,L01.240.960
20598928,2010-07-03T00:00:00,Visual Acuity,E01.370.380.850.950
20598928,2010-07-03T00:00:00,Visual Acuity,F02.463.593.932.901
20598928,2010-07-03T00:00:00,Visual Acuity,G14.940
20212359,2010-07-04T00:00:00,Actins,D05.750.078.730.250
20212359,2010-07-04T00:00:00,Actins,D12.776.210.500.100
20212359,2010-07-04T00:00:00,Actins,D12.776.220.525.255
20212359,2010-07-04T00:00:00,Animals,B01.050
20212359,2010-07-04T00:00:00,Cell Adhesion,G04.299.117
20212359,2010-07-04T00:00:00,Cell Movement,G04.299.283
20212359,2010-07-04T00:00:00,Cell Movement,G07.700.560.500.180
20212359,2010-07-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20462262,2010-07-06T00:00:00,"Models, Theoretical",E05.599
20462262,2010-07-06T00:00:00,Nanoparticles,J01.637.512.600
20462262,2010-07-06T00:00:00,Nanotechnology,H01.603
20462262,2010-07-06T00:00:00,Nanotechnology,J01.897.520.600
20462262,2010-07-06T00:00:00,Polyethylene Glycols,D02.033.455.250.700
20462262,2010-07-06T00:00:00,Polyethylene Glycols,D05.750.741
20462262,2010-07-06T00:00:00,Polyethylene Glycols,D25.720.741
20462262,2010-07-06T00:00:00,Polyethylene Glycols,J01.637.051.720.741
20462262,2010-07-06T00:00:00,Polymers,D05.750
20462262,2010-07-06T00:00:00,Polymers,D25.720
20462262,2010-07-06T00:00:00,Polymers,J01.637.051.720
20595557,2010-07-07T00:00:00,Guidelines as Topic,N04.761.700.350
20595557,2010-07-07T00:00:00,Guidelines as Topic,N05.700.350
20595557,2010-07-07T00:00:00,Internship and Residency,I02.358.399.644
20595557,2010-07-07T00:00:00,Orthopedics,H02.403.810.494
20595557,2010-07-07T00:00:00,Personnel Staffing and Scheduling,N04.452.677.650
20595557,2010-07-07T00:00:00,Workload,N04.452.677.950
20607434,2010-07-07T00:00:00,Adolescent,M01.060.057
20607434,2010-07-07T00:00:00,Adult,M01.060.116
20607434,2010-07-07T00:00:00,Aged,M01.060.116.100
20607434,2010-07-07T00:00:00,Employment,N01.824.245
20607434,2010-07-07T00:00:00,Health Promotion,N02.370
20607434,2010-07-07T00:00:00,Health Promotion,N02.421.726.507
20607434,2010-07-07T00:00:00,Healthcare Disparities,N04.590.374.380
20607434,2010-07-07T00:00:00,Healthcare Disparities,N05.300.493
20607434,2010-07-07T00:00:00,Hispanic Americans,M01.686.754.441
20607434,2010-07-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20607434,2010-07-07T00:00:00,Middle Aged,M01.060.116.630
20607434,2010-07-07T00:00:00,Patient Education as Topic,I02.233.332.500
20607434,2010-07-07T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
20607434,2010-07-07T00:00:00,Patient Education as Topic,N02.421.726.407.680
20607434,2010-07-07T00:00:00,Questionnaires,E05.318.308.750
20607434,2010-07-07T00:00:00,Questionnaires,L01.280.800
20607434,2010-07-07T00:00:00,Questionnaires,N05.715.360.300.695
20607434,2010-07-07T00:00:00,Questionnaires,N06.850.520.308.750
20607434,2010-07-07T00:00:00,Sexual Behavior,F01.145.802
20607434,2010-07-07T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
20607434,2010-07-07T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
20607434,2010-07-07T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
20607434,2010-07-07T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
20610564,2010-07-07T00:00:00,"Adaptor Proteins, Signal Transducing",D12.644.360.024
20610564,2010-07-07T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.157.057
20610564,2010-07-07T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.476.024
20610564,2010-07-07T00:00:00,Amino Acid Sequence,G02.111.570.060
20610564,2010-07-07T00:00:00,Amino Acid Sequence,L01.453.245.667.060
20610564,2010-07-07T00:00:00,Animals,B01.050
20610564,2010-07-07T00:00:00,Cell Differentiation,G04.299.151
20610564,2010-07-07T00:00:00,Cell Line,A11.251.210
20610564,2010-07-07T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
20610564,2010-07-07T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
20610564,2010-07-07T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
20610564,2010-07-07T00:00:00,"Microscopy, Confocal",E05.595.395
20610564,2010-07-07T00:00:00,Molecular Sequence Data,L01.453.245.667
20610564,2010-07-07T00:00:00,Osteoclasts,A11.329.372.700
20610564,2010-07-07T00:00:00,Osteoclasts,A11.627.482.700
20610564,2010-07-07T00:00:00,Phosphorylation,G02.111.087.677
20610564,2010-07-07T00:00:00,Phosphorylation,G02.149.115.677
20610564,2010-07-07T00:00:00,Phosphorylation,G02.149.465.700
20610564,2010-07-07T00:00:00,Phosphorylation,G02.607.750.700
20610564,2010-07-07T00:00:00,Phosphorylation,G03.495.790
20610564,2010-07-07T00:00:00,Protein-Tyrosine Kinases,D08.811.913.696.620.682.725
20610564,2010-07-07T00:00:00,RNA Interference,G05.355.315.203.374.790
20610564,2010-07-07T00:00:00,"Receptors, IgG",D12.776.543.750.705.871.300
20610564,2010-07-07T00:00:00,"Receptors, IgG",D23.050.301.264.035.695
20610564,2010-07-07T00:00:00,"Receptors, IgG",D23.101.100.110.695
20610564,2010-07-07T00:00:00,Transcription Factors,D12.776.930
20615096,2010-07-08T00:00:00,Adipocytes,A11.329.114
20615096,2010-07-08T00:00:00,Animals,B01.050
20615096,2010-07-08T00:00:00,Body Weight,C23.888.144
20615096,2010-07-08T00:00:00,Body Weight,E01.370.600.115.100.160.120
20615096,2010-07-08T00:00:00,Body Weight,E05.041.124.160.750
20615096,2010-07-08T00:00:00,Body Weight,G07.100.100.160.120
20615096,2010-07-08T00:00:00,Body Weight,G07.700.320.249.314.120
20615096,2010-07-08T00:00:00,Cell Differentiation,G04.299.151
20615096,2010-07-08T00:00:00,Collagen Type I,D05.750.078.280.300.100
20615096,2010-07-08T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
20615096,2010-07-08T00:00:00,Dietary Fats,D10.212.302
20615096,2010-07-08T00:00:00,Dietary Fats,J02.500.375
20615096,2010-07-08T00:00:00,Obesity,C18.654.726.500
20615096,2010-07-08T00:00:00,Obesity,C23.888.144.699.500
20615096,2010-07-08T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
20615096,2010-07-08T00:00:00,Obesity,G07.100.100.160.120.699.500
20615096,2010-07-08T00:00:00,Osteonectin,D12.776.157.125.715
20615096,2010-07-08T00:00:00,Osteonectin,D12.776.395.600
20616211,2010-07-08T00:00:00,"Analgesics, Non-Narcotic",D27.505.696.663.850.014.040
20616211,2010-07-08T00:00:00,"Analgesics, Non-Narcotic",D27.505.954.427.040.100
20616211,2010-07-08T00:00:00,Animals,B01.050
20616211,2010-07-08T00:00:00,Cell Survival,G04.299.316
20616211,2010-07-08T00:00:00,Hepatocytes,A11.436.348
20616211,2010-07-08T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
20616211,2010-07-08T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
20616211,2010-07-08T00:00:00,Oxidative Stress,G03.495.710
20616211,2010-07-08T00:00:00,Oxidative Stress,G07.700.830.750
20616211,2010-07-08T00:00:00,Oxygen,D01.268.185.550
20616211,2010-07-08T00:00:00,Oxygen,D01.362.670
20616211,2010-07-08T00:00:00,Reactive Nitrogen Species,D01.625.700
20616211,2010-07-08T00:00:00,Reactive Nitrogen Species,D02.654.846
20616211,2010-07-08T00:00:00,Reactive Oxygen Species,D01.339.431
20616211,2010-07-08T00:00:00,Reactive Oxygen Species,D01.650.775
20616302,2010-07-08T00:00:00,Disability Evaluation,E01.370.400
20616302,2010-07-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20616302,2010-07-08T00:00:00,"Models, Neurological",E05.599.395.642
20616302,2010-07-08T00:00:00,Movement Disorders,C10.228.662
20616302,2010-07-08T00:00:00,"Muscle, Skeletal",A02.633.567
20616302,2010-07-08T00:00:00,"Muscle, Skeletal",A10.690.552.500
20616302,2010-07-08T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
20616302,2010-07-08T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
20616302,2010-07-08T00:00:00,Physical Therapy Modalities,E02.779
20616302,2010-07-08T00:00:00,Recovery of Function,G16.757
20616302,2010-07-08T00:00:00,Stroke,C10.228.140.300.775
20616302,2010-07-08T00:00:00,Stroke,C14.907.253.855
20616302,2010-07-08T00:00:00,Task Performance and Analysis,F02.784.412.846
20616302,2010-07-08T00:00:00,Task Performance and Analysis,F02.784.692.746
20616302,2010-07-08T00:00:00,Task Performance and Analysis,F02.808.600
20616323,2010-07-08T00:00:00,African Continental Ancestry Group,M01.686.508.100
20616323,2010-07-08T00:00:00,Cardiovascular Diseases,C14
20616323,2010-07-08T00:00:00,"Constriction, Pathologic",C23.300.287
20616323,2010-07-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20616323,2010-07-08T00:00:00,Risk Factors,E05.318.740.600.800.725
20616323,2010-07-08T00:00:00,Risk Factors,N05.715.350.200.700
20616323,2010-07-08T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20616323,2010-07-08T00:00:00,Risk Factors,N06.850.490.625.750
20616323,2010-07-08T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20616323,2010-07-08T00:00:00,Smoking,F01.145.466.753
20622049,2010-07-09T00:00:00,Adolescent,M01.060.057
20622049,2010-07-09T00:00:00,Adult,M01.060.116
20622049,2010-07-09T00:00:00,Aged,M01.060.116.100
20622049,2010-07-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20622049,2010-07-09T00:00:00,Interviews as Topic,E05.318.308.420
20622049,2010-07-09T00:00:00,Interviews as Topic,L01.280.520
20622049,2010-07-09T00:00:00,Interviews as Topic,N05.715.360.300.400
20622049,2010-07-09T00:00:00,Interviews as Topic,N06.850.520.308.420
20622049,2010-07-09T00:00:00,Middle Aged,M01.060.116.630
20622049,2010-07-09T00:00:00,Primary Health Care,N04.590.233.727
20622049,2010-07-09T00:00:00,Psychological Tests,F04.711
20622049,2010-07-09T00:00:00,Sex Factors,N05.715.350.675
20622049,2010-07-09T00:00:00,Sex Factors,N06.850.490.875
20622049,2010-07-09T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
20622049,2010-07-09T00:00:00,Young Adult,M01.060.116.815
20621509,2010-07-10T00:00:00,"Data Interpretation, Statistical",E05.245.380
20621509,2010-07-10T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
20621509,2010-07-10T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
20621509,2010-07-10T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
20621509,2010-07-10T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
20621509,2010-07-10T00:00:00,Disability Evaluation,E01.370.400
20621509,2010-07-10T00:00:00,Double-Blind Method,E05.318.780.300
20621509,2010-07-10T00:00:00,Double-Blind Method,E05.581.500.300
20621509,2010-07-10T00:00:00,Double-Blind Method,N05.715.360.780.320
20621509,2010-07-10T00:00:00,Double-Blind Method,N06.850.520.445.300
20621509,2010-07-10T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
20621509,2010-07-10T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
20621509,2010-07-10T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
20621509,2010-07-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20621509,2010-07-10T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
20621509,2010-07-10T00:00:00,Recovery of Function,G16.757
20621509,2010-07-10T00:00:00,Risk Assessment,E05.318.740.600.800.715
20621509,2010-07-10T00:00:00,Risk Assessment,N04.452.871.715
20621509,2010-07-10T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20621509,2010-07-10T00:00:00,Risk Assessment,N06.850.505.715
20621509,2010-07-10T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20621509,2010-07-10T00:00:00,Risk Factors,E05.318.740.600.800.725
20621509,2010-07-10T00:00:00,Risk Factors,N05.715.350.200.700
20621509,2010-07-10T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20621509,2010-07-10T00:00:00,Risk Factors,N06.850.490.625.750
20621509,2010-07-10T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20621509,2010-07-10T00:00:00,Stroke,C10.228.140.300.775
20621509,2010-07-10T00:00:00,Stroke,C14.907.253.855
20621509,2010-07-10T00:00:00,Thrombolytic Therapy,E02.319.913
20621509,2010-07-10T00:00:00,Time Factors,G01.910.857
20621509,2010-07-10T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
20621509,2010-07-10T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
20621509,2010-07-10T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
20621509,2010-07-10T00:00:00,Tissue Plasminogen Activator,D23.119.970
20621509,2010-07-10T00:00:00,Treatment Outcome,E01.789.800
20621509,2010-07-10T00:00:00,Treatment Outcome,N04.761.559.590.800
20621509,2010-07-10T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20621509,2010-07-10T00:00:00,United States,Z01.107.567.875
20623126,2010-07-11T00:00:00,Contrast Media,D27.720.259
20623126,2010-07-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20623126,2010-07-11T00:00:00,Liver,A03.620
20623126,2010-07-11T00:00:00,Liver Neoplasms,C04.588.274.623
20623126,2010-07-11T00:00:00,Liver Neoplasms,C06.301.623
20623126,2010-07-11T00:00:00,Liver Neoplasms,C06.552.697
20623126,2010-07-11T00:00:00,Middle Aged,M01.060.116.630
20623126,2010-07-11T00:00:00,Radiation Dosage,E05.799.513
20623126,2010-07-11T00:00:00,Radiation Dosage,G01.201.875.740
20623126,2010-07-11T00:00:00,Radiation Dosage,N06.850.810.250
20623126,2010-07-11T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
20623126,2010-07-11T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
20623126,2010-07-11T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
20623126,2010-07-11T00:00:00,"Radiography, Dual-Energy Scanned Projection",E01.370.350.600.350.700.700
20623126,2010-07-11T00:00:00,"Radiography, Dual-Energy Scanned Projection",E01.370.350.700.700.700
20623126,2010-07-11T00:00:00,"Radiography, Dual-Energy Scanned Projection",E01.370.350.760.700
20623126,2010-07-11T00:00:00,"Radiography, Dual-Energy Scanned Projection",L01.224.308.380.800
20623126,2010-07-11T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20623126,2010-07-11T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20623126,2010-07-11T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20623126,2010-07-11T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20623126,2010-07-11T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20622909,2010-07-12T00:00:00,Algorithms,G17.035
20622909,2010-07-12T00:00:00,Algorithms,L01.224.050
20622909,2010-07-12T00:00:00,Anti-HIV Agents,D27.505.954.122.388.077.088
20622909,2010-07-12T00:00:00,Cyclophosphamide,D02.455.526.728.650.730.243
20622909,2010-07-12T00:00:00,Cyclophosphamide,D02.705.670.243
20622909,2010-07-12T00:00:00,Granulocyte Colony-Stimulating Factor,D12.644.276.374.410.240.350
20622909,2010-07-12T00:00:00,Granulocyte Colony-Stimulating Factor,D12.776.395.240.200
20622909,2010-07-12T00:00:00,Granulocyte Colony-Stimulating Factor,D12.776.467.374.410.240.350
20622909,2010-07-12T00:00:00,Granulocyte Colony-Stimulating Factor,D23.529.374.410.240.350
20622909,2010-07-12T00:00:00,Granulocyte-Macrophage Colony-Stimulating Factor,D12.644.276.374.410.240.375
20622909,2010-07-12T00:00:00,Granulocyte-Macrophage Colony-Stimulating Factor,D12.776.395.240.300
20622909,2010-07-12T00:00:00,Granulocyte-Macrophage Colony-Stimulating Factor,D12.776.467.374.410.240.375
20622909,2010-07-12T00:00:00,Granulocyte-Macrophage Colony-Stimulating Factor,D23.529.374.410.240.375
20622909,2010-07-12T00:00:00,Hematopoietic Stem Cell Mobilization,E02.095.410
20622909,2010-07-12T00:00:00,Heterocyclic Compounds,D03
20622909,2010-07-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20622909,2010-07-12T00:00:00,Individualized Medicine,E02.574
20622909,2010-07-12T00:00:00,Individualized Medicine,H02.403.200.700
20622909,2010-07-12T00:00:00,Middle Aged,M01.060.116.630
20625106,2010-07-12T00:00:00,Aging,G07.700.320.124
20625106,2010-07-12T00:00:00,Animals,B01.050
20625106,2010-07-12T00:00:00,Cell Death,G04.299.139
20625106,2010-07-12T00:00:00,Cell Division,G04.299.134.220
20625106,2010-07-12T00:00:00,Cell Division,G04.299.233.750.500
20625106,2010-07-12T00:00:00,Cell Division,G05.355.105
20625106,2010-07-12T00:00:00,Cell Division,G07.700.320.249.410.750.500
20625106,2010-07-12T00:00:00,Cell Survival,G04.299.316
20625106,2010-07-12T00:00:00,"Disease Models, Animal",C22.232
20625106,2010-07-12T00:00:00,"Disease Models, Animal",E05.598.500
20625106,2010-07-12T00:00:00,"Disease Models, Animal",E05.599.395.080
20625106,2010-07-12T00:00:00,Disease Progression,C23.550.291.656
20625106,2010-07-12T00:00:00,Extracellular Matrix,A11.284.295.310
20625106,2010-07-12T00:00:00,Heart Failure,C14.280.434
20625106,2010-07-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20625106,2010-07-12T00:00:00,Myocardial Infarction,C14.280.647.500
20625106,2010-07-12T00:00:00,Myocardial Infarction,C14.907.585.500
20625106,2010-07-12T00:00:00,Proteomics,H01.158.201.843
20625106,2010-07-12T00:00:00,Proteomics,H01.158.273.180.350.700
20625106,2010-07-12T00:00:00,Proteomics,H01.158.273.343.350.700
20625106,2010-07-12T00:00:00,Proteomics,H01.181.122.738
20625106,2010-07-12T00:00:00,Signal Transduction,G02.111.087.800
20625106,2010-07-12T00:00:00,Signal Transduction,G02.149.115.800
20625106,2010-07-12T00:00:00,Signal Transduction,G04.299.880
20625106,2010-07-12T00:00:00,Ventricular Remodeling,C23.300.985
20625106,2010-07-12T00:00:00,Ventricular Remodeling,G09.330.190.962.975
20625111,2010-07-12T00:00:00,Angiotensin-Converting Enzyme Inhibitors,D27.505.519.389.745.085
20625111,2010-07-12T00:00:00,Antihypertensive Agents,D27.505.954.411.162
20625111,2010-07-12T00:00:00,Double-Blind Method,E05.318.780.300
20625111,2010-07-12T00:00:00,Double-Blind Method,E05.581.500.300
20625111,2010-07-12T00:00:00,Double-Blind Method,N05.715.360.780.320
20625111,2010-07-12T00:00:00,Double-Blind Method,N06.850.520.445.300
20625111,2010-07-12T00:00:00,Enalapril,D12.644.456.345.360
20625111,2010-07-12T00:00:00,"Endothelium, Vascular",A07.231.330
20625111,2010-07-12T00:00:00,"Endothelium, Vascular",A10.272.491.355
20625111,2010-07-12T00:00:00,Heart Failure,C14.280.434
20625111,2010-07-12T00:00:00,Heart Ventricles,A07.541.560
20625111,2010-07-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20625111,2010-07-12T00:00:00,Infant,M01.060.703
20625111,2010-07-12T00:00:00,Stroke Volume,E01.370.370.380.150.700
20625111,2010-07-12T00:00:00,Stroke Volume,G09.330.380.124.882
20635003,2010-07-12T00:00:00,Actins,D05.750.078.730.250
20635003,2010-07-12T00:00:00,Actins,D12.776.210.500.100
20635003,2010-07-12T00:00:00,Actins,D12.776.220.525.255
20635003,2010-07-12T00:00:00,Animals,B01.050
20635003,2010-07-12T00:00:00,"Myocytes, Cardiac",A07.541.704.570
20635003,2010-07-12T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
20635003,2010-07-12T00:00:00,"Myocytes, Cardiac",A11.620.500
20635003,2010-07-12T00:00:00,Protein Isoforms,D12.776.800
20635003,2010-07-12T00:00:00,"Ventricular Dysfunction, Right",C14.280.945.910
20635003,2010-07-12T00:00:00,Ventricular Pressure,G09.330.190.962.950
20635003,2010-07-12T00:00:00,Ventricular Pressure,G09.330.380.937
20627221,2010-07-13T00:00:00,Abdominal Pain,C23.888.646.100
20627221,2010-07-13T00:00:00,Abdominal Pain,C23.888.821.030
20627221,2010-07-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20627221,2010-07-13T00:00:00,Middle Aged,M01.060.116.630
20627221,2010-07-13T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
20627221,2010-07-13T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
20627221,2010-07-13T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
20627221,2010-07-13T00:00:00,"Vena Cava, Inferior",A07.231.908.949.648
20628055,2010-07-13T00:00:00,Alkaline Ceramidase,D08.811.277.087.250.300
20628055,2010-07-13T00:00:00,Antineoplastic Agents,D27.505.954.248
20628055,2010-07-13T00:00:00,Ceramides,D02.065.313
20628055,2010-07-13T00:00:00,Ceramides,D09.400.410.420.525.200
20628055,2010-07-13T00:00:00,Ceramides,D10.390.470.675.200
20628055,2010-07-13T00:00:00,Ceramides,D10.570.877.360.612.200
20628055,2010-07-13T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
20628055,2010-07-13T00:00:00,Fenretinide,D02.455.326.271.665.202.495.270
20628055,2010-07-13T00:00:00,Fenretinide,D02.455.426.392.368.367.379.249.700.270
20628055,2010-07-13T00:00:00,Fenretinide,D02.455.849.131.495.270
20628055,2010-07-13T00:00:00,Fenretinide,D23.767.261.700.270
20628055,2010-07-13T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
20628055,2010-07-13T00:00:00,Flow Cytometry,E05.200.500.386.350
20628055,2010-07-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20628055,2010-07-13T00:00:00,Neoplasms,C04
20628055,2010-07-13T00:00:00,Polymerase Chain Reaction,E05.393.620.500
20628055,2010-07-13T00:00:00,Tandem Mass Spectrometry,E05.196.566.880
20628070,2010-07-13T00:00:00,Biological Markers,D23.101
20628070,2010-07-13T00:00:00,Computer Simulation,L01.224.160
20628070,2010-07-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20628070,2010-07-13T00:00:00,"Models, Biological",E05.599.395
20628070,2010-07-13T00:00:00,Periodontal Diseases,C07.465.714
20628070,2010-07-13T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
20628070,2010-07-13T00:00:00,Regression Analysis,E05.318.740.750
20628070,2010-07-13T00:00:00,Regression Analysis,N05.715.360.750.695
20628070,2010-07-13T00:00:00,Regression Analysis,N06.850.520.830.750
20630519,2010-07-13T00:00:00,Animals,B01.050
20630519,2010-07-13T00:00:00,Artifacts,E05.047
20630519,2010-07-13T00:00:00,"Disease Models, Animal",C22.232
20630519,2010-07-13T00:00:00,"Disease Models, Animal",E05.598.500
20630519,2010-07-13T00:00:00,"Disease Models, Animal",E05.599.395.080
20630519,2010-07-13T00:00:00,Endosonography,E01.370.350.850.280
20630519,2010-07-13T00:00:00,Gastric Mucosa,A03.556.875.875.440
20630519,2010-07-13T00:00:00,Gastric Mucosa,A10.615.550.291
20630519,2010-07-13T00:00:00,Swine,B01.050.150.900.649.077.880
20630519,2010-07-13T00:00:00,"Ultrasonography, Interventional",E01.370.350.850.855
20630519,2010-07-13T00:00:00,Vasoconstrictor Agents,D27.505.954.411.793
20629541,2010-07-14T00:00:00,Animals,B01.050
20629541,2010-07-14T00:00:00,Bone Morphogenetic Protein 2,D12.644.276.954.200.200
20629541,2010-07-14T00:00:00,Bone Morphogenetic Protein 2,D12.776.467.942.200.200
20629541,2010-07-14T00:00:00,Bone Morphogenetic Protein 2,D23.529.942.200.200
20629541,2010-07-14T00:00:00,Cell Movement,G04.299.283
20629541,2010-07-14T00:00:00,Cell Movement,G07.700.560.500.180
20629541,2010-07-14T00:00:00,Chickens,B01.050.150.900.248.350.150
20629541,2010-07-14T00:00:00,Chickens,B01.050.150.900.248.617.192
20629541,2010-07-14T00:00:00,Extracellular Matrix,A11.284.295.310
20629541,2010-07-14T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
20629541,2010-07-14T00:00:00,Heart Valves,A07.541.510
20629541,2010-07-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20629541,2010-07-14T00:00:00,"Models, Biological",E05.599.395
20629541,2010-07-14T00:00:00,Phenotype,G05.695
20629541,2010-07-14T00:00:00,Stem Cells,A11.872
20629541,2010-07-14T00:00:00,Tissue Engineering,E05.200.249.750
20629541,2010-07-14T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
20629541,2010-07-14T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
20629541,2010-07-14T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
20631069,2010-07-14T00:00:00,Animals,B01.050
20631069,2010-07-14T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
20631069,2010-07-14T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
20631069,2010-07-14T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
20631069,2010-07-14T00:00:00,Calcium,D01.268.552.100
20631069,2010-07-14T00:00:00,Calcium,D01.552.539.288
20631069,2010-07-14T00:00:00,Calcium,D23.119.100
20631069,2010-07-14T00:00:00,Ceramides,D02.065.313
20631069,2010-07-14T00:00:00,Ceramides,D09.400.410.420.525.200
20631069,2010-07-14T00:00:00,Ceramides,D10.390.470.675.200
20631069,2010-07-14T00:00:00,Ceramides,D10.570.877.360.612.200
20631069,2010-07-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20631069,2010-07-14T00:00:00,Pyridines,D03.383.725
20631069,2010-07-14T00:00:00,Reactive Oxygen Species,D01.339.431
20631069,2010-07-14T00:00:00,Reactive Oxygen Species,D01.650.775
20631069,2010-07-14T00:00:00,Signal Transduction,G02.111.087.800
20631069,2010-07-14T00:00:00,Signal Transduction,G02.149.115.800
20631069,2010-07-14T00:00:00,Signal Transduction,G04.299.880
20636410,2010-07-14T00:00:00,African Continental Ancestry Group,M01.686.508.100
20636410,2010-07-14T00:00:00,Child,M01.060.406
20636410,2010-07-14T00:00:00,Graft Rejection,G12.425.901.545.328
20636410,2010-07-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20636410,2010-07-14T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
20636410,2010-07-14T00:00:00,Kidney Transplantation,E02.870.500
20636410,2010-07-14T00:00:00,Kidney Transplantation,E04.936.450.485
20636410,2010-07-14T00:00:00,Kidney Transplantation,E04.950.774.400
20636410,2010-07-14T00:00:00,Risk Factors,E05.318.740.600.800.725
20636410,2010-07-14T00:00:00,Risk Factors,N05.715.350.200.700
20636410,2010-07-14T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20636410,2010-07-14T00:00:00,Risk Factors,N06.850.490.625.750
20636410,2010-07-14T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20636410,2010-07-14T00:00:00,Treatment Outcome,E01.789.800
20636410,2010-07-14T00:00:00,Treatment Outcome,N04.761.559.590.800
20636410,2010-07-14T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20637198,2010-07-14T00:00:00,Binding Sites,G02.111.570.120
20637198,2010-07-14T00:00:00,Carrier Proteins,D12.776.157
20637198,2010-07-14T00:00:00,"Diagnosis, Differential",E01.171
20637198,2010-07-14T00:00:00,Disease Progression,C23.550.291.656
20637198,2010-07-14T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
20637198,2010-07-14T00:00:00,Flow Cytometry,E05.200.500.386.350
20637198,2010-07-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20637198,2010-07-14T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
20637198,2010-07-14T00:00:00,"Microscopy, Fluorescence",E05.595.458
20800192,2010-07-14T00:00:00,"Accidents, Traffic",N06.850.135.392
20800192,2010-07-14T00:00:00,Adult,M01.060.116
20800192,2010-07-14T00:00:00,Automobiles,J01.937.500.100
20800192,2010-07-14T00:00:00,"Databases, Factual",L01.470.750.750
20800192,2010-07-14T00:00:00,"Databases, Factual",L01.700.508.300.188.400
20800192,2010-07-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20800192,2010-07-14T00:00:00,Kidney,A05.810.453
20800192,2010-07-14T00:00:00,Middle Aged,M01.060.116.630
20800192,2010-07-14T00:00:00,United States,Z01.107.567.875
20706608,2010-07-15T00:00:00,Case-Control Studies,E05.318.760.500.500
20706608,2010-07-15T00:00:00,Case-Control Studies,N05.715.360.775.175.200
20706608,2010-07-15T00:00:00,Case-Control Studies,N06.850.520.450.500.500
20706608,2010-07-15T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
20706608,2010-07-15T00:00:00,Genetic Predisposition to Disease,G05.380.355
20706608,2010-07-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20706608,2010-07-15T00:00:00,Interferon Type I,D12.644.276.374.440.890
20706608,2010-07-15T00:00:00,Interferon Type I,D12.644.276.718.500
20706608,2010-07-15T00:00:00,Interferon Type I,D12.776.467.374.440.890
20706608,2010-07-15T00:00:00,Interferon Type I,D12.776.467.718.500
20706608,2010-07-15T00:00:00,Interferon Type I,D23.529.374.440.890
20706608,2010-07-15T00:00:00,Interferon Type I,D23.529.718.500
20706608,2010-07-15T00:00:00,Linkage Disequilibrium,G05.540.500
20706608,2010-07-15T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
20706608,2010-07-15T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
20706608,2010-07-15T00:00:00,Phenotype,G05.695
20706608,2010-07-15T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
20706608,2010-07-15T00:00:00,Sex Factors,N05.715.350.675
20706608,2010-07-15T00:00:00,Sex Factors,N06.850.490.875
20636435,2010-07-16T00:00:00,Amino Acid Sequence,G02.111.570.060
20636435,2010-07-16T00:00:00,Amino Acid Sequence,L01.453.245.667.060
20636435,2010-07-16T00:00:00,Graft Rejection,G12.425.901.545.328
20636435,2010-07-16T00:00:00,Hematopoietic Stem Cell Transplantation,E04.936.225.687.500
20636435,2010-07-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20636435,2010-07-16T00:00:00,Middle Aged,M01.060.116.630
20636435,2010-07-16T00:00:00,Molecular Sequence Data,L01.453.245.667
20637663,2010-07-16T00:00:00,Cataract,C11.510.245
20637663,2010-07-16T00:00:00,Cataract Extraction,E04.540.825.249
20637663,2010-07-16T00:00:00,Glucocorticoids,D06.472.040.543
20637663,2010-07-16T00:00:00,Glucocorticoids,D27.505.696.399.472.488
20637663,2010-07-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20637663,2010-07-16T00:00:00,Infant,M01.060.703
20637663,2010-07-16T00:00:00,Treatment Outcome,E01.789.800
20637663,2010-07-16T00:00:00,Treatment Outcome,N04.761.559.590.800
20637663,2010-07-16T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20637663,2010-07-16T00:00:00,Visual Acuity,E01.370.380.850.950
20637663,2010-07-16T00:00:00,Visual Acuity,F02.463.593.932.901
20637663,2010-07-16T00:00:00,Visual Acuity,G14.940
20637666,2010-07-16T00:00:00,Adolescent,M01.060.057
20637666,2010-07-16T00:00:00,Child,M01.060.406
20637666,2010-07-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20637666,2010-07-16T00:00:00,Pilot Projects,E05.318.760.750
20637666,2010-07-16T00:00:00,Pilot Projects,E05.337.737
20637666,2010-07-16T00:00:00,Pilot Projects,N05.715.360.775.625
20637666,2010-07-16T00:00:00,Pilot Projects,N06.850.520.450.720
20637666,2010-07-16T00:00:00,Software,L01.224.900
20637666,2010-07-16T00:00:00,United States,Z01.107.567.875
20637666,2010-07-16T00:00:00,Video Games,I03.450.642.693.930
20637666,2010-07-16T00:00:00,Video Games,L01.224.900.930
20637666,2010-07-16T00:00:00,Vision Disorders,C10.597.751.941
20637666,2010-07-16T00:00:00,Vision Disorders,C11.966
20637666,2010-07-16T00:00:00,Vision Disorders,C23.888.592.763.941
20637666,2010-07-16T00:00:00,Visual Acuity,E01.370.380.850.950
20637666,2010-07-16T00:00:00,Visual Acuity,F02.463.593.932.901
20637666,2010-07-16T00:00:00,Visual Acuity,G14.940
20638060,2010-07-16T00:00:00,Adult,M01.060.116
20638060,2010-07-16T00:00:00,Aged,M01.060.116.100
20638060,2010-07-16T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
20638060,2010-07-16T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
20638060,2010-07-16T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
20638060,2010-07-16T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
20638060,2010-07-16T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
20638060,2010-07-16T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
20638060,2010-07-16T00:00:00,Equipment Failure Analysis,E05.325.192
20638060,2010-07-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20638060,2010-07-16T00:00:00,Middle Aged,M01.060.116.630
20638060,2010-07-16T00:00:00,Stents,E07.695.750
20639305,2010-07-16T00:00:00,Aged,M01.060.116.100
20639305,2010-07-16T00:00:00,"Aneurysm, Dissecting",C14.907.055.050
20639305,2010-07-16T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.055.239.125
20639305,2010-07-16T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.109.139.125
20639305,2010-07-16T00:00:00,Aortic Diseases,C14.907.109
20639305,2010-07-16T00:00:00,Blood Vessel Prosthesis Implantation,E04.100.814.200
20639305,2010-07-16T00:00:00,Blood Vessel Prosthesis Implantation,E04.650.200
20639305,2010-07-16T00:00:00,Hematoma,C23.550.414.838
20639305,2010-07-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20639305,2010-07-16T00:00:00,Magnetic Resonance Angiography,E01.370.350.500.500
20639305,2010-07-16T00:00:00,Magnetic Resonance Angiography,E01.370.350.825.500.500
20639305,2010-07-16T00:00:00,Magnetic Resonance Angiography,E01.370.370.050.500
20639305,2010-07-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20639305,2010-07-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20639305,2010-07-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20639305,2010-07-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20639305,2010-07-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20639305,2010-07-16T00:00:00,Treatment Outcome,E01.789.800
20639305,2010-07-16T00:00:00,Treatment Outcome,N04.761.559.590.800
20639305,2010-07-16T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20640974,2010-07-16T00:00:00,Adult,M01.060.116
20640974,2010-07-16T00:00:00,African Americans,M01.686.508.100.100
20640974,2010-07-16T00:00:00,African Americans,M01.686.754.100
20640974,2010-07-16T00:00:00,European Continental Ancestry Group,M01.686.508.400
20640974,2010-07-16T00:00:00,Hispanic Americans,M01.686.754.441
20640974,2010-07-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20640974,2010-07-16T00:00:00,Pregnancy,G08.686.785.760.769
20640974,2010-07-16T00:00:00,Pregnancy Complications,C13.703
20640974,2010-07-16T00:00:00,Risk Factors,E05.318.740.600.800.725
20640974,2010-07-16T00:00:00,Risk Factors,N05.715.350.200.700
20640974,2010-07-16T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20640974,2010-07-16T00:00:00,Risk Factors,N06.850.490.625.750
20640974,2010-07-16T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20640974,2010-07-16T00:00:00,South Carolina,Z01.107.567.875.075.662
20640974,2010-07-16T00:00:00,South Carolina,Z01.107.567.875.750.700
20640974,2010-07-16T00:00:00,Vitamin D,D04.808.812.768
20640974,2010-07-16T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
20640974,2010-07-16T00:00:00,Young Adult,M01.060.116.815
20691538,2010-07-16T00:00:00,Adsorption,G02.149.047
20691538,2010-07-16T00:00:00,Adsorption,G02.149.767.029
20691538,2010-07-16T00:00:00,Adsorption,G02.842.750.029
20691538,2010-07-16T00:00:00,Disinfectants,D27.505.954.122.425
20691538,2010-07-16T00:00:00,Disinfectants,D27.720.274
20691538,2010-07-16T00:00:00,Disinfection,N06.850.780.200.450.850.375
20638823,2010-07-17T00:00:00,Disability Evaluation,E01.370.400
20638823,2010-07-17T00:00:00,Hand,A01.378.800.667
20638823,2010-07-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20638823,2010-07-17T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
20638823,2010-07-17T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
20638823,2010-07-17T00:00:00,Patient Satisfaction,N04.452.822.360.600
20638823,2010-07-17T00:00:00,Patient Satisfaction,N05.300.150.600.630
20638823,2010-07-17T00:00:00,Patient Satisfaction,N05.715.360.600
20638823,2010-07-17T00:00:00,Questionnaires,E05.318.308.750
20638823,2010-07-17T00:00:00,Questionnaires,L01.280.800
20638823,2010-07-17T00:00:00,Questionnaires,N05.715.360.300.695
20638823,2010-07-17T00:00:00,Questionnaires,N06.850.520.308.750
20638823,2010-07-17T00:00:00,Research Design,E05.581.500
20638823,2010-07-17T00:00:00,Research Design,H01.770.644.728
20643648,2010-07-19T00:00:00,Animals,B01.050
20643648,2010-07-19T00:00:00,Collagen,D05.750.078.280
20643648,2010-07-19T00:00:00,Collagen,D12.776.860.300.250
20643648,2010-07-19T00:00:00,Fibrosis,C23.550.355
20643648,2010-07-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20643648,2010-07-19T00:00:00,Matrix Metalloproteinase 14,D08.811.277.656.300.480.525.300.500
20643648,2010-07-19T00:00:00,Matrix Metalloproteinase 14,D08.811.277.656.675.374.525.300.500
20643648,2010-07-19T00:00:00,Myocardial Infarction,C14.280.647.500
20643648,2010-07-19T00:00:00,Myocardial Infarction,C14.907.585.500
20643648,2010-07-19T00:00:00,Myocardium,A02.633.580
20643648,2010-07-19T00:00:00,Myocardium,A07.541.704
20643648,2010-07-19T00:00:00,Myocardium,A10.690.552.750
20643648,2010-07-19T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
20643648,2010-07-19T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
20643648,2010-07-19T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
20643648,2010-07-19T00:00:00,Signal Transduction,G02.111.087.800
20643648,2010-07-19T00:00:00,Signal Transduction,G02.149.115.800
20643648,2010-07-19T00:00:00,Signal Transduction,G04.299.880
20643648,2010-07-19T00:00:00,Ventricular Remodeling,C23.300.985
20643648,2010-07-19T00:00:00,Ventricular Remodeling,G09.330.190.962.975
20643872,2010-07-19T00:00:00,Adolescent,M01.060.057
20643872,2010-07-19T00:00:00,Adult,M01.060.116
20643872,2010-07-19T00:00:00,Aged,M01.060.116.100
20643872,2010-07-19T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
20643872,2010-07-19T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
20643872,2010-07-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20643872,2010-07-19T00:00:00,Incidence,E05.318.308.985.525.375
20643872,2010-07-19T00:00:00,Incidence,L01.280.975.525.375
20643872,2010-07-19T00:00:00,Incidence,N01.224.935.597.500
20643872,2010-07-19T00:00:00,Incidence,N06.850.505.400.975.525.375
20643872,2010-07-19T00:00:00,Incidence,N06.850.520.308.985.525.375
20643872,2010-07-19T00:00:00,Interviews as Topic,E05.318.308.420
20643872,2010-07-19T00:00:00,Interviews as Topic,L01.280.520
20643872,2010-07-19T00:00:00,Interviews as Topic,N05.715.360.300.400
20643872,2010-07-19T00:00:00,Interviews as Topic,N06.850.520.308.420
20643872,2010-07-19T00:00:00,Middle Aged,M01.060.116.630
20643872,2010-07-19T00:00:00,Risk Reduction Behavior,F01.145.699
20643872,2010-07-19T00:00:00,Smoking,F01.145.466.753
20643872,2010-07-19T00:00:00,Young Adult,M01.060.116.815
20644167,2010-07-19T00:00:00,Animals,B01.050
20644167,2010-07-19T00:00:00,Ankle Joint,A02.835.583.378.062
20644167,2010-07-19T00:00:00,Arthritis,C05.550.114
20644167,2010-07-19T00:00:00,Cyclooxygenase 2,D08.811.600.720.750
20644167,2010-07-19T00:00:00,Gene Expression Profiling,E05.393.332
20644167,2010-07-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20644167,2010-07-19T00:00:00,Joints,A02.835.583
20644167,2010-07-19T00:00:00,Lysophospholipids,D10.570.755.375.760.550
20644167,2010-07-19T00:00:00,Osteoclasts,A11.329.372.700
20644167,2010-07-19T00:00:00,Osteoclasts,A11.627.482.700
20644167,2010-07-19T00:00:00,Phosphotransferases (Alcohol Group Acceptor),D08.811.913.696.620
20644167,2010-07-19T00:00:00,Sphingolipids,D10.570.877
20644167,2010-07-19T00:00:00,Sphingolipids,D10.808
20644167,2010-07-19T00:00:00,Sphingosine,D02.033.100.700
20644167,2010-07-19T00:00:00,Sphingosine,D02.033.455.843
20644167,2010-07-19T00:00:00,Sphingosine,D02.092.063.700
20644167,2010-07-19T00:00:00,Suppressor of Cytokine Signaling Proteins,D12.644.360.024.374
20644167,2010-07-19T00:00:00,Suppressor of Cytokine Signaling Proteins,D12.776.157.057.249
20644167,2010-07-19T00:00:00,Suppressor of Cytokine Signaling Proteins,D12.776.476.024.437
20644167,2010-07-19T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
20644167,2010-07-19T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
20644167,2010-07-19T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
20644167,2010-07-19T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
20644167,2010-07-19T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
20644167,2010-07-19T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
20644167,2010-07-19T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
20644167,2010-07-19T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
20644167,2010-07-19T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
20644167,2010-07-19T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
20644167,2010-07-19T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
20645934,2010-07-20T00:00:00,Adult,M01.060.116
20645934,2010-07-20T00:00:00,Alcohol Deterrents,D27.505.954.427.020
20645934,2010-07-20T00:00:00,Alcoholism,C21.739.100.250
20645934,2010-07-20T00:00:00,Alcoholism,F03.900.100.350
20645934,2010-07-20T00:00:00,Behavior Therapy,F04.754.137
20645934,2010-07-20T00:00:00,Combined Modality Therapy,E02.186
20645934,2010-07-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20645934,2010-07-20T00:00:00,Naltrexone,D03.132.577.249.706.550
20645934,2010-07-20T00:00:00,Naltrexone,D03.549.686.750.550
20645934,2010-07-20T00:00:00,Naltrexone,D03.605.497.750.550
20645934,2010-07-20T00:00:00,Naltrexone,D04.615.723.795.706.550
20645934,2010-07-20T00:00:00,Narcotic Antagonists,D27.505.696.543
20645934,2010-07-20T00:00:00,Narcotic Antagonists,D27.505.696.663.850.512
20645934,2010-07-20T00:00:00,Narcotic Antagonists,D27.505.954.427.550
20645934,2010-07-20T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
20645934,2010-07-20T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
20645934,2010-07-20T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
20645934,2010-07-20T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
20645934,2010-07-20T00:00:00,Sex Characteristics,G08.686.815
20645934,2010-07-20T00:00:00,Taurine,D02.455.326.146.100.850
20645934,2010-07-20T00:00:00,Taurine,D02.886.645.600.055.850
20645934,2010-07-20T00:00:00,Treatment Outcome,E01.789.800
20645934,2010-07-20T00:00:00,Treatment Outcome,N04.761.559.590.800
20645934,2010-07-20T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20645941,2010-07-20T00:00:00,Adolescent,M01.060.057
20645941,2010-07-20T00:00:00,Adult,M01.060.116
20645941,2010-07-20T00:00:00,Blood Grouping and Crossmatching,E01.450.375.120
20645941,2010-07-20T00:00:00,Blood Grouping and Crossmatching,E01.450.495.385.120
20645941,2010-07-20T00:00:00,Blood Grouping and Crossmatching,E05.478.594.385.120
20645941,2010-07-20T00:00:00,Graft Rejection,G12.425.901.545.328
20645941,2010-07-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20645941,2010-07-20T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
20645941,2010-07-20T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
20645941,2010-07-20T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
20645941,2010-07-20T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
20645941,2010-07-20T00:00:00,Kidney Transplantation,E02.870.500
20645941,2010-07-20T00:00:00,Kidney Transplantation,E04.936.450.485
20645941,2010-07-20T00:00:00,Kidney Transplantation,E04.950.774.400
20645941,2010-07-20T00:00:00,Living Donors,M01.898.656
20645941,2010-07-20T00:00:00,Middle Aged,M01.060.116.630
20645941,2010-07-20T00:00:00,Renin,D08.811.277.656.074.500.780
20645941,2010-07-20T00:00:00,Renin,D08.811.277.656.300.048.780
20645941,2010-07-20T00:00:00,Renin,D08.811.277.656.837.750
20645941,2010-07-20T00:00:00,Time Factors,G01.910.857
20645941,2010-07-20T00:00:00,Treatment Outcome,E01.789.800
20645941,2010-07-20T00:00:00,Treatment Outcome,N04.761.559.590.800
20645941,2010-07-20T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20645941,2010-07-20T00:00:00,Waiting Lists,N04.452.095.738
20645941,2010-07-20T00:00:00,Young Adult,M01.060.116.815
20647254,2010-07-20T00:00:00,Animals,B01.050
20647254,2010-07-20T00:00:00,"Antibodies, Antinuclear",D12.776.124.486.485.114.323.204
20647254,2010-07-20T00:00:00,"Antibodies, Antinuclear",D12.776.124.790.651.114.323.204
20647254,2010-07-20T00:00:00,"Antibodies, Antinuclear",D12.776.377.715.548.114.323.204
20647254,2010-07-20T00:00:00,Bone Marrow Transplantation,E04.936.580.040
20647254,2010-07-20T00:00:00,Creatinine,D03.383.129.308.207
20647254,2010-07-20T00:00:00,Gene Expression Regulation,G05.355.315
20647254,2010-07-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20647254,2010-07-20T00:00:00,Lupus Nephritis,C12.777.419.570.363.680
20647254,2010-07-20T00:00:00,Lupus Nephritis,C13.351.968.419.570.363.680
20647254,2010-07-20T00:00:00,Lupus Nephritis,C17.300.480.680
20647254,2010-07-20T00:00:00,Lupus Nephritis,C20.111.590.560
20647254,2010-07-20T00:00:00,Mesenchymal Stem Cell Transplantation,E04.936.225.687.625
20647254,2010-07-20T00:00:00,Proteinuria,C12.777.934.734
20647254,2010-07-20T00:00:00,Proteinuria,C13.351.968.934.734
20647254,2010-07-20T00:00:00,Proteinuria,C23.888.942.750
20647331,2010-07-20T00:00:00,Animals,B01.050
20647331,2010-07-20T00:00:00,Apoptosis,G04.299.139.160
20647331,2010-07-20T00:00:00,Cell Aging,G04.299.119
20647331,2010-07-20T00:00:00,Cell Proliferation,G04.299.233.750
20647331,2010-07-20T00:00:00,Cell Proliferation,G07.700.320.249.410.750
20647331,2010-07-20T00:00:00,Cyclin-Dependent Kinase Inhibitor p21,D12.644.360.225.500
20647331,2010-07-20T00:00:00,Cyclin-Dependent Kinase Inhibitor p21,D12.776.167.187.500
20647331,2010-07-20T00:00:00,Cyclin-Dependent Kinase Inhibitor p21,D12.776.476.225.500
20647331,2010-07-20T00:00:00,Cyclin-Dependent Kinase Inhibitor p21,D12.776.624.776.355.500
20647331,2010-07-20T00:00:00,Fibroblasts,A11.329.228
20647331,2010-07-20T00:00:00,Fibroblasts,A11.872.228
20647331,2010-07-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20647331,2010-07-20T00:00:00,Phenotype,G05.695
20647331,2010-07-20T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
20647331,2010-07-20T00:00:00,Prostatic Neoplasms,C12.294.260.750
20647331,2010-07-20T00:00:00,Prostatic Neoplasms,C12.294.565.625
20647331,2010-07-20T00:00:00,Prostatic Neoplasms,C12.758.409.750
20647331,2010-07-20T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
20647331,2010-07-20T00:00:00,Proto-Oncogene Proteins,D12.776.624.664.700
20647331,2010-07-20T00:00:00,Proto-Oncogene Proteins c-pim-1,D08.811.913.696.620.682.700.776
20647331,2010-07-20T00:00:00,Proto-Oncogene Proteins c-pim-1,D12.776.624.664.700.191
20647331,2010-07-20T00:00:00,"RNA, Messenger",D13.444.735.544
20647331,2010-07-20T00:00:00,Tumor Suppressor Protein p53,D12.776.260.820
20647331,2010-07-20T00:00:00,Tumor Suppressor Protein p53,D12.776.624.776.775
20647331,2010-07-20T00:00:00,Tumor Suppressor Protein p53,D12.776.660.825
20647331,2010-07-20T00:00:00,Tumor Suppressor Protein p53,D12.776.744.845
20647331,2010-07-20T00:00:00,beta-Galactosidase,D08.811.277.450.410.100
20647395,2010-07-20T00:00:00,African Americans,M01.686.508.100.100
20647395,2010-07-20T00:00:00,African Americans,M01.686.754.100
20647395,2010-07-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20647395,2010-07-20T00:00:00,Middle Aged,M01.060.116.630
20647395,2010-07-20T00:00:00,Risk Factors,E05.318.740.600.800.725
20647395,2010-07-20T00:00:00,Risk Factors,N05.715.350.200.700
20647395,2010-07-20T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20647395,2010-07-20T00:00:00,Risk Factors,N06.850.490.625.750
20647395,2010-07-20T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20647395,2010-07-20T00:00:00,Vitamin D,D04.808.812.768
20647395,2010-07-20T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
20650885,2010-07-21T00:00:00,Alligators and Crocodiles,B01.050.150.900.833.100
20650885,2010-07-21T00:00:00,Animals,B01.050
20650885,2010-07-21T00:00:00,Embryonic Development,G07.700.320.500.325.180
20650885,2010-07-21T00:00:00,Embryonic Development,G08.686.785.760.170.104
20650885,2010-07-21T00:00:00,Environmental Exposure,N06.850.460.350
20650885,2010-07-21T00:00:00,Estradiol,D04.808.365.415.248
20650885,2010-07-21T00:00:00,Estradiol,D06.472.334.851.437.500
20650885,2010-07-21T00:00:00,Progesterone,D04.808.745.745.654.829
20650885,2010-07-21T00:00:00,Progesterone,D06.472.334.734.623
20650885,2010-07-21T00:00:00,Progesterone,D06.472.334.851.687.750
20650885,2010-07-21T00:00:00,Testosterone,D04.808.054.079.429.824
20650885,2010-07-21T00:00:00,Testosterone,D06.472.334.851.968.984
20654701,2010-07-21T00:00:00,Amygdala,A08.186.211.464.090
20654701,2010-07-21T00:00:00,Amygdala,A08.186.211.730.885.287.249.152
20654701,2010-07-21T00:00:00,Animals,B01.050
20654701,2010-07-21T00:00:00,"Behavior, Addictive",F01.145.527.100.120
20654701,2010-07-21T00:00:00,Cocaine,D02.145.074.722.388
20654701,2010-07-21T00:00:00,Cocaine,D03.132.889.354
20654701,2010-07-21T00:00:00,Cocaine,D03.605.869.388
20654701,2010-07-21T00:00:00,Cocaine,D04.075.080.875.099.722.388
20654701,2010-07-21T00:00:00,"Conditioning, Operant",F02.463.425.179.509
20654701,2010-07-21T00:00:00,Cues,F02.463.425.234
20654701,2010-07-21T00:00:00,Cytoskeletal Proteins,D12.776.220
20654701,2010-07-21T00:00:00,Gene Expression,G05.355.310
20654701,2010-07-21T00:00:00,Hippocampus,A08.186.211.464.405
20654701,2010-07-21T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
20654701,2010-07-21T00:00:00,Nerve Tissue Proteins,D12.776.641
20654701,2010-07-21T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20654701,2010-07-21T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
20654701,2010-07-21T00:00:00,Self Administration,E02.319.890
20654701,2010-07-21T00:00:00,Self Administration,E02.900.890
20654701,2010-07-21T00:00:00,Time Factors,G01.910.857
20660127,2010-07-21T00:00:00,Adult,M01.060.116
20660127,2010-07-21T00:00:00,Ceramides,D02.065.313
20660127,2010-07-21T00:00:00,Ceramides,D09.400.410.420.525.200
20660127,2010-07-21T00:00:00,Ceramides,D10.390.470.675.200
20660127,2010-07-21T00:00:00,Ceramides,D10.570.877.360.612.200
20660127,2010-07-21T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
20660127,2010-07-21T00:00:00,Heparin,D09.698.373.400
20660127,2010-07-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20660127,2010-07-21T00:00:00,Proteomics,H01.158.201.843
20660127,2010-07-21T00:00:00,Proteomics,H01.158.273.180.350.700
20660127,2010-07-21T00:00:00,Proteomics,H01.158.273.343.350.700
20660127,2010-07-21T00:00:00,Proteomics,H01.181.122.738
20660127,2010-07-21T00:00:00,Sphingolipids,D10.570.877
20660127,2010-07-21T00:00:00,Sphingolipids,D10.808
20660127,2010-07-21T00:00:00,Sphingosine,D02.033.100.700
20660127,2010-07-21T00:00:00,Sphingosine,D02.033.455.843
20660127,2010-07-21T00:00:00,Sphingosine,D02.092.063.700
20660127,2010-07-21T00:00:00,Tandem Mass Spectrometry,E05.196.566.880
20664581,2010-07-21T00:00:00,Animals,B01.050
20664581,2010-07-21T00:00:00,"Behavior, Addictive",F01.145.527.100.120
20664581,2010-07-21T00:00:00,Cocaine,D02.145.074.722.388
20664581,2010-07-21T00:00:00,Cocaine,D03.132.889.354
20664581,2010-07-21T00:00:00,Cocaine,D03.605.869.388
20664581,2010-07-21T00:00:00,Cocaine,D04.075.080.875.099.722.388
20664581,2010-07-21T00:00:00,Dopamine,D02.092.211.215.311.342
20664581,2010-07-21T00:00:00,Dopamine,D02.092.311.342
20664581,2010-07-21T00:00:00,Neural Inhibition,G07.265.337.615
20664581,2010-07-21T00:00:00,Neural Inhibition,G07.700.240.615
20664581,2010-07-21T00:00:00,Neural Inhibition,G11.561.600.625
20664581,2010-07-21T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
20664581,2010-07-21T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20664581,2010-07-21T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
20664581,2010-07-21T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.070.300.400.500
20664581,2010-07-21T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.100.150.400.500
20664581,2010-07-21T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.720.300.300.400.500
20664581,2010-07-21T00:00:00,Substance Withdrawal Syndrome,C21.739.835
20664581,2010-07-21T00:00:00,Substance Withdrawal Syndrome,F03.900.825
20568780,2010-07-22T00:00:00,Antineoplastic Agents,D27.505.954.248
20568780,2010-07-22T00:00:00,Cell Survival,G04.299.316
20568780,2010-07-22T00:00:00,Histone Demethylases,D08.811.682.662.582.475
20568780,2010-07-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20568780,2010-07-22T00:00:00,Membrane Proteins,D12.776.543
20568780,2010-07-22T00:00:00,Recombinant Proteins,D12.776.828
20652961,2010-07-22T00:00:00,Antihypertensive Agents,D27.505.954.411.162
20652961,2010-07-22T00:00:00,Hospitalization,E02.760.400
20652961,2010-07-22T00:00:00,Hospitalization,N02.421.585.400
20652961,2010-07-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20652961,2010-07-22T00:00:00,Hypertension,C14.907.489
20655277,2010-07-22T00:00:00,Cell Line,A11.251.210
20655277,2010-07-22T00:00:00,Cell Proliferation,G04.299.233.750
20655277,2010-07-22T00:00:00,Cell Proliferation,G07.700.320.249.410.750
20655277,2010-07-22T00:00:00,Cytokines,D12.644.276.374
20655277,2010-07-22T00:00:00,Cytokines,D12.776.467.374
20655277,2010-07-22T00:00:00,Cytokines,D23.529.374
20655277,2010-07-22T00:00:00,Gene Expression,G05.355.310
20655277,2010-07-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20655277,2010-07-22T00:00:00,Inflammation,C23.550.470
20655277,2010-07-22T00:00:00,"Macrophages, Alveolar",A11.329.372.600
20655277,2010-07-22T00:00:00,"Macrophages, Alveolar",A11.627.482.600
20655277,2010-07-22T00:00:00,"Macrophages, Alveolar",A11.733.397.600
20655277,2010-07-22T00:00:00,"Macrophages, Alveolar",A15.382.680.397.600
20655277,2010-07-22T00:00:00,"Macrophages, Alveolar",A15.382.812.522.600
20655954,2010-07-23T00:00:00,Animals,B01.050
20655954,2010-07-23T00:00:00,"Behavior, Animal",F01.145.113
20655954,2010-07-23T00:00:00,Cocaine,D02.145.074.722.388
20655954,2010-07-23T00:00:00,Cocaine,D03.132.889.354
20655954,2010-07-23T00:00:00,Cocaine,D03.605.869.388
20655954,2010-07-23T00:00:00,Cocaine,D04.075.080.875.099.722.388
20655954,2010-07-23T00:00:00,Conditioning (Psychology),F02.463.425.179
20655954,2010-07-23T00:00:00,Motor Activity,F01.145.632
20655954,2010-07-23T00:00:00,Motor Activity,G11.427.590.530.698
20655954,2010-07-23T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20655954,2010-07-23T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
20655954,2010-07-23T00:00:00,Self Administration,E02.319.890
20655954,2010-07-23T00:00:00,Self Administration,E02.900.890
21990643,2010-07-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21990643,2010-07-23T00:00:00,Magnetic Resonance Angiography,E01.370.350.500.500
21990643,2010-07-23T00:00:00,Magnetic Resonance Angiography,E01.370.350.825.500.500
21990643,2010-07-23T00:00:00,Magnetic Resonance Angiography,E01.370.370.050.500
21990643,2010-07-23T00:00:00,Middle Aged,M01.060.116.630
21990643,2010-07-23T00:00:00,Stents,E07.695.750
21990643,2010-07-23T00:00:00,Time Factors,G01.910.857
21990643,2010-07-23T00:00:00,Treatment Outcome,E01.789.800
21990643,2010-07-23T00:00:00,Treatment Outcome,N04.761.559.590.800
21990643,2010-07-23T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21990643,2010-07-23T00:00:00,Vertebrobasilar Insufficiency,C10.228.140.300.150.956
21990643,2010-07-23T00:00:00,Vertebrobasilar Insufficiency,C14.907.253.092.956
21990643,2010-07-23T00:00:00,Vertebrobasilar Insufficiency,C14.907.253.956
20656386,2010-07-24T00:00:00,Adsorption,G02.149.047
20656386,2010-07-24T00:00:00,Adsorption,G02.149.767.029
20656386,2010-07-24T00:00:00,Adsorption,G02.842.750.029
20656386,2010-07-24T00:00:00,Environmental Remediation,N06.850.460.375
20656386,2010-07-24T00:00:00,Radiation Monitoring,E05.799.638
20656386,2010-07-24T00:00:00,Radiation Monitoring,N06.850.780.375.700
20656386,2010-07-24T00:00:00,Radiation Monitoring,N06.850.810.370
20656386,2010-07-24T00:00:00,"Water Pollutants, Radioactive",D20.693.903
20656386,2010-07-24T00:00:00,"Water Pollutants, Radioactive",D27.888.284.903.821
20656492,2010-07-24T00:00:00,Aged,M01.060.116.100
20656492,2010-07-24T00:00:00,Ankle Joint,A02.835.583.378.062
20656492,2010-07-24T00:00:00,Hip Joint,A02.835.583.411
20656492,2010-07-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20656492,2010-07-24T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
20656492,2010-07-24T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
20656492,2010-07-24T00:00:00,Knee Joint,A02.835.583.475
20656492,2010-07-24T00:00:00,Leg,A01.378.610.500
20656492,2010-07-24T00:00:00,Middle Aged,M01.060.116.630
20656492,2010-07-24T00:00:00,"Muscle, Skeletal",A02.633.567
20656492,2010-07-24T00:00:00,"Muscle, Skeletal",A10.690.552.500
20656492,2010-07-24T00:00:00,Paresis,C10.597.636
20656492,2010-07-24T00:00:00,Paresis,C23.888.592.643
20656492,2010-07-24T00:00:00,Walking,G11.427.590.530.568.900
20656492,2010-07-24T00:00:00,Walking,G11.427.590.530.698.940
20656492,2010-07-24T00:00:00,Walking,I03.450.642.845.940
20656517,2010-07-24T00:00:00,Aged,M01.060.116.100
20656517,2010-07-24T00:00:00,Dental Care,E06.170
20656517,2010-07-24T00:00:00,Dental Care,N02.421.240.190
20656517,2010-07-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20656517,2010-07-24T00:00:00,Middle Aged,M01.060.116.630
20656517,2010-07-24T00:00:00,Periodontitis,C07.465.714.533
20656517,2010-07-24T00:00:00,Risk Assessment,E05.318.740.600.800.715
20656517,2010-07-24T00:00:00,Risk Assessment,N04.452.871.715
20656517,2010-07-24T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20656517,2010-07-24T00:00:00,Risk Assessment,N06.850.505.715
20656517,2010-07-24T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20656517,2010-07-24T00:00:00,Risk Factors,E05.318.740.600.800.725
20656517,2010-07-24T00:00:00,Risk Factors,N05.715.350.200.700
20656517,2010-07-24T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20656517,2010-07-24T00:00:00,Risk Factors,N06.850.490.625.750
20656517,2010-07-24T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20656517,2010-07-24T00:00:00,Stroke,C10.228.140.300.775
20656517,2010-07-24T00:00:00,Stroke,C14.907.253.855
20656517,2010-07-24T00:00:00,Time Factors,G01.910.857
20656517,2010-07-24T00:00:00,United States,Z01.107.567.875
20656518,2010-07-24T00:00:00,Aged,M01.060.116.100
20656518,2010-07-24T00:00:00,Brain Ischemia,C10.228.140.300.150
20656518,2010-07-24T00:00:00,Brain Ischemia,C14.907.253.092
20656518,2010-07-24T00:00:00,Cardiovascular Diseases,C14
20656518,2010-07-24T00:00:00,Disability Evaluation,E01.370.400
20656518,2010-07-24T00:00:00,Hospitalization,E02.760.400
20656518,2010-07-24T00:00:00,Hospitalization,N02.421.585.400
20656518,2010-07-24T00:00:00,"Hospitals, University",N02.278.020.300.310
20656518,2010-07-24T00:00:00,"Hospitals, University",N02.278.421.639.725
20656518,2010-07-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20656518,2010-07-24T00:00:00,Middle Aged,M01.060.116.630
20656518,2010-07-24T00:00:00,Patient Discharge,E02.760.400.610
20656518,2010-07-24T00:00:00,Patient Discharge,N02.421.585.400.610
20656518,2010-07-24T00:00:00,Recovery of Function,G16.757
20656518,2010-07-24T00:00:00,Risk Assessment,E05.318.740.600.800.715
20656518,2010-07-24T00:00:00,Risk Assessment,N04.452.871.715
20656518,2010-07-24T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20656518,2010-07-24T00:00:00,Risk Assessment,N06.850.505.715
20656518,2010-07-24T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20656518,2010-07-24T00:00:00,Risk Factors,E05.318.740.600.800.725
20656518,2010-07-24T00:00:00,Risk Factors,N05.715.350.200.700
20656518,2010-07-24T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20656518,2010-07-24T00:00:00,Risk Factors,N06.850.490.625.750
20656518,2010-07-24T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20656518,2010-07-24T00:00:00,Stroke,C10.228.140.300.775
20656518,2010-07-24T00:00:00,Stroke,C14.907.253.855
20656518,2010-07-24T00:00:00,Time Factors,G01.910.857
20659426,2010-07-24T00:00:00,Animals,B01.050
20659426,2010-07-24T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
20659426,2010-07-24T00:00:00,Cholesterol,D04.808.247.222.284
20659426,2010-07-24T00:00:00,Cholesterol,D04.808.247.808.197
20659426,2010-07-24T00:00:00,Cholesterol,D10.570.938.208
20659426,2010-07-24T00:00:00,Cholesterol,D10.851.208
20659426,2010-07-24T00:00:00,Neurons,A08.663
20659426,2010-07-24T00:00:00,Neurons,A11.671
20659426,2010-07-24T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20659426,2010-07-24T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
20661658,2010-07-27T00:00:00,Adult,M01.060.116
20661658,2010-07-27T00:00:00,Aged,M01.060.116.100
20661658,2010-07-27T00:00:00,Algorithms,G17.035
20661658,2010-07-27T00:00:00,Algorithms,L01.224.050
20661658,2010-07-27T00:00:00,Exercise Therapy,E02.779.483
20661658,2010-07-27T00:00:00,Exercise Therapy,E02.831.387
20661658,2010-07-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20661658,2010-07-27T00:00:00,Middle Aged,M01.060.116.630
20661658,2010-07-27T00:00:00,Motor Activity,F01.145.632
20661658,2010-07-27T00:00:00,Motor Activity,G11.427.590.530.698
20661658,2010-07-27T00:00:00,Neoplasms,C04
20661658,2010-07-27T00:00:00,Patient Selection,E05.581.500.653
20661658,2010-07-27T00:00:00,Patient Selection,N04.590.731
20661658,2010-07-27T00:00:00,Quality of Life,I01.800
20661658,2010-07-27T00:00:00,Quality of Life,K01.752.400.750
20661658,2010-07-27T00:00:00,Survivors,M01.643.836
20661658,2010-07-27T00:00:00,Survivors,M01.860
20661700,2010-07-27T00:00:00,Heart Diseases,C14.280
20661700,2010-07-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20661700,2010-07-27T00:00:00,Middle Aged,M01.060.116.630
20661700,2010-07-27T00:00:00,Pericardium,A07.541.795
20661700,2010-07-27T00:00:00,Pericardium,A10.615.789.470
20661700,2010-07-27T00:00:00,"Tomography, Spiral Computed",E01.370.350.350.810.800
20661700,2010-07-27T00:00:00,"Tomography, Spiral Computed",E01.370.350.600.350.700.810.800
20661700,2010-07-27T00:00:00,"Tomography, Spiral Computed",E01.370.350.700.700.810.800
20661700,2010-07-27T00:00:00,"Tomography, Spiral Computed",E01.370.350.700.810.810.800
20661700,2010-07-27T00:00:00,"Tomography, Spiral Computed",E01.370.350.825.810.810.800
20663199,2010-07-27T00:00:00,Algorithms,G17.035
20663199,2010-07-27T00:00:00,Algorithms,L01.224.050
20663199,2010-07-27T00:00:00,Computer Simulation,L01.224.160
20663199,2010-07-27T00:00:00,Evaluation Studies as Topic,E05.337
20663199,2010-07-27T00:00:00,Evaluation Studies as Topic,N05.715.360.335
20663873,2010-07-27T00:00:00,Animals,B01.050
20663873,2010-07-27T00:00:00,Cell Cycle Proteins,D12.776.167
20663873,2010-07-27T00:00:00,Cell Line,A11.251.210
20663873,2010-07-27T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
20663873,2010-07-27T00:00:00,Flow Cytometry,E05.200.500.386.350
20663873,2010-07-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20663873,2010-07-27T00:00:00,Phosphorylation,G02.111.087.677
20663873,2010-07-27T00:00:00,Phosphorylation,G02.149.115.677
20663873,2010-07-27T00:00:00,Phosphorylation,G02.149.465.700
20663873,2010-07-27T00:00:00,Phosphorylation,G02.607.750.700
20663873,2010-07-27T00:00:00,Phosphorylation,G03.495.790
20663873,2010-07-27T00:00:00,Proto-Oncogene Proteins c-pim-1,D08.811.913.696.620.682.700.776
20663873,2010-07-27T00:00:00,Proto-Oncogene Proteins c-pim-1,D12.776.624.664.700.191
20663873,2010-07-27T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20663873,2010-07-27T00:00:00,S-Phase Kinase-Associated Proteins,D12.776.157.743
20668062,2010-07-28T00:00:00,Gene Regulatory Networks,G05.360.080.689.360
20668062,2010-07-28T00:00:00,"Genes, Plant",G05.360.340.024.340.393
20668062,2010-07-28T00:00:00,"Genes, Plant",G05.360.340.365.500
20668062,2010-07-28T00:00:00,Genetic Loci,G05.360.340.024.380
20668062,2010-07-28T00:00:00,Internet,L01.224.230.110.500
20668062,2010-07-28T00:00:00,Mutation,G05.365.590
20668062,2010-07-28T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
20668062,2010-07-28T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
20668062,2010-07-28T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
20668062,2010-07-28T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
20668062,2010-07-28T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
20668062,2010-07-28T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
20668062,2010-07-28T00:00:00,Phenotype,G05.695
20673830,2010-07-29T00:00:00,Animals,B01.050
20673830,2010-07-29T00:00:00,Apoptosis,G04.299.139.160
20673830,2010-07-29T00:00:00,Calpain,D08.811.277.656.262.500.120
20673830,2010-07-29T00:00:00,Calpain,D08.811.277.656.300.200.120
20673830,2010-07-29T00:00:00,Cell Line,A11.251.210
20673830,2010-07-29T00:00:00,Inflammation,C23.550.470
20673830,2010-07-29T00:00:00,Interferon-gamma,D12.644.276.374.440.893
20673830,2010-07-29T00:00:00,Interferon-gamma,D12.644.276.374.480.350
20673830,2010-07-29T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
20673830,2010-07-29T00:00:00,Interferon-gamma,D12.644.276.718.550
20673830,2010-07-29T00:00:00,Interferon-gamma,D12.776.467.374.440.893
20673830,2010-07-29T00:00:00,Interferon-gamma,D12.776.467.374.480.350
20673830,2010-07-29T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
20673830,2010-07-29T00:00:00,Interferon-gamma,D12.776.467.718.550
20673830,2010-07-29T00:00:00,Interferon-gamma,D23.529.374.440.893
20673830,2010-07-29T00:00:00,Interferon-gamma,D23.529.374.480.350
20673830,2010-07-29T00:00:00,Interferon-gamma,D23.529.374.480.615.350
20673830,2010-07-29T00:00:00,Interferon-gamma,D23.529.718.550
20673830,2010-07-29T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20626559,2010-07-30T00:00:00,Adrenergic Uptake Inhibitors,D27.505.519.625.050.601
20626559,2010-07-30T00:00:00,Adrenergic Uptake Inhibitors,D27.505.519.625.600.050
20626559,2010-07-30T00:00:00,Adrenergic Uptake Inhibitors,D27.505.696.577.050.601
20626559,2010-07-30T00:00:00,Adrenergic Uptake Inhibitors,D27.505.696.577.600.050
20626559,2010-07-30T00:00:00,Amphetamine,D02.092.471.683.152.110
20626559,2010-07-30T00:00:00,Calcium,D01.268.552.100
20626559,2010-07-30T00:00:00,Calcium,D01.552.539.288
20626559,2010-07-30T00:00:00,Calcium,D23.119.100
20626559,2010-07-30T00:00:00,Cell Membrane,A11.284.149
20626559,2010-07-30T00:00:00,Central Nervous System Stimulants,D27.505.696.282
20626559,2010-07-30T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
20626559,2010-07-30T00:00:00,Down-Regulation,G02.111.087.225
20626559,2010-07-30T00:00:00,Down-Regulation,G02.149.115.225
20626559,2010-07-30T00:00:00,Down-Regulation,G05.355.315.200
20626559,2010-07-30T00:00:00,Down-Regulation,G07.690.812.230
20626559,2010-07-30T00:00:00,Down-Regulation,G07.700.680.230
20626559,2010-07-30T00:00:00,Endocytosis,G04.299.482
20626559,2010-07-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20626559,2010-07-30T00:00:00,Mutation,G05.365.590
20626559,2010-07-30T00:00:00,Norepinephrine Plasma Membrane Transport Proteins,D12.776.157.530.450.625.186
20626559,2010-07-30T00:00:00,Norepinephrine Plasma Membrane Transport Proteins,D12.776.157.530.562.374.500.750
20626559,2010-07-30T00:00:00,Norepinephrine Plasma Membrane Transport Proteins,D12.776.543.585.450.625.186
20626559,2010-07-30T00:00:00,Norepinephrine Plasma Membrane Transport Proteins,D12.776.543.585.562.374.500.750
20626559,2010-07-30T00:00:00,Pregnancy,G08.686.785.760.769
20626559,2010-07-30T00:00:00,Protein Kinase C,D08.811.913.696.620.682.700.725
20626559,2010-07-30T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
20626559,2010-07-30T00:00:00,Serine,D12.125.154.800
20626559,2010-07-30T00:00:00,Serine,D12.125.837
20626559,2010-07-30T00:00:00,Signal Transduction,G02.111.087.800
20626559,2010-07-30T00:00:00,Signal Transduction,G02.149.115.800
20626559,2010-07-30T00:00:00,Signal Transduction,G04.299.880
20626559,2010-07-30T00:00:00,Threonine,D12.125.142.815
20626559,2010-07-30T00:00:00,Threonine,D12.125.154.900
20626559,2010-07-30T00:00:00,Threonine,D12.125.901
20673865,2010-07-30T00:00:00,Adolescent,M01.060.057
20673865,2010-07-30T00:00:00,Adult,M01.060.116
20673865,2010-07-30T00:00:00,Child,M01.060.406
20673865,2010-07-30T00:00:00,"Child, Preschool",M01.060.406.448
20673865,2010-07-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20673865,2010-07-30T00:00:00,Molecular Sequence Data,L01.453.245.667
20673865,2010-07-30T00:00:00,Phenotype,G05.695
20673865,2010-07-30T00:00:00,"Sequence Analysis, DNA",E05.393.760.700
20673865,2010-07-30T00:00:00,Spermatozoa,A05.360.490.890
20673865,2010-07-30T00:00:00,Spermatozoa,A11.497.760
20673865,2010-07-30T00:00:00,"Translocation, Genetic",C23.550.210.870
20673865,2010-07-30T00:00:00,"Translocation, Genetic",G05.355.600.860
20673865,2010-07-30T00:00:00,"Translocation, Genetic",G05.365.590.175.870
20875564,2010-07-30T00:00:00,Plant Leaves,A18.024.812
20624375,2010-07-31T00:00:00,Action Potentials,G04.580.100
20624375,2010-07-31T00:00:00,Action Potentials,G07.265.750.100
20624375,2010-07-31T00:00:00,Action Potentials,G11.561.570.100
20624375,2010-07-31T00:00:00,Animals,B01.050
20624375,2010-07-31T00:00:00,Neurons,A08.663
20624375,2010-07-31T00:00:00,Neurons,A11.671
20624375,2010-07-31T00:00:00,Physical Stimulation,E05.723
20624375,2010-07-31T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
20624375,2010-07-31T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20624375,2010-07-31T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
20674239,2010-07-31T00:00:00,African Americans,M01.686.508.100.100
20674239,2010-07-31T00:00:00,African Americans,M01.686.754.100
20674239,2010-07-31T00:00:00,Aged,M01.060.116.100
20674239,2010-07-31T00:00:00,Communication,F01.145.209
20674239,2010-07-31T00:00:00,Communication,L01.143
20674239,2010-07-31T00:00:00,Data Collection,E05.318.308
20674239,2010-07-31T00:00:00,Data Collection,L01.280
20674239,2010-07-31T00:00:00,Data Collection,N05.715.360.300
20674239,2010-07-31T00:00:00,Data Collection,N06.850.520.308
20674239,2010-07-31T00:00:00,Educational Measurement,I02.399
20674239,2010-07-31T00:00:00,European Continental Ancestry Group,M01.686.508.400
20674239,2010-07-31T00:00:00,Health Education,I02.233.332
20674239,2010-07-31T00:00:00,Health Education,N02.421.143.827.407
20674239,2010-07-31T00:00:00,Health Education,N02.421.726.407
20674239,2010-07-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20674239,2010-07-31T00:00:00,Middle Aged,M01.060.116.630
20674239,2010-07-31T00:00:00,Physician-Patient Relations,F01.829.401.650.675
20674239,2010-07-31T00:00:00,Physician-Patient Relations,N05.300.660.625
20674239,2010-07-31T00:00:00,Program Evaluation,E05.337.820
20674239,2010-07-31T00:00:00,Program Evaluation,N04.761.685
20674239,2010-07-31T00:00:00,Program Evaluation,N05.715.360.650
20674239,2010-07-31T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
20674239,2010-07-31T00:00:00,Prostatic Neoplasms,C12.294.260.750
20674239,2010-07-31T00:00:00,Prostatic Neoplasms,C12.294.565.625
20674239,2010-07-31T00:00:00,Prostatic Neoplasms,C12.758.409.750
20674239,2010-07-31T00:00:00,Self Efficacy,F01.752.747.792.700
20674239,2010-07-31T00:00:00,South Carolina,Z01.107.567.875.075.662
20674239,2010-07-31T00:00:00,South Carolina,Z01.107.567.875.750.700
19841574,2010-08-01T00:00:00,Aged,M01.060.116.100
19841574,2010-08-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
19841574,2010-08-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
19841574,2010-08-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
19841574,2010-08-01T00:00:00,Cisplatin,D01.210.375
19841574,2010-08-01T00:00:00,Cisplatin,D01.625.125
19841574,2010-08-01T00:00:00,Cisplatin,D01.710.100
19841574,2010-08-01T00:00:00,Combined Modality Therapy,E02.186
19841574,2010-08-01T00:00:00,Esophageal Neoplasms,C04.588.274.476.205
19841574,2010-08-01T00:00:00,Esophageal Neoplasms,C04.588.443.353
19841574,2010-08-01T00:00:00,Esophageal Neoplasms,C06.301.371.205
19841574,2010-08-01T00:00:00,Esophageal Neoplasms,C06.405.117.430
19841574,2010-08-01T00:00:00,Esophageal Neoplasms,C06.405.249.205
19841574,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19841574,2010-08-01T00:00:00,Middle Aged,M01.060.116.630
19841574,2010-08-01T00:00:00,Neoplasm Staging,E01.370.550
20186736,2010-08-01T00:00:00,Animals,B01.050
20186736,2010-08-01T00:00:00,Biocompatible Materials,D25.130
20186736,2010-08-01T00:00:00,Biocompatible Materials,D27.720.102.130
20186736,2010-08-01T00:00:00,Biocompatible Materials,J01.637.051.130
20186736,2010-08-01T00:00:00,Bone and Bones,A02.835.232
20186736,2010-08-01T00:00:00,Bone and Bones,A10.165.265
20186736,2010-08-01T00:00:00,Cattle,B01.050.150.900.649.077.380.271
20186736,2010-08-01T00:00:00,Chick Embryo,A13.350.150
20186736,2010-08-01T00:00:00,Chick Embryo,A16.331.200
20186736,2010-08-01T00:00:00,Chondrocytes,A11.329.171
20186736,2010-08-01T00:00:00,Collagen,D05.750.078.280
20186736,2010-08-01T00:00:00,Collagen,D12.776.860.300.250
20186736,2010-08-01T00:00:00,Compressive Strength,G01.374.180
20186736,2010-08-01T00:00:00,Extracellular Matrix,A11.284.295.310
20186736,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20186736,2010-08-01T00:00:00,Materials Testing,E05.570
20186736,2010-08-01T00:00:00,Protein Isoforms,D12.776.800
20186736,2010-08-01T00:00:00,"Stress, Mechanical",G01.374.676.830
20186736,2010-08-01T00:00:00,"Stress, Mechanical",G01.595.540.830
20186736,2010-08-01T00:00:00,Tissue Engineering,E05.200.249.750
20345222,2010-08-01T00:00:00,Adult,M01.060.116
20345222,2010-08-01T00:00:00,Aged,M01.060.116.100
20345222,2010-08-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
20345222,2010-08-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
20345222,2010-08-01T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
20345222,2010-08-01T00:00:00,Brain Neoplasms,C04.588.614.250.195
20345222,2010-08-01T00:00:00,Brain Neoplasms,C10.228.140.211
20345222,2010-08-01T00:00:00,Brain Neoplasms,C10.551.240.250
20345222,2010-08-01T00:00:00,Combined Modality Therapy,E02.186
20345222,2010-08-01T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
20345222,2010-08-01T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
20345222,2010-08-01T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
20345222,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20345222,2010-08-01T00:00:00,Middle Aged,M01.060.116.630
20345222,2010-08-01T00:00:00,"Radiotherapy, Adjuvant",E02.186.775
20345222,2010-08-01T00:00:00,"Radiotherapy, Adjuvant",E02.815.600
20345222,2010-08-01T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
20345222,2010-08-01T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
20345222,2010-08-01T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
20345222,2010-08-01T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
20345222,2010-08-01T00:00:00,Young Adult,M01.060.116.815
20386968,2010-08-01T00:00:00,Adolescent,M01.060.057
20386968,2010-08-01T00:00:00,Adult,M01.060.116
20386968,2010-08-01T00:00:00,Aged,M01.060.116.100
20386968,2010-08-01T00:00:00,Diabetes Mellitus,C18.452.394.750
20386968,2010-08-01T00:00:00,Diabetes Mellitus,C19.246
20386968,2010-08-01T00:00:00,Healthcare Disparities,N04.590.374.380
20386968,2010-08-01T00:00:00,Healthcare Disparities,N05.300.493
20386968,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20386968,2010-08-01T00:00:00,Middle Aged,M01.060.116.630
20386968,2010-08-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
20386968,2010-08-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
20386968,2010-08-01T00:00:00,Rural Health Services,N02.421.816
20386968,2010-08-01T00:00:00,United States,Z01.107.567.875
20386968,2010-08-01T00:00:00,Young Adult,M01.060.116.815
20506234,2010-08-01T00:00:00,Adult,M01.060.116
20506234,2010-08-01T00:00:00,African Americans,M01.686.508.100.100
20506234,2010-08-01T00:00:00,African Americans,M01.686.754.100
20506234,2010-08-01T00:00:00,Aged,M01.060.116.100
20506234,2010-08-01T00:00:00,"Arthritis, Rheumatoid",C05.550.114.154
20506234,2010-08-01T00:00:00,"Arthritis, Rheumatoid",C05.799.114
20506234,2010-08-01T00:00:00,"Arthritis, Rheumatoid",C17.300.775.099
20506234,2010-08-01T00:00:00,"Arthritis, Rheumatoid",C20.111.199
20506234,2010-08-01T00:00:00,Disease Progression,C23.550.291.656
20506234,2010-08-01T00:00:00,Hand,A01.378.800.667
20506234,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20506234,2010-08-01T00:00:00,Middle Aged,M01.060.116.630
20506234,2010-08-01T00:00:00,Osteoporosis,C05.116.198.579
20506343,2010-08-01T00:00:00,Adolescent,M01.060.057
20506343,2010-08-01T00:00:00,Adult,M01.060.116
20506343,2010-08-01T00:00:00,"Antibodies, Antinuclear",D12.776.124.486.485.114.323.204
20506343,2010-08-01T00:00:00,"Antibodies, Antinuclear",D12.776.124.790.651.114.323.204
20506343,2010-08-01T00:00:00,"Antibodies, Antinuclear",D12.776.377.715.548.114.323.204
20506343,2010-08-01T00:00:00,Complement C3,D12.776.124.050.140
20506343,2010-08-01T00:00:00,Complement C3,D12.776.124.486.274.250
20506343,2010-08-01T00:00:00,DNA,D13.444.308
20506343,2010-08-01T00:00:00,Disease Progression,C23.550.291.656
20506343,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20506343,2010-08-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
20506343,2010-08-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
20506343,2010-08-01T00:00:00,Mesenchymal Stem Cell Transplantation,E04.936.225.687.625
20506343,2010-08-01T00:00:00,Middle Aged,M01.060.116.630
20506343,2010-08-01T00:00:00,Treatment Outcome,E01.789.800
20506343,2010-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20506343,2010-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20536395,2010-08-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
20536395,2010-08-01T00:00:00,Alzheimer Disease,C10.574.945.249
20536395,2010-08-01T00:00:00,Alzheimer Disease,F03.087.400.100
20536395,2010-08-01T00:00:00,Amyloid Precursor Protein Secretases,D08.811.277.656.300.032
20536395,2010-08-01T00:00:00,Amyloid beta-Protein Precursor,D12.776.049.025.150
20536395,2010-08-01T00:00:00,Amyloid beta-Protein Precursor,D12.776.811.050
20536395,2010-08-01T00:00:00,Animals,B01.050
20536395,2010-08-01T00:00:00,Aspartic Acid Endopeptidases,D08.811.277.656.074.500
20536395,2010-08-01T00:00:00,Aspartic Acid Endopeptidases,D08.811.277.656.300.048
20536395,2010-08-01T00:00:00,Cathepsin B,D08.811.277.656.224.125
20536395,2010-08-01T00:00:00,Cathepsin B,D08.811.277.656.262.500.133
20536395,2010-08-01T00:00:00,Cathepsin B,D08.811.277.656.300.200.133
20536395,2010-08-01T00:00:00,"Disease Models, Animal",C22.232
20536395,2010-08-01T00:00:00,"Disease Models, Animal",E05.598.500
20536395,2010-08-01T00:00:00,"Disease Models, Animal",E05.599.395.080
20536395,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20536395,2010-08-01T00:00:00,Neurons,A08.663
20536395,2010-08-01T00:00:00,Neurons,A11.671
20564683,2010-08-01T00:00:00,Adolescent,M01.060.057
20564683,2010-08-01T00:00:00,African Americans,M01.686.508.100.100
20564683,2010-08-01T00:00:00,African Americans,M01.686.754.100
20564683,2010-08-01T00:00:00,Antisocial Personality Disorder,F03.675.050
20564683,2010-08-01T00:00:00,Cognitive Therapy,F04.754.137.428
20564683,2010-08-01T00:00:00,Community Mental Health Services,F04.408.307
20564683,2010-08-01T00:00:00,Community Mental Health Services,N02.421.143.183
20564683,2010-08-01T00:00:00,Community Mental Health Services,N02.421.461.232
20564683,2010-08-01T00:00:00,Cultural Competency,I01.880.143.364
20564683,2010-08-01T00:00:00,Education,I02
20564683,2010-08-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
20564683,2010-08-01T00:00:00,Family Therapy,F04.754.864.581.273
20564683,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20564683,2010-08-01T00:00:00,Juvenile Delinquency,I01.880.735.479
20564683,2010-08-01T00:00:00,Substance-Related Disorders,C21.739
20564683,2010-08-01T00:00:00,Substance-Related Disorders,F03.900
20571434,2010-08-01T00:00:00,Adult,M01.060.116
20571434,2010-08-01T00:00:00,Alcohol Drinking,F01.145.317.269
20571434,2010-08-01T00:00:00,Alcoholism,C21.739.100.250
20571434,2010-08-01T00:00:00,Alcoholism,F03.900.100.350
20571434,2010-08-01T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
20571434,2010-08-01T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
20571434,2010-08-01T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
20571434,2010-08-01T00:00:00,Brain,A08.186.211
20571434,2010-08-01T00:00:00,Brain Mapping,E01.370.350.086
20571434,2010-08-01T00:00:00,Brain Mapping,E01.370.376.149
20571434,2010-08-01T00:00:00,Brain Mapping,E05.132
20571434,2010-08-01T00:00:00,Corpus Striatum,A08.186.211.730.885.287.249.487
20571434,2010-08-01T00:00:00,Cues,F02.463.425.234
20571434,2010-08-01T00:00:00,Dopamine,D02.092.211.215.311.342
20571434,2010-08-01T00:00:00,Dopamine,D02.092.311.342
20571434,2010-08-01T00:00:00,Double-Blind Method,E05.318.780.300
20571434,2010-08-01T00:00:00,Double-Blind Method,E05.581.500.300
20571434,2010-08-01T00:00:00,Double-Blind Method,N05.715.360.780.320
20571434,2010-08-01T00:00:00,Double-Blind Method,N06.850.520.445.300
20571434,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20571434,2010-08-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20571434,2010-08-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20571434,2010-08-01T00:00:00,Piperazines,D03.383.606
20571434,2010-08-01T00:00:00,Quinolones,D03.438.810.835
20571434,2010-08-01T00:00:00,Young Adult,M01.060.116.815
20602431,2010-08-01T00:00:00,"Adaptation, Psychological",F01.058
20602431,2010-08-01T00:00:00,Adolescent,M01.060.057
20602431,2010-08-01T00:00:00,Alcoholic Intoxication,C21.739.100.175
20602431,2010-08-01T00:00:00,Alcoholic Intoxication,F03.900.100.300
20602431,2010-08-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
20602431,2010-08-01T00:00:00,Health Surveys,E05.318.308.250
20602431,2010-08-01T00:00:00,Health Surveys,N05.715.360.300.375
20602431,2010-08-01T00:00:00,Health Surveys,N06.850.520.308.250
20602431,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20602431,2010-08-01T00:00:00,Incidence,E05.318.308.985.525.375
20602431,2010-08-01T00:00:00,Incidence,L01.280.975.525.375
20602431,2010-08-01T00:00:00,Incidence,N01.224.935.597.500
20602431,2010-08-01T00:00:00,Incidence,N06.850.505.400.975.525.375
20602431,2010-08-01T00:00:00,Incidence,N06.850.520.308.985.525.375
20602431,2010-08-01T00:00:00,Rape,I01.198.240.748.640
20602431,2010-08-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
20602431,2010-08-01T00:00:00,Substance-Related Disorders,C21.739
20602431,2010-08-01T00:00:00,Substance-Related Disorders,F03.900
20602431,2010-08-01T00:00:00,United States,Z01.107.567.875
20602431,2010-08-01T00:00:00,Violence,I01.198.240.856
20602431,2010-08-01T00:00:00,Violence,I01.880.735.900
20602431,2010-08-01T00:00:00,Young Adult,M01.060.116.815
20628317,2010-08-01T00:00:00,Adolescent,M01.060.057
20628317,2010-08-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
20628317,2010-08-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
20628317,2010-08-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
20628317,2010-08-01T00:00:00,"Child, Preschool",M01.060.406.448
20628317,2010-08-01T00:00:00,Combined Modality Therapy,E02.186
20628317,2010-08-01T00:00:00,Hematopoietic Stem Cell Transplantation,E04.936.225.687.500
20628317,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20628317,2010-08-01T00:00:00,Kidney Neoplasms,C04.588.945.947.535
20628317,2010-08-01T00:00:00,Kidney Neoplasms,C12.758.820.750
20628317,2010-08-01T00:00:00,Kidney Neoplasms,C12.777.419.473
20628317,2010-08-01T00:00:00,Kidney Neoplasms,C13.351.937.820.535
20628317,2010-08-01T00:00:00,Kidney Neoplasms,C13.351.968.419.473
20628317,2010-08-01T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
20628317,2010-08-01T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
20628317,2010-08-01T00:00:00,Salvage Therapy,E02.186.800
20628317,2010-08-01T00:00:00,Salvage Therapy,E02.895
20628317,2010-08-01T00:00:00,Wilms Tumor,C04.557.435.595
20628317,2010-08-01T00:00:00,Wilms Tumor,C04.588.945.947.535.585
20628317,2010-08-01T00:00:00,Wilms Tumor,C04.700.635
20628317,2010-08-01T00:00:00,Wilms Tumor,C12.758.820.750.585
20628317,2010-08-01T00:00:00,Wilms Tumor,C12.777.419.473.585
20628317,2010-08-01T00:00:00,Wilms Tumor,C13.351.937.820.535.585
20628317,2010-08-01T00:00:00,Wilms Tumor,C13.351.968.419.473.585
20628317,2010-08-01T00:00:00,Wilms Tumor,C16.320.700.642
20629574,2010-08-01T00:00:00,Aged,M01.060.116.100
20629574,2010-08-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
20629574,2010-08-01T00:00:00,Body Mass Index,E05.041.124.125
20629574,2010-08-01T00:00:00,Body Mass Index,G07.100.100.125
20629574,2010-08-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
20629574,2010-08-01T00:00:00,Ethnic Groups,M01.686.754
20629574,2010-08-01T00:00:00,Ethnic Groups,N01.224.317
20629574,2010-08-01T00:00:00,Health Status,I01.240.425
20629574,2010-08-01T00:00:00,Health Status,N01.224.425
20629574,2010-08-01T00:00:00,Health Status,N06.850.505.400.425
20629574,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20629574,2010-08-01T00:00:00,Middle Aged,M01.060.116.630
20629574,2010-08-01T00:00:00,Obesity,C18.654.726.500
20629574,2010-08-01T00:00:00,Obesity,C23.888.144.699.500
20629574,2010-08-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
20629574,2010-08-01T00:00:00,Obesity,G07.100.100.160.120.699.500
20629574,2010-08-01T00:00:00,Overweight,C23.888.144.699
20629574,2010-08-01T00:00:00,Overweight,E01.370.600.115.100.160.120.699
20629574,2010-08-01T00:00:00,Overweight,G07.100.100.160.120.699
20629574,2010-08-01T00:00:00,Quality of Life,I01.800
20629574,2010-08-01T00:00:00,Quality of Life,K01.752.400.750
20629574,2010-08-01T00:00:00,Regression Analysis,E05.318.740.750
20629574,2010-08-01T00:00:00,Regression Analysis,N05.715.360.750.695
20629574,2010-08-01T00:00:00,Regression Analysis,N06.850.520.830.750
20629574,2010-08-01T00:00:00,United States,Z01.107.567.875
20629574,2010-08-01T00:00:00,Weight Gain,C23.888.144.243.926
20629574,2010-08-01T00:00:00,Weight Gain,G07.700.320.249.314.120.200.926
20632416,2010-08-01T00:00:00,Diffusion,G01.595.200
20632416,2010-08-01T00:00:00,Diffusion,G02.149.767.560
20632416,2010-08-01T00:00:00,Diffusion,G02.842.750.560
20632416,2010-08-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
20632416,2010-08-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
20632416,2010-08-01T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
20632416,2010-08-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
20632416,2010-08-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20632416,2010-08-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20632416,2010-08-01T00:00:00,"Models, Theoretical",E05.599
20632416,2010-08-01T00:00:00,Water,D01.455.900
20632416,2010-08-01T00:00:00,Water,D01.650.550.925
20637918,2010-08-01T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
20637918,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20637918,2010-08-01T00:00:00,Neoplasm Invasiveness,C04.697.645
20637918,2010-08-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
20637918,2010-08-01T00:00:00,Stents,E07.695.750
20637918,2010-08-01T00:00:00,Surgical Flaps,A10.850.710
20637918,2010-08-01T00:00:00,Surgical Flaps,E07.862.710
20637918,2010-08-01T00:00:00,Thoracic Surgical Procedures,E04.928
20637918,2010-08-01T00:00:00,Time Factors,G01.910.857
20637918,2010-08-01T00:00:00,Trachea,A04.889
20637918,2010-08-01T00:00:00,Treatment Outcome,E01.789.800
20637918,2010-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20637918,2010-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20647121,2010-08-01T00:00:00,"Child, Preschool",M01.060.406.448
20647121,2010-08-01T00:00:00,Deglutition Disorders,C06.405.117.119
20647121,2010-08-01T00:00:00,Deglutition Disorders,C09.775.174
20647121,2010-08-01T00:00:00,Gastrostomy,E04.210.496
20647121,2010-08-01T00:00:00,Gastrostomy,E04.579.408
20647121,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20647121,2010-08-01T00:00:00,Infant,M01.060.703
20647121,2010-08-01T00:00:00,Laryngostenosis,C08.360.591
20647121,2010-08-01T00:00:00,Laryngostenosis,C09.400.591
20647121,2010-08-01T00:00:00,Laryngostenosis,C16.131.740.658
20647121,2010-08-01T00:00:00,"Pneumonia, Aspiration",C08.381.677.529
20647121,2010-08-01T00:00:00,"Pneumonia, Aspiration",C08.730.610.529
20647121,2010-08-01T00:00:00,Postoperative Complications,C23.550.767
20647121,2010-08-01T00:00:00,Reconstructive Surgical Procedures,E04.680
20647121,2010-08-01T00:00:00,Tracheal Stenosis,C08.907.663
20647121,2010-08-01T00:00:00,Tracheotomy,E04.580.907
20647121,2010-08-01T00:00:00,Tracheotomy,E04.928.790
20647121,2010-08-01T00:00:00,Treatment Outcome,E01.789.800
20647121,2010-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20647121,2010-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20647121,2010-08-01T00:00:00,Weight Gain,C23.888.144.243.926
20647121,2010-08-01T00:00:00,Weight Gain,G07.700.320.249.314.120.200.926
20648593,2010-08-01T00:00:00,Diagnostic Imaging,E01.370.350
20648593,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20648593,2010-08-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
20648593,2010-08-01T00:00:00,Lung Neoplasms,C08.381.540
20648593,2010-08-01T00:00:00,Lung Neoplasms,C08.785.520
20648593,2010-08-01T00:00:00,Lymph Node Excision,E04.446
20648593,2010-08-01T00:00:00,Melanoma,C04.557.465.625.650.510
20648593,2010-08-01T00:00:00,Melanoma,C04.557.580.625.650.510
20648593,2010-08-01T00:00:00,Melanoma,C04.557.665.510
20648593,2010-08-01T00:00:00,Neoplasms,C04
20648593,2010-08-01T00:00:00,Patient Selection,E05.581.500.653
20648593,2010-08-01T00:00:00,Patient Selection,N04.590.731
20648593,2010-08-01T00:00:00,Pneumonectomy,E04.928.600.600
20648593,2010-08-01T00:00:00,Sarcoma,C04.557.450.795
20649874,2010-08-01T00:00:00,Adult,M01.060.116
20649874,2010-08-01T00:00:00,Biological Markers,D23.101
20649874,2010-08-01T00:00:00,Chronic Disease,C23.550.291.500
20649874,2010-08-01T00:00:00,Creatinine,D03.383.129.308.207
20649874,2010-08-01T00:00:00,Hemorrhage,C23.550.414
20649874,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20649874,2010-08-01T00:00:00,Kidney,A05.810.453
20649874,2010-08-01T00:00:00,Kidney Diseases,C12.777.419
20649874,2010-08-01T00:00:00,Kidney Diseases,C13.351.968.419
20649874,2010-08-01T00:00:00,Middle Aged,M01.060.116.630
20649874,2010-08-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
20649874,2010-08-01T00:00:00,Risk Assessment,N04.452.871.715
20649874,2010-08-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20649874,2010-08-01T00:00:00,Risk Assessment,N06.850.505.715
20649874,2010-08-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20649874,2010-08-01T00:00:00,South Carolina,Z01.107.567.875.075.662
20649874,2010-08-01T00:00:00,South Carolina,Z01.107.567.875.750.700
20649874,2010-08-01T00:00:00,Time Factors,G01.910.857
20650877,2010-08-01T00:00:00,Adolescent,M01.060.057
20650877,2010-08-01T00:00:00,Adult,M01.060.116
20650877,2010-08-01T00:00:00,"Antibodies, Antinuclear",D12.776.124.486.485.114.323.204
20650877,2010-08-01T00:00:00,"Antibodies, Antinuclear",D12.776.124.790.651.114.323.204
20650877,2010-08-01T00:00:00,"Antibodies, Antinuclear",D12.776.377.715.548.114.323.204
20650877,2010-08-01T00:00:00,Child,M01.060.406
20650877,2010-08-01T00:00:00,DNA,D13.444.308
20650877,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20650877,2010-08-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
20650877,2010-08-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
20650877,2010-08-01T00:00:00,Lupus Nephritis,C12.777.419.570.363.680
20650877,2010-08-01T00:00:00,Lupus Nephritis,C13.351.968.419.570.363.680
20650877,2010-08-01T00:00:00,Lupus Nephritis,C17.300.480.680
20650877,2010-08-01T00:00:00,Lupus Nephritis,C20.111.590.560
20650877,2010-08-01T00:00:00,Mesenchymal Stem Cell Transplantation,E04.936.225.687.625
20650877,2010-08-01T00:00:00,"T-Lymphocytes, Regulatory",A11.118.637.555.567.569.200.700
20650877,2010-08-01T00:00:00,"T-Lymphocytes, Regulatory",A15.145.229.637.555.567.569.200.700
20650877,2010-08-01T00:00:00,"T-Lymphocytes, Regulatory",A15.382.490.555.567.569.200.700
20650877,2010-08-01T00:00:00,Treatment Outcome,E01.789.800
20650877,2010-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20650877,2010-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20650877,2010-08-01T00:00:00,Young Adult,M01.060.116.815
20651257,2010-08-01T00:00:00,Adolescent,M01.060.057
20651257,2010-08-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
20651257,2010-08-01T00:00:00,Body Mass Index,E05.041.124.125
20651257,2010-08-01T00:00:00,Body Mass Index,G07.100.100.125
20651257,2010-08-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
20651257,2010-08-01T00:00:00,Body Weight,C23.888.144
20651257,2010-08-01T00:00:00,Body Weight,E01.370.600.115.100.160.120
20651257,2010-08-01T00:00:00,Body Weight,E05.041.124.160.750
20651257,2010-08-01T00:00:00,Body Weight,G07.100.100.160.120
20651257,2010-08-01T00:00:00,Body Weight,G07.700.320.249.314.120
20651257,2010-08-01T00:00:00,Child,M01.060.406
20651257,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20651257,2010-08-01T00:00:00,Obesity,C18.654.726.500
20651257,2010-08-01T00:00:00,Obesity,C23.888.144.699.500
20651257,2010-08-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
20651257,2010-08-01T00:00:00,Obesity,G07.100.100.160.120.699.500
20651257,2010-08-01T00:00:00,South Carolina,Z01.107.567.875.075.662
20651257,2010-08-01T00:00:00,South Carolina,Z01.107.567.875.750.700
20651257,2010-08-01T00:00:00,United States,Z01.107.567.875
20656169,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20656169,2010-08-01T00:00:00,Hyperopia,C11.744.479
20656169,2010-08-01T00:00:00,Intraocular Pressure,G14.440
20656169,2010-08-01T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
20656169,2010-08-01T00:00:00,"Lens, Crystalline",A09.371.060.500
20656169,2010-08-01T00:00:00,Treatment Outcome,E01.789.800
20656169,2010-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20656169,2010-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20656169,2010-08-01T00:00:00,Visual Acuity,E01.370.380.850.950
20656169,2010-08-01T00:00:00,Visual Acuity,F02.463.593.932.901
20656169,2010-08-01T00:00:00,Visual Acuity,G14.940
20656169,2010-08-01T00:00:00,Young Adult,M01.060.116.815
20657340,2010-08-01T00:00:00,Adolescent,M01.060.057
20657340,2010-08-01T00:00:00,"Catheterization, Central Venous",E02.148.167
20657340,2010-08-01T00:00:00,Child,M01.060.406
20657340,2010-08-01T00:00:00,"Child, Preschool",M01.060.406.448
20657340,2010-08-01T00:00:00,Critical Illness,C23.550.291.625
20657340,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20657340,2010-08-01T00:00:00,Infant,M01.060.703
20657340,2010-08-01T00:00:00,"Infant, Newborn",M01.060.703.520
20657340,2010-08-01T00:00:00,"Intensive Care Units, Pediatric",N02.278.388.493.390
20657340,2010-08-01T00:00:00,Treatment Outcome,E01.789.800
20657340,2010-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20657340,2010-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20657340,2010-08-01T00:00:00,Young Adult,M01.060.116.815
20658594,2010-08-01T00:00:00,Adult,M01.060.116
20658594,2010-08-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
20658594,2010-08-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
20658594,2010-08-01T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
20658594,2010-08-01T00:00:00,Azathioprine,D02.886.759.111
20658594,2010-08-01T00:00:00,Azathioprine,D03.438.759.534.090
20658594,2010-08-01T00:00:00,Azathioprine,D13.570.900.111
20658594,2010-08-01T00:00:00,"Diagnosis, Differential",E01.171
20658594,2010-08-01T00:00:00,Gingival Diseases,C07.465.714.258
20658594,2010-08-01T00:00:00,"Hepatitis, Autoimmune",C06.552.380.350.050
20658594,2010-08-01T00:00:00,"Hepatitis, Autoimmune",C20.111.567
20658594,2010-08-01T00:00:00,"Herpesvirus 4, Human",B04.280.382.400.500.450
20658594,2010-08-01T00:00:00,"Herpesvirus 4, Human",B04.909.204.210.400.500.400
20658594,2010-08-01T00:00:00,"Herpesvirus 4, Human",B04.909.204.382.400.500.400
20658594,2010-08-01T00:00:00,"Herpesvirus 4, Human",B04.909.574.204.500.500.400
20658594,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20658594,2010-08-01T00:00:00,Iatrogenic Disease,C23.550.291.875
20658594,2010-08-01T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
20658594,2010-08-01T00:00:00,Prednisone,D04.808.745.432.719.702
20658594,2010-08-01T00:00:00,Remission Induction,E02.860
20658810,2010-08-01T00:00:00,Adolescent,M01.060.057
20658810,2010-08-01T00:00:00,Child,M01.060.406
20658810,2010-08-01T00:00:00,Community Mental Health Services,F04.408.307
20658810,2010-08-01T00:00:00,Community Mental Health Services,N02.421.143.183
20658810,2010-08-01T00:00:00,Community Mental Health Services,N02.421.461.232
20658810,2010-08-01T00:00:00,Evidence-Based Medicine,H02.249.750
20658810,2010-08-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
20658810,2010-08-01T00:00:00,Family Therapy,F04.754.864.581.273
20658810,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20658810,2010-08-01T00:00:00,Juvenile Delinquency,I01.880.735.479
20658810,2010-08-01T00:00:00,Mental Disorders,F03
20658810,2010-08-01T00:00:00,Rural Population,N01.600.725
20659224,2010-08-01T00:00:00,Adolescent,M01.060.057
20659224,2010-08-01T00:00:00,Adult,M01.060.116
20659224,2010-08-01T00:00:00,Bariatric Surgery,E02.065.062
20659224,2010-08-01T00:00:00,Bariatric Surgery,E04.062
20659224,2010-08-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
20659224,2010-08-01T00:00:00,Body Mass Index,E05.041.124.125
20659224,2010-08-01T00:00:00,Body Mass Index,G07.100.100.125
20659224,2010-08-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
20659224,2010-08-01T00:00:00,Feeding Behavior,F01.145.113.547
20659224,2010-08-01T00:00:00,Feeding Behavior,F01.145.407
20659224,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20659224,2010-08-01T00:00:00,Obesity,C18.654.726.500
20659224,2010-08-01T00:00:00,Obesity,C23.888.144.699.500
20659224,2010-08-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
20659224,2010-08-01T00:00:00,Obesity,G07.100.100.160.120.699.500
20659224,2010-08-01T00:00:00,Patient Selection,E05.581.500.653
20659224,2010-08-01T00:00:00,Patient Selection,N04.590.731
20659224,2010-08-01T00:00:00,Quality of Life,I01.800
20659224,2010-08-01T00:00:00,Quality of Life,K01.752.400.750
20659224,2010-08-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
20659224,2010-08-01T00:00:00,Risk Assessment,N04.452.871.715
20659224,2010-08-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20659224,2010-08-01T00:00:00,Risk Assessment,N06.850.505.715
20659224,2010-08-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20659224,2010-08-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20659224,2010-08-01T00:00:00,Risk Factors,N05.715.350.200.700
20659224,2010-08-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20659224,2010-08-01T00:00:00,Risk Factors,N06.850.490.625.750
20659224,2010-08-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20659224,2010-08-01T00:00:00,Time Factors,G01.910.857
20659224,2010-08-01T00:00:00,Treatment Outcome,E01.789.800
20659224,2010-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20659224,2010-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20659224,2010-08-01T00:00:00,Weight Loss,C23.888.144.243.963
20659224,2010-08-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
20659224,2010-08-01T00:00:00,Young Adult,M01.060.116.815
20664404,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20664404,2010-08-01T00:00:00,Pelvic Inflammatory Disease,C01.539.635.500
20664404,2010-08-01T00:00:00,Pelvic Inflammatory Disease,C13.351.500.056.750
20675678,2010-08-01T00:00:00,Aircraft,J01.937.285.100
20675678,2010-08-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
20675678,2010-08-01T00:00:00,Bronchoscopy,E01.370.386.105
20675678,2010-08-01T00:00:00,Bronchoscopy,E01.370.388.250.100
20675678,2010-08-01T00:00:00,Bronchoscopy,E04.800.250.100
20675678,2010-08-01T00:00:00,Bronchoscopy,E04.928.600.080
20675678,2010-08-01T00:00:00,Cystic Fibrosis,C06.689.202
20675678,2010-08-01T00:00:00,Cystic Fibrosis,C08.381.187
20675678,2010-08-01T00:00:00,Cystic Fibrosis,C16.320.190
20675678,2010-08-01T00:00:00,Cystic Fibrosis,C16.614.213
20675678,2010-08-01T00:00:00,Decision Making,F02.463.785.373
20675678,2010-08-01T00:00:00,Delphi Technique,L01.280.800.310
20675678,2010-08-01T00:00:00,"Embolization, Therapeutic",E02.520.360
20675678,2010-08-01T00:00:00,Hemoptysis,C08.381.348
20675678,2010-08-01T00:00:00,Hemoptysis,C23.550.414.896
20675678,2010-08-01T00:00:00,Hemoptysis,C23.888.852.430
20675678,2010-08-01T00:00:00,Hospitalization,E02.760.400
20675678,2010-08-01T00:00:00,Hospitalization,N02.421.585.400
20675678,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20675678,2010-08-01T00:00:00,Lung,A04.411
20675678,2010-08-01T00:00:00,Lung Transplantation,E04.928.600.495
20675678,2010-08-01T00:00:00,Lung Transplantation,E04.936.450.495
20675678,2010-08-01T00:00:00,Patient Selection,E05.581.500.653
20675678,2010-08-01T00:00:00,Patient Selection,N04.590.731
20675678,2010-08-01T00:00:00,Pneumothorax,C08.528.778
20675678,2010-08-01T00:00:00,"Saline Solution, Hypertonic",D26.776.314.890
20675678,2010-08-01T00:00:00,Travel,I03.883
20683283,2010-08-01T00:00:00,Adult,M01.060.116
20683283,2010-08-01T00:00:00,Aged,M01.060.116.100
20683283,2010-08-01T00:00:00,Alveolar Ridge Augmentation,E04.545.550.100
20683283,2010-08-01T00:00:00,Alveolar Ridge Augmentation,E06.645.550.100
20683283,2010-08-01T00:00:00,Anticoagulants,D27.505.954.502.119
20683283,2010-08-01T00:00:00,Bone Screws,E07.695.130
20683283,2010-08-01T00:00:00,Bone Screws,E07.858.442.660.115
20683283,2010-08-01T00:00:00,Bone Screws,E07.858.690.650.115
20683283,2010-08-01T00:00:00,Bone Transplantation,E04.555.130
20683283,2010-08-01T00:00:00,Bone Transplantation,E04.936.450.050
20683283,2010-08-01T00:00:00,Dental Implants,D25.339.312
20683283,2010-08-01T00:00:00,Dental Implants,E06.780.345.593
20683283,2010-08-01T00:00:00,Dental Implants,E07.695.185
20683283,2010-08-01T00:00:00,Dental Implants,J01.637.051.339.312
20683283,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20683283,2010-08-01T00:00:00,Maxilla,A02.835.232.781.324.502.645
20683283,2010-08-01T00:00:00,Maxilla,A14.521.645
20683283,2010-08-01T00:00:00,"Membranes, Artificial",D25.479
20683283,2010-08-01T00:00:00,"Membranes, Artificial",J01.637.051.479
20683283,2010-08-01T00:00:00,"Membranes, Artificial",J01.637.087.500
20683283,2010-08-01T00:00:00,Middle Aged,M01.060.116.630
20683283,2010-08-01T00:00:00,Recombinant Proteins,D12.776.828
20683283,2010-08-01T00:00:00,Surgical Flaps,A10.850.710
20683283,2010-08-01T00:00:00,Surgical Flaps,E07.862.710
20683283,2010-08-01T00:00:00,Treatment Outcome,E01.789.800
20683283,2010-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20683283,2010-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20683283,2010-08-01T00:00:00,Wound Healing,G16.100.856.891
20684056,2010-08-01T00:00:00,Adult,M01.060.116
20684056,2010-08-01T00:00:00,Aged,M01.060.116.100
20684056,2010-08-01T00:00:00,Cerebrospinal Fluid Otorrhea,C10.597.230
20684056,2010-08-01T00:00:00,Cerebrospinal Fluid Otorrhea,C10.900.300.131
20684056,2010-08-01T00:00:00,Cerebrospinal Fluid Otorrhea,C21.866.260.177
20684056,2010-08-01T00:00:00,Cerebrospinal Fluid Otorrhea,C21.866.915.300.250
20684056,2010-08-01T00:00:00,Cerebrospinal Fluid Otorrhea,C23.888.592.230
20684056,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20684056,2010-08-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20684056,2010-08-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20684056,2010-08-01T00:00:00,Meningocele,C10.500.680.598
20684056,2010-08-01T00:00:00,Meningocele,C16.131.666.680.598
20684056,2010-08-01T00:00:00,Middle Aged,M01.060.116.630
20684056,2010-08-01T00:00:00,Otologic Surgical Procedures,E04.580.450
20684056,2010-08-01T00:00:00,Temporal Bone,A02.835.232.781.885
20684056,2010-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20684056,2010-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20684056,2010-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20684056,2010-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20684056,2010-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20684058,2010-08-01T00:00:00,Auditory Threshold,F02.463.593.071.173
20684058,2010-08-01T00:00:00,Auditory Threshold,F02.463.593.710.190
20684058,2010-08-01T00:00:00,Child,M01.060.406
20684058,2010-08-01T00:00:00,Ear Canal,A09.246.272.396
20684058,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20684058,2010-08-01T00:00:00,Otologic Surgical Procedures,E04.580.450
20684058,2010-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20684058,2010-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20684058,2010-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20684058,2010-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20684058,2010-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20684058,2010-08-01T00:00:00,Treatment Outcome,E01.789.800
20684058,2010-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20684058,2010-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20684898,2010-08-01T00:00:00,Academic Medical Centers,N02.278.020
20684898,2010-08-01T00:00:00,Adult,M01.060.116
20684898,2010-08-01T00:00:00,Aged,M01.060.116.100
20684898,2010-08-01T00:00:00,Depressive Disorder,F03.600.300
20684898,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20684898,2010-08-01T00:00:00,Middle Aged,M01.060.116.630
20684898,2010-08-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
20684898,2010-08-01T00:00:00,Spinal Cord Injuries,C10.900.850
20684898,2010-08-01T00:00:00,Spinal Cord Injuries,C21.866.819
20684898,2010-08-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
20684898,2010-08-01T00:00:00,Time Factors,G01.910.857
20684902,2010-08-01T00:00:00,Adult,M01.060.116
20684902,2010-08-01T00:00:00,Depressive Disorder,F03.600.300
20684902,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20684902,2010-08-01T00:00:00,Middle Aged,M01.060.116.630
20684902,2010-08-01T00:00:00,Physical Therapy Modalities,E02.779
20684902,2010-08-01T00:00:00,Psychometrics,F04.711.780
20684902,2010-08-01T00:00:00,Questionnaires,E05.318.308.750
20684902,2010-08-01T00:00:00,Questionnaires,L01.280.800
20684902,2010-08-01T00:00:00,Questionnaires,N05.715.360.300.695
20684902,2010-08-01T00:00:00,Questionnaires,N06.850.520.308.750
20684902,2010-08-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
20684902,2010-08-01T00:00:00,Spinal Cord Injuries,C10.900.850
20684902,2010-08-01T00:00:00,Spinal Cord Injuries,C21.866.819
20684902,2010-08-01T00:00:00,Time Factors,G01.910.857
20690195,2010-08-01T00:00:00,Activities of Daily Living,E02.831.067
20690195,2010-08-01T00:00:00,Activities of Daily Living,I03.050
20690195,2010-08-01T00:00:00,Activities of Daily Living,N02.421.784.110
20690195,2010-08-01T00:00:00,Aged,M01.060.116.100
20690195,2010-08-01T00:00:00,Attitude to Health,F01.100.150
20690195,2010-08-01T00:00:00,Attitude to Health,N05.300.150
20690195,2010-08-01T00:00:00,Disability Evaluation,E01.370.400
20690195,2010-08-01T00:00:00,Elder Abuse,I01.198.240.856.350.390
20690195,2010-08-01T00:00:00,Elder Abuse,I01.880.735.900.350.390
20690195,2010-08-01T00:00:00,Geriatric Assessment,E05.318.308.225
20690195,2010-08-01T00:00:00,Geriatric Assessment,I01.240.425.350
20690195,2010-08-01T00:00:00,Geriatric Assessment,L01.280.360
20690195,2010-08-01T00:00:00,Geriatric Assessment,N01.224.425.350
20690195,2010-08-01T00:00:00,Geriatric Assessment,N05.715.360.300.360
20690195,2010-08-01T00:00:00,Geriatric Assessment,N06.850.505.400.425.350
20690195,2010-08-01T00:00:00,Geriatric Assessment,N06.850.520.308.225
20690195,2010-08-01T00:00:00,Health Surveys,E05.318.308.250
20690195,2010-08-01T00:00:00,Health Surveys,N05.715.360.300.375
20690195,2010-08-01T00:00:00,Health Surveys,N06.850.520.308.250
20690195,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20690195,2010-08-01T00:00:00,Middle Aged,M01.060.116.630
20690195,2010-08-01T00:00:00,Rural Population,N01.600.725
20690195,2010-08-01T00:00:00,Sex Offenses,I01.198.240.748
20690195,2010-08-01T00:00:00,South Carolina,Z01.107.567.875.075.662
20690195,2010-08-01T00:00:00,South Carolina,Z01.107.567.875.750.700
20690195,2010-08-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
20695941,2010-08-01T00:00:00,Cardiovascular Diseases,C14
20695941,2010-08-01T00:00:00,Chronic Disease,C23.550.291.500
20695941,2010-08-01T00:00:00,Guidelines as Topic,N04.761.700.350
20695941,2010-08-01T00:00:00,Guidelines as Topic,N05.700.350
20695941,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20695941,2010-08-01T00:00:00,Kidney Diseases,C12.777.419
20695941,2010-08-01T00:00:00,Kidney Diseases,C13.351.968.419
20695941,2010-08-01T00:00:00,Proteinuria,C12.777.934.734
20695941,2010-08-01T00:00:00,Proteinuria,C13.351.968.934.734
20695941,2010-08-01T00:00:00,Proteinuria,C23.888.942.750
20695941,2010-08-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20695941,2010-08-01T00:00:00,Risk Factors,N05.715.350.200.700
20695941,2010-08-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20695941,2010-08-01T00:00:00,Risk Factors,N06.850.490.625.750
20695941,2010-08-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20699736,2010-08-01T00:00:00,Adolescent,M01.060.057
20699736,2010-08-01T00:00:00,Adult,M01.060.116
20699736,2010-08-01T00:00:00,Brain Injuries,C10.228.140.199
20699736,2010-08-01T00:00:00,Brain Injuries,C10.900.300.087
20699736,2010-08-01T00:00:00,Brain Injuries,C21.866.260.118
20699736,2010-08-01T00:00:00,Brain Injuries,C21.866.915.300.200
20699736,2010-08-01T00:00:00,Child,M01.060.406
20699736,2010-08-01T00:00:00,"Child, Preschool",M01.060.406.448
20699736,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20699736,2010-08-01T00:00:00,Intracranial Hypertension,C10.228.140.631
20699736,2010-08-01T00:00:00,Intracranial Pressure,G11.561.170.505
20699736,2010-08-01T00:00:00,Postoperative Care,E02.760.722.700
20699736,2010-08-01T00:00:00,Postoperative Care,E04.624
20699736,2010-08-01T00:00:00,Postoperative Care,N02.421.585.722.700
20699736,2010-08-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
20699736,2010-08-01T00:00:00,Risk Assessment,N04.452.871.715
20699736,2010-08-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20699736,2010-08-01T00:00:00,Risk Assessment,N06.850.505.715
20699736,2010-08-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20699736,2010-08-01T00:00:00,Trauma Centers,N02.278.354.422.336.500
20699736,2010-08-01T00:00:00,Trauma Centers,N02.421.297.195.480
20699736,2010-08-01T00:00:00,Trauma Centers,N04.452.442.422.336.400
20699736,2010-08-01T00:00:00,Treatment Outcome,E01.789.800
20699736,2010-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20699736,2010-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20699736,2010-08-01T00:00:00,Young Adult,M01.060.116.815
20711041,2010-08-01T00:00:00,Adolescent,M01.060.057
20711041,2010-08-01T00:00:00,Angiography,E01.370.350.700.060
20711041,2010-08-01T00:00:00,Angiography,E01.370.370.050
20711041,2010-08-01T00:00:00,Cardiovascular Diseases,C14
20711041,2010-08-01T00:00:00,Child,M01.060.406
20711041,2010-08-01T00:00:00,"Child, Preschool",M01.060.406.448
20711041,2010-08-01T00:00:00,"Heart Defects, Congenital",C14.240.400
20711041,2010-08-01T00:00:00,"Heart Defects, Congenital",C14.280.400
20711041,2010-08-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
20711041,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20711041,2010-08-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
20711041,2010-08-01T00:00:00,Risk Assessment,N04.452.871.715
20711041,2010-08-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20711041,2010-08-01T00:00:00,Risk Assessment,N06.850.505.715
20711041,2010-08-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20711041,2010-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20711041,2010-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20711041,2010-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20711041,2010-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20711041,2010-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20712781,2010-08-01T00:00:00,Ferritins,D12.776.157.427.249
20712781,2010-08-01T00:00:00,Ferritins,D12.776.556.579.249
20712781,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20712781,2010-08-01T00:00:00,Iron,D01.268.556.412
20712781,2010-08-01T00:00:00,Iron,D01.268.956.287
20712781,2010-08-01T00:00:00,Iron,D01.552.544.412
20712781,2010-08-01T00:00:00,Liver,A03.620
20712781,2010-08-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20712781,2010-08-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20712781,2010-08-01T00:00:00,"Phantoms, Imaging",E07.671
20713831,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20713831,2010-08-01T00:00:00,Middle Aged,M01.060.116.630
20713838,2010-08-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
20713838,2010-08-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
20713838,2010-08-01T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
20713838,2010-08-01T00:00:00,Antineoplastic Agents,D27.505.954.248
20713838,2010-08-01T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
20713838,2010-08-01T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
20713838,2010-08-01T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
20713838,2010-08-01T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
20713838,2010-08-01T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
20713838,2010-08-01T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
20713838,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20713838,2010-08-01T00:00:00,Middle Aged,M01.060.116.630
20713838,2010-08-01T00:00:00,"Skin Diseases, Vesiculobullous",C17.800.865
20716759,2010-08-01T00:00:00,Angioplasty,E02.148.050
20716759,2010-08-01T00:00:00,Angioplasty,E04.100.814.050
20716759,2010-08-01T00:00:00,Atrial Fibrillation,C14.280.067.198
20716759,2010-08-01T00:00:00,Atrial Fibrillation,C23.550.073.198
20716759,2010-08-01T00:00:00,Catheter Ablation,E01.370.370.380.410.200
20716759,2010-08-01T00:00:00,Catheter Ablation,E02.148.110
20716759,2010-08-01T00:00:00,Catheter Ablation,E02.148.442.110
20716759,2010-08-01T00:00:00,Catheter Ablation,E02.154.402.110
20716759,2010-08-01T00:00:00,Catheter Ablation,E04.014.170.402.110
20716759,2010-08-01T00:00:00,Catheterization,E02.148
20716759,2010-08-01T00:00:00,Catheterization,E05.157
20716759,2010-08-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.350.400.200
20716759,2010-08-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.350.850.220.230
20716759,2010-08-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.370.380.220.230
20716759,2010-08-01T00:00:00,"Echocardiography, Transesophageal",E01.370.350.850.220.235
20716759,2010-08-01T00:00:00,"Echocardiography, Transesophageal",E01.370.370.380.220.235
20716759,2010-08-01T00:00:00,Hemoptysis,C08.381.348
20716759,2010-08-01T00:00:00,Hemoptysis,C23.550.414.896
20716759,2010-08-01T00:00:00,Hemoptysis,C23.888.852.430
20716759,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20716759,2010-08-01T00:00:00,Middle Aged,M01.060.116.630
20716759,2010-08-01T00:00:00,Postoperative Complications,C23.550.767
20716759,2010-08-01T00:00:00,Pulmonary Veins,A07.231.908.713
20716759,2010-08-01T00:00:00,Pulmonary Veno-Occlusive Disease,C08.381.780
20716759,2010-08-01T00:00:00,Pulmonary Veno-Occlusive Disease,C14.907.690
20716759,2010-08-01T00:00:00,Stents,E07.695.750
20725143,2010-08-01T00:00:00,Aspartic Acid Endopeptidases,D08.811.277.656.074.500
20725143,2010-08-01T00:00:00,Aspartic Acid Endopeptidases,D08.811.277.656.300.048
20725143,2010-08-01T00:00:00,Endothelin-1,D12.644.276.400.225
20725143,2010-08-01T00:00:00,Endothelin-1,D12.776.467.400.225
20725143,2010-08-01T00:00:00,Endothelin-1,D23.529.400.225
20725143,2010-08-01T00:00:00,Gene Expression,G05.355.310
20725143,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20725143,2010-08-01T00:00:00,Neoplasm Invasiveness,C04.697.645
20725143,2010-08-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
20725143,2010-08-01T00:00:00,Phosphorylation,G02.111.087.677
20725143,2010-08-01T00:00:00,Phosphorylation,G02.149.115.677
20725143,2010-08-01T00:00:00,Phosphorylation,G02.149.465.700
20725143,2010-08-01T00:00:00,Phosphorylation,G02.607.750.700
20725143,2010-08-01T00:00:00,Phosphorylation,G03.495.790
20725143,2010-08-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
20725143,2010-08-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
20725143,2010-08-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
20725143,2010-08-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
20726409,2010-08-01T00:00:00,Adult,M01.060.116
20726409,2010-08-01T00:00:00,Aged,M01.060.116.100
20726409,2010-08-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
20726409,2010-08-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
20726409,2010-08-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
20726409,2010-08-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
20726409,2010-08-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
20726409,2010-08-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
20726409,2010-08-01T00:00:00,Endosonography,E01.370.350.850.280
20726409,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20726409,2010-08-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20726409,2010-08-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20726409,2010-08-01T00:00:00,Middle Aged,M01.060.116.630
20726409,2010-08-01T00:00:00,Pancreatic Neoplasms,C04.588.274.761
20726409,2010-08-01T00:00:00,Pancreatic Neoplasms,C04.588.322.421
20726409,2010-08-01T00:00:00,Pancreatic Neoplasms,C06.301.761
20726409,2010-08-01T00:00:00,Pancreatic Neoplasms,C06.689.667
20726409,2010-08-01T00:00:00,Pancreatic Neoplasms,C19.344.421
20726409,2010-08-01T00:00:00,Preoperative Care,E02.760.795
20726409,2010-08-01T00:00:00,Preoperative Care,E04.641
20726409,2010-08-01T00:00:00,Preoperative Care,N02.421.585.795
20726409,2010-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20726409,2010-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20726409,2010-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20726409,2010-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20726409,2010-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20726419,2010-08-01T00:00:00,"Anastomosis, Surgical",E04.035
20726419,2010-08-01T00:00:00,Colon,A03.556.124.526.356
20726419,2010-08-01T00:00:00,Colon,A03.556.249.249.356
20726419,2010-08-01T00:00:00,Combined Modality Therapy,E02.186
20726419,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20726419,2010-08-01T00:00:00,Middle Aged,M01.060.116.630
20726419,2010-08-01T00:00:00,Postoperative Complications,C23.550.767
20726419,2010-08-01T00:00:00,Smoking,F01.145.466.753
20731496,2010-08-01T00:00:00,Adolescent,M01.060.057
20731496,2010-08-01T00:00:00,Adult,M01.060.116
20731496,2010-08-01T00:00:00,Child,M01.060.406
20731496,2010-08-01T00:00:00,Child Abuse,I01.198.240.856.350.250
20731496,2010-08-01T00:00:00,Child Abuse,I01.880.735.900.350.250
20731496,2010-08-01T00:00:00,Child Abuse,I01.880.787.293.292
20731496,2010-08-01T00:00:00,Community Mental Health Services,F04.408.307
20731496,2010-08-01T00:00:00,Community Mental Health Services,N02.421.143.183
20731496,2010-08-01T00:00:00,Community Mental Health Services,N02.421.461.232
20731496,2010-08-01T00:00:00,Education,I02
20731496,2010-08-01T00:00:00,Family Therapy,F04.754.864.581.273
20731496,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20731496,2010-08-01T00:00:00,Parenting,F01.829.263.370.310
20731496,2010-08-01T00:00:00,Parents,F01.829.263.500.320
20731496,2010-08-01T00:00:00,Parents,I01.880.225.500.340
20731496,2010-08-01T00:00:00,Parents,M01.620
20731496,2010-08-01T00:00:00,Social Support,I01.880.656.600
20731496,2010-08-01T00:00:00,Treatment Outcome,E01.789.800
20731496,2010-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20731496,2010-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20882537,2010-08-01T00:00:00,Diffusion,G01.595.200
20882537,2010-08-01T00:00:00,Diffusion,G02.149.767.560
20882537,2010-08-01T00:00:00,Diffusion,G02.842.750.560
20882537,2010-08-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
20882537,2010-08-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
20882537,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20882537,2010-08-01T00:00:00,"Models, Biological",E05.599.395
20882537,2010-08-01T00:00:00,Monte Carlo Method,E05.318.740.525
20882537,2010-08-01T00:00:00,Monte Carlo Method,L01.906.575.422
20882537,2010-08-01T00:00:00,Monte Carlo Method,N05.715.360.750.540
20882537,2010-08-01T00:00:00,Monte Carlo Method,N06.850.520.830.525
20882537,2010-08-01T00:00:00,Time Factors,G01.910.857
20886561,2010-08-01T00:00:00,Animals,B01.050
20886561,2010-08-01T00:00:00,Central Nervous System,A08.186
20886561,2010-08-01T00:00:00,Diffusion,G01.595.200
20886561,2010-08-01T00:00:00,Diffusion,G02.149.767.560
20886561,2010-08-01T00:00:00,Diffusion,G02.842.750.560
20886561,2010-08-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
20886561,2010-08-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
20886561,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20886561,2010-08-01T00:00:00,Water,D01.455.900
20886561,2010-08-01T00:00:00,Water,D01.650.550.925
21513622,2010-08-01T00:00:00,Abdominal Pain,C23.888.646.100
21513622,2010-08-01T00:00:00,Abdominal Pain,C23.888.821.030
21513622,2010-08-01T00:00:00,Adult,M01.060.116
21513622,2010-08-01T00:00:00,"Diagnosis, Differential",E01.171
21513622,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21513622,2010-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
21513622,2010-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
21513622,2010-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
21513622,2010-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
21513622,2010-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
21513629,2010-08-01T00:00:00,Adult,M01.060.116
21513629,2010-08-01T00:00:00,"Diagnosis, Differential",E01.171
21513629,2010-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21513629,2010-08-01T00:00:00,Pancreatectomy,E04.210.752
21513629,2010-08-01T00:00:00,Sarcoidosis,C15.604.515.827
20679253,2010-08-02T00:00:00,Animals,B01.050
20679253,2010-08-02T00:00:00,Antineoplastic Agents,D27.505.954.248
20679253,2010-08-02T00:00:00,Apoptosis,G04.299.139.160
20679253,2010-08-02T00:00:00,Brain Neoplasms,C04.588.614.250.195
20679253,2010-08-02T00:00:00,Brain Neoplasms,C10.228.140.211
20679253,2010-08-02T00:00:00,Brain Neoplasms,C10.551.240.250
20679253,2010-08-02T00:00:00,Combined Modality Therapy,E02.186
20679253,2010-08-02T00:00:00,Fenretinide,D02.455.326.271.665.202.495.270
20679253,2010-08-02T00:00:00,Fenretinide,D02.455.426.392.368.367.379.249.700.270
20679253,2010-08-02T00:00:00,Fenretinide,D02.455.849.131.495.270
20679253,2010-08-02T00:00:00,Fenretinide,D23.767.261.700.270
20679253,2010-08-02T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
20679253,2010-08-02T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
20679253,2010-08-02T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
20679253,2010-08-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20602533,2010-08-03T00:00:00,Electrolytes,D01.248
20682655,2010-08-03T00:00:00,Fas Ligand Protein,D12.644.276.374.750.249
20682655,2010-08-03T00:00:00,Fas Ligand Protein,D12.644.276.972.249
20682655,2010-08-03T00:00:00,Fas Ligand Protein,D12.776.395.550.312
20682655,2010-08-03T00:00:00,Fas Ligand Protein,D12.776.467.374.750.249
20682655,2010-08-03T00:00:00,Fas Ligand Protein,D12.776.467.972.249
20682655,2010-08-03T00:00:00,Fas Ligand Protein,D12.776.543.550.312
20682655,2010-08-03T00:00:00,Fas Ligand Protein,D23.050.301.264.035.283
20682655,2010-08-03T00:00:00,Fas Ligand Protein,D23.101.100.110.282
20682655,2010-08-03T00:00:00,Fas Ligand Protein,D23.529.374.750.249
20682655,2010-08-03T00:00:00,Fas Ligand Protein,D23.529.972.249
20682655,2010-08-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20682655,2010-08-03T00:00:00,Phosphotyrosine,D12.125.072.050.875.750
20682655,2010-08-03T00:00:00,Phosphotyrosine,D12.125.740.740
20682655,2010-08-03T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
20682655,2010-08-03T00:00:00,Pyridines,D03.383.725
20682655,2010-08-03T00:00:00,Reactive Oxygen Species,D01.339.431
20682655,2010-08-03T00:00:00,Reactive Oxygen Species,D01.650.775
20682655,2010-08-03T00:00:00,Signal Transduction,G02.111.087.800
20682655,2010-08-03T00:00:00,Signal Transduction,G02.149.115.800
20682655,2010-08-03T00:00:00,Signal Transduction,G04.299.880
20682655,2010-08-03T00:00:00,src-Family Kinases,D08.811.913.696.620.682.725.800
20685657,2010-08-04T00:00:00,Actins,D05.750.078.730.250
20685657,2010-08-04T00:00:00,Actins,D12.776.210.500.100
20685657,2010-08-04T00:00:00,Actins,D12.776.220.525.255
20685657,2010-08-04T00:00:00,Animals,B01.050
20685657,2010-08-04T00:00:00,Gene Expression Regulation,G05.355.315
20685657,2010-08-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20685657,2010-08-04T00:00:00,Interferon-gamma,D12.644.276.374.440.893
20685657,2010-08-04T00:00:00,Interferon-gamma,D12.644.276.374.480.350
20685657,2010-08-04T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
20685657,2010-08-04T00:00:00,Interferon-gamma,D12.644.276.718.550
20685657,2010-08-04T00:00:00,Interferon-gamma,D12.776.467.374.440.893
20685657,2010-08-04T00:00:00,Interferon-gamma,D12.776.467.374.480.350
20685657,2010-08-04T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
20685657,2010-08-04T00:00:00,Interferon-gamma,D12.776.467.718.550
20685657,2010-08-04T00:00:00,Interferon-gamma,D23.529.374.440.893
20685657,2010-08-04T00:00:00,Interferon-gamma,D23.529.374.480.350
20685657,2010-08-04T00:00:00,Interferon-gamma,D23.529.374.480.615.350
20685657,2010-08-04T00:00:00,Interferon-gamma,D23.529.718.550
20685657,2010-08-04T00:00:00,"Muscle, Smooth",A02.633.570
20685657,2010-08-04T00:00:00,"Muscle, Smooth",A10.690.467
20685657,2010-08-04T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
20685657,2010-08-04T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
20685657,2010-08-04T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
20685657,2010-08-04T00:00:00,"RNA, Messenger",D13.444.735.544
20685657,2010-08-04T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20685657,2010-08-04T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
20685657,2010-08-04T00:00:00,STAT1 Transcription Factor,D12.644.360.024.303.500.500
20685657,2010-08-04T00:00:00,STAT1 Transcription Factor,D12.644.360.024.342.100
20685657,2010-08-04T00:00:00,STAT1 Transcription Factor,D12.776.157.057.061.500.500
20685657,2010-08-04T00:00:00,STAT1 Transcription Factor,D12.776.157.057.186.100
20685657,2010-08-04T00:00:00,STAT1 Transcription Factor,D12.776.260.513.249.500
20685657,2010-08-04T00:00:00,STAT1 Transcription Factor,D12.776.476.024.387.500.500
20685657,2010-08-04T00:00:00,STAT1 Transcription Factor,D12.776.476.024.421.100
20685657,2010-08-04T00:00:00,STAT1 Transcription Factor,D12.776.930.354.249.500
20685657,2010-08-04T00:00:00,STAT1 Transcription Factor,D12.776.930.840.100
20685657,2010-08-04T00:00:00,Serum Response Factor,D12.776.260.400.249.875
20685657,2010-08-04T00:00:00,Serum Response Factor,D12.776.930.397.875
20685657,2010-08-04T00:00:00,Signal Transduction,G02.111.087.800
20685657,2010-08-04T00:00:00,Signal Transduction,G02.149.115.800
20685657,2010-08-04T00:00:00,Signal Transduction,G04.299.880
20691790,2010-08-04T00:00:00,Brain,A08.186.211
20691790,2010-08-04T00:00:00,Brain Mapping,E01.370.350.086
20691790,2010-08-04T00:00:00,Brain Mapping,E01.370.376.149
20691790,2010-08-04T00:00:00,Brain Mapping,E05.132
20691790,2010-08-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20691790,2010-08-04T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
20691790,2010-08-04T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20691790,2010-08-04T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20691790,2010-08-04T00:00:00,"Models, Neurological",E05.599.395.642
21386491,2010-08-04T00:00:00,Carbon,D01.268.150
21386491,2010-08-04T00:00:00,Electric Conductivity,G01.201.249.277
21386491,2010-08-04T00:00:00,Nanotubes,J01.637.512.850
21386491,2010-08-04T00:00:00,Refractometry,E05.196.808
21386491,2010-08-04T00:00:00,Refractometry,H01.671.617.755
21386491,2010-08-04T00:00:00,Surface Properties,G02.842.850
21386505,2010-08-04T00:00:00,Electric Conductivity,G01.201.249.277
21386505,2010-08-04T00:00:00,Materials Testing,E05.570
21386505,2010-08-04T00:00:00,"Nanotubes, Carbon",D01.268.150.250.500
21386505,2010-08-04T00:00:00,"Nanotubes, Carbon",J01.637.512.850.500
21386505,2010-08-04T00:00:00,Temperature,G01.906.595
21386505,2010-08-04T00:00:00,Temperature,G16.500.275.063.725.710
21386505,2010-08-04T00:00:00,Temperature,G16.500.750.775.710
21386505,2010-08-04T00:00:00,Temperature,N06.230.150.450
21386505,2010-08-04T00:00:00,Temperature,N06.230.300.100.725.710
20688804,2010-08-05T00:00:00,Adolescent,M01.060.057
20688804,2010-08-05T00:00:00,Adolescent Psychology,F04.096.628.065
20688804,2010-08-05T00:00:00,Case-Control Studies,E05.318.760.500.500
20688804,2010-08-05T00:00:00,Case-Control Studies,N05.715.360.775.175.200
20688804,2010-08-05T00:00:00,Case-Control Studies,N06.850.520.450.500.500
20688804,2010-08-05T00:00:00,Fibromyalgia,C05.651.324
20688804,2010-08-05T00:00:00,Fibromyalgia,C05.799.321
20688804,2010-08-05T00:00:00,Fibromyalgia,C10.668.491.425
20688804,2010-08-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20688804,2010-08-05T00:00:00,Interpersonal Relations,F01.829.401
20688804,2010-08-05T00:00:00,Mood Disorders,F03.600
20688804,2010-08-05T00:00:00,Pain Measurement,E01.370.376.550.600
20688804,2010-08-05T00:00:00,Self Concept,F01.752.747.792
20688804,2010-08-05T00:00:00,Social Isolation,F01.145.813.781
20688804,2010-08-05T00:00:00,Social Isolation,I01.880.683
20688804,2010-08-05T00:00:00,Syndrome,C23.550.288.500
20688804,2010-08-05T00:00:00,Young Adult,M01.060.116.815
20851268,2010-08-05T00:00:00,Adolescent,M01.060.057
20851268,2010-08-05T00:00:00,Adult,M01.060.116
20851268,2010-08-05T00:00:00,Aged,M01.060.116.100
20851268,2010-08-05T00:00:00,Depression,F01.145.126.350
20851268,2010-08-05T00:00:00,"Depressive Disorder, Major",F03.600.300.375
20851268,2010-08-05T00:00:00,Diabetes Mellitus,C18.452.394.750
20851268,2010-08-05T00:00:00,Diabetes Mellitus,C19.246
20851268,2010-08-05T00:00:00,Health Expenditures,N03.219.151.450
20851268,2010-08-05T00:00:00,Health Expenditures,N05.300.385
20851268,2010-08-05T00:00:00,Health Status,I01.240.425
20851268,2010-08-05T00:00:00,Health Status,N01.224.425
20851268,2010-08-05T00:00:00,Health Status,N06.850.505.400.425
20851268,2010-08-05T00:00:00,Health Surveys,E05.318.308.250
20851268,2010-08-05T00:00:00,Health Surveys,N05.715.360.300.375
20851268,2010-08-05T00:00:00,Health Surveys,N06.850.520.308.250
20851268,2010-08-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20851268,2010-08-05T00:00:00,Income,N01.824.417
20851268,2010-08-05T00:00:00,Middle Aged,M01.060.116.630
20851268,2010-08-05T00:00:00,United States,Z01.107.567.875
20851268,2010-08-05T00:00:00,Young Adult,M01.060.116.815
20693443,2010-08-06T00:00:00,Carbon Dioxide,D01.200.200
20693443,2010-08-06T00:00:00,Carbon Dioxide,D01.362.150
20693443,2010-08-06T00:00:00,Carbon Dioxide,D01.650.550.200
20693443,2010-08-06T00:00:00,Carbon Monoxide,D01.200.250
20693443,2010-08-06T00:00:00,Carbon Monoxide,D01.362.200
20693443,2010-08-06T00:00:00,Carbon Monoxide,D01.650.550.250
20693443,2010-08-06T00:00:00,Chlorine,D01.268.380.150
20693443,2010-08-06T00:00:00,Chlorine,D01.362.225
20693443,2010-08-06T00:00:00,Fatty Acids,D10.251
20693443,2010-08-06T00:00:00,Molecular Sequence Data,L01.453.245.667
20693443,2010-08-06T00:00:00,"Sequence Analysis, DNA",E05.393.760.700
20692641,2010-08-08T00:00:00,Adult,M01.060.116
20692641,2010-08-08T00:00:00,African Continental Ancestry Group,M01.686.508.100
20692641,2010-08-08T00:00:00,Case-Control Studies,E05.318.760.500.500
20692641,2010-08-08T00:00:00,Case-Control Studies,N05.715.360.775.175.200
20692641,2010-08-08T00:00:00,Case-Control Studies,N06.850.520.450.500.500
20692641,2010-08-08T00:00:00,European Continental Ancestry Group,M01.686.508.400
20692641,2010-08-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20692641,2010-08-08T00:00:00,Pre-Eclampsia,C13.703.395.249
20692641,2010-08-08T00:00:00,Pregnancy,G08.686.785.760.769
20692641,2010-08-08T00:00:00,Vitamin D,D04.808.812.768
20692641,2010-08-08T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
20696056,2010-08-09T00:00:00,Adult,M01.060.116
20696056,2010-08-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20696056,2010-08-09T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
20696056,2010-08-09T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
20696056,2010-08-09T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
20696056,2010-08-09T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.606.586
20696056,2010-08-09T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.619.393.522.400
20696056,2010-08-09T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.705.500.380.500
20696056,2010-08-09T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.606.586
20696056,2010-08-09T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.619.393.522.400
20696056,2010-08-09T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.705.500.380.500
20696056,2010-08-09T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.606.586
20696056,2010-08-09T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.619.393.522.400
20696056,2010-08-09T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.705.500.380.500
20696056,2010-08-09T00:00:00,Immunoglobulin Gm Allotypes,G12.500.400.586
20696056,2010-08-09T00:00:00,Membrane Proteins,D12.776.543
20696056,2010-08-09T00:00:00,Middle Aged,M01.060.116.630
20696056,2010-08-09T00:00:00,Phenotype,G05.695
20696056,2010-08-09T00:00:00,Protozoan Proteins,D12.776.820
20696056,2010-08-09T00:00:00,Young Adult,M01.060.116.815
20696956,2010-08-09T00:00:00,Aged,M01.060.116.100
20696956,2010-08-09T00:00:00,Cost of Illness,I01.137
20696956,2010-08-09T00:00:00,Cost of Illness,N03.219.151.165
20696956,2010-08-09T00:00:00,Drug Prescriptions,E02.319.307
20696956,2010-08-09T00:00:00,Drug Prescriptions,N02.421.668.778.500
20696956,2010-08-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20696956,2010-08-09T00:00:00,United States,Z01.107.567.875
20697032,2010-08-09T00:00:00,Aged,M01.060.116.100
20697032,2010-08-09T00:00:00,Hospitalization,E02.760.400
20697032,2010-08-09T00:00:00,Hospitalization,N02.421.585.400
20697032,2010-08-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20697032,2010-08-09T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
20697032,2010-08-09T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
20697032,2010-08-09T00:00:00,Middle Aged,M01.060.116.630
20697032,2010-08-09T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
20697032,2010-08-09T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
20697032,2010-08-09T00:00:00,Patient Discharge,E02.760.400.610
20697032,2010-08-09T00:00:00,Patient Discharge,N02.421.585.400.610
20697032,2010-08-09T00:00:00,Secondary Prevention,N02.421.726.825
20697032,2010-08-09T00:00:00,Secondary Prevention,N06.850.780.750
20697032,2010-08-09T00:00:00,Stroke,C10.228.140.300.775
20697032,2010-08-09T00:00:00,Stroke,C14.907.253.855
20730059,2010-08-09T00:00:00,Atrial Fibrillation,C14.280.067.198
20730059,2010-08-09T00:00:00,Atrial Fibrillation,C23.550.073.198
20730059,2010-08-09T00:00:00,Catheter Ablation,E01.370.370.380.410.200
20730059,2010-08-09T00:00:00,Catheter Ablation,E02.148.110
20730059,2010-08-09T00:00:00,Catheter Ablation,E02.148.442.110
20730059,2010-08-09T00:00:00,Catheter Ablation,E02.154.402.110
20730059,2010-08-09T00:00:00,Catheter Ablation,E04.014.170.402.110
20730059,2010-08-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20730059,2010-08-09T00:00:00,Pericardium,A07.541.795
20730059,2010-08-09T00:00:00,Pericardium,A10.615.789.470
20730059,2010-08-09T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
20730059,2010-08-09T00:00:00,Practice Guidelines as Topic,N05.700.350.650
20730059,2010-08-09T00:00:00,"Surgical Procedures, Minimally Invasive",E04.800
20697652,2010-08-10T00:00:00,Animals,B01.050
20697652,2010-08-10T00:00:00,Coloring Agents,D27.720.233
20697652,2010-08-10T00:00:00,Coloring Agents,D27.720.470.330
20697652,2010-08-10T00:00:00,Fluorescence Resonance Energy Transfer,E05.196.712.516.600.676.500
20697652,2010-08-10T00:00:00,Fluorescence Resonance Energy Transfer,G01.154.100.240.280
20697652,2010-08-10T00:00:00,Fluorescence Resonance Energy Transfer,G01.595.100.240.280
20697652,2010-08-10T00:00:00,Fluorescence Resonance Energy Transfer,G02.111.087.242.280
20697652,2010-08-10T00:00:00,Fluorescence Resonance Energy Transfer,G02.149.115.242.280
20697652,2010-08-10T00:00:00,Gold,D01.268.556.322
20697652,2010-08-10T00:00:00,Gold,D01.268.956.186
20697652,2010-08-10T00:00:00,Gold,D01.552.544.322
20697652,2010-08-10T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
20697652,2010-08-10T00:00:00,"Microscopy, Fluorescence",E05.595.458
20697652,2010-08-10T00:00:00,"Models, Chemical",E05.599.495
20697652,2010-08-10T00:00:00,"Models, Statistical",E05.318.740.500
20697652,2010-08-10T00:00:00,"Models, Statistical",E05.599.835
20697652,2010-08-10T00:00:00,"Models, Statistical",N05.715.360.750.530
20697652,2010-08-10T00:00:00,"Models, Statistical",N06.850.520.830.500
20697652,2010-08-10T00:00:00,Nanoparticles,J01.637.512.600
20697652,2010-08-10T00:00:00,Nanotechnology,H01.603
20697652,2010-08-10T00:00:00,Nanotechnology,J01.897.520.600
20697652,2010-08-10T00:00:00,Oxygen,D01.268.185.550
20697652,2010-08-10T00:00:00,Oxygen,D01.362.670
20697652,2010-08-10T00:00:00,Polymers,D05.750
20697652,2010-08-10T00:00:00,Polymers,D25.720
20697652,2010-08-10T00:00:00,Polymers,J01.637.051.720
20697652,2010-08-10T00:00:00,"Spectrometry, Fluorescence",E05.196.712.516.600.676
20697652,2010-08-10T00:00:00,"Spectrometry, Fluorescence",E05.196.867.726
20697652,2010-08-10T00:00:00,Time Factors,G01.910.857
20708079,2010-08-11T00:00:00,Animals,B01.050
20708079,2010-08-11T00:00:00,Collagen,D05.750.078.280
20708079,2010-08-11T00:00:00,Collagen,D12.776.860.300.250
20708079,2010-08-11T00:00:00,Collagen Type I,D05.750.078.280.300.100
20708079,2010-08-11T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
20708079,2010-08-11T00:00:00,Dermis,A17.815.180
20708079,2010-08-11T00:00:00,Extracellular Matrix,A11.284.295.310
20708079,2010-08-11T00:00:00,Gene Deletion,G05.355.600.800.320
20708079,2010-08-11T00:00:00,Gene Deletion,G05.365.590.762.320
20708079,2010-08-11T00:00:00,"Hernia, Abdominal",C23.300.707.374
20708079,2010-08-11T00:00:00,Osteonectin,D12.776.157.125.715
20708079,2010-08-11T00:00:00,Osteonectin,D12.776.395.600
20708079,2010-08-11T00:00:00,Phenotype,G05.695
20708079,2010-08-11T00:00:00,Procollagen,D12.776.811.690
20708079,2010-08-11T00:00:00,Procollagen,D12.776.860.300.250.600
20707790,2010-08-12T00:00:00,Aged,M01.060.116.100
20707790,2010-08-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20707790,2010-08-12T00:00:00,Muscarinic Antagonists,D27.505.519.625.120.200.500
20707790,2010-08-12T00:00:00,Muscarinic Antagonists,D27.505.696.577.120.200.500
20707790,2010-08-12T00:00:00,Patient Satisfaction,N04.452.822.360.600
20707790,2010-08-12T00:00:00,Patient Satisfaction,N05.300.150.600.630
20707790,2010-08-12T00:00:00,Patient Satisfaction,N05.715.360.600
20707790,2010-08-12T00:00:00,Quality of Life,I01.800
20707790,2010-08-12T00:00:00,Quality of Life,K01.752.400.750
20707790,2010-08-12T00:00:00,Treatment Outcome,E01.789.800
20707790,2010-08-12T00:00:00,Treatment Outcome,N04.761.559.590.800
20707790,2010-08-12T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20707790,2010-08-12T00:00:00,"Urinary Bladder, Overactive",C12.777.829.866
20707790,2010-08-12T00:00:00,"Urinary Bladder, Overactive",C13.351.968.829.813
20707790,2010-08-12T00:00:00,"Urinary Bladder, Overactive",C23.888.942.775
20708324,2010-08-12T00:00:00,Adolescent,M01.060.057
20708324,2010-08-12T00:00:00,Adult,M01.060.116
20708324,2010-08-12T00:00:00,Age Factors,N05.715.350.075
20708324,2010-08-12T00:00:00,Age Factors,N06.850.490.250
20708324,2010-08-12T00:00:00,Aged,M01.060.116.100
20708324,2010-08-12T00:00:00,Child,M01.060.406
20708324,2010-08-12T00:00:00,"Child, Preschool",M01.060.406.448
20708324,2010-08-12T00:00:00,Color,G01.201.875.770.578.199
20708324,2010-08-12T00:00:00,Color,G01.590.540.199
20708324,2010-08-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20708324,2010-08-12T00:00:00,Infant,M01.060.703
20708324,2010-08-12T00:00:00,Lip Diseases,C07.465.409
20708324,2010-08-12T00:00:00,Middle Aged,M01.060.116.630
20708324,2010-08-12T00:00:00,Mouth Diseases,C07.465
20708324,2010-08-12T00:00:00,Mouth Mucosa,A10.615.550.599
20708324,2010-08-12T00:00:00,Mouth Mucosa,A14.549.512
20708324,2010-08-12T00:00:00,Mucocele,C04.182.511
20708324,2010-08-12T00:00:00,Sex Factors,N05.715.350.675
20708324,2010-08-12T00:00:00,Sex Factors,N06.850.490.875
20708324,2010-08-12T00:00:00,South Carolina,Z01.107.567.875.075.662
20708324,2010-08-12T00:00:00,South Carolina,Z01.107.567.875.750.700
20708324,2010-08-12T00:00:00,Tongue Diseases,C07.465.910
20708324,2010-08-12T00:00:00,Young Adult,M01.060.116.815
20708636,2010-08-12T00:00:00,Animals,B01.050
20708636,2010-08-12T00:00:00,CHO Cells,A11.251.210.200
20708636,2010-08-12T00:00:00,CHO Cells,A11.436.155
20708636,2010-08-12T00:00:00,Cricetinae,B01.050.150.900.649.865.635.150
20708636,2010-08-12T00:00:00,DNA-Binding Proteins,D12.776.260
20708636,2010-08-12T00:00:00,Endonucleases,D08.811.277.352.355
20708636,2010-08-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20708636,2010-08-12T00:00:00,Mitosis,G04.299.134.220.220.781
20708636,2010-08-12T00:00:00,Mitosis,G05.355.105.220.781
20708636,2010-08-12T00:00:00,Phenotype,G05.695
20708636,2010-08-12T00:00:00,"Recombination, Genetic",G05.355.760
20709805,2010-08-13T00:00:00,Animals,B01.050
20709805,2010-08-13T00:00:00,Bacteremia,C01.252.100
20709805,2010-08-13T00:00:00,Bacteremia,C01.539.757.100
20709805,2010-08-13T00:00:00,Bacteremia,C23.550.470.790.500.100
20709805,2010-08-13T00:00:00,"Disease Models, Animal",C22.232
20709805,2010-08-13T00:00:00,"Disease Models, Animal",E05.598.500
20709805,2010-08-13T00:00:00,"Disease Models, Animal",E05.599.395.080
20709805,2010-08-13T00:00:00,Inflammation,C23.550.470
20709805,2010-08-13T00:00:00,NF-kappa B,D12.776.260.600
20709805,2010-08-13T00:00:00,NF-kappa B,D12.776.660.600
20709805,2010-08-13T00:00:00,NF-kappa B,D12.776.930.600
20709805,2010-08-13T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20709805,2010-08-13T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
20709805,2010-08-13T00:00:00,Sepsis,C01.539.757
20709805,2010-08-13T00:00:00,Sepsis,C23.550.470.790.500
20709805,2010-08-13T00:00:00,Signal Transduction,G02.111.087.800
20709805,2010-08-13T00:00:00,Signal Transduction,G02.149.115.800
20709805,2010-08-13T00:00:00,Signal Transduction,G04.299.880
20709805,2010-08-13T00:00:00,Thiazoles,D02.886.675
20709805,2010-08-13T00:00:00,Thiazoles,D03.383.129.708
20420519,2010-08-15T00:00:00,Calmodulin,D12.644.360.381.249
20420519,2010-08-15T00:00:00,Calmodulin,D12.776.157.125.412.249
20420519,2010-08-15T00:00:00,Calmodulin,D12.776.476.387.249
20420519,2010-08-15T00:00:00,Elastin,D05.750.078.421
20420519,2010-08-15T00:00:00,Elastin,D12.776.860.300.350
20420519,2010-08-15T00:00:00,Hydrogels,D20.280.320.375
20420519,2010-08-15T00:00:00,Hydrogels,D26.255.165.320.375
20420519,2010-08-15T00:00:00,Leucine Zippers,G02.111.570.790.709.600.040.520
20420519,2010-08-15T00:00:00,Peptides,D12.644
20420519,2010-08-15T00:00:00,Protein Conformation,G02.111.570.790.709
20420519,2010-08-15T00:00:00,Protein Engineering,E05.393.420.601
20575058,2010-08-15T00:00:00,Animals,B01.050
20575058,2010-08-15T00:00:00,Biological Markers,D23.101
20575058,2010-08-15T00:00:00,Cochlea,A09.246.631.246
20575058,2010-08-15T00:00:00,"Evoked Potentials, Auditory, Brain Stem",G07.265.500.370.300
20575058,2010-08-15T00:00:00,"Evoked Potentials, Auditory, Brain Stem",G11.561.270.370.300
20575058,2010-08-15T00:00:00,"Hair Cells, Auditory",A08.663.650.250
20575058,2010-08-15T00:00:00,"Hair Cells, Auditory",A08.663.650.915.750.600.350
20575058,2010-08-15T00:00:00,"Hair Cells, Auditory",A08.800.950.750.600.350
20575058,2010-08-15T00:00:00,"Hair Cells, Auditory",A09.246.631.246.577.325
20575058,2010-08-15T00:00:00,"Hair Cells, Auditory",A11.671.650.250
20575058,2010-08-15T00:00:00,"Hair Cells, Auditory",A11.671.650.915.750.600.350
20575058,2010-08-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20575058,2010-08-15T00:00:00,"Mice, Inbred Strains",B01.050.050.157.520
20575058,2010-08-15T00:00:00,"Mice, Inbred Strains",B01.050.050.199.520.520
20575058,2010-08-15T00:00:00,"Mice, Inbred Strains",B01.050.150.900.649.865.635.505.500.400
20575058,2010-08-15T00:00:00,Neuroglia,A08.637
20575058,2010-08-15T00:00:00,Neuroglia,A11.650
20575058,2010-08-15T00:00:00,Neurons,A08.663
20575058,2010-08-15T00:00:00,Neurons,A11.671
20575058,2010-08-15T00:00:00,Schwann Cells,A08.637.800
20575058,2010-08-15T00:00:00,Schwann Cells,A08.800.800.690
20575058,2010-08-15T00:00:00,Schwann Cells,A11.650.800
20575058,2010-08-15T00:00:00,Spiral Ganglion,A08.340.390.800
20575058,2010-08-15T00:00:00,Spiral Ganglion,A08.800.350.800
20575058,2010-08-15T00:00:00,Spiral Ganglion,A08.800.800.120.910.120.800
20575058,2010-08-15T00:00:00,Spiral Ganglion,A09.246.631.246.900
20589673,2010-08-15T00:00:00,Animals,B01.050
20589673,2010-08-15T00:00:00,Apoptosis,G04.299.139.160
20589673,2010-08-15T00:00:00,CHO Cells,A11.251.210.200
20589673,2010-08-15T00:00:00,CHO Cells,A11.436.155
20589673,2010-08-15T00:00:00,Cell Survival,G04.299.316
20589673,2010-08-15T00:00:00,Cricetinae,B01.050.150.900.649.865.635.150
20589673,2010-08-15T00:00:00,Green Fluorescent Proteins,D12.776.532.265
20589673,2010-08-15T00:00:00,Plasmids,G05.360.600
20623621,2010-08-15T00:00:00,Animals,B01.050
20623621,2010-08-15T00:00:00,Calpain,D08.811.277.656.262.500.120
20623621,2010-08-15T00:00:00,Calpain,D08.811.277.656.300.200.120
20623621,2010-08-15T00:00:00,Cell Death,G04.299.139
20623621,2010-08-15T00:00:00,Down-Regulation,G02.111.087.225
20623621,2010-08-15T00:00:00,Down-Regulation,G02.149.115.225
20623621,2010-08-15T00:00:00,Down-Regulation,G05.355.315.200
20623621,2010-08-15T00:00:00,Down-Regulation,G07.690.812.230
20623621,2010-08-15T00:00:00,Down-Regulation,G07.700.680.230
20623621,2010-08-15T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.114.703.300
20623621,2010-08-15T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.314.350.250
20623621,2010-08-15T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C20.111.258.625.300
20623621,2010-08-15T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",E05.598.500.500.500
20623621,2010-08-15T00:00:00,Inflammation,C23.550.470
20623621,2010-08-15T00:00:00,Multiple Sclerosis,C10.114.375.500
20623621,2010-08-15T00:00:00,Multiple Sclerosis,C10.314.350.500
20623621,2010-08-15T00:00:00,Multiple Sclerosis,C20.111.258.250.500
20623621,2010-08-15T00:00:00,Nerve Tissue Proteins,D12.776.641
20623621,2010-08-15T00:00:00,Oligodendroglia,A08.637.600
20623621,2010-08-15T00:00:00,Oligodendroglia,A11.650.600
20623621,2010-08-15T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20623621,2010-08-15T00:00:00,Spinal Cord,A08.186.854
20666474,2010-08-15T00:00:00,Environmental Monitoring,N06.850.460.350.080
20666474,2010-08-15T00:00:00,Environmental Monitoring,N06.850.780.375
20666474,2010-08-15T00:00:00,Ethylene Dichlorides,D02.455.326.146.379.350
20666474,2010-08-15T00:00:00,Ethylene Dichlorides,D02.455.526.439.458
20666474,2010-08-15T00:00:00,Geologic Sediments,G01.311.500
20666474,2010-08-15T00:00:00,Geologic Sediments,G16.500.320
20666474,2010-08-15T00:00:00,Pressure,G01.374.715
20666474,2010-08-15T00:00:00,Soil Pollutants,D27.888.284.756
20666474,2010-08-15T00:00:00,Temperature,G01.906.595
20666474,2010-08-15T00:00:00,Temperature,G16.500.275.063.725.710
20666474,2010-08-15T00:00:00,Temperature,G16.500.750.775.710
20666474,2010-08-15T00:00:00,Temperature,N06.230.150.450
20666474,2010-08-15T00:00:00,Temperature,N06.230.300.100.725.710
20704238,2010-08-15T00:00:00,Adsorption,G02.149.047
20704238,2010-08-15T00:00:00,Adsorption,G02.149.767.029
20704238,2010-08-15T00:00:00,Adsorption,G02.842.750.029
20704238,2010-08-15T00:00:00,Carbon,D01.268.150
20704238,2010-08-15T00:00:00,Charcoal,D01.268.150.150
20704238,2010-08-15T00:00:00,"Models, Chemical",E05.599.495
20704238,2010-08-15T00:00:00,"Nanotubes, Carbon",D01.268.150.250.500
20704238,2010-08-15T00:00:00,"Nanotubes, Carbon",J01.637.512.850.500
20704238,2010-08-15T00:00:00,Temperature,G01.906.595
20704238,2010-08-15T00:00:00,Temperature,G16.500.275.063.725.710
20704238,2010-08-15T00:00:00,Temperature,G16.500.750.775.710
20704238,2010-08-15T00:00:00,Temperature,N06.230.150.450
20704238,2010-08-15T00:00:00,Temperature,N06.230.300.100.725.710
20715097,2010-08-16T00:00:00,Animals,B01.050
20715097,2010-08-16T00:00:00,Apoptosis,G04.299.139.160
20715097,2010-08-16T00:00:00,Cell Differentiation,G04.299.151
20715097,2010-08-16T00:00:00,Cytochrome P-450 CYP1A1,D08.244.453.040.555
20715097,2010-08-16T00:00:00,Cytochrome P-450 CYP1A1,D08.811.682.690.708.170.040.332
20715097,2010-08-16T00:00:00,Cytochrome P-450 CYP1A1,D12.776.422.220.453.040.332
20715097,2010-08-16T00:00:00,Environmental Pollutants,D27.888.284
20715097,2010-08-16T00:00:00,Fetus,A16.378
20715097,2010-08-16T00:00:00,Gene Expression Regulation,G05.355.315
20715097,2010-08-16T00:00:00,Pregnancy,G08.686.785.760.769
20715097,2010-08-16T00:00:00,"Receptors, Aryl Hydrocarbon",D12.776.260.698.209.715
20715097,2010-08-16T00:00:00,"Receptors, Aryl Hydrocarbon",D12.776.826.209.715
20715097,2010-08-16T00:00:00,"Receptors, Aryl Hydrocarbon",D12.776.930.662
20715097,2010-08-16T00:00:00,"Receptors, Aryl Hydrocarbon",D12.776.930.669.209.715
20715097,2010-08-16T00:00:00,Stilbenes,D02.455.426.559.389.150.700
20715097,2010-08-16T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.550.500
20715097,2010-08-16T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.569.500
20715097,2010-08-16T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.550.500
20715097,2010-08-16T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.569.500
20715097,2010-08-16T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.550.500
20715097,2010-08-16T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.569.500
20715097,2010-08-16T00:00:00,Tetrachlorodibenzodioxin,D03.383.231.900
20715097,2010-08-16T00:00:00,Thymus Gland,A10.549.750
20715097,2010-08-16T00:00:00,Thymus Gland,A15.382.520.604.750
20719365,2010-08-16T00:00:00,Aged,M01.060.116.100
20719365,2010-08-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20719365,2010-08-16T00:00:00,Lymph Node Excision,E04.446
20719365,2010-08-16T00:00:00,Prostatectomy,E04.950.774.860.625
20719365,2010-08-16T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
20719365,2010-08-16T00:00:00,Prostatic Neoplasms,C12.294.260.750
20719365,2010-08-16T00:00:00,Prostatic Neoplasms,C12.294.565.625
20719365,2010-08-16T00:00:00,Prostatic Neoplasms,C12.758.409.750
20705219,2010-08-17T00:00:00,Adult,M01.060.116
20705219,2010-08-17T00:00:00,Aged,M01.060.116.100
20705219,2010-08-17T00:00:00,Coronary Artery Disease,C14.280.647.250.260
20705219,2010-08-17T00:00:00,Coronary Artery Disease,C14.907.137.126.339
20705219,2010-08-17T00:00:00,Coronary Artery Disease,C14.907.585.250.260
20705219,2010-08-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20705219,2010-08-17T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
20705219,2010-08-17T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
20705219,2010-08-17T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
20705219,2010-08-17T00:00:00,Hypercholesterolemia,C18.452.584.500.500.396
20705219,2010-08-17T00:00:00,Middle Aged,M01.060.116.630
20705219,2010-08-17T00:00:00,Risk Factors,E05.318.740.600.800.725
20705219,2010-08-17T00:00:00,Risk Factors,N05.715.350.200.700
20705219,2010-08-17T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20705219,2010-08-17T00:00:00,Risk Factors,N06.850.490.625.750
20705219,2010-08-17T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20716524,2010-08-17T00:00:00,Animals,B01.050
20716524,2010-08-17T00:00:00,Carrier Proteins,D12.776.157
20716524,2010-08-17T00:00:00,Cell Line,A11.251.210
20716524,2010-08-17T00:00:00,Cell Membrane,A11.284.149
20716524,2010-08-17T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D08.811.277.040.330.300.200.100.200
20716524,2010-08-17T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.644.360.375.100.200
20716524,2010-08-17T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.157.325.332.100.200
20716524,2010-08-17T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.476.375.100.200
20716524,2010-08-17T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.543.325.100.200
20716524,2010-08-17T00:00:00,Gene Expression Regulation,G05.355.315
20716524,2010-08-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20716524,2010-08-17T00:00:00,Membrane Proteins,D12.776.543
20716524,2010-08-17T00:00:00,"Models, Biological",E05.599.395
20716524,2010-08-17T00:00:00,Signal Transduction,G02.111.087.800
20716524,2010-08-17T00:00:00,Signal Transduction,G02.149.115.800
20716524,2010-08-17T00:00:00,Signal Transduction,G04.299.880
20719540,2010-08-17T00:00:00,Age Factors,N05.715.350.075
20719540,2010-08-17T00:00:00,Age Factors,N06.850.490.250
20719540,2010-08-17T00:00:00,Aged,M01.060.116.100
20719540,2010-08-17T00:00:00,Hospitals,N02.278.421
20719540,2010-08-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20719540,2010-08-17T00:00:00,Incidence,E05.318.308.985.525.375
20719540,2010-08-17T00:00:00,Incidence,L01.280.975.525.375
20719540,2010-08-17T00:00:00,Incidence,N01.224.935.597.500
20719540,2010-08-17T00:00:00,Incidence,N06.850.505.400.975.525.375
20719540,2010-08-17T00:00:00,Incidence,N06.850.520.308.985.525.375
20719540,2010-08-17T00:00:00,Middle Aged,M01.060.116.630
20719540,2010-08-17T00:00:00,Regression Analysis,E05.318.740.750
20719540,2010-08-17T00:00:00,Regression Analysis,N05.715.360.750.695
20719540,2010-08-17T00:00:00,Regression Analysis,N06.850.520.830.750
20719540,2010-08-17T00:00:00,Risk Assessment,E05.318.740.600.800.715
20719540,2010-08-17T00:00:00,Risk Assessment,N04.452.871.715
20719540,2010-08-17T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20719540,2010-08-17T00:00:00,Risk Assessment,N06.850.505.715
20719540,2010-08-17T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20719540,2010-08-17T00:00:00,Risk Factors,E05.318.740.600.800.725
20719540,2010-08-17T00:00:00,Risk Factors,N05.715.350.200.700
20719540,2010-08-17T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20719540,2010-08-17T00:00:00,Risk Factors,N06.850.490.625.750
20719540,2010-08-17T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20719540,2010-08-17T00:00:00,Sex Factors,N05.715.350.675
20719540,2010-08-17T00:00:00,Sex Factors,N06.850.490.875
20719540,2010-08-17T00:00:00,Stroke,C10.228.140.300.775
20719540,2010-08-17T00:00:00,Stroke,C14.907.253.855
20719540,2010-08-17T00:00:00,Time Factors,G01.910.857
20719540,2010-08-17T00:00:00,United States,Z01.107.567.875
20720112,2010-08-18T00:00:00,Adult,M01.060.116
20720112,2010-08-18T00:00:00,Aged,M01.060.116.100
20720112,2010-08-18T00:00:00,Functional Laterality,F02.830.297.425
20720112,2010-08-18T00:00:00,Functional Laterality,G11.561.225.425
20720112,2010-08-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20720112,2010-08-18T00:00:00,Magnetic Resonance Angiography,E01.370.350.500.500
20720112,2010-08-18T00:00:00,Magnetic Resonance Angiography,E01.370.350.825.500.500
20720112,2010-08-18T00:00:00,Magnetic Resonance Angiography,E01.370.370.050.500
20720112,2010-08-18T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20720112,2010-08-18T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20720112,2010-08-18T00:00:00,Middle Aged,M01.060.116.630
20720112,2010-08-18T00:00:00,"Nerve Fibers, Myelinated",A08.663.542.512
20720112,2010-08-18T00:00:00,"Nerve Fibers, Myelinated",A11.671.514
20720112,2010-08-18T00:00:00,Parietal Lobe,A08.186.211.730.885.287.500.670
20720112,2010-08-18T00:00:00,Stroke,C10.228.140.300.775
20720112,2010-08-18T00:00:00,Stroke,C14.907.253.855
20720130,2010-08-18T00:00:00,Aging,G07.700.320.124
20720130,2010-08-18T00:00:00,Animals,B01.050
20720130,2010-08-18T00:00:00,Cell Size,G04.190
20720130,2010-08-18T00:00:00,Contrast Sensitivity,E01.370.380.850.950.500
20720130,2010-08-18T00:00:00,Contrast Sensitivity,F02.463.593.932.869.435.110
20720130,2010-08-18T00:00:00,Contrast Sensitivity,F02.463.593.932.901.500
20720130,2010-08-18T00:00:00,Contrast Sensitivity,G14.940.500
20720130,2010-08-18T00:00:00,"Mice, Inbred DBA",B01.050.050.157.520.460
20720130,2010-08-18T00:00:00,"Mice, Inbred DBA",B01.050.050.199.520.520.460
20720130,2010-08-18T00:00:00,"Mice, Inbred DBA",B01.050.150.900.649.865.635.505.500.400.460
20720130,2010-08-18T00:00:00,Photic Stimulation,E05.723.729
20720130,2010-08-18T00:00:00,Retina,A09.371.729
20720130,2010-08-18T00:00:00,Retinal Rod Photoreceptor Cells,A08.663.650.850.625.670.650
20720130,2010-08-18T00:00:00,Retinal Rod Photoreceptor Cells,A08.663.650.915.937.670.650
20720130,2010-08-18T00:00:00,Retinal Rod Photoreceptor Cells,A08.800.950.937.670.650
20720130,2010-08-18T00:00:00,Retinal Rod Photoreceptor Cells,A09.371.729.831.625.670.650
20720130,2010-08-18T00:00:00,Retinal Rod Photoreceptor Cells,A11.671.650.850.625.670.650
20720130,2010-08-18T00:00:00,Retinal Rod Photoreceptor Cells,A11.671.650.915.937.670.650
20720130,2010-08-18T00:00:00,Vision Disorders,C10.597.751.941
20720130,2010-08-18T00:00:00,Vision Disorders,C11.966
20720130,2010-08-18T00:00:00,Vision Disorders,C23.888.592.763.941
20720130,2010-08-18T00:00:00,Vision Tests,E01.370.380.850
20720130,2010-08-18T00:00:00,"Vision, Ocular",F02.830.816.964
20720130,2010-08-18T00:00:00,"Vision, Ocular",G02.111.087.800.480.900
20720130,2010-08-18T00:00:00,"Vision, Ocular",G02.149.115.800.480.900
20720130,2010-08-18T00:00:00,"Vision, Ocular",G04.299.880.480.900
20720130,2010-08-18T00:00:00,"Vision, Ocular",G11.561.600.810.964
20720130,2010-08-18T00:00:00,"Vision, Ocular",G14.640.816
20724325,2010-08-19T00:00:00,Adolescent,M01.060.057
20724325,2010-08-19T00:00:00,Adrenal Cortex Hormones,D06.472.040
20724325,2010-08-19T00:00:00,Age Factors,N05.715.350.075
20724325,2010-08-19T00:00:00,Age Factors,N06.850.490.250
20724325,2010-08-19T00:00:00,Anti-Asthmatic Agents,D27.505.954.796.050
20724325,2010-08-19T00:00:00,Asthma,C08.127.108
20724325,2010-08-19T00:00:00,Asthma,C08.381.495.108
20724325,2010-08-19T00:00:00,Asthma,C08.674.095
20724325,2010-08-19T00:00:00,Asthma,C20.543.480.680.095
20724325,2010-08-19T00:00:00,Child,M01.060.406
20724325,2010-08-19T00:00:00,"Child, Preschool",M01.060.406.448
20724325,2010-08-19T00:00:00,Hospitalization,E02.760.400
20724325,2010-08-19T00:00:00,Hospitalization,N02.421.585.400
20724325,2010-08-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20724325,2010-08-19T00:00:00,Patient Education as Topic,I02.233.332.500
20724325,2010-08-19T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
20724325,2010-08-19T00:00:00,Patient Education as Topic,N02.421.726.407.680
20724325,2010-08-19T00:00:00,Sex Factors,N05.715.350.675
20724325,2010-08-19T00:00:00,Sex Factors,N06.850.490.875
20724325,2010-08-19T00:00:00,Treatment Outcome,E01.789.800
20724325,2010-08-19T00:00:00,Treatment Outcome,N04.761.559.590.800
20724325,2010-08-19T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20724709,2010-08-19T00:00:00,Aged,M01.060.116.100
20724709,2010-08-19T00:00:00,Cerebral Hemorrhage,C10.228.140.300.535.200
20724709,2010-08-19T00:00:00,Cerebral Hemorrhage,C14.907.253.573.200
20724709,2010-08-19T00:00:00,Cerebral Hemorrhage,C23.550.414.913.100
20724709,2010-08-19T00:00:00,"Databases, Factual",L01.470.750.750
20724709,2010-08-19T00:00:00,"Databases, Factual",L01.700.508.300.188.400
20724709,2010-08-19T00:00:00,Drug Prescriptions,E02.319.307
20724709,2010-08-19T00:00:00,Drug Prescriptions,N02.421.668.778.500
20724709,2010-08-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20724709,2010-08-19T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
20724709,2010-08-19T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
20724709,2010-08-19T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
20724709,2010-08-19T00:00:00,Middle Aged,M01.060.116.630
20724709,2010-08-19T00:00:00,Patient Discharge,E02.760.400.610
20724709,2010-08-19T00:00:00,Patient Discharge,N02.421.585.400.610
20724709,2010-08-19T00:00:00,Physician's Practice Patterns,N04.590.748
20724709,2010-08-19T00:00:00,Physician's Practice Patterns,N05.300.625
20724709,2010-08-19T00:00:00,Sex Factors,N05.715.350.675
20724709,2010-08-19T00:00:00,Sex Factors,N06.850.490.875
20728596,2010-08-20T00:00:00,Animals,B01.050
20728596,2010-08-20T00:00:00,Cell Line,A11.251.210
20728596,2010-08-20T00:00:00,Cell Proliferation,G04.299.233.750
20728596,2010-08-20T00:00:00,Cell Proliferation,G07.700.320.249.410.750
20728596,2010-08-20T00:00:00,Cholecalciferol,D04.808.247.222.159
20728596,2010-08-20T00:00:00,Cholecalciferol,D04.808.247.808.146
20728596,2010-08-20T00:00:00,Cholecalciferol,D04.808.812.768.196
20728596,2010-08-20T00:00:00,Cholecalciferol,D10.570.938.146
20728596,2010-08-20T00:00:00,Cytokines,D12.644.276.374
20728596,2010-08-20T00:00:00,Cytokines,D12.776.467.374
20728596,2010-08-20T00:00:00,Cytokines,D23.529.374
20728596,2010-08-20T00:00:00,Immunologic Factors,D27.505.696.477
20728596,2010-08-20T00:00:00,Lipopolysaccharides,D09.400.500
20728596,2010-08-20T00:00:00,Lipopolysaccharides,D09.698.718.450
20728596,2010-08-20T00:00:00,Lipopolysaccharides,D10.494
20728596,2010-08-20T00:00:00,Lipopolysaccharides,D23.050.161.616.525
20728596,2010-08-20T00:00:00,Lipopolysaccharides,D23.946.123.329.500
20728596,2010-08-20T00:00:00,Macrophages,A11.329.372
20728596,2010-08-20T00:00:00,Macrophages,A11.627.482
20728596,2010-08-20T00:00:00,Macrophages,A11.733.397
20728596,2010-08-20T00:00:00,Macrophages,A15.382.680.397
20728596,2010-08-20T00:00:00,Macrophages,A15.382.812.522
20728596,2010-08-20T00:00:00,NF-kappa B,D12.776.260.600
20728596,2010-08-20T00:00:00,NF-kappa B,D12.776.660.600
20728596,2010-08-20T00:00:00,NF-kappa B,D12.776.930.600
20728596,2010-08-20T00:00:00,Nitric Oxide,D01.339.387
20728596,2010-08-20T00:00:00,Nitric Oxide,D01.625.550.500
20728596,2010-08-20T00:00:00,Nitric Oxide,D01.625.700.500
20728596,2010-08-20T00:00:00,Nitric Oxide,D01.650.550.587.600
20728596,2010-08-20T00:00:00,Sitosterols,D04.808.247.222.857
20728596,2010-08-20T00:00:00,Sitosterols,D04.808.247.808.756.669
20729399,2010-08-20T00:00:00,Animals,B01.050
20729399,2010-08-20T00:00:00,Apoptosis,G04.299.139.160
20729399,2010-08-20T00:00:00,Apoptosis Regulatory Proteins,D12.644.360.075
20729399,2010-08-20T00:00:00,Apoptosis Regulatory Proteins,D12.776.476.075
20729399,2010-08-20T00:00:00,"Endothelium, Vascular",A07.231.330
20729399,2010-08-20T00:00:00,"Endothelium, Vascular",A10.272.491.355
20729399,2010-08-20T00:00:00,Membrane Proteins,D12.776.543
20729399,2010-08-20T00:00:00,"Models, Animal",E05.598
20729399,2010-08-20T00:00:00,Nerve Tissue Proteins,D12.776.641
20729399,2010-08-20T00:00:00,Nitric Oxide,D01.339.387
20729399,2010-08-20T00:00:00,Nitric Oxide,D01.625.550.500
20729399,2010-08-20T00:00:00,Nitric Oxide,D01.625.700.500
20729399,2010-08-20T00:00:00,Nitric Oxide,D01.650.550.587.600
20729399,2010-08-20T00:00:00,Nitric Oxide Synthase Type III,D08.811.682.664.500.772.750
20729399,2010-08-20T00:00:00,Oxidative Stress,G03.495.710
20729399,2010-08-20T00:00:00,Oxidative Stress,G07.700.830.750
20729399,2010-08-20T00:00:00,Proto-Oncogene Proteins,D12.776.624.664.700
20729399,2010-08-20T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
20729399,2010-08-20T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
20729399,2010-08-20T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
20729399,2010-08-20T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20729399,2010-08-20T00:00:00,Reactive Oxygen Species,D01.339.431
20729399,2010-08-20T00:00:00,Reactive Oxygen Species,D01.650.775
20729399,2010-08-20T00:00:00,Serpins,D12.644.822.750
20729399,2010-08-20T00:00:00,Serpins,D12.644.861
20729399,2010-08-20T00:00:00,Serpins,D12.776.645.750
20729399,2010-08-20T00:00:00,Serpins,D12.776.872
20729399,2010-08-20T00:00:00,Signal Transduction,G02.111.087.800
20729399,2010-08-20T00:00:00,Signal Transduction,G02.149.115.800
20729399,2010-08-20T00:00:00,Signal Transduction,G04.299.880
20729399,2010-08-20T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
20729399,2010-08-20T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
20729399,2010-08-20T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
20729399,2010-08-20T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
20729399,2010-08-20T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
20729399,2010-08-20T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
20729399,2010-08-20T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
20729399,2010-08-20T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
20729399,2010-08-20T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
20729399,2010-08-20T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
20729399,2010-08-20T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
20730861,2010-08-20T00:00:00,Animals,B01.050
20730861,2010-08-20T00:00:00,Biological Markers,D23.101
20730861,2010-08-20T00:00:00,Chick Embryo,A13.350.150
20730861,2010-08-20T00:00:00,Chick Embryo,A16.331.200
20730861,2010-08-20T00:00:00,"Embryo, Nonmammalian",A13.350
20730861,2010-08-20T00:00:00,"Embryo, Nonmammalian",A16.331
20730861,2010-08-20T00:00:00,Extracellular Matrix,A11.284.295.310
20730861,2010-08-20T00:00:00,Protein Isoforms,D12.776.800
20730861,2010-08-20T00:00:00,Versicans,D09.698.735.830.750
20730861,2010-08-20T00:00:00,Versicans,D12.776.395.650.750.750
20730861,2010-08-20T00:00:00,Versicans,D12.776.503.280.625
20730861,2010-08-20T00:00:00,Wing,A13.395.823
20731671,2010-08-20T00:00:00,Animals,B01.050
20731671,2010-08-20T00:00:00,"Antibodies, Antinuclear",D12.776.124.486.485.114.323.204
20731671,2010-08-20T00:00:00,"Antibodies, Antinuclear",D12.776.124.790.651.114.323.204
20731671,2010-08-20T00:00:00,"Antibodies, Antinuclear",D12.776.377.715.548.114.323.204
20731671,2010-08-20T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
20731671,2010-08-20T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
20731671,2010-08-20T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
20731671,2010-08-20T00:00:00,B-Lymphocytes,A11.063.438
20731671,2010-08-20T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
20731671,2010-08-20T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
20731671,2010-08-20T00:00:00,B-Lymphocytes,A15.382.032.438
20731671,2010-08-20T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
20731671,2010-08-20T00:00:00,Gene Expression,G05.355.310
20731671,2010-08-20T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
20731671,2010-08-20T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
20731671,2010-08-20T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
20731671,2010-08-20T00:00:00,Kidney,A05.810.453
20731671,2010-08-20T00:00:00,Lupus Nephritis,C12.777.419.570.363.680
20731671,2010-08-20T00:00:00,Lupus Nephritis,C13.351.968.419.570.363.680
20731671,2010-08-20T00:00:00,Lupus Nephritis,C17.300.480.680
20731671,2010-08-20T00:00:00,Lupus Nephritis,C20.111.590.560
20731671,2010-08-20T00:00:00,Proteinuria,C12.777.934.734
20731671,2010-08-20T00:00:00,Proteinuria,C13.351.968.934.734
20731671,2010-08-20T00:00:00,Proteinuria,C23.888.942.750
20731671,2010-08-20T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.260.665.400
20731671,2010-08-20T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.624.664.700.175.400
20731671,2010-08-20T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.930.635.400
20731671,2010-08-20T00:00:00,Spleen,A10.549.700
20731671,2010-08-20T00:00:00,Spleen,A15.382.520.604.700
20731671,2010-08-20T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
20731671,2010-08-20T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
20731671,2010-08-20T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
20733337,2010-08-20T00:00:00,Aged,M01.060.116.100
20733337,2010-08-20T00:00:00,Antineoplastic Agents,D27.505.954.248
20733337,2010-08-20T00:00:00,"Carcinoma, Renal Cell",C04.557.470.200.025.390
20733337,2010-08-20T00:00:00,"Carcinoma, Renal Cell",C04.588.945.947.535.160
20733337,2010-08-20T00:00:00,"Carcinoma, Renal Cell",C12.758.820.750.160
20733337,2010-08-20T00:00:00,"Carcinoma, Renal Cell",C12.777.419.473.160
20733337,2010-08-20T00:00:00,"Carcinoma, Renal Cell",C13.351.937.820.535.160
20733337,2010-08-20T00:00:00,"Carcinoma, Renal Cell",C13.351.968.419.473.160
20733337,2010-08-20T00:00:00,Ethnic Groups,M01.686.754
20733337,2010-08-20T00:00:00,Ethnic Groups,N01.224.317
20733337,2010-08-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20733337,2010-08-20T00:00:00,Kidney Neoplasms,C04.588.945.947.535
20733337,2010-08-20T00:00:00,Kidney Neoplasms,C12.758.820.750
20733337,2010-08-20T00:00:00,Kidney Neoplasms,C12.777.419.473
20733337,2010-08-20T00:00:00,Kidney Neoplasms,C13.351.937.820.535
20733337,2010-08-20T00:00:00,Kidney Neoplasms,C13.351.968.419.473
20733337,2010-08-20T00:00:00,Middle Aged,M01.060.116.630
20733337,2010-08-20T00:00:00,Neoplasm Staging,E01.370.550
20733337,2010-08-20T00:00:00,Pyridines,D03.383.725
21029344,2010-08-20T00:00:00,Antihypertensive Agents,D27.505.954.411.162
21029344,2010-08-20T00:00:00,Blood Pressure,E01.370.600.875.249
21029344,2010-08-20T00:00:00,Blood Pressure,G09.330.380.076
21029344,2010-08-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21029344,2010-08-20T00:00:00,Hypertension,C14.907.489
21029344,2010-08-20T00:00:00,Middle Aged,M01.060.116.630
21029344,2010-08-20T00:00:00,Pyridines,D03.383.725
21029344,2010-08-20T00:00:00,Renin-Angiotensin System,G03.495.805
21029344,2010-08-20T00:00:00,Renin-Angiotensin System,G09.330.190.400.750
20733306,2010-08-21T00:00:00,Aged,M01.060.116.100
20733306,2010-08-21T00:00:00,Alleles,G05.360.340.024.340.030
20733306,2010-08-21T00:00:00,Alzheimer Disease,C10.228.140.380.100
20733306,2010-08-21T00:00:00,Alzheimer Disease,C10.574.945.249
20733306,2010-08-21T00:00:00,Alzheimer Disease,F03.087.400.100
20733306,2010-08-21T00:00:00,Apolipoproteins E,D10.532.091.500
20733306,2010-08-21T00:00:00,Apolipoproteins E,D12.776.070.400.500
20733306,2010-08-21T00:00:00,Apolipoproteins E,D12.776.521.120.500
20733306,2010-08-21T00:00:00,Cholinesterase Inhibitors,D27.505.519.389.275
20733306,2010-08-21T00:00:00,Cholinesterase Inhibitors,D27.505.519.625.120.300
20733306,2010-08-21T00:00:00,Cholinesterase Inhibitors,D27.505.696.577.120.300
20733306,2010-08-21T00:00:00,Edema,C23.888.277
20733306,2010-08-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20733306,2010-08-21T00:00:00,Hypoglycemic Agents,D27.505.696.422
20733306,2010-08-21T00:00:00,Intelligence Tests,F04.711.141.493
20733306,2010-08-21T00:00:00,"Interview, Psychological",F04.669.599
20733306,2010-08-21T00:00:00,Middle Aged,M01.060.116.630
20733306,2010-08-21T00:00:00,Piperidines,D03.383.621
20733306,2010-08-21T00:00:00,Treatment Outcome,E01.789.800
20733306,2010-08-21T00:00:00,Treatment Outcome,N04.761.559.590.800
20733306,2010-08-21T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20970689,2010-08-21T00:00:00,Chronic Disease,C23.550.291.500
20970689,2010-08-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20970689,2010-08-21T00:00:00,Inflammation,C23.550.470
20970689,2010-08-21T00:00:00,Rhinitis,C08.460.799
20970689,2010-08-21T00:00:00,Rhinitis,C08.730.674
20970689,2010-08-21T00:00:00,Rhinitis,C09.603.799
20970689,2010-08-21T00:00:00,Sinusitis,C08.460.692.752
20970689,2010-08-21T00:00:00,Sinusitis,C08.730.749
20970689,2010-08-21T00:00:00,Sinusitis,C09.603.692.752
20736037,2010-08-22T00:00:00,Adult,M01.060.116
20736037,2010-08-22T00:00:00,Aged,M01.060.116.100
20736037,2010-08-22T00:00:00,Breast Neoplasms,C04.588.180
20736037,2010-08-22T00:00:00,Breast Neoplasms,C17.800.090.500
20736037,2010-08-22T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
20736037,2010-08-22T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
20736037,2010-08-22T00:00:00,Genetic Predisposition to Disease,G05.380.355
20736037,2010-08-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20736037,2010-08-22T00:00:00,"Immunity, Humoral",G12.450.050.420
20736037,2010-08-22T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.606.586
20736037,2010-08-22T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.619.393.522.400
20736037,2010-08-22T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.705.500.380.500
20736037,2010-08-22T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.606.586
20736037,2010-08-22T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.619.393.522.400
20736037,2010-08-22T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.705.500.380.500
20736037,2010-08-22T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.606.586
20736037,2010-08-22T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.619.393.522.400
20736037,2010-08-22T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.705.500.380.500
20736037,2010-08-22T00:00:00,Immunoglobulin Gm Allotypes,G12.500.400.586
20736037,2010-08-22T00:00:00,Middle Aged,M01.060.116.630
20736037,2010-08-22T00:00:00,Neoplasm Staging,E01.370.550
20736037,2010-08-22T00:00:00,"Polymorphism, Genetic",G05.365.795
20736037,2010-08-22T00:00:00,"Receptor, erbB-2",D08.811.913.696.620.682.725.400.150
20736037,2010-08-22T00:00:00,"Receptor, erbB-2",D12.776.543.750.060.374
20736037,2010-08-22T00:00:00,"Receptor, erbB-2",D12.776.543.750.750.400.350
20736037,2010-08-22T00:00:00,"Receptor, erbB-2",D12.776.624.664.700.642
20736037,2010-08-22T00:00:00,"Receptor, erbB-2",D23.101.840.642
20729910,2010-08-23T00:00:00,Actins,D05.750.078.730.250
20729910,2010-08-23T00:00:00,Actins,D12.776.210.500.100
20729910,2010-08-23T00:00:00,Actins,D12.776.220.525.255
20729910,2010-08-23T00:00:00,Aldehyde Dehydrogenase,D08.811.682.657.163.249
20729910,2010-08-23T00:00:00,Cell Movement,G04.299.283
20729910,2010-08-23T00:00:00,Cell Movement,G07.700.560.500.180
20729910,2010-08-23T00:00:00,Cofilin 1,D05.750.078.730.212.500
20729910,2010-08-23T00:00:00,Cofilin 1,D12.776.220.525.212.500
20729910,2010-08-23T00:00:00,Dietary Supplements,J02.500.456
20729910,2010-08-23T00:00:00,Enzyme Inhibitors,D27.505.519.389
20729910,2010-08-23T00:00:00,Folic Acid,D03.438.733.631.400
20729910,2010-08-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20729910,2010-08-23T00:00:00,Mutation,G05.365.590
20729910,2010-08-23T00:00:00,Neoplasm Invasiveness,C04.697.645
20729910,2010-08-23T00:00:00,Neoplasm Invasiveness,C23.550.727.645
20729910,2010-08-23T00:00:00,Phosphorylation,G02.111.087.677
20729910,2010-08-23T00:00:00,Phosphorylation,G02.149.115.677
20729910,2010-08-23T00:00:00,Phosphorylation,G02.149.465.700
20729910,2010-08-23T00:00:00,Phosphorylation,G02.607.750.700
20729910,2010-08-23T00:00:00,Phosphorylation,G03.495.790
20729910,2010-08-23T00:00:00,Protein Phosphatase 1,D08.811.277.352.650.625.687
20729910,2010-08-23T00:00:00,Protein Phosphatase 2,D08.811.277.352.650.625.706
20729910,2010-08-23T00:00:00,Protein Phosphatase 2,D12.644.360.583
20729910,2010-08-23T00:00:00,Protein Phosphatase 2,D12.776.476.561
20827416,2010-08-23T00:00:00,Bacterial Infections,C01.252
20827416,2010-08-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20827416,2010-08-23T00:00:00,"Obstetric Labor, Premature",C13.703.420.491
20827416,2010-08-23T00:00:00,Pregnancy,G08.686.785.760.769
20827416,2010-08-23T00:00:00,Premature Birth,C13.703.420.491.500
20827416,2010-08-23T00:00:00,Toll-Like Receptors,D12.776.543.750.705.910.500
20827416,2010-08-23T00:00:00,Uterus,A05.360.319.679
20733143,2010-08-24T00:00:00,Adolescent,M01.060.057
20733143,2010-08-24T00:00:00,Adult,M01.060.116
20733143,2010-08-24T00:00:00,Aged,M01.060.116.100
20733143,2010-08-24T00:00:00,Brain Ischemia,C10.228.140.300.150
20733143,2010-08-24T00:00:00,Brain Ischemia,C14.907.253.092
20733143,2010-08-24T00:00:00,Disability Evaluation,E01.370.400
20733143,2010-08-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20733143,2010-08-24T00:00:00,Middle Aged,M01.060.116.630
20733143,2010-08-24T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
20733143,2010-08-24T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
20733143,2010-08-24T00:00:00,Stroke,C10.228.140.300.775
20733143,2010-08-24T00:00:00,Stroke,C14.907.253.855
20733143,2010-08-24T00:00:00,Young Adult,M01.060.116.815
20733300,2010-08-24T00:00:00,Aged,M01.060.116.100
20733300,2010-08-24T00:00:00,Albuminuria,C12.777.934.734.269
20733300,2010-08-24T00:00:00,Albuminuria,C13.351.968.934.734.269
20733300,2010-08-24T00:00:00,Albuminuria,C23.888.942.750.269
20733300,2010-08-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20733300,2010-08-24T00:00:00,Middle Aged,M01.060.116.630
20733300,2010-08-24T00:00:00,Risk Factors,E05.318.740.600.800.725
20733300,2010-08-24T00:00:00,Risk Factors,N05.715.350.200.700
20733300,2010-08-24T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20733300,2010-08-24T00:00:00,Risk Factors,N06.850.490.625.750
20733300,2010-08-24T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20733300,2010-08-24T00:00:00,Stroke,C10.228.140.300.775
20733300,2010-08-24T00:00:00,Stroke,C14.907.253.855
20735845,2010-08-24T00:00:00,Animals,B01.050
20735845,2010-08-24T00:00:00,Blood Transfusion,E02.095.135
20735845,2010-08-24T00:00:00,Cytokines,D12.644.276.374
20735845,2010-08-24T00:00:00,Cytokines,D12.776.467.374
20735845,2010-08-24T00:00:00,Cytokines,D23.529.374
20735845,2010-08-24T00:00:00,Liver,A03.620
20735845,2010-08-24T00:00:00,Liver Diseases,C06.552
20735845,2010-08-24T00:00:00,Nitric Oxide Synthase Type II,D08.811.682.664.500.772.500
20735845,2010-08-24T00:00:00,Plant Extracts,D20.215.784.500
20735845,2010-08-24T00:00:00,Plant Extracts,D26.667
20735845,2010-08-24T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20735845,2010-08-24T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
20735845,2010-08-24T00:00:00,Reactive Nitrogen Species,D01.625.700
20735845,2010-08-24T00:00:00,Reactive Nitrogen Species,D02.654.846
20735845,2010-08-24T00:00:00,Reactive Oxygen Species,D01.339.431
20735845,2010-08-24T00:00:00,Reactive Oxygen Species,D01.650.775
20735845,2010-08-24T00:00:00,Resuscitation,E02.365.647
20735845,2010-08-24T00:00:00,Tyrosine,D12.125.072.050.875
20736364,2010-08-24T00:00:00,Breast Neoplasms,C04.588.180
20736364,2010-08-24T00:00:00,Breast Neoplasms,C17.800.090.500
20736364,2010-08-24T00:00:00,Cell Division,G04.299.134.220
20736364,2010-08-24T00:00:00,Cell Division,G04.299.233.750.500
20736364,2010-08-24T00:00:00,Cell Division,G05.355.105
20736364,2010-08-24T00:00:00,Cell Division,G07.700.320.249.410.750.500
20736364,2010-08-24T00:00:00,"Cell Transformation, Neoplastic",C04.697.152
20736364,2010-08-24T00:00:00,"Cell Transformation, Neoplastic",C23.550.727.152
20736364,2010-08-24T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
20736364,2010-08-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20736364,2010-08-24T00:00:00,Intercellular Signaling Peptides and Proteins,D12.644.276
20736364,2010-08-24T00:00:00,Intercellular Signaling Peptides and Proteins,D12.776.467
20736364,2010-08-24T00:00:00,Intercellular Signaling Peptides and Proteins,D23.529
20736364,2010-08-24T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
20736364,2010-08-24T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
20736364,2010-08-24T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
20736364,2010-08-24T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
20736364,2010-08-24T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
20736364,2010-08-24T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
20736364,2010-08-24T00:00:00,Phosphorylation,G02.111.087.677
20736364,2010-08-24T00:00:00,Phosphorylation,G02.149.115.677
20736364,2010-08-24T00:00:00,Phosphorylation,G02.149.465.700
20736364,2010-08-24T00:00:00,Phosphorylation,G02.607.750.700
20736364,2010-08-24T00:00:00,Phosphorylation,G03.495.790
20736364,2010-08-24T00:00:00,"RNA, Messenger",D13.444.735.544
20736364,2010-08-24T00:00:00,"Receptor, erbB-2",D08.811.913.696.620.682.725.400.150
20736364,2010-08-24T00:00:00,"Receptor, erbB-2",D12.776.543.750.060.374
20736364,2010-08-24T00:00:00,"Receptor, erbB-2",D12.776.543.750.750.400.350
20736364,2010-08-24T00:00:00,"Receptor, erbB-2",D12.776.624.664.700.642
20736364,2010-08-24T00:00:00,"Receptor, erbB-2",D23.101.840.642
20736364,2010-08-24T00:00:00,Signal Transduction,G02.111.087.800
20736364,2010-08-24T00:00:00,Signal Transduction,G02.149.115.800
20736364,2010-08-24T00:00:00,Signal Transduction,G04.299.880
20883225,2010-08-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20883225,2010-08-24T00:00:00,Neoplasms,C04
20883225,2010-08-24T00:00:00,Risk Factors,E05.318.740.600.800.725
20883225,2010-08-24T00:00:00,Risk Factors,N05.715.350.200.700
20883225,2010-08-24T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20883225,2010-08-24T00:00:00,Risk Factors,N06.850.490.625.750
20883225,2010-08-24T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20739277,2010-08-25T00:00:00,Animals,B01.050
20739277,2010-08-25T00:00:00,Biological Transport,G03.495.166
20739277,2010-08-25T00:00:00,CHO Cells,A11.251.210.200
20739277,2010-08-25T00:00:00,CHO Cells,A11.436.155
20739277,2010-08-25T00:00:00,Cell Membrane,A11.284.149
20739277,2010-08-25T00:00:00,Cricetinae,B01.050.150.900.649.865.635.150
20739277,2010-08-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20739277,2010-08-25T00:00:00,"Models, Biological",E05.599.395
20739277,2010-08-25T00:00:00,RNA-Binding Proteins,D12.776.157.725
20739277,2010-08-25T00:00:00,RNA-Binding Proteins,D12.776.664.962
20739277,2010-08-25T00:00:00,"Receptors, Adrenergic, beta-2",D12.776.543.750.070.300.300.340.725
20739277,2010-08-25T00:00:00,"Receptors, Adrenergic, beta-2",D12.776.543.750.100.150.300.340.725
20739277,2010-08-25T00:00:00,"Receptors, Adrenergic, beta-2",D12.776.543.750.720.300.300.300.340.200
20739277,2010-08-25T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
20739664,2010-08-25T00:00:00,Animals,B01.050
20739664,2010-08-25T00:00:00,Cyclic AMP,D03.438.759.646.138.395
20739664,2010-08-25T00:00:00,Cyclic AMP,D13.695.462.200
20739664,2010-08-25T00:00:00,Cyclic AMP,D13.695.667.138.395
20739664,2010-08-25T00:00:00,Cyclic AMP,D13.695.827.068.395
20739664,2010-08-25T00:00:00,DNA-Binding Proteins,D12.776.260
20739664,2010-08-25T00:00:00,Gene Expression Profiling,E05.393.332
20739664,2010-08-25T00:00:00,Gene Silencing,G05.355.315.203.374
20739664,2010-08-25T00:00:00,Granulosa Cells,A05.360.319.114.630.535.200
20739664,2010-08-25T00:00:00,Granulosa Cells,A06.407.312.497.535.300
20739664,2010-08-25T00:00:00,Granulosa Cells,A11.382.812
20739664,2010-08-25T00:00:00,Granulosa Cells,A11.436.329
20739664,2010-08-25T00:00:00,Insulin-Like Growth Factor I,D12.644.276.937.400
20739664,2010-08-25T00:00:00,Insulin-Like Growth Factor I,D12.776.124.862.400
20739664,2010-08-25T00:00:00,Insulin-Like Growth Factor I,D12.776.467.937.400
20739664,2010-08-25T00:00:00,Insulin-Like Growth Factor I,D23.529.937.400
20739664,2010-08-25T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
20739664,2010-08-25T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
20739664,2010-08-25T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
20739664,2010-08-25T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
20739664,2010-08-25T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
20739664,2010-08-25T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
20739664,2010-08-25T00:00:00,RNA Interference,G05.355.315.203.374.790
20739664,2010-08-25T00:00:00,"RNA, Messenger",D13.444.735.544
20798124,2010-08-26T00:00:00,Bayes Theorem,E05.318.740.600.200
20798124,2010-08-26T00:00:00,Bayes Theorem,N05.715.360.750.625.150
20798124,2010-08-26T00:00:00,Bayes Theorem,N06.850.520.830.600.200
20798124,2010-08-26T00:00:00,Computer Simulation,L01.224.160
20798124,2010-08-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20798124,2010-08-26T00:00:00,"Models, Statistical",E05.318.740.500
20798124,2010-08-26T00:00:00,"Models, Statistical",E05.599.835
20798124,2010-08-26T00:00:00,"Models, Statistical",N05.715.360.750.530
20798124,2010-08-26T00:00:00,"Models, Statistical",N06.850.520.830.500
20798124,2010-08-26T00:00:00,Refuse Disposal,N06.850.780.200.800.800.700
20798124,2010-08-26T00:00:00,Refuse Disposal,N06.850.860.510.900.600
20798124,2010-08-26T00:00:00,Risk Assessment,E05.318.740.600.800.715
20798124,2010-08-26T00:00:00,Risk Assessment,N04.452.871.715
20798124,2010-08-26T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20798124,2010-08-26T00:00:00,Risk Assessment,N06.850.505.715
20798124,2010-08-26T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20798371,2010-08-26T00:00:00,Adult,M01.060.116
20798371,2010-08-26T00:00:00,Aged,M01.060.116.100
20798371,2010-08-26T00:00:00,Biological Markers,D23.101
20798371,2010-08-26T00:00:00,Brain Ischemia,C10.228.140.300.150
20798371,2010-08-26T00:00:00,Brain Ischemia,C14.907.253.092
20798371,2010-08-26T00:00:00,Gene Expression Profiling,E05.393.332
20798371,2010-08-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20798371,2010-08-26T00:00:00,Middle Aged,M01.060.116.630
20798371,2010-08-26T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
20798371,2010-08-26T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
20798371,2010-08-26T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
20798371,2010-08-26T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
20798371,2010-08-26T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
20798371,2010-08-26T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
20798371,2010-08-26T00:00:00,Risk Factors,E05.318.740.600.800.725
20798371,2010-08-26T00:00:00,Risk Factors,N05.715.350.200.700
20798371,2010-08-26T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20798371,2010-08-26T00:00:00,Risk Factors,N06.850.490.625.750
20798371,2010-08-26T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20798371,2010-08-26T00:00:00,Stroke,C10.228.140.300.775
20798371,2010-08-26T00:00:00,Stroke,C14.907.253.855
20843518,2010-08-26T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.567.342
20843518,2010-08-26T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.646.750.249
20843518,2010-08-26T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.644.360.450.169
20843518,2010-08-26T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.776.476.450.169
20843518,2010-08-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20843518,2010-08-26T00:00:00,Lipopolysaccharides,D09.400.500
20843518,2010-08-26T00:00:00,Lipopolysaccharides,D09.698.718.450
20843518,2010-08-26T00:00:00,Lipopolysaccharides,D10.494
20843518,2010-08-26T00:00:00,Lipopolysaccharides,D23.050.161.616.525
20843518,2010-08-26T00:00:00,Lipopolysaccharides,D23.946.123.329.500
20843518,2010-08-26T00:00:00,Macrophages,A11.329.372
20843518,2010-08-26T00:00:00,Macrophages,A11.627.482
20843518,2010-08-26T00:00:00,Macrophages,A11.733.397
20843518,2010-08-26T00:00:00,Macrophages,A15.382.680.397
20843518,2010-08-26T00:00:00,Macrophages,A15.382.812.522
20843518,2010-08-26T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.205.351
20843518,2010-08-26T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.525.700.100
20843518,2010-08-26T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.205.351
20843518,2010-08-26T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.525.700.100
20843518,2010-08-26T00:00:00,Piperidines,D03.383.621
20843518,2010-08-26T00:00:00,Toll-Like Receptor 4,D12.776.543.750.705.910.500.400
20843518,2010-08-26T00:00:00,Uracil,D03.383.742.698.875
20801113,2010-08-27T00:00:00,Animals,B01.050
20801113,2010-08-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20801113,2010-08-27T00:00:00,Retina,A09.371.729
20801113,2010-08-27T00:00:00,Retinal Pigment Epithelium,A09.371.670.500
20801113,2010-08-27T00:00:00,Retinal Pigment Epithelium,A09.371.729.887
20801113,2010-08-27T00:00:00,"Vision, Ocular",F02.830.816.964
20801113,2010-08-27T00:00:00,"Vision, Ocular",G02.111.087.800.480.900
20801113,2010-08-27T00:00:00,"Vision, Ocular",G02.149.115.800.480.900
20801113,2010-08-27T00:00:00,"Vision, Ocular",G04.299.880.480.900
20801113,2010-08-27T00:00:00,"Vision, Ocular",G11.561.600.810.964
20801113,2010-08-27T00:00:00,"Vision, Ocular",G14.640.816
20804486,2010-08-27T00:00:00,Aged,M01.060.116.100
20804486,2010-08-27T00:00:00,Case-Control Studies,E05.318.760.500.500
20804486,2010-08-27T00:00:00,Case-Control Studies,N05.715.360.775.175.200
20804486,2010-08-27T00:00:00,Case-Control Studies,N06.850.520.450.500.500
20804486,2010-08-27T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
20804486,2010-08-27T00:00:00,Genetic Predisposition to Disease,G05.380.355
20804486,2010-08-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20804486,2010-08-27T00:00:00,Middle Aged,M01.060.116.630
20804486,2010-08-27T00:00:00,Pilot Projects,E05.318.760.750
20804486,2010-08-27T00:00:00,Pilot Projects,E05.337.737
20804486,2010-08-27T00:00:00,Pilot Projects,N05.715.360.775.625
20804486,2010-08-27T00:00:00,Pilot Projects,N06.850.520.450.720
20804486,2010-08-27T00:00:00,"Polymorphism, Genetic",G05.365.795
20804486,2010-08-27T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
20804486,2010-08-27T00:00:00,Prostatic Neoplasms,C12.294.260.750
20804486,2010-08-27T00:00:00,Prostatic Neoplasms,C12.294.565.625
20804486,2010-08-27T00:00:00,Prostatic Neoplasms,C12.758.409.750
20804486,2010-08-27T00:00:00,Risk Factors,E05.318.740.600.800.725
20804486,2010-08-27T00:00:00,Risk Factors,N05.715.350.200.700
20804486,2010-08-27T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20804486,2010-08-27T00:00:00,Risk Factors,N06.850.490.625.750
20804486,2010-08-27T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20807363,2010-08-27T00:00:00,Child,M01.060.406
20807363,2010-08-27T00:00:00,Cicatrix,A10.165.450.300
20807363,2010-08-27T00:00:00,Cicatrix,C23.550.355.274
20807363,2010-08-27T00:00:00,Cicatrix,G16.100.856.891.249
20807363,2010-08-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20807363,2010-08-27T00:00:00,Skin,A17.815
20683893,2010-08-30T00:00:00,Asthma,C08.127.108
20683893,2010-08-30T00:00:00,Asthma,C08.381.495.108
20683893,2010-08-30T00:00:00,Asthma,C08.674.095
20683893,2010-08-30T00:00:00,Asthma,C20.543.480.680.095
20683893,2010-08-30T00:00:00,Bayes Theorem,E05.318.740.600.200
20683893,2010-08-30T00:00:00,Bayes Theorem,N05.715.360.750.625.150
20683893,2010-08-30T00:00:00,Bayes Theorem,N06.850.520.830.600.200
20683893,2010-08-30T00:00:00,Computer Simulation,L01.224.160
20683893,2010-08-30T00:00:00,"Data Interpretation, Statistical",E05.245.380
20683893,2010-08-30T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
20683893,2010-08-30T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
20683893,2010-08-30T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
20683893,2010-08-30T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
20683893,2010-08-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20683893,2010-08-30T00:00:00,"Models, Biological",E05.599.395
20683893,2010-08-30T00:00:00,Risk Factors,E05.318.740.600.800.725
20683893,2010-08-30T00:00:00,Risk Factors,N05.715.350.200.700
20683893,2010-08-30T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20683893,2010-08-30T00:00:00,Risk Factors,N06.850.490.625.750
20683893,2010-08-30T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20800895,2010-08-30T00:00:00,Animals,B01.050
20800895,2010-08-30T00:00:00,Complement Activation,G12.425.255
20800895,2010-08-30T00:00:00,Inflammation,C23.550.470
20800895,2010-08-30T00:00:00,Reperfusion Injury,C14.907.725
20800895,2010-08-30T00:00:00,Reperfusion Injury,C23.550.767.877
20800895,2010-08-30T00:00:00,Toll-Like Receptor 4,D12.776.543.750.705.910.500.400
20805292,2010-08-30T00:00:00,Adolescent,M01.060.057
20805292,2010-08-30T00:00:00,Adult,M01.060.116
20805292,2010-08-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20805292,2010-08-30T00:00:00,Middle Aged,M01.060.116.630
20805292,2010-08-30T00:00:00,Smoking,F01.145.466.753
20805292,2010-08-30T00:00:00,Smoking Cessation,F01.145.940.700
20805292,2010-08-30T00:00:00,Young Adult,M01.060.116.815
20805374,2010-08-30T00:00:00,"Adaptor Proteins, Signal Transducing",D12.644.360.024
20805374,2010-08-30T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.157.057
20805374,2010-08-30T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.476.024
20805374,2010-08-30T00:00:00,Albuterol,D02.033.100.291.057
20805374,2010-08-30T00:00:00,Albuterol,D02.092.063.291.057
20805374,2010-08-30T00:00:00,Albuterol,D02.092.471.683.061
20805374,2010-08-30T00:00:00,Bronchodilator Agents,D27.505.696.663.050.110
20805374,2010-08-30T00:00:00,Bronchodilator Agents,D27.505.954.796.050.100
20805374,2010-08-30T00:00:00,Cell Proliferation,G04.299.233.750
20805374,2010-08-30T00:00:00,Cell Proliferation,G07.700.320.249.410.750
20805374,2010-08-30T00:00:00,Cyclic AMP-Dependent Protein Kinases,D08.811.913.696.620.682.700.150.125
20805374,2010-08-30T00:00:00,Cyclic AMP-Dependent Protein Kinases,D12.644.360.200.125
20805374,2010-08-30T00:00:00,Cyclic AMP-Dependent Protein Kinases,D12.776.476.200.125
20805374,2010-08-30T00:00:00,Dinoprostone,D10.251.355.255.100.637.250.200
20805374,2010-08-30T00:00:00,Dinoprostone,D10.251.355.255.550.250.200
20805374,2010-08-30T00:00:00,Dinoprostone,D23.469.050.175.725.780.200
20805374,2010-08-30T00:00:00,Green Fluorescent Proteins,D12.776.532.265
20805374,2010-08-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20805374,2010-08-30T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.567.342.500
20805374,2010-08-30T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.646.750.249.500
20805374,2010-08-30T00:00:00,Mitogen-Activated Protein Kinase 1,D12.644.360.450.169.500
20805374,2010-08-30T00:00:00,Mitogen-Activated Protein Kinase 1,D12.776.476.450.169.500
20805374,2010-08-30T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.567.342.750
20805374,2010-08-30T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.646.750.249.750
20805374,2010-08-30T00:00:00,Mitogen-Activated Protein Kinase 3,D12.644.360.450.169.750
20805374,2010-08-30T00:00:00,Mitogen-Activated Protein Kinase 3,D12.776.476.450.169.750
20805374,2010-08-30T00:00:00,"Muscle, Smooth",A02.633.570
20805374,2010-08-30T00:00:00,"Muscle, Smooth",A10.690.467
20805374,2010-08-30T00:00:00,"Myocytes, Smooth Muscle",A11.620.520
20805374,2010-08-30T00:00:00,Phosphorylation,G02.111.087.677
20805374,2010-08-30T00:00:00,Phosphorylation,G02.149.115.677
20805374,2010-08-30T00:00:00,Phosphorylation,G02.149.465.700
20805374,2010-08-30T00:00:00,Phosphorylation,G02.607.750.700
20805374,2010-08-30T00:00:00,Phosphorylation,G03.495.790
20805374,2010-08-30T00:00:00,Time Factors,G01.910.857
20805374,2010-08-30T00:00:00,Trachea,A04.889
20809477,2010-08-30T00:00:00,Adolescent,M01.060.057
20809477,2010-08-30T00:00:00,Adult,M01.060.116
20809477,2010-08-30T00:00:00,Aged,M01.060.116.100
20809477,2010-08-30T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
20809477,2010-08-30T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
20809477,2010-08-30T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
20809477,2010-08-30T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
20809477,2010-08-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20809477,2010-08-30T00:00:00,Liver Transplantation,E04.210.650
20809477,2010-08-30T00:00:00,Liver Transplantation,E04.936.450.490
20809477,2010-08-30T00:00:00,Liver Transplantation,E04.936.580.490
20809477,2010-08-30T00:00:00,"Lymphohistiocytosis, Hemophagocytic",C15.604.250.410.575
20809477,2010-08-30T00:00:00,Middle Aged,M01.060.116.630
20809477,2010-08-30T00:00:00,Rheumatic Diseases,C05.799
20809477,2010-08-30T00:00:00,Rheumatic Diseases,C17.300.775
20809477,2010-08-30T00:00:00,Syndrome,C23.550.288.500
20809477,2010-08-30T00:00:00,Treatment Outcome,E01.789.800
20809477,2010-08-30T00:00:00,Treatment Outcome,N04.761.559.590.800
20809477,2010-08-30T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20809477,2010-08-30T00:00:00,Young Adult,M01.060.116.815
20795582,2010-08-31T00:00:00,Aged,M01.060.116.100
20795582,2010-08-31T00:00:00,Caregivers,M01.085
20795582,2010-08-31T00:00:00,Caregivers,M01.526.485.200
20795582,2010-08-31T00:00:00,Caregivers,N02.360.200
20795582,2010-08-31T00:00:00,Dementia,C10.228.140.380
20795582,2010-08-31T00:00:00,Dementia,F03.087.400
20795582,2010-08-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20795582,2010-08-31T00:00:00,Interviews as Topic,E05.318.308.420
20795582,2010-08-31T00:00:00,Interviews as Topic,L01.280.520
20795582,2010-08-31T00:00:00,Interviews as Topic,N05.715.360.300.400
20795582,2010-08-31T00:00:00,Interviews as Topic,N06.850.520.308.420
20805833,2010-08-31T00:00:00,Adult,M01.060.116
20805833,2010-08-31T00:00:00,Disability Evaluation,E01.370.400
20805833,2010-08-31T00:00:00,Employment,N01.824.245
20805833,2010-08-31T00:00:00,Health Status,I01.240.425
20805833,2010-08-31T00:00:00,Health Status,N01.224.425
20805833,2010-08-31T00:00:00,Health Status,N06.850.505.400.425
20805833,2010-08-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20805833,2010-08-31T00:00:00,Middle Aged,M01.060.116.630
20805833,2010-08-31T00:00:00,Spinal Cord Injuries,C10.228.854.770
20805833,2010-08-31T00:00:00,Spinal Cord Injuries,C10.900.850
20805833,2010-08-31T00:00:00,Spinal Cord Injuries,C21.866.819
19751251,2010-09-01T00:00:00,Biometry,E05.318.740.225
19751251,2010-09-01T00:00:00,Biometry,N06.850.505.200
19751251,2010-09-01T00:00:00,Case-Control Studies,E05.318.760.500.500
19751251,2010-09-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
19751251,2010-09-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
19751251,2010-09-01T00:00:00,Computer Simulation,L01.224.160
19751251,2010-09-01T00:00:00,"Data Interpretation, Statistical",E05.245.380
19751251,2010-09-01T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
19751251,2010-09-01T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
19751251,2010-09-01T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
19751251,2010-09-01T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
19751251,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19751251,2010-09-01T00:00:00,Multiple Myeloma,C04.557.595.500
19751251,2010-09-01T00:00:00,Multiple Myeloma,C14.907.454.460
19751251,2010-09-01T00:00:00,Multiple Myeloma,C15.378.147.780.650
19751251,2010-09-01T00:00:00,Multiple Myeloma,C15.378.463.835.460
19751251,2010-09-01T00:00:00,Multiple Myeloma,C20.683.515.845
19751251,2010-09-01T00:00:00,Multiple Myeloma,C20.683.780.650
19751251,2010-09-01T00:00:00,"Polymorphism, Genetic",G05.365.795
20100136,2010-09-01T00:00:00,Antifungal Agents,D27.505.954.122.136
20100136,2010-09-01T00:00:00,Cryptococcosis,C01.703.248
20100136,2010-09-01T00:00:00,Cryptococcus neoformans,B01.300.381.258.366
20100136,2010-09-01T00:00:00,Cryptococcus neoformans,B01.300.930.316.366
20100136,2010-09-01T00:00:00,Fluconazole,D03.383.129.799.450
20100136,2010-09-01T00:00:00,Fungemia,C01.539.757.360
20100136,2010-09-01T00:00:00,Fungemia,C01.703.360
20100136,2010-09-01T00:00:00,Fungemia,C23.550.470.790.500.360
20100136,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20100136,2010-09-01T00:00:00,Middle Aged,M01.060.116.630
20109065,2010-09-01T00:00:00,Animals,B01.050
20109065,2010-09-01T00:00:00,"Animals, Newborn",B01.050.050.282
20109065,2010-09-01T00:00:00,Cell Differentiation,G04.299.151
20109065,2010-09-01T00:00:00,Cell Line,A11.251.210
20109065,2010-09-01T00:00:00,Heart,A07.541
20109065,2010-09-01T00:00:00,"Models, Biological",E05.599.395
20109065,2010-09-01T00:00:00,"Myocytes, Cardiac",A07.541.704.570
20109065,2010-09-01T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
20109065,2010-09-01T00:00:00,"Myocytes, Cardiac",A11.620.500
20109065,2010-09-01T00:00:00,Sodium-Calcium Exchanger,D12.776.157.530.450.162.442
20109065,2010-09-01T00:00:00,Sodium-Calcium Exchanger,D12.776.543.585.450.162.442
20109065,2010-09-01T00:00:00,Stem Cells,A11.872
20109065,2010-09-01T00:00:00,Tissue Engineering,E05.200.249.750
20384655,2010-09-01T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
20384655,2010-09-01T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
20384655,2010-09-01T00:00:00,"Defibrillators, Implantable",E07.695.175
20384655,2010-09-01T00:00:00,Electric Countershock,E02.342.287
20384655,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20384655,2010-09-01T00:00:00,Patient Selection,E05.581.500.653
20384655,2010-09-01T00:00:00,Patient Selection,N04.590.731
20384655,2010-09-01T00:00:00,Primary Prevention,N02.421.726.758
20384655,2010-09-01T00:00:00,Primary Prevention,N06.850.780.680
20384655,2010-09-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
20384655,2010-09-01T00:00:00,Risk Assessment,N04.452.871.715
20384655,2010-09-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20384655,2010-09-01T00:00:00,Risk Assessment,N06.850.505.715
20384655,2010-09-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20384655,2010-09-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20384655,2010-09-01T00:00:00,Risk Factors,N05.715.350.200.700
20384655,2010-09-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20384655,2010-09-01T00:00:00,Risk Factors,N06.850.490.625.750
20384655,2010-09-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20384655,2010-09-01T00:00:00,"Tachycardia, Ventricular",C14.280.067.845.940
20384655,2010-09-01T00:00:00,"Tachycardia, Ventricular",C23.550.073.845.940
20384655,2010-09-01T00:00:00,Treatment Outcome,E01.789.800
20384655,2010-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20384655,2010-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20384655,2010-09-01T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
20412283,2010-09-01T00:00:00,Adult,M01.060.116
20412283,2010-09-01T00:00:00,Brain,A08.186.211
20412283,2010-09-01T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
20412283,2010-09-01T00:00:00,"Epilepsy, Temporal Lobe",C10.228.140.490.360.290
20412283,2010-09-01T00:00:00,Hippocampus,A08.186.211.464.405
20412283,2010-09-01T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
20412283,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20412283,2010-09-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
20412283,2010-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20412283,2010-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20412283,2010-09-01T00:00:00,Middle Aged,M01.060.116.630
20412283,2010-09-01T00:00:00,Temporal Lobe,A08.186.211.730.885.287.500.863
20415526,2010-09-01T00:00:00,Adult,M01.060.116
20415526,2010-09-01T00:00:00,Brain,A08.186.211
20415526,2010-09-01T00:00:00,Brain Injuries,C10.228.140.199
20415526,2010-09-01T00:00:00,Brain Injuries,C10.900.300.087
20415526,2010-09-01T00:00:00,Brain Injuries,C21.866.260.118
20415526,2010-09-01T00:00:00,Brain Injuries,C21.866.915.300.200
20415526,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20415526,2010-09-01T00:00:00,Intracranial Pressure,G11.561.170.505
20415526,2010-09-01T00:00:00,"Monitoring, Physiologic",E01.370.520
20415526,2010-09-01T00:00:00,Oxygen,D01.268.185.550
20415526,2010-09-01T00:00:00,Oxygen,D01.362.670
20415526,2010-09-01T00:00:00,Time Factors,G01.910.857
20415526,2010-09-01T00:00:00,Treatment Outcome,E01.789.800
20415526,2010-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20415526,2010-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20482290,2010-09-01T00:00:00,Adult,M01.060.116
20482290,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20482290,2010-09-01T00:00:00,Life Change Events,F01.829.458.410
20482290,2010-09-01T00:00:00,Pregnancy,G08.686.785.760.769
20482290,2010-09-01T00:00:00,Pregnancy Complications,C13.703
20482290,2010-09-01T00:00:00,Psychiatric Status Rating Scales,F04.586
20482290,2010-09-01T00:00:00,Questionnaires,E05.318.308.750
20482290,2010-09-01T00:00:00,Questionnaires,L01.280.800
20482290,2010-09-01T00:00:00,Questionnaires,N05.715.360.300.695
20482290,2010-09-01T00:00:00,Questionnaires,N06.850.520.308.750
20482290,2010-09-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20482290,2010-09-01T00:00:00,Risk Factors,N05.715.350.200.700
20482290,2010-09-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20482290,2010-09-01T00:00:00,Risk Factors,N06.850.490.625.750
20482290,2010-09-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20482290,2010-09-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
20544310,2010-09-01T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
20544310,2010-09-01T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
20544310,2010-09-01T00:00:00,"Defibrillators, Implantable",E07.695.175
20544310,2010-09-01T00:00:00,Disease Progression,C23.550.291.656
20544310,2010-09-01T00:00:00,Heart Failure,C14.280.434
20544310,2010-09-01T00:00:00,Heart Ventricles,A07.541.560
20544310,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20544310,2010-09-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
20544310,2010-09-01T00:00:00,Risk Assessment,N04.452.871.715
20544310,2010-09-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20544310,2010-09-01T00:00:00,Risk Assessment,N06.850.505.715
20544310,2010-09-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20544310,2010-09-01T00:00:00,Treatment Outcome,E01.789.800
20544310,2010-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20544310,2010-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20553412,2010-09-01T00:00:00,Apoptosis,G04.299.139.160
20553412,2010-09-01T00:00:00,Cell Survival,G04.299.316
20553412,2010-09-01T00:00:00,Drug Delivery Systems,E02.319.300
20553412,2010-09-01T00:00:00,Mitochondria,A11.284.430.214.190.875.564
20553412,2010-09-01T00:00:00,Mitochondria,A11.284.835.626
20553412,2010-09-01T00:00:00,Molecular Structure,G02.111.570
20553412,2010-09-01T00:00:00,Molecular Structure,G02.575
20553412,2010-09-01T00:00:00,Molecular Structure,G02.842.575
20553412,2010-09-01T00:00:00,Muramidase,D08.811.277.450.642
20553412,2010-09-01T00:00:00,Photochemotherapy,E02.186.500
20553412,2010-09-01T00:00:00,Photochemotherapy,E02.319.685
20553412,2010-09-01T00:00:00,Photochemotherapy,E02.774.722
20553412,2010-09-01T00:00:00,Photosensitizing Agents,D27.505.696.750.710
20553412,2010-09-01T00:00:00,Photosensitizing Agents,D27.505.954.444.600
20556796,2010-09-01T00:00:00,Adenosine,D03.438.759.590.138
20556796,2010-09-01T00:00:00,Adenosine,D13.570.583.138
20556796,2010-09-01T00:00:00,Adenosine,D13.570.800.096
20556796,2010-09-01T00:00:00,Binding Sites,G02.111.570.120
20556796,2010-09-01T00:00:00,Computational Biology,H01.158.273.180
20556796,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20556796,2010-09-01T00:00:00,Internet,L01.224.230.110.500
20556796,2010-09-01T00:00:00,"Models, Molecular",E05.599.595
20556796,2010-09-01T00:00:00,"Mutation, Missense",G05.365.590.650
20585906,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20585906,2010-09-01T00:00:00,"Urinary Bladder, Overactive",C12.777.829.866
20585906,2010-09-01T00:00:00,"Urinary Bladder, Overactive",C13.351.968.829.813
20585906,2010-09-01T00:00:00,"Urinary Bladder, Overactive",C23.888.942.775
20585906,2010-09-01T00:00:00,Urodynamics,G08.852.898
20589630,2010-09-01T00:00:00,Algorithms,G17.035
20589630,2010-09-01T00:00:00,Algorithms,L01.224.050
20589630,2010-09-01T00:00:00,"Databases, Factual",L01.470.750.750
20589630,2010-09-01T00:00:00,"Databases, Factual",L01.700.508.300.188.400
20589630,2010-09-01T00:00:00,Protein Stability,G02.111.700
20589630,2010-09-01T00:00:00,Proteins,D12.776
20632128,2010-09-01T00:00:00,Animals,B01.050
20632128,2010-09-01T00:00:00,Anticarcinogenic Agents,D27.505.696.706.018
20632128,2010-09-01T00:00:00,Anticarcinogenic Agents,D27.505.954.248.125
20632128,2010-09-01T00:00:00,Anticarcinogenic Agents,D27.720.799.018
20632128,2010-09-01T00:00:00,Antioxidants,D27.505.519.217
20632128,2010-09-01T00:00:00,Antioxidants,D27.505.696.706.125
20632128,2010-09-01T00:00:00,Antioxidants,D27.720.799.047
20632128,2010-09-01T00:00:00,Cell Death,G04.299.139
20632128,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20632128,2010-09-01T00:00:00,Neoplasms,C04
20632128,2010-09-01T00:00:00,Organoselenium Compounds,D02.712
20632128,2010-09-01T00:00:00,Reactive Oxygen Species,D01.339.431
20632128,2010-09-01T00:00:00,Reactive Oxygen Species,D01.650.775
20632128,2010-09-01T00:00:00,Selenium,D01.268.185.850
20632128,2010-09-01T00:00:00,Selenium,D01.578.700
20632128,2010-09-01T00:00:00,Sulfur,D01.268.185.900
20634691,2010-09-01T00:00:00,Animals,B01.050
20634691,2010-09-01T00:00:00,"Behavior, Addictive",F01.145.527.100.120
20634691,2010-09-01T00:00:00,Drug Delivery Systems,E02.319.300
20634691,2010-09-01T00:00:00,Glutamic Acid,D12.125.067.750
20634691,2010-09-01T00:00:00,Glutamic Acid,D12.125.119.450
20634691,2010-09-01T00:00:00,Glutamic Acid,D12.125.427.300
20634691,2010-09-01T00:00:00,Homeostasis,G07.700.360
20634691,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20634691,2010-09-01T00:00:00,Neuronal Plasticity,G11.561.600.635
20634691,2010-09-01T00:00:00,Substance-Related Disorders,C21.739
20634691,2010-09-01T00:00:00,Substance-Related Disorders,F03.900
20634691,2010-09-01T00:00:00,Synapses,A08.850
20634691,2010-09-01T00:00:00,Synapses,A11.284.149.165.420.780
20647937,2010-09-01T00:00:00,Adult,M01.060.116
20647937,2010-09-01T00:00:00,"Analgesics, Opioid",D27.505.696.663.850.014.520
20647937,2010-09-01T00:00:00,"Analgesics, Opioid",D27.505.954.427.040.325
20647937,2010-09-01T00:00:00,"Analgesics, Opioid",D27.505.954.427.210.049
20647937,2010-09-01T00:00:00,Critical Illness,C23.550.291.625
20647937,2010-09-01T00:00:00,Delirium,C10.597.606.337.500
20647937,2010-09-01T00:00:00,Delirium,C23.888.592.604.339.500
20647937,2010-09-01T00:00:00,Delirium,F01.700.250.500
20647937,2010-09-01T00:00:00,Delirium,F03.087.350
20647937,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20647937,2010-09-01T00:00:00,Intensive Care Units,N02.278.388.493
20647937,2010-09-01T00:00:00,Markov Chains,E05.318.740.600.500
20647937,2010-09-01T00:00:00,Markov Chains,E05.318.740.996.500
20647937,2010-09-01T00:00:00,Markov Chains,G17.830.500
20647937,2010-09-01T00:00:00,Markov Chains,N05.715.360.750.625.500
20647937,2010-09-01T00:00:00,Markov Chains,N05.715.360.750.770.500
20647937,2010-09-01T00:00:00,Markov Chains,N06.850.520.830.600.500
20647937,2010-09-01T00:00:00,Markov Chains,N06.850.520.830.996.500
20647937,2010-09-01T00:00:00,Methadone,D02.522.675
20647937,2010-09-01T00:00:00,Middle Aged,M01.060.116.630
20647937,2010-09-01T00:00:00,"Respiration, Artificial",E02.365.647.729
20647937,2010-09-01T00:00:00,"Respiration, Artificial",E02.880.820
20647937,2010-09-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20647937,2010-09-01T00:00:00,Risk Factors,N05.715.350.200.700
20647937,2010-09-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20647937,2010-09-01T00:00:00,Risk Factors,N06.850.490.625.750
20647937,2010-09-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20674781,2010-09-01T00:00:00,Anti-Infective Agents,D27.505.954.122
20674781,2010-09-01T00:00:00,Bacterial Infections,C01.252
20674781,2010-09-01T00:00:00,Diagnostic Imaging,E01.370.350
20674781,2010-09-01T00:00:00,Gynecologic Surgical Procedures,E04.950.300
20674781,2010-09-01T00:00:00,Hospitalization,E02.760.400
20674781,2010-09-01T00:00:00,Hospitalization,N02.421.585.400
20674781,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20674781,2010-09-01T00:00:00,Hysterectomy,E04.950.300.399
20674781,2010-09-01T00:00:00,Postoperative Complications,C23.550.767
20674781,2010-09-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20674781,2010-09-01T00:00:00,Risk Factors,N05.715.350.200.700
20674781,2010-09-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20674781,2010-09-01T00:00:00,Risk Factors,N06.850.490.625.750
20674781,2010-09-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20674781,2010-09-01T00:00:00,Surgical Wound Infection,C01.539.947.692
20674781,2010-09-01T00:00:00,Surgical Wound Infection,C23.550.767.925
20689481,2010-09-01T00:00:00,Adolescent,M01.060.057
20689481,2010-09-01T00:00:00,Adult,M01.060.116
20689481,2010-09-01T00:00:00,Aged,M01.060.116.100
20689481,2010-09-01T00:00:00,Glucocorticoids,D06.472.040.543
20689481,2010-09-01T00:00:00,Glucocorticoids,D27.505.696.399.472.488
20689481,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20689481,2010-09-01T00:00:00,Middle Aged,M01.060.116.630
20689481,2010-09-01T00:00:00,Nasal Obstruction,C08.460.525
20689481,2010-09-01T00:00:00,Nasal Obstruction,C08.618.846.185.525
20689481,2010-09-01T00:00:00,Nasal Obstruction,C09.603.525
20689481,2010-09-01T00:00:00,Prednisone,D04.808.745.432.719.702
20689481,2010-09-01T00:00:00,Respiratory Tract Diseases,C08
20689481,2010-09-01T00:00:00,Sarcoidosis,C15.604.515.827
20689481,2010-09-01T00:00:00,Treatment Outcome,E01.789.800
20689481,2010-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20689481,2010-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20692536,2010-09-01T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
20692536,2010-09-01T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
20692536,2010-09-01T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
20692536,2010-09-01T00:00:00,Autoimmune Diseases,C20.111
20692536,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20692536,2010-09-01T00:00:00,"Scleroderma, Systemic",C17.300.799
20692536,2010-09-01T00:00:00,"Scleroderma, Systemic",C17.800.784
20692536,2010-09-01T00:00:00,Serologic Tests,E01.450.495.735
20692536,2010-09-01T00:00:00,Serologic Tests,E05.478.594.760
20692538,2010-09-01T00:00:00,Biological Markers,D23.101
20692538,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20692538,2010-09-01T00:00:00,Lung Diseases,C08.381
20692538,2010-09-01T00:00:00,"Scleroderma, Diffuse",C17.300.799.602
20692538,2010-09-01T00:00:00,"Scleroderma, Diffuse",C17.800.784.602
20692540,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20692540,2010-09-01T00:00:00,Lung Diseases,C08.381
20692540,2010-09-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
20692540,2010-09-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
20692540,2010-09-01T00:00:00,Pleural Diseases,C08.528
20692541,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20692541,2010-09-01T00:00:00,"Hypertension, Pulmonary",C08.381.423
20692541,2010-09-01T00:00:00,"Lung Diseases, Interstitial",C08.381.483
20692560,2010-09-01T00:00:00,Case-Control Studies,E05.318.760.500.500
20692560,2010-09-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
20692560,2010-09-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
20692560,2010-09-01T00:00:00,Cataract,C11.510.245
20692560,2010-09-01T00:00:00,Endophthalmitis,C01.252.354.900.350
20692560,2010-09-01T00:00:00,Endophthalmitis,C01.539.375.354.900.350
20692560,2010-09-01T00:00:00,Endophthalmitis,C01.539.375.450.900.350
20692560,2010-09-01T00:00:00,Endophthalmitis,C01.703.343.900.350
20692560,2010-09-01T00:00:00,Endophthalmitis,C11.294.354.900.350
20692560,2010-09-01T00:00:00,Endophthalmitis,C11.294.450.900.350
20692560,2010-09-01T00:00:00,Endophthalmitis,C11.941.879.960.380
20692560,2010-09-01T00:00:00,Glucocorticoids,D06.472.040.543
20692560,2010-09-01T00:00:00,Glucocorticoids,D27.505.696.399.472.488
20692560,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20692560,2010-09-01T00:00:00,Infant,M01.060.703
20692560,2010-09-01T00:00:00,Intraocular Pressure,G14.440
20692560,2010-09-01T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
20692560,2010-09-01T00:00:00,Postoperative Complications,C23.550.767
20692560,2010-09-01T00:00:00,Treatment Outcome,E01.789.800
20692560,2010-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20692560,2010-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20692560,2010-09-01T00:00:00,Visual Acuity,E01.370.380.850.950
20692560,2010-09-01T00:00:00,Visual Acuity,F02.463.593.932.901
20692560,2010-09-01T00:00:00,Visual Acuity,G14.940
20699699,2010-09-01T00:00:00,Animals,B01.050
20699699,2010-09-01T00:00:00,"Models, Biological",E05.599.395
20699699,2010-09-01T00:00:00,"Neoplasms, Radiation-Induced",C04.682
20699699,2010-09-01T00:00:00,"Neoplasms, Radiation-Induced",C21.866.733.476
20699699,2010-09-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
20699699,2010-09-01T00:00:00,Risk Assessment,N04.452.871.715
20699699,2010-09-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20699699,2010-09-01T00:00:00,Risk Assessment,N06.850.505.715
20699699,2010-09-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20707775,2010-09-01T00:00:00,"Behavior, Addictive",F01.145.527.100.120
20707775,2010-09-01T00:00:00,"Child, Preschool",M01.060.406.448
20707775,2010-09-01T00:00:00,Decision Making,F02.463.785.373
20707775,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20707775,2010-09-01T00:00:00,Qualitative Research,H01.770.644.241.850
20707775,2010-09-01T00:00:00,"Remission, Spontaneous",C23.550.291.656.700
20707775,2010-09-01T00:00:00,"Remission, Spontaneous",G16.100.870
20716307,2010-09-01T00:00:00,Adult,M01.060.116
20716307,2010-09-01T00:00:00,Anxiety Disorders,F03.080
20716307,2010-09-01T00:00:00,Bipolar Disorder,F03.600.150.150
20716307,2010-09-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
20716307,2010-09-01T00:00:00,Clinical Trials as Topic,E05.337.250
20716307,2010-09-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
20716307,2010-09-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
20716307,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20716307,2010-09-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20716307,2010-09-01T00:00:00,Risk Factors,N05.715.350.200.700
20716307,2010-09-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20716307,2010-09-01T00:00:00,Risk Factors,N06.850.490.625.750
20716307,2010-09-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20716307,2010-09-01T00:00:00,Substance-Related Disorders,C21.739
20716307,2010-09-01T00:00:00,Substance-Related Disorders,F03.900
20716307,2010-09-01T00:00:00,Violence,I01.198.240.856
20716307,2010-09-01T00:00:00,Violence,I01.880.735.900
20723641,2010-09-01T00:00:00,Adult,M01.060.116
20723641,2010-09-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
20723641,2010-09-01T00:00:00,Body Mass Index,E05.041.124.125
20723641,2010-09-01T00:00:00,Body Mass Index,G07.100.100.125
20723641,2010-09-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
20723641,2010-09-01T00:00:00,Calcinosis,C18.452.174.130
20723641,2010-09-01T00:00:00,Coronary Artery Disease,C14.280.647.250.260
20723641,2010-09-01T00:00:00,Coronary Artery Disease,C14.907.137.126.339
20723641,2010-09-01T00:00:00,Coronary Artery Disease,C14.907.585.250.260
20723641,2010-09-01T00:00:00,Diet,E05.272
20723641,2010-09-01T00:00:00,Diet,G07.610.240
20723641,2010-09-01T00:00:00,Exercise,G11.427.590.237
20723641,2010-09-01T00:00:00,Exercise,I03.350
20723641,2010-09-01T00:00:00,Health Behavior,F01.145.488
20723641,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20723641,2010-09-01T00:00:00,Life Style,F01.829.458
20723641,2010-09-01T00:00:00,Middle Aged,M01.060.116.630
20723641,2010-09-01T00:00:00,Social Support,I01.880.656.600
20723721,2010-09-01T00:00:00,Epithelial Cells,A11.436
20723721,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20723721,2010-09-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
20723721,2010-09-01T00:00:00,Lung Neoplasms,C08.381.540
20723721,2010-09-01T00:00:00,Lung Neoplasms,C08.785.520
20723721,2010-09-01T00:00:00,Mesoderm,A16.504.660
20723721,2010-09-01T00:00:00,Neoplasm Invasiveness,C04.697.645
20723721,2010-09-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
20723721,2010-09-01T00:00:00,Phenotype,G05.695
20723721,2010-09-01T00:00:00,"Tumor Markers, Biological",D23.101.840
20723788,2010-09-01T00:00:00,Endoscopy,E01.370.388.250
20723788,2010-09-01T00:00:00,Endoscopy,E04.800.250
20723788,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20723788,2010-09-01T00:00:00,Middle Aged,M01.060.116.630
20723788,2010-09-01T00:00:00,Treatment Outcome,E01.789.800
20723788,2010-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20723788,2010-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20732536,2010-09-01T00:00:00,Animals,B01.050
20732536,2010-09-01T00:00:00,Cattle,B01.050.150.900.649.077.380.271
20732536,2010-09-01T00:00:00,"Heart Defects, Congenital",C14.240.400
20732536,2010-09-01T00:00:00,"Heart Defects, Congenital",C14.280.400
20732536,2010-09-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
20732536,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20732536,2010-09-01T00:00:00,Infant,M01.060.703
20732536,2010-09-01T00:00:00,Postoperative Complications,C23.550.767
20733431,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20733431,2010-09-01T00:00:00,Infant,M01.060.703
20733431,2010-09-01T00:00:00,Lumbar Vertebrae,A02.835.232.834.519
20733431,2010-09-01T00:00:00,"Monitoring, Intraoperative",E01.370.520.510
20733431,2010-09-01T00:00:00,"Monitoring, Intraoperative",E04.510
20733431,2010-09-01T00:00:00,Neural Tube Defects,C10.500.680
20733431,2010-09-01T00:00:00,Neural Tube Defects,C16.131.666.680
20733431,2010-09-01T00:00:00,Scoliosis,C05.116.900.800.875
20733431,2010-09-01T00:00:00,Treatment Outcome,E01.789.800
20733431,2010-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20733431,2010-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20733431,2010-09-01T00:00:00,Upper Extremity,A01.378.800
20736622,2010-09-01T00:00:00,Curriculum,I02.158
20736622,2010-09-01T00:00:00,"Education, Medical",I02.358.399
20736622,2010-09-01T00:00:00,"Schools, Medical",I02.783.660.552
20736622,2010-09-01T00:00:00,"Schools, Medical",N02.278.020.578
20736622,2010-09-01T00:00:00,South Carolina,Z01.107.567.875.075.662
20736622,2010-09-01T00:00:00,South Carolina,Z01.107.567.875.750.700
20736862,2010-09-01T00:00:00,Aged,M01.060.116.100
20736862,2010-09-01T00:00:00,Ambulatory Care,E02.760.106
20736862,2010-09-01T00:00:00,Ambulatory Care,N02.421.585.106
20736862,2010-09-01T00:00:00,Arterial Occlusive Diseases,C14.907.137
20736862,2010-09-01T00:00:00,Brachial Artery,A07.231.114.139
20736862,2010-09-01T00:00:00,"Hospitals, University",N02.278.020.300.310
20736862,2010-09-01T00:00:00,"Hospitals, University",N02.278.421.639.725
20736862,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20736862,2010-09-01T00:00:00,Middle Aged,M01.060.116.630
20738743,2010-09-01T00:00:00,Adolescent,M01.060.057
20738743,2010-09-01T00:00:00,Attitude to Health,F01.100.150
20738743,2010-09-01T00:00:00,Attitude to Health,N05.300.150
20738743,2010-09-01T00:00:00,Career Choice,F02.463.785.373.346.400
20738743,2010-09-01T00:00:00,Child,M01.060.406
20738743,2010-09-01T00:00:00,Cultural Diversity,I01.076.201.450.350
20738743,2010-09-01T00:00:00,Cultural Diversity,I01.880.143.450
20738743,2010-09-01T00:00:00,Data Collection,E05.318.308
20738743,2010-09-01T00:00:00,Data Collection,L01.280
20738743,2010-09-01T00:00:00,Data Collection,N05.715.360.300
20738743,2010-09-01T00:00:00,Data Collection,N06.850.520.308
20738743,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20738743,2010-09-01T00:00:00,"Models, Psychological",E05.599.695
20738743,2010-09-01T00:00:00,Nursing,H02.478
20738743,2010-09-01T00:00:00,Nursing,N04.452.758.377
20738743,2010-09-01T00:00:00,Psychometrics,F04.711.780
20738743,2010-09-01T00:00:00,Questionnaires,E05.318.308.750
20738743,2010-09-01T00:00:00,Questionnaires,L01.280.800
20738743,2010-09-01T00:00:00,Questionnaires,N05.715.360.300.695
20738743,2010-09-01T00:00:00,Questionnaires,N06.850.520.308.750
20738743,2010-09-01T00:00:00,Research Design,E05.581.500
20738743,2010-09-01T00:00:00,Research Design,H01.770.644.728
20738743,2010-09-01T00:00:00,Social Perception,F02.463.593.752
20738743,2010-09-01T00:00:00,Students,I02.233.748
20738743,2010-09-01T00:00:00,Students,I02.851
20738743,2010-09-01T00:00:00,Students,M01.848
20805539,2010-09-01T00:00:00,Adult,M01.060.116
20805539,2010-09-01T00:00:00,Brain Mapping,E01.370.350.086
20805539,2010-09-01T00:00:00,Brain Mapping,E01.370.376.149
20805539,2010-09-01T00:00:00,Brain Mapping,E05.132
20805539,2010-09-01T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
20805539,2010-09-01T00:00:00,Decision Making,F02.463.785.373
20805539,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20805539,2010-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20805539,2010-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20805539,2010-09-01T00:00:00,Risk-Taking,F01.145.722
20805539,2010-09-01T00:00:00,Uncertainty,E05.318.740.600.900
20805539,2010-09-01T00:00:00,Uncertainty,F02.463.785.373.820
20805539,2010-09-01T00:00:00,Uncertainty,G17.680.875
20805539,2010-09-01T00:00:00,Uncertainty,N05.715.360.750.625.850
20805539,2010-09-01T00:00:00,Uncertainty,N06.850.520.830.600.900
20805539,2010-09-01T00:00:00,Young Adult,M01.060.116.815
20805784,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20805784,2010-09-01T00:00:00,Infant,M01.060.703
20805784,2010-09-01T00:00:00,"Radiography, Abdominal",E01.370.350.700.715
20805784,2010-09-01T00:00:00,Time Factors,G01.910.857
20805784,2010-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20805784,2010-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20805784,2010-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20805784,2010-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20805784,2010-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20805784,2010-09-01T00:00:00,Treatment Outcome,E01.789.800
20805784,2010-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20805784,2010-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20811150,2010-09-01T00:00:00,Animals,B01.050
20811150,2010-09-01T00:00:00,"Cardiomyopathy, Hypertrophic",C14.280.238.100
20811150,2010-09-01T00:00:00,"Cardiomyopathy, Hypertrophic",C14.280.484.150.070.160
20811150,2010-09-01T00:00:00,Cell Proliferation,G04.299.233.750
20811150,2010-09-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
20811150,2010-09-01T00:00:00,"Disease Models, Animal",C22.232
20811150,2010-09-01T00:00:00,"Disease Models, Animal",E05.598.500
20811150,2010-09-01T00:00:00,"Disease Models, Animal",E05.599.395.080
20811150,2010-09-01T00:00:00,Fibrosis,C23.550.355
20811150,2010-09-01T00:00:00,Mutation,G05.365.590
20811150,2010-09-01T00:00:00,Myocardium,A02.633.580
20811150,2010-09-01T00:00:00,Myocardium,A07.541.704
20811150,2010-09-01T00:00:00,Myocardium,A10.690.552.750
20811150,2010-09-01T00:00:00,"Myocytes, Cardiac",A07.541.704.570
20811150,2010-09-01T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
20811150,2010-09-01T00:00:00,"Myocytes, Cardiac",A11.620.500
20811150,2010-09-01T00:00:00,Signal Transduction,G02.111.087.800
20811150,2010-09-01T00:00:00,Signal Transduction,G02.149.115.800
20811150,2010-09-01T00:00:00,Signal Transduction,G04.299.880
20811150,2010-09-01T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
20811150,2010-09-01T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
20811150,2010-09-01T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
20811150,2010-09-01T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
20811150,2010-09-01T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
20811150,2010-09-01T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
20811150,2010-09-01T00:00:00,Transforming Growth Factor beta,D23.529.374.687
20811150,2010-09-01T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
20811150,2010-09-01T00:00:00,Transforming Growth Factor beta,D23.529.960.720
20821664,2010-09-01T00:00:00,Alligators and Crocodiles,B01.050.150.900.833.100
20821664,2010-09-01T00:00:00,Animals,B01.050
20821664,2010-09-01T00:00:00,Environmental Monitoring,N06.850.460.350.080
20821664,2010-09-01T00:00:00,Environmental Monitoring,N06.850.780.375
20821664,2010-09-01T00:00:00,Estradiol,D04.808.365.415.248
20821664,2010-09-01T00:00:00,Estradiol,D06.472.334.851.437.500
20821664,2010-09-01T00:00:00,Estrogen Receptor alpha,D12.776.260.698.750.350.174
20821664,2010-09-01T00:00:00,Estrogen Receptor alpha,D12.776.826.750.350.174
20821664,2010-09-01T00:00:00,Estrogen Receptor alpha,D12.776.930.669.750.350.174
20821664,2010-09-01T00:00:00,Estrogens,D27.505.696.399.472.277
20821664,2010-09-01T00:00:00,Herbicides,D27.720.031.700.366
20821664,2010-09-01T00:00:00,Herbicides,D27.720.723.366
20821664,2010-09-01T00:00:00,Herbicides,D27.888.723.366
20821664,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20821664,2010-09-01T00:00:00,Triazines,D03.383.931
20821664,2010-09-01T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
20828469,2010-09-01T00:00:00,"Colony Count, Microbial",E05.200.875.220
20828469,2010-09-01T00:00:00,Hot Temperature,G01.906.595.543
20828469,2010-09-01T00:00:00,Hot Temperature,G16.500.275.063.725.710.380
20828469,2010-09-01T00:00:00,Hot Temperature,G16.500.750.775.710.380
20828469,2010-09-01T00:00:00,Hot Temperature,N06.230.300.100.725.232
20828469,2010-09-01T00:00:00,Hot Temperature,N06.230.300.100.725.710.380
20828469,2010-09-01T00:00:00,"Models, Biological",E05.599.395
20833618,2010-09-01T00:00:00,Adult,M01.060.116
20833618,2010-09-01T00:00:00,Aged,M01.060.116.100
20833618,2010-09-01T00:00:00,Animals,B01.050
20833618,2010-09-01T00:00:00,Health Education,I02.233.332
20833618,2010-09-01T00:00:00,Health Education,N02.421.143.827.407
20833618,2010-09-01T00:00:00,Health Education,N02.421.726.407
20833618,2010-09-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
20833618,2010-09-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
20833618,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20833618,2010-09-01T00:00:00,Middle Aged,M01.060.116.630
20833618,2010-09-01T00:00:00,Pharmaceutical Preparations,D26
20833618,2010-09-01T00:00:00,Questionnaires,E05.318.308.750
20833618,2010-09-01T00:00:00,Questionnaires,L01.280.800
20833618,2010-09-01T00:00:00,Questionnaires,N05.715.360.300.695
20833618,2010-09-01T00:00:00,Questionnaires,N06.850.520.308.750
20833618,2010-09-01T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
20833618,2010-09-01T00:00:00,Water Supply,N06.850.860.510.915
20833618,2010-09-01T00:00:00,Young Adult,M01.060.116.815
20833985,2010-09-01T00:00:00,Adolescent,M01.060.057
20833985,2010-09-01T00:00:00,Adult,M01.060.116
20833985,2010-09-01T00:00:00,African Americans,M01.686.508.100.100
20833985,2010-09-01T00:00:00,African Americans,M01.686.754.100
20833985,2010-09-01T00:00:00,HIV Infections,C02.782.815.616.400
20833985,2010-09-01T00:00:00,HIV Infections,C02.800.801.400
20833985,2010-09-01T00:00:00,HIV Infections,C20.673.480
20833985,2010-09-01T00:00:00,Health Services Accessibility,N04.590.374.350
20833985,2010-09-01T00:00:00,Health Services Accessibility,N05.300.430
20833985,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20833985,2010-09-01T00:00:00,Middle Aged,M01.060.116.630
20833985,2010-09-01T00:00:00,Patient Satisfaction,N04.452.822.360.600
20833985,2010-09-01T00:00:00,Patient Satisfaction,N05.300.150.600.630
20833985,2010-09-01T00:00:00,Patient Satisfaction,N05.715.360.600
20833985,2010-09-01T00:00:00,Pilot Projects,E05.318.760.750
20833985,2010-09-01T00:00:00,Pilot Projects,E05.337.737
20833985,2010-09-01T00:00:00,Pilot Projects,N05.715.360.775.625
20833985,2010-09-01T00:00:00,Pilot Projects,N06.850.520.450.720
20833985,2010-09-01T00:00:00,Quality of Health Care,N04.761
20833985,2010-09-01T00:00:00,Quality of Health Care,N05.715
20833985,2010-09-01T00:00:00,United States,Z01.107.567.875
20833985,2010-09-01T00:00:00,Young Adult,M01.060.116.815
20836336,2010-09-01T00:00:00,Academic Medical Centers,N02.278.020
20836336,2010-09-01T00:00:00,"History, 19th Century",K01.400.504.937
20836336,2010-09-01T00:00:00,"History, 20th Century",K01.400.504.968
20836336,2010-09-01T00:00:00,Internship and Residency,I02.358.399.644
20836336,2010-09-01T00:00:00,South Carolina,Z01.107.567.875.075.662
20836336,2010-09-01T00:00:00,South Carolina,Z01.107.567.875.750.700
20836361,2010-09-01T00:00:00,Adult,M01.060.116
20836361,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20836361,2010-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20836361,2010-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20836361,2010-09-01T00:00:00,Neoplasm Invasiveness,C04.697.645
20836361,2010-09-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
20836361,2010-09-01T00:00:00,Neurilemmoma,C04.557.465.625.650.595
20836361,2010-09-01T00:00:00,Neurilemmoma,C04.557.580.600.290
20836361,2010-09-01T00:00:00,Neurilemmoma,C04.557.580.600.610.595
20836361,2010-09-01T00:00:00,Neurilemmoma,C04.557.580.625.650.595
20836361,2010-09-01T00:00:00,Neurilemmoma,C10.551.775.500.500
20836361,2010-09-01T00:00:00,Neurilemmoma,C10.668.829.725.500.500
20836361,2010-09-01T00:00:00,Retroperitoneal Neoplasms,C04.588.033.731
20836361,2010-09-01T00:00:00,"Vena Cava, Inferior",A07.231.908.949.648
20839716,2010-09-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.555.110.110.110
20839716,2010-09-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.650.110.110
20839716,2010-09-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
20839716,2010-09-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
20839716,2010-09-01T00:00:00,Blood Transfusion,E02.095.135
20839716,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20839716,2010-09-01T00:00:00,"Pain, Postoperative",C23.550.767.700
20839716,2010-09-01T00:00:00,"Pain, Postoperative",C23.888.646.530
20849476,2010-09-01T00:00:00,Adult,M01.060.116
20849476,2010-09-01T00:00:00,Echocardiography,E01.370.350.850.220
20849476,2010-09-01T00:00:00,Echocardiography,E01.370.370.380.220
20849476,2010-09-01T00:00:00,"Electrodes, Implanted",E07.305.250.319
20849476,2010-09-01T00:00:00,Heart Atria,A07.541.358
20849476,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20849476,2010-09-01T00:00:00,"Surgery, Computer-Assisted",E02.950.875
20849476,2010-09-01T00:00:00,"Surgery, Computer-Assisted",E04.749
20849476,2010-09-01T00:00:00,"Surgery, Computer-Assisted",L01.700.508.100.710.800
20849476,2010-09-01T00:00:00,Treatment Outcome,E01.789.800
20849476,2010-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20849476,2010-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20850083,2010-09-01T00:00:00,Adult,M01.060.116
20850083,2010-09-01T00:00:00,Anesthesia,E03.155
20850083,2010-09-01T00:00:00,"Anesthesia, General",E03.155.197
20850083,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20850083,2010-09-01T00:00:00,Laryngeal Diseases,C08.360
20850083,2010-09-01T00:00:00,Laryngeal Diseases,C09.400
20850083,2010-09-01T00:00:00,Larynx,A04.329
20850083,2010-09-01T00:00:00,Preoperative Care,E02.760.795
20850083,2010-09-01T00:00:00,Preoperative Care,E04.641
20850083,2010-09-01T00:00:00,Preoperative Care,N02.421.585.795
20850083,2010-09-01T00:00:00,Reconstructive Surgical Procedures,E04.680
20850083,2010-09-01T00:00:00,Trachea,A04.889
20859015,2010-09-01T00:00:00,"Abdomen, Acute",C23.888.646.100.200
20859015,2010-09-01T00:00:00,"Abdomen, Acute",C23.888.821.030.249
20859015,2010-09-01T00:00:00,Child,M01.060.406
20859015,2010-09-01T00:00:00,"Child, Preschool",M01.060.406.448
20859015,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20859015,2010-09-01T00:00:00,Incidence,E05.318.308.985.525.375
20859015,2010-09-01T00:00:00,Incidence,L01.280.975.525.375
20859015,2010-09-01T00:00:00,Incidence,N01.224.935.597.500
20859015,2010-09-01T00:00:00,Incidence,N06.850.505.400.975.525.375
20859015,2010-09-01T00:00:00,Incidence,N06.850.520.308.985.525.375
20859015,2010-09-01T00:00:00,Infant,M01.060.703
20859015,2010-09-01T00:00:00,"Infant, Newborn",M01.060.703.520
20859015,2010-09-01T00:00:00,Laparoscopy,E01.370.388.250.520
20859015,2010-09-01T00:00:00,Laparoscopy,E04.800.250.520
20859015,2010-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20859015,2010-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20859015,2010-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20859015,2010-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20859015,2010-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20883230,2010-09-01T00:00:00,Adult,M01.060.116
20883230,2010-09-01T00:00:00,Attitude of Health Personnel,F01.100.050
20883230,2010-09-01T00:00:00,Attitude of Health Personnel,N05.300.100
20883230,2010-09-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
20883230,2010-09-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
20883230,2010-09-01T00:00:00,Hospitalization,E02.760.400
20883230,2010-09-01T00:00:00,Hospitalization,N02.421.585.400
20883230,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20883230,2010-09-01T00:00:00,Hypertension,C14.907.489
20883230,2010-09-01T00:00:00,Internship and Residency,I02.358.399.644
20884443,2010-09-01T00:00:00,Aged,M01.060.116.100
20884443,2010-09-01T00:00:00,Aortic Valve,A07.541.510.110
20884443,2010-09-01T00:00:00,Aortic Valve Stenosis,C14.280.484.150
20884443,2010-09-01T00:00:00,Aortic Valve Stenosis,C14.280.955.249
20884443,2010-09-01T00:00:00,Bioprosthesis,E07.695.100
20884443,2010-09-01T00:00:00,Heart Valve Prosthesis Implantation,E04.100.376.485
20884443,2010-09-01T00:00:00,Heart Valve Prosthesis Implantation,E04.650.410
20884443,2010-09-01T00:00:00,Heart Valve Prosthesis Implantation,E04.928.220.410
20884443,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20890162,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20890162,2010-09-01T00:00:00,Internet,L01.224.230.110.500
20890162,2010-09-01T00:00:00,Social Support,I01.880.656.600
20922926,2010-09-01T00:00:00,Aged,M01.060.116.100
20922926,2010-09-01T00:00:00,Ethnic Groups,M01.686.754
20922926,2010-09-01T00:00:00,Ethnic Groups,N01.224.317
20922926,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20922926,2010-09-01T00:00:00,Middle Aged,M01.060.116.630
20922926,2010-09-01T00:00:00,Occupational Therapy,E02.831.489
20922926,2010-09-01T00:00:00,Occupational Therapy,H02.010.500
20922926,2010-09-01T00:00:00,Stroke,C10.228.140.300.775
20922926,2010-09-01T00:00:00,Stroke,C14.907.253.855
20922926,2010-09-01T00:00:00,United States,Z01.107.567.875
20922926,2010-09-01T00:00:00,Veterans,M01.930
20931424,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20931424,2010-09-01T00:00:00,Signal Transduction,G02.111.087.800
20931424,2010-09-01T00:00:00,Signal Transduction,G02.149.115.800
20931424,2010-09-01T00:00:00,Signal Transduction,G04.299.880
20931424,2010-09-01T00:00:00,Stomach Neoplasms,C04.588.274.476.767
20931424,2010-09-01T00:00:00,Stomach Neoplasms,C06.301.371.767
20931424,2010-09-01T00:00:00,Stomach Neoplasms,C06.405.249.767
20931424,2010-09-01T00:00:00,Stomach Neoplasms,C06.405.748.789
20931424,2010-09-01T00:00:00,Wnt Proteins,D12.644.276.984
20931424,2010-09-01T00:00:00,Wnt Proteins,D12.776.467.984
20931424,2010-09-01T00:00:00,Wnt Proteins,D23.529.984
20931424,2010-09-01T00:00:00,beta Catenin,D12.776.091.249
20931424,2010-09-01T00:00:00,beta Catenin,D12.776.220.145.500
20931424,2010-09-01T00:00:00,beta Catenin,D12.776.930.130
20945752,2010-09-01T00:00:00,Dental Impression Materials,D25.339.334
20945752,2010-09-01T00:00:00,Dental Impression Materials,J01.637.051.339.334
20945752,2010-09-01T00:00:00,Dental Models,E06.261
20945752,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20945752,2010-09-01T00:00:00,Jaw Relation Record,E06.520
20945752,2010-09-01T00:00:00,"Jaw, Edentulous, Partially",C05.500.480.450
20945752,2010-09-01T00:00:00,"Jaw, Edentulous, Partially",C07.320.480.450
20945752,2010-09-01T00:00:00,"Jaw, Edentulous, Partially",C07.465.550.425.450
20945752,2010-09-01T00:00:00,"Jaw, Edentulous, Partially",C07.793.597.425.450
21033348,2010-09-01T00:00:00,Animals,B01.050
21033348,2010-09-01T00:00:00,Ethanol,D02.033.375
21033348,2010-09-01T00:00:00,Hepatocytes,A11.436.348
21033348,2010-09-01T00:00:00,Ion Channel Gating,G02.111.087.800.400
21033348,2010-09-01T00:00:00,Ion Channel Gating,G02.149.115.800.400
21033348,2010-09-01T00:00:00,Ion Channel Gating,G04.299.500
21033348,2010-09-01T00:00:00,Ion Channel Gating,G04.299.880.400
21033348,2010-09-01T00:00:00,Ion Channel Gating,G07.265.337.500
21033348,2010-09-01T00:00:00,Ion Channel Gating,G07.700.240.500
21033348,2010-09-01T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
21033348,2010-09-01T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
21033348,2010-09-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
21033348,2010-09-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
21033348,2010-09-01T00:00:00,Voltage-Dependent Anion Channels,D12.776.157.530.400.500.520
21033348,2010-09-01T00:00:00,Voltage-Dependent Anion Channels,D12.776.543.550.425.730.520
21033348,2010-09-01T00:00:00,Voltage-Dependent Anion Channels,D12.776.543.585.400.730.520
21171722,2010-09-01T00:00:00,Adsorption,G02.149.047
21171722,2010-09-01T00:00:00,Adsorption,G02.149.767.029
21171722,2010-09-01T00:00:00,Adsorption,G02.842.750.029
21171722,2010-09-01T00:00:00,Molecular Dynamics Simulation,E05.599.595.500
21171722,2010-09-01T00:00:00,Molecular Dynamics Simulation,G02.575.750
21171722,2010-09-01T00:00:00,Molecular Dynamics Simulation,L01.224.160.500
21171722,2010-09-01T00:00:00,Proteins,D12.776
21290027,2010-09-01T00:00:00,Anticoagulants,D27.505.954.502.119
21290027,2010-09-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.555.110.110.110
21290027,2010-09-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.650.110.110
21290027,2010-09-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
21290027,2010-09-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
21290027,2010-09-01T00:00:00,"Databases, Factual",L01.470.750.750
21290027,2010-09-01T00:00:00,"Databases, Factual",L01.700.508.300.188.400
21290027,2010-09-01T00:00:00,"Heparin, Low-Molecular-Weight",D09.698.373.400.300
21290027,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21290027,2010-09-01T00:00:00,Physician's Practice Patterns,N04.590.748
21290027,2010-09-01T00:00:00,Physician's Practice Patterns,N05.300.625
21290027,2010-09-01T00:00:00,Postoperative Complications,C23.550.767
21290027,2010-09-01T00:00:00,Venous Thromboembolism,C14.907.355.590.700
21290027,2010-09-01T00:00:00,Venous Thromboembolism,C14.907.355.830.850.700
21290027,2010-09-01T00:00:00,Warfarin,D03.438.150.446.520.914
21290027,2010-09-01T00:00:00,Warfarin,D03.830.219.446.520.914
21290029,2010-09-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.555.110.110.110
21290029,2010-09-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.650.110.110
21290029,2010-09-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
21290029,2010-09-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
21290029,2010-09-01T00:00:00,"Databases, Factual",L01.470.750.750
21290029,2010-09-01T00:00:00,"Databases, Factual",L01.700.508.300.188.400
21290029,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21290029,2010-09-01T00:00:00,Orthopedics,H02.403.810.494
21290029,2010-09-01T00:00:00,Physician's Practice Patterns,N04.590.748
21290029,2010-09-01T00:00:00,Physician's Practice Patterns,N05.300.625
21290029,2010-09-01T00:00:00,Postoperative Complications,C23.550.767
21290029,2010-09-01T00:00:00,Research Design,E05.581.500
21290029,2010-09-01T00:00:00,Research Design,H01.770.644.728
21410033,2010-09-01T00:00:00,Adult,M01.060.116
21410033,2010-09-01T00:00:00,Aged,M01.060.116.100
21410033,2010-09-01T00:00:00,Gastrointestinal Tract,A03.556
21410033,2010-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21410033,2010-09-01T00:00:00,Liver Diseases,C06.552
21410033,2010-09-01T00:00:00,Middle Aged,M01.060.116.630
20813856,2010-09-02T00:00:00,Adult,M01.060.116
20813856,2010-09-02T00:00:00,Heart Transplantation,E04.100.376.475
20813856,2010-09-02T00:00:00,Heart Transplantation,E04.928.220.390
20813856,2010-09-02T00:00:00,Heart Transplantation,E04.936.450.475
20813856,2010-09-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20813856,2010-09-02T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
20813856,2010-09-02T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
20813856,2010-09-02T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
20813856,2010-09-02T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
20813856,2010-09-02T00:00:00,Kidney Transplantation,E02.870.500
20813856,2010-09-02T00:00:00,Kidney Transplantation,E04.936.450.485
20813856,2010-09-02T00:00:00,Kidney Transplantation,E04.950.774.400
20813856,2010-09-02T00:00:00,Liver Transplantation,E04.210.650
20813856,2010-09-02T00:00:00,Liver Transplantation,E04.936.450.490
20813856,2010-09-02T00:00:00,Liver Transplantation,E04.936.580.490
20813856,2010-09-02T00:00:00,Lung Transplantation,E04.928.600.495
20813856,2010-09-02T00:00:00,Lung Transplantation,E04.936.450.495
20813856,2010-09-02T00:00:00,Middle Aged,M01.060.116.630
20813856,2010-09-02T00:00:00,Renal Dialysis,E02.870.300
20813856,2010-09-02T00:00:00,Renal Dialysis,E02.912.800
20813856,2010-09-02T00:00:00,Risk Assessment,E05.318.740.600.800.715
20813856,2010-09-02T00:00:00,Risk Assessment,N04.452.871.715
20813856,2010-09-02T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20813856,2010-09-02T00:00:00,Risk Assessment,N06.850.505.715
20813856,2010-09-02T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20813856,2010-09-02T00:00:00,Risk Factors,E05.318.740.600.800.725
20813856,2010-09-02T00:00:00,Risk Factors,N05.715.350.200.700
20813856,2010-09-02T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20813856,2010-09-02T00:00:00,Risk Factors,N06.850.490.625.750
20813856,2010-09-02T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20813856,2010-09-02T00:00:00,Time Factors,G01.910.857
20813856,2010-09-02T00:00:00,United States,Z01.107.567.875
20813856,2010-09-02T00:00:00,Waiting Lists,N04.452.095.738
20814000,2010-09-02T00:00:00,Aged,M01.060.116.100
20814000,2010-09-02T00:00:00,Cognition Disorders,F03.087.250
20814000,2010-09-02T00:00:00,Disability Evaluation,E01.370.400
20814000,2010-09-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20814000,2010-09-02T00:00:00,Middle Aged,M01.060.116.630
20814000,2010-09-02T00:00:00,Recombinant Proteins,D12.776.828
20814000,2010-09-02T00:00:00,Stroke,C10.228.140.300.775
20814000,2010-09-02T00:00:00,Stroke,C14.907.253.855
20814000,2010-09-02T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
20814000,2010-09-02T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
20814000,2010-09-02T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
20814000,2010-09-02T00:00:00,Tissue Plasminogen Activator,D23.119.970
20814000,2010-09-02T00:00:00,Treatment Outcome,E01.789.800
20814000,2010-09-02T00:00:00,Treatment Outcome,N04.761.559.590.800
20814000,2010-09-02T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20814000,2010-09-02T00:00:00,United States,Z01.107.567.875
20814414,2010-09-02T00:00:00,Adult,M01.060.116
20814414,2010-09-02T00:00:00,Consumer Satisfaction,N04.452.822.360
20814414,2010-09-02T00:00:00,Energy Intake,G07.610.240.340
20814414,2010-09-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20814414,2010-09-02T00:00:00,Middle Aged,M01.060.116.630
20814414,2010-09-02T00:00:00,Young Adult,M01.060.116.815
20824093,2010-09-02T00:00:00,Animals,B01.050
20824093,2010-09-02T00:00:00,Antigen-Antibody Complex,D12.776.124.486.485.114.257
20824093,2010-09-02T00:00:00,Antigen-Antibody Complex,D12.776.124.790.651.114.257
20824093,2010-09-02T00:00:00,Antigen-Antibody Complex,D12.776.377.715.548.114.257
20824093,2010-09-02T00:00:00,Antigen-Antibody Complex,D23.050.101
20824093,2010-09-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20824093,2010-09-02T00:00:00,"Lipoproteins, LDL",D10.532.515
20824093,2010-09-02T00:00:00,"Lipoproteins, LDL",D12.776.521.550
20824093,2010-09-02T00:00:00,Lysosomes,A11.284.430.214.190.875.190.550
20824093,2010-09-02T00:00:00,Macrophages,A11.329.372
20824093,2010-09-02T00:00:00,Macrophages,A11.627.482
20824093,2010-09-02T00:00:00,Macrophages,A11.733.397
20824093,2010-09-02T00:00:00,Macrophages,A15.382.680.397
20824093,2010-09-02T00:00:00,Macrophages,A15.382.812.522
20824093,2010-09-02T00:00:00,Oxidative Stress,G03.495.710
20824093,2010-09-02T00:00:00,Oxidative Stress,G07.700.830.750
20824093,2010-09-02T00:00:00,Protein Transport,G03.495.166.700
21085125,2010-09-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20813938,2010-09-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20813938,2010-09-03T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.606.586
20813938,2010-09-03T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.619.393.522.400
20813938,2010-09-03T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.705.500.380.500
20813938,2010-09-03T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.606.586
20813938,2010-09-03T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.619.393.522.400
20813938,2010-09-03T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.705.500.380.500
20813938,2010-09-03T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.606.586
20813938,2010-09-03T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.619.393.522.400
20813938,2010-09-03T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.705.500.380.500
20813938,2010-09-03T00:00:00,Immunoglobulin Gm Allotypes,G12.500.400.586
20813938,2010-09-03T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
20817935,2010-09-04T00:00:00,Adult,M01.060.116
20817935,2010-09-04T00:00:00,African Continental Ancestry Group,M01.686.508.100
20817935,2010-09-04T00:00:00,Aging,G07.700.320.124
20817935,2010-09-04T00:00:00,Biological Markers,D23.101
20817935,2010-09-04T00:00:00,European Continental Ancestry Group,M01.686.508.400
20817935,2010-09-04T00:00:00,Health Status,I01.240.425
20817935,2010-09-04T00:00:00,Health Status,N01.224.425
20817935,2010-09-04T00:00:00,Health Status,N06.850.505.400.425
20817935,2010-09-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20817935,2010-09-04T00:00:00,Life Style,F01.829.458
20817935,2010-09-04T00:00:00,Middle Aged,M01.060.116.630
20817935,2010-09-04T00:00:00,South Carolina,Z01.107.567.875.075.662
20817935,2010-09-04T00:00:00,South Carolina,Z01.107.567.875.750.700
20673028,2010-09-06T00:00:00,Animals,B01.050
20673028,2010-09-06T00:00:00,Bioreactors,E07.115
20673028,2010-09-06T00:00:00,Bioreactors,J01.897.120.115
20673028,2010-09-06T00:00:00,Cell Line,A11.251.210
20673028,2010-09-06T00:00:00,Collagen,D05.750.078.280
20673028,2010-09-06T00:00:00,Collagen,D12.776.860.300.250
20673028,2010-09-06T00:00:00,Heart Valves,A07.541.510
20673028,2010-09-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20673028,2010-09-06T00:00:00,Swine,B01.050.150.900.649.077.880
20673028,2010-09-06T00:00:00,Tissue Engineering,E05.200.249.750
20673028,2010-09-06T00:00:00,Tissue Scaffolds,E07.206.627
20673028,2010-09-06T00:00:00,Tissue Scaffolds,E07.695.825
20712357,2010-09-07T00:00:00,Cellulose,D05.750.078.562.180
20712357,2010-09-07T00:00:00,Cellulose,D09.698.365.180
20712357,2010-09-07T00:00:00,Cellulose,D25.720.099.500
20712357,2010-09-07T00:00:00,Cellulose,J01.637.051.720.099.500
20712357,2010-09-07T00:00:00,Gossypium,B01.650.388.100.700.244
20712357,2010-09-07T00:00:00,Nanostructures,J01.637.512
20712357,2010-09-07T00:00:00,Surface Properties,G02.842.850
20823267,2010-09-07T00:00:00,Animals,B01.050
20823267,2010-09-07T00:00:00,Cell Differentiation,G04.299.151
20823267,2010-09-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20823267,2010-09-07T00:00:00,Peptide Fragments,D12.644.541
20823267,2010-09-07T00:00:00,Pregnancy,G08.686.785.760.769
20823267,2010-09-07T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.260.665.400
20823267,2010-09-07T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.624.664.700.175.400
20823267,2010-09-07T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.930.635.400
20823267,2010-09-07T00:00:00,Thrombocytopenia,C15.378.140.855
20823888,2010-09-07T00:00:00,Aged,M01.060.116.100
20823888,2010-09-07T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
20823888,2010-09-07T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
20823888,2010-09-07T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
20823888,2010-09-07T00:00:00,"Carcinoma, Renal Cell",C04.557.470.200.025.390
20823888,2010-09-07T00:00:00,"Carcinoma, Renal Cell",C04.588.945.947.535.160
20823888,2010-09-07T00:00:00,"Carcinoma, Renal Cell",C12.758.820.750.160
20823888,2010-09-07T00:00:00,"Carcinoma, Renal Cell",C12.777.419.473.160
20823888,2010-09-07T00:00:00,"Carcinoma, Renal Cell",C13.351.937.820.535.160
20823888,2010-09-07T00:00:00,"Carcinoma, Renal Cell",C13.351.968.419.473.160
20823888,2010-09-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20823888,2010-09-07T00:00:00,Kidney Neoplasms,C04.588.945.947.535
20823888,2010-09-07T00:00:00,Kidney Neoplasms,C12.758.820.750
20823888,2010-09-07T00:00:00,Kidney Neoplasms,C12.777.419.473
20823888,2010-09-07T00:00:00,Kidney Neoplasms,C13.351.937.820.535
20823888,2010-09-07T00:00:00,Kidney Neoplasms,C13.351.968.419.473
20823888,2010-09-07T00:00:00,Middle Aged,M01.060.116.630
20823888,2010-09-07T00:00:00,Pyridines,D03.383.725
20823888,2010-09-07T00:00:00,Pyrroles,D03.383.129.578
20823888,2010-09-07T00:00:00,Quinazolines,D03.438.786
20823888,2010-09-07T00:00:00,Tandem Mass Spectrometry,E05.196.566.880
20826464,2010-09-07T00:00:00,Amyloid Precursor Protein Secretases,D08.811.277.656.300.032
20826464,2010-09-07T00:00:00,Amyloid beta-Protein Precursor,D12.776.049.025.150
20826464,2010-09-07T00:00:00,Amyloid beta-Protein Precursor,D12.776.811.050
20826464,2010-09-07T00:00:00,Animals,B01.050
20826464,2010-09-07T00:00:00,Aspartic Acid Endopeptidases,D08.811.277.656.074.500
20826464,2010-09-07T00:00:00,Aspartic Acid Endopeptidases,D08.811.277.656.300.048
20826464,2010-09-07T00:00:00,Cell Membrane,A11.284.149
20826464,2010-09-07T00:00:00,Cell Survival,G04.299.316
20826464,2010-09-07T00:00:00,Endoplasmic Reticulum,A11.284.430.214.190.875.248
20826464,2010-09-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20826464,2010-09-07T00:00:00,Membrane Transport Proteins,D12.776.157.530
20826464,2010-09-07T00:00:00,Membrane Transport Proteins,D12.776.543.585
20826464,2010-09-07T00:00:00,Neurons,A08.663
20826464,2010-09-07T00:00:00,Neurons,A11.671
20828636,2010-09-07T00:00:00,Adverse Drug Reaction Reporting Systems,E05.337.800.120
20828636,2010-09-07T00:00:00,Adverse Drug Reaction Reporting Systems,L01.453.270.120
20828636,2010-09-07T00:00:00,Adverse Drug Reaction Reporting Systems,N02.421.668.320.120
20828636,2010-09-07T00:00:00,Algorithms,G17.035
20828636,2010-09-07T00:00:00,Algorithms,L01.224.050
20828636,2010-09-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20828636,2010-09-07T00:00:00,Information Management,L01.399
20828636,2010-09-07T00:00:00,Information Systems,L01.700.508.300
20828636,2010-09-07T00:00:00,Internet,L01.224.230.110.500
20828636,2010-09-07T00:00:00,Multicenter Studies as Topic,E05.318.760.535.500
20828636,2010-09-07T00:00:00,Multicenter Studies as Topic,E05.337.250.500
20828636,2010-09-07T00:00:00,Multicenter Studies as Topic,N05.715.360.775.235.545
20828636,2010-09-07T00:00:00,Multicenter Studies as Topic,N06.850.520.450.535.500
20828636,2010-09-07T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
20828636,2010-09-07T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
20828636,2010-09-07T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
20828636,2010-09-07T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
20828636,2010-09-07T00:00:00,United States,Z01.107.567.875
20839678,2010-09-07T00:00:00,Anticoagulants,D27.505.954.502.119
20839678,2010-09-07T00:00:00,"Arthroplasty, Replacement, Hip",E04.555.110.110.110
20839678,2010-09-07T00:00:00,"Arthroplasty, Replacement, Hip",E04.650.110.110
20839678,2010-09-07T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
20839678,2010-09-07T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
20839678,2010-09-07T00:00:00,"Heparin, Low-Molecular-Weight",D09.698.373.400.300
20839678,2010-09-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20839678,2010-09-07T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
20839678,2010-09-07T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
20839678,2010-09-07T00:00:00,Practice Guidelines as Topic,N05.700.350.650
20839678,2010-09-07T00:00:00,Pulmonary Embolism,C08.381.746
20839678,2010-09-07T00:00:00,Pulmonary Embolism,C14.907.355.350.700
20839678,2010-09-07T00:00:00,Venous Thrombosis,C14.907.355.830.925
20839678,2010-09-07T00:00:00,Warfarin,D03.438.150.446.520.914
20839678,2010-09-07T00:00:00,Warfarin,D03.830.219.446.520.914
20868629,2010-09-07T00:00:00,Adult,M01.060.116
20868629,2010-09-07T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
20868629,2010-09-07T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
20868629,2010-09-07T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
20868629,2010-09-07T00:00:00,Bipolar Disorder,F03.600.150.150
20868629,2010-09-07T00:00:00,Health Services,N02.421
20868629,2010-09-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20868629,2010-09-07T00:00:00,Middle Aged,M01.060.116.630
20868629,2010-09-07T00:00:00,Psychiatric Status Rating Scales,F04.586
20868629,2010-09-07T00:00:00,Treatment Outcome,E01.789.800
20868629,2010-09-07T00:00:00,Treatment Outcome,N04.761.559.590.800
20868629,2010-09-07T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20868629,2010-09-07T00:00:00,United States,Z01.107.567.875
20826789,2010-09-08T00:00:00,ADAM Proteins,D08.811.277.656.675.374.102
20826789,2010-09-08T00:00:00,ADAM Proteins,D09.400.430.500
20826789,2010-09-08T00:00:00,ADAM Proteins,D12.776.395.033
20826789,2010-09-08T00:00:00,Animals,B01.050
20826789,2010-09-08T00:00:00,Diabetes Mellitus,C18.452.394.750
20826789,2010-09-08T00:00:00,Diabetes Mellitus,C19.246
20826789,2010-09-08T00:00:00,Glycoproteins,D09.400.430
20826789,2010-09-08T00:00:00,Glycoproteins,D12.776.395
20826789,2010-09-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20826789,2010-09-08T00:00:00,Intercellular Signaling Peptides and Proteins,D12.644.276
20826789,2010-09-08T00:00:00,Intercellular Signaling Peptides and Proteins,D12.776.467
20826789,2010-09-08T00:00:00,Intercellular Signaling Peptides and Proteins,D23.529
20826789,2010-09-08T00:00:00,Kallikreins,D08.811.277.656.300.760.442
20826789,2010-09-08T00:00:00,Kallikreins,D08.811.277.656.959.350.442
20826789,2010-09-08T00:00:00,Kallikreins,D12.776.124.125.597
20826789,2010-09-08T00:00:00,Kallikreins,D23.119.597
20826789,2010-09-08T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
20826789,2010-09-08T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
20826789,2010-09-08T00:00:00,MAP Kinase Signaling System,G03.495.553.560
20826789,2010-09-08T00:00:00,MAP Kinase Signaling System,G04.299.880.560
20826789,2010-09-08T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.567.342.500
20826789,2010-09-08T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.646.750.249.500
20826789,2010-09-08T00:00:00,Mitogen-Activated Protein Kinase 1,D12.644.360.450.169.500
20826789,2010-09-08T00:00:00,Mitogen-Activated Protein Kinase 1,D12.776.476.450.169.500
20826789,2010-09-08T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.567.342.750
20826789,2010-09-08T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.646.750.249.750
20826789,2010-09-08T00:00:00,Mitogen-Activated Protein Kinase 3,D12.644.360.450.169.750
20826789,2010-09-08T00:00:00,Mitogen-Activated Protein Kinase 3,D12.776.476.450.169.750
20826789,2010-09-08T00:00:00,"Muscle, Smooth, Vascular",A02.633.570.491
20826789,2010-09-08T00:00:00,"Muscle, Smooth, Vascular",A07.231.491
20826789,2010-09-08T00:00:00,"Muscle, Smooth, Vascular",A10.690.467.491
20826789,2010-09-08T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20826789,2010-09-08T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
20826789,2010-09-08T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
20826789,2010-09-08T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
20826789,2010-09-08T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
20826789,2010-09-08T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
20826076,2010-09-09T00:00:00,Adolescent,M01.060.057
20826076,2010-09-09T00:00:00,Caregivers,M01.085
20826076,2010-09-09T00:00:00,Caregivers,M01.526.485.200
20826076,2010-09-09T00:00:00,Caregivers,N02.360.200
20826076,2010-09-09T00:00:00,Child,M01.060.406
20826076,2010-09-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20826076,2010-09-09T00:00:00,Juvenile Delinquency,I01.880.735.479
20826076,2010-09-09T00:00:00,Marijuana Abuse,C21.739.635
20826076,2010-09-09T00:00:00,Marijuana Abuse,F03.900.635
20826076,2010-09-09T00:00:00,"Models, Statistical",E05.318.740.500
20826076,2010-09-09T00:00:00,"Models, Statistical",E05.599.835
20826076,2010-09-09T00:00:00,"Models, Statistical",N05.715.360.750.530
20826076,2010-09-09T00:00:00,"Models, Statistical",N06.850.520.830.500
20826076,2010-09-09T00:00:00,Regression Analysis,E05.318.740.750
20826076,2010-09-09T00:00:00,Regression Analysis,N05.715.360.750.695
20826076,2010-09-09T00:00:00,Regression Analysis,N06.850.520.830.750
20826076,2010-09-09T00:00:00,Substance Abuse Detection,E05.885
20826076,2010-09-09T00:00:00,Substance Abuse Detection,N06.850.780.500.765
20826076,2010-09-09T00:00:00,Substance-Related Disorders,C21.739
20826076,2010-09-09T00:00:00,Substance-Related Disorders,F03.900
20826076,2010-09-09T00:00:00,Treatment Outcome,E01.789.800
20826076,2010-09-09T00:00:00,Treatment Outcome,N04.761.559.590.800
20826076,2010-09-09T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20829233,2010-09-09T00:00:00,Activities of Daily Living,E02.831.067
20829233,2010-09-09T00:00:00,Activities of Daily Living,I03.050
20829233,2010-09-09T00:00:00,Activities of Daily Living,N02.421.784.110
20829233,2010-09-09T00:00:00,Aged,M01.060.116.100
20829233,2010-09-09T00:00:00,Anxiety,F01.470.132
20829233,2010-09-09T00:00:00,Depression,F01.145.126.350
20829233,2010-09-09T00:00:00,Elder Abuse,I01.198.240.856.350.390
20829233,2010-09-09T00:00:00,Elder Abuse,I01.880.735.900.350.390
20829233,2010-09-09T00:00:00,Emotions,F01.470
20829233,2010-09-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20829233,2010-09-09T00:00:00,Interviews as Topic,E05.318.308.420
20829233,2010-09-09T00:00:00,Interviews as Topic,L01.280.520
20829233,2010-09-09T00:00:00,Interviews as Topic,N05.715.360.300.400
20829233,2010-09-09T00:00:00,Interviews as Topic,N06.850.520.308.420
20829233,2010-09-09T00:00:00,Middle Aged,M01.060.116.630
20829233,2010-09-09T00:00:00,Risk Factors,E05.318.740.600.800.725
20829233,2010-09-09T00:00:00,Risk Factors,N05.715.350.200.700
20829233,2010-09-09T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20829233,2010-09-09T00:00:00,Risk Factors,N06.850.490.625.750
20829233,2010-09-09T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20829233,2010-09-09T00:00:00,Rural Population,N01.600.725
20829233,2010-09-09T00:00:00,Social Support,I01.880.656.600
20829233,2010-09-09T00:00:00,South Carolina,Z01.107.567.875.075.662
20829233,2010-09-09T00:00:00,South Carolina,Z01.107.567.875.750.700
20829233,2010-09-09T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
20602408,2010-09-10T00:00:00,Electric Conductivity,G01.201.249.277
20602408,2010-09-10T00:00:00,"Membranes, Artificial",D25.479
20602408,2010-09-10T00:00:00,"Membranes, Artificial",J01.637.051.479
20602408,2010-09-10T00:00:00,"Membranes, Artificial",J01.637.087.500
20602408,2010-09-10T00:00:00,Protons,D01.248.497.300.459.700
20602408,2010-09-10T00:00:00,Protons,D01.435.550
20602408,2010-09-10T00:00:00,Protons,G01.249.765
20602408,2010-09-10T00:00:00,Surface Properties,G02.842.850
20828419,2010-09-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20828419,2010-09-10T00:00:00,Middle Aged,M01.060.116.630
20828419,2010-09-10T00:00:00,Multiple Myeloma,C04.557.595.500
20828419,2010-09-10T00:00:00,Multiple Myeloma,C14.907.454.460
20828419,2010-09-10T00:00:00,Multiple Myeloma,C15.378.147.780.650
20828419,2010-09-10T00:00:00,Multiple Myeloma,C15.378.463.835.460
20828419,2010-09-10T00:00:00,Multiple Myeloma,C20.683.515.845
20828419,2010-09-10T00:00:00,Multiple Myeloma,C20.683.780.650
20831365,2010-09-10T00:00:00,Aged,M01.060.116.100
20831365,2010-09-10T00:00:00,Antifungal Agents,D27.505.954.122.136
20831365,2010-09-10T00:00:00,Hemoptysis,C08.381.348
20831365,2010-09-10T00:00:00,Hemoptysis,C23.550.414.896
20831365,2010-09-10T00:00:00,Hemoptysis,C23.888.852.430
20831365,2010-09-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20831365,2010-09-10T00:00:00,Kidney Transplantation,E02.870.500
20831365,2010-09-10T00:00:00,Kidney Transplantation,E04.936.450.485
20831365,2010-09-10T00:00:00,Kidney Transplantation,E04.950.774.400
20831365,2010-09-10T00:00:00,Pyrimidines,D03.383.742
20831365,2010-09-10T00:00:00,Sarcoidosis,C15.604.515.827
20831365,2010-09-10T00:00:00,Triazoles,D03.383.129.799
21088729,2010-09-10T00:00:00,"Education, Pharmacy",I02.358.525
21088729,2010-09-10T00:00:00,Educational Technology,J01.897.280
21088729,2010-09-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21088729,2010-09-10T00:00:00,"Schools, Pharmacy",I02.783.660.694
21088729,2010-09-10T00:00:00,United States,Z01.107.567.875
20666606,2010-09-13T00:00:00,"Adaptor Proteins, Vesicular Transport",D12.776.543.990.150
20666606,2010-09-13T00:00:00,Animals,B01.050
20666606,2010-09-13T00:00:00,Collagen,D05.750.078.280
20666606,2010-09-13T00:00:00,Collagen,D12.776.860.300.250
20666606,2010-09-13T00:00:00,Heart Ventricles,A07.541.560
20666606,2010-09-13T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
20666606,2010-09-13T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
20666606,2010-09-13T00:00:00,Mesenchymal Stem Cell Transplantation,E04.936.225.687.625
20666606,2010-09-13T00:00:00,Myocardial Infarction,C14.280.647.500
20666606,2010-09-13T00:00:00,Myocardial Infarction,C14.907.585.500
20666606,2010-09-13T00:00:00,Myocardium,A02.633.580
20666606,2010-09-13T00:00:00,Myocardium,A07.541.704
20666606,2010-09-13T00:00:00,Myocardium,A10.690.552.750
20666606,2010-09-13T00:00:00,Protein Biosynthesis,G02.111.087.675.871
20666606,2010-09-13T00:00:00,Protein Biosynthesis,G02.149.115.675.871
20666606,2010-09-13T00:00:00,Protein Biosynthesis,G03.495.770.871
20666606,2010-09-13T00:00:00,Protein Biosynthesis,G05.355.310.670
20666606,2010-09-13T00:00:00,RNA Interference,G05.355.315.203.374.790
20666606,2010-09-13T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20666606,2010-09-13T00:00:00,"Transcription, Genetic",G02.111.087.847
20666606,2010-09-13T00:00:00,"Transcription, Genetic",G02.149.115.847
20666606,2010-09-13T00:00:00,"Transcription, Genetic",G05.355.310.700
20666606,2010-09-13T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
20666606,2010-09-13T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
20666606,2010-09-13T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
20666606,2010-09-13T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
20666606,2010-09-13T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
20666606,2010-09-13T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
20666606,2010-09-13T00:00:00,Transforming Growth Factor beta,D23.529.374.687
20666606,2010-09-13T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
20666606,2010-09-13T00:00:00,Transforming Growth Factor beta,D23.529.960.720
20837654,2010-09-13T00:00:00,Adult,M01.060.116
20837654,2010-09-13T00:00:00,Aged,M01.060.116.100
20837654,2010-09-13T00:00:00,Community-Based Participatory Research,N05.425.104
20837654,2010-09-13T00:00:00,Health Policy,I01.880.604.825.608.400
20837654,2010-09-13T00:00:00,Health Policy,N03.706.825.608.428
20837654,2010-09-13T00:00:00,Health Promotion,N02.370
20837654,2010-09-13T00:00:00,Health Promotion,N02.421.726.507
20837654,2010-09-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20837654,2010-09-13T00:00:00,Middle Aged,M01.060.116.630
20837654,2010-09-13T00:00:00,"Models, Theoretical",E05.599
20837654,2010-09-13T00:00:00,Qualitative Research,H01.770.644.241.850
20837920,2010-09-14T00:00:00,Cardiopulmonary Resuscitation,E02.365.647.110
20837920,2010-09-14T00:00:00,"Databases, Factual",L01.470.750.750
20837920,2010-09-14T00:00:00,"Databases, Factual",L01.700.508.300.188.400
20837920,2010-09-14T00:00:00,Extracorporeal Membrane Oxygenation,E02.880.301
20837920,2010-09-14T00:00:00,Extracorporeal Membrane Oxygenation,E04.292.451
20837920,2010-09-14T00:00:00,Heart Diseases,C14.280
20837920,2010-09-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20837920,2010-09-14T00:00:00,Infant,M01.060.703
20837920,2010-09-14T00:00:00,Risk Factors,E05.318.740.600.800.725
20837920,2010-09-14T00:00:00,Risk Factors,N05.715.350.200.700
20837920,2010-09-14T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20837920,2010-09-14T00:00:00,Risk Factors,N06.850.490.625.750
20837920,2010-09-14T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20837920,2010-09-14T00:00:00,Time Factors,G01.910.857
20841387,2010-09-14T00:00:00,Case-Control Studies,E05.318.760.500.500
20841387,2010-09-14T00:00:00,Case-Control Studies,N05.715.360.775.175.200
20841387,2010-09-14T00:00:00,Case-Control Studies,N06.850.520.450.500.500
20841387,2010-09-14T00:00:00,Diet,E05.272
20841387,2010-09-14T00:00:00,Diet,G07.610.240
20841387,2010-09-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20841387,2010-09-14T00:00:00,Lung Neoplasms,C04.588.894.797.520
20841387,2010-09-14T00:00:00,Lung Neoplasms,C08.381.540
20841387,2010-09-14T00:00:00,Lung Neoplasms,C08.785.520
20841387,2010-09-14T00:00:00,Middle Aged,M01.060.116.630
20841387,2010-09-14T00:00:00,Risk Assessment,E05.318.740.600.800.715
20841387,2010-09-14T00:00:00,Risk Assessment,N04.452.871.715
20841387,2010-09-14T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20841387,2010-09-14T00:00:00,Risk Assessment,N06.850.505.715
20841387,2010-09-14T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20841387,2010-09-14T00:00:00,Risk Factors,E05.318.740.600.800.725
20841387,2010-09-14T00:00:00,Risk Factors,N05.715.350.200.700
20841387,2010-09-14T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20841387,2010-09-14T00:00:00,Risk Factors,N06.850.490.625.750
20841387,2010-09-14T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20841387,2010-09-14T00:00:00,Smoking,F01.145.466.753
20841387,2010-09-14T00:00:00,Smoking Cessation,F01.145.940.700
20841473,2010-09-14T00:00:00,Animals,B01.050
20841473,2010-09-14T00:00:00,Apoptosis,G04.299.139.160
20841473,2010-09-14T00:00:00,Disease Progression,C23.550.291.656
20841473,2010-09-14T00:00:00,Inbreeding,E05.820.150.520
20841473,2010-09-14T00:00:00,Inbreeding,G05.355.090.403
20841473,2010-09-14T00:00:00,Lymphocyte Activation,E01.450.495.482
20841473,2010-09-14T00:00:00,Lymphocyte Activation,E05.478.594.530
20841473,2010-09-14T00:00:00,Lymphocyte Activation,G12.425.747
20841473,2010-09-14T00:00:00,Lymphocyte Activation,G12.450.050.400.545
20841473,2010-09-14T00:00:00,"Neovascularization, Pathologic",C23.550.589.500
20841473,2010-09-14T00:00:00,Nitric Oxide Synthase Type II,D08.811.682.664.500.772.500
20841473,2010-09-14T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
20841473,2010-09-14T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
20841473,2010-09-14T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
20841473,2010-09-14T00:00:00,"T-Lymphocytes, Cytotoxic",A11.118.637.555.283.875
20841473,2010-09-14T00:00:00,"T-Lymphocytes, Cytotoxic",A11.118.637.555.567.569.220.200
20841473,2010-09-14T00:00:00,"T-Lymphocytes, Cytotoxic",A15.145.229.637.555.283.875
20841473,2010-09-14T00:00:00,"T-Lymphocytes, Cytotoxic",A15.145.229.637.555.567.569.220.200
20841473,2010-09-14T00:00:00,"T-Lymphocytes, Cytotoxic",A15.382.490.555.283.875
20841473,2010-09-14T00:00:00,"T-Lymphocytes, Cytotoxic",A15.382.490.555.567.569.220.200
20841473,2010-09-14T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
20841473,2010-09-14T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
20841473,2010-09-14T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
20694977,2010-09-15T00:00:00,Animals,B01.050
20694977,2010-09-15T00:00:00,"Leukocytes, Mononuclear",A11.118.637.555
20694977,2010-09-15T00:00:00,"Leukocytes, Mononuclear",A15.145.229.637.555
20694977,2010-09-15T00:00:00,"Leukocytes, Mononuclear",A15.382.490.555
20694977,2010-09-15T00:00:00,Myocardium,A02.633.580
20694977,2010-09-15T00:00:00,Myocardium,A07.541.704
20694977,2010-09-15T00:00:00,Myocardium,A10.690.552.750
20694977,2010-09-15T00:00:00,Phenotype,G05.695
20694977,2010-09-15T00:00:00,Tissue Engineering,E05.200.249.750
20694977,2010-09-15T00:00:00,Tissue Scaffolds,E07.206.627
20694977,2010-09-15T00:00:00,Tissue Scaffolds,E07.695.825
20837060,2010-09-15T00:00:00,Animals,B01.050
20837060,2010-09-15T00:00:00,Executive Function,F02.463.217
20837060,2010-09-15T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
20837060,2010-09-15T00:00:00,Genetic Predisposition to Disease,G05.380.355
20837060,2010-09-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20837060,2010-09-15T00:00:00,Impulsive Behavior,F01.145.527
20837060,2010-09-15T00:00:00,Motivation,F01.658
20837060,2010-09-15T00:00:00,Motivation,F01.752.543.500.750
20837060,2010-09-15T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
20837060,2010-09-15T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20837060,2010-09-15T00:00:00,Risk Factors,E05.318.740.600.800.725
20837060,2010-09-15T00:00:00,Risk Factors,N05.715.350.200.700
20837060,2010-09-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20837060,2010-09-15T00:00:00,Risk Factors,N06.850.490.625.750
20837060,2010-09-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20837060,2010-09-15T00:00:00,Risk Reduction Behavior,F01.145.699
20837060,2010-09-15T00:00:00,Substance-Related Disorders,C21.739
20837060,2010-09-15T00:00:00,Substance-Related Disorders,F03.900
20847035,2010-09-16T00:00:00,Adolescent,M01.060.057
20847035,2010-09-16T00:00:00,Case-Control Studies,E05.318.760.500.500
20847035,2010-09-16T00:00:00,Case-Control Studies,N05.715.360.775.175.200
20847035,2010-09-16T00:00:00,Case-Control Studies,N06.850.520.450.500.500
20847035,2010-09-16T00:00:00,Cerebral Palsy,C10.228.140.140.254
20847035,2010-09-16T00:00:00,Child,M01.060.406
20847035,2010-09-16T00:00:00,Disability Evaluation,E01.370.400
20847035,2010-09-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20847035,2010-09-16T00:00:00,Isometric Contraction,G11.427.590.540.472
20847035,2010-09-16T00:00:00,Knee Joint,A02.835.583.475
20847035,2010-09-16T00:00:00,Quadriceps Muscle,A02.633.567.850
20847035,2010-09-16T00:00:00,Young Adult,M01.060.116.815
21111381,2010-09-16T00:00:00,Adolescent,M01.060.057
21111381,2010-09-16T00:00:00,Adult,M01.060.116
21111381,2010-09-16T00:00:00,Aged,M01.060.116.100
21111381,2010-09-16T00:00:00,Blood Transfusion,E02.095.135
21111381,2010-09-16T00:00:00,Gastric Bypass,E02.065.062.249
21111381,2010-09-16T00:00:00,Gastric Bypass,E04.035.398.385
21111381,2010-09-16T00:00:00,Gastric Bypass,E04.062.249
21111381,2010-09-16T00:00:00,Gastric Bypass,E04.210.457.430
21111381,2010-09-16T00:00:00,Gastrointestinal Hemorrhage,C06.405.227
21111381,2010-09-16T00:00:00,Gastrointestinal Hemorrhage,C23.550.414.788
21111381,2010-09-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21111381,2010-09-16T00:00:00,Length of Stay,E02.760.400.480
21111381,2010-09-16T00:00:00,Length of Stay,N02.421.585.400.480
21111381,2010-09-16T00:00:00,Middle Aged,M01.060.116.630
21111381,2010-09-16T00:00:00,Postoperative Complications,C23.550.767
21111381,2010-09-16T00:00:00,Reoperation,E04.690
21111381,2010-09-16T00:00:00,Risk Factors,E05.318.740.600.800.725
21111381,2010-09-16T00:00:00,Risk Factors,N05.715.350.200.700
21111381,2010-09-16T00:00:00,Risk Factors,N05.715.360.750.625.700.700
21111381,2010-09-16T00:00:00,Risk Factors,N06.850.490.625.750
21111381,2010-09-16T00:00:00,Risk Factors,N06.850.520.830.600.800.725
21111381,2010-09-16T00:00:00,Treatment Outcome,E01.789.800
21111381,2010-09-16T00:00:00,Treatment Outcome,N04.761.559.590.800
21111381,2010-09-16T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21111381,2010-09-16T00:00:00,Young Adult,M01.060.116.815
20848205,2010-09-17T00:00:00,Adult,M01.060.116
20848205,2010-09-17T00:00:00,Aged,M01.060.116.100
20848205,2010-09-17T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
20848205,2010-09-17T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
20848205,2010-09-17T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
20848205,2010-09-17T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
20848205,2010-09-17T00:00:00,Gastrointestinal Hemorrhage,C06.405.227
20848205,2010-09-17T00:00:00,Gastrointestinal Hemorrhage,C23.550.414.788
20848205,2010-09-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20848205,2010-09-17T00:00:00,Middle Aged,M01.060.116.630
20848205,2010-09-17T00:00:00,Young Adult,M01.060.116.815
20850009,2010-09-17T00:00:00,DNA Replication,G02.111.087.222
20850009,2010-09-17T00:00:00,DNA Replication,G02.149.115.222
20850009,2010-09-17T00:00:00,DNA Replication,G05.355.200
20850009,2010-09-17T00:00:00,DNA-Binding Proteins,D12.776.260
20850009,2010-09-17T00:00:00,Schizosaccharomyces,B01.300.107.797
20850009,2010-09-17T00:00:00,Schizosaccharomyces,B01.300.930.720
20850009,2010-09-17T00:00:00,Transcription Factors,D12.776.930
20850181,2010-09-17T00:00:00,Adolescent,M01.060.057
20850181,2010-09-17T00:00:00,Adult,M01.060.116
20850181,2010-09-17T00:00:00,Child,M01.060.406
20850181,2010-09-17T00:00:00,"Child Abuse, Sexual",I01.198.240.748.300
20850181,2010-09-17T00:00:00,"Child Abuse, Sexual",I01.198.240.856.350.250.255
20850181,2010-09-17T00:00:00,"Child Abuse, Sexual",I01.880.735.900.350.250.255
20850181,2010-09-17T00:00:00,"Child Abuse, Sexual",I01.880.787.293.292.325
20850181,2010-09-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20850181,2010-09-17T00:00:00,Psychiatric Status Rating Scales,F04.586
20850181,2010-09-17T00:00:00,Psychometrics,F04.711.780
20850181,2010-09-17T00:00:00,Questionnaires,E05.318.308.750
20850181,2010-09-17T00:00:00,Questionnaires,L01.280.800
20850181,2010-09-17T00:00:00,Questionnaires,N05.715.360.300.695
20850181,2010-09-17T00:00:00,Questionnaires,N06.850.520.308.750
20850181,2010-09-17T00:00:00,Social Support,I01.880.656.600
20850181,2010-09-17T00:00:00,Young Adult,M01.060.116.815
20852254,2010-09-17T00:00:00,Amino Acid Sequence,G02.111.570.060
20852254,2010-09-17T00:00:00,Amino Acid Sequence,L01.453.245.667.060
20852254,2010-09-17T00:00:00,Catalytic Domain,G02.111.570.120.704
20852254,2010-09-17T00:00:00,Catalytic Domain,G02.111.570.790.709.610.189
20852254,2010-09-17T00:00:00,DNA Repair,G02.111.087.219
20852254,2010-09-17T00:00:00,DNA Repair,G02.149.115.219
20852254,2010-09-17T00:00:00,DNA Repair,G05.355.195
20852254,2010-09-17T00:00:00,Escherichia coli,B03.440.450.425.325.300
20852254,2010-09-17T00:00:00,Escherichia coli,B03.660.250.150.180.100
20852254,2010-09-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20852254,2010-09-17T00:00:00,Hydrogen Bonding,G02.149.767.620
20852254,2010-09-17T00:00:00,Hydrogen Bonding,G02.842.750.620
20852254,2010-09-17T00:00:00,"Models, Molecular",E05.599.595
20852254,2010-09-17T00:00:00,Molecular Sequence Data,L01.453.245.667
20852254,2010-09-17T00:00:00,"Mutagenesis, Site-Directed",E05.393.420.601.575
20853052,2010-09-19T00:00:00,Adult,M01.060.116
20853052,2010-09-19T00:00:00,Aged,M01.060.116.100
20853052,2010-09-19T00:00:00,Breast Neoplasms,C04.588.180
20853052,2010-09-19T00:00:00,Breast Neoplasms,C17.800.090.500
20853052,2010-09-19T00:00:00,"Carcinoma, Ductal",C04.557.470.200.025.232
20853052,2010-09-19T00:00:00,"Carcinoma, Ductal",C04.557.470.615.132
20853052,2010-09-19T00:00:00,"Carcinoma, Lobular",C04.557.470.200.025.305
20853052,2010-09-19T00:00:00,"Carcinoma, Lobular",C04.557.470.615.305
20853052,2010-09-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20853052,2010-09-19T00:00:00,Lymph Nodes,A10.549.400
20853052,2010-09-19T00:00:00,Lymph Nodes,A15.382.520.604.412
20853052,2010-09-19T00:00:00,Middle Aged,M01.060.116.630
20853052,2010-09-19T00:00:00,Neoplasm Invasiveness,C04.697.645
20853052,2010-09-19T00:00:00,Neoplasm Invasiveness,C23.550.727.645
20853052,2010-09-19T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
20853052,2010-09-19T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
20853052,2010-09-19T00:00:00,Neoplasm Staging,E01.370.550
20853052,2010-09-19T00:00:00,"RNA, Messenger",D13.444.735.544
20853052,2010-09-19T00:00:00,"Tumor Markers, Biological",D23.101.840
20951543,2010-09-19T00:00:00,Behavior Therapy,F04.754.137
20951543,2010-09-19T00:00:00,Combat Disorders,F03.080.931.249
20951543,2010-09-19T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
20951543,2010-09-19T00:00:00,Emotions,F01.470
20951543,2010-09-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20951543,2010-09-19T00:00:00,Patient Satisfaction,N04.452.822.360.600
20951543,2010-09-19T00:00:00,Patient Satisfaction,N05.300.150.600.630
20951543,2010-09-19T00:00:00,Patient Satisfaction,N05.715.360.600
20951543,2010-09-19T00:00:00,Social Adjustment,F01.145.813.621
20951543,2010-09-19T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
20951543,2010-09-19T00:00:00,Treatment Outcome,E01.789.800
20951543,2010-09-19T00:00:00,Treatment Outcome,N04.761.559.590.800
20951543,2010-09-19T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20951543,2010-09-19T00:00:00,Veterans,M01.930
20851531,2010-09-20T00:00:00,Adolescent,M01.060.057
20851531,2010-09-20T00:00:00,"Behavior, Addictive",F01.145.527.100.120
20851531,2010-09-20T00:00:00,Cues,F02.463.425.234
20851531,2010-09-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20851531,2010-09-20T00:00:00,Marijuana Abuse,C21.739.635
20851531,2010-09-20T00:00:00,Marijuana Abuse,F03.900.635
20851531,2010-09-20T00:00:00,Young Adult,M01.060.116.815
20855611,2010-09-20T00:00:00,Cell Membrane,A11.284.149
20855611,2010-09-20T00:00:00,Cholesterol,D04.808.247.222.284
20855611,2010-09-20T00:00:00,Cholesterol,D04.808.247.808.197
20855611,2010-09-20T00:00:00,Cholesterol,D10.570.938.208
20855611,2010-09-20T00:00:00,Cholesterol,D10.851.208
20855611,2010-09-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20855611,2010-09-20T00:00:00,Signal Transduction,G02.111.087.800
20855611,2010-09-20T00:00:00,Signal Transduction,G02.149.115.800
20855611,2010-09-20T00:00:00,Signal Transduction,G04.299.880
20855611,2010-09-20T00:00:00,Sphingolipids,D10.570.877
20855611,2010-09-20T00:00:00,Sphingolipids,D10.808
20855611,2010-09-20T00:00:00,"Stress, Physiological",G07.700.830
21112446,2010-09-20T00:00:00,Adolescent,M01.060.057
21112446,2010-09-20T00:00:00,Adult,M01.060.116
21112446,2010-09-20T00:00:00,Aged,M01.060.116.100
21112446,2010-09-20T00:00:00,Alcoholism,C21.739.100.250
21112446,2010-09-20T00:00:00,Alcoholism,F03.900.100.350
21112446,2010-09-20T00:00:00,"Depressive Disorder, Major",F03.600.300.375
21112446,2010-09-20T00:00:00,Diabetes Mellitus,C18.452.394.750
21112446,2010-09-20T00:00:00,Diabetes Mellitus,C19.246
21112446,2010-09-20T00:00:00,Health Behavior,F01.145.488
21112446,2010-09-20T00:00:00,Health Surveys,E05.318.308.250
21112446,2010-09-20T00:00:00,Health Surveys,N05.715.360.300.375
21112446,2010-09-20T00:00:00,Health Surveys,N06.850.520.308.250
21112446,2010-09-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21112446,2010-09-20T00:00:00,Mammography,E01.370.350.700.500
21112446,2010-09-20T00:00:00,Mass Screening,E01.370.500
21112446,2010-09-20T00:00:00,Mass Screening,E05.318.308.250.580
21112446,2010-09-20T00:00:00,Mass Screening,N02.421.143.827.233.443
21112446,2010-09-20T00:00:00,Mass Screening,N02.421.726.233.443
21112446,2010-09-20T00:00:00,Mass Screening,N05.715.360.300.375.500
21112446,2010-09-20T00:00:00,Mass Screening,N06.850.520.308.250.580
21112446,2010-09-20T00:00:00,Mass Screening,N06.850.780.500
21112446,2010-09-20T00:00:00,Middle Aged,M01.060.116.630
21112446,2010-09-20T00:00:00,Neoplasms,C04
21112446,2010-09-20T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
21112446,2010-09-20T00:00:00,Prostate-Specific Antigen,D08.811.277.656.300.760.442.750
21112446,2010-09-20T00:00:00,Prostate-Specific Antigen,D08.811.277.656.959.350.442.750
21112446,2010-09-20T00:00:00,Prostate-Specific Antigen,D12.776.866.249.500
21112446,2010-09-20T00:00:00,Prostate-Specific Antigen,D23.050.285.625
21112446,2010-09-20T00:00:00,Prostate-Specific Antigen,D23.101.840.625
21112446,2010-09-20T00:00:00,Quality of Life,I01.800
21112446,2010-09-20T00:00:00,Quality of Life,K01.752.400.750
21112446,2010-09-20T00:00:00,Self Care,E02.900
21112446,2010-09-20T00:00:00,Self Care,N02.421.784.680
21112446,2010-09-20T00:00:00,Sigmoidoscopy,E01.370.372.250.250.200.700
21112446,2010-09-20T00:00:00,Sigmoidoscopy,E01.370.388.250.250.250.160.800
21112446,2010-09-20T00:00:00,Sigmoidoscopy,E04.210.240.250.160.800
21112446,2010-09-20T00:00:00,Sigmoidoscopy,E04.800.250.250.250.160.800
21112446,2010-09-20T00:00:00,United States,Z01.107.567.875
21112446,2010-09-20T00:00:00,Young Adult,M01.060.116.815
20704258,2010-09-21T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
20704258,2010-09-21T00:00:00,Cephalosporins,D02.065.589.099.249
20704258,2010-09-21T00:00:00,Cephalosporins,D02.886.665.074
20704258,2010-09-21T00:00:00,Cephalosporins,D04.075.080.875.099.221.249
20704258,2010-09-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20704258,2010-09-21T00:00:00,Microbial Sensitivity Tests,E05.200.875.595
20704258,2010-09-21T00:00:00,Microbial Sensitivity Tests,E05.337.550.400
20704258,2010-09-21T00:00:00,Mutation,G05.365.590
20704258,2010-09-21T00:00:00,Neisseria gonorrhoeae,B03.440.400.425.550.550.474
20704258,2010-09-21T00:00:00,Neisseria gonorrhoeae,B03.660.075.525.520.400
20704258,2010-09-21T00:00:00,Penicillin-Binding Proteins,D08.811.710
20704258,2010-09-21T00:00:00,Penicillin-Binding Proteins,D12.776.097.545
20704258,2010-09-21T00:00:00,Penicillins,D02.065.589.099.750
20704258,2010-09-21T00:00:00,Penicillins,D02.886.108.750
20704258,2010-09-21T00:00:00,Penicillins,D03.438.260.825
20704258,2010-09-21T00:00:00,Penicillins,D03.605.084.737
20704258,2010-09-21T00:00:00,Penicillins,D04.075.080.875.099.221.750
20726582,2010-09-21T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
20726582,2010-09-21T00:00:00,"Crystallography, X-Ray",E05.196.309.742.225
20726582,2010-09-21T00:00:00,Escherichia coli,B03.440.450.425.325.300
20726582,2010-09-21T00:00:00,Escherichia coli,B03.660.250.150.180.100
20726582,2010-09-21T00:00:00,Penicillin-Binding Proteins,D08.811.710
20726582,2010-09-21T00:00:00,Penicillin-Binding Proteins,D12.776.097.545
20845508,2010-09-21T00:00:00,Abdominal Pain,C23.888.646.100
20845508,2010-09-21T00:00:00,Abdominal Pain,C23.888.821.030
20845508,2010-09-21T00:00:00,Adult,M01.060.116
20845508,2010-09-21T00:00:00,Disability Evaluation,E01.370.400
20845508,2010-09-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20845508,2010-09-21T00:00:00,Pilot Projects,E05.318.760.750
20845508,2010-09-21T00:00:00,Pilot Projects,E05.337.737
20845508,2010-09-21T00:00:00,Pilot Projects,N05.715.360.775.625
20845508,2010-09-21T00:00:00,Pilot Projects,N06.850.520.450.720
20845508,2010-09-21T00:00:00,Questionnaires,E05.318.308.750
20845508,2010-09-21T00:00:00,Questionnaires,L01.280.800
20845508,2010-09-21T00:00:00,Questionnaires,N05.715.360.300.695
20845508,2010-09-21T00:00:00,Questionnaires,N06.850.520.308.750
20865800,2010-09-21T00:00:00,Animals,B01.050
20865800,2010-09-21T00:00:00,"Chromatography, Gel",E05.196.181.400.250
20865800,2010-09-21T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
20865800,2010-09-21T00:00:00,Flow Cytometry,E05.200.500.386.350
20865800,2010-09-21T00:00:00,Membrane Glycoproteins,D12.776.395.550
20865800,2010-09-21T00:00:00,Membrane Glycoproteins,D12.776.543.550
20865800,2010-09-21T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
20865800,2010-09-21T00:00:00,"Microscopy, Fluorescence",E05.595.458
20865800,2010-09-21T00:00:00,Molecular Chaperones,D12.776.580
20865800,2010-09-21T00:00:00,Polymerase Chain Reaction,E05.393.620.500
20865800,2010-09-21T00:00:00,Protein Folding,G01.154.100.640
20865800,2010-09-21T00:00:00,Protein Folding,G01.595.100.640
20865800,2010-09-21T00:00:00,Protein Folding,G02.111.087.690
20865800,2010-09-21T00:00:00,Protein Folding,G02.149.115.690
20865800,2010-09-21T00:00:00,Tandem Mass Spectrometry,E05.196.566.880
20865800,2010-09-21T00:00:00,Toll-Like Receptors,D12.776.543.750.705.910.500
20865800,2010-09-21T00:00:00,"Transduction, Genetic",E05.393.350.800
20865800,2010-09-21T00:00:00,"Transduction, Genetic",G05.355.760.850
20958842,2010-09-21T00:00:00,Adolescent,M01.060.057
20958842,2010-09-21T00:00:00,Adrenergic Uptake Inhibitors,D27.505.519.625.050.601
20958842,2010-09-21T00:00:00,Adrenergic Uptake Inhibitors,D27.505.519.625.600.050
20958842,2010-09-21T00:00:00,Adrenergic Uptake Inhibitors,D27.505.696.577.050.601
20958842,2010-09-21T00:00:00,Adrenergic Uptake Inhibitors,D27.505.696.577.600.050
20958842,2010-09-21T00:00:00,Adult,M01.060.116
20958842,2010-09-21T00:00:00,Aged,M01.060.116.100
20958842,2010-09-21T00:00:00,Attention Deficit Disorder with Hyperactivity,F03.550.150.150
20958842,2010-09-21T00:00:00,Double-Blind Method,E05.318.780.300
20958842,2010-09-21T00:00:00,Double-Blind Method,E05.581.500.300
20958842,2010-09-21T00:00:00,Double-Blind Method,N05.715.360.780.320
20958842,2010-09-21T00:00:00,Double-Blind Method,N06.850.520.445.300
20958842,2010-09-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20958842,2010-09-21T00:00:00,Marijuana Abuse,C21.739.635
20958842,2010-09-21T00:00:00,Marijuana Abuse,F03.900.635
20958842,2010-09-21T00:00:00,Middle Aged,M01.060.116.630
20958842,2010-09-21T00:00:00,Propylamines,D02.092.831
20873688,2010-09-22T00:00:00,Aged,M01.060.116.100
20873688,2010-09-22T00:00:00,Antifungal Agents,D27.505.954.122.136
20873688,2010-09-22T00:00:00,Dermatologic Agents,D27.505.954.444
20873688,2010-09-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20873688,2010-09-22T00:00:00,Risk Factors,E05.318.740.600.800.725
20873688,2010-09-22T00:00:00,Risk Factors,N05.715.350.200.700
20873688,2010-09-22T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20873688,2010-09-22T00:00:00,Risk Factors,N06.850.490.625.750
20873688,2010-09-22T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20873695,2010-09-22T00:00:00,Adolescent,M01.060.057
20873695,2010-09-22T00:00:00,Biometry,E05.318.740.225
20873695,2010-09-22T00:00:00,Biometry,N06.850.505.200
20873695,2010-09-22T00:00:00,Cataract,C11.510.245
20873695,2010-09-22T00:00:00,Cataract Extraction,E04.540.825.249
20873695,2010-09-22T00:00:00,Child,M01.060.406
20873695,2010-09-22T00:00:00,"Child, Preschool",M01.060.406.448
20873695,2010-09-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20873695,2010-09-22T00:00:00,Infant,M01.060.703
20873695,2010-09-22T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
20873695,2010-09-22T00:00:00,"Lens, Crystalline",A09.371.060.500
20873695,2010-09-22T00:00:00,"Lenses, Intraocular",E07.632.500.460
20873695,2010-09-22T00:00:00,"Lenses, Intraocular",E07.695.460
20873695,2010-09-22T00:00:00,Treatment Outcome,E01.789.800
20873695,2010-09-22T00:00:00,Treatment Outcome,N04.761.559.590.800
20873695,2010-09-22T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20873695,2010-09-22T00:00:00,Visual Acuity,E01.370.380.850.950
20873695,2010-09-22T00:00:00,Visual Acuity,F02.463.593.932.901
20873695,2010-09-22T00:00:00,Visual Acuity,G14.940
20864496,2010-09-23T00:00:00,Algorithms,G17.035
20864496,2010-09-23T00:00:00,Algorithms,L01.224.050
20864496,2010-09-23T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
20864496,2010-09-23T00:00:00,Genetic Predisposition to Disease,G05.380.355
20864496,2010-09-23T00:00:00,Genome-Wide Association Study,E05.318.416.249
20864496,2010-09-23T00:00:00,Genome-Wide Association Study,E05.318.780.392
20864496,2010-09-23T00:00:00,Genome-Wide Association Study,E05.393.385.500
20864496,2010-09-23T00:00:00,Genome-Wide Association Study,E05.393.522.500
20864496,2010-09-23T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
20864496,2010-09-23T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
20864496,2010-09-23T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
20864496,2010-09-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20864496,2010-09-23T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
20864496,2010-09-23T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
20864496,2010-09-23T00:00:00,Sex Factors,N05.715.350.675
20864496,2010-09-23T00:00:00,Sex Factors,N06.850.490.875
20864944,2010-09-23T00:00:00,African Americans,M01.686.508.100.100
20864944,2010-09-23T00:00:00,African Americans,M01.686.754.100
20864944,2010-09-23T00:00:00,Aged,M01.060.116.100
20864944,2010-09-23T00:00:00,Blood Pressure,E01.370.600.875.249
20864944,2010-09-23T00:00:00,Blood Pressure,G09.330.380.076
20864944,2010-09-23T00:00:00,European Continental Ancestry Group,M01.686.508.400
20864944,2010-09-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20864944,2010-09-23T00:00:00,Middle Aged,M01.060.116.630
20864944,2010-09-23T00:00:00,Risk Assessment,E05.318.740.600.800.715
20864944,2010-09-23T00:00:00,Risk Assessment,N04.452.871.715
20864944,2010-09-23T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20864944,2010-09-23T00:00:00,Risk Assessment,N06.850.505.715
20864944,2010-09-23T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20864944,2010-09-23T00:00:00,Risk Factors,E05.318.740.600.800.725
20864944,2010-09-23T00:00:00,Risk Factors,N05.715.350.200.700
20864944,2010-09-23T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20864944,2010-09-23T00:00:00,Risk Factors,N06.850.490.625.750
20864944,2010-09-23T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20864944,2010-09-23T00:00:00,Stroke,C10.228.140.300.775
20864944,2010-09-23T00:00:00,Stroke,C14.907.253.855
20864944,2010-09-23T00:00:00,United States,Z01.107.567.875
20871110,2010-09-24T00:00:00,Hospitals,N02.278.421
20871110,2010-09-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20871110,2010-09-24T00:00:00,Occupational Exposure,N06.850.460.350.600
20871110,2010-09-24T00:00:00,Smoking,F01.145.466.753
20871110,2010-09-24T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
20871110,2010-09-24T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
21185525,2010-09-24T00:00:00,Adolescent,M01.060.057
21185525,2010-09-24T00:00:00,African Americans,M01.686.508.100.100
21185525,2010-09-24T00:00:00,African Americans,M01.686.754.100
21185525,2010-09-24T00:00:00,Awareness,F02.463.188.150
21185525,2010-09-24T00:00:00,"Blood Pressure Monitoring, Ambulatory",E01.370.370.140.100
21185525,2010-09-24T00:00:00,"Blood Pressure Monitoring, Ambulatory",E01.370.520.500.100
21185525,2010-09-24T00:00:00,Cardiovascular Diseases,C14
21185525,2010-09-24T00:00:00,Health Promotion,N02.370
21185525,2010-09-24T00:00:00,Health Promotion,N02.421.726.507
21185525,2010-09-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21185525,2010-09-24T00:00:00,Hypertension,C14.907.489
21185525,2010-09-24T00:00:00,Meditation,E02.190.525.374
21185525,2010-09-24T00:00:00,Meditation,E02.190.901.455
21185525,2010-09-24T00:00:00,Meditation,F04.754.137.750.500
21185525,2010-09-24T00:00:00,Respiratory Mechanics,G09.772.770.755.700
21185525,2010-09-24T00:00:00,Sodium,D01.268.549.750
21185525,2010-09-24T00:00:00,Sodium,D01.552.528.850
21185525,2010-09-24T00:00:00,Treatment Outcome,E01.789.800
21185525,2010-09-24T00:00:00,Treatment Outcome,N04.761.559.590.800
21185525,2010-09-24T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21185525,2010-09-24T00:00:00,United States,Z01.107.567.875
20869713,2010-09-25T00:00:00,Aged,M01.060.116.100
20869713,2010-09-25T00:00:00,"Biopsy, Fine-Needle",E01.370.388.100.100.500
20869713,2010-09-25T00:00:00,"Biopsy, Fine-Needle",E01.450.230.100.100.500
20869713,2010-09-25T00:00:00,"Biopsy, Fine-Needle",E01.450.865.100.100.500
20869713,2010-09-25T00:00:00,"Biopsy, Fine-Needle",E04.074.119.500
20869713,2010-09-25T00:00:00,Endosonography,E01.370.350.850.280
20869713,2010-09-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20869713,2010-09-25T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
20869713,2010-09-25T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
20869713,2010-09-25T00:00:00,Pancreatectomy,E04.210.752
20869713,2010-09-25T00:00:00,Pancreatic Neoplasms,C04.588.274.761
20869713,2010-09-25T00:00:00,Pancreatic Neoplasms,C04.588.322.421
20869713,2010-09-25T00:00:00,Pancreatic Neoplasms,C06.301.761
20869713,2010-09-25T00:00:00,Pancreatic Neoplasms,C06.689.667
20869713,2010-09-25T00:00:00,Pancreatic Neoplasms,C19.344.421
20875489,2010-09-25T00:00:00,Adolescent,M01.060.057
20875489,2010-09-25T00:00:00,Adult,M01.060.116
20875489,2010-09-25T00:00:00,Animals,B01.050
20875489,2010-09-25T00:00:00,"Antigens, Bacterial",D23.050.161
20875489,2010-09-25T00:00:00,Bacterial Proteins,D12.776.097
20875489,2010-09-25T00:00:00,Carrier State,N06.850.160
20875489,2010-09-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20875489,2010-09-25T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
20875489,2010-09-25T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
20875489,2010-09-25T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
20875489,2010-09-25T00:00:00,Meningococcal Infections,C01.252.400.625.549
20875489,2010-09-25T00:00:00,Middle Aged,M01.060.116.630
20875489,2010-09-25T00:00:00,Rabbits,B01.050.150.900.649.521.700
20875489,2010-09-25T00:00:00,Young Adult,M01.060.116.815
20871896,2010-09-27T00:00:00,Antioxidants,D27.505.519.217
20871896,2010-09-27T00:00:00,Antioxidants,D27.505.696.706.125
20871896,2010-09-27T00:00:00,Antioxidants,D27.720.799.047
20871896,2010-09-27T00:00:00,Electrons,G01.201.750
20871896,2010-09-27T00:00:00,Electrons,G01.249.335
20871896,2010-09-27T00:00:00,Iron,D01.268.556.412
20871896,2010-09-27T00:00:00,Iron,D01.268.956.287
20871896,2010-09-27T00:00:00,Iron,D01.552.544.412
20885931,2010-09-27T00:00:00,Animals,B01.050
20885931,2010-09-27T00:00:00,Brain Chemistry,G02.111.100
20885931,2010-09-27T00:00:00,Brain Chemistry,G03.200
20885931,2010-09-27T00:00:00,Gene Expression Regulation,G05.355.315
20885931,2010-09-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20885931,2010-09-27T00:00:00,"Mice, Inbred CBA",B01.050.050.157.520.440
20885931,2010-09-27T00:00:00,"Mice, Inbred CBA",B01.050.050.199.520.520.440
20885931,2010-09-27T00:00:00,"Mice, Inbred CBA",B01.050.150.900.649.865.635.505.500.400.440
20885931,2010-09-27T00:00:00,Microglia,A08.637.400
20885931,2010-09-27T00:00:00,Microglia,A11.650.400
20807313,2010-09-28T00:00:00,Alzheimer Disease,C10.228.140.380.100
20807313,2010-09-28T00:00:00,Alzheimer Disease,C10.574.945.249
20807313,2010-09-28T00:00:00,Alzheimer Disease,F03.087.400.100
20807313,2010-09-28T00:00:00,Cerebrovascular Disorders,C10.228.140.300
20807313,2010-09-28T00:00:00,Cerebrovascular Disorders,C14.907.253
20807313,2010-09-28T00:00:00,Diabetes Complications,C19.246.099
20807313,2010-09-28T00:00:00,Diet,E05.272
20807313,2010-09-28T00:00:00,Diet,G07.610.240
20807313,2010-09-28T00:00:00,Heart Diseases,C14.280
20807313,2010-09-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20807313,2010-09-28T00:00:00,Insulin Resistance,C18.452.394.968.500
20807313,2010-09-28T00:00:00,Insulin Resistance,G07.690.320.617
20807313,2010-09-28T00:00:00,Life Style,F01.829.458
20807313,2010-09-28T00:00:00,Metabolic Diseases,C18.452
20807313,2010-09-28T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
20807313,2010-09-28T00:00:00,Metabolic Syndrome X,C18.452.625
20851613,2010-09-28T00:00:00,Ceramides,D02.065.313
20851613,2010-09-28T00:00:00,Ceramides,D09.400.410.420.525.200
20851613,2010-09-28T00:00:00,Ceramides,D10.390.470.675.200
20851613,2010-09-28T00:00:00,Ceramides,D10.570.877.360.612.200
20851613,2010-09-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20851613,2010-09-28T00:00:00,Magnetic Resonance Spectroscopy,E05.196.867.519
20851613,2010-09-28T00:00:00,Sphingolipids,D10.570.877
20851613,2010-09-28T00:00:00,Sphingolipids,D10.808
20851613,2010-09-28T00:00:00,Time Factors,G01.910.857
20878547,2010-09-29T00:00:00,Child,M01.060.406
20878547,2010-09-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20878547,2010-09-29T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
20878547,2010-09-29T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
20878547,2010-09-29T00:00:00,Pediatrics,H02.403.670
20878547,2010-09-29T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
20878547,2010-09-29T00:00:00,Practice Guidelines as Topic,N05.700.350.650
20878547,2010-09-29T00:00:00,Schizophrenia,F03.700.750
20878547,2010-09-29T00:00:00,United States,Z01.107.567.875
20880662,2010-09-29T00:00:00,Alcohol Drinking,F01.145.317.269
20880662,2010-09-29T00:00:00,Animals,B01.050
20880662,2010-09-29T00:00:00,Ethanol,D02.033.375
20880662,2010-09-29T00:00:00,Self Administration,E02.319.890
20880662,2010-09-29T00:00:00,Self Administration,E02.900.890
20880662,2010-09-29T00:00:00,Sex Factors,N05.715.350.675
20880662,2010-09-29T00:00:00,Sex Factors,N06.850.490.875
20880662,2010-09-29T00:00:00,Social Isolation,F01.145.813.781
20880662,2010-09-29T00:00:00,Social Isolation,I01.880.683
20880662,2010-09-29T00:00:00,"Stress, Psychological",F01.145.126.990
20880662,2010-09-29T00:00:00,"Stress, Psychological",F02.830.900
20881011,2010-09-29T00:00:00,Adolescent,M01.060.057
20881011,2010-09-29T00:00:00,Adult,M01.060.116
20881011,2010-09-29T00:00:00,Age of Onset,N05.715.350.075.100
20881011,2010-09-29T00:00:00,Age of Onset,N06.850.490.250.100
20881011,2010-09-29T00:00:00,Child,M01.060.406
20881011,2010-09-29T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
20881011,2010-09-29T00:00:00,Genetic Predisposition to Disease,G05.380.355
20881011,2010-09-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20881011,2010-09-29T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
20881011,2010-09-29T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
20881011,2010-09-29T00:00:00,Middle Aged,M01.060.116.630
20881011,2010-09-29T00:00:00,Phenotype,G05.695
20881011,2010-09-29T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
20881011,2010-09-29T00:00:00,Young Adult,M01.060.116.815
20881059,2010-09-29T00:00:00,"Adaptor Proteins, Vesicular Transport",D12.776.543.990.150
20881059,2010-09-29T00:00:00,Animals,B01.050
20881059,2010-09-29T00:00:00,Endocytosis,G04.299.482
20881059,2010-09-29T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
20881059,2010-09-29T00:00:00,"Microscopy, Fluorescence",E05.595.458
20881059,2010-09-29T00:00:00,Mutation,G05.365.590
20881059,2010-09-29T00:00:00,Phosphorylation,G02.111.087.677
20881059,2010-09-29T00:00:00,Phosphorylation,G02.149.115.677
20881059,2010-09-29T00:00:00,Phosphorylation,G02.149.465.700
20881059,2010-09-29T00:00:00,Phosphorylation,G02.607.750.700
20881059,2010-09-29T00:00:00,Phosphorylation,G03.495.790
20881059,2010-09-29T00:00:00,Protein Transport,G03.495.166.700
20881059,2010-09-29T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
20881059,2010-09-29T00:00:00,RNA Interference,G05.355.315.203.374.790
20881059,2010-09-29T00:00:00,Vesicular Transport Proteins,D12.776.543.990
20881059,2010-09-29T00:00:00,rab GTP-Binding Proteins,D08.811.277.040.330.300.400.400
20881059,2010-09-29T00:00:00,rab GTP-Binding Proteins,D12.644.360.525.400
20881059,2010-09-29T00:00:00,rab GTP-Binding Proteins,D12.776.157.325.515.400
20881059,2010-09-29T00:00:00,rab GTP-Binding Proteins,D12.776.476.525.400
20884243,2010-09-29T00:00:00,Aortic Diseases,C14.907.109
20884243,2010-09-29T00:00:00,Bibliometrics,L01.178.682.099.325
20884243,2010-09-29T00:00:00,Bibliometrics,L01.453.183.291
20884243,2010-09-29T00:00:00,Cerebrovascular Disorders,C10.228.140.300
20884243,2010-09-29T00:00:00,Cerebrovascular Disorders,C14.907.253
20884243,2010-09-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20884243,2010-09-29T00:00:00,Medical Oncology,H02.403.429.515
20884243,2010-09-29T00:00:00,North America,Z01.107.567
20884243,2010-09-29T00:00:00,Time Factors,G01.910.857
20884243,2010-09-29T00:00:00,Vascular Surgical Procedures,E04.100.814
20879964,2010-09-30T00:00:00,Adolescent,M01.060.057
20879964,2010-09-30T00:00:00,Adult,M01.060.116
20879964,2010-09-30T00:00:00,Aged,M01.060.116.100
20879964,2010-09-30T00:00:00,Blood Glucose,D09.546.359.448.500
20879964,2010-09-30T00:00:00,Diabetes Complications,C19.246.099
20879964,2010-09-30T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
20879964,2010-09-30T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
20879964,2010-09-30T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
20879964,2010-09-30T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
20879964,2010-09-30T00:00:00,Health Literacy,I02.233.332.186.500
20879964,2010-09-30T00:00:00,Health Literacy,N02.421.143.827.407.228.500
20879964,2010-09-30T00:00:00,Health Literacy,N02.421.726.407.228.500
20879964,2010-09-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20879964,2010-09-30T00:00:00,Middle Aged,M01.060.116.630
20879964,2010-09-30T00:00:00,Motivation,F01.658
20879964,2010-09-30T00:00:00,Motivation,F01.752.543.500.750
20879964,2010-09-30T00:00:00,Self Care,E02.900
20879964,2010-09-30T00:00:00,Self Care,N02.421.784.680
20879964,2010-09-30T00:00:00,Social Environment,I01.880.656
20879964,2010-09-30T00:00:00,Social Support,I01.880.656.600
20879964,2010-09-30T00:00:00,Young Adult,M01.060.116.815
20884696,2010-09-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20884696,2010-09-30T00:00:00,"Renal Insufficiency, Chronic",C12.777.419.780.750
20884696,2010-09-30T00:00:00,"Renal Insufficiency, Chronic",C13.351.968.419.780.750
20884696,2010-09-30T00:00:00,Risk Factors,E05.318.740.600.800.725
20884696,2010-09-30T00:00:00,Risk Factors,N05.715.350.200.700
20884696,2010-09-30T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20884696,2010-09-30T00:00:00,Risk Factors,N06.850.490.625.750
20884696,2010-09-30T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20884696,2010-09-30T00:00:00,Stroke,C10.228.140.300.775
20884696,2010-09-30T00:00:00,Stroke,C14.907.253.855
20954571,2010-09-30T00:00:00,Attitude of Health Personnel,F01.100.050
20954571,2010-09-30T00:00:00,Attitude of Health Personnel,N05.300.100
20954571,2010-09-30T00:00:00,Civil Defense,I01.451.227
20954571,2010-09-30T00:00:00,Clinical Competence,I02.399.630.210
20954571,2010-09-30T00:00:00,Clinical Competence,N04.761.210
20954571,2010-09-30T00:00:00,Cooperative Behavior,F01.145.813.115
20954571,2010-09-30T00:00:00,Curriculum,I02.158
20954571,2010-09-30T00:00:00,Disaster Planning,N06.230.100.035
20954571,2010-09-30T00:00:00,"Education, Nursing, Baccalaureate",I02.358.462.316
20954571,2010-09-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20954571,2010-09-30T00:00:00,Mass Casualty Incidents,I01.198.240.856.800.537
20954571,2010-09-30T00:00:00,Mass Casualty Incidents,I01.880.735.900.800.575
20954571,2010-09-30T00:00:00,Mass Casualty Incidents,N06.230.100.160
20954571,2010-09-30T00:00:00,Organizational Objectives,N04.452.615
20954571,2010-09-30T00:00:00,Program Development,N04.452.760
20954571,2010-09-30T00:00:00,"Students, Nursing",I02.851.686.685
20954571,2010-09-30T00:00:00,"Students, Nursing",M01.848.769.685
20954571,2010-09-30T00:00:00,United States,Z01.107.567.875
20073074,2010-10-01T00:00:00,Adult,M01.060.116
20073074,2010-10-01T00:00:00,Aged,M01.060.116.100
20073074,2010-10-01T00:00:00,Animals,B01.050
20073074,2010-10-01T00:00:00,Electrosurgery,E04.262
20073074,2010-10-01T00:00:00,Facial Paralysis,C07.465.327
20073074,2010-10-01T00:00:00,Facial Paralysis,C10.597.622.214
20073074,2010-10-01T00:00:00,Facial Paralysis,C23.888.592.636.214
20073074,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20073074,2010-10-01T00:00:00,Middle Aged,M01.060.116.630
20073074,2010-10-01T00:00:00,Parotid Gland,A03.556.500.760.464
20073074,2010-10-01T00:00:00,Parotid Gland,A10.336.779.464
20073074,2010-10-01T00:00:00,Parotid Gland,A14.549.760.464
20073074,2010-10-01T00:00:00,Parotid Neoplasms,C04.588.443.591.824.695
20073074,2010-10-01T00:00:00,Parotid Neoplasms,C07.465.565.824.695
20073074,2010-10-01T00:00:00,Parotid Neoplasms,C07.465.815.470.770
20073074,2010-10-01T00:00:00,Parotid Neoplasms,C07.465.815.718.589
20073074,2010-10-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20073074,2010-10-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
20073074,2010-10-01T00:00:00,Sciatic Nerve,A08.800.800.720.450.760
20449644,2010-10-01T00:00:00,Aggression,F01.145.126.125
20449644,2010-10-01T00:00:00,Aggression,F01.145.813.045
20449644,2010-10-01T00:00:00,Attention Deficit Disorder with Hyperactivity,F03.550.150.150
20449644,2010-10-01T00:00:00,Attention Deficit and Disruptive Behavior Disorders,F03.550.150
20449644,2010-10-01T00:00:00,Child,M01.060.406
20449644,2010-10-01T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
20449644,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20449644,2010-10-01T00:00:00,Inhibition (Psychology),F01.145.544
20449644,2010-10-01T00:00:00,Inhibition (Psychology),F02.463.425.475
20449644,2010-10-01T00:00:00,Inhibition (Psychology),F02.739.794.405
20449644,2010-10-01T00:00:00,Juvenile Delinquency,I01.880.735.479
20449644,2010-10-01T00:00:00,Neuropsychological Tests,F04.711.513
20449644,2010-10-01T00:00:00,"Pattern Recognition, Visual",F02.463.593.524.500
20449644,2010-10-01T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.622
20449644,2010-10-01T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.869.435.673
20449644,2010-10-01T00:00:00,Psychometrics,F04.711.780
20449644,2010-10-01T00:00:00,Psychomotor Performance,F02.808
20449644,2010-10-01T00:00:00,Psychomotor Performance,G11.427.700
20449644,2010-10-01T00:00:00,Psychomotor Performance,G11.561.623
20449644,2010-10-01T00:00:00,Reaction Time,F02.830.650
20449644,2010-10-01T00:00:00,Reaction Time,F04.669.817
20449644,2010-10-01T00:00:00,Reaction Time,G11.561.677
20533289,2010-10-01T00:00:00,Adult,M01.060.116
20533289,2010-10-01T00:00:00,African Americans,M01.686.508.100.100
20533289,2010-10-01T00:00:00,African Americans,M01.686.754.100
20533289,2010-10-01T00:00:00,Age of Onset,N05.715.350.075.100
20533289,2010-10-01T00:00:00,Age of Onset,N06.850.490.250.100
20533289,2010-10-01T00:00:00,"Arthritis, Rheumatoid",C05.550.114.154
20533289,2010-10-01T00:00:00,"Arthritis, Rheumatoid",C05.799.114
20533289,2010-10-01T00:00:00,"Arthritis, Rheumatoid",C17.300.775.099
20533289,2010-10-01T00:00:00,"Arthritis, Rheumatoid",C20.111.199
20533289,2010-10-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
20533289,2010-10-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
20533289,2010-10-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
20533289,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20533289,2010-10-01T00:00:00,Middle Aged,M01.060.116.630
20533289,2010-10-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
20533289,2010-10-01T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
20533289,2010-10-01T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
20533289,2010-10-01T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
20533289,2010-10-01T00:00:00,RANK Ligand,D12.644.276.374.750.562
20533289,2010-10-01T00:00:00,RANK Ligand,D12.644.276.972.562
20533289,2010-10-01T00:00:00,RANK Ligand,D12.776.467.374.750.562
20533289,2010-10-01T00:00:00,RANK Ligand,D12.776.467.972.562
20533289,2010-10-01T00:00:00,RANK Ligand,D23.529.374.750.562
20533289,2010-10-01T00:00:00,RANK Ligand,D23.529.972.562
20533289,2010-10-01T00:00:00,"RNA, Messenger",D13.444.735.544
20586527,2010-10-01T00:00:00,Aged,M01.060.116.100
20586527,2010-10-01T00:00:00,Deep Brain Stimulation,E02.342.250
20586527,2010-10-01T00:00:00,Deep Brain Stimulation,E04.190
20586527,2010-10-01T00:00:00,Double-Blind Method,E05.318.780.300
20586527,2010-10-01T00:00:00,Double-Blind Method,E05.581.500.300
20586527,2010-10-01T00:00:00,Double-Blind Method,N05.715.360.780.320
20586527,2010-10-01T00:00:00,Double-Blind Method,N06.850.520.445.300
20586527,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20586527,2010-10-01T00:00:00,Middle Aged,M01.060.116.630
20586527,2010-10-01T00:00:00,Parkinson Disease,C10.228.140.079.862.500
20586527,2010-10-01T00:00:00,Parkinson Disease,C10.228.662.600.400
20586527,2010-10-01T00:00:00,Parkinson Disease,C10.574.812
20629639,2010-10-01T00:00:00,Hot Temperature,G01.906.595.543
20629639,2010-10-01T00:00:00,Hot Temperature,G16.500.275.063.725.710.380
20629639,2010-10-01T00:00:00,Hot Temperature,G16.500.750.775.710.380
20629639,2010-10-01T00:00:00,Hot Temperature,N06.230.300.100.725.232
20629639,2010-10-01T00:00:00,Hot Temperature,N06.230.300.100.725.710.380
20629639,2010-10-01T00:00:00,RNA Stability,G02.111.780
20629639,2010-10-01T00:00:00,"RNA, Messenger",D13.444.735.544
20629639,2010-10-01T00:00:00,Saccharomyces cerevisiae,B01.300.107.795.785.800
20629639,2010-10-01T00:00:00,Saccharomyces cerevisiae,B01.300.930.705.655
20629639,2010-10-01T00:00:00,Saccharomyces cerevisiae Proteins,D12.776.354.750
20629639,2010-10-01T00:00:00,Sphingolipids,D10.570.877
20629639,2010-10-01T00:00:00,Sphingolipids,D10.808
20629639,2010-10-01T00:00:00,"Stress, Physiological",G07.700.830
20733532,2010-10-01T00:00:00,Adult,M01.060.116
20733532,2010-10-01T00:00:00,Aged,M01.060.116.100
20733532,2010-10-01T00:00:00,Health Facilities,N02.278
20733532,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20733532,2010-10-01T00:00:00,Kidney Transplantation,E02.870.500
20733532,2010-10-01T00:00:00,Kidney Transplantation,E04.936.450.485
20733532,2010-10-01T00:00:00,Kidney Transplantation,E04.950.774.400
20733532,2010-10-01T00:00:00,Middle Aged,M01.060.116.630
20733532,2010-10-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
20733532,2010-10-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
20733532,2010-10-01T00:00:00,Tissue Donors,M01.898
20733532,2010-10-01T00:00:00,Tissue and Organ Procurement,N02.421.911
20733532,2010-10-01T00:00:00,United States,Z01.107.567.875
20808257,2010-10-01T00:00:00,Aged,M01.060.116.100
20808257,2010-10-01T00:00:00,Colonoscopy,E01.370.372.250.250.200
20808257,2010-10-01T00:00:00,Colonoscopy,E01.370.388.250.250.250.160
20808257,2010-10-01T00:00:00,Colonoscopy,E04.210.240.250.160
20808257,2010-10-01T00:00:00,Colonoscopy,E04.800.250.250.250.160
20808257,2010-10-01T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
20808257,2010-10-01T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
20808257,2010-10-01T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
20808257,2010-10-01T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
20808257,2010-10-01T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
20808257,2010-10-01T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
20808257,2010-10-01T00:00:00,Early Detection of Cancer,E01.390.500
20808257,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20808257,2010-10-01T00:00:00,Mass Screening,E01.370.500
20808257,2010-10-01T00:00:00,Mass Screening,E05.318.308.250.580
20808257,2010-10-01T00:00:00,Mass Screening,N02.421.143.827.233.443
20808257,2010-10-01T00:00:00,Mass Screening,N02.421.726.233.443
20808257,2010-10-01T00:00:00,Mass Screening,N05.715.360.300.375.500
20808257,2010-10-01T00:00:00,Mass Screening,N06.850.520.308.250.580
20808257,2010-10-01T00:00:00,Mass Screening,N06.850.780.500
20808257,2010-10-01T00:00:00,Middle Aged,M01.060.116.630
20808257,2010-10-01T00:00:00,Physician's Practice Patterns,N04.590.748
20808257,2010-10-01T00:00:00,Physician's Practice Patterns,N05.300.625
20808257,2010-10-01T00:00:00,Primary Health Care,N04.590.233.727
20808257,2010-10-01T00:00:00,"Quality Indicators, Health Care",N04.761.789
20808257,2010-10-01T00:00:00,United States,Z01.107.567.875
20809677,2010-10-01T00:00:00,Adolescent,M01.060.057
20809677,2010-10-01T00:00:00,Adult,M01.060.116
20809677,2010-10-01T00:00:00,Aged,M01.060.116.100
20809677,2010-10-01T00:00:00,Diabetes Mellitus,C18.452.394.750
20809677,2010-10-01T00:00:00,Diabetes Mellitus,C19.246
20809677,2010-10-01T00:00:00,Fruit,A18.024.500
20809677,2010-10-01T00:00:00,Fruit,J02.500.562
20809677,2010-10-01T00:00:00,Health Behavior,F01.145.488
20809677,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20809677,2010-10-01T00:00:00,Middle Aged,M01.060.116.630
20809677,2010-10-01T00:00:00,Motor Activity,F01.145.632
20809677,2010-10-01T00:00:00,Motor Activity,G11.427.590.530.698
20809677,2010-10-01T00:00:00,"Quality Indicators, Health Care",N04.761.789
20809677,2010-10-01T00:00:00,Quality of Health Care,N04.761
20809677,2010-10-01T00:00:00,Quality of Health Care,N05.715
20809677,2010-10-01T00:00:00,Self Care,E02.900
20809677,2010-10-01T00:00:00,Self Care,N02.421.784.680
20809677,2010-10-01T00:00:00,United States,Z01.107.567.875
20809677,2010-10-01T00:00:00,Young Adult,M01.060.116.815
20809812,2010-10-01T00:00:00,Abdominal Pain,C23.888.646.100
20809812,2010-10-01T00:00:00,Abdominal Pain,C23.888.821.030
20809812,2010-10-01T00:00:00,Adult,M01.060.116
20809812,2010-10-01T00:00:00,Digestive System Surgical Procedures,E04.210
20809812,2010-10-01T00:00:00,Endoscopy,E01.370.388.250
20809812,2010-10-01T00:00:00,Endoscopy,E04.800.250
20809812,2010-10-01T00:00:00,"Hernia, Abdominal",C23.300.707.374
20809812,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20809812,2010-10-01T00:00:00,Iatrogenic Disease,C23.550.291.875
20809812,2010-10-01T00:00:00,Laparoscopy,E01.370.388.250.520
20809812,2010-10-01T00:00:00,Laparoscopy,E04.800.250.520
20809812,2010-10-01T00:00:00,Pancreatitis,C06.689.750
20818984,2010-10-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
20818984,2010-10-01T00:00:00,Bacterial Infections,C01.252
20818984,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20818984,2010-10-01T00:00:00,Microbial Sensitivity Tests,E05.200.875.595
20818984,2010-10-01T00:00:00,Microbial Sensitivity Tests,E05.337.550.400
20818984,2010-10-01T00:00:00,Ofloxacin,D03.438.810.835.322.500
20818984,2010-10-01T00:00:00,"Pneumonia, Ventilator-Associated",C01.539.248.500
20818984,2010-10-01T00:00:00,"Pneumonia, Ventilator-Associated",C08.381.520.750.750
20818984,2010-10-01T00:00:00,"Pneumonia, Ventilator-Associated",C08.381.677.800
20818984,2010-10-01T00:00:00,"Pneumonia, Ventilator-Associated",C08.730.610.750
20824778,2010-10-01T00:00:00,Adult,M01.060.116
20824778,2010-10-01T00:00:00,Endoscopy,E01.370.388.250
20824778,2010-10-01T00:00:00,Endoscopy,E04.800.250
20824778,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20824778,2010-10-01T00:00:00,Nasal Obstruction,C08.460.525
20824778,2010-10-01T00:00:00,Nasal Obstruction,C08.618.846.185.525
20824778,2010-10-01T00:00:00,Nasal Obstruction,C09.603.525
20824778,2010-10-01T00:00:00,Rhinitis,C08.460.799
20824778,2010-10-01T00:00:00,Rhinitis,C08.730.674
20824778,2010-10-01T00:00:00,Rhinitis,C09.603.799
20824778,2010-10-01T00:00:00,Turbinates,A02.835.232.781.324.948
20824778,2010-10-01T00:00:00,Turbinates,A04.531.898
20838068,2010-10-01T00:00:00,Critical Pathways,N04.590.233.624.625
20838068,2010-10-01T00:00:00,Critical Pathways,N04.590.275
20838068,2010-10-01T00:00:00,Delivery Rooms,N02.278.388.150
20838068,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20838068,2010-10-01T00:00:00,"Infant, Newborn",M01.060.703.520
20838068,2010-10-01T00:00:00,"Infant, Premature",M01.060.703.520.520
20838068,2010-10-01T00:00:00,"Intensive Care, Neonatal",E02.760.190.400.405
20838068,2010-10-01T00:00:00,"Intensive Care, Neonatal",N02.421.088.120.120
20838068,2010-10-01T00:00:00,"Intensive Care, Neonatal",N02.421.585.190.400.405
20838068,2010-10-01T00:00:00,Neonatology,H02.403.670.400
20838068,2010-10-01T00:00:00,Patient Care Team,N04.590.715
20838068,2010-10-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
20838068,2010-10-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
20838068,2010-10-01T00:00:00,Time Factors,G01.910.857
20838071,2010-10-01T00:00:00,Delivery Rooms,N02.278.388.150
20838071,2010-10-01T00:00:00,"Environment, Controlled",N06.230.150
20838071,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20838071,2010-10-01T00:00:00,"Infant, Newborn",M01.060.703.520
20838071,2010-10-01T00:00:00,"Infant, Premature",M01.060.703.520.520
20838071,2010-10-01T00:00:00,"Infant, Very Low Birth Weight",M01.060.703.520.460.600
20838071,2010-10-01T00:00:00,"Intensive Care, Neonatal",E02.760.190.400.405
20838071,2010-10-01T00:00:00,"Intensive Care, Neonatal",N02.421.088.120.120
20838071,2010-10-01T00:00:00,"Intensive Care, Neonatal",N02.421.585.190.400.405
20838071,2010-10-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
20838071,2010-10-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
20838071,2010-10-01T00:00:00,Time Factors,G01.910.857
20838075,2010-10-01T00:00:00,Fluid Therapy,E02.319.360
20838075,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20838075,2010-10-01T00:00:00,Infant Nutritional Physiological Phenomena,G07.610.220.500
20838075,2010-10-01T00:00:00,"Infant, Newborn",M01.060.703.520
20838075,2010-10-01T00:00:00,"Infant, Premature",M01.060.703.520.520
20838075,2010-10-01T00:00:00,"Infant, Very Low Birth Weight",M01.060.703.520.460.600
20838075,2010-10-01T00:00:00,Time Factors,G01.910.857
20838077,2010-10-01T00:00:00,"Education, Medical, Graduate",I02.358.337.350
20838077,2010-10-01T00:00:00,"Education, Medical, Graduate",I02.358.399.350
20838077,2010-10-01T00:00:00,Health Care Sector,J01.576.489
20838077,2010-10-01T00:00:00,Health Care Sector,N03.219.650
20838077,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20838077,2010-10-01T00:00:00,Internship and Residency,I02.358.399.644
20838077,2010-10-01T00:00:00,Neonatology,H02.403.670.400
20838077,2010-10-01T00:00:00,Teaching,I02.903
20842052,2010-10-01T00:00:00,Adolescent,M01.060.057
20842052,2010-10-01T00:00:00,Adult,M01.060.116
20842052,2010-10-01T00:00:00,Aged,M01.060.116.100
20842052,2010-10-01T00:00:00,Cell Proliferation,G04.299.233.750
20842052,2010-10-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
20842052,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20842052,2010-10-01T00:00:00,"Immunotherapy, Adoptive",E02.095.465.425.400.330.050.400
20842052,2010-10-01T00:00:00,"Immunotherapy, Adoptive",E05.478.550.520.050.400
20842052,2010-10-01T00:00:00,Interferon-gamma,D12.644.276.374.440.893
20842052,2010-10-01T00:00:00,Interferon-gamma,D12.644.276.374.480.350
20842052,2010-10-01T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
20842052,2010-10-01T00:00:00,Interferon-gamma,D12.644.276.718.550
20842052,2010-10-01T00:00:00,Interferon-gamma,D12.776.467.374.440.893
20842052,2010-10-01T00:00:00,Interferon-gamma,D12.776.467.374.480.350
20842052,2010-10-01T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
20842052,2010-10-01T00:00:00,Interferon-gamma,D12.776.467.718.550
20842052,2010-10-01T00:00:00,Interferon-gamma,D23.529.374.440.893
20842052,2010-10-01T00:00:00,Interferon-gamma,D23.529.374.480.350
20842052,2010-10-01T00:00:00,Interferon-gamma,D23.529.374.480.615.350
20842052,2010-10-01T00:00:00,Interferon-gamma,D23.529.718.550
20842052,2010-10-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
20842052,2010-10-01T00:00:00,Lung Neoplasms,C08.381.540
20842052,2010-10-01T00:00:00,Lung Neoplasms,C08.785.520
20842052,2010-10-01T00:00:00,"Lymphocytes, Tumor-Infiltrating",A11.118.637.555.567.650
20842052,2010-10-01T00:00:00,"Lymphocytes, Tumor-Infiltrating",A15.145.229.637.555.567.650
20842052,2010-10-01T00:00:00,"Lymphocytes, Tumor-Infiltrating",A15.382.490.555.567.650
20842052,2010-10-01T00:00:00,Melanoma,C04.557.465.625.650.510
20842052,2010-10-01T00:00:00,Melanoma,C04.557.580.625.650.510
20842052,2010-10-01T00:00:00,Melanoma,C04.557.665.510
20842052,2010-10-01T00:00:00,Middle Aged,M01.060.116.630
20842052,2010-10-01T00:00:00,Remission Induction,E02.860
20852097,2010-10-01T00:00:00,Animals,B01.050
20852097,2010-10-01T00:00:00,Chickens,B01.050.150.900.248.350.150
20852097,2010-10-01T00:00:00,Chickens,B01.050.150.900.248.617.192
20852097,2010-10-01T00:00:00,Diet,E05.272
20852097,2010-10-01T00:00:00,Diet,G07.610.240
20852097,2010-10-01T00:00:00,Dietary Fats,D10.212.302
20852097,2010-10-01T00:00:00,Dietary Fats,J02.500.375
20852097,2010-10-01T00:00:00,Mycoplasma Infections,C01.252.400.610.610
20852097,2010-10-01T00:00:00,Mycoplasma gallisepticum,B03.440.560.580.553.553.345
20852097,2010-10-01T00:00:00,Time Factors,G01.910.857
20869115,2010-10-01T00:00:00,Adolescent,M01.060.057
20869115,2010-10-01T00:00:00,Child,M01.060.406
20869115,2010-10-01T00:00:00,Crime Victims,M01.135
20869115,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20869115,2010-10-01T00:00:00,Life Change Events,F01.829.458.410
20869115,2010-10-01T00:00:00,Mood Disorders,F03.600
20869115,2010-10-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20869115,2010-10-01T00:00:00,Risk Factors,N05.715.350.200.700
20869115,2010-10-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20869115,2010-10-01T00:00:00,Risk Factors,N06.850.490.625.750
20869115,2010-10-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20869115,2010-10-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
20869115,2010-10-01T00:00:00,Substance-Related Disorders,C21.739
20869115,2010-10-01T00:00:00,Substance-Related Disorders,F03.900
20869115,2010-10-01T00:00:00,United States,Z01.107.567.875
20869115,2010-10-01T00:00:00,Violence,I01.198.240.856
20869115,2010-10-01T00:00:00,Violence,I01.880.735.900
20876779,2010-10-01T00:00:00,HIV Seropositivity,C02.782.815.616.400.500
20876779,2010-10-01T00:00:00,HIV Seropositivity,C02.800.801.400.500
20876779,2010-10-01T00:00:00,HIV Seropositivity,C20.673.480.500
20876779,2010-10-01T00:00:00,HIV-1,B04.820.650.589.650.350.400
20876779,2010-10-01T00:00:00,HIV-1,B04.909.777.731.589.650.350.400
20876779,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20876779,2010-10-01T00:00:00,"RNA, Viral",D13.444.735.828
20880509,2010-10-01T00:00:00,Amyotrophic Lateral Sclerosis,C10.228.854.139
20880509,2010-10-01T00:00:00,Amyotrophic Lateral Sclerosis,C10.574.562.250
20880509,2010-10-01T00:00:00,Amyotrophic Lateral Sclerosis,C10.574.950.050
20880509,2010-10-01T00:00:00,Amyotrophic Lateral Sclerosis,C10.668.460.250
20880509,2010-10-01T00:00:00,Amyotrophic Lateral Sclerosis,C18.452.845.800.050
20880509,2010-10-01T00:00:00,Animals,B01.050
20880509,2010-10-01T00:00:00,Astrocytes,A08.637.200
20880509,2010-10-01T00:00:00,Astrocytes,A11.650.200
20880509,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20880509,2010-10-01T00:00:00,Motor Neurons,A08.663.655.500
20880509,2010-10-01T00:00:00,Motor Neurons,A11.671.655.500
20880509,2010-10-01T00:00:00,Nitric Oxide,D01.339.387
20880509,2010-10-01T00:00:00,Nitric Oxide,D01.625.550.500
20880509,2010-10-01T00:00:00,Nitric Oxide,D01.625.700.500
20880509,2010-10-01T00:00:00,Nitric Oxide,D01.650.550.587.600
20880509,2010-10-01T00:00:00,Superoxide Dismutase,D08.811.682.881
20881142,2010-10-01T00:00:00,Adult,M01.060.116
20881142,2010-10-01T00:00:00,Brain Injuries,C10.228.140.199
20881142,2010-10-01T00:00:00,Brain Injuries,C10.900.300.087
20881142,2010-10-01T00:00:00,Brain Injuries,C21.866.260.118
20881142,2010-10-01T00:00:00,Brain Injuries,C21.866.915.300.200
20881142,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20881142,2010-10-01T00:00:00,Mental Disorders,F03
20881142,2010-10-01T00:00:00,Middle Aged,M01.060.116.630
20881142,2010-10-01T00:00:00,Sex Factors,N05.715.350.675
20881142,2010-10-01T00:00:00,Sex Factors,N06.850.490.875
20881142,2010-10-01T00:00:00,South Carolina,Z01.107.567.875.075.662
20881142,2010-10-01T00:00:00,South Carolina,Z01.107.567.875.750.700
20881142,2010-10-01T00:00:00,Substance-Related Disorders,C21.739
20881142,2010-10-01T00:00:00,Substance-Related Disorders,F03.900
20881142,2010-10-01T00:00:00,Violence,I01.198.240.856
20881142,2010-10-01T00:00:00,Violence,I01.880.735.900
20881777,2010-10-01T00:00:00,Case-Control Studies,E05.318.760.500.500
20881777,2010-10-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
20881777,2010-10-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
20881777,2010-10-01T00:00:00,Gastrointestinal Tract,A03.556
20881777,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20881777,2010-10-01T00:00:00,Middle Aged,M01.060.116.630
20881777,2010-10-01T00:00:00,Regression Analysis,E05.318.740.750
20881777,2010-10-01T00:00:00,Regression Analysis,N05.715.360.750.695
20881777,2010-10-01T00:00:00,Regression Analysis,N06.850.520.830.750
20881777,2010-10-01T00:00:00,Surgical Wound Infection,C01.539.947.692
20881777,2010-10-01T00:00:00,Surgical Wound Infection,C23.550.767.925
20881908,2010-10-01T00:00:00,"Accidents, Traffic",N06.850.135.392
20881908,2010-10-01T00:00:00,Adolescent,M01.060.057
20881908,2010-10-01T00:00:00,Age Factors,N05.715.350.075
20881908,2010-10-01T00:00:00,Age Factors,N06.850.490.250
20881908,2010-10-01T00:00:00,Child,M01.060.406
20881908,2010-10-01T00:00:00,"Child, Preschool",M01.060.406.448
20881908,2010-10-01T00:00:00,Esophagus,A03.556.875.500
20881908,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20881908,2010-10-01T00:00:00,Infant,M01.060.703
20881908,2010-10-01T00:00:00,"Intubation, Intratracheal",E05.497.578
20881908,2010-10-01T00:00:00,Neck Injuries,C21.866.700
20881908,2010-10-01T00:00:00,Pressure,G01.374.715
20881908,2010-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20881908,2010-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20881908,2010-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20881908,2010-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20881908,2010-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20881908,2010-10-01T00:00:00,Trachea,A04.889
20883872,2010-10-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
20883872,2010-10-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
20883872,2010-10-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
20883872,2010-10-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
20883872,2010-10-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
20883872,2010-10-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
20883872,2010-10-01T00:00:00,Endosonography,E01.370.350.850.280
20883872,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20883872,2010-10-01T00:00:00,Pancreatitis,C06.689.750
20883872,2010-10-01T00:00:00,Patient Selection,E05.581.500.653
20883872,2010-10-01T00:00:00,Patient Selection,N04.590.731
20883872,2010-10-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
20883872,2010-10-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
20883872,2010-10-01T00:00:00,United States,Z01.107.567.875
20888132,2010-10-01T00:00:00,Aged,M01.060.116.100
20888132,2010-10-01T00:00:00,Anesthesia,E03.155
20888132,2010-10-01T00:00:00,Brachytherapy,E02.815.150
20888132,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20888132,2010-10-01T00:00:00,Middle Aged,M01.060.116.630
20888132,2010-10-01T00:00:00,Palladium,D01.268.556.680
20888132,2010-10-01T00:00:00,Palladium,D01.268.956.718
20888132,2010-10-01T00:00:00,Palladium,D01.552.544.680
20888132,2010-10-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
20888132,2010-10-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
20888132,2010-10-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
20888132,2010-10-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
20888132,2010-10-01T00:00:00,Radioisotopes,D01.496.749
20888132,2010-10-01T00:00:00,Radiotherapy Dosage,E02.815.639
20888132,2010-10-01T00:00:00,"Radiotherapy Planning, Computer-Assisted",E02.950.825
20888132,2010-10-01T00:00:00,"Radiotherapy Planning, Computer-Assisted",L01.700.508.100.710.600.608
20888132,2010-10-01T00:00:00,Time Factors,G01.910.857
20888820,2010-10-01T00:00:00,Animals,B01.050
20888820,2010-10-01T00:00:00,Gastric Acid,A12.200.307.603
20888820,2010-10-01T00:00:00,H(+)-K(+)-Exchanging ATPase,D08.811.277.040.025.325.625
20888820,2010-10-01T00:00:00,H(+)-K(+)-Exchanging ATPase,D12.776.157.530.450.250.875.500.625
20888820,2010-10-01T00:00:00,H(+)-K(+)-Exchanging ATPase,D12.776.543.585.450.250.875.500.625
20888820,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20888820,2010-10-01T00:00:00,Intracellular Membranes,A11.284.149.450
20888820,2010-10-01T00:00:00,Intracellular Membranes,A11.284.835.514
20888820,2010-10-01T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
20888820,2010-10-01T00:00:00,"Microscopy, Fluorescence",E05.595.458
20888820,2010-10-01T00:00:00,Mutation,G05.365.590
20888820,2010-10-01T00:00:00,"Parietal Cells, Gastric",A03.556.875.875.440.708
20888820,2010-10-01T00:00:00,"Parietal Cells, Gastric",A10.615.550.291.650
20888820,2010-10-01T00:00:00,"Parietal Cells, Gastric",A11.436.708
20888820,2010-10-01T00:00:00,Protein Transport,G03.495.166.700
20888820,2010-10-01T00:00:00,Proteomics,H01.158.201.843
20888820,2010-10-01T00:00:00,Proteomics,H01.158.273.180.350.700
20888820,2010-10-01T00:00:00,Proteomics,H01.158.273.343.350.700
20888820,2010-10-01T00:00:00,Proteomics,H01.181.122.738
20888820,2010-10-01T00:00:00,Rabbits,B01.050.150.900.649.521.700
20888820,2010-10-01T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
20888820,2010-10-01T00:00:00,Tandem Mass Spectrometry,E05.196.566.880
20888820,2010-10-01T00:00:00,rab GTP-Binding Proteins,D08.811.277.040.330.300.400.400
20888820,2010-10-01T00:00:00,rab GTP-Binding Proteins,D12.644.360.525.400
20888820,2010-10-01T00:00:00,rab GTP-Binding Proteins,D12.776.157.325.515.400
20888820,2010-10-01T00:00:00,rab GTP-Binding Proteins,D12.776.476.525.400
20888845,2010-10-01T00:00:00,Animals,B01.050
20888845,2010-10-01T00:00:00,Cyclic AMP,D03.438.759.646.138.395
20888845,2010-10-01T00:00:00,Cyclic AMP,D13.695.462.200
20888845,2010-10-01T00:00:00,Cyclic AMP,D13.695.667.138.395
20888845,2010-10-01T00:00:00,Cyclic AMP,D13.695.827.068.395
20888845,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20888845,2010-10-01T00:00:00,Protein Isoforms,D12.776.800
20888845,2010-10-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20888845,2010-10-01T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.070.300.400.500
20888845,2010-10-01T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.100.150.400.500
20888845,2010-10-01T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.720.300.300.400.500
20889473,2010-10-01T00:00:00,Air Pollutants,D27.888.284.101
20889473,2010-10-01T00:00:00,"Air Pollution, Indoor",N06.850.460.100.080
20889473,2010-10-01T00:00:00,Environmental Monitoring,N06.850.460.350.080
20889473,2010-10-01T00:00:00,Environmental Monitoring,N06.850.780.375
20889473,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20889473,2010-10-01T00:00:00,New York,Z01.107.567.875.075.437
20889473,2010-10-01T00:00:00,New York,Z01.107.567.875.350.530
20889473,2010-10-01T00:00:00,New York,Z01.107.567.875.500.530
20889473,2010-10-01T00:00:00,Smoking,F01.145.466.753
20889473,2010-10-01T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
20889473,2010-10-01T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
20889475,2010-10-01T00:00:00,Attitude to Health,F01.100.150
20889475,2010-10-01T00:00:00,Attitude to Health,N05.300.150
20889475,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20889475,2010-10-01T00:00:00,Middle Aged,M01.060.116.630
20889475,2010-10-01T00:00:00,Motivation,F01.658
20889475,2010-10-01T00:00:00,Motivation,F01.752.543.500.750
20889475,2010-10-01T00:00:00,Risk Reduction Behavior,F01.145.699
20889475,2010-10-01T00:00:00,Self Efficacy,F01.752.747.792.700
20889475,2010-10-01T00:00:00,Smoking,F01.145.466.753
20889475,2010-10-01T00:00:00,Smoking Cessation,F01.145.940.700
20889475,2010-10-01T00:00:00,Tobacco Use Disorder,C21.739.912
20889475,2010-10-01T00:00:00,Tobacco Use Disorder,F03.900.912
20889475,2010-10-01T00:00:00,United States,Z01.107.567.875
20889475,2010-10-01T00:00:00,Young Adult,M01.060.116.815
20889476,2010-10-01T00:00:00,Adult,M01.060.116
20889476,2010-10-01T00:00:00,Attitude to Health,F01.100.150
20889476,2010-10-01T00:00:00,Attitude to Health,N05.300.150
20889476,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20889476,2010-10-01T00:00:00,Middle Aged,M01.060.116.630
20889476,2010-10-01T00:00:00,Motivation,F01.658
20889476,2010-10-01T00:00:00,Motivation,F01.752.543.500.750
20889476,2010-10-01T00:00:00,Risk Reduction Behavior,F01.145.699
20889476,2010-10-01T00:00:00,Self Efficacy,F01.752.747.792.700
20889476,2010-10-01T00:00:00,Smoking,F01.145.466.753
20889476,2010-10-01T00:00:00,Smoking Cessation,F01.145.940.700
20889476,2010-10-01T00:00:00,Time Factors,G01.910.857
20889476,2010-10-01T00:00:00,Tobacco Use Disorder,C21.739.912
20889476,2010-10-01T00:00:00,Tobacco Use Disorder,F03.900.912
20889476,2010-10-01T00:00:00,United States,Z01.107.567.875
20889476,2010-10-01T00:00:00,Young Adult,M01.060.116.815
20889479,2010-10-01T00:00:00,Adult,M01.060.116
20889479,2010-10-01T00:00:00,Attitude to Health,F01.100.150
20889479,2010-10-01T00:00:00,Attitude to Health,N05.300.150
20889479,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20889479,2010-10-01T00:00:00,Middle Aged,M01.060.116.630
20889479,2010-10-01T00:00:00,Motivation,F01.658
20889479,2010-10-01T00:00:00,Motivation,F01.752.543.500.750
20889479,2010-10-01T00:00:00,Risk Reduction Behavior,F01.145.699
20889479,2010-10-01T00:00:00,Self Efficacy,F01.752.747.792.700
20889479,2010-10-01T00:00:00,Smoking,F01.145.466.753
20889479,2010-10-01T00:00:00,Smoking Cessation,F01.145.940.700
20889479,2010-10-01T00:00:00,Tobacco Use Disorder,C21.739.912
20889479,2010-10-01T00:00:00,Tobacco Use Disorder,F03.900.912
20889479,2010-10-01T00:00:00,United States,Z01.107.567.875
20889479,2010-10-01T00:00:00,Young Adult,M01.060.116.815
20889481,2010-10-01T00:00:00,Attitude to Health,F01.100.150
20889481,2010-10-01T00:00:00,Attitude to Health,N05.300.150
20889481,2010-10-01T00:00:00,Health Behavior,F01.145.488
20889481,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20889481,2010-10-01T00:00:00,Middle Aged,M01.060.116.630
20889481,2010-10-01T00:00:00,Motivation,F01.658
20889481,2010-10-01T00:00:00,Motivation,F01.752.543.500.750
20889481,2010-10-01T00:00:00,Risk Reduction Behavior,F01.145.699
20889481,2010-10-01T00:00:00,Self Efficacy,F01.752.747.792.700
20889481,2010-10-01T00:00:00,Smoking,F01.145.466.753
20889481,2010-10-01T00:00:00,Smoking Cessation,F01.145.940.700
20889481,2010-10-01T00:00:00,Tobacco Use Disorder,C21.739.912
20889481,2010-10-01T00:00:00,Tobacco Use Disorder,F03.900.912
20889481,2010-10-01T00:00:00,United States,Z01.107.567.875
20889481,2010-10-01T00:00:00,Young Adult,M01.060.116.815
20889483,2010-10-01T00:00:00,Attitude to Health,F01.100.150
20889483,2010-10-01T00:00:00,Attitude to Health,N05.300.150
20889483,2010-10-01T00:00:00,Health Services Accessibility,N04.590.374.350
20889483,2010-10-01T00:00:00,Health Services Accessibility,N05.300.430
20889483,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20889483,2010-10-01T00:00:00,Middle Aged,M01.060.116.630
20889483,2010-10-01T00:00:00,Risk Reduction Behavior,F01.145.699
20889483,2010-10-01T00:00:00,Self Efficacy,F01.752.747.792.700
20889483,2010-10-01T00:00:00,Smoking,F01.145.466.753
20889483,2010-10-01T00:00:00,Smoking Cessation,F01.145.940.700
20889483,2010-10-01T00:00:00,Social Support,I01.880.656.600
20889483,2010-10-01T00:00:00,Tobacco Use Disorder,C21.739.912
20889483,2010-10-01T00:00:00,Tobacco Use Disorder,F03.900.912
20889483,2010-10-01T00:00:00,United States,Z01.107.567.875
20889483,2010-10-01T00:00:00,Young Adult,M01.060.116.815
20924250,2010-10-01T00:00:00,Adverse Drug Reaction Reporting Systems,E05.337.800.120
20924250,2010-10-01T00:00:00,Adverse Drug Reaction Reporting Systems,L01.453.270.120
20924250,2010-10-01T00:00:00,Adverse Drug Reaction Reporting Systems,N02.421.668.320.120
20924250,2010-10-01T00:00:00,"Hospitals, University",N02.278.020.300.310
20924250,2010-10-01T00:00:00,"Hospitals, University",N02.278.421.639.725
20924250,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20924250,2010-10-01T00:00:00,Quality of Health Care,N04.761
20924250,2010-10-01T00:00:00,Quality of Health Care,N05.715
20929466,2010-10-01T00:00:00,African Americans,M01.686.508.100.100
20929466,2010-10-01T00:00:00,African Americans,M01.686.754.100
20929466,2010-10-01T00:00:00,Age Factors,N05.715.350.075
20929466,2010-10-01T00:00:00,Age Factors,N06.850.490.250
20929466,2010-10-01T00:00:00,Aged,M01.060.116.100
20929466,2010-10-01T00:00:00,Attitude to Health,F01.100.150
20929466,2010-10-01T00:00:00,Attitude to Health,N05.300.150
20929466,2010-10-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
20929466,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20929466,2010-10-01T00:00:00,Influenza Vaccines,D20.215.894.899.302
20929466,2010-10-01T00:00:00,"Influenza, Human",C02.782.620.365
20929466,2010-10-01T00:00:00,"Influenza, Human",C08.730.310
20929466,2010-10-01T00:00:00,Middle Aged,M01.060.116.630
20929466,2010-10-01T00:00:00,Minority Groups,I01.880.371
20929466,2010-10-01T00:00:00,Patient Compliance,F01.145.488.500
20929466,2010-10-01T00:00:00,Patient Compliance,N05.300.150.600.600
20929466,2010-10-01T00:00:00,Pneumococcal Vaccines,D20.215.894.135.750.600
20929466,2010-10-01T00:00:00,Rural Population,N01.600.725
20929466,2010-10-01T00:00:00,United States,Z01.107.567.875
20929466,2010-10-01T00:00:00,Vaccination,E02.095.465.425.400.530.890
20929466,2010-10-01T00:00:00,Vaccination,E05.478.550.600.890
20929466,2010-10-01T00:00:00,Vaccination,N02.421.726.758.310.890
20929466,2010-10-01T00:00:00,Vaccination,N06.850.780.200.425.900
20929466,2010-10-01T00:00:00,Vaccination,N06.850.780.680.310.890
20934199,2010-10-01T00:00:00,Body Fluids,A12.207
20934199,2010-10-01T00:00:00,Chlorine,D01.268.380.150
20934199,2010-10-01T00:00:00,Chlorine,D01.362.225
20934199,2010-10-01T00:00:00,Disinfection,N06.850.780.200.450.850.375
20934199,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20934199,2010-10-01T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
20934199,2010-10-01T00:00:00,Water Purification,N06.850.780.200.800.800.900.900
20934199,2010-10-01T00:00:00,Water Purification,N06.850.860.510.900.900
20934199,2010-10-01T00:00:00,Water Purification,N06.850.860.510.915.900
20935196,2010-10-01T00:00:00,Air Pollutants,D27.888.284.101
20935196,2010-10-01T00:00:00,Carbon Monoxide,D01.200.250
20935196,2010-10-01T00:00:00,Carbon Monoxide,D01.362.200
20935196,2010-10-01T00:00:00,Carbon Monoxide,D01.650.550.250
20935196,2010-10-01T00:00:00,China,Z01.252.474.164
20935196,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20935196,2010-10-01T00:00:00,Smoking,F01.145.466.753
20935196,2010-10-01T00:00:00,Tobacco,B01.650.388.100.905.900
20935196,2010-10-01T00:00:00,Tobacco Industry,J01.576.919
20936919,2010-10-01T00:00:00,Adult,M01.060.116
20936919,2010-10-01T00:00:00,Age Factors,N05.715.350.075
20936919,2010-10-01T00:00:00,Age Factors,N06.850.490.250
20936919,2010-10-01T00:00:00,Aged,M01.060.116.100
20936919,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20936919,2010-10-01T00:00:00,Incidence,E05.318.308.985.525.375
20936919,2010-10-01T00:00:00,Incidence,L01.280.975.525.375
20936919,2010-10-01T00:00:00,Incidence,N01.224.935.597.500
20936919,2010-10-01T00:00:00,Incidence,N06.850.505.400.975.525.375
20936919,2010-10-01T00:00:00,Incidence,N06.850.520.308.985.525.375
20936919,2010-10-01T00:00:00,Middle Aged,M01.060.116.630
20936919,2010-10-01T00:00:00,Obesity,C18.654.726.500
20936919,2010-10-01T00:00:00,Obesity,C23.888.144.699.500
20936919,2010-10-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
20936919,2010-10-01T00:00:00,Obesity,G07.100.100.160.120.699.500
20936919,2010-10-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20936919,2010-10-01T00:00:00,Risk Factors,N05.715.350.200.700
20936919,2010-10-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20936919,2010-10-01T00:00:00,Risk Factors,N06.850.490.625.750
20936919,2010-10-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20936919,2010-10-01T00:00:00,Sex Factors,N05.715.350.675
20936919,2010-10-01T00:00:00,Sex Factors,N06.850.490.875
20936919,2010-10-01T00:00:00,Stroke,C10.228.140.300.775
20936919,2010-10-01T00:00:00,Stroke,C14.907.253.855
20936919,2010-10-01T00:00:00,United States,Z01.107.567.875
20938272,2010-10-01T00:00:00,Adult,M01.060.116
20938272,2010-10-01T00:00:00,Aged,M01.060.116.100
20938272,2010-10-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
20938272,2010-10-01T00:00:00,Bacterial Infections,C01.252
20938272,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20938272,2010-10-01T00:00:00,Intensive Care Units,N02.278.388.493
20938272,2010-10-01T00:00:00,Microbial Sensitivity Tests,E05.200.875.595
20938272,2010-10-01T00:00:00,Microbial Sensitivity Tests,E05.337.550.400
20938272,2010-10-01T00:00:00,Middle Aged,M01.060.116.630
20938272,2010-10-01T00:00:00,"Pneumonia, Ventilator-Associated",C01.539.248.500
20938272,2010-10-01T00:00:00,"Pneumonia, Ventilator-Associated",C08.381.520.750.750
20938272,2010-10-01T00:00:00,"Pneumonia, Ventilator-Associated",C08.381.677.800
20938272,2010-10-01T00:00:00,"Pneumonia, Ventilator-Associated",C08.730.610.750
20938272,2010-10-01T00:00:00,Pseudomonas Infections,C01.252.400.739
20938272,2010-10-01T00:00:00,Pseudomonas aeruginosa,B03.440.400.425.625.625.100
20938272,2010-10-01T00:00:00,Pseudomonas aeruginosa,B03.660.250.580.590.050
20938272,2010-10-01T00:00:00,Staphylococcus aureus,B03.300.390.400.800.750.100
20938272,2010-10-01T00:00:00,Staphylococcus aureus,B03.510.100.750.750.100
20938272,2010-10-01T00:00:00,Staphylococcus aureus,B03.510.400.790.750.100
20938272,2010-10-01T00:00:00,Wounds and Injuries,C21.866
20939726,2010-10-01T00:00:00,Aged,M01.060.116.100
20939726,2010-10-01T00:00:00,Arterial Occlusive Diseases,C14.907.137
20939726,2010-10-01T00:00:00,Brachiocephalic Trunk,A07.231.114.145
20939726,2010-10-01T00:00:00,Cerebrovascular Disorders,C10.228.140.300
20939726,2010-10-01T00:00:00,Cerebrovascular Disorders,C14.907.253
20939726,2010-10-01T00:00:00,"Constriction, Pathologic",C23.300.287
20939726,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20939726,2010-10-01T00:00:00,Stents,E07.695.750
20939726,2010-10-01T00:00:00,Treatment Outcome,E01.789.800
20939726,2010-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20939726,2010-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20954776,2010-10-01T00:00:00,Adolescent,M01.060.057
20954776,2010-10-01T00:00:00,Adolescent Behavior,F01.145.022
20954776,2010-10-01T00:00:00,Behavior Therapy,F04.754.137
20954776,2010-10-01T00:00:00,Child,M01.060.406
20954776,2010-10-01T00:00:00,Cognitive Therapy,F04.754.137.428
20954776,2010-10-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
20954776,2010-10-01T00:00:00,Crime,I01.198.240
20954776,2010-10-01T00:00:00,Crime,I01.880.735.191
20954776,2010-10-01T00:00:00,Family Therapy,F04.754.864.581.273
20954776,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20954776,2010-10-01T00:00:00,Juvenile Delinquency,I01.880.735.479
20954776,2010-10-01T00:00:00,Psychotherapy,F04.754
20954776,2010-10-01T00:00:00,Treatment Outcome,E01.789.800
20954776,2010-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20954776,2010-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20954776,2010-10-01T00:00:00,Violence,I01.198.240.856
20954776,2010-10-01T00:00:00,Violence,I01.880.735.900
20956756,2010-10-01T00:00:00,Adult,M01.060.116
20956756,2010-10-01T00:00:00,Endoscopy,E01.370.388.250
20956756,2010-10-01T00:00:00,Endoscopy,E04.800.250
20956756,2010-10-01T00:00:00,Foreign Bodies,C21.866.392
20956756,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20956756,2010-10-01T00:00:00,Nasal Obstruction,C08.460.525
20956756,2010-10-01T00:00:00,Nasal Obstruction,C08.618.846.185.525
20956756,2010-10-01T00:00:00,Nasal Obstruction,C09.603.525
20956756,2010-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20956756,2010-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20956756,2010-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20956756,2010-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20956756,2010-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20958948,2010-10-01T00:00:00,Adult,M01.060.116
20958948,2010-10-01T00:00:00,Aged,M01.060.116.100
20958948,2010-10-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
20958948,2010-10-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
20958948,2010-10-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
20958948,2010-10-01T00:00:00,Cisplatin,D01.210.375
20958948,2010-10-01T00:00:00,Cisplatin,D01.625.125
20958948,2010-10-01T00:00:00,Cisplatin,D01.710.100
20958948,2010-10-01T00:00:00,Combined Modality Therapy,E02.186
20958948,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20958948,2010-10-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
20958948,2010-10-01T00:00:00,Lung Neoplasms,C08.381.540
20958948,2010-10-01T00:00:00,Lung Neoplasms,C08.785.520
20958948,2010-10-01T00:00:00,Middle Aged,M01.060.116.630
20958948,2010-10-01T00:00:00,Neoplasm Staging,E01.370.550
20958948,2010-10-01T00:00:00,Radiotherapy Dosage,E02.815.639
20958948,2010-10-01T00:00:00,Treatment Outcome,E01.789.800
20958948,2010-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20958948,2010-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20962304,2010-10-01T00:00:00,Activities of Daily Living,E02.831.067
20962304,2010-10-01T00:00:00,Activities of Daily Living,I03.050
20962304,2010-10-01T00:00:00,Activities of Daily Living,N02.421.784.110
20962304,2010-10-01T00:00:00,Caregivers,M01.085
20962304,2010-10-01T00:00:00,Caregivers,M01.526.485.200
20962304,2010-10-01T00:00:00,Caregivers,N02.360.200
20962304,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20962304,2010-10-01T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
20962304,2010-10-01T00:00:00,Patient Education as Topic,I02.233.332.500
20962304,2010-10-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
20962304,2010-10-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
20962304,2010-10-01T00:00:00,Teaching,I02.903
20965446,2010-10-01T00:00:00,Brain,A08.186.211
20965446,2010-10-01T00:00:00,Deep Brain Stimulation,E02.342.250
20965446,2010-10-01T00:00:00,Deep Brain Stimulation,E04.190
20965446,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20965446,2010-10-01T00:00:00,Periodicals as Topic,L01.178.682.829.678
20965446,2010-10-01T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
20965446,2010-10-01T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
20965446,2010-10-01T00:00:00,Treatment Outcome,E01.789.800
20965446,2010-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20965446,2010-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20968265,2010-10-01T00:00:00,Adolescent,M01.060.057
20968265,2010-10-01T00:00:00,Adult,M01.060.116
20968265,2010-10-01T00:00:00,Aged,M01.060.116.100
20968265,2010-10-01T00:00:00,Depressive Disorder,F03.600.300
20968265,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20968265,2010-10-01T00:00:00,Middle Aged,M01.060.116.630
20968265,2010-10-01T00:00:00,"Outpatient Clinics, Hospital",N02.278.035.380
20968265,2010-10-01T00:00:00,"Outpatient Clinics, Hospital",N02.278.354.422.527
20968265,2010-10-01T00:00:00,"Outpatient Clinics, Hospital",N04.452.442.422.527
20968265,2010-10-01T00:00:00,Primary Health Care,N04.590.233.727
20968265,2010-10-01T00:00:00,Sex Factors,N05.715.350.675
20968265,2010-10-01T00:00:00,Sex Factors,N06.850.490.875
20968265,2010-10-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
20968265,2010-10-01T00:00:00,United States,Z01.107.567.875
20968265,2010-10-01T00:00:00,Veterans,M01.930
20968265,2010-10-01T00:00:00,Wounds and Injuries,C21.866
20968265,2010-10-01T00:00:00,Young Adult,M01.060.116.815
21036699,2010-10-01T00:00:00,Acetylglucosamine,D09.067.342.531.050
21036699,2010-10-01T00:00:00,Animals,B01.050
21036699,2010-10-01T00:00:00,Dendritic Cells,A11.066.270
21036699,2010-10-01T00:00:00,Dendritic Cells,A11.436.270
21036699,2010-10-01T00:00:00,Dendritic Cells,A15.382.066.270
21036699,2010-10-01T00:00:00,Dendritic Cells,A15.382.812.260
21036699,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21089778,2010-10-01T00:00:00,Algorithms,G17.035
21089778,2010-10-01T00:00:00,Algorithms,L01.224.050
21089778,2010-10-01T00:00:00,Brain Neoplasms,C04.588.614.250.195
21089778,2010-10-01T00:00:00,Brain Neoplasms,C10.228.140.211
21089778,2010-10-01T00:00:00,Brain Neoplasms,C10.551.240.250
21089778,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21089778,2010-10-01T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
21089778,2010-10-01T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
21089778,2010-10-01T00:00:00,Patient Positioning,E02.760.670
21089778,2010-10-01T00:00:00,Patient Positioning,N02.421.585.700
21089778,2010-10-01T00:00:00,"Phantoms, Imaging",E07.671
21089778,2010-10-01T00:00:00,Radiosurgery,E02.815.530
21089778,2010-10-01T00:00:00,Radiosurgery,E04.525.800.650
21089778,2010-10-01T00:00:00,Radiosurgery,E05.873.500
21089778,2010-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
21089778,2010-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
21089778,2010-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
21089778,2010-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
21089778,2010-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
21183881,2010-10-01T00:00:00,Cryptococcosis,C01.703.248
21183881,2010-10-01T00:00:00,Hot Temperature,G01.906.595.543
21183881,2010-10-01T00:00:00,Hot Temperature,G16.500.275.063.725.710.380
21183881,2010-10-01T00:00:00,Hot Temperature,G16.500.750.775.710.380
21183881,2010-10-01T00:00:00,Hot Temperature,N06.230.300.100.725.232
21183881,2010-10-01T00:00:00,Hot Temperature,N06.230.300.100.725.710.380
21183881,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21183881,2010-10-01T00:00:00,Middle Aged,M01.060.116.630
21183881,2010-10-01T00:00:00,Organ Transplantation,E04.936.450
21183881,2010-10-01T00:00:00,United States,Z01.107.567.875
21548506,2010-10-01T00:00:00,Curriculum,I02.158
21548506,2010-10-01T00:00:00,Family Practice,H02.403.280
21548506,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21548506,2010-10-01T00:00:00,Internship and Residency,I02.358.399.644
21548506,2010-10-01T00:00:00,Medication Errors,E02.319.529
21548506,2010-10-01T00:00:00,Medication Errors,N02.421.450.500
21548506,2010-10-01T00:00:00,"Models, Educational",E05.599.545
21548506,2010-10-01T00:00:00,"Models, Educational",I02.903.302
21548506,2010-10-01T00:00:00,Program Development,N04.452.760
21548506,2010-10-01T00:00:00,Teaching,I02.903
21548506,2010-10-01T00:00:00,United States,Z01.107.567.875
22546436,2010-10-01T00:00:00,Animals,B01.050
22546436,2010-10-01T00:00:00,Gossypium,B01.650.388.100.700.244
22546436,2010-10-01T00:00:00,Insect Control,N06.850.780.200.650.425
22546436,2010-10-01T00:00:00,South Carolina,Z01.107.567.875.075.662
22546436,2010-10-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23270031,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23270031,2010-10-01T00:00:00,"Thoracic Surgery, Video-Assisted",E01.370.388.250.840.830
23270031,2010-10-01T00:00:00,"Thoracic Surgery, Video-Assisted",E01.370.388.250.950.830
23270031,2010-10-01T00:00:00,"Thoracic Surgery, Video-Assisted",E04.800.250.840.830
23270031,2010-10-01T00:00:00,"Thoracic Surgery, Video-Assisted",E04.800.250.950.830
23270031,2010-10-01T00:00:00,"Thoracic Surgery, Video-Assisted",E04.928.752.830
23270031,2010-10-01T00:00:00,Thyroid Diseases,C19.874
23270032,2010-10-01T00:00:00,Biomedical Research,H01.770.644.145
23270032,2010-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23270032,2010-10-01T00:00:00,Organ Transplantation,E04.936.450
23270032,2010-10-01T00:00:00,Tissue and Organ Procurement,N02.421.911
20888786,2010-10-02T00:00:00,Aged,M01.060.116.100
20888786,2010-10-02T00:00:00,Combined Modality Therapy,E02.186
20888786,2010-10-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20888786,2010-10-02T00:00:00,Vascular Surgical Procedures,E04.100.814
20889984,2010-10-02T00:00:00,Animals,B01.050
20889984,2010-10-02T00:00:00,Cardiomegaly,C14.280.195
20889984,2010-10-02T00:00:00,Cardiomegaly,C23.300.775.250
20889984,2010-10-02T00:00:00,Heart Failure,C14.280.434
20889984,2010-10-02T00:00:00,Myocardial Contraction,G09.330.190.541
20889984,2010-10-02T00:00:00,Myocardial Contraction,G11.427.590.540.570
20889984,2010-10-02T00:00:00,Phosphorylation,G02.111.087.677
20889984,2010-10-02T00:00:00,Phosphorylation,G02.149.115.677
20889984,2010-10-02T00:00:00,Phosphorylation,G02.149.465.700
20889984,2010-10-02T00:00:00,Phosphorylation,G02.607.750.700
20889984,2010-10-02T00:00:00,Phosphorylation,G03.495.790
20889984,2010-10-02T00:00:00,Protein Phosphatase 2,D08.811.277.352.650.625.706
20889984,2010-10-02T00:00:00,Protein Phosphatase 2,D12.644.360.583
20889984,2010-10-02T00:00:00,Protein Phosphatase 2,D12.776.476.561
20921310,2010-10-04T00:00:00,Animals,B01.050
20921310,2010-10-04T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
20921310,2010-10-04T00:00:00,Dog Diseases,C22.268
20921310,2010-10-04T00:00:00,Dogs,B01.050.150.900.649.147.153.200
20921310,2010-10-04T00:00:00,Ehrlichia canis,B03.440.040.287.090
20921310,2010-10-04T00:00:00,Ehrlichia canis,B03.660.050.020.287.090
20921310,2010-10-04T00:00:00,Ehrlichiosis,C01.252.400.054.160
20921310,2010-10-04T00:00:00,Ehrlichiosis,C01.252.400.825.200
20921310,2010-10-04T00:00:00,Polymerase Chain Reaction,E05.393.620.500
20923994,2010-10-05T00:00:00,Aged,M01.060.116.100
20923994,2010-10-05T00:00:00,Biological Markers,D23.101
20923994,2010-10-05T00:00:00,Coronary Disease,C14.280.647.250
20923994,2010-10-05T00:00:00,Coronary Disease,C14.907.585.250
20923994,2010-10-05T00:00:00,Disease Progression,C23.550.291.656
20923994,2010-10-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20923994,2010-10-05T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
20923994,2010-10-05T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
20923994,2010-10-05T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
20923994,2010-10-05T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
20923994,2010-10-05T00:00:00,Middle Aged,M01.060.116.630
20923994,2010-10-05T00:00:00,Stroke,C10.228.140.300.775
20923994,2010-10-05T00:00:00,Stroke,C14.907.253.855
20925084,2010-10-05T00:00:00,Actins,D05.750.078.730.250
20925084,2010-10-05T00:00:00,Actins,D12.776.210.500.100
20925084,2010-10-05T00:00:00,Actins,D12.776.220.525.255
20925084,2010-10-05T00:00:00,Biomimetic Materials,J01.637.087
20925084,2010-10-05T00:00:00,Cell Adhesion,G04.299.117
20925084,2010-10-05T00:00:00,Collagen Type I,D05.750.078.280.300.100
20925084,2010-10-05T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
20925084,2010-10-05T00:00:00,Dermis,A17.815.180
20925084,2010-10-05T00:00:00,Fibroblasts,A11.329.228
20925084,2010-10-05T00:00:00,Fibroblasts,A11.872.228
20925084,2010-10-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20925084,2010-10-05T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
20925084,2010-10-05T00:00:00,"Microscopy, Fluorescence",E05.595.458
20925084,2010-10-05T00:00:00,Polymers,D05.750
20925084,2010-10-05T00:00:00,Polymers,D25.720
20925084,2010-10-05T00:00:00,Polymers,J01.637.051.720
20926399,2010-10-05T00:00:00,Animals,B01.050
20926399,2010-10-05T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
20926399,2010-10-05T00:00:00,Flow Cytometry,E05.200.500.386.350
20926399,2010-10-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20926399,2010-10-05T00:00:00,"Immunotherapy, Adoptive",E02.095.465.425.400.330.050.400
20926399,2010-10-05T00:00:00,"Immunotherapy, Adoptive",E05.478.550.520.050.400
20926399,2010-10-05T00:00:00,Membrane Glycoproteins,D12.776.395.550
20926399,2010-10-05T00:00:00,Membrane Glycoproteins,D12.776.543.550
20926399,2010-10-05T00:00:00,Mesothelioma,C04.557.470.035.510
20926399,2010-10-05T00:00:00,Mesothelioma,C04.557.470.660.510
20926399,2010-10-05T00:00:00,"RNA, Messenger",D13.444.735.544
20926399,2010-10-05T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
20926399,2010-10-05T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
20926399,2010-10-05T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
20926399,2010-10-05T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
20923672,2010-10-06T00:00:00,Animals,B01.050
20923672,2010-10-06T00:00:00,Cattle,B01.050.150.900.649.077.380.271
20923672,2010-10-06T00:00:00,"Crystallography, X-Ray",E05.196.309.742.225
20923672,2010-10-06T00:00:00,Retinal Rod Photoreceptor Cells,A08.663.650.850.625.670.650
20923672,2010-10-06T00:00:00,Retinal Rod Photoreceptor Cells,A08.663.650.915.937.670.650
20923672,2010-10-06T00:00:00,Retinal Rod Photoreceptor Cells,A08.800.950.937.670.650
20923672,2010-10-06T00:00:00,Retinal Rod Photoreceptor Cells,A09.371.729.831.625.670.650
20923672,2010-10-06T00:00:00,Retinal Rod Photoreceptor Cells,A11.671.650.850.625.670.650
20923672,2010-10-06T00:00:00,Retinal Rod Photoreceptor Cells,A11.671.650.915.937.670.650
20923672,2010-10-06T00:00:00,Retinoids,D02.455.326.271.665.202.495
20923672,2010-10-06T00:00:00,Retinoids,D02.455.426.392.368.367.379.249.700
20923672,2010-10-06T00:00:00,Retinoids,D02.455.849.131.495
20923672,2010-10-06T00:00:00,Retinoids,D23.767.261.700
20923672,2010-10-06T00:00:00,Rhodopsin,D12.776.543.750.100.955
20923672,2010-10-06T00:00:00,Rhodopsin,D23.767.930.750.500.500
20926589,2010-10-06T00:00:00,Amino Acid Sequence,G02.111.570.060
20926589,2010-10-06T00:00:00,Amino Acid Sequence,L01.453.245.667.060
20926589,2010-10-06T00:00:00,Animals,B01.050
20926589,2010-10-06T00:00:00,Estrogen Receptor alpha,D12.776.260.698.750.350.174
20926589,2010-10-06T00:00:00,Estrogen Receptor alpha,D12.776.826.750.350.174
20926589,2010-10-06T00:00:00,Estrogen Receptor alpha,D12.776.930.669.750.350.174
20926589,2010-10-06T00:00:00,Molecular Sequence Data,L01.453.245.667
20926589,2010-10-06T00:00:00,Phylogeny,G05.697
20926589,2010-10-06T00:00:00,Phylogeny,G16.100.275.605
20926589,2010-10-06T00:00:00,Phylogeny,L01.100.697
20926589,2010-10-06T00:00:00,Reptiles,B01.050.150.900.833
20926633,2010-10-06T00:00:00,Animals,B01.050
20926633,2010-10-06T00:00:00,Cell Line,A11.251.210
20926633,2010-10-06T00:00:00,"Kidney Tubules, Collecting",A05.810.453.736.560.510
20926633,2010-10-06T00:00:00,Telomerase,D08.811.913.696.445.308.300.750.750
20926633,2010-10-06T00:00:00,Telomerase,D12.776.157.725.500.921
20926633,2010-10-06T00:00:00,Telomerase,D12.776.664.962.500.921
20930164,2010-10-07T00:00:00,Aged,M01.060.116.100
20930164,2010-10-07T00:00:00,Albuminuria,C12.777.934.734.269
20930164,2010-10-07T00:00:00,Albuminuria,C13.351.968.934.734.269
20930164,2010-10-07T00:00:00,Albuminuria,C23.888.942.750.269
20930164,2010-10-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20930164,2010-10-07T00:00:00,Incidence,E05.318.308.985.525.375
20930164,2010-10-07T00:00:00,Incidence,L01.280.975.525.375
20930164,2010-10-07T00:00:00,Incidence,N01.224.935.597.500
20930164,2010-10-07T00:00:00,Incidence,N06.850.505.400.975.525.375
20930164,2010-10-07T00:00:00,Incidence,N06.850.520.308.985.525.375
20930164,2010-10-07T00:00:00,Middle Aged,M01.060.116.630
20930164,2010-10-07T00:00:00,Risk Factors,E05.318.740.600.800.725
20930164,2010-10-07T00:00:00,Risk Factors,N05.715.350.200.700
20930164,2010-10-07T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20930164,2010-10-07T00:00:00,Risk Factors,N06.850.490.625.750
20930164,2010-10-07T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20930164,2010-10-07T00:00:00,Stroke,C10.228.140.300.775
20930164,2010-10-07T00:00:00,Stroke,C14.907.253.855
20931365,2010-10-07T00:00:00,HIV Infections,C02.782.815.616.400
20931365,2010-10-07T00:00:00,HIV Infections,C02.800.801.400
20931365,2010-10-07T00:00:00,HIV Infections,C20.673.480
20931365,2010-10-07T00:00:00,HIV Protease Inhibitors,D27.505.519.389.745.420
20931365,2010-10-07T00:00:00,HIV Protease Inhibitors,D27.505.954.122.388.077.088.420
20931365,2010-10-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20931365,2010-10-07T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
20931365,2010-10-07T00:00:00,Practice Guidelines as Topic,N05.700.350.650
20931365,2010-10-07T00:00:00,Ritonavir,D02.886.675.653
20931365,2010-10-07T00:00:00,Ritonavir,D03.383.129.708.653
20934940,2010-10-07T00:00:00,Animals,B01.050
20934940,2010-10-07T00:00:00,Cell Survival,G04.299.316
20934940,2010-10-07T00:00:00,Computer Simulation,L01.224.160
20934940,2010-10-07T00:00:00,Electric Conductivity,G01.201.249.277
20934940,2010-10-07T00:00:00,Hot Temperature,G01.906.595.543
20934940,2010-10-07T00:00:00,Hot Temperature,G16.500.275.063.725.710.380
20934940,2010-10-07T00:00:00,Hot Temperature,G16.500.750.775.710.380
20934940,2010-10-07T00:00:00,Hot Temperature,N06.230.300.100.725.232
20934940,2010-10-07T00:00:00,Hot Temperature,N06.230.300.100.725.710.380
20934940,2010-10-07T00:00:00,"Hyperthermia, Induced",E02.565
20934940,2010-10-07T00:00:00,"Hyperthermia, Induced",E02.779.496
20934940,2010-10-07T00:00:00,Liver,A03.620
20934940,2010-10-07T00:00:00,Liver Neoplasms,C04.588.274.623
20934940,2010-10-07T00:00:00,Liver Neoplasms,C06.301.623
20934940,2010-10-07T00:00:00,Liver Neoplasms,C06.552.697
20934940,2010-10-07T00:00:00,"Models, Biological",E05.599.395
20934940,2010-10-07T00:00:00,"Phantoms, Imaging",E07.671
20934940,2010-10-07T00:00:00,Sepharose,D09.698.813
20934940,2010-10-07T00:00:00,Swine,B01.050.150.900.649.077.880
20931136,2010-10-08T00:00:00,Animals,B01.050
20931136,2010-10-08T00:00:00,Eye,A01.456.505.420
20931136,2010-10-08T00:00:00,Eye,A09.371
20931136,2010-10-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20931136,2010-10-08T00:00:00,Mass Spectrometry,E05.196.566
20931136,2010-10-08T00:00:00,Molecular Structure,G02.111.570
20931136,2010-10-08T00:00:00,Molecular Structure,G02.575
20931136,2010-10-08T00:00:00,Molecular Structure,G02.842.575
20931136,2010-10-08T00:00:00,Pyridinium Compounds,D03.383.725.762
20931136,2010-10-08T00:00:00,Retinoids,D02.455.326.271.665.202.495
20931136,2010-10-08T00:00:00,Retinoids,D02.455.426.392.368.367.379.249.700
20931136,2010-10-08T00:00:00,Retinoids,D02.455.849.131.495
20931136,2010-10-08T00:00:00,Retinoids,D23.767.261.700
20934835,2010-10-08T00:00:00,Adolescent,M01.060.057
20934835,2010-10-08T00:00:00,Behavior Therapy,F04.754.137
20934835,2010-10-08T00:00:00,Child,M01.060.406
20934835,2010-10-08T00:00:00,"Conditioning, Operant",F02.463.425.179.509
20934835,2010-10-08T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
20934835,2010-10-08T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
20934835,2010-10-08T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
20934835,2010-10-08T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
20934835,2010-10-08T00:00:00,Double-Blind Method,E05.318.780.300
20934835,2010-10-08T00:00:00,Double-Blind Method,E05.581.500.300
20934835,2010-10-08T00:00:00,Double-Blind Method,N05.715.360.780.320
20934835,2010-10-08T00:00:00,Double-Blind Method,N06.850.520.445.300
20934835,2010-10-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20934835,2010-10-08T00:00:00,Medication Adherence,F01.145.488.500.500
20934835,2010-10-08T00:00:00,Medication Adherence,N05.300.150.600.600.500
20934835,2010-10-08T00:00:00,Smoking Cessation,F01.145.940.700
20934835,2010-10-08T00:00:00,Tobacco Use Disorder,C21.739.912
20934835,2010-10-08T00:00:00,Tobacco Use Disorder,F03.900.912
20934835,2010-10-08T00:00:00,Treatment Outcome,E01.789.800
20934835,2010-10-08T00:00:00,Treatment Outcome,N04.761.559.590.800
20934835,2010-10-08T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20934835,2010-10-08T00:00:00,Young Adult,M01.060.116.815
20935147,2010-10-08T00:00:00,Animals,B01.050
20935147,2010-10-08T00:00:00,"Disease Models, Animal",C22.232
20935147,2010-10-08T00:00:00,"Disease Models, Animal",E05.598.500
20935147,2010-10-08T00:00:00,"Disease Models, Animal",E05.599.395.080
20935147,2010-10-08T00:00:00,Fibrillar Collagens,D05.750.078.280.300
20935147,2010-10-08T00:00:00,Fibrillar Collagens,D12.776.860.300.250.300
20935147,2010-10-08T00:00:00,Fibrosis,C23.550.355
20935147,2010-10-08T00:00:00,Hemodynamics,G09.330.190.400
20935147,2010-10-08T00:00:00,Hemodynamics,G09.330.380
20935147,2010-10-08T00:00:00,Matrix Metalloproteinase 14,D08.811.277.656.300.480.525.300.500
20935147,2010-10-08T00:00:00,Matrix Metalloproteinase 14,D08.811.277.656.675.374.525.300.500
20935147,2010-10-08T00:00:00,Myocardial Infarction,C14.280.647.500
20935147,2010-10-08T00:00:00,Myocardial Infarction,C14.907.585.500
20935147,2010-10-08T00:00:00,Myocardium,A02.633.580
20935147,2010-10-08T00:00:00,Myocardium,A07.541.704
20935147,2010-10-08T00:00:00,Myocardium,A10.690.552.750
20935147,2010-10-08T00:00:00,"RNA, Messenger",D13.444.735.544
20935147,2010-10-08T00:00:00,Reperfusion Injury,C14.907.725
20935147,2010-10-08T00:00:00,Reperfusion Injury,C23.550.767.877
20935147,2010-10-08T00:00:00,Swine,B01.050.150.900.649.077.880
20935147,2010-10-08T00:00:00,Time Factors,G01.910.857
20935147,2010-10-08T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
20935147,2010-10-08T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
20935147,2010-10-08T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
20935147,2010-10-08T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
20935147,2010-10-08T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
20935147,2010-10-08T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
20935147,2010-10-08T00:00:00,Transforming Growth Factor beta,D23.529.374.687
20935147,2010-10-08T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
20935147,2010-10-08T00:00:00,Transforming Growth Factor beta,D23.529.960.720
20935147,2010-10-08T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
20935147,2010-10-08T00:00:00,Ventricular Remodeling,C23.300.985
20935147,2010-10-08T00:00:00,Ventricular Remodeling,G09.330.190.962.975
20936258,2010-10-09T00:00:00,Adult,M01.060.116
20936258,2010-10-09T00:00:00,Aged,M01.060.116.100
20936258,2010-10-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20936258,2010-10-09T00:00:00,Middle Aged,M01.060.116.630
20936258,2010-10-09T00:00:00,Pelvic Organ Prolapse,C23.300.842.500
20863132,2010-10-11T00:00:00,Animals,B01.050
20863132,2010-10-11T00:00:00,Cell Line,A11.251.210
20863132,2010-10-11T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
20863132,2010-10-11T00:00:00,Flow Cytometry,E05.200.500.386.350
20863132,2010-10-11T00:00:00,Fluorenes,D02.455.426.559.847.389
20863132,2010-10-11T00:00:00,Fluorenes,D04.615.389
20863132,2010-10-11T00:00:00,Macrophages,A11.329.372
20863132,2010-10-11T00:00:00,Macrophages,A11.627.482
20863132,2010-10-11T00:00:00,Macrophages,A11.733.397
20863132,2010-10-11T00:00:00,Macrophages,A15.382.680.397
20863132,2010-10-11T00:00:00,Macrophages,A15.382.812.522
20863132,2010-10-11T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
20863132,2010-10-11T00:00:00,"Microscopy, Fluorescence",E05.595.458
20863132,2010-10-11T00:00:00,Nanoparticles,J01.637.512.600
20863132,2010-10-11T00:00:00,Polymers,D05.750
20863132,2010-10-11T00:00:00,Polymers,D25.720
20863132,2010-10-11T00:00:00,Polymers,J01.637.051.720
20937624,2010-10-11T00:00:00,Adolescent,M01.060.057
20937624,2010-10-11T00:00:00,Adult,M01.060.116
20937624,2010-10-11T00:00:00,Age of Onset,N05.715.350.075.100
20937624,2010-10-11T00:00:00,Age of Onset,N06.850.490.250.100
20937624,2010-10-11T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
20937624,2010-10-11T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
20937624,2010-10-11T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
20937624,2010-10-11T00:00:00,C-Reactive Protein,D12.776.034.145
20937624,2010-10-11T00:00:00,C-Reactive Protein,D12.776.124.050.120
20937624,2010-10-11T00:00:00,C-Reactive Protein,D12.776.124.486.157
20937624,2010-10-11T00:00:00,Case-Control Studies,E05.318.760.500.500
20937624,2010-10-11T00:00:00,Case-Control Studies,N05.715.360.775.175.200
20937624,2010-10-11T00:00:00,Case-Control Studies,N06.850.520.450.500.500
20937624,2010-10-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20937624,2010-10-11T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
20937624,2010-10-11T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
20937624,2010-10-11T00:00:00,Lupus Nephritis,C12.777.419.570.363.680
20937624,2010-10-11T00:00:00,Lupus Nephritis,C13.351.968.419.570.363.680
20937624,2010-10-11T00:00:00,Lupus Nephritis,C17.300.480.680
20937624,2010-10-11T00:00:00,Lupus Nephritis,C20.111.590.560
20937624,2010-10-11T00:00:00,Middle Aged,M01.060.116.630
20937624,2010-10-11T00:00:00,Risk Factors,E05.318.740.600.800.725
20937624,2010-10-11T00:00:00,Risk Factors,N05.715.350.200.700
20937624,2010-10-11T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20937624,2010-10-11T00:00:00,Risk Factors,N06.850.490.625.750
20937624,2010-10-11T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20937624,2010-10-11T00:00:00,Young Adult,M01.060.116.815
20940143,2010-10-11T00:00:00,Ceramides,D02.065.313
20940143,2010-10-11T00:00:00,Ceramides,D09.400.410.420.525.200
20940143,2010-10-11T00:00:00,Ceramides,D10.390.470.675.200
20940143,2010-10-11T00:00:00,Ceramides,D10.570.877.360.612.200
20940143,2010-10-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20940143,2010-10-11T00:00:00,Oxidoreductases,D08.811.682
20940143,2010-10-11T00:00:00,"RNA, Messenger",D13.444.735.544
20940143,2010-10-11T00:00:00,Sphingolipids,D10.570.877
20940143,2010-10-11T00:00:00,Sphingolipids,D10.808
21179251,2010-10-11T00:00:00,Organizational Objectives,N04.452.615
21179251,2010-10-11T00:00:00,"Schools, Pharmacy",I02.783.660.694
21179251,2010-10-11T00:00:00,United States,Z01.107.567.875
21179269,2010-10-11T00:00:00,"Education, Pharmacy",I02.358.525
21179269,2010-10-11T00:00:00,Pharmacists,M01.526.485.780
21179269,2010-10-11T00:00:00,Pharmacists,N02.360.780
20933269,2010-10-12T00:00:00,Animals,B01.050
20933269,2010-10-12T00:00:00,Biocompatible Materials,D25.130
20933269,2010-10-12T00:00:00,Biocompatible Materials,D27.720.102.130
20933269,2010-10-12T00:00:00,Biocompatible Materials,J01.637.051.130
20933269,2010-10-12T00:00:00,Cattle,B01.050.150.900.649.077.380.271
20933269,2010-10-12T00:00:00,Cell Differentiation,G04.299.151
20933269,2010-10-12T00:00:00,Cytokines,D12.644.276.374
20933269,2010-10-12T00:00:00,Cytokines,D12.776.467.374
20933269,2010-10-12T00:00:00,Cytokines,D23.529.374
20933269,2010-10-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20933269,2010-10-12T00:00:00,Interleukin-10,D12.644.276.374.465.510
20933269,2010-10-12T00:00:00,Interleukin-10,D12.776.467.374.465.510
20933269,2010-10-12T00:00:00,Interleukin-10,D23.529.374.465.510
20933269,2010-10-12T00:00:00,Macrophages,A11.329.372
20933269,2010-10-12T00:00:00,Macrophages,A11.627.482
20933269,2010-10-12T00:00:00,Macrophages,A11.733.397
20933269,2010-10-12T00:00:00,Macrophages,A15.382.680.397
20933269,2010-10-12T00:00:00,Macrophages,A15.382.812.522
20933269,2010-10-12T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.205.351
20933269,2010-10-12T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.525.700.100
20933269,2010-10-12T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.205.351
20933269,2010-10-12T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.525.700.100
20933269,2010-10-12T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.205.352
20933269,2010-10-12T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.252.420
20933269,2010-10-12T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.525.700.150
20933269,2010-10-12T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.205.352
20933269,2010-10-12T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.252.420
20933269,2010-10-12T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.525.700.150
20933269,2010-10-12T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.205.360
20933269,2010-10-12T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.252.445
20933269,2010-10-12T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.525.700.350
20933269,2010-10-12T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.205.360
20933269,2010-10-12T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.252.445
20933269,2010-10-12T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.525.700.350
20933269,2010-10-12T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
20933269,2010-10-12T00:00:00,"Microscopy, Confocal",E05.595.395
20933269,2010-10-12T00:00:00,Pericardium,A07.541.795
20933269,2010-10-12T00:00:00,Pericardium,A10.615.789.470
20933269,2010-10-12T00:00:00,Polymerase Chain Reaction,E05.393.620.500
20938655,2010-10-12T00:00:00,Adolescent,M01.060.057
20938655,2010-10-12T00:00:00,Angiotensin-Converting Enzyme Inhibitors,D27.505.519.389.745.085
20938655,2010-10-12T00:00:00,Anti-Arrhythmia Agents,D27.505.954.411.097
20938655,2010-10-12T00:00:00,Child,M01.060.406
20938655,2010-10-12T00:00:00,Diagnostic Imaging,E01.370.350
20938655,2010-10-12T00:00:00,Fontan Procedure,E04.035.410.295
20938655,2010-10-12T00:00:00,Fontan Procedure,E04.100.376.410.295
20938655,2010-10-12T00:00:00,Fontan Procedure,E04.928.220.370.295
20938655,2010-10-12T00:00:00,"Heart Defects, Congenital",C14.240.400
20938655,2010-10-12T00:00:00,"Heart Defects, Congenital",C14.280.400
20938655,2010-10-12T00:00:00,"Heart Defects, Congenital",C16.131.240.400
20938655,2010-10-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20938655,2010-10-12T00:00:00,Physician's Practice Patterns,N04.590.748
20938655,2010-10-12T00:00:00,Physician's Practice Patterns,N05.300.625
20938655,2010-10-12T00:00:00,Postoperative Complications,C23.550.767
20938655,2010-10-12T00:00:00,Regression Analysis,E05.318.740.750
20938655,2010-10-12T00:00:00,Regression Analysis,N05.715.360.750.695
20938655,2010-10-12T00:00:00,Regression Analysis,N06.850.520.830.750
20938655,2010-10-12T00:00:00,Thrombolytic Therapy,E02.319.913
20938655,2010-10-12T00:00:00,United States,Z01.107.567.875
20938680,2010-10-12T00:00:00,Animals,B01.050
20938680,2010-10-12T00:00:00,Corpus Striatum,A08.186.211.730.885.287.249.487
20938680,2010-10-12T00:00:00,Gene Deletion,G05.355.600.800.320
20938680,2010-10-12T00:00:00,Gene Deletion,G05.365.590.762.320
20938680,2010-10-12T00:00:00,Gene Expression Regulation,G05.355.315
20940404,2010-10-12T00:00:00,Breast Neoplasms,C04.588.180
20940404,2010-10-12T00:00:00,Breast Neoplasms,C17.800.090.500
20940404,2010-10-12T00:00:00,Cell Proliferation,G04.299.233.750
20940404,2010-10-12T00:00:00,Cell Proliferation,G07.700.320.249.410.750
20940404,2010-10-12T00:00:00,Cell Survival,G04.299.316
20940404,2010-10-12T00:00:00,"Cell Transformation, Neoplastic",C04.697.152
20940404,2010-10-12T00:00:00,"Cell Transformation, Neoplastic",C23.550.727.152
20940404,2010-10-12T00:00:00,Gene Expression Profiling,E05.393.332
20940404,2010-10-12T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
20940404,2010-10-12T00:00:00,Histones,D12.776.660.470
20940404,2010-10-12T00:00:00,Histones,D12.776.664.469
20940404,2010-10-12T00:00:00,Homeodomain Proteins,D12.776.260.400
20940404,2010-10-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20940404,2010-10-12T00:00:00,Nuclear Proteins,D12.776.660
20940404,2010-10-12T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
20940404,2010-10-12T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
20940404,2010-10-12T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
20940404,2010-10-12T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
20940404,2010-10-12T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
20940404,2010-10-12T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
20940404,2010-10-12T00:00:00,Phenotype,G05.695
20940404,2010-10-12T00:00:00,"RNA, Messenger",D13.444.735.544
20940404,2010-10-12T00:00:00,Transcription Factors,D12.776.930
20940404,2010-10-12T00:00:00,"Tumor Markers, Biological",D23.101.840
20942566,2010-10-13T00:00:00,Animals,B01.050
20942566,2010-10-13T00:00:00,Drug-Induced Liver Injury,C06.552.195
20942566,2010-10-13T00:00:00,Drug-Induced Liver Injury,C21.613.260
20942566,2010-10-13T00:00:00,Glutathione,D12.644.456.448
20942566,2010-10-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20942566,2010-10-13T00:00:00,Liver,A03.620
20942566,2010-10-13T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
20942566,2010-10-13T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
20942566,2010-10-13T00:00:00,Oxidative Stress,G03.495.710
20942566,2010-10-13T00:00:00,Oxidative Stress,G07.700.830.750
20942566,2010-10-13T00:00:00,Peroxynitrous Acid,D01.625.600.800
20942566,2010-10-13T00:00:00,Peroxynitrous Acid,D01.625.700.750
20944547,2010-10-13T00:00:00,Animals,B01.050
20944547,2010-10-13T00:00:00,Blood Urea Nitrogen,E01.370.390.400.100
20944547,2010-10-13T00:00:00,Blood Urea Nitrogen,E01.450.150.100.115
20944547,2010-10-13T00:00:00,Complement Activation,G12.425.255
20944547,2010-10-13T00:00:00,"Disease Models, Animal",C22.232
20944547,2010-10-13T00:00:00,"Disease Models, Animal",E05.598.500
20944547,2010-10-13T00:00:00,"Disease Models, Animal",E05.599.395.080
20944547,2010-10-13T00:00:00,Fibrin,D12.776.124.270
20944547,2010-10-13T00:00:00,Kidney,A05.810.453
20944547,2010-10-13T00:00:00,"Mice, Inbred CBA",B01.050.050.157.520.440
20944547,2010-10-13T00:00:00,"Mice, Inbred CBA",B01.050.050.199.520.520.440
20944547,2010-10-13T00:00:00,"Mice, Inbred CBA",B01.050.150.900.649.865.635.505.500.400.440
20944547,2010-10-13T00:00:00,"Mice, Inbred DBA",B01.050.050.157.520.460
20944547,2010-10-13T00:00:00,"Mice, Inbred DBA",B01.050.050.199.520.520.460
20944547,2010-10-13T00:00:00,"Mice, Inbred DBA",B01.050.150.900.649.865.635.505.500.400.460
20944547,2010-10-13T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
20944547,2010-10-13T00:00:00,Oxidative Stress,G03.495.710
20944547,2010-10-13T00:00:00,Oxidative Stress,G07.700.830.750
20944547,2010-10-13T00:00:00,Pre-Eclampsia,C13.703.395.249
20944547,2010-10-13T00:00:00,Pregnancy,G08.686.785.760.769
20944547,2010-10-13T00:00:00,Proteinuria,C12.777.934.734
20944547,2010-10-13T00:00:00,Proteinuria,C13.351.968.934.734
20944547,2010-10-13T00:00:00,Proteinuria,C23.888.942.750
20944547,2010-10-13T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
20944547,2010-10-13T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
20944547,2010-10-13T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
20944547,2010-10-13T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
20944547,2010-10-13T00:00:00,Vascular Endothelial Growth Factor Receptor-1,D08.811.913.696.620.682.725.400.950.100
20944547,2010-10-13T00:00:00,Vascular Endothelial Growth Factor Receptor-1,D12.776.543.750.060.750.100
20944547,2010-10-13T00:00:00,Vascular Endothelial Growth Factor Receptor-1,D12.776.543.750.750.400.910.100
20942997,2010-10-14T00:00:00,Animals,B01.050
20942997,2010-10-14T00:00:00,"Behavior, Animal",F01.145.113
20942997,2010-10-14T00:00:00,Cell Membrane,A11.284.149
20942997,2010-10-14T00:00:00,Cocaine-Related Disorders,C21.739.300
20942997,2010-10-14T00:00:00,Cocaine-Related Disorders,F03.900.300
20942997,2010-10-14T00:00:00,Corpus Striatum,A08.186.211.730.885.287.249.487
20942997,2010-10-14T00:00:00,Cytoskeletal Proteins,D12.776.220
20942997,2010-10-14T00:00:00,Nerve Tissue Proteins,D12.776.641
20942997,2010-10-14T00:00:00,Neuronal Plasticity,G11.561.600.635
20942997,2010-10-14T00:00:00,Neurons,A08.663
20942997,2010-10-14T00:00:00,Neurons,A11.671
20942997,2010-10-14T00:00:00,"RNA, Messenger",D13.444.735.544
20942997,2010-10-14T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20942997,2010-10-14T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
20942997,2010-10-14T00:00:00,"Receptors, AMPA",D12.776.543.750.720.200.450.200
20946629,2010-10-14T00:00:00,Aged,M01.060.116.100
20946629,2010-10-14T00:00:00,Animals,B01.050
20946629,2010-10-14T00:00:00,Antineoplastic Agents,D27.505.954.248
20946629,2010-10-14T00:00:00,Breast Neoplasms,C04.588.180
20946629,2010-10-14T00:00:00,Breast Neoplasms,C17.800.090.500
20946629,2010-10-14T00:00:00,Gene Expression Profiling,E05.393.332
20946629,2010-10-14T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
20946629,2010-10-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20946629,2010-10-14T00:00:00,Middle Aged,M01.060.116.630
20946629,2010-10-14T00:00:00,Oxidoreductases Acting on CH-NH Group Donors,D08.811.682.662
20946629,2010-10-14T00:00:00,Polyamines,D02.092.782
20946629,2010-10-14T00:00:00,Recombinant Proteins,D12.776.828
20946629,2010-10-14T00:00:00,Spermine,D02.092.211.415.701.801.821
20946629,2010-10-14T00:00:00,Spermine,D02.092.782.802
20947571,2010-10-14T00:00:00,Algorithms,G17.035
20947571,2010-10-14T00:00:00,Algorithms,L01.224.050
20947571,2010-10-14T00:00:00,Double-Blind Method,E05.318.780.300
20947571,2010-10-14T00:00:00,Double-Blind Method,E05.581.500.300
20947571,2010-10-14T00:00:00,Double-Blind Method,N05.715.360.780.320
20947571,2010-10-14T00:00:00,Double-Blind Method,N06.850.520.445.300
20947571,2010-10-14T00:00:00,Health Status,I01.240.425
20947571,2010-10-14T00:00:00,Health Status,N01.224.425
20947571,2010-10-14T00:00:00,Health Status,N06.850.505.400.425
20947571,2010-10-14T00:00:00,Heart Failure,C14.280.434
20947571,2010-10-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20947571,2010-10-14T00:00:00,"Monitoring, Physiologic",E01.370.520
20947571,2010-10-14T00:00:00,Poisson Distribution,E05.318.740.994.750
20947571,2010-10-14T00:00:00,Poisson Distribution,G17.820.750
20947571,2010-10-14T00:00:00,Poisson Distribution,N05.715.360.750.750.620
20947571,2010-10-14T00:00:00,Poisson Distribution,N06.850.520.830.994.750
20947571,2010-10-14T00:00:00,United States,Z01.107.567.875
20947857,2010-10-14T00:00:00,Adult,M01.060.116
20947857,2010-10-14T00:00:00,Aged,M01.060.116.100
20947857,2010-10-14T00:00:00,Cerebral Hemorrhage,C10.228.140.300.535.200
20947857,2010-10-14T00:00:00,Cerebral Hemorrhage,C14.907.253.573.200
20947857,2010-10-14T00:00:00,Cerebral Hemorrhage,C23.550.414.913.100
20947857,2010-10-14T00:00:00,Diagnostic Imaging,E01.370.350
20947857,2010-10-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20947857,2010-10-14T00:00:00,Incidence,E05.318.308.985.525.375
20947857,2010-10-14T00:00:00,Incidence,L01.280.975.525.375
20947857,2010-10-14T00:00:00,Incidence,N01.224.935.597.500
20947857,2010-10-14T00:00:00,Incidence,N06.850.505.400.975.525.375
20947857,2010-10-14T00:00:00,Incidence,N06.850.520.308.985.525.375
20947857,2010-10-14T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20947857,2010-10-14T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20947857,2010-10-14T00:00:00,Middle Aged,M01.060.116.630
20947857,2010-10-14T00:00:00,Risk Factors,E05.318.740.600.800.725
20947857,2010-10-14T00:00:00,Risk Factors,N05.715.350.200.700
20947857,2010-10-14T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20947857,2010-10-14T00:00:00,Risk Factors,N06.850.490.625.750
20947857,2010-10-14T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20947857,2010-10-14T00:00:00,Thrombolytic Therapy,E02.319.913
20947857,2010-10-14T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
20947857,2010-10-14T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
20947857,2010-10-14T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
20947857,2010-10-14T00:00:00,Tissue Plasminogen Activator,D23.119.970
20947857,2010-10-14T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20947857,2010-10-14T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20947857,2010-10-14T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20947857,2010-10-14T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20947857,2010-10-14T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20949510,2010-10-14T00:00:00,Algorithms,G17.035
20949510,2010-10-14T00:00:00,Algorithms,L01.224.050
20949510,2010-10-14T00:00:00,Bacterial Proteins,D12.776.097
20949510,2010-10-14T00:00:00,"Models, Molecular",E05.599.595
20949510,2010-10-14T00:00:00,Molecular Dynamics Simulation,E05.599.595.500
20949510,2010-10-14T00:00:00,Molecular Dynamics Simulation,G02.575.750
20949510,2010-10-14T00:00:00,Molecular Dynamics Simulation,L01.224.160.500
20949510,2010-10-14T00:00:00,Temperature,G01.906.595
20949510,2010-10-14T00:00:00,Temperature,G16.500.275.063.725.710
20949510,2010-10-14T00:00:00,Temperature,G16.500.750.775.710
20949510,2010-10-14T00:00:00,Temperature,N06.230.150.450
20949510,2010-10-14T00:00:00,Temperature,N06.230.300.100.725.710
20949552,2010-10-14T00:00:00,Adolescent,M01.060.057
20949552,2010-10-14T00:00:00,Adult,M01.060.116
20949552,2010-10-14T00:00:00,Aged,M01.060.116.100
20949552,2010-10-14T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
20949552,2010-10-14T00:00:00,Anticonvulsants,D27.505.954.427.080
20949552,2010-10-14T00:00:00,Antifungal Agents,D27.505.954.122.136
20949552,2010-10-14T00:00:00,Drug-Induced Liver Injury,C06.552.195
20949552,2010-10-14T00:00:00,Drug-Induced Liver Injury,C21.613.260
20949552,2010-10-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20949552,2010-10-14T00:00:00,Liver Transplantation,E04.210.650
20949552,2010-10-14T00:00:00,Liver Transplantation,E04.936.450.490
20949552,2010-10-14T00:00:00,Liver Transplantation,E04.936.580.490
20949552,2010-10-14T00:00:00,Middle Aged,M01.060.116.630
20951235,2010-10-14T00:00:00,Adult,M01.060.116
20951235,2010-10-14T00:00:00,Delivery of Health Care,N04.590.374
20951235,2010-10-14T00:00:00,Delivery of Health Care,N05.300
20951235,2010-10-14T00:00:00,Health Services Accessibility,N04.590.374.350
20951235,2010-10-14T00:00:00,Health Services Accessibility,N05.300.430
20951235,2010-10-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20951235,2010-10-14T00:00:00,Implosive Therapy,F04.754.137.506.325
20951235,2010-10-14T00:00:00,Mental Health Services,F04.408
20951235,2010-10-14T00:00:00,Mental Health Services,N02.421.461
20951235,2010-10-14T00:00:00,Military Personnel,M01.526.625
20951235,2010-10-14T00:00:00,Office Visits,N04.452.758.635
20951235,2010-10-14T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
20951235,2010-10-14T00:00:00,Telemedicine,H02.403.840
20951235,2010-10-14T00:00:00,Telemedicine,L01.178.847.652
20951235,2010-10-14T00:00:00,Telemedicine,N04.590.374.800
20951235,2010-10-14T00:00:00,Young Adult,M01.060.116.815
21094370,2010-10-14T00:00:00,Echocardiography,E01.370.350.850.220
21094370,2010-10-14T00:00:00,Echocardiography,E01.370.370.380.220
21094370,2010-10-14T00:00:00,Heart Failure,C14.280.434
21094370,2010-10-14T00:00:00,Heart Transplantation,E04.100.376.475
21094370,2010-10-14T00:00:00,Heart Transplantation,E04.928.220.390
21094370,2010-10-14T00:00:00,Heart Transplantation,E04.936.450.475
21094370,2010-10-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21094370,2010-10-14T00:00:00,Middle Aged,M01.060.116.630
21094370,2010-10-14T00:00:00,Waiting Lists,N04.452.095.738
20831385,2010-10-15T00:00:00,Animals,B01.050
20831385,2010-10-15T00:00:00,Antigen-Presenting Cells,A11.066
20831385,2010-10-15T00:00:00,Antigen-Presenting Cells,A15.382.066
20831385,2010-10-15T00:00:00,"Antigens, Viral",D23.050.327
20831385,2010-10-15T00:00:00,CD4-Positive T-Lymphocytes,A11.118.637.555.567.569.200
20831385,2010-10-15T00:00:00,CD4-Positive T-Lymphocytes,A15.145.229.637.555.567.569.200
20831385,2010-10-15T00:00:00,CD4-Positive T-Lymphocytes,A15.382.490.555.567.569.200
20831385,2010-10-15T00:00:00,Cytokines,D12.644.276.374
20831385,2010-10-15T00:00:00,Cytokines,D12.776.467.374
20831385,2010-10-15T00:00:00,Cytokines,D23.529.374
20831385,2010-10-15T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
20831385,2010-10-15T00:00:00,Genetic Predisposition to Disease,G05.380.355
20831385,2010-10-15T00:00:00,Interferon-gamma,D12.644.276.374.440.893
20831385,2010-10-15T00:00:00,Interferon-gamma,D12.644.276.374.480.350
20831385,2010-10-15T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
20831385,2010-10-15T00:00:00,Interferon-gamma,D12.644.276.718.550
20831385,2010-10-15T00:00:00,Interferon-gamma,D12.776.467.374.440.893
20831385,2010-10-15T00:00:00,Interferon-gamma,D12.776.467.374.480.350
20831385,2010-10-15T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
20831385,2010-10-15T00:00:00,Interferon-gamma,D12.776.467.718.550
20831385,2010-10-15T00:00:00,Interferon-gamma,D23.529.374.440.893
20831385,2010-10-15T00:00:00,Interferon-gamma,D23.529.374.480.350
20831385,2010-10-15T00:00:00,Interferon-gamma,D23.529.374.480.615.350
20831385,2010-10-15T00:00:00,Interferon-gamma,D23.529.718.550
20831385,2010-10-15T00:00:00,Leishmaniasis,C03.752.300.500
20831385,2010-10-15T00:00:00,Leishmaniasis,C03.858.560
20831385,2010-10-15T00:00:00,Leishmaniasis,C17.800.838.775.560
20831385,2010-10-15T00:00:00,Membrane Glycoproteins,D12.776.395.550
20831385,2010-10-15T00:00:00,Membrane Glycoproteins,D12.776.543.550
20831385,2010-10-15T00:00:00,"Mice, Inbred CBA",B01.050.050.157.520.440
20831385,2010-10-15T00:00:00,"Mice, Inbred CBA",B01.050.050.199.520.520.440
20831385,2010-10-15T00:00:00,"Mice, Inbred CBA",B01.050.150.900.649.865.635.505.500.400.440
20831385,2010-10-15T00:00:00,"Mice, Inbred Strains",B01.050.050.157.520
20831385,2010-10-15T00:00:00,"Mice, Inbred Strains",B01.050.050.199.520.520
20831385,2010-10-15T00:00:00,"Mice, Inbred Strains",B01.050.150.900.649.865.635.505.500.400
20831385,2010-10-15T00:00:00,Superantigens,D23.050.820
20951508,2010-10-15T00:00:00,Adult,M01.060.116
20951508,2010-10-15T00:00:00,Age Factors,N05.715.350.075
20951508,2010-10-15T00:00:00,Age Factors,N06.850.490.250
20951508,2010-10-15T00:00:00,Aged,M01.060.116.100
20951508,2010-10-15T00:00:00,Brachytherapy,E02.815.150
20951508,2010-10-15T00:00:00,Breast Neoplasms,C04.588.180
20951508,2010-10-15T00:00:00,Breast Neoplasms,C17.800.090.500
20951508,2010-10-15T00:00:00,"Carcinoma, Ductal, Breast",C04.557.470.200.025.232.500
20951508,2010-10-15T00:00:00,"Carcinoma, Ductal, Breast",C04.557.470.615.132.500
20951508,2010-10-15T00:00:00,"Carcinoma, Ductal, Breast",C04.588.180.390
20951508,2010-10-15T00:00:00,"Carcinoma, Ductal, Breast",C17.800.090.500.390
20951508,2010-10-15T00:00:00,"Carcinoma, Intraductal, Noninfiltrating",C04.557.470.200.025.275
20951508,2010-10-15T00:00:00,"Carcinoma, Intraductal, Noninfiltrating",C04.557.470.615.275
20951508,2010-10-15T00:00:00,"Chemotherapy, Adjuvant",E02.186.170
20951508,2010-10-15T00:00:00,"Chemotherapy, Adjuvant",E02.319.170
20951508,2010-10-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20951508,2010-10-15T00:00:00,Lymph Node Excision,E04.446
20951508,2010-10-15T00:00:00,Middle Aged,M01.060.116.630
20951508,2010-10-15T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
20951508,2010-10-15T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
20951508,2010-10-15T00:00:00,Risk Assessment,E05.318.740.600.800.715
20951508,2010-10-15T00:00:00,Risk Assessment,N04.452.871.715
20951508,2010-10-15T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
20951508,2010-10-15T00:00:00,Risk Assessment,N06.850.505.715
20951508,2010-10-15T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
20951508,2010-10-15T00:00:00,Time Factors,G01.910.857
20951732,2010-10-15T00:00:00,Animals,B01.050
20951732,2010-10-15T00:00:00,Antineoplastic Agents,D27.505.954.248
20951732,2010-10-15T00:00:00,Bone Marrow,A15.382.216
20951732,2010-10-15T00:00:00,Cell Proliferation,G04.299.233.750
20951732,2010-10-15T00:00:00,Cell Proliferation,G07.700.320.249.410.750
20951732,2010-10-15T00:00:00,Cytokines,D12.644.276.374
20951732,2010-10-15T00:00:00,Cytokines,D12.776.467.374
20951732,2010-10-15T00:00:00,Cytokines,D23.529.374
20951732,2010-10-15T00:00:00,Glutathione,D12.644.456.448
20951732,2010-10-15T00:00:00,Hematopoietic Stem Cells,A11.148.378
20951732,2010-10-15T00:00:00,Hematopoietic Stem Cells,A11.872.378
20951732,2010-10-15T00:00:00,Hematopoietic Stem Cells,A15.378.316.378
20951732,2010-10-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20951732,2010-10-15T00:00:00,Immune System,A15.382
20951732,2010-10-15T00:00:00,Neoplasms,C04
20951732,2010-10-15T00:00:00,Reactive Oxygen Species,D01.339.431
20951732,2010-10-15T00:00:00,Reactive Oxygen Species,D01.650.775
20951833,2010-10-15T00:00:00,Adult,M01.060.116
20951833,2010-10-15T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
20951833,2010-10-15T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
20951833,2010-10-15T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
20951833,2010-10-15T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
20951833,2010-10-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20951833,2010-10-15T00:00:00,Middle Aged,M01.060.116.630
20951833,2010-10-15T00:00:00,Stents,E07.695.750
20951833,2010-10-15T00:00:00,Treatment Outcome,E01.789.800
20951833,2010-10-15T00:00:00,Treatment Outcome,N04.761.559.590.800
20951833,2010-10-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20952585,2010-10-15T00:00:00,Animals,B01.050
20952585,2010-10-15T00:00:00,Complement Activation,G12.425.255
20952585,2010-10-15T00:00:00,"Complement Pathway, Alternative",G12.425.255.695
20952585,2010-10-15T00:00:00,Demyelinating Diseases,C10.314
20952585,2010-10-15T00:00:00,Macrophages,A11.329.372
20952585,2010-10-15T00:00:00,Macrophages,A11.627.482
20952585,2010-10-15T00:00:00,Macrophages,A11.733.397
20952585,2010-10-15T00:00:00,Macrophages,A15.382.680.397
20952585,2010-10-15T00:00:00,Macrophages,A15.382.812.522
20952585,2010-10-15T00:00:00,Neutrophils,A11.118.637.415.583
20952585,2010-10-15T00:00:00,Neutrophils,A11.627.340.583
20952585,2010-10-15T00:00:00,Neutrophils,A11.733.689
20952585,2010-10-15T00:00:00,Neutrophils,A15.145.229.637.415.583
20952585,2010-10-15T00:00:00,Neutrophils,A15.382.490.315.583
20952585,2010-10-15T00:00:00,Neutrophils,A15.382.680.689
20952585,2010-10-15T00:00:00,Recovery of Function,G16.757
20952585,2010-10-15T00:00:00,Spinal Cord Injuries,C10.228.854.770
20952585,2010-10-15T00:00:00,Spinal Cord Injuries,C10.900.850
20952585,2010-10-15T00:00:00,Spinal Cord Injuries,C21.866.819
20954266,2010-10-15T00:00:00,Computer-Assisted Instruction,I02.903.573.208
20954266,2010-10-15T00:00:00,Curriculum,I02.158
20954266,2010-10-15T00:00:00,"Education, Medical, Undergraduate",I02.358.399.450
20954266,2010-10-15T00:00:00,Educational Measurement,I02.399
20954266,2010-10-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20954266,2010-10-15T00:00:00,Internet,L01.224.230.110.500
20954266,2010-10-15T00:00:00,Learning,F02.463.425
20954266,2010-10-15T00:00:00,Learning,F02.784.629.529
20954266,2010-10-15T00:00:00,Perception,F02.463.593
20954266,2010-10-15T00:00:00,Program Evaluation,E05.337.820
20954266,2010-10-15T00:00:00,Program Evaluation,N04.761.685
20954266,2010-10-15T00:00:00,Program Evaluation,N05.715.360.650
20954266,2010-10-15T00:00:00,"Schools, Medical",I02.783.660.552
20954266,2010-10-15T00:00:00,"Schools, Medical",N02.278.020.578
20954266,2010-10-15T00:00:00,South Carolina,Z01.107.567.875.075.662
20954266,2010-10-15T00:00:00,South Carolina,Z01.107.567.875.750.700
20954266,2010-10-15T00:00:00,"Students, Medical",I02.851.686.602
20954266,2010-10-15T00:00:00,"Students, Medical",M01.848.769.602
20954266,2010-10-15T00:00:00,Teaching,I02.903
20954266,2010-10-15T00:00:00,Time Factors,G01.910.857
20954266,2010-10-15T00:00:00,Video Recording,L01.240.960
20953596,2010-10-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20953596,2010-10-16T00:00:00,Infant,M01.060.703
20953596,2010-10-16T00:00:00,Nephrocalcinosis,C12.777.419.590
20953596,2010-10-16T00:00:00,Nephrocalcinosis,C13.351.968.419.590
20953596,2010-10-16T00:00:00,Nephrocalcinosis,C18.452.174.130.560
20953596,2010-10-16T00:00:00,"Radiography, Abdominal",E01.370.350.700.715
20953596,2010-10-16T00:00:00,Ultrasonography,E01.370.350.850
20836514,2010-10-18T00:00:00,Antioxidants,D27.505.519.217
20836514,2010-10-18T00:00:00,Antioxidants,D27.505.696.706.125
20836514,2010-10-18T00:00:00,Antioxidants,D27.720.799.047
20836514,2010-10-18T00:00:00,Copper,D01.268.556.195
20836514,2010-10-18T00:00:00,Copper,D01.268.956.170
20836514,2010-10-18T00:00:00,Copper,D01.552.544.195
20836514,2010-10-18T00:00:00,Magnetic Resonance Spectroscopy,E05.196.867.519
20836514,2010-10-18T00:00:00,Organometallic Compounds,D01.632
20836514,2010-10-18T00:00:00,Organometallic Compounds,D02.691
20836514,2010-10-18T00:00:00,Pyrazoles,D03.383.129.539
20836514,2010-10-18T00:00:00,Selenium,D01.268.185.850
20836514,2010-10-18T00:00:00,Selenium,D01.578.700
20836514,2010-10-18T00:00:00,Sulfur,D01.268.185.900
20956547,2010-10-18T00:00:00,Animals,B01.050
20956547,2010-10-18T00:00:00,Apoptosis Regulatory Proteins,D12.644.360.075
20956547,2010-10-18T00:00:00,Apoptosis Regulatory Proteins,D12.776.476.075
20956547,2010-10-18T00:00:00,B-Lymphocytes,A11.063.438
20956547,2010-10-18T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
20956547,2010-10-18T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
20956547,2010-10-18T00:00:00,B-Lymphocytes,A15.382.032.438
20956547,2010-10-18T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
20956547,2010-10-18T00:00:00,Cell Proliferation,G04.299.233.750
20956547,2010-10-18T00:00:00,Cell Proliferation,G07.700.320.249.410.750
20956547,2010-10-18T00:00:00,Cell Survival,G04.299.316
20956547,2010-10-18T00:00:00,Cyclin-Dependent Kinase Inhibitor p27,D12.644.360.225.600
20956547,2010-10-18T00:00:00,Cyclin-Dependent Kinase Inhibitor p27,D12.776.167.187.600
20956547,2010-10-18T00:00:00,Cyclin-Dependent Kinase Inhibitor p27,D12.776.476.225.600
20956547,2010-10-18T00:00:00,Cyclin-Dependent Kinase Inhibitor p27,D12.776.624.776.355.600
20956547,2010-10-18T00:00:00,Gene Deletion,G05.355.600.800.320
20956547,2010-10-18T00:00:00,Gene Deletion,G05.365.590.762.320
20956547,2010-10-18T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
20956547,2010-10-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20956547,2010-10-18T00:00:00,Membrane Proteins,D12.776.543
20956547,2010-10-18T00:00:00,PTEN Phosphohydrolase,D08.811.277.352.650.850
20956547,2010-10-18T00:00:00,PTEN Phosphohydrolase,D12.776.476.590
20956547,2010-10-18T00:00:00,PTEN Phosphohydrolase,D12.776.624.776.695
20956547,2010-10-18T00:00:00,Proto-Oncogene Proteins,D12.776.624.664.700
20956547,2010-10-18T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.644.360.075.718
20956547,2010-10-18T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.476.075.718
20956547,2010-10-18T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.624.664.700.169
21990815,2010-10-18T00:00:00,Aged,M01.060.116.100
21990815,2010-10-18T00:00:00,Angiography,E01.370.350.700.060
21990815,2010-10-18T00:00:00,Angiography,E01.370.370.050
21990815,2010-10-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21990815,2010-10-18T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
21990815,2010-10-18T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
21990815,2010-10-18T00:00:00,Middle Aged,M01.060.116.630
21990815,2010-10-18T00:00:00,Postoperative Care,E02.760.722.700
21990815,2010-10-18T00:00:00,Postoperative Care,E04.624
21990815,2010-10-18T00:00:00,Postoperative Care,N02.421.585.722.700
21990815,2010-10-18T00:00:00,Spinal Cord,A08.186.854
20860702,2010-10-19T00:00:00,Aging,G07.700.320.124
20860702,2010-10-19T00:00:00,Animals,B01.050
20860702,2010-10-19T00:00:00,Body Weight,C23.888.144
20860702,2010-10-19T00:00:00,Body Weight,E01.370.600.115.100.160.120
20860702,2010-10-19T00:00:00,Body Weight,E05.041.124.160.750
20860702,2010-10-19T00:00:00,Body Weight,G07.100.100.160.120
20860702,2010-10-19T00:00:00,Body Weight,G07.700.320.249.314.120
20860702,2010-10-19T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
20860702,2010-10-19T00:00:00,Corpus Striatum,A08.186.211.730.885.287.249.487
20860702,2010-10-19T00:00:00,Dopamine,D02.092.211.215.311.342
20860702,2010-10-19T00:00:00,Dopamine,D02.092.311.342
20860702,2010-10-19T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.157.530.450.625.124
20860702,2010-10-19T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.157.530.562.374.500.500
20860702,2010-10-19T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.543.585.450.625.124
20860702,2010-10-19T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.543.585.562.374.500.500
20860702,2010-10-19T00:00:00,Extracellular Space,A10.082.500
20860702,2010-10-19T00:00:00,Extracellular Space,A11.284.295
20860702,2010-10-19T00:00:00,Motor Activity,F01.145.632
20860702,2010-10-19T00:00:00,Motor Activity,G11.427.590.530.698
20860702,2010-10-19T00:00:00,Postural Balance,G11.427.690
20860702,2010-10-19T00:00:00,Postural Balance,G11.561.600.810.541.595
20860702,2010-10-19T00:00:00,Substantia Nigra,A08.186.211.132.659.822.731
20860702,2010-10-19T00:00:00,Substantia Nigra,A08.186.211.653.822.731
20860702,2010-10-19T00:00:00,Synaptosomes,A11.284.835.859
20860702,2010-10-19T00:00:00,Vesicular Monoamine Transport Proteins,D12.776.157.530.450.162.887.500.500
20860702,2010-10-19T00:00:00,Vesicular Monoamine Transport Proteins,D12.776.157.530.562.750.500.500
20860702,2010-10-19T00:00:00,Vesicular Monoamine Transport Proteins,D12.776.543.585.450.162.887.500.500
20860702,2010-10-19T00:00:00,Vesicular Monoamine Transport Proteins,D12.776.543.585.562.750.500.500
20959639,2010-10-19T00:00:00,Hospital Costs,N03.219.151.400.687
20959639,2010-10-19T00:00:00,Hospital Costs,N03.219.262.500
20959639,2010-10-19T00:00:00,Hospital Costs,N05.300.375.500
20959639,2010-10-19T00:00:00,Hospitals,N02.278.421
20959639,2010-10-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20959639,2010-10-19T00:00:00,Length of Stay,E02.760.400.480
20959639,2010-10-19T00:00:00,Length of Stay,N02.421.585.400.480
20959639,2010-10-19T00:00:00,Middle Aged,M01.060.116.630
20959639,2010-10-19T00:00:00,Parenteral Nutrition,E02.421.505
20959639,2010-10-19T00:00:00,Parenteral Nutrition,E02.642.500.505
20959639,2010-10-19T00:00:00,Patient Care Team,N04.590.715
20959639,2010-10-19T00:00:00,South Carolina,Z01.107.567.875.075.662
20959639,2010-10-19T00:00:00,South Carolina,Z01.107.567.875.750.700
20960579,2010-10-19T00:00:00,Aged,M01.060.116.100
20960579,2010-10-19T00:00:00,Brain,A08.186.211
20960579,2010-10-19T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
20960579,2010-10-19T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
20960579,2010-10-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20960579,2010-10-19T00:00:00,Middle Aged,M01.060.116.630
20959991,2010-10-20T00:00:00,Aged,M01.060.116.100
20959991,2010-10-20T00:00:00,Brachytherapy,E02.815.150
20959991,2010-10-20T00:00:00,Data Collection,E05.318.308
20959991,2010-10-20T00:00:00,Data Collection,L01.280
20959991,2010-10-20T00:00:00,Data Collection,N05.715.360.300
20959991,2010-10-20T00:00:00,Data Collection,N06.850.520.308
20959991,2010-10-20T00:00:00,Drug Therapy,E02.319
20959991,2010-10-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20959991,2010-10-20T00:00:00,Middle Aged,M01.060.116.630
20959991,2010-10-20T00:00:00,Neoplasm Staging,E01.370.550
20959991,2010-10-20T00:00:00,Patient Preference,N04.452.822.360.600.500
20959991,2010-10-20T00:00:00,Patient Preference,N05.300.150.600.630.500
20959991,2010-10-20T00:00:00,Physician's Practice Patterns,N04.590.748
20959991,2010-10-20T00:00:00,Physician's Practice Patterns,N05.300.625
20959991,2010-10-20T00:00:00,Prostatectomy,E04.950.774.860.625
20959991,2010-10-20T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
20959991,2010-10-20T00:00:00,Prostatic Neoplasms,C12.294.260.750
20959991,2010-10-20T00:00:00,Prostatic Neoplasms,C12.294.565.625
20959991,2010-10-20T00:00:00,Prostatic Neoplasms,C12.758.409.750
20959991,2010-10-20T00:00:00,Referral and Consultation,N04.452.758.849
20959991,2010-10-20T00:00:00,Urology,H02.403.810.860
20961970,2010-10-20T00:00:00,"Databases, Factual",L01.470.750.750
20961970,2010-10-20T00:00:00,"Databases, Factual",L01.700.508.300.188.400
20961970,2010-10-20T00:00:00,Rural Population,N01.600.725
20961970,2010-10-20T00:00:00,South Carolina,Z01.107.567.875.075.662
20961970,2010-10-20T00:00:00,South Carolina,Z01.107.567.875.750.700
20961970,2010-10-20T00:00:00,Urban Population,N01.600.900
20962256,2010-10-20T00:00:00,Animals,B01.050
20962256,2010-10-20T00:00:00,"Complement Pathway, Alternative",G12.425.255.695
20962256,2010-10-20T00:00:00,Cytokines,D12.644.276.374
20962256,2010-10-20T00:00:00,Cytokines,D12.776.467.374
20962256,2010-10-20T00:00:00,Cytokines,D23.529.374
20962256,2010-10-20T00:00:00,Drug Delivery Systems,E02.319.300
20962256,2010-10-20T00:00:00,Heart Transplantation,E04.100.376.475
20962256,2010-10-20T00:00:00,Heart Transplantation,E04.928.220.390
20962256,2010-10-20T00:00:00,Heart Transplantation,E04.936.450.475
20962256,2010-10-20T00:00:00,Macrophages,A11.329.372
20962256,2010-10-20T00:00:00,Macrophages,A11.627.482
20962256,2010-10-20T00:00:00,Macrophages,A11.733.397
20962256,2010-10-20T00:00:00,Macrophages,A15.382.680.397
20962256,2010-10-20T00:00:00,Macrophages,A15.382.812.522
20962256,2010-10-20T00:00:00,Neutrophils,A11.118.637.415.583
20962256,2010-10-20T00:00:00,Neutrophils,A11.627.340.583
20962256,2010-10-20T00:00:00,Neutrophils,A11.733.689
20962256,2010-10-20T00:00:00,Neutrophils,A15.145.229.637.415.583
20962256,2010-10-20T00:00:00,Neutrophils,A15.382.490.315.583
20962256,2010-10-20T00:00:00,Neutrophils,A15.382.680.689
20962256,2010-10-20T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
20970524,2010-10-20T00:00:00,Adult,M01.060.116
20970524,2010-10-20T00:00:00,Blood Glucose,D09.546.359.448.500
20970524,2010-10-20T00:00:00,Body Mass Index,E01.370.600.115.100.125
20970524,2010-10-20T00:00:00,Body Mass Index,E05.041.124.125
20970524,2010-10-20T00:00:00,Body Mass Index,G07.100.100.125
20970524,2010-10-20T00:00:00,Body Mass Index,N06.850.505.200.100.175
20970524,2010-10-20T00:00:00,Exercise,G11.427.590.237
20970524,2010-10-20T00:00:00,Exercise,I03.350
20970524,2010-10-20T00:00:00,Gastric Bypass,E02.065.062.249
20970524,2010-10-20T00:00:00,Gastric Bypass,E04.035.398.385
20970524,2010-10-20T00:00:00,Gastric Bypass,E04.062.249
20970524,2010-10-20T00:00:00,Gastric Bypass,E04.210.457.430
20970524,2010-10-20T00:00:00,Heart Conduction System,A07.541.409
20970524,2010-10-20T00:00:00,Hemodynamics,G09.330.190.400
20970524,2010-10-20T00:00:00,Hemodynamics,G09.330.380
20970524,2010-10-20T00:00:00,Homeostasis,G07.700.360
20970524,2010-10-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20970524,2010-10-20T00:00:00,Middle Aged,M01.060.116.630
20970524,2010-10-20T00:00:00,"Obesity, Morbid",C18.654.726.500.700
20970524,2010-10-20T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
20970524,2010-10-20T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
20970524,2010-10-20T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
20970524,2010-10-20T00:00:00,Weight Loss,C23.888.144.243.963
20970524,2010-10-20T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
21990789,2010-10-20T00:00:00,Angioplasty,E02.148.050
21990789,2010-10-20T00:00:00,Angioplasty,E04.100.814.050
21990789,2010-10-20T00:00:00,Catheterization,E02.148
21990789,2010-10-20T00:00:00,Catheterization,E05.157
21990789,2010-10-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21990789,2010-10-20T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.150.477.200.450
21990789,2010-10-20T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.510.200.387
21990789,2010-10-20T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.775.200.200.450
21990789,2010-10-20T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.092.477.200.450
21990789,2010-10-20T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.560.200.387
21990789,2010-10-20T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.855.200.200.450
21990789,2010-10-20T00:00:00,Middle Aged,M01.060.116.630
21990789,2010-10-20T00:00:00,Stents,E07.695.750
21990789,2010-10-20T00:00:00,Stroke,C10.228.140.300.775
21990789,2010-10-20T00:00:00,Stroke,C14.907.253.855
20966040,2010-10-21T00:00:00,Adult,M01.060.116
20966040,2010-10-21T00:00:00,Aged,M01.060.116.100
20966040,2010-10-21T00:00:00,Heart Failure,C14.280.434
20966040,2010-10-21T00:00:00,Heart Transplantation,E04.100.376.475
20966040,2010-10-21T00:00:00,Heart Transplantation,E04.928.220.390
20966040,2010-10-21T00:00:00,Heart Transplantation,E04.936.450.475
20966040,2010-10-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20966040,2010-10-21T00:00:00,Middle Aged,M01.060.116.630
20966040,2010-10-21T00:00:00,Risk Factors,E05.318.740.600.800.725
20966040,2010-10-21T00:00:00,Risk Factors,N05.715.350.200.700
20966040,2010-10-21T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20966040,2010-10-21T00:00:00,Risk Factors,N06.850.490.625.750
20966040,2010-10-21T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20966040,2010-10-21T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20966040,2010-10-21T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20966040,2010-10-21T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20966040,2010-10-21T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20966040,2010-10-21T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20966040,2010-10-21T00:00:00,Treatment Outcome,E01.789.800
20966040,2010-10-21T00:00:00,Treatment Outcome,N04.761.559.590.800
20966040,2010-10-21T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20966421,2010-10-21T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
20966421,2010-10-21T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
20966421,2010-10-21T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
20966421,2010-10-21T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
20966421,2010-10-21T00:00:00,Anticoagulants,D27.505.954.502.119
20966421,2010-10-21T00:00:00,Cerebral Hemorrhage,C10.228.140.300.535.200
20966421,2010-10-21T00:00:00,Cerebral Hemorrhage,C14.907.253.573.200
20966421,2010-10-21T00:00:00,Cerebral Hemorrhage,C23.550.414.913.100
20966421,2010-10-21T00:00:00,Embolism,C14.907.355.350
20966421,2010-10-21T00:00:00,Evidence-Based Medicine,H02.249.750
20966421,2010-10-21T00:00:00,Evidence-Based Medicine,H02.403.200.400
20966421,2010-10-21T00:00:00,"Foramen Ovale, Patent",C14.240.400.560.375.258
20966421,2010-10-21T00:00:00,"Foramen Ovale, Patent",C14.280.400.560.375.258
20966421,2010-10-21T00:00:00,"Foramen Ovale, Patent",C16.131.240.400.560.375.258
20966421,2010-10-21T00:00:00,Heart Diseases,C14.280
20966421,2010-10-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20966421,2010-10-21T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
20966421,2010-10-21T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
20966421,2010-10-21T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
20966421,2010-10-21T00:00:00,Pregnancy,G08.686.785.760.769
20966421,2010-10-21T00:00:00,Risk Factors,E05.318.740.600.800.725
20966421,2010-10-21T00:00:00,Risk Factors,N05.715.350.200.700
20966421,2010-10-21T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20966421,2010-10-21T00:00:00,Risk Factors,N06.850.490.625.750
20966421,2010-10-21T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20966421,2010-10-21T00:00:00,Stroke,C10.228.140.300.775
20966421,2010-10-21T00:00:00,Stroke,C14.907.253.855
20966421,2010-10-21T00:00:00,Thrombosis,C14.907.355.830
20964717,2010-10-22T00:00:00,Adolescent,M01.060.057
20964717,2010-10-22T00:00:00,Adult,M01.060.116
20964717,2010-10-22T00:00:00,African Americans,M01.686.508.100.100
20964717,2010-10-22T00:00:00,African Americans,M01.686.754.100
20964717,2010-10-22T00:00:00,Aged,M01.060.116.100
20964717,2010-10-22T00:00:00,Graft Rejection,G12.425.901.545.328
20964717,2010-10-22T00:00:00,Graft Survival,G12.425.901.545.340
20964717,2010-10-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20964717,2010-10-22T00:00:00,Kidney Transplantation,E02.870.500
20964717,2010-10-22T00:00:00,Kidney Transplantation,E04.936.450.485
20964717,2010-10-22T00:00:00,Kidney Transplantation,E04.950.774.400
20964717,2010-10-22T00:00:00,Middle Aged,M01.060.116.630
20964717,2010-10-22T00:00:00,Young Adult,M01.060.116.815
20971769,2010-10-22T00:00:00,Animals,B01.050
20971769,2010-10-22T00:00:00,Coronary Vessels,A07.231.114.269
20971769,2010-10-22T00:00:00,Coronary Vessels,A07.231.908.194
20971769,2010-10-22T00:00:00,Echocardiography,E01.370.350.850.220
20971769,2010-10-22T00:00:00,Echocardiography,E01.370.370.380.220
20971769,2010-10-22T00:00:00,"Hypertrophy, Left Ventricular",C14.280.195.400
20971769,2010-10-22T00:00:00,"Hypertrophy, Left Ventricular",C23.300.775.250.400
20971769,2010-10-22T00:00:00,"Myocytes, Cardiac",A07.541.704.570
20971769,2010-10-22T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
20971769,2010-10-22T00:00:00,"Myocytes, Cardiac",A11.620.500
20971769,2010-10-22T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
20974291,2010-10-23T00:00:00,Binomial Distribution,E05.318.740.994.250
20974291,2010-10-23T00:00:00,Binomial Distribution,G17.820.250
20974291,2010-10-23T00:00:00,Binomial Distribution,N05.715.360.750.750.150
20974291,2010-10-23T00:00:00,Binomial Distribution,N06.850.520.830.994.250
20974291,2010-10-23T00:00:00,Clinical Trials as Topic,E05.318.760.535
20974291,2010-10-23T00:00:00,Clinical Trials as Topic,E05.337.250
20974291,2010-10-23T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
20974291,2010-10-23T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
20974291,2010-10-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20974291,2010-10-23T00:00:00,"Models, Statistical",E05.318.740.500
20974291,2010-10-23T00:00:00,"Models, Statistical",E05.599.835
20974291,2010-10-23T00:00:00,"Models, Statistical",N05.715.360.750.530
20974291,2010-10-23T00:00:00,"Models, Statistical",N06.850.520.830.500
20974291,2010-10-23T00:00:00,Probability,E05.318.740.600
20974291,2010-10-23T00:00:00,Probability,G17.680
20974291,2010-10-23T00:00:00,Probability,N05.715.360.750.625
20974291,2010-10-23T00:00:00,Probability,N06.850.520.830.600
20974291,2010-10-23T00:00:00,Research Design,E05.581.500
20974291,2010-10-23T00:00:00,Research Design,H01.770.644.728
20974291,2010-10-23T00:00:00,Uncertainty,E05.318.740.600.900
20974291,2010-10-23T00:00:00,Uncertainty,F02.463.785.373.820
20974291,2010-10-23T00:00:00,Uncertainty,G17.680.875
20974291,2010-10-23T00:00:00,Uncertainty,N05.715.360.750.625.850
20974291,2010-10-23T00:00:00,Uncertainty,N06.850.520.830.600.900
20977904,2010-10-25T00:00:00,Adolescent,M01.060.057
20977904,2010-10-25T00:00:00,Adult,M01.060.116
20977904,2010-10-25T00:00:00,Aged,M01.060.116.100
20977904,2010-10-25T00:00:00,Carrier Proteins,D12.776.157
20977904,2010-10-25T00:00:00,Child,M01.060.406
20977904,2010-10-25T00:00:00,"Child, Preschool",M01.060.406.448
20977904,2010-10-25T00:00:00,Cystic Fibrosis,C06.689.202
20977904,2010-10-25T00:00:00,Cystic Fibrosis,C08.381.187
20977904,2010-10-25T00:00:00,Cystic Fibrosis,C16.320.190
20977904,2010-10-25T00:00:00,Cystic Fibrosis,C16.614.213
20977904,2010-10-25T00:00:00,Cystic Fibrosis Transmembrane Conductance Regulator,D12.776.157.530.400.175.125
20977904,2010-10-25T00:00:00,Cystic Fibrosis Transmembrane Conductance Regulator,D12.776.543.550.425.175.125
20977904,2010-10-25T00:00:00,Cystic Fibrosis Transmembrane Conductance Regulator,D12.776.543.585.400.175.125
20977904,2010-10-25T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
20977904,2010-10-25T00:00:00,Genetic Predisposition to Disease,G05.380.355
20977904,2010-10-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20977904,2010-10-25T00:00:00,Infant,M01.060.703
20977904,2010-10-25T00:00:00,Middle Aged,M01.060.116.630
20977904,2010-10-25T00:00:00,Molecular Sequence Data,L01.453.245.667
20977904,2010-10-25T00:00:00,"Pancreatitis, Chronic",C06.689.750.830
20977904,2010-10-25T00:00:00,Young Adult,M01.060.116.815
20980099,2010-10-25T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
20980099,2010-10-25T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
20980099,2010-10-25T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
20980099,2010-10-25T00:00:00,Homeodomain Proteins,D12.776.260.400
20980099,2010-10-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20980099,2010-10-25T00:00:00,Lung Neoplasms,C04.588.894.797.520
20980099,2010-10-25T00:00:00,Lung Neoplasms,C08.381.540
20980099,2010-10-25T00:00:00,Lung Neoplasms,C08.785.520
20980099,2010-10-25T00:00:00,Repressor Proteins,D12.776.260.703
20980099,2010-10-25T00:00:00,Repressor Proteins,D12.776.930.700
20980099,2010-10-25T00:00:00,Transcription Factors,D12.776.930
20977524,2010-10-26T00:00:00,Aged,M01.060.116.100
20977524,2010-10-26T00:00:00,Brain,A08.186.211
20977524,2010-10-26T00:00:00,Brain Ischemia,C10.228.140.300.150
20977524,2010-10-26T00:00:00,Brain Ischemia,C14.907.253.092
20977524,2010-10-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20977524,2010-10-26T00:00:00,Middle Aged,M01.060.116.630
20977524,2010-10-26T00:00:00,Stroke,C10.228.140.300.775
20977524,2010-10-26T00:00:00,Stroke,C14.907.253.855
20977537,2010-10-26T00:00:00,Adolescent,M01.060.057
20977537,2010-10-26T00:00:00,Adult,M01.060.116
20977537,2010-10-26T00:00:00,"Biofeedback, Psychology",E02.190.525.123
20977537,2010-10-26T00:00:00,"Biofeedback, Psychology",F02.830.131
20977537,2010-10-26T00:00:00,"Biofeedback, Psychology",F04.754.137.301
20977537,2010-10-26T00:00:00,"Biofeedback, Psychology",F04.754.308.500
20977537,2010-10-26T00:00:00,"Biofeedback, Psychology",L01.143.283.425.624.500
20977537,2010-10-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20977537,2010-10-26T00:00:00,Image Enhancement,E01.370.350.600.350
20977537,2010-10-26T00:00:00,Image Enhancement,L01.224.308.380
20977537,2010-10-26T00:00:00,Imagination,F02.463.188.634
20977537,2010-10-26T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20977537,2010-10-26T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20977537,2010-10-26T00:00:00,Middle Aged,M01.060.116.630
20977537,2010-10-26T00:00:00,Motor Cortex,A08.186.211.730.885.287.500.270.548
20977537,2010-10-26T00:00:00,Movement,G07.700.560
20977537,2010-10-26T00:00:00,Movement,G11.427.590.530
20977537,2010-10-26T00:00:00,Task Performance and Analysis,F02.784.412.846
20977537,2010-10-26T00:00:00,Task Performance and Analysis,F02.784.692.746
20977537,2010-10-26T00:00:00,Task Performance and Analysis,F02.808.600
20977537,2010-10-26T00:00:00,Young Adult,M01.060.116.815
21093009,2010-10-26T00:00:00,Adsorption,G02.149.047
21093009,2010-10-26T00:00:00,Adsorption,G02.149.767.029
21093009,2010-10-26T00:00:00,Adsorption,G02.842.750.029
21093009,2010-10-26T00:00:00,Charcoal,D01.268.150.150
21093009,2010-10-26T00:00:00,"Nanotubes, Carbon",D01.268.150.250.500
21093009,2010-10-26T00:00:00,"Nanotubes, Carbon",J01.637.512.850.500
21093009,2010-10-26T00:00:00,Organic Chemicals,D02
21093009,2010-10-26T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
21093009,2010-10-26T00:00:00,Water Purification,N06.850.780.200.800.800.900.900
21093009,2010-10-26T00:00:00,Water Purification,N06.850.860.510.900.900
21093009,2010-10-26T00:00:00,Water Purification,N06.850.860.510.915.900
20977821,2010-10-27T00:00:00,Adolescent,M01.060.057
20977821,2010-10-27T00:00:00,Biological Markers,D23.101
20977821,2010-10-27T00:00:00,"Cardiomyopathy, Dilated",C14.280.195.160
20977821,2010-10-27T00:00:00,"Cardiomyopathy, Dilated",C14.280.238.070
20977821,2010-10-27T00:00:00,Child,M01.060.406
20977821,2010-10-27T00:00:00,"Child, Preschool",M01.060.406.448
20977821,2010-10-27T00:00:00,Disease Progression,C23.550.291.656
20977821,2010-10-27T00:00:00,Homeostasis,G07.700.360
20977821,2010-10-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20977821,2010-10-27T00:00:00,Infant,M01.060.703
20977821,2010-10-27T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
20977821,2010-10-27T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
20977821,2010-10-27T00:00:00,Tissue Inhibitor of Metalloproteinases,D12.776.926
20978933,2010-10-27T00:00:00,Breast Neoplasms,C04.588.180
20978933,2010-10-27T00:00:00,Breast Neoplasms,C17.800.090.500
20978933,2010-10-27T00:00:00,Case-Control Studies,E05.318.760.500.500
20978933,2010-10-27T00:00:00,Case-Control Studies,N05.715.360.775.175.200
20978933,2010-10-27T00:00:00,Case-Control Studies,N06.850.520.450.500.500
20978933,2010-10-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20978933,2010-10-27T00:00:00,"Polymorphism, Genetic",G05.365.795
20978933,2010-10-27T00:00:00,"Receptors, IgG",D12.776.543.750.705.871.300
20978933,2010-10-27T00:00:00,"Receptors, IgG",D23.050.301.264.035.695
20978933,2010-10-27T00:00:00,"Receptors, IgG",D23.101.100.110.695
20978933,2010-10-27T00:00:00,"Tumor Markers, Biological",D23.101.840
20980456,2010-10-27T00:00:00,Adult,M01.060.116
20980456,2010-10-27T00:00:00,Antigen-Antibody Complex,D12.776.124.486.485.114.257
20980456,2010-10-27T00:00:00,Antigen-Antibody Complex,D12.776.124.790.651.114.257
20980456,2010-10-27T00:00:00,Antigen-Antibody Complex,D12.776.377.715.548.114.257
20980456,2010-10-27T00:00:00,Antigen-Antibody Complex,D23.050.101
20980456,2010-10-27T00:00:00,Carotid Arteries,A07.231.114.186
20980456,2010-10-27T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
20980456,2010-10-27T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
20980456,2010-10-27T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
20980456,2010-10-27T00:00:00,Disease Progression,C23.550.291.656
20980456,2010-10-27T00:00:00,"Glycosylation End Products, Advanced",D02.415
20980456,2010-10-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20980456,2010-10-27T00:00:00,"Lipoproteins, LDL",D10.532.515
20980456,2010-10-27T00:00:00,"Lipoproteins, LDL",D12.776.521.550
20980456,2010-10-27T00:00:00,Risk Factors,E05.318.740.600.800.725
20980456,2010-10-27T00:00:00,Risk Factors,N05.715.350.200.700
20980456,2010-10-27T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20980456,2010-10-27T00:00:00,Risk Factors,N06.850.490.625.750
20980456,2010-10-27T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20980695,2010-10-27T00:00:00,Animals,B01.050
20980695,2010-10-27T00:00:00,CD4-Positive T-Lymphocytes,A11.118.637.555.567.569.200
20980695,2010-10-27T00:00:00,CD4-Positive T-Lymphocytes,A15.145.229.637.555.567.569.200
20980695,2010-10-27T00:00:00,CD4-Positive T-Lymphocytes,A15.382.490.555.567.569.200
20980695,2010-10-27T00:00:00,Cell Differentiation,G04.299.151
20980695,2010-10-27T00:00:00,Fetal Blood,A12.207.152.200
20980695,2010-10-27T00:00:00,Fetal Blood,A15.145.300
20980695,2010-10-27T00:00:00,Fetal Blood,A16.378.200
20980695,2010-10-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20980695,2010-10-27T00:00:00,Interferon-gamma,D12.644.276.374.440.893
20980695,2010-10-27T00:00:00,Interferon-gamma,D12.644.276.374.480.350
20980695,2010-10-27T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
20980695,2010-10-27T00:00:00,Interferon-gamma,D12.644.276.718.550
20980695,2010-10-27T00:00:00,Interferon-gamma,D12.776.467.374.440.893
20980695,2010-10-27T00:00:00,Interferon-gamma,D12.776.467.374.480.350
20980695,2010-10-27T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
20980695,2010-10-27T00:00:00,Interferon-gamma,D12.776.467.718.550
20980695,2010-10-27T00:00:00,Interferon-gamma,D23.529.374.440.893
20980695,2010-10-27T00:00:00,Interferon-gamma,D23.529.374.480.350
20980695,2010-10-27T00:00:00,Interferon-gamma,D23.529.374.480.615.350
20980695,2010-10-27T00:00:00,Interferon-gamma,D23.529.718.550
20980695,2010-10-27T00:00:00,Lymphocyte Activation,E01.450.495.482
20980695,2010-10-27T00:00:00,Lymphocyte Activation,E05.478.594.530
20980695,2010-10-27T00:00:00,Lymphocyte Activation,G12.425.747
20980695,2010-10-27T00:00:00,Lymphocyte Activation,G12.450.050.400.545
20980695,2010-10-27T00:00:00,Neoplasms,C04
20980695,2010-10-27T00:00:00,Signal Transduction,G02.111.087.800
20980695,2010-10-27T00:00:00,Signal Transduction,G02.149.115.800
20980695,2010-10-27T00:00:00,Signal Transduction,G04.299.880
20980695,2010-10-27T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.550.500
20980695,2010-10-27T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.569.500
20980695,2010-10-27T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.550.500
20980695,2010-10-27T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.569.500
20980695,2010-10-27T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.550.500
20980695,2010-10-27T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.569.500
21029250,2010-10-28T00:00:00,Aged,M01.060.116.100
21029250,2010-10-28T00:00:00,Aging,G07.700.320.124
21029250,2010-10-28T00:00:00,Cognition,F02.463.188
21029250,2010-10-28T00:00:00,Dementia,C10.228.140.380
21029250,2010-10-28T00:00:00,Dementia,F03.087.400
21029250,2010-10-28T00:00:00,Ghrelin,D06.472.699.301
21029250,2010-10-28T00:00:00,Ghrelin,D12.644.548.322
21029250,2010-10-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21029250,2010-10-28T00:00:00,Neuropsychological Tests,F04.711.513
21031435,2010-10-28T00:00:00,Adenocarcinoma,C04.557.470.200.025
21031435,2010-10-28T00:00:00,Aged,M01.060.116.100
21031435,2010-10-28T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
21031435,2010-10-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21031435,2010-10-28T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
21031435,2010-10-28T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
21031435,2010-10-28T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
21031435,2010-10-28T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
21031435,2010-10-28T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
21031435,2010-10-28T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
21031435,2010-10-28T00:00:00,Peroxiredoxins,D08.811.682.732.850
21031435,2010-10-28T00:00:00,Prostate-Specific Antigen,D08.811.277.656.300.760.442.750
21031435,2010-10-28T00:00:00,Prostate-Specific Antigen,D08.811.277.656.959.350.442.750
21031435,2010-10-28T00:00:00,Prostate-Specific Antigen,D12.776.866.249.500
21031435,2010-10-28T00:00:00,Prostate-Specific Antigen,D23.050.285.625
21031435,2010-10-28T00:00:00,Prostate-Specific Antigen,D23.101.840.625
21031435,2010-10-28T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
21031435,2010-10-28T00:00:00,Prostatic Neoplasms,C12.294.260.750
21031435,2010-10-28T00:00:00,Prostatic Neoplasms,C12.294.565.625
21031435,2010-10-28T00:00:00,Prostatic Neoplasms,C12.758.409.750
21031435,2010-10-28T00:00:00,"RNA, Messenger",D13.444.735.544
21031435,2010-10-28T00:00:00,Tissue Array Analysis,E05.196.630.570.850
21031435,2010-10-28T00:00:00,Tissue Array Analysis,E05.588.570.850
21031435,2010-10-28T00:00:00,"Tumor Markers, Biological",D23.101.840
21035450,2010-10-28T00:00:00,Aggression,F01.145.126.125
21035450,2010-10-28T00:00:00,Aggression,F01.145.813.045
21035450,2010-10-28T00:00:00,Androgens,D27.505.696.399.472.161
21035450,2010-10-28T00:00:00,Animals,B01.050
21035450,2010-10-28T00:00:00,Testosterone,D04.808.054.079.429.824
21035450,2010-10-28T00:00:00,Testosterone,D06.472.334.851.968.984
21337412,2010-10-28T00:00:00,Algorithms,G17.035
21337412,2010-10-28T00:00:00,Algorithms,L01.224.050
21337412,2010-10-28T00:00:00,Artifacts,E05.047
21337412,2010-10-28T00:00:00,Brain,A08.186.211
21337412,2010-10-28T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
21337412,2010-10-28T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
21337412,2010-10-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21337412,2010-10-28T00:00:00,Image Enhancement,E01.370.350.600.350
21337412,2010-10-28T00:00:00,Image Enhancement,L01.224.308.380
21337412,2010-10-28T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
21337412,2010-10-28T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
21337412,2010-10-28T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
21034224,2010-10-29T00:00:00,Adult,M01.060.116
21034224,2010-10-29T00:00:00,African Americans,M01.686.508.100.100
21034224,2010-10-29T00:00:00,African Americans,M01.686.754.100
21034224,2010-10-29T00:00:00,Age Factors,N05.715.350.075
21034224,2010-10-29T00:00:00,Age Factors,N06.850.490.250
21034224,2010-10-29T00:00:00,Aged,M01.060.116.100
21034224,2010-10-29T00:00:00,Aqueous Humor,A09.371.060.067.070
21034224,2010-10-29T00:00:00,Aqueous Humor,A12.207.270.040
21034224,2010-10-29T00:00:00,Cataract,C11.510.245
21034224,2010-10-29T00:00:00,European Continental Ancestry Group,M01.686.508.400
21034224,2010-10-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21034224,2010-10-29T00:00:00,Middle Aged,M01.060.116.630
21034250,2010-10-29T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
21034250,2010-10-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21034250,2010-10-29T00:00:00,Transferrin,D12.776.124.050.800
21034250,2010-10-29T00:00:00,Transferrin,D12.776.124.790.223.839
21034250,2010-10-29T00:00:00,Transferrin,D12.776.157.427.500
21034250,2010-10-29T00:00:00,Transferrin,D12.776.377.715.182.839
21034250,2010-10-29T00:00:00,Transferrin,D12.776.556.579.500
21035871,2010-10-29T00:00:00,Adolescent,M01.060.057
21035871,2010-10-29T00:00:00,Biometry,E05.318.740.225
21035871,2010-10-29T00:00:00,Biometry,N06.850.505.200
21035871,2010-10-29T00:00:00,Cataract,C11.510.245
21035871,2010-10-29T00:00:00,Cataract Extraction,E04.540.825.249
21035871,2010-10-29T00:00:00,Child,M01.060.406
21035871,2010-10-29T00:00:00,"Child, Preschool",M01.060.406.448
21035871,2010-10-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21035871,2010-10-29T00:00:00,Infant,M01.060.703
21035871,2010-10-29T00:00:00,"Infant, Newborn",M01.060.703.520
21035871,2010-10-29T00:00:00,"Lens, Crystalline",A09.371.060.500
21035871,2010-10-29T00:00:00,"Lenses, Intraocular",E07.632.500.460
21035871,2010-10-29T00:00:00,"Lenses, Intraocular",E07.695.460
21036869,2010-10-29T00:00:00,Animals,B01.050
21036869,2010-10-29T00:00:00,Computer Graphics,L01.224.108
21036869,2010-10-29T00:00:00,Computer Graphics,L01.296.110
21036869,2010-10-29T00:00:00,"Databases, Genetic",L01.470.750.750.325
21036869,2010-10-29T00:00:00,"Databases, Genetic",L01.700.508.300.188.400.325
21036869,2010-10-29T00:00:00,Drosophila Proteins,D12.776.466.462
21036869,2010-10-29T00:00:00,Gene Expression,G05.355.310
21036869,2010-10-29T00:00:00,Gene Regulatory Networks,G05.360.080.689.360
21036869,2010-10-29T00:00:00,MicroRNAs,D13.150.650.319
21036869,2010-10-29T00:00:00,MicroRNAs,D13.444.735.150.319
21036869,2010-10-29T00:00:00,MicroRNAs,D13.444.735.790.099
21036869,2010-10-29T00:00:00,Protein Interaction Mapping,E05.601.690
21036869,2010-10-29T00:00:00,Systems Integration,H01.770.787
21036869,2010-10-29T00:00:00,Systems Integration,L01.906.787
21036869,2010-10-29T00:00:00,Transcription Factors,D12.776.930
21036869,2010-10-29T00:00:00,User-Computer Interface,L01.224.900.910
21036898,2010-10-29T00:00:00,Animals,B01.050
21036898,2010-10-29T00:00:00,Antineoplastic Agents,D27.505.954.248
21036898,2010-10-29T00:00:00,Bryostatins,D02.540.505.112
21036898,2010-10-29T00:00:00,Dendritic Cells,A11.066.270
21036898,2010-10-29T00:00:00,Dendritic Cells,A11.436.270
21036898,2010-10-29T00:00:00,Dendritic Cells,A15.382.066.270
21036898,2010-10-29T00:00:00,Dendritic Cells,A15.382.812.260
21036898,2010-10-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21036898,2010-10-29T00:00:00,"Immunity, Innate",G12.450.575
21036898,2010-10-29T00:00:00,NF-kappa B,D12.776.260.600
21036898,2010-10-29T00:00:00,NF-kappa B,D12.776.660.600
21036898,2010-10-29T00:00:00,NF-kappa B,D12.776.930.600
21036898,2010-10-29T00:00:00,Phenotype,G05.695
21036898,2010-10-29T00:00:00,Toll-Like Receptor 4,D12.776.543.750.705.910.500.400
21051309,2010-10-29T00:00:00,Angiography,E01.370.350.700.060
21051309,2010-10-29T00:00:00,Angiography,E01.370.370.050
21051309,2010-10-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21051309,2010-10-29T00:00:00,Perfusion Imaging,E01.370.350.710.600
21051309,2010-10-29T00:00:00,Perfusion Imaging,E01.370.384.730.354
21051309,2010-10-29T00:00:00,Pulmonary Embolism,C08.381.746
21051309,2010-10-29T00:00:00,Pulmonary Embolism,C14.907.355.350.700
21051309,2010-10-29T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
21051309,2010-10-29T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
21051309,2010-10-29T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
21051309,2010-10-29T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
21051309,2010-10-29T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
21051309,2010-10-29T00:00:00,"Ventricular Dysfunction, Right",C14.280.945.910
21300307,2010-10-29T00:00:00,Autonomic Nervous System,A08.800.050
21300307,2010-10-29T00:00:00,"Cardiac Pacing, Artificial",E02.145
21300307,2010-10-29T00:00:00,Chronic Disease,C23.550.291.500
21300307,2010-10-29T00:00:00,Electric Stimulation,E05.723.402
21300307,2010-10-29T00:00:00,Heart Failure,C14.280.434
21300307,2010-10-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21300307,2010-10-29T00:00:00,"Hypertrophy, Left Ventricular",C14.280.195.400
21300307,2010-10-29T00:00:00,"Hypertrophy, Left Ventricular",C23.300.775.250.400
21300307,2010-10-29T00:00:00,Renin-Angiotensin System,G03.495.805
21300307,2010-10-29T00:00:00,Renin-Angiotensin System,G09.330.190.400.750
21300307,2010-10-29T00:00:00,Stroke Volume,E01.370.370.380.150.700
21300307,2010-10-29T00:00:00,Stroke Volume,G09.330.380.124.882
21300307,2010-10-29T00:00:00,Time Factors,G01.910.857
21300307,2010-10-29T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
20699655,2010-10-30T00:00:00,Animals,B01.050
20699655,2010-10-30T00:00:00,Drosophila Proteins,D12.776.466.462
20699655,2010-10-30T00:00:00,Drosophila melanogaster,B01.050.500.131.617.289.310.250.500
20699655,2010-10-30T00:00:00,Embryonic Development,G07.700.320.500.325.180
20699655,2010-10-30T00:00:00,Embryonic Development,G08.686.785.760.170.104
20699655,2010-10-30T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
20699655,2010-10-30T00:00:00,Phosphorylation,G02.111.087.677
20699655,2010-10-30T00:00:00,Phosphorylation,G02.149.115.677
20699655,2010-10-30T00:00:00,Phosphorylation,G02.149.465.700
20699655,2010-10-30T00:00:00,Phosphorylation,G02.607.750.700
20699655,2010-10-30T00:00:00,Phosphorylation,G03.495.790
20699655,2010-10-30T00:00:00,Signal Transduction,G02.111.087.800
20699655,2010-10-30T00:00:00,Signal Transduction,G02.149.115.800
20699655,2010-10-30T00:00:00,Signal Transduction,G04.299.880
20699655,2010-10-30T00:00:00,Wnt Proteins,D12.644.276.984
20699655,2010-10-30T00:00:00,Wnt Proteins,D12.776.467.984
20699655,2010-10-30T00:00:00,Wnt Proteins,D23.529.984
21035792,2010-10-30T00:00:00,Animals,B01.050
21035792,2010-10-30T00:00:00,Carrier Proteins,D12.776.157
21035792,2010-10-30T00:00:00,Down-Regulation,G02.111.087.225
21035792,2010-10-30T00:00:00,Down-Regulation,G02.149.115.225
21035792,2010-10-30T00:00:00,Down-Regulation,G05.355.315.200
21035792,2010-10-30T00:00:00,Down-Regulation,G07.690.812.230
21035792,2010-10-30T00:00:00,Down-Regulation,G07.700.680.230
21035792,2010-10-30T00:00:00,"Memory, Short-Term",F02.463.425.540.407
21035792,2010-10-30T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
21035792,2010-10-30T00:00:00,"Receptors, AMPA",D12.776.543.750.720.200.450.200
21035792,2010-10-30T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
21036492,2010-10-30T00:00:00,Adult,M01.060.116
21036492,2010-10-30T00:00:00,Counseling,F02.784.176
21036492,2010-10-30T00:00:00,Counseling,F04.408.413
21036492,2010-10-30T00:00:00,Counseling,N02.421.143.303
21036492,2010-10-30T00:00:00,Counseling,N02.421.461.363
21036492,2010-10-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21036492,2010-10-30T00:00:00,Middle Aged,M01.060.116.630
21036492,2010-10-30T00:00:00,Smoking Cessation,F01.145.940.700
21036492,2010-10-30T00:00:00,Tobacco Use Disorder,C21.739.912
21036492,2010-10-30T00:00:00,Tobacco Use Disorder,F03.900.912
21036671,2010-10-30T00:00:00,"Cardiomyopathy, Hypertrophic",C14.280.238.100
21036671,2010-10-30T00:00:00,"Cardiomyopathy, Hypertrophic",C14.280.484.150.070.160
21036671,2010-10-30T00:00:00,Ethanol,D02.033.375
21036671,2010-10-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21036671,2010-10-30T00:00:00,Middle Aged,M01.060.116.630
21036671,2010-10-30T00:00:00,Takotsubo Cardiomyopathy,C14.280.945.900.500
21036671,2010-10-30T00:00:00,Treatment Outcome,E01.789.800
21036671,2010-10-30T00:00:00,Treatment Outcome,N04.761.559.590.800
21036671,2010-10-30T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21036671,2010-10-30T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
21041019,2010-10-30T00:00:00,ATP-Binding Cassette Transporters,D12.776.157.530.100
21041019,2010-10-30T00:00:00,ATP-Binding Cassette Transporters,D12.776.395.550.020
21041019,2010-10-30T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.550.192
21041019,2010-10-30T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.585.100
21041019,2010-10-30T00:00:00,Adenocarcinoma,C04.557.470.200.025
21041019,2010-10-30T00:00:00,Animals,B01.050
21041019,2010-10-30T00:00:00,Cell Movement,G04.299.283
21041019,2010-10-30T00:00:00,Cell Movement,G07.700.560.500.180
21041019,2010-10-30T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
21041019,2010-10-30T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
21041019,2010-10-30T00:00:00,Neoplasm Invasiveness,C04.697.645
21041019,2010-10-30T00:00:00,Neoplasm Invasiveness,C23.550.727.645
21041019,2010-10-30T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
21041019,2010-10-30T00:00:00,Prostatic Neoplasms,C12.294.260.750
21041019,2010-10-30T00:00:00,Prostatic Neoplasms,C12.294.565.625
21041019,2010-10-30T00:00:00,Prostatic Neoplasms,C12.758.409.750
20434196,2010-11-01T00:00:00,Aged,M01.060.116.100
20434196,2010-11-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
20434196,2010-11-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
20434196,2010-11-01T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
20434196,2010-11-01T00:00:00,"Biopsy, Needle",E01.370.388.100.100
20434196,2010-11-01T00:00:00,"Biopsy, Needle",E01.450.230.100.100
20434196,2010-11-01T00:00:00,"Biopsy, Needle",E01.450.865.100.100
20434196,2010-11-01T00:00:00,"Biopsy, Needle",E01.450.865.632.100
20434196,2010-11-01T00:00:00,"Biopsy, Needle",E04.074.119
20434196,2010-11-01T00:00:00,Cryosurgery,E04.014.180
20434196,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20434196,2010-11-01T00:00:00,Neoplasm Staging,E01.370.550
20434196,2010-11-01T00:00:00,Prostate-Specific Antigen,D08.811.277.656.300.760.442.750
20434196,2010-11-01T00:00:00,Prostate-Specific Antigen,D08.811.277.656.959.350.442.750
20434196,2010-11-01T00:00:00,Prostate-Specific Antigen,D12.776.866.249.500
20434196,2010-11-01T00:00:00,Prostate-Specific Antigen,D23.050.285.625
20434196,2010-11-01T00:00:00,Prostate-Specific Antigen,D23.101.840.625
20434196,2010-11-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
20434196,2010-11-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
20434196,2010-11-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
20434196,2010-11-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
20434196,2010-11-01T00:00:00,Salvage Therapy,E02.186.800
20434196,2010-11-01T00:00:00,Salvage Therapy,E02.895
20434196,2010-11-01T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.350.800.800
20434196,2010-11-01T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.600.350.800.800
20434196,2010-11-01T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.710.800.800
20434196,2010-11-01T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.825.800.800
20434196,2010-11-01T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.384.730.800.800
20463615,2010-11-01T00:00:00,Chest Pain,C23.888.646.215
20463615,2010-11-01T00:00:00,Contrast Media,D27.720.259
20463615,2010-11-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
20463615,2010-11-01T00:00:00,Coronary Angiography,E01.370.370.050.200
20463615,2010-11-01T00:00:00,Coronary Angiography,E01.370.370.380.200
20463615,2010-11-01T00:00:00,Coronary Vessel Anomalies,C14.240.400.210
20463615,2010-11-01T00:00:00,Coronary Vessel Anomalies,C14.280.400.210
20463615,2010-11-01T00:00:00,Coronary Vessel Anomalies,C16.131.240.400.210
20463615,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20463615,2010-11-01T00:00:00,Hypertension,C14.907.489
20463615,2010-11-01T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
20463615,2010-11-01T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
20463615,2010-11-01T00:00:00,Middle Aged,M01.060.116.630
20463615,2010-11-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
20463615,2010-11-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
20463615,2010-11-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
20463615,2010-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20463615,2010-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20463615,2010-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20463615,2010-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20463615,2010-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20550586,2010-11-01T00:00:00,Environmental Remediation,N06.850.460.375
20550586,2010-11-01T00:00:00,Geologic Sediments,G01.311.500
20550586,2010-11-01T00:00:00,Geologic Sediments,G16.500.320
20550586,2010-11-01T00:00:00,"Models, Theoretical",E05.599
20550586,2010-11-01T00:00:00,Temperature,G01.906.595
20550586,2010-11-01T00:00:00,Temperature,G16.500.275.063.725.710
20550586,2010-11-01T00:00:00,Temperature,G16.500.750.775.710
20550586,2010-11-01T00:00:00,Temperature,N06.230.150.450
20550586,2010-11-01T00:00:00,Temperature,N06.230.300.100.725.710
20550586,2010-11-01T00:00:00,Water Movements,G16.500.240.960
20550586,2010-11-01T00:00:00,Water Movements,N06.230.850
20578043,2010-11-01T00:00:00,Animals,B01.050
20578043,2010-11-01T00:00:00,"Animals, Newborn",B01.050.050.282
20578043,2010-11-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
20578043,2010-11-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
20578043,2010-11-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
20578043,2010-11-01T00:00:00,Lovastatin,D02.455.426.559.847.638.400
20578043,2010-11-01T00:00:00,Lovastatin,D04.615.638.400
20578043,2010-11-01T00:00:00,"Nerve Fibers, Myelinated",A08.663.542.512
20578043,2010-11-01T00:00:00,"Nerve Fibers, Myelinated",A11.671.514
20578043,2010-11-01T00:00:00,Neuroprotective Agents,D27.505.696.706.548
20578043,2010-11-01T00:00:00,Neuroprotective Agents,D27.505.954.427.575
20578043,2010-11-01T00:00:00,Oligodendroglia,A08.637.600
20578043,2010-11-01T00:00:00,Oligodendroglia,A11.650.600
20578043,2010-11-01T00:00:00,PTEN Phosphohydrolase,D08.811.277.352.650.850
20578043,2010-11-01T00:00:00,PTEN Phosphohydrolase,D12.776.476.590
20578043,2010-11-01T00:00:00,PTEN Phosphohydrolase,D12.776.624.776.695
20578043,2010-11-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20578043,2010-11-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
20578043,2010-11-01T00:00:00,Stem Cells,A11.872
20613676,2010-11-01T00:00:00,Aged,M01.060.116.100
20613676,2010-11-01T00:00:00,Breast Neoplasms,C04.588.180
20613676,2010-11-01T00:00:00,Breast Neoplasms,C17.800.090.500
20613676,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20613676,2010-11-01T00:00:00,Mammography,E01.370.350.700.500
20613676,2010-11-01T00:00:00,Middle Aged,M01.060.116.630
20613676,2010-11-01T00:00:00,Vitamin D,D04.808.812.768
20613681,2010-11-01T00:00:00,Acetylcysteine,D02.886.030.230.259
20613681,2010-11-01T00:00:00,Acetylcysteine,D12.125.166.230.259
20613681,2010-11-01T00:00:00,Animals,B01.050
20613681,2010-11-01T00:00:00,"Animals, Newborn",B01.050.050.282
20613681,2010-11-01T00:00:00,Cytokines,D12.644.276.374
20613681,2010-11-01T00:00:00,Cytokines,D12.776.467.374
20613681,2010-11-01T00:00:00,Cytokines,D23.529.374
20613681,2010-11-01T00:00:00,Echocardiography,E01.370.350.850.220
20613681,2010-11-01T00:00:00,Echocardiography,E01.370.370.380.220
20613681,2010-11-01T00:00:00,Endotoxins,D23.946.123.329
20613681,2010-11-01T00:00:00,Heart,A07.541
20659069,2010-11-01T00:00:00,Adult,M01.060.116
20659069,2010-11-01T00:00:00,Aged,M01.060.116.100
20659069,2010-11-01T00:00:00,Alcoholism,C21.739.100.250
20659069,2010-11-01T00:00:00,Alcoholism,F03.900.100.350
20659069,2010-11-01T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
20659069,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20659069,2010-11-01T00:00:00,Liver,A03.620
20659069,2010-11-01T00:00:00,Medical Records,E05.318.308.940.968
20659069,2010-11-01T00:00:00,Medical Records,L01.280.900.968
20659069,2010-11-01T00:00:00,Medical Records,N04.452.859.564
20659069,2010-11-01T00:00:00,Medical Records,N05.715.360.300.715.500
20659069,2010-11-01T00:00:00,Medical Records,N06.850.520.308.940.968
20659069,2010-11-01T00:00:00,Middle Aged,M01.060.116.630
20659069,2010-11-01T00:00:00,Serum Albumin,D12.776.034.841
20659069,2010-11-01T00:00:00,Serum Albumin,D12.776.124.050.700
20659069,2010-11-01T00:00:00,Serum Albumin,D12.776.124.727
20659069,2010-11-01T00:00:00,Transferrin,D12.776.124.050.800
20659069,2010-11-01T00:00:00,Transferrin,D12.776.124.790.223.839
20659069,2010-11-01T00:00:00,Transferrin,D12.776.157.427.500
20659069,2010-11-01T00:00:00,Transferrin,D12.776.377.715.182.839
20659069,2010-11-01T00:00:00,Transferrin,D12.776.556.579.500
20665498,2010-11-01T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
20665498,2010-11-01T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
20665498,2010-11-01T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
20665498,2010-11-01T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
20665498,2010-11-01T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
20665498,2010-11-01T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
20665498,2010-11-01T00:00:00,DNA Mismatch Repair,G02.111.087.219.220
20665498,2010-11-01T00:00:00,DNA Mismatch Repair,G02.149.115.219.220
20665498,2010-11-01T00:00:00,DNA Mismatch Repair,G05.355.195.220
20665498,2010-11-01T00:00:00,Hispanic Americans,M01.686.754.441
20665498,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20665498,2010-11-01T00:00:00,Middle Aged,M01.060.116.630
20665498,2010-11-01T00:00:00,United States,Z01.107.567.875
20738255,2010-11-01T00:00:00,Adenosine Triphosphate,D03.438.759.646.138.236
20738255,2010-11-01T00:00:00,Adenosine Triphosphate,D13.695.667.138.236
20738255,2010-11-01T00:00:00,Adenosine Triphosphate,D13.695.827.068.236
20738255,2010-11-01T00:00:00,Animals,B01.050
20738255,2010-11-01T00:00:00,Calcium,D01.268.552.100
20738255,2010-11-01T00:00:00,Calcium,D01.552.539.288
20738255,2010-11-01T00:00:00,Calcium,D23.119.100
20738255,2010-11-01T00:00:00,Catalytic Domain,G02.111.570.120.704
20738255,2010-11-01T00:00:00,Catalytic Domain,G02.111.570.790.709.610.189
20738255,2010-11-01T00:00:00,Cell Death,G04.299.139
20738255,2010-11-01T00:00:00,Cyclic AMP-Dependent Protein Kinases,D08.811.913.696.620.682.700.150.125
20738255,2010-11-01T00:00:00,Cyclic AMP-Dependent Protein Kinases,D12.644.360.200.125
20738255,2010-11-01T00:00:00,Cyclic AMP-Dependent Protein Kinases,D12.776.476.200.125
20738255,2010-11-01T00:00:00,Hepatocytes,A11.436.348
20738255,2010-11-01T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
20738255,2010-11-01T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
20738255,2010-11-01T00:00:00,Phosphorylation,G02.111.087.677
20738255,2010-11-01T00:00:00,Phosphorylation,G02.149.115.677
20738255,2010-11-01T00:00:00,Phosphorylation,G02.149.465.700
20738255,2010-11-01T00:00:00,Phosphorylation,G02.607.750.700
20738255,2010-11-01T00:00:00,Phosphorylation,G03.495.790
20738255,2010-11-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
20738255,2010-11-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
20738255,2010-11-01T00:00:00,Reperfusion Injury,C14.907.725
20738255,2010-11-01T00:00:00,Reperfusion Injury,C23.550.767.877
20803260,2010-11-01T00:00:00,Adult,M01.060.116
20803260,2010-11-01T00:00:00,Gastroplasty,E02.065.062.750
20803260,2010-11-01T00:00:00,Gastroplasty,E04.062.750
20803260,2010-11-01T00:00:00,Gastroplasty,E04.210.485
20803260,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20803260,2010-11-01T00:00:00,Laparoscopy,E01.370.388.250.520
20803260,2010-11-01T00:00:00,Laparoscopy,E04.800.250.520
20803260,2010-11-01T00:00:00,Manometry,E05.559
20803260,2010-11-01T00:00:00,Middle Aged,M01.060.116.630
20803260,2010-11-01T00:00:00,Postoperative Complications,C23.550.767
20803260,2010-11-01T00:00:00,Reoperation,E04.690
20803260,2010-11-01T00:00:00,Treatment Outcome,E01.789.800
20803260,2010-11-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20803260,2010-11-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20803260,2010-11-01T00:00:00,Weight Loss,C23.888.144.243.963
20803260,2010-11-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
20827209,2010-11-01T00:00:00,Gynecologic Surgical Procedures,E04.950.300
20827209,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20827209,2010-11-01T00:00:00,Laparoscopy,E01.370.388.250.520
20827209,2010-11-01T00:00:00,Laparoscopy,E04.800.250.520
20827209,2010-11-01T00:00:00,Pelvic Organ Prolapse,C23.300.842.500
20827209,2010-11-01T00:00:00,Robotics,H01.671.293.643
20827209,2010-11-01T00:00:00,Robotics,J01.897.104.834
20827209,2010-11-01T00:00:00,Robotics,L01.224.065.630
20827209,2010-11-01T00:00:00,Treatment Outcome,E01.789.800
20827209,2010-11-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20827209,2010-11-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20865699,2010-11-01T00:00:00,Animals,B01.050
20865699,2010-11-01T00:00:00,"Nanotubes, Carbon",D01.268.150.250.500
20865699,2010-11-01T00:00:00,"Nanotubes, Carbon",J01.637.512.850.500
20865699,2010-11-01T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
20879857,2010-11-01T00:00:00,Adult,M01.060.116
20879857,2010-11-01T00:00:00,Aged,M01.060.116.100
20879857,2010-11-01T00:00:00,Cryptococcosis,C01.703.248
20879857,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20879857,2010-11-01T00:00:00,Middle Aged,M01.060.116.630
20879857,2010-11-01T00:00:00,Postoperative Complications,C23.550.767
20879857,2010-11-01T00:00:00,Time Factors,G01.910.857
20879857,2010-11-01T00:00:00,Tissue Donors,M01.898
20889151,2010-11-01T00:00:00,Adult,M01.060.116
20889151,2010-11-01T00:00:00,Demography,I01.240
20889151,2010-11-01T00:00:00,Demography,N01.224
20889151,2010-11-01T00:00:00,Demography,N06.850.505.400
20889151,2010-11-01T00:00:00,Environmental Exposure,N06.850.460.350
20889151,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20889151,2010-11-01T00:00:00,Hypertension,C14.907.489
20889151,2010-11-01T00:00:00,Middle Aged,M01.060.116.630
20889151,2010-11-01T00:00:00,Radiation Monitoring,E05.799.638
20889151,2010-11-01T00:00:00,Radiation Monitoring,N06.850.780.375.700
20889151,2010-11-01T00:00:00,Radiation Monitoring,N06.850.810.370
20889151,2010-11-01T00:00:00,Uranium,D01.268.033.950
20889151,2010-11-01T00:00:00,Uranium,D01.268.271.100.950
20889151,2010-11-01T00:00:00,Uranium,D01.268.556.900
20889151,2010-11-01T00:00:00,Uranium,D01.552.020.940
20889151,2010-11-01T00:00:00,Uranium,D01.552.544.900
20937441,2010-11-01T00:00:00,Adult,M01.060.116
20937441,2010-11-01T00:00:00,Aged,M01.060.116.100
20937441,2010-11-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
20937441,2010-11-01T00:00:00,Cardiovascular Diseases,C14
20937441,2010-11-01T00:00:00,Disease Progression,C23.550.291.656
20937441,2010-11-01T00:00:00,Health Behavior,F01.145.488
20937441,2010-11-01T00:00:00,Health Promotion,N02.370
20937441,2010-11-01T00:00:00,Health Promotion,N02.421.726.507
20937441,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20937441,2010-11-01T00:00:00,Hypercholesterolemia,C18.452.584.500.500.396
20937441,2010-11-01T00:00:00,Life Style,F01.829.458
20937441,2010-11-01T00:00:00,Mass Screening,E01.370.500
20937441,2010-11-01T00:00:00,Mass Screening,E05.318.308.250.580
20937441,2010-11-01T00:00:00,Mass Screening,N02.421.143.827.233.443
20937441,2010-11-01T00:00:00,Mass Screening,N02.421.726.233.443
20937441,2010-11-01T00:00:00,Mass Screening,N05.715.360.300.375.500
20937441,2010-11-01T00:00:00,Mass Screening,N06.850.520.308.250.580
20937441,2010-11-01T00:00:00,Mass Screening,N06.850.780.500
20937441,2010-11-01T00:00:00,Middle Aged,M01.060.116.630
20937441,2010-11-01T00:00:00,Risk Factors,E05.318.740.600.800.725
20937441,2010-11-01T00:00:00,Risk Factors,N05.715.350.200.700
20937441,2010-11-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20937441,2010-11-01T00:00:00,Risk Factors,N06.850.490.625.750
20937441,2010-11-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20937441,2010-11-01T00:00:00,Smoking Cessation,F01.145.940.700
20937441,2010-11-01T00:00:00,Weight Loss,C23.888.144.243.963
20937441,2010-11-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
20949524,2010-11-01T00:00:00,"Abnormalities, Multiple",C16.131.077
20949524,2010-11-01T00:00:00,Adult,M01.060.116
20949524,2010-11-01T00:00:00,Child,M01.060.406
20949524,2010-11-01T00:00:00,"Child, Preschool",M01.060.406.448
20949524,2010-11-01T00:00:00,Eye Movements,G11.427.590.530.140
20949524,2010-11-01T00:00:00,Eye Movements,G14.640.260
20949524,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20949524,2010-11-01T00:00:00,Infant,M01.060.703
20949524,2010-11-01T00:00:00,Intelligence Tests,F04.711.141.493
20949524,2010-11-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
20949524,2010-11-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
20949524,2010-11-01T00:00:00,Mutation,G05.365.590
20949524,2010-11-01T00:00:00,Pregnancy,G08.686.785.760.769
20949524,2010-11-01T00:00:00,Sodium-Hydrogen Antiporter,D12.776.157.530.450.162.775
20949524,2010-11-01T00:00:00,Sodium-Hydrogen Antiporter,D12.776.543.550.190.775
20949524,2010-11-01T00:00:00,Sodium-Hydrogen Antiporter,D12.776.543.585.450.162.775
20949524,2010-11-01T00:00:00,Syndrome,C23.550.288.500
20965378,2010-11-01T00:00:00,Attitude of Health Personnel,F01.100.050
20965378,2010-11-01T00:00:00,Attitude of Health Personnel,N05.300.100
20965378,2010-11-01T00:00:00,Early Detection of Cancer,E01.390.500
20965378,2010-11-01T00:00:00,Evidence-Based Medicine,H02.249.750
20965378,2010-11-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
20965378,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20965378,2010-11-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
20965378,2010-11-01T00:00:00,Lung Neoplasms,C08.381.540
20965378,2010-11-01T00:00:00,Lung Neoplasms,C08.785.520
20965378,2010-11-01T00:00:00,Physician's Practice Patterns,N04.590.748
20965378,2010-11-01T00:00:00,Physician's Practice Patterns,N05.300.625
20965378,2010-11-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
20965378,2010-11-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
20965378,2010-11-01T00:00:00,"Radiography, Thoracic",E01.370.350.700.730
20965378,2010-11-01T00:00:00,Smoking,F01.145.466.753
20965378,2010-11-01T00:00:00,"Tomography, Spiral Computed",E01.370.350.350.810.800
20965378,2010-11-01T00:00:00,"Tomography, Spiral Computed",E01.370.350.600.350.700.810.800
20965378,2010-11-01T00:00:00,"Tomography, Spiral Computed",E01.370.350.700.700.810.800
20965378,2010-11-01T00:00:00,"Tomography, Spiral Computed",E01.370.350.700.810.810.800
20965378,2010-11-01T00:00:00,"Tomography, Spiral Computed",E01.370.350.825.810.810.800
20965378,2010-11-01T00:00:00,United States,Z01.107.567.875
20971231,2010-11-01T00:00:00,Adolescent,M01.060.057
20971231,2010-11-01T00:00:00,Adult,M01.060.116
20971231,2010-11-01T00:00:00,Aged,M01.060.116.100
20971231,2010-11-01T00:00:00,Bacterial Infections,C01.252
20971231,2010-11-01T00:00:00,Child,M01.060.406
20971231,2010-11-01T00:00:00,"Child, Preschool",M01.060.406.448
20971231,2010-11-01T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
20971231,2010-11-01T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
20971231,2010-11-01T00:00:00,"Defibrillators, Implantable",E07.695.175
20971231,2010-11-01T00:00:00,Device Removal,E04.199
20971231,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20971231,2010-11-01T00:00:00,Middle Aged,M01.060.116.630
20971231,2010-11-01T00:00:00,"Pacemaker, Artificial",E07.858.082.748
20972973,2010-11-01T00:00:00,"Chromatography, Gel",E05.196.181.400.250
20972973,2010-11-01T00:00:00,Molecular Weight,G02.842.580
20974329,2010-11-01T00:00:00,Adolescent,M01.060.057
20974329,2010-11-01T00:00:00,Adult,M01.060.116
20974329,2010-11-01T00:00:00,Aged,M01.060.116.100
20974329,2010-11-01T00:00:00,Chronic Disease,C23.550.291.500
20974329,2010-11-01T00:00:00,Endoscopy,E01.370.388.250
20974329,2010-11-01T00:00:00,Endoscopy,E04.800.250
20974329,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20974329,2010-11-01T00:00:00,Middle Aged,M01.060.116.630
20974329,2010-11-01T00:00:00,Otorhinolaryngologic Surgical Procedures,E04.580
20974329,2010-11-01T00:00:00,Quality of Life,I01.800
20974329,2010-11-01T00:00:00,Quality of Life,K01.752.400.750
20974329,2010-11-01T00:00:00,Questionnaires,E05.318.308.750
20974329,2010-11-01T00:00:00,Questionnaires,L01.280.800
20974329,2010-11-01T00:00:00,Questionnaires,N05.715.360.300.695
20974329,2010-11-01T00:00:00,Questionnaires,N06.850.520.308.750
20974329,2010-11-01T00:00:00,Rhinitis,C08.460.799
20974329,2010-11-01T00:00:00,Rhinitis,C08.730.674
20974329,2010-11-01T00:00:00,Rhinitis,C09.603.799
20974329,2010-11-01T00:00:00,Sinusitis,C08.460.692.752
20974329,2010-11-01T00:00:00,Sinusitis,C08.730.749
20974329,2010-11-01T00:00:00,Sinusitis,C09.603.692.752
20974329,2010-11-01T00:00:00,Time Factors,G01.910.857
20974329,2010-11-01T00:00:00,Treatment Outcome,E01.789.800
20974329,2010-11-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20974329,2010-11-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20974329,2010-11-01T00:00:00,Young Adult,M01.060.116.815
20977332,2010-11-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
20977332,2010-11-01T00:00:00,Clinical Trials as Topic,E05.337.250
20977332,2010-11-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
20977332,2010-11-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
20977332,2010-11-01T00:00:00,Depressive Disorder,F03.600.300
20977332,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20977332,2010-11-01T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
20977332,2010-11-01T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
20977332,2010-11-01T00:00:00,Treatment Outcome,E01.789.800
20977332,2010-11-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20977332,2010-11-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21031542,2010-11-01T00:00:00,Animals,B01.050
21031542,2010-11-01T00:00:00,Enzyme Inhibitors,D27.505.519.389
21031542,2010-11-01T00:00:00,Graft Rejection,G12.425.901.545.328
21031542,2010-11-01T00:00:00,Graft Survival,G12.425.901.545.340
21031542,2010-11-01T00:00:00,Liver,A03.620
21031542,2010-11-01T00:00:00,Liver Transplantation,E04.210.650
21031542,2010-11-01T00:00:00,Liver Transplantation,E04.936.450.490
21031542,2010-11-01T00:00:00,Liver Transplantation,E04.936.580.490
21031542,2010-11-01T00:00:00,Nitric Oxide Synthase Type II,D08.811.682.664.500.772.500
21031542,2010-11-01T00:00:00,Peroxynitrous Acid,D01.625.600.800
21031542,2010-11-01T00:00:00,Peroxynitrous Acid,D01.625.700.750
21031542,2010-11-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
21031542,2010-11-01T00:00:00,Reactive Nitrogen Species,D01.625.700
21031542,2010-11-01T00:00:00,Reactive Nitrogen Species,D02.654.846
21031542,2010-11-01T00:00:00,Tyrosine,D12.125.072.050.875
21031583,2010-11-01T00:00:00,Adolescent,M01.060.057
21031583,2010-11-01T00:00:00,Adult,M01.060.116
21031583,2010-11-01T00:00:00,Aged,M01.060.116.100
21031583,2010-11-01T00:00:00,Atrial Fibrillation,C14.280.067.198
21031583,2010-11-01T00:00:00,Atrial Fibrillation,C23.550.073.198
21031583,2010-11-01T00:00:00,Biological Markers,D23.101
21031583,2010-11-01T00:00:00,Brain Ischemia,C10.228.140.300.150
21031583,2010-11-01T00:00:00,Brain Ischemia,C14.907.253.092
21031583,2010-11-01T00:00:00,Embolism,C14.907.355.350
21031583,2010-11-01T00:00:00,Gene Expression Profiling,E05.393.332
21031583,2010-11-01T00:00:00,Genome-Wide Association Study,E05.318.416.249
21031583,2010-11-01T00:00:00,Genome-Wide Association Study,E05.318.780.392
21031583,2010-11-01T00:00:00,Genome-Wide Association Study,E05.393.385.500
21031583,2010-11-01T00:00:00,Genome-Wide Association Study,E05.393.522.500
21031583,2010-11-01T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
21031583,2010-11-01T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
21031583,2010-11-01T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
21031583,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21031583,2010-11-01T00:00:00,Middle Aged,M01.060.116.630
21031583,2010-11-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
21031583,2010-11-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
21031583,2010-11-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
21031583,2010-11-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
21031583,2010-11-01T00:00:00,Risk Factors,E05.318.740.600.800.725
21031583,2010-11-01T00:00:00,Risk Factors,N05.715.350.200.700
21031583,2010-11-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
21031583,2010-11-01T00:00:00,Risk Factors,N06.850.490.625.750
21031583,2010-11-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
21031583,2010-11-01T00:00:00,Stroke,C10.228.140.300.775
21031583,2010-11-01T00:00:00,Stroke,C14.907.253.855
21034896,2010-11-01T00:00:00,Adolescent,M01.060.057
21034896,2010-11-01T00:00:00,Adult,M01.060.116
21034896,2010-11-01T00:00:00,Aged,M01.060.116.100
21034896,2010-11-01T00:00:00,"Biopsy, Fine-Needle",E01.370.388.100.100.500
21034896,2010-11-01T00:00:00,"Biopsy, Fine-Needle",E01.450.230.100.100.500
21034896,2010-11-01T00:00:00,"Biopsy, Fine-Needle",E01.450.865.100.100.500
21034896,2010-11-01T00:00:00,"Biopsy, Fine-Needle",E04.074.119.500
21034896,2010-11-01T00:00:00,Endosonography,E01.370.350.850.280
21034896,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21034896,2010-11-01T00:00:00,Middle Aged,M01.060.116.630
21034896,2010-11-01T00:00:00,Young Adult,M01.060.116.815
21034899,2010-11-01T00:00:00,Adolescent,M01.060.057
21034899,2010-11-01T00:00:00,Adult,M01.060.116
21034899,2010-11-01T00:00:00,Aged,M01.060.116.100
21034899,2010-11-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
21034899,2010-11-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
21034899,2010-11-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
21034899,2010-11-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
21034899,2010-11-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
21034899,2010-11-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
21034899,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21034899,2010-11-01T00:00:00,Manometry,E05.559
21034899,2010-11-01T00:00:00,Middle Aged,M01.060.116.630
21034899,2010-11-01T00:00:00,Multicenter Studies as Topic,E05.318.760.535.500
21034899,2010-11-01T00:00:00,Multicenter Studies as Topic,E05.337.250.500
21034899,2010-11-01T00:00:00,Multicenter Studies as Topic,N05.715.360.775.235.545
21034899,2010-11-01T00:00:00,Multicenter Studies as Topic,N06.850.520.450.535.500
21034899,2010-11-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
21034899,2010-11-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
21034899,2010-11-01T00:00:00,Pain,C10.597.617
21034899,2010-11-01T00:00:00,Pain,C23.888.592.612
21034899,2010-11-01T00:00:00,Pain,C23.888.646
21034899,2010-11-01T00:00:00,Pain,F02.830.816.444
21034899,2010-11-01T00:00:00,Pain,G11.561.600.810.444
21034899,2010-11-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
21034899,2010-11-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
21034899,2010-11-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
21034899,2010-11-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
21034899,2010-11-01T00:00:00,Research Design,E05.581.500
21034899,2010-11-01T00:00:00,Research Design,H01.770.644.728
21034899,2010-11-01T00:00:00,Young Adult,M01.060.116.815
21034915,2010-11-01T00:00:00,Catheterization,E02.148
21034915,2010-11-01T00:00:00,Catheterization,E05.157
21034915,2010-11-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
21034915,2010-11-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
21034915,2010-11-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
21034915,2010-11-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
21034915,2010-11-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
21034915,2010-11-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
21034915,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21034915,2010-11-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
21034915,2010-11-01T00:00:00,Risk Assessment,N04.452.871.715
21034915,2010-11-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
21034915,2010-11-01T00:00:00,Risk Assessment,N06.850.505.715
21034915,2010-11-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
21034949,2010-11-01T00:00:00,Child,M01.060.406
21034949,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21034949,2010-11-01T00:00:00,"Thoracic Surgery, Video-Assisted",E01.370.388.250.840.830
21034949,2010-11-01T00:00:00,"Thoracic Surgery, Video-Assisted",E01.370.388.250.950.830
21034949,2010-11-01T00:00:00,"Thoracic Surgery, Video-Assisted",E04.800.250.840.830
21034949,2010-11-01T00:00:00,"Thoracic Surgery, Video-Assisted",E04.800.250.950.830
21034949,2010-11-01T00:00:00,"Thoracic Surgery, Video-Assisted",E04.928.752.830
21034949,2010-11-01T00:00:00,United States,Z01.107.567.875
21036295,2010-11-01T00:00:00,Adolescent,M01.060.057
21036295,2010-11-01T00:00:00,Adult,M01.060.116
21036295,2010-11-01T00:00:00,Biomedical Research,H01.770.644.145
21036295,2010-11-01T00:00:00,Brain Injuries,C10.228.140.199
21036295,2010-11-01T00:00:00,Brain Injuries,C10.900.300.087
21036295,2010-11-01T00:00:00,Brain Injuries,C21.866.260.118
21036295,2010-11-01T00:00:00,Brain Injuries,C21.866.915.300.200
21036295,2010-11-01T00:00:00,Child,M01.060.406
21036295,2010-11-01T00:00:00,Emergencies,C23.550.291.781
21036295,2010-11-01T00:00:00,Emergencies,N06.230.100.083
21036295,2010-11-01T00:00:00,Emergencies,N06.850.376
21036295,2010-11-01T00:00:00,Emergency Medical Services,N02.421.297
21036295,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21036295,2010-11-01T00:00:00,Mental Disorders,F03
21036295,2010-11-01T00:00:00,National Institutes of Health (U.S.),I01.409.137.500.600.480
21036295,2010-11-01T00:00:00,National Institutes of Health (U.S.),N03.540.348.500.500.600.480
21036295,2010-11-01T00:00:00,Pregnancy,G08.686.785.760.769
21036295,2010-11-01T00:00:00,United States,Z01.107.567.875
21041307,2010-11-01T00:00:00,Animals,B01.050
21041307,2010-11-01T00:00:00,Chlorine,D01.268.380.150
21041307,2010-11-01T00:00:00,Chlorine,D01.362.225
21041307,2010-11-01T00:00:00,Extracellular Space,A10.082.500
21041307,2010-11-01T00:00:00,Extracellular Space,A11.284.295
21041307,2010-11-01T00:00:00,Gene Expression Regulation,G05.355.315
21041307,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21041307,2010-11-01T00:00:00,Interleukin-4,D12.644.276.374.465.504
21041307,2010-11-01T00:00:00,Interleukin-4,D12.776.467.374.465.504
21041307,2010-11-01T00:00:00,Interleukin-4,D23.529.374.465.504
21041307,2010-11-01T00:00:00,Membrane Proteins,D12.776.543
21041307,2010-11-01T00:00:00,Neoplasm Proteins,D12.776.624
21041307,2010-11-01T00:00:00,"RNA, Messenger",D13.444.735.544
21041307,2010-11-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
21041721,2010-11-01T00:00:00,Animals,B01.050
21041721,2010-11-01T00:00:00,Cell Line,A11.251.210
21041721,2010-11-01T00:00:00,Ceramides,D02.065.313
21041721,2010-11-01T00:00:00,Ceramides,D09.400.410.420.525.200
21041721,2010-11-01T00:00:00,Ceramides,D10.390.470.675.200
21041721,2010-11-01T00:00:00,Ceramides,D10.570.877.360.612.200
21041721,2010-11-01T00:00:00,Down-Regulation,G02.111.087.225
21041721,2010-11-01T00:00:00,Down-Regulation,G02.149.115.225
21041721,2010-11-01T00:00:00,Down-Regulation,G05.355.315.200
21041721,2010-11-01T00:00:00,Down-Regulation,G07.690.812.230
21041721,2010-11-01T00:00:00,Down-Regulation,G07.700.680.230
21041721,2010-11-01T00:00:00,Gene Silencing,G05.355.315.203.374
21041721,2010-11-01T00:00:00,Lipopolysaccharides,D09.400.500
21041721,2010-11-01T00:00:00,Lipopolysaccharides,D09.698.718.450
21041721,2010-11-01T00:00:00,Lipopolysaccharides,D10.494
21041721,2010-11-01T00:00:00,Lipopolysaccharides,D23.050.161.616.525
21041721,2010-11-01T00:00:00,Lipopolysaccharides,D23.946.123.329.500
21041721,2010-11-01T00:00:00,Lysophospholipids,D10.570.755.375.760.550
21041721,2010-11-01T00:00:00,Phosphotransferases (Alcohol Group Acceptor),D08.811.913.696.620
21041721,2010-11-01T00:00:00,Sphingosine,D02.033.100.700
21041721,2010-11-01T00:00:00,Sphingosine,D02.033.455.843
21041721,2010-11-01T00:00:00,Sphingosine,D02.092.063.700
21041721,2010-11-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
21041721,2010-11-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
21041721,2010-11-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
21041721,2010-11-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
21041721,2010-11-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
21041721,2010-11-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
21041721,2010-11-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
21041721,2010-11-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
21041721,2010-11-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
21041721,2010-11-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
21041721,2010-11-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
21042062,2010-11-01T00:00:00,Bone and Bones,A02.835.232
21042062,2010-11-01T00:00:00,Bone and Bones,A10.165.265
21042062,2010-11-01T00:00:00,Brain,A08.186.211
21042062,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21042062,2010-11-01T00:00:00,Liver,A03.620
21042062,2010-11-01T00:00:00,Lung,A04.411
21042062,2010-11-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
21042062,2010-11-01T00:00:00,Lung Neoplasms,C08.381.540
21042062,2010-11-01T00:00:00,Lung Neoplasms,C08.785.520
21042062,2010-11-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
21042062,2010-11-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
21042062,2010-11-01T00:00:00,Neoplasm Staging,E01.370.550
21042062,2010-11-01T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
21042062,2010-11-01T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
21042062,2010-11-01T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
21042062,2010-11-01T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
21042062,2010-11-01T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
21042062,2010-11-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
21042062,2010-11-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
21042062,2010-11-01T00:00:00,Radiology,H02.403.740
21042062,2010-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
21042062,2010-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
21042062,2010-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
21042062,2010-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
21042062,2010-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
21042062,2010-11-01T00:00:00,United States,Z01.107.567.875
21044720,2010-11-01T00:00:00,Adult,M01.060.116
21044720,2010-11-01T00:00:00,Disability Evaluation,E01.370.400
21044720,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21044720,2010-11-01T00:00:00,Middle Aged,M01.060.116.630
21044720,2010-11-01T00:00:00,Questionnaires,E05.318.308.750
21044720,2010-11-01T00:00:00,Questionnaires,L01.280.800
21044720,2010-11-01T00:00:00,Questionnaires,N05.715.360.300.695
21044720,2010-11-01T00:00:00,Questionnaires,N06.850.520.308.750
21044720,2010-11-01T00:00:00,Risk Factors,E05.318.740.600.800.725
21044720,2010-11-01T00:00:00,Risk Factors,N05.715.350.200.700
21044720,2010-11-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
21044720,2010-11-01T00:00:00,Risk Factors,N06.850.490.625.750
21044720,2010-11-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
21044720,2010-11-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
21044720,2010-11-01T00:00:00,Spinal Cord Injuries,C10.900.850
21044720,2010-11-01T00:00:00,Spinal Cord Injuries,C21.866.819
21044720,2010-11-01T00:00:00,Time Factors,G01.910.857
21044720,2010-11-01T00:00:00,United States,Z01.107.567.875
21044720,2010-11-01T00:00:00,Wounds and Injuries,C21.866
21044767,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21044767,2010-11-01T00:00:00,Proteomics,H01.158.201.843
21044767,2010-11-01T00:00:00,Proteomics,H01.158.273.180.350.700
21044767,2010-11-01T00:00:00,Proteomics,H01.158.273.343.350.700
21044767,2010-11-01T00:00:00,Proteomics,H01.181.122.738
21044767,2010-11-01T00:00:00,"Renal Insufficiency, Chronic",C12.777.419.780.750
21044767,2010-11-01T00:00:00,"Renal Insufficiency, Chronic",C13.351.968.419.780.750
21057229,2010-11-01T00:00:00,Aged,M01.060.116.100
21057229,2010-11-01T00:00:00,Exercise Therapy,E02.779.483
21057229,2010-11-01T00:00:00,Exercise Therapy,E02.831.387
21057229,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21057229,2010-11-01T00:00:00,Internet,L01.224.230.110.500
21057229,2010-11-01T00:00:00,Middle Aged,M01.060.116.630
21057229,2010-11-01T00:00:00,Motor Activity,F01.145.632
21057229,2010-11-01T00:00:00,Motor Activity,G11.427.590.530.698
21057229,2010-11-01T00:00:00,Patient Compliance,F01.145.488.500
21057229,2010-11-01T00:00:00,Patient Compliance,N05.300.150.600.600
21057229,2010-11-01T00:00:00,Patient Education as Topic,I02.233.332.500
21057229,2010-11-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
21057229,2010-11-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
21057229,2010-11-01T00:00:00,"Therapy, Computer-Assisted",E02.950
21057229,2010-11-01T00:00:00,"Therapy, Computer-Assisted",L01.700.508.100.710
21057229,2010-11-01T00:00:00,Treatment Outcome,E01.789.800
21057229,2010-11-01T00:00:00,Treatment Outcome,N04.761.559.590.800
21057229,2010-11-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21057229,2010-11-01T00:00:00,Varicose Ulcer,C14.907.927.730
21057229,2010-11-01T00:00:00,Varicose Ulcer,C17.800.893.592.730
21061211,2010-11-01T00:00:00,Cooperative Behavior,F01.145.813.115
21061211,2010-11-01T00:00:00,"Physicians, Family",M01.526.485.810.770
21061211,2010-11-01T00:00:00,"Physicians, Family",N02.360.810.770
21061211,2010-11-01T00:00:00,Primary Health Care,N04.590.233.727
21061211,2010-11-01T00:00:00,United States,Z01.107.567.875
21080812,2010-11-01T00:00:00,Aging,G07.700.320.124
21080812,2010-11-01T00:00:00,Cardiovascular Diseases,C14
21080812,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21080812,2010-11-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
21080812,2010-11-01T00:00:00,Risk Factors,E05.318.740.600.800.725
21080812,2010-11-01T00:00:00,Risk Factors,N05.715.350.200.700
21080812,2010-11-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
21080812,2010-11-01T00:00:00,Risk Factors,N06.850.490.625.750
21080812,2010-11-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
21084905,2010-11-01T00:00:00,Adult,M01.060.116
21084905,2010-11-01T00:00:00,Aged,M01.060.116.100
21084905,2010-11-01T00:00:00,Angiography,E01.370.350.700.060
21084905,2010-11-01T00:00:00,Angiography,E01.370.370.050
21084905,2010-11-01T00:00:00,Contrast Media,D27.720.259
21084905,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21084905,2010-11-01T00:00:00,Liver,A03.620
21084905,2010-11-01T00:00:00,Middle Aged,M01.060.116.630
21084905,2010-11-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
21084905,2010-11-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
21084905,2010-11-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
21084905,2010-11-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
21084905,2010-11-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
21084905,2010-11-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
21084905,2010-11-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
21084905,2010-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
21084905,2010-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
21084905,2010-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
21084905,2010-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
21084905,2010-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
21110606,2010-11-01T00:00:00,Acoustic Stimulation,E02.037
21110606,2010-11-01T00:00:00,Acoustic Stimulation,E02.190.888.030
21110606,2010-11-01T00:00:00,Acoustic Stimulation,E05.723.136
21110606,2010-11-01T00:00:00,Adult,M01.060.116
21110606,2010-11-01T00:00:00,Aged,M01.060.116.100
21110606,2010-11-01T00:00:00,Algorithms,G17.035
21110606,2010-11-01T00:00:00,Algorithms,L01.224.050
21110606,2010-11-01T00:00:00,Hearing Aids,E07.814.458
21110606,2010-11-01T00:00:00,Hearing Loss,C09.218.458.341
21110606,2010-11-01T00:00:00,Hearing Loss,C10.597.751.418.341
21110606,2010-11-01T00:00:00,Hearing Loss,C23.888.592.763.393.341
21110606,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21110606,2010-11-01T00:00:00,Middle Aged,M01.060.116.630
21110606,2010-11-01T00:00:00,Speech Perception,F02.463.593.071.875
21110606,2010-11-01T00:00:00,Young Adult,M01.060.116.815
21121225,2010-11-01T00:00:00,Adolescent,M01.060.057
21121225,2010-11-01T00:00:00,Adult,M01.060.116
21121225,2010-11-01T00:00:00,African Americans,M01.686.508.100.100
21121225,2010-11-01T00:00:00,African Americans,M01.686.754.100
21121225,2010-11-01T00:00:00,Aged,M01.060.116.100
21121225,2010-11-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
21121225,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21121225,2010-11-01T00:00:00,Hypertension,C14.907.489
21121225,2010-11-01T00:00:00,Medication Adherence,F01.145.488.500.500
21121225,2010-11-01T00:00:00,Medication Adherence,N05.300.150.600.600.500
21121225,2010-11-01T00:00:00,Middle Aged,M01.060.116.630
21121225,2010-11-01T00:00:00,Risk Reduction Behavior,F01.145.699
21121225,2010-11-01T00:00:00,Rural Population,N01.600.725
21121225,2010-11-01T00:00:00,United States,Z01.107.567.875
21121225,2010-11-01T00:00:00,Urban Population,N01.600.900
21121225,2010-11-01T00:00:00,Young Adult,M01.060.116.815
21140684,2010-11-01T00:00:00,Colonoscopy,E01.370.372.250.250.200
21140684,2010-11-01T00:00:00,Colonoscopy,E01.370.388.250.250.250.160
21140684,2010-11-01T00:00:00,Colonoscopy,E04.210.240.250.160
21140684,2010-11-01T00:00:00,Colonoscopy,E04.800.250.250.250.160
21140684,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21140684,2010-11-01T00:00:00,Middle Aged,M01.060.116.630
21140684,2010-11-01T00:00:00,Spleen,A10.549.700
21140684,2010-11-01T00:00:00,Spleen,A15.382.520.604.700
21140712,2010-11-01T00:00:00,Appendicitis,C06.405.205.099
21140712,2010-11-01T00:00:00,Appendicitis,C06.405.469.110.207
21140712,2010-11-01T00:00:00,Appendix,A03.556.124.526.209.290
21140712,2010-11-01T00:00:00,Appendix,A03.556.249.249.209.290
21140712,2010-11-01T00:00:00,"Hernia, Inguinal",C23.300.707.374.875
21140712,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21144928,2010-11-01T00:00:00,Animals,B01.050
21144928,2010-11-01T00:00:00,Debridement,E04.176
21144928,2010-11-01T00:00:00,Femoral Fractures,C21.866.404.061
21144928,2010-11-01T00:00:00,Femoral Fractures,C21.866.558.276
21144928,2010-11-01T00:00:00,"Fracture Fixation, Intramedullary",E04.555.300.300.300
21144928,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21144928,2010-11-01T00:00:00,Pressure,G01.374.715
21144928,2010-11-01T00:00:00,Risk Factors,E05.318.740.600.800.725
21144928,2010-11-01T00:00:00,Risk Factors,N05.715.350.200.700
21144928,2010-11-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
21144928,2010-11-01T00:00:00,Risk Factors,N06.850.490.625.750
21144928,2010-11-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
21144928,2010-11-01T00:00:00,Treatment Outcome,E01.789.800
21144928,2010-11-01T00:00:00,Treatment Outcome,N04.761.559.590.800
21144928,2010-11-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21144938,2010-11-01T00:00:00,Adult,M01.060.116
21144938,2010-11-01T00:00:00,Biological Markers,D23.101
21144938,2010-11-01T00:00:00,Femoral Fractures,C21.866.404.061
21144938,2010-11-01T00:00:00,Femoral Fractures,C21.866.558.276
21144938,2010-11-01T00:00:00,"Fracture Fixation, Intramedullary",E04.555.300.300.300
21144938,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21144938,2010-11-01T00:00:00,Multiple Trauma,C21.866.640
21144938,2010-11-01T00:00:00,South Carolina,Z01.107.567.875.075.662
21144938,2010-11-01T00:00:00,South Carolina,Z01.107.567.875.750.700
21144938,2010-11-01T00:00:00,Thoracic Injuries,C21.866.891
21144938,2010-11-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
21144938,2010-11-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
21144938,2010-11-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
21144938,2010-11-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
21144938,2010-11-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
21144938,2010-11-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
21144938,2010-11-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
21144938,2010-11-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
21144938,2010-11-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
21144938,2010-11-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
21144938,2010-11-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
21149835,2010-11-01T00:00:00,Curriculum,I02.158
21149835,2010-11-01T00:00:00,"Education, Medical",I02.358.399
21149835,2010-11-01T00:00:00,"Education, Medical, Graduate",I02.358.337.350
21149835,2010-11-01T00:00:00,"Education, Medical, Graduate",I02.358.399.350
21149835,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21149835,2010-11-01T00:00:00,Internship and Residency,I02.358.399.644
21149840,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21149840,2010-11-01T00:00:00,"Insurance, Health, Reimbursement",N03.219.521.576.343.480
21149840,2010-11-01T00:00:00,"Insurance, Health, Reimbursement",N03.219.521.710
21149840,2010-11-01T00:00:00,Medicare,N03.219.521.346.506.564.663
21149840,2010-11-01T00:00:00,Medicare,N03.219.521.576.343.840
21149840,2010-11-01T00:00:00,Medicare,N03.706.615.696
21149840,2010-11-01T00:00:00,Patient Care Team,N04.590.715
21149840,2010-11-01T00:00:00,Physicians,M01.526.485.810
21149840,2010-11-01T00:00:00,Physicians,N02.360.810
21149840,2010-11-01T00:00:00,United States,Z01.107.567.875
21149842,2010-11-01T00:00:00,Bariatric Surgery,E02.065.062
21149842,2010-11-01T00:00:00,Bariatric Surgery,E04.062
21149842,2010-11-01T00:00:00,Health Facilities,N02.278
21149842,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21149842,2010-11-01T00:00:00,"Insurance, Health, Reimbursement",N03.219.521.576.343.480
21149842,2010-11-01T00:00:00,"Insurance, Health, Reimbursement",N03.219.521.710
21149842,2010-11-01T00:00:00,Interdisciplinary Communication,F01.145.209.381
21149842,2010-11-01T00:00:00,Interdisciplinary Communication,F01.829.401.205.249
21149842,2010-11-01T00:00:00,Interdisciplinary Communication,L01.143.474
21149842,2010-11-01T00:00:00,Malnutrition,C18.654.521
21149842,2010-11-01T00:00:00,"Models, Organizational",E05.599.670
21149842,2010-11-01T00:00:00,"Models, Organizational",N04.452.534
21149842,2010-11-01T00:00:00,Program Development,N04.452.760
21149843,2010-11-01T00:00:00,Budgets,N03.219.463.060
21149843,2010-11-01T00:00:00,Data Collection,E05.318.308
21149843,2010-11-01T00:00:00,Data Collection,L01.280
21149843,2010-11-01T00:00:00,Data Collection,N05.715.360.300
21149843,2010-11-01T00:00:00,Data Collection,N06.850.520.308
21149843,2010-11-01T00:00:00,Delivery of Health Care,N04.590.374
21149843,2010-11-01T00:00:00,Delivery of Health Care,N05.300
21149843,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21149843,2010-11-01T00:00:00,North America,Z01.107.567
21149843,2010-11-01T00:00:00,Physicians,M01.526.485.810
21149843,2010-11-01T00:00:00,Physicians,N02.360.810
21149844,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21149844,2010-11-01T00:00:00,Physicians,M01.526.485.810
21149844,2010-11-01T00:00:00,Physicians,N02.360.810
21149844,2010-11-01T00:00:00,Research,H01.770.644
21150394,2010-11-01T00:00:00,Angiography,E01.370.350.700.060
21150394,2010-11-01T00:00:00,Angiography,E01.370.370.050
21150394,2010-11-01T00:00:00,Blood Pressure,E01.370.600.875.249
21150394,2010-11-01T00:00:00,Blood Pressure,G09.330.380.076
21150394,2010-11-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
21150394,2010-11-01T00:00:00,Clinical Trials as Topic,E05.337.250
21150394,2010-11-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
21150394,2010-11-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
21150394,2010-11-01T00:00:00,"Constriction, Pathologic",C23.300.287
21150394,2010-11-01T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
21150394,2010-11-01T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
21150394,2010-11-01T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
21150394,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21150394,2010-11-01T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
21150394,2010-11-01T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
21150394,2010-11-01T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
21150394,2010-11-01T00:00:00,Risk Factors,E05.318.740.600.800.725
21150394,2010-11-01T00:00:00,Risk Factors,N05.715.350.200.700
21150394,2010-11-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
21150394,2010-11-01T00:00:00,Risk Factors,N06.850.490.625.750
21150394,2010-11-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
21150394,2010-11-01T00:00:00,Stroke,C10.228.140.300.775
21150394,2010-11-01T00:00:00,Stroke,C14.907.253.855
21150496,2010-11-01T00:00:00,Attitude to Health,F01.100.150
21150496,2010-11-01T00:00:00,Attitude to Health,N05.300.150
21150496,2010-11-01T00:00:00,Health Promotion,N02.370
21150496,2010-11-01T00:00:00,Health Promotion,N02.421.726.507
21150496,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21150496,2010-11-01T00:00:00,Neoplasms,C04
21150496,2010-11-01T00:00:00,Nurse's Role,F01.829.316.616.625.450
21150496,2010-11-01T00:00:00,Nurse's Role,N05.300.100.337
21150496,2010-11-01T00:00:00,Survivors,M01.643.836
21150496,2010-11-01T00:00:00,Survivors,M01.860
21180659,2010-11-01T00:00:00,Bipolar Disorder,F03.600.150.150
21180659,2010-11-01T00:00:00,Blood Proteins,D12.776.124
21180659,2010-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21180659,2010-11-01T00:00:00,Middle Aged,M01.060.116.630
21180659,2010-11-01T00:00:00,Valproic Acid,D02.241.081.944.509.900
21180659,2010-11-01T00:00:00,Valproic Acid,D10.251.400.895.593.900
21313804,2010-11-01T00:00:00,Alkaloids,D03.132
21313804,2010-11-01T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
21313804,2010-11-01T00:00:00,Mass Spectrometry,E05.196.566
21313804,2010-11-01T00:00:00,Plant Extracts,D20.215.784.500
21313804,2010-11-01T00:00:00,Plant Extracts,D26.667
20956217,2010-11-02T00:00:00,Cardiology,H02.403.429.163
20956217,2010-11-02T00:00:00,Cardiopulmonary Resuscitation,E02.365.647.110
20956217,2010-11-02T00:00:00,Cardiovascular Diseases,C14
20956217,2010-11-02T00:00:00,Emergency Medical Services,N02.421.297
20956217,2010-11-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20956217,2010-11-02T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
20956217,2010-11-02T00:00:00,Practice Guidelines as Topic,N05.700.350.650
20956217,2010-11-02T00:00:00,United States,Z01.107.567.875
20956227,2010-11-02T00:00:00,Adult,M01.060.116
20956227,2010-11-02T00:00:00,Cardiology,H02.403.429.163
20956227,2010-11-02T00:00:00,Cardiopulmonary Resuscitation,E02.365.647.110
20956227,2010-11-02T00:00:00,Emergency Medical Services,N02.421.297
20956227,2010-11-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20956227,2010-11-02T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
20956227,2010-11-02T00:00:00,Practice Guidelines as Topic,N05.700.350.650
20956227,2010-11-02T00:00:00,Quality of Life,I01.800
20956227,2010-11-02T00:00:00,Quality of Life,K01.752.400.750
20956227,2010-11-02T00:00:00,Recovery of Function,G16.757
20956227,2010-11-02T00:00:00,Stroke,C10.228.140.300.775
20956227,2010-11-02T00:00:00,Stroke,C14.907.253.855
20956227,2010-11-02T00:00:00,Time Factors,G01.910.857
20956227,2010-11-02T00:00:00,United States,Z01.107.567.875
20929226,2010-11-03T00:00:00,Fluorescent Dyes,D27.720.233.348
20929226,2010-11-03T00:00:00,Fluorescent Dyes,D27.720.470.330.348
20929226,2010-11-03T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
20929226,2010-11-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20929226,2010-11-03T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
20929226,2010-11-03T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
20929226,2010-11-03T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
20929226,2010-11-03T00:00:00,Polymers,D05.750
20929226,2010-11-03T00:00:00,Polymers,D25.720
20929226,2010-11-03T00:00:00,Polymers,J01.637.051.720
20929226,2010-11-03T00:00:00,Semiconductors,E07.305.625
20929226,2010-11-03T00:00:00,"Spectrometry, Fluorescence",E05.196.712.516.600.676
20929226,2010-11-03T00:00:00,"Spectrometry, Fluorescence",E05.196.867.726
21051037,2010-11-03T00:00:00,Action Potentials,G04.580.100
21051037,2010-11-03T00:00:00,Action Potentials,G07.265.750.100
21051037,2010-11-03T00:00:00,Action Potentials,G11.561.570.100
21051037,2010-11-03T00:00:00,Animals,B01.050
21051037,2010-11-03T00:00:00,Attention,F02.830.104.214
21051037,2010-11-03T00:00:00,Methamphetamine,D02.092.471.683.152.619
21051037,2010-11-03T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
21051037,2010-11-03T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
21051037,2010-11-03T00:00:00,Self Administration,E02.319.890
21051037,2010-11-03T00:00:00,Self Administration,E02.900.890
21051673,2010-11-04T00:00:00,Adult,M01.060.116
21051673,2010-11-04T00:00:00,Aged,M01.060.116.100
21051673,2010-11-04T00:00:00,Angioplasty,E02.148.050
21051673,2010-11-04T00:00:00,Angioplasty,E04.100.814.050
21051673,2010-11-04T00:00:00,Ethnic Groups,M01.686.754
21051673,2010-11-04T00:00:00,Ethnic Groups,N01.224.317
21051673,2010-11-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21051673,2010-11-04T00:00:00,Hypertension,C14.907.489
21051673,2010-11-04T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
21051673,2010-11-04T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
21051673,2010-11-04T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
21051673,2010-11-04T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.150.477.200.450
21051673,2010-11-04T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.510.200.387
21051673,2010-11-04T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.775.200.200.450
21051673,2010-11-04T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.092.477.200.450
21051673,2010-11-04T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.560.200.387
21051673,2010-11-04T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.855.200.200.450
21051673,2010-11-04T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
21051673,2010-11-04T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
21051673,2010-11-04T00:00:00,Middle Aged,M01.060.116.630
21051673,2010-11-04T00:00:00,Risk Factors,E05.318.740.600.800.725
21051673,2010-11-04T00:00:00,Risk Factors,N05.715.350.200.700
21051673,2010-11-04T00:00:00,Risk Factors,N05.715.360.750.625.700.700
21051673,2010-11-04T00:00:00,Risk Factors,N06.850.490.625.750
21051673,2010-11-04T00:00:00,Risk Factors,N06.850.520.830.600.800.725
21051673,2010-11-04T00:00:00,Stents,E07.695.750
21051673,2010-11-04T00:00:00,Stroke,C10.228.140.300.775
21051673,2010-11-04T00:00:00,Stroke,C14.907.253.855
21051673,2010-11-04T00:00:00,Subarachnoid Hemorrhage,C10.228.140.300.535.800
21051673,2010-11-04T00:00:00,Subarachnoid Hemorrhage,C14.907.253.573.800
21051673,2010-11-04T00:00:00,Subarachnoid Hemorrhage,C23.550.414.913.850
21051673,2010-11-04T00:00:00,Thrombectomy,E04.100.814.842
21051673,2010-11-04T00:00:00,Thrombolytic Therapy,E02.319.913
21051673,2010-11-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
21051673,2010-11-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
21051673,2010-11-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
21051673,2010-11-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
21051673,2010-11-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
21051673,2010-11-04T00:00:00,Treatment Outcome,E01.789.800
21051673,2010-11-04T00:00:00,Treatment Outcome,N04.761.559.590.800
21051673,2010-11-04T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21054692,2010-11-04T00:00:00,Alcohol Drinking,F01.145.317.269
21054692,2010-11-04T00:00:00,Alcoholism,C21.739.100.250
21054692,2010-11-04T00:00:00,Alcoholism,F03.900.100.350
21054692,2010-11-04T00:00:00,Amygdala,A08.186.211.464.090
21054692,2010-11-04T00:00:00,Amygdala,A08.186.211.730.885.287.249.152
21054692,2010-11-04T00:00:00,Animals,B01.050
21054692,2010-11-04T00:00:00,Biosensing Techniques,E05.601.123
21054692,2010-11-04T00:00:00,Brain Mapping,E01.370.350.086
21054692,2010-11-04T00:00:00,Brain Mapping,E01.370.376.149
21054692,2010-11-04T00:00:00,Brain Mapping,E05.132
21054692,2010-11-04T00:00:00,Cues,F02.463.425.234
21054692,2010-11-04T00:00:00,Glutamic Acid,D12.125.067.750
21054692,2010-11-04T00:00:00,Glutamic Acid,D12.125.119.450
21054692,2010-11-04T00:00:00,Glutamic Acid,D12.125.427.300
21054692,2010-11-04T00:00:00,Motivation,F01.658
21054692,2010-11-04T00:00:00,Motivation,F01.752.543.500.750
21054692,2010-11-04T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
21054692,2010-11-04T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
21054692,2010-11-04T00:00:00,Self Administration,E02.319.890
21054692,2010-11-04T00:00:00,Self Administration,E02.900.890
21054692,2010-11-04T00:00:00,Synaptic Transmission,G02.111.087.800.850
21054692,2010-11-04T00:00:00,Synaptic Transmission,G02.149.115.800.850
21054692,2010-11-04T00:00:00,Synaptic Transmission,G04.299.880.850
21054692,2010-11-04T00:00:00,Synaptic Transmission,G07.265.337.900
21054692,2010-11-04T00:00:00,Synaptic Transmission,G07.700.240.900
21054692,2010-11-04T00:00:00,Synaptic Transmission,G11.561.600.835
21053920,2010-11-05T00:00:00,Electric Power Supplies,E07.305.124
21053920,2010-11-05T00:00:00,Polymethacrylic Acids,D02.241.081.069.800
21053920,2010-11-05T00:00:00,Polymethacrylic Acids,D05.750.716.822.111.650
21053920,2010-11-05T00:00:00,Polymethacrylic Acids,D25.720.716.822.111.650
21053920,2010-11-05T00:00:00,Polymethacrylic Acids,J01.637.051.720.716.822.111.650
21054135,2010-11-05T00:00:00,Adult,M01.060.116
21054135,2010-11-05T00:00:00,Aged,M01.060.116.100
21054135,2010-11-05T00:00:00,Health Expenditures,N03.219.151.450
21054135,2010-11-05T00:00:00,Health Expenditures,N05.300.385
21054135,2010-11-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21054135,2010-11-05T00:00:00,Income,N01.824.417
21054135,2010-11-05T00:00:00,Middle Aged,M01.060.116.630
21054135,2010-11-05T00:00:00,Regression Analysis,E05.318.740.750
21054135,2010-11-05T00:00:00,Regression Analysis,N05.715.360.750.695
21054135,2010-11-05T00:00:00,Regression Analysis,N06.850.520.830.750
21054135,2010-11-05T00:00:00,Rural Population,N01.600.725
21054135,2010-11-05T00:00:00,United States,Z01.107.567.875
21054135,2010-11-05T00:00:00,Urban Population,N01.600.900
21054135,2010-11-05T00:00:00,Young Adult,M01.060.116.815
21056409,2010-11-05T00:00:00,Animals,B01.050
21056409,2010-11-05T00:00:00,"Animals, Newborn",B01.050.050.282
21056409,2010-11-05T00:00:00,Calcium,D01.268.552.100
21056409,2010-11-05T00:00:00,Calcium,D01.552.539.288
21056409,2010-11-05T00:00:00,Calcium,D23.119.100
21056409,2010-11-05T00:00:00,Central Nervous System Depressants,D27.505.696.277
21056409,2010-11-05T00:00:00,Central Nervous System Depressants,D27.505.954.427.210
21056409,2010-11-05T00:00:00,"Disease Models, Animal",C22.232
21056409,2010-11-05T00:00:00,"Disease Models, Animal",E05.598.500
21056409,2010-11-05T00:00:00,"Disease Models, Animal",E05.599.395.080
21056409,2010-11-05T00:00:00,Drug Interactions,G07.690.812.240
21056409,2010-11-05T00:00:00,Drug Interactions,G07.700.680.240
21056409,2010-11-05T00:00:00,Ethanol,D02.033.375
21056409,2010-11-05T00:00:00,Gene Expression Regulation,G05.355.315
21056409,2010-11-05T00:00:00,Glutamic Acid,D12.125.067.750
21056409,2010-11-05T00:00:00,Glutamic Acid,D12.125.119.450
21056409,2010-11-05T00:00:00,Glutamic Acid,D12.125.427.300
21056409,2010-11-05T00:00:00,Hippocampus,A08.186.211.464.405
21056409,2010-11-05T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
21056409,2010-11-05T00:00:00,Neuronal Plasticity,G11.561.600.635
21056409,2010-11-05T00:00:00,Neurons,A08.663
21056409,2010-11-05T00:00:00,Neurons,A11.671
21056409,2010-11-05T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
21056409,2010-11-05T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
21056409,2010-11-05T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
21056409,2010-11-05T00:00:00,Substance Withdrawal Syndrome,C21.739.835
21056409,2010-11-05T00:00:00,Substance Withdrawal Syndrome,F03.900.825
21056409,2010-11-05T00:00:00,Synapses,A08.850
21056409,2010-11-05T00:00:00,Synapses,A11.284.149.165.420.780
21056409,2010-11-05T00:00:00,Time Factors,G01.910.857
21057061,2010-11-05T00:00:00,Anticoagulants,D27.505.954.502.119
21057061,2010-11-05T00:00:00,Drug Monitoring,E01.370.520.200
21057061,2010-11-05T00:00:00,Extracorporeal Membrane Oxygenation,E02.880.301
21057061,2010-11-05T00:00:00,Extracorporeal Membrane Oxygenation,E04.292.451
21057061,2010-11-05T00:00:00,"Heparin, Low-Molecular-Weight",D09.698.373.400.300
21057061,2010-11-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21057061,2010-11-05T00:00:00,Infant,M01.060.703
21281981,2010-11-05T00:00:00,Adult,M01.060.116
21281981,2010-11-05T00:00:00,Age Factors,N05.715.350.075
21281981,2010-11-05T00:00:00,Age Factors,N06.850.490.250
21281981,2010-11-05T00:00:00,Aged,M01.060.116.100
21281981,2010-11-05T00:00:00,Alleles,G05.360.340.024.340.030
21281981,2010-11-05T00:00:00,Body Mass Index,E01.370.600.115.100.125
21281981,2010-11-05T00:00:00,Body Mass Index,E05.041.124.125
21281981,2010-11-05T00:00:00,Body Mass Index,G07.100.100.125
21281981,2010-11-05T00:00:00,Body Mass Index,N06.850.505.200.100.175
21281981,2010-11-05T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
21281981,2010-11-05T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
21281981,2010-11-05T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
21281981,2010-11-05T00:00:00,Genetic Predisposition to Disease,G05.380.355
21281981,2010-11-05T00:00:00,Hepacivirus,B04.450.410
21281981,2010-11-05T00:00:00,Hepacivirus,B04.820.250.475
21281981,2010-11-05T00:00:00,Hepacivirus,B04.909.777.310.475
21281981,2010-11-05T00:00:00,Hepatitis C,C02.440.440
21281981,2010-11-05T00:00:00,Hepatitis C,C02.782.350.350
21281981,2010-11-05T00:00:00,Hepatitis C,C06.552.380.705.440
21281981,2010-11-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21281981,2010-11-05T00:00:00,Immunoglobulin Allotypes,D12.776.124.486.485.114.606
21281981,2010-11-05T00:00:00,Immunoglobulin Allotypes,D12.776.124.790.651.114.606
21281981,2010-11-05T00:00:00,Immunoglobulin Allotypes,D12.776.377.715.548.114.606
21281981,2010-11-05T00:00:00,Immunoglobulin Allotypes,G12.500.400
21281981,2010-11-05T00:00:00,Middle Aged,M01.060.116.630
21281981,2010-11-05T00:00:00,Sex Factors,N05.715.350.675
21281981,2010-11-05T00:00:00,Sex Factors,N06.850.490.875
21057772,2010-11-06T00:00:00,Amphetamine,D02.092.471.683.152.110
21057772,2010-11-06T00:00:00,Animals,B01.050
21057772,2010-11-06T00:00:00,"Behavior, Animal",F01.145.113
21057772,2010-11-06T00:00:00,Benzazepines,D03.438.079
21057772,2010-11-06T00:00:00,Central Nervous System Stimulants,D27.505.696.282
21057772,2010-11-06T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
21057772,2010-11-06T00:00:00,Corpus Striatum,A08.186.211.730.885.287.249.487
21057772,2010-11-06T00:00:00,Drug Interactions,G07.690.812.240
21057772,2010-11-06T00:00:00,Drug Interactions,G07.700.680.240
21057772,2010-11-06T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.567.342
21057772,2010-11-06T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.646.750.249
21057772,2010-11-06T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.644.360.450.169
21057772,2010-11-06T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.776.476.450.169
21057772,2010-11-06T00:00:00,Gene Expression Regulation,G05.355.315
21057772,2010-11-06T00:00:00,Motor Activity,F01.145.632
21057772,2010-11-06T00:00:00,Motor Activity,G11.427.590.530.698
21057772,2010-11-06T00:00:00,Phosphoproteins,D12.776.744
21057772,2010-11-06T00:00:00,Phosphorylation,G02.111.087.677
21057772,2010-11-06T00:00:00,Phosphorylation,G02.149.115.677
21057772,2010-11-06T00:00:00,Phosphorylation,G02.149.465.700
21057772,2010-11-06T00:00:00,Phosphorylation,G02.607.750.700
21057772,2010-11-06T00:00:00,Phosphorylation,G03.495.790
21057772,2010-11-06T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
21057772,2010-11-06T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
21057772,2010-11-06T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.070.300.400.500
21057772,2010-11-06T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.100.150.400.500
21057772,2010-11-06T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.720.300.300.400.500
21057772,2010-11-06T00:00:00,Time Factors,G01.910.857
21057774,2010-11-06T00:00:00,Animals,B01.050
21057774,2010-11-06T00:00:00,"Behavior, Addictive",F01.145.527.100.120
21057774,2010-11-06T00:00:00,"Behavior, Animal",F01.145.113
21057774,2010-11-06T00:00:00,Central Nervous System Stimulants,D27.505.696.282
21057774,2010-11-06T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
21057774,2010-11-06T00:00:00,Cocaine,D02.145.074.722.388
21057774,2010-11-06T00:00:00,Cocaine,D03.132.889.354
21057774,2010-11-06T00:00:00,Cocaine,D03.605.869.388
21057774,2010-11-06T00:00:00,Cocaine,D04.075.080.875.099.722.388
21057774,2010-11-06T00:00:00,Cocaine-Related Disorders,C21.739.300
21057774,2010-11-06T00:00:00,Cocaine-Related Disorders,F03.900.300
21057774,2010-11-06T00:00:00,Conditioning (Psychology),F02.463.425.179
21057774,2010-11-06T00:00:00,Cues,F02.463.425.234
21057774,2010-11-06T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
21057774,2010-11-06T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
21057774,2010-11-06T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
21057774,2010-11-06T00:00:00,Self Administration,E02.319.890
21057774,2010-11-06T00:00:00,Self Administration,E02.900.890
21057774,2010-11-06T00:00:00,Time Factors,G01.910.857
21059988,2010-11-08T00:00:00,Adult,M01.060.116
21059988,2010-11-08T00:00:00,Breast Feeding,G07.610.220.500.500
21059988,2010-11-08T00:00:00,Breast Feeding,G07.610.593.185
21059988,2010-11-08T00:00:00,Breast Feeding,G07.700.620.185
21059988,2010-11-08T00:00:00,Dietary Supplements,J02.500.456
21059988,2010-11-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21059988,2010-11-08T00:00:00,Multiple Sclerosis,C10.114.375.500
21059988,2010-11-08T00:00:00,Multiple Sclerosis,C10.314.350.500
21059988,2010-11-08T00:00:00,Multiple Sclerosis,C20.111.258.250.500
21059988,2010-11-08T00:00:00,Postpartum Period,G08.686.702
21059988,2010-11-08T00:00:00,Pregnancy,G08.686.785.760.769
21059988,2010-11-08T00:00:00,Vitamin D,D04.808.812.768
21059988,2010-11-08T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
21062461,2010-11-09T00:00:00,Bacterial Adhesion,G06.099.112.100
21062461,2010-11-09T00:00:00,Bacterial Adhesion,G06.590.110.100
21062461,2010-11-09T00:00:00,Bacterial Proteins,D12.776.097
21062461,2010-11-09T00:00:00,Cell Line,A11.251.210
21062461,2010-11-09T00:00:00,Endothelial Cells,A11.436.275
21062461,2010-11-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21062461,2010-11-09T00:00:00,Meningococcal Infections,C01.252.400.625.549
21062461,2010-11-09T00:00:00,Molecular Sequence Data,L01.453.245.667
21062461,2010-11-09T00:00:00,Neisseria meningitidis,B03.440.400.425.550.550.641
21062461,2010-11-09T00:00:00,Neisseria meningitidis,B03.660.075.525.520.500
21062482,2010-11-09T00:00:00,Animals,B01.050
21062482,2010-11-09T00:00:00,Dogs,B01.050.150.900.649.147.153.200
21062482,2010-11-09T00:00:00,Gene Expression Profiling,E05.393.332
21062482,2010-11-09T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
21062482,2010-11-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21062482,2010-11-09T00:00:00,Inflammation,C23.550.470
21062482,2010-11-09T00:00:00,Mutation,G05.365.590
21062482,2010-11-09T00:00:00,"Neovascularization, Pathologic",C23.550.589.500
21062482,2010-11-09T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
21062482,2010-11-09T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
21062482,2010-11-09T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
21062482,2010-11-09T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
21062482,2010-11-09T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
21062482,2010-11-09T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
21067747,2010-11-09T00:00:00,Adult,M01.060.116
21067747,2010-11-09T00:00:00,Aged,M01.060.116.100
21067747,2010-11-09T00:00:00,"Biopsy, Fine-Needle",E01.370.388.100.100.500
21067747,2010-11-09T00:00:00,"Biopsy, Fine-Needle",E01.450.230.100.100.500
21067747,2010-11-09T00:00:00,"Biopsy, Fine-Needle",E01.450.865.100.100.500
21067747,2010-11-09T00:00:00,"Biopsy, Fine-Needle",E04.074.119.500
21067747,2010-11-09T00:00:00,Endosonography,E01.370.350.850.280
21067747,2010-11-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21067747,2010-11-09T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
21067747,2010-11-09T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
21067747,2010-11-09T00:00:00,Middle Aged,M01.060.116.630
21067747,2010-11-09T00:00:00,Neoplasm Staging,E01.370.550
21067747,2010-11-09T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
21067747,2010-11-09T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
21067747,2010-11-09T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
21067747,2010-11-09T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
21067747,2010-11-09T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
21068071,2010-11-10T00:00:00,Animals,B01.050
21068071,2010-11-10T00:00:00,Apoptosis,G04.299.139.160
21068071,2010-11-10T00:00:00,Biological Markers,D23.101
21068071,2010-11-10T00:00:00,"Calcium Channels, L-Type",D12.776.157.530.400.150.400
21068071,2010-11-10T00:00:00,"Calcium Channels, L-Type",D12.776.543.550.425.150.400
21068071,2010-11-10T00:00:00,"Calcium Channels, L-Type",D12.776.543.585.400.150.400
21068071,2010-11-10T00:00:00,Cell Death,G04.299.139
21068071,2010-11-10T00:00:00,Cell Line,A11.251.210
21068071,2010-11-10T00:00:00,Estrogens,D27.505.696.399.472.277
21068071,2010-11-10T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.567.342
21068071,2010-11-10T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.646.750.249
21068071,2010-11-10T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.644.360.450.169
21068071,2010-11-10T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.776.476.450.169
21068071,2010-11-10T00:00:00,Motor Neurons,A08.663.655.500
21068071,2010-11-10T00:00:00,Motor Neurons,A11.671.655.500
21068071,2010-11-10T00:00:00,Neuroblastoma,C04.557.465.625.600.590.650.550
21068071,2010-11-10T00:00:00,Neuroblastoma,C04.557.470.670.590.650.550
21068071,2010-11-10T00:00:00,Neuroblastoma,C04.557.580.625.600.590.650.550
21068071,2010-11-10T00:00:00,Neuroprotective Agents,D27.505.696.706.548
21068071,2010-11-10T00:00:00,Neuroprotective Agents,D27.505.954.427.575
21068071,2010-11-10T00:00:00,Phosphorylation,G02.111.087.677
21068071,2010-11-10T00:00:00,Phosphorylation,G02.149.115.677
21068071,2010-11-10T00:00:00,Phosphorylation,G02.149.465.700
21068071,2010-11-10T00:00:00,Phosphorylation,G02.607.750.700
21068071,2010-11-10T00:00:00,Phosphorylation,G03.495.790
21068071,2010-11-10T00:00:00,Pyrazoles,D03.383.129.539
21068071,2010-11-10T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
21068071,2010-11-10T00:00:00,"Receptors, Estrogen",D12.776.260.698.750.350
21068071,2010-11-10T00:00:00,"Receptors, Estrogen",D12.776.826.750.350
21068071,2010-11-10T00:00:00,"Receptors, Estrogen",D12.776.930.669.750.350
21068071,2010-11-10T00:00:00,Signal Transduction,G02.111.087.800
21068071,2010-11-10T00:00:00,Signal Transduction,G02.149.115.800
21068071,2010-11-10T00:00:00,Signal Transduction,G04.299.880
21068071,2010-11-10T00:00:00,Spinal Cord,A08.186.854
21068071,2010-11-10T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
21068071,2010-11-10T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
21068071,2010-11-10T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
21068071,2010-11-10T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
21068071,2010-11-10T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
21068071,2010-11-10T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
21068071,2010-11-10T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
21068071,2010-11-10T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
21068071,2010-11-10T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
21068071,2010-11-10T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
21068071,2010-11-10T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
21068341,2010-11-10T00:00:00,Aged,M01.060.116.100
21068341,2010-11-10T00:00:00,Biphenyl Compounds,D02.455.426.559.389.185
21068341,2010-11-10T00:00:00,Heart Failure,C14.280.434
21068341,2010-11-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21068341,2010-11-10T00:00:00,Neutrophils,A11.118.637.415.583
21068341,2010-11-10T00:00:00,Neutrophils,A11.627.340.583
21068341,2010-11-10T00:00:00,Neutrophils,A11.733.689
21068341,2010-11-10T00:00:00,Neutrophils,A15.145.229.637.415.583
21068341,2010-11-10T00:00:00,Neutrophils,A15.382.490.315.583
21068341,2010-11-10T00:00:00,Neutrophils,A15.382.680.689
21068341,2010-11-10T00:00:00,Peptide Fragments,D12.644.541
21068341,2010-11-10T00:00:00,Stroke Volume,E01.370.370.380.150.700
21068341,2010-11-10T00:00:00,Stroke Volume,G09.330.380.124.882
21068341,2010-11-10T00:00:00,Treatment Outcome,E01.789.800
21068341,2010-11-10T00:00:00,Treatment Outcome,N04.761.559.590.800
21068341,2010-11-10T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21070320,2010-11-10T00:00:00,African Americans,M01.686.508.100.100
21070320,2010-11-10T00:00:00,African Americans,M01.686.754.100
21070320,2010-11-10T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
21070320,2010-11-10T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
21070320,2010-11-10T00:00:00,Health Status,I01.240.425
21070320,2010-11-10T00:00:00,Health Status,N01.224.425
21070320,2010-11-10T00:00:00,Health Status,N06.850.505.400.425
21070320,2010-11-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21070320,2010-11-10T00:00:00,Middle Aged,M01.060.116.630
21070320,2010-11-10T00:00:00,Serum Albumin,D12.776.034.841
21070320,2010-11-10T00:00:00,Serum Albumin,D12.776.124.050.700
21070320,2010-11-10T00:00:00,Serum Albumin,D12.776.124.727
21070320,2010-11-10T00:00:00,United States,Z01.107.567.875
21085667,2010-11-10T00:00:00,Adolescent,M01.060.057
21085667,2010-11-10T00:00:00,Adult,M01.060.116
21085667,2010-11-10T00:00:00,Conditioning (Psychology),F02.463.425.179
21085667,2010-11-10T00:00:00,Cues,F02.463.425.234
21085667,2010-11-10T00:00:00,Eating,G07.610.593.260
21085667,2010-11-10T00:00:00,Eating,G07.700.620.260
21085667,2010-11-10T00:00:00,Eating,G10.261.326.240
21085667,2010-11-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21085667,2010-11-10T00:00:00,Questionnaires,E05.318.308.750
21085667,2010-11-10T00:00:00,Questionnaires,L01.280.800
21085667,2010-11-10T00:00:00,Questionnaires,N05.715.360.300.695
21085667,2010-11-10T00:00:00,Questionnaires,N06.850.520.308.750
21085667,2010-11-10T00:00:00,Smoking,F01.145.466.753
21085667,2010-11-10T00:00:00,Smoking Cessation,F01.145.940.700
21085667,2010-11-10T00:00:00,Young Adult,M01.060.116.815
20971104,2010-11-11T00:00:00,Enzyme Inhibitors,D27.505.519.389
20971104,2010-11-11T00:00:00,Microbodies,A11.284.430.214.190.500.585
20971104,2010-11-11T00:00:00,Microbodies,A11.284.430.214.190.875.190.190.755
20971104,2010-11-11T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
20971104,2010-11-11T00:00:00,"Microscopy, Fluorescence",E05.595.458
20971104,2010-11-11T00:00:00,Pilot Projects,E05.318.760.750
20971104,2010-11-11T00:00:00,Pilot Projects,E05.337.737
20971104,2010-11-11T00:00:00,Pilot Projects,N05.715.360.775.625
20971104,2010-11-11T00:00:00,Pilot Projects,N06.850.520.450.720
20971104,2010-11-11T00:00:00,Recombinant Proteins,D12.776.828
20971104,2010-11-11T00:00:00,Trypanosoma brucei brucei,B01.268.475.868.887.080
21068740,2010-11-11T00:00:00,Adolescent,M01.060.057
21068740,2010-11-11T00:00:00,African Americans,M01.686.508.100.100
21068740,2010-11-11T00:00:00,African Americans,M01.686.754.100
21068740,2010-11-11T00:00:00,Blood Pressure,E01.370.600.875.249
21068740,2010-11-11T00:00:00,Blood Pressure,G09.330.380.076
21068740,2010-11-11T00:00:00,"Blood Pressure Monitoring, Ambulatory",E01.370.370.140.100
21068740,2010-11-11T00:00:00,"Blood Pressure Monitoring, Ambulatory",E01.370.520.500.100
21068740,2010-11-11T00:00:00,European Continental Ancestry Group,M01.686.508.400
21068740,2010-11-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21068740,2010-11-11T00:00:00,"Stress, Psychological",F01.145.126.990
21068740,2010-11-11T00:00:00,"Stress, Psychological",F02.830.900
21068740,2010-11-11T00:00:00,Young Adult,M01.060.116.815
21068780,2010-11-11T00:00:00,Alveolar Bone Loss,C05.116.264.150
21068780,2010-11-11T00:00:00,Alveolar Bone Loss,C07.465.714.354.500
21068780,2010-11-11T00:00:00,Animals,B01.050
21068780,2010-11-11T00:00:00,Dual Specificity Phosphatase 1,D08.811.277.352.650.587.200
21068780,2010-11-11T00:00:00,Dual Specificity Phosphatase 1,D08.811.277.352.650.625.225.200
21068780,2010-11-11T00:00:00,Dual Specificity Phosphatase 1,D08.811.277.352.650.775.250.200
21068780,2010-11-11T00:00:00,Dual Specificity Phosphatase 1,D12.644.360.268.200
21068780,2010-11-11T00:00:00,Dual Specificity Phosphatase 1,D12.644.360.445.100
21068780,2010-11-11T00:00:00,Dual Specificity Phosphatase 1,D12.776.476.268.200
21068780,2010-11-11T00:00:00,Dual Specificity Phosphatase 1,D12.776.476.445.200
21068780,2010-11-11T00:00:00,Gene Transfer Techniques,E05.393.350
21068780,2010-11-11T00:00:00,"Immunity, Innate",G12.450.575
21068780,2010-11-11T00:00:00,Inflammation,C23.550.470
21068780,2010-11-11T00:00:00,Osteoclasts,A11.329.372.700
21068780,2010-11-11T00:00:00,Osteoclasts,A11.627.482.700
21068780,2010-11-11T00:00:00,Phosphorylation,G02.111.087.677
21068780,2010-11-11T00:00:00,Phosphorylation,G02.149.115.677
21068780,2010-11-11T00:00:00,Phosphorylation,G02.149.465.700
21068780,2010-11-11T00:00:00,Phosphorylation,G02.607.750.700
21068780,2010-11-11T00:00:00,Phosphorylation,G03.495.790
21068780,2010-11-11T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
21075043,2010-11-11T00:00:00,Animals,B01.050
21075043,2010-11-11T00:00:00,Antineoplastic Agents,D27.505.954.248
21075043,2010-11-11T00:00:00,Drug Discovery,E05.295
21075043,2010-11-11T00:00:00,Drug Discovery,H01.158.703.007.675
21075043,2010-11-11T00:00:00,Drug Discovery,H01.181.466.675
21075043,2010-11-11T00:00:00,Glutathione,D12.644.456.448
21075043,2010-11-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21075043,2010-11-11T00:00:00,Neoplasms,C04
21131170,2010-11-11T00:00:00,Adult,M01.060.116
21131170,2010-11-11T00:00:00,Combat Disorders,F03.080.931.249
21131170,2010-11-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21131170,2010-11-11T00:00:00,Implosive Therapy,F04.754.137.506.325
21131170,2010-11-11T00:00:00,Psychiatric Status Rating Scales,F04.586
21131170,2010-11-11T00:00:00,Regression Analysis,E05.318.740.750
21131170,2010-11-11T00:00:00,Regression Analysis,N05.715.360.750.695
21131170,2010-11-11T00:00:00,Regression Analysis,N06.850.520.830.750
21131170,2010-11-11T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
21131170,2010-11-11T00:00:00,Treatment Outcome,E01.789.800
21131170,2010-11-11T00:00:00,Treatment Outcome,N04.761.559.590.800
21131170,2010-11-11T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21131170,2010-11-11T00:00:00,Veterans,M01.930
21073182,2010-11-12T00:00:00,Adsorption,G02.149.047
21073182,2010-11-12T00:00:00,Adsorption,G02.149.767.029
21073182,2010-11-12T00:00:00,Adsorption,G02.842.750.029
21073182,2010-11-12T00:00:00,Amino Acid Sequence,G02.111.570.060
21073182,2010-11-12T00:00:00,Amino Acid Sequence,L01.453.245.667.060
21073182,2010-11-12T00:00:00,Peptides,D12.644
21073182,2010-11-12T00:00:00,Surface Plasmon Resonance,E05.196.890
21073182,2010-11-12T00:00:00,Surface Plasmon Resonance,E05.601.123.700
21074198,2010-11-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21074198,2010-11-12T00:00:00,Prostatectomy,E04.950.774.860.625
21074198,2010-11-12T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
21074198,2010-11-12T00:00:00,Prostatic Neoplasms,C12.294.260.750
21074198,2010-11-12T00:00:00,Prostatic Neoplasms,C12.294.565.625
21074198,2010-11-12T00:00:00,Prostatic Neoplasms,C12.758.409.750
21074198,2010-11-12T00:00:00,"Surgical Procedures, Minimally Invasive",E04.800
21074198,2010-11-12T00:00:00,Treatment Outcome,E01.789.800
21074198,2010-11-12T00:00:00,Treatment Outcome,N04.761.559.590.800
21074198,2010-11-12T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21075062,2010-11-12T00:00:00,Adolescent,M01.060.057
21075062,2010-11-12T00:00:00,Adult,M01.060.116
21075062,2010-11-12T00:00:00,Aged,M01.060.116.100
21075062,2010-11-12T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
21075062,2010-11-12T00:00:00,Child,M01.060.406
21075062,2010-11-12T00:00:00,Cough,C08.618.248
21075062,2010-11-12T00:00:00,Cough,C23.888.852.293
21075062,2010-11-12T00:00:00,Cystic Fibrosis,C06.689.202
21075062,2010-11-12T00:00:00,Cystic Fibrosis,C08.381.187
21075062,2010-11-12T00:00:00,Cystic Fibrosis,C16.320.190
21075062,2010-11-12T00:00:00,Cystic Fibrosis,C16.614.213
21075062,2010-11-12T00:00:00,Drug Delivery Systems,E02.319.300
21075062,2010-11-12T00:00:00,Drug Monitoring,E01.370.520.200
21075062,2010-11-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21075062,2010-11-12T00:00:00,Middle Aged,M01.060.116.630
21075062,2010-11-12T00:00:00,Powders,D26.255.779
21075062,2010-11-12T00:00:00,Powders,D27.720.280.779
21075062,2010-11-12T00:00:00,Pseudomonas Infections,C01.252.400.739
21075062,2010-11-12T00:00:00,Pseudomonas aeruginosa,B03.440.400.425.625.625.100
21075062,2010-11-12T00:00:00,Pseudomonas aeruginosa,B03.660.250.580.590.050
21075062,2010-11-12T00:00:00,Treatment Outcome,E01.789.800
21075062,2010-11-12T00:00:00,Treatment Outcome,N04.761.559.590.800
21075062,2010-11-12T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21076089,2010-11-12T00:00:00,Adult,M01.060.116
21076089,2010-11-12T00:00:00,Aged,M01.060.116.100
21076089,2010-11-12T00:00:00,Breast Neoplasms,C04.588.180
21076089,2010-11-12T00:00:00,Breast Neoplasms,C17.800.090.500
21076089,2010-11-12T00:00:00,Fluorodeoxyglucose F18,D09.254.229.500
21076089,2010-11-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21076089,2010-11-12T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
21076089,2010-11-12T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
21076089,2010-11-12T00:00:00,Middle Aged,M01.060.116.630
21076089,2010-11-12T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
21076089,2010-11-12T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
21076089,2010-11-12T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
21076089,2010-11-12T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
21076089,2010-11-12T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
21076089,2010-11-12T00:00:00,Radiopharmaceuticals,D27.720.470.410.650
21076204,2010-11-12T00:00:00,Animals,B01.050
21076204,2010-11-12T00:00:00,Cattle,B01.050.150.900.649.077.380.271
21076204,2010-11-12T00:00:00,Cell Movement,G04.299.283
21076204,2010-11-12T00:00:00,Cell Movement,G07.700.560.500.180
21076204,2010-11-12T00:00:00,"Endothelium, Vascular",A07.231.330
21076204,2010-11-12T00:00:00,"Endothelium, Vascular",A10.272.491.355
21076204,2010-11-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21131171,2010-11-12T00:00:00,Adolescent,M01.060.057
21131171,2010-11-12T00:00:00,Child,M01.060.406
21131171,2010-11-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21131171,2010-11-12T00:00:00,Interviews as Topic,E05.318.308.420
21131171,2010-11-12T00:00:00,Interviews as Topic,L01.280.520
21131171,2010-11-12T00:00:00,Interviews as Topic,N05.715.360.300.400
21131171,2010-11-12T00:00:00,Interviews as Topic,N06.850.520.308.420
21131171,2010-11-12T00:00:00,Life Change Events,F01.829.458.410
21131171,2010-11-12T00:00:00,"Models, Psychological",E05.599.695
21131171,2010-11-12T00:00:00,Psychiatric Status Rating Scales,F04.586
21131171,2010-11-12T00:00:00,Questionnaires,E05.318.308.750
21131171,2010-11-12T00:00:00,Questionnaires,L01.280.800
21131171,2010-11-12T00:00:00,Questionnaires,N05.715.360.300.695
21131171,2010-11-12T00:00:00,Questionnaires,N06.850.520.308.750
21131171,2010-11-12T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
21131171,2010-11-12T00:00:00,United States,Z01.107.567.875
21075457,2010-11-13T00:00:00,Calpain,D08.811.277.656.262.500.120
21075457,2010-11-13T00:00:00,Calpain,D08.811.277.656.300.200.120
21075457,2010-11-13T00:00:00,Cytokines,D12.644.276.374
21075457,2010-11-13T00:00:00,Cytokines,D12.776.467.374
21075457,2010-11-13T00:00:00,Cytokines,D23.529.374
21075457,2010-11-13T00:00:00,Gene Expression,G05.355.310
21075457,2010-11-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21075457,2010-11-13T00:00:00,"Leukocytes, Mononuclear",A11.118.637.555
21075457,2010-11-13T00:00:00,"Leukocytes, Mononuclear",A15.145.229.637.555
21075457,2010-11-13T00:00:00,"Leukocytes, Mononuclear",A15.382.490.555
21075457,2010-11-13T00:00:00,Middle Aged,M01.060.116.630
21075457,2010-11-13T00:00:00,Multiple Sclerosis,C10.114.375.500
21075457,2010-11-13T00:00:00,Multiple Sclerosis,C10.314.350.500
21075457,2010-11-13T00:00:00,Multiple Sclerosis,C20.111.258.250.500
21078415,2010-11-13T00:00:00,Algorithms,G17.035
21078415,2010-11-13T00:00:00,Algorithms,L01.224.050
21078415,2010-11-13T00:00:00,Bias (Epidemiology),N05.715.350.150
21078415,2010-11-13T00:00:00,Bias (Epidemiology),N06.850.490.500
21078415,2010-11-13T00:00:00,"Data Interpretation, Statistical",E05.245.380
21078415,2010-11-13T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
21078415,2010-11-13T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
21078415,2010-11-13T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
21078415,2010-11-13T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
21078415,2010-11-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21078415,2010-11-13T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
21078415,2010-11-13T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
21078415,2010-11-13T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
21078415,2010-11-13T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
21078415,2010-11-13T00:00:00,Stroke,C10.228.140.300.775
21078415,2010-11-13T00:00:00,Stroke,C14.907.253.855
21078415,2010-11-13T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
21078415,2010-11-13T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
21078415,2010-11-13T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
21078415,2010-11-13T00:00:00,Tissue Plasminogen Activator,D23.119.970
21078415,2010-11-13T00:00:00,Treatment Outcome,E01.789.800
21078415,2010-11-13T00:00:00,Treatment Outcome,N04.761.559.590.800
21078415,2010-11-13T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21255735,2010-11-13T00:00:00,Adult,M01.060.116
21255735,2010-11-13T00:00:00,Aged,M01.060.116.100
21255735,2010-11-13T00:00:00,Body Mass Index,E01.370.600.115.100.125
21255735,2010-11-13T00:00:00,Body Mass Index,E05.041.124.125
21255735,2010-11-13T00:00:00,Body Mass Index,G07.100.100.125
21255735,2010-11-13T00:00:00,Body Mass Index,N06.850.505.200.100.175
21255735,2010-11-13T00:00:00,Bulimia,C23.888.821.645.500
21255735,2010-11-13T00:00:00,Feeding Behavior,F01.145.113.547
21255735,2010-11-13T00:00:00,Feeding Behavior,F01.145.407
21255735,2010-11-13T00:00:00,Gastric Bypass,E02.065.062.249
21255735,2010-11-13T00:00:00,Gastric Bypass,E04.035.398.385
21255735,2010-11-13T00:00:00,Gastric Bypass,E04.062.249
21255735,2010-11-13T00:00:00,Gastric Bypass,E04.210.457.430
21255735,2010-11-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21255735,2010-11-13T00:00:00,Middle Aged,M01.060.116.630
21255735,2010-11-13T00:00:00,Time Factors,G01.910.857
21255735,2010-11-13T00:00:00,Treatment Outcome,E01.789.800
21255735,2010-11-13T00:00:00,Treatment Outcome,N04.761.559.590.800
21255735,2010-11-13T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21255735,2010-11-13T00:00:00,Weight Loss,C23.888.144.243.963
21255735,2010-11-13T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
21255735,2010-11-13T00:00:00,Young Adult,M01.060.116.815
20810133,2010-11-15T00:00:00,Ethnic Groups,M01.686.754
20810133,2010-11-15T00:00:00,Ethnic Groups,N01.224.317
20810133,2010-11-15T00:00:00,Folic Acid,D03.438.733.631.400
20810133,2010-11-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20810133,2010-11-15T00:00:00,Hypercholesterolemia,C18.452.584.500.500.396
20810133,2010-11-15T00:00:00,Middle Aged,M01.060.116.630
20810133,2010-11-15T00:00:00,Risk Factors,E05.318.740.600.800.725
20810133,2010-11-15T00:00:00,Risk Factors,N05.715.350.200.700
20810133,2010-11-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
20810133,2010-11-15T00:00:00,Risk Factors,N06.850.490.625.750
20810133,2010-11-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
20810133,2010-11-15T00:00:00,Smoking,F01.145.466.753
20810133,2010-11-15T00:00:00,Stroke,C10.228.140.300.775
20810133,2010-11-15T00:00:00,Stroke,C14.907.253.855
20810133,2010-11-15T00:00:00,Treatment Outcome,E01.789.800
20810133,2010-11-15T00:00:00,Treatment Outcome,N04.761.559.590.800
20810133,2010-11-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21078782,2010-11-15T00:00:00,Adult,M01.060.116
21078782,2010-11-15T00:00:00,Child,M01.060.406
21078782,2010-11-15T00:00:00,Documentation,L01.453.245
21078782,2010-11-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21078782,2010-11-15T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
21078782,2010-11-15T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
21078782,2010-11-15T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
21078782,2010-11-15T00:00:00,Infant,M01.060.703
21078782,2010-11-15T00:00:00,Liver,A03.620
21078782,2010-11-15T00:00:00,Pregnancy,G08.686.785.760.769
21078782,2010-11-15T00:00:00,Research Design,E05.581.500
21078782,2010-11-15T00:00:00,Research Design,H01.770.644.728
21078782,2010-11-15T00:00:00,Societies,N03.540.828
21098426,2010-11-15T00:00:00,Aged,M01.060.116.100
21098426,2010-11-15T00:00:00,Algorithms,G17.035
21098426,2010-11-15T00:00:00,Algorithms,L01.224.050
21098426,2010-11-15T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
21098426,2010-11-15T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
21098426,2010-11-15T00:00:00,"Defibrillators, Implantable",E07.695.175
21098426,2010-11-15T00:00:00,Echocardiography,E01.370.350.850.220
21098426,2010-11-15T00:00:00,Echocardiography,E01.370.370.380.220
21098426,2010-11-15T00:00:00,Heart Failure,C14.280.434
21098426,2010-11-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21098426,2010-11-15T00:00:00,Middle Aged,M01.060.116.630
21098426,2010-11-15T00:00:00,Quality of Life,I01.800
21098426,2010-11-15T00:00:00,Quality of Life,K01.752.400.750
21098426,2010-11-15T00:00:00,Stroke Volume,E01.370.370.380.150.700
21098426,2010-11-15T00:00:00,Stroke Volume,G09.330.380.124.882
21098426,2010-11-15T00:00:00,Treatment Outcome,E01.789.800
21098426,2010-11-15T00:00:00,Treatment Outcome,N04.761.559.590.800
21098426,2010-11-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21098426,2010-11-15T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
21098426,2010-11-15T00:00:00,Walking,G11.427.590.530.568.900
21098426,2010-11-15T00:00:00,Walking,G11.427.590.530.698.940
21098426,2010-11-15T00:00:00,Walking,I03.450.642.845.940
21080052,2010-11-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21080052,2010-11-16T00:00:00,Incidence,E05.318.308.985.525.375
21080052,2010-11-16T00:00:00,Incidence,L01.280.975.525.375
21080052,2010-11-16T00:00:00,Incidence,N01.224.935.597.500
21080052,2010-11-16T00:00:00,Incidence,N06.850.505.400.975.525.375
21080052,2010-11-16T00:00:00,Incidence,N06.850.520.308.985.525.375
21080052,2010-11-16T00:00:00,Neoplasms,C04
21080052,2010-11-16T00:00:00,South Carolina,Z01.107.567.875.075.662
21080052,2010-11-16T00:00:00,South Carolina,Z01.107.567.875.750.700
21080052,2010-11-16T00:00:00,Uranium,D01.268.033.950
21080052,2010-11-16T00:00:00,Uranium,D01.268.271.100.950
21080052,2010-11-16T00:00:00,Uranium,D01.268.556.900
21080052,2010-11-16T00:00:00,Uranium,D01.552.020.940
21080052,2010-11-16T00:00:00,Uranium,D01.552.544.900
21080052,2010-11-16T00:00:00,"Water Pollutants, Radioactive",D20.693.903
21080052,2010-11-16T00:00:00,"Water Pollutants, Radioactive",D27.888.284.903.821
21081756,2010-11-16T00:00:00,Apoptosis,G04.299.139.160
21081756,2010-11-16T00:00:00,Caspases,D08.811.277.656.262.500.126
21081756,2010-11-16T00:00:00,Caspases,D08.811.277.656.300.200.126
21081756,2010-11-16T00:00:00,Caspases,D12.644.360.075.405
21081756,2010-11-16T00:00:00,Caspases,D12.776.476.075.405
21081756,2010-11-16T00:00:00,Ceramides,D02.065.313
21081756,2010-11-16T00:00:00,Ceramides,D09.400.410.420.525.200
21081756,2010-11-16T00:00:00,Ceramides,D10.390.470.675.200
21081756,2010-11-16T00:00:00,Ceramides,D10.570.877.360.612.200
21081756,2010-11-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21081756,2010-11-16T00:00:00,Mitochondria,A11.284.430.214.190.875.564
21081756,2010-11-16T00:00:00,Mitochondria,A11.284.835.626
21081756,2010-11-16T00:00:00,Pyridinium Compounds,D03.383.725.762
21081756,2010-11-16T00:00:00,bcl-2-Associated X Protein,D12.644.360.075.718.400
21081756,2010-11-16T00:00:00,bcl-2-Associated X Protein,D12.776.476.075.718.400
21084274,2010-11-16T00:00:00,Biomimetic Materials,J01.637.087
21084274,2010-11-16T00:00:00,Biphenyl Compounds,D02.455.426.559.389.185
21084274,2010-11-16T00:00:00,Cell Aging,G04.299.119
21084274,2010-11-16T00:00:00,Cell Cycle,G04.299.134
21084274,2010-11-16T00:00:00,Cyclin-Dependent Kinase Inhibitor p21,D12.644.360.225.500
21084274,2010-11-16T00:00:00,Cyclin-Dependent Kinase Inhibitor p21,D12.776.167.187.500
21084274,2010-11-16T00:00:00,Cyclin-Dependent Kinase Inhibitor p21,D12.776.476.225.500
21084274,2010-11-16T00:00:00,Cyclin-Dependent Kinase Inhibitor p21,D12.776.624.776.355.500
21084274,2010-11-16T00:00:00,DNA Damage,C21.111
21084274,2010-11-16T00:00:00,DNA Damage,G05.355.180
21084274,2010-11-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21084274,2010-11-16T00:00:00,Interleukin-6,D12.644.276.374.465.506
21084274,2010-11-16T00:00:00,Interleukin-6,D12.776.467.374.465.506
21084274,2010-11-16T00:00:00,Interleukin-6,D23.529.374.465.506
21084274,2010-11-16T00:00:00,Neoplasms,C04
21084274,2010-11-16T00:00:00,Peptide Fragments,D12.644.541
21084274,2010-11-16T00:00:00,Piperazines,D03.383.606
21084274,2010-11-16T00:00:00,Proto-Oncogene Proteins,D12.776.624.664.700
21084274,2010-11-16T00:00:00,Tumor Suppressor Protein p53,D12.776.260.820
21084274,2010-11-16T00:00:00,Tumor Suppressor Protein p53,D12.776.624.776.775
21084274,2010-11-16T00:00:00,Tumor Suppressor Protein p53,D12.776.660.825
21084274,2010-11-16T00:00:00,Tumor Suppressor Protein p53,D12.776.744.845
21084436,2010-11-17T00:00:00,Adenocarcinoma,C04.557.470.200.025
21084436,2010-11-17T00:00:00,Aged,M01.060.116.100
21084436,2010-11-17T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
21084436,2010-11-17T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
21084436,2010-11-17T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
21084436,2010-11-17T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
21084436,2010-11-17T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
21084436,2010-11-17T00:00:00,Cisplatin,D01.210.375
21084436,2010-11-17T00:00:00,Cisplatin,D01.625.125
21084436,2010-11-17T00:00:00,Cisplatin,D01.710.100
21084436,2010-11-17T00:00:00,Combined Modality Therapy,E02.186
21084436,2010-11-17T00:00:00,Esophageal Neoplasms,C04.588.274.476.205
21084436,2010-11-17T00:00:00,Esophageal Neoplasms,C04.588.443.353
21084436,2010-11-17T00:00:00,Esophageal Neoplasms,C06.301.371.205
21084436,2010-11-17T00:00:00,Esophageal Neoplasms,C06.405.117.430
21084436,2010-11-17T00:00:00,Esophageal Neoplasms,C06.405.249.205
21084436,2010-11-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21084436,2010-11-17T00:00:00,Middle Aged,M01.060.116.630
21084436,2010-11-17T00:00:00,Neoplasm Staging,E01.370.550
21084436,2010-11-17T00:00:00,Treatment Outcome,E01.789.800
21084436,2010-11-17T00:00:00,Treatment Outcome,N04.761.559.590.800
21084436,2010-11-17T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21093163,2010-11-17T00:00:00,Busulfan,D02.033.455.125.125
21093163,2010-11-17T00:00:00,Busulfan,D02.455.326.146.100.050.500.100
21093163,2010-11-17T00:00:00,Busulfan,D02.886.645.600.055.050.510.100
21093163,2010-11-17T00:00:00,Cell Aging,G04.299.119
21093163,2010-11-17T00:00:00,Cell Line,A11.251.210
21093163,2010-11-17T00:00:00,DNA Damage,C21.111
21093163,2010-11-17T00:00:00,DNA Damage,G05.355.180
21093163,2010-11-17T00:00:00,Down-Regulation,G02.111.087.225
21093163,2010-11-17T00:00:00,Down-Regulation,G02.149.115.225
21093163,2010-11-17T00:00:00,Down-Regulation,G05.355.315.200
21093163,2010-11-17T00:00:00,Down-Regulation,G07.690.812.230
21093163,2010-11-17T00:00:00,Down-Regulation,G07.700.680.230
21093163,2010-11-17T00:00:00,Fibroblasts,A11.329.228
21093163,2010-11-17T00:00:00,Fibroblasts,A11.872.228
21093163,2010-11-17T00:00:00,Gene Silencing,G05.355.315.203.374
21093163,2010-11-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21093163,2010-11-17T00:00:00,MicroRNAs,D13.150.650.319
21093163,2010-11-17T00:00:00,MicroRNAs,D13.444.735.150.319
21093163,2010-11-17T00:00:00,MicroRNAs,D13.444.735.790.099
21093163,2010-11-17T00:00:00,Microarray Analysis,E05.196.630.570
21093163,2010-11-17T00:00:00,Microarray Analysis,E05.588.570
21093163,2010-11-17T00:00:00,Neoplasms,C04
21156319,2010-11-17T00:00:00,Adolescent,M01.060.057
21156319,2010-11-17T00:00:00,Adult,M01.060.116
21156319,2010-11-17T00:00:00,Antigen-Antibody Complex,D12.776.124.486.485.114.257
21156319,2010-11-17T00:00:00,Antigen-Antibody Complex,D12.776.124.790.651.114.257
21156319,2010-11-17T00:00:00,Antigen-Antibody Complex,D12.776.377.715.548.114.257
21156319,2010-11-17T00:00:00,Antigen-Antibody Complex,D23.050.101
21156319,2010-11-17T00:00:00,Calcinosis,C18.452.174.130
21156319,2010-11-17T00:00:00,Coronary Angiography,E01.370.350.700.060.200
21156319,2010-11-17T00:00:00,Coronary Angiography,E01.370.370.050.200
21156319,2010-11-17T00:00:00,Coronary Angiography,E01.370.370.380.200
21156319,2010-11-17T00:00:00,Coronary Artery Disease,C14.280.647.250.260
21156319,2010-11-17T00:00:00,Coronary Artery Disease,C14.907.137.126.339
21156319,2010-11-17T00:00:00,Coronary Artery Disease,C14.907.585.250.260
21156319,2010-11-17T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
21156319,2010-11-17T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
21156319,2010-11-17T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
21156319,2010-11-17T00:00:00,Diabetic Angiopathies,C14.907.320
21156319,2010-11-17T00:00:00,Diabetic Angiopathies,C19.246.099.500
21156319,2010-11-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21156319,2010-11-17T00:00:00,Hypoglycemic Agents,D27.505.696.422
21156319,2010-11-17T00:00:00,"Immunity, Humoral",G12.450.050.420
21156319,2010-11-17T00:00:00,Insulin,D06.472.699.587.740.625
21156319,2010-11-17T00:00:00,Insulin,D12.644.548.586.740.625
21156319,2010-11-17T00:00:00,"Lipoproteins, LDL",D10.532.515
21156319,2010-11-17T00:00:00,"Lipoproteins, LDL",D12.776.521.550
21156319,2010-11-17T00:00:00,Regression Analysis,E05.318.740.750
21156319,2010-11-17T00:00:00,Regression Analysis,N05.715.360.750.695
21156319,2010-11-17T00:00:00,Regression Analysis,N06.850.520.830.750
21156319,2010-11-17T00:00:00,Risk Assessment,E05.318.740.600.800.715
21156319,2010-11-17T00:00:00,Risk Assessment,N04.452.871.715
21156319,2010-11-17T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
21156319,2010-11-17T00:00:00,Risk Assessment,N06.850.505.715
21156319,2010-11-17T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
21156319,2010-11-17T00:00:00,Risk Factors,E05.318.740.600.800.725
21156319,2010-11-17T00:00:00,Risk Factors,N05.715.350.200.700
21156319,2010-11-17T00:00:00,Risk Factors,N05.715.360.750.625.700.700
21156319,2010-11-17T00:00:00,Risk Factors,N06.850.490.625.750
21156319,2010-11-17T00:00:00,Risk Factors,N06.850.520.830.600.800.725
21156319,2010-11-17T00:00:00,Time Factors,G01.910.857
21156319,2010-11-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
21156319,2010-11-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
21156319,2010-11-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
21156319,2010-11-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
21156319,2010-11-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
21156319,2010-11-17T00:00:00,United States,Z01.107.567.875
21156319,2010-11-17T00:00:00,Young Adult,M01.060.116.815
21083406,2010-11-18T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
21083406,2010-11-18T00:00:00,Genetic Predisposition to Disease,G05.380.355
21083406,2010-11-18T00:00:00,Genome-Wide Association Study,E05.318.416.249
21083406,2010-11-18T00:00:00,Genome-Wide Association Study,E05.318.780.392
21083406,2010-11-18T00:00:00,Genome-Wide Association Study,E05.393.385.500
21083406,2010-11-18T00:00:00,Genome-Wide Association Study,E05.393.522.500
21083406,2010-11-18T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
21083406,2010-11-18T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
21083406,2010-11-18T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
21083406,2010-11-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21083406,2010-11-18T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.606.586
21083406,2010-11-18T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.619.393.522.400
21083406,2010-11-18T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.705.500.380.500
21083406,2010-11-18T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.606.586
21083406,2010-11-18T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.619.393.522.400
21083406,2010-11-18T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.705.500.380.500
21083406,2010-11-18T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.606.586
21083406,2010-11-18T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.619.393.522.400
21083406,2010-11-18T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.705.500.380.500
21083406,2010-11-18T00:00:00,Immunoglobulin Gm Allotypes,G12.500.400.586
21083406,2010-11-18T00:00:00,Lung Neoplasms,C04.588.894.797.520
21083406,2010-11-18T00:00:00,Lung Neoplasms,C08.381.540
21083406,2010-11-18T00:00:00,Lung Neoplasms,C08.785.520
21083406,2010-11-18T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
21087390,2010-11-18T00:00:00,Aged,M01.060.116.100
21087390,2010-11-18T00:00:00,Blood Transfusion,E02.095.135
21087390,2010-11-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21087390,2010-11-18T00:00:00,Intraoperative Complications,C23.550.505
21087390,2010-11-18T00:00:00,Length of Stay,E02.760.400.480
21087390,2010-11-18T00:00:00,Length of Stay,N02.421.585.400.480
21087390,2010-11-18T00:00:00,Middle Aged,M01.060.116.630
21087390,2010-11-18T00:00:00,Postoperative Complications,C23.550.767
21087390,2010-11-18T00:00:00,Prostatectomy,E04.950.774.860.625
21087390,2010-11-18T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
21087390,2010-11-18T00:00:00,Prostatic Neoplasms,C12.294.260.750
21087390,2010-11-18T00:00:00,Prostatic Neoplasms,C12.294.565.625
21087390,2010-11-18T00:00:00,Prostatic Neoplasms,C12.758.409.750
21087390,2010-11-18T00:00:00,Reoperation,E04.690
21087390,2010-11-18T00:00:00,Robotics,H01.671.293.643
21087390,2010-11-18T00:00:00,Robotics,J01.897.104.834
21087390,2010-11-18T00:00:00,Robotics,L01.224.065.630
21087390,2010-11-18T00:00:00,Treatment Outcome,E01.789.800
21087390,2010-11-18T00:00:00,Treatment Outcome,N04.761.559.590.800
21087390,2010-11-18T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21087390,2010-11-18T00:00:00,United States,Z01.107.567.875
21087412,2010-11-18T00:00:00,Graft Rejection,G12.425.901.545.328
21087412,2010-11-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21087412,2010-11-18T00:00:00,Kidney Transplantation,E02.870.500
21087412,2010-11-18T00:00:00,Kidney Transplantation,E04.936.450.485
21087412,2010-11-18T00:00:00,Kidney Transplantation,E04.950.774.400
21087412,2010-11-18T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
21087412,2010-11-18T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
21087412,2010-11-18T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
21087412,2010-11-18T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
21087412,2010-11-18T00:00:00,Research Design,E05.581.500
21087412,2010-11-18T00:00:00,Research Design,H01.770.644.728
21087477,2010-11-18T00:00:00,Gene Expression,G05.355.310
21087477,2010-11-18T00:00:00,Gene Expression Regulation,G05.355.315
21087477,2010-11-18T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
21087477,2010-11-18T00:00:00,Genetic Predisposition to Disease,G05.380.355
21087477,2010-11-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21087477,2010-11-18T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
21087477,2010-11-18T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
21087477,2010-11-18T00:00:00,Lupus Nephritis,C12.777.419.570.363.680
21087477,2010-11-18T00:00:00,Lupus Nephritis,C13.351.968.419.570.363.680
21087477,2010-11-18T00:00:00,Lupus Nephritis,C17.300.480.680
21087477,2010-11-18T00:00:00,Lupus Nephritis,C20.111.590.560
21087477,2010-11-18T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
21087477,2010-11-18T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
21087477,2010-11-18T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
21087477,2010-11-18T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.260.665.400
21087477,2010-11-18T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.624.664.700.175.400
21087477,2010-11-18T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.930.635.400
21087929,2010-11-18T00:00:00,DNA Helicases,D08.811.277.040.025.159
21087929,2010-11-18T00:00:00,DNA Helicases,D08.811.399.340
21087929,2010-11-18T00:00:00,"DNA, Fungal",D13.444.308.300
21087929,2010-11-18T00:00:00,DNA-Binding Proteins,D12.776.260
21087929,2010-11-18T00:00:00,Retroelements,D13.444.308.760
21087929,2010-11-18T00:00:00,Retroelements,G02.111.570.080.708.330.800
21087929,2010-11-18T00:00:00,Retroelements,G05.360.080.708.330.800
21087929,2010-11-18T00:00:00,Retroelements,G05.360.340.024.425.800
21087929,2010-11-18T00:00:00,Saccharomyces cerevisiae,B01.300.107.795.785.800
21087929,2010-11-18T00:00:00,Saccharomyces cerevisiae,B01.300.930.705.655
21087929,2010-11-18T00:00:00,Saccharomyces cerevisiae Proteins,D12.776.354.750
21262501,2010-11-18T00:00:00,Antihypertensive Agents,D27.505.954.411.162
21262501,2010-11-18T00:00:00,Cardiovascular Diseases,C14
21262501,2010-11-18T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
21262501,2010-11-18T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
21262501,2010-11-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21262501,2010-11-18T00:00:00,Hypertension,C14.907.489
21262501,2010-11-18T00:00:00,"Lipoproteins, HDL",D10.532.432
21262501,2010-11-18T00:00:00,"Lipoproteins, HDL",D12.776.521.479
21262501,2010-11-18T00:00:00,"Lipoproteins, LDL",D10.532.515
21262501,2010-11-18T00:00:00,"Lipoproteins, LDL",D12.776.521.550
21262501,2010-11-18T00:00:00,Obesity,C18.654.726.500
21262501,2010-11-18T00:00:00,Obesity,C23.888.144.699.500
21262501,2010-11-18T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
21262501,2010-11-18T00:00:00,Obesity,G07.100.100.160.120.699.500
21344449,2010-11-18T00:00:00,Adult,M01.060.116
21344449,2010-11-18T00:00:00,Autoantigens,D23.050.422
21344449,2010-11-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21344449,2010-11-18T00:00:00,Insulin-Like Growth Factor I,D12.644.276.937.400
21344449,2010-11-18T00:00:00,Insulin-Like Growth Factor I,D12.776.124.862.400
21344449,2010-11-18T00:00:00,Insulin-Like Growth Factor I,D12.776.467.937.400
21344449,2010-11-18T00:00:00,Insulin-Like Growth Factor I,D23.529.937.400
21344449,2010-11-18T00:00:00,Middle Aged,M01.060.116.630
21344449,2010-11-18T00:00:00,Paranasal Sinuses,A04.531.621
21344449,2010-11-18T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
21344449,2010-11-18T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
21344449,2010-11-18T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
21344449,2010-11-18T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
21344449,2010-11-18T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
21094955,2010-11-20T00:00:00,Age Factors,N05.715.350.075
21094955,2010-11-20T00:00:00,Age Factors,N06.850.490.250
21094955,2010-11-20T00:00:00,Aged,M01.060.116.100
21094955,2010-11-20T00:00:00,Cardiovascular Diseases,C14
21094955,2010-11-20T00:00:00,Chronic Disease,C23.550.291.500
21094955,2010-11-20T00:00:00,Dementia,C10.228.140.380
21094955,2010-11-20T00:00:00,Dementia,F03.087.400
21094955,2010-11-20T00:00:00,Diabetes Mellitus,C18.452.394.750
21094955,2010-11-20T00:00:00,Diabetes Mellitus,C19.246
21094955,2010-11-20T00:00:00,Hospital Mortality,E05.318.308.985.550.400
21094955,2010-11-20T00:00:00,Hospital Mortality,L01.280.975.550.400
21094955,2010-11-20T00:00:00,Hospital Mortality,N01.224.935.698.400
21094955,2010-11-20T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
21094955,2010-11-20T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
21094955,2010-11-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21094955,2010-11-20T00:00:00,Inpatients,M01.643.470
21094955,2010-11-20T00:00:00,Kidney Diseases,C12.777.419
21094955,2010-11-20T00:00:00,Kidney Diseases,C13.351.968.419
21094955,2010-11-20T00:00:00,Liver Diseases,C06.552
21094955,2010-11-20T00:00:00,Lung Diseases,C08.381
21094955,2010-11-20T00:00:00,Middle Aged,M01.060.116.630
21094955,2010-11-20T00:00:00,Neoplasms,C04
21094955,2010-11-20T00:00:00,Sex Factors,N05.715.350.675
21094955,2010-11-20T00:00:00,Sex Factors,N06.850.490.875
21094955,2010-11-20T00:00:00,Stroke,C10.228.140.300.775
21094955,2010-11-20T00:00:00,Stroke,C14.907.253.855
21094955,2010-11-20T00:00:00,Subarachnoid Hemorrhage,C10.228.140.300.535.800
21094955,2010-11-20T00:00:00,Subarachnoid Hemorrhage,C14.907.253.573.800
21094955,2010-11-20T00:00:00,Subarachnoid Hemorrhage,C23.550.414.913.850
21094955,2010-11-20T00:00:00,United States,Z01.107.567.875
21090714,2010-11-22T00:00:00,Helium,D01.268.613.350
21090714,2010-11-22T00:00:00,Helium,D01.362.641.352
21090714,2010-11-22T00:00:00,Nanoparticles,J01.637.512.600
21090714,2010-11-22T00:00:00,Nitrogen,D01.268.604
21090714,2010-11-22T00:00:00,Nitrogen,D01.362.625
21090714,2010-11-22T00:00:00,Refractometry,E05.196.808
21090714,2010-11-22T00:00:00,Refractometry,H01.671.617.755
21090714,2010-11-22T00:00:00,Surface Plasmon Resonance,E05.196.890
21090714,2010-11-22T00:00:00,Surface Plasmon Resonance,E05.601.123.700
21098276,2010-11-22T00:00:00,Animals,B01.050
21098276,2010-11-22T00:00:00,Cell Proliferation,G04.299.233.750
21098276,2010-11-22T00:00:00,Cell Proliferation,G07.700.320.249.410.750
21098276,2010-11-22T00:00:00,Dendritic Cells,A11.066.270
21098276,2010-11-22T00:00:00,Dendritic Cells,A11.436.270
21098276,2010-11-22T00:00:00,Dendritic Cells,A15.382.066.270
21098276,2010-11-22T00:00:00,Dendritic Cells,A15.382.812.260
21098276,2010-11-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21098276,2010-11-22T00:00:00,Interleukin-15,D12.644.276.374.465.515
21098276,2010-11-22T00:00:00,Interleukin-15,D12.776.467.374.465.515
21098276,2010-11-22T00:00:00,Interleukin-15,D23.529.374.465.515
21098276,2010-11-22T00:00:00,Interleukin-15 Receptor alpha Subunit,D12.776.543.750.705.852.420.800.550
21098276,2010-11-22T00:00:00,Lymphocyte Activation,E01.450.495.482
21098276,2010-11-22T00:00:00,Lymphocyte Activation,E05.478.594.530
21098276,2010-11-22T00:00:00,Lymphocyte Activation,G12.425.747
21098276,2010-11-22T00:00:00,Lymphocyte Activation,G12.450.050.400.545
21098276,2010-11-22T00:00:00,Monocytes,A11.118.637.555.652
21098276,2010-11-22T00:00:00,Monocytes,A11.148.580
21098276,2010-11-22T00:00:00,Monocytes,A11.627.624
21098276,2010-11-22T00:00:00,Monocytes,A11.733.547
21098276,2010-11-22T00:00:00,Monocytes,A15.145.229.637.555.652
21098276,2010-11-22T00:00:00,Monocytes,A15.378.316.580
21098276,2010-11-22T00:00:00,Monocytes,A15.382.490.555.652
21098276,2010-11-22T00:00:00,Monocytes,A15.382.680.547
21098276,2010-11-22T00:00:00,Monocytes,A15.382.812.547
21139879,2010-11-22T00:00:00,Awareness,F02.463.188.150
21139879,2010-11-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21139879,2010-11-22T00:00:00,Risk Assessment,E05.318.740.600.800.715
21139879,2010-11-22T00:00:00,Risk Assessment,N04.452.871.715
21139879,2010-11-22T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
21139879,2010-11-22T00:00:00,Risk Assessment,N06.850.505.715
21139879,2010-11-22T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
21139879,2010-11-22T00:00:00,Smoking,F01.145.466.753
21139879,2010-11-22T00:00:00,Smoking Cessation,F01.145.940.700
21139879,2010-11-22T00:00:00,Tobacco,B01.650.388.100.905.900
21087711,2010-11-23T00:00:00,Aged,M01.060.116.100
21087711,2010-11-23T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
21087711,2010-11-23T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
21087711,2010-11-23T00:00:00,"Defibrillators, Implantable",E07.695.175
21087711,2010-11-23T00:00:00,Double-Blind Method,E05.318.780.300
21087711,2010-11-23T00:00:00,Double-Blind Method,E05.581.500.300
21087711,2010-11-23T00:00:00,Double-Blind Method,N05.715.360.780.320
21087711,2010-11-23T00:00:00,Double-Blind Method,N06.850.520.445.300
21087711,2010-11-23T00:00:00,Heart Failure,C14.280.434
21087711,2010-11-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21087711,2010-11-23T00:00:00,Middle Aged,M01.060.116.630
21087711,2010-11-23T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
21091965,2010-11-23T00:00:00,"Cardiomyopathy, Hypertrophic",C14.280.238.100
21091965,2010-11-23T00:00:00,"Cardiomyopathy, Hypertrophic",C14.280.484.150.070.160
21091965,2010-11-23T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
21091965,2010-11-23T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
21091965,2010-11-23T00:00:00,"Defibrillators, Implantable",E07.695.175
21091965,2010-11-23T00:00:00,Electric Countershock,E02.342.287
21091965,2010-11-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21091965,2010-11-23T00:00:00,Middle Aged,M01.060.116.630
21091965,2010-11-23T00:00:00,Treatment Outcome,E01.789.800
21091965,2010-11-23T00:00:00,Treatment Outcome,N04.761.559.590.800
21091965,2010-11-23T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21091965,2010-11-23T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
21102575,2010-11-23T00:00:00,Adult,M01.060.116
21102575,2010-11-23T00:00:00,Alcoholism,C21.739.100.250
21102575,2010-11-23T00:00:00,Alcoholism,F03.900.100.350
21102575,2010-11-23T00:00:00,Antisocial Personality Disorder,F03.675.050
21102575,2010-11-23T00:00:00,Health Surveys,E05.318.308.250
21102575,2010-11-23T00:00:00,Health Surveys,N05.715.360.300.375
21102575,2010-11-23T00:00:00,Health Surveys,N06.850.520.308.250
21102575,2010-11-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21102575,2010-11-23T00:00:00,Impulsive Behavior,F01.145.527
21102575,2010-11-23T00:00:00,Middle Aged,M01.060.116.630
21102575,2010-11-23T00:00:00,Questionnaires,E05.318.308.750
21102575,2010-11-23T00:00:00,Questionnaires,L01.280.800
21102575,2010-11-23T00:00:00,Questionnaires,N05.715.360.300.695
21102575,2010-11-23T00:00:00,Questionnaires,N06.850.520.308.750
21102575,2010-11-23T00:00:00,Risk Factors,E05.318.740.600.800.725
21102575,2010-11-23T00:00:00,Risk Factors,N05.715.350.200.700
21102575,2010-11-23T00:00:00,Risk Factors,N05.715.360.750.625.700.700
21102575,2010-11-23T00:00:00,Risk Factors,N06.850.490.625.750
21102575,2010-11-23T00:00:00,Risk Factors,N06.850.520.830.600.800.725
21102575,2010-11-23T00:00:00,Spinal Cord Injuries,C10.228.854.770
21102575,2010-11-23T00:00:00,Spinal Cord Injuries,C10.900.850
21102575,2010-11-23T00:00:00,Spinal Cord Injuries,C21.866.819
21102575,2010-11-23T00:00:00,Young Adult,M01.060.116.815
21104316,2010-11-23T00:00:00,Adenosine Triphosphate,D03.438.759.646.138.236
21104316,2010-11-23T00:00:00,Adenosine Triphosphate,D13.695.667.138.236
21104316,2010-11-23T00:00:00,Adenosine Triphosphate,D13.695.827.068.236
21104316,2010-11-23T00:00:00,Animals,B01.050
21104316,2010-11-23T00:00:00,Ion Channel Gating,G02.111.087.800.400
21104316,2010-11-23T00:00:00,Ion Channel Gating,G02.149.115.800.400
21104316,2010-11-23T00:00:00,Ion Channel Gating,G04.299.500
21104316,2010-11-23T00:00:00,Ion Channel Gating,G04.299.880.400
21104316,2010-11-23T00:00:00,Ion Channel Gating,G07.265.337.500
21104316,2010-11-23T00:00:00,Ion Channel Gating,G07.700.240.500
21104316,2010-11-23T00:00:00,"Mechanotransduction, Cellular",G01.154.100.440
21104316,2010-11-23T00:00:00,"Mechanotransduction, Cellular",G01.595.100.440
21104316,2010-11-23T00:00:00,"Mechanotransduction, Cellular",G02.111.087.800.580
21104316,2010-11-23T00:00:00,"Mechanotransduction, Cellular",G02.149.115.800.580
21104316,2010-11-23T00:00:00,"Mechanotransduction, Cellular",G04.299.880.580
21104316,2010-11-23T00:00:00,Pressure,G01.374.715
21104316,2010-11-23T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
21104316,2010-11-23T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
21104316,2010-11-23T00:00:00,Urinary Bladder,A05.810.890
21106691,2010-11-24T00:00:00,Animals,B01.050
21106691,2010-11-24T00:00:00,"DNA, Mitochondrial",D13.444.308.283.225
21106691,2010-11-24T00:00:00,Green Fluorescent Proteins,D12.776.532.265
21106691,2010-11-24T00:00:00,Hepatocytes,A11.436.348
21106691,2010-11-24T00:00:00,Lysosomes,A11.284.430.214.190.875.190.550
21106691,2010-11-24T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
21106691,2010-11-24T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
21106691,2010-11-24T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
21106691,2010-11-24T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
21107554,2010-11-24T00:00:00,Child,M01.060.406
21107554,2010-11-24T00:00:00,"Child, Preschool",M01.060.406.448
21107554,2010-11-24T00:00:00,Fontan Procedure,E04.035.410.295
21107554,2010-11-24T00:00:00,Fontan Procedure,E04.100.376.410.295
21107554,2010-11-24T00:00:00,Fontan Procedure,E04.928.220.370.295
21107554,2010-11-24T00:00:00,Heart Ventricles,A07.541.560
21107554,2010-11-24T00:00:00,Hemodynamics,G09.330.190.400
21107554,2010-11-24T00:00:00,Hemodynamics,G09.330.380
21107554,2010-11-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21107554,2010-11-24T00:00:00,Hypoplastic Left Heart Syndrome,C14.240.400.625
21107554,2010-11-24T00:00:00,Hypoplastic Left Heart Syndrome,C14.280.400.625
21107554,2010-11-24T00:00:00,Hypoplastic Left Heart Syndrome,C16.131.240.400.625
21107554,2010-11-24T00:00:00,Infant,M01.060.703
21107554,2010-11-24T00:00:00,Pulmonary Artery,A07.231.114.715
21107554,2010-11-24T00:00:00,Time Factors,G01.910.857
21107554,2010-11-24T00:00:00,"Ventricular Dysfunction, Right",C14.280.945.910
21254057,2010-11-24T00:00:00,Adolescent,M01.060.057
21254057,2010-11-24T00:00:00,Adult,M01.060.116
21254057,2010-11-24T00:00:00,Anxiety,F01.470.132
21254057,2010-11-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21254057,2010-11-24T00:00:00,"Models, Psychological",E05.599.695
21254057,2010-11-24T00:00:00,Phobic Disorders,F03.080.725
21254057,2010-11-24T00:00:00,Psychometrics,F04.711.780
21254057,2010-11-24T00:00:00,Students,I02.233.748
21254057,2010-11-24T00:00:00,Students,I02.851
21254057,2010-11-24T00:00:00,Students,M01.848
21254057,2010-11-24T00:00:00,Young Adult,M01.060.116.815
21111489,2010-11-26T00:00:00,Animals,B01.050
21111489,2010-11-26T00:00:00,Cell Separation,E05.200.500.363
21111489,2010-11-26T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.114.703.300
21111489,2010-11-26T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.314.350.250
21111489,2010-11-26T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C20.111.258.625.300
21111489,2010-11-26T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",E05.598.500.500.500
21111489,2010-11-26T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
21111489,2010-11-26T00:00:00,Flow Cytometry,E05.200.500.386.350
21111489,2010-11-26T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
21111489,2010-11-26T00:00:00,Peptides,D12.644
21112710,2010-11-27T00:00:00,Adult,M01.060.116
21112710,2010-11-27T00:00:00,"Carcinoma, Hepatocellular",C04.557.470.200.025.255
21112710,2010-11-27T00:00:00,"Carcinoma, Hepatocellular",C04.588.274.623.160
21112710,2010-11-27T00:00:00,"Carcinoma, Hepatocellular",C06.301.623.160
21112710,2010-11-27T00:00:00,"Carcinoma, Hepatocellular",C06.552.697.160
21112710,2010-11-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21112710,2010-11-27T00:00:00,Liver Neoplasms,C04.588.274.623
21112710,2010-11-27T00:00:00,Liver Neoplasms,C06.301.623
21112710,2010-11-27T00:00:00,Liver Neoplasms,C06.552.697
21112710,2010-11-27T00:00:00,Liver Transplantation,E04.210.650
21112710,2010-11-27T00:00:00,Liver Transplantation,E04.936.450.490
21112710,2010-11-27T00:00:00,Liver Transplantation,E04.936.580.490
21112710,2010-11-27T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
21112710,2010-11-27T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
21115479,2010-11-29T00:00:00,Adenylate Cyclase,D08.811.520.650.200
21115479,2010-11-29T00:00:00,Adenylate Cyclase,D12.644.360.050
21115479,2010-11-29T00:00:00,Adenylate Cyclase,D12.776.476.050
21115479,2010-11-29T00:00:00,Animals,B01.050
21115479,2010-11-29T00:00:00,Gene Expression,G05.355.310
21115479,2010-11-29T00:00:00,Glutathione Transferase,D08.811.913.225.500
21115479,2010-11-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21115479,2010-11-29T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
21116566,2010-11-29T00:00:00,Carbohydrates,D09
21116566,2010-11-29T00:00:00,Molecular Structure,G02.111.570
21116566,2010-11-29T00:00:00,Molecular Structure,G02.575
21116566,2010-11-29T00:00:00,Molecular Structure,G02.842.575
21116566,2010-11-29T00:00:00,Polymers,D05.750
21116566,2010-11-29T00:00:00,Polymers,D25.720
21116566,2010-11-29T00:00:00,Polymers,J01.637.051.720
21116286,2010-11-30T00:00:00,Acid Ceramidase,D08.811.277.087.250.100
21116286,2010-11-30T00:00:00,Antineoplastic Agents,D27.505.954.248
21116286,2010-11-30T00:00:00,Ceramides,D02.065.313
21116286,2010-11-30T00:00:00,Ceramides,D09.400.410.420.525.200
21116286,2010-11-30T00:00:00,Ceramides,D10.390.470.675.200
21116286,2010-11-30T00:00:00,Ceramides,D10.570.877.360.612.200
21116286,2010-11-30T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
21116286,2010-11-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21116286,2010-11-30T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
21116286,2010-11-30T00:00:00,Prostatic Neoplasms,C12.294.260.750
21116286,2010-11-30T00:00:00,Prostatic Neoplasms,C12.294.565.625
21116286,2010-11-30T00:00:00,Prostatic Neoplasms,C12.758.409.750
21122992,2010-11-30T00:00:00,Adult,M01.060.116
21122992,2010-11-30T00:00:00,Emotions,F01.470
21122992,2010-11-30T00:00:00,Functional Laterality,F02.830.297.425
21122992,2010-11-30T00:00:00,Functional Laterality,G11.561.225.425
21122992,2010-11-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21122992,2010-11-30T00:00:00,Pain Measurement,E01.370.376.550.600
21122992,2010-11-30T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
21122992,2010-11-30T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
21122992,2010-11-30T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
21123118,2010-11-30T00:00:00,Animals,B01.050
21123118,2010-11-30T00:00:00,CHO Cells,A11.251.210.200
21123118,2010-11-30T00:00:00,CHO Cells,A11.436.155
21123118,2010-11-30T00:00:00,Cricetinae,B01.050.150.900.649.865.635.150
21123118,2010-11-30T00:00:00,DNA Repair,G02.111.087.219
21123118,2010-11-30T00:00:00,DNA Repair,G02.149.115.219
21123118,2010-11-30T00:00:00,DNA Repair,G05.355.195
21123118,2010-11-30T00:00:00,DNA-Binding Proteins,D12.776.260
21123118,2010-11-30T00:00:00,Endonucleases,D08.811.277.352.355
21123118,2010-11-30T00:00:00,Point Mutation,G05.365.590.675
21123118,2010-11-30T00:00:00,"Recombination, Genetic",G05.355.760
21152397,2010-11-30T00:00:00,Azo Compounds,D02.172
21152397,2010-11-30T00:00:00,Calcium,D01.268.552.100
21152397,2010-11-30T00:00:00,Calcium,D01.552.539.288
21152397,2010-11-30T00:00:00,Calcium,D23.119.100
21152397,2010-11-30T00:00:00,Endothelial Cells,A11.436.275
21152397,2010-11-30T00:00:00,Glutathione,D12.644.456.448
21152397,2010-11-30T00:00:00,Homeostasis,G07.700.360
21152397,2010-11-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21152397,2010-11-30T00:00:00,Membrane Proteins,D12.776.543
21152397,2010-11-30T00:00:00,Nitric Oxide,D01.339.387
21152397,2010-11-30T00:00:00,Nitric Oxide,D01.625.550.500
21152397,2010-11-30T00:00:00,Nitric Oxide,D01.625.700.500
21152397,2010-11-30T00:00:00,Nitric Oxide,D01.650.550.587.600
21152397,2010-11-30T00:00:00,Nitric Oxide Synthase,D08.811.682.664.500.772
21152397,2010-11-30T00:00:00,Nitric Oxide Synthase Type II,D08.811.682.664.500.772.500
21152397,2010-11-30T00:00:00,Nitric Oxide Synthase Type III,D08.811.682.664.500.772.750
21152397,2010-11-30T00:00:00,RNA Interference,G05.355.315.203.374.790
20421836,2010-12-01T00:00:00,Aged,M01.060.116.100
20421836,2010-12-01T00:00:00,Data Collection,E05.318.308
20421836,2010-12-01T00:00:00,Data Collection,L01.280
20421836,2010-12-01T00:00:00,Data Collection,N05.715.360.300
20421836,2010-12-01T00:00:00,Data Collection,N06.850.520.308
20421836,2010-12-01T00:00:00,Exercise,G11.427.590.237
20421836,2010-12-01T00:00:00,Exercise,I03.350
20421836,2010-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20421836,2010-12-01T00:00:00,Middle Aged,M01.060.116.630
20421836,2010-12-01T00:00:00,Questionnaires,E05.318.308.750
20421836,2010-12-01T00:00:00,Questionnaires,L01.280.800
20421836,2010-12-01T00:00:00,Questionnaires,N05.715.360.300.695
20421836,2010-12-01T00:00:00,Questionnaires,N06.850.520.308.750
20603872,2010-12-01T00:00:00,Animals,B01.050
20603872,2010-12-01T00:00:00,Cell Adhesion Molecules,D12.776.395.550.200
20603872,2010-12-01T00:00:00,Cell Adhesion Molecules,D12.776.543.550.200
20603872,2010-12-01T00:00:00,Cell Adhesion Molecules,D23.050.301.350
20603872,2010-12-01T00:00:00,Dermis,A17.815.180
20603872,2010-12-01T00:00:00,Fibroblasts,A11.329.228
20603872,2010-12-01T00:00:00,Fibroblasts,A11.872.228
20603872,2010-12-01T00:00:00,Fluorescent Dyes,D27.720.233.348
20603872,2010-12-01T00:00:00,Fluorescent Dyes,D27.720.470.330.348
20603872,2010-12-01T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
20603872,2010-12-01T00:00:00,"Spheroids, Cellular",A11.251.800
20603872,2010-12-01T00:00:00,Tissue Engineering,E05.200.249.750
20635125,2010-12-01T00:00:00,Health Personnel,M01.526.485
20635125,2010-12-01T00:00:00,Health Personnel,N02.360
20635125,2010-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20635125,2010-12-01T00:00:00,Learning,F02.463.425
20635125,2010-12-01T00:00:00,Learning,F02.784.629.529
20635125,2010-12-01T00:00:00,Narration,E05.318.308.502
20635125,2010-12-01T00:00:00,Narration,F01.145.209.459
20635125,2010-12-01T00:00:00,Narration,L01.280.660
20635125,2010-12-01T00:00:00,Narration,N05.715.360.300.480
20635125,2010-12-01T00:00:00,Narration,N06.850.520.308.502
20635125,2010-12-01T00:00:00,Teaching,I02.903
20672366,2010-12-01T00:00:00,Child,M01.060.406
20672366,2010-12-01T00:00:00,DNA Methylation,G02.111.087.029.538.161
20672366,2010-12-01T00:00:00,DNA Methylation,G02.111.087.218
20672366,2010-12-01T00:00:00,DNA Methylation,G02.149.115.029.538.161
20672366,2010-12-01T00:00:00,DNA Methylation,G02.149.115.218
20672366,2010-12-01T00:00:00,DNA Methylation,G03.495.130.538.161
20672366,2010-12-01T00:00:00,DNA Methylation,G05.355.190
20672366,2010-12-01T00:00:00,Homeodomain Proteins,D12.776.260.400
20672366,2010-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20672366,2010-12-01T00:00:00,Phenotype,G05.695
20672366,2010-12-01T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
20672366,2010-12-01T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
20672366,2010-12-01T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
20672366,2010-12-01T00:00:00,Transcription Factors,D12.776.930
20717918,2010-12-01T00:00:00,Animals,B01.050
20717918,2010-12-01T00:00:00,Bone Resorption,C05.116.264
20717918,2010-12-01T00:00:00,Bone Resorption,G11.427.590.195.150
20717918,2010-12-01T00:00:00,Cell Differentiation,G04.299.151
20717918,2010-12-01T00:00:00,Cell Line,A11.251.210
20717918,2010-12-01T00:00:00,"Fractures, Bone",C21.866.404
20717918,2010-12-01T00:00:00,Gene Expression Profiling,E05.393.332
20717918,2010-12-01T00:00:00,Macrophages,A11.329.372
20717918,2010-12-01T00:00:00,Macrophages,A11.627.482
20717918,2010-12-01T00:00:00,Macrophages,A11.733.397
20717918,2010-12-01T00:00:00,Macrophages,A15.382.680.397
20717918,2010-12-01T00:00:00,Macrophages,A15.382.812.522
20717918,2010-12-01T00:00:00,"Models, Biological",E05.599.395
20717918,2010-12-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
20717918,2010-12-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
20717918,2010-12-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
20717918,2010-12-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
20717918,2010-12-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
20717918,2010-12-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
20717918,2010-12-01T00:00:00,Osteoclasts,A11.329.372.700
20717918,2010-12-01T00:00:00,Osteoclasts,A11.627.482.700
20717918,2010-12-01T00:00:00,Space Flight,J01.937.285.850
20717918,2010-12-01T00:00:00,Weightlessness,G01.595.060.535.369.400.900
20835896,2010-12-01T00:00:00,Adult,M01.060.116
20835896,2010-12-01T00:00:00,Double-Blind Method,E05.318.780.300
20835896,2010-12-01T00:00:00,Double-Blind Method,E05.581.500.300
20835896,2010-12-01T00:00:00,Double-Blind Method,N05.715.360.780.320
20835896,2010-12-01T00:00:00,Double-Blind Method,N06.850.520.445.300
20835896,2010-12-01T00:00:00,Gastroplasty,E02.065.062.750
20835896,2010-12-01T00:00:00,Gastroplasty,E04.062.750
20835896,2010-12-01T00:00:00,Gastroplasty,E04.210.485
20835896,2010-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20835896,2010-12-01T00:00:00,Laparoscopy,E01.370.388.250.520
20835896,2010-12-01T00:00:00,Laparoscopy,E04.800.250.520
20835896,2010-12-01T00:00:00,Middle Aged,M01.060.116.630
20835896,2010-12-01T00:00:00,Obesity,C18.654.726.500
20835896,2010-12-01T00:00:00,Obesity,C23.888.144.699.500
20835896,2010-12-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
20835896,2010-12-01T00:00:00,Obesity,G07.100.100.160.120.699.500
20835896,2010-12-01T00:00:00,Satiety Response,F02.830.749.658
20835896,2010-12-01T00:00:00,Treatment Outcome,E01.789.800
20835896,2010-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20835896,2010-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20835896,2010-12-01T00:00:00,Weight Loss,C23.888.144.243.963
20835896,2010-12-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
20962632,2010-12-01T00:00:00,Autoimmune Diseases,C20.111
20962632,2010-12-01T00:00:00,Bone Diseases,C05.116
20962632,2010-12-01T00:00:00,Bone and Bones,A02.835.232
20962632,2010-12-01T00:00:00,Bone and Bones,A10.165.265
20962632,2010-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20962632,2010-12-01T00:00:00,Inflammation,C23.550.470
20962632,2010-12-01T00:00:00,Vitamin D,D04.808.812.768
20962632,2010-12-01T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
21038970,2010-12-01T00:00:00,Aged,M01.060.116.100
21038970,2010-12-01T00:00:00,Combat Disorders,F03.080.931.249
21038970,2010-12-01T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
21038970,2010-12-01T00:00:00,Employment,N01.824.245
21038970,2010-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21038970,2010-12-01T00:00:00,Life Change Events,F01.829.458.410
21038970,2010-12-01T00:00:00,Middle Aged,M01.060.116.630
21038970,2010-12-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
21038970,2010-12-01T00:00:00,United States,Z01.107.567.875
21038970,2010-12-01T00:00:00,Veterans,M01.930
21038990,2010-12-01T00:00:00,Aging,G07.700.320.124
21038990,2010-12-01T00:00:00,Bicycling,I03.450.642.845.140
21038990,2010-12-01T00:00:00,Child,M01.060.406
21038990,2010-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21038990,2010-12-01T00:00:00,Judgment,F02.463.785.626
21038990,2010-12-01T00:00:00,Space Perception,F02.463.593.778
21038990,2010-12-01T00:00:00,Space Perception,F02.463.593.932.869
21038990,2010-12-01T00:00:00,User-Computer Interface,L01.224.900.910
21038990,2010-12-01T00:00:00,Young Adult,M01.060.116.815
21042208,2010-12-01T00:00:00,Aged,M01.060.116.100
21042208,2010-12-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
21042208,2010-12-01T00:00:00,Alzheimer Disease,C10.574.945.249
21042208,2010-12-01T00:00:00,Alzheimer Disease,F03.087.400.100
21042208,2010-12-01T00:00:00,Discrimination (Psychology),F02.463.593.257
21042208,2010-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21042208,2010-12-01T00:00:00,Neuropsychological Tests,F04.711.513
21042208,2010-12-01T00:00:00,Psychomotor Performance,F02.808
21042208,2010-12-01T00:00:00,Psychomotor Performance,G11.427.700
21042208,2010-12-01T00:00:00,Psychomotor Performance,G11.561.623
21042208,2010-12-01T00:00:00,Visual Perception,F02.463.593.932
21093762,2010-12-01T00:00:00,Colonic Polyps,C23.300.825.411.235
21093762,2010-12-01T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
21093762,2010-12-01T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
21093762,2010-12-01T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
21093762,2010-12-01T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
21093762,2010-12-01T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
21093762,2010-12-01T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
21093762,2010-12-01T00:00:00,"Education, Medical, Continuing",I02.358.212.350
21093762,2010-12-01T00:00:00,"Education, Medical, Continuing",I02.358.399.250
21093762,2010-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21109079,2010-12-01T00:00:00,Adult,M01.060.116
21109079,2010-12-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
21109079,2010-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21109079,2010-12-01T00:00:00,Middle Aged,M01.060.116.630
21109079,2010-12-01T00:00:00,"Surgical Procedures, Minimally Invasive",E04.800
21109079,2010-12-01T00:00:00,Thyroid Diseases,C19.874
21110319,2010-12-01T00:00:00,Animals,B01.050
21110319,2010-12-01T00:00:00,Bone Marrow,A15.382.216
21110319,2010-12-01T00:00:00,Granulocyte Colony-Stimulating Factor,D12.644.276.374.410.240.350
21110319,2010-12-01T00:00:00,Granulocyte Colony-Stimulating Factor,D12.776.395.240.200
21110319,2010-12-01T00:00:00,Granulocyte Colony-Stimulating Factor,D12.776.467.374.410.240.350
21110319,2010-12-01T00:00:00,Granulocyte Colony-Stimulating Factor,D23.529.374.410.240.350
21110319,2010-12-01T00:00:00,Hematopoietic Stem Cell Mobilization,E02.095.410
21110319,2010-12-01T00:00:00,Immunosuppression,E02.095.465.425.450
21110319,2010-12-01T00:00:00,Immunosuppression,E05.478.610
21110319,2010-12-01T00:00:00,Myeloid Cells,A11.627
21110319,2010-12-01T00:00:00,Piperidines,D03.383.621
21110319,2010-12-01T00:00:00,Pyrazoles,D03.383.129.539
21110319,2010-12-01T00:00:00,"Receptor, Cannabinoid, CB1",D12.776.543.750.100.125.100
21110319,2010-12-01T00:00:00,"Receptor, Cannabinoid, CB2",D12.776.543.750.100.125.200
21111312,2010-12-01T00:00:00,Adolescent,M01.060.057
21111312,2010-12-01T00:00:00,Cataract,C11.510.245
21111312,2010-12-01T00:00:00,Cataract Extraction,E04.540.825.249
21111312,2010-12-01T00:00:00,Child,M01.060.406
21111312,2010-12-01T00:00:00,"Child, Preschool",M01.060.406.448
21111312,2010-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21111312,2010-12-01T00:00:00,Incidence,E05.318.308.985.525.375
21111312,2010-12-01T00:00:00,Incidence,L01.280.975.525.375
21111312,2010-12-01T00:00:00,Incidence,N01.224.935.597.500
21111312,2010-12-01T00:00:00,Incidence,N06.850.505.400.975.525.375
21111312,2010-12-01T00:00:00,Incidence,N06.850.520.308.985.525.375
21111312,2010-12-01T00:00:00,Infant,M01.060.703
21111312,2010-12-01T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
21113977,2010-12-01T00:00:00,Adult,M01.060.116
21113977,2010-12-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
21113977,2010-12-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
21113977,2010-12-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
21113977,2010-12-01T00:00:00,Connective Tissue Growth Factor,D12.644.276.200.100
21113977,2010-12-01T00:00:00,Connective Tissue Growth Factor,D12.776.467.200.100
21113977,2010-12-01T00:00:00,Connective Tissue Growth Factor,D12.776.860.300.200.100
21113977,2010-12-01T00:00:00,Connective Tissue Growth Factor,D23.529.237.100
21113977,2010-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21113977,2010-12-01T00:00:00,Neoplasm Proteins,D12.776.624
21113977,2010-12-01T00:00:00,Treatment Outcome,E01.789.800
21113977,2010-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
21113977,2010-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21119330,2010-12-01T00:00:00,Aged,M01.060.116.100
21119330,2010-12-01T00:00:00,"Endocarditis, Bacterial",C01.252.300
21119330,2010-12-01T00:00:00,"Endocarditis, Bacterial",C01.539.190.249
21119330,2010-12-01T00:00:00,"Endocarditis, Bacterial",C14.260.249
21119330,2010-12-01T00:00:00,"Endocarditis, Bacterial",C14.280.282.407
21119330,2010-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21119330,2010-12-01T00:00:00,Middle Aged,M01.060.116.630
21119330,2010-12-01T00:00:00,Renal Dialysis,E02.870.300
21119330,2010-12-01T00:00:00,Renal Dialysis,E02.912.800
21119330,2010-12-01T00:00:00,Staphylococcus aureus,B03.300.390.400.800.750.100
21119330,2010-12-01T00:00:00,Staphylococcus aureus,B03.510.100.750.750.100
21119330,2010-12-01T00:00:00,Staphylococcus aureus,B03.510.400.790.750.100
21119335,2010-12-01T00:00:00,Case Management,N04.590.233.624.250
21119335,2010-12-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
21119335,2010-12-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
21119335,2010-12-01T00:00:00,Evidence-Based Medicine,H02.249.750
21119335,2010-12-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
21119335,2010-12-01T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
21119335,2010-12-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
21119335,2010-12-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
21119335,2010-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21119335,2010-12-01T00:00:00,Hypoglycemic Agents,D27.505.696.422
21119335,2010-12-01T00:00:00,Inpatients,M01.643.470
21119335,2010-12-01T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
21119335,2010-12-01T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
21119335,2010-12-01T00:00:00,Life Style,F01.829.458
21119335,2010-12-01T00:00:00,"Monitoring, Physiologic",E01.370.520
21119335,2010-12-01T00:00:00,Patient Discharge,E02.760.400.610
21119335,2010-12-01T00:00:00,Patient Discharge,N02.421.585.400.610
21119335,2010-12-01T00:00:00,Risk Factors,E05.318.740.600.800.725
21119335,2010-12-01T00:00:00,Risk Factors,N05.715.350.200.700
21119335,2010-12-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
21119335,2010-12-01T00:00:00,Risk Factors,N06.850.490.625.750
21119335,2010-12-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
21119335,2010-12-01T00:00:00,Secondary Prevention,N02.421.726.825
21119335,2010-12-01T00:00:00,Secondary Prevention,N06.850.780.750
21119335,2010-12-01T00:00:00,Stroke,C10.228.140.300.775
21119335,2010-12-01T00:00:00,Stroke,C14.907.253.855
21119335,2010-12-01T00:00:00,Treatment Outcome,E01.789.800
21119335,2010-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
21119335,2010-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21120996,2010-12-01T00:00:00,Adult,M01.060.116
21120996,2010-12-01T00:00:00,African Americans,M01.686.508.100.100
21120996,2010-12-01T00:00:00,African Americans,M01.686.754.100
21120996,2010-12-01T00:00:00,Alleles,G05.360.340.024.340.030
21120996,2010-12-01T00:00:00,"Arthritis, Rheumatoid",C05.550.114.154
21120996,2010-12-01T00:00:00,"Arthritis, Rheumatoid",C05.799.114
21120996,2010-12-01T00:00:00,"Arthritis, Rheumatoid",C17.300.775.099
21120996,2010-12-01T00:00:00,"Arthritis, Rheumatoid",C20.111.199
21120996,2010-12-01T00:00:00,Case-Control Studies,E05.318.760.500.500
21120996,2010-12-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
21120996,2010-12-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
21120996,2010-12-01T00:00:00,DNA-Binding Proteins,D12.776.260
21120996,2010-12-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
21120996,2010-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21120996,2010-12-01T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
21120996,2010-12-01T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
21120996,2010-12-01T00:00:00,Middle Aged,M01.060.116.630
21120996,2010-12-01T00:00:00,Nuclear Proteins,D12.776.660
21120996,2010-12-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
21120996,2010-12-01T00:00:00,Risk Factors,E05.318.740.600.800.725
21120996,2010-12-01T00:00:00,Risk Factors,N05.715.350.200.700
21120996,2010-12-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
21120996,2010-12-01T00:00:00,Risk Factors,N06.850.490.625.750
21120996,2010-12-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
21121523,2010-12-01T00:00:00,Bulimia,C23.888.821.645.500
21121523,2010-12-01T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
21121523,2010-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21121523,2010-12-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
21121523,2010-12-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
21121523,2010-12-01T00:00:00,Periodontal Diseases,C07.465.714
21121523,2010-12-01T00:00:00,Thrombocytopenia,C15.378.140.855
21123536,2010-12-01T00:00:00,"Antigens, Bacterial",D23.050.161
21123536,2010-12-01T00:00:00,Carrier State,N06.850.160
21123536,2010-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21123536,2010-12-01T00:00:00,Meningococcal Infections,C01.252.400.625.549
21123536,2010-12-01T00:00:00,Neisseria meningitidis,B03.440.400.425.550.550.641
21123536,2010-12-01T00:00:00,Neisseria meningitidis,B03.660.075.525.520.500
21123536,2010-12-01T00:00:00,Polymerase Chain Reaction,E05.393.620.500
21123536,2010-12-01T00:00:00,Students,I02.233.748
21123536,2010-12-01T00:00:00,Students,I02.851
21123536,2010-12-01T00:00:00,Students,M01.848
21129409,2010-12-01T00:00:00,Animals,B01.050
21129409,2010-12-01T00:00:00,Discrimination Learning,F02.463.425.280
21129409,2010-12-01T00:00:00,Motivation,F01.658
21129409,2010-12-01T00:00:00,Motivation,F01.752.543.500.750
21129409,2010-12-01T00:00:00,Nicotine,D03.132.760.570
21129409,2010-12-01T00:00:00,Nicotine,D03.383.725.518
21129409,2010-12-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
21129409,2010-12-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
21135640,2010-12-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
21135640,2010-12-01T00:00:00,"Diagnosis, Differential",E01.171
21135640,2010-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21135640,2010-12-01T00:00:00,Middle Aged,M01.060.116.630
21135640,2010-12-01T00:00:00,Psychiatric Status Rating Scales,F04.586
21135640,2010-12-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
21142324,2010-12-01T00:00:00,Animals,B01.050
21142324,2010-12-01T00:00:00,Carotid Arteries,A07.231.114.186
21142324,2010-12-01T00:00:00,Computer Simulation,L01.224.160
21142324,2010-12-01T00:00:00,Finite Element Analysis,E05.355
21142324,2010-12-01T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
21142324,2010-12-01T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
21142324,2010-12-01T00:00:00,"Models, Cardiovascular",E05.599.395.161
21142324,2010-12-01T00:00:00,Pressure,G01.374.715
21142324,2010-12-01T00:00:00,"Stress, Mechanical",G01.374.676.830
21142324,2010-12-01T00:00:00,"Stress, Mechanical",G01.595.540.830
21146663,2010-12-01T00:00:00,Body Weight,C23.888.144
21146663,2010-12-01T00:00:00,Body Weight,E01.370.600.115.100.160.120
21146663,2010-12-01T00:00:00,Body Weight,E05.041.124.160.750
21146663,2010-12-01T00:00:00,Body Weight,G07.100.100.160.120
21146663,2010-12-01T00:00:00,Body Weight,G07.700.320.249.314.120
21146663,2010-12-01T00:00:00,Child,M01.060.406
21146663,2010-12-01T00:00:00,Disease Progression,C23.550.291.656
21146663,2010-12-01T00:00:00,Fontan Procedure,E04.035.410.295
21146663,2010-12-01T00:00:00,Fontan Procedure,E04.100.376.410.295
21146663,2010-12-01T00:00:00,Fontan Procedure,E04.928.220.370.295
21146663,2010-12-01T00:00:00,"Heart Defects, Congenital",C14.240.400
21146663,2010-12-01T00:00:00,"Heart Defects, Congenital",C14.280.400
21146663,2010-12-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
21146663,2010-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21146663,2010-12-01T00:00:00,"Hypertrophy, Left Ventricular",C14.280.195.400
21146663,2010-12-01T00:00:00,"Hypertrophy, Left Ventricular",C23.300.775.250.400
21146663,2010-12-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
21146663,2010-12-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
21146663,2010-12-01T00:00:00,Overweight,C23.888.144.699
21146663,2010-12-01T00:00:00,Overweight,E01.370.600.115.100.160.120.699
21146663,2010-12-01T00:00:00,Overweight,G07.100.100.160.120.699
21146663,2010-12-01T00:00:00,Questionnaires,E05.318.308.750
21146663,2010-12-01T00:00:00,Questionnaires,L01.280.800
21146663,2010-12-01T00:00:00,Questionnaires,N05.715.360.300.695
21146663,2010-12-01T00:00:00,Questionnaires,N06.850.520.308.750
21146663,2010-12-01T00:00:00,Risk Factors,E05.318.740.600.800.725
21146663,2010-12-01T00:00:00,Risk Factors,N05.715.350.200.700
21146663,2010-12-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
21146663,2010-12-01T00:00:00,Risk Factors,N06.850.490.625.750
21146663,2010-12-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
21150519,2010-12-01T00:00:00,Adult,M01.060.116
21150519,2010-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21150519,2010-12-01T00:00:00,Length of Stay,E02.760.400.480
21150519,2010-12-01T00:00:00,Length of Stay,N02.421.585.400.480
21150519,2010-12-01T00:00:00,New York,Z01.107.567.875.075.437
21150519,2010-12-01T00:00:00,New York,Z01.107.567.875.350.530
21150519,2010-12-01T00:00:00,New York,Z01.107.567.875.500.530
21150519,2010-12-01T00:00:00,Postoperative Complications,C23.550.767
21150519,2010-12-01T00:00:00,Time Factors,G01.910.857
21150519,2010-12-01T00:00:00,"Wounds, Nonpenetrating",C21.866.974
21156463,2010-12-01T00:00:00,"Abnormalities, Multiple",C16.131.077
21156463,2010-12-01T00:00:00,Adult,M01.060.116
21156463,2010-12-01T00:00:00,Aged,M01.060.116.100
21156463,2010-12-01T00:00:00,Anemia,C15.378.071
21156463,2010-12-01T00:00:00,Bone and Bones,A02.835.232
21156463,2010-12-01T00:00:00,Bone and Bones,A10.165.265
21156463,2010-12-01T00:00:00,"Diagnosis, Differential",E01.171
21156463,2010-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21156463,2010-12-01T00:00:00,Hypercalcemia,C18.452.174.451
21156463,2010-12-01T00:00:00,Hypercalcemia,C18.452.950.340
21156463,2010-12-01T00:00:00,Middle Aged,M01.060.116.630
21156463,2010-12-01T00:00:00,Multiple Myeloma,C04.557.595.500
21156463,2010-12-01T00:00:00,Multiple Myeloma,C14.907.454.460
21156463,2010-12-01T00:00:00,Multiple Myeloma,C15.378.147.780.650
21156463,2010-12-01T00:00:00,Multiple Myeloma,C15.378.463.835.460
21156463,2010-12-01T00:00:00,Multiple Myeloma,C20.683.515.845
21156463,2010-12-01T00:00:00,Multiple Myeloma,C20.683.780.650
21156463,2010-12-01T00:00:00,Renal Insufficiency,C12.777.419.780
21156463,2010-12-01T00:00:00,Renal Insufficiency,C13.351.968.419.780
21156463,2010-12-01T00:00:00,Syndrome,C23.550.288.500
21176034,2010-12-01T00:00:00,Aged,M01.060.116.100
21176034,2010-12-01T00:00:00,Attention,F02.830.104.214
21176034,2010-12-01T00:00:00,Bipolar Disorder,F03.600.150.150
21176034,2010-12-01T00:00:00,Case-Control Studies,E05.318.760.500.500
21176034,2010-12-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
21176034,2010-12-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
21176034,2010-12-01T00:00:00,Cognition Disorders,F03.087.250
21176034,2010-12-01T00:00:00,Fluorodeoxyglucose F18,D09.254.229.500
21176034,2010-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21176034,2010-12-01T00:00:00,Limbic System,A08.186.211.464
21176034,2010-12-01T00:00:00,Middle Aged,M01.060.116.630
21176034,2010-12-01T00:00:00,Neuropsychological Tests,F04.711.513
21176034,2010-12-01T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
21176034,2010-12-01T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
21176034,2010-12-01T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
21176034,2010-12-01T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
21176034,2010-12-01T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
21176034,2010-12-01T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
21199434,2010-12-01T00:00:00,Aged,M01.060.116.100
21199434,2010-12-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
21199434,2010-12-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
21199434,2010-12-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
21199434,2010-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21199434,2010-12-01T00:00:00,Lung,A04.411
21199434,2010-12-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
21199434,2010-12-01T00:00:00,Lung Neoplasms,C08.381.540
21199434,2010-12-01T00:00:00,Lung Neoplasms,C08.785.520
21199434,2010-12-01T00:00:00,Middle Aged,M01.060.116.630
21199434,2010-12-01T00:00:00,Neoplasm Staging,E01.370.550
21199434,2010-12-01T00:00:00,Radiotherapy Dosage,E02.815.639
21199434,2010-12-01T00:00:00,Treatment Outcome,E01.789.800
21199434,2010-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
21199434,2010-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21246173,2010-12-01T00:00:00,"Education, Medical, Graduate",I02.358.337.350
21246173,2010-12-01T00:00:00,"Education, Medical, Graduate",I02.358.399.350
21246173,2010-12-01T00:00:00,"Hospitals, University",N02.278.020.300.310
21246173,2010-12-01T00:00:00,"Hospitals, University",N02.278.421.639.725
21246173,2010-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21246173,2010-12-01T00:00:00,"Schools, Medical",I02.783.660.552
21246173,2010-12-01T00:00:00,"Schools, Medical",N02.278.020.578
21246173,2010-12-01T00:00:00,South Carolina,Z01.107.567.875.075.662
21246173,2010-12-01T00:00:00,South Carolina,Z01.107.567.875.750.700
21309294,2010-12-01T00:00:00,"Anesthesia, Intravenous",E03.155.308
21309294,2010-12-01T00:00:00,"Anesthetics, Inhalation",D27.505.696.277.100.035.060
21309294,2010-12-01T00:00:00,"Anesthetics, Inhalation",D27.505.954.427.210.100.035.060
21309294,2010-12-01T00:00:00,Child,M01.060.406
21309294,2010-12-01T00:00:00,Drug Monitoring,E01.370.520.200
21309294,2010-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21309294,2010-12-01T00:00:00,Nurse Anesthetists,M01.526.485.650.600
21309294,2010-12-01T00:00:00,Nurse Anesthetists,N02.360.650.600
21309294,2010-12-01T00:00:00,Propofol,D02.755.773
21309294,2010-12-01T00:00:00,Psychomotor Agitation,C10.597.350.600
21309294,2010-12-01T00:00:00,Psychomotor Agitation,C10.597.606.881.700
21309294,2010-12-01T00:00:00,Psychomotor Agitation,C23.888.592.350.600
21309294,2010-12-01T00:00:00,Psychomotor Agitation,C23.888.592.604.882.700
21309294,2010-12-01T00:00:00,Psychomotor Agitation,F01.700.875.700
21309294,2010-12-01T00:00:00,Research Design,E05.581.500
21309294,2010-12-01T00:00:00,Research Design,H01.770.644.728
21309294,2010-12-01T00:00:00,Treatment Outcome,E01.789.800
21309294,2010-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
21309294,2010-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21313923,2010-12-01T00:00:00,Cardiopulmonary Bypass,E04.292.413
21313923,2010-12-01T00:00:00,Periodicals as Topic,L01.178.682.829.678
21313923,2010-12-01T00:00:00,Physician's Practice Patterns,N04.590.748
21313923,2010-12-01T00:00:00,Physician's Practice Patterns,N05.300.625
21313923,2010-12-01T00:00:00,United States,Z01.107.567.875
21500611,2010-12-01T00:00:00,"Decision Support Systems, Clinical",L01.700.508.300.190
21500611,2010-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21500611,2010-12-01T00:00:00,"Medical Records Systems, Computerized",E05.318.308.940.968.625
21500611,2010-12-01T00:00:00,"Medical Records Systems, Computerized",L01.280.900.968.775
21500611,2010-12-01T00:00:00,"Medical Records Systems, Computerized",L01.700.508.300.695
21500611,2010-12-01T00:00:00,"Medical Records Systems, Computerized",N04.452.859.564.650
21500611,2010-12-01T00:00:00,"Medical Records Systems, Computerized",N05.715.360.300.715.500.530
21500611,2010-12-01T00:00:00,"Medical Records Systems, Computerized",N06.850.520.308.940.968.625
21500611,2010-12-01T00:00:00,Medication Adherence,F01.145.488.500.500
21500611,2010-12-01T00:00:00,Medication Adherence,N05.300.150.600.600.500
21500611,2010-12-01T00:00:00,Medication Errors,E02.319.529
21500611,2010-12-01T00:00:00,Medication Errors,N02.421.450.500
21500611,2010-12-01T00:00:00,"Models, Theoretical",E05.599
21500611,2010-12-01T00:00:00,Primary Health Care,N04.590.233.727
21500611,2010-12-01T00:00:00,Qualitative Research,H01.770.644.241.850
21500611,2010-12-01T00:00:00,Quality of Health Care,N04.761
21500611,2010-12-01T00:00:00,Quality of Health Care,N05.715
21500611,2010-12-01T00:00:00,South Carolina,Z01.107.567.875.075.662
21500611,2010-12-01T00:00:00,South Carolina,Z01.107.567.875.750.700
21510013,2010-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21510013,2010-12-01T00:00:00,Iron,D01.268.556.412
21510013,2010-12-01T00:00:00,Iron,D01.268.956.287
21510013,2010-12-01T00:00:00,Iron,D01.552.544.412
21510013,2010-12-01T00:00:00,Transferrin,D12.776.124.050.800
21510013,2010-12-01T00:00:00,Transferrin,D12.776.124.790.223.839
21510013,2010-12-01T00:00:00,Transferrin,D12.776.157.427.500
21510013,2010-12-01T00:00:00,Transferrin,D12.776.377.715.182.839
21510013,2010-12-01T00:00:00,Transferrin,D12.776.556.579.500
21127304,2010-12-02T00:00:00,Evidence-Based Medicine,H02.249.750
21127304,2010-12-02T00:00:00,Evidence-Based Medicine,H02.403.200.400
21127304,2010-12-02T00:00:00,Health Personnel,M01.526.485
21127304,2010-12-02T00:00:00,Health Personnel,N02.360
21127304,2010-12-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21127304,2010-12-02T00:00:00,Primary Prevention,N02.421.726.758
21127304,2010-12-02T00:00:00,Primary Prevention,N06.850.780.680
21127304,2010-12-02T00:00:00,Risk Factors,E05.318.740.600.800.725
21127304,2010-12-02T00:00:00,Risk Factors,N05.715.350.200.700
21127304,2010-12-02T00:00:00,Risk Factors,N05.715.360.750.625.700.700
21127304,2010-12-02T00:00:00,Risk Factors,N06.850.490.625.750
21127304,2010-12-02T00:00:00,Risk Factors,N06.850.520.830.600.800.725
21127304,2010-12-02T00:00:00,Stroke,C10.228.140.300.775
21127304,2010-12-02T00:00:00,Stroke,C14.907.253.855
21127304,2010-12-02T00:00:00,United States,Z01.107.567.875
21127808,2010-12-02T00:00:00,Animals,B01.050
21127808,2010-12-02T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
21127808,2010-12-02T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
21127808,2010-12-02T00:00:00,Environmental Exposure,N06.850.460.350
21127808,2010-12-02T00:00:00,Environmental Pollutants,D27.888.284
21127808,2010-12-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21127808,2010-12-02T00:00:00,Hypertension,C14.907.489
21127808,2010-12-02T00:00:00,Polychlorinated Biphenyls,D02.455.426.559.389.185.698
21127808,2010-12-02T00:00:00,Polychlorinated Biphenyls,D02.455.526.439.773
21129719,2010-12-02T00:00:00,Aged,M01.060.116.100
21129719,2010-12-02T00:00:00,Disease Progression,C23.550.291.656
21129719,2010-12-02T00:00:00,Echocardiography,E01.370.350.850.220
21129719,2010-12-02T00:00:00,Echocardiography,E01.370.370.380.220
21129719,2010-12-02T00:00:00,Heart Failure,C14.280.434
21129719,2010-12-02T00:00:00,Heart Ventricles,A07.541.560
21129719,2010-12-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21129719,2010-12-02T00:00:00,"Hypertrophy, Left Ventricular",C14.280.195.400
21129719,2010-12-02T00:00:00,"Hypertrophy, Left Ventricular",C23.300.775.250.400
21129719,2010-12-02T00:00:00,Stroke Volume,E01.370.370.380.150.700
21129719,2010-12-02T00:00:00,Stroke Volume,G09.330.380.124.882
21129719,2010-12-02T00:00:00,Time Factors,G01.910.857
21129719,2010-12-02T00:00:00,Ventricular Remodeling,C23.300.985
21129719,2010-12-02T00:00:00,Ventricular Remodeling,G09.330.190.962.975
21127968,2010-12-03T00:00:00,Animals,B01.050
21127968,2010-12-03T00:00:00,Calpain,D08.811.277.656.262.500.120
21127968,2010-12-03T00:00:00,Calpain,D08.811.277.656.300.200.120
21127968,2010-12-03T00:00:00,Cell Death,G04.299.139
21127968,2010-12-03T00:00:00,Cytokines,D12.644.276.374
21127968,2010-12-03T00:00:00,Cytokines,D12.776.467.374
21127968,2010-12-03T00:00:00,Cytokines,D23.529.374
21127968,2010-12-03T00:00:00,Estradiol,D04.808.365.415.248
21127968,2010-12-03T00:00:00,Estradiol,D06.472.334.851.437.500
21127968,2010-12-03T00:00:00,Estrogen Receptor alpha,D12.776.260.698.750.350.174
21127968,2010-12-03T00:00:00,Estrogen Receptor alpha,D12.776.826.750.350.174
21127968,2010-12-03T00:00:00,Estrogen Receptor alpha,D12.776.930.669.750.350.174
21127968,2010-12-03T00:00:00,Estrogens,D27.505.696.399.472.277
21127968,2010-12-03T00:00:00,Lipopolysaccharides,D09.400.500
21127968,2010-12-03T00:00:00,Lipopolysaccharides,D09.698.718.450
21127968,2010-12-03T00:00:00,Lipopolysaccharides,D10.494
21127968,2010-12-03T00:00:00,Lipopolysaccharides,D23.050.161.616.525
21127968,2010-12-03T00:00:00,Lipopolysaccharides,D23.946.123.329.500
21127968,2010-12-03T00:00:00,Microglia,A08.637.400
21127968,2010-12-03T00:00:00,Microglia,A11.650.400
21127968,2010-12-03T00:00:00,Pyrazoles,D03.383.129.539
21127968,2010-12-03T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
21127971,2010-12-03T00:00:00,Animals,B01.050
21127971,2010-12-03T00:00:00,Apoptosis,G04.299.139.160
21127971,2010-12-03T00:00:00,Calpain,D08.811.277.656.262.500.120
21127971,2010-12-03T00:00:00,Calpain,D08.811.277.656.300.200.120
21127971,2010-12-03T00:00:00,Hippocampus,A08.186.211.464.405
21127971,2010-12-03T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
21127971,2010-12-03T00:00:00,Ion Channel Gating,G02.111.087.800.400
21127971,2010-12-03T00:00:00,Ion Channel Gating,G02.149.115.800.400
21127971,2010-12-03T00:00:00,Ion Channel Gating,G04.299.500
21127971,2010-12-03T00:00:00,Ion Channel Gating,G04.299.880.400
21127971,2010-12-03T00:00:00,Ion Channel Gating,G07.265.337.500
21127971,2010-12-03T00:00:00,Ion Channel Gating,G07.700.240.500
21127971,2010-12-03T00:00:00,Neurons,A08.663
21127971,2010-12-03T00:00:00,Neurons,A11.671
21127971,2010-12-03T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
21127971,2010-12-03T00:00:00,Reactive Oxygen Species,D01.339.431
21127971,2010-12-03T00:00:00,Reactive Oxygen Species,D01.650.775
21127971,2010-12-03T00:00:00,bcl-2-Associated X Protein,D12.644.360.075.718.400
21127971,2010-12-03T00:00:00,bcl-2-Associated X Protein,D12.776.476.075.718.400
21128067,2010-12-03T00:00:00,Adult,M01.060.116
21128067,2010-12-03T00:00:00,Aged,M01.060.116.100
21128067,2010-12-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21128067,2010-12-03T00:00:00,Middle Aged,M01.060.116.630
21128067,2010-12-03T00:00:00,Risk Factors,E05.318.740.600.800.725
21128067,2010-12-03T00:00:00,Risk Factors,N05.715.350.200.700
21128067,2010-12-03T00:00:00,Risk Factors,N05.715.360.750.625.700.700
21128067,2010-12-03T00:00:00,Risk Factors,N06.850.490.625.750
21128067,2010-12-03T00:00:00,Risk Factors,N06.850.520.830.600.800.725
21128067,2010-12-03T00:00:00,Suburethral Slings,E07.695.752
21128067,2010-12-03T00:00:00,Urinary Bladder Neck Obstruction,C12.777.767.700.962
21128067,2010-12-03T00:00:00,Urinary Bladder Neck Obstruction,C12.777.829.760
21128067,2010-12-03T00:00:00,Urinary Bladder Neck Obstruction,C13.351.968.767.700.850
21128067,2010-12-03T00:00:00,Urinary Bladder Neck Obstruction,C13.351.968.829.601
21128067,2010-12-03T00:00:00,"Urinary Incontinence, Stress",C12.777.934.852.249
21128067,2010-12-03T00:00:00,"Urinary Incontinence, Stress",C13.351.968.934.814.500
21128067,2010-12-03T00:00:00,"Urinary Incontinence, Stress",C23.888.942.800.500
21128067,2010-12-03T00:00:00,Urodynamics,G08.852.898
21128067,2010-12-03T00:00:00,Urologic Surgical Procedures,E04.950.774
21130732,2010-12-03T00:00:00,Animals,B01.050
21130732,2010-12-03T00:00:00,Calcium,D01.268.552.100
21130732,2010-12-03T00:00:00,Calcium,D01.552.539.288
21130732,2010-12-03T00:00:00,Calcium,D23.119.100
21130732,2010-12-03T00:00:00,Endoplasmic Reticulum,A11.284.430.214.190.875.248
21130732,2010-12-03T00:00:00,Fluorescent Dyes,D27.720.233.348
21130732,2010-12-03T00:00:00,Fluorescent Dyes,D27.720.470.330.348
21130732,2010-12-03T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
21130732,2010-12-03T00:00:00,"Kidney Tubules, Proximal",A05.810.453.736.560.570
21130732,2010-12-03T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
21130732,2010-12-03T00:00:00,"Microscopy, Confocal",E05.595.395
21130732,2010-12-03T00:00:00,Rabbits,B01.050.150.900.649.521.700
21132164,2010-12-03T00:00:00,Crystallization,E05.196.300
21132164,2010-12-03T00:00:00,Crystallization,G02.149.767.505
21132164,2010-12-03T00:00:00,Crystallization,G02.842.750.505
21132164,2010-12-03T00:00:00,Equipment Failure Analysis,E05.325.192
21132164,2010-12-03T00:00:00,Materials Testing,E05.570
21132164,2010-12-03T00:00:00,Multiprotein Complexes,D05.500
21132164,2010-12-03T00:00:00,Nanostructures,J01.637.512
21132164,2010-12-03T00:00:00,Nanotechnology,H01.603
21132164,2010-12-03T00:00:00,Nanotechnology,J01.897.520.600
21132164,2010-12-03T00:00:00,Peptides,D12.644
21132164,2010-12-03T00:00:00,Surface Properties,G02.842.850
21132164,2010-12-03T00:00:00,Tissue Scaffolds,E07.206.627
21132164,2010-12-03T00:00:00,Tissue Scaffolds,E07.695.825
21377123,2010-12-04T00:00:00,"Adaptation, Physiological",G07.700.062
21377123,2010-12-04T00:00:00,"Adaptation, Physiological",G16.100.057.500
21377123,2010-12-04T00:00:00,Adult,M01.060.116
21377123,2010-12-04T00:00:00,Altitude,G16.500.275.058
21377123,2010-12-04T00:00:00,Altitude,N06.230.058
21377123,2010-12-04T00:00:00,Exercise,G11.427.590.237
21377123,2010-12-04T00:00:00,Exercise,I03.350
21377123,2010-12-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21377123,2010-12-04T00:00:00,Middle Aged,M01.060.116.630
21165023,2010-12-06T00:00:00,Equipment Failure Analysis,E05.325.192
21165023,2010-12-06T00:00:00,Fiber Optic Technology,H01.671.617.249
21165023,2010-12-06T00:00:00,Glass,J01.637.241.400
21165023,2010-12-06T00:00:00,Glass,J01.637.437
21165023,2010-12-06T00:00:00,Materials Testing,E05.570
21165023,2010-12-06T00:00:00,Photometry,E05.196.712
21165023,2010-12-06T00:00:00,Refractometry,E05.196.808
21165023,2010-12-06T00:00:00,Refractometry,H01.671.617.755
21165023,2010-12-06T00:00:00,Systems Integration,H01.770.787
21165023,2010-12-06T00:00:00,Systems Integration,L01.906.787
21165023,2010-12-06T00:00:00,Transducers,E07.305.812
21136279,2010-12-07T00:00:00,Animals,B01.050
21136279,2010-12-07T00:00:00,Brain,A08.186.211
21136279,2010-12-07T00:00:00,Central Nervous System,A08.186
21136279,2010-12-07T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.114.703.300
21136279,2010-12-07T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.314.350.250
21136279,2010-12-07T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C20.111.258.625.300
21136279,2010-12-07T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",E05.598.500.500.500
21136279,2010-12-07T00:00:00,Inflammation,C23.550.470
21136279,2010-12-07T00:00:00,Lymphocytes,A11.118.637.555.567
21136279,2010-12-07T00:00:00,Lymphocytes,A15.145.229.637.555.567
21136279,2010-12-07T00:00:00,Lymphocytes,A15.382.490.555.567
21136279,2010-12-07T00:00:00,Macrophages,A11.329.372
21136279,2010-12-07T00:00:00,Macrophages,A11.627.482
21136279,2010-12-07T00:00:00,Macrophages,A11.733.397
21136279,2010-12-07T00:00:00,Macrophages,A15.382.680.397
21136279,2010-12-07T00:00:00,Macrophages,A15.382.812.522
21136279,2010-12-07T00:00:00,Multiple Sclerosis,C10.114.375.500
21136279,2010-12-07T00:00:00,Multiple Sclerosis,C10.314.350.500
21136279,2010-12-07T00:00:00,Multiple Sclerosis,C20.111.258.250.500
21136279,2010-12-07T00:00:00,Peptides,D12.644
21136279,2010-12-07T00:00:00,Time Factors,G01.910.857
21138294,2010-12-07T00:00:00,Adsorption,G02.149.047
21138294,2010-12-07T00:00:00,Adsorption,G02.149.767.029
21138294,2010-12-07T00:00:00,Adsorption,G02.842.750.029
21138294,2010-12-07T00:00:00,Environmental Remediation,N06.850.460.375
21138294,2010-12-07T00:00:00,Radiation Monitoring,E05.799.638
21138294,2010-12-07T00:00:00,Radiation Monitoring,N06.850.780.375.700
21138294,2010-12-07T00:00:00,Radiation Monitoring,N06.850.810.370
21138294,2010-12-07T00:00:00,Rivers,G01.311.750
21138294,2010-12-07T00:00:00,Rivers,G16.500.275.280.500
21138294,2010-12-07T00:00:00,Rivers,N06.230.232.500
21138294,2010-12-07T00:00:00,South Carolina,Z01.107.567.875.075.662
21138294,2010-12-07T00:00:00,South Carolina,Z01.107.567.875.750.700
21138294,2010-12-07T00:00:00,Water Movements,G16.500.240.960
21138294,2010-12-07T00:00:00,Water Movements,N06.230.850
21138294,2010-12-07T00:00:00,"Water Pollutants, Radioactive",D20.693.903
21138294,2010-12-07T00:00:00,"Water Pollutants, Radioactive",D27.888.284.903.821
21139061,2010-12-07T00:00:00,Alveolar Bone Loss,C05.116.264.150
21139061,2010-12-07T00:00:00,Alveolar Bone Loss,C07.465.714.354.500
21139061,2010-12-07T00:00:00,Animals,B01.050
21139061,2010-12-07T00:00:00,Cell Line,A11.251.210
21139061,2010-12-07T00:00:00,Gene Silencing,G05.355.315.203.374
21139061,2010-12-07T00:00:00,Inflammation,C23.550.470
21139061,2010-12-07T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
21139061,2010-12-07T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
21139061,2010-12-07T00:00:00,Macrophages,A11.329.372
21139061,2010-12-07T00:00:00,Macrophages,A11.627.482
21139061,2010-12-07T00:00:00,Macrophages,A11.733.397
21139061,2010-12-07T00:00:00,Macrophages,A15.382.680.397
21139061,2010-12-07T00:00:00,Macrophages,A15.382.812.522
21139061,2010-12-07T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
21139061,2010-12-07T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
21139061,2010-12-07T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
20969653,2010-12-08T00:00:00,Age Factors,N05.715.350.075
20969653,2010-12-08T00:00:00,Age Factors,N06.850.490.250
20969653,2010-12-08T00:00:00,Animals,B01.050
20969653,2010-12-08T00:00:00,"Disease Models, Animal",C22.232
20969653,2010-12-08T00:00:00,"Disease Models, Animal",E05.598.500
20969653,2010-12-08T00:00:00,"Disease Models, Animal",E05.599.395.080
20969653,2010-12-08T00:00:00,Dopamine,D02.092.211.215.311.342
20969653,2010-12-08T00:00:00,Dopamine,D02.092.311.342
20969653,2010-12-08T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.644.276.860.381.500
20969653,2010-12-08T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.776.467.860.381.500
20969653,2010-12-08T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.776.641.600.381.500
20969653,2010-12-08T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D23.529.850.381.500
20969653,2010-12-08T00:00:00,Lipopolysaccharides,D09.400.500
20969653,2010-12-08T00:00:00,Lipopolysaccharides,D09.698.718.450
20969653,2010-12-08T00:00:00,Lipopolysaccharides,D10.494
20969653,2010-12-08T00:00:00,Lipopolysaccharides,D23.050.161.616.525
20969653,2010-12-08T00:00:00,Lipopolysaccharides,D23.946.123.329.500
20969653,2010-12-08T00:00:00,Neurodegenerative Diseases,C10.574
20969653,2010-12-08T00:00:00,Neurons,A08.663
20969653,2010-12-08T00:00:00,Neurons,A11.671
20969653,2010-12-08T00:00:00,Pregnancy,G08.686.785.760.769
20969653,2010-12-08T00:00:00,Prenatal Exposure Delayed Effects,C13.703.824.500
20969653,2010-12-08T00:00:00,Substantia Nigra,A08.186.211.132.659.822.731
20969653,2010-12-08T00:00:00,Substantia Nigra,A08.186.211.653.822.731
20969653,2010-12-08T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
20969653,2010-12-08T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
20969653,2010-12-08T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
20969653,2010-12-08T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
20969653,2010-12-08T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
20969653,2010-12-08T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
20969653,2010-12-08T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
20969653,2010-12-08T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
20969653,2010-12-08T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
20969653,2010-12-08T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
20969653,2010-12-08T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
20969653,2010-12-08T00:00:00,Tyrosine 3-Monooxygenase,D08.811.682.690.708.923
20969653,2010-12-08T00:00:00,Tyrosine 3-Monooxygenase,D12.776.556.579.374.925
21143244,2010-12-08T00:00:00,Adult,M01.060.116
21143244,2010-12-08T00:00:00,Aged,M01.060.116.100
21143244,2010-12-08T00:00:00,Alcohol Drinking,F01.145.317.269
21143244,2010-12-08T00:00:00,Alcoholism,C21.739.100.250
21143244,2010-12-08T00:00:00,Alcoholism,F03.900.100.350
21143244,2010-12-08T00:00:00,"Behavior, Addictive",F01.145.527.100.120
21143244,2010-12-08T00:00:00,Cues,F02.463.425.234
21143244,2010-12-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21143244,2010-12-08T00:00:00,Middle Aged,M01.060.116.630
21143244,2010-12-08T00:00:00,Questionnaires,E05.318.308.750
21143244,2010-12-08T00:00:00,Questionnaires,L01.280.800
21143244,2010-12-08T00:00:00,Questionnaires,N05.715.360.300.695
21143244,2010-12-08T00:00:00,Questionnaires,N06.850.520.308.750
21143244,2010-12-08T00:00:00,"Stress, Psychological",F01.145.126.990
21143244,2010-12-08T00:00:00,"Stress, Psychological",F02.830.900
21143244,2010-12-08T00:00:00,Time Factors,G01.910.857
21143244,2010-12-08T00:00:00,Young Adult,M01.060.116.815
21144620,2010-12-08T00:00:00,Aging,G07.700.320.124
21144620,2010-12-08T00:00:00,Animals,B01.050
21144620,2010-12-08T00:00:00,Corpus Striatum,A08.186.211.730.885.287.249.487
21144620,2010-12-08T00:00:00,Dopamine,D02.092.211.215.311.342
21144620,2010-12-08T00:00:00,Dopamine,D02.092.311.342
21144620,2010-12-08T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.157.530.450.625.124
21144620,2010-12-08T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.157.530.562.374.500.500
21144620,2010-12-08T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.543.585.450.625.124
21144620,2010-12-08T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.543.585.562.374.500.500
21144620,2010-12-08T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.644.276.860.381.500
21144620,2010-12-08T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.776.467.860.381.500
21144620,2010-12-08T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.776.641.600.381.500
21144620,2010-12-08T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D23.529.850.381.500
21144620,2010-12-08T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.070.300.400.500
21144620,2010-12-08T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.100.150.400.500
21144620,2010-12-08T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.720.300.300.400.500
21144638,2010-12-08T00:00:00,Animals,B01.050
21144638,2010-12-08T00:00:00,Glutathione,D12.644.456.448
21144638,2010-12-08T00:00:00,Hydrogen Peroxide,D01.248.497.158.685.750.424
21144638,2010-12-08T00:00:00,Hydrogen Peroxide,D01.339.431.374.424
21144638,2010-12-08T00:00:00,Hydrogen Peroxide,D01.650.550.750.400
21144638,2010-12-08T00:00:00,"Models, Animal",E05.598
21144638,2010-12-08T00:00:00,Myocardial Reperfusion,E04.100.700.600
21144638,2010-12-08T00:00:00,Myocardial Reperfusion,E05.680.730.600
21144638,2010-12-08T00:00:00,Oxidative Stress,G03.495.710
21144638,2010-12-08T00:00:00,Oxidative Stress,G07.700.830.750
21144638,2010-12-08T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
21144638,2010-12-08T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
21147820,2010-12-08T00:00:00,Adolescent,M01.060.057
21147820,2010-12-08T00:00:00,Adult,M01.060.116
21147820,2010-12-08T00:00:00,Aged,M01.060.116.100
21147820,2010-12-08T00:00:00,"Cardiomyopathy, Dilated",C14.280.195.160
21147820,2010-12-08T00:00:00,"Cardiomyopathy, Dilated",C14.280.238.070
21147820,2010-12-08T00:00:00,Child,M01.060.406
21147820,2010-12-08T00:00:00,"Child, Preschool",M01.060.406.448
21147820,2010-12-08T00:00:00,Cytokines,D12.644.276.374
21147820,2010-12-08T00:00:00,Cytokines,D12.776.467.374
21147820,2010-12-08T00:00:00,Cytokines,D23.529.374
21147820,2010-12-08T00:00:00,Extracellular Matrix,A11.284.295.310
21147820,2010-12-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21147820,2010-12-08T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
21147820,2010-12-08T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
21147820,2010-12-08T00:00:00,Middle Aged,M01.060.116.630
21147820,2010-12-08T00:00:00,Myocardium,A02.633.580
21147820,2010-12-08T00:00:00,Myocardium,A07.541.704
21147820,2010-12-08T00:00:00,Myocardium,A10.690.552.750
21147820,2010-12-08T00:00:00,Tissue Inhibitor of Metalloproteinases,D12.776.926
21147894,2010-12-08T00:00:00,Adolescent,M01.060.057
21147894,2010-12-08T00:00:00,Adult,M01.060.116
21147894,2010-12-08T00:00:00,Aged,M01.060.116.100
21147894,2010-12-08T00:00:00,Benzazepines,D03.438.079
21147894,2010-12-08T00:00:00,Data Collection,E05.318.308
21147894,2010-12-08T00:00:00,Data Collection,L01.280
21147894,2010-12-08T00:00:00,Data Collection,N05.715.360.300
21147894,2010-12-08T00:00:00,Data Collection,N06.850.520.308
21147894,2010-12-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21147894,2010-12-08T00:00:00,Medication Adherence,F01.145.488.500.500
21147894,2010-12-08T00:00:00,Medication Adherence,N05.300.150.600.600.500
21147894,2010-12-08T00:00:00,Middle Aged,M01.060.116.630
21147894,2010-12-08T00:00:00,Nicotine,D03.132.760.570
21147894,2010-12-08T00:00:00,Nicotine,D03.383.725.518
21147894,2010-12-08T00:00:00,Prescription Drugs,D26.670
21147894,2010-12-08T00:00:00,Smoking Cessation,F01.145.940.700
21147894,2010-12-08T00:00:00,Time Factors,G01.910.857
21147894,2010-12-08T00:00:00,Tobacco Use Disorder,C21.739.912
21147894,2010-12-08T00:00:00,Tobacco Use Disorder,F03.900.912
21147894,2010-12-08T00:00:00,Treatment Outcome,E01.789.800
21147894,2010-12-08T00:00:00,Treatment Outcome,N04.761.559.590.800
21147894,2010-12-08T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21147894,2010-12-08T00:00:00,United States,Z01.107.567.875
21147894,2010-12-08T00:00:00,Young Adult,M01.060.116.815
21148174,2010-12-08T00:00:00,Child,M01.060.406
21148174,2010-12-08T00:00:00,Child Psychology,F04.096.628.193
21148174,2010-12-08T00:00:00,Epilepsy,C10.228.140.490
21148174,2010-12-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21150906,2010-12-08T00:00:00,Allosteric Regulation,G02.111.087.040
21150906,2010-12-08T00:00:00,Allosteric Regulation,G02.149.115.040
21150906,2010-12-08T00:00:00,Animals,B01.050
21150906,2010-12-08T00:00:00,Hippocampus,A08.186.211.464.405
21150906,2010-12-08T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
21150906,2010-12-08T00:00:00,Methamphetamine,D02.092.471.683.152.619
21150906,2010-12-08T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
21150906,2010-12-08T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.100.450
21150906,2010-12-08T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.720.200.450.500
21150906,2010-12-08T00:00:00,Self Administration,E02.319.890
21150906,2010-12-08T00:00:00,Self Administration,E02.900.890
21171162,2010-12-08T00:00:00,Animals,B01.050
21171162,2010-12-08T00:00:00,Biomimetic Materials,J01.637.087
21171162,2010-12-08T00:00:00,Collagen,D05.750.078.280
21171162,2010-12-08T00:00:00,Collagen,D12.776.860.300.250
21171162,2010-12-08T00:00:00,DNA,D13.444.308
21171162,2010-12-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21171162,2010-12-08T00:00:00,Materials Testing,E05.570
21171162,2010-12-08T00:00:00,Stem Cells,A11.872
21171162,2010-12-08T00:00:00,Time Factors,G01.910.857
21171162,2010-12-08T00:00:00,Tissue Scaffolds,E07.206.627
21171162,2010-12-08T00:00:00,Tissue Scaffolds,E07.695.825
21171162,2010-12-08T00:00:00,Water,D01.455.900
21171162,2010-12-08T00:00:00,Water,D01.650.550.925
21990848,2010-12-08T00:00:00,Angiography,E01.370.350.700.060
21990848,2010-12-08T00:00:00,Angiography,E01.370.370.050
21990848,2010-12-08T00:00:00,Arteries,A07.231.114
21990848,2010-12-08T00:00:00,Balloon Occlusion,E02.148.106
21990848,2010-12-08T00:00:00,Balloon Occlusion,E02.520.179
21990848,2010-12-08T00:00:00,"Embolization, Therapeutic",E02.520.360
21990848,2010-12-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21990848,2010-12-08T00:00:00,Middle Aged,M01.060.116.630
21145211,2010-12-09T00:00:00,Adult,M01.060.116
21145211,2010-12-09T00:00:00,Brain,A08.186.211
21145211,2010-12-09T00:00:00,Brain Mapping,E01.370.350.086
21145211,2010-12-09T00:00:00,Brain Mapping,E01.370.376.149
21145211,2010-12-09T00:00:00,Brain Mapping,E05.132
21145211,2010-12-09T00:00:00,Case-Control Studies,E05.318.760.500.500
21145211,2010-12-09T00:00:00,Case-Control Studies,N05.715.360.775.175.200
21145211,2010-12-09T00:00:00,Case-Control Studies,N06.850.520.450.500.500
21145211,2010-12-09T00:00:00,Cognition Disorders,F03.087.250
21145211,2010-12-09T00:00:00,Decision Making,F02.463.785.373
21145211,2010-12-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21145211,2010-12-09T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
21145211,2010-12-09T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
21145211,2010-12-09T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
21145211,2010-12-09T00:00:00,Neuropsychological Tests,F04.711.513
21145211,2010-12-09T00:00:00,Oxygen,D01.268.185.550
21145211,2010-12-09T00:00:00,Oxygen,D01.362.670
21145211,2010-12-09T00:00:00,Young Adult,M01.060.116.815
21145668,2010-12-09T00:00:00,Adolescent,M01.060.057
21145668,2010-12-09T00:00:00,Adult,M01.060.116
21145668,2010-12-09T00:00:00,Aged,M01.060.116.100
21145668,2010-12-09T00:00:00,Amphetamine-Related Disorders,C21.739.225
21145668,2010-12-09T00:00:00,Amphetamine-Related Disorders,F03.900.225
21145668,2010-12-09T00:00:00,Child,M01.060.406
21145668,2010-12-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21145668,2010-12-09T00:00:00,Methamphetamine,D02.092.471.683.152.619
21145668,2010-12-09T00:00:00,Middle Aged,M01.060.116.630
21145668,2010-12-09T00:00:00,South Carolina,Z01.107.567.875.075.662
21145668,2010-12-09T00:00:00,South Carolina,Z01.107.567.875.750.700
21145668,2010-12-09T00:00:00,Substance Abuse Treatment Centers,N02.278.035.128.800
21145668,2010-12-09T00:00:00,Substance Abuse Treatment Centers,N02.278.808.930
21145668,2010-12-09T00:00:00,United States,Z01.107.567.875
21145668,2010-12-09T00:00:00,Young Adult,M01.060.116.815
21148411,2010-12-09T00:00:00,Angiotensin II,D06.472.699.094.078
21148411,2010-12-09T00:00:00,Angiotensin II,D12.644.400.070.078
21148411,2010-12-09T00:00:00,Angiotensin II,D12.644.456.073.041
21148411,2010-12-09T00:00:00,Angiotensin II,D12.644.548.058.078
21148411,2010-12-09T00:00:00,Angiotensin II,D12.776.641.650.070.078
21148411,2010-12-09T00:00:00,Angiotensin II,D23.469.050.050.050
21148411,2010-12-09T00:00:00,Animals,B01.050
21148411,2010-12-09T00:00:00,Cell Proliferation,G04.299.233.750
21148411,2010-12-09T00:00:00,Cell Proliferation,G07.700.320.249.410.750
21148411,2010-12-09T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.567.342
21148411,2010-12-09T00:00:00,Extracellular Signal-Regulated MAP Kinases,D08.811.913.696.620.682.700.646.750.249
21148411,2010-12-09T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.644.360.450.169
21148411,2010-12-09T00:00:00,Extracellular Signal-Regulated MAP Kinases,D12.776.476.450.169
21148411,2010-12-09T00:00:00,Integrin alpha5beta1,D12.776.395.550.625.379
21148411,2010-12-09T00:00:00,Integrin alpha5beta1,D12.776.543.550.625.379
21148411,2010-12-09T00:00:00,Integrin alpha5beta1,D12.776.543.750.705.408.530.750
21148411,2010-12-09T00:00:00,Integrin alpha5beta1,D12.776.543.750.705.408.850.349
21148411,2010-12-09T00:00:00,Integrin alpha5beta1,D12.776.543.750.705.675.460
21148411,2010-12-09T00:00:00,Integrin alpha5beta1,D12.776.543.750.705.876.374
21148411,2010-12-09T00:00:00,Integrins,D12.776.543.750.705.408
21148411,2010-12-09T00:00:00,"Muscle, Smooth, Vascular",A02.633.570.491
21148411,2010-12-09T00:00:00,"Muscle, Smooth, Vascular",A07.231.491
21148411,2010-12-09T00:00:00,"Muscle, Smooth, Vascular",A10.690.467.491
21148411,2010-12-09T00:00:00,"Myocytes, Smooth Muscle",A11.620.520
21148411,2010-12-09T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
21148411,2010-12-09T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
21148411,2010-12-09T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.100.047.625
21148411,2010-12-09T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.720.600.150.625
21148411,2010-12-09T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.750.130.750
21148411,2010-12-09T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.750.555.150.750
21151011,2010-12-09T00:00:00,Adult,M01.060.116
21151011,2010-12-09T00:00:00,Blood Pressure,E01.370.600.875.249
21151011,2010-12-09T00:00:00,Blood Pressure,G09.330.380.076
21151011,2010-12-09T00:00:00,Genome-Wide Association Study,E05.318.416.249
21151011,2010-12-09T00:00:00,Genome-Wide Association Study,E05.318.780.392
21151011,2010-12-09T00:00:00,Genome-Wide Association Study,E05.393.385.500
21151011,2010-12-09T00:00:00,Genome-Wide Association Study,E05.393.522.500
21151011,2010-12-09T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
21151011,2010-12-09T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
21151011,2010-12-09T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
21151011,2010-12-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21151011,2010-12-09T00:00:00,Middle Aged,M01.060.116.630
21151011,2010-12-09T00:00:00,Quantitative Trait Loci,G05.360.340.024.380.937
21146185,2010-12-10T00:00:00,Child,M01.060.406
21146185,2010-12-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21146185,2010-12-10T00:00:00,Kidney,A05.810.453
21146185,2010-12-10T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
21146185,2010-12-10T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
21146185,2010-12-10T00:00:00,Ovary,A05.360.319.114.630
21146185,2010-12-10T00:00:00,Ovary,A05.360.576.497
21146185,2010-12-10T00:00:00,Ovary,A06.407.312.497
21146185,2010-12-10T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
21146185,2010-12-10T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
21146185,2010-12-10T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
21146185,2010-12-10T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
21146185,2010-12-10T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
21148554,2010-12-10T00:00:00,Animals,B01.050
21148554,2010-12-10T00:00:00,Apoptosis,G04.299.139.160
21148554,2010-12-10T00:00:00,Brain,A08.186.211
21148554,2010-12-10T00:00:00,Calcium,D01.268.552.100
21148554,2010-12-10T00:00:00,Calcium,D01.552.539.288
21148554,2010-12-10T00:00:00,Calcium,D23.119.100
21148554,2010-12-10T00:00:00,Calpain,D08.811.277.656.262.500.120
21148554,2010-12-10T00:00:00,Calpain,D08.811.277.656.300.200.120
21148554,2010-12-10T00:00:00,Homeostasis,G07.700.360
21148554,2010-12-10T00:00:00,Mitochondria,A11.284.430.214.190.875.564
21148554,2010-12-10T00:00:00,Mitochondria,A11.284.835.626
21148554,2010-12-10T00:00:00,Mitochondrial Proteins,D12.776.575
21148554,2010-12-10T00:00:00,Nerve Tissue Proteins,D12.776.641
21148554,2010-12-10T00:00:00,Oligodendroglia,A08.637.600
21148554,2010-12-10T00:00:00,Oligodendroglia,A11.650.600
21148554,2010-12-10T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
21148554,2010-12-10T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
21148554,2010-12-10T00:00:00,Sphingosine N-Acyltransferase,D08.811.913.050.712
21148554,2010-12-10T00:00:00,Stem Cells,A11.872
21148601,2010-12-10T00:00:00,Delphi Technique,L01.280.800.310
21148601,2010-12-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21148601,2010-12-10T00:00:00,Internationality,I01.615
21148601,2010-12-10T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
21148601,2010-12-10T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
21148601,2010-12-10T00:00:00,Terminology as Topic,L01.143.506.598.400
21152998,2010-12-10T00:00:00,Animals,B01.050
21152998,2010-12-10T00:00:00,Carbon Isotopes,D01.496.123
21152998,2010-12-10T00:00:00,Fibroins,D12.776.878.500
21152998,2010-12-10T00:00:00,Nitrogen Isotopes,D01.496.586
21152998,2010-12-10T00:00:00,"Nuclear Magnetic Resonance, Biomolecular",E05.196.867.519.550
21152998,2010-12-10T00:00:00,Spiders,B01.050.500.131.166.803
21272197,2010-12-10T00:00:00,Antihypertensive Agents,D27.505.954.411.162
21272197,2010-12-10T00:00:00,Blood Pressure,E01.370.600.875.249
21272197,2010-12-10T00:00:00,Blood Pressure,G09.330.380.076
21272197,2010-12-10T00:00:00,Case-Control Studies,E05.318.760.500.500
21272197,2010-12-10T00:00:00,Case-Control Studies,N05.715.360.775.175.200
21272197,2010-12-10T00:00:00,Case-Control Studies,N06.850.520.450.500.500
21272197,2010-12-10T00:00:00,Clinical Competence,I02.399.630.210
21272197,2010-12-10T00:00:00,Clinical Competence,N04.761.210
21272197,2010-12-10T00:00:00,Data Collection,E05.318.308
21272197,2010-12-10T00:00:00,Data Collection,L01.280
21272197,2010-12-10T00:00:00,Data Collection,N05.715.360.300
21272197,2010-12-10T00:00:00,Data Collection,N06.850.520.308
21272197,2010-12-10T00:00:00,"Education, Medical, Continuing",I02.358.212.350
21272197,2010-12-10T00:00:00,"Education, Medical, Continuing",I02.358.399.250
21272197,2010-12-10T00:00:00,Evidence-Based Medicine,H02.249.750
21272197,2010-12-10T00:00:00,Evidence-Based Medicine,H02.403.200.400
21272197,2010-12-10T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
21272197,2010-12-10T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
21272197,2010-12-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21272197,2010-12-10T00:00:00,Hypertension,C14.907.489
21272197,2010-12-10T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
21272197,2010-12-10T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
21272197,2010-12-10T00:00:00,Physician's Practice Patterns,N04.590.748
21272197,2010-12-10T00:00:00,Physician's Practice Patterns,N05.300.625
21272197,2010-12-10T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
21272197,2010-12-10T00:00:00,Practice Guidelines as Topic,N05.700.350.650
21272197,2010-12-10T00:00:00,Treatment Outcome,E01.789.800
21272197,2010-12-10T00:00:00,Treatment Outcome,N04.761.559.590.800
21272197,2010-12-10T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21152603,2010-12-13T00:00:00,Crystallization,E05.196.300
21152603,2010-12-13T00:00:00,Crystallization,G02.149.767.505
21152603,2010-12-13T00:00:00,Crystallization,G02.842.750.505
21152603,2010-12-13T00:00:00,Lipids,D10
21152603,2010-12-13T00:00:00,Membrane Proteins,D12.776.543
21152603,2010-12-13T00:00:00,Nanostructures,J01.637.512
21152603,2010-12-13T00:00:00,Polyethylene Glycols,D02.033.455.250.700
21152603,2010-12-13T00:00:00,Polyethylene Glycols,D05.750.741
21152603,2010-12-13T00:00:00,Polyethylene Glycols,D25.720.741
21152603,2010-12-13T00:00:00,Polyethylene Glycols,J01.637.051.720.741
21152603,2010-12-13T00:00:00,Polymers,D05.750
21152603,2010-12-13T00:00:00,Polymers,D25.720
21152603,2010-12-13T00:00:00,Polymers,J01.637.051.720
21214713,2010-12-13T00:00:00,African Continental Ancestry Group,M01.686.508.100
21214713,2010-12-13T00:00:00,Antihypertensive Agents,D27.505.954.411.162
21214713,2010-12-13T00:00:00,Blood Pressure,E01.370.600.875.249
21214713,2010-12-13T00:00:00,Blood Pressure,G09.330.380.076
21214713,2010-12-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21214713,2010-12-13T00:00:00,Hypertension,C14.907.489
21214713,2010-12-13T00:00:00,Life Style,F01.829.458
21216652,2010-12-13T00:00:00,Environmental Exposure,N06.850.460.350
21216652,2010-12-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21216652,2010-12-13T00:00:00,Risk Factors,E05.318.740.600.800.725
21216652,2010-12-13T00:00:00,Risk Factors,N05.715.350.200.700
21216652,2010-12-13T00:00:00,Risk Factors,N05.715.360.750.625.700.700
21216652,2010-12-13T00:00:00,Risk Factors,N06.850.490.625.750
21216652,2010-12-13T00:00:00,Risk Factors,N06.850.520.830.600.800.725
21216652,2010-12-13T00:00:00,Urban Population,N01.600.900
20869063,2010-12-15T00:00:00,Nanowires,J01.637.512.925
20869063,2010-12-15T00:00:00,Silver,D01.268.556.812
20869063,2010-12-15T00:00:00,Silver,D01.268.956.843
20869063,2010-12-15T00:00:00,Silver,D01.552.544.812
20869063,2010-12-15T00:00:00,Surface Properties,G02.842.850
20869063,2010-12-15T00:00:00,Temperature,G01.906.595
20869063,2010-12-15T00:00:00,Temperature,G16.500.275.063.725.710
20869063,2010-12-15T00:00:00,Temperature,G16.500.750.775.710
20869063,2010-12-15T00:00:00,Temperature,N06.230.150.450
20869063,2010-12-15T00:00:00,Temperature,N06.230.300.100.725.710
20981690,2010-12-15T00:00:00,Adolescent,M01.060.057
20981690,2010-12-15T00:00:00,Adult,M01.060.116
20981690,2010-12-15T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
20981690,2010-12-15T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
20981690,2010-12-15T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
20981690,2010-12-15T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
20981690,2010-12-15T00:00:00,Blood Transfusion,E02.095.135
20981690,2010-12-15T00:00:00,Child,M01.060.406
20981690,2010-12-15T00:00:00,Ferritins,D12.776.157.427.249
20981690,2010-12-15T00:00:00,Ferritins,D12.776.556.579.249
20981690,2010-12-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20981690,2010-12-15T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
20981690,2010-12-15T00:00:00,Liver,A03.620
20981690,2010-12-15T00:00:00,Young Adult,M01.060.116.815
21157476,2010-12-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21157476,2010-12-15T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
21157476,2010-12-15T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
21157476,2010-12-15T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
21157476,2010-12-15T00:00:00,Multicenter Studies as Topic,E05.318.760.535.500
21157476,2010-12-15T00:00:00,Multicenter Studies as Topic,E05.337.250.500
21157476,2010-12-15T00:00:00,Multicenter Studies as Topic,N05.715.360.775.235.545
21157476,2010-12-15T00:00:00,Multicenter Studies as Topic,N06.850.520.450.535.500
21157476,2010-12-15T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
21157476,2010-12-15T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
21157476,2010-12-15T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
21157476,2010-12-15T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
21159641,2010-12-15T00:00:00,Adenosine Triphosphate,D03.438.759.646.138.236
21159641,2010-12-15T00:00:00,Adenosine Triphosphate,D13.695.667.138.236
21159641,2010-12-15T00:00:00,Adenosine Triphosphate,D13.695.827.068.236
21159641,2010-12-15T00:00:00,Animals,B01.050
21159641,2010-12-15T00:00:00,"Carcinoma, Hepatocellular",C04.557.470.200.025.255
21159641,2010-12-15T00:00:00,"Carcinoma, Hepatocellular",C04.588.274.623.160
21159641,2010-12-15T00:00:00,"Carcinoma, Hepatocellular",C06.301.623.160
21159641,2010-12-15T00:00:00,"Carcinoma, Hepatocellular",C06.552.697.160
21159641,2010-12-15T00:00:00,Cell Membrane,A11.284.149
21159641,2010-12-15T00:00:00,Cyclic AMP,D03.438.759.646.138.395
21159641,2010-12-15T00:00:00,Cyclic AMP,D13.695.462.200
21159641,2010-12-15T00:00:00,Cyclic AMP,D13.695.667.138.395
21159641,2010-12-15T00:00:00,Cyclic AMP,D13.695.827.068.395
21159641,2010-12-15T00:00:00,Cyclic AMP-Dependent Protein Kinases,D08.811.913.696.620.682.700.150.125
21159641,2010-12-15T00:00:00,Cyclic AMP-Dependent Protein Kinases,D12.644.360.200.125
21159641,2010-12-15T00:00:00,Cyclic AMP-Dependent Protein Kinases,D12.776.476.200.125
21159641,2010-12-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21159641,2010-12-15T00:00:00,Liver Neoplasms,C04.588.274.623
21159641,2010-12-15T00:00:00,Liver Neoplasms,C06.301.623
21159641,2010-12-15T00:00:00,Liver Neoplasms,C06.552.697
21159641,2010-12-15T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
21159641,2010-12-15T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
21159641,2010-12-15T00:00:00,Neoplasms,C04
21159641,2010-12-15T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
21159641,2010-12-15T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
21159641,2010-12-15T00:00:00,Tubulin,D05.750.078.734.800
21159641,2010-12-15T00:00:00,Tubulin,D12.776.220.600.800
21159641,2010-12-15T00:00:00,Tubulin,D12.776.641.920
21159942,2010-12-15T00:00:00,Adolescent,M01.060.057
21159942,2010-12-15T00:00:00,Adult,M01.060.116
21159942,2010-12-15T00:00:00,Aged,M01.060.116.100
21159942,2010-12-15T00:00:00,Child,M01.060.406
21159942,2010-12-15T00:00:00,"Child, Preschool",M01.060.406.448
21159942,2010-12-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21159942,2010-12-15T00:00:00,Infant,M01.060.703
21159942,2010-12-15T00:00:00,"Infant, Newborn",M01.060.703.520
21159942,2010-12-15T00:00:00,Middle Aged,M01.060.116.630
21159942,2010-12-15T00:00:00,"RNA, Viral",D13.444.735.828
21159942,2010-12-15T00:00:00,Time Factors,G01.910.857
21159942,2010-12-15T00:00:00,United States,Z01.107.567.875
21159942,2010-12-15T00:00:00,Virology,H01.158.273.540.859
21159942,2010-12-15T00:00:00,Young Adult,M01.060.116.815
21160029,2010-12-15T00:00:00,Animals,B01.050
21160029,2010-12-15T00:00:00,Cytoskeletal Proteins,D12.776.220
21160029,2010-12-15T00:00:00,Genetic Vectors,G05.360.337
21160029,2010-12-15T00:00:00,Hepatocytes,A11.436.348
21160029,2010-12-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21160029,2010-12-15T00:00:00,Membrane Proteins,D12.776.543
21160029,2010-12-15T00:00:00,Phosphorylation,G02.111.087.677
21160029,2010-12-15T00:00:00,Phosphorylation,G02.149.115.677
21160029,2010-12-15T00:00:00,Phosphorylation,G02.149.465.700
21160029,2010-12-15T00:00:00,Phosphorylation,G02.607.750.700
21160029,2010-12-15T00:00:00,Phosphorylation,G03.495.790
21160029,2010-12-15T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
21160056,2010-12-15T00:00:00,Adult,M01.060.116
21160056,2010-12-15T00:00:00,Aged,M01.060.116.100
21160056,2010-12-15T00:00:00,Diabetes Complications,C19.246.099
21160056,2010-12-15T00:00:00,Heart Diseases,C14.280
21160056,2010-12-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21160056,2010-12-15T00:00:00,Hypercholesterolemia,C18.452.584.500.500.396
21160056,2010-12-15T00:00:00,Hypertension,C14.907.489
21160056,2010-12-15T00:00:00,Incidence,E05.318.308.985.525.375
21160056,2010-12-15T00:00:00,Incidence,L01.280.975.525.375
21160056,2010-12-15T00:00:00,Incidence,N01.224.935.597.500
21160056,2010-12-15T00:00:00,Incidence,N06.850.505.400.975.525.375
21160056,2010-12-15T00:00:00,Incidence,N06.850.520.308.985.525.375
21160056,2010-12-15T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
21160056,2010-12-15T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
21160056,2010-12-15T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
21160056,2010-12-15T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
21160056,2010-12-15T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
21160056,2010-12-15T00:00:00,Metabolic Syndrome X,C18.452.625
21160056,2010-12-15T00:00:00,Middle Aged,M01.060.116.630
21160056,2010-12-15T00:00:00,Motor Activity,F01.145.632
21160056,2010-12-15T00:00:00,Motor Activity,G11.427.590.530.698
21160056,2010-12-15T00:00:00,Overweight,C23.888.144.699
21160056,2010-12-15T00:00:00,Overweight,E01.370.600.115.100.160.120.699
21160056,2010-12-15T00:00:00,Overweight,G07.100.100.160.120.699
21160056,2010-12-15T00:00:00,Smoking,F01.145.466.753
21160056,2010-12-15T00:00:00,Stroke,C10.228.140.300.775
21160056,2010-12-15T00:00:00,Stroke,C14.907.253.855
21160056,2010-12-15T00:00:00,United States,Z01.107.567.875
21160056,2010-12-15T00:00:00,Young Adult,M01.060.116.815
21163497,2010-12-15T00:00:00,Age Factors,N05.715.350.075
21163497,2010-12-15T00:00:00,Age Factors,N06.850.490.250
21163497,2010-12-15T00:00:00,Angiotensin-Converting Enzyme Inhibitors,D27.505.519.389.745.085
21163497,2010-12-15T00:00:00,Cardiac Surgical Procedures,E04.100.376
21163497,2010-12-15T00:00:00,Cardiac Surgical Procedures,E04.928.220
21163497,2010-12-15T00:00:00,"Child, Preschool",M01.060.406.448
21163497,2010-12-15T00:00:00,Down Syndrome,C10.597.606.643.220
21163497,2010-12-15T00:00:00,Down Syndrome,C16.131.077.327
21163497,2010-12-15T00:00:00,Down Syndrome,C16.131.260.260
21163497,2010-12-15T00:00:00,Down Syndrome,C16.320.180.260
21163497,2010-12-15T00:00:00,"Echocardiography, Doppler, Color",E01.370.350.850.220.220.220
21163497,2010-12-15T00:00:00,"Echocardiography, Doppler, Color",E01.370.350.850.850.220.220
21163497,2010-12-15T00:00:00,"Echocardiography, Doppler, Color",E01.370.350.850.850.850.850.220
21163497,2010-12-15T00:00:00,"Echocardiography, Doppler, Color",E01.370.370.380.220.220.220
21163497,2010-12-15T00:00:00,Hospital Mortality,E05.318.308.985.550.400
21163497,2010-12-15T00:00:00,Hospital Mortality,L01.280.975.550.400
21163497,2010-12-15T00:00:00,Hospital Mortality,N01.224.935.698.400
21163497,2010-12-15T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
21163497,2010-12-15T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
21163497,2010-12-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21163497,2010-12-15T00:00:00,Infant,M01.060.703
21163497,2010-12-15T00:00:00,"Infant, Newborn",M01.060.703.520
21163497,2010-12-15T00:00:00,Intensive Care,E02.760.190.400
21163497,2010-12-15T00:00:00,Intensive Care,N02.421.585.190.400
21163497,2010-12-15T00:00:00,Length of Stay,E02.760.400.480
21163497,2010-12-15T00:00:00,Length of Stay,N02.421.585.400.480
21163497,2010-12-15T00:00:00,Risk Assessment,E05.318.740.600.800.715
21163497,2010-12-15T00:00:00,Risk Assessment,N04.452.871.715
21163497,2010-12-15T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
21163497,2010-12-15T00:00:00,Risk Assessment,N06.850.505.715
21163497,2010-12-15T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
21163497,2010-12-15T00:00:00,Risk Factors,E05.318.740.600.800.725
21163497,2010-12-15T00:00:00,Risk Factors,N05.715.350.200.700
21163497,2010-12-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
21163497,2010-12-15T00:00:00,Risk Factors,N06.850.490.625.750
21163497,2010-12-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
21163497,2010-12-15T00:00:00,Time Factors,G01.910.857
21163497,2010-12-15T00:00:00,Treatment Outcome,E01.789.800
21163497,2010-12-15T00:00:00,Treatment Outcome,N04.761.559.590.800
21163497,2010-12-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21163497,2010-12-15T00:00:00,United States,Z01.107.567.875
21163614,2010-12-15T00:00:00,Cyclic AMP-Dependent Protein Kinases,D08.811.913.696.620.682.700.150.125
21163614,2010-12-15T00:00:00,Cyclic AMP-Dependent Protein Kinases,D12.644.360.200.125
21163614,2010-12-15T00:00:00,Cyclic AMP-Dependent Protein Kinases,D12.776.476.200.125
21163614,2010-12-15T00:00:00,Ethanol,D02.033.375
21163614,2010-12-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21163614,2010-12-15T00:00:00,Mutation,G05.365.590
21163614,2010-12-15T00:00:00,Phosphorylation,G02.111.087.677
21163614,2010-12-15T00:00:00,Phosphorylation,G02.149.115.677
21163614,2010-12-15T00:00:00,Phosphorylation,G02.149.465.700
21163614,2010-12-15T00:00:00,Phosphorylation,G02.607.750.700
21163614,2010-12-15T00:00:00,Phosphorylation,G03.495.790
21163614,2010-12-15T00:00:00,Protein Kinase C,D08.811.913.696.620.682.700.725
21163614,2010-12-15T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
21163614,2010-12-15T00:00:00,Recombinant Proteins,D12.776.828
21163614,2010-12-15T00:00:00,Serine,D12.125.154.800
21163614,2010-12-15T00:00:00,Serine,D12.125.837
21181319,2010-12-15T00:00:00,Adult,M01.060.116
21181319,2010-12-15T00:00:00,Aged,M01.060.116.100
21181319,2010-12-15T00:00:00,Double-Blind Method,E05.318.780.300
21181319,2010-12-15T00:00:00,Double-Blind Method,E05.581.500.300
21181319,2010-12-15T00:00:00,Double-Blind Method,N05.715.360.780.320
21181319,2010-12-15T00:00:00,Double-Blind Method,N06.850.520.445.300
21181319,2010-12-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21181319,2010-12-15T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
21181319,2010-12-15T00:00:00,Middle Aged,M01.060.116.630
21181319,2010-12-15T00:00:00,"Monitoring, Physiologic",E01.370.520
21181319,2010-12-15T00:00:00,Peptic Ulcer,C06.405.469.275.800
21181319,2010-12-15T00:00:00,Peptic Ulcer,C06.405.608
21181319,2010-12-15T00:00:00,Peptic Ulcer,C06.405.748.586
21181319,2010-12-15T00:00:00,Proton Pump Inhibitors,D27.505.519.389.848
21181319,2010-12-15T00:00:00,Treatment Outcome,E01.789.800
21181319,2010-12-15T00:00:00,Treatment Outcome,N04.761.559.590.800
21181319,2010-12-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21376857,2010-12-15T00:00:00,Auditory Perception,F02.463.593.071
21376857,2010-12-15T00:00:00,Automobile Driving,I03.125
21376857,2010-12-15T00:00:00,Computer Simulation,L01.224.160
21376857,2010-12-15T00:00:00,Discrimination (Psychology),F02.463.593.257
21376857,2010-12-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21376857,2010-12-15T00:00:00,Risk-Taking,F01.145.722
21376857,2010-12-15T00:00:00,Visual Perception,F02.463.593.932
21376857,2010-12-15T00:00:00,Young Adult,M01.060.116.815
21990220,2010-12-15T00:00:00,Adult,M01.060.116
21990220,2010-12-15T00:00:00,Aged,M01.060.116.100
21990220,2010-12-15T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
21990220,2010-12-15T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
21990220,2010-12-15T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
21990220,2010-12-15T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
21990220,2010-12-15T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
21990220,2010-12-15T00:00:00,Combined Modality Therapy,E02.186
21990220,2010-12-15T00:00:00,Head and Neck Neoplasms,C04.588.443
21990220,2010-12-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21990220,2010-12-15T00:00:00,Middle Aged,M01.060.116.630
21990220,2010-12-15T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
21990220,2010-12-15T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
21990220,2010-12-15T00:00:00,Neoplasm Staging,E01.370.550
21990220,2010-12-15T00:00:00,"Radiotherapy, Intensity-Modulated",E02.815.635.700.700
21990220,2010-12-15T00:00:00,"Radiotherapy, Intensity-Modulated",L01.700.508.100.710.600.550.700
21990220,2010-12-15T00:00:00,Risk Assessment,E05.318.740.600.800.715
21990220,2010-12-15T00:00:00,Risk Assessment,N04.452.871.715
21990220,2010-12-15T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
21990220,2010-12-15T00:00:00,Risk Assessment,N06.850.505.715
21990220,2010-12-15T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
21163916,2010-12-16T00:00:00,Aged,M01.060.116.100
21163916,2010-12-16T00:00:00,Alleles,G05.360.340.024.340.030
21163916,2010-12-16T00:00:00,Alzheimer Disease,C10.228.140.380.100
21163916,2010-12-16T00:00:00,Alzheimer Disease,C10.574.945.249
21163916,2010-12-16T00:00:00,Alzheimer Disease,F03.087.400.100
21163916,2010-12-16T00:00:00,Apolipoproteins E,D10.532.091.500
21163916,2010-12-16T00:00:00,Apolipoproteins E,D12.776.070.400.500
21163916,2010-12-16T00:00:00,Apolipoproteins E,D12.776.521.120.500
21163916,2010-12-16T00:00:00,Biological Markers,D23.101
21163916,2010-12-16T00:00:00,Cognition Disorders,F03.087.250
21163916,2010-12-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21163916,2010-12-16T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
21163916,2010-12-16T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
21163916,2010-12-16T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
21163916,2010-12-16T00:00:00,Middle Aged,M01.060.116.630
21163916,2010-12-16T00:00:00,Risk Factors,E05.318.740.600.800.725
21163916,2010-12-16T00:00:00,Risk Factors,N05.715.350.200.700
21163916,2010-12-16T00:00:00,Risk Factors,N05.715.360.750.625.700.700
21163916,2010-12-16T00:00:00,Risk Factors,N06.850.490.625.750
21163916,2010-12-16T00:00:00,Risk Factors,N06.850.520.830.600.800.725
21164127,2010-12-16T00:00:00,Age Factors,N05.715.350.075
21164127,2010-12-16T00:00:00,Age Factors,N06.850.490.250
21164127,2010-12-16T00:00:00,Aged,M01.060.116.100
21164127,2010-12-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21164127,2010-12-16T00:00:00,Middle Aged,M01.060.116.630
21164127,2010-12-16T00:00:00,Serum Albumin,D12.776.034.841
21164127,2010-12-16T00:00:00,Serum Albumin,D12.776.124.050.700
21164127,2010-12-16T00:00:00,Serum Albumin,D12.776.124.727
21164127,2010-12-16T00:00:00,Stroke,C10.228.140.300.775
21164127,2010-12-16T00:00:00,Stroke,C14.907.253.855
21164127,2010-12-16T00:00:00,Thrombolytic Therapy,E02.319.913
21164127,2010-12-16T00:00:00,Time Factors,G01.910.857
21168185,2010-12-17T00:00:00,Autoimmunity,G12.450.192
21168185,2010-12-17T00:00:00,Blood Coagulation,G09.188.124.560.150
21168185,2010-12-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21168185,2010-12-17T00:00:00,"Lung Diseases, Interstitial",C08.381.483
21168185,2010-12-17T00:00:00,Pulmonary Fibrosis,C08.381.765
21168185,2010-12-17T00:00:00,"Scleroderma, Systemic",C17.300.799
21168185,2010-12-17T00:00:00,"Scleroderma, Systemic",C17.800.784
21178299,2010-12-17T00:00:00,Adult,M01.060.116
21178299,2010-12-17T00:00:00,Aged,M01.060.116.100
21178299,2010-12-17T00:00:00,Alleles,G05.360.340.024.340.030
21178299,2010-12-17T00:00:00,Ethnic Groups,M01.686.754
21178299,2010-12-17T00:00:00,Ethnic Groups,N01.224.317
21178299,2010-12-17T00:00:00,European Continental Ancestry Group,M01.686.508.400
21178299,2010-12-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21178299,2010-12-17T00:00:00,Middle Aged,M01.060.116.630
21178299,2010-12-17T00:00:00,P-Glycoprotein,D12.776.157.530.100.652.500
21178299,2010-12-17T00:00:00,P-Glycoprotein,D12.776.157.530.450.074.500.500.750
21178299,2010-12-17T00:00:00,P-Glycoprotein,D12.776.395.550.020.610.610
21178299,2010-12-17T00:00:00,P-Glycoprotein,D12.776.543.550.192.610.610
21178299,2010-12-17T00:00:00,P-Glycoprotein,D12.776.543.585.100.610.500
21178299,2010-12-17T00:00:00,P-Glycoprotein,D12.776.543.585.450.074.500.500.750
21178299,2010-12-17T00:00:00,"Polymorphism, Genetic",G05.365.795
21168857,2010-12-18T00:00:00,"Child, Preschool",M01.060.406.448
21168857,2010-12-18T00:00:00,Double-Blind Method,E05.318.780.300
21168857,2010-12-18T00:00:00,Double-Blind Method,E05.581.500.300
21168857,2010-12-18T00:00:00,Double-Blind Method,N05.715.360.780.320
21168857,2010-12-18T00:00:00,Double-Blind Method,N06.850.520.445.300
21168857,2010-12-18T00:00:00,Drug Resistance,G07.690.320
21168857,2010-12-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21168857,2010-12-18T00:00:00,"Immunoglobulins, Intravenous",D12.776.124.486.485.114.619.393.536
21168857,2010-12-18T00:00:00,"Immunoglobulins, Intravenous",D12.776.124.486.485.114.632
21168857,2010-12-18T00:00:00,"Immunoglobulins, Intravenous",D12.776.124.790.651.114.632
21168857,2010-12-18T00:00:00,"Immunoglobulins, Intravenous",D12.776.377.715.548.114.632
21168857,2010-12-18T00:00:00,Immunologic Factors,D27.505.696.477
21168857,2010-12-18T00:00:00,Infant,M01.060.703
21168857,2010-12-18T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
21168857,2010-12-18T00:00:00,Treatment Outcome,E01.789.800
21168857,2010-12-18T00:00:00,Treatment Outcome,N04.761.559.590.800
21168857,2010-12-18T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21173236,2010-12-20T00:00:00,Acetylcysteine,D02.886.030.230.259
21173236,2010-12-20T00:00:00,Acetylcysteine,D12.125.166.230.259
21173236,2010-12-20T00:00:00,Animals,B01.050
21173236,2010-12-20T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
21173236,2010-12-20T00:00:00,Cocaine-Related Disorders,C21.739.300
21173236,2010-12-20T00:00:00,Cocaine-Related Disorders,F03.900.300
21173236,2010-12-20T00:00:00,Glutamic Acid,D12.125.067.750
21173236,2010-12-20T00:00:00,Glutamic Acid,D12.125.119.450
21173236,2010-12-20T00:00:00,Glutamic Acid,D12.125.427.300
21173236,2010-12-20T00:00:00,Homeostasis,G07.700.360
21173236,2010-12-20T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
21173236,2010-12-20T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
21173236,2010-12-20T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
21173236,2010-12-20T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.100.450
21173236,2010-12-20T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.720.200.450.500
21173236,2010-12-20T00:00:00,Signal Transduction,G02.111.087.800
21173236,2010-12-20T00:00:00,Signal Transduction,G02.149.115.800
21173236,2010-12-20T00:00:00,Signal Transduction,G04.299.880
21173236,2010-12-20T00:00:00,Synaptic Transmission,G02.111.087.800.850
21173236,2010-12-20T00:00:00,Synaptic Transmission,G02.149.115.800.850
21173236,2010-12-20T00:00:00,Synaptic Transmission,G04.299.880.850
21173236,2010-12-20T00:00:00,Synaptic Transmission,G07.265.337.900
21173236,2010-12-20T00:00:00,Synaptic Transmission,G07.700.240.900
21173236,2010-12-20T00:00:00,Synaptic Transmission,G11.561.600.835
21173258,2010-12-20T00:00:00,Environmental Monitoring,N06.850.460.350.080
21173258,2010-12-20T00:00:00,Environmental Monitoring,N06.850.780.375
21173258,2010-12-20T00:00:00,Mass Spectrometry,E05.196.566
21173258,2010-12-20T00:00:00,"Models, Theoretical",E05.599
21173258,2010-12-20T00:00:00,Nitrogen Isotopes,D01.496.586
21173258,2010-12-20T00:00:00,Rivers,G01.311.750
21173258,2010-12-20T00:00:00,Rivers,G16.500.275.280.500
21173258,2010-12-20T00:00:00,Rivers,N06.230.232.500
21173258,2010-12-20T00:00:00,United States,Z01.107.567.875
21173387,2010-12-20T00:00:00,Aged,M01.060.116.100
21173387,2010-12-20T00:00:00,Case-Control Studies,E05.318.760.500.500
21173387,2010-12-20T00:00:00,Case-Control Studies,N05.715.360.775.175.200
21173387,2010-12-20T00:00:00,Case-Control Studies,N06.850.520.450.500.500
21173387,2010-12-20T00:00:00,Dementia,C10.228.140.380
21173387,2010-12-20T00:00:00,Dementia,F03.087.400
21173387,2010-12-20T00:00:00,Discrimination (Psychology),F02.463.593.257
21173387,2010-12-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21173387,2010-12-20T00:00:00,Neuropsychological Tests,F04.711.513
21173387,2010-12-20T00:00:00,Psychometrics,F04.711.780
21176133,2010-12-21T00:00:00,Adolescent,M01.060.057
21176133,2010-12-21T00:00:00,Adult,M01.060.116
21176133,2010-12-21T00:00:00,DNA Methylation,G02.111.087.029.538.161
21176133,2010-12-21T00:00:00,DNA Methylation,G02.111.087.218
21176133,2010-12-21T00:00:00,DNA Methylation,G02.149.115.029.538.161
21176133,2010-12-21T00:00:00,DNA Methylation,G02.149.115.218
21176133,2010-12-21T00:00:00,DNA Methylation,G03.495.130.538.161
21176133,2010-12-21T00:00:00,DNA Methylation,G05.355.190
21176133,2010-12-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21176133,2010-12-21T00:00:00,Obesity,C18.654.726.500
21176133,2010-12-21T00:00:00,Obesity,C23.888.144.699.500
21176133,2010-12-21T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
21176133,2010-12-21T00:00:00,Obesity,G07.100.100.160.120.699.500
21176133,2010-12-21T00:00:00,Young Adult,M01.060.116.815
21179012,2010-12-21T00:00:00,Adult,M01.060.116
21179012,2010-12-21T00:00:00,"Diagnosis, Differential",E01.171
21179012,2010-12-21T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
21179012,2010-12-21T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
21179012,2010-12-21T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
21179012,2010-12-21T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
21179012,2010-12-21T00:00:00,Esophagus,A03.556.875.500
21179012,2010-12-21T00:00:00,Extracellular Space,A10.082.500
21179012,2010-12-21T00:00:00,Extracellular Space,A11.284.295
21179012,2010-12-21T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
21179012,2010-12-21T00:00:00,Heartburn,C23.888.821.525
21179012,2010-12-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21179012,2010-12-21T00:00:00,"Microscopy, Electron, Transmission",E01.370.350.515.402.580
21179012,2010-12-21T00:00:00,"Microscopy, Electron, Transmission",E05.595.402.580
21179012,2010-12-21T00:00:00,Middle Aged,M01.060.116.630
21179012,2010-12-21T00:00:00,Proton Pump Inhibitors,D27.505.519.389.848
21175109,2010-12-22T00:00:00,Aged,M01.060.116.100
21175109,2010-12-22T00:00:00,Chronic Disease,C23.550.291.500
21175109,2010-12-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21175109,2010-12-22T00:00:00,Middle Aged,M01.060.116.630
21175109,2010-12-22T00:00:00,Vitamin D,D04.808.812.768
21175109,2010-12-22T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
21186077,2010-12-22T00:00:00,Adult,M01.060.116
21186077,2010-12-22T00:00:00,Aged,M01.060.116.100
21186077,2010-12-22T00:00:00,"Carcinoma, Renal Cell",C04.557.470.200.025.390
21186077,2010-12-22T00:00:00,"Carcinoma, Renal Cell",C04.588.945.947.535.160
21186077,2010-12-22T00:00:00,"Carcinoma, Renal Cell",C12.758.820.750.160
21186077,2010-12-22T00:00:00,"Carcinoma, Renal Cell",C12.777.419.473.160
21186077,2010-12-22T00:00:00,"Carcinoma, Renal Cell",C13.351.937.820.535.160
21186077,2010-12-22T00:00:00,"Carcinoma, Renal Cell",C13.351.968.419.473.160
21186077,2010-12-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21186077,2010-12-22T00:00:00,Incidence,E05.318.308.985.525.375
21186077,2010-12-22T00:00:00,Incidence,L01.280.975.525.375
21186077,2010-12-22T00:00:00,Incidence,N01.224.935.597.500
21186077,2010-12-22T00:00:00,Incidence,N06.850.505.400.975.525.375
21186077,2010-12-22T00:00:00,Incidence,N06.850.520.308.985.525.375
21186077,2010-12-22T00:00:00,Kidney Neoplasms,C04.588.945.947.535
21186077,2010-12-22T00:00:00,Kidney Neoplasms,C12.758.820.750
21186077,2010-12-22T00:00:00,Kidney Neoplasms,C12.777.419.473
21186077,2010-12-22T00:00:00,Kidney Neoplasms,C13.351.937.820.535
21186077,2010-12-22T00:00:00,Kidney Neoplasms,C13.351.968.419.473
21186077,2010-12-22T00:00:00,Lymph Node Excision,E04.446
21186077,2010-12-22T00:00:00,Middle Aged,M01.060.116.630
21186077,2010-12-22T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
21186077,2010-12-22T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
21186077,2010-12-22T00:00:00,Neoplasm Staging,E01.370.550
21186077,2010-12-22T00:00:00,Nephrectomy,E04.950.774.435
21186077,2010-12-22T00:00:00,Postoperative Complications,C23.550.767
21186077,2010-12-22T00:00:00,Young Adult,M01.060.116.815
21186782,2010-12-22T00:00:00,Crystallization,E05.196.300
21186782,2010-12-22T00:00:00,Crystallization,G02.149.767.505
21186782,2010-12-22T00:00:00,Crystallization,G02.842.750.505
21186782,2010-12-22T00:00:00,Electric Conductivity,G01.201.249.277
21186782,2010-12-22T00:00:00,Materials Testing,E05.570
21186782,2010-12-22T00:00:00,Nanostructures,J01.637.512
21186782,2010-12-22T00:00:00,Nanotechnology,H01.603
21186782,2010-12-22T00:00:00,Nanotechnology,J01.897.520.600
21186782,2010-12-22T00:00:00,Semiconductors,E07.305.625
21186782,2010-12-22T00:00:00,Surface Properties,G02.842.850
21181282,2010-12-23T00:00:00,Adult,M01.060.116
21181282,2010-12-23T00:00:00,Aged,M01.060.116.100
21181282,2010-12-23T00:00:00,Aging,G07.700.320.124
21181282,2010-12-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21181282,2010-12-23T00:00:00,"Lens, Crystalline",A09.371.060.500
21181282,2010-12-23T00:00:00,Membrane Proteins,D12.776.543
21181282,2010-12-23T00:00:00,Middle Aged,M01.060.116.630
21181282,2010-12-23T00:00:00,Young Adult,M01.060.116.815
21185389,2010-12-23T00:00:00,Adult,M01.060.116
21185389,2010-12-23T00:00:00,Aged,M01.060.116.100
21185389,2010-12-23T00:00:00,Anti-Infective Agents,D27.505.954.122
21185389,2010-12-23T00:00:00,BK Virus,B04.280.640.615.100
21185389,2010-12-23T00:00:00,BK Virus,B04.909.204.210.620.615.100
21185389,2010-12-23T00:00:00,BK Virus,B04.909.574.204.670.615.100
21185389,2010-12-23T00:00:00,BK Virus,B04.909.675.615.100
21185389,2010-12-23T00:00:00,Hematopoietic Stem Cell Transplantation,E04.936.225.687.500
21185389,2010-12-23T00:00:00,Hemorrhage,C23.550.414
21185389,2010-12-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21185389,2010-12-23T00:00:00,Middle Aged,M01.060.116.630
21185401,2010-12-23T00:00:00,Aged,M01.060.116.100
21185401,2010-12-23T00:00:00,Heart Failure,C14.280.434
21185401,2010-12-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21185401,2010-12-23T00:00:00,Incidence,E05.318.308.985.525.375
21185401,2010-12-23T00:00:00,Incidence,L01.280.975.525.375
21185401,2010-12-23T00:00:00,Incidence,N01.224.935.597.500
21185401,2010-12-23T00:00:00,Incidence,N06.850.505.400.975.525.375
21185401,2010-12-23T00:00:00,Incidence,N06.850.520.308.985.525.375
21185401,2010-12-23T00:00:00,Middle Aged,M01.060.116.630
21185401,2010-12-23T00:00:00,"Tachycardia, Ventricular",C14.280.067.845.940
21185401,2010-12-23T00:00:00,"Tachycardia, Ventricular",C23.550.073.845.940
21185401,2010-12-23T00:00:00,Treatment Outcome,E01.789.800
21185401,2010-12-23T00:00:00,Treatment Outcome,N04.761.559.590.800
21185401,2010-12-23T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21185401,2010-12-23T00:00:00,Ventricular Fibrillation,C14.280.067.922
21185401,2010-12-23T00:00:00,Ventricular Fibrillation,C23.550.073.922
21205426,2010-12-23T00:00:00,Animals,B01.050
21205426,2010-12-23T00:00:00,Chick Embryo,A13.350.150
21205426,2010-12-23T00:00:00,Chick Embryo,A16.331.200
21205426,2010-12-23T00:00:00,Chickens,B01.050.150.900.248.350.150
21205426,2010-12-23T00:00:00,Chickens,B01.050.150.900.248.617.192
21205426,2010-12-23T00:00:00,Extracellular Matrix,A11.284.295.310
21205426,2010-12-23T00:00:00,Extracellular Matrix Proteins,D12.776.860.300
21205426,2010-12-23T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
21205426,2010-12-23T00:00:00,Heart Valves,A07.541.510
21205426,2010-12-23T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
21205426,2010-12-23T00:00:00,"Microscopy, Confocal",E05.595.395
21205426,2010-12-23T00:00:00,"Microscopy, Electron, Transmission",E01.370.350.515.402.580
21205426,2010-12-23T00:00:00,"Microscopy, Electron, Transmission",E05.595.402.580
21205427,2010-12-23T00:00:00,Animals,B01.050
21205427,2010-12-23T00:00:00,Carotid Arteries,A07.231.114.186
21205427,2010-12-23T00:00:00,Carotid Artery Diseases,C10.228.140.300.200
21205427,2010-12-23T00:00:00,Carotid Artery Diseases,C14.907.253.123
21205427,2010-12-23T00:00:00,Diagnostic Imaging,E01.370.350
21205427,2010-12-23T00:00:00,Fluorescent Dyes,D27.720.233.348
21205427,2010-12-23T00:00:00,Fluorescent Dyes,D27.720.470.330.348
21205427,2010-12-23T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
21205427,2010-12-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21205427,2010-12-23T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
21205427,2010-12-23T00:00:00,"Microscopy, Fluorescence",E05.595.458
21370410,2010-12-23T00:00:00,Adolescent,M01.060.057
21370410,2010-12-23T00:00:00,Adult,M01.060.116
21370410,2010-12-23T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
21370410,2010-12-23T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
21370410,2010-12-23T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
21370410,2010-12-23T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
21370410,2010-12-23T00:00:00,Blood Transfusion,E02.095.135
21370410,2010-12-23T00:00:00,Child,M01.060.406
21370410,2010-12-23T00:00:00,"Child, Preschool",M01.060.406.448
21370410,2010-12-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21370410,2010-12-23T00:00:00,Stroke,C10.228.140.300.775
21370410,2010-12-23T00:00:00,Stroke,C14.907.253.855
21370410,2010-12-23T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.700.560.260.850
21370410,2010-12-23T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.260.850
21370410,2010-12-23T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.850.870
21370410,2010-12-23T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.376.560.260.850
21370410,2010-12-23T00:00:00,Young Adult,M01.060.116.815
21493421,2010-12-23T00:00:00,Adult,M01.060.116
21493421,2010-12-23T00:00:00,Aged,M01.060.116.100
21493421,2010-12-23T00:00:00,Bone Screws,E07.695.130
21493421,2010-12-23T00:00:00,Bone Screws,E07.858.442.660.115
21493421,2010-12-23T00:00:00,Bone Screws,E07.858.690.650.115
21493421,2010-12-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21493421,2010-12-23T00:00:00,Mandible,A02.835.232.781.324.502.632
21493421,2010-12-23T00:00:00,Mandible,A14.521.632
21493421,2010-12-23T00:00:00,Middle Aged,M01.060.116.630
21493421,2010-12-23T00:00:00,"Sleep Apnea, Obstructive",C08.618.085.852.850
21493421,2010-12-23T00:00:00,"Sleep Apnea, Obstructive",C10.886.425.800.750.850
21493421,2010-12-23T00:00:00,Treatment Outcome,E01.789.800
21493421,2010-12-23T00:00:00,Treatment Outcome,N04.761.559.590.800
21493421,2010-12-23T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21184105,2010-12-24T00:00:00,Adult,M01.060.116
21184105,2010-12-24T00:00:00,Aged,M01.060.116.100
21184105,2010-12-24T00:00:00,Endosonography,E01.370.350.850.280
21184105,2010-12-24T00:00:00,Gastrointestinal Stromal Tumors,C04.588.274.476.308
21184105,2010-12-24T00:00:00,Gastrointestinal Stromal Tumors,C06.301.371.308
21184105,2010-12-24T00:00:00,Gastrointestinal Stromal Tumors,C06.405.249.308
21184105,2010-12-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21184105,2010-12-24T00:00:00,Middle Aged,M01.060.116.630
21184105,2010-12-24T00:00:00,"Ultrasonography, Interventional",E01.370.350.850.855
21187121,2010-12-25T00:00:00,Alligators and Crocodiles,B01.050.150.900.833.100
21187121,2010-12-25T00:00:00,Amino Acid Sequence,G02.111.570.060
21187121,2010-12-25T00:00:00,Amino Acid Sequence,L01.453.245.667.060
21187121,2010-12-25T00:00:00,Animals,B01.050
21187121,2010-12-25T00:00:00,Gene Expression Profiling,E05.393.332
21187121,2010-12-25T00:00:00,Gene Expression Regulation,G05.355.315
21187121,2010-12-25T00:00:00,Molecular Sequence Data,L01.453.245.667
21187121,2010-12-25T00:00:00,Phylogeny,G05.697
21187121,2010-12-25T00:00:00,Phylogeny,G16.100.275.605
21187121,2010-12-25T00:00:00,Phylogeny,L01.100.697
21187121,2010-12-25T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
21187121,2010-12-25T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
21187121,2010-12-25T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
21187121,2010-12-25T00:00:00,"RNA, Messenger",D13.444.735.544
21187121,2010-12-25T00:00:00,"Sequence Analysis, DNA",E05.393.760.700
21187121,2010-12-25T00:00:00,"Sequence Homology, Amino Acid",G02.111.810.200
21187121,2010-12-25T00:00:00,"Sequence Homology, Amino Acid",G05.810.200
21187121,2010-12-25T00:00:00,"Transcription, Genetic",G02.111.087.847
21187121,2010-12-25T00:00:00,"Transcription, Genetic",G02.149.115.847
21187121,2010-12-25T00:00:00,"Transcription, Genetic",G05.355.310.700
21188469,2010-12-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21188469,2010-12-25T00:00:00,Middle Aged,M01.060.116.630
21188469,2010-12-25T00:00:00,Neurosurgical Procedures,E04.525
21042239,2010-12-27T00:00:00,Adrenal Cortex Hormones,D06.472.040
21042239,2010-12-27T00:00:00,Adult,M01.060.116
21042239,2010-12-27T00:00:00,Aged,M01.060.116.100
21042239,2010-12-27T00:00:00,Combined Modality Therapy,E02.186
21042239,2010-12-27T00:00:00,Creatinine,D03.383.129.308.207
21042239,2010-12-27T00:00:00,Graft Rejection,G12.425.901.545.328
21042239,2010-12-27T00:00:00,Graft Survival,G12.425.901.545.340
21042239,2010-12-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21042239,2010-12-27T00:00:00,Kidney Transplantation,E02.870.500
21042239,2010-12-27T00:00:00,Kidney Transplantation,E04.936.450.485
21042239,2010-12-27T00:00:00,Kidney Transplantation,E04.950.774.400
21042239,2010-12-27T00:00:00,Liver Transplantation,E04.210.650
21042239,2010-12-27T00:00:00,Liver Transplantation,E04.936.450.490
21042239,2010-12-27T00:00:00,Liver Transplantation,E04.936.580.490
21042239,2010-12-27T00:00:00,Middle Aged,M01.060.116.630
21042239,2010-12-27T00:00:00,Pancreas Transplantation,E04.210.725
21042239,2010-12-27T00:00:00,Pancreas Transplantation,E04.936.450.650
21085061,2010-12-27T00:00:00,Adolescent,M01.060.057
21085061,2010-12-27T00:00:00,Adult,M01.060.116
21085061,2010-12-27T00:00:00,Aged,M01.060.116.100
21085061,2010-12-27T00:00:00,Diabetic Nephropathies,C12.777.419.192
21085061,2010-12-27T00:00:00,Diabetic Nephropathies,C13.351.968.419.192
21085061,2010-12-27T00:00:00,Diabetic Nephropathies,C19.246.099.875
21085061,2010-12-27T00:00:00,Diet,E05.272
21085061,2010-12-27T00:00:00,Diet,G07.610.240
21085061,2010-12-27T00:00:00,Ethnic Groups,M01.686.754
21085061,2010-12-27T00:00:00,Ethnic Groups,N01.224.317
21085061,2010-12-27T00:00:00,Glomerulonephritis,C12.777.419.570.363
21085061,2010-12-27T00:00:00,Glomerulonephritis,C13.351.968.419.570.363
21085061,2010-12-27T00:00:00,Graft Rejection,G12.425.901.545.328
21085061,2010-12-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21085061,2010-12-27T00:00:00,Kidney Transplantation,E02.870.500
21085061,2010-12-27T00:00:00,Kidney Transplantation,E04.936.450.485
21085061,2010-12-27T00:00:00,Kidney Transplantation,E04.950.774.400
21085061,2010-12-27T00:00:00,Middle Aged,M01.060.116.630
21085061,2010-12-27T00:00:00,Reoperation,E04.690
21085061,2010-12-27T00:00:00,Tissue Donors,M01.898
21085061,2010-12-27T00:00:00,Treatment Outcome,E01.789.800
21085061,2010-12-27T00:00:00,Treatment Outcome,N04.761.559.590.800
21085061,2010-12-27T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21085061,2010-12-27T00:00:00,United States,Z01.107.567.875
21187426,2010-12-27T00:00:00,Animals,B01.050
21187426,2010-12-27T00:00:00,Cell Proliferation,G04.299.233.750
21187426,2010-12-27T00:00:00,Cell Proliferation,G07.700.320.249.410.750
21187426,2010-12-27T00:00:00,Cell Survival,G04.299.316
21187426,2010-12-27T00:00:00,Fibroblasts,A11.329.228
21187426,2010-12-27T00:00:00,Fibroblasts,A11.872.228
21187426,2010-12-27T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
21187426,2010-12-27T00:00:00,Heat-Shock Proteins,D12.776.580.216
21187426,2010-12-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21187426,2010-12-27T00:00:00,Multiprotein Complexes,D05.500
21187426,2010-12-27T00:00:00,Proteins,D12.776
21187426,2010-12-27T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.260.676
21187426,2010-12-27T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.624.664.700.189
21187426,2010-12-27T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.660.765
21187426,2010-12-27T00:00:00,Proto-Oncogene Proteins c-pim-1,D08.811.913.696.620.682.700.776
21187426,2010-12-27T00:00:00,Proto-Oncogene Proteins c-pim-1,D12.776.624.664.700.191
21187426,2010-12-27T00:00:00,Trans-Activators,D12.776.260.755
21187426,2010-12-27T00:00:00,Trans-Activators,D12.776.930.900
21187426,2010-12-27T00:00:00,Trans-Activators,D12.776.964.925.984
21187426,2010-12-27T00:00:00,Transcription Factors,D12.776.930
21193063,2010-12-27T00:00:00,Aged,M01.060.116.100
21193063,2010-12-27T00:00:00,Heart Failure,C14.280.434
21193063,2010-12-27T00:00:00,Hemodynamics,G09.330.190.400
21193063,2010-12-27T00:00:00,Hemodynamics,G09.330.380
21193063,2010-12-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21193063,2010-12-27T00:00:00,Middle Aged,M01.060.116.630
21190261,2010-12-28T00:00:00,Adolescent,M01.060.057
21190261,2010-12-28T00:00:00,Adult,M01.060.116
21190261,2010-12-28T00:00:00,Ferritins,D12.776.157.427.249
21190261,2010-12-28T00:00:00,Ferritins,D12.776.556.579.249
21190261,2010-12-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21190261,2010-12-28T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
21190261,2010-12-28T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
21190261,2010-12-28T00:00:00,Myocardium,A02.633.580
21190261,2010-12-28T00:00:00,Myocardium,A07.541.704
21190261,2010-12-28T00:00:00,Myocardium,A10.690.552.750
21190261,2010-12-28T00:00:00,Treatment Outcome,E01.789.800
21190261,2010-12-28T00:00:00,Treatment Outcome,N04.761.559.590.800
21190261,2010-12-28T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21190261,2010-12-28T00:00:00,Young Adult,M01.060.116.815
21193273,2010-12-28T00:00:00,Adult,M01.060.116
21193273,2010-12-28T00:00:00,Cocaine,D02.145.074.722.388
21193273,2010-12-28T00:00:00,Cocaine,D03.132.889.354
21193273,2010-12-28T00:00:00,Cocaine,D03.605.869.388
21193273,2010-12-28T00:00:00,Cocaine,D04.075.080.875.099.722.388
21193273,2010-12-28T00:00:00,Cocaine-Related Disorders,C21.739.300
21193273,2010-12-28T00:00:00,Cocaine-Related Disorders,F03.900.300
21193273,2010-12-28T00:00:00,Cognition Disorders,F03.087.250
21193273,2010-12-28T00:00:00,Corpus Striatum,A08.186.211.730.885.287.249.487
21193273,2010-12-28T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
21193273,2010-12-28T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
21193273,2010-12-28T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
21193273,2010-12-28T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
21193273,2010-12-28T00:00:00,Frontal Lobe,A08.186.211.730.885.287.500.270
21193273,2010-12-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21193273,2010-12-28T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
21193273,2010-12-28T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
21193273,2010-12-28T00:00:00,Motor Cortex,A08.186.211.730.885.287.500.270.548
21193273,2010-12-28T00:00:00,Movement,G07.700.560
21193273,2010-12-28T00:00:00,Movement,G11.427.590.530
21193273,2010-12-28T00:00:00,Reaction Time,F02.830.650
21193273,2010-12-28T00:00:00,Reaction Time,F04.669.817
21193273,2010-12-28T00:00:00,Reaction Time,G11.561.677
21191126,2010-12-29T00:00:00,Alveolar Bone Loss,C05.116.264.150
21191126,2010-12-29T00:00:00,Alveolar Bone Loss,C07.465.714.354.500
21191126,2010-12-29T00:00:00,Animals,B01.050
21191126,2010-12-29T00:00:00,Collagen Type I,D05.750.078.280.300.100
21191126,2010-12-29T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
21191126,2010-12-29T00:00:00,Extracellular Matrix Proteins,D12.776.860.300
21191126,2010-12-29T00:00:00,Gingival Diseases,C07.465.714.258
21191126,2010-12-29T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
21191126,2010-12-29T00:00:00,Lipopolysaccharides,D09.400.500
21191126,2010-12-29T00:00:00,Lipopolysaccharides,D09.698.718.450
21191126,2010-12-29T00:00:00,Lipopolysaccharides,D10.494
21191126,2010-12-29T00:00:00,Lipopolysaccharides,D23.050.161.616.525
21191126,2010-12-29T00:00:00,Lipopolysaccharides,D23.946.123.329.500
21191126,2010-12-29T00:00:00,Maxilla,A02.835.232.781.324.502.645
21191126,2010-12-29T00:00:00,Maxilla,A14.521.645
21191126,2010-12-29T00:00:00,"Mice, Inbred Strains",B01.050.050.157.520
21191126,2010-12-29T00:00:00,"Mice, Inbred Strains",B01.050.050.199.520.520
21191126,2010-12-29T00:00:00,"Mice, Inbred Strains",B01.050.150.900.649.865.635.505.500.400
21191126,2010-12-29T00:00:00,Osteonectin,D12.776.157.125.715
21191126,2010-12-29T00:00:00,Osteonectin,D12.776.395.600
21191126,2010-12-29T00:00:00,Periodontitis,C07.465.714.533
21191126,2010-12-29T00:00:00,X-Ray Microtomography,E01.370.350.700.810.810.900
21191126,2010-12-29T00:00:00,X-Ray Microtomography,E01.370.350.825.810.810.900
21268004,2010-12-29T00:00:00,Animals,B01.050
21268004,2010-12-29T00:00:00,Antibodies,D12.776.124.486.485.114
21268004,2010-12-29T00:00:00,Antibodies,D12.776.124.790.651.114
21268004,2010-12-29T00:00:00,Antibodies,D12.776.377.715.548.114
21268004,2010-12-29T00:00:00,Apoptosis,G04.299.139.160
21268004,2010-12-29T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
21268004,2010-12-29T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
21268004,2010-12-29T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
21268004,2010-12-29T00:00:00,Cell Death,G04.299.139
21268004,2010-12-29T00:00:00,Cell Proliferation,G04.299.233.750
21268004,2010-12-29T00:00:00,Cell Proliferation,G07.700.320.249.410.750
21268004,2010-12-29T00:00:00,Cell Survival,G04.299.316
21268004,2010-12-29T00:00:00,Gene Expression,G05.355.310
21268004,2010-12-29T00:00:00,Interleukin-2,D12.644.276.374.465.502
21268004,2010-12-29T00:00:00,Interleukin-2,D12.644.276.374.480.372
21268004,2010-12-29T00:00:00,Interleukin-2,D12.776.467.374.465.502
21268004,2010-12-29T00:00:00,Interleukin-2,D12.776.467.374.480.372
21268004,2010-12-29T00:00:00,Interleukin-2,D23.529.374.465.502
21268004,2010-12-29T00:00:00,Interleukin-2,D23.529.374.480.372
21268004,2010-12-29T00:00:00,Lymphocyte Activation,E01.450.495.482
21268004,2010-12-29T00:00:00,Lymphocyte Activation,E05.478.594.530
21268004,2010-12-29T00:00:00,Lymphocyte Activation,G12.425.747
21268004,2010-12-29T00:00:00,Lymphocyte Activation,G12.450.050.400.545
21268004,2010-12-29T00:00:00,NF-kappa B,D12.776.260.600
21268004,2010-12-29T00:00:00,NF-kappa B,D12.776.660.600
21268004,2010-12-29T00:00:00,NF-kappa B,D12.776.930.600
21268004,2010-12-29T00:00:00,Phosphorylation,G02.111.087.677
21268004,2010-12-29T00:00:00,Phosphorylation,G02.149.115.677
21268004,2010-12-29T00:00:00,Phosphorylation,G02.149.465.700
21268004,2010-12-29T00:00:00,Phosphorylation,G02.607.750.700
21268004,2010-12-29T00:00:00,Phosphorylation,G03.495.790
21268004,2010-12-29T00:00:00,"Receptors, Tumor Necrosis Factor, Type I",D12.776.543.750.073.750
21268004,2010-12-29T00:00:00,"Receptors, Tumor Necrosis Factor, Type I",D12.776.543.750.705.852.760.597
21268004,2010-12-29T00:00:00,"Receptors, Tumor Necrosis Factor, Type I",D23.050.301.264.035.908
21268004,2010-12-29T00:00:00,"Receptors, Tumor Necrosis Factor, Type I",D23.101.100.110.912
21268004,2010-12-29T00:00:00,Signal Transduction,G02.111.087.800
21268004,2010-12-29T00:00:00,Signal Transduction,G02.149.115.800
21268004,2010-12-29T00:00:00,Signal Transduction,G04.299.880
21268004,2010-12-29T00:00:00,Transcription Factor RelA,D12.776.260.600.249
21268004,2010-12-29T00:00:00,Transcription Factor RelA,D12.776.660.600.249
21268004,2010-12-29T00:00:00,Transcription Factor RelA,D12.776.930.600.249
21268004,2010-12-29T00:00:00,"Transduction, Genetic",E05.393.350.800
21268004,2010-12-29T00:00:00,"Transduction, Genetic",G05.355.760.850
21268004,2010-12-29T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
21268004,2010-12-29T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
21268004,2010-12-29T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
21268004,2010-12-29T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
21268004,2010-12-29T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
21268004,2010-12-29T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
21268004,2010-12-29T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
21268004,2010-12-29T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
21268004,2010-12-29T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
21268004,2010-12-29T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
21268004,2010-12-29T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
21493422,2010-12-29T00:00:00,Continuous Positive Airway Pressure,E02.880.820.790.259
21493422,2010-12-29T00:00:00,Double-Blind Method,E05.318.780.300
21493422,2010-12-29T00:00:00,Double-Blind Method,E05.581.500.300
21493422,2010-12-29T00:00:00,Double-Blind Method,N05.715.360.780.320
21493422,2010-12-29T00:00:00,Double-Blind Method,N06.850.520.445.300
21493422,2010-12-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21493422,2010-12-29T00:00:00,Middle Aged,M01.060.116.630
21493422,2010-12-29T00:00:00,Patient Compliance,F01.145.488.500
21493422,2010-12-29T00:00:00,Patient Compliance,N05.300.150.600.600
21493422,2010-12-29T00:00:00,"Sleep Apnea, Obstructive",C08.618.085.852.850
21493422,2010-12-29T00:00:00,"Sleep Apnea, Obstructive",C10.886.425.800.750.850
21493422,2010-12-29T00:00:00,Treatment Outcome,E01.789.800
21493422,2010-12-29T00:00:00,Treatment Outcome,N04.761.559.590.800
21493422,2010-12-29T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21191399,2010-12-30T00:00:00,Animals,B01.050
21191399,2010-12-30T00:00:00,Biological Markers,D23.101
21191399,2010-12-30T00:00:00,Cell Differentiation,G04.299.151
21191399,2010-12-30T00:00:00,Down-Regulation,G02.111.087.225
21191399,2010-12-30T00:00:00,Down-Regulation,G02.149.115.225
21191399,2010-12-30T00:00:00,Down-Regulation,G05.355.315.200
21191399,2010-12-30T00:00:00,Down-Regulation,G07.690.812.230
21191399,2010-12-30T00:00:00,Down-Regulation,G07.700.680.230
21191399,2010-12-30T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
21191399,2010-12-30T00:00:00,Hair Follicle,A10.272.497.500
21191399,2010-12-30T00:00:00,Hair Follicle,A17.360.710
21191399,2010-12-30T00:00:00,Hair Follicle,A17.815.250.500
21191399,2010-12-30T00:00:00,Homeodomain Proteins,D12.776.260.400
21191399,2010-12-30T00:00:00,Keratinocytes,A11.436.397
21193455,2010-12-30T00:00:00,Animals,B01.050
21193455,2010-12-30T00:00:00,Antineoplastic Agents,D27.505.954.248
21193455,2010-12-30T00:00:00,Apoptosis,G04.299.139.160
21193455,2010-12-30T00:00:00,"Carcinoma, Hepatocellular",C04.557.470.200.025.255
21193455,2010-12-30T00:00:00,"Carcinoma, Hepatocellular",C04.588.274.623.160
21193455,2010-12-30T00:00:00,"Carcinoma, Hepatocellular",C06.301.623.160
21193455,2010-12-30T00:00:00,"Carcinoma, Hepatocellular",C06.552.697.160
21193455,2010-12-30T00:00:00,Cell Cycle,G04.299.134
21193455,2010-12-30T00:00:00,Ceramides,D02.065.313
21193455,2010-12-30T00:00:00,Ceramides,D09.400.410.420.525.200
21193455,2010-12-30T00:00:00,Ceramides,D10.390.470.675.200
21193455,2010-12-30T00:00:00,Ceramides,D10.570.877.360.612.200
21193455,2010-12-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21193455,2010-12-30T00:00:00,Liposomes,D25.479.517
21193455,2010-12-30T00:00:00,Liposomes,D26.255.260.517
21193455,2010-12-30T00:00:00,Liposomes,D27.720.280.260.517
21193455,2010-12-30T00:00:00,Liposomes,J01.637.051.479.517
21193455,2010-12-30T00:00:00,Liposomes,J01.637.087.500.517
21193455,2010-12-30T00:00:00,Liver Neoplasms,C04.588.274.623
21193455,2010-12-30T00:00:00,Liver Neoplasms,C06.301.623
21193455,2010-12-30T00:00:00,Liver Neoplasms,C06.552.697
21193455,2010-12-30T00:00:00,Nanoparticles,J01.637.512.600
21193455,2010-12-30T00:00:00,"Neovascularization, Pathologic",C23.550.589.500
21193455,2010-12-30T00:00:00,Phosphorylation,G02.111.087.677
21193455,2010-12-30T00:00:00,Phosphorylation,G02.149.115.677
21193455,2010-12-30T00:00:00,Phosphorylation,G02.149.465.700
21193455,2010-12-30T00:00:00,Phosphorylation,G02.607.750.700
21193455,2010-12-30T00:00:00,Phosphorylation,G03.495.790
21193455,2010-12-30T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
21193455,2010-12-30T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
21193455,2010-12-30T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
21194677,2010-12-30T00:00:00,African Americans,M01.686.508.100.100
21194677,2010-12-30T00:00:00,African Americans,M01.686.754.100
21194677,2010-12-30T00:00:00,"Antigens, CD44",D12.776.395.550.200.625.144
21194677,2010-12-30T00:00:00,"Antigens, CD44",D12.776.543.550.200.625.144
21194677,2010-12-30T00:00:00,"Antigens, CD44",D12.776.543.750.705.877.144
21194677,2010-12-30T00:00:00,"Antigens, CD44",D23.050.301.264.035.850.144
21194677,2010-12-30T00:00:00,"Antigens, CD44",D23.050.301.350.625.144
21194677,2010-12-30T00:00:00,"Antigens, CD44",D23.101.100.110.850.144
21194677,2010-12-30T00:00:00,European Continental Ancestry Group,M01.686.508.400
21194677,2010-12-30T00:00:00,Genetic Loci,G05.360.340.024.380
21194677,2010-12-30T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
21194677,2010-12-30T00:00:00,Genetic Predisposition to Disease,G05.380.355
21194677,2010-12-30T00:00:00,Hispanic Americans,M01.686.754.441
21194677,2010-12-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21194677,2010-12-30T00:00:00,Linkage Disequilibrium,G05.540.500
21194677,2010-12-30T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
21194677,2010-12-30T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
21194677,2010-12-30T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
21194865,2010-12-30T00:00:00,Adenosine,D03.438.759.590.138
21194865,2010-12-30T00:00:00,Adenosine,D13.570.583.138
21194865,2010-12-30T00:00:00,Adenosine,D13.570.800.096
21194865,2010-12-30T00:00:00,Aged,M01.060.116.100
21194865,2010-12-30T00:00:00,Chest Pain,C23.888.646.215
21194865,2010-12-30T00:00:00,Coronary Angiography,E01.370.350.700.060.200
21194865,2010-12-30T00:00:00,Coronary Angiography,E01.370.370.050.200
21194865,2010-12-30T00:00:00,Coronary Angiography,E01.370.370.380.200
21194865,2010-12-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21194865,2010-12-30T00:00:00,Middle Aged,M01.060.116.630
21194865,2010-12-30T00:00:00,Myocardial Perfusion Imaging,E01.370.350.710.600.500
21194865,2010-12-30T00:00:00,Myocardial Perfusion Imaging,E01.370.370.380.500
21194865,2010-12-30T00:00:00,Myocardial Perfusion Imaging,E01.370.384.730.354.500
21194865,2010-12-30T00:00:00,Pilot Projects,E05.318.760.750
21194865,2010-12-30T00:00:00,Pilot Projects,E05.337.737
21194865,2010-12-30T00:00:00,Pilot Projects,N05.715.360.775.625
21194865,2010-12-30T00:00:00,Pilot Projects,N06.850.520.450.720
21194865,2010-12-30T00:00:00,"Radiography, Dual-Energy Scanned Projection",E01.370.350.600.350.700.700
21194865,2010-12-30T00:00:00,"Radiography, Dual-Energy Scanned Projection",E01.370.350.700.700.700
21194865,2010-12-30T00:00:00,"Radiography, Dual-Energy Scanned Projection",E01.370.350.760.700
21194865,2010-12-30T00:00:00,"Radiography, Dual-Energy Scanned Projection",L01.224.308.380.800
21194865,2010-12-30T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
21194865,2010-12-30T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
21194865,2010-12-30T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
21194865,2010-12-30T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
21194865,2010-12-30T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
21194865,2010-12-30T00:00:00,Vasodilator Agents,D27.505.954.411.918
20027107,2011-01-01T00:00:00,Angiography,E01.370.350.700.060
20027107,2011-01-01T00:00:00,Angiography,E01.370.370.050
20027107,2011-01-01T00:00:00,"Antimetabolites, Antineoplastic",D27.505.519.186.144
20027107,2011-01-01T00:00:00,"Antimetabolites, Antineoplastic",D27.505.954.248.144
20027107,2011-01-01T00:00:00,"Antimetabolites, Antineoplastic",D27.888.569.042.030
20027107,2011-01-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
20027107,2011-01-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
20027107,2011-01-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
20027107,2011-01-01T00:00:00,"Breast Neoplasms, Male",C04.588.180.260
20027107,2011-01-01T00:00:00,"Breast Neoplasms, Male",C17.800.090.500.260
20027107,2011-01-01T00:00:00,"Carcinoma, Ductal, Breast",C04.557.470.200.025.232.500
20027107,2011-01-01T00:00:00,"Carcinoma, Ductal, Breast",C04.557.470.615.132.500
20027107,2011-01-01T00:00:00,"Carcinoma, Ductal, Breast",C04.588.180.390
20027107,2011-01-01T00:00:00,"Carcinoma, Ductal, Breast",C17.800.090.500.390
20027107,2011-01-01T00:00:00,Deoxycytidine,D03.383.742.680.245.500
20027107,2011-01-01T00:00:00,Deoxycytidine,D13.570.230.329
20027107,2011-01-01T00:00:00,Deoxycytidine,D13.570.685.245.500
20027107,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20027107,2011-01-01T00:00:00,Liver Neoplasms,C04.588.274.623
20027107,2011-01-01T00:00:00,Liver Neoplasms,C06.301.623
20027107,2011-01-01T00:00:00,Liver Neoplasms,C06.552.697
20027107,2011-01-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
20027107,2011-01-01T00:00:00,Lung Neoplasms,C08.381.540
20027107,2011-01-01T00:00:00,Lung Neoplasms,C08.785.520
20027107,2011-01-01T00:00:00,Middle Aged,M01.060.116.630
20027107,2011-01-01T00:00:00,Obesity,C18.654.726.500
20027107,2011-01-01T00:00:00,Obesity,C23.888.144.699.500
20027107,2011-01-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
20027107,2011-01-01T00:00:00,Obesity,G07.100.100.160.120.699.500
20192950,2011-01-01T00:00:00,Adult,M01.060.116
20192950,2011-01-01T00:00:00,Alcoholism,C21.739.100.250
20192950,2011-01-01T00:00:00,Alcoholism,F03.900.100.350
20192950,2011-01-01T00:00:00,Alleles,G05.360.340.024.340.030
20192950,2011-01-01T00:00:00,Antisocial Personality Disorder,F03.675.050
20192950,2011-01-01T00:00:00,Cognitive Therapy,F04.754.137.428
20192950,2011-01-01T00:00:00,Genetic Variation,G05.365
20192950,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20192950,2011-01-01T00:00:00,Middle Aged,M01.060.116.630
20192950,2011-01-01T00:00:00,Motivation,F01.658
20192950,2011-01-01T00:00:00,Motivation,F01.752.543.500.750
20192950,2011-01-01T00:00:00,Personality Inventory,F04.711.647.513
20192950,2011-01-01T00:00:00,"Polymorphism, Genetic",G05.365.795
20192950,2011-01-01T00:00:00,Psychotherapy,F04.754
20192950,2011-01-01T00:00:00,Serotonin Plasma Membrane Transport Proteins,D12.776.157.530.450.625.311
20192950,2011-01-01T00:00:00,Serotonin Plasma Membrane Transport Proteins,D12.776.157.530.562.374.875
20192950,2011-01-01T00:00:00,Serotonin Plasma Membrane Transport Proteins,D12.776.543.585.450.625.374
20192950,2011-01-01T00:00:00,Serotonin Plasma Membrane Transport Proteins,D12.776.543.585.562.374.875
20192950,2011-01-01T00:00:00,Sex Factors,N05.715.350.675
20192950,2011-01-01T00:00:00,Sex Factors,N06.850.490.875
20683885,2011-01-01T00:00:00,Animals,B01.050
20683885,2011-01-01T00:00:00,Cell Differentiation,G04.299.151
20683885,2011-01-01T00:00:00,Gene Expression Regulation,G05.355.315
20683885,2011-01-01T00:00:00,Homeodomain Proteins,D12.776.260.400
20683885,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20683885,2011-01-01T00:00:00,Osteoblasts,A11.329.629
20683885,2011-01-01T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
20683885,2011-01-01T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
20683885,2011-01-01T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
20683885,2011-01-01T00:00:00,Protein Isoforms,D12.776.800
20683885,2011-01-01T00:00:00,Stromal Cells,A11.329.830
20683885,2011-01-01T00:00:00,Transcription Factors,D12.776.930
20683885,2011-01-01T00:00:00,"Transcription, Genetic",G02.111.087.847
20683885,2011-01-01T00:00:00,"Transcription, Genetic",G02.149.115.847
20683885,2011-01-01T00:00:00,"Transcription, Genetic",G05.355.310.700
20683885,2011-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
20683885,2011-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
20683885,2011-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
20683885,2011-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
20683885,2011-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
20683885,2011-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
20683885,2011-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
20683885,2011-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
20683885,2011-01-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
20683885,2011-01-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
20683885,2011-01-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
20706140,2011-01-01T00:00:00,Adult,M01.060.116
20706140,2011-01-01T00:00:00,Aged,M01.060.116.100
20706140,2011-01-01T00:00:00,Aortic Valve,A07.541.510.110
20706140,2011-01-01T00:00:00,Bioprosthesis,E07.695.100
20706140,2011-01-01T00:00:00,"Cardiomyopathy, Dilated",C14.280.195.160
20706140,2011-01-01T00:00:00,"Cardiomyopathy, Dilated",C14.280.238.070
20706140,2011-01-01T00:00:00,Extracorporeal Membrane Oxygenation,E02.880.301
20706140,2011-01-01T00:00:00,Extracorporeal Membrane Oxygenation,E04.292.451
20706140,2011-01-01T00:00:00,Heart Failure,C14.280.434
20706140,2011-01-01T00:00:00,Heart Transplantation,E04.100.376.475
20706140,2011-01-01T00:00:00,Heart Transplantation,E04.928.220.390
20706140,2011-01-01T00:00:00,Heart Transplantation,E04.936.450.475
20706140,2011-01-01T00:00:00,Heart Valve Prosthesis,E07.695.310
20706140,2011-01-01T00:00:00,Heart Valve Prosthesis Implantation,E04.100.376.485
20706140,2011-01-01T00:00:00,Heart Valve Prosthesis Implantation,E04.650.410
20706140,2011-01-01T00:00:00,Heart Valve Prosthesis Implantation,E04.928.220.410
20706140,2011-01-01T00:00:00,Heart-Assist Devices,E04.050.430
20706140,2011-01-01T00:00:00,Heart-Assist Devices,E07.695.300.300
20706140,2011-01-01T00:00:00,Heart-Assist Devices,E07.858.082.374.300
20706140,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20706140,2011-01-01T00:00:00,Intensive Care,E02.760.190.400
20706140,2011-01-01T00:00:00,Intensive Care,N02.421.585.190.400
20706140,2011-01-01T00:00:00,Intracranial Hemorrhages,C10.228.140.300.535
20706140,2011-01-01T00:00:00,Intracranial Hemorrhages,C14.907.253.573
20706140,2011-01-01T00:00:00,Intracranial Hemorrhages,C23.550.414.913
20706140,2011-01-01T00:00:00,Middle Aged,M01.060.116.630
20706140,2011-01-01T00:00:00,Mitral Valve,A07.541.510.507
20706140,2011-01-01T00:00:00,Postoperative Complications,C23.550.767
20706140,2011-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
20706140,2011-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
20706140,2011-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
20706140,2011-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
20706140,2011-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
20842714,2011-01-01T00:00:00,Arthritis,C05.550.114
20842714,2011-01-01T00:00:00,Child,M01.060.406
20842714,2011-01-01T00:00:00,Health Personnel,M01.526.485
20842714,2011-01-01T00:00:00,Health Personnel,N02.360
20842714,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20842714,2011-01-01T00:00:00,Quality of Health Care,N04.761
20842714,2011-01-01T00:00:00,Quality of Health Care,N05.715
20842714,2011-01-01T00:00:00,Questionnaires,E05.318.308.750
20842714,2011-01-01T00:00:00,Questionnaires,L01.280.800
20842714,2011-01-01T00:00:00,Questionnaires,N05.715.360.300.695
20842714,2011-01-01T00:00:00,Questionnaires,N06.850.520.308.750
20865396,2011-01-01T00:00:00,Drug Delivery Systems,E02.319.300
20865396,2011-01-01T00:00:00,Enzymes,D08.811
20865396,2011-01-01T00:00:00,Lactic Acid,D02.241.511.459.450
20865396,2011-01-01T00:00:00,Liposomes,D25.479.517
20865396,2011-01-01T00:00:00,Liposomes,D26.255.260.517
20865396,2011-01-01T00:00:00,Liposomes,D27.720.280.260.517
20865396,2011-01-01T00:00:00,Liposomes,J01.637.051.479.517
20865396,2011-01-01T00:00:00,Liposomes,J01.637.087.500.517
20865396,2011-01-01T00:00:00,Molecular Structure,G02.111.570
20865396,2011-01-01T00:00:00,Molecular Structure,G02.575
20865396,2011-01-01T00:00:00,Molecular Structure,G02.842.575
20865396,2011-01-01T00:00:00,Muramidase,D08.811.277.450.642
20865396,2011-01-01T00:00:00,Nanoparticles,J01.637.512.600
20865396,2011-01-01T00:00:00,Polyglycolic Acid,D05.750.728.780
20865396,2011-01-01T00:00:00,Polyglycolic Acid,D25.720.728.780
20865396,2011-01-01T00:00:00,Polyglycolic Acid,J01.637.051.720.728.780
20865396,2011-01-01T00:00:00,Reactive Oxygen Species,D01.339.431
20865396,2011-01-01T00:00:00,Reactive Oxygen Species,D01.650.775
20865396,2011-01-01T00:00:00,Superoxide Dismutase,D08.811.682.881
20865396,2011-01-01T00:00:00,Thrombolytic Therapy,E02.319.913
20881846,2011-01-01T00:00:00,Adult,M01.060.116
20881846,2011-01-01T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
20881846,2011-01-01T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
20881846,2011-01-01T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
20881846,2011-01-01T00:00:00,Anxiety Disorders,F03.080
20881846,2011-01-01T00:00:00,Dibenzothiazepines,D02.886.680.702.500
20881846,2011-01-01T00:00:00,Dibenzothiazepines,D03.494.276
20881846,2011-01-01T00:00:00,Double-Blind Method,E05.318.780.300
20881846,2011-01-01T00:00:00,Double-Blind Method,E05.581.500.300
20881846,2011-01-01T00:00:00,Double-Blind Method,N05.715.360.780.320
20881846,2011-01-01T00:00:00,Double-Blind Method,N06.850.520.445.300
20881846,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20881846,2011-01-01T00:00:00,Treatment Outcome,E01.789.800
20881846,2011-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20881846,2011-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20888129,2011-01-01T00:00:00,Adult,M01.060.116
20888129,2011-01-01T00:00:00,Behavior Therapy,F04.754.137
20888129,2011-01-01T00:00:00,Carbon Monoxide,D01.200.250
20888129,2011-01-01T00:00:00,Carbon Monoxide,D01.362.200
20888129,2011-01-01T00:00:00,Carbon Monoxide,D01.650.550.250
20888129,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20888129,2011-01-01T00:00:00,Motivation,F01.658
20888129,2011-01-01T00:00:00,Motivation,F01.752.543.500.750
20888129,2011-01-01T00:00:00,Nicotinic Agonists,D27.505.519.625.120.140.700
20888129,2011-01-01T00:00:00,Nicotinic Agonists,D27.505.696.577.120.140.700
20888129,2011-01-01T00:00:00,Smoking,F01.145.466.753
20888129,2011-01-01T00:00:00,Smoking Cessation,F01.145.940.700
20888129,2011-01-01T00:00:00,Treatment Outcome,E01.789.800
20888129,2011-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
20888129,2011-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
20957425,2011-01-01T00:00:00,Child,M01.060.406
20957425,2011-01-01T00:00:00,Child Welfare,I01.880.787.293
20957425,2011-01-01T00:00:00,Clinical Competence,I02.399.630.210
20957425,2011-01-01T00:00:00,Clinical Competence,N04.761.210
20957425,2011-01-01T00:00:00,Family Therapy,F04.754.864.581.273
20957425,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
20957425,2011-01-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
20957425,2011-01-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
20957425,2011-01-01T00:00:00,Psychotherapy,F04.754
20957425,2011-01-01T00:00:00,United States,Z01.107.567.875
21071784,2011-01-01T00:00:00,"Accidents, Traffic",N06.850.135.392
21071784,2011-01-01T00:00:00,Age Factors,N05.715.350.075
21071784,2011-01-01T00:00:00,Age Factors,N06.850.490.250
21071784,2011-01-01T00:00:00,Bicycling,I03.450.642.845.140
21071784,2011-01-01T00:00:00,Child,M01.060.406
21071784,2011-01-01T00:00:00,Child Behavior,F01.145.179
21071784,2011-01-01T00:00:00,"Child, Preschool",M01.060.406.448
21071784,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21071784,2011-01-01T00:00:00,Judgment,F02.463.785.626
21071784,2011-01-01T00:00:00,Social Environment,I01.880.656
21071784,2011-01-01T00:00:00,User-Computer Interface,L01.224.900.910
21071784,2011-01-01T00:00:00,Visual Perception,F02.463.593.932
21098982,2011-01-01T00:00:00,Age Factors,N05.715.350.075
21098982,2011-01-01T00:00:00,Age Factors,N06.850.490.250
21098982,2011-01-01T00:00:00,Animals,B01.050
21098982,2011-01-01T00:00:00,"Disease Models, Animal",C22.232
21098982,2011-01-01T00:00:00,"Disease Models, Animal",E05.598.500
21098982,2011-01-01T00:00:00,"Disease Models, Animal",E05.599.395.080
21098982,2011-01-01T00:00:00,Down Syndrome,C10.597.606.643.220
21098982,2011-01-01T00:00:00,Down Syndrome,C16.131.077.327
21098982,2011-01-01T00:00:00,Down Syndrome,C16.131.260.260
21098982,2011-01-01T00:00:00,Down Syndrome,C16.320.180.260
21098982,2011-01-01T00:00:00,Maze Learning,F02.463.425.507
21098982,2011-01-01T00:00:00,Norepinephrine,D02.033.100.291.502
21098982,2011-01-01T00:00:00,Norepinephrine,D02.092.063.480
21098982,2011-01-01T00:00:00,Norepinephrine,D02.092.211.215.311.560
21098982,2011-01-01T00:00:00,Norepinephrine,D02.092.311.461.484
21116053,2011-01-01T00:00:00,Amyloid beta-Protein Precursor,D12.776.049.025.150
21116053,2011-01-01T00:00:00,Amyloid beta-Protein Precursor,D12.776.811.050
21116053,2011-01-01T00:00:00,Animals,B01.050
21116053,2011-01-01T00:00:00,Brain,A08.186.211
21116053,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21116053,2011-01-01T00:00:00,Maze Learning,F02.463.425.507
21150758,2011-01-01T00:00:00,Adult,M01.060.116
21150758,2011-01-01T00:00:00,Aged,M01.060.116.100
21150758,2011-01-01T00:00:00,Anticoagulants,D27.505.954.502.119
21150758,2011-01-01T00:00:00,Blood Coagulation Disorders,C15.378.100
21150758,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21150758,2011-01-01T00:00:00,Middle Aged,M01.060.116.630
21150758,2011-01-01T00:00:00,Subarachnoid Hemorrhage,C10.228.140.300.535.800
21150758,2011-01-01T00:00:00,Subarachnoid Hemorrhage,C14.907.253.573.800
21150758,2011-01-01T00:00:00,Subarachnoid Hemorrhage,C23.550.414.913.850
21150758,2011-01-01T00:00:00,Treatment Outcome,E01.789.800
21150758,2011-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
21150758,2011-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21150758,2011-01-01T00:00:00,Young Adult,M01.060.116.815
21157234,2011-01-01T00:00:00,Diffusion of Innovation,L01.143.320
21157234,2011-01-01T00:00:00,Hospitals,N02.278.421
21157234,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21157234,2011-01-01T00:00:00,Medical Order Entry Systems,L01.700.508.300.408.600
21157234,2011-01-01T00:00:00,Medical Order Entry Systems,L01.700.508.300.680.360.450
21157234,2011-01-01T00:00:00,Medical Order Entry Systems,L01.700.508.300.695.600
21157234,2011-01-01T00:00:00,Medical Order Entry Systems,N04.452.442.452.500
21157234,2011-01-01T00:00:00,Medical Order Entry Systems,N04.452.515.360.500
21157234,2011-01-01T00:00:00,Medical Order Entry Systems,N04.452.859.564.650.500
21157234,2011-01-01T00:00:00,"Quality Indicators, Health Care",N04.761.789
21157234,2011-01-01T00:00:00,Regression Analysis,E05.318.740.750
21157234,2011-01-01T00:00:00,Regression Analysis,N05.715.360.750.695
21157234,2011-01-01T00:00:00,Regression Analysis,N06.850.520.830.750
21157234,2011-01-01T00:00:00,United States,Z01.107.567.875
21160332,2011-01-01T00:00:00,Adult,M01.060.116
21160332,2011-01-01T00:00:00,African Americans,M01.686.508.100.100
21160332,2011-01-01T00:00:00,African Americans,M01.686.754.100
21160332,2011-01-01T00:00:00,Amputation,E04.555.080
21160332,2011-01-01T00:00:00,Chronic Disease,C23.550.291.500
21160332,2011-01-01T00:00:00,Community Health Services,N02.421.143
21160332,2011-01-01T00:00:00,Diabetes Mellitus,C18.452.394.750
21160332,2011-01-01T00:00:00,Diabetes Mellitus,C19.246
21160332,2011-01-01T00:00:00,Health Care Coalitions,N03.540.452.188
21160332,2011-01-01T00:00:00,Health Promotion,N02.370
21160332,2011-01-01T00:00:00,Health Promotion,N02.421.726.507
21160332,2011-01-01T00:00:00,Health Services Accessibility,N04.590.374.350
21160332,2011-01-01T00:00:00,Health Services Accessibility,N05.300.430
21160332,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21160332,2011-01-01T00:00:00,Leg,A01.378.610.500
21160332,2011-01-01T00:00:00,"Models, Organizational",E05.599.670
21160332,2011-01-01T00:00:00,"Models, Organizational",N04.452.534
21160332,2011-01-01T00:00:00,Organizational Objectives,N04.452.615
21160332,2011-01-01T00:00:00,Patient Education as Topic,I02.233.332.500
21160332,2011-01-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
21160332,2011-01-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
21166527,2011-01-01T00:00:00,Animals,B01.050
21166527,2011-01-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
21166527,2011-01-01T00:00:00,Coronary Angiography,E01.370.370.050.200
21166527,2011-01-01T00:00:00,Coronary Angiography,E01.370.370.380.200
21166527,2011-01-01T00:00:00,Coronary Artery Disease,C14.280.647.250.260
21166527,2011-01-01T00:00:00,Coronary Artery Disease,C14.907.137.126.339
21166527,2011-01-01T00:00:00,Coronary Artery Disease,C14.907.585.250.260
21166527,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21166527,2011-01-01T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
21166527,2011-01-01T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
21166527,2011-01-01T00:00:00,Myocardial Perfusion Imaging,E01.370.350.710.600.500
21166527,2011-01-01T00:00:00,Myocardial Perfusion Imaging,E01.370.370.380.500
21166527,2011-01-01T00:00:00,Myocardial Perfusion Imaging,E01.370.384.730.354.500
21166527,2011-01-01T00:00:00,Stents,E07.695.750
21166527,2011-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
21166527,2011-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
21166527,2011-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
21166527,2011-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
21166527,2011-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
21166920,2011-01-01T00:00:00,Cell Movement,G04.299.283
21166920,2011-01-01T00:00:00,Cell Movement,G07.700.560.500.180
21166920,2011-01-01T00:00:00,Connective Tissue Growth Factor,D12.644.276.200.100
21166920,2011-01-01T00:00:00,Connective Tissue Growth Factor,D12.776.467.200.100
21166920,2011-01-01T00:00:00,Connective Tissue Growth Factor,D12.776.860.300.200.100
21166920,2011-01-01T00:00:00,Connective Tissue Growth Factor,D23.529.237.100
21166920,2011-01-01T00:00:00,Endothelial Cells,A11.436.275
21166920,2011-01-01T00:00:00,Gene Expression Regulation,G05.355.315
21166920,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21166920,2011-01-01T00:00:00,Lysophospholipids,D10.570.755.375.760.550
21166920,2011-01-01T00:00:00,"Neovascularization, Pathologic",C23.550.589.500
21166920,2011-01-01T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
21166920,2011-01-01T00:00:00,Skin,A17.815
21166920,2011-01-01T00:00:00,Sphingosine,D02.033.100.700
21166920,2011-01-01T00:00:00,Sphingosine,D02.033.455.843
21166920,2011-01-01T00:00:00,Sphingosine,D02.092.063.700
21171878,2011-01-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
21171878,2011-01-01T00:00:00,Centers for Disease Control and Prevention (U.S.),I01.409.137.500.600.650.225
21171878,2011-01-01T00:00:00,Centers for Disease Control and Prevention (U.S.),N03.540.348.500.500.600.650.225
21171878,2011-01-01T00:00:00,Chlamydia Infections,C01.252.400.210.210
21171878,2011-01-01T00:00:00,Chlamydia Infections,C01.252.810.301
21171878,2011-01-01T00:00:00,Chlamydia Infections,C01.539.778.281.301
21171878,2011-01-01T00:00:00,Chlamydia Infections,C12.294.668.281.301
21171878,2011-01-01T00:00:00,Chlamydia Infections,C13.351.500.711.281.301
21171878,2011-01-01T00:00:00,Chlamydia trachomatis,B03.440.190.190.190.750
21171878,2011-01-01T00:00:00,Gonorrhea,C01.252.400.625.391
21171878,2011-01-01T00:00:00,Gonorrhea,C01.252.810.401
21171878,2011-01-01T00:00:00,Gonorrhea,C01.539.778.281.401
21171878,2011-01-01T00:00:00,Gonorrhea,C12.294.668.281.401
21171878,2011-01-01T00:00:00,Gonorrhea,C13.351.500.711.281.401
21171878,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21171878,2011-01-01T00:00:00,Mycoplasma Infections,C01.252.400.610.610
21171878,2011-01-01T00:00:00,Neisseria gonorrhoeae,B03.440.400.425.550.550.474
21171878,2011-01-01T00:00:00,Neisseria gonorrhoeae,B03.660.075.525.520.400
21171878,2011-01-01T00:00:00,Pelvic Inflammatory Disease,C01.539.635.500
21171878,2011-01-01T00:00:00,Pelvic Inflammatory Disease,C13.351.500.056.750
21171878,2011-01-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
21171878,2011-01-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
21171878,2011-01-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
21171878,2011-01-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
21171878,2011-01-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
21171878,2011-01-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
21171878,2011-01-01T00:00:00,United States,Z01.107.567.875
21172513,2011-01-01T00:00:00,"Child, Preschool",M01.060.406.448
21172513,2011-01-01T00:00:00,Heart Diseases,C14.280
21172513,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21172513,2011-01-01T00:00:00,Infant,M01.060.703
21172513,2011-01-01T00:00:00,"Infant, Newborn",M01.060.703.520
21172513,2011-01-01T00:00:00,Length of Stay,E02.760.400.480
21172513,2011-01-01T00:00:00,Length of Stay,N02.421.585.400.480
21172513,2011-01-01T00:00:00,Postoperative Care,E02.760.722.700
21172513,2011-01-01T00:00:00,Postoperative Care,E04.624
21172513,2011-01-01T00:00:00,Postoperative Care,N02.421.585.722.700
21172513,2011-01-01T00:00:00,Postoperative Complications,C23.550.767
21172513,2011-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
21172513,2011-01-01T00:00:00,Risk Factors,N05.715.350.200.700
21172513,2011-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
21172513,2011-01-01T00:00:00,Risk Factors,N06.850.490.625.750
21172513,2011-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
21172513,2011-01-01T00:00:00,Treatment Outcome,E01.789.800
21172513,2011-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
21172513,2011-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21172537,2011-01-01T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
21172537,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21172537,2011-01-01T00:00:00,"Infant, Newborn",M01.060.703.520
21175275,2011-01-01T00:00:00,Aged,M01.060.116.100
21175275,2011-01-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
21175275,2011-01-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
21175275,2011-01-01T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
21175275,2011-01-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
21175275,2011-01-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
21175275,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21175275,2011-01-01T00:00:00,Middle Aged,M01.060.116.630
21175275,2011-01-01T00:00:00,Psychotic Disorders,F03.700.675
21175275,2011-01-01T00:00:00,Veterans,M01.930
21175388,2011-01-01T00:00:00,Endometrial Neoplasms,C04.588.945.418.948.585
21175388,2011-01-01T00:00:00,Endometrial Neoplasms,C13.351.500.852.762.200
21175388,2011-01-01T00:00:00,Endometrial Neoplasms,C13.351.937.418.875.200
21175388,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21175388,2011-01-01T00:00:00,Lymph Node Excision,E04.446
21175388,2011-01-01T00:00:00,Lymph Nodes,A10.549.400
21175388,2011-01-01T00:00:00,Lymph Nodes,A15.382.520.604.412
21175388,2011-01-01T00:00:00,"Radiotherapy, Adjuvant",E02.186.775
21175388,2011-01-01T00:00:00,"Radiotherapy, Adjuvant",E02.815.600
21182116,2011-01-01T00:00:00,Adolescent,M01.060.057
21182116,2011-01-01T00:00:00,Algorithms,G17.035
21182116,2011-01-01T00:00:00,Algorithms,L01.224.050
21182116,2011-01-01T00:00:00,Attention Deficit Disorder with Hyperactivity,F03.550.150.150
21182116,2011-01-01T00:00:00,Child,M01.060.406
21182116,2011-01-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
21182116,2011-01-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
21182116,2011-01-01T00:00:00,Evidence-Based Medicine,H02.249.750
21182116,2011-01-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
21182116,2011-01-01T00:00:00,Frontal Lobe,A08.186.211.730.885.287.500.270
21182116,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21182116,2011-01-01T00:00:00,Image Enhancement,E01.370.350.600.350
21182116,2011-01-01T00:00:00,Image Enhancement,L01.224.308.380
21182116,2011-01-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
21182116,2011-01-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
21182116,2011-01-01T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
21182116,2011-01-01T00:00:00,"Nerve Fibers, Myelinated",A08.663.542.512
21182116,2011-01-01T00:00:00,"Nerve Fibers, Myelinated",A11.671.514
21182116,2011-01-01T00:00:00,Pilot Projects,E05.318.760.750
21182116,2011-01-01T00:00:00,Pilot Projects,E05.337.737
21182116,2011-01-01T00:00:00,Pilot Projects,N05.715.360.775.625
21182116,2011-01-01T00:00:00,Pilot Projects,N06.850.520.450.720
21183103,2011-01-01T00:00:00,Cataract,C11.510.245
21183103,2011-01-01T00:00:00,Cataract Extraction,E04.540.825.249
21183103,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21183103,2011-01-01T00:00:00,Incidence,E05.318.308.985.525.375
21183103,2011-01-01T00:00:00,Incidence,L01.280.975.525.375
21183103,2011-01-01T00:00:00,Incidence,N01.224.935.597.500
21183103,2011-01-01T00:00:00,Incidence,N06.850.505.400.975.525.375
21183103,2011-01-01T00:00:00,Incidence,N06.850.520.308.985.525.375
21183103,2011-01-01T00:00:00,Infant,M01.060.703
21183103,2011-01-01T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
21183103,2011-01-01T00:00:00,"Lenses, Intraocular",E07.632.500.460
21183103,2011-01-01T00:00:00,"Lenses, Intraocular",E07.695.460
21183103,2011-01-01T00:00:00,Postoperative Complications,C23.550.767
21183103,2011-01-01T00:00:00,Reoperation,E04.690
21183103,2011-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
21183103,2011-01-01T00:00:00,Risk Factors,N05.715.350.200.700
21183103,2011-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
21183103,2011-01-01T00:00:00,Risk Factors,N06.850.490.625.750
21183103,2011-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
21183103,2011-01-01T00:00:00,Treatment Outcome,E01.789.800
21183103,2011-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
21183103,2011-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21183103,2011-01-01T00:00:00,Visual Acuity,E01.370.380.850.950
21183103,2011-01-01T00:00:00,Visual Acuity,F02.463.593.932.901
21183103,2011-01-01T00:00:00,Visual Acuity,G14.940
21183112,2011-01-01T00:00:00,Cataract,C11.510.245
21183112,2011-01-01T00:00:00,Cataract Extraction,E04.540.825.249
21183112,2011-01-01T00:00:00,Child,M01.060.406
21183112,2011-01-01T00:00:00,"Child, Preschool",M01.060.406.448
21183112,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21183112,2011-01-01T00:00:00,Infant,M01.060.703
21183112,2011-01-01T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
21183112,2011-01-01T00:00:00,Postoperative Complications,C23.550.767
21184870,2011-01-01T00:00:00,"Biopsy, Fine-Needle",E01.370.388.100.100.500
21184870,2011-01-01T00:00:00,"Biopsy, Fine-Needle",E01.450.230.100.100.500
21184870,2011-01-01T00:00:00,"Biopsy, Fine-Needle",E01.450.865.100.100.500
21184870,2011-01-01T00:00:00,"Biopsy, Fine-Needle",E04.074.119.500
21184870,2011-01-01T00:00:00,Contrast Media,D27.720.259
21184870,2011-01-01T00:00:00,Endosonography,E01.370.350.850.280
21184870,2011-01-01T00:00:00,Esophageal Neoplasms,C04.588.274.476.205
21184870,2011-01-01T00:00:00,Esophageal Neoplasms,C04.588.443.353
21184870,2011-01-01T00:00:00,Esophageal Neoplasms,C06.301.371.205
21184870,2011-01-01T00:00:00,Esophageal Neoplasms,C06.405.117.430
21184870,2011-01-01T00:00:00,Esophageal Neoplasms,C06.405.249.205
21184870,2011-01-01T00:00:00,Fluorocarbons,D02.455.526.510.435
21184870,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21184870,2011-01-01T00:00:00,Image Enhancement,E01.370.350.600.350
21184870,2011-01-01T00:00:00,Image Enhancement,L01.224.308.380
21184870,2011-01-01T00:00:00,Lipids,D10
21184870,2011-01-01T00:00:00,Liver Neoplasms,C04.588.274.623
21184870,2011-01-01T00:00:00,Liver Neoplasms,C06.301.623
21184870,2011-01-01T00:00:00,Liver Neoplasms,C06.552.697
21184870,2011-01-01T00:00:00,Pancreatic Neoplasms,C04.588.274.761
21184870,2011-01-01T00:00:00,Pancreatic Neoplasms,C04.588.322.421
21184870,2011-01-01T00:00:00,Pancreatic Neoplasms,C06.301.761
21184870,2011-01-01T00:00:00,Pancreatic Neoplasms,C06.689.667
21184870,2011-01-01T00:00:00,Pancreatic Neoplasms,C19.344.421
21184870,2011-01-01T00:00:00,Pilot Projects,E05.318.760.750
21184870,2011-01-01T00:00:00,Pilot Projects,E05.337.737
21184870,2011-01-01T00:00:00,Pilot Projects,N05.715.360.775.625
21184870,2011-01-01T00:00:00,Pilot Projects,N06.850.520.450.720
21190259,2011-01-01T00:00:00,Blood Proteins,D12.776.124
21190259,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21190259,2011-01-01T00:00:00,Molecular Weight,G02.842.580
21190259,2011-01-01T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
21192187,2011-01-01T00:00:00,Adult,M01.060.116
21192187,2011-01-01T00:00:00,Aged,M01.060.116.100
21192187,2011-01-01T00:00:00,Brain Ischemia,C10.228.140.300.150
21192187,2011-01-01T00:00:00,Brain Ischemia,C14.907.253.092
21192187,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21192187,2011-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
21192187,2011-01-01T00:00:00,Risk Factors,N05.715.350.200.700
21192187,2011-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
21192187,2011-01-01T00:00:00,Risk Factors,N06.850.490.625.750
21192187,2011-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
21192187,2011-01-01T00:00:00,Stroke,C10.228.140.300.775
21192187,2011-01-01T00:00:00,Stroke,C14.907.253.855
21193464,2011-01-01T00:00:00,Academic Medical Centers,N02.278.020
21193464,2011-01-01T00:00:00,Adult,M01.060.116
21193464,2011-01-01T00:00:00,Aged,M01.060.116.100
21193464,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21193464,2011-01-01T00:00:00,Middle Aged,M01.060.116.630
21193464,2011-01-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
21193464,2011-01-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
21193464,2011-01-01T00:00:00,Renal Dialysis,E02.870.300
21193464,2011-01-01T00:00:00,Renal Dialysis,E02.912.800
21193464,2011-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
21193464,2011-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
21193464,2011-01-01T00:00:00,Time Factors,G01.910.857
21193464,2011-01-01T00:00:00,Treatment Outcome,E01.789.800
21193464,2011-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
21193464,2011-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21193464,2011-01-01T00:00:00,Vascular Patency,G09.330.920
21199773,2011-01-01T00:00:00,Cytokines,D12.644.276.374
21199773,2011-01-01T00:00:00,Cytokines,D12.776.467.374
21199773,2011-01-01T00:00:00,Cytokines,D23.529.374
21199773,2011-01-01T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
21199773,2011-01-01T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
21199773,2011-01-01T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
21199773,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21199773,2011-01-01T00:00:00,"Tumor Markers, Biological",D23.101.840
21199777,2011-01-01T00:00:00,Animals,B01.050
21199777,2011-01-01T00:00:00,Cocaine-Related Disorders,C21.739.300
21199777,2011-01-01T00:00:00,Cocaine-Related Disorders,F03.900.300
21199777,2011-01-01T00:00:00,Glutamic Acid,D12.125.067.750
21199777,2011-01-01T00:00:00,Glutamic Acid,D12.125.119.450
21199777,2011-01-01T00:00:00,Glutamic Acid,D12.125.427.300
21199777,2011-01-01T00:00:00,Homeostasis,G07.700.360
21199777,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21199777,2011-01-01T00:00:00,Neuronal Plasticity,G11.561.600.635
21209253,2011-01-01T00:00:00,Aging,G07.700.320.124
21209253,2011-01-01T00:00:00,Apoptosis,G04.299.139.160
21209253,2011-01-01T00:00:00,Chronic Disease,C23.550.291.500
21209253,2011-01-01T00:00:00,Disease Progression,C23.550.291.656
21209253,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21209253,2011-01-01T00:00:00,Kidney,A05.810.453
21209253,2011-01-01T00:00:00,Kidney Diseases,C12.777.419
21209253,2011-01-01T00:00:00,Kidney Diseases,C13.351.968.419
21209253,2011-01-01T00:00:00,Telomerase,D08.811.913.696.445.308.300.750.750
21209253,2011-01-01T00:00:00,Telomerase,D12.776.157.725.500.921
21209253,2011-01-01T00:00:00,Telomerase,D12.776.664.962.500.921
21209406,2011-01-01T00:00:00,Career Choice,F02.463.785.373.346.400
21209406,2011-01-01T00:00:00,Clinical Competence,I02.399.630.210
21209406,2011-01-01T00:00:00,Clinical Competence,N04.761.210
21209406,2011-01-01T00:00:00,Education,I02
21209406,2011-01-01T00:00:00,Fellowships and Scholarships,N03.219.483.838.276
21209406,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21209406,2011-01-01T00:00:00,Internship and Residency,I02.358.399.644
21209406,2011-01-01T00:00:00,National Institutes of Health (U.S.),I01.409.137.500.600.480
21209406,2011-01-01T00:00:00,National Institutes of Health (U.S.),N03.540.348.500.500.600.480
21209406,2011-01-01T00:00:00,Program Development,N04.452.760
21209406,2011-01-01T00:00:00,Psychiatry,F04.096.544
21209406,2011-01-01T00:00:00,Psychiatry,H02.403.690
21209406,2011-01-01T00:00:00,Research,H01.770.644
21209406,2011-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
21209406,2011-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
21209406,2011-01-01T00:00:00,"Students, Medical",I02.851.686.602
21209406,2011-01-01T00:00:00,"Students, Medical",M01.848.769.602
21209406,2011-01-01T00:00:00,United States,Z01.107.567.875
21211149,2011-01-01T00:00:00,Animals,B01.050
21211149,2011-01-01T00:00:00,CHO Cells,A11.251.210.200
21211149,2011-01-01T00:00:00,CHO Cells,A11.436.155
21211149,2011-01-01T00:00:00,Cell Survival,G04.299.316
21211149,2011-01-01T00:00:00,Cricetinae,B01.050.150.900.649.865.635.150
21211149,2011-01-01T00:00:00,Dextrans,D05.750.078.562.272
21211149,2011-01-01T00:00:00,Dextrans,D09.698.365.272
21211149,2011-01-01T00:00:00,Fluorescent Dyes,D27.720.233.348
21211149,2011-01-01T00:00:00,Fluorescent Dyes,D27.720.470.330.348
21211149,2011-01-01T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
21211149,2011-01-01T00:00:00,Lysosomes,A11.284.430.214.190.875.190.550
21211149,2011-01-01T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
21211149,2011-01-01T00:00:00,"Microscopy, Fluorescence",E05.595.458
21211149,2011-01-01T00:00:00,Water,D01.455.900
21211149,2011-01-01T00:00:00,Water,D01.650.550.925
21217480,2011-01-01T00:00:00,Adult,M01.060.116
21217480,2011-01-01T00:00:00,Cervical Vertebrae,A02.835.232.834.151
21217480,2011-01-01T00:00:00,Deglutition,G10.261.326.215
21217480,2011-01-01T00:00:00,Deglutition Disorders,C06.405.117.119
21217480,2011-01-01T00:00:00,Deglutition Disorders,C09.775.174
21217480,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21217480,2011-01-01T00:00:00,Spinal Fractures,C21.866.117.500.500
21217480,2011-01-01T00:00:00,Spinal Fractures,C21.866.404.812
21217480,2011-01-01T00:00:00,Spinal Fractures,C21.866.831.600
21217480,2011-01-01T00:00:00,Treatment Outcome,E01.789.800
21217480,2011-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
21217480,2011-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21217480,2011-01-01T00:00:00,"Wounds, Nonpenetrating",C21.866.974
21224431,2011-01-01T00:00:00,Bariatric Surgery,E02.065.062
21224431,2011-01-01T00:00:00,Bariatric Surgery,E04.062
21224431,2011-01-01T00:00:00,Catheterization,E02.148
21224431,2011-01-01T00:00:00,Catheterization,E05.157
21224431,2011-01-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
21224431,2011-01-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
21224431,2011-01-01T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
21224431,2011-01-01T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
21224431,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21224431,2011-01-01T00:00:00,Obesity,C18.654.726.500
21224431,2011-01-01T00:00:00,Obesity,C23.888.144.699.500
21224431,2011-01-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
21224431,2011-01-01T00:00:00,Obesity,G07.100.100.160.120.699.500
21224431,2011-01-01T00:00:00,Treatment Outcome,E01.789.800
21224431,2011-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
21224431,2011-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21224431,2011-01-01T00:00:00,United States,Z01.107.567.875
21224431,2011-01-01T00:00:00,Weight Loss,C23.888.144.243.963
21224431,2011-01-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
21229450,2011-01-01T00:00:00,Adolescent,M01.060.057
21229450,2011-01-01T00:00:00,Alcohol Drinking,F01.145.317.269
21229450,2011-01-01T00:00:00,Crime Victims,M01.135
21229450,2011-01-01T00:00:00,Health Surveys,E05.318.308.250
21229450,2011-01-01T00:00:00,Health Surveys,N05.715.360.300.375
21229450,2011-01-01T00:00:00,Health Surveys,N06.850.520.308.250
21229450,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21229450,2011-01-01T00:00:00,Interpersonal Relations,F01.829.401
21229450,2011-01-01T00:00:00,Smoking,F01.145.466.753
21229450,2011-01-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
21229450,2011-01-01T00:00:00,Substance-Related Disorders,C21.739
21229450,2011-01-01T00:00:00,Substance-Related Disorders,F03.900
21229957,2011-01-01T00:00:00,Adolescent,M01.060.057
21229957,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21229957,2011-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
21229957,2011-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
21229957,2011-01-01T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
21229957,2011-01-01T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
21229957,2011-01-01T00:00:00,Oculomotor Muscles,A02.633.567.700
21229957,2011-01-01T00:00:00,Oculomotor Muscles,A09.371.613
21229957,2011-01-01T00:00:00,Orbit,A02.835.232.781.324.690
21229957,2011-01-01T00:00:00,Orbital Neoplasms,C04.588.149.721.656
21229957,2011-01-01T00:00:00,Orbital Neoplasms,C04.588.364.659
21229957,2011-01-01T00:00:00,Orbital Neoplasms,C05.116.231.754.659
21229957,2011-01-01T00:00:00,Orbital Neoplasms,C11.319.457
21229957,2011-01-01T00:00:00,Orbital Neoplasms,C11.675.659
21229957,2011-01-01T00:00:00,Reconstructive Surgical Procedures,E04.680
21229957,2011-01-01T00:00:00,Rectus Abdominis,A02.633.567.050.800
21240777,2011-01-01T00:00:00,Adult,M01.060.116
21240777,2011-01-01T00:00:00,Cardiovascular Diseases,C14
21240777,2011-01-01T00:00:00,Cardiovascular System,A07
21240777,2011-01-01T00:00:00,Clinical Competence,I02.399.630.210
21240777,2011-01-01T00:00:00,Clinical Competence,N04.761.210
21240777,2011-01-01T00:00:00,Computer Simulation,L01.224.160
21240777,2011-01-01T00:00:00,"Education, Medical, Undergraduate",I02.358.399.450
21240777,2011-01-01T00:00:00,Educational Measurement,I02.399
21240777,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21240777,2011-01-01T00:00:00,Learning,F02.463.425
21240777,2011-01-01T00:00:00,Learning,F02.784.629.529
21240777,2011-01-01T00:00:00,"Students, Medical",I02.851.686.602
21240777,2011-01-01T00:00:00,"Students, Medical",M01.848.769.602
21240777,2011-01-01T00:00:00,Teaching,I02.903
21240777,2011-01-01T00:00:00,United States,Z01.107.567.875
21242551,2011-01-01T00:00:00,Age of Onset,N05.715.350.075.100
21242551,2011-01-01T00:00:00,Age of Onset,N06.850.490.250.100
21242551,2011-01-01T00:00:00,Child,M01.060.406
21242551,2011-01-01T00:00:00,"Child, Preschool",M01.060.406.448
21242551,2011-01-01T00:00:00,Cleft Palate,C05.500.460.185
21242551,2011-01-01T00:00:00,Cleft Palate,C05.660.207.540.460.185
21242551,2011-01-01T00:00:00,Cleft Palate,C07.320.440.185
21242551,2011-01-01T00:00:00,Cleft Palate,C07.465.525.185
21242551,2011-01-01T00:00:00,Cleft Palate,C07.650.500.460.185
21242551,2011-01-01T00:00:00,Cleft Palate,C07.650.525.185
21242551,2011-01-01T00:00:00,Cleft Palate,C16.131.621.207.540.460.185
21242551,2011-01-01T00:00:00,Cleft Palate,C16.131.850.500.460.185
21242551,2011-01-01T00:00:00,Cleft Palate,C16.131.850.525.185
21242551,2011-01-01T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
21242551,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21242551,2011-01-01T00:00:00,Laryngoscopy,E01.370.386.460
21242551,2011-01-01T00:00:00,Laryngoscopy,E01.370.388.250.525
21242551,2011-01-01T00:00:00,Laryngoscopy,E04.580.373
21242551,2011-01-01T00:00:00,Laryngoscopy,E04.800.250.525
21242551,2011-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
21242551,2011-01-01T00:00:00,Risk Factors,N05.715.350.200.700
21242551,2011-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
21242551,2011-01-01T00:00:00,Risk Factors,N06.850.490.625.750
21242551,2011-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
21242557,2011-01-01T00:00:00,Adolescent,M01.060.057
21242557,2011-01-01T00:00:00,Adult,M01.060.116
21242557,2011-01-01T00:00:00,Aged,M01.060.116.100
21242557,2011-01-01T00:00:00,"Decision Support Systems, Clinical",L01.700.508.300.190
21242557,2011-01-01T00:00:00,Electronic Health Records,E05.318.308.940.968.625.500
21242557,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21242557,2011-01-01T00:00:00,Middle Aged,M01.060.116.630
21242557,2011-01-01T00:00:00,Office Visits,N04.452.758.635
21242557,2011-01-01T00:00:00,Physician's Practice Patterns,N04.590.748
21242557,2011-01-01T00:00:00,Physician's Practice Patterns,N05.300.625
21242557,2011-01-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
21242557,2011-01-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
21242557,2011-01-01T00:00:00,Primary Health Care,N04.590.233.727
21242557,2011-01-01T00:00:00,Questionnaires,E05.318.308.750
21242557,2011-01-01T00:00:00,Questionnaires,L01.280.800
21242557,2011-01-01T00:00:00,Questionnaires,N05.715.360.300.695
21242557,2011-01-01T00:00:00,Questionnaires,N06.850.520.308.750
21242557,2011-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
21242557,2011-01-01T00:00:00,Risk Factors,N05.715.350.200.700
21242557,2011-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
21242557,2011-01-01T00:00:00,Risk Factors,N06.850.490.625.750
21242557,2011-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
21242557,2011-01-01T00:00:00,Risk Reduction Behavior,F01.145.699
21242557,2011-01-01T00:00:00,Young Adult,M01.060.116.815
21253929,2011-01-01T00:00:00,Aged,M01.060.116.100
21253929,2011-01-01T00:00:00,Crime Victims,M01.135
21253929,2011-01-01T00:00:00,Elder Abuse,I01.198.240.856.350.390
21253929,2011-01-01T00:00:00,Elder Abuse,I01.880.735.900.350.390
21253929,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21253929,2011-01-01T00:00:00,Middle Aged,M01.060.116.630
21253929,2011-01-01T00:00:00,Sex Factors,N05.715.350.675
21253929,2011-01-01T00:00:00,Sex Factors,N06.850.490.875
21253929,2011-01-01T00:00:00,Social Support,I01.880.656.600
21253929,2011-01-01T00:00:00,United States,Z01.107.567.875
21266258,2011-01-01T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.196.401.250
21266258,2011-01-01T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.196.401.402.250
21266258,2011-01-01T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.301.300.230
21266258,2011-01-01T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.301.300.319.450
21266258,2011-01-01T00:00:00,Glutathione,D12.644.456.448
21266258,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21266258,2011-01-01T00:00:00,Oxidative Stress,G03.495.710
21266258,2011-01-01T00:00:00,Oxidative Stress,G07.700.830.750
21266258,2011-01-01T00:00:00,Protein Disulfide-Isomerases,D08.811.399.475.800.550
21266258,2011-01-01T00:00:00,Proteins,D12.776
21266258,2011-01-01T00:00:00,Reactive Nitrogen Species,D01.625.700
21266258,2011-01-01T00:00:00,Reactive Nitrogen Species,D02.654.846
21266258,2011-01-01T00:00:00,Signal Transduction,G02.111.087.800
21266258,2011-01-01T00:00:00,Signal Transduction,G02.149.115.800
21266258,2011-01-01T00:00:00,Signal Transduction,G04.299.880
21266258,2011-01-01T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
21266258,2011-01-01T00:00:00,"Stress, Physiological",G07.700.830
21308590,2011-01-01T00:00:00,African Americans,M01.686.508.100.100
21308590,2011-01-01T00:00:00,African Americans,M01.686.754.100
21308590,2011-01-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
21308590,2011-01-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
21308590,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21308590,2011-01-01T00:00:00,Papillomavirus Infections,C02.256.650
21308590,2011-01-01T00:00:00,Papillomavirus Infections,C02.928.725
21308590,2011-01-01T00:00:00,Papillomavirus Vaccines,D20.215.894.899.498
21308590,2011-01-01T00:00:00,Perception,F02.463.593
21308590,2011-01-01T00:00:00,Questionnaires,E05.318.308.750
21308590,2011-01-01T00:00:00,Questionnaires,L01.280.800
21308590,2011-01-01T00:00:00,Questionnaires,N05.715.360.300.695
21308590,2011-01-01T00:00:00,Questionnaires,N06.850.520.308.750
21308590,2011-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
21308590,2011-01-01T00:00:00,Risk Factors,N05.715.350.200.700
21308590,2011-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
21308590,2011-01-01T00:00:00,Risk Factors,N06.850.490.625.750
21308590,2011-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
21308590,2011-01-01T00:00:00,Sex Factors,N05.715.350.675
21308590,2011-01-01T00:00:00,Sex Factors,N06.850.490.875
21308590,2011-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
21308590,2011-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
21308590,2011-01-01T00:00:00,Students,I02.233.748
21308590,2011-01-01T00:00:00,Students,I02.851
21308590,2011-01-01T00:00:00,Students,M01.848
21308590,2011-01-01T00:00:00,Young Adult,M01.060.116.815
21309371,2011-01-01T00:00:00,Data Collection,E05.318.308
21309371,2011-01-01T00:00:00,Data Collection,L01.280
21309371,2011-01-01T00:00:00,Data Collection,N05.715.360.300
21309371,2011-01-01T00:00:00,Data Collection,N06.850.520.308
21309371,2011-01-01T00:00:00,Disability Evaluation,E01.370.400
21309371,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21309371,2011-01-01T00:00:00,Occupational Therapy,E02.831.489
21309371,2011-01-01T00:00:00,Occupational Therapy,H02.010.500
21309371,2011-01-01T00:00:00,Upper Extremity,A01.378.800
21309371,2011-01-01T00:00:00,Wounds and Injuries,C21.866
21314431,2011-01-01T00:00:00,Animals,B01.050
21314431,2011-01-01T00:00:00,"Disease Models, Animal",C22.232
21314431,2011-01-01T00:00:00,"Disease Models, Animal",E05.598.500
21314431,2011-01-01T00:00:00,"Disease Models, Animal",E05.599.395.080
21314431,2011-01-01T00:00:00,Dogs,B01.050.150.900.649.147.153.200
21314431,2011-01-01T00:00:00,Extracellular Space,A10.082.500
21314431,2011-01-01T00:00:00,Extracellular Space,A11.284.295
21314431,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21314431,2011-01-01T00:00:00,Myocardial Infarction,C14.280.647.500
21314431,2011-01-01T00:00:00,Myocardial Infarction,C14.907.585.500
21314431,2011-01-01T00:00:00,Signal Transduction,G02.111.087.800
21314431,2011-01-01T00:00:00,Signal Transduction,G02.149.115.800
21314431,2011-01-01T00:00:00,Signal Transduction,G04.299.880
21314431,2011-01-01T00:00:00,Stem Cells,A11.872
21314431,2011-01-01T00:00:00,Swine,B01.050.150.900.649.077.880
21314431,2011-01-01T00:00:00,Ventricular Remodeling,C23.300.985
21314431,2011-01-01T00:00:00,Ventricular Remodeling,G09.330.190.962.975
21317065,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21318894,2011-01-01T00:00:00,Animals,B01.050
21318894,2011-01-01T00:00:00,Cell Survival,G04.299.316
21318894,2011-01-01T00:00:00,Histone Deacetylase Inhibitors,D27.505.519.389.360
21318894,2011-01-01T00:00:00,Histones,D12.776.660.470
21318894,2011-01-01T00:00:00,Histones,D12.776.664.469
21318894,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21318894,2011-01-01T00:00:00,Polyamines,D02.092.782
21318894,2011-01-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
21333125,2011-01-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
21333125,2011-01-01T00:00:00,Health Personnel,M01.526.485
21333125,2011-01-01T00:00:00,Health Personnel,N02.360
21333125,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21333125,2011-01-01T00:00:00,Primary Health Care,N04.590.233.727
21333125,2011-01-01T00:00:00,Problem-Based Learning,F02.463.425.720
21333125,2011-01-01T00:00:00,Problem-Based Learning,I02.158.660
21333125,2011-01-01T00:00:00,Problem-Based Learning,I02.903.565
21333125,2011-01-01T00:00:00,Time Factors,G01.910.857
21381482,2011-01-01T00:00:00,Biocompatible Materials,D25.130
21381482,2011-01-01T00:00:00,Biocompatible Materials,D27.720.102.130
21381482,2011-01-01T00:00:00,Biocompatible Materials,J01.637.051.130
21381482,2011-01-01T00:00:00,Equipment Failure Analysis,E05.325.192
21381482,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21381482,2011-01-01T00:00:00,Knee Prosthesis,E07.695.400.410
21381482,2011-01-01T00:00:00,Materials Testing,E05.570
21381482,2011-01-01T00:00:00,Polyethylenes,D02.455.326.271.665.550
21381482,2011-01-01T00:00:00,Polyethylenes,D05.750.716.507
21381482,2011-01-01T00:00:00,Polyethylenes,D25.720.716.507
21381482,2011-01-01T00:00:00,Polyethylenes,J01.637.051.720.716.507
21381482,2011-01-01T00:00:00,Prosthesis Failure,C23.550.767.865
21381482,2011-01-01T00:00:00,Prosthesis Failure,E05.325.771
21396304,2011-01-01T00:00:00,Adult,M01.060.116
21396304,2011-01-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
21396304,2011-01-01T00:00:00,Body Mass Index,E05.041.124.125
21396304,2011-01-01T00:00:00,Body Mass Index,G07.100.100.125
21396304,2011-01-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
21396304,2011-01-01T00:00:00,Gastric Bypass,E02.065.062.249
21396304,2011-01-01T00:00:00,Gastric Bypass,E04.035.398.385
21396304,2011-01-01T00:00:00,Gastric Bypass,E04.062.249
21396304,2011-01-01T00:00:00,Gastric Bypass,E04.210.457.430
21396304,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21396304,2011-01-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
21396304,2011-01-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
21396304,2011-01-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
21396304,2011-01-01T00:00:00,Middle Aged,M01.060.116.630
21396304,2011-01-01T00:00:00,"Obesity, Morbid",C18.654.726.500.700
21396304,2011-01-01T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
21396304,2011-01-01T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
21396304,2011-01-01T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
21396304,2011-01-01T00:00:00,Perioperative Care,E02.760.722
21396304,2011-01-01T00:00:00,Perioperative Care,E04.604
21396304,2011-01-01T00:00:00,Perioperative Care,N02.421.585.722
21396304,2011-01-01T00:00:00,Postoperative Complications,C23.550.767
21396304,2011-01-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
21396304,2011-01-01T00:00:00,Risk Assessment,N04.452.871.715
21396304,2011-01-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
21396304,2011-01-01T00:00:00,Risk Assessment,N06.850.505.715
21396304,2011-01-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
21396304,2011-01-01T00:00:00,Treatment Outcome,E01.789.800
21396304,2011-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
21396304,2011-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21396304,2011-01-01T00:00:00,Weight Loss,C23.888.144.243.963
21396304,2011-01-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
21396327,2011-01-01T00:00:00,"History, 19th Century",K01.400.504.937
21396327,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21396327,2011-01-01T00:00:00,Hygiene,E02.547
21396327,2011-01-01T00:00:00,Hygiene,N06.850.670
21396327,2011-01-01T00:00:00,"Surgical Procedures, Operative",E04
21396330,2011-01-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
21396330,2011-01-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
21396330,2011-01-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
21396330,2011-01-01T00:00:00,"Biopsy, Needle",E01.370.388.100.100
21396330,2011-01-01T00:00:00,"Biopsy, Needle",E01.450.230.100.100
21396330,2011-01-01T00:00:00,"Biopsy, Needle",E01.450.865.100.100
21396330,2011-01-01T00:00:00,"Biopsy, Needle",E01.450.865.632.100
21396330,2011-01-01T00:00:00,"Biopsy, Needle",E04.074.119
21396330,2011-01-01T00:00:00,Combined Modality Therapy,E02.186
21396330,2011-01-01T00:00:00,Deglutition Disorders,C06.405.117.119
21396330,2011-01-01T00:00:00,Deglutition Disorders,C09.775.174
21396330,2011-01-01T00:00:00,Esophageal Neoplasms,C04.588.274.476.205
21396330,2011-01-01T00:00:00,Esophageal Neoplasms,C04.588.443.353
21396330,2011-01-01T00:00:00,Esophageal Neoplasms,C06.301.371.205
21396330,2011-01-01T00:00:00,Esophageal Neoplasms,C06.405.117.430
21396330,2011-01-01T00:00:00,Esophageal Neoplasms,C06.405.249.205
21396330,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21396330,2011-01-01T00:00:00,Middle Aged,M01.060.116.630
21396330,2011-01-01T00:00:00,Neoplasm Staging,E01.370.550
21396330,2011-01-01T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
21396330,2011-01-01T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
21396330,2011-01-01T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
21396330,2011-01-01T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
21396330,2011-01-01T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
21396330,2011-01-01T00:00:00,Treatment Outcome,E01.789.800
21396330,2011-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
21396330,2011-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21422528,2011-01-01T00:00:00,Amyloid beta-Protein Precursor,D12.776.049.025.150
21422528,2011-01-01T00:00:00,Amyloid beta-Protein Precursor,D12.776.811.050
21422528,2011-01-01T00:00:00,Animals,B01.050
21422528,2011-01-01T00:00:00,Bone and Bones,A02.835.232
21422528,2011-01-01T00:00:00,Bone and Bones,A10.165.265
21422528,2011-01-01T00:00:00,Brain,A08.186.211
21422528,2011-01-01T00:00:00,Cholecalciferol,D04.808.247.222.159
21422528,2011-01-01T00:00:00,Cholecalciferol,D04.808.247.808.146
21422528,2011-01-01T00:00:00,Cholecalciferol,D04.808.812.768.196
21422528,2011-01-01T00:00:00,Cholecalciferol,D10.570.938.146
21422528,2011-01-01T00:00:00,"Disease Models, Animal",C22.232
21422528,2011-01-01T00:00:00,"Disease Models, Animal",E05.598.500
21422528,2011-01-01T00:00:00,"Disease Models, Animal",E05.599.395.080
21422528,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21422528,2011-01-01T00:00:00,Maze Learning,F02.463.425.507
21422528,2011-01-01T00:00:00,Nerve Growth Factor,D12.644.276.860.437
21422528,2011-01-01T00:00:00,Nerve Growth Factor,D12.776.467.860.437
21422528,2011-01-01T00:00:00,Nerve Growth Factor,D12.776.641.600.437
21422528,2011-01-01T00:00:00,Nerve Growth Factor,D23.529.850.437
21422528,2011-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
21422528,2011-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
21422528,2011-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
21422528,2011-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
21422528,2011-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
21422528,2011-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
21422528,2011-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
21422528,2011-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
21422528,2011-01-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
21422528,2011-01-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
21422528,2011-01-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
21443449,2011-01-01T00:00:00,Adolescent,M01.060.057
21443449,2011-01-01T00:00:00,Evidence-Based Medicine,H02.249.750
21443449,2011-01-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
21443449,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21443449,2011-01-01T00:00:00,Juvenile Delinquency,I01.880.735.479
21443449,2011-01-01T00:00:00,"Models, Psychological",E05.599.695
21443449,2011-01-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
21443449,2011-01-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
21443449,2011-01-01T00:00:00,Patient Compliance,F01.145.488.500
21443449,2011-01-01T00:00:00,Patient Compliance,N05.300.150.600.600
21443449,2011-01-01T00:00:00,Psychotherapy,F04.754
21443449,2011-01-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
21443449,2011-01-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
21443449,2011-01-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
21443449,2011-01-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
21443449,2011-01-01T00:00:00,Treatment Outcome,E01.789.800
21443449,2011-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
21443449,2011-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21443449,2011-01-01T00:00:00,United States,Z01.107.567.875
21456990,2011-01-01T00:00:00,Computer Simulation,L01.224.160
21456990,2011-01-01T00:00:00,Cooperative Behavior,F01.145.813.115
21456990,2011-01-01T00:00:00,"Education, Medical",I02.358.399
21456990,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21456990,2011-01-01T00:00:00,"Models, Theoretical",E05.599
21456990,2011-01-01T00:00:00,Patient Simulation,I02.903.525
21456990,2011-01-01T00:00:00,United States,Z01.107.567.875
21462724,2011-01-01T00:00:00,African Americans,M01.686.508.100.100
21462724,2011-01-01T00:00:00,African Americans,M01.686.754.100
21462724,2011-01-01T00:00:00,Diabetes Mellitus,C18.452.394.750
21462724,2011-01-01T00:00:00,Diabetes Mellitus,C19.246
21462724,2011-01-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
21462724,2011-01-01T00:00:00,Healthcare Disparities,N04.590.374.380
21462724,2011-01-01T00:00:00,Healthcare Disparities,N05.300.493
21462724,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21462724,2011-01-01T00:00:00,Middle Aged,M01.060.116.630
21462724,2011-01-01T00:00:00,Population Surveillance,E05.318.308.250.700
21462724,2011-01-01T00:00:00,Population Surveillance,N05.715.360.300.375.625
21462724,2011-01-01T00:00:00,Population Surveillance,N06.850.520.308.250.700
21462724,2011-01-01T00:00:00,Population Surveillance,N06.850.780.675
21462724,2011-01-01T00:00:00,Self Care,E02.900
21462724,2011-01-01T00:00:00,Self Care,N02.421.784.680
21462724,2011-01-01T00:00:00,Vaccination,E02.095.465.425.400.530.890
21462724,2011-01-01T00:00:00,Vaccination,E05.478.550.600.890
21462724,2011-01-01T00:00:00,Vaccination,N02.421.726.758.310.890
21462724,2011-01-01T00:00:00,Vaccination,N06.850.780.200.425.900
21462724,2011-01-01T00:00:00,Vaccination,N06.850.780.680.310.890
21462733,2011-01-01T00:00:00,Adolescent,M01.060.057
21462733,2011-01-01T00:00:00,"Blood Pressure Monitoring, Ambulatory",E01.370.370.140.100
21462733,2011-01-01T00:00:00,"Blood Pressure Monitoring, Ambulatory",E01.370.520.500.100
21462733,2011-01-01T00:00:00,Health Education,I02.233.332
21462733,2011-01-01T00:00:00,Health Education,N02.421.143.827.407
21462733,2011-01-01T00:00:00,Health Education,N02.421.726.407
21462733,2011-01-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
21462733,2011-01-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
21462733,2011-01-01T00:00:00,Hispanic Americans,M01.686.754.441
21462733,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21462733,2011-01-01T00:00:00,Hypertension,C14.907.489
21462733,2011-01-01T00:00:00,Mass Screening,E01.370.500
21462733,2011-01-01T00:00:00,Mass Screening,E05.318.308.250.580
21462733,2011-01-01T00:00:00,Mass Screening,N02.421.143.827.233.443
21462733,2011-01-01T00:00:00,Mass Screening,N02.421.726.233.443
21462733,2011-01-01T00:00:00,Mass Screening,N05.715.360.300.375.500
21462733,2011-01-01T00:00:00,Mass Screening,N06.850.520.308.250.580
21462733,2011-01-01T00:00:00,Mass Screening,N06.850.780.500
21462733,2011-01-01T00:00:00,Minority Groups,I01.880.371
21462733,2011-01-01T00:00:00,Obesity,C18.654.726.500
21462733,2011-01-01T00:00:00,Obesity,C23.888.144.699.500
21462733,2011-01-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
21462733,2011-01-01T00:00:00,Obesity,G07.100.100.160.120.699.500
21462733,2011-01-01T00:00:00,School Health Services,N02.421.143.827.809
21462733,2011-01-01T00:00:00,School Health Services,N02.421.726.809
21462733,2011-01-01T00:00:00,Students,I02.233.748
21462733,2011-01-01T00:00:00,Students,I02.851
21462733,2011-01-01T00:00:00,Students,M01.848
21462733,2011-01-01T00:00:00,Urban Population,N01.600.900
21465437,2011-01-01T00:00:00,Activities of Daily Living,E02.831.067
21465437,2011-01-01T00:00:00,Activities of Daily Living,I03.050
21465437,2011-01-01T00:00:00,Activities of Daily Living,N02.421.784.110
21465437,2011-01-01T00:00:00,Adult,M01.060.116
21465437,2011-01-01T00:00:00,Aged,M01.060.116.100
21465437,2011-01-01T00:00:00,Aging,G07.700.320.124
21465437,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21465437,2011-01-01T00:00:00,Middle Aged,M01.060.116.630
21465437,2011-01-01T00:00:00,Needs Assessment,I02.594
21465437,2011-01-01T00:00:00,Needs Assessment,N03.349.380.565
21465437,2011-01-01T00:00:00,Needs Assessment,N05.300.537
21465437,2011-01-01T00:00:00,Robotics,H01.671.293.643
21465437,2011-01-01T00:00:00,Robotics,J01.897.104.834
21465437,2011-01-01T00:00:00,Robotics,L01.224.065.630
21465437,2011-01-01T00:00:00,United States,Z01.107.567.875
21493396,2011-01-01T00:00:00,Adult,M01.060.116
21493396,2011-01-01T00:00:00,Aged,M01.060.116.100
21493396,2011-01-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C10.597.267
21493396,2011-01-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C10.900.300.153
21493396,2011-01-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C21.866.260.207
21493396,2011-01-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C21.866.915.300.300
21493396,2011-01-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C23.888.592.264
21493396,2011-01-01T00:00:00,"Diagnosis, Differential",E01.171
21493396,2011-01-01T00:00:00,Electrophoresis,E05.196.401
21493396,2011-01-01T00:00:00,Electrophoresis,E05.301.300
21493396,2011-01-01T00:00:00,Electrophoresis,G02.149.767.570
21493396,2011-01-01T00:00:00,Electrophoresis,G02.842.750.570
21493396,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21493396,2011-01-01T00:00:00,Middle Aged,M01.060.116.630
21493396,2011-01-01T00:00:00,Spinal Puncture,E01.370.376.700
21493396,2011-01-01T00:00:00,Spinal Puncture,E01.450.230.700
21493396,2011-01-01T00:00:00,Spinal Puncture,E01.450.865.632.700
21493396,2011-01-01T00:00:00,Transferrin,D12.776.124.050.800
21493396,2011-01-01T00:00:00,Transferrin,D12.776.124.790.223.839
21493396,2011-01-01T00:00:00,Transferrin,D12.776.157.427.500
21493396,2011-01-01T00:00:00,Transferrin,D12.776.377.715.182.839
21493396,2011-01-01T00:00:00,Transferrin,D12.776.556.579.500
21525570,2011-01-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
21525570,2011-01-01T00:00:00,Alzheimer Disease,C10.574.945.249
21525570,2011-01-01T00:00:00,Alzheimer Disease,F03.087.400.100
21525570,2011-01-01T00:00:00,Drug Discovery,E05.295
21525570,2011-01-01T00:00:00,Drug Discovery,H01.158.703.007.675
21525570,2011-01-01T00:00:00,Drug Discovery,H01.181.466.675
21525570,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21525570,2011-01-01T00:00:00,Neurodegenerative Diseases,C10.574
21553781,2011-01-01T00:00:00,Anticoagulants,D27.505.954.502.119
21553781,2011-01-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
21553781,2011-01-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
21553781,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21553781,2011-01-01T00:00:00,Orthopedic Procedures,E02.718
21553781,2011-01-01T00:00:00,Orthopedic Procedures,E04.555
21553781,2011-01-01T00:00:00,Pyrazoles,D03.383.129.539
21553781,2011-01-01T00:00:00,Pyridines,D03.383.725
21553781,2011-01-01T00:00:00,Pyridones,D03.383.725.791
21553781,2011-01-01T00:00:00,Thiophenes,D02.886.778
21553781,2011-01-01T00:00:00,Thiophenes,D03.383.903
21553781,2011-01-01T00:00:00,Venous Thromboembolism,C14.907.355.590.700
21553781,2011-01-01T00:00:00,Venous Thromboembolism,C14.907.355.830.850.700
21560901,2011-01-01T00:00:00,Adult,M01.060.116
21560901,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21560901,2011-01-01T00:00:00,Leg,A01.378.610.500
21560901,2011-01-01T00:00:00,Skin Temperature,G07.110.753
21560901,2011-01-01T00:00:00,Skin Temperature,G13.750.844
21613740,2011-01-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
21613740,2011-01-01T00:00:00,Alzheimer Disease,C10.574.945.249
21613740,2011-01-01T00:00:00,Alzheimer Disease,F03.087.400.100
21613740,2011-01-01T00:00:00,Amyloid Precursor Protein Secretases,D08.811.277.656.300.032
21613740,2011-01-01T00:00:00,Animals,B01.050
21613740,2011-01-01T00:00:00,Aspartic Acid Endopeptidases,D08.811.277.656.074.500
21613740,2011-01-01T00:00:00,Aspartic Acid Endopeptidases,D08.811.277.656.300.048
21613740,2011-01-01T00:00:00,Brain,A08.186.211
21613740,2011-01-01T00:00:00,Cathepsin B,D08.811.277.656.224.125
21613740,2011-01-01T00:00:00,Cathepsin B,D08.811.277.656.262.500.133
21613740,2011-01-01T00:00:00,Cathepsin B,D08.811.277.656.300.200.133
21613740,2011-01-01T00:00:00,"Disease Models, Animal",C22.232
21613740,2011-01-01T00:00:00,"Disease Models, Animal",E05.598.500
21613740,2011-01-01T00:00:00,"Disease Models, Animal",E05.599.395.080
21623021,2011-01-01T00:00:00,Community-Based Participatory Research,N05.425.104
21623021,2011-01-01T00:00:00,Documentation,L01.453.245
21623021,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21623021,2011-01-01T00:00:00,Interviews as Topic,E05.318.308.420
21623021,2011-01-01T00:00:00,Interviews as Topic,L01.280.520
21623021,2011-01-01T00:00:00,Interviews as Topic,N05.715.360.300.400
21623021,2011-01-01T00:00:00,Interviews as Topic,N06.850.520.308.420
21623021,2011-01-01T00:00:00,"Models, Organizational",E05.599.670
21623021,2011-01-01T00:00:00,"Models, Organizational",N04.452.534
21623021,2011-01-01T00:00:00,"Models, Psychological",E05.599.695
21623021,2011-01-01T00:00:00,Program Development,N04.452.760
21623021,2011-01-01T00:00:00,"Schools, Medical",I02.783.660.552
21623021,2011-01-01T00:00:00,"Schools, Medical",N02.278.020.578
21623021,2011-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
21623021,2011-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
21749014,2011-01-01T00:00:00,Adult,M01.060.116
21749014,2011-01-01T00:00:00,African Americans,M01.686.508.100.100
21749014,2011-01-01T00:00:00,African Americans,M01.686.754.100
21749014,2011-01-01T00:00:00,Aged,M01.060.116.100
21749014,2011-01-01T00:00:00,Diabetes Complications,C19.246.099
21749014,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21749014,2011-01-01T00:00:00,Hypercholesterolemia,C18.452.584.500.500.396
21749014,2011-01-01T00:00:00,Hypertension,C14.907.489
21749014,2011-01-01T00:00:00,Middle Aged,M01.060.116.630
21749014,2011-01-01T00:00:00,Obesity,C18.654.726.500
21749014,2011-01-01T00:00:00,Obesity,C23.888.144.699.500
21749014,2011-01-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
21749014,2011-01-01T00:00:00,Obesity,G07.100.100.160.120.699.500
21749014,2011-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
21749014,2011-01-01T00:00:00,Risk Factors,N05.715.350.200.700
21749014,2011-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
21749014,2011-01-01T00:00:00,Risk Factors,N06.850.490.625.750
21749014,2011-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
21749014,2011-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
21749014,2011-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
21774138,2011-01-01T00:00:00,Adult,M01.060.116
21774138,2011-01-01T00:00:00,African Americans,M01.686.508.100.100
21774138,2011-01-01T00:00:00,African Americans,M01.686.754.100
21774138,2011-01-01T00:00:00,Age Factors,N05.715.350.075
21774138,2011-01-01T00:00:00,Age Factors,N06.850.490.250
21774138,2011-01-01T00:00:00,Aged,M01.060.116.100
21774138,2011-01-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
21774138,2011-01-01T00:00:00,Body Mass Index,E05.041.124.125
21774138,2011-01-01T00:00:00,Body Mass Index,G07.100.100.125
21774138,2011-01-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
21774138,2011-01-01T00:00:00,Chronic Periodontitis,C07.465.714.533.324
21774138,2011-01-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
21774138,2011-01-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
21774138,2011-01-01T00:00:00,Disease Progression,C23.550.291.656
21774138,2011-01-01T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
21774138,2011-01-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
21774138,2011-01-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
21774138,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21774138,2011-01-01T00:00:00,Income,N01.824.417
21774138,2011-01-01T00:00:00,Medicare,N03.219.521.346.506.564.663
21774138,2011-01-01T00:00:00,Medicare,N03.219.521.576.343.840
21774138,2011-01-01T00:00:00,Medicare,N03.706.615.696
21774138,2011-01-01T00:00:00,Middle Aged,M01.060.116.630
21774138,2011-01-01T00:00:00,Periodontal Diseases,C07.465.714
21774138,2011-01-01T00:00:00,Periodontal Pocket,C07.465.714.533.750
21774138,2011-01-01T00:00:00,Sex Factors,N05.715.350.675
21774138,2011-01-01T00:00:00,Sex Factors,N06.850.490.875
21774138,2011-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
21774138,2011-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
21774138,2011-01-01T00:00:00,United States,Z01.107.567.875
21781430,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21781430,2011-01-01T00:00:00,Immunization,E02.095.465.425.400
21781430,2011-01-01T00:00:00,Immunization,E05.478.550
21781430,2011-01-01T00:00:00,Immunization,N02.421.726.758.310
21781430,2011-01-01T00:00:00,Immunization,N06.850.780.200.425
21781430,2011-01-01T00:00:00,Immunization,N06.850.780.680.310
21781430,2011-01-01T00:00:00,Immunization Schedule,E02.095.465.425.400.470
21781430,2011-01-01T00:00:00,Immunization Schedule,E05.478.550.545
21781430,2011-01-01T00:00:00,Infant,M01.060.703
21781430,2011-01-01T00:00:00,Office Visits,N04.452.758.635
21781430,2011-01-01T00:00:00,Pediatrics,H02.403.670
21781430,2011-01-01T00:00:00,Physician's Practice Patterns,N04.590.748
21781430,2011-01-01T00:00:00,Physician's Practice Patterns,N05.300.625
21781430,2011-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
21781430,2011-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
21796550,2011-01-01T00:00:00,Adenocarcinoma,C04.557.470.200.025
21796550,2011-01-01T00:00:00,Apoptosis,G04.299.139.160
21796550,2011-01-01T00:00:00,Cell Survival,G04.299.316
21796550,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21796550,2011-01-01T00:00:00,Hydrogen Peroxide,D01.248.497.158.685.750.424
21796550,2011-01-01T00:00:00,Hydrogen Peroxide,D01.339.431.374.424
21796550,2011-01-01T00:00:00,Hydrogen Peroxide,D01.650.550.750.400
21796550,2011-01-01T00:00:00,Matrix Metalloproteinase 7,D08.811.277.656.300.480.525.700.250
21796550,2011-01-01T00:00:00,Matrix Metalloproteinase 7,D08.811.277.656.675.374.525.700.250
21796550,2011-01-01T00:00:00,Oxidative Stress,G03.495.710
21796550,2011-01-01T00:00:00,Oxidative Stress,G07.700.830.750
21796550,2011-01-01T00:00:00,"RNA, Messenger",D13.444.735.544
21796550,2011-01-01T00:00:00,Stomach Neoplasms,C04.588.274.476.767
21796550,2011-01-01T00:00:00,Stomach Neoplasms,C06.301.371.767
21796550,2011-01-01T00:00:00,Stomach Neoplasms,C06.405.249.767
21796550,2011-01-01T00:00:00,Stomach Neoplasms,C06.405.748.789
21823952,2011-01-01T00:00:00,Adolescent,M01.060.057
21823952,2011-01-01T00:00:00,Child,M01.060.406
21823952,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21823952,2011-01-01T00:00:00,Rape,I01.198.240.748.640
21823952,2011-01-01T00:00:00,Students,I02.233.748
21823952,2011-01-01T00:00:00,Students,I02.851
21823952,2011-01-01T00:00:00,Students,M01.848
21823952,2011-01-01T00:00:00,Truth Disclosure,F01.145.209.259.800
21823952,2011-01-01T00:00:00,United States,Z01.107.567.875
21823952,2011-01-01T00:00:00,Young Adult,M01.060.116.815
21823953,2011-01-01T00:00:00,"Adaptation, Psychological",F01.058
21823953,2011-01-01T00:00:00,Adolescent,M01.060.057
21823953,2011-01-01T00:00:00,Health Status,I01.240.425
21823953,2011-01-01T00:00:00,Health Status,N01.224.425
21823953,2011-01-01T00:00:00,Health Status,N06.850.505.400.425
21823953,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21823953,2011-01-01T00:00:00,Rape,I01.198.240.748.640
21823953,2011-01-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
21823953,2011-01-01T00:00:00,Risk Assessment,N04.452.871.715
21823953,2011-01-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
21823953,2011-01-01T00:00:00,Risk Assessment,N06.850.505.715
21823953,2011-01-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
21823953,2011-01-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
21823953,2011-01-01T00:00:00,"Stress, Psychological",F01.145.126.990
21823953,2011-01-01T00:00:00,"Stress, Psychological",F02.830.900
21823953,2011-01-01T00:00:00,Students,I02.233.748
21823953,2011-01-01T00:00:00,Students,I02.851
21823953,2011-01-01T00:00:00,Students,M01.848
21823953,2011-01-01T00:00:00,Substance-Related Disorders,C21.739
21823953,2011-01-01T00:00:00,Substance-Related Disorders,F03.900
21823953,2011-01-01T00:00:00,United States,Z01.107.567.875
21823953,2011-01-01T00:00:00,Young Adult,M01.060.116.815
21844579,2011-01-01T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
21844579,2011-01-01T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
21844579,2011-01-01T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
21844579,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21844579,2011-01-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.500.620.670.325.350
21844579,2011-01-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.750.600.670.325.350
21844579,2011-01-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.285.350
21844579,2011-01-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.661.475.350
21844579,2011-01-01T00:00:00,Keratinocytes,A11.436.397
21844579,2011-01-01T00:00:00,Liver Transplantation,E04.210.650
21844579,2011-01-01T00:00:00,Liver Transplantation,E04.936.450.490
21844579,2011-01-01T00:00:00,Liver Transplantation,E04.936.580.490
21844579,2011-01-01T00:00:00,Middle Aged,M01.060.116.630
21844579,2011-01-01T00:00:00,Pancytopenia,C15.378.700
21844579,2011-01-01T00:00:00,Skin,A17.815
21854151,2011-01-01T00:00:00,Adult,M01.060.116
21854151,2011-01-01T00:00:00,Education,I02
21854151,2011-01-01T00:00:00,"Education, Medical",I02.358.399
21854151,2011-01-01T00:00:00,Feedback,L01.143.283.425
21854151,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21854151,2011-01-01T00:00:00,Interviews as Topic,E05.318.308.420
21854151,2011-01-01T00:00:00,Interviews as Topic,L01.280.520
21854151,2011-01-01T00:00:00,Interviews as Topic,N05.715.360.300.400
21854151,2011-01-01T00:00:00,Interviews as Topic,N06.850.520.308.420
21854151,2011-01-01T00:00:00,Middle Aged,M01.060.116.630
21854151,2011-01-01T00:00:00,"Models, Theoretical",E05.599
21854151,2011-01-01T00:00:00,Program Evaluation,E05.337.820
21854151,2011-01-01T00:00:00,Program Evaluation,N04.761.685
21854151,2011-01-01T00:00:00,Program Evaluation,N05.715.360.650
21854151,2011-01-01T00:00:00,Self Concept,F01.752.747.792
21870218,2011-01-01T00:00:00,Allosteric Regulation,G02.111.087.040
21870218,2011-01-01T00:00:00,Allosteric Regulation,G02.149.115.040
21870218,2011-01-01T00:00:00,Animals,B01.050
21870218,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21870218,2011-01-01T00:00:00,"Models, Biological",E05.599.395
21870218,2011-01-01T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
21870218,2011-01-01T00:00:00,Signal Transduction,G02.111.087.800
21870218,2011-01-01T00:00:00,Signal Transduction,G02.149.115.800
21870218,2011-01-01T00:00:00,Signal Transduction,G04.299.880
21907907,2011-01-01T00:00:00,Animals,B01.050
21907907,2011-01-01T00:00:00,Drug Discovery,E05.295
21907907,2011-01-01T00:00:00,Drug Discovery,H01.158.703.007.675
21907907,2011-01-01T00:00:00,Drug Discovery,H01.181.466.675
21907907,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21907907,2011-01-01T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
21907907,2011-01-01T00:00:00,Signal Transduction,G02.111.087.800
21907907,2011-01-01T00:00:00,Signal Transduction,G02.149.115.800
21907907,2011-01-01T00:00:00,Signal Transduction,G04.299.880
21907907,2011-01-01T00:00:00,Treatment Outcome,E01.789.800
21907907,2011-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
21907907,2011-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
21910079,2011-01-01T00:00:00,Animals,B01.050
21910079,2011-01-01T00:00:00,Apoptosis,G04.299.139.160
21910079,2011-01-01T00:00:00,Cardiomyopathies,C14.280.238
21910079,2011-01-01T00:00:00,Ceramides,D02.065.313
21910079,2011-01-01T00:00:00,Ceramides,D09.400.410.420.525.200
21910079,2011-01-01T00:00:00,Ceramides,D10.390.470.675.200
21910079,2011-01-01T00:00:00,Ceramides,D10.570.877.360.612.200
21910079,2011-01-01T00:00:00,Dietary Fats,D10.212.302
21910079,2011-01-01T00:00:00,Dietary Fats,J02.500.375
21910079,2011-01-01T00:00:00,Fatty Acids,D10.251
21910079,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21910079,2011-01-01T00:00:00,Inflammation,C23.550.470
21910079,2011-01-01T00:00:00,Insulin Resistance,C18.452.394.968.500
21910079,2011-01-01T00:00:00,Insulin Resistance,G07.690.320.617
21910079,2011-01-01T00:00:00,Metabolic Diseases,C18.452
21910079,2011-01-01T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
21910079,2011-01-01T00:00:00,Metabolic Syndrome X,C18.452.625
21910079,2011-01-01T00:00:00,Obesity,C18.654.726.500
21910079,2011-01-01T00:00:00,Obesity,C23.888.144.699.500
21910079,2011-01-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
21910079,2011-01-01T00:00:00,Obesity,G07.100.100.160.120.699.500
21910079,2011-01-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
21910079,2011-01-01T00:00:00,Sphingolipids,D10.570.877
21910079,2011-01-01T00:00:00,Sphingolipids,D10.808
21910082,2011-01-01T00:00:00,Animals,B01.050
21910082,2011-01-01T00:00:00,Apoptosis,G04.299.139.160
21910082,2011-01-01T00:00:00,Coronary Disease,C14.280.647.250
21910082,2011-01-01T00:00:00,Coronary Disease,C14.907.585.250
21910082,2011-01-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
21910082,2011-01-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
21910082,2011-01-01T00:00:00,Homeostasis,G07.700.360
21910082,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21910082,2011-01-01T00:00:00,Inflammation,C23.550.470
21910082,2011-01-01T00:00:00,Lipoproteins,D10.532
21910082,2011-01-01T00:00:00,Lipoproteins,D12.776.521
21910082,2011-01-01T00:00:00,Lysophospholipids,D10.570.755.375.760.550
21910082,2011-01-01T00:00:00,Sphingolipids,D10.570.877
21910082,2011-01-01T00:00:00,Sphingolipids,D10.808
21910082,2011-01-01T00:00:00,Sphingomyelin Phosphodiesterase,D08.811.277.352.640.750
21910082,2011-01-01T00:00:00,Sphingosine,D02.033.100.700
21910082,2011-01-01T00:00:00,Sphingosine,D02.033.455.843
21910082,2011-01-01T00:00:00,Sphingosine,D02.092.063.700
21940249,2011-01-01T00:00:00,Adult,M01.060.116
21940249,2011-01-01T00:00:00,"History, 19th Century",K01.400.504.937
21940249,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21940249,2011-01-01T00:00:00,Language,F01.145.209.399
21940249,2011-01-01T00:00:00,Language,L01.143.506
21940249,2011-01-01T00:00:00,Social Adjustment,F01.145.813.621
21940249,2011-01-01T00:00:00,Suicide,F01.145.126.980.875
21940249,2011-01-01T00:00:00,Suicide,I01.880.735.856
21954692,2011-01-01T00:00:00,Blood Coagulation,G09.188.124.560.150
21954692,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21954692,2011-01-01T00:00:00,"Surgical Procedures, Operative",E04
21954692,2011-01-01T00:00:00,Surgical Wound Infection,C01.539.947.692
21954692,2011-01-01T00:00:00,Surgical Wound Infection,C23.550.767.925
21962070,2011-01-01T00:00:00,Adult,M01.060.116
21962070,2011-01-01T00:00:00,Ferritins,D12.776.157.427.249
21962070,2011-01-01T00:00:00,Ferritins,D12.776.556.579.249
21962070,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
21962070,2011-01-01T00:00:00,Oxygen,D01.268.185.550
21962070,2011-01-01T00:00:00,Oxygen,D01.362.670
21962070,2011-01-01T00:00:00,Young Adult,M01.060.116.815
22038213,2011-01-01T00:00:00,Animals,B01.050
22038213,2011-01-01T00:00:00,"Antigens, CD",D23.050.301.264.035
22038213,2011-01-01T00:00:00,"Antigens, CD",D23.101.100.110
22038213,2011-01-01T00:00:00,Biological Markers,D23.101
22038213,2011-01-01T00:00:00,Cytokines,D12.644.276.374
22038213,2011-01-01T00:00:00,Cytokines,D12.776.467.374
22038213,2011-01-01T00:00:00,Cytokines,D23.529.374
22038213,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22038213,2011-01-01T00:00:00,"Immunity, Innate",G12.450.575
22038213,2011-01-01T00:00:00,Inflammation,C23.550.470
22038213,2011-01-01T00:00:00,Macrophages,A11.329.372
22038213,2011-01-01T00:00:00,Macrophages,A11.627.482
22038213,2011-01-01T00:00:00,Macrophages,A11.733.397
22038213,2011-01-01T00:00:00,Macrophages,A15.382.680.397
22038213,2011-01-01T00:00:00,Macrophages,A15.382.812.522
22038213,2011-01-01T00:00:00,Monocytes,A11.118.637.555.652
22038213,2011-01-01T00:00:00,Monocytes,A11.148.580
22038213,2011-01-01T00:00:00,Monocytes,A11.627.624
22038213,2011-01-01T00:00:00,Monocytes,A11.733.547
22038213,2011-01-01T00:00:00,Monocytes,A15.145.229.637.555.652
22038213,2011-01-01T00:00:00,Monocytes,A15.378.316.580
22038213,2011-01-01T00:00:00,Monocytes,A15.382.490.555.652
22038213,2011-01-01T00:00:00,Monocytes,A15.382.680.547
22038213,2011-01-01T00:00:00,Monocytes,A15.382.812.547
22057593,2011-01-01T00:00:00,Education,I02
22057593,2011-01-01T00:00:00,"Faculty, Medical",I02.463.373
22057593,2011-01-01T00:00:00,"Faculty, Medical",M01.526.339.373
22057593,2011-01-01T00:00:00,"Faculty, Medical",M01.526.485.375
22057593,2011-01-01T00:00:00,"Faculty, Medical",N02.360.375
22057593,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22057593,2011-01-01T00:00:00,Interprofessional Relations,F01.829.401.205
22057593,2011-01-01T00:00:00,Psychometrics,F04.711.780
22057593,2011-01-01T00:00:00,Questionnaires,E05.318.308.750
22057593,2011-01-01T00:00:00,Questionnaires,L01.280.800
22057593,2011-01-01T00:00:00,Questionnaires,N05.715.360.300.695
22057593,2011-01-01T00:00:00,Questionnaires,N06.850.520.308.750
22085328,2011-01-01T00:00:00,Adolescent,M01.060.057
22085328,2011-01-01T00:00:00,African Americans,M01.686.508.100.100
22085328,2011-01-01T00:00:00,African Americans,M01.686.754.100
22085328,2011-01-01T00:00:00,Child,M01.060.406
22085328,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22085328,2011-01-01T00:00:00,Pilot Projects,E05.318.760.750
22085328,2011-01-01T00:00:00,Pilot Projects,E05.337.737
22085328,2011-01-01T00:00:00,Pilot Projects,N05.715.360.775.625
22085328,2011-01-01T00:00:00,Pilot Projects,N06.850.520.450.720
22085328,2011-01-01T00:00:00,Questionnaires,E05.318.308.750
22085328,2011-01-01T00:00:00,Questionnaires,L01.280.800
22085328,2011-01-01T00:00:00,Questionnaires,N05.715.360.300.695
22085328,2011-01-01T00:00:00,Questionnaires,N06.850.520.308.750
22085328,2011-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
22085328,2011-01-01T00:00:00,Risk Factors,N05.715.350.200.700
22085328,2011-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22085328,2011-01-01T00:00:00,Risk Factors,N06.850.490.625.750
22085328,2011-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22085328,2011-01-01T00:00:00,Rural Population,N01.600.725
22085328,2011-01-01T00:00:00,Self Administration,E02.319.890
22085328,2011-01-01T00:00:00,Self Administration,E02.900.890
22085328,2011-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
22085328,2011-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
22085328,2011-01-01T00:00:00,United States,Z01.107.567.875
22087519,2011-01-01T00:00:00,Adolescent,M01.060.057
22087519,2011-01-01T00:00:00,Child,M01.060.406
22087519,2011-01-01T00:00:00,"Child, Preschool",M01.060.406.448
22087519,2011-01-01T00:00:00,Cost of Illness,I01.137
22087519,2011-01-01T00:00:00,Cost of Illness,N03.219.151.165
22087519,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22087519,2011-01-01T00:00:00,Questionnaires,E05.318.308.750
22087519,2011-01-01T00:00:00,Questionnaires,L01.280.800
22087519,2011-01-01T00:00:00,Questionnaires,N05.715.360.300.695
22087519,2011-01-01T00:00:00,Questionnaires,N06.850.520.308.750
22165568,2011-01-01T00:00:00,Adult,M01.060.116
22165568,2011-01-01T00:00:00,African Americans,M01.686.508.100.100
22165568,2011-01-01T00:00:00,African Americans,M01.686.754.100
22165568,2011-01-01T00:00:00,Attitude to Health,F01.100.150
22165568,2011-01-01T00:00:00,Attitude to Health,N05.300.150
22165568,2011-01-01T00:00:00,Genomics,H01.158.273.180.350
22165568,2011-01-01T00:00:00,Genomics,H01.158.273.343.350
22165568,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22165568,2011-01-01T00:00:00,Patient Selection,E05.581.500.653
22165568,2011-01-01T00:00:00,Patient Selection,N04.590.731
22165568,2011-01-01T00:00:00,United States,Z01.107.567.875
22234665,2011-01-01T00:00:00,Aged,M01.060.116.100
22234665,2011-01-01T00:00:00,Disability Evaluation,E01.370.400
22234665,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22234665,2011-01-01T00:00:00,Middle Aged,M01.060.116.630
22234665,2011-01-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
22234665,2011-01-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
22234665,2011-01-01T00:00:00,Recovery of Function,G16.757
22234665,2011-01-01T00:00:00,Stroke,C10.228.140.300.775
22234665,2011-01-01T00:00:00,Stroke,C14.907.253.855
22234665,2011-01-01T00:00:00,Upper Extremity,A01.378.800
22238841,2011-01-01T00:00:00,Anxiety Disorders,F03.080
22238841,2011-01-01T00:00:00,Catecholamines,D02.092.211.215.311
22238841,2011-01-01T00:00:00,Catecholamines,D02.092.311
22238841,2011-01-01T00:00:00,Coronary Disease,C14.280.647.250
22238841,2011-01-01T00:00:00,Coronary Disease,C14.907.585.250
22238841,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22238841,2011-01-01T00:00:00,Hypertension,C14.907.489
22238841,2011-01-01T00:00:00,Hypothalamo-Hypophyseal System,A06.688.357
22238841,2011-01-01T00:00:00,Hypothalamo-Hypophyseal System,A08.186.211.730.317.357.352.435
22238841,2011-01-01T00:00:00,Hypothalamo-Hypophyseal System,A08.713.357
22238841,2011-01-01T00:00:00,Obsessive-Compulsive Disorder,F03.080.600
22238841,2011-01-01T00:00:00,Panic Disorder,F03.080.700
22238841,2011-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
22238841,2011-01-01T00:00:00,Risk Factors,N05.715.350.200.700
22238841,2011-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22238841,2011-01-01T00:00:00,Risk Factors,N06.850.490.625.750
22238841,2011-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22238841,2011-01-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
22255624,2011-01-01T00:00:00,Algorithms,G17.035
22255624,2011-01-01T00:00:00,Algorithms,L01.224.050
22255624,2011-01-01T00:00:00,Artificial Intelligence,L01.224.065
22255624,2011-01-01T00:00:00,Brain,A08.186.211
22255624,2011-01-01T00:00:00,Electroencephalography,E01.370.376.300
22255624,2011-01-01T00:00:00,Electroencephalography,E01.370.405.245
22255624,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22255624,2011-01-01T00:00:00,"Pattern Recognition, Automated",L01.725
22255624,2011-01-01T00:00:00,User-Computer Interface,L01.224.900.910
22322640,2011-01-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
22322640,2011-01-01T00:00:00,Clinical Trials as Topic,E05.337.250
22322640,2011-01-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
22322640,2011-01-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
22322640,2011-01-01T00:00:00,Copper,D01.268.556.195
22322640,2011-01-01T00:00:00,Copper,D01.268.956.170
22322640,2011-01-01T00:00:00,Copper,D01.552.544.195
22322640,2011-01-01T00:00:00,Cross Infection,C01.539.248
22322640,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22322640,2011-01-01T00:00:00,Hygiene,E02.547
22322640,2011-01-01T00:00:00,Hygiene,N06.850.670
22322640,2011-01-01T00:00:00,Research Design,E05.581.500
22322640,2011-01-01T00:00:00,Research Design,H01.770.644.728
22372025,2011-01-01T00:00:00,African Americans,M01.686.508.100.100
22372025,2011-01-01T00:00:00,African Americans,M01.686.754.100
22372025,2011-01-01T00:00:00,African Continental Ancestry Group,M01.686.508.100
22372025,2011-01-01T00:00:00,Chronic Disease,C23.550.291.500
22372025,2011-01-01T00:00:00,Combined Modality Therapy,E02.186
22372025,2011-01-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
22372025,2011-01-01T00:00:00,Electroconvulsive Therapy,F04.570.200.583
22372025,2011-01-01T00:00:00,Electroconvulsive Therapy,F04.669.224.300
22372025,2011-01-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
22372025,2011-01-01T00:00:00,Healthcare Disparities,N04.590.374.380
22372025,2011-01-01T00:00:00,Healthcare Disparities,N05.300.493
22372025,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22372025,2011-01-01T00:00:00,Mass Screening,E01.370.500
22372025,2011-01-01T00:00:00,Mass Screening,E05.318.308.250.580
22372025,2011-01-01T00:00:00,Mass Screening,N02.421.143.827.233.443
22372025,2011-01-01T00:00:00,Mass Screening,N02.421.726.233.443
22372025,2011-01-01T00:00:00,Mass Screening,N05.715.360.300.375.500
22372025,2011-01-01T00:00:00,Mass Screening,N06.850.520.308.250.580
22372025,2011-01-01T00:00:00,Mass Screening,N06.850.780.500
22372025,2011-01-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
22372025,2011-01-01T00:00:00,Primary Health Care,N04.590.233.727
22372025,2011-01-01T00:00:00,Psychotherapy,F04.754
22372025,2011-01-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.600.850
22372025,2011-01-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.850.900
22372025,2011-01-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.600.850
22372025,2011-01-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.850.900
22372025,2011-01-01T00:00:00,Treatment Outcome,E01.789.800
22372025,2011-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22372025,2011-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22372025,2011-01-01T00:00:00,United States,Z01.107.567.875
22409091,2011-01-01T00:00:00,Adult,M01.060.116
22409091,2011-01-01T00:00:00,Child,M01.060.406
22409091,2011-01-01T00:00:00,Chronic Disease,C23.550.291.500
22409091,2011-01-01T00:00:00,Cognitive Therapy,F04.754.137.428
22409091,2011-01-01T00:00:00,Cooperative Behavior,F01.145.813.115
22409091,2011-01-01T00:00:00,Decision Making,F02.463.785.373
22409091,2011-01-01T00:00:00,Executive Function,F02.463.217
22409091,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22409091,2011-01-01T00:00:00,Interdisciplinary Communication,F01.145.209.381
22409091,2011-01-01T00:00:00,Interdisciplinary Communication,F01.829.401.205.249
22409091,2011-01-01T00:00:00,Interdisciplinary Communication,L01.143.474
22409091,2011-01-01T00:00:00,Mass Screening,E01.370.500
22409091,2011-01-01T00:00:00,Mass Screening,E05.318.308.250.580
22409091,2011-01-01T00:00:00,Mass Screening,N02.421.143.827.233.443
22409091,2011-01-01T00:00:00,Mass Screening,N02.421.726.233.443
22409091,2011-01-01T00:00:00,Mass Screening,N05.715.360.300.375.500
22409091,2011-01-01T00:00:00,Mass Screening,N06.850.520.308.250.580
22409091,2011-01-01T00:00:00,Mass Screening,N06.850.780.500
22409091,2011-01-01T00:00:00,Patient Care Team,N04.590.715
22409091,2011-01-01T00:00:00,Patient Compliance,F01.145.488.500
22409091,2011-01-01T00:00:00,Patient Compliance,N05.300.150.600.600
22428349,2011-01-01T00:00:00,Adult,M01.060.116
22428349,2011-01-01T00:00:00,African Americans,M01.686.508.100.100
22428349,2011-01-01T00:00:00,African Americans,M01.686.754.100
22428349,2011-01-01T00:00:00,Aged,M01.060.116.100
22428349,2011-01-01T00:00:00,Chronic Disease,C23.550.291.500
22428349,2011-01-01T00:00:00,Cryotherapy,E02.258
22428349,2011-01-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
22428349,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22428349,2011-01-01T00:00:00,Middle Aged,M01.060.116.630
22428349,2011-01-01T00:00:00,Pain,C10.597.617
22428349,2011-01-01T00:00:00,Pain,C23.888.592.612
22428349,2011-01-01T00:00:00,Pain,C23.888.646
22428349,2011-01-01T00:00:00,Pain,F02.830.816.444
22428349,2011-01-01T00:00:00,Pain,G11.561.600.810.444
22428349,2011-01-01T00:00:00,Pain Measurement,E01.370.376.550.600
22428349,2011-01-01T00:00:00,Questionnaires,E05.318.308.750
22428349,2011-01-01T00:00:00,Questionnaires,L01.280.800
22428349,2011-01-01T00:00:00,Questionnaires,N05.715.360.300.695
22428349,2011-01-01T00:00:00,Questionnaires,N06.850.520.308.750
22439295,2011-01-01T00:00:00,Alcohol Deterrents,D27.505.954.427.020
22439295,2011-01-01T00:00:00,Alcoholism,C21.739.100.250
22439295,2011-01-01T00:00:00,Alcoholism,F03.900.100.350
22439295,2011-01-01T00:00:00,Disulfiram,D02.241.081.251.869.220.250
22439295,2011-01-01T00:00:00,Disulfiram,D02.886.520.150.175
22439295,2011-01-01T00:00:00,Disulfiram,D02.886.706.200.200
22439295,2011-01-01T00:00:00,Fructose,D09.546.359.250
22439295,2011-01-01T00:00:00,Fructose,D09.546.465.354
22439295,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22439295,2011-01-01T00:00:00,Naltrexone,D03.132.577.249.706.550
22439295,2011-01-01T00:00:00,Naltrexone,D03.549.686.750.550
22439295,2011-01-01T00:00:00,Naltrexone,D03.605.497.750.550
22439295,2011-01-01T00:00:00,Naltrexone,D04.615.723.795.706.550
22439295,2011-01-01T00:00:00,Narcotic Antagonists,D27.505.696.543
22439295,2011-01-01T00:00:00,Narcotic Antagonists,D27.505.696.663.850.512
22439295,2011-01-01T00:00:00,Narcotic Antagonists,D27.505.954.427.550
22439295,2011-01-01T00:00:00,Taurine,D02.455.326.146.100.850
22439295,2011-01-01T00:00:00,Taurine,D02.886.645.600.055.850
22439295,2011-01-01T00:00:00,Treatment Outcome,E01.789.800
22439295,2011-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
22439295,2011-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22616358,2011-01-01T00:00:00,Adolescent,M01.060.057
22616358,2011-01-01T00:00:00,Adult,M01.060.116
22616358,2011-01-01T00:00:00,Alcohol Drinking,F01.145.317.269
22616358,2011-01-01T00:00:00,Chronic Disease,C23.550.291.500
22616358,2011-01-01T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
22616358,2011-01-01T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
22616358,2011-01-01T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
22616358,2011-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22616358,2011-01-01T00:00:00,Risk-Taking,F01.145.722
22616358,2011-01-01T00:00:00,Young Adult,M01.060.116.815
